Details of Disease

General Information of Disease (ID: DISAT1Z9)

• Disease Name: Advanced cancer
• Synonyms: MT; malignant tumor; organ system cancer; malignant neoplasm (disease); CA; cancer; malignant Growth; malignant neoplastic disease; neoplasm (disease), malignant; malignant neoplasm; malignant tumour; neoplasm, malignant; malignancy; cell type cancer; primary cancer
• Disease Class: 2A00-2F9Z: Solid tumour/cancer
• Definition: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.
• Disease Hierarchy:
  DISTBY9Z: Tumour
  DISAT1Z9: Advanced cancer
• ICD Code:
  ICD-11: ICD-11: 2A00-2F9Z
  ICD-10: ICD-10: C00-C96
  ICD-9: ICD-9: 140-229
  Expand ICD-9: 140,141,142,143,144,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000
• Disease Identifiers:
  MONDO ID: MONDO_0004992
  MESH ID: D009369
  UMLS CUI: C0006826
  MedGen ID: 14297
  SNOMED CT ID: 1240414004

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 20 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Cortisone Acetate	DMG8K57	Approved	Small molecular drug	[1]
Cyclophosphamide	DM4O2Z7	Approved	Small molecular drug	[2]
Dactinomycin	DM2YGNW	Approved	Small molecular drug	[3]
Docetaxel	DMDI269	Approved	Small molecular drug	[4]
Donepezil	DMIYG7Z	Approved	Small molecular drug	[5]
Everolimus	DM8X2EH	Approved	Small molecular drug	[6]
Ifosfamide	DMCT3I8	Approved	Small molecular drug	[7]
Irinotecan	DMP6SC2	Approved	Small molecular drug	[8]
Lenalidomide	DM6Q7U4	Approved	Small molecular drug	[9]
Methadone	DMTW6IU	Approved	Small molecular drug	[10]
Methyltestosterone	DMWLFGO	Approved	Small molecular drug	[11]
Morphine	DMRMS0L	Approved	Small molecular drug	[12]
Nadrolone phenylpropionate	DMZVLY8	Approved	Small molecular drug	[13]
Norethindrone	DMTY169	Approved	Small molecular drug	[14]
Pegaspargase	DM2S26S	Approved	NA	[15]
Sirolimus	DMGW1ID	Approved	Small molecular drug	[16]
Thalidomide	DM70BU5	Approved	Small molecular drug	[17]
Tolbutamide	DM02AWV	Approved	Small molecular drug	[18]
Vinblastine	DM5TVS3	Approved	Small molecular drug	[19]
Vinorelbine	DMVXFYE	Approved	Small molecular drug	[20]

This Disease is Treated as An Indication in 11 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
BMS-986205	DM3MAYQ	Phase 3	NA	[21]
GI-6301	DMOMS7R	Phase 2	Vaccine	[22]
Metoprine	DM5GQD7	Phase 2	Small molecular drug	[23]
Sodium stibogluconate	DMH5MVE	Phase 2	NA	[24]
V81444	DMPWHU6	Phase 1/2	NA	[21]
AutoSynVax	DM326VO	Phase 1	NA	[21]
CPI-006	DMJSFTX	Phase 1	Antibody	[21]
FAZ053	DM71HLX	Phase 1	Monoclonal antibody	[25]
FS118	DM0QH9K	Phase 1	Antibody	[25]
LY3164530	DM9RTXM	Phase 1	Monoclonal antibody	[26]
REGN3767	DM8XMBQ	Phase 1	NA	[21]

Molecular Interaction Atlas (MIA) of This Disease

This Disease Is Related to 1647 DTT Molecule(s)

Gene Name	DTT ID	Evidence Level	Mode of Inheritance	REF
ABCA1	TTJW1GN	Limited	Biomarker	[27]
ABCB4	TTJUXV6	Limited	Biomarker	[28]
ACVRL1	TTGYPTC	Limited	Biomarker	[29]
ADAM8	TTQWYMD	Limited	Biomarker	[30]
ADK	TTL732K	Limited	Biomarker	[31]
ADORA2B	TTNE7KG	Limited	Biomarker	[32]
AMOT	TTI48OS	Limited	Biomarker	[33]
ANG	TTURHFP	Limited	Biomarker	[34]
APLN	TT87D3J	Limited	Biomarker	[35]
APOA4	TTNC3WS	Limited	Genetic Variation	[36]
APOB	TTN1IE2	Limited	Genetic Variation	[37]
ARAF	TT5TURO	Limited	Altered Expression	[38]
ASIC3	TTLGDIS	Limited	Biomarker	[39]
ATG2B	TTG6KCU	Limited	Genetic Variation	[40]
ATP7B	TTOPO51	Limited	Altered Expression	[41]
AZGP1	TTUPYLV	Limited	Biomarker	[42]
BCHE	TT3MSAO	Limited	Altered Expression	[43]
BRD1	TTT09OB	Limited	Biomarker	[44]
BRD7	TT07ZS1	Limited	Biomarker	[45]
BTLA	TTER58P	Limited	Biomarker	[46]
CA2	TTANPDJ	Limited	Biomarker	[47]
CACNA1D	TT7RGTM	Limited	Altered Expression	[48]
CACNA1F	TTJ0SO4	Limited	Altered Expression	[48]
CACNA1I	TTQZFTH	Limited	Biomarker	[48]
CASP1	TTCQIBE	Limited	Biomarker	[49]
CASP10	TTX5HEK	Limited	Biomarker	[50]
CBL	TT7QT13	Limited	Genetic Variation	[51]
CCR4	TT7HQD0	Limited	Biomarker	[52]
CD163	TTTZ9DE	Limited	Biomarker	[53]
CD33	TTJVYO3	Limited	Biomarker	[54]
CD59	TTBGTEJ	Limited	Altered Expression	[55]
CDH11	TTRGWZC	Limited	Biomarker	[56]
CDH2	TT1WS0T	Limited	Biomarker	[57]
CDH3	TTARMD9	Limited	Biomarker	[58]
CDK19	TTNABU9	Limited	Genetic Variation	[59]
CDK5R1	TTBYM6V	Limited	Altered Expression	[60]
CDKL1	TTBTI6P	Limited	Altered Expression	[61]
CHIT1	TTDYX6T	Limited	Altered Expression	[62]
CHRM3	TTQ13Z5	Limited	Genetic Variation	[63]
CNTN2	TT2Z1WB	Limited	Altered Expression	[64]
COL1A2	TTUABC1	Limited	Biomarker	[65]
CPM	TTVOH2M	Limited	Biomarker	[66]
CPS1	TT42M75	Limited	Biomarker	[67]
CR1	TTEA8OW	Limited	Altered Expression	[68]
CRTC1	TT4GO0F	Limited	Biomarker	[69]
CRYAB	TT7RUHB	Limited	Biomarker	[70]
CSK	TTX6F0Q	Limited	Biomarker	[71]
CSNK1D	TTH30UI	Limited	Altered Expression	[72]
CTSC	TT4H0V2	Limited	Biomarker	[73]
CTSK	TTDZN01	Limited	Altered Expression	[74]
CX3CL1	TT1OFBQ	Limited	Biomarker	[75]
CXCL13	TT0NIZ1	Limited	Biomarker	[76]
CXCL2	TTZF0K2	Limited	Biomarker	[77]
CXCL9	TTWE5PB	Limited	Biomarker	[78]
CXCR1	TTMWT8Z	Limited	Biomarker	[79]
CXCR5	TTIW59R	Limited	Altered Expression	[80]
CYBB	TT5T8MR	Limited	Biomarker	[81]
CYP2J2	TTNE1C7	Limited	Biomarker	[82]
DCPS	TTLSW9V	Limited	Biomarker	[83]
DDIT4	TTVEOY6	Limited	Altered Expression	[84]
DFFB	TT2SRE0	Limited	Biomarker	[85]
DKK2	TTST5KX	Limited	Biomarker	[86]
DLK1	TTF4AVB	Limited	Biomarker	[87]
DLL1	TT9CFQD	Limited	Biomarker	[88]
DMD	TTWLFXU	Limited	Genetic Variation	[89]
DNAJB1	TTPXAWS	Limited	Altered Expression	[90]
DPYSL2	TTZCW3T	Limited	Biomarker	[91]
DRD2	TTEX248	Limited	Biomarker	[92]
DUSP10	TTF3RJ0	Limited	Biomarker	[93]
DUSP5	TTZN92A	Limited	Altered Expression	[94]
DYRK2	TT84OS6	Limited	Biomarker	[95]
E2F2	TT5FYX0	Limited	Biomarker	[96]
E2F3	TTWIJYH	Limited	Biomarker	[97]
EGFL6	TTXJGAR	Limited	Altered Expression	[98]
EGLN1	TT9ISBX	Limited	Biomarker	[99]
EGLN2	TTMHFRY	Limited	Genetic Variation	[100]
EIF4E2	TT2ZSKV	Limited	Biomarker	[101]
EIF5A2	TTH53G9	Limited	Altered Expression	[102]
ELANE	TTPLTSQ	Limited	Altered Expression	[103]
ENOX2	TTUJZRL	Limited	Biomarker	[104]
ENPP1	TTZTIWS	Limited	Biomarker	[105]
EPHA4	TTG84D3	Limited	Biomarker	[106]
ERAP2	TTVGS1C	Limited	Biomarker	[107]
EYA2	TTUY9C6	Limited	Altered Expression	[108]
F13A1	TTXI2RA	Limited	Biomarker	[109]
FABP4	TTHWMFZ	Limited	Biomarker	[110]
FAM83B	TT1Q347	Limited	Biomarker	[111]
FBXO3	TTUX14L	Limited	Biomarker	[112]
FCGR1A	TTZK4I3	Limited	Biomarker	[113]
FCGR2A	TTXT21W	Limited	Biomarker	[114]
FDPS	TTIKWV4	Limited	Biomarker	[115]
FES	TTLBY21	Limited	Biomarker	[116]
FFAR4	TT08JVB	Limited	Biomarker	[117]
FGF23	TT2IZ4K	Limited	Altered Expression	[118]
FHL1	TTI7ENL	Limited	Altered Expression	[119]
FKBP5	TT0J5KQ	Limited	Biomarker	[120]
FMNL1	TTW20PQ	Limited	Biomarker	[121]
FNDC1	TTQJCV8	Limited	Altered Expression	[122]
FOSL2	TT689IR	Limited	Biomarker	[123]
FOXJ2	TTV1FDA	Limited	Biomarker	[124]
FOXP1	TT0MUCI	Limited	Biomarker	[125]
FOXQ1	TTEJZOL	Limited	Biomarker	[126]
FPR3	TT16TM5	Limited	Biomarker	[127]
FST	TTDNM9W	Limited	Biomarker	[128]
FTH1	TT975ZT	Limited	Altered Expression	[129]
G3BP1	TTG0R8Z	Limited	Biomarker	[130]
G6PC	TTBQMJ8	Limited	Biomarker	[131]
GAN	TT6WNG2	Limited	Genetic Variation	[132]
GATA3	TT45KOB	Limited	Altered Expression	[133]
GATA4	TT1VDN2	Limited	Posttranslational Modification	[134]
GBA	TT1B5PU	Limited	Genetic Variation	[135]
GCK	TTDLNGZ	Limited	Biomarker	[136]
GJB2	TTRGZX3	Limited	Biomarker	[137]
GPR17	TTMPART	Limited	Biomarker	[138]
GPR183	TTME5YJ	Limited	Biomarker	[139]
GPR3	TTHZVSK	Limited	Biomarker	[140]
GREM1	TTOUZN5	Limited	Genetic Variation	[141]
GRHL2	TTUGH4C	Limited	Biomarker	[142]
GRIK3	TTNP6O2	Limited	Biomarker	[143]
GRIN2A	TTKJEMQ	Limited	Posttranslational Modification	[144]
GRK5	TTTCXO0	Limited	Biomarker	[145]
GRM1	TTVBPDM	Limited	Biomarker	[146]
GUSB	TTHS7CM	Limited	Altered Expression	[147]
HCAR2	TTWNV8U	Limited	Biomarker	[148]
HDAC4	TTTQGH8	Limited	Biomarker	[149]
HGFAC	TTD96RW	Limited	Altered Expression	[150]
HMGCR	TTPADOQ	Limited	Genetic Variation	[151]
HOXA7	TTMRE4Q	Limited	Altered Expression	[152]
HPD	TT8DSFC	Limited	Altered Expression	[153]
HSD17B2	TT0PT1R	Limited	Altered Expression	[154]
HSP90AB1	TTH5YN2	Limited	Altered Expression	[155]
IFNAR2	TTMQB37	Limited	Biomarker	[156]
IL11	TTGUYTR	Limited	Biomarker	[157]
IL21R	TTZO9B0	Limited	Biomarker	[158]
IL3RA	TTENHJ0	Limited	Biomarker	[159]
IRAK1	TTXAJWN	Limited	Biomarker	[160]
IRAK4	TTILUKB	Limited	Biomarker	[161]
IRF1	TT4TU3L	Limited	Biomarker	[162]
IRF8	TTHUBNK	Limited	Altered Expression	[163]
IRS2	TTF95B8	Limited	Biomarker	[164]
ITGA1	TTPERWV	Limited	Biomarker	[165]
ITGA11	TTANXZ7	Limited	Biomarker	[166]
ITGA2	TTSJ542	Limited	Altered Expression	[167]
ITGA6	TT165T3	Limited	Biomarker	[168]
ITGAE	TTH0Z37	Limited	Biomarker	[169]
ITK	TT3C80U	Limited	Biomarker	[170]
JAG2	TTOJY1B	Limited	Altered Expression	[171]
KCNJ1	TTJ13ST	Limited	Altered Expression	[172]
KCNK3	TTGR91N	Limited	Biomarker	[173]
KCNN4	TT7M9I6	Limited	Altered Expression	[174]
KDM1B	TT8VP2T	Limited	Biomarker	[175]
KDM2A	TT8XTY2	Limited	Biomarker	[176]
KDM5A	TTIG67W	Limited	Altered Expression	[177]
KDM7A	TT0NYMP	Limited	Biomarker	[178]
KIF20B	TTQECT2	Limited	Biomarker	[179]
KIF26B	TTQWICZ	Limited	Genetic Variation	[180]
KLRC1	TTC4IMS	Limited	Biomarker	[181]
KLRG1	TT299E6	Limited	Biomarker	[182]
LAMC2	TTNS7H3	Limited	Biomarker	[183]
LATS2	TTML7FG	Limited	Altered Expression	[184]
LGMN	TTPTWV5	Limited	Biomarker	[185]
LILRB1	TTC0QRJ	Limited	Biomarker	[186]
LIMK2	TTASMD8	Limited	Biomarker	[187]
LNPEP	TTY2KP7	Limited	Biomarker	[188]
LPL	TTOF3WZ	Limited	Altered Expression	[189]
LTB	TTHQ6US	Limited	Altered Expression	[190]
LTBR	TTFO0PM	Limited	Biomarker	[191]
LY75	TTG180Q	Limited	Altered Expression	[192]
M6PR	TT95ICL	Limited	Biomarker	[193]
MAGEA4	TT9EQUY	Limited	Altered Expression	[194]
MAP3K1	TTW8TJI	Limited	Biomarker	[195]
MAP3K14	TT4LIAC	Limited	Biomarker	[191]
MAPK9	TT3IVG2	Limited	Biomarker	[196]
MAS1	TTOISYB	Limited	Biomarker	[197]
MAZ	TT059DA	Limited	Altered Expression	[198]
METAP2	TTZL0OI	Limited	Biomarker	[199]
MFGE8	TT1GLAJ	Limited	Altered Expression	[200]
MGAM	TTXWASR	Limited	Biomarker	[201]
MSI2	TTTXQF6	Limited	Biomarker	[202]
MUC17	TTVO0JU	Limited	Biomarker	[203]
MVD	TTE5J6X	Limited	Biomarker	[204]
MYH2	TTBIL13	Limited	Altered Expression	[205]
NEDD4	TT1QU6G	Limited	Biomarker	[206]
NELL1	TT7H4BF	Limited	Biomarker	[207]
NISCH	TT789FN	Limited	Biomarker	[208]
NLRC5	TTWZC78	Limited	Biomarker	[209]
NLRX1	TTKT026	Limited	Biomarker	[210]
NOD1	TTYSRXM	Limited	Genetic Variation	[211]
NPR2	TTNB7IF	Limited	Genetic Variation	[135]
NQO2	TTJLP0R	Limited	Biomarker	[212]
NR3C2	TT26PHO	Limited	Biomarker	[213]
NR4A3	TTJQB49	Limited	Biomarker	[214]
NTF4	TTIM2WO	Limited	Biomarker	[215]
NTSR2	TT31Q0V	Limited	Biomarker	[216]
NUAK1	TT65FL0	Limited	Biomarker	[217]
OGFR	TT6IEYX	Limited	Biomarker	[218]
OPA1	TTTU49Q	Limited	Biomarker	[219]
OPRM1	TTKWM86	Limited	Genetic Variation	[220]
OSM	TTIVXSE	Limited	Biomarker	[221]
P2RX1	TTJW7B3	Limited	Altered Expression	[222]
P2RX3	TT2THBD	Limited	Altered Expression	[222]
P2RX4	TT1NLOA	Limited	Biomarker	[223]
P2RY13	TT1FE3L	Limited	Biomarker	[224]
P2RY2	TTOZHQC	Limited	Biomarker	[225]
P4HA1	TTNH25W	Limited	Genetic Variation	[226]
PAH	TTGSVH2	Limited	Altered Expression	[227]
PAK2	TT279WO	Limited	Altered Expression	[228]
PAM	TTF4ZPC	Limited	Biomarker	[229]
PARG	TT39J16	Limited	Biomarker	[230]
PARP3	TTD8MEH	Limited	Biomarker	[231]
PCSK5	TTPFWHU	Limited	Biomarker	[232]
PDE10A	TTJW4LU	Limited	Biomarker	[233]
PFKFB2	TTQYVKD	Limited	Posttranslational Modification	[234]
PGRMC1	TTY3LAZ	Limited	Biomarker	[235]
PIKFYVE	TTA4M1N	Limited	Biomarker	[236]
PIM3	TTCGOIN	Limited	Altered Expression	[237]
PLA2G2A	TTO8QRU	Limited	Biomarker	[238]
PLA2G4A	TTT1JVS	Limited	Biomarker	[239]
PLD2	TTRLMKF	Limited	Biomarker	[240]
PLK2	TT976FS	Limited	Altered Expression	[241]
PLOD2	TT8MEUD	Limited	Biomarker	[242]
POLA1	TTGPJ0U	Limited	Biomarker	[243]
PPT1	TTSQC14	Limited	Altered Expression	[244]
PRKACA	TT5U49F	Limited	Altered Expression	[90]
PRKCZ	TTBSN0L	Limited	Biomarker	[245]
PRKG1	TT7IZSA	Limited	Biomarker	[233]
PRLR	TTBPXMA	Limited	Altered Expression	[246]
PSEN1	TTZ3S8C	Limited	Genetic Variation	[247]
PSEN2	TTWN3F4	Limited	Genetic Variation	[248]
PTGER3	TTPNGDE	Limited	Altered Expression	[249]
PTPRZ1	TT4SEA8	Limited	Altered Expression	[250]
QPCT	TTJ7YTV	Limited	Genetic Variation	[251]
RAB22A	TTAJ746	Limited	Altered Expression	[252]
RBCK1	TTIKUVC	Limited	Altered Expression	[253]
RCE1	TT2AP5B	Limited	Biomarker	[254]
RGS6	TTJ96M8	Limited	Biomarker	[255]
RHO	TTH0KSX	Limited	Biomarker	[256]
RHOB	TT6LPFO	Limited	Altered Expression	[257]
RICTOR	TT143WL	Limited	Biomarker	[258]
RIPK4	TTB4S01	Limited	Altered Expression	[259]
RNPEP	TTD74YX	Limited	Altered Expression	[260]
ROBO1	TTND1YP	Limited	Altered Expression	[261]
ROCK2	TTGWKQJ	Limited	Biomarker	[262]
ROR2	TTUDPCI	Limited	Altered Expression	[263]
RORA	TT1TYN7	Limited	Posttranslational Modification	[264]
RSPO3	TT7HJTF	Limited	Biomarker	[265]
RTN4	TT7GXMU	Limited	Biomarker	[266]
RXRA	TT6PEUO	Limited	Biomarker	[267]
S100B	TTQ0V86	Limited	Biomarker	[268]
S1PR1	TT9JZCK	Limited	Biomarker	[269]
S1PR5	TTDZCKV	Limited	Biomarker	[270]
SENP1	TTW9HY5	Limited	Biomarker	[271]
SERPINH1	TTPSWQG	Limited	Biomarker	[272]
SGCG	TTSMT9W	Limited	Biomarker	[273]
SHH	TTIENCJ	Limited	Biomarker	[274]
SIK2	TTCUGZR	Limited	Biomarker	[275]
SLAMF6	TTSIYJ6	Limited	Biomarker	[276]
SLC15A1	TT5LF3C	Limited	Biomarker	[277]
SLC26A4	TT7X02I	Limited	Biomarker	[278]
SLC29A1	TTLXAKE	Limited	Biomarker	[279]
SLC46A1	TTY8Z2E	Limited	Altered Expression	[280]
SLC47A2	TT7HXSL	Limited	Biomarker	[281]
SLC6A5	TTI0138	Limited	Altered Expression	[282]
SLC6A8	TTYUHB5	Limited	Biomarker	[283]
SLCO2A1	TTKVTQO	Limited	Altered Expression	[284]
SMPD1	TTJTM88	Limited	Biomarker	[285]
SOST	TTYRO4F	Limited	Biomarker	[286]
SPAG6	TTDAKTW	Limited	Biomarker	[287]
SPHK2	TTCN0M9	Limited	Biomarker	[288]
SPTBN1	TTS9BDA	Limited	Biomarker	[289]
SREBF2	TTRQ4AP	Limited	Altered Expression	[290]
SRGN	TTCHB06	Limited	Biomarker	[291]
SRPK2	TTCZEJ9	Limited	Biomarker	[292]
SSRP1	TTETDKQ	Limited	Biomarker	[293]
ST8SIA4	TTDP8YM	Limited	Biomarker	[294]
STAB1	TTJFEOC	Limited	Biomarker	[295]
STC1	TTDLUER	Limited	Biomarker	[296]
STEAP1	TT9E64S	Limited	Altered Expression	[297]
STEAP2	TTOXF5J	Limited	Altered Expression	[298]
SUV39H1	TTUWQTK	Limited	Altered Expression	[299]
SVIL	TTBLQS5	Limited	Altered Expression	[300]
TAGLN2	TTP6BIJ	Limited	Altered Expression	[301]
TCIRG1	TTVRN05	Limited	Biomarker	[302]
TF	TT8WXAV	Limited	Biomarker	[303]
TGFB2	TTI0KH6	Limited	Biomarker	[304]
TIGIT	TTWNL74	Limited	Biomarker	[305]
TIRAP	TTKU0LS	Limited	Genetic Variation	[306]
TLR8	TT8CWFK	Limited	Biomarker	[307]
TMBIM6	TT7QSMG	Limited	Altered Expression	[308]
TMSB4X	TTMVAIU	Limited	Biomarker	[309]
TNFRSF14	TTWGTC1	Limited	Biomarker	[310]
TNFRSF21	TT8UA0T	Limited	Genetic Variation	[311]
TNFSF12	TTBTDM1	Limited	Biomarker	[312]
TNFSF15	TTEST6I	Limited	Altered Expression	[313]
TREM2	TTQRMSJ	Limited	Altered Expression	[314]
TRIM24	TT9Q7AE	Limited	Biomarker	[315]
TRIM27	TTTO3QN	Limited	Biomarker	[316]
TRPC1	TTA76X0	Limited	Biomarker	[317]
TRPM1	TTTDAI9	Limited	Genetic Variation	[318]
TRPM4	TTJ2HKA	Limited	Biomarker	[319]
TRPV6	TTBK14N	Limited	Biomarker	[320]
TYRP1	TTFRV98	Limited	Biomarker	[321]
UBC	TTBP3XA	Limited	Genetic Variation	[322]
UBE2T	TT0A1R8	Limited	Biomarker	[323]
USP2	TTUEQ1W	Limited	Biomarker	[324]
USP30	TTQ9EDI	Limited	Biomarker	[325]
USP44	TTJLTNM	Limited	Biomarker	[326]
UTRN	TTNO1VA	Limited	Biomarker	[327]
VCAM1	TTHCEF6	Limited	Biomarker	[328]
VKORC1	TTEUC8H	Limited	Genetic Variation	[329]
WWP2	TT6TU05	Limited	Biomarker	[330]
YES1	TT0SQ8J	Limited	Biomarker	[331]
ZEB2	TTT2WK4	Limited	Biomarker	[332]
ZFAND5	TTLFY3S	Limited	Altered Expression	[333]
ZFP36L1	TT8QVJO	Limited	Altered Expression	[334]
ZNF217	TTY3BRA	Limited	Biomarker	[335]
ADAM9	TTTYQNS	Disputed	Biomarker	[336]
ANO7	TT2X79I	Disputed	Altered Expression	[337]
BLK	TTNDSC3	Disputed	Altered Expression	[338]
CELA1	TT3NKIB	Disputed	Biomarker	[339]
DAG1	TT4X7PG	Disputed	Biomarker	[340]
FLNA	TTSTRZY	Disputed	Biomarker	[341]
GPD1	TTKTEAH	Disputed	Biomarker	[342]
IL15RA	TTGN89I	Disputed	Biomarker	[343]
IL23A	TTC1GLB	Disputed	Biomarker	[344]
ITGA4	TTJMF9P	Disputed	Biomarker	[345]
KDM3A	TTKXS4A	Disputed	Altered Expression	[346]
NPR3	TTWVLS6	Disputed	Altered Expression	[347]
REL	TT1ZCTH	Disputed	Biomarker	[348]
RRM2	TT1S4LJ	Disputed	Biomarker	[349]
TKT	TT04R7I	Disputed	Genetic Variation	[350]
TST	TT51OTS	Disputed	Biomarker	[351]
ADAMTS1	TTS2TEI	moderate	Genetic Variation	[352]
ADCYAP1	TTW4LYC	moderate	Biomarker	[353]
ADCYAP1R1	TT5OREU	moderate	Biomarker	[354]
AGPAT2	TT9AYVR	moderate	Altered Expression	[355]
ALAD	TTJHKYD	moderate	Biomarker	[356]
AMHR2	TTZDCPK	moderate	Biomarker	[357]
BCL2L2	TTQ79W8	moderate	Biomarker	[358]
BDNF	TTSMLOH	moderate	Biomarker	[359]
BMX	TTN2I9E	moderate	Biomarker	[360]
BTG1	TTL7N2W	moderate	Biomarker	[361]
CACNA2D3	TTN7T29	moderate	Biomarker	[362]
CBLB	TTHRAIJ	moderate	Biomarker	[363]
CCKAR	TTCG0AL	moderate	Altered Expression	[364]
CCR9	TTIPS8B	moderate	Biomarker	[365]
CD209	TTBXIM9	moderate	Genetic Variation	[366]
CD52	TTQT5S9	moderate	Biomarker	[367]
CD69	TTPQE9F	moderate	Biomarker	[368]
CDC25A	TTLZS4Q	moderate	Biomarker	[369]
CDC42BPA	TT5Z0EF	moderate	Biomarker	[370]
CDK3	TTMYWL7	moderate	Biomarker	[371]
CES1	TTMF541	moderate	Biomarker	[372]
CFH	TTUW6OP	moderate	Biomarker	[373]
CHM	TTOA18V	moderate	Biomarker	[374]
CHRNA9	TTQACP9	moderate	Genetic Variation	[375]
CLDN18	TT6PKBX	moderate	Altered Expression	[376]
CLK1	TTE6YDG	moderate	Biomarker	[377]
CSNK1E	TTA8PLI	moderate	Biomarker	[378]
CTSE	TTLXC4Q	moderate	Biomarker	[379]
CUL3	TTPCU0Q	moderate	Biomarker	[380]
CYP24A1	TT82UI1	moderate	Genetic Variation	[381]
DAPK3	TTERVQN	moderate	Biomarker	[382]
DCK	TTJOCE4	moderate	Genetic Variation	[383]
DCLK3	TTMYK4Z	moderate	Biomarker	[384]
DPEP1	TTYUENF	moderate	Biomarker	[385]
DUSP9	TT1GV6C	moderate	Biomarker	[386]
EBP	TT4VQZX	moderate	Biomarker	[387]
EHMT2	TTS6RZT	moderate	Biomarker	[388]
EIF2AK3	TT79U1M	moderate	Biomarker	[389]
ENAH	TTY36UA	moderate	Altered Expression	[390]
ENPP3	TTD4TKP	moderate	Altered Expression	[391]
ENSA	TTQD0YT	moderate	Posttranslational Modification	[392]
F11R	TT3C8EG	moderate	Altered Expression	[393]
F8	TT1290U	moderate	Biomarker	[394]
F9	TTFEZ5Q	moderate	Biomarker	[395]
FER	TTRA9G0	moderate	Altered Expression	[396]
FGR	TTPOGS1	moderate	Altered Expression	[397]
FOSL1	TTY8LZG	moderate	Biomarker	[398]
FOXC1	TTNT3YA	moderate	Altered Expression	[399]
FURIN	TTH9WF6	moderate	Biomarker	[400]
GABRA3	TT37EDJ	moderate	Biomarker	[401]
GABRE	TTBY4OD	moderate	Altered Expression	[402]
GALR2	TTBPW3J	moderate	Biomarker	[403]
GCLM	TTNFESW	moderate	Biomarker	[404]
GNRHR	TT8R70G	moderate	Biomarker	[405]
GPR12	TT3IPW2	moderate	Biomarker	[406]
HAX1	TT21BYA	moderate	Biomarker	[407]
HBB	TTM6HK1	moderate	Genetic Variation	[408]
HCRT	TTU5HJP	moderate	Altered Expression	[409]
HDAC10	TTYHPU6	moderate	Biomarker	[410]
HEXA	TTJI5JW	moderate	Posttranslational Modification	[411]
HKDC1	TTVUI8G	moderate	Biomarker	[412]
HOXA5	TTXSVQP	moderate	Biomarker	[413]
HSD17B1	TTIWB6L	moderate	Biomarker	[414]
HTR1D	TT6MSOK	moderate	Biomarker	[415]
HTT	TTIWZ0O	moderate	Biomarker	[416]
IDS	TTNY2AP	moderate	Altered Expression	[417]
IFNL1	TTM624L	moderate	Biomarker	[418]
IFNL3	TTRF4Q2	moderate	Biomarker	[419]
IGFBP6	TTLAYV8	moderate	Biomarker	[420]
IL11RA	TTZPLJS	moderate	Biomarker	[421]
IL31RA	TT9HPX0	moderate	Biomarker	[422]
ITGAL	TT48WR6	moderate	Biomarker	[423]
ITGB2	TTIJWR7	moderate	Biomarker	[423]
KDM4A	TTZHPB8	moderate	Biomarker	[424]
KIR2DL2	TTU0P73	moderate	Genetic Variation	[425]
KIR3DL2	TTQH3N0	moderate	Biomarker	[426]
LILRB4	TTREOKA	moderate	Biomarker	[427]
LIMK1	TTWL9TY	moderate	Altered Expression	[428]
MAN2A1	TT34DCN	moderate	Altered Expression	[429]
MAPKAP1	TTWDKCL	moderate	Biomarker	[430]
MELTF	TT8OBT3	moderate	Altered Expression	[431]
MMP15	TTNSTO3	moderate	Biomarker	[432]
NEK9	TTM57AW	moderate	Biomarker	[433]
NOP2	TTBLG3H	moderate	Altered Expression	[434]
NOTCH4	TTXDIK2	moderate	Altered Expression	[435]
NPM1	TTHBS98	moderate	Biomarker	[436]
NPY4R	TTW4N16	moderate	Genetic Variation	[437]
P2RY4	TT24DGP	moderate	Biomarker	[438]
PCSK6	TT75LN9	moderate	Biomarker	[439]
PDGFA	TTSM78N	moderate	Altered Expression	[440]
PDGFB	TTQA6SX	moderate	Biomarker	[441]
PLA2G7	TTDNFMT	moderate	Altered Expression	[442]
PLCG1	TT6T4JI	moderate	Biomarker	[443]
PNP	TTMCF1Y	moderate	Biomarker	[444]
PPARD	TT2JWF6	moderate	Biomarker	[445]
PPID	TTNAFOU	moderate	Biomarker	[446]
PPP2CA	TTHTKNY	moderate	Biomarker	[447]
PRDX4	TTPBL9I	moderate	Biomarker	[448]
PRKCI	TTWJTHX	moderate	Biomarker	[449]
PRKDC	TTK3PY9	moderate	Biomarker	[450]
PSMB5	TT68GPI	moderate	Biomarker	[451]
RAB7A	TTF6WAQ	moderate	Biomarker	[452]
RCVRN	TTDQTEY	moderate	Altered Expression	[453]
REG4	TTVZEHU	moderate	Biomarker	[454]
RNF34	TTEWDK1	moderate	Biomarker	[455]
RPS6KA3	TTUM2ZR	moderate	Altered Expression	[456]
RPS6KA6	TT3KYWB	moderate	Altered Expression	[457]
RYR1	TTU5CIX	moderate	Biomarker	[458]
SAA1	TTY0DN9	moderate	Genetic Variation	[459]
SERPINB3	TT6QLPX	moderate	Altered Expression	[460]
SGPP1	TTN0VRB	moderate	Altered Expression	[461]
SLC19A3	TT9BTWM	moderate	Biomarker	[462]
SLC1A5	TTF7WRM	moderate	Altered Expression	[463]
SLC25A1	TTTD730	moderate	Biomarker	[464]
SLC2A4	TTP6MT5	moderate	Biomarker	[465]
SLC33A1	TTL69WB	moderate	Biomarker	[466]
SLC38A1	TT1YE9Z	moderate	Genetic Variation	[467]
SLC6A12	TTQBMPI	moderate	Posttranslational Modification	[468]
SORT1	TTRX9AV	moderate	Biomarker	[469]
STK32B	TT4D2GZ	moderate	Biomarker	[470]
STK38	TT27XFN	moderate	Biomarker	[471]
STS	TTHM0R1	moderate	Altered Expression	[472]
SUGT1	TT7Q9WR	moderate	Biomarker	[473]
TENT4B	TTB5R6M	moderate	Biomarker	[474]
TMPRSS6	TTL9KE7	moderate	Biomarker	[475]
TNFRSF17	TTZ3P4W	moderate	Biomarker	[476]
TPBG	TT70MLA	moderate	Altered Expression	[477]
TPP1	TTOVYPT	moderate	Biomarker	[478]
TRH	TT2Z39D	moderate	Biomarker	[479]
TRPA1	TTELV3W	moderate	Biomarker	[480]
TRPC4	TTX0H5W	moderate	Biomarker	[481]
USP8	TT1J07C	moderate	Biomarker	[482]
VANGL1	TT18WJB	moderate	Biomarker	[483]
VTCN1	TTCK85E	moderate	Altered Expression	[484]
ABAT	TTT2LD9	Strong	Biomarker	[485]
ABCA4	TTLB52K	Strong	Altered Expression	[486]
ABCB11	TTUXCAF	Strong	Genetic Variation	[487]
ABCC4	TTUEAFL	Strong	Biomarker	[488]
ABCG1	TTMWDGU	Strong	Biomarker	[489]
ABHD6	TTSINOV	Strong	Biomarker	[490]
ABL2	TT1A6HL	Strong	Biomarker	[491]
ACACB	TTY84UG	Strong	Biomarker	[492]
ACAT1	TTK3C21	Strong	Biomarker	[493]
ACHE	TT1RS9F	Strong	Biomarker	[494]
ACKR3	TTRQJTC	Strong	Biomarker	[495]
ACLY	TT0Z6Y2	Strong	Biomarker	[496]
ACO2	TTMTF2P	Strong	Biomarker	[497]
ACR	TTAHE2N	Strong	Genetic Variation	[498]
ACTG1	TTGAZF9	Strong	Biomarker	[499]
ACVR1	TTJNBQA	Strong	Biomarker	[500]
ACVR2B	TTLFRKS	Strong	Biomarker	[501]
ADA	TTLP57V	Strong	Biomarker	[502]
ADAM10	TTVXEGU	Strong	Altered Expression	[503]
ADAMTS13	TTUREBK	Strong	Biomarker	[504]
ADAMTS4	TTYG6BU	Strong	Altered Expression	[505]
ADAMTS5	TTXSU2Y	Strong	Biomarker	[506]
ADCY1	TTV1ZSQ	Strong	Biomarker	[223]
ADCY2	TTBQ9IM	Strong	Biomarker	[507]
ADH1A	TT5AHZ0	Strong	Altered Expression	[508]
ADH7	TT3LE7P	Strong	Genetic Variation	[509]
ADM	TTV14YH	Strong	Biomarker	[510]
ADM2	TTM642F	Strong	Biomarker	[511]
ADORA2A	TTM2AOE	Strong	Altered Expression	[512]
ADORA3	TTJFY5U	Strong	Altered Expression	[513]
ADRA1A	TTNGILX	Strong	Biomarker	[495]
ADRA2B	TTWM4TY	Strong	Biomarker	[495]
ADRA2C	TT2NUT5	Strong	Altered Expression	[514]
ADRB1	TTR6W5O	Strong	Altered Expression	[515]
ADRB3	TTMXGCW	Strong	Biomarker	[516]
AGER	TTMO9HF	Strong	Biomarker	[517]
AGK	TTJETQC	Strong	Biomarker	[518]
AGPAT1	TTPL1TK	Strong	Altered Expression	[519]
AGRP	TT4DE1O	Strong	Genetic Variation	[520]
AGTR2	TTQVOEI	Strong	Biomarker	[521]
AHCY	TTE2KUJ	Strong	Altered Expression	[522]
AHSG	TTKF4WV	Strong	Genetic Variation	[523]
AICDA	TTKRTP6	Strong	Biomarker	[524]
AKR1B1	TTFBNVI	Strong	Biomarker	[525]
AKR1C3	TT5ZWB6	Strong	Biomarker	[526]
ALCAM	TT2AFT6	Strong	Altered Expression	[527]
ALKBH5	TTOHB1M	Strong	Biomarker	[528]
ALPI	TTHYMUV	Strong	Biomarker	[529]
ALPL	TTMR5UV	Strong	Genetic Variation	[530]
AMACR	TTLN1AP	Strong	Genetic Variation	[531]
AMD1	TTBFROQ	Strong	Biomarker	[532]
ANGPT2	TTKLQTJ	Strong	Altered Expression	[533]
ANGPTL4	TTWALY5	Strong	Biomarker	[534]
ANK1	TTKFPMH	Strong	Altered Expression	[535]
ANTXR2	TTOD34I	Strong	Biomarker	[536]
ANXA1	TTUCK4B	Strong	Biomarker	[537]
ANXA10	TT0NL6U	Strong	Altered Expression	[538]
ANXA2	TT4YANI	Strong	Biomarker	[539]
ANXA8	TTSW16P	Strong	Biomarker	[540]
AOC1	TTM3B5R	Strong	Biomarker	[541]
AOC3	TT7HC21	Strong	Biomarker	[542]
APC2	TTSMK36	Strong	Biomarker	[543]
APEH	TTYWEDQ	Strong	Genetic Variation	[544]
APLNR	TTJ8E43	Strong	Biomarker	[545]
APOA1	TT5S8DR	Strong	Biomarker	[36]
APOC3	TTXOZQ1	Strong	Genetic Variation	[546]
APOE	TTKS9CB	Strong	Biomarker	[547]
APOL1	TTDB8PW	Strong	Altered Expression	[548]
AQP1	TTSF1KH	Strong	Altered Expression	[549]
AQP3	TTLDNMQ	Strong	Altered Expression	[550]
AQP9	TTQEI32	Strong	Biomarker	[551]
AREG	TT76B3W	Strong	Altered Expression	[552]
ARF1	TT70KXY	Strong	Biomarker	[553]
ARG1	TT7ZQEV	Strong	Altered Expression	[554]
ARL2	TTIDSFT	Strong	Biomarker	[555]
ARRB1	TTMVD4A	Strong	Biomarker	[556]
ARRB2	TT8SO2I	Strong	Biomarker	[557]
ASAP3	TTB4ZEN	Strong	Biomarker	[558]
ASIC2	TTVMWLP	Strong	Genetic Variation	[559]
ASPA	TT6TLZP	Strong	Biomarker	[560]
ASRGL1	TT4WT91	Strong	Altered Expression	[561]
ATAT1	TTWUHQ1	Strong	Altered Expression	[562]
ATF3	TTCE793	Strong	Biomarker	[563]
ATIC	TT9NVXQ	Strong	Biomarker	[564]
ATP1A1	TTWK8D0	Strong	Altered Expression	[565]
ATP2A2	TTE6THL	Strong	Genetic Variation	[566]
ATP4A	TTF1QVM	Strong	Biomarker	[567]
ATRAID	TTFLIKM	Strong	Biomarker	[568]
ATXN3	TT6A17J	Strong	Biomarker	[569]
AURKC	TTLYXIT	Strong	Posttranslational Modification	[570]
AVPR2	TTK8R02	Strong	Biomarker	[571]
AXL	TTZPY6J	Strong	Biomarker	[572]
BACE1	TTJUNZF	Strong	Biomarker	[573]
BACE2	TT69DB8	Strong	Altered Expression	[574]
BAGE	TTS5GLJ	Strong	Altered Expression	[575]
BAK1	TTFM7V0	Strong	Genetic Variation	[576]
BAP1	TT47RXJ	Strong	Altered Expression	[577]
BBC3	TT7JUKC	Strong	Biomarker	[578]
BCAT1	TTES57P	Strong	Biomarker	[579]
BCL11A	TTR61MW	Strong	Biomarker	[580]
BCL2A1	TTGT9C7	Strong	Biomarker	[581]
BGN	TT0JPVF	Strong	Altered Expression	[582]
BIRC2	TTQ5LRD	Strong	Biomarker	[583]
BIRC3	TTAIWZN	Strong	Biomarker	[584]
BIRC5	TTTPU1G	Strong	Genetic Variation	[585]
BMP1	TT0L58T	Strong	Biomarker	[586]
BMP10	TTTG6H1	Strong	Altered Expression	[587]
BMP2	TTP3IGX	Strong	Genetic Variation	[588]
BMP4	TTD3BSX	Strong	Biomarker	[589]
BMP6	TT07RIB	Strong	Altered Expression	[590]
BMP7	TTKOBRA	Strong	Altered Expression	[591]
BMPR2	TTGKF90	Strong	Biomarker	[592]
BPHL	TTTZ3EU	Strong	Biomarker	[230]
BPI	TTXCSDR	Strong	Biomarker	[593]
BRD3	TTHE657	Strong	Altered Expression	[594]
BRD4	TTSRAOU	Strong	Biomarker	[595]
BRD9	TTR7L5Y	Strong	Biomarker	[596]
BRDT	TT7CPI5	Strong	Biomarker	[597]
BRIP1	TTZV7LJ	Strong	Genetic Variation	[598]
BRS3	TTKYEPM	Strong	Biomarker	[495]
BST2	TT90BJT	Strong	Biomarker	[599]
C1QBP	TTWTD7F	Strong	Altered Expression	[600]
C5	TTKANGO	Strong	Biomarker	[601]
C5AR1	TTHXFA1	Strong	Biomarker	[601]
C9orf72	TTA4SHR	Strong	Biomarker	[602]
CA12	TTSYM0R	Strong	Biomarker	[603]
CA14	TTEYTKG	Strong	Altered Expression	[604]
CA5A	TT75WPO	Strong	Biomarker	[605]
CACNA1G	TT729IR	Strong	Altered Expression	[606]
CACNA1H	TTZPWGN	Strong	Biomarker	[607]
CACNA2D1	TTFK1JQ	Strong	Biomarker	[608]
CACNA2D2	TTU8P3M	Strong	Biomarker	[609]
CALCR	TTLWS2O	Strong	Biomarker	[283]
CAMKK2	TTV298Y	Strong	Biomarker	[610]
CAMP	TTULOB6	Strong	Biomarker	[611]
CAPN2	TTG5QB7	Strong	Biomarker	[612]
CARM1	TTIZQFJ	Strong	Biomarker	[613]
CASP2	TT12VNG	Strong	Biomarker	[614]
CASP5	TTWR48J	Strong	Biomarker	[615]
CASP6	TTKW4ML	Strong	Biomarker	[616]
CASP7	TTM7Y45	Strong	Biomarker	[617]
CASP9	TTB6T7O	Strong	Altered Expression	[618]
CBR1	TTVG0SN	Strong	Biomarker	[619]
CBS	TTVZJ7G	Strong	Biomarker	[620]
CBX7	TTBN3HC	Strong	Biomarker	[621]
CCKBR	TTVFO0U	Strong	Altered Expression	[622]
CCL11	TTCF05Y	Strong	Biomarker	[623]
CCL17	TTMPHAE	Strong	Altered Expression	[624]
CCL20	TT2XAZY	Strong	Biomarker	[625]
CCL21	TTLZK1U	Strong	Altered Expression	[626]
CCL22	TTBTWI1	Strong	Biomarker	[627]
CCL3	TT8I4WB	Strong	Altered Expression	[628]
CCN2	TTIL516	Strong	Altered Expression	[166]
CCNA2	TTAMQ62	Strong	Altered Expression	[629]
CCNB1	TT9P6OW	Strong	Altered Expression	[630]
CCND3	TT1JXNR	Strong	Altered Expression	[631]
CCNE1	TTCEJ4F	Strong	Altered Expression	[632]
CCNE2	TTLDRGX	Strong	Biomarker	[633]
CCR1	TTC24WT	Strong	Biomarker	[634]
CCR2	TTFZYTO	Strong	Biomarker	[635]
CCR3	TTD3XFU	Strong	Biomarker	[636]
CCR7	TT2GIDQ	Strong	Biomarker	[637]
CCR8	TTE836A	Strong	Biomarker	[638]
CD160	TTOFEAS	Strong	Altered Expression	[639]
CD1A	TTBGTFN	Strong	Biomarker	[640]
CD2	TTJDUNO	Strong	Biomarker	[641]
CD200	TT0BE68	Strong	Biomarker	[642]
CD22	TTM6QSK	Strong	Altered Expression	[643]
CD248	TTYJWT7	Strong	Biomarker	[644]
CD27	TTDO1MV	Strong	Biomarker	[645]
CD34	TTZAVYN	Strong	Altered Expression	[646]
CD37	TTFCW29	Strong	Altered Expression	[647]
CD38	TTPURFN	Strong	Biomarker	[648]
CD40	TT1ERKL	Strong	Biomarker	[649]
CD40LG	TTIJP3Q	Strong	Biomarker	[650]
CD46	TTMS7DF	Strong	Altered Expression	[651]
CD47	TT28S46	Strong	Biomarker	[652]
CD55	TT5Z9WY	Strong	Biomarker	[653]
CD58	TT5KSBY	Strong	Biomarker	[654]
CD6	TTMF6KC	Strong	Biomarker	[655]
CD7	TTP6B8O	Strong	Biomarker	[656]
CD70	TTNCIE0	Strong	Altered Expression	[657]
CD74	TTCMYP9	Strong	Biomarker	[658]
CD79B	TTBN5I7	Strong	Altered Expression	[659]
CD80	TT89Z17	Strong	Altered Expression	[660]
CD83	TTT9MRQ	Strong	Biomarker	[661]
CD96	TT83C4X	Strong	Biomarker	[662]
CDC20	TTBKFDV	Strong	Biomarker	[663]
CDC25B	TTR0SWN	Strong	Biomarker	[664]
CDC25C	TTESBNC	Strong	Biomarker	[665]
CDC37	TT5SOEU	Strong	Genetic Variation	[666]
CDC7	TTSMTDI	Strong	Altered Expression	[667]
CDH5	TTXLCFO	Strong	Altered Expression	[668]
CDH6	TT9QHUK	Strong	Biomarker	[669]
CDK1	TTH6V3D	Strong	Biomarker	[670]
CDK11B	TT5Q79O	Strong	Biomarker	[671]
CDK12	TTJ21A9	Strong	Biomarker	[672]
CDK13	TTRIM0E	Strong	Biomarker	[673]
CDK5	TTL4Q97	Strong	Biomarker	[674]
CDK6	TTO0FDJ	Strong	Altered Expression	[675]
CDK7	TTQYF7G	Strong	Biomarker	[676]
CDK8	TTBJR4L	Strong	Biomarker	[677]
CDK9	TT1LVF2	Strong	Biomarker	[678]
CDKN1C	TTBSUAR	Strong	Altered Expression	[679]
CEACAM1	TTA9CK4	Strong	Biomarker	[680]
CEACAM6	TTIGH2W	Strong	Biomarker	[681]
CEBPA	TT5LWG1	Strong	Altered Expression	[682]
CEBPB	TTUI35N	Strong	Biomarker	[683]
CENPE	TTZD5QR	Strong	Biomarker	[684]
CEP250	TTPOA6U	Strong	Altered Expression	[685]
CFB	TTA0P7K	Strong	Biomarker	[686]
CFD	TT8D13I	Strong	Biomarker	[687]
CFI	TT6ATLX	Strong	Biomarker	[688]
CFLAR	TTJZQYH	Strong	Biomarker	[689]
CFP	TTLA0VS	Strong	Biomarker	[687]
CHKA	TT10AWB	Strong	Biomarker	[690]
CHPF	TTAZB7S	Strong	Biomarker	[691]
CHRM1	TTZ9SOR	Strong	Biomarker	[692]
CHRNA4	TT4H1MQ	Strong	Biomarker	[693]
CHRNB4	TTTVAFQ	Strong	Genetic Variation	[694]
CHST15	TTFK7E1	Strong	Altered Expression	[695]
CLCA1	TT3AF4R	Strong	Biomarker	[696]
CLCF1	TTI6V13	Strong	Biomarker	[697]
CLCN3	TT8XNZ7	Strong	Biomarker	[698]
CLDN4	TTMTS9H	Strong	Biomarker	[699]
CLDN6	TTKSV48	Strong	Altered Expression	[700]
CLEC12A	TT70N8V	Strong	Biomarker	[701]
CLEC6A	TTQ02HK	Strong	Biomarker	[702]
CLIC1	TT8KZG6	Strong	Biomarker	[703]
CLN3	TTORF9W	Strong	Biomarker	[704]
CLU	TTRL76H	Strong	Biomarker	[705]
CMA1	TT8VUE0	Strong	Biomarker	[706]
CMKLR1	TT4UGZL	Strong	Biomarker	[707]
CNR1	TT6OEDT	Strong	Biomarker	[708]
CNR2	TTMSFAW	Strong	Biomarker	[709]
CNTN1	TTPR8FK	Strong	Altered Expression	[710]
COASY	TT4YO0Z	Strong	Biomarker	[711]
COL6A3	TT5WCAH	Strong	Biomarker	[712]
COL7A1	TTBCOKN	Strong	Genetic Variation	[713]
COPS5	TTSTNJR	Strong	Biomarker	[714]
CPB2	TTP18AY	Strong	Genetic Variation	[715]
CPT1B	TTDL0NY	Strong	Biomarker	[716]
CR2	TT0HUN7	Strong	Altered Expression	[717]
CRAT	TTC8M31	Strong	Altered Expression	[718]
CRBN	TTDKGTC	Strong	Biomarker	[719]
CREB1	TTH4AN3	Strong	Altered Expression	[720]
CRH	TTA7YIZ	Strong	Biomarker	[721]
CRHBP	TT3PKZE	Strong	Altered Expression	[722]
CRHR1	TT7EFHR	Strong	Biomarker	[723]
CRHR2	TTIY658	Strong	Biomarker	[724]
CRK	TTFEUYR	Strong	Altered Expression	[725]
CRTC2	TTFWETR	Strong	Biomarker	[726]
CRY1	TT5MLZR	Strong	Altered Expression	[727]
CRY2	TTAO58M	Strong	Altered Expression	[728]
CRYZ	TTP6UO8	Strong	Biomarker	[729]
CS	TTZA6B3	Strong	Biomarker	[730]
CSE1L	TTTRULD	Strong	Biomarker	[731]
CSF1R	TT7MRDV	Strong	Biomarker	[732]
CSF3R	TTC70AJ	Strong	Genetic Variation	[733]
CSNK1A1	TTFQEMX	Strong	Biomarker	[734]
CSNK1G2	TT0UZJ9	Strong	Altered Expression	[735]
CSNK1G3	TT34L5N	Strong	Biomarker	[736]
CSNK2A1	TTER6YH	Strong	Biomarker	[737]
CSNK2A2	TT7GR5W	Strong	Biomarker	[737]
CSPG4	TT7MYXI	Strong	Biomarker	[738]
CTCFL	TTY0RZT	Strong	Biomarker	[739]
CTDSP1	TTHZAF0	Strong	Biomarker	[740]
CTH	TTLQUZS	Strong	Biomarker	[741]
CTPS1	TTN12BZ	Strong	Biomarker	[742]
CTSA	TT5NILS	Strong	Genetic Variation	[743]
CTSD	TTPT2QI	Strong	Biomarker	[744]
CTSF	TTJOKD1	Strong	Biomarker	[745]
CTSH	TT3G406	Strong	Altered Expression	[746]
CTSS	TTUMQVO	Strong	Biomarker	[747]
CUL7	TTI8R0P	Strong	Biomarker	[748]
CX3CR1	TT2T98G	Strong	Altered Expression	[749]
CXCL1	TTLK1RW	Strong	Altered Expression	[750]
CXCL10	TTQOVYA	Strong	Altered Expression	[751]
CXCL11	TTWG0RE	Strong	Biomarker	[752]
CXCR3	TT1UCIJ	Strong	Biomarker	[753]
CXCR6	TT2BVUA	Strong	Biomarker	[495]
CXXC5	TTVS4C3	Strong	Biomarker	[754]
CYP11B2	TT9MNE2	Strong	Biomarker	[755]
CYP26A1	TTD7Q0R	Strong	Altered Expression	[756]
CYP2B6	TTMH124	Strong	Biomarker	[757]
CYP2C19	TTZ58XG	Strong	Genetic Variation	[758]
CYP2C9	TTR40YJ	Strong	Biomarker	[759]
CYP51A1	TT67TDP	Strong	Biomarker	[760]
DAAM2	TTN0Z6H	Strong	Biomarker	[761]
DAO	TT7Y3EJ	Strong	Biomarker	[762]
DBH	TTYIP79	Strong	Biomarker	[763]
DCTPP1	TTZ1YIS	Strong	Altered Expression	[764]
DDC	TTN451K	Strong	Biomarker	[765]
DDR2	TTU98HG	Strong	Biomarker	[766]
DDX5	TTZKPVC	Strong	Biomarker	[767]
DDX58	TTVB0O3	Strong	Biomarker	[768]
DEFB4A	TTIVY12	Strong	Biomarker	[769]
DEPTOR	TTLYP6D	Strong	Biomarker	[770]
DGKA	TTGL8F0	Strong	Altered Expression	[771]
DGKZ	TTSBBXL	Strong	Biomarker	[772]
DHCR24	TTTK0NH	Strong	Biomarker	[773]
DHODH	TTLVP78	Strong	Biomarker	[774]
DHPS	TTBO2A9	Strong	Biomarker	[775]
DIO1	TTU3X26	Strong	Altered Expression	[776]
DLL3	TT1C9K6	Strong	Biomarker	[777]
DLL4	TTV23LH	Strong	Biomarker	[778]
DMPK	TTZQTY2	Strong	Genetic Variation	[779]
DNM1	TTE3JW9	Strong	Biomarker	[780]
DNMT3L	TT3FDAV	Strong	Biomarker	[781]
DPP7	TTOYT5L	Strong	Biomarker	[782]
DPP8	TTJGLZF	Strong	Biomarker	[783]
DPP9	TTNDUL7	Strong	Biomarker	[783]
DPYD	TTZPS91	Strong	Biomarker	[784]
DRD5	TTS2PH3	Strong	Genetic Variation	[92]
DSG3	TTEO4P8	Strong	Biomarker	[785]
DTL	TT8396I	Strong	Biomarker	[786]
DUSP1	TTG8HIM	Strong	Altered Expression	[787]
DUSP3	TTIFAYS	Strong	Biomarker	[788]
DUSP8	TTK0TF2	Strong	Genetic Variation	[789]
DUT	TTH6MBO	Strong	Biomarker	[790]
DYNAP	TTCVQYE	Strong	Biomarker	[791]
DYRK1A	TTSBVFO	Strong	Biomarker	[792]
EBI3	TTJF68X	Strong	Biomarker	[793]
ECE1	TTQ9RYT	Strong	Altered Expression	[794]
EDNRA	TTKRD0G	Strong	Biomarker	[495]
EDNRB	TT3ZTGU	Strong	Biomarker	[795]
EED	TTFNJ4R	Strong	Biomarker	[796]
EEF2K	TT1QFLA	Strong	Biomarker	[797]
EIF2AK1	TTRUJBV	Strong	Biomarker	[798]
EIF2AK2	TTXEZJ4	Strong	Altered Expression	[799]
EIF2AK4	TT9U4EP	Strong	Biomarker	[800]
EIF4EBP1	TTKGEBL	Strong	Posttranslational Modification	[801]
EIF4EBP2	TTNBTCW	Strong	Biomarker	[802]
EIF5A	TTIVCNR	Strong	Biomarker	[803]
ELAVL1	TTPC9D0	Strong	Biomarker	[804]
EML4	TT92GY4	Strong	Genetic Variation	[805]
ENG	TTB30LE	Strong	Biomarker	[806]
ENPEP	TT9PBIL	Strong	Biomarker	[807]
ENPP2	TTSCIM2	Strong	Biomarker	[808]
EPHA2	TTRJB2G	Strong	Biomarker	[809]
EPHA5	TTV9KOD	Strong	Altered Expression	[810]
EPHA6	TTFAHWI	Strong	Altered Expression	[811]
EPHA7	TTAHTVG	Strong	Genetic Variation	[812]
EPHA8	TTHZ2LW	Strong	Biomarker	[813]
EPHB2	TTKPV6O	Strong	Altered Expression	[814]
EPHB3	TT5LM7U	Strong	Biomarker	[815]
EPHB6	TTZEMUY	Strong	Biomarker	[816]
EPHX2	TT7WVHI	Strong	Biomarker	[372]
EPOR	TTAUX24	Strong	Biomarker	[817]
EPX	TTCIO0M	Strong	Altered Expression	[818]
ERAP1	TT60XFL	Strong	Biomarker	[107]
EREG	TTYSB89	Strong	Biomarker	[819]
ERF	TTGXULC	Strong	Altered Expression	[820]
ESRRA	TTPNQAC	Strong	Biomarker	[821]
ESRRB	TTKF0XS	Strong	Biomarker	[822]
ESRRG	TT9ZRHB	Strong	Biomarker	[823]
ETS1	TTTGPSD	Strong	Altered Expression	[824]
EZR	TTE47YC	Strong	Biomarker	[825]
F11	TTDM4ZU	Strong	Altered Expression	[826]
F12	TTRJSMV	Strong	Biomarker	[827]
F2RL1	TTQR74A	Strong	Biomarker	[828]
F2RL2	TTVSEBF	Strong	Biomarker	[829]
F2RL3	TTD0652	Strong	Altered Expression	[830]
FABP1	TTIV96N	Strong	Biomarker	[831]
FABP5	TTNT2S6	Strong	Altered Expression	[832]
FADS2	TTT2VDU	Strong	Genetic Variation	[833]
FAM83D	TTFIW7J	Strong	Biomarker	[834]
FANCF	TTNZKFJ	Strong	Posttranslational Modification	[835]
FAP	TTGPQ0F	Strong	Altered Expression	[836]
FASLG	TTO7014	Strong	Biomarker	[837]
FAT1	TTGUJYV	Strong	Genetic Variation	[838]
FBXO11	TT6G10V	Strong	Altered Expression	[839]
FCAR	TTGUJAO	Strong	Biomarker	[840]
FCGR2B	TT5RWKQ	Strong	Biomarker	[841]
FCGR3A	TTIFOC0	Strong	Biomarker	[842]
FDFT1	TTFQEO5	Strong	Biomarker	[843]
FDXR	TT3W4IX	Strong	Altered Expression	[844]
FFAR1	TTB8FUC	Strong	Biomarker	[845]
FFAR2	TT0FYAN	Strong	Altered Expression	[846]
FGF10	TTNPEFX	Strong	Biomarker	[847]
FGF2	TTGKIED	Strong	Altered Expression	[848]
FGF21	TTQ916P	Strong	Altered Expression	[849]
FGF4	TTCEKVZ	Strong	Biomarker	[850]
FGF7	TTFY134	Strong	Biomarker	[847]
FGF8	TTIUF3J	Strong	Biomarker	[851]
FGG	TTR31L7	Strong	Biomarker	[852]
FGL2	TTYBS89	Strong	Altered Expression	[853]
FKBP10	TT4P8O2	Strong	Biomarker	[854]
FKBP1A	TTMW94E	Strong	Biomarker	[855]
FKBP7	TTO1ENI	Strong	Biomarker	[856]
FLT4	TTDCBX5	Strong	Biomarker	[857]
FN3K	TTP6W8J	Strong	Altered Expression	[858]
FOLR1	TTVC37M	Strong	Biomarker	[859]
FOLR2	TTT54CI	Strong	Biomarker	[860]
FOS	TTOM5AU	Strong	Altered Expression	[861]
FOXP3	TT1X3QF	Strong	Biomarker	[862]
FPR2	TTOJ1NF	Strong	Biomarker	[863]
FSTL3	TTWRPM8	Strong	Altered Expression	[864]
FUS	TTKGYZ9	Strong	Biomarker	[865]
FUT3	TTUPAD7	Strong	Biomarker	[866]
FZD10	TTP1S2F	Strong	Altered Expression	[867]
FZD7	TTUQMO5	Strong	Biomarker	[868]
GABRP	TT3E0DI	Strong	Altered Expression	[869]
GAD1	TTKGEP3	Strong	Altered Expression	[870]
GAD2	TT7UY6K	Strong	Biomarker	[871]
GAL	TTXZAJ5	Strong	Biomarker	[872]
GALC	TT5IZRB	Strong	Altered Expression	[873]
GALNS	TTT9YPO	Strong	Altered Expression	[874]
GALR1	TTX3HNZ	Strong	Posttranslational Modification	[875]
GAPDH	TTUGSWA	Strong	Biomarker	[876]
GAS6	TT69QD2	Strong	Altered Expression	[877]
GAST	TT4LRVO	Strong	Biomarker	[878]
GCG	TT6Y4PN	Strong	Biomarker	[879]
GCGR	TT9O6WS	Strong	Biomarker	[880]
GCH1	TTLSWP6	Strong	Genetic Variation	[881]
GDA	TTK4JTZ	Strong	Biomarker	[882]
GDF2	TTAP4T1	Strong	Biomarker	[883]
GDNF	TTF23ML	Strong	Biomarker	[884]
GEM	TTAZF9M	Strong	Biomarker	[885]
GGH	TTZJRL0	Strong	Altered Expression	[886]
GGT1	TTZVT7O	Strong	Biomarker	[887]
GHR	TTHJWYD	Strong	Biomarker	[888]
GJA3	TTFZRG0	Strong	Altered Expression	[889]
GJA4	TTQO1VY	Strong	Biomarker	[890]
GJA8	TTJ7ATH	Strong	Biomarker	[661]
GJB1	TTSJIRP	Strong	Biomarker	[891]
GJB4	TTBRDFI	Strong	Biomarker	[892]
GLIPR1	TTEQF1O	Strong	Biomarker	[893]
GLP1R	TTVIMDE	Strong	Biomarker	[797]
GLRX	TTRJCNG	Strong	Biomarker	[894]
GLUL	TTURQ2G	Strong	Biomarker	[895]
GM2A	TTGOFW6	Strong	Biomarker	[896]
GMNN	TT390KA	Strong	Biomarker	[897]
GNAI1	TTL1HWR	Strong	Biomarker	[898]
GNAI3	TT8QF3W	Strong	Biomarker	[898]
GNE	TT4DP5S	Strong	Altered Expression	[899]
GNG7	TTCMBKF	Strong	Altered Expression	[900]
GOT1	TTU507L	Strong	Biomarker	[901]
GP1BA	TTVB0Q9	Strong	Genetic Variation	[902]
GP6	TTTJUVZ	Strong	Biomarker	[903]
GPER1	TTDSB34	Strong	Biomarker	[904]
GPNMB	TT7315J	Strong	Biomarker	[905]
GPR101	TTUKZVG	Strong	Biomarker	[906]
GPR132	TTNBW4F	Strong	Altered Expression	[907]
GPR137	TTATO6X	Strong	Altered Expression	[908]
GPR18	TTSLJAR	Strong	Biomarker	[909]
GPR31	TT71ZLK	Strong	Biomarker	[910]
GPR55	TTNET8J	Strong	Biomarker	[911]
GPR87	TTO897C	Strong	Altered Expression	[912]
GPRC5D	TTHRAPJ	Strong	Genetic Variation	[913]
GPRC6A	TTI1PRE	Strong	Biomarker	[914]
GRB2	TTEYRJ9	Strong	Biomarker	[915]
GRIA1	TTVPQTF	Strong	Biomarker	[916]
GRIA4	TTPJR0G	Strong	Altered Expression	[917]
GRIN1	TTLD29N	Strong	Altered Expression	[918]
GRIN2D	TT5POTG	Strong	Biomarker	[919]
GRK2	TTAZ3MN	Strong	Biomarker	[920]
GRM8	TT0IFKL	Strong	Biomarker	[921]
GRN	TT0LWE3	Strong	Genetic Variation	[922]
GRPR	TTC1MVT	Strong	Altered Expression	[923]
GSK3A	TTQWAU1	Strong	Biomarker	[924]
GSK3B	TTRSMW9	Strong	Biomarker	[925]
GZMB	TTKEPHX	Strong	Biomarker	[926]
HAL	TTXQOZW	Strong	Biomarker	[927]
HAMP	TTRV5YJ	Strong	Biomarker	[928]
HBEGF	TT15SL0	Strong	Altered Expression	[929]
HCAR3	TT8WFXV	Strong	Biomarker	[930]
HCK	TT42OGM	Strong	Altered Expression	[931]
HDAC2	TTSHTOI	Strong	Biomarker	[932]
HDAC3	TT4YWTO	Strong	Biomarker	[933]
HDAC5	TTUELN5	Strong	Biomarker	[149]
HDAC6	TT5ZKDI	Strong	Biomarker	[934]
HDAC7	TTMUEK1	Strong	Biomarker	[935]
HDAC8	TTT6LFV	Strong	Altered Expression	[936]
HDAC9	TT8M4E1	Strong	Biomarker	[937]
HDC	TTV9GOF	Strong	Biomarker	[938]
HEXIM1	TTFOKAH	Strong	Altered Expression	[939]
HHAT	TT1VNCG	Strong	Biomarker	[940]
HIPK2	TTOB49C	Strong	Biomarker	[941]
HK2	TTK02H8	Strong	Biomarker	[942]
HLA-G	TTLKFB3	Strong	Biomarker	[943]
HMBS	TTT0HW3	Strong	Biomarker	[944]
HMGB2	TTA78JQ	Strong	Biomarker	[945]
HMGCS2	TTS0EZJ	Strong	Biomarker	[946]
HMOX2	TTWZRL4	Strong	Biomarker	[947]
HNF4A	TT2F3CD	Strong	Biomarker	[948]
HNMT	TT2B6EV	Strong	Biomarker	[949]
HNRNPA1	TTPJ9XK	Strong	Altered Expression	[950]
HOXA11	TTEX4ZA	Strong	Altered Expression	[951]
HRH1	TTTIBOJ	Strong	Altered Expression	[952]
HRH3	TT9JNIC	Strong	Altered Expression	[953]
HRH4	TTXJ178	Strong	Biomarker	[954]
HSD11B1	TTN7BL9	Strong	Biomarker	[955]
HSD11B2	TT9H85R	Strong	Genetic Variation	[956]
HSD17B13	TTDJYZR	Strong	Altered Expression	[414]
HSP90B1	TTFPKXQ	Strong	Altered Expression	[957]
HSPB1	TT9AZWY	Strong	Altered Expression	[958]
HSPB3	TTLH8WG	Strong	Altered Expression	[958]
HSPB8	TTY0OJN	Strong	Biomarker	[959]
HSPD1	TT9HL5R	Strong	Altered Expression	[960]
HSPE1	TTWYMFE	Strong	Biomarker	[961]
HSPG2	TT5UM29	Strong	Biomarker	[962]
HTR1A	TTSQIFT	Strong	Biomarker	[963]
HTR2B	TT0K1SC	Strong	Biomarker	[964]
HTR2C	TTWJBZ5	Strong	Biomarker	[965]
HTR3A	TTPC4TU	Strong	Genetic Variation	[966]
HTR4	TT07C3Y	Strong	Genetic Variation	[967]
HTRA1	TT8POQR	Strong	Biomarker	[968]
IAPP	TTHN8EM	Strong	Biomarker	[529]
ICA1	TTMX06B	Strong	Biomarker	[449]
ICOS	TTE5VP6	Strong	Biomarker	[969]
ICOSLG	TTB9Z8R	Strong	Biomarker	[970]
IDO2	TTALN9W	Strong	Biomarker	[971]
IFNAR1	TTSYFMA	Strong	Biomarker	[972]
IFNB1	TT4TZ8J	Strong	Biomarker	[973]
IGFBP1	TTCJTWF	Strong	Biomarker	[974]
IGFBP2	TTU4QSN	Strong	Biomarker	[974]
IGFBP5	TTDWEA8	Strong	Biomarker	[975]
IKBKB	TTJ3E9X	Strong	Biomarker	[976]
IKZF3	TTCZVFZ	Strong	Genetic Variation	[977]
IL12B	TTGW72V	Strong	Genetic Variation	[978]
IL12RB2	TT4SWR8	Strong	Biomarker	[979]
IL13RA1	TTNEAMG	Strong	Biomarker	[980]
IL15	TTJFA35	Strong	Biomarker	[981]
IL1R1	TTWOTEA	Strong	Biomarker	[982]
IL1RAP	TTWS50K	Strong	Biomarker	[983]
IL1RN	TT6GSR3	Strong	Biomarker	[984]
IL20	TTNZMY2	Strong	Biomarker	[985]
IL21	TT9QEJ6	Strong	Biomarker	[986]
IL25	TTVMO5W	Strong	Altered Expression	[987]
IL2RA	TT10Y9E	Strong	Biomarker	[988]
IL31	TT1RJXK	Strong	Biomarker	[989]
IL37	TTQTX98	Strong	Biomarker	[990]
ILDR2	TT0R2QD	Strong	Biomarker	[991]
IMP3	TTEJA2R	Strong	Genetic Variation	[992]
IMPA2	TTXWL6D	Strong	Biomarker	[993]
IMPDH2	TTTB4UP	Strong	Biomarker	[684]
INHBA	TTVB30D	Strong	Biomarker	[994]
INPP1	TTW0PHM	Strong	Altered Expression	[995]
INPP5D	TTTP2Z1	Strong	Altered Expression	[996]
INSR	TTCBFJO	Strong	Genetic Variation	[997]
IRAK3	TTBPJOK	Strong	Posttranslational Modification	[998]
IRF3	TTYR7OH	Strong	Altered Expression	[999]
IRS1	TTAJSQ0	Strong	Biomarker	[1000]
ISG15	TTVOH3T	Strong	Biomarker	[1001]
ITGA5	TTHIZP9	Strong	Altered Expression	[1002]
ITGAM	TTB69FJ	Strong	Biomarker	[1003]
ITGAV	TTT1R2L	Strong	Biomarker	[1004]
ITGB1	TTBVIQC	Strong	Biomarker	[345]
ITGB3	TTJA1ZO	Strong	Biomarker	[1005]
ITGB6	TTKQSXZ	Strong	Biomarker	[1006]
ITGB8	TTIF29E	Strong	Altered Expression	[1007]
ITPR1	TT5HWAT	Strong	Altered Expression	[1008]
ITPR3	TTH1769	Strong	Altered Expression	[1009]
JAK1	TT6DM01	Strong	Biomarker	[1010]
JAK3	TTT7PJU	Strong	Genetic Variation	[1011]
JUP	TTREN0G	Strong	Biomarker	[787]
KAT2B	TTVK7SB	Strong	Biomarker	[1012]
KAT6A	TT6O1J0	Strong	Biomarker	[1013]
KAT6B	TTH4VJL	Strong	Biomarker	[1013]
KCNA5	TTW0CMT	Strong	Biomarker	[1014]
KCNH1	TT9XKUC	Strong	Biomarker	[1015]
KCNH2	TTQ6VDM	Strong	Biomarker	[1016]
KCNJ11	TT329V4	Strong	Biomarker	[1017]
KCNJ2	TTH7UO3	Strong	Altered Expression	[1018]
KCNJ3	TTGM19J	Strong	Altered Expression	[1019]
KCNJ4	TTXF0ZW	Strong	Biomarker	[1020]
KCNK18	TTHT87J	Strong	Biomarker	[173]
KCNMA1	TTE87WJ	Strong	Biomarker	[1021]
KCNN3	TT9JH25	Strong	Altered Expression	[1022]
KCNQ1	TT846HF	Strong	Biomarker	[1023]
KDM1A	TTNR0UQ	Strong	Biomarker	[1024]
KDM4C	TTV8CRH	Strong	Biomarker	[1025]
KDM5B	TTCLI75	Strong	Biomarker	[1026]
KDM5C	TT94UCF	Strong	Altered Expression	[1027]
KDM6B	TTDIJUQ	Strong	Biomarker	[1028]
KEAP1	TT3Z6Y9	Strong	Genetic Variation	[1029]
KHDRBS1	TTAT6C7	Strong	Biomarker	[1030]
KHK	TTPAFR9	Strong	Altered Expression	[1031]
KIF11	TTBGTCW	Strong	Biomarker	[1032]
KIR2DS1	TTVWAGF	Strong	Biomarker	[426]
KIR2DS2	TTV3CFI	Strong	Biomarker	[1033]
KISS1R	TT3KBZY	Strong	Altered Expression	[1034]
KITLG	TTDJ51N	Strong	Biomarker	[1035]
KLB	TTARBVH	Strong	Biomarker	[1036]
KLF4	TTTI53X	Strong	Altered Expression	[1037]
KLK1	TT5T3P6	Strong	Biomarker	[1038]
KLK14	TTDA81R	Strong	Altered Expression	[1039]
KLK2	TTJLNAW	Strong	Genetic Variation	[1040]
KLK5	TTULSEW	Strong	Altered Expression	[1041]
KLK8	TTH5MRS	Strong	Altered Expression	[1042]
KMO	TTIY56R	Strong	Altered Expression	[1043]
KMT5B	TTJGV7F	Strong	Altered Expression	[1044]
KNG1	TTDJ4MY	Strong	Biomarker	[1045]
KPNB1	TTHOJ5F	Strong	Biomarker	[1046]
KRT17	TTKV0EC	Strong	Biomarker	[1047]
KYNU	TTWQM3J	Strong	Biomarker	[1048]
L1CAM	TTC9D3K	Strong	Biomarker	[1049]
L3MBTL3	TTQDMJN	Strong	Genetic Variation	[1050]
LAG3	TTNVXAW	Strong	Biomarker	[1051]
LAIR1	TTSI7A8	Strong	Altered Expression	[1052]
LAMP1	TTC214J	Strong	Altered Expression	[1053]
LANCL1	TTZW8NS	Strong	Biomarker	[979]
LARP1	TTSN1YP	Strong	Biomarker	[1054]
LBP	TTVQJLY	Strong	Biomarker	[1055]
LCN2	TTKTLAI	Strong	Biomarker	[1056]
LCT	TTA0OSE	Strong	Genetic Variation	[1057]
LDHA	TTW76JE	Strong	Genetic Variation	[1058]
LGR4	TTY6C71	Strong	Biomarker	[1059]
LHCGR	TT2O4W9	Strong	Genetic Variation	[1060]
LIF	TTGZ5WN	Strong	Biomarker	[1061]
LILRB2	TTHC6XU	Strong	Altered Expression	[1062]
LIPE	TTLUQ8E	Strong	Biomarker	[1063]
LIPG	TTHSZXO	Strong	Biomarker	[1064]
LMO2	TTFX379	Strong	Biomarker	[1065]
LONP1	TTM1VPZ	Strong	Altered Expression	[237]
LOX	TTQHNAM	Strong	Altered Expression	[1066]
LOXL2	TTFSUHX	Strong	Altered Expression	[1067]
LPA	TTU9LGY	Strong	Biomarker	[1068]
LPAR1	TTQ6S1K	Strong	Altered Expression	[1069]
LPAR2	TTB7Y8I	Strong	Biomarker	[495]
LPAR3	TTE2YJR	Strong	Biomarker	[914]
LPAR6	TTZDAGB	Strong	Biomarker	[1068]
LRP2	TTPH1AJ	Strong	Altered Expression	[1070]
LRP5	TT7VMG4	Strong	Biomarker	[1071]
LRP6	TTSXOWE	Strong	Biomarker	[1071]
LRRC32	TT0FAYT	Strong	Altered Expression	[1072]
LRRK2	TTK0FEA	Strong	Biomarker	[1073]
LSS	TT7O8ZA	Strong	Biomarker	[1074]
LTA4H	TTXZEAJ	Strong	Biomarker	[1075]
LTB4R	TTN53ZF	Strong	Biomarker	[1076]
LTK	TT1JZG6	Strong	Genetic Variation	[1077]
LY6D	TTINE9B	Strong	Altered Expression	[1078]
LY6K	TT5GKHN	Strong	Biomarker	[1079]
LYVE1	TTG8DNU	Strong	Biomarker	[1080]
MAD1L1	TTNE9U7	Strong	Biomarker	[1081]
MAG	TT9XFON	Strong	Biomarker	[1082]
MAGEA2	TTOZT28	Strong	Biomarker	[1083]
MAGEA6	TTJIWMO	Strong	Altered Expression	[1084]
MAGEC1	TT9M6NA	Strong	Biomarker	[1085]
MAGEC2	TTKGUEB	Strong	Altered Expression	[1086]
MALT1	TTCI81G	Strong	Altered Expression	[1087]
MANF	TT56RYE	Strong	Biomarker	[1088]
MAOA	TT3WG5C	Strong	Biomarker	[1089]
MAOB	TTGP7BY	Strong	Biomarker	[1090]
MAP2K2	TT8H9GB	Strong	Genetic Variation	[1091]
MAP2K5	TTV3O87	Strong	Altered Expression	[1092]
MAP3K10	TT9FN4J	Strong	Altered Expression	[1093]
MAP3K11	TTETX6Q	Strong	Biomarker	[1094]
MAP3K2	TTIX0ZU	Strong	Biomarker	[1095]
MAP3K3	TTJZNIG	Strong	Biomarker	[1096]
MAP3K5	TTOQCD8	Strong	Altered Expression	[1097]
MAP4	TT0VFPN	Strong	Posttranslational Modification	[1098]
MAP4K1	TTSHWUP	Strong	Biomarker	[1099]
MAP4K3	TTI0AHJ	Strong	Altered Expression	[1100]
MAP4K4	TT6NI13	Strong	Biomarker	[1101]
MAPK12	TTYT93M	Strong	Altered Expression	[1102]
MAPK14	TTQBR95	Strong	Altered Expression	[725]
MAPK7	TTU6FSC	Strong	Biomarker	[1103]
MAPK8	TT0K6EO	Strong	Altered Expression	[1104]
MAPK8IP1	TTXKZ8Q	Strong	Biomarker	[1105]
MARK2	TTAJ45Y	Strong	Genetic Variation	[1106]
MASP2	TTR01E9	Strong	Biomarker	[1107]
MAT2A	TTSMPXQ	Strong	Biomarker	[1108]
MBP	TT2RY5P	Strong	Biomarker	[1109]
MC1R	TT0MV2T	Strong	Genetic Variation	[1110]
MC2R	TTPWFDX	Strong	Biomarker	[1111]
MCHR1	TTX4RTB	Strong	Biomarker	[1112]
MCM7	TT1RM3F	Strong	Biomarker	[1113]
MCOLN1	TT9XBVO	Strong	Biomarker	[1114]
MECP2	TTTAU9R	Strong	Biomarker	[1115]
MERTK	TTO7LKR	Strong	Biomarker	[1116]
MGAT1	TTYJRN5	Strong	Altered Expression	[1117]
MGLL	TTZ963I	Strong	Biomarker	[1118]
MIF	TT6804T	Strong	Biomarker	[1119]
MKNK1	TTEZAUX	Strong	Biomarker	[1120]
MKNK2	TTRECN3	Strong	Biomarker	[1121]
MMP10	TTXLEG7	Strong	Altered Expression	[1122]
MMP11	TTZW4MV	Strong	Biomarker	[1123]
MMP12	TTXZ0KQ	Strong	Biomarker	[1124]
MMP21	TTYRF5E	Strong	Altered Expression	[1125]
MMP8	TTGA1IV	Strong	Biomarker	[1126]
MPL	TTIHYA4	Strong	Altered Expression	[1127]
MRC2	TTYVR8M	Strong	Biomarker	[1128]
MRGPRX1	TTIX6PK	Strong	Biomarker	[914]
MRM2	TTUQ7WN	Strong	Biomarker	[1129]
MSI1	TTSM4BA	Strong	Altered Expression	[1130]
MSLN	TT4RXME	Strong	Biomarker	[1131]
MSMB	TTYH1ZK	Strong	Biomarker	[1132]
MST1R	TTBQ3OC	Strong	Biomarker	[1133]
MTDH	TTH6SA5	Strong	Altered Expression	[1134]
MTM1	TTY2TCU	Strong	Genetic Variation	[1135]
MTNR1A	TT0WAIE	Strong	Biomarker	[1136]
MTNR1B	TT32JK8	Strong	Biomarker	[1136]
MUC15	TTGQ6MI	Strong	Genetic Variation	[1137]
MYCBP	TTVW4XU	Strong	Altered Expression	[1138]
MYLK	TT18ETS	Strong	Posttranslational Modification	[1139]
NAAA	TTMN4HY	Strong	Biomarker	[1140]
NAALAD2	TTUWQLT	Strong	Biomarker	[1141]
NACC1	TT4AQ5F	Strong	Biomarker	[1142]
NAGLU	TTDM6HZ	Strong	Genetic Variation	[1143]
NAPRT	TTVR1FW	Strong	Altered Expression	[1144]
NCF1	TTZ4JC3	Strong	Biomarker	[1145]
NCK1	TTMA3VF	Strong	Altered Expression	[1146]
NCL	TTK1V5Q	Strong	Biomarker	[1147]
NCOA3	TT124R0	Strong	Altered Expression	[1148]
NCOA4	TT8OY02	Strong	Biomarker	[1149]
NCR1	TTQNRJM	Strong	Biomarker	[1150]
NDUFA13	TTRU1NG	Strong	Biomarker	[1151]
NECTIN4	TTPO9EG	Strong	Biomarker	[1152]
NEDD9	TT1UREA	Strong	Altered Expression	[1153]
NEK1	TTO5QT2	Strong	Biomarker	[1154]
NEK2	TT3VZ24	Strong	Biomarker	[1155]
NEK6	TT8I2M7	Strong	Altered Expression	[1156]
NEK7	TTJ5SWP	Strong	Altered Expression	[1157]
NFKBIA	TTSHAEB	Strong	Biomarker	[1158]
NGF	TTDN3LF	Strong	Biomarker	[1159]
NGFR	TTEDJN4	Strong	Biomarker	[1160]
NLRP1	TTQX29T	Strong	Biomarker	[1161]
NLRP3	TT4EN8X	Strong	Biomarker	[1162]
NME9	TTHSVK0	Strong	Biomarker	[1163]
NNT	TTKIH76	Strong	Biomarker	[1164]
NODAL	TTK2O1Q	Strong	Biomarker	[1165]
NOTCH2	TT82FVD	Strong	Altered Expression	[1166]
NOTCH3	TTVX7IA	Strong	Biomarker	[1167]
NPPB	TTY63XT	Strong	Biomarker	[1168]
NPR1	TTM9IYA	Strong	Biomarker	[1169]
NPY2R	TTJ6WK9	Strong	Biomarker	[1170]
NPY5R	TTY6EWA	Strong	Biomarker	[1171]
NR1D1	TTAD1O8	Strong	Biomarker	[1172]
NR1H2	TTXA6PH	Strong	Biomarker	[1173]
NR1H4	TTS4UGC	Strong	Biomarker	[1174]
NR1I2	TT7LCTF	Strong	Biomarker	[1175]
NR3C1	TTOZRK6	Strong	Biomarker	[1176]
NR4A1	TTMXE2Q	Strong	Biomarker	[1177]
NR4A2	TT9HKN3	Strong	Altered Expression	[651]
NRAS	TTW2R9X	Strong	Genetic Variation	[1178]
NRN1	TTS05MJ	Strong	Altered Expression	[1179]
NRP2	TTRXUVC	Strong	Altered Expression	[1180]
NSD1	TTTSJ3H	Strong	Biomarker	[1181]
NTF3	TTZHKV9	Strong	Biomarker	[1182]
NTRK2	TTKN7QR	Strong	Biomarker	[1183]
NUAK2	TTHVOTQ	Strong	Biomarker	[1184]
NUF2	TTIXBFP	Strong	Genetic Variation	[1185]
OAT	TTTSCQ2	Strong	Biomarker	[1186]
ODC1	TTUMGNO	Strong	Altered Expression	[1187]
OGDH	TTH8T6I	Strong	Altered Expression	[1188]
OLFM4	TTK1CX7	Strong	Altered Expression	[1189]
OLR1	TTKSND3	Strong	Altered Expression	[1148]
OPRD1	TT27RFC	Strong	Biomarker	[1190]
OR51E2	TTZRE3C	Strong	Altered Expression	[1191]
ORAI1	TTE76YK	Strong	Biomarker	[1192]
OSMR	TTAH0KM	Strong	Biomarker	[1193]
OTC	TT5KIO9	Strong	Biomarker	[1194]
OXER1	TT7WBSV	Strong	Biomarker	[914]
OXTR	TTSCIUP	Strong	Altered Expression	[1195]
P2RY1	TTA93TL	Strong	Biomarker	[1196]
P2RY11	TTYXPCO	Strong	Genetic Variation	[1197]
P2RY12	TTZ1DT0	Strong	Genetic Variation	[1198]
P2RY8	TT84EWY	Strong	Genetic Variation	[135]
PAGE5	TTNWOIT	Strong	Biomarker	[1199]
PAK1	TTFN95D	Strong	Biomarker	[1200]
PAK4	TT7Y3BZ	Strong	Biomarker	[1201]
PAWR	TT3I4WV	Strong	Altered Expression	[830]
PBK	TTMY6BZ	Strong	Biomarker	[1202]
PBRM1	TTH8ZRL	Strong	Biomarker	[1203]
PCSK1	TTED9LZ	Strong	Biomarker	[1204]
PCSK7	TTD30LY	Strong	Biomarker	[1205]
PCYT1B	TTUAIKM	Strong	Altered Expression	[1206]
PDCD1LG2	TTW14O3	Strong	Biomarker	[1207]
PDCD2	TTYOVWN	Strong	Biomarker	[1208]
PDE3A	TT06AWU	Strong	Biomarker	[1209]
PDE4A	TTZ97H5	Strong	Altered Expression	[1210]
PDE4B	TTVIAT9	Strong	Biomarker	[1211]
PDE5A	TTJ0IQB	Strong	Biomarker	[1212]
PDE7A	TT1BC3A	Strong	Biomarker	[1213]
PDGFD	TTSN0GA	Strong	Biomarker	[1214]
PDGFRB	TTI7421	Strong	Biomarker	[1215]
PDK1	TTCZOF2	Strong	Biomarker	[1216]
PDK2	TTJGCKM	Strong	Biomarker	[1217]
PDK3	TTDEQIP	Strong	Biomarker	[1218]
PDXK	TTXI3KF	Strong	Genetic Variation	[1219]
PDZK1	TTDTBLM	Strong	Biomarker	[1220]
PECAM1	TT4EZB2	Strong	Biomarker	[1221]
PEPD	TTLZXI0	Strong	Biomarker	[1222]
PF4	TTSG7Q5	Strong	Altered Expression	[1223]
PFKFB3	TTTHMQJ	Strong	Biomarker	[1224]
PGC	TT7K6AD	Strong	Biomarker	[1225]
PHF8	TT81PFE	Strong	Biomarker	[1226]
PHGDH	TT8DRCK	Strong	Biomarker	[1227]
PHLDB3	TT1KS9D	Strong	Biomarker	[1228]
PIGU	TT2LHI6	Strong	Altered Expression	[722]
PIM1	TTTN5QW	Strong	Altered Expression	[1229]
PIM2	TT69J2Z	Strong	Altered Expression	[237]
PINX1	TT4FJ3A	Strong	Biomarker	[1230]
PKD2L1	TTAHD89	Strong	Biomarker	[1231]
PKN1	TTSL41O	Strong	Biomarker	[1232]
PKN3	TTW3P4R	Strong	Biomarker	[1233]
PLA2G1B	TT9V5JH	Strong	Biomarker	[1234]
PLA2R1	TTHKW7D	Strong	Biomarker	[1235]
PLAC1	TTM18HX	Strong	Biomarker	[1236]
PLAT	TTXAGYU	Strong	Biomarker	[1237]
PLAUR	TTNOSTX	Strong	Biomarker	[1238]
PLK4	TTGPNZQ	Strong	Biomarker	[1239]
PLOD1	TTEKJP3	Strong	Altered Expression	[1240]
PLXDC1	TTPSK7A	Strong	Biomarker	[1241]
PMEL	TT8MK59	Strong	Biomarker	[1242]
PML	TTLH9NY	Strong	Biomarker	[1243]
PNPLA3	TTEUAEH	Strong	Genetic Variation	[1244]
POLB	TTA0XPV	Strong	Genetic Variation	[1245]
PON1	TT9LX82	Strong	Altered Expression	[1246]
PORCN	TTNFBTO	Strong	Altered Expression	[1247]
POSTN	TT8ALTZ	Strong	Biomarker	[1248]
PPARGC1B	TTKSQ3W	Strong	Biomarker	[1249]
PPIF	TTRFQTB	Strong	Biomarker	[446]
PPM1A	TTLA7IX	Strong	Altered Expression	[1250]
PPM1D	TTENJAB	Strong	Genetic Variation	[1251]
PPME1	TTXQ54R	Strong	Altered Expression	[1252]
PPP1CA	TTFLH0E	Strong	Altered Expression	[1253]
PPP2R5A	TTLONKX	Strong	Biomarker	[1254]
PPP5C	TTTW7FJ	Strong	Biomarker	[1255]
PRAME	TTPH7T0	Strong	Biomarker	[1256]
PRCP	TTTJZ4M	Strong	Altered Expression	[1257]
PRDX5	TTLPJWH	Strong	Altered Expression	[1258]
PREP	TTNGKET	Strong	Biomarker	[1259]
PRKCA	TTFJ8Q1	Strong	Biomarker	[1260]
PRKCB	TTYPXQF	Strong	Genetic Variation	[1261]
PRKCE	TT57MT2	Strong	Biomarker	[1262]
PRKCH	TTONI0R	Strong	Biomarker	[1263]
PRKCQ	TT1MS7X	Strong	Altered Expression	[1264]
PRMT7	TTAR2P0	Strong	Biomarker	[1265]
PRNP	TTY5F9C	Strong	Biomarker	[1266]
PROC	TTZUXYS	Strong	Biomarker	[1267]
PROKR1	TTB9CIL	Strong	Biomarker	[1268]
PROKR2	TTM67AX	Strong	Biomarker	[1268]
PRSS1	TT2WR1T	Strong	Genetic Variation	[1269]
PRSS8	TTT4N0Q	Strong	Altered Expression	[1270]
PRTN3	TT5MLC4	Strong	Biomarker	[1271]
PSMB10	TTPNACM	Strong	Altered Expression	[1272]
PSMB6	TT8EPLT	Strong	Genetic Variation	[1273]
PSMB8	TTEAD9J	Strong	Genetic Variation	[1274]
PSMD10	TT2H4LN	Strong	Altered Expression	[1275]
PTAFR	TTQL5VC	Strong	Biomarker	[1276]
PTBP1	TTWMX0U	Strong	Biomarker	[1277]
PTGDR	TTNVEIR	Strong	Biomarker	[1278]
PTGER2	TT1ZAVI	Strong	Biomarker	[1279]
PTGES	TTYLQ8V	Strong	Biomarker	[1280]
PTGFR	TTT2ZAR	Strong	Biomarker	[1281]
PTH	TT6F7GZ	Strong	Biomarker	[1282]
PTK2	TTON5IT	Strong	Biomarker	[1283]
PTK7	TTXH2ZN	Strong	Biomarker	[1284]
PTN	TTA9EJK	Strong	Biomarker	[1285]
PTPN1	TTELIN2	Strong	Biomarker	[1286]
PTPN13	TT405FP	Strong	Biomarker	[1287]
PTPN14	TTNIR6C	Strong	Biomarker	[1288]
PTPN2	TTY8PUS	Strong	Biomarker	[1289]
PTPN6	TT369M5	Strong	Biomarker	[1290]
PTPN7	TT2C1DT	Strong	Altered Expression	[1291]
PTPRC	TTUS45N	Strong	Biomarker	[1292]
PVRIG	TTOGCNT	Strong	Biomarker	[1293]
PYY	TTVFJLX	Strong	Biomarker	[1294]
RABL3	TTYGK57	Strong	Genetic Variation	[1295]
RAC1	TT2M9CG	Strong	Biomarker	[1296]
RAC3	TT9BQ50	Strong	Biomarker	[1297]
RACK1	TTJ10AL	Strong	Altered Expression	[1298]
RALBP1	TTVSRUA	Strong	Biomarker	[1299]
RAPGEF4	TTOS63B	Strong	Biomarker	[1300]
RARA	TTW38KT	Strong	Altered Expression	[1301]
RARG	TT1Q3IE	Strong	Biomarker	[1302]
RASA1	TTPNZ1F	Strong	Genetic Variation	[1303]
RBBP9	TTUA38Z	Strong	Biomarker	[1304]
RBP4	TT0C8BY	Strong	Altered Expression	[1305]
RBPJ	TT72D4Z	Strong	Biomarker	[1306]
RECK	TTRZBW7	Strong	Biomarker	[1307]
REN	TTB2MXP	Strong	Biomarker	[197]
RGS2	TTKB7T3	Strong	Altered Expression	[1308]
RGS4	TTGTKX9	Strong	Biomarker	[1309]
RHAG	TTVHFE8	Strong	Biomarker	[1310]
RHBDF2	TTH1ZOP	Strong	Genetic Variation	[1311]
RIPK2	TTCQ2E5	Strong	Biomarker	[1312]
RNASEL	TT7V0K4	Strong	Biomarker	[1313]
RNF6	TT4S09X	Strong	Biomarker	[1314]
RNMT	TTG45HY	Strong	Altered Expression	[1315]
ROBO4	TT3S9TY	Strong	Altered Expression	[1316]
ROCK1	TTZN7RP	Strong	Altered Expression	[1317]
ROR1	TTDEJAU	Strong	Altered Expression	[1318]
RORB	TTGB2LZ	Strong	Genetic Variation	[1319]
RPS12	TTD81N3	Strong	Genetic Variation	[1320]
RPS6KA1	TTIXKA4	Strong	Altered Expression	[1321]
RPS6KA5	TTYXEPL	Strong	Biomarker	[1322]
RPS6KB1	TTG0U4H	Strong	Biomarker	[1323]
RPS6KB2	TTMVQXO	Strong	Biomarker	[1324]
RRM1	TTWP0NS	Strong	Altered Expression	[1325]
RSPO1	TTI9HL4	Strong	Biomarker	[1326]
RTN4R	TTVRZUO	Strong	Biomarker	[1327]
RXFP1	TTMAHD1	Strong	Biomarker	[1328]
RXRB	TTKLV96	Strong	Biomarker	[1329]
RXRG	TTH029C	Strong	Altered Expression	[1330]
S100A12	TTQ4ESF	Strong	Altered Expression	[1331]
S100A6	TT716MY	Strong	Biomarker	[1332]
S100A8	TT4AF6N	Strong	Biomarker	[1333]
S100A9	TT0TMQG	Strong	Biomarker	[1334]
S1PR2	TTVSMOH	Strong	Biomarker	[1335]
SATB1	TTLFRIC	Strong	Biomarker	[1336]
SCAP	TTL6U2P	Strong	Altered Expression	[1337]
SCGB1D2	TT5D314	Strong	Altered Expression	[1338]
SCGB2A2	TT1W3RE	Strong	Biomarker	[1339]
SCN1A	TTANOZH	Strong	Biomarker	[1142]
SCN2A	TTLJTUF	Strong	Biomarker	[1340]
SCN9A	TT4G2JS	Strong	Genetic Variation	[1341]
SCT	TTOBVIN	Strong	Biomarker	[1342]
SCUBE2	TTWREQP	Strong	Biomarker	[1343]
SDC1	TTYDSVG	Strong	Biomarker	[1344]
SDC2	TT5H2F0	Strong	Altered Expression	[1345]
SDHD	TTVH9W8	Strong	Genetic Variation	[1346]
SELL	TT2IYXF	Strong	Biomarker	[1347]
SELP	TTE5VG0	Strong	Genetic Variation	[1348]
SEMA3A	TTVKD3S	Strong	Biomarker	[1349]
SERPINC1	TT4QPUL	Strong	Biomarker	[1350]
SERPIND1	TT8XSKJ	Strong	Biomarker	[1351]
SERPINF1	TTR59S1	Strong	Biomarker	[1352]
SERPING1	TTVQ6R9	Strong	Biomarker	[1353]
SETD7	TTJ0FSU	Strong	Biomarker	[1354]
SF3B1	TTL2WUI	Strong	Genetic Variation	[1355]
SFRP4	TTX8I1Y	Strong	Genetic Variation	[1356]
SFTPD	TTGLMU7	Strong	Biomarker	[1357]
SGCA	TTS9Q5V	Strong	Biomarker	[1358]
SGCB	TTEDCQ0	Strong	Biomarker	[1359]
SGO1	TTBPKGD	Strong	Altered Expression	[1360]
SGSH	TTPJ2SH	Strong	Biomarker	[1361]
SHCBP1	TTZ9WGL	Strong	Biomarker	[1362]
SIGLEC15	TTBSZPF	Strong	Biomarker	[1363]
SIK3	TTW6L4V	Strong	Biomarker	[1364]
SIRT2	TTLKF5M	Strong	Biomarker	[1365]
SIRT5	TTH0IOD	Strong	Biomarker	[1366]
SLC10A1	TTWZRY5	Strong	Biomarker	[1367]
SLC12A4	TTJ8C67	Strong	Altered Expression	[1368]
SLC14A1	TTWVJU1	Strong	Altered Expression	[1369]
SLC16A1	TTN1J82	Strong	Biomarker	[706]
SLC17A5	TTFSUIA	Strong	Biomarker	[1370]
SLC18A2	TTNZRI3	Strong	Biomarker	[1371]
SLC19A1	TT09I7D	Strong	Altered Expression	[1372]
SLC19A2	TT2A1DZ	Strong	Altered Expression	[1373]
SLC1A3	TT8WRDA	Strong	Biomarker	[1374]
SLC22A1	TTM5Q4V	Strong	Biomarker	[1375]
SLC22A3	TTG2UMS	Strong	Altered Expression	[1376]
SLC23A2	TTOP832	Strong	Altered Expression	[1377]
SLC25A4	TTU5A6Q	Strong	Biomarker	[1378]
SLC2A9	TTIF3GB	Strong	Altered Expression	[1379]
SLC30A8	TTXIGT7	Strong	Genetic Variation	[1380]
SLC37A4	TT1KPBZ	Strong	Biomarker	[1381]
SLC38A2	TTUSC27	Strong	Altered Expression	[1382]
SLC38A7	TTEARWC	Strong	Biomarker	[1383]
SLC39A6	TTZN1CF	Strong	Biomarker	[1384]
SLC3A2	TT5CZSM	Strong	Biomarker	[1385]
SLC44A4	TT0NYDG	Strong	Altered Expression	[1386]
SLC52A2	TT6TKEN	Strong	Biomarker	[1387]
SLC5A1	TT2UE56	Strong	Altered Expression	[1388]
SLC5A5	TTW7HI9	Strong	Biomarker	[1389]
SLC6A14	TTB6H2S	Strong	Altered Expression	[1390]
SLC6A4	TT3ROYC	Strong	Genetic Variation	[1391]
SLC7A1	TT4S150	Strong	Altered Expression	[718]
SLC7A5	TTPH2JB	Strong	Biomarker	[1392]
SLC8A1	TTCF82X	Strong	Biomarker	[1393]
SLCO1A2	TTUGD21	Strong	Biomarker	[1394]
SLK	TT8K4DE	Strong	Biomarker	[1395]
SMAD1	TT9GR53	Strong	Biomarker	[1396]
SMAD7	TT0J32Z	Strong	Biomarker	[1397]
SMAD9	TTX8EBV	Strong	Posttranslational Modification	[1398]
SMARCA4	TTVQEZS	Strong	Biomarker	[1399]
SMN1	TT8QL6X	Strong	Altered Expression	[1400]
SMYD2	TT7YJFO	Strong	Altered Expression	[1401]
SNCG	TT5TQNZ	Strong	Biomarker	[1402]
SOCS1	TT8COJM	Strong	Biomarker	[1403]
SORD	TTLSRBZ	Strong	Genetic Variation	[1404]
SOX5	TTXHSZK	Strong	Biomarker	[1405]
SP1	TTZEP6S	Strong	Biomarker	[1406]
SPN	TTOZAX0	Strong	Altered Expression	[1407]
SPOCK1	TTF23RE	Strong	Altered Expression	[1408]
SPRY1	TT0PSN6	Strong	Altered Expression	[1409]
SQLE	TTE14XG	Strong	Biomarker	[1410]
SQSTM1	TTOT2RY	Strong	Biomarker	[1030]
SRD5A1	TTTU72V	Strong	Biomarker	[1411]
SRD5A2	TTT02K8	Strong	Altered Expression	[1412]
SRPK1	TTU3WV6	Strong	Biomarker	[1413]
SSTR3	TTJX3UE	Strong	Altered Expression	[1414]
SSTR4	TTAE1BR	Strong	Biomarker	[495]
SSTR5	TT2BC4G	Strong	Biomarker	[1415]
SSX2IP	TTZXB07	Strong	Biomarker	[1416]
ST14	TTPRO7W	Strong	Altered Expression	[1417]
STAB2	TTM3DAY	Strong	Biomarker	[1418]
STAR	TTEI40H	Strong	Biomarker	[1419]
STAT6	TTWOE1T	Strong	Biomarker	[1420]
STC2	TT4EFTR	Strong	Altered Expression	[1421]
STK16	TTFGN19	Strong	Biomarker	[1422]
STK17A	TTEYF03	Strong	Altered Expression	[1423]
STK33	TTP34DQ	Strong	Biomarker	[1424]
STK36	TTX5KEQ	Strong	Biomarker	[1425]
STK38L	TTNM4ZH	Strong	Biomarker	[471]
STK39	TTYQTIU	Strong	Biomarker	[1426]
STOML2	TTOI329	Strong	Altered Expression	[1427]
STRAP	TT165DP	Strong	Biomarker	[1428]
STYK1	TTRMCYJ	Strong	Biomarker	[1429]
SUCNR1	TT4FX9Y	Strong	Biomarker	[1430]
SYK	TT2HUPM	Strong	Biomarker	[1431]
TAAR1	TTIU98M	Strong	Biomarker	[1432]
TACC3	TTQ4UFD	Strong	Biomarker	[1433]
TACR1	TTZPO1L	Strong	Altered Expression	[1434]
TAGLN	TTDRZ9H	Strong	Biomarker	[1435]
TAOK1	TTQY9DH	Strong	Altered Expression	[1436]
TAOK3	TTO7L0V	Strong	Biomarker	[1437]
TBK1	TTMP03S	Strong	Biomarker	[1438]
TBL1X	TTAL6S1	Strong	Biomarker	[1439]
TBL1XR1	TTYXT16	Strong	Biomarker	[1440]
TBX21	TTNF9PH	Strong	Biomarker	[1441]
TBXA2R	TT2O84V	Strong	Biomarker	[1442]
TDG	TTEXRQD	Strong	Altered Expression	[1443]
TDGF1	TTN7HMG	Strong	Altered Expression	[1444]
TDO2	TTXNCBV	Strong	Altered Expression	[1445]
TDP1	TT64IHJ	Strong	Biomarker	[1446]
TDP2	TTYF26D	Strong	Biomarker	[1447]
TEC	TT1ZV49	Strong	Biomarker	[1448]
TEK	TT9VGXW	Strong	Biomarker	[1449]
TEP1	TTQGAVX	Strong	Biomarker	[1450]
TERF1	TT1Y6J2	Strong	Biomarker	[1451]
TERF2	TT5XSLT	Strong	Altered Expression	[1452]
TFAP2A	TTDY4BS	Strong	Altered Expression	[1453]
TFF1	TTNOJIZ	Strong	Altered Expression	[1454]
TFPI	TT068JH	Strong	Biomarker	[1455]
TFRC	TT8MG4S	Strong	Biomarker	[1456]
TGFB3	TTWOMY8	Strong	Altered Expression	[1457]
TGM1	TT7A949	Strong	Biomarker	[1458]
TGM2	TT2F4OL	Strong	Biomarker	[1459]
THPO	TTCG5PE	Strong	Biomarker	[1127]
THRA	TTTSEPU	Strong	Biomarker	[1460]
THRB	TTGER3L	Strong	Altered Expression	[1461]
TIAM1	TTNU6I5	Strong	Biomarker	[1462]
TIE1	TTT4236	Strong	Biomarker	[1463]
TIPARP	TT2FRAN	Strong	Biomarker	[1464]
TKTL1	TTNQ1J3	Strong	Biomarker	[1465]
TLN1	TTQSMFG	Strong	Biomarker	[1466]
TLR5	TTCXP8J	Strong	Altered Expression	[1467]
TLR7	TTRJ1K4	Strong	Biomarker	[1468]
TMEM219	TTY078U	Strong	Biomarker	[1469]
TMEM97	TT9NXW4	Strong	Biomarker	[1470]
TMPRSS11D	TTWHYC8	Strong	Altered Expression	[1471]
TMPRSS2	TT1GM2Z	Strong	Biomarker	[1472]
TNFAIP3	TT5W0IO	Strong	Biomarker	[1473]
TNFRSF10B	TTW20TU	Strong	Biomarker	[1474]
TNFRSF11A	TT3K9S2	Strong	Biomarker	[1475]
TNFRSF11B	TT2CJ75	Strong	Biomarker	[1476]
TNFRSF12A	TTKPS7V	Strong	Biomarker	[1477]
TNFRSF13B	TTL9OD4	Strong	Altered Expression	[1478]
TNFRSF1A	TTG043C	Strong	Biomarker	[1479]
TNFRSF25	TTDV6BQ	Strong	Biomarker	[1480]
TNFRSF4	TTL31H0	Strong	Biomarker	[1481]
TNFRSF9	TTPW9LJ	Strong	Biomarker	[1482]
TNFSF11	TT9E8HR	Strong	Biomarker	[1483]
TNFSF13	TTOI1RM	Strong	Biomarker	[1484]
TNFSF13B	TTWMIDN	Strong	Biomarker	[1485]
TNFSF14	TTKVENM	Strong	Biomarker	[1486]
TNFSF4	TTBW580	Strong	Biomarker	[1487]
TNK2	TTIET93	Strong	Biomarker	[1488]
TNKS	TTVUSO7	Strong	Biomarker	[1489]
TNNC1	TT8RDXP	Strong	Altered Expression	[1490]
TNNI3	TTNLDK6	Strong	Biomarker	[1491]
TNS4	TT1K65C	Strong	Altered Expression	[1492]
TOP1	TTGTQHC	Strong	Biomarker	[1493]
TOP2A	TTCGY2K	Strong	Genetic Variation	[1447]
TOP2B	TT4NVEM	Strong	Altered Expression	[1494]
TPT1	TT3PTB6	Strong	Biomarker	[1495]
TPX2	TT0PHL4	Strong	Biomarker	[1496]
TRB	TT84HCW	Strong	Biomarker	[1497]
TRBC1	TT1DHW2	Strong	Biomarker	[1498]
TREM1	TTHZQP0	Strong	Altered Expression	[1499]
TRIM37	TTAMCSL	Strong	Biomarker	[1500]
TRIM59	TT613U4	Strong	Biomarker	[1501]
TRIP10	TTKHTGE	Strong	Genetic Variation	[1502]
TRPC5	TT32NQ1	Strong	Biomarker	[481]
TRPC6	TTRBT3W	Strong	Biomarker	[1503]
TRPM2	TTEBMN7	Strong	Biomarker	[1504]
TRPM3	TTO3TD8	Strong	Biomarker	[1505]
TRPM7	TTFPVZO	Strong	Biomarker	[1506]
TRPM8	TTXDKTO	Strong	Biomarker	[1507]
TRPV4	TTKP2SU	Strong	Biomarker	[1508]
TSHR	TT6NYJA	Strong	Genetic Variation	[1509]
TSLP	TTHMW3T	Strong	Biomarker	[1510]
TSPO	TTPTXIN	Strong	Genetic Variation	[63]
TTR	TTPOYU7	Strong	Altered Expression	[1511]
TXN	TTZJ5U9	Strong	Biomarker	[1512]
TXNIP	TTTLDZK	Strong	Altered Expression	[1513]
TXNRD1	TTR7UJ3	Strong	Biomarker	[1514]
TYK2	TTBYWP2	Strong	Biomarker	[1515]
TYMP	TTO0IB8	Strong	Altered Expression	[1516]
TYR	TTULVH8	Strong	Biomarker	[1517]
TYRO3	TTIEMFN	Strong	Biomarker	[1518]
UBE3A	TTUZX6V	Strong	Biomarker	[1519]
UCHL3	TT23UD6	Strong	Biomarker	[1520]
UCHL5	TTSX29Z	Strong	Altered Expression	[1521]
UCP1	TTI12YJ	Strong	Biomarker	[1522]
UCP2	TTSC2YM	Strong	Biomarker	[1523]
UGCG	TTPHEX3	Strong	Biomarker	[1524]
UGT1A1	TT34ZAF	Strong	Biomarker	[1525]
ULK1	TT4D7MJ	Strong	Biomarker	[1526]
UMPS	TTAFJUD	Strong	Altered Expression	[1527]
USP10	TT5IH09	Strong	Posttranslational Modification	[1528]
USP13	TTVJIO2	Strong	Biomarker	[1529]
USP14	TTVSYP9	Strong	Biomarker	[1530]
USP33	TT4E85Q	Strong	Biomarker	[1531]
UTS2	TTERU0T	Strong	Biomarker	[1532]
UTS2R	TTW5UDX	Strong	Genetic Variation	[1533]
VDAC1	TTAMKGB	Strong	Biomarker	[1534]
VEGFB	TTPJQHE	Strong	Biomarker	[1535]
VSIR	TT51SK8	Strong	Biomarker	[1536]
VWF	TT3SZBT	Strong	Biomarker	[1537]
WAS	TTE8T73	Strong	Biomarker	[1538]
WEE1	TTJFOAL	Strong	Biomarker	[1539]
WNT5A	TTKG7F8	Strong	Biomarker	[1540]
WNT7A	TT8NARC	Strong	Biomarker	[1541]
WRN	TT2H5WQ	Strong	Genetic Variation	[1542]
XPA	TTGT87E	Strong	Biomarker	[1543]
ZNF224	TT1CDXL	Strong	Biomarker	[1544]
ZUP1	TTZC0KV	Strong	Biomarker	[1545]
ACVR2A	TTX2DRI	Definitive	Genetic Variation	[1546]
ANGPT1	TTWNQ1T	Definitive	Biomarker	[1547]
ANPEP	TTPHMWB	Definitive	Altered Expression	[1548]
APCS	TTB7VAT	Definitive	Biomarker	[1549]
ASPH	TT2KHP7	Definitive	Altered Expression	[1550]
ATAD2	TT9A0HI	Definitive	Biomarker	[1551]
BIRC7	TTHZ8TA	Definitive	Biomarker	[1552]
CAPN1	TT1WBIJ	Definitive	Biomarker	[1553]
CDCA8	TT04YCM	Definitive	Altered Expression	[1554]
CNP	TT71P0H	Definitive	Biomarker	[1555]
CPE	TTXPWO6	Definitive	Altered Expression	[1556]
CRLF2	TTRMZ0N	Definitive	Biomarker	[1557]
CUBN	TT9YLCR	Definitive	Altered Expression	[1558]
DNASE1	TTYWGOJ	Definitive	Biomarker	[1559]
DNM2	TTVRA5G	Definitive	Biomarker	[1560]
EGFL7	TT7WD0H	Definitive	Biomarker	[1561]
ETS2	TT9AH0M	Definitive	Altered Expression	[1562]
EZH1	TTNJA0C	Definitive	Biomarker	[1563]
FSCN1	TTTRS9B	Definitive	Altered Expression	[1564]
GADD45B	TTMDW9L	Definitive	Altered Expression	[1565]
GHRHR	TTG4R8V	Definitive	Biomarker	[1566]
GPBAR1	TTSDVTR	Definitive	Biomarker	[1567]
GRK3	TT5A4DX	Definitive	Biomarker	[1568]
GSN	TTUH7OM	Definitive	Biomarker	[1569]
ID2	TTW8A5N	Definitive	Genetic Variation	[1570]
KISS1	TTU2O6T	Definitive	Altered Expression	[1571]
KLK4	TT4319X	Definitive	Altered Expression	[1572]
LALBA	TTBRLU3	Definitive	Biomarker	[1573]
LTB4R2	TTVJX54	Definitive	Biomarker	[1574]
LTF	TTSZDQU	Definitive	Altered Expression	[1575]
MAGEA1	TT63M7Q	Definitive	Altered Expression	[1576]
MCAM	TTHRE05	Definitive	Altered Expression	[1577]
MLANA	TT362RB	Definitive	Biomarker	[1578]
MMP16	TTNP4CU	Definitive	Biomarker	[1579]
NTRK3	TTXABCW	Definitive	Genetic Variation	[1580]
PDE4D	TTSKMI8	Definitive	Biomarker	[1581]
PGD	TTZ3IFB	Definitive	Biomarker	[1582]
PLD1	TT3T17P	Definitive	Biomarker	[1583]
PLIN1	TTIV27N	Definitive	Altered Expression	[1584]
PMS1	TTX1ISF	Definitive	Genetic Variation	[1585]
PNKP	TTHR3IE	Definitive	Biomarker	[1586]
PTGDR2	TTQDMX5	Definitive	Biomarker	[1587]
RENBP	TTZCG0Q	Definitive	Biomarker	[1588]
RGMA	TTURJV4	Definitive	Biomarker	[1589]
RPS6KA2	TT0ZW9O	Definitive	Altered Expression	[1321]
SCGB1A1	TTONPVW	Definitive	Altered Expression	[1590]
SCN10A	TT90XZ8	Definitive	Biomarker	[1591]
SGPL1	TT618Q2	Definitive	Altered Expression	[1592]
SLC12A3	TTP362L	Definitive	Genetic Variation	[1593]
SREBF1	TTER0UB	Definitive	Altered Expression	[1594]
SRMS	TT7YMXZ	Definitive	Altered Expression	[1595]
SSTR1	TTIND6G	Definitive	Genetic Variation	[1596]
STK4	TTCPLVN	Definitive	Biomarker	[1597]
STXBP4	TTKS60G	Definitive	Biomarker	[1598]
TAP1	TT7JZI8	Definitive	Genetic Variation	[1599]
TRIM28	TTQ2BKV	Definitive	Biomarker	[1600]
ULK3	TTYENHQ	Definitive	Biomarker	[1601]
ZAP70	TTUMHT8	Definitive	Altered Expression	[1602]

This Disease Is Related to 76 DTP Molecule(s)

Gene Name	DTP ID	Evidence Level	Mode of Inheritance	REF
SLC25A16	DTNU9EW	Limited	Biomarker	[1603]
SLC25A19	DTT82QK	Limited	Biomarker	[1604]
SLC25A5	DTL1TRY	Limited	Biomarker	[1605]
SLC35A1	DTVZIRG	Limited	Altered Expression	[1606]
SLC35A2	DT0567K	Limited	Biomarker	[1525]
SLC39A3	DTH08M7	Limited	Altered Expression	[1607]
SLC39A4	DTEZCUM	Limited	Altered Expression	[1608]
SLC39A7	DTDQSAM	Limited	Biomarker	[1384]
SLC45A2	DTNCJAT	Limited	Biomarker	[1609]
SLC50A1	DTI9CQU	Limited	Biomarker	[1610]
SLC5A8	DTE3TAW	Limited	Biomarker	[1611]
SLC7A9	DTP7AEQ	Limited	Biomarker	[1612]
SLC9C1	DT9J8DO	Limited	Biomarker	[1613]
SLC16A9	DTQK5O9	moderate	Biomarker	[1614]
SLC20A1	DTMULXV	moderate	Biomarker	[1615]
SLC22A5	DT3HUVD	moderate	Biomarker	[1616]
SLC25A21	DT2UQYR	moderate	Biomarker	[1617]
SLC25A37	DTLBGTZ	moderate	Biomarker	[1618]
SLC31A1	DTP8L4F	moderate	Altered Expression	[1619]
SLC31A2	DT8Q56F	moderate	Altered Expression	[1620]
SLC43A2	DTK02I1	moderate	Biomarker	[1621]
SLC52A1	DT7NOKR	moderate	Biomarker	[1387]
ABCA2	DTJ4NEG	Strong	Biomarker	[1622]
ABCB5	DTKVEXO	Strong	Biomarker	[1623]
ABCB6	DTF9Y2V	Strong	Biomarker	[1624]
ABCB9	DT68UV2	Strong	Biomarker	[1625]
ABCC5	DTYVM24	Strong	Biomarker	[1626]
ABCD1	DTKM9DZ	Strong	Biomarker	[1627]
ATP12A	DT5NLZA	Strong	Biomarker	[567]
ATP2B1	DTJWQ1L	Strong	Biomarker	[1628]
ATP7A	DT0LT17	Strong	Biomarker	[1629]
CACNG2	DTRL7OG	Strong	Genetic Variation	[1630]
KCNK2	DTENHUP	Strong	Biomarker	[1631]
SLC11A1	DT650XW	Strong	Biomarker	[1632]
SLC12A2	DTHKL3Q	Strong	Altered Expression	[1368]
SLC14A2	DT8QC7K	Strong	Genetic Variation	[1533]
SLC16A10	DTPAQJO	Strong	Biomarker	[1633]
SLC16A12	DTZOKFJ	Strong	Posttranslational Modification	[264]
SLC16A7	DTLT3UG	Strong	Biomarker	[1634]
SLC17A1	DT8ARWJ	Strong	Biomarker	[1635]
SLC17A9	DT9BI8W	Strong	Altered Expression	[1636]
SLC18A1	DTM953D	Strong	Altered Expression	[1371]
SLC1A4	DTC54PX	Strong	Genetic Variation	[1637]
SLC22A17	DTXI9E6	Strong	Biomarker	[1638]
SLC24A3	DTO18LP	Strong	Biomarker	[1639]
SLC25A11	DT0YAUQ	Strong	Biomarker	[1640]
SLC25A20	DTQOUM4	Strong	Biomarker	[47]
SLC25A22	DTJCWP8	Strong	Biomarker	[1641]
SLC25A29	DT96BT4	Strong	Biomarker	[1642]
SLC25A3	DTCRIWV	Strong	Biomarker	[1643]
SLC26A2	DTFSLX5	Strong	Altered Expression	[1644]
SLC27A2	DTXK9WA	Strong	Altered Expression	[1645]
SLC27A3	DTEW95J	Strong	Biomarker	[1646]
SLC2A13	DT0NSKB	Strong	Biomarker	[1647]
SLC2A2	DTUJPOL	Strong	Altered Expression	[1648]
SLC2A3	DT9SQ3L	Strong	Biomarker	[1649]
SLC2A5	DTOR02F	Strong	Genetic Variation	[1650]
SLC2A6	DTS4MKQ	Strong	Altered Expression	[1651]
SLC30A3	DTKMECW	Strong	Genetic Variation	[1652]
SLC30A9	DT2I79L	Strong	Altered Expression	[1653]
SLC35B2	DT81RKJ	Strong	Biomarker	[1654]
SLC37A1	DTH9SQJ	Strong	Biomarker	[1655]
SLC39A1	DTLWPXS	Strong	Biomarker	[1656]
SLC39A10	DTK02RZ	Strong	Altered Expression	[1384]
SLC39A2	DTL8VXO	Strong	Altered Expression	[1657]
SLC39A8	DTLPQGT	Strong	Genetic Variation	[1652]
SLC43A3	DTGBPR5	Strong	Biomarker	[1658]
SLC4A1	DTB0Q3P	Strong	Altered Expression	[1659]
SLC4A2	DTF7GAL	Strong	Biomarker	[603]
SLC4A7	DT03V27	Strong	Biomarker	[1660]
SLC52A3	DTBVQIO	Strong	Altered Expression	[1661]
SLC6A6	DTHWCVA	Strong	Biomarker	[1662]
SLC7A2	DTWY9RT	Strong	Biomarker	[1663]
SLC7A3	DTXQR1W	Strong	Biomarker	[1664]
SLC7A7	DTE4HJ8	Strong	Biomarker	[1665]
SLC9A6	DTN0JXW	Strong	Biomarker	[1666]

This Disease Is Related to 122 DME Molecule(s)

Gene Name	DME ID	Evidence Level	Mode of Inheritance	REF
ADH4	DEOCWU3	Limited	Altered Expression	[508]
AKR1C1	DE7P2FB	Limited	Altered Expression	[1667]
BAAT	DERA3OF	Limited	Biomarker	[1668]
CPA4	DEXKD7J	Limited	Biomarker	[1669]
CYP27A1	DEBS639	Limited	Genetic Variation	[1670]
EGLN3	DEMQTKH	Limited	Biomarker	[1671]
FAAH	DEUM1EX	Limited	Biomarker	[1672]
FPGS	DECWT2V	Limited	Biomarker	[1673]
HSD17B7	DEDMWFX	Limited	Altered Expression	[414]
INPP4A	DEBJ2NL	Limited	Biomarker	[1674]
MARS1	DE0K52I	Limited	Biomarker	[1675]
MAT2B	DEKF1OH	Limited	Biomarker	[1676]
MSRA	DEU2ZBY	Limited	Biomarker	[1677]
N6AMT1	DEOT0QC	Limited	Genetic Variation	[1678]
NAT10	DEZV4AP	Limited	Biomarker	[1679]
PGM1	DEA3VM1	Limited	Altered Expression	[1680]
PNPO	DE3Z1RA	Limited	Biomarker	[1681]
SI	DE5EO4Y	Limited	Biomarker	[201]
UGT1A4	DELOY3P	Limited	Biomarker	[1525]
UGT1A6	DESD26P	Limited	Biomarker	[1525]
UGT1A8	DE2GB8N	Limited	Biomarker	[1525]
UGT2B10	DEI8NGH	Limited	Genetic Variation	[1682]
UGT2B7	DEB3CV1	Limited	Genetic Variation	[1683]
AKR7A2	DE4G629	moderate	Genetic Variation	[1684]
CYP4A11	DE2XQGW	moderate	Biomarker	[1685]
DIO3	DET89OV	moderate	Genetic Variation	[1686]
G6PC3	DEE1B8O	moderate	Biomarker	[1687]
ME1	DE97WM8	moderate	Biomarker	[1688]
MSMO1	DE5FUD0	moderate	Biomarker	[1689]
MT2A	DEFKGT7	moderate	Biomarker	[1136]
PARK7	DEPOVCH	moderate	Biomarker	[1690]
SCLY	DEH4TD6	moderate	Biomarker	[1691]
SULT1A3	DEP7E8X	moderate	Biomarker	[1692]
UGT2A1	DEGKRXT	moderate	Genetic Variation	[1693]
UGT2B17	DEAZDL8	moderate	Biomarker	[1694]
UGT2B4	DENUPDX	moderate	Altered Expression	[1695]
ACP5	DESITDW	Strong	Altered Expression	[1696]
ACSS2	DEE76VW	Strong	Genetic Variation	[1697]
ADH6	DE017IC	Strong	Altered Expression	[508]
AKR1A1	DED2FW3	Strong	Altered Expression	[508]
AKR1B10	DEP6GT1	Strong	Altered Expression	[1698]
AKR1C2	DEOY5ZM	Strong	Biomarker	[1699]
AKR1C4	DEAJN47	Strong	Altered Expression	[1667]
ALDH1A2	DEKN1H4	Strong	Biomarker	[1700]
APRT	DE2MV1R	Strong	Biomarker	[1701]
AS3MT	DE9KJP3	Strong	Genetic Variation	[1678]
BLMH	DECH1VP	Strong	Biomarker	[1702]
CES2	DETHCPD	Strong	Genetic Variation	[1703]
CHDH	DEAHED0	Strong	Genetic Variation	[1704]
CHST3	DEQIZP2	Strong	Altered Expression	[1705]
CMPK1	DEMPH4I	Strong	Genetic Variation	[1706]
CYB5R3	DE4A3BL	Strong	Biomarker	[1707]
CYP2A13	DEXZA9U	Strong	Genetic Variation	[1708]
CYP2C18	DEZMWRE	Strong	Biomarker	[1709]
CYP2C8	DES5XRU	Strong	Biomarker	[1710]
CYP2F1	DED5AT3	Strong	Altered Expression	[1711]
CYP2R1	DEBIHM3	Strong	Genetic Variation	[1712]
CYP2S1	DE6NMGO	Strong	Biomarker	[1713]
CYP3A7	DERD86B	Strong	Biomarker	[1714]
CYP7B1	DE36TMY	Strong	Altered Expression	[1715]
DDAH1	DEY0TQC	Strong	Altered Expression	[1716]
DHRS3	DEXPVUN	Strong	Biomarker	[1717]
DHRS9	DEGTU5I	Strong	Altered Expression	[1718]
DTYMK	DEOTVYU	Strong	Biomarker	[1719]
FADS1	DE05S8C	Strong	Biomarker	[1720]
FMO5	DEBMX7C	Strong	Altered Expression	[1721]
FNTA	DEFNVD7	Strong	Biomarker	[1722]
GCLC	DESYL1F	Strong	Biomarker	[1723]
GFPT2	DERQCJM	Strong	Altered Expression	[1724]
GLDC	DEIN8FB	Strong	Biomarker	[1725]
GLS	DE3E0VT	Strong	Biomarker	[1726]
GMDS	DE8K7F3	Strong	Genetic Variation	[1727]
GPT	DER5HFI	Strong	Genetic Variation	[1728]
HIF1AN	DEY1CBW	Strong	Biomarker	[1729]
HK1	DEDMAGE	Strong	Biomarker	[1730]
HPGD	DEHKSC6	Strong	Biomarker	[1731]
HPRT1	DEVXTP5	Strong	Altered Expression	[1732]
HSD17B12	DE915QP	Strong	Biomarker	[1733]
KYAT1	DES9MCU	Strong	Biomarker	[1734]
LAP3	DENZF0O	Strong	Altered Expression	[1735]
LDHC	DEQG7F9	Strong	Biomarker	[1736]
MAT1A	DEQ6NC9	Strong	Genetic Variation	[1737]
MMEL1	DEYCUQ2	Strong	Altered Expression	[1738]
MTRR	DE6NIY9	Strong	Genetic Variation	[1739]
NAT1	DE7OAB3	Strong	Biomarker	[1740]
NDUFS2	DEKX5CD	Strong	Altered Expression	[1741]
NMNAT2	DE2HB58	Strong	Biomarker	[1742]
NNMT	DECVGJ3	Strong	Altered Expression	[1743]
NT5C	DE4E31Z	Strong	Altered Expression	[1744]
P4HA2	DE5EGK0	Strong	Biomarker	[1745]
P4HA3	DE2L4RX	Strong	Genetic Variation	[1746]
PAPSS1	DEDG68B	Strong	Biomarker	[1747]
PCK1	DEPLH5Z	Strong	Biomarker	[1748]
PCYT2	DEIX1PO	Strong	Biomarker	[1749]
PER1	DE9HF0I	Strong	Altered Expression	[1750]
PGPEP1	DEVDR46	Strong	Altered Expression	[1257]
PLPP1	DE6WXTH	Strong	Biomarker	[1751]
PMM2	DEBRX3L	Strong	Biomarker	[1752]
PON2	DEHJU7E	Strong	Biomarker	[1753]
PON3	DETXQZ1	Strong	Biomarker	[1754]
PRODH	DEVJIHS	Strong	Biomarker	[1755]
PTGDS	DER3H9C	Strong	Biomarker	[278]
RDH14	DEWDJU4	Strong	Biomarker	[1756]
SAT1	DEMWO83	Strong	Biomarker	[1757]
SMOX	DEOH5V3	Strong	Biomarker	[1758]
SPR	DEJVDAT	Strong	Biomarker	[1759]
SULT1A2	DERUZL7	Strong	Biomarker	[1760]
TGM3	DEOEB3Q	Strong	Biomarker	[1761]
THOP1	DE95LJC	Strong	Biomarker	[1762]
UBASH3B	DE10BJ5	Strong	Biomarker	[1763]
UCK2	DETN1O0	Strong	Biomarker	[1764]
UGT1A10	DEL5N6Y	Strong	Biomarker	[1525]
UGT1A3	DEF2WXN	Strong	Biomarker	[1525]
UGT1A5	DEPF954	Strong	Biomarker	[1525]
UGT1A9	DE85D2P	Strong	Biomarker	[1525]
UPP1	DEFZWAX	Strong	Altered Expression	[1765]
UPP2	DEBQ2WU	Strong	Altered Expression	[1766]
UPRT	DE20ETR	Strong	Genetic Variation	[1767]
WARS1	DEPVE0M	Strong	Altered Expression	[1768]
CHPF2	DEBH7ND	Definitive	Altered Expression	[1769]
CRMP1	DE0EUXB	Definitive	Biomarker	[327]
CYP4F3	DEFCMPI	Definitive	Altered Expression	[1770]

This Disease Is Related to 4151 DOT Molecule(s)

Gene Name	DOT ID	Evidence Level	Mode of Inheritance	REF
AAMP	OTZXBSS4	Limited	Altered Expression	[1771]
ACAP2	OTYNZPC4	Limited	Biomarker	[1772]
ACCS	OTHIHI9D	Limited	Genetic Variation	[1697]
ACO1	OT2VUR7L	Limited	Biomarker	[1773]
ACOT7	OT7C68YV	Limited	Biomarker	[499]
ACTBL2	OTD6B81U	Limited	Biomarker	[499]
ACTL8	OTUDD0QT	Limited	Biomarker	[1774]
ACTR2	OT3C8U5T	Limited	Biomarker	[1775]
ADAM23	OTVWT6JZ	Limited	Biomarker	[1776]
ADAM32	OTUJR3Q3	Limited	Biomarker	[1777]
ADGRE2	OTUYJVYG	Limited	Biomarker	[1778]
ADGRE5	OTTSB84Q	Limited	Biomarker	[1778]
ADGRL2	OTCXD2YR	Limited	Altered Expression	[1779]
AEBP1	OTBI1RZ6	Limited	Altered Expression	[1780]
AFAP1	OTR473H8	Limited	Biomarker	[1781]
AFF1	OTT2C78E	Limited	Biomarker	[1782]
AFF4	OTTL5Y8R	Limited	Biomarker	[1782]
AGO1	OTD3R434	Limited	Biomarker	[1783]
AHNAK	OT6KH1WG	Limited	Biomarker	[1784]
AIFM2	OT57XWXO	Limited	Biomarker	[1785]
AJUBA	OTNW7YPK	Limited	Biomarker	[1786]
ALDH3A1	OTAYZZE6	Limited	Biomarker	[894]
ALKBH2	OTSQW0BG	Limited	Biomarker	[1787]
AMFR	OTQRX7LC	Limited	Altered Expression	[1788]
AMOTL1	OT40G45S	Limited	Altered Expression	[1789]
AMT	OTQYEWZQ	Limited	Biomarker	[1790]
AMY1A	OT6G4B8O	Limited	Biomarker	[1791]
ANK3	OTJ3IRBP	Limited	Biomarker	[1792]
ANKEF1	OTFH7ZM3	Limited	Genetic Variation	[1793]
ANKK1	OT0OM1O0	Limited	Genetic Variation	[1794]
ANP32A	OTRHPFO2	Limited	Altered Expression	[1795]
AP5M1	OTDLWEBL	Limited	Biomarker	[1796]
APOBEC1	OTY8QX2R	Limited	Genetic Variation	[1797]
APOBEC3C	OTPL0AI1	Limited	Biomarker	[1798]
ARC	OTN2QQPG	Limited	Biomarker	[1799]
ARF6	OTVV7KJO	Limited	Biomarker	[1800]
ARHGAP10	OT84ATF5	Limited	Biomarker	[1801]
ARHGAP15	OT9CKHDC	Limited	Altered Expression	[1802]
ARHGEF12	OTM2D3LT	Limited	Biomarker	[1803]
ARHGEF28	OT3F32IU	Limited	Biomarker	[1804]
ARL13B	OT9PYPV1	Limited	Biomarker	[1805]
ARMC8	OTNAXGM7	Limited	Biomarker	[1806]
ARMCX5-GPRASP2	OT2N7NQR	Limited	Biomarker	[1807]
ARNT	OTMSIEZY	Limited	Altered Expression	[1808]
ASCL1	OTI4X44G	Limited	Altered Expression	[1809]
ASH2L	OT3HG324	Limited	Biomarker	[1810]
ASPN	OTYJM80N	Limited	Biomarker	[1811]
ATAD3A	OTWF6HBP	Limited	Biomarker	[1812]
ATF1	OT251CI0	Limited	Genetic Variation	[1813]
ATF5	OT03QCLM	Limited	Biomarker	[1814]
ATG16L1	OTEOYC5D	Limited	Biomarker	[1815]
ATG4B	OTQ4RNRM	Limited	Biomarker	[1816]
ATOH8	OT7SY3BN	Limited	Biomarker	[1817]
ATP11B	OTQOXTH2	Limited	Biomarker	[1818]
ATP2B2	OT1NPZ9T	Limited	Biomarker	[1819]
ATP5F1A	OT3FZDLX	Limited	Genetic Variation	[1820]
ATP6V0A1	OT1IK0KA	Limited	Biomarker	[1821]
B3GALNT2	OTOF6O2B	Limited	Biomarker	[1822]
B3GAT1	OTXFP98E	Limited	Biomarker	[1823]
B4GALT3	OTHX77K8	Limited	Biomarker	[1824]
BANF1	OTP7Z38L	Limited	Genetic Variation	[1825]
BATF2	OT4XBZC9	Limited	Altered Expression	[1826]
BATF3	OTI61WXQ	Limited	Biomarker	[1827]
BCL2L12	OTS6IFZY	Limited	Altered Expression	[1828]
BCL6B	OT1T5KM6	Limited	Biomarker	[1829]
BCL7A	OTYFUJTP	Limited	Biomarker	[1830]
BCO2	OTP1L0BZ	Limited	Biomarker	[1831]
BCOR	OTG013AX	Limited	Genetic Variation	[1832]
BGLAP	OTK1YLWQ	Limited	Genetic Variation	[1833]
BHLHA15	OTY7IER8	Limited	Biomarker	[1834]
BHLHE41	OTY9GJ1Y	Limited	Genetic Variation	[1835]
BID	OTOSHSHU	Limited	Biomarker	[1836]
BLID	OT479VJV	Limited	Altered Expression	[1837]
BMS1	OTEGQ8ZO	Limited	Biomarker	[1838]
BPTF	OTD1RZAD	Limited	Biomarker	[1839]
BRD8	OTIKS3PC	Limited	Altered Expression	[434]
BTC	OTW4B2O0	Limited	Altered Expression	[1840]
BTF3	OT5ZZFJL	Limited	Altered Expression	[1841]
BVES	OT4GT1WC	Limited	Biomarker	[1842]
C11orf58	OTUHIICR	Limited	Biomarker	[1107]
C1QA	OT6XKVVA	Limited	Biomarker	[1843]
C6	OTCKR304	Limited	Biomarker	[1844]
CA11	OT8RX3AJ	Limited	Altered Expression	[1845]
CABIN1	OT4G5CIK	Limited	Genetic Variation	[1846]
CADM4	OT0TFMFE	Limited	Biomarker	[1847]
CALU	OTSYQN71	Limited	Biomarker	[1848]
CAMKMT	OTLJBRUW	Limited	Biomarker	[1849]
CAND1	OTGB6NU0	Limited	Biomarker	[1850]
CAP2	OTC1WFNO	Limited	Biomarker	[1851]
CAPN5	OTQ8QM7K	Limited	Genetic Variation	[1852]
CAPRIN1	OTEJAMS3	Limited	Biomarker	[1853]
CAPZA1	OTAXA66U	Limited	Biomarker	[1854]
CARD9	OTJ81AWD	Limited	Biomarker	[1855]
CARF	OTWE0T6Q	Limited	Altered Expression	[1856]
CASP14	OTKY93H9	Limited	Altered Expression	[1857]
CASP8AP2	OTTWT68S	Limited	Biomarker	[1858]
CBFA2T2	OTNOIB23	Limited	Genetic Variation	[1859]
CBX2	OTOQ5WS4	Limited	Altered Expression	[1860]
CBX8	OT4U5V1T	Limited	Altered Expression	[1861]
CCDC30	OTTB5SIQ	Limited	Genetic Variation	[1862]
CCL27	OTUZYC61	Limited	Biomarker	[1863]
CCL28	OTY6XNQ7	Limited	Biomarker	[1864]
CCL4	OT6B8P25	Limited	Biomarker	[1865]
CCL4L2	OTDBSXOU	Limited	Biomarker	[1865]
CCL7	OTDIS99H	Limited	Biomarker	[1866]
CCN4	OT69BER9	Limited	Biomarker	[1867]
CCN5	OTADU8JJ	Limited	Biomarker	[1868]
CCNB3	OT5V72D3	Limited	Biomarker	[1869]
CCNY	OTK1KG5W	Limited	Biomarker	[1870]
CCT3	OTL6EOS1	Limited	Altered Expression	[1871]
CD177	OTS79FNF	Limited	Biomarker	[1872]
CD247	OT45FGUX	Limited	Altered Expression	[1873]
CD81	OTQFXNAZ	Limited	Biomarker	[1874]
CDC27	OTDT45XJ	Limited	Biomarker	[1875]
CDC6	OTX93FE7	Limited	Biomarker	[1876]
CDCA7	OT12HDZY	Limited	Biomarker	[1877]
CDH17	OT9EV2XK	Limited	Biomarker	[1878]
CDK20	OTOLNN68	Limited	Biomarker	[1879]
CDK5RAP2	OTRKEVTY	Limited	Biomarker	[1880]
CDKN2D	OT2TTZPZ	Limited	Biomarker	[1881]
CDS1	OT2F591M	Limited	Biomarker	[1882]
CDX1	OTOHTMJE	Limited	Biomarker	[1883]
CELF1	OT6JQ5RS	Limited	Biomarker	[1884]
CENPA	OT0NEJ4X	Limited	Biomarker	[1885]
CEP131	OT6PF80T	Limited	Biomarker	[1886]
CEP164	OTLNRPAR	Limited	Altered Expression	[1887]
CEP76	OTL2SJX0	Limited	Genetic Variation	[1888]
CETN1	OTGQ8JOZ	Limited	Genetic Variation	[1889]
CHD4	OTBDEHDP	Limited	Altered Expression	[1890]
CHD9	OTWNFDKJ	Limited	Biomarker	[1891]
CHGB	OT7SAQT2	Limited	Altered Expression	[1453]
CHI3L1	OT2Z7VJH	Limited	Altered Expression	[1892]
CHP1	OTHTXN1A	Limited	Biomarker	[1893]
CIB2	OT9ZJX1I	Limited	Biomarker	[1894]
CIITA	OTRJNZFO	Limited	Biomarker	[1895]
CISD1	OT0MTVGF	Limited	Biomarker	[1896]
CKMT1A	OTCINHH5	Limited	Biomarker	[1897]
CLCA2	OTF191LZ	Limited	Altered Expression	[1898]
CLDN15	OT9K0KI7	Limited	Altered Expression	[1899]
CLDN2	OTRF3D6Y	Limited	Biomarker	[1900]
CLEC1B	OTO38TRG	Limited	Altered Expression	[1901]
CLEC7A	OTRTBH27	Limited	Altered Expression	[1902]
CMAS	OTFQJG3C	Limited	Biomarker	[1903]
CMPK2	OTOG90R0	Limited	Genetic Variation	[1706]
CMTM1	OTKN7E89	Limited	Biomarker	[1904]
CMTM4	OTA3Z072	Limited	Biomarker	[1905]
CMTM5	OTMS7NDP	Limited	Biomarker	[1906]
CNBP	OTTGM9NK	Limited	Biomarker	[1907]
CNGB1	OTA5DE38	Limited	Biomarker	[1072]
CNN2	OTH3CSXA	Limited	Altered Expression	[1908]
CNNM3	OTJXP2SL	Limited	Altered Expression	[1909]
CNOT3	OT4D5Z9L	Limited	Altered Expression	[1910]
COL11A1	OTB0DRMS	Limited	Biomarker	[65]
COL5A2	OT5VOSQE	Limited	Biomarker	[65]
COMMD7	OTWWJ97D	Limited	Biomarker	[1911]
COPS6	OTG9AAG0	Limited	Altered Expression	[1912]
CORT	OTX3GUHB	Limited	Biomarker	[1913]
COX7A2L	OTY21FKV	Limited	Biomarker	[1914]
CPSF6	OTM6QYNQ	Limited	Genetic Variation	[1915]
CPT1A	OTI862QH	Limited	Biomarker	[1916]
CPT1C	OT8F1MBF	Limited	Biomarker	[1916]
CREB3	OT9617UO	Limited	Altered Expression	[1917]
CREB3L1	OT2JHIHM	Limited	Altered Expression	[1918]
CRIM1	OTTZNV6Y	Limited	Altered Expression	[1919]
CSAD	OT3I2G0A	Limited	Biomarker	[1920]
CSDE1	OT15D7GH	Limited	Biomarker	[438]
CSNK2B	OT2WW7R1	Limited	Biomarker	[1921]
CSPP1	OTNX7GD4	Limited	Biomarker	[1922]
CST11	OT0DJDP6	Limited	Biomarker	[1923]
CST7	OTQWZUVQ	Limited	Biomarker	[1924]
CTBP2	OTGZGT87	Limited	Biomarker	[1925]
CTNNA1	OTFC725Z	Limited	Biomarker	[1806]
CTNNBIP1	OTX9SBJG	Limited	Biomarker	[1926]
CTRL	OTB6NA5O	Limited	Biomarker	[1927]
CXCL16	OTD49T9R	Limited	Altered Expression	[1928]
CXXC1	OTO10D1N	Limited	Biomarker	[1929]
CYFIP1	OTOBEH24	Limited	Biomarker	[1930]
DACH1	OTMKNAGG	Limited	Biomarker	[1931]
DACT2	OTNLCC0K	Limited	Altered Expression	[1932]
DBNL	OTT2OQOV	Limited	Biomarker	[1924]
DBR1	OTLTWLTE	Limited	Biomarker	[1933]
DBT	OT4KZ5R9	Limited	Biomarker	[1934]
DCX	OTISR7K3	Limited	Biomarker	[346]
DDB2	OTO8HVVB	Limited	Altered Expression	[1935]
DDX39A	OT0Z6E1K	Limited	Biomarker	[1612]
DDX39B	OTEVCFVU	Limited	Biomarker	[1612]
DDX41	OT6KEIHP	Limited	Genetic Variation	[1355]
DDX6	OTKWXVDY	Limited	Altered Expression	[1936]
DEFA1	OT5N1B9B	Limited	Biomarker	[1937]
DEFB1	OT5SV0E4	Limited	Altered Expression	[1938]
DEPDC1B	OTMVFOT1	Limited	Biomarker	[1939]
DEUP1	OTXLM86J	Limited	Biomarker	[1940]
DGKB	OTTT9SZJ	Limited	Biomarker	[1941]
DGKE	OTWS86AS	Limited	Biomarker	[1941]
DGKG	OTBL32T3	Limited	Biomarker	[1942]
DHX32	OTDYB66V	Limited	Biomarker	[1943]
DHX9	OT5AAOQI	Limited	Altered Expression	[1944]
DIAPH2	OTBEYFEZ	Limited	Biomarker	[1061]
DLG5	OTU9Z17K	Limited	Altered Expression	[722]
DMAP1	OT1ZMQTU	Limited	Biomarker	[1945]
DNAJB7	OT4BOECZ	Limited	Biomarker	[1946]
DNASE1L1	OT9ZOFN9	Limited	Biomarker	[1947]
DNM1L	OTXK1Q1G	Limited	Biomarker	[327]
DOCK8	OTNQLL21	Limited	Genetic Variation	[1948]
DSN1	OTHROI0H	Limited	Altered Expression	[1949]
DUOX2	OTU14HCN	Limited	Biomarker	[1950]
DUSP6	OT4H6RKW	Limited	Biomarker	[1951]
E2F4	OTB3JFH4	Limited	Biomarker	[1952]
EEF1A1	OT00THXS	Limited	Altered Expression	[1953]
EFEMP1	OTZVUOOB	Limited	Altered Expression	[1954]
EFNA1	OTU2NUA2	Limited	Biomarker	[1955]
EFNB2	OT0DCUOM	Limited	Biomarker	[1956]
EIF3C	OTR8RF9X	Limited	Altered Expression	[1957]
EIF4A3	OTYYFE7K	Limited	Biomarker	[1958]
EIF4EBP3	OTYY2WS5	Limited	Biomarker	[1959]
ELMO1	OTY2ORXK	Limited	Biomarker	[1960]
ELOC	OT0XHHWP	Limited	Biomarker	[1961]
ELSPBP1	OT79E7DW	Limited	Genetic Variation	[1962]
EMP1	OTSZHUHQ	Limited	Altered Expression	[1963]
ENDOU	OTB7OF7Y	Limited	Biomarker	[1964]
ENKUR	OTXXBBQT	Limited	Altered Expression	[1965]
ENO2	OTRODL0T	Limited	Biomarker	[1966]
ENTPD5	OTFH05B9	Limited	Biomarker	[1967]
ENY2	OTTNU8RK	Limited	Biomarker	[1968]
EPC1	OT3Q25ND	Limited	Genetic Variation	[1969]
EPSTI1	OT75I1UH	Limited	Biomarker	[1970]
EQTN	OT3H2N9D	Limited	Biomarker	[1971]
ERCC6	OT2QZKSF	Limited	Altered Expression	[1972]
ERMP1	OT9CIEO2	Limited	Altered Expression	[1973]
ERP29	OTNKANMH	Limited	Biomarker	[1974]
ERVW-1	OTWV8DXJ	Limited	Altered Expression	[1975]
ESM1	OT331Y8V	Limited	Altered Expression	[1976]
ESRP2	OTVTKJ4I	Limited	Biomarker	[1977]
EXOSC6	OTAC10N6	Limited	Biomarker	[1964]
EXPH5	OTOMXDUO	Limited	Biomarker	[1978]
EXT1	OTRPALJK	Limited	Biomarker	[1979]
EXTL1	OTMSNY9N	Limited	Posttranslational Modification	[1980]
EYA1	OTHU807A	Limited	Genetic Variation	[1981]
FARP2	OTNRQIMK	Limited	Biomarker	[1982]
FBL	OTRODIE5	Limited	Biomarker	[1983]
FBRS	OTUVH446	Limited	Biomarker	[1984]
FBXL3	OTDQ1QKV	Limited	Genetic Variation	[1985]
FBXL4	OTZECCIQ	Limited	Biomarker	[1986]
FBXO39	OTPRR6SK	Limited	Biomarker	[1987]
FBXO7	OTGTN8TJ	Limited	Biomarker	[1988]
FBXO8	OTZNGJGW	Limited	Biomarker	[1984]
FBXW11	OT2A6RLR	Limited	Biomarker	[1989]
FCRL1	OTXOYT29	Limited	Altered Expression	[1990]
FDCSP	OT8KGE9M	Limited	Altered Expression	[1991]
FERMT3	OTFQOT3C	Limited	Biomarker	[1992]
FGD1	OTV3T64P	Limited	Genetic Variation	[1993]
FGD5	OT5VIRP2	Limited	Biomarker	[1994]
FHL2	OT0OAYWT	Limited	Altered Expression	[1995]
FHL5	OT6C00Z1	Limited	Biomarker	[499]
FKBP2	OTHBZHX0	Limited	Posttranslational Modification	[1996]
FLCN	OTVM78XM	Limited	Biomarker	[1997]
FLNB	OTPCOYL6	Limited	Genetic Variation	[1599]
FLVCR1	OT9XCFOC	Limited	Biomarker	[1998]
FNDC3B	OTBILGDR	Limited	Biomarker	[1999]
FNDC5	OT5CSK9X	Limited	Altered Expression	[2000]
FOXK1	OTLZGS7J	Limited	Altered Expression	[2001]
FOXK2	OTFXDZ3R	Limited	Biomarker	[2002]
FOXL2	OTFRQUYL	Limited	Genetic Variation	[2003]
FOXN1	OTE80D6I	Limited	Altered Expression	[2004]
FUNDC1	OTA6IVKQ	Limited	Biomarker	[2005]
FZD1	OTZATHVS	Limited	Biomarker	[2006]
FZD6	OTBCPII8	Limited	Biomarker	[2007]
G2E3	OT06BFRQ	Limited	Biomarker	[2008]
GAB1	OTQKE6V4	Limited	Biomarker	[2009]
GABBR2	OT67RIFY	Limited	Biomarker	[2010]
GASK1B	OT2HPHEI	Limited	Biomarker	[2011]
GATA1	OTX1R7O1	Limited	Altered Expression	[2012]
GCA	OTAJ7ZHG	Limited	Biomarker	[2013]
GDF11	OTOSNMND	Limited	Biomarker	[2014]
GDPD3	OTOHM9QM	Limited	Biomarker	[2015]
GFER	OTVK43OK	Limited	Biomarker	[1361]
GGTLC1	OTWJKUHQ	Limited	Altered Expression	[2016]
GLI3	OTKDOE94	Limited	Biomarker	[2017]
GLIS3	OTBC960E	Limited	Genetic Variation	[2018]
GLS2	OT08MSHL	Limited	Biomarker	[2019]
GLUD1	OTXKOCUH	Limited	Posttranslational Modification	[2020]
GNAI2	OTTLGRGH	Limited	Biomarker	[898]
GNPAT	OTF6LWPO	Limited	Biomarker	[325]
GNPTAB	OT2Z03OB	Limited	Biomarker	[2021]
GOLT1A	OTY8H2OF	Limited	Altered Expression	[2022]
GPAA1	OTWVRR35	Limited	Altered Expression	[2023]
GPAM	OTR1XD9B	Limited	Altered Expression	[2024]
GPC1	OTQKRSSV	Limited	Biomarker	[2025]
GPHN	OTAKK1SV	Limited	Biomarker	[2026]
GPR158	OTYOC1RQ	Limited	Altered Expression	[2027]
GPR4	OTIBF32I	Limited	Biomarker	[1934]
GPR68	OT1NXSMN	Limited	Altered Expression	[2028]
GPRC5A	OTPOCWR7	Limited	Posttranslational Modification	[2029]
GPT2	OTS5VF7N	Limited	Altered Expression	[2030]
GRHL3	OT1V4ZEH	Limited	Altered Expression	[2031]
GRWD1	OT6M13ZV	Limited	Altered Expression	[2032]
GSKIP	OTEYSV5M	Limited	Biomarker	[40]
H2AZ1	OT3KJJNQ	Limited	Biomarker	[2033]
H3-4	OTY6ITYF	Limited	Biomarker	[2034]
H4C1	OTB71W46	Limited	Posttranslational Modification	[2035]
HACD1	OTEC7EP7	Limited	Biomarker	[188]
HADH	OTJDOL20	Limited	Genetic Variation	[2036]
HAS2	OTTD3PAL	Limited	Biomarker	[2037]
HBP1	OTDPGGDV	Limited	Biomarker	[2038]
HCP5	OTV0YRI8	Limited	Altered Expression	[2039]
HELLS	OTVVV668	Limited	Biomarker	[2040]
HEPACAM	OT1MJ51D	Limited	Biomarker	[2041]
HES1	OT8P19W2	Limited	Biomarker	[2042]
HES7	OT6F9R7P	Limited	Biomarker	[2043]
HLA-DRB4	OTNXIHQU	Limited	Biomarker	[2044]
HLA-E	OTX1CTFB	Limited	Biomarker	[2045]
HMGB3	OTCJ2EZY	Limited	Altered Expression	[2046]
HNRNPA0	OTCP792K	Limited	Genetic Variation	[2047]
HNRNPD	OT5UO1FA	Limited	Biomarker	[2048]
HNRNPM	OTFU3OEZ	Limited	Biomarker	[2049]
HORMAD1	OT7DR5T2	Limited	Biomarker	[2050]
HOXA1	OTMSOJ7D	Limited	Biomarker	[2051]
HOXB7	OTC7WYU8	Limited	Altered Expression	[2052]
HOXC10	OT5WF17M	Limited	Biomarker	[2053]
HOXC8	OTJUYU8J	Limited	Biomarker	[2054]
HSF2	OTXNJIJ9	Limited	Biomarker	[2055]
HSPA6	OTH4S7WB	Limited	Biomarker	[1920]
HUS1	OTY1XON9	Limited	Genetic Variation	[2056]
IARS2	OTDX4SCA	Limited	Biomarker	[2057]
ID4	OTPMJ39I	Limited	Altered Expression	[2058]
IER5	OTJPTXMD	Limited	Biomarker	[2059]
IFI44L	OTXKORJP	Limited	Biomarker	[2060]
IFIT1	OTXOQDSG	Limited	Biomarker	[2061]
IFIT3	OTPGHZB9	Limited	Biomarker	[2061]
IFITM1	OTECO1G8	Limited	Genetic Variation	[2062]
IFNGR1	OTCTQBWW	Limited	Biomarker	[2063]
IKBKG	OTNWJWSD	Limited	Biomarker	[2064]
IL22RA1	OTGVKLBR	Limited	Altered Expression	[2065]
ING5	OTRNNSFM	Limited	Biomarker	[2066]
INPP5E	OTJF2AZ9	Limited	Biomarker	[2067]
INPPL1	OTCDAVBQ	Limited	Biomarker	[2068]
INSRR	OT3F75WA	Limited	Biomarker	[2069]
INVS	OT8KPESR	Limited	Biomarker	[2070]
IPO7	OTDFMQ00	Limited	Altered Expression	[2071]
IRF5	OT8SIIAP	Limited	Biomarker	[2072]
IRF9	OTK4MYQJ	Limited	Biomarker	[2073]
IRX2	OTBHXXQ2	Limited	Biomarker	[2074]
ISOC1	OTAO7Z87	Limited	Altered Expression	[2075]
ISX	OTULQRWA	Limited	Biomarker	[2076]
ITGA10	OTM0V5AO	Limited	Altered Expression	[2077]
ITGA3	OTBCH21D	Limited	Biomarker	[2078]
ITGA7	OTTBTAYW	Limited	Altered Expression	[2079]
ITGB5	OT21MF51	Limited	Biomarker	[2080]
ITPKA	OTX5ERUD	Limited	Altered Expression	[2081]
ITPRIP	OT9YEJXS	Limited	Biomarker	[2082]
JARID2	OT14UM8H	Limited	Altered Expression	[2083]
JCAD	OT7G1WJW	Limited	Biomarker	[2084]
JTB	OT314JB6	Limited	Biomarker	[230]
KANK3	OTEZFS98	Limited	Biomarker	[2085]
KAT5	OTL7257A	Limited	Biomarker	[2086]
KCNIP3	OTCQPEM4	Limited	Biomarker	[2087]
KDM2B	OTDMCVW7	Limited	Altered Expression	[299]
KDM4B	OT5P1UPY	Limited	Altered Expression	[2088]
KIAA0513	OT7AVTFB	Limited	Biomarker	[1777]
KIF13A	OTSSZGBQ	Limited	Biomarker	[193]
KIF2A	OT2WQ6QD	Limited	Biomarker	[2089]
KIF3B	OT0HJREB	Limited	Genetic Variation	[2090]
KIFAP3	OT450PAO	Limited	Biomarker	[1107]
KLF14	OT8BXLBS	Limited	Biomarker	[2091]
KLF16	OTTPV4NB	Limited	Biomarker	[2092]
KLF17	OT5NWVP7	Limited	Altered Expression	[2093]
KLF2	OTIP1UFX	Limited	Altered Expression	[2094]
KLF9	OTBFEJRQ	Limited	Altered Expression	[2095]
KMT2B	OTMMAZQX	Limited	Altered Expression	[296]
KMT2D	OTTVHCLY	Limited	Altered Expression	[296]
KRIT1	OT58AP1I	Limited	Biomarker	[1849]
KRT18	OTVLQFIP	Limited	Biomarker	[2096]
KRT72	OTAXW63A	Limited	Altered Expression	[2097]
LAMP5	OTC672RM	Limited	Biomarker	[2098]
LARP4	OTB10IJH	Limited	Genetic Variation	[2099]
LBR	OT1HG3HG	Limited	Biomarker	[2100]
LCOR	OT1K7DKB	Limited	Altered Expression	[2101]
LCP1	OTK61F2A	Limited	Biomarker	[2102]
LDOC1	OTWZH4O9	Limited	Biomarker	[2103]
LEMD1	OTII3FTO	Limited	Biomarker	[2104]
LETM1	OT8N4MRU	Limited	Altered Expression	[2105]
LHX3	OTQ5BAJ9	Limited	Biomarker	[2106]
LIMD1	OTN1CG6R	Limited	Biomarker	[2107]
LRBA	OTOUZN9G	Limited	Biomarker	[2108]
LRIT1	OTNEQPMZ	Limited	Biomarker	[1362]
LRP4	OTO4M459	Limited	Biomarker	[2109]
LRRC15	OTX7JL8H	Limited	Altered Expression	[2110]
LRRC26	OTXEFL76	Limited	Biomarker	[2111]
LSM7	OTHZ2XPX	Limited	Genetic Variation	[2112]
LSR	OTR8Y32X	Limited	Biomarker	[2113]
LTBP2	OTS88GSD	Limited	Biomarker	[2114]
LYPD4	OTYNO8BS	Limited	Biomarker	[2115]
LYPD5	OTGP7UKA	Limited	Altered Expression	[2116]
LYPLA1	OTENU47T	Limited	Biomarker	[2117]
MADD	OTUFYVGG	Limited	Biomarker	[2118]
MAGI1	OTMV4ASV	Limited	Genetic Variation	[2119]
MAL	OTBM30SW	Limited	Biomarker	[2120]
MANEA	OTV7L8I6	Limited	Altered Expression	[2121]
MAP1LC3B	OTUYHB84	Limited	Genetic Variation	[2122]
MAP1LC3C	OTM4ECDK	Limited	Biomarker	[2123]
MAPRE1	OTCVQD60	Limited	Altered Expression	[2124]
MARCHF8	OTH7PNN2	Limited	Biomarker	[2125]
MARK4	OT6Z2TGV	Limited	Biomarker	[2126]
MCF2	OTB9N93T	Limited	Biomarker	[2127]
MCM2	OTGGORIQ	Limited	Biomarker	[1113]
MCM3	OTOOHQPM	Limited	Biomarker	[2128]
MCM8	OTC93H3S	Limited	Biomarker	[2129]
MDGA2	OTIJ0T5J	Limited	Biomarker	[2130]
MED17	OTEZR5GC	Limited	Genetic Variation	[2131]
MED18	OT6M6CQ8	Limited	Biomarker	[2132]
MED19	OTT9RT5N	Limited	Biomarker	[2133]
MED23	OTKZQT0R	Limited	Biomarker	[2134]
MEF2A	OTV2SF6E	Limited	Genetic Variation	[2135]
MEIS1	OTH9DKAD	Limited	Biomarker	[2136]
MFHAS1	OTS922CJ	Limited	Biomarker	[2137]
MGA	OTTLB216	Limited	Biomarker	[2138]
MINDY4	OTBZ2SZB	Limited	Altered Expression	[2139]
MLKL	OTDSLC81	Limited	Altered Expression	[2140]
MMP19	OTLSTT2B	Limited	Altered Expression	[2141]
MMP26	OT9O89KU	Limited	Altered Expression	[2142]
MNAT1	OTXLOYCB	Limited	Biomarker	[2143]
MNX1	OTXP9FH1	Limited	Altered Expression	[2144]
MOCOS	OT0TL3Q5	Limited	Biomarker	[2145]
MOSPD2	OTTN4NR7	Limited	Biomarker	[2146]
MPPE1	OTINBJVE	Limited	Biomarker	[2147]
MPST	OTCDPH5D	Limited	Biomarker	[2148]
MRGPRF	OT74OZ2Z	Limited	Altered Expression	[2149]
MRO	OT5U38CP	Limited	Biomarker	[2150]
MS4A2	OTMCAS2D	Limited	Biomarker	[2151]
MS4A3	OT0CEJOO	Limited	Altered Expression	[2152]
MT1B	OTUA4FFH	Limited	Biomarker	[2153]
MTHFD1	OTMKHVWC	Limited	Altered Expression	[2154]
MTMR3	OTBIT23O	Limited	Altered Expression	[2155]
MUCL3	OTGAD3I0	Limited	Biomarker	[2156]
MX1	OT6X8G5T	Limited	Genetic Variation	[2157]
MYCL	OT1MFQ5U	Limited	Biomarker	[2158]
MYF5	OTTVO2S5	Limited	Genetic Variation	[2159]
MYH9	OT94Z706	Limited	Biomarker	[2160]
MYO1B	OTGZUJ0I	Limited	Altered Expression	[503]
MYO6	OTJQYRC7	Limited	Biomarker	[2161]
MZF1	OTMVZCPW	Limited	Posttranslational Modification	[2162]
N4BP2L1	OTEGV3GO	Limited	Biomarker	[2163]
NAA10	OTYB9R6I	Limited	Biomarker	[2164]
NANS	OTMQ2FUH	Limited	Biomarker	[2165]
NCR3	OT20M764	Limited	Biomarker	[2166]
NDRG4	OTJBOTD8	Limited	Altered Expression	[2167]
NECAB3	OTRASC9G	Limited	Biomarker	[2168]
NECTIN2	OTIE0W6O	Limited	Altered Expression	[1293]
NEIL3	OTBCI2NS	Limited	Biomarker	[2169]
NEUROD6	OTLFL6K8	Limited	Altered Expression	[2170]
NFAT5	OTKIE59S	Limited	Biomarker	[2171]
NFATC1	OT4TMERS	Limited	Biomarker	[2172]
NGLY1	OTZBQD5Q	Limited	Biomarker	[2173]
NIPBL	OTF6OOLU	Limited	Biomarker	[2174]
NKX2-3	OTF4IL5J	Limited	Altered Expression	[2175]
NLRC3	OTWLLFFN	Limited	Biomarker	[2176]
NME2	OTCYGLHV	Limited	Biomarker	[2177]
NNAT	OTNRLO7G	Limited	Biomarker	[2178]
NOX5	OTHTH59G	Limited	Biomarker	[2179]
NPAS2	OTMRT2TS	Limited	Biomarker	[2180]
NPB	OT0U82T3	Limited	Biomarker	[2181]
NRF1	OTOXWNV8	Limited	Biomarker	[2182]
NSD2	OTQ6SW4R	Limited	Biomarker	[2183]
NSMCE2	OTJXLDC9	Limited	Biomarker	[2184]
NSUN2	OTZCNM33	Limited	Biomarker	[2185]
NUDT2	OTMHM1DH	Limited	Biomarker	[2186]
NUP214	OTWEA19O	Limited	Biomarker	[2187]
NUP37	OTPZH72U	Limited	Biomarker	[2188]
NXF1	OTEFHXG6	Limited	Genetic Variation	[1599]
OAS2	OT64CCTM	Limited	Altered Expression	[2189]
OCA2	OTDWIGBF	Limited	Biomarker	[2190]
OCIAD1	OTJBY7PV	Limited	Biomarker	[2191]
OCM	OTQRML29	Limited	Biomarker	[2192]
OTUB1	OT8WWM9O	Limited	Biomarker	[2193]
OTX1	OTRGSGH9	Limited	Biomarker	[2194]
OVOL2	OTFM1GKF	Limited	Biomarker	[2195]
OXA1L	OTS0BFRD	Limited	Biomarker	[2196]
OXCT1	OT536PE7	Limited	Biomarker	[2197]
OXR1	OTPIDMT3	Limited	Biomarker	[2198]
P2RX2	OT0LF34A	Limited	Altered Expression	[222]
PA2G4	OT7IG7HT	Limited	Biomarker	[2199]
PADI2	OTT40K94	Limited	Biomarker	[2200]
PAF1	OTDDGUBQ	Limited	Biomarker	[2201]
PAFAH1B1	OT9T2TCJ	Limited	Genetic Variation	[1355]
PAFAH1B2	OTRDWN2V	Limited	Biomarker	[1964]
PAK5	OT32WQGL	Limited	Altered Expression	[2202]
PANX3	OTKRQZ1T	Limited	Biomarker	[2203]
PATZ1	OT0X9WGR	Limited	Biomarker	[2204]
PAX2	OTKP1N8F	Limited	Altered Expression	[2205]
PAXIP1	OTRHTKG3	Limited	Biomarker	[2206]
PBX1	OTORABGO	Limited	Altered Expression	[2207]
PCBP1	OTHN0TD7	Limited	Altered Expression	[2208]
PCDH19	OTSOW3MV	Limited	Altered Expression	[2209]
PDCD6	OT2YA5M8	Limited	Altered Expression	[2210]
PDGFRL	OTJPRECT	Limited	Biomarker	[2211]
PDP1	OT82RTMT	Limited	Biomarker	[2212]
PEG10	OTWD2278	Limited	Biomarker	[2213]
PELI1	OTMLBCLC	Limited	Biomarker	[2214]
PER3	OTVKYVJA	Limited	Altered Expression	[1750]
PFKP	OTFP7AA8	Limited	Biomarker	[2215]
PFN1	OTHTGA1H	Limited	Biomarker	[2216]
PFN2	OT5SSSA7	Limited	Altered Expression	[2217]
PGAM5	OT6Q5M0C	Limited	Biomarker	[2218]
PGRMC2	OTH6G1CV	Limited	Altered Expression	[2219]
PHF5A	OTS94JFM	Limited	Biomarker	[2220]
PHF6	OT8DXI40	Limited	Altered Expression	[2221]
PHLPP2	OTXB1OUI	Limited	Biomarker	[2222]
PIGR	OT6GLSUL	Limited	Altered Expression	[2223]
PIR	OT8ALXHU	Limited	Biomarker	[2224]
PITX1	OTA0UN4C	Limited	Altered Expression	[2225]
PITX3	OTE2KT8P	Limited	Altered Expression	[2226]
PKP2	OTJOVF68	Limited	Altered Expression	[2227]
PLA1A	OT2IXYNX	Limited	Genetic Variation	[2228]
PLA2G15	OT6VJTPA	Limited	Genetic Variation	[1697]
PLCL1	OTJL2C79	Limited	Biomarker	[2229]
PLOD3	OTT00T7Q	Limited	Altered Expression	[2230]
PLXNA2	OTNNBJMQ	Limited	Biomarker	[2231]
POLG2	OTDBMZJB	Limited	Biomarker	[2232]
POLR2F	OTF9T8I2	Limited	Biomarker	[1821]
POLR3G	OTU3TGQ9	Limited	Biomarker	[2233]
POLRMT	OT5Q8ZUJ	Limited	Genetic Variation	[2232]
POMT2	OTO1ZQZX	Limited	Biomarker	[2234]
POT1	OTNBXJCQ	Limited	Genetic Variation	[2235]
POTEM	OT7L2HGH	Limited	Biomarker	[499]
POU3F3	OT6BBXPD	Limited	Biomarker	[2236]
POU5F1B	OT0FKQ51	Limited	Biomarker	[2237]
PPIL1	OTS5S837	Limited	Biomarker	[2238]
PPIL3	OT0GPU73	Limited	Biomarker	[2239]
PPP1R12C	OT9Q86JO	Limited	Genetic Variation	[1859]
PPP1R13B	OTC88VQO	Limited	Genetic Variation	[1859]
PRB2	OTAD4JZ0	Limited	Biomarker	[2240]
PRDM16	OT0BGA27	Limited	Biomarker	[2241]
PRDM5	OTU1GB68	Limited	Altered Expression	[264]
PRDM6	OTKY12D9	Limited	Biomarker	[2242]
PRDM8	OTRA3265	Limited	Genetic Variation	[2243]
PRDM9	OTWAHLUR	Limited	Biomarker	[2244]
PRG3	OTZ40GRN	Limited	Biomarker	[2245]
PRKAB2	OTLVN68B	Limited	Biomarker	[2246]
PRKAG2	OTHTAM54	Limited	Biomarker	[2247]
PRMT6	OT5V3XIN	Limited	Biomarker	[2248]
PROCA1	OT1MY922	Limited	Biomarker	[2249]
PRPF38B	OTQLH551	Limited	Altered Expression	[282]
PRRT2	OTCJUBDO	Limited	Altered Expression	[308]
PRRX1	OTTZK5G8	Limited	Biomarker	[2250]
PRRX2	OT8UR4AU	Limited	Biomarker	[2251]
PRXL2A	OTR4X7UH	Limited	Altered Expression	[2252]
PSD	OTUZIXUZ	Limited	Biomarker	[2253]
PSMB1	OTYRFBAH	Limited	Biomarker	[2254]
PSMB4	OTOJ9OHA	Limited	Biomarker	[2255]
PSME3	OTSTC4YY	Limited	Biomarker	[2256]
PTOV1	OT94WT5X	Limited	Altered Expression	[2257]
PTPN12	OT5WA666	Limited	Biomarker	[2258]
PTPN5	OT2H1KDK	Limited	Biomarker	[2259]
PTPRO	OTFLKWOY	Limited	Biomarker	[2260]
PTPRU	OTHDO0QG	Limited	Biomarker	[1643]
PVR	OT3N91T7	Limited	Altered Expression	[2261]
PYCR1	OTQHB52T	Limited	Biomarker	[2262]
QRSL1	OTJDU2UG	Limited	Biomarker	[2263]
RAB11FIP1	OT0T71OW	Limited	Biomarker	[2264]
RAB1B	OTAFCUAS	Limited	Biomarker	[2265]
RAB38	OTU0NZU0	Limited	Altered Expression	[2266]
RAB39A	OTZG4LQF	Limited	Altered Expression	[2267]
RAB3D	OTGKRR3C	Limited	Altered Expression	[2268]
RAC2	OTAOHFNH	Limited	Biomarker	[2269]
RAD18	OTQ9PLNT	Limited	Biomarker	[2270]
RAD51D	OTKOU5XN	Limited	Biomarker	[2271]
RAMAC	OTAFAKPR	Limited	Biomarker	[2272]
RANBP3	OTI8ESC3	Limited	Biomarker	[2273]
RAP1B	OTHEIIMM	Limited	Altered Expression	[2274]
RAP1GDS1	OTH70UHD	Limited	Biomarker	[2275]
RASAL2	OTGMMX6W	Limited	Biomarker	[2276]
RASSF4	OT7YLOFH	Limited	Biomarker	[2277]
RBBP6	OTTVG4HU	Limited	Biomarker	[2278]
RBFOX2	OTXY1WVH	Limited	Biomarker	[2279]
RBFOX3	OTL0F3D6	Limited	Biomarker	[2280]
RBM38	OTPO8EXU	Limited	Biomarker	[2281]
RBM39	OTCMPTF9	Limited	Biomarker	[2282]
RBP1	OTRP1MFC	Limited	Altered Expression	[2283]
REPS2	OTSE3TRP	Limited	Biomarker	[2284]
REV3L	OT0OP8EJ	Limited	Altered Expression	[2285]
RFC1	OT3L5PK3	Limited	Altered Expression	[1372]
RFC4	OTWALD2R	Limited	Altered Expression	[2286]
RFX2	OTK6VQ1B	Limited	Biomarker	[2287]
RGS11	OTIAZ36F	Limited	Biomarker	[2288]
RHBDD1	OTL5J132	Limited	Biomarker	[2289]
RHOC	OTOLE1FT	Limited	Altered Expression	[2290]
RHOV	OTW4N3QN	Limited	Biomarker	[1893]
RIT1	OTVNOGOH	Limited	Biomarker	[2291]
RMDN2	OTK5WSFI	Limited	Altered Expression	[2292]
RNASE4	OTA5SZLC	Limited	Altered Expression	[2293]
RNF123	OTL59S8J	Limited	Posttranslational Modification	[2294]
RNF139	OT0PR1X5	Limited	Biomarker	[2295]
RNF168	OT6AZXX8	Limited	Biomarker	[2296]
RNF2	OTFPLOIN	Limited	Biomarker	[2297]
RNF8	OTRR43PZ	Limited	Biomarker	[2298]
RPA1	OT76POLP	Limited	Biomarker	[2299]
RPL3	OTX6VXLB	Limited	Biomarker	[2300]
RPL5	OTM8EBRI	Limited	Altered Expression	[2301]
RPRD1B	OTB41D5K	Limited	Altered Expression	[2302]
RPS15A	OT0BUA12	Limited	Genetic Variation	[2303]
RPS19	OTBKGP48	Limited	Genetic Variation	[2304]
RPS24	OTSNKIL5	Limited	Biomarker	[2305]
RPS3	OT0K3TMH	Limited	Biomarker	[2306]
RPS7	OTIK25WI	Limited	Biomarker	[2307]
RRAGC	OTV3XCV8	Limited	Genetic Variation	[2308]
RRN3	OTKGOZ49	Limited	Altered Expression	[2309]
RYBP	OTZZ4P2Z	Limited	Biomarker	[2310]
S100A11	OTI57KDN	Limited	Altered Expression	[2311]
S100A14	OTVFJJ91	Limited	Biomarker	[2312]
S100A7	OTJFVJRF	Limited	Biomarker	[2313]
SAV1	OTSAEV92	Limited	Biomarker	[2314]
SEC14L1	OTA75FET	Limited	Biomarker	[2315]
SEC23A	OTBRNIJ3	Limited	Biomarker	[2316]
SEC23B	OT2NFSIQ	Limited	Altered Expression	[2317]
SELENOK	OTKM7N7P	Limited	Biomarker	[2318]
SELENOP	OT02B8IR	Limited	Genetic Variation	[2319]
SEMA3C	OTEGUY7F	Limited	Biomarker	[2320]
SEMA4A	OT8901H3	Limited	Biomarker	[2321]
SEMA6D	OTU0UAZS	Limited	Biomarker	[2322]
SERPINA2	OT7UW9HA	Limited	Biomarker	[2323]
SERPINA5	OTTZXPGD	Limited	Genetic Variation	[2324]
SERPINA7	OTUYVTSU	Limited	Biomarker	[2325]
SERPINB4	OT88LHZ8	Limited	Altered Expression	[2326]
SERPINB6	OT7G55IK	Limited	Biomarker	[188]
SERTAD1	OTBHKZQP	Limited	Genetic Variation	[2327]
SETBP1	OTKGCOSR	Limited	Biomarker	[2328]
SETD3	OTO5RAU2	Limited	Altered Expression	[2329]
SFRP5	OTLCVVSH	Limited	Posttranslational Modification	[1356]
SGMS2	OT3NHO99	Limited	Biomarker	[2330]
SHMT2	OT5NCAZN	Limited	Biomarker	[2331]
SHOX2	OTLCZZJW	Limited	Biomarker	[2332]
SIAH1	OT29A838	Limited	Altered Expression	[2333]
SIAH3	OT85KW6H	Limited	Altered Expression	[2333]
SIVA1	OTDT0XZK	Limited	Biomarker	[2334]
SKIL	OTNBXH32	Limited	Biomarker	[2335]
SKP1	OT5BPAZ4	Limited	Biomarker	[2336]
SLC35F2	OTSAD4EQ	Limited	Altered Expression	[2337]
SLITRK1	OT1QQ7FR	Limited	Biomarker	[2338]
SLU7	OTZUUICN	Limited	Genetic Variation	[2339]
SLURP1	OT89YD2E	Limited	Biomarker	[83]
SMARCA5	OT5GR4Z2	Limited	Genetic Variation	[2340]
SMC1A	OT9ZMRK9	Limited	Biomarker	[2341]
SMC4	OTEJE6AG	Limited	Altered Expression	[2342]
SMCP	OTXKY794	Limited	Biomarker	[2145]
SMG1	OTTS3SXE	Limited	Biomarker	[808]
SNTA1	OTUICTGZ	Limited	Biomarker	[2343]
SNX10	OT05B7BT	Limited	Biomarker	[2344]
SON	OT9VWV18	Limited	Biomarker	[2345]
SOX10	OTF25ULQ	Limited	Biomarker	[2346]
SOX12	OT93P8C9	Limited	Biomarker	[2347]
SPAAR	OTWXG2R8	Limited	Biomarker	[2348]
SPRED1	OTKX7P8G	Limited	Biomarker	[2349]
SPRY2	OTH0CRCZ	Limited	Biomarker	[2350]
SPTA1	OT1YMP65	Limited	Genetic Variation	[2351]
SRA1	OTYOGMTG	Limited	Altered Expression	[2352]
SRGAP2	OTUWFMCQ	Limited	Biomarker	[2353]
SRL	OT7IEBWZ	Limited	Altered Expression	[2354]
SRM	OT4N5MDP	Limited	Biomarker	[2355]
SRSF2	OTVDHO6U	Limited	Genetic Variation	[733]
SSR1	OTQ6GDL2	Limited	Genetic Variation	[2356]
SSR3	OTJQP0IZ	Limited	Altered Expression	[2357]
ST8SIA3	OTG9MXV9	Limited	Altered Expression	[2358]
STAG2	OTR6X1Q7	Limited	Genetic Variation	[2359]
STK24	OTGUHOIL	Limited	Biomarker	[2360]
STK3	OTLNSCQD	Limited	Altered Expression	[2361]
STRA6	OT2IDF27	Limited	Biomarker	[2362]
STRIP2	OTQLZ6Z7	Limited	Genetic Variation	[2363]
STUB1	OTSUYI9A	Limited	Biomarker	[2364]
STX2	OTO2IDDR	Limited	Biomarker	[2365]
SUMF1	OTALXO2A	Limited	Biomarker	[2234]
SUPT5H	OTCS9LW3	Limited	Biomarker	[2366]
SYBU	OT3FQV7N	Limited	Altered Expression	[2292]
SYNGR2	OTJX84RI	Limited	Genetic Variation	[2112]
TADA3	OTNUAIO9	Limited	Biomarker	[2367]
TAF4B	OTCICY31	Limited	Altered Expression	[2368]
TAFA4	OT0RHMNG	Limited	Posttranslational Modification	[2369]
TAP2	OTWSYFI7	Limited	Genetic Variation	[1599]
TARBP2	OT1QQ8H3	Limited	Altered Expression	[2370]
TBCE	OTGBSTKS	Limited	Biomarker	[2371]
TBX15	OTAZ9QDX	Limited	Genetic Variation	[2372]
TBX5	OT70PISV	Limited	Biomarker	[1989]
TCFL5	OTJL4348	Limited	Biomarker	[2373]
TDRD1	OT0CBCI3	Limited	Altered Expression	[2374]
TDRD10	OT5WIRLE	Limited	Biomarker	[2375]
TEAD1	OTK6971C	Limited	Biomarker	[2376]
TENM1	OTSKSU4V	Limited	Biomarker	[2377]
TENM2	OTPLUYEF	Limited	Biomarker	[2378]
TES	OTL8PP6V	Limited	Altered Expression	[2379]
TESC	OTI8C76M	Limited	Genetic Variation	[1593]
TFDP3	OTI4K6MN	Limited	Altered Expression	[2380]
TGFB1I1	OTIK337D	Limited	Altered Expression	[2381]
TGIF1	OTN9VHAG	Limited	Biomarker	[2382]
THBS2	OTXET551	Limited	Biomarker	[2383]
THOC5	OTHY50SK	Limited	Biomarker	[2384]
THUMPD1	OTKU8KWH	Limited	Biomarker	[2385]
TLE1	OT50MRZ1	Limited	Biomarker	[2386]
TM4SF4	OTRI8EHN	Limited	Altered Expression	[2387]
TM4SF5	OTPAV531	Limited	Biomarker	[2388]
TMBIM4	OT8712PP	Limited	Biomarker	[2389]
TMEM100	OTRJ6OHY	Limited	Biomarker	[2390]
TMEM115	OT3OO484	Limited	Genetic Variation	[2391]
TMEM132C	OT3297S6	Limited	Biomarker	[2375]
TMEM165	OTMVJ0GA	Limited	Biomarker	[2392]
TMEM184B	OTBZY7E9	Limited	Biomarker	[2393]
TMEM45B	OTVQCO8N	Limited	Biomarker	[2394]
TMEM50B	OTWJK2XZ	Limited	Genetic Variation	[2112]
TMEM98	OTKDUEED	Limited	Altered Expression	[2395]
TMOD4	OTXLGJ4R	Limited	Biomarker	[2396]
TOX3	OTC9NR4W	Limited	Altered Expression	[2397]
TP53AIP1	OT1XVNDP	Limited	Biomarker	[2398]
TRAM1	OT3I0H8E	Limited	Biomarker	[1480]
TRDMT1	OTAYQ8ZF	Limited	Genetic Variation	[2399]
TRIB1	OTPEO17G	Limited	Biomarker	[2400]
TRIM14	OTLQKUG0	Limited	Biomarker	[2401]
TRIM16	OTLRXYOZ	Limited	Biomarker	[2402]
TRIM3	OT704FQ0	Limited	Biomarker	[2403]
TRIM35	OTT9V87M	Limited	Biomarker	[2404]
TRIM44	OT0B1T2B	Limited	Altered Expression	[2405]
TRIM65	OTSQTK3A	Limited	Biomarker	[2406]
TSPAN2	OTTDPQF1	Limited	Biomarker	[2407]
TSPY1	OTPY57X4	Limited	Biomarker	[2408]
A1CF	OTJBKFA1	Disputed	Biomarker	[560]
ACP1	OTJ9CKLU	Disputed	Biomarker	[2409]
BAG3	OTVXYUDQ	Disputed	Genetic Variation	[2410]
COMMD5	OT6R7DXN	Disputed	Biomarker	[2411]
DBF4B	OTARSHZM	Disputed	Biomarker	[2412]
EBAG9	OTTQLQCP	Disputed	Biomarker	[2413]
EI24	OTD4NOYS	Disputed	Biomarker	[2414]
EIF2B1	OT4NCVY1	Disputed	Altered Expression	[2415]
EIF2B2	OTQQMHM1	Disputed	Altered Expression	[2415]
EIF2B4	OTTM5SX1	Disputed	Altered Expression	[2415]
ELOVL6	OTB26UJJ	Disputed	Altered Expression	[2416]
ERV3-1	OT4CW64T	Disputed	Biomarker	[2417]
FBXO4	OT6VYX67	Disputed	Biomarker	[2418]
FBXW4	OTEGSZOX	Disputed	Biomarker	[2419]
FCRL3	OTIFXFWL	Disputed	Genetic Variation	[2420]
HS3ST2	OTWFA0GJ	Disputed	Biomarker	[2421]
IL12RB1	OTM1IJO2	Disputed	Biomarker	[979]
MEST	OT8Q4U8Y	Disputed	Biomarker	[2422]
MFN1	OTCBXQZF	Disputed	Altered Expression	[2423]
NEFM	OT8VCBNF	Disputed	Biomarker	[2424]
NMT1	OT42GQ3D	Disputed	Biomarker	[2425]
NOP16	OT2829ZC	Disputed	Altered Expression	[2426]
NSG2	OTJ0NSPL	Disputed	Posttranslational Modification	[2427]
PELP1	OTVXQNOT	Disputed	Altered Expression	[2428]
PIK3IP1	OTWE5G4T	Disputed	Biomarker	[2429]
PLCB2	OTPAHDGO	Disputed	Altered Expression	[2430]
PLET1	OTUXMPIH	Disputed	Biomarker	[2431]
PRKRA	OTUTVZZU	Disputed	Biomarker	[2432]
PYROXD2	OTJIX22S	Disputed	Altered Expression	[2433]
RASGRP4	OT15PWN4	Disputed	Biomarker	[2434]
ROPN1L	OTRWZJ68	Disputed	Biomarker	[560]
RPS4X	OTIH80EK	Disputed	Altered Expression	[2435]
SAR1A	OTSSRVGV	Disputed	Biomarker	[2436]
SBSN	OT89RKJH	Disputed	Biomarker	[2437]
ST8SIA2	OTRBBBD8	Disputed	Biomarker	[2438]
STOM	OTC8R6EH	Disputed	Biomarker	[2439]
TGFBI	OTR443C5	Disputed	Biomarker	[2440]
THRAP3	OTG25JOG	Disputed	Genetic Variation	[2441]
TPM1	OTD73X6R	Disputed	Altered Expression	[2442]
A4GNT	OT8GOL3T	moderate	Altered Expression	[2443]
ABCE1	OTH19LOA	moderate	Biomarker	[2444]
ACSM3	OT0AE1IV	moderate	Biomarker	[2445]
ACTA2	OTEDLG8E	moderate	Altered Expression	[2446]
ADA2	OTGCV24S	moderate	Genetic Variation	[2447]
ADAM11	OTPTVW5W	moderate	Biomarker	[2448]
ADNP	OTEGICWR	moderate	Genetic Variation	[2449]
AGFG2	OTXQZHCR	moderate	Altered Expression	[2450]
AGR3	OTONJPDP	moderate	Biomarker	[2451]
AK6	OT84OHHP	moderate	Biomarker	[2452]
AKAP9	OT7Z2YRP	moderate	Biomarker	[2453]
ALOX15B	OTWQQ08W	moderate	Biomarker	[2454]
ALX4	OTNS9A29	moderate	Genetic Variation	[2455]
ANAPC11	OTK2SJXR	moderate	Altered Expression	[2456]
ANLN	OTXJY54C	moderate	Genetic Variation	[2457]
ANOS1	OTZJT4KN	moderate	Altered Expression	[2458]
API5	OTYX9YCZ	moderate	Biomarker	[2459]
APPL1	OT8VR95S	moderate	Biomarker	[2460]
ARHGAP1	OT0H2ZBZ	moderate	Genetic Variation	[2461]
ARHGAP35	OTJ8POG0	moderate	Genetic Variation	[2461]
ARHGAP42	OTIDSJMK	moderate	Altered Expression	[2462]
ARHGDIA	OTEXWJDO	moderate	Biomarker	[2463]
ARID2	OTIRJXWM	moderate	Genetic Variation	[2464]
ARL11	OTF6UDDB	moderate	Genetic Variation	[2465]
ARPC2	OTSOKOMY	moderate	Biomarker	[2466]
ARSH	OTG0X9UQ	moderate	Biomarker	[2467]
ARSL	OTF1VTCR	moderate	Biomarker	[2468]
ASPG	OT5E2EKR	moderate	Genetic Variation	[2469]
ASXL2	OTNG4E2M	moderate	Biomarker	[2470]
ASXL3	OTNDJWEZ	moderate	Biomarker	[2471]
ATG4A	OTDHXAPG	moderate	Biomarker	[2472]
ATP2B4	OTMWFDAC	moderate	Altered Expression	[2473]
AXIN1	OTRGZGZ5	moderate	Biomarker	[2474]
AZIN1	OTX5W77I	moderate	Biomarker	[2475]
BAG6	OT4Z0S2U	moderate	Biomarker	[2476]
BCL2L10	OTYXQJ3I	moderate	Altered Expression	[2477]
BMF	OT90NSLI	moderate	Genetic Variation	[2478]
BPIFA1	OTQFD2J5	moderate	Biomarker	[2479]
BRAT1	OT5ABVYX	moderate	Biomarker	[2480]
BRF1	OTQC6DMG	moderate	Biomarker	[2481]
BRF2	OT2C6TH2	moderate	Biomarker	[2482]
BRMS1L	OTJIW47U	moderate	Biomarker	[2483]
BTNL2	OTTTEMZA	moderate	Genetic Variation	[2484]
C1GALT1	OT2ZSZ6P	moderate	Altered Expression	[2485]
C1QL1	OTNQ0G3E	moderate	Biomarker	[721]
C2orf68	OTNNFK6R	moderate	Altered Expression	[2486]
C4orf3	OT6TFN1O	moderate	Biomarker	[2487]
CABLES1	OTMN4XSX	moderate	Biomarker	[2488]
CALML6	OTHVPDSD	moderate	Genetic Variation	[1889]
CAPN6	OT8K5PR5	moderate	Biomarker	[2489]
CBX6	OTO1I9W0	moderate	Biomarker	[2490]
CCAR1	OTUXLQZZ	moderate	Biomarker	[455]
CCDC178	OTS6N7I6	moderate	Biomarker	[2491]
CCDC54	OTW5WCX9	moderate	Altered Expression	[2492]
CCDC6	OTXRQDYG	moderate	Biomarker	[395]
CCL24	OT9LGHV0	moderate	Biomarker	[2493]
CCN6	OTRFHQ2Z	moderate	Biomarker	[2494]
CCNF	OTJFVU43	moderate	Biomarker	[2495]
CD109	OTDADBM4	moderate	Altered Expression	[2496]
CD1B	OT4D5EG7	moderate	Biomarker	[2497]
CD1C	OT4XINUJ	moderate	Biomarker	[2498]
CDCA2	OTX8UF9J	moderate	Biomarker	[2499]
CDCA3	OTUI8QK3	moderate	Biomarker	[2500]
CDCA5	OTZLCQ5U	moderate	Biomarker	[2501]
CDK10	OTKP7TTR	moderate	Biomarker	[2502]
CDKAL1	OTA0SGNE	moderate	Genetic Variation	[2503]
CEMP1	OTUEH5X5	moderate	Biomarker	[2504]
CEP152	OTOKZR9B	moderate	Biomarker	[2505]
CEP192	OTBLFV7T	moderate	Biomarker	[2505]
CEP70	OTMY5KAE	moderate	Biomarker	[2506]
CERS5	OT5A2DNI	moderate	Altered Expression	[2507]
CGB1	OT7NFGXF	moderate	Biomarker	[2508]
CGB2	OTZJW4TH	moderate	Biomarker	[2508]
CGGBP1	OTLEGQIH	moderate	Biomarker	[2509]
CHAF1B	OTOMK4KH	moderate	Genetic Variation	[2510]
CHCHD2	OTL5PA3Y	moderate	Altered Expression	[2511]
CHD2	OTRKL6YC	moderate	Biomarker	[2512]
CHSY1	OTB1XSSF	moderate	Biomarker	[2513]
CISD2	OTVS7S2H	moderate	Biomarker	[2514]
CKAP5	OTEMFY7X	moderate	Biomarker	[2515]
CLC	OTYMYR85	moderate	Genetic Variation	[2516]
CLDN11	OTNN6UTL	moderate	Biomarker	[2517]
CLEC11A	OT9KBH7C	moderate	Biomarker	[2518]
CMTM3	OTS75IGC	moderate	Biomarker	[2519]
CMTM8	OTG28GH2	moderate	Biomarker	[2520]
CNOT7	OTJBKCPI	moderate	Biomarker	[2521]
CNOT8	OT6CMCS0	moderate	Biomarker	[2521]
CNTRL	OTQI3VBA	moderate	Biomarker	[2522]
CPSF2	OTU6QXZE	moderate	Altered Expression	[2523]
CRABP1	OTISDG5X	moderate	Altered Expression	[2524]
CREBRF	OT2GK1HI	moderate	Biomarker	[2525]
CSH1	OT33HTRR	moderate	Altered Expression	[1972]
CSH2	OTW8JVAN	moderate	Altered Expression	[1972]
CT83	OTQEGHAB	moderate	Biomarker	[2526]
CTNND2	OTYKE30Y	moderate	Biomarker	[2527]
CTR9	OTP151PZ	moderate	Biomarker	[2528]
CTSZ	OTSCX2LL	moderate	Biomarker	[2529]
CUL1	OTXPE1UZ	moderate	Biomarker	[2530]
CUZD1	OTDQJVZ8	moderate	Biomarker	[2531]
CXCL6	OTFTCQ4O	moderate	Biomarker	[2532]
CYP2A7	OTRJ3P2Z	moderate	Biomarker	[2533]
CYP2U1	OT6RXLXS	moderate	Biomarker	[2534]
DAB1	OTPL9MA3	moderate	Altered Expression	[2535]
DAZAP2	OTNURO9F	moderate	Biomarker	[2536]
DCBLD2	OTB71I02	moderate	Altered Expression	[2537]
DCTN3	OTQOSUES	moderate	Biomarker	[2538]
DCUN1D1	OT8UJLZU	moderate	Altered Expression	[2539]
DCUN1D5	OTHPMYHX	moderate	Biomarker	[2540]
DDX1	OT3U8FD0	moderate	Biomarker	[2541]
DDX11	OT1WR3MD	moderate	Biomarker	[2542]
DDX19A	OTBTDR44	moderate	Genetic Variation	[2543]
DDX21	OTV73GMZ	moderate	Altered Expression	[2544]
DDX31	OTNWY581	moderate	Biomarker	[2545]
DEDD	OTIL349E	moderate	Biomarker	[2546]
DEF6	OTIRBYVK	moderate	Genetic Variation	[2547]
DKK4	OTWCCVF6	moderate	Biomarker	[2548]
DMP1	OTBWBWW7	moderate	Biomarker	[2549]
DNAJA3	OT61924T	moderate	Biomarker	[2550]
DOK6	OTX55OIF	moderate	Biomarker	[2551]
DSC3	OTYG47F8	moderate	Biomarker	[2552]
DSG2	OTJPB2TO	moderate	Altered Expression	[2553]
DSPP	OT1TYNDN	moderate	Biomarker	[2554]
DTX3L	OTCCO2QZ	moderate	Biomarker	[2555]
DUSP4	OT6WAO12	moderate	Biomarker	[2556]
DYM	OTQ670WI	moderate	Biomarker	[2557]
DYNLL2	OTLIT58K	moderate	Biomarker	[2558]
ECD	OT3L3PCU	moderate	Genetic Variation	[2559]
ECRG4	OTHZYUXX	moderate	Biomarker	[2560]
EEF1A2	OT9Z23K5	moderate	Biomarker	[2561]
EFNA2	OTEAUKRX	moderate	Biomarker	[2562]
EGR3	OTGPJIRA	moderate	Altered Expression	[2563]
EIF3D	OTDOMP80	moderate	Biomarker	[2564]
EIF3F	OTU20K6L	moderate	Biomarker	[2518]
EIF4E3	OTTWVS2R	moderate	Biomarker	[2565]
ELP1	OTYEWBF7	moderate	Biomarker	[2528]
ELP3	OTT5UKSZ	moderate	Biomarker	[2566]
EMSY	OTBQ3KQE	moderate	Biomarker	[2567]
EN2	OT7EZCM2	moderate	Altered Expression	[2568]
ENTPD2	OTZ2PKPM	moderate	Biomarker	[2569]
ESPL1	OTMGEVOK	moderate	Biomarker	[2570]
EXOSC5	OTADUQ7H	moderate	Biomarker	[2571]
FAM107A	OTBG61YZ	moderate	Altered Expression	[2572]
FBLN1	OT5MHHOP	moderate	Biomarker	[2573]
FMN2	OTUY7BSV	moderate	Biomarker	[2574]
FOXL1	OT89XFPN	moderate	Biomarker	[2575]
FRK	OTEKV1SC	moderate	Biomarker	[2576]
FSTL5	OT18C29S	moderate	Altered Expression	[2577]
FZD4	OTGLZIE0	moderate	Biomarker	[2451]
GABPB1	OTEXDEJN	moderate	Altered Expression	[2578]
GALNT3	OT7M67WT	moderate	Biomarker	[2579]
GALNT6	OTOQQVH1	moderate	Biomarker	[2580]
GAPDHS	OT7YUSA5	moderate	Biomarker	[2581]
GCNT3	OTQ9ALTR	moderate	Biomarker	[2582]
GDF10	OTEVXGJ7	moderate	Altered Expression	[2583]
GDPD5	OTUM65JL	moderate	Altered Expression	[2584]
GEN1	OT1XFQXF	moderate	Biomarker	[2585]
GINS2	OT974IYI	moderate	Altered Expression	[2586]
GLUD2	OTF3GGYY	moderate	Altered Expression	[2587]
GOLGA2	OT5S9KYM	moderate	Biomarker	[2588]
GOLGA7	OT72NQLJ	moderate	Genetic Variation	[2589]
GOT2	OT6XBWN0	moderate	Altered Expression	[2590]
GPM6A	OT8G13EG	moderate	Biomarker	[2591]
GPM6B	OT8Q1582	moderate	Biomarker	[2591]
GPX2	OTXI2NTI	moderate	Altered Expression	[2592]
GSC	OT4DH7PR	moderate	Biomarker	[2593]
GSPT1	OT18H1B0	moderate	Genetic Variation	[2594]
GTF2IRD1	OTEG9KU1	moderate	Biomarker	[2595]
GTPBP4	OT6ZHAWC	moderate	Biomarker	[2596]
GTSE1	OTPP742Z	moderate	Altered Expression	[2597]
H3-3B	OT9XHQ3C	moderate	Genetic Variation	[2598]
HAND1	OTN4IPVV	moderate	Biomarker	[2599]
HAS1	OTJIAG1W	moderate	Biomarker	[2600]
HELQ	OTL1STJT	moderate	Biomarker	[2601]
HFM1	OTHV3EFE	moderate	Genetic Variation	[2602]
HGS	OTCYYCAC	moderate	Genetic Variation	[2603]
HHIP	OT77RQYS	moderate	Altered Expression	[2604]
HIVEP3	OTM3QT3L	moderate	Biomarker	[2605]
HMG20B	OTY94WRA	moderate	Biomarker	[2606]
HNRNPU	OTLQN1E2	moderate	Altered Expression	[434]
HP1BP3	OTTJ5LX2	moderate	Biomarker	[2607]
HPCAL1	OTOBBFRD	moderate	Biomarker	[2608]
HRG	OTPLUFOG	moderate	Biomarker	[2609]
HSH2D	OTOGB2BR	moderate	Biomarker	[2610]
HTRA4	OT58M21J	moderate	Biomarker	[2611]
ID3	OTUULW5Z	moderate	Altered Expression	[2612]
IFI16	OT4SPU0U	moderate	Biomarker	[2613]
IFT20	OTKJS2BZ	moderate	Biomarker	[2614]
IGSF1	OT3XD6U2	moderate	Altered Expression	[434]
IL17C	OTKXIVNQ	moderate	Biomarker	[2615]
IL18BP	OTW0LRYZ	moderate	Genetic Variation	[2616]
IL3	OT0CQ35N	moderate	Altered Expression	[2617]
IL4I1	OTK54C63	moderate	Biomarker	[2618]
IL6R	OTCQL07Z	moderate	Biomarker	[2619]
IMMP2L	OT9WGAFD	moderate	Altered Expression	[2620]
IMPA1	OTBUVW1Z	moderate	Genetic Variation	[2621]
INHA	OT7HWCO3	moderate	Altered Expression	[2622]
INSM1	OTG8RV8E	moderate	Biomarker	[2623]
INTS1	OT7TY1M1	moderate	Biomarker	[2624]
IRF2	OTAZRUW3	moderate	Biomarker	[2625]
IRGM	OTKD3O5Z	moderate	Biomarker	[2626]
IRS4	OTTOL40K	moderate	Altered Expression	[735]
ISL1	OTVNVKAX	moderate	Altered Expression	[2627]
ISM1	OTZTK2TV	moderate	Biomarker	[2628]
ITLN1	OT7ZLJVV	moderate	Biomarker	[2629]
KANK1	OT2E7A6W	moderate	Biomarker	[2630]
KATNB1	OT7CLZKS	moderate	Biomarker	[2631]
KCTD7	OTRU3EOK	moderate	Biomarker	[2632]
KDM4D	OTN6KAE6	moderate	Biomarker	[424]
KIDINS220	OTLBH2MA	moderate	Biomarker	[2633]
KIR3DS1	OTJWIO4T	moderate	Biomarker	[2634]
KLHDC7B	OT2H5BNX	moderate	Altered Expression	[2635]
KLHL1	OTAX6SAD	moderate	Biomarker	[2636]
KLRC2	OTT4N86S	moderate	Biomarker	[2637]
KNSTRN	OTYA7UXS	moderate	Genetic Variation	[2638]
KRR1	OTCMJ3K3	moderate	Biomarker	[2639]
KRT81	OTMKIK2S	moderate	Genetic Variation	[2640]
LAMP3	OTN0XL3W	moderate	Genetic Variation	[2641]
LAMTOR1	OTIBJBW9	moderate	Biomarker	[568]
LARP7	OTLLOZTL	moderate	Biomarker	[2642]
LCN1	OT8BWXTV	moderate	Biomarker	[2643]
LETMD1	OTZTZ4RD	moderate	Biomarker	[2644]
LGALS8	OT71LJ8T	moderate	Biomarker	[2645]
LMX1B	OTM8145D	moderate	Altered Expression	[2646]
LOXL1	OTA0NEJU	moderate	Altered Expression	[2647]
LPCAT1	OTCV7AGV	moderate	Biomarker	[2648]
LRIG2	OTDUBLIH	moderate	Biomarker	[2649]
LRP1B	OT4YZG2N	moderate	Biomarker	[2650]
LRRFIP1	OTN7XAUD	moderate	Biomarker	[2651]
LRWD1	OTHRVJQC	moderate	Biomarker	[2652]
LSM2	OTHL77NY	moderate	Biomarker	[2653]
LTBP3	OTME98V7	moderate	Genetic Variation	[2654]
MACF1	OTVIHD77	moderate	Altered Expression	[2655]
MACROH2A1	OTV2DQDD	moderate	Biomarker	[2656]
MACROH2A2	OTAKSVYV	moderate	Biomarker	[2657]
MAEL	OTZ2VU30	moderate	Biomarker	[2658]
MAP2K3	OTI2OREX	moderate	Biomarker	[2659]
MAP3K13	OTS93BTX	moderate	Altered Expression	[2660]
MARK1	OTP7KL47	moderate	Altered Expression	[2661]
MASTL	OTQ7YKK5	moderate	Altered Expression	[2662]
MATK	OTVOJJLJ	moderate	Biomarker	[2663]
MAX	OTKZ0YKM	moderate	Biomarker	[2664]
MDH1	OTJEO4E8	moderate	Altered Expression	[1188]
MDH2	OT7364GY	moderate	Altered Expression	[2665]
MED1	OTOO24C4	moderate	Biomarker	[2666]
MED30	OTM3INJN	moderate	Biomarker	[2667]
METTL3	OTSXP1M3	moderate	Biomarker	[2668]
METTL8	OT7E09Y4	moderate	Biomarker	[2669]
MFAP4	OT5W64QY	moderate	Biomarker	[2670]
MID1	OTWN1PGU	moderate	Altered Expression	[2671]
MLLT3	OTXH4DDG	moderate	Biomarker	[2672]
MLXIP	OT30UNI7	moderate	Biomarker	[2125]
MLXIPL	OTR9MLLW	moderate	Altered Expression	[1648]
MT1F	OTZVUYG1	moderate	Biomarker	[2673]
MTBP	OTWLCW9C	moderate	Biomarker	[2674]
MTUS1	OTBPALMU	moderate	Biomarker	[2675]
MYLIP	OTL0PFGV	moderate	Biomarker	[2125]
MYO10	OTHB78ZQ	moderate	Biomarker	[2676]
MYO9B	OTQ94R5K	moderate	Altered Expression	[2677]
NAA80	OTLWR71Z	moderate	Genetic Variation	[2678]
NAALADL2	OT2HOGPQ	moderate	Altered Expression	[2679]
NCKAP1	OTEZQXXJ	moderate	Biomarker	[2680]
NCKIPSD	OT24UORN	moderate	Altered Expression	[2681]
NCOR2	OTY917X0	moderate	Genetic Variation	[2682]
NCSTN	OT5QBTA4	moderate	Biomarker	[2683]
NDST1	OT9E10W2	moderate	Biomarker	[2605]
NEIL2	OTV6JEON	moderate	Altered Expression	[2684]
NEK5	OTHDXCYZ	moderate	Biomarker	[2685]
NFATC2	OTK5T6HZ	moderate	Biomarker	[2686]
NHLH1	OTXN5B9R	moderate	Biomarker	[2687]
NINL	OTWIK6HT	moderate	Biomarker	[2688]
NIPSNAP3B	OTHMMYD5	moderate	Altered Expression	[2689]
NOP53	OTA2YKO6	moderate	Altered Expression	[2690]
NPRL2	OTOB10MO	moderate	Biomarker	[2691]
NR1D2	OT9CVF41	moderate	Biomarker	[2692]
NR5A1	OTOULYR4	moderate	Genetic Variation	[2693]
NRSN2	OT4OS3M2	moderate	Biomarker	[2694]
NSFL1C	OTIKQF3U	moderate	Biomarker	[2518]
NSG1	OTRIMA50	moderate	Altered Expression	[2695]
NSMAF	OTYNVZ23	moderate	Biomarker	[2522]
NSUN5	OTBN7RS8	moderate	Altered Expression	[434]
NT5C3A	OT67KZJA	moderate	Biomarker	[2696]
NUDT5	OTHYCBA6	moderate	Biomarker	[2697]
NUP88	OT647WOR	moderate	Biomarker	[2698]
NUTM2A	OTQ4VQXE	moderate	Genetic Variation	[2699]
OCIAD2	OTSWB4SZ	moderate	Altered Expression	[2700]
ODAM	OTT666SJ	moderate	Biomarker	[2701]
OIP5	OTI5C2DE	moderate	Biomarker	[2702]
OPCML	OT93PQ6Y	moderate	Altered Expression	[2703]
OPN4	OT1LZ7TS	moderate	Biomarker	[2704]
ORAI3	OTUP3OH3	moderate	Biomarker	[2705]
OTP	OTS0JN6Y	moderate	Biomarker	[2706]
OTX2	OTTV05B1	moderate	Biomarker	[2707]
PAQR3	OTTKJ9Y4	moderate	Posttranslational Modification	[2708]
PAX6	OTOC9876	moderate	Genetic Variation	[2709]
PBOV1	OT67PERT	moderate	Biomarker	[2710]
PCDH17	OTRK0M05	moderate	Biomarker	[2711]
PCMT1	OTGYVSGU	moderate	Biomarker	[2712]
PCNT	OTW4Z65J	moderate	Biomarker	[2713]
PCP4	OTM1XXYX	moderate	Biomarker	[2714]
PDZK1IP1	OTWA6M5K	moderate	Altered Expression	[2715]
PHF1	OTW2PSIR	moderate	Biomarker	[2716]
PHLDB2	OTDKMB2G	moderate	Biomarker	[2717]
PI4K2A	OTL9L6MX	moderate	Biomarker	[354]
PIAS3	OT3TWH9R	moderate	Biomarker	[2718]
PIGA	OT51UWUR	moderate	Genetic Variation	[2719]
PIK3R4	OTRL8QP8	moderate	Biomarker	[2528]
PLA2G10	OTRZ2L5A	moderate	Biomarker	[238]
PLA2G2D	OTU604XM	moderate	Altered Expression	[2720]
PLA2G6	OT5FL0WU	moderate	Altered Expression	[248]
PLXND1	OTNK9ALK	moderate	Biomarker	[2721]
PNN	OT0HXICH	moderate	Biomarker	[2722]
POLQ	OTBHK0E6	moderate	Altered Expression	[2723]
POLR2A	OTHJQ1DZ	moderate	Biomarker	[2724]
POMP	OTMPM1P5	moderate	Biomarker	[2725]
POU1F1	OTXT8A5C	moderate	Biomarker	[1615]
POU2F2	OTPV0J0C	moderate	Biomarker	[2726]
PPA1	OTHZK1QB	moderate	Biomarker	[2727]
PPP1R12A	OT4AVU95	moderate	Genetic Variation	[2728]
PPP1R13L	OTNCPLWE	moderate	Altered Expression	[2729]
PPP1R2	OTNLOUQR	moderate	Biomarker	[2730]
PPP1R7	OTY5IE69	moderate	Altered Expression	[2731]
PPP1R9B	OTDCTHTT	moderate	Biomarker	[1253]
PPP3R1	OTGQNFJQ	moderate	Biomarker	[2732]
PREX2	OTYT1J6J	moderate	Genetic Variation	[2733]
PRSS50	OTC5JAVO	moderate	Altered Expression	[2734]
PSMA1	OTNBVM2U	moderate	Biomarker	[2735]
PSMG1	OTZ5I6UM	moderate	Biomarker	[354]
PTPMT1	OT9WVC6N	moderate	Biomarker	[2736]
PTPRT	OTV5TXNN	moderate	Altered Expression	[2737]
PTTG1IP	OTX21QTE	moderate	Altered Expression	[2738]
PYCARD	OT67RON3	moderate	Altered Expression	[472]
RAB17	OT7NBUGQ	moderate	Biomarker	[2739]
RAB24	OTOFNAJK	moderate	Biomarker	[2740]
RAB31	OTMLXQZ0	moderate	Genetic Variation	[2741]
RAB3GAP2	OTQTE0GI	moderate	Biomarker	[2528]
RAB40A	OT7JMR2K	moderate	Biomarker	[2742]
RAB40AL	OTZWO8A5	moderate	Biomarker	[2742]
RAB40B	OTCA9ZF5	moderate	Biomarker	[2743]
RAB7B	OT60A0E9	moderate	Biomarker	[452]
RAD51B	OTCJVRMY	moderate	Biomarker	[2744]
RAG1	OTV131E4	moderate	Biomarker	[2745]
RAP2B	OTD2NDQP	moderate	Biomarker	[2746]
RAPH1	OTMQXW7S	moderate	Biomarker	[2747]
RASA2	OTL06RG2	moderate	Altered Expression	[2748]
RASGRP1	OTX9WN2E	moderate	Biomarker	[2749]
RBMX	OTFZN66E	moderate	Biomarker	[2476]
RBP2	OTR8QG5V	moderate	Biomarker	[2750]
RBPMS2	OTY24L1F	moderate	Biomarker	[2751]
RCAN1	OT1MVXC7	moderate	Biomarker	[2752]
RGN	OTD04KB1	moderate	Biomarker	[2753]
RGPD2	OTMUZ0HX	moderate	Altered Expression	[2450]
RHOXF1	OT3SC14T	moderate	Biomarker	[2754]
RIN1	OTPBROUD	moderate	Biomarker	[2755]
RING1	OTCWTAX0	moderate	Biomarker	[2756]
RNASET2	OTWY64L7	moderate	Biomarker	[2757]
RNF144A	OTCG27CT	moderate	Biomarker	[2758]
RNF41	OTN1DQOY	moderate	Biomarker	[2759]
RPL10A	OTDLCJ53	moderate	Biomarker	[2760]
RPL31	OTV9E1OE	moderate	Altered Expression	[2761]
RPLP1	OT7B0SIB	moderate	Biomarker	[2762]
RPS6	OTT4D1LN	moderate	Biomarker	[2763]
RTCA	OTSJRVTD	moderate	Biomarker	[2764]
RTEL1	OTI3PJCT	moderate	Biomarker	[2765]
RTL1	OTOT33IM	moderate	Biomarker	[1578]
RTN4IP1	OTHUZANE	moderate	Altered Expression	[2766]
SAA2	OTYAVJWG	moderate	Genetic Variation	[459]
SAFB	OTGRV2LW	moderate	Biomarker	[2767]
SARS1	OTFKXQ1O	moderate	Biomarker	[2768]
SARS2	OTU4T99W	moderate	Biomarker	[2768]
SCAF1	OT16TM3N	moderate	Biomarker	[2769]
SCRIB	OTW4N3FV	moderate	Altered Expression	[2770]
SDC4	OTKUVUGZ	moderate	Biomarker	[2771]
SELENBP1	OT3NZNTR	moderate	Biomarker	[2772]
SELENOF	OT2JFB3S	moderate	Altered Expression	[2773]
SELENOW	OTVSKPAN	moderate	Altered Expression	[2774]
SEMA6B	OT3VVVUO	moderate	Biomarker	[2775]
SEMA7A	OT0ZJK64	moderate	Biomarker	[2776]
SERPINI1	OTUJHIJW	moderate	Biomarker	[2777]
SF3A1	OTI733D7	moderate	Biomarker	[2778]
SFTPC	OTIZJD09	moderate	Altered Expression	[2779]
SGPP2	OTIDIJCR	moderate	Altered Expression	[2780]
SGTA	OTKOJ3JB	moderate	Biomarker	[473]
SH3BGRL	OTUOCTMT	moderate	Biomarker	[2781]
SH3PXD2A	OTYRQJIH	moderate	Biomarker	[2782]
SH3PXD2B	OTAOMCDJ	moderate	Biomarker	[2782]
SHC1	OT1J5IRN	moderate	Biomarker	[2783]
SHQ1	OTFBXX2H	moderate	Biomarker	[2784]
SIAH2	OTKED2XN	moderate	Altered Expression	[2333]
SIRT4	OT5S0J23	moderate	Biomarker	[2785]
SLC22A18	OT9C3KR4	moderate	Biomarker	[2403]
SMARCC1	OTUOMBE7	moderate	Biomarker	[2786]
SOCS5	OTN1ABYR	moderate	Biomarker	[2787]
SOD3	OTIOZQAB	moderate	Biomarker	[2788]
SOSTDC1	OTAKDNSM	moderate	Biomarker	[2789]
SOX8	OTEJXYZM	moderate	Altered Expression	[2790]
SP4	OTWB30IZ	moderate	Altered Expression	[2791]
SPA17	OT8J7T7U	moderate	Altered Expression	[2492]
SPAG11A	OTNQ9UB0	moderate	Biomarker	[1279]
SPART	OTIVOS2I	moderate	Biomarker	[2792]
SPPL2A	OTCVF6MM	moderate	Biomarker	[2793]
SPPL3	OT2HLJF6	moderate	Altered Expression	[2620]
SPSB1	OTGY26U4	moderate	Genetic Variation	[2794]
SSX3	OTGJV5UZ	moderate	Biomarker	[2795]
ST6GALNAC2	OT9PBQVT	moderate	Biomarker	[2796]
ST7L	OT0I8XNI	moderate	Altered Expression	[2797]
STARD10	OTWVNFV4	moderate	Altered Expression	[2798]
STRN4	OTHK2ZN6	moderate	Biomarker	[2799]
STX1A	OTSBUZB4	moderate	Genetic Variation	[2800]
SUMO1	OTJFD4P5	moderate	Biomarker	[2801]
SUN2	OT2IQJUC	moderate	Biomarker	[2802]
SYCE1L	OTXU44F3	moderate	Biomarker	[2636]
SYNE2	OTBUXGQ0	moderate	Biomarker	[2803]
TAPBP	OTL81AVZ	moderate	Biomarker	[2804]
TAS2R38	OTX5MM36	moderate	Biomarker	[395]
TBPL2	OTDEC1KO	moderate	Biomarker	[2805]
TCEAL1	OTAPG2L5	moderate	Altered Expression	[2695]
TEAD4	OTJS0T2B	moderate	Biomarker	[2806]
TEX10	OTNTU9CB	moderate	Altered Expression	[2807]
TEX101	OTNO747E	moderate	Biomarker	[2808]
TFAP2C	OTUDIW05	moderate	Biomarker	[2809]
TGFBR3	OTQOOUC4	moderate	Biomarker	[2810]
TIA1	OTGPN3P8	moderate	Biomarker	[2811]
TINF2	OT861N2N	moderate	Altered Expression	[2812]
TIPRL	OTS2FZ8O	moderate	Biomarker	[2813]
TMEM132A	OTNUI7O1	moderate	Genetic Variation	[2814]
TMEM260	OTICII2L	moderate	Genetic Variation	[2589]
TMEM52B	OTOC70IF	moderate	Altered Expression	[2815]
TMEM59	OTX4EKES	moderate	Altered Expression	[2816]
TMEM74	OT3IZBM0	moderate	Biomarker	[2817]
TMUB1	OTR4RO3N	moderate	Altered Expression	[2818]
TNFRSF19	OTTVT4MB	moderate	Biomarker	[2819]
TNS3	OTPG2D8Z	moderate	Altered Expression	[2820]
TREX1	OTQG7K12	moderate	Biomarker	[2821]
TRIM25	OT35SG1R	moderate	Altered Expression	[2822]
TRIM31	OT7VW6RP	moderate	Altered Expression	[2823]
TRIM63	OTUSWA74	moderate	Biomarker	[2824]
TRIO	OT71X1AK	moderate	Biomarker	[2825]
TRPS1	OT7XPPEL	moderate	Biomarker	[2826]
TSC22D1	OTN4GFWD	moderate	Biomarker	[2827]
TSHZ1	OTYQ9ECW	moderate	Biomarker	[2828]
TSNAX	OTZ9SGWB	moderate	Altered Expression	[2829]
TTL	OTSS1CK4	moderate	Biomarker	[2830]
TTLL1	OTCE097J	moderate	Biomarker	[2830]
A2M	OTFTX90K	Strong	Biomarker	[2831]
A2ML1	OTWNUXIS	Strong	Altered Expression	[2832]
A4GALT	OTPX3UGY	Strong	Biomarker	[2833]
AADAC	OT8VACT2	Strong	Biomarker	[2419]
AANAT	OTUBJ7SX	Strong	Biomarker	[2834]
AASDHPPT	OTA6OR6C	Strong	Biomarker	[2835]
AATF	OT1QOKLD	Strong	Biomarker	[2836]
ABCC12	OTYB58S2	Strong	Biomarker	[2837]
ABCF2	OTXIBZ3N	Strong	Biomarker	[2838]
ABHD5	OTY829Z3	Strong	Altered Expression	[2839]
ABI1	OT5H4M62	Strong	Biomarker	[2840]
ABI3	OTQTDSHP	Strong	Biomarker	[2841]
ABI3BP	OTW8DN50	Strong	Biomarker	[2842]
ABR	OTZQK8JF	Strong	Biomarker	[2843]
ABRAXAS2	OTAW1I4C	Strong	Biomarker	[2844]
ABTB1	OTKKPQJL	Strong	Biomarker	[2845]
ACADL	OTP7Y0UF	Strong	Biomarker	[2846]
ACD	OTC54EPO	Strong	Biomarker	[478]
ACER2	OTS3DDE5	Strong	Biomarker	[2847]
ACKR2	OTWYY14H	Strong	Altered Expression	[2848]
ACKR4	OTZPWT2N	Strong	Altered Expression	[2849]
ACOT8	OTHY684G	Strong	Genetic Variation	[2850]
ACRBP	OT0MK3L1	Strong	Biomarker	[2851]
ACSBG1	OTM040MW	Strong	Genetic Variation	[2852]
ACSL3	OT3MWER1	Strong	Biomarker	[2853]
ACSL4	OTI71MUJ	Strong	Biomarker	[2854]
ACSS1	OT6C1WQD	Strong	Biomarker	[2855]
ACSS3	OTWB58F5	Strong	Biomarker	[2856]
ACTB	OT1MCP2F	Strong	Biomarker	[2857]
ACTG2	OTRDWUO0	Strong	Biomarker	[499]
ACTL6A	OT0EC5BQ	Strong	Biomarker	[2858]
ACVR1C	OTOTYERF	Strong	Altered Expression	[2859]
ACY1	OT9WU7X3	Strong	Biomarker	[2860]
ACY3	OTZWAB73	Strong	Biomarker	[2861]
ACYP2	OTRB4S6X	Strong	Genetic Variation	[2862]
ADAD1	OTXRDF3Z	Strong	Genetic Variation	[2863]
ADAM12	OTZKOTDB	Strong	Biomarker	[2864]
ADAM28	OT3GBVHL	Strong	Altered Expression	[2865]
ADAMTS12	OTG7HEA2	Strong	Posttranslational Modification	[2866]
ADAMTS15	OTYB6JS3	Strong	Genetic Variation	[2867]
ADAMTS18	OTRMFI04	Strong	Biomarker	[2868]
ADAMTS2	OTTK22NO	Strong	Biomarker	[2869]
ADAMTS6	OTSZE6L4	Strong	Altered Expression	[2870]
ADAMTSL3	OTMC2WFG	Strong	Genetic Variation	[2871]
ADAP2	OTGQ8UH7	Strong	Genetic Variation	[2872]
ADAR	OTQNOHR8	Strong	Biomarker	[2873]
ADARB1	OTGKSZEV	Strong	Biomarker	[2874]
ADARB2	OTDJKS39	Strong	Altered Expression	[2875]
ADCY10	OTYSTB0R	Strong	Altered Expression	[2876]
ADCY3	OTGOQM6B	Strong	Biomarker	[2877]
ADCY8	OTR1WCZX	Strong	Biomarker	[2878]
ADGRA2	OTBT4W36	Strong	Biomarker	[1241]
ADGRA3	OTPJEV0S	Strong	Biomarker	[2879]
ADGRB1	OTJSEXRC	Strong	Biomarker	[2880]
ADGRF1	OTRAOBYH	Strong	Biomarker	[2881]
ADGRF4	OT4PTCTF	Strong	Biomarker	[2882]
ADGRG1	OTQBB8NT	Strong	Altered Expression	[2883]
ADGRL4	OTN1GAG7	Strong	Biomarker	[2884]
ADIPOR1	OT65ZFZN	Strong	Altered Expression	[2885]
ADIRF	OTTJP8D4	Strong	Biomarker	[2886]
ADM5	OTFOA92Z	Strong	Altered Expression	[2887]
ADO	OTRLGQ7V	Strong	Biomarker	[2888]
AFAP1L2	OTJBI0VN	Strong	Biomarker	[2889]
AFDN	OTTRU341	Strong	Altered Expression	[2890]
AFF3	OTR0705Z	Strong	Biomarker	[2891]
AFM	OTPOR8IO	Strong	Biomarker	[2892]
AGAP2	OTEYO9TM	Strong	Altered Expression	[2893]
AGBL2	OTCX9987	Strong	Biomarker	[1534]
AGFG1	OTI8ZKC4	Strong	Biomarker	[2894]
AGGF1	OTA7U2T8	Strong	Altered Expression	[2895]
AGO2	OT4JY32Q	Strong	Biomarker	[2896]
AGPS	OTFBFPV4	Strong	Altered Expression	[2897]
AGRN	OTWJENAZ	Strong	Biomarker	[2898]
AHI1	OT8K2YWY	Strong	Biomarker	[2899]
AHNAK2	OTD2X4BX	Strong	Biomarker	[2900]
AHRR	OTSJ12W6	Strong	Genetic Variation	[2901]
AHSA1	OTC7AFHT	Strong	Altered Expression	[725]
AIF1L	OTDEOB80	Strong	Altered Expression	[2902]
AIM2	OT86QUI8	Strong	Biomarker	[2903]
AIRE	OTA7G1Y1	Strong	Biomarker	[2904]
AJAP1	OTAAW121	Strong	Biomarker	[2905]
AK3	OTM59ZGG	Strong	Biomarker	[2906]
AK4	OTA0T02Q	Strong	Biomarker	[2907]
AKAP13	OTOZAR14	Strong	Biomarker	[2908]
AKAP4	OTL4Z99V	Strong	Biomarker	[2909]
AKIP1	OT7XPG27	Strong	Biomarker	[2910]
AKIRIN2	OTQ6WSKW	Strong	Biomarker	[2911]
AKNA	OTQ6E2C8	Strong	Biomarker	[2912]
AKR7A3	OTW3GO4Y	Strong	Biomarker	[2913]
AKT1S1	OT4JHN4Y	Strong	Biomarker	[2914]
ALDH1A3	OT1C9NKQ	Strong	Biomarker	[1700]
ALDH1L1	OT15HOJX	Strong	Altered Expression	[2915]
ALDH1L2	OTCH86VF	Strong	Biomarker	[2916]
ALDH7A1	OTV57BZD	Strong	Altered Expression	[2917]
ALDH9A1	OTNWHUJ1	Strong	Genetic Variation	[2918]
ALDOA	OTWRFTIB	Strong	Biomarker	[2919]
ALG1	OTVXPA9E	Strong	Biomarker	[1136]
ALG2	OT77B384	Strong	Altered Expression	[2210]
ALG3	OTPOL1QW	Strong	Biomarker	[2920]
ALKBH1	OTADGU5D	Strong	Biomarker	[1787]
ALKBH3	OTS1CD9Z	Strong	Altered Expression	[2921]
ALKBH7	OTJVS8CF	Strong	Genetic Variation	[2922]
ALKBH8	OTXN70DV	Strong	Altered Expression	[2923]
ALPK1	OTBW6SGD	Strong	Biomarker	[2924]
ALPK2	OTWZZDQ9	Strong	Genetic Variation	[2925]
ALPP	OTZU4G9W	Strong	Biomarker	[529]
AMBP	OTLU8GU8	Strong	Altered Expression	[2926]
AMBRA1	OTY0YGT9	Strong	Biomarker	[2927]
AMELX	OTIN26MM	Strong	Biomarker	[2928]
AMER1	OT8EFJPM	Strong	Altered Expression	[2929]
AMH	OT5FH4BD	Strong	Biomarker	[2930]
AMPD1	OTU17BCI	Strong	Biomarker	[2931]
AMPD2	OTBS30JU	Strong	Biomarker	[2932]
AMPH	OTWPGWZX	Strong	Biomarker	[2933]
ANAPC10	OTM03SME	Strong	Biomarker	[2934]
ANGPTL1	OTXIN6V5	Strong	Biomarker	[2935]
ANGPTL2	OTB6JG41	Strong	Biomarker	[1775]
ANGPTL6	OTOQ5W67	Strong	Biomarker	[2936]
ANKHD1	OTVYQ7ZL	Strong	Biomarker	[2937]
ANKRD11	OTV0V70M	Strong	Biomarker	[2938]
ANKRD26	OT2ENKKV	Strong	Genetic Variation	[2939]
ANKRD30A	OTJXYAE5	Strong	Altered Expression	[2940]
ANKRD36B	OT3MW415	Strong	Altered Expression	[2941]
ANKRD46	OTG8X76U	Strong	Biomarker	[2942]
ANKRD9	OT7VGO6G	Strong	Biomarker	[2943]
ANO10	OTG3BNOU	Strong	Genetic Variation	[2944]
ANO6	OTTA5KQJ	Strong	Genetic Variation	[2944]
ANP32B	OT3SQMLU	Strong	Biomarker	[2945]
ANXA13	OTM33P73	Strong	Biomarker	[2946]
ANXA3	OTDD8OI7	Strong	Biomarker	[2947]
ANXA4	OTUCRYXL	Strong	Biomarker	[2948]
ANXA6	OT9KIQ0Y	Strong	Altered Expression	[2949]
AP1S3	OTPCMV24	Strong	Altered Expression	[2950]
AP2A1	OTEFZB21	Strong	Biomarker	[2951]
AP2B1	OTL6LZJ4	Strong	Biomarker	[2952]
AP2M1	OTQCOSFN	Strong	Altered Expression	[2953]
APAF1	OTJWIVY0	Strong	Biomarker	[2954]
APBA2	OTXD8ID1	Strong	Posttranslational Modification	[2955]
APBA3	OTAAATXF	Strong	Biomarker	[2956]
APBB1	OTZPVSSC	Strong	Biomarker	[2957]
APBB3	OTNUTR0N	Strong	Biomarker	[2958]
APCDD1	OTV9AD0L	Strong	Biomarker	[2959]
APH1A	OT97F1TU	Strong	Biomarker	[2960]
APLP2	OTTFE53M	Strong	Biomarker	[2961]
APOBEC3A	OTYO6F5P	Strong	Altered Expression	[2962]
APOBEC3H	OTXIH4X4	Strong	Biomarker	[2963]
APOC1	OTA58CED	Strong	Biomarker	[2964]
APOD	OTT77XW8	Strong	Biomarker	[2965]
APOM	OTI3FQQC	Strong	Biomarker	[2966]
APPL2	OT9S4C4K	Strong	Biomarker	[2967]
APTX	OTPAS5G8	Strong	Biomarker	[2968]
AQP2	OTQLBKK6	Strong	Altered Expression	[2969]
AQP5	OT77GBY8	Strong	Biomarker	[2970]
ARAP3	OTUWZTH7	Strong	Altered Expression	[2971]
AREL1	OTSYV9R3	Strong	Altered Expression	[2972]
ARF3	OTYYQX85	Strong	Genetic Variation	[2973]
ARFGEF1	OTPAU0L4	Strong	Altered Expression	[2974]
ARHGAP11A	OTVQCFVP	Strong	Biomarker	[2975]
ARHGAP17	OTEABPLV	Strong	Altered Expression	[2976]
ARHGAP26	OTNGQU7A	Strong	Biomarker	[2977]
ARHGAP45	OTL86FEQ	Strong	Biomarker	[2978]
ARHGAP9	OTJNHX96	Strong	Altered Expression	[2979]
ARHGDIB	OT9PD6CS	Strong	Biomarker	[2980]
ARHGEF11	OTDOMEH6	Strong	Genetic Variation	[2981]
ARHGEF2	OTBQTFRT	Strong	Altered Expression	[2982]
ARHGEF25	OT7162TD	Strong	Altered Expression	[2983]
ARHGEF39	OT9UKTQ5	Strong	Altered Expression	[2984]
ARHGEF4	OTR2VG0W	Strong	Biomarker	[2985]
ARHGEF40	OTFSKXG9	Strong	Biomarker	[2986]
ARHGEF7	OT9BPJCL	Strong	Biomarker	[2987]
ARID1A	OTRWDV3P	Strong	Biomarker	[2988]
ARID1B	OTILK3Q7	Strong	Biomarker	[2989]
ARID3B	OTUP9MS4	Strong	Biomarker	[2990]
ARID4B	OTYLPILE	Strong	Altered Expression	[2991]
ARID5B	OTUQ4CQY	Strong	Genetic Variation	[2992]
ARIH1	OTO3XDR2	Strong	Genetic Variation	[2993]
ARL3	OT3OGOMX	Strong	Biomarker	[2994]
ARL4C	OTQ3QNNU	Strong	Altered Expression	[2995]
ARL6IP5	OTYZ6BEQ	Strong	Biomarker	[2996]
ARMH1	OTTJC0D6	Strong	Biomarker	[979]
ARMT1	OTS7WBCP	Strong	Genetic Variation	[2997]
ARPC5	OTFNMMDL	Strong	Biomarker	[2998]
ARPIN	OTNNYP9A	Strong	Altered Expression	[2999]
ARRDC3	OTAKW7R9	Strong	Altered Expression	[3000]
ARSF	OTC0L12N	Strong	Genetic Variation	[3001]
ARSG	OTT7TDW7	Strong	Biomarker	[1386]
ART1	OT7FBG5W	Strong	Genetic Variation	[3002]
ARTN	OTWIWGL6	Strong	Genetic Variation	[520]
ASAH1	OT1DNGXL	Strong	Biomarker	[3003]
ASB4	OTI4AFZL	Strong	Biomarker	[3004]
ASCC1	OTH4VAP9	Strong	Altered Expression	[3005]
ASCC2	OT3B204T	Strong	Biomarker	[1242]
ASCC3	OTF6DCYB	Strong	Biomarker	[3006]
ASCL2	OT3D62WB	Strong	Biomarker	[3007]
ASF1A	OT4S44GP	Strong	Altered Expression	[3008]
ASH1L	OTUT5NLJ	Strong	Biomarker	[3009]
ASL	OTI2NGQR	Strong	Biomarker	[3010]
ASPM	OTKXQMNA	Strong	Altered Expression	[3011]
ASPRV1	OT8WVIBW	Strong	Biomarker	[3012]
ASPSCR1	OTXTOD10	Strong	Genetic Variation	[3013]
ASS1	OT4ZMG0Q	Strong	Biomarker	[3014]
ASTN1	OT23FQIB	Strong	Genetic Variation	[3015]
ASZ1	OTLM93UO	Strong	Altered Expression	[3016]
ATAD3B	OTL508AF	Strong	Biomarker	[3017]
ATAD5	OTI8ABKF	Strong	Genetic Variation	[3018]
ATE1	OT3QNM39	Strong	Biomarker	[3019]
ATF2	OTNIZPEA	Strong	Altered Expression	[3020]
ATF7IP	OTU6ZA7F	Strong	Biomarker	[3021]
ATG101	OTG8QUXY	Strong	Biomarker	[3022]
ATG12	OTJRO09Y	Strong	Biomarker	[3023]
ATG3	OT28VBVK	Strong	Biomarker	[3024]
ATG4C	OTD9HN3X	Strong	Genetic Variation	[916]
ATG9A	OTAZWZH7	Strong	Biomarker	[3025]
ATL1	OTR2788Y	Strong	Biomarker	[3026]
ATN1	OTNZFLKY	Strong	Biomarker	[3027]
ATOH1	OTBZYG2R	Strong	Biomarker	[3028]
ATP13A2	OTKWBUGK	Strong	Biomarker	[3029]
ATP1B2	OTYTBYVU	Strong	Altered Expression	[3030]
ATP2A3	OTFYDEES	Strong	Genetic Variation	[1747]
ATP2C1	OTQN51T3	Strong	Altered Expression	[3031]
ATP5F1B	OTLFZUQK	Strong	Biomarker	[3032]
ATP5PD	OTAJDLE2	Strong	Biomarker	[3033]
ATP6AP2	OT0IABVV	Strong	Biomarker	[3034]
ATP6V0C	OTKPL09B	Strong	Biomarker	[3035]
ATP6V0D2	OTMOZJO0	Strong	Biomarker	[3036]
ATP6V1C1	OT2LI8ZG	Strong	Biomarker	[3037]
ATP6V1E1	OT76J5R9	Strong	Altered Expression	[3038]
ATRIP	OT78O9LF	Strong	Biomarker	[3039]
ATRX	OT77RSQW	Strong	Biomarker	[1539]
ATXN1	OTQF0HNR	Strong	Biomarker	[3040]
ATXN1L	OTYIHGTD	Strong	Biomarker	[3041]
ATXN2L	OTP5M3R9	Strong	Biomarker	[3042]
AXIN2	OTRMGQNU	Strong	Genetic Variation	[3043]
AZI2	OT61Q7Q8	Strong	Genetic Variation	[2850]
AZIN2	OT8OB7CG	Strong	Biomarker	[3044]
AZU1	OTHXU264	Strong	Biomarker	[3045]
B3GNT3	OTVT1Q25	Strong	Biomarker	[3046]
B3GNT6	OTAX8BNJ	Strong	Altered Expression	[3047]
B4GALNT1	OTCY80HS	Strong	Altered Expression	[3048]
B4GALNT2	OT85V4QV	Strong	Altered Expression	[3049]
B4GALNT3	OT6BFB22	Strong	Altered Expression	[3050]
B4GALT1	OTBCXEK7	Strong	Altered Expression	[3051]
B4GALT5	OTHMZY12	Strong	Altered Expression	[3052]
BAALC	OTUZSRVF	Strong	Altered Expression	[3053]
BAD	OT63ERYM	Strong	Posttranslational Modification	[3054]
BAG1	OTRQNIA4	Strong	Biomarker	[3055]
BAGE4	OT2LPTMI	Strong	Biomarker	[3056]
BAIAP2L1	OTZ71SK9	Strong	Biomarker	[3057]
BAIAP2L2	OTQDY90J	Strong	Biomarker	[3058]
BANP	OT1JMTBD	Strong	Biomarker	[3059]
BAZ1A	OTWHOVZS	Strong	Biomarker	[3060]
BAZ1B	OTD5KR2J	Strong	Altered Expression	[3061]
BCAM	OTHZOPSD	Strong	Biomarker	[3062]
BCAN	OTPVY3ZR	Strong	Biomarker	[3063]
BCAP31	OTKSACR4	Strong	Biomarker	[3064]
BCAS1	OTQKJR81	Strong	Altered Expression	[3065]
BCAS2	OTRMF2WY	Strong	Biomarker	[3066]
BCAS3	OTDVAX6B	Strong	Altered Expression	[3067]
BCKDHB	OT8OSVYU	Strong	Genetic Variation	[3068]
BCL3	OT1M5B95	Strong	Biomarker	[3069]
BCL7B	OT8DQQRD	Strong	Genetic Variation	[1830]
BCL7C	OT8P2IFT	Strong	Biomarker	[3070]
BCL9	OTRBIPR4	Strong	Genetic Variation	[3071]
BCL9L	OTTWI90E	Strong	Altered Expression	[3072]
BCS1L	OT5PY5CY	Strong	Genetic Variation	[3073]
BDP1	OTJ408I9	Strong	Altered Expression	[3074]
BEND5	OT6J6LY3	Strong	Biomarker	[3075]
BEST1	OTWHE1ZC	Strong	Genetic Variation	[89]
BEX2	OT4G5SIC	Strong	Biomarker	[1104]
BEX3	OTW1V1L5	Strong	Altered Expression	[3076]
BEX4	OT3LXD15	Strong	Altered Expression	[3077]
BFAR	OTTBG0V7	Strong	Biomarker	[3078]
BHLHE40	OTITX14U	Strong	Altered Expression	[3079]
BICRA	OTDTPGW0	Strong	Altered Expression	[3080]
BIN1	OTK8O0X8	Strong	Altered Expression	[3081]
BIN2	OT4S45WJ	Strong	Biomarker	[916]
BIRC6	OTCQJAB0	Strong	Biomarker	[3082]
BLCAP	OTGJVU0C	Strong	Altered Expression	[3083]
BLVRB	OTHCFN2C	Strong	Biomarker	[3084]
BMPR1A	OTQOA4ZH	Strong	Genetic Variation	[3085]
BMPR1B	OTGFN0OD	Strong	Biomarker	[3086]
BNC1	OTGJ5WUF	Strong	Altered Expression	[3087]
BNIP3L	OTJKOMXE	Strong	Biomarker	[3088]
BOLA2	OTVZP6YB	Strong	Biomarker	[3089]
BPIFA2	OTLFSDZD	Strong	Biomarker	[1132]
BRAP	OTB7BAFQ	Strong	Biomarker	[3090]
BRI3BP	OTWCFPRM	Strong	Altered Expression	[3091]
BTBD3	OTZ607YT	Strong	Biomarker	[3092]
BTBD7	OTNUV6MQ	Strong	Biomarker	[3093]
BTBD8	OT3A3RD7	Strong	Biomarker	[3094]
BTD	OTJYTQ69	Strong	Altered Expression	[3095]
BTG2	OTZF6K1H	Strong	Genetic Variation	[3096]
BTG3	OT9ANHVT	Strong	Biomarker	[3097]
BTN3A1	OTGZADIX	Strong	Biomarker	[3098]
BTN3A2	OT3DIBU3	Strong	Biomarker	[3098]
BTNL9	OT3PWOH6	Strong	Altered Expression	[3099]
BTRC	OT2EZDGR	Strong	Altered Expression	[3100]
BUB3	OTU91HAU	Strong	Biomarker	[2128]
BUD23	OTJS7VU3	Strong	Biomarker	[3101]
BUD31	OTN3HZYF	Strong	Altered Expression	[3102]
C14orf28	OTMAF0NU	Strong	Biomarker	[3103]
C15orf48	OT85J32K	Strong	Altered Expression	[3104]
C16orf96	OTE0B1QV	Strong	Genetic Variation	[3105]
C1GALT1C1	OTRTZUF5	Strong	Genetic Variation	[3106]
C1QL3	OT4TZH3J	Strong	Biomarker	[3107]
C1QTNF9B	OTNJEZC0	Strong	Biomarker	[3108]
C4BPA	OTHNH6Y8	Strong	Biomarker	[3109]
C4BPB	OTJ70B0K	Strong	Biomarker	[3110]
C5AR2	OTP1Q82J	Strong	Biomarker	[3111]
C6orf141	OTUS3SIQ	Strong	Altered Expression	[3112]
C6orf47	OTMKBNDD	Strong	Biomarker	[3113]
C8orf34	OTXCTHDG	Strong	Genetic Variation	[2863]
CABYR	OTKYMT99	Strong	Altered Expression	[3114]
CACUL1	OT6P1ZVP	Strong	Biomarker	[3115]
CACYBP	OTJMZD2T	Strong	Altered Expression	[2759]
CADM1	OTRWG9QS	Strong	Altered Expression	[3116]
CADM2	OT45PVKC	Strong	Altered Expression	[3117]
CAGE1	OTF3HI3N	Strong	Biomarker	[3118]
CALM2	OTNYA92F	Strong	Biomarker	[1849]
CAMK1D	OTU24HAU	Strong	Biomarker	[3119]
CAMK2B	OTS9YK3E	Strong	Altered Expression	[2974]
CAMK2G	OTHD9KJG	Strong	Biomarker	[3120]
CAMK4	OT47RDGV	Strong	Biomarker	[3121]
CAND2	OTOMOG3R	Strong	Biomarker	[1747]
CANT1	OT1TPWQR	Strong	Biomarker	[3122]
CANX	OTYP1F6J	Strong	Biomarker	[3123]
CAPG	OTJ86KI6	Strong	Biomarker	[3124]
CAPN3	OTCHG3YK	Strong	Biomarker	[3125]
CAPNS1	OT95EBBD	Strong	Biomarker	[3126]
CARD10	OT2RPM4I	Strong	Biomarker	[67]
CARD11	OTRCTLYC	Strong	Biomarker	[3127]
CARD8	OTXXZYWU	Strong	Altered Expression	[3128]
CARTPT	OTTE4V9S	Strong	Biomarker	[3129]
CASC3	OTLK3K4U	Strong	Biomarker	[3130]
CAST	OTBXZZGF	Strong	Altered Expression	[3131]
CASTOR1	OTYIH7WK	Strong	Biomarker	[3132]
CASZ1	OTWJ2OR8	Strong	Biomarker	[3133]
CAV2	OT1FGRQX	Strong	Biomarker	[3134]
CAVIN1	OTFO915U	Strong	Biomarker	[3135]
CAVIN2	OTFHHDRU	Strong	Altered Expression	[3136]
CAVIN3	OTOLBK79	Strong	Altered Expression	[3137]
CBFB	OTIAC6W4	Strong	Genetic Variation	[3138]
CBLC	OT3RKZI9	Strong	Biomarker	[3139]
CBLL1	OTZUQBYX	Strong	Altered Expression	[3140]
CBX1	OT2L4XZX	Strong	Biomarker	[3141]
CBX3	OTOP9RLD	Strong	Biomarker	[3142]
CCDC134	OT70OQQV	Strong	Biomarker	[3143]
CCDC34	OTZ3AGSQ	Strong	Altered Expression	[3144]
CCDC51	OTOJNHNA	Strong	Biomarker	[3145]
CCDC8	OTO295IH	Strong	Biomarker	[3146]
CCDC80	OTOZSYEM	Strong	Altered Expression	[3147]
CCDC83	OTF1ETS6	Strong	Biomarker	[3148]
CCDC85C	OT1AOJCS	Strong	Altered Expression	[3149]
CCDC88A	OT3SSYYC	Strong	Altered Expression	[3150]
CCL1	OT23NON8	Strong	Genetic Variation	[3151]
CCL15	OTOGZ85M	Strong	Biomarker	[3152]
CCL18	OT7JYSK9	Strong	Altered Expression	[3153]
CCL8	OTCTWYN8	Strong	Biomarker	[3154]
CCN3	OTOW5YL4	Strong	Altered Expression	[3155]
CCNA1	OTX4HD45	Strong	Biomarker	[3156]
CCNB2	OTIEXTDK	Strong	Altered Expression	[3157]
CCND2	OTDULQF9	Strong	Biomarker	[3158]
CCNG1	OT17IA9L	Strong	Altered Expression	[3159]
CCNG2	OTII38K2	Strong	Biomarker	[3160]
CCNH	OTKDU3SR	Strong	Biomarker	[2188]
CCNJ	OTCR4WVV	Strong	Biomarker	[3161]
CCNL1	OTAJSS3D	Strong	Biomarker	[3162]
CCNL2	OT0NIKYM	Strong	Biomarker	[3163]
CCNO	OT68CH0B	Strong	Biomarker	[3164]
CCNQ	OT183N7L	Strong	Biomarker	[3163]
CCNT1	OTDYVGCP	Strong	Biomarker	[678]
CCR10	OT7ZWSSD	Strong	Biomarker	[3165]
CCS	OTXHT3QO	Strong	Genetic Variation	[3166]
CCSER1	OTVLD4J3	Strong	Genetic Variation	[3167]
CCT2	OTW1VV4E	Strong	Altered Expression	[1206]
CCT4	OT5D452X	Strong	Biomarker	[3168]
CCT6A	OTCYWL5F	Strong	Biomarker	[3169]
CD151	OTF3UZS7	Strong	Biomarker	[3170]
CD164	OTZ7FIU8	Strong	Biomarker	[2420]
CD1D	OT3ROU4J	Strong	Altered Expression	[3171]
CD200R1	OT65Q9M6	Strong	Biomarker	[3172]
CD244	OTSMR85N	Strong	Biomarker	[3173]
CD48	OT83ZNPP	Strong	Biomarker	[3174]
CD5L	OTPY4WQR	Strong	Biomarker	[3175]
CD63	OT2UGZA9	Strong	Biomarker	[3176]
CD68	OTOYEY3J	Strong	Biomarker	[3177]
CD84	OTAY5B0F	Strong	Biomarker	[3178]
CD8A	OTDWQJXK	Strong	Altered Expression	[3179]
CD8B	OTMZ1T7J	Strong	Altered Expression	[3180]
CD93	OT6HZT6H	Strong	Biomarker	[3181]
CD99	OTPUZ5DE	Strong	Altered Expression	[3182]
CDC14A	OTL10OY6	Strong	Genetic Variation	[3183]
CDC23	OTC4O83E	Strong	Biomarker	[3184]
CDC34	OTNBK390	Strong	Altered Expression	[3185]
CDC40	OTOYUNHN	Strong	Altered Expression	[3186]
CDC42	OT5QBC5M	Strong	Biomarker	[3187]
CDC42BPB	OTO6NT7Q	Strong	Biomarker	[3188]
CDC5L	OTTPFUU5	Strong	Biomarker	[2898]
CDH12	OTF2HCGA	Strong	Biomarker	[3189]
CDH13	OTD2CYM5	Strong	Posttranslational Modification	[3190]
CDH22	OTQEUWQN	Strong	Biomarker	[3191]
CDH23	OTOJGQ7S	Strong	Biomarker	[3192]
CDH4	OT8LH3HN	Strong	Biomarker	[3193]
CDK14	OT385ZH1	Strong	Biomarker	[3194]
CDK15	OT8S67QS	Strong	Genetic Variation	[3195]
CDK16	OTUBXIIT	Strong	Biomarker	[1870]
CDK2AP1	OTNFOHDJ	Strong	Biomarker	[3196]
CDK2AP2	OTR99SJ8	Strong	Altered Expression	[3197]
CDKN2AIP	OT80RRQJ	Strong	Biomarker	[3198]
CDKN3	OTBE3H07	Strong	Biomarker	[3199]
CDO1	OTLG1P77	Strong	Posttranslational Modification	[3200]
CDR2	OTD3ZJST	Strong	Biomarker	[3201]
CDSN	OTQW4HV6	Strong	Altered Expression	[1741]
CDT1	OTVY53VG	Strong	Biomarker	[3202]
CEACAM4	OT0C7YUD	Strong	Biomarker	[3203]
CEBPD	OTNBIPMY	Strong	Altered Expression	[1148]
CEBPE	OTKZA25M	Strong	Genetic Variation	[2992]
CEBPZ	OT11BATG	Strong	Altered Expression	[3204]
CELF2	OTLJJ4VT	Strong	Biomarker	[3205]
CELSR2	OTON6JSZ	Strong	Altered Expression	[3206]
CELSR3	OT8P6QNJ	Strong	Altered Expression	[3207]
CEMIP	OTK80FYN	Strong	Biomarker	[3208]
CENPF	OT7AG0SW	Strong	Biomarker	[3209]
CENPH	OTPOO9LK	Strong	Altered Expression	[3210]
CENPO	OTXAH83Y	Strong	Altered Expression	[3211]
CENPU	OTQ4TZRS	Strong	Altered Expression	[3212]
CENPV	OTPQ0KT9	Strong	Biomarker	[3213]
CENPW	OTZL05QN	Strong	Biomarker	[3214]
CENPX	OTG1RAKJ	Strong	Biomarker	[3215]
CEP55	OTGSG2PA	Strong	Altered Expression	[3216]
CEP57	OTPOHLIX	Strong	Altered Expression	[3217]
CEP63	OTX3TTZH	Strong	Biomarker	[3218]
CEP72	OTVYNPNL	Strong	Altered Expression	[3219]
CEP78	OTTAI5S2	Strong	Biomarker	[3220]
CEP85L	OTSHJFOT	Strong	Biomarker	[3221]
CERS1	OT6EYRM3	Strong	Biomarker	[3222]
CERS2	OTRAHYYP	Strong	Altered Expression	[3223]
CERS4	OTV5ENAX	Strong	Altered Expression	[2507]
CERS6	OTOP4GV1	Strong	Biomarker	[2507]
CERT1	OTNUCNHX	Strong	Biomarker	[3224]
CFAP36	OTXR1FWX	Strong	Biomarker	[3225]
CFC1	OT5DHGI8	Strong	Genetic Variation	[3226]
CFHR1	OT72R16T	Strong	Biomarker	[3227]
CGAS	OTJYIXNB	Strong	Biomarker	[3228]
CHAC1	OTJGE772	Strong	Altered Expression	[3229]
CHAF1A	OTXSSY4H	Strong	Biomarker	[3230]
CHCHD5	OTVESFOA	Strong	Biomarker	[3231]
CHCHD6	OT8F9BHW	Strong	Biomarker	[3232]
CHD1	OT9R9G0H	Strong	Biomarker	[3233]
CHD1L	OT7CZK7C	Strong	Biomarker	[3234]
CHD5	OTS5EVHH	Strong	Biomarker	[3235]
CHD7	OTHNIZWZ	Strong	Biomarker	[3236]
CHD8	OTS7A6AF	Strong	Biomarker	[3237]
CHERP	OTJL4OB3	Strong	Biomarker	[3238]
CHFR	OTRAD2TT	Strong	Biomarker	[3239]
CHGA	OTXYX5JH	Strong	Biomarker	[3240]
CHL1	OT6E6E8P	Strong	Biomarker	[3241]
CHMP1A	OTVQ5UWX	Strong	Biomarker	[3242]
CHMP3	OT0963JJ	Strong	Altered Expression	[3243]
CHMP4C	OT5X8A3O	Strong	Biomarker	[3244]
CHORDC1	OT3W6F1U	Strong	Altered Expression	[3245]
CHP2	OT4UMKUR	Strong	Altered Expression	[3246]
CHPT1	OT4FJ0K3	Strong	Biomarker	[3247]
CHRD	OTNM60Y1	Strong	Biomarker	[3248]
CHRNA3	OTCZQY1U	Strong	Genetic Variation	[694]
CHRNB3	OTE5XENW	Strong	Genetic Variation	[694]
CHST4	OTESMIW5	Strong	Biomarker	[3249]
CHTF18	OTQK3FI4	Strong	Biomarker	[3250]
CHTOP	OTMMNZ65	Strong	Biomarker	[3251]
CIAO3	OT0V91PK	Strong	Biomarker	[3252]
CIB1	OT4BVCRU	Strong	Genetic Variation	[3253]
CIC	OTFXCHNZ	Strong	Biomarker	[3254]
CILK1	OTWOYEYP	Strong	Genetic Variation	[3195]
CIRBP	OTXWTPBL	Strong	Biomarker	[3255]
CISD3	OT0MM1MW	Strong	Biomarker	[2514]
CITED2	OT812TV7	Strong	Biomarker	[3256]
CIZ1	OT3UKHPI	Strong	Biomarker	[3257]
CKAP2L	OT4T73GG	Strong	Altered Expression	[3258]
CKB	OTUCKOTT	Strong	Biomarker	[3259]
CKLF	OTHLPHA0	Strong	Biomarker	[3260]
CKMT2	OT1KNPI1	Strong	Biomarker	[3261]
CKS2	OTPTMHIV	Strong	Altered Expression	[3262]
CLCA4	OTCRR1M9	Strong	Biomarker	[3263]
CLDN10	OT2CVAKY	Strong	Altered Expression	[3264]
CLDN16	OTTHAIKR	Strong	Altered Expression	[3265]
CLDN3	OT71MN9S	Strong	Biomarker	[3266]
CLDN5	OTUX60YO	Strong	Altered Expression	[3267]
CLEC12B	OTNOW66C	Strong	Biomarker	[3268]
CLEC14A	OT0UJQ4O	Strong	Altered Expression	[3269]
CLEC18B	OTW1BFMQ	Strong	Altered Expression	[3270]
CLEC2D	OTVRLKPM	Strong	Biomarker	[3271]
CLEC3A	OTTOAEGT	Strong	Altered Expression	[3272]
CLEC3B	OTFD29NF	Strong	Biomarker	[3273]
CLEC4D	OTT7X1UC	Strong	Biomarker	[3274]
CLIP1	OTTGAEJE	Strong	Altered Expression	[3275]
CLIP2	OTSCIQIY	Strong	Altered Expression	[3275]
CLOCK	OTNEOJY7	Strong	Genetic Variation	[3276]
CLPTM1	OT14QP7N	Strong	Biomarker	[3277]
CLPTM1L	OTDJWQXI	Strong	Biomarker	[3278]
CLSPN	OTZZXNDK	Strong	Biomarker	[3279]
CLTA	OTLHOXMQ	Strong	Biomarker	[1848]
CLTC	OTBFASMA	Strong	Biomarker	[3280]
CMIP	OTZN8Z4A	Strong	Genetic Variation	[3281]
CMTM6	OT70T27A	Strong	Altered Expression	[3282]
CNDP1	OTOYSQG7	Strong	Altered Expression	[3283]
CNIH3	OTNLZ2QS	Strong	Genetic Variation	[2863]
CNKSR1	OTSNAEQ9	Strong	Biomarker	[3284]
CNMD	OTHND8EL	Strong	Altered Expression	[3285]
CNN1	OTVPG39Z	Strong	Altered Expression	[3286]
CNNM4	OTUXJRM1	Strong	Altered Expression	[3287]
CNOT1	OTTEU05F	Strong	Biomarker	[3288]
CNTN3	OTC1274J	Strong	Biomarker	[2145]
CNTNAP1	OT5Y03EU	Strong	Biomarker	[3289]
COL10A1	OTC4G2YC	Strong	Biomarker	[3290]
COL12A1	OTHLTV53	Strong	Biomarker	[3291]
COL13A1	OTM9IM6J	Strong	Biomarker	[3292]
COL17A1	OTID5AH2	Strong	Altered Expression	[3293]
COL1A1	OTI31178	Strong	Biomarker	[3294]
COL3A1	OTT1EMLM	Strong	Biomarker	[3295]
COL4A1	OTL6D1YE	Strong	Biomarker	[3296]
COL4A2	OTJK1LKN	Strong	Biomarker	[65]
COL4A5	OTHG60RE	Strong	Biomarker	[65]
COL4A6	OTUREU5Z	Strong	Biomarker	[65]
COL5A1	OT24078H	Strong	Biomarker	[3297]
COL6A6	OT4MVGRW	Strong	Biomarker	[65]
COL9A1	OTWBR27Y	Strong	Genetic Variation	[838]
COLEC10	OTMBADGZ	Strong	Biomarker	[3298]
COMMD1	OT7WUD5R	Strong	Biomarker	[3299]
COMP	OTS2FPMI	Strong	Biomarker	[863]
COPB2	OT82JIGC	Strong	Altered Expression	[3300]
COPE	OTBKHBT7	Strong	Biomarker	[3301]
COPS3	OTZWPJ24	Strong	Biomarker	[3302]
COPS8	OTNAD2S4	Strong	Biomarker	[3303]
CORIN	OT4SK7DK	Strong	Biomarker	[3304]
CORO1A	OTVAZOHC	Strong	Altered Expression	[679]
CORO1C	OTXDF9T3	Strong	Biomarker	[3305]
COX1	OTG3O9BN	Strong	Biomarker	[3306]
COX14	OTQ378WN	Strong	Altered Expression	[3307]
COX19	OTIJ64B9	Strong	Altered Expression	[3308]
COX3	OTNNGBYJ	Strong	Genetic Variation	[3309]
COX5A	OTP0961M	Strong	Altered Expression	[3310]
COX5B	OTDP94F3	Strong	Biomarker	[3311]
COX7A2	OTVT146E	Strong	Biomarker	[3312]
COX7B	OT67PIDP	Strong	Biomarker	[3313]
COX8A	OTU0NR39	Strong	Altered Expression	[3310]
CPD	OT2CS64Y	Strong	Biomarker	[3314]
CPEB1	OTLCXC6H	Strong	Biomarker	[3315]
CPEB3	OTP1GQCH	Strong	Altered Expression	[3316]
CPEB4	OTW1SCZW	Strong	Altered Expression	[3317]
CPNE5	OTU882I6	Strong	Biomarker	[3318]
CPOX	OTIAY121	Strong	Altered Expression	[3310]
CPQ	OTTNZNLD	Strong	Biomarker	[3319]
CPSF4	OT53UK5L	Strong	Biomarker	[3320]
CPT2	OTIN6G20	Strong	Biomarker	[1916]
CPVL	OTOJL31C	Strong	Biomarker	[3321]
CRABP2	OTY01V9G	Strong	Altered Expression	[3322]
CRCP	OT4K9BT7	Strong	Altered Expression	[3323]
CREB3L2	OT09MHV0	Strong	Biomarker	[3324]
CREB5	OTJDUJPI	Strong	Altered Expression	[3325]
CRIP1	OT0EICG3	Strong	Biomarker	[3326]
CRISP2	OT8HLTV5	Strong	Biomarker	[3327]
CRISP3	OTBSWMPL	Strong	Biomarker	[3328]
CRKL	OTOYSD1R	Strong	Altered Expression	[3329]
CRLF3	OTT9TMXN	Strong	Biomarker	[2073]
CRNKL1	OTWBQNGU	Strong	Biomarker	[3304]
CRNN	OTAORBR4	Strong	Biomarker	[3330]
CRTAC1	OT4PGEVE	Strong	Biomarker	[3331]
CRX	OTH435SV	Strong	Biomarker	[3332]
CRYBG3	OTHXQCX7	Strong	Biomarker	[3333]
CRYGC	OTYSTQWI	Strong	Biomarker	[1865]
CRYGD	OTW29JC4	Strong	Biomarker	[3334]
CRYL1	OT0SJSJM	Strong	Genetic Variation	[3335]
CRYM	OTRGSR6B	Strong	Biomarker	[3336]
CSHL1	OTQKU2F5	Strong	Biomarker	[1306]
CSMD1	OTIVDSC4	Strong	Altered Expression	[3337]
CSRP1	OTUS7RM2	Strong	Biomarker	[3338]
CSRP2	OT4SW0HI	Strong	Altered Expression	[3339]
CST3	OTNZ6AO4	Strong	Biomarker	[3340]
CSTA	OT1K68KE	Strong	Biomarker	[3341]
CSTF2	OTR6G4II	Strong	Biomarker	[3342]
CT45A1	OT80VTZO	Strong	Biomarker	[3343]
CT45A2	OT9X9KTC	Strong	Altered Expression	[3344]
CT55	OTQC0H27	Strong	Biomarker	[3345]
CTAG2	OT8HISP4	Strong	Biomarker	[3346]
CTAGE1	OTWM7KSJ	Strong	Biomarker	[3347]
CTBP1	OTVYH2DH	Strong	Biomarker	[3237]
CTDSPL	OTZJ0CZK	Strong	Biomarker	[3348]
CTNNA3	OT9Z0P1E	Strong	Biomarker	[3349]
CTNNAL1	OTESJ6JD	Strong	Biomarker	[3350]
CTNNBL1	OT6KLHPA	Strong	Biomarker	[3351]
CTNND1	OTUMPSHR	Strong	Biomarker	[3352]
CTTN	OTJRG4ES	Strong	Posttranslational Modification	[3353]
CTU1	OTNTM9D1	Strong	Biomarker	[3354]
CUEDC2	OTWMOLAJ	Strong	Biomarker	[3355]
CUL4B	OT2QX4DO	Strong	Altered Expression	[3356]
CXCL14	OTM189TA	Strong	Biomarker	[3357]
CYCS	OTBFALJD	Strong	Genetic Variation	[3358]
CYFIP2	OTCAY35T	Strong	Altered Expression	[3359]
CYGB	OTX153DQ	Strong	Biomarker	[3360]
CYLC1	OTM0LL34	Strong	Altered Expression	[3361]
CYP2D7	OTYJTL3S	Strong	Genetic Variation	[3362]
CYP2W1	OTXSB1AE	Strong	Genetic Variation	[3363]
CYP4V2	OTQKNK0D	Strong	Genetic Variation	[3364]
CYP4Z1	OTKRGJBG	Strong	Biomarker	[3365]
CYREN	OT5ZL00R	Strong	Genetic Variation	[3366]
CYRIB	OTLRN4L1	Strong	Genetic Variation	[1747]
CYTB	OTAHB98A	Strong	Biomarker	[3309]
D2HGDH	OTLHXW69	Strong	Biomarker	[3367]
DAB2	OTRMQTMZ	Strong	Biomarker	[3368]
DACT1	OT19Z704	Strong	Biomarker	[3369]
DAD1	OTUUNQBT	Strong	Biomarker	[2887]
DAP3	OTNPEZYM	Strong	Biomarker	[3370]
DAPK1	OTNCNUCO	Strong	Biomarker	[3371]
DAPK2	OTWODUQG	Strong	Biomarker	[327]
DAXX	OTX6O7PL	Strong	Genetic Variation	[3372]
DAZAP1	OTWLY0UE	Strong	Biomarker	[3373]
DAZL	OTZMTD4R	Strong	Genetic Variation	[3374]
DBF4	OTBL7JHQ	Strong	Biomarker	[3375]
DBN1	OTZVKG8A	Strong	Altered Expression	[3376]
DBP	OTE0W7LN	Strong	Biomarker	[3377]
DCAF1	OT3ZDVOE	Strong	Biomarker	[2894]
DCAF13	OTQQ0QXT	Strong	Altered Expression	[3378]
DCAF15	OTWBXZ0E	Strong	Biomarker	[3379]
DCDC2	OTSUFH1H	Strong	Biomarker	[3380]
DCLRE1C	OTW3KB1I	Strong	Biomarker	[3381]
DCP1A	OT3NCON3	Strong	Biomarker	[3382]
DCT	OTYVNTBG	Strong	Biomarker	[3383]
DCTN4	OTM7C943	Strong	Biomarker	[1030]
DDIAS	OTTGG2PM	Strong	Posttranslational Modification	[3384]
DDIT3	OTI8YKKE	Strong	Biomarker	[3385]
DDT	OTF5HTYL	Strong	Biomarker	[3386]
DDX10	OTH48438	Strong	Genetic Variation	[3387]
DDX17	OTXRMMBP	Strong	Biomarker	[3388]
DDX18	OTKB9C3S	Strong	Biomarker	[3389]
DDX19B	OT2084EJ	Strong	Biomarker	[2345]
DDX20	OT6G8YF3	Strong	Genetic Variation	[3390]
DDX27	OT64NCZ6	Strong	Altered Expression	[3391]
DDX3X	OTDO4TRX	Strong	Biomarker	[3392]
DDX3Y	OTKL1FNX	Strong	Biomarker	[3393]
DDX4	OTQOV093	Strong	Biomarker	[3394]
DDX43	OTK1RYSK	Strong	Biomarker	[3395]
DDX49	OT13VWB7	Strong	Biomarker	[3396]
DDX51	OTLMA7AH	Strong	Biomarker	[3397]
DDX53	OTHK3EGZ	Strong	Biomarker	[3398]
DDX56	OTGURA53	Strong	Biomarker	[3399]
DEAF1	OTCLX3ZW	Strong	Genetic Variation	[3400]
DECR1	OTCDIR6X	Strong	Altered Expression	[3401]
DEFA6	OTDJADMQ	Strong	Altered Expression	[3402]
DEFB103B	OT8RWY64	Strong	Altered Expression	[1938]
DENR	OTXP9HOY	Strong	Biomarker	[3403]
DERL1	OTJUS74N	Strong	Altered Expression	[3404]
DERL2	OTI3TUUZ	Strong	Biomarker	[3405]
DES	OTI09KBW	Strong	Biomarker	[3406]
DESI1	OTFNIW98	Strong	Biomarker	[3407]
DESI2	OTHUOKOC	Strong	Biomarker	[3408]
DGCR8	OT62LXE4	Strong	Altered Expression	[3388]
DGKD	OTNI8HAH	Strong	Biomarker	[3409]
DGLUCY	OTZD17IM	Strong	Altered Expression	[3410]
DGUOK	OT78HUZB	Strong	Biomarker	[1941]
DHDDS	OTVLYBUS	Strong	Biomarker	[3247]
DHRS11	OTU3J0ZL	Strong	Altered Expression	[414]
DHRS2	OTFHWIY8	Strong	Altered Expression	[3411]
DHX15	OT4F98TK	Strong	Biomarker	[3412]
DHX16	OTW8KZAU	Strong	Biomarker	[3413]
DHX33	OTREUESJ	Strong	Altered Expression	[3414]
DHX58	OT19BYB1	Strong	Biomarker	[3415]
DIAPH1	OTZBYPLH	Strong	Biomarker	[3416]
DIDO1	OT9PB547	Strong	Genetic Variation	[3085]
DIO2	OTGPNSLH	Strong	Altered Expression	[3417]
DIP2A	OTXPTR8R	Strong	Biomarker	[3418]
DIPK2A	OTL1DBIM	Strong	Biomarker	[3416]
DIRAS3	OT3XHLQA	Strong	Biomarker	[3419]
DIS3	OT7UPHJS	Strong	Genetic Variation	[3420]
DIS3L2	OTWABM04	Strong	Biomarker	[3421]
DLD	OT378CU9	Strong	Biomarker	[3422]
DLEC1	OTMKKBUW	Strong	Posttranslational Modification	[3423]
DLG1	OTCRZYWT	Strong	Altered Expression	[3424]
DLG3	OTH591WK	Strong	Biomarker	[3425]
DLGAP4	OTNELLIN	Strong	Altered Expression	[3426]
DLGAP5	OTWCN39U	Strong	Altered Expression	[3426]
DLK2	OT56Y83S	Strong	Biomarker	[3427]
DLX1	OT7BH057	Strong	Biomarker	[3428]
DLX2	OTKC2DQ0	Strong	Biomarker	[3429]
DLX3	OTARP5SQ	Strong	Biomarker	[3430]
DLX4	OTLWVCN4	Strong	Altered Expression	[3431]
DLX5	OTEEFBEU	Strong	Altered Expression	[3432]
DMBT1	OTVNU9D9	Strong	Altered Expression	[3433]
DMTF1	OTDKO9OO	Strong	Biomarker	[3434]
DMTN	OTDTKPBW	Strong	Altered Expression	[3435]
DNA2	OT4DJFFU	Strong	Biomarker	[3436]
DNAAF3	OT3OHO0O	Strong	Genetic Variation	[3437]
DNAAF4	OTVDYBJE	Strong	Altered Expression	[3438]
DNAH5	OTC21RUS	Strong	Genetic Variation	[3437]
DNAH8	OTGES2OU	Strong	Biomarker	[3439]
DNAI1	OTF6C65Q	Strong	Genetic Variation	[3437]
DNAJA1	OT38BZQQ	Strong	Biomarker	[3440]
DNAJB4	OTUD01BK	Strong	Altered Expression	[3441]
DNAJB6	OTMHIIAN	Strong	Biomarker	[3442]
DNAJB8	OT2CDBH6	Strong	Altered Expression	[3443]
DNAJC10	OTD2EG0R	Strong	Therapeutic	[3444]
DNAJC12	OTNU59PT	Strong	Biomarker	[3445]
DNAJC2	OT3JDA0R	Strong	Biomarker	[3446]
DNAJC21	OT8C14QA	Strong	Genetic Variation	[3447]
DNALI1	OTTB3L8N	Strong	Biomarker	[3448]
DNASE1L3	OTEUIMC2	Strong	Genetic Variation	[3449]
DNASE2	OT6RC1BL	Strong	Biomarker	[3450]
DND1	OTHLC8TA	Strong	Biomarker	[3451]
DNLZ	OT48CG1W	Strong	Biomarker	[3452]
DNM3	OTDMUGCR	Strong	Biomarker	[3453]
DNTTIP1	OTAP29SS	Strong	Biomarker	[3454]
DOC2A	OT5G9V94	Strong	Biomarker	[3455]
DOCK1	OTCFV3ON	Strong	Biomarker	[3456]
DOCK2	OTZTS3PA	Strong	Biomarker	[3457]
DOCK3	OTF3YS2W	Strong	Biomarker	[3458]
DOCK4	OTH3XY8B	Strong	Genetic Variation	[3459]
DOCK5	OT63I0CL	Strong	Altered Expression	[3460]
DOHH	OTDRAT3F	Strong	Biomarker	[775]
DOK1	OTGVRLW6	Strong	Altered Expression	[3461]
DPPA4	OTAEOACS	Strong	Biomarker	[3462]
DPT	OTINRFC7	Strong	Biomarker	[1480]
DPYS	OTLTUIVL	Strong	Biomarker	[784]
DPYSL3	OTINJV20	Strong	Biomarker	[3463]
DPYSL4	OT3SBS2S	Strong	Biomarker	[3464]
DRAM1	OTIJTXEN	Strong	Biomarker	[3465]
DROSHA	OTCE68KZ	Strong	Genetic Variation	[3466]
DSC1	OTNII6GZ	Strong	Altered Expression	[3467]
DSC2	OTODVH8K	Strong	Biomarker	[3468]
DSCC1	OTPUVLZT	Strong	Altered Expression	[3469]
DSE	OTQ108VJ	Strong	Altered Expression	[3470]
DSG1	OT11HC3A	Strong	Biomarker	[3471]
DSP	OTB2MOP8	Strong	Biomarker	[3472]
DST	OTHZBM4X	Strong	Biomarker	[3473]
DSTN	OTMXO4YB	Strong	Biomarker	[3474]
DUOX1	OTQ2AEW0	Strong	Altered Expression	[3475]
DUSP11	OTU6C41M	Strong	Genetic Variation	[789]
DUSP12	OT8WB1YB	Strong	Genetic Variation	[789]
DUSP16	OTK7S078	Strong	Biomarker	[3476]
DUSP2	OTH54FMR	Strong	Biomarker	[354]
DUSP22	OTEZ3U85	Strong	Biomarker	[3477]
DUSP23	OTE2PG54	Strong	Altered Expression	[3478]
DUSP26	OTI7WIYN	Strong	Biomarker	[3479]
DUSP28	OTDYDBN7	Strong	Biomarker	[3480]
DUSP7	OT6Z5AHP	Strong	Altered Expression	[3481]
DVL2	OTMNYNCM	Strong	Altered Expression	[3482]
DVL3	OTPRROHJ	Strong	Altered Expression	[3482]
DYNC1H1	OTD1KRKO	Strong	Genetic Variation	[3483]
DYNLL1	OTR69LHT	Strong	Biomarker	[3484]
E2F5	OT1XWING	Strong	Biomarker	[3485]
E2F7	OTWW358N	Strong	Altered Expression	[3486]
E2F8	OTQKZGFP	Strong	Altered Expression	[3487]
EAF2	OTSOET5L	Strong	Biomarker	[3488]
EBF1	OTZ61YYH	Strong	Altered Expression	[3489]
EBF3	OTB0IWLW	Strong	Biomarker	[3490]
EBNA1BP2	OTBRVMZH	Strong	Biomarker	[979]
EBPL	OT59J1GY	Strong	Biomarker	[3491]
ECEL1	OTJ6GNUP	Strong	Altered Expression	[3492]
ECM1	OT1K65VW	Strong	Biomarker	[3493]
ECT2	OTQDUCT6	Strong	Biomarker	[3494]
EDIL3	OTDVVNS0	Strong	Altered Expression	[3495]
EDN3	OTN7Q9BE	Strong	Posttranslational Modification	[3496]
EEF1D	OTM5ZD8Y	Strong	Biomarker	[3497]
EEF1E1	OTRA6XOB	Strong	Biomarker	[568]
EEF1G	OTW7DH2F	Strong	Biomarker	[3498]
EEF2	OTZ7SZ39	Strong	Biomarker	[3499]
EFEMP2	OT0I2B4J	Strong	Biomarker	[3500]
EFHD2	OTM9VMN3	Strong	Altered Expression	[3501]
EFNA5	OTOH4DRR	Strong	Biomarker	[3502]
EFNB3	OT12WTXQ	Strong	Biomarker	[3503]
EFS	OT06O7XL	Strong	Altered Expression	[3504]
EGFL8	OTECTJ7K	Strong	Biomarker	[3505]
EGR2	OTAVQ78J	Strong	Biomarker	[3506]
EHD1	OTDMEKLV	Strong	Biomarker	[3507]
EHD2	OTTX391J	Strong	Biomarker	[3508]
EHD3	OTOKC2G5	Strong	Genetic Variation	[3509]
EHF	OTY6TPWD	Strong	Biomarker	[3510]
EID3	OTAND0C7	Strong	Biomarker	[3511]
EIF1	OTB4GZ0V	Strong	Biomarker	[3512]
EIF2B5	OTV3R4RB	Strong	Altered Expression	[3513]
EIF2S2	OTXF0B09	Strong	Altered Expression	[2415]
EIF2S3	OTARRES9	Strong	Altered Expression	[3514]
EIF3B	OTF67VPH	Strong	Biomarker	[3515]
EIF3E	OTI0WG98	Strong	Biomarker	[3516]
EIF3H	OT61RBF5	Strong	Biomarker	[2668]
EIF3I	OTE07WND	Strong	Biomarker	[3517]
EIF3J	OTJ4TAWK	Strong	Altered Expression	[3518]
EIF3K	OTGTKVGO	Strong	Altered Expression	[3519]
EIF3M	OTVWEV60	Strong	Altered Expression	[3520]
EIF4A1	OTMTBX6N	Strong	Biomarker	[3521]
EIF4A2	OT08H03R	Strong	Biomarker	[3522]
EIF4G1	OT2CF1E6	Strong	Biomarker	[3523]
EIF4H	OTGZI072	Strong	Biomarker	[3524]
EIF6	OTEXMUED	Strong	Biomarker	[3525]
ELAC2	OTY3BOF6	Strong	Biomarker	[3526]
ELAVL2	OT6EJ8MQ	Strong	Altered Expression	[3527]
ELF1	OTV5LKIA	Strong	Biomarker	[3528]
ELF3	OTUTLEQO	Strong	Biomarker	[3529]
ELF4	OT167PR5	Strong	Altered Expression	[3060]
ELF5	OTLRU8YF	Strong	Biomarker	[3530]
ELK1	OTH9MXD6	Strong	Biomarker	[3531]
ELL	OTCBN5LF	Strong	Biomarker	[3488]
ELMO3	OTQHO9VM	Strong	Biomarker	[3532]
ELOF1	OT8BXS5U	Strong	Biomarker	[3528]
ELOVL5	OT375W1Z	Strong	Altered Expression	[3533]
EMB	OT67E3Q1	Strong	Biomarker	[3534]
EMC10	OTQ6S50X	Strong	Biomarker	[3535]
EMD	OTR8ZANE	Strong	Biomarker	[3536]
EME1	OTD9RKD9	Strong	Biomarker	[3537]
EMP2	OTPS2H0L	Strong	Biomarker	[3538]
EMP3	OTODMJ1D	Strong	Biomarker	[3538]
ENC1	OTJEUB6U	Strong	Biomarker	[3539]
ENHO	OT91QASK	Strong	Biomarker	[3540]
ENO1	OTB1KWJS	Strong	Biomarker	[2238]
ENOSF1	OT65D3ZK	Strong	Biomarker	[3541]
ENOX1	OT4WOLA8	Strong	Biomarker	[3542]
ENTPD4	OTJ2O8BW	Strong	Biomarker	[3543]
EOMES	OTB9VQFA	Strong	Biomarker	[3544]
EP400	OTVQ75NX	Strong	Biomarker	[1969]
EPB41L3	OTS6CHG2	Strong	Biomarker	[3545]
EPB41L4B	OT2K30P7	Strong	Altered Expression	[3546]
EPGN	OT3EG75W	Strong	Biomarker	[3547]
EPHA10	OT1XJGFG	Strong	Altered Expression	[3548]
EPM2A	OTJU4IAG	Strong	Biomarker	[3549]
EPN1	OT4Q1NIV	Strong	Biomarker	[3550]
EPS15	OT7NPP8U	Strong	Biomarker	[3507]
EPS8	OTZ6ES6V	Strong	Biomarker	[3551]
ERAS	OT528IZO	Strong	Biomarker	[3552]
ERBIN	OTNWTUA8	Strong	Altered Expression	[3553]
ERCC3	OTVAW3P1	Strong	Biomarker	[3554]
ERCC6L	OTE9V7D9	Strong	Biomarker	[3555]
ERLIN2	OT551BVG	Strong	Biomarker	[3556]
ERO1A	OTVKOQWM	Strong	Biomarker	[3557]
ERRFI1	OT7VZ2IZ	Strong	Altered Expression	[3558]
ESCO1	OTZ9P12A	Strong	Biomarker	[3559]
ESCO2	OTJEMAQU	Strong	Biomarker	[3560]
ESRP1	OTNCS4SL	Strong	Biomarker	[1977]
ESS2	OTZ08VCZ	Strong	Biomarker	[3561]
ESX1	OTZUPU2C	Strong	Altered Expression	[3562]
ESYT1	OTA8NSJF	Strong	Biomarker	[3563]
ETFB	OT6Q6FBD	Strong	Biomarker	[3564]
ETV1	OT6PMJIK	Strong	Biomarker	[3565]
ETV4	OT8C98UZ	Strong	Biomarker	[3566]
ETV7	OTIAADPA	Strong	Biomarker	[3567]
EVA1A	OTCY3Q2M	Strong	Altered Expression	[3568]
EVPL	OTZIAFEK	Strong	Biomarker	[3569]
EVX1	OT4A84VD	Strong	Biomarker	[3570]
EWSR1	OT7SRHV3	Strong	Altered Expression	[2959]
EXO5	OTIN7L7I	Strong	Biomarker	[3571]
EXOC1	OTX1CC39	Strong	Biomarker	[3572]
EXOC2	OT5QG1WG	Strong	Biomarker	[3573]
EXOC7	OT4YA137	Strong	Biomarker	[3574]
FA2H	OT8HA13U	Strong	Biomarker	[3575]
FABP6	OTIRQWLW	Strong	Altered Expression	[3576]
FABP7	OTRE2H4G	Strong	Biomarker	[3577]
FADD	OTV7GFHH	Strong	Biomarker	[3578]
FAH	OTGZA1YR	Strong	Genetic Variation	[3579]
FAM107B	OT5RG4J0	Strong	Altered Expression	[3580]
FAM135B	OTCSYBI7	Strong	Biomarker	[3581]
FAM13C	OTVAGUOV	Strong	Biomarker	[3582]
FAM163A	OT0MYZ0F	Strong	Altered Expression	[3583]
FAM168A	OTDXQCS5	Strong	Biomarker	[3584]
FAM20C	OTW5YZ7X	Strong	Biomarker	[3585]
FAM210B	OT2QHEQ6	Strong	Biomarker	[3586]
FAM3C	OTBR6U9G	Strong	Biomarker	[3587]
FAM72A	OTBZYSR3	Strong	Altered Expression	[3588]
FAM72B	OT6AOG64	Strong	Altered Expression	[3588]
FAM83A	OTBI16V7	Strong	Biomarker	[3589]
FAM83H	OTN0SF11	Strong	Altered Expression	[3590]
FANCB	OTMZTXB5	Strong	Biomarker	[3591]
FANCD2	OTVEB5LF	Strong	Genetic Variation	[247]
FANCE	OTKRPBW1	Strong	Biomarker	[3592]
FANCG	OT7MC8TZ	Strong	Altered Expression	[3593]
FANCL	OTJC7QPQ	Strong	Biomarker	[3592]
FANCM	OTNJG99Z	Strong	Genetic Variation	[3594]
FARP1	OTL1EBTM	Strong	Altered Expression	[3595]
FASTK	OTTHFZMP	Strong	Biomarker	[3197]
FBLIM1	OTFHXMON	Strong	Biomarker	[3596]
FBLN5	OTLVNZ8U	Strong	Biomarker	[3597]
FBLN7	OT1XRDP6	Strong	Altered Expression	[3598]
FBN1	OTYCJT63	Strong	Altered Expression	[3599]
FBN2	OT3KYJQL	Strong	Genetic Variation	[3600]
FBP1	OTQBANEP	Strong	Biomarker	[3601]
FBXL2	OT5EZ7PD	Strong	Biomarker	[3602]
FBXO16	OTTEJJVJ	Strong	Biomarker	[3603]
FBXO17	OTDSRA7P	Strong	Altered Expression	[3604]
FBXO22	OTEJ5MO0	Strong	Biomarker	[2336]
FBXO31	OTF96IC2	Strong	Biomarker	[3605]
FBXO32	OTUE978R	Strong	Altered Expression	[3606]
FBXO45	OTD4D2OP	Strong	Biomarker	[3607]
FBXO6	OT58MKP3	Strong	Altered Expression	[3608]
FCGR3B	OTSLSPZG	Strong	Biomarker	[842]
FCHSD2	OTKXLIJ6	Strong	Altered Expression	[3609]
FCN2	OTTHJBKZ	Strong	Genetic Variation	[3610]
FCN3	OTPRENLS	Strong	Biomarker	[3611]
FCRL4	OT3DVTRV	Strong	Altered Expression	[3612]
FCRL5	OTA7VHNE	Strong	Biomarker	[3613]
FCRLA	OT6MK4M1	Strong	Altered Expression	[3614]
FEN1	OT6QGG7O	Strong	Biomarker	[3615]
FERMT1	OT626PBA	Strong	Biomarker	[3616]
FETUB	OT7V07NI	Strong	Biomarker	[3617]
FEZ1	OTWCXPRE	Strong	Biomarker	[3618]
FEZF1	OTRX4NOT	Strong	Altered Expression	[3619]
FGF12	OTBM9QIO	Strong	Biomarker	[3620]
FGF13	OTHNNVSG	Strong	Biomarker	[3621]
FGF20	OTJIQ8YZ	Strong	Biomarker	[3622]
FGF5	OTQXGHBY	Strong	Altered Expression	[3623]
FGF6	OTRJ679P	Strong	Biomarker	[3624]
FGF9	OT2SKDGM	Strong	Biomarker	[3625]
FGFRL1	OT8HZ3ZL	Strong	Biomarker	[3626]
FGL1	OTT0QHQ1	Strong	Biomarker	[3627]
FILIP1L	OTPY8IMS	Strong	Altered Expression	[3628]
FJX1	OT8SVTSS	Strong	Altered Expression	[3629]
FKBP9	OTGRFVKZ	Strong	Biomarker	[3630]
FKTN	OTQ9GCXL	Strong	Biomarker	[3631]
FLG	OTE9QDV6	Strong	Genetic Variation	[3632]
FLNC	OT3F8J6Y	Strong	Altered Expression	[3633]
FLOT1	OT0JPPJZ	Strong	Biomarker	[3634]
FLOT2	OTZ0QR5L	Strong	Altered Expression	[3635]
FLRT2	OTGD8TID	Strong	Altered Expression	[3636]
FLT3LG	OTU0YGC4	Strong	Biomarker	[1791]
FMNL2	OT9OVWCV	Strong	Biomarker	[3637]
FMNL3	OTRP8R4W	Strong	Altered Expression	[3638]
FMOD	OT9EJ5H8	Strong	Biomarker	[3639]
FMR1NB	OT5IC2M2	Strong	Biomarker	[3640]
FNDC3A	OTUX3S2I	Strong	Biomarker	[3641]
FOSB	OTW6C05J	Strong	Altered Expression	[3642]
FOXA1	OTEBY0TD	Strong	Biomarker	[3643]
FOXA3	OTRGT2OT	Strong	Altered Expression	[3644]
FOXD1	OT80PRHS	Strong	Genetic Variation	[3645]
FOXD2	OTAF63YV	Strong	Biomarker	[3646]
FOXD3	OTXYV6GO	Strong	Altered Expression	[3647]
FOXF1	OT2CJZ5K	Strong	Altered Expression	[3648]
FOXF2	OTV20NGX	Strong	Biomarker	[126]
FOXG1	OTAW57J4	Strong	Biomarker	[3649]
FOXJ1	OT7LLBZ7	Strong	Biomarker	[3650]
FOXN2	OTBPLTCM	Strong	Altered Expression	[3651]
FOXN3	OTOJYJZP	Strong	Biomarker	[3652]
FOXO3	OTHXQG4P	Strong	Altered Expression	[3653]
FOXO4	OT90X9LN	Strong	Biomarker	[3654]
FRAS1	OTLPESF3	Strong	Biomarker	[3655]
FRAT1	OT1PS84E	Strong	Biomarker	[3656]
FRAT2	OT481GQ4	Strong	Biomarker	[3657]
FRG1	OTEJ8HSD	Strong	Genetic Variation	[3658]
FRY	OT74IAG2	Strong	Biomarker	[3659]
FSD1	OT8P6PT3	Strong	Biomarker	[3660]
FSD1L	OTBQ48RF	Strong	Biomarker	[3660]
FSIP1	OTYLL6GM	Strong	Altered Expression	[3661]
FSTL1	OT6KEZUD	Strong	Biomarker	[3662]
FUBP1	OT77SC9N	Strong	Altered Expression	[3663]
FUCA1	OTW71IK4	Strong	Altered Expression	[3664]
FUT2	OTLXM6WI	Strong	Biomarker	[3665]
FUT6	OTBZUQ7F	Strong	Altered Expression	[866]
FUT8	OTJJCVG1	Strong	Biomarker	[3666]
FUT9	OTLIJBQY	Strong	Altered Expression	[3667]
FXR1	OTEMQ1SR	Strong	Biomarker	[3668]
FXYD3	OT9PPRHE	Strong	Biomarker	[3669]
FXYD5	OT81DIOD	Strong	Altered Expression	[3670]
FYCO1	OTKZHTZ5	Strong	Biomarker	[3671]
FZD2	OT952ML1	Strong	Biomarker	[3672]
FZD5	OTXFFY56	Strong	Biomarker	[3673]
FZD8	OTZ9IRFL	Strong	Genetic Variation	[3674]
FZR1	OT0WGWZS	Strong	Genetic Variation	[3675]
G0S2	OT8FL49L	Strong	Biomarker	[3676]
GAB3	OTKX1KEC	Strong	Altered Expression	[3677]
GABARAP	OTAQUX6E	Strong	Biomarker	[3678]
GABARAPL1	OT4U7SBG	Strong	Altered Expression	[3679]
GADD45G	OT8V1J4M	Strong	Genetic Variation	[227]
GADL1	OTJM4A0R	Strong	Biomarker	[3044]
GAL3ST1	OTSFFZRD	Strong	Biomarker	[3680]
GALNT11	OTANT9E6	Strong	Biomarker	[3681]
GALNT12	OTVIBUST	Strong	Genetic Variation	[3682]
GALNT14	OT9BSDDQ	Strong	Altered Expression	[3683]
GALNT2	OTZZ5386	Strong	Biomarker	[691]
GALNT5	OTCV61V1	Strong	Biomarker	[3684]
GALNT7	OTUJSCAO	Strong	Altered Expression	[3685]
GAS8	OT8KT2AK	Strong	Genetic Variation	[3686]
GATA2	OTBP2QQ2	Strong	Genetic Variation	[3687]
GATA5	OTO81B63	Strong	Biomarker	[3688]
GATAD1	OT0UZ3EP	Strong	Biomarker	[3689]
GATAD2B	OTJL128N	Strong	Altered Expression	[2949]
GBE1	OTK2N05B	Strong	Biomarker	[3690]
GBP1	OTUM7RPJ	Strong	Altered Expression	[3691]
GBX2	OTW0ZI4D	Strong	Biomarker	[3692]
GC	OTWS63BY	Strong	Genetic Variation	[3693]
GCAT	OT6WZPWV	Strong	Biomarker	[3694]
GCHFR	OTEOT8GI	Strong	Biomarker	[3695]
GCKR	OTSIWXGG	Strong	Genetic Variation	[1652]
GCNT1	OTF6OC66	Strong	Altered Expression	[2582]
GCNT2	OTRUIMC4	Strong	Biomarker	[3696]
GCSAM	OTZNOPYK	Strong	Biomarker	[3697]
GCSH	OTNC1OKA	Strong	Genetic Variation	[3698]
GDF1	OTZ1VRBH	Strong	Biomarker	[3699]
GDI2	OTGLY3I7	Strong	Altered Expression	[3700]
GEMIN2	OT4L6TLL	Strong	Biomarker	[3701]
GFI1	OT9HB9H8	Strong	Biomarker	[3702]
GFI1B	OTRDW8YO	Strong	Altered Expression	[3703]
GFPT1	OTQBDO45	Strong	Altered Expression	[1724]
GFRA1	OT3WBVYB	Strong	Biomarker	[3704]
GGNBP2	OT7K9YZV	Strong	Biomarker	[3705]
GGPS1	OTVEHG28	Strong	Biomarker	[3706]
GIMAP5	OTMND7IR	Strong	Biomarker	[3707]
GINS1	OTVQZMMQ	Strong	Biomarker	[3708]
GINS3	OT8NVXTD	Strong	Altered Expression	[3709]
GIPC1	OTXLVCPJ	Strong	Biomarker	[207]
GIT1	OTHO92S5	Strong	Altered Expression	[718]
GKN1	OT7ZYFQ9	Strong	Biomarker	[3710]
GKN2	OTR9DOYG	Strong	Biomarker	[3711]
GLCE	OTPRSHX5	Strong	Altered Expression	[3712]
GLDN	OTA8TQU9	Strong	Biomarker	[3713]
GLG1	OT7X0W3N	Strong	Biomarker	[3714]
GLIS1	OTBDNB26	Strong	Biomarker	[3715]
GLIS2	OTOUUV1X	Strong	Genetic Variation	[3715]
GLRX3	OTUPAU1N	Strong	Biomarker	[3716]
GLYAT	OT3WWYXD	Strong	Genetic Variation	[3717]
GLYATL1	OTS8JSRY	Strong	Altered Expression	[3718]
GLYR1	OTY0VAVL	Strong	Genetic Variation	[2863]
GNA12	OT3IRZH3	Strong	Genetic Variation	[922]
GNA13	OTVDL515	Strong	Altered Expression	[3719]
GNA15	OTFYRZGV	Strong	Altered Expression	[519]
GNAS	OTMH8BKJ	Strong	Genetic Variation	[3720]
GNB1	OTLL7L74	Strong	Genetic Variation	[3721]
GNB3	OTA6HYBA	Strong	Genetic Variation	[3722]
GNG4	OTOXNDI9	Strong	Genetic Variation	[3723]
GNL3L	OTZYEFST	Strong	Biomarker	[3724]
GNLY	OTZJKA8C	Strong	Biomarker	[3725]
GNMT	OT0O2OQO	Strong	Altered Expression	[3726]
GOLGA1	OTBBPBG0	Strong	Altered Expression	[3727]
GOLGA4	OTCMEHNJ	Strong	Biomarker	[3728]
GOLGB1	OT2S0GK8	Strong	Genetic Variation	[3729]
GOLM1	OTOZSV6O	Strong	Altered Expression	[3730]
GOPC	OTRBGH71	Strong	Biomarker	[3596]
GOSR1	OTX8TMVU	Strong	Biomarker	[3448]
GPC2	OT3WSQE1	Strong	Altered Expression	[3731]
GPC4	OTUJ14DW	Strong	Altered Expression	[3732]
GPC6	OTNJBESF	Strong	Altered Expression	[3733]
GPD2	OTV232Y7	Strong	Biomarker	[3734]
GPKOW	OTGS3H0M	Strong	Biomarker	[3735]
GPLD1	OTUUQOVY	Strong	Altered Expression	[3736]
GPN3	OTZ4584O	Strong	Biomarker	[3737]
GPR151	OT7EACU6	Strong	Biomarker	[914]
GPR162	OTK4LT3K	Strong	Biomarker	[521]
GPR42	OTEB0ROY	Strong	Biomarker	[495]
GPR50	OT0EJBM4	Strong	Biomarker	[3738]
GPR65	OTCF5O4G	Strong	Altered Expression	[3739]
GPRC5C	OT45AJT3	Strong	Biomarker	[3740]
GPSM2	OT6RPMRM	Strong	Biomarker	[3741]
GPX4	OTRAFFX2	Strong	Altered Expression	[3742]
GRAP	OTO1P7YX	Strong	Biomarker	[3743]
GRAP2	OTS5NIZ3	Strong	Altered Expression	[725]
GRB14	OTFET2YM	Strong	Biomarker	[3744]
GRB7	OTF8Y9XY	Strong	Biomarker	[3745]
GREB1	OTU6ZA26	Strong	Altered Expression	[3746]
GRHL1	OTZ4MNEW	Strong	Altered Expression	[2031]
GRIP1	OT958HK1	Strong	Biomarker	[3747]
GRK6	OT4LZTP9	Strong	Biomarker	[3748]
GRP	OT8JDFNI	Strong	Biomarker	[3749]
GSDMA	OT912R2E	Strong	Biomarker	[3750]
GSDMB	OTWA7P10	Strong	Altered Expression	[3751]
GSDMD	OTH39BKI	Strong	Biomarker	[3752]
GSDME	OT1ZWY32	Strong	Posttranslational Modification	[3753]
GSTM2	OTG4WT05	Strong	Biomarker	[3754]
GSTT2B	OTCMRDLE	Strong	Genetic Variation	[3755]
GTF2H1	OTCRXC6B	Strong	Biomarker	[1030]
GTF2H2	OTK72L9I	Strong	Biomarker	[3756]
GTF2H3	OT87W5QJ	Strong	Biomarker	[3756]
GTF3A	OTVROUVQ	Strong	Altered Expression	[3757]
GUCA2B	OTZERX04	Strong	Biomarker	[3758]
GUK1	OTLI0HRU	Strong	Biomarker	[3759]
GYPB	OTESHUIX	Strong	Genetic Variation	[3760]
GYPE	OTBHAG6A	Strong	Genetic Variation	[3760]
GZMA	OT43R33L	Strong	Biomarker	[3761]
GZMM	OTEC5CWT	Strong	Biomarker	[3762]
H1-0	OTRLJK4Z	Strong	Biomarker	[3763]
H2AC11	OTN9P0BO	Strong	Biomarker	[3641]
H2AC18	OTCE5JC7	Strong	Altered Expression	[3764]
H2AC20	OTEIVLM1	Strong	Altered Expression	[3764]
H2BC12	OTQ8V0KG	Strong	Biomarker	[3641]
H2BC21	OT0FDCUC	Strong	Biomarker	[3641]
H2BC9	OTQ9XX72	Strong	Biomarker	[3045]
H3C1	OTGBGOZW	Strong	Biomarker	[3765]
H6PD	OTO7TNDD	Strong	Biomarker	[3766]
HACE1	OTEZULKD	Strong	Biomarker	[3767]
HADHB	OT4Y1I62	Strong	Biomarker	[3768]
HAO2	OTDWSQ0L	Strong	Biomarker	[3769]
HARS1	OTHOEOTS	Strong	Genetic Variation	[2603]
HAT1	OT307KEN	Strong	Biomarker	[3770]
HAUS3	OTFNDWNE	Strong	Altered Expression	[3771]
HBD	OTRQG4WA	Strong	Altered Expression	[3772]
HBE1	OTJPKMX4	Strong	Biomarker	[3773]
HBZ	OTMHGFSS	Strong	Biomarker	[3774]
HCST	OTILCB4K	Strong	Biomarker	[3775]
HDGFL3	OTNN7WYH	Strong	Biomarker	[3776]
HDLBP	OTKDEEYX	Strong	Biomarker	[3777]
HEATR1	OTOWIB9Z	Strong	Biomarker	[3778]
HEATR6	OTD3MYS0	Strong	Genetic Variation	[3779]
HECTD3	OTTGP4OK	Strong	Biomarker	[3780]
HELT	OTI77HDK	Strong	Biomarker	[3781]
HERC2	OTNQYKOB	Strong	Biomarker	[3782]
HERC4	OTU4DSDE	Strong	Biomarker	[3783]
HERC5	OTZ5PR39	Strong	Genetic Variation	[3784]
HERPUD1	OT9EROL6	Strong	Biomarker	[3785]
HES3	OTJ1J42N	Strong	Altered Expression	[3786]
HES6	OTWO5SCF	Strong	Biomarker	[3787]
HEY1	OTJQL0I3	Strong	Genetic Variation	[3788]
HGD	OTTKLQOO	Strong	Biomarker	[3789]
HHEX	OTLIUVYX	Strong	Biomarker	[3790]
HHLA2	OTYBTVQS	Strong	Biomarker	[3791]
HIC1	OTI9TWY4	Strong	Biomarker	[3792]
HID1	OTVJIFSU	Strong	Genetic Variation	[3793]
HILPDA	OTEID3ZM	Strong	Biomarker	[3794]
HIP1	OT7AKCFQ	Strong	Biomarker	[3795]
HIPK3	OT4WYQM2	Strong	Biomarker	[3796]
HIVEP1	OT7CAG4A	Strong	Biomarker	[3797]
HIVEP2	OTVOMCW4	Strong	Altered Expression	[3798]
HLA-DOA	OTZE5Q7R	Strong	Altered Expression	[3799]
HLA-DOB	OTKADDUB	Strong	Biomarker	[3800]
HLA-DPB1	OTW8JHU2	Strong	Genetic Variation	[3801]
HLA-DRA	OT7KZMP2	Strong	Biomarker	[3802]
HLA-DRB5	OTUX5TWM	Strong	Biomarker	[3803]
HLA-F	OT76CM19	Strong	Biomarker	[3804]
HLF	OTTRK9XN	Strong	Biomarker	[3805]
HLTF	OTRX2OSF	Strong	Altered Expression	[2539]
HLX	OT7DTH46	Strong	Biomarker	[3806]
HM13	OTGEO1LP	Strong	Altered Expression	[3807]
HMCN1	OTLZAS0P	Strong	Biomarker	[3808]
HMGB4	OT28OBR2	Strong	Biomarker	[3809]
HMMR	OT4M0JTZ	Strong	Altered Expression	[3810]
HNRNPH1	OTFRWOLM	Strong	Altered Expression	[3811]
HNRNPH2	OTMGP4J7	Strong	Altered Expression	[3811]
HNRNPK	OTNPRM8U	Strong	Altered Expression	[3812]
HNRNPR	OT3FITK2	Strong	Biomarker	[3813]
HNRNPUL2	OTJ6JTGT	Strong	Altered Expression	[3814]
HOOK1	OTTTKV7V	Strong	Altered Expression	[3815]
HOOK2	OTPO4NQV	Strong	Biomarker	[3816]
HOPX	OTBSR6C9	Strong	Altered Expression	[3817]
HOXA4	OTNVTQDT	Strong	Biomarker	[3818]
HOXA6	OTHJP8M2	Strong	Posttranslational Modification	[3819]
HOXA9	OTKNK5H0	Strong	Biomarker	[3820]
HOXB1	OTGC0EKI	Strong	Altered Expression	[3821]
HOXB3	OT9UC5PE	Strong	Biomarker	[3822]
HOXB8	OTKHOD17	Strong	Altered Expression	[3823]
HOXB9	OTMVHQOU	Strong	Biomarker	[3824]
HOXC11	OT8NMHM6	Strong	Biomarker	[3825]
HOXC13	OT52AVNA	Strong	Genetic Variation	[3826]
HOXC6	OTBCRAZV	Strong	Altered Expression	[3827]
HOXD10	OT0NOWU2	Strong	Biomarker	[3828]
HOXD11	OT9XGA4G	Strong	Altered Expression	[3829]
HOXD13	OTWSC8TF	Strong	Altered Expression	[3830]
HOXD3	OTBUZ35T	Strong	Biomarker	[3831]
HOXD4	OTQR4WCG	Strong	Genetic Variation	[3832]
HOXD8	OTJ5H7AT	Strong	Altered Expression	[3833]
HOXD9	OTZ4GVR1	Strong	Altered Expression	[3723]
HPR	OTXSC9UB	Strong	Biomarker	[3834]
HPS5	OTLO2374	Strong	Biomarker	[3380]
HRK	OTR4GWJ0	Strong	Genetic Variation	[3835]
HS3ST1	OT5DVN9P	Strong	Biomarker	[2605]
HSBP1	OTHZRMOF	Strong	Biomarker	[3836]
HSD17B6	OTSB55D2	Strong	Biomarker	[3837]
HSDL2	OT4IN0MV	Strong	Altered Expression	[3838]
HSPA14	OTZCA5LK	Strong	Biomarker	[3839]
HSPA1L	OTC2V1K6	Strong	Genetic Variation	[3840]
HSPB2	OTS01646	Strong	Altered Expression	[958]
HSPB6	OTFPLGZI	Strong	Biomarker	[3841]
HSPB7	OTLATAOV	Strong	Posttranslational Modification	[3842]
HSPH1	OTVRR73T	Strong	Genetic Variation	[3843]
HTR3C	OT65ZLIJ	Strong	Genetic Variation	[3844]
HTRA2	OTC7616F	Strong	Altered Expression	[3845]
HTRA3	OTXJ0H4X	Strong	Biomarker	[3846]
HUWE1	OTFH6BJS	Strong	Biomarker	[3847]
HYAL3	OTG6VUSP	Strong	Biomarker	[3848]
HYDIN	OTY88F5F	Strong	Biomarker	[3849]
HYLS1	OT3SW5UC	Strong	Biomarker	[3850]
HYOU1	OTBGBSOV	Strong	Altered Expression	[3851]
IARS1	OT9WXH5N	Strong	Biomarker	[3852]
IBTK	OTB2GM4G	Strong	Altered Expression	[3853]
ICAM2	OT3E070F	Strong	Altered Expression	[3854]
ICAM3	OTTZ5A5D	Strong	Biomarker	[3855]
ICAM5	OTDGGAFH	Strong	Altered Expression	[3856]
IER2	OT5OY8BO	Strong	Biomarker	[3857]
IER3	OTZJI5FZ	Strong	Biomarker	[3858]
IFI44	OTOKSZVA	Strong	Biomarker	[3859]
IFI6	OTWOOAM4	Strong	Biomarker	[3860]
IFIH1	OTZA2AHA	Strong	Biomarker	[3861]
IFIT2	OTI4EOAR	Strong	Altered Expression	[3862]
IFITM3	OT2QP8D3	Strong	Biomarker	[3863]
IFNA17	OTHXRYG3	Strong	Biomarker	[3864]
IFNLR1	OTWWWK45	Strong	Altered Expression	[3865]
IGF2BP2	OT4ZSEEE	Strong	Biomarker	[3866]
IGF2BP3	OTB97VIK	Strong	Biomarker	[3867]
IGFALS	OTTWCZYM	Strong	Biomarker	[3868]
IGFBP4	OT2HZRBD	Strong	Altered Expression	[3869]
IGFBPL1	OTY4HVN8	Strong	Posttranslational Modification	[3870]
IGSF11	OTQEG2X1	Strong	Biomarker	[3871]
IGSF9	OTNTKWS2	Strong	Altered Expression	[3872]
IKBIP	OTVFQEPA	Strong	Biomarker	[3873]
IKBKE	OT5VYOSM	Strong	Biomarker	[3874]
IL17B	OTS86H50	Strong	Biomarker	[985]
IL17RA	OTVVI8ER	Strong	Biomarker	[3875]
IL17RB	OT0KDNSF	Strong	Biomarker	[3876]
IL17RC	OTEFOBSS	Strong	Genetic Variation	[3877]
IL18R1	OT83XMPQ	Strong	Biomarker	[793]
IL1F10	OTJAASGC	Strong	Biomarker	[3878]
IL27RA	OTSQBAKI	Strong	Biomarker	[3879]
IL36A	OTHBEL5H	Strong	Biomarker	[3880]
IL9R	OTILCLXA	Strong	Altered Expression	[3881]
ILF2	OTWWVM9X	Strong	Altered Expression	[3882]
ILF3	OTKMZ5K5	Strong	Altered Expression	[3883]
ILKAP	OT2A6FSA	Strong	Altered Expression	[3884]
ILRUN	OTE8FHQD	Strong	Altered Expression	[3885]
IMPACT	OTQ923OB	Strong	Biomarker	[3886]
INA	OT1D33T4	Strong	Altered Expression	[3887]
INCENP	OT9HFRYK	Strong	Genetic Variation	[1050]
INF2	OT8ZM13C	Strong	Biomarker	[3888]
ING1	OTEZBRKW	Strong	Altered Expression	[3889]
ING2	OT6H0EWF	Strong	Altered Expression	[3179]
ING3	OTDIJXFP	Strong	Altered Expression	[3890]
ING4	OT0VVG4V	Strong	Altered Expression	[3891]
INKA2	OT9RA64U	Strong	Altered Expression	[3892]
INO80	OTJBMS8T	Strong	Altered Expression	[3893]
INPP4B	OTLROA7G	Strong	Biomarker	[3894]
INPP5J	OT8M7KWA	Strong	Altered Expression	[3895]
INSL4	OTK9F0LX	Strong	Altered Expression	[3896]
INTS6	OT6GDV46	Strong	Altered Expression	[3897]
IP6K2	OTCUMUUP	Strong	Altered Expression	[3898]
IPO13	OT887N3O	Strong	Altered Expression	[3899]
IPO9	OT1DGLQE	Strong	Biomarker	[3900]
IQGAP1	OTZRWTGA	Strong	Biomarker	[3901]
IQGAP2	OTX2UA7P	Strong	Biomarker	[3902]
IQGAP3	OT4RZV2M	Strong	Altered Expression	[3903]
IQSEC1	OTK1PBFD	Strong	Biomarker	[3904]
IREB2	OT747D24	Strong	Altered Expression	[3905]
IRF4	OT1DHQ1P	Strong	Biomarker	[3906]
IRF6	OTKJ44EV	Strong	Biomarker	[3907]
IRF7	OTC1A2PQ	Strong	Biomarker	[3908]
ISG20	OTCWRJJW	Strong	Biomarker	[3909]
ITFG1	OTX0PCR3	Strong	Biomarker	[3910]
ITGA2B	OT4Y17PY	Strong	Biomarker	[3911]
ITGA9	OTHN1IKA	Strong	Biomarker	[3912]
ITGBL1	OTJDHE17	Strong	Altered Expression	[3913]
ITIH1	OTSXJGQF	Strong	Altered Expression	[3914]
ITIH4	OT460OO1	Strong	Biomarker	[3915]
ITIH5	OTP46PZM	Strong	Biomarker	[3916]
ITPK1	OTP4PGL6	Strong	Genetic Variation	[1652]
ITPKB	OTSVVPAV	Strong	Biomarker	[3917]
ITPRID2	OTO3JDX5	Strong	Altered Expression	[3918]
IVD	OT8JFXUQ	Strong	Biomarker	[3919]
IVL	OT4VPNGY	Strong	Biomarker	[3920]
IVNS1ABP	OTYHL4I7	Strong	Biomarker	[3921]
JADE3	OTEQR3MN	Strong	Biomarker	[3922]
JAM3	OTX0F9QL	Strong	Biomarker	[3923]
JAZF1	OTXTYSYD	Strong	Genetic Variation	[3924]
JDP2	OTW35WKX	Strong	Biomarker	[3925]
JHY	OTWS4K0E	Strong	Biomarker	[3926]
JMJD6	OTILR7E4	Strong	Biomarker	[3927]
JOSD1	OT6BAFAY	Strong	Altered Expression	[3928]
JRK	OTO8E77P	Strong	Biomarker	[3929]
JUNB	OTG2JXV5	Strong	Altered Expression	[3642]
JUND	OTNKACJD	Strong	Altered Expression	[3642]
KALRN	OT8WRCBH	Strong	Altered Expression	[3930]
KANSL1	OTYNSNNZ	Strong	Genetic Variation	[3931]
KANSL1L	OTOAH2RR	Strong	Genetic Variation	[3931]
KARS1	OT0EU4SV	Strong	Biomarker	[3932]
KAT2A	OTN0W2SW	Strong	Biomarker	[3933]
KAT7	OTUN98IC	Strong	Altered Expression	[3934]
KAT8	OT5LPQTR	Strong	Biomarker	[3935]
KCMF1	OTVTKFAU	Strong	Altered Expression	[3936]
KCNE1	OTZNQUW9	Strong	Genetic Variation	[2863]
KCNE2	OTUO214Y	Strong	Genetic Variation	[2863]
KDELR2	OT9QW7Q0	Strong	Biomarker	[3937]
KDM6A	OTZM3MJJ	Strong	Genetic Variation	[3938]
KDM8	OTCN5ST8	Strong	Altered Expression	[3939]
KDSR	OTCIES3H	Strong	Altered Expression	[3940]
KIAA0825	OTANX32T	Strong	Genetic Variation	[2863]
KIF13B	OTAFS1YV	Strong	Biomarker	[3941]
KIF15	OTJRJEXL	Strong	Biomarker	[1227]
KIF18B	OTOBUDOE	Strong	Biomarker	[3942]
KIF1A	OT3JVEGV	Strong	Biomarker	[2742]
KIF1B	OTI1XQTO	Strong	Biomarker	[3943]
KIF20A	OTXOQHE0	Strong	Altered Expression	[3944]
KIF21A	OT511XD9	Strong	Biomarker	[3945]
KIF23	OTY850JC	Strong	Altered Expression	[3946]
KIF2C	OTJ8G3NP	Strong	Biomarker	[3947]
KIF4A	OT3UWL7D	Strong	Altered Expression	[3948]
KIF5B	OTT34MT8	Strong	Genetic Variation	[3949]
KIFC1	OTNQDS00	Strong	Biomarker	[3950]
KIN	OTB2DNQU	Strong	Biomarker	[3951]
KIR3DL1	OTPOSXFX	Strong	Biomarker	[426]
KLF1	OT1FK08U	Strong	Genetic Variation	[3952]
KLF10	OT4F4UGS	Strong	Biomarker	[3953]
KLF11	OTKVQDJD	Strong	Biomarker	[3954]
KLF12	OTVH4KD4	Strong	Altered Expression	[3955]
KLF13	OTMIKHZ4	Strong	Biomarker	[3956]
KLF15	OTGMQMVR	Strong	Biomarker	[3957]
KLF3	OTIIAC18	Strong	Biomarker	[3958]
KLF8	OTUC5CDB	Strong	Biomarker	[206]
KLHDC2	OTBHH882	Strong	Biomarker	[3959]
KLHDC8B	OTKP6LCR	Strong	Genetic Variation	[3960]
KLHL31	OTXZVWDL	Strong	Biomarker	[3961]
KLHL5	OTRDVST4	Strong	Altered Expression	[3961]
KLHL6	OTLDECOX	Strong	Biomarker	[3962]
KLHL7	OT2OF1O8	Strong	Biomarker	[3963]
KLK11	OT5PKX7Y	Strong	Biomarker	[3964]
KLK12	OTNYK59J	Strong	Biomarker	[3965]
KLK13	OT8LOD2U	Strong	Altered Expression	[3966]
KLK15	OT7BVG17	Strong	Biomarker	[3967]
KLRB1	OTQ2959Y	Strong	Biomarker	[3271]
KMT2C	OTC59BCO	Strong	Biomarker	[2479]
KMT2E	OTYOLNOG	Strong	Biomarker	[3968]
KNL1	OT4Q3LHV	Strong	Biomarker	[3969]
KNTC1	OTI2OOFN	Strong	Biomarker	[3970]
KPNA2	OTU7FOE6	Strong	Biomarker	[3971]
KRT1	OTIOJWA4	Strong	Altered Expression	[3918]
KRT14	OTUVZ1DW	Strong	Altered Expression	[3972]
KRT15	OTS6WLF7	Strong	Biomarker	[3973]
KRT16	OTGA0EQN	Strong	Biomarker	[3974]
KRT23	OTQW6UAG	Strong	Biomarker	[3975]
KRT31	OTB6RCAH	Strong	Altered Expression	[2978]
KRT5	OTVGI9HT	Strong	Biomarker	[3976]
KRT76	OT2V7AP3	Strong	Altered Expression	[3977]
KRT8	OTTM4X11	Strong	Biomarker	[3978]
KYAT3	OTO4U2QK	Strong	Altered Expression	[3979]
L1TD1	OTB2W20Y	Strong	Biomarker	[3980]
L3MBTL1	OT8M52QY	Strong	Genetic Variation	[3981]
LACTB	OTRWGNBF	Strong	Altered Expression	[3982]
LAMA1	OTQZMP86	Strong	Biomarker	[2877]
LAMA2	OTFROQWE	Strong	Biomarker	[3983]
LAMA5	OTIIXE4M	Strong	Biomarker	[3984]
LAMB1	OT6J9LJR	Strong	Biomarker	[3985]
LAMB4	OT0NOOB2	Strong	Genetic Variation	[3986]
LAMC1	OTIG527N	Strong	Biomarker	[3987]
LAMC3	OTKNAYJO	Strong	Biomarker	[3988]
LAMTOR2	OTHEDISB	Strong	Altered Expression	[3197]
LAMTOR5	OTER0U8L	Strong	Biomarker	[3989]
LAPTM5	OT2XI2JG	Strong	Altered Expression	[3990]
LARP4B	OT2HI0QE	Strong	Biomarker	[3991]
LARP6	OTUQ9QS9	Strong	Altered Expression	[3992]
LAT	OTZC1XZ1	Strong	Biomarker	[1392]
LAT2	OTWJDKIH	Strong	Biomarker	[3993]
LAYN	OT9A9Q1X	Strong	Biomarker	[3994]
LCE2B	OTA53PGQ	Strong	Biomarker	[3995]
LDB1	OT20EAPR	Strong	Biomarker	[3996]
LDLRAD4	OTQUX50Z	Strong	Biomarker	[3997]
LDLRAP1	OT6QTX7R	Strong	Altered Expression	[2458]
LGALS3BP	OT9AGQKH	Strong	Biomarker	[3998]
LGALS4	OTKQCG0H	Strong	Biomarker	[3999]
LGI1	OTPS77HO	Strong	Genetic Variation	[4000]
LGI3	OT0CZ85H	Strong	Altered Expression	[4001]
LGR6	OTPZ1PWR	Strong	Biomarker	[914]
LHFPL4	OT57WPMB	Strong	Posttranslational Modification	[4002]
LHFPL6	OTY6LHJY	Strong	Posttranslational Modification	[4002]
LHPP	OT9AGAIJ	Strong	Biomarker	[4003]
LHX2	OTK61NP8	Strong	Altered Expression	[4004]
LHX6	OT47UQZ5	Strong	Altered Expression	[4005]
LIG1	OTEEQS43	Strong	Biomarker	[4006]
LIG3	OT48SKET	Strong	Biomarker	[4007]
LIMA1	OTONPC9R	Strong	Biomarker	[4008]
LIMCH1	OTYPC4XA	Strong	Altered Expression	[4009]
LIME1	OTJWUQSK	Strong	Altered Expression	[4010]
LIMS1	OT729S0T	Strong	Biomarker	[4011]
LIMS2	OTZ7IIPM	Strong	Altered Expression	[4012]
LIMS3	OTTMS7V8	Strong	Altered Expression	[4012]
LIN7A	OTFL3PUX	Strong	Altered Expression	[4013]
LIN9	OTLHW00C	Strong	Altered Expression	[4014]
LIPC	OTZY5SC9	Strong	Altered Expression	[4015]
LIPH	OTRGYLKL	Strong	Biomarker	[4016]
LITAF	OTT5JX1F	Strong	Biomarker	[4017]
LLGL1	OTAIQSXZ	Strong	Biomarker	[4018]
LLGL2	OTU8ZDC4	Strong	Biomarker	[4018]
LMLN	OTQF0JPY	Strong	Biomarker	[4019]
LMNB1	OT100T3P	Strong	Biomarker	[4020]
LMNB2	OTXRDUOS	Strong	Altered Expression	[4021]
LMO1	OTB59SKB	Strong	Biomarker	[4022]
LMO3	OTR7AJHN	Strong	Biomarker	[4023]
LMO4	OT5NDCT9	Strong	Biomarker	[4023]
LMTK2	OT93MVIC	Strong	Altered Expression	[4024]
LMX1A	OTEEYD5L	Strong	Biomarker	[4025]
LNX1	OTZWFMAZ	Strong	Biomarker	[4026]
LONP2	OTRZCYWU	Strong	Biomarker	[4027]
LORICRIN	OTFRPVEO	Strong	Altered Expression	[4028]
LOXL3	OTLLY1QI	Strong	Biomarker	[4029]
LOXL4	OT6XY2JL	Strong	Biomarker	[4030]
LPIN1	OTQ75KF2	Strong	Biomarker	[4031]
LPP	OT6TU8SE	Strong	Biomarker	[4032]
LPXN	OTUNV3CK	Strong	Biomarker	[4033]
LRATD1	OT65IL83	Strong	Posttranslational Modification	[4034]
LRATD2	OTEZBUUL	Strong	Biomarker	[4035]
LRIG1	OTY5HZN5	Strong	Altered Expression	[4036]
LRIG3	OT6TKZTU	Strong	Altered Expression	[4037]
LRP8	OTZ71YV2	Strong	Genetic Variation	[4038]
LRPAP1	OT6DVD2Q	Strong	Biomarker	[4039]
LRRC3B	OT9VDGPR	Strong	Biomarker	[4040]
LRRC8A	OT23OE7H	Strong	Biomarker	[4041]
LRRFIP2	OTU8GUMV	Strong	Biomarker	[3728]
LRSAM1	OTOKWR6C	Strong	Genetic Variation	[4042]
LST1	OTUVG424	Strong	Altered Expression	[4043]
LTO1	OTQ17ZDT	Strong	Biomarker	[4044]
LUC7L3	OTKDED8A	Strong	Genetic Variation	[4045]
LUM	OTSRC874	Strong	Biomarker	[4046]
LXN	OTZQ2M6Y	Strong	Altered Expression	[4047]
LY6E	OTMG16BZ	Strong	Biomarker	[4048]
LYL1	OTCNOV1M	Strong	Biomarker	[4049]
LYPD1	OT0HSGML	Strong	Genetic Variation	[4050]
LYPD3	OTLR2PYX	Strong	Biomarker	[4051]
LYPD8	OT5B9NNM	Strong	Altered Expression	[1590]
LYST	OTIUB1B3	Strong	Genetic Variation	[4052]
LZTS1	OTXXL864	Strong	Altered Expression	[4053]
LZTS2	OTQFSQEE	Strong	Biomarker	[4054]
LZTS3	OTFFMOJN	Strong	Biomarker	[3618]
MACROD1	OTWFEVRW	Strong	Altered Expression	[4055]
MACROD2	OTNQCHC6	Strong	Genetic Variation	[4056]
MAD2L1BP	OT2O2IUJ	Strong	Genetic Variation	[1380]
MAEA	OTPA2FDE	Strong	Altered Expression	[4057]
MAF	OT1GR3IZ	Strong	Altered Expression	[4058]
MAF1	OTKB0N8Q	Strong	Biomarker	[4059]
MAFK	OTZJUE4P	Strong	Biomarker	[568]
MAGEA11	OTLT6Q3G	Strong	Genetic Variation	[4060]
MAGEA12	OT8ULELL	Strong	Biomarker	[4061]
MAGEB2	OTAGUVU5	Strong	Biomarker	[4062]
MAGEB6	OTOTV1FU	Strong	Biomarker	[4063]
MAGED1	OT6EOLFC	Strong	Biomarker	[4064]
MAGED2	OTMEWNSE	Strong	Biomarker	[4065]
MAGED4B	OTO37U7W	Strong	Altered Expression	[4066]
MAGEE1	OTOQQO2X	Strong	Biomarker	[4067]
MAGEE2	OTL3E0G7	Strong	Biomarker	[930]
MAGEF1	OTUU40U3	Strong	Biomarker	[4068]
MAGEH1	OTVE05K7	Strong	Biomarker	[4069]
MAGI2	OTXDDKZS	Strong	Biomarker	[4070]
MAGOH	OTWRYTOX	Strong	Biomarker	[4071]
MAGOHB	OTOD1QC3	Strong	Biomarker	[4071]
MAGT1	OTQSAV5C	Strong	Biomarker	[529]
MAK16	OTD546E5	Strong	Biomarker	[1277]
MAML1	OTQA4DDN	Strong	Biomarker	[4072]
MAML2	OT1TSVAR	Strong	Genetic Variation	[4073]
MAML3	OTZFV53Z	Strong	Altered Expression	[4074]
MAN1B1	OTI780UB	Strong	Altered Expression	[4075]
MAP1LC3A	OTPMGIU4	Strong	Biomarker	[4076]
MAP2K6	OTK13JKC	Strong	Biomarker	[4077]
MAP6	OTPUI00F	Strong	Genetic Variation	[4078]
MAP9	OTZD5099	Strong	Altered Expression	[4079]
MAPK13	OT0W9GE7	Strong	Altered Expression	[4080]
MAPK4	OTVWWUYS	Strong	Biomarker	[4081]
MAPK6	OTDDNF3Q	Strong	Altered Expression	[1102]
MAPK8IP3	OT0X8ACY	Strong	Biomarker	[4082]
MARCHF1	OTI2EYO6	Strong	Genetic Variation	[4083]
MARCHF2	OTADQ0OA	Strong	Biomarker	[4084]
MARCHF3	OT89V4N5	Strong	Genetic Variation	[4085]
MARCHF4	OTK43VNA	Strong	Genetic Variation	[2863]
MARCHF5	OTBK6BBM	Strong	Genetic Variation	[4086]
MARCHF9	OTWF84QT	Strong	Genetic Variation	[4087]
MAST1	OTEYFN5O	Strong	Biomarker	[4088]
MAU2	OTALDF8Q	Strong	Biomarker	[4089]
MAVS	OTTQ0J64	Strong	Biomarker	[4090]
MBD1	OTD19VO6	Strong	Altered Expression	[4091]
MBD3	OTRL76H5	Strong	Altered Expression	[3460]
MBD4	OTWR9YXE	Strong	Altered Expression	[4092]
MBLAC1	OTZRBZA5	Strong	Biomarker	[4093]
MBTPS2	OT67CC7W	Strong	Biomarker	[4094]
MCAT	OTH07FIW	Strong	Biomarker	[706]
MCF2L	OTEURA8N	Strong	Biomarker	[4095]
MCFD2	OTM0XU0U	Strong	Biomarker	[4096]
MCIDAS	OTK1JVAH	Strong	Genetic Variation	[4097]
MCM10	OTV0O3JN	Strong	Altered Expression	[4098]
MCM3AP	OT895FEC	Strong	Altered Expression	[4099]
MCM5	OTAHLB62	Strong	Biomarker	[4100]
MCPH1	OTYT3TT5	Strong	Biomarker	[4101]
MCRS1	OT8K2X8P	Strong	Biomarker	[4102]
MCTP1	OTSFI0HS	Strong	Genetic Variation	[2863]
MCTS1	OT7SAOJP	Strong	Biomarker	[706]
MCU	OTQZAYWQ	Strong	Biomarker	[4103]
MDC1	OTEUQH4J	Strong	Biomarker	[4104]
MDFIC	OTSRYBWZ	Strong	Biomarker	[4105]
ME2	OTO4LL76	Strong	Biomarker	[4106]
ME3	OT3XMLYG	Strong	Altered Expression	[4107]
MECOM	OTP983W8	Strong	Biomarker	[637]
MED15	OT0D0JVD	Strong	Biomarker	[4108]
MED20	OTWLPQAP	Strong	Altered Expression	[4109]
MED28	OTEDM1L5	Strong	Biomarker	[4110]
MED31	OTFVKXJE	Strong	Altered Expression	[4109]
MED4	OTALFN4S	Strong	Genetic Variation	[4111]
MEF2B	OT880SE6	Strong	Genetic Variation	[4112]
MEF2C	OTZGF1Y5	Strong	Biomarker	[4113]
MEF2D	OT7CEIG0	Strong	Altered Expression	[4114]
MEGF8	OT5G38CH	Strong	Altered Expression	[2772]
MEIS2	OTG4ADLM	Strong	Biomarker	[4115]
MEOX2	OTKZCJCB	Strong	Altered Expression	[4116]
MESP1	OTY5QDBN	Strong	Genetic Variation	[4117]
METTL14	OT6TPQMH	Strong	Biomarker	[528]
METTL16	OT99VP8Y	Strong	Biomarker	[2669]
METTL9	OT3YR9B2	Strong	Biomarker	[4118]
MEX3B	OTPUZ8CW	Strong	Biomarker	[4119]
MFAP1	OTZN4FT3	Strong	Biomarker	[1701]
MFAP5	OT46VXSG	Strong	Biomarker	[4120]
MFF	OTEVIXOM	Strong	Biomarker	[4121]
MFSD12	OT54Y9TN	Strong	Biomarker	[4122]
MFSD2A	OTVG1VG0	Strong	Biomarker	[4123]
MGAT3	OTXI5X4T	Strong	Altered Expression	[4124]
MGAT4A	OT0ZW5FM	Strong	Altered Expression	[4125]
MGAT4B	OTEHCPLY	Strong	Altered Expression	[4126]
MGAT5	OTU4DD4G	Strong	Genetic Variation	[4127]
MGAT5B	OT5HP73K	Strong	Biomarker	[4127]
MGP	OTZWU3FU	Strong	Altered Expression	[4128]
MIA2	OTOGTUTU	Strong	Biomarker	[4129]
MIA3	OTBVIZQD	Strong	Genetic Variation	[4130]
MIB2	OTJCC3HS	Strong	Biomarker	[4131]
MICA	OTPEIEAR	Strong	Biomarker	[4132]
MICAL1	OTJEDVWA	Strong	Biomarker	[4133]
MICAL2	OT04OQQJ	Strong	Altered Expression	[4134]
MICALL2	OT1IQM3K	Strong	Biomarker	[4135]
MICOS10	OTB6D21A	Strong	Biomarker	[3734]
MICU1	OTS7N0LE	Strong	Biomarker	[4136]
MIEF1	OTFSP3FS	Strong	Biomarker	[4137]
MIER3	OTL5BGOB	Strong	Genetic Variation	[4138]
MINK1	OTKB0RA8	Strong	Biomarker	[4139]
MIP	OTEBLU3E	Strong	Altered Expression	[4140]
MIPEP	OTB2IHCT	Strong	Biomarker	[4141]
MITF	OT6XJCZH	Strong	Biomarker	[4142]
MKKS	OTLF5T11	Strong	Altered Expression	[2458]
MKS1	OT83W5PB	Strong	Biomarker	[1688]
MLH3	OT91PPBI	Strong	Genetic Variation	[4143]
MLIP	OTMT7AII	Strong	Biomarker	[4144]
MLLT10	OTURMDV7	Strong	Biomarker	[4145]
MLLT11	OTG5RVHC	Strong	Biomarker	[4146]
MLN	OTBZ5SE5	Strong	Altered Expression	[4147]
MMAB	OTOWOEJN	Strong	Biomarker	[2323]
MMP20	OT16S5S3	Strong	Biomarker	[2554]
MMP23B	OT2OR6TS	Strong	Biomarker	[4148]
MMP25	OT3BG37V	Strong	Biomarker	[4149]
MMRN1	OT7ZNYHT	Strong	Altered Expression	[4150]
MMS19	OTAXB34N	Strong	Altered Expression	[4068]
MMUT	OTBBBV70	Strong	Biomarker	[4151]
MN1	OTVQR4R9	Strong	Genetic Variation	[4152]
MNT	OTPC4ANL	Strong	Genetic Variation	[4153]
MOB1A	OTSPBZ4Z	Strong	Genetic Variation	[4154]
MOB3B	OTZJQG1D	Strong	Biomarker	[4155]
MOK	OTQK7M9V	Strong	Genetic Variation	[4156]
MORC1	OTCCJKFN	Strong	Biomarker	[4157]
MORC2	OT52A8BJ	Strong	Biomarker	[4158]
MORF4L1	OTEA6FYJ	Strong	Biomarker	[4159]
MOS	OTNMQPFJ	Strong	Altered Expression	[4160]
MPC1	OT6DYFUO	Strong	Altered Expression	[4161]
MPC2	OT0GHXGG	Strong	Altered Expression	[4162]
MPG	OTAHW80B	Strong	Biomarker	[4163]
MPHOSPH8	OTYI2WNS	Strong	Biomarker	[4164]
MPI	OTBH6ZK1	Strong	Biomarker	[4165]
MRAS	OTNCVCQW	Strong	Genetic Variation	[4166]
MRGPRX3	OTRKCCDS	Strong	Biomarker	[914]
MRGPRX4	OTOBHZVA	Strong	Biomarker	[914]
MRPL28	OT4LUTZU	Strong	Biomarker	[4167]
MRPL33	OTA3YDH0	Strong	Biomarker	[4168]
MRPL36	OTZ9QV3U	Strong	Genetic Variation	[4169]
MRPL43	OTM12XS9	Strong	Genetic Variation	[4170]
MRPS23	OTDVWT5V	Strong	Altered Expression	[4171]
MRTFA	OTCVXASM	Strong	Altered Expression	[4172]
MSC	OTBRPZL5	Strong	Biomarker	[4173]
MSH5	OTDARQT3	Strong	Genetic Variation	[4174]
MSL1	OTXLFYLB	Strong	Genetic Variation	[3931]
MSRB3	OT4UZXMN	Strong	Biomarker	[4175]
MST1	OTOC4UNG	Strong	Biomarker	[4176]
MSTO1	OT37XCNP	Strong	Altered Expression	[1093]
MSX1	OT5U41ZP	Strong	Biomarker	[4177]
MSX2	OT1WDKE1	Strong	Altered Expression	[4178]
MT1E	OTXJKU4Y	Strong	Biomarker	[4179]
MT1H	OT0MVBM6	Strong	Biomarker	[1136]
MT1M	OTVT8PLU	Strong	Biomarker	[1136]
MT1X	OT9AKFVS	Strong	Biomarker	[1136]
MT3	OTVCZ7HI	Strong	Altered Expression	[4180]
MTCH2	OTV3E4GU	Strong	Biomarker	[4181]
MTF2	OTNL1O2O	Strong	Biomarker	[4182]
MTFMT	OT1OIVJL	Strong	Biomarker	[4183]
MTG1	OTC9U1LI	Strong	Altered Expression	[4184]
MTHFD1L	OTV01EFP	Strong	Biomarker	[4185]
MTHFD2	OT1LQSGX	Strong	Biomarker	[4186]
MTHFD2L	OTDYNXRG	Strong	Biomarker	[4187]
MTMR11	OTHL2O08	Strong	Genetic Variation	[4045]
MTMR6	OTQPAWI3	Strong	Biomarker	[4188]
MTMR7	OT47NVYM	Strong	Biomarker	[4189]
MTO1	OT7HCZ1D	Strong	Altered Expression	[4190]
MUC13	OTWKS9MF	Strong	Altered Expression	[4191]
MUC4	OTLT11V1	Strong	Biomarker	[4192]
MUC6	OTPVL723	Strong	Altered Expression	[4193]
MUC7	OTSTMP0X	Strong	Genetic Variation	[1137]
MUCL1	OT9QUFL3	Strong	Altered Expression	[4194]
MUS81	OTVZ4E60	Strong	Posttranslational Modification	[4195]
MVP	OTJGHJRB	Strong	Biomarker	[4196]
MXD1	OTS5CTHX	Strong	Biomarker	[4197]
MXD3	OT4U88UP	Strong	Biomarker	[4198]
MXRA5	OTXZBWCU	Strong	Biomarker	[4199]
MYBPH	OTQJBPUR	Strong	Altered Expression	[4200]
MYCBPAP	OT3W21WR	Strong	Biomarker	[4201]
MYEF2	OTSXZ356	Strong	Genetic Variation	[2135]
MYEOV	OTDC7UHL	Strong	Genetic Variation	[4202]
MYH11	OTVNVWY3	Strong	Biomarker	[4203]
MYH14	OT1TZEJK	Strong	Biomarker	[4204]
MYH6	OT3YNCH1	Strong	Biomarker	[2161]
MYH8	OT9F350W	Strong	Genetic Variation	[4205]
MYL2	OT78PC0C	Strong	Biomarker	[1281]
MYO18A	OT2YPT7O	Strong	Biomarker	[4206]
MYO5A	OTMWLP3E	Strong	Altered Expression	[4207]
MYOC	OT6DAHNF	Strong	Biomarker	[4208]
MYOCD	OTSJNHTH	Strong	Altered Expression	[4209]
MYOD1	OTV2S79X	Strong	Genetic Variation	[4210]
MYOG	OTPLJKFA	Strong	Biomarker	[4210]
MYOM2	OTD2UOXW	Strong	Biomarker	[4211]
MYT1	OTC3660I	Strong	Altered Expression	[4212]
MYT1L	OTV45MAS	Strong	Altered Expression	[2170]
MZB1	OT071TET	Strong	Biomarker	[4213]
NAA15	OT53SIZG	Strong	Biomarker	[4214]
NAA25	OTS3QVF1	Strong	Altered Expression	[434]
NAB2	OTG4BDF3	Strong	Biomarker	[4215]
NABP2	OTQU8081	Strong	Biomarker	[4216]
NAE1	OTMC6F3Y	Strong	Altered Expression	[4217]
NAGA	OTNUEUZY	Strong	Altered Expression	[4218]
NAIP	OTLA925F	Strong	Altered Expression	[4219]
NANOG	OTUEY1FM	Strong	Altered Expression	[4220]
NANOS3	OTGX9IQU	Strong	Biomarker	[4221]
NAP1L5	OTF4Q6ZW	Strong	Biomarker	[3351]
NASP	OTNE4THC	Strong	Biomarker	[4222]
NAV3	OT97M1TR	Strong	Genetic Variation	[4223]
NAXE	OTRZPISQ	Strong	Altered Expression	[4224]
NBEAL1	OTLJ11N3	Strong	Genetic Variation	[4225]
NBEAL2	OTMCAXWR	Strong	Biomarker	[4226]
NBL1	OTT37U4O	Strong	Biomarker	[4227]
NBR1	OTVRL7J9	Strong	Biomarker	[4228]
NCAPD2	OT8VGE2O	Strong	Biomarker	[4229]
NCAPG	OT1AI9EO	Strong	Biomarker	[4230]
NCAPG2	OTZYENKO	Strong	Altered Expression	[4231]
NCBP1	OTYBR927	Strong	Biomarker	[4232]
NCOA2	OTMQFPBB	Strong	Altered Expression	[397]
NCOA5	OTOGWTWB	Strong	Biomarker	[4233]
NCOA6	OTOMIGTV	Strong	Biomarker	[4234]
NCOR1	OT04XNOU	Strong	Altered Expression	[4235]
NCR2	OT2H13BX	Strong	Altered Expression	[4236]
NCR3LG1	OT15YWU7	Strong	Altered Expression	[2166]
ND1	OTCLGIXV	Strong	Genetic Variation	[4237]
NDC1	OTF2GQC1	Strong	Altered Expression	[4238]
NDC80	OTS7D306	Strong	Biomarker	[4239]
NDN	OTYBYJ82	Strong	Biomarker	[4240]
NDP	OTGDJ4US	Strong	Biomarker	[4241]
NDRG1	OTVO66BO	Strong	Biomarker	[4242]
NDRG2	OT5L6KD7	Strong	Biomarker	[4243]
NDST4	OTEKG7JJ	Strong	Biomarker	[4244]
NDUFA4L2	OTK0PG7R	Strong	Biomarker	[4245]
NDUFAB1	OTF906UR	Strong	Biomarker	[4246]
NDUFS8	OTMEAWKO	Strong	Altered Expression	[3308]
NEBL	OT2WH1NC	Strong	Biomarker	[4247]
NECTIN1	OTTE5ZR6	Strong	Altered Expression	[4248]
NECTIN3	OTS8N7MK	Strong	Altered Expression	[4249]
NEDD4L	OT1B19RU	Strong	Genetic Variation	[4250]
NEFH	OTMSCW5I	Strong	Biomarker	[4251]
NEFL	OTQESJV4	Strong	Biomarker	[2424]
NEGR1	OT57ECW9	Strong	Biomarker	[4252]
NEIL1	OTHBU5DJ	Strong	Genetic Variation	[4253]
NEK3	OTKWD5FY	Strong	Biomarker	[4254]
NELL2	OTS4MJZ7	Strong	Altered Expression	[1180]
NETO1	OTXP9A63	Strong	Genetic Variation	[916]
NETO2	OT0YAMC0	Strong	Altered Expression	[4255]
NEU3	OTQ5PQOW	Strong	Biomarker	[4256]
NEU4	OTM16O9F	Strong	Altered Expression	[4257]
NEUROG1	OTMJZP9G	Strong	Biomarker	[4258]
NEXN	OTKB0B0H	Strong	Biomarker	[4259]
NFAM1	OT4PKH8L	Strong	Altered Expression	[2224]
NFATC3	OTYOORME	Strong	Biomarker	[4260]
NFE2	OTLM94BI	Strong	Biomarker	[4261]
NFE2L3	OT1MGXT0	Strong	Biomarker	[2725]
NFIB	OTX94PD0	Strong	Biomarker	[4262]
NFIC	OTLMCUIB	Strong	Biomarker	[4263]
NFIL3	OTQH9HM3	Strong	Biomarker	[4264]
NFKBIE	OTLAYEL9	Strong	Biomarker	[4265]
NFYA	OTWFFOVH	Strong	Altered Expression	[4266]
NFYC	OTZVVEV7	Strong	Altered Expression	[4267]
NGB	OTW0SIUY	Strong	Biomarker	[4268]
NHS	OTKE8QAT	Strong	Genetic Variation	[4269]
NIBAN3	OTJVFMAS	Strong	Posttranslational Modification	[4270]
NID1	OTKLBLS6	Strong	Biomarker	[4271]
NID2	OTHC33FF	Strong	Biomarker	[4272]
NINJ1	OTLRZ1EU	Strong	Biomarker	[4273]
NIPAL1	OTRYI60X	Strong	Altered Expression	[4274]
NIT1	OT1KHPKJ	Strong	Altered Expression	[4275]
NIT2	OTC1RAH3	Strong	Biomarker	[4276]
NKD1	OTY3MO97	Strong	Altered Expression	[4277]
NKX2-8	OT6Q3DJ0	Strong	Biomarker	[4278]
NKX3-2	OTH4NRH7	Strong	Biomarker	[4279]
NLGN4X	OTDJGBK8	Strong	Altered Expression	[4280]
NLK	OT2LETFS	Strong	Biomarker	[4281]
NLN	OTFRITPU	Strong	Biomarker	[2704]
NLRC4	OTAIA3NA	Strong	Altered Expression	[4282]
NLRP4	OT864X7M	Strong	Biomarker	[1756]
NLRP6	OTEREN4W	Strong	Biomarker	[4283]
NMBR	OTBJEGPN	Strong	Biomarker	[4284]
NME4	OT2JTT42	Strong	Altered Expression	[4285]
NME5	OTE8OLFN	Strong	Biomarker	[4286]
NMS	OTFYS4LO	Strong	Altered Expression	[4287]
NMU	OTW9X7BQ	Strong	Biomarker	[4288]
NOC2L	OTNT7R33	Strong	Biomarker	[4289]
NOG	OTGRHHPG	Strong	Altered Expression	[4290]
NOL4	OTWI587R	Strong	Genetic Variation	[4002]
NOL7	OTIJ1KQI	Strong	Altered Expression	[4291]
NONO	OTN36Q6U	Strong	Genetic Variation	[4292]
NOVA1	OT6A9KHY	Strong	Biomarker	[4293]
NOX1	OTZPJQCC	Strong	Altered Expression	[4294]
NOXA1	OTQDX9RY	Strong	Biomarker	[1145]
NPC1	OTRIPICX	Strong	Biomarker	[4295]
NPC2	OTE9UEJC	Strong	Altered Expression	[4296]
NPNT	OTFZAO1G	Strong	Biomarker	[4297]
NPS	OTEG25A2	Strong	Genetic Variation	[4298]
NPTXR	OTQJEOIH	Strong	Altered Expression	[4299]
NR2C2	OTDZWVOJ	Strong	Biomarker	[4300]
NR2E1	OTW47GKM	Strong	Altered Expression	[651]
NR2E3	OTO3GBHQ	Strong	Genetic Variation	[4301]
NR2F1	OTGWZWYL	Strong	Biomarker	[4302]
NR2F2	OTJFS67N	Strong	Genetic Variation	[4303]
NR2F6	OTNVO2B6	Strong	Biomarker	[4304]
NRARP	OTMYHUV2	Strong	Biomarker	[4305]
NRBP2	OTJSTU62	Strong	Biomarker	[4306]
NRIP1	OTIZOJQV	Strong	Altered Expression	[2101]
NRM	OTK7F9XZ	Strong	Altered Expression	[4307]
NSD3	OT3677ZG	Strong	Biomarker	[4308]
NSMCE1	OTZJTA5X	Strong	Posttranslational Modification	[4034]
NTHL1	OTPQXPT1	Strong	Genetic Variation	[4309]
NTM	OTHF0UQU	Strong	Biomarker	[4310]
NTMT1	OTLRH78U	Strong	Genetic Variation	[4311]
NTN4	OTDRRMP3	Strong	Biomarker	[4312]
NTS	OTPGDNQS	Strong	Biomarker	[4313]
NUBP1	OTE8RAKZ	Strong	Biomarker	[711]
NUDCD1	OT8DS3CX	Strong	Altered Expression	[4314]
NUDT1	OTZSES3W	Strong	Biomarker	[4315]
NUDT15	OTX8SZOT	Strong	Genetic Variation	[4316]
NUDT21	OTZHKWAR	Strong	Biomarker	[4317]
NUMA1	OTTKAVG4	Strong	Biomarker	[4318]
NUMB	OTMB586Q	Strong	Biomarker	[4319]
NUMBL	OTWMTMMH	Strong	Posttranslational Modification	[4320]
NUP153	OTCAS0AR	Strong	Biomarker	[4321]
NUP62	OTMN63DH	Strong	Biomarker	[1030]
NUP98	OTNT12G2	Strong	Altered Expression	[4322]
NUPR1	OT4FU8C0	Strong	Biomarker	[4323]
NUSAP1	OT85HIJ5	Strong	Biomarker	[4324]
NUTM1	OTONYC08	Strong	Altered Expression	[4325]
NVL	OTWTGVTI	Strong	Biomarker	[4326]
NXT1	OT0VO6AY	Strong	Biomarker	[4167]
OAS3	OT6E5FYS	Strong	Biomarker	[1242]
OAZ1	OTPT0PKZ	Strong	Altered Expression	[4327]
OBSCN	OTT14OVX	Strong	Genetic Variation	[4328]
OCLN	OTSUTVWL	Strong	Biomarker	[4329]
OGA	OT7ZBWT1	Strong	Biomarker	[4330]
OGN	OTKP5S4L	Strong	Altered Expression	[4331]
OGT	OT1Z1ZXE	Strong	Biomarker	[4332]
OLIG1	OTIMFI31	Strong	Biomarker	[2006]
OLIG2	OTMCN6D3	Strong	Biomarker	[4333]
OMA1	OT0JRVY7	Strong	Biomarker	[219]
OMP	OT7JH0DY	Strong	Biomarker	[4334]
ONECUT1	OTK1QUQT	Strong	Altered Expression	[4335]
ONECUT2	OTHUE5YY	Strong	Biomarker	[4336]
OPN1LW	OTFNUZ7O	Strong	Biomarker	[1471]
OPN1MW	OTPJ7LX4	Strong	Genetic Variation	[3729]
OPTN	OT2UXWH9	Strong	Biomarker	[4337]
OR10A4	OTYYB8SY	Strong	Biomarker	[4338]
OR2AG1	OTEITRP4	Strong	Biomarker	[4339]
OR6V1	OTOHC63I	Strong	Genetic Variation	[2863]
ORC5	OTFPW8DE	Strong	Altered Expression	[4340]
ORC6	OTKQN3KP	Strong	Biomarker	[4341]
ORM1	OTZKSBRE	Strong	Genetic Variation	[4342]
OSBP	OT7R0OQQ	Strong	Biomarker	[4343]
OSBPL1A	OTQ33OQV	Strong	Biomarker	[4344]
OSBPL3	OT9G194Y	Strong	Genetic Variation	[4345]
OSBPL5	OTI1UJXT	Strong	Biomarker	[4346]
OSCP1	OTZ4IFGJ	Strong	Biomarker	[214]
OSGIN1	OT9KIVZW	Strong	Altered Expression	[4347]
OSR1	OTB19LEQ	Strong	Biomarker	[4348]
OTOP2	OTDXHLKN	Strong	Altered Expression	[4349]
OTUB2	OTZUMPH2	Strong	Biomarker	[4350]
OTUD1	OTE6O5XB	Strong	Altered Expression	[4351]
OTUD7A	OT3GCY98	Strong	Biomarker	[4352]
OTULIN	OTEE02J4	Strong	Altered Expression	[4353]
OVGP1	OTL2W9M5	Strong	Genetic Variation	[4354]
P2RX6	OT1FNTXA	Strong	Altered Expression	[222]
P3H4	OTZPXYSH	Strong	Biomarker	[4355]
P4HB	OTTYNYPF	Strong	Biomarker	[3557]
P4HTM	OTKELL7F	Strong	Altered Expression	[4356]
PACC1	OTKBS8CC	Strong	Altered Expression	[4357]
PADI1	OT13WAQX	Strong	Biomarker	[4358]
PAEP	OTQA0NV4	Strong	Biomarker	[4359]
PAG1	OTFOJUIQ	Strong	Biomarker	[1471]
PAGE1	OT7SQGM8	Strong	Altered Expression	[4360]
PAGE4	OT2VLWT0	Strong	Altered Expression	[4360]
PAGR1	OTXR5PQ8	Strong	Biomarker	[4361]
PAICS	OTMZN747	Strong	Biomarker	[4362]
PAIP2B	OT7MUY3B	Strong	Altered Expression	[4363]
PAK3	OT80M3BV	Strong	Biomarker	[4364]
PAK6	OTAHPZTT	Strong	Posttranslational Modification	[4365]
PALD1	OTLGUM8H	Strong	Biomarker	[4366]
PALLD	OTZ2MUJZ	Strong	Biomarker	[4366]
PALM2AKAP2	OTI618VF	Strong	Altered Expression	[4367]
PAN2	OTB65N2I	Strong	Biomarker	[1756]
PANK1	OT2CZVRT	Strong	Biomarker	[4368]
PANK2	OTFBW889	Strong	Biomarker	[1361]
PANX1	OTXPEDOK	Strong	Biomarker	[4369]
PAPPA	OTTTG9PG	Strong	Genetic Variation	[4370]
PAPPA2	OTXYGTUZ	Strong	Genetic Variation	[4371]
PARD3	OTH5BPLO	Strong	Biomarker	[829]
PARD3B	OTGZ43YI	Strong	Altered Expression	[4372]
PARL	OT7DMHSA	Strong	Biomarker	[2218]
PARN	OTTG4PE3	Strong	Altered Expression	[4373]
PARP14	OTFXJAKK	Strong	Biomarker	[196]
PARP15	OTYO1C46	Strong	Biomarker	[4374]
PARP6	OTWSXW4O	Strong	Biomarker	[4375]
PARPBP	OTPZDGW7	Strong	Altered Expression	[4376]
PARVB	OT9OGVWX	Strong	Biomarker	[4377]
PARVG	OT7WIMXM	Strong	Altered Expression	[4378]
PASD1	OTZZWR7L	Strong	Altered Expression	[4379]
PAX1	OT0Y3MIM	Strong	Posttranslational Modification	[4380]
PAX7	OTDMQRPO	Strong	Biomarker	[4381]
PAX9	OT25J0F7	Strong	Altered Expression	[4382]
PBX3	OT8WMVM4	Strong	Biomarker	[1095]
PC	OT6O0V51	Strong	Biomarker	[4383]
PCBD1	OTDSRUD5	Strong	Genetic Variation	[3437]
PCBP4	OTDLL4NB	Strong	Biomarker	[1471]
PCDH18	OTTLQWRN	Strong	Biomarker	[4384]
PCDH8	OTDDOQM2	Strong	Biomarker	[4385]
PCDH9	OTX3BFV4	Strong	Biomarker	[4386]
PCDHGC3	OTDXTUMI	Strong	Biomarker	[4387]
PCGF1	OTHOU68T	Strong	Biomarker	[4388]
PCLO	OTXJZZ98	Strong	Biomarker	[4389]
PCNP	OTJUQ122	Strong	Biomarker	[4390]
PCSK1N	OT7ZRW2F	Strong	Biomarker	[4391]
PDC	OT1UUVYY	Strong	Biomarker	[4392]
PDCD10	OTCHJTSF	Strong	Biomarker	[4393]
PDCD4	OTZ6NXUX	Strong	Biomarker	[4394]
PDE6B	OTOJMB1V	Strong	Biomarker	[4395]
PDHA1	OTGEU8IK	Strong	Altered Expression	[4396]
PDIA2	OTC2WMXS	Strong	Biomarker	[4358]
PDIA4	OTVFUJ13	Strong	Biomarker	[4397]
PDIK1L	OTISF4KG	Strong	Posttranslational Modification	[4398]
PDK4	OTCMHMBZ	Strong	Altered Expression	[4399]
PDLIM1	OT4EGCPG	Strong	Altered Expression	[503]
PDLIM2	OTEURRPD	Strong	Biomarker	[4400]
PDLIM4	OT23LZYY	Strong	Posttranslational Modification	[4401]
PDLIM5	OTLQVV22	Strong	Biomarker	[2107]
PDLIM7	OTAZVODU	Strong	Biomarker	[4402]
PDPN	OTBUV19I	Strong	Biomarker	[4403]
PDRG1	OT8ZMFZE	Strong	Altered Expression	[4404]
PDSS2	OTEOQBMX	Strong	Altered Expression	[4405]
PEA15	OTKCKTSX	Strong	Biomarker	[4406]
PEAK1	OTVVM637	Strong	Biomarker	[4407]
PEBP4	OTKDCVC6	Strong	Altered Expression	[4408]
PER2	OTU2B1DJ	Strong	Biomarker	[4409]
PERP	OTP0YL53	Strong	Genetic Variation	[4410]
PES1	OTMZK7XE	Strong	Biomarker	[674]
PF4V1	OT2CXM6L	Strong	Biomarker	[4411]
PFDN5	OTTKPTUP	Strong	Biomarker	[4412]
PFDN6	OTI8IPNC	Strong	Biomarker	[4413]
PFKFB4	OTQYEXL2	Strong	Altered Expression	[4414]
PFKM	OT1QY9JM	Strong	Biomarker	[4415]
PGAM1	OTZ5DB06	Strong	Biomarker	[4416]
PGAP2	OTUW3SAX	Strong	Biomarker	[4417]
PGK1	OT6V1ICH	Strong	Altered Expression	[1732]
PGLYRP2	OTF8319A	Strong	Biomarker	[4418]
PGP	OT6QQ7OR	Strong	Biomarker	[4419]
PHF19	OTF6RUCR	Strong	Biomarker	[4420]
PHF2	OTJCIQR2	Strong	Biomarker	[4421]
PHF20L1	OTCLYOCL	Strong	Biomarker	[4422]
PHF21B	OTU5GLCQ	Strong	Altered Expression	[4423]
PHF7	OTDRYXSD	Strong	Altered Expression	[4424]
PHIP	OTZY806Z	Strong	Biomarker	[4425]
PHKA2	OTJE1KXL	Strong	Altered Expression	[4426]
PHLDA1	OTFTWMIQ	Strong	Biomarker	[4427]
PHLDA2	OTMV9DPP	Strong	Altered Expression	[4428]
PHLDA3	OTXFUDO2	Strong	Biomarker	[4429]
PHLPP1	OTIFXW8D	Strong	Biomarker	[1261]
PHOX2B	OT3SFR2O	Strong	Genetic Variation	[4430]
PHRF1	OT21KEGX	Strong	Biomarker	[4431]
PIAS1	OTZVAHZI	Strong	Biomarker	[4432]
PIAS4	OTB7SVMZ	Strong	Altered Expression	[4433]
PICALM	OTQVRPMQ	Strong	Biomarker	[4434]
PID1	OT5YJ7FI	Strong	Biomarker	[4435]
PIDD1	OTWFM930	Strong	Biomarker	[4436]
PIEZO1	OTBG1FU4	Strong	Altered Expression	[4437]
PIEZO2	OTQ7AT38	Strong	Altered Expression	[4438]
PIGH	OTMCFF0K	Strong	Biomarker	[4439]
PIGS	OTCC4CEN	Strong	Biomarker	[4440]
PIGX	OTUN0WC4	Strong	Biomarker	[4441]
PIK3C2A	OTFBU4GD	Strong	Biomarker	[4442]
PIK3C2G	OTW3LY1C	Strong	Genetic Variation	[4443]
PIK3C3	OTLUM9L7	Strong	Biomarker	[4444]
PIK3R3	OTXGJ8N1	Strong	Biomarker	[4445]
PIK3R5	OT4LNXJU	Strong	Genetic Variation	[4446]
PIMREG	OTKC8T3E	Strong	Altered Expression	[4447]
PINK1	OT50NR57	Strong	Biomarker	[2218]
PIP4K2B	OTF1VGJ9	Strong	Altered Expression	[4448]
PIP4K2C	OTHRWR93	Strong	Biomarker	[4449]
PIP5K1B	OT8JQ1F7	Strong	Genetic Variation	[4450]
PIP5KL1	OT6ZJFEC	Strong	Altered Expression	[4451]
PIPOX	OTWTCOTN	Strong	Biomarker	[4452]
PISD	OTP9COQT	Strong	Biomarker	[4453]
PITPNM1	OTIUYAG5	Strong	Biomarker	[4454]
PITPNM3	OTHLZY8D	Strong	Altered Expression	[4455]
PITX2	OTWMXAOY	Strong	Biomarker	[4456]
PIWIL2	OT1PXQIF	Strong	Biomarker	[4457]
PJA2	OT45TMC4	Strong	Altered Expression	[4458]
PKD2	OTIXBU8H	Strong	Altered Expression	[4459]
PKHD1	OTAH8SMF	Strong	Biomarker	[4460]
PLA2G3	OT3K7TMY	Strong	Biomarker	[4461]
PLAAT3	OTVXXJ5K	Strong	Genetic Variation	[4462]
PLAAT4	OTI66SAJ	Strong	Biomarker	[768]
PLAGL2	OT6AP4V2	Strong	Altered Expression	[4463]
PLB1	OTZ6TTYV	Strong	Biomarker	[1235]
PLCB4	OTPA0QHW	Strong	Biomarker	[4464]
PLCD1	OT6WFVXZ	Strong	Altered Expression	[4465]
PLCE1	OTJISZOX	Strong	Genetic Variation	[4466]
PLCG2	OTGVC9MY	Strong	Genetic Variation	[4467]
PLEK	OTB73XXA	Strong	Biomarker	[1228]
PLEKHF1	OT9OL16U	Strong	Biomarker	[4468]
PLEKHG5	OTL0S21W	Strong	Biomarker	[207]
PLEKHO1	OTMVUQ9W	Strong	Biomarker	[4469]
PLEKHS1	OT1ZGH1K	Strong	Biomarker	[4470]
PLIN2	OTRXJ9UN	Strong	Biomarker	[4471]
PLK3	OT19CT2Z	Strong	Biomarker	[4472]
PLP1	OT8CM9CX	Strong	Biomarker	[4473]
PLPP2	OT0BQAXX	Strong	Biomarker	[4474]
PLPP3	OTSSF7BK	Strong	Biomarker	[1751]
PLS3	OTYBM4PK	Strong	Biomarker	[4475]
PLVAP	OTAQGWYA	Strong	Altered Expression	[4476]
PLXNA1	OTN0BING	Strong	Biomarker	[4477]
PLXNA3	OTMZIBVG	Strong	Biomarker	[4478]
PLXNB1	OTCA7JIT	Strong	Biomarker	[4479]
PLXNB2	OT56I2VD	Strong	Biomarker	[4480]
PLXNB3	OTXRKPOO	Strong	Genetic Variation	[4481]
PLXNC1	OTJ5XKYY	Strong	Altered Expression	[4482]
PMP2	OTKYV2NE	Strong	Biomarker	[4483]
PNKD	OT6G9UXN	Strong	Biomarker	[4484]
PNO1	OT010GIS	Strong	Biomarker	[4485]
PNPLA2	OTR3ERMR	Strong	Biomarker	[1352]
PNPT1	OTBR2Q0F	Strong	Biomarker	[4486]
PODXL	OTPNQXF3	Strong	Altered Expression	[4487]
POGLUT1	OTDX7GZD	Strong	Biomarker	[4488]
POGZ	OT4CYWC1	Strong	Biomarker	[4489]
POLD1	OTWO4UCJ	Strong	Genetic Variation	[4490]
POLD3	OTEQEFQ2	Strong	Altered Expression	[2949]
POLDIP2	OT8SZSJ6	Strong	Altered Expression	[725]
POLDIP3	OTTB5SV7	Strong	Altered Expression	[4491]
POLE3	OTOELRF6	Strong	Altered Expression	[3588]
POLH	OTN07WXU	Strong	Genetic Variation	[4492]
POLK	OTKZ38JH	Strong	Genetic Variation	[4493]
POLL	OTZ24QGM	Strong	Genetic Variation	[4494]
POLR1A	OTDWI0TG	Strong	Biomarker	[4495]
POLR2E	OTH5IL2A	Strong	Genetic Variation	[4496]
POLR3A	OT5MSK10	Strong	Biomarker	[4495]
POP1	OTBIYMJ0	Strong	Biomarker	[4497]
POTED	OTAUSTUK	Strong	Altered Expression	[4498]
POTEF	OTV3WXYE	Strong	Altered Expression	[4499]
POU2AF1	OTOO6WHL	Strong	Biomarker	[4500]
POU2F1	OTK7ELJ0	Strong	Biomarker	[1375]
POU2F3	OTIOOJWD	Strong	Altered Expression	[4501]
POU4F1	OTMHYGWQ	Strong	Genetic Variation	[4502]
POU4F2	OT6SW5H0	Strong	Biomarker	[4503]
POU4F3	OTILD0XS	Strong	Biomarker	[4504]
POU6F1	OTGSP4XJ	Strong	Altered Expression	[4505]
POU6F2	OTNSW95F	Strong	Genetic Variation	[4506]
PPAN	OT0UFQBZ	Strong	Genetic Variation	[1197]
PPBP	OT1FHGQS	Strong	Biomarker	[4507]
PPFIA1	OTYYFA9C	Strong	Biomarker	[4508]
PPIL2	OTL9Y4IO	Strong	Altered Expression	[4509]
PPL	OTTM4WDO	Strong	Genetic Variation	[2863]
PPM1E	OTXRH3YA	Strong	Biomarker	[4510]
PPM1F	OTU0MVR7	Strong	Biomarker	[4510]
PPM1H	OTKSVU7S	Strong	Biomarker	[4511]
PPP1CB	OTYFTYFR	Strong	Biomarker	[4512]
PPP1CC	OTRZO26U	Strong	Biomarker	[4512]
PPP1R10	OT7GE3BN	Strong	Biomarker	[4513]
PPP1R11	OTSHYPPW	Strong	Altered Expression	[4514]
PPP1R14A	OTQODWZB	Strong	Posttranslational Modification	[4515]
PPP1R15A	OTYG179K	Strong	Biomarker	[4516]
PPP1R15B	OTL5RWA8	Strong	Genetic Variation	[4517]
PPP1R1B	OTSIJMQ9	Strong	Biomarker	[4518]
PPP1R3A	OTJL9VYP	Strong	Genetic Variation	[789]
PPP1R3B	OTVCRXEZ	Strong	Biomarker	[4519]
PPP1R3C	OTEU05TX	Strong	Biomarker	[4519]
PPP1R8	OTH5KB2P	Strong	Biomarker	[2164]
PPP2R2A	OT9297OG	Strong	Biomarker	[4520]
PPP2R2C	OTXK0SDM	Strong	Biomarker	[1978]
PPP2R3A	OTSK5GFC	Strong	Biomarker	[4521]
PPP2R5C	OTF7CGO2	Strong	Altered Expression	[4522]
PPP2R5E	OT8GPFT5	Strong	Biomarker	[4523]
PPP6C	OTR1STMJ	Strong	Biomarker	[4524]
PPP6R2	OTERHESI	Strong	Biomarker	[4525]
PPRC1	OT6GB3WR	Strong	Biomarker	[4526]
PPT2	OTD5VJ9A	Strong	Biomarker	[4527]
PRAF2	OT1QN4LV	Strong	Altered Expression	[4528]
PRAG1	OTV83SGI	Strong	Biomarker	[4529]
PRAM1	OTZN3DWD	Strong	Altered Expression	[4530]
PRC1	OTHD0XS0	Strong	Biomarker	[1870]
PRCC	OTJ0KRYX	Strong	Genetic Variation	[4531]
PRDM14	OTWZKY4L	Strong	Biomarker	[4532]
PRDM2	OT8L7CGX	Strong	Altered Expression	[4533]
PRDX1	OTZ3BEC4	Strong	Biomarker	[801]
PRDX2	OTLWCY9T	Strong	Biomarker	[4534]
PRDX3	OTLB2WEU	Strong	Altered Expression	[4535]
PRDX6	OTS8KC8A	Strong	Altered Expression	[4536]
PREX1	OTUTPVA9	Strong	Genetic Variation	[4537]
PRF1	OTFVXD7H	Strong	Genetic Variation	[4538]
PRG2	OT0BCPQG	Strong	Biomarker	[3797]
PRICKLE1	OT9HHEM9	Strong	Biomarker	[483]
PRIM1	OTWWP8Y6	Strong	Altered Expression	[4539]
PRIMA1	OT9ITT3P	Strong	Biomarker	[4540]
PRKAA2	OTU1KZPV	Strong	Biomarker	[4541]
PRKAB1	OT1OG4QZ	Strong	Biomarker	[4541]
PRKACG	OTKOQYF8	Strong	Genetic Variation	[3195]
PRKD2	OTIFSVI8	Strong	Biomarker	[4542]
PRKD3	OT987HJI	Strong	Biomarker	[4543]
PRLH	OTJBP360	Strong	Biomarker	[3790]
PRM3	OT6574BF	Strong	Altered Expression	[4544]
PRMT2	OT63JZCI	Strong	Altered Expression	[4545]
PRND	OTH4EEMI	Strong	Altered Expression	[4546]
PROK1	OT8S7RUG	Strong	Biomarker	[1232]
PROK2	OT70IFEZ	Strong	Biomarker	[4547]
PROM2	OTT8IVS7	Strong	Biomarker	[4548]
PROX1	OT68R6IO	Strong	Biomarker	[4549]
PRPF31	OTSJ0Z1Y	Strong	Biomarker	[4550]
PRPF40A	OT6EXJZN	Strong	Altered Expression	[4551]
PRPF40B	OTBPUXVD	Strong	Altered Expression	[4551]
PRPF6	OT3U0ABN	Strong	Biomarker	[2653]
PRPF8	OTU39JZI	Strong	Biomarker	[3413]
PRPS2	OTCY1B1O	Strong	Biomarker	[4552]
PRR11	OT2JJ08Z	Strong	Biomarker	[4553]
PRR15L	OT6J9UKK	Strong	Biomarker	[4554]
PRSS2	OTOMVUWL	Strong	Biomarker	[4555]
PRSS22	OTANEFGM	Strong	Altered Expression	[4556]
PRSS23	OT6DQAM1	Strong	Altered Expression	[4557]
PRSS27	OTC4G4UF	Strong	Biomarker	[4558]
PRSS3	OTN3S5YB	Strong	Biomarker	[4559]
PRSS55	OTXXWI5Y	Strong	Biomarker	[3327]
PRUNE1	OTQ3UHWQ	Strong	Biomarker	[4560]
PRUNE2	OTGW2974	Strong	Biomarker	[4561]
PRX	OT34Z10B	Strong	Biomarker	[4562]
PRXL2C	OTI8ZAK8	Strong	Altered Expression	[4563]
PSD4	OTEFB87Z	Strong	Altered Expression	[4564]
PSG1	OT1U4ZZW	Strong	Biomarker	[4565]
PSMA2	OTJRT2ZL	Strong	Biomarker	[4566]
PSMA4	OTAD2XXI	Strong	Biomarker	[4567]
PSMA6	OTJ6RPX5	Strong	Biomarker	[4568]
PSMA7	OTPHI6ST	Strong	Biomarker	[4569]
PSMC2	OTJ4V337	Strong	Altered Expression	[4570]
PSMD14	OTJWHMZ5	Strong	Altered Expression	[4571]
PSMD4	OTH1VZTM	Strong	Altered Expression	[4572]
PSMD7	OT7PZZ4K	Strong	Biomarker	[979]
PSMD8	OTY6X27P	Strong	Altered Expression	[3038]
PSME2	OTYPP33T	Strong	Biomarker	[4573]
PSPC1	OTYS6WQ8	Strong	Biomarker	[2808]
PSPH	OTV1PVAX	Strong	Biomarker	[1132]
PSPN	OT54LLZJ	Strong	Biomarker	[1132]
PTBP3	OTVVYKIF	Strong	Biomarker	[4574]
PTCH1	OTMG07H5	Strong	Genetic Variation	[4575]
PTCHD3	OTFQ1VGM	Strong	Biomarker	[4576]
PTCRA	OTQTO5QZ	Strong	Altered Expression	[826]
PTF1A	OT7SWA57	Strong	Biomarker	[2073]
PTGES3	OTPPQWI0	Strong	Altered Expression	[60]
PTMA	OT2W4T1M	Strong	Biomarker	[4577]
PTPN22	OTDCNTC3	Strong	Biomarker	[3179]
PTPN23	OT5WDPXB	Strong	Biomarker	[4578]
PTPN3	OTSLZBVY	Strong	Posttranslational Modification	[4579]
PTPN4	OT6SXU5Y	Strong	Altered Expression	[4580]
PTPRD	OTZPJ3GX	Strong	Posttranslational Modification	[4581]
PTPRF	OTH5KF2D	Strong	Biomarker	[4582]
PTPRG	OT9N2WOF	Strong	Biomarker	[4583]
PTPRK	OTAP5AT3	Strong	Genetic Variation	[4584]
PUDP	OTEPEJLX	Strong	Altered Expression	[4585]
PUF60	OTG90DYF	Strong	Biomarker	[1982]
PUM3	OTN1IPNS	Strong	Biomarker	[4391]
PWWP3A	OTXQVL4U	Strong	Altered Expression	[4586]
PXDN	OTFGGM9R	Strong	Biomarker	[4587]
PXN	OTVMMUOF	Strong	Biomarker	[4588]
PYDC1	OTC2DD7L	Strong	Biomarker	[4589]
PYGB	OT2ZTJT0	Strong	Biomarker	[4590]
PYGO2	OTZHB2OI	Strong	Biomarker	[4591]
QKI	OTTAUGLB	Strong	Biomarker	[4592]
QPCTL	OTJD4K8A	Strong	Biomarker	[4593]
QSOX1	OT4ZPK4P	Strong	Biomarker	[4594]
RAB10	OT8ZN26V	Strong	Genetic Variation	[2268]
RAB11A	OTC4FW0J	Strong	Biomarker	[4595]
RAB13	OTIQ484I	Strong	Altered Expression	[4596]
RAB14	OTF1J0TB	Strong	Biomarker	[4597]
RAB1A	OTKPHRD0	Strong	Biomarker	[4598]
RAB20	OTP9OOVS	Strong	Altered Expression	[3898]
RAB21	OTH3WGLG	Strong	Altered Expression	[4599]
RAB25	OTW0W6NP	Strong	Altered Expression	[4600]
RAB27A	OT9SQRWY	Strong	Altered Expression	[4601]
RAB27B	OTPF9D0K	Strong	Altered Expression	[4602]
RAB2A	OT6SK83U	Strong	Altered Expression	[4603]
RAB34	OTHKTSA0	Strong	Biomarker	[4604]
RAB35	OTRH1E2T	Strong	Biomarker	[4605]
RAB37	OTRL8IUO	Strong	Biomarker	[4606]
RAB43	OTVCSILI	Strong	Altered Expression	[4607]
RAB5A	OTFR2KM4	Strong	Biomarker	[4608]
RAB5C	OTQE5QQ2	Strong	Biomarker	[4609]
RAB6A	OTLS86J5	Strong	Biomarker	[4610]
RAB6B	OT5N57RK	Strong	Genetic Variation	[2973]
RAB8A	OTPB54Y3	Strong	Biomarker	[4611]
RABAC1	OTGB32NG	Strong	Biomarker	[4612]
RABEP1	OTQROTGT	Strong	Biomarker	[4613]
RABEPK	OTCZSREH	Strong	Biomarker	[979]
RABGEF1	OTWC3Z3R	Strong	Altered Expression	[4614]
RACGAP1	OTQE8IEH	Strong	Altered Expression	[4615]
RAD17	OT1I93DT	Strong	Altered Expression	[4616]
RAD23A	OTBPAWHX	Strong	Biomarker	[4617]
RAD23B	OT0PGOG3	Strong	Genetic Variation	[4618]
RAD51C	OTUD6SY5	Strong	Biomarker	[4619]
RAD52	OT0OTDHI	Strong	Biomarker	[4620]
RAD54B	OTMWB2P2	Strong	Altered Expression	[4621]
RAD9A	OTJ3AJQU	Strong	Biomarker	[4622]
RADIL	OTQTRGMB	Strong	Biomarker	[2968]
RAE1	OT54OKC3	Strong	Biomarker	[2384]
RAG2	OTG9UYTW	Strong	Biomarker	[4623]
RAI1	OTKLQU00	Strong	Genetic Variation	[4624]
RAI2	OTR8LX4J	Strong	Altered Expression	[4625]
RALA	OT734R7X	Strong	Biomarker	[4626]
RALGAPB	OTY8CGA3	Strong	Altered Expression	[2832]
RALGDS	OTG36NI7	Strong	Biomarker	[4627]
RAN	OT2TER5M	Strong	Altered Expression	[4628]
RANBP2	OTFG5CVF	Strong	Altered Expression	[2450]
RANBP6	OT90MVD4	Strong	Biomarker	[4629]
RANBP9	OTM8COM5	Strong	Biomarker	[4630]
RAP1A	OT5RH6TI	Strong	Altered Expression	[4614]
RAP1GAP	OTC31ONQ	Strong	Biomarker	[4631]
RAPGEF1	OTZ0TBN1	Strong	Biomarker	[4632]
RARRES1	OTETUPP5	Strong	Biomarker	[1534]
RARRES2	OT1BJE8K	Strong	Biomarker	[4633]
RARS1	OTHPZ6JN	Strong	Biomarker	[1081]
RASD1	OT2BAJHK	Strong	Biomarker	[4634]
RASGRF1	OTNWJ7EN	Strong	Biomarker	[3187]
RASGRF2	OT67DAGF	Strong	Biomarker	[4635]
RASGRP3	OTEMEV3P	Strong	Biomarker	[4636]
RASIP1	OTCRY2AN	Strong	Altered Expression	[4637]
RASSF2	OT2JHDO4	Strong	Biomarker	[787]
RASSF3	OT4V9SRK	Strong	Biomarker	[4638]
RASSF7	OT0V4EIZ	Strong	Biomarker	[4639]
RBBP4	OTG3BT3M	Strong	Biomarker	[4640]
RBBP7	OTLB56HX	Strong	Altered Expression	[4641]
RBL1	OTDEBFYC	Strong	Biomarker	[4642]
RBM10	OTES2MES	Strong	Biomarker	[4643]
RBM15	OT8ZPGWF	Strong	Genetic Variation	[4644]
RBM17	OT9ROJCL	Strong	Altered Expression	[4645]
RBM3	OTAJ7R31	Strong	Biomarker	[4646]
RBM4	OT5SFQA3	Strong	Biomarker	[4647]
RBM45	OTWTHD77	Strong	Genetic Variation	[4648]
RBM5	OTCBWHHV	Strong	Biomarker	[4649]
RBM6	OTI99KAZ	Strong	Altered Expression	[4650]
RBM8A	OT5SR6G0	Strong	Biomarker	[4651]
RBMS3	OTFSC9MR	Strong	Biomarker	[1277]
RBMXL1	OTMGCWWB	Strong	Altered Expression	[3979]
RBP7	OT0J3CPT	Strong	Biomarker	[4652]
RBPMS	OT1RDKR9	Strong	Biomarker	[4653]
RBX1	OTYA1UIO	Strong	Altered Expression	[4654]
RCC1	OT25AGMB	Strong	Biomarker	[4655]
RCC2	OTUJVTLS	Strong	Biomarker	[4656]
RCCD1	OT60N06L	Strong	Genetic Variation	[1050]
RCN1	OT3JBGAG	Strong	Biomarker	[4657]
RCOR1	OTREADPC	Strong	Biomarker	[4658]
RDX	OTNSYUN6	Strong	Altered Expression	[4596]
REG1A	OTMHUH1D	Strong	Biomarker	[1132]
RELB	OTU3QYEF	Strong	Altered Expression	[190]
RELN	OTLKMW1O	Strong	Altered Expression	[2535]
REM1	OTUXL0HC	Strong	Biomarker	[4659]
RERE	OT3G4GBZ	Strong	Biomarker	[4660]
RERG	OTF6MMLV	Strong	Altered Expression	[4661]
RETREG1	OTYOSLZX	Strong	Biomarker	[4662]
RETREG2	OT5CJTMK	Strong	Biomarker	[4663]
REV1	OTHIKICX	Strong	Biomarker	[4664]
REXO1	OTZT6RAW	Strong	Biomarker	[4665]
RFC3	OT1MS7AO	Strong	Biomarker	[4666]
RFLNA	OT6GS3XQ	Strong	Altered Expression	[4667]
RFPL4A	OTROUM09	Strong	Altered Expression	[4668]
RFX1	OTZUDMPR	Strong	Biomarker	[4669]
RFXANK	OTDX1026	Strong	Altered Expression	[4670]
RGL4	OTTAEWCF	Strong	Genetic Variation	[4671]
RGS17	OT5RVUDS	Strong	Biomarker	[4672]
RGS22	OTCTFGW6	Strong	Biomarker	[4673]
RGS5	OTUY0Q2I	Strong	Altered Expression	[4674]
RGS7	OTDQA90X	Strong	Biomarker	[4675]
RHBDD2	OTX54ILM	Strong	Altered Expression	[4676]
RHBDF1	OTCQ7UDS	Strong	Biomarker	[4677]
RHEB	OTFLTSEC	Strong	Genetic Variation	[4678]
RHOBTB1	OTGE8K45	Strong	Biomarker	[4679]
RHOBTB2	OT2DATFX	Strong	Biomarker	[4680]
RHOG	OTJ7J1WA	Strong	Biomarker	[4681]
RHOH	OT1J9SEB	Strong	Genetic Variation	[4682]
RHOJ	OTWI65OA	Strong	Altered Expression	[4683]
RHOQ	OTUBTU57	Strong	Altered Expression	[4684]
RHOU	OTERIAD4	Strong	Altered Expression	[4685]
RHOXF2	OTKQWLKZ	Strong	Altered Expression	[4686]
RHPN1	OTYZ1NV8	Strong	Biomarker	[4687]
RIBC2	OTDB4FM2	Strong	Biomarker	[4688]
RIDA	OTW4098I	Strong	Biomarker	[1132]
RIF1	OTPE49OE	Strong	Biomarker	[4689]
RINT1	OTMO19ZD	Strong	Biomarker	[4690]
RIOK1	OT1OS3H3	Strong	Altered Expression	[4691]
RIOK3	OTZYZVIX	Strong	Altered Expression	[4692]
RIOX1	OTN41QXP	Strong	Biomarker	[4693]
RIPOR2	OTXB6LIR	Strong	Altered Expression	[4694]
RLN2	OTY3OG71	Strong	Genetic Variation	[4695]
RMC1	OT7K8MTJ	Strong	Biomarker	[4696]
RMDN1	OTE1NB6U	Strong	Altered Expression	[2292]
RMDN3	OTKO7AUM	Strong	Altered Expression	[2292]
RMI1	OT1ZVTFL	Strong	Biomarker	[4697]
RNASE1	OTKZ7CO9	Strong	Biomarker	[4698]
RNASE2	OT8Z4FNE	Strong	Biomarker	[4699]
RNASEH2A	OT8G3G7K	Strong	Biomarker	[4700]
RND1	OTOC223Z	Strong	Altered Expression	[4701]
RND3	OTXMXPIH	Strong	Biomarker	[4702]
RNF11	OTFBJSKQ	Strong	Biomarker	[4703]
RNF111	OTO3QT6Q	Strong	Biomarker	[4704]
RNF113A	OTR6N7HU	Strong	Biomarker	[4705]
RNF121	OTA0YMLW	Strong	Biomarker	[4706]
RNF126	OTTECSYY	Strong	Biomarker	[4707]
RNF135	OT18NH5N	Strong	Biomarker	[2872]
RNF146	OTE4CO7E	Strong	Biomarker	[4708]
RNF17	OTKOEPRW	Strong	Biomarker	[1685]
RNF180	OT2GKIKE	Strong	Biomarker	[4709]
RNF187	OTXTN1HP	Strong	Biomarker	[4710]
RNF19A	OTKWCV80	Strong	Altered Expression	[725]
RNF20	OT9NK6ZT	Strong	Biomarker	[4711]
RNF26	OTPXA60S	Strong	Altered Expression	[4712]
RNF40	OTC8SDA3	Strong	Biomarker	[4713]
RNGTT	OT59E0KX	Strong	Biomarker	[4714]
RNH1	OT6EC79B	Strong	Biomarker	[4715]
RNPC3	OTW5MKC1	Strong	Biomarker	[4716]
RNPS1	OT7G4COD	Strong	Altered Expression	[4717]
RO60	OTLGM5A8	Strong	Biomarker	[4718]
ROBO3	OTPVG40S	Strong	Biomarker	[768]
ROGDI	OTZ7LSKJ	Strong	Genetic Variation	[2863]
ROM1	OTE7H0YV	Strong	Altered Expression	[4719]
ROMO1	OTIEYVBW	Strong	Altered Expression	[4720]
RP9	OTGQY66H	Strong	Biomarker	[4118]
RPA2	OTZ54WAF	Strong	Biomarker	[4721]
RPAIN	OTBMXAYK	Strong	Biomarker	[2894]
RPE	OT0XT3JU	Strong	Biomarker	[4722]
RPL10	OTBHOZGC	Strong	Biomarker	[4477]
RPL11	OT3VZ6OE	Strong	Biomarker	[2301]
RPL17	OTTYMPS6	Strong	Biomarker	[4723]
RPL18	OTJCH62J	Strong	Biomarker	[4724]
RPL22L1	OTNWGF5C	Strong	Altered Expression	[4725]
RPL23	OTXI1YLM	Strong	Altered Expression	[4726]
RPL24	OTCY9DEB	Strong	Biomarker	[4727]
RPL29	OTUFIBJL	Strong	Biomarker	[4728]
RPL30	OTLQVY1Z	Strong	Genetic Variation	[4729]
RPL34	OT0U9VMQ	Strong	Altered Expression	[4730]
RPL36A	OT1LYV85	Strong	Altered Expression	[3558]
RPN2	OTJ1SKOA	Strong	Biomarker	[4731]
RPP14	OT4OYFSK	Strong	Altered Expression	[3197]
RPRD1A	OTXTV6FU	Strong	Biomarker	[4732]
RPS10	OTE3VSAH	Strong	Biomarker	[4733]
RPS11	OTILZE44	Strong	Biomarker	[4734]
RPS14	OTB90KV5	Strong	Genetic Variation	[4735]
RPS15	OT0WYZYG	Strong	Genetic Variation	[4736]
RPS19BP1	OTDRYLFA	Strong	Biomarker	[4737]
RPS2	OTSMTZVB	Strong	Altered Expression	[4738]
RRAD	OTW2O4GD	Strong	Biomarker	[4739]
RRAGA	OTKISLG4	Strong	Biomarker	[4740]
RRAS	OTBBF28C	Strong	Altered Expression	[60]
RRAS2	OT83NCEB	Strong	Altered Expression	[4741]
RRBP1	OT4ZTPTM	Strong	Biomarker	[4742]
RREB1	OT62460U	Strong	Altered Expression	[4743]
RRM2B	OTE8GBUR	Strong	Biomarker	[4744]
RRP1	OT4A8HR3	Strong	Biomarker	[4745]
RRP1B	OTHDRVML	Strong	Biomarker	[4745]
RRS1	OTTNCZN6	Strong	Biomarker	[4746]
RSPO2	OT3HHXU0	Strong	Altered Expression	[4747]
RSU1	OTO5GHT1	Strong	Biomarker	[4748]
RTKN	OTSS8XR6	Strong	Biomarker	[4749]
RTKN2	OTV2AXQM	Strong	Biomarker	[4750]
RTL10	OTHGB81W	Strong	Biomarker	[4751]
RTN1	OTCX1SMK	Strong	Biomarker	[4752]
RTRAF	OTJ6NVMW	Strong	Biomarker	[4753]
RUFY1	OTIXX2TR	Strong	Biomarker	[4754]
RUFY3	OTMA4YA4	Strong	Biomarker	[4755]
RUNDC3B	OT8ZPQLC	Strong	Biomarker	[2563]
RUNX1T1	OT30DED5	Strong	Biomarker	[4756]
RUVBL1	OTWV19L7	Strong	Biomarker	[4757]
RUVBL2	OTGWJ4T4	Strong	Altered Expression	[4758]
RYK	OTZ3WWZH	Strong	Biomarker	[4759]
S100A1	OT1F2G4J	Strong	Biomarker	[4760]
S100A10	OTI71243	Strong	Altered Expression	[4761]
S100A16	OT3ERKQI	Strong	Altered Expression	[4762]
S100A2	OTTGHJ1H	Strong	Altered Expression	[4763]
S100A7A	OTNM8DCP	Strong	Biomarker	[4764]
S100PBP	OT6O7Y14	Strong	Altered Expression	[4765]
SAFB2	OTQ1IH80	Strong	Altered Expression	[4766]
SAGE1	OT4H6FFA	Strong	Biomarker	[4767]
SALL2	OTQWI68Q	Strong	Biomarker	[4768]
SALL3	OTJ2LZKQ	Strong	Genetic Variation	[3723]
SAMD4A	OT4MKCC8	Strong	Biomarker	[4769]
SAMD5	OT95NRVS	Strong	Altered Expression	[4770]
SAMD9	OTDG48P0	Strong	Genetic Variation	[4771]
SAMD9L	OTKEJUCI	Strong	Genetic Variation	[4771]
SAMHD1	OTBCIBC7	Strong	Genetic Variation	[4772]
SARDH	OTQ49Q27	Strong	Genetic Variation	[1404]
SARNP	OTE0OVK5	Strong	Biomarker	[4773]
SART1	OTHMOGO1	Strong	Altered Expression	[4774]
SASH1	OTQA8BD4	Strong	Biomarker	[4775]
SASS6	OT1V8H40	Strong	Altered Expression	[4776]
SATB2	OT2W80XC	Strong	Biomarker	[4777]
SBDS	OTHDCCIB	Strong	Genetic Variation	[4778]
SBK1	OTCO4NEI	Strong	Genetic Variation	[4779]
SBSPON	OTBHAW5K	Strong	Biomarker	[4780]
SCAF11	OTX59D0X	Strong	Biomarker	[3701]
SCAI	OTAK3TMO	Strong	Genetic Variation	[4781]
SCARA5	OTOVA96E	Strong	Biomarker	[4782]
SCFD1	OTN4T7JI	Strong	Biomarker	[4783]
SCG2	OTXWUQQL	Strong	Biomarker	[4784]
SCGB1D4	OTEM6CR0	Strong	Biomarker	[4785]
SCGB2A1	OT9L87U9	Strong	Altered Expression	[4786]
SCGB3A1	OTIR98RB	Strong	Posttranslational Modification	[4787]
SCGB3A2	OTB63PHR	Strong	Biomarker	[4788]
SCIN	OT6U09OL	Strong	Biomarker	[4789]
SCN4B	OT3JSUWO	Strong	Altered Expression	[4790]
SCNN1B	OT61QQTL	Strong	Biomarker	[4791]
SCO2	OTJQQDRS	Strong	Altered Expression	[1516]
SCRN1	OTELM5C2	Strong	Biomarker	[4792]
SCRT1	OTWTE24S	Strong	Altered Expression	[4793]
SCTR	OTC80IMR	Strong	Biomarker	[4794]
SCUBE3	OT2EADLC	Strong	Genetic Variation	[4795]
SDC3	OT1P0LJM	Strong	Altered Expression	[4796]
SDCBP	OTS3NCC5	Strong	Biomarker	[4797]
SDF4	OTQ7WFYW	Strong	Biomarker	[4798]
SDHA	OTOJ8QFF	Strong	Genetic Variation	[4799]
SDS	OT5WTJ2M	Strong	Genetic Variation	[1404]
SEC14L5	OTY8AX2J	Strong	Genetic Variation	[2863]
SEC24D	OTXR3KC9	Strong	Biomarker	[3873]
SEC62	OTCWEL5F	Strong	Biomarker	[4800]
SEL1L	OTC0FB7T	Strong	Biomarker	[4801]
SELENOH	OTZ0QU22	Strong	Biomarker	[4802]
SELENOM	OTJ7PORS	Strong	Biomarker	[4803]
SELENOS	OTUEWIU9	Strong	Genetic Variation	[4804]
SEM1	OTASLBM1	Strong	Biomarker	[4805]
SEMA3B	OTCZCPMS	Strong	Altered Expression	[4806]
SEMA3E	OTD4S36H	Strong	Biomarker	[4807]
SEMA3F	OTQFMS8S	Strong	Biomarker	[4808]
SEMA4C	OTF5JHQ0	Strong	Altered Expression	[4809]
SEMA4F	OTVP97ZV	Strong	Biomarker	[4810]
SEMA4G	OT7BCPU7	Strong	Genetic Variation	[4170]
SEMA5A	OTUOIOJV	Strong	Biomarker	[4811]
SEMA5B	OTUVSKK0	Strong	Genetic Variation	[1652]
SEMA6A	OTDQ7QAW	Strong	Biomarker	[4812]
SEMG1	OT6Z4BPQ	Strong	Genetic Variation	[4813]
SEMG2	OTK525XE	Strong	Biomarker	[4784]
SENP2	OTPQJXIR	Strong	Biomarker	[4814]
SENP3	OTFQDOMC	Strong	Biomarker	[4815]
SENP6	OT05LLF4	Strong	Biomarker	[4816]
SEPTIN1	OT4GVSU3	Strong	Biomarker	[4817]
SEPTIN10	OTPPNZUA	Strong	Altered Expression	[4818]
SEPTIN4	OTD16B30	Strong	Biomarker	[4819]
SEPTIN7	OTJI08YX	Strong	Biomarker	[4761]
SERP2	OT5GA6JZ	Strong	Biomarker	[4820]
SERPINA3	OT9BP2S0	Strong	Biomarker	[499]
SERPINE2	OTYF5340	Strong	Biomarker	[157]
SERTAD2	OTYIG6TP	Strong	Altered Expression	[4821]
SESN2	OT889IXY	Strong	Biomarker	[4822]
SESN3	OTJRY1Y5	Strong	Posttranslational Modification	[4823]
SESTD1	OTHH06X8	Strong	Biomarker	[2986]
SET	OTGYYQJO	Strong	Biomarker	[4824]
SETD1A	OTVVWRIC	Strong	Biomarker	[4825]
SETD4	OTBMCZQA	Strong	Biomarker	[4826]
SETDB1	OTWVUA1B	Strong	Biomarker	[4827]
SETX	OTG3JNOQ	Strong	Biomarker	[4828]
SEZ6L2	OTUIKN2I	Strong	Biomarker	[1422]
SF3B2	OTNW2U4Y	Strong	Biomarker	[4829]
SF3B3	OTAC9LZT	Strong	Biomarker	[4830]
SF3B6	OTPRKS6S	Strong	Altered Expression	[3197]
SFMBT1	OTKMZIBW	Strong	Posttranslational Modification	[4831]
SFPQ	OTLCIAPJ	Strong	Biomarker	[2960]
SFRP1	OT0U9G41	Strong	Biomarker	[4832]
SFRP2	OT8GZ0CA	Strong	Biomarker	[4833]
SFTPA1	OT87XL1U	Strong	Biomarker	[4834]
SFTPA2	OT6SFOMU	Strong	Biomarker	[4835]
SFTPB	OTOHS07E	Strong	Altered Expression	[4836]
SGK3	OTQ6QO99	Strong	Biomarker	[4837]
SGSM1	OTS2PWT4	Strong	Biomarker	[2269]
SGSM3	OTIB1P8A	Strong	Biomarker	[4838]
SH2B1	OTJZO2CI	Strong	Biomarker	[4839]
SH2B2	OTEDHHDH	Strong	Genetic Variation	[4840]
SH2D1A	OTLU49I5	Strong	Biomarker	[1549]
SH3BGRL3	OTKMW34I	Strong	Biomarker	[4841]
SH3BP1	OTGED7Z2	Strong	Biomarker	[4842]
SH3BP4	OTVIRKW7	Strong	Biomarker	[4843]
SH3GL3	OTX6BOCN	Strong	Biomarker	[4844]
SH3KBP1	OTIUA60B	Strong	Biomarker	[4845]
SHARPIN	OTU1J2KH	Strong	Biomarker	[4846]
SHBG	OTPWU5IW	Strong	Genetic Variation	[4847]
SHC3	OT305NPA	Strong	Biomarker	[4848]
SHISA3	OTE8TPCP	Strong	Biomarker	[4849]
SHKBP1	OTJXWLEH	Strong	Biomarker	[4850]
SHOC1	OTP51XIP	Strong	Altered Expression	[1657]
SHPRH	OTKCBWWS	Strong	Biomarker	[4851]
SHROOM3	OTQKC5X2	Strong	Biomarker	[4259]
SIGIRR	OTNC3XFD	Strong	Biomarker	[4852]
SIGLEC1	OTNWSQA9	Strong	Altered Expression	[4853]
SIGLEC9	OTZC7SIM	Strong	Biomarker	[4854]
SIM1	OTYKFPKZ	Strong	Biomarker	[4855]
SIN3A	OTM8OZWV	Strong	Altered Expression	[4856]
SIN3B	OTFB59FK	Strong	Biomarker	[4857]
SIPA1	OTXY5RXC	Strong	Biomarker	[4858]
SIRT7	OT5M4OT4	Strong	Biomarker	[4859]
SIT1	OT7MDF09	Strong	Biomarker	[4860]
SIX1	OT70YYWM	Strong	Altered Expression	[4861]
SIX2	OTYOVGSC	Strong	Biomarker	[4862]
SIX4	OTG2HFH0	Strong	Biomarker	[4863]
SKA1	OTDYJ12A	Strong	Biomarker	[4864]
SKA2	OTVYF4XT	Strong	Biomarker	[4865]
SLAMF1	OTBTT3ZQ	Strong	Altered Expression	[4866]
SLAMF8	OTATVST8	Strong	Biomarker	[4867]
SLC12A9	OTR7VRAK	Strong	Biomarker	[4868]
SLC22A24	OTNVZ8Z1	Strong	Biomarker	[4869]
SLC25A43	OTY6MWVD	Strong	Biomarker	[4870]
SLC26A8	OTNCW8RJ	Strong	Biomarker	[1633]
SLC2A4RG	OTW3LX8D	Strong	Biomarker	[3187]
SLC35G1	OTKZUA8O	Strong	Biomarker	[3407]
SLC46A3	OTEMDLPS	Strong	Biomarker	[4871]
SLC7A4	OTAVC6QS	Strong	Biomarker	[4872]
SLFN11	OTJWFPMY	Strong	Biomarker	[4873]
SLFN12	OTTBXM25	Strong	Biomarker	[1209]
SLFN5	OTT1AESL	Strong	Biomarker	[4874]
SLN	OTERIU75	Strong	Biomarker	[4875]
SLPI	OTUNFUU8	Strong	Biomarker	[3269]
SLTM	OT0VRZA6	Strong	Altered Expression	[1315]
SMAD2	OTC6VB4K	Strong	Biomarker	[4876]
SMAGP	OT57BZII	Strong	Biomarker	[4877]
SMARCAD1	OT90AZTX	Strong	Biomarker	[4878]
SMARCAL1	OTTKXLUZ	Strong	Biomarker	[4879]
SMARCB1	OT2LP7LJ	Strong	Biomarker	[4880]
SMC3	OTWGFRHD	Strong	Genetic Variation	[4881]
SMDT1	OTDBR8D1	Strong	Biomarker	[4882]
SMIM10L2B	OT04IG2N	Strong	Altered Expression	[4883]
SMN2	OT54RLO1	Strong	Altered Expression	[1400]
SMPX	OTLSHGBF	Strong	Biomarker	[1306]
SMTNL1	OT8F009J	Strong	Genetic Variation	[4884]
SMURF1	OT5UIZR8	Strong	Biomarker	[4885]
SMURF2	OT3TRVL7	Strong	Biomarker	[4886]
SNAI1	OTDPYAMC	Strong	Biomarker	[4887]
SNAP91	OTE3EXWZ	Strong	Biomarker	[4434]
SNCB	OTELSEK6	Strong	Biomarker	[4888]
SNF8	OTRQA2AI	Strong	Biomarker	[4889]
SNIP1	OTL3RA91	Strong	Biomarker	[4890]
SNPH	OTL6XBFA	Strong	Biomarker	[4891]
SNRPA1	OTWJZFAP	Strong	Altered Expression	[4892]
SNRPG	OTWX4XK1	Strong	Biomarker	[4893]
SNW1	OTKWG3PS	Strong	Altered Expression	[4894]
SNX1	OTXQSJ1J	Strong	Biomarker	[4895]
SNX5	OT6ZOWMU	Strong	Altered Expression	[4896]
SNX9	OTLNQ0ZM	Strong	Biomarker	[4897]
SOAT1	OTB4Y5RJ	Strong	Biomarker	[4898]
SOCS2	OTBPNKJQ	Strong	Biomarker	[4899]
SOCS6	OT2O5ZBK	Strong	Biomarker	[4900]
SOHLH1	OT3RBLSK	Strong	Altered Expression	[4901]
SOHLH2	OTB9EM6C	Strong	Biomarker	[4902]
SORBS1	OTWH8762	Strong	Biomarker	[188]
SORBS2	OTJSX44Y	Strong	Biomarker	[4903]
SORL1	OTQ8FFNS	Strong	Altered Expression	[4904]
SOX1	OTVI1RAR	Strong	Biomarker	[4905]
SOX11	OT4LG7LA	Strong	Altered Expression	[4906]
SOX15	OTTB37I1	Strong	Biomarker	[4907]
SOX17	OT9H4WWE	Strong	Biomarker	[4908]
SOX18	OTPUMHWA	Strong	Biomarker	[4908]
SOX21	OTNT50CC	Strong	Biomarker	[4909]
SOX30	OTGT38E3	Strong	Biomarker	[4910]
SOX4	OTSS40SS	Strong	Biomarker	[4911]
SOX6	OTT0W0LE	Strong	Biomarker	[4912]
SOX7	OTOZOFAG	Strong	Biomarker	[4913]
SOX9	OTVDJFGN	Strong	Biomarker	[4914]
SP100	OTN8SD5W	Strong	Altered Expression	[4915]
SP110	OTFW6WH7	Strong	Biomarker	[4916]
SP140	OTQZHFMT	Strong	Biomarker	[4917]
SPACA9	OTVRFX49	Strong	Biomarker	[4918]
SPAG4	OTVXS2SM	Strong	Biomarker	[4919]
SPAG5	OTCLJ56M	Strong	Altered Expression	[4920]
SPAG9	OT45AHMB	Strong	Biomarker	[4921]
SPANXA1	OTMK3QIS	Strong	Biomarker	[4922]
SPATA19	OT47CHQR	Strong	Altered Expression	[4923]
SPC24	OT1HVYV4	Strong	Biomarker	[4924]
SPC25	OTCAS0OH	Strong	Biomarker	[4925]
SPDYA	OTYKC1AJ	Strong	Biomarker	[4926]
SPECC1	OTPEML48	Strong	Biomarker	[4752]
SPEN	OT37A2MD	Strong	Biomarker	[2476]
SPESP1	OTWXKKTJ	Strong	Biomarker	[4927]
SPG21	OTMKJSYS	Strong	Biomarker	[4918]
SPIN1	OT69VAOX	Strong	Altered Expression	[4928]
SPIN3	OT5PTQSH	Strong	Biomarker	[4929]
SPINK1	OTSUVAL2	Strong	Biomarker	[4930]
SPINK2	OTSFBT0G	Strong	Biomarker	[4931]
SPINK4	OTHTCW94	Strong	Biomarker	[4932]
SPINK7	OTK3VOI3	Strong	Biomarker	[4933]
SPINT2	OTQV7BKQ	Strong	Altered Expression	[4934]
SPNS2	OTPODAPU	Strong	Biomarker	[4935]
SPOCK2	OTXSVTSA	Strong	Posttranslational Modification	[4034]
SPON2	OTE7JLNM	Strong	Biomarker	[4936]
SPP2	OTX254AR	Strong	Biomarker	[4937]
SPRR3	OTN9QJKG	Strong	Biomarker	[4938]
SPRTN	OT01D5CE	Strong	Biomarker	[4939]
SPRY4	OT2VK9N0	Strong	Biomarker	[4940]
SPSB3	OTHGEE2K	Strong	Altered Expression	[4941]
SPTAN1	OT6VY3A3	Strong	Biomarker	[4942]
SPTLC1	OTN0Z98K	Strong	Biomarker	[4943]
SPZ1	OTQH8HJ5	Strong	Biomarker	[3327]
SRARP	OTR3TNTJ	Strong	Posttranslational Modification	[3842]
SRCIN1	OTQZNQQ5	Strong	Biomarker	[4944]
SRF	OTW18FQN	Strong	Altered Expression	[2001]
SRI	OT4R3EAC	Strong	Biomarker	[4945]
SRP68	OTZ7HIID	Strong	Genetic Variation	[4946]
SRP72	OTPV73W7	Strong	Genetic Variation	[2939]
SRPX	OT5B9LXS	Strong	Biomarker	[3808]
SRPX2	OT6A63TX	Strong	Biomarker	[4947]
SRRM2	OTSIMMC9	Strong	Biomarker	[1277]
SRSF1	OTF61HOV	Strong	Altered Expression	[4948]
SRSF3	OTOFT707	Strong	Altered Expression	[3883]
SRSF5	OTC5WP98	Strong	Genetic Variation	[2603]
SRSF6	OTGLOSYE	Strong	Biomarker	[4949]
SRSF7	OTRS4W4S	Strong	Biomarker	[4950]
SRXN1	OTYDBO4L	Strong	Biomarker	[4951]
SSBP1	OTH2PZWH	Strong	Biomarker	[1690]
SSBP2	OTYG1G80	Strong	Posttranslational Modification	[4952]
SSH1	OT4BE2M4	Strong	Biomarker	[4953]
SSH2	OT8NCK82	Strong	Genetic Variation	[3085]
SSX4	OT0E4H2D	Strong	Biomarker	[2795]
SSX5	OTNOHH4H	Strong	Genetic Variation	[4954]
ST13	OTNML6UP	Strong	Biomarker	[2073]
ST3GAL1	OTFCO8QX	Strong	Altered Expression	[4955]
ST3GAL3	OTOORKUE	Strong	Biomarker	[4956]
ST3GAL4	OTNENJZQ	Strong	Altered Expression	[4957]
ST6GAL1	OT7US3NO	Strong	Biomarker	[4958]
ST6GALNAC1	OT3JQD99	Strong	Biomarker	[4959]
ST6GALNAC5	OTH91ETM	Strong	Biomarker	[4960]
ST7	OTZG8RC6	Strong	Biomarker	[4961]
ST8SIA1	OTGND2YZ	Strong	Altered Expression	[4962]
STAG1	OT564IX4	Strong	Biomarker	[4963]
STAP2	OTEB1VVI	Strong	Biomarker	[4964]
STARD13	OTB4U1HY	Strong	Biomarker	[2558]
STARD3	OTSTC5B5	Strong	Altered Expression	[4965]
STARD8	OTY9IAKW	Strong	Biomarker	[4966]
STAT2	OTO9G2RZ	Strong	Altered Expression	[4967]
STAT5A	OTBSJGN3	Strong	Biomarker	[4968]
STAT5B	OTZVPEBT	Strong	Biomarker	[4968]
STEAP4	OTFTLAEZ	Strong	Altered Expression	[4969]
STIL	OT9799VN	Strong	Biomarker	[2987]
STIM1	OT8CLQ1W	Strong	Biomarker	[4970]
STING1	OTDAP4G0	Strong	Biomarker	[4971]
STIP1	OT7TXLOX	Strong	Biomarker	[4972]
STK26	OTW4QE0D	Strong	Biomarker	[4973]
STK31	OT3ZLRH0	Strong	Biomarker	[1677]
STOML3	OTLQGALK	Strong	Biomarker	[4974]
STPG4	OT5K4UFL	Strong	Biomarker	[901]
STX11	OTHFRSFP	Strong	Genetic Variation	[4975]
STX17	OT8TUN64	Strong	Biomarker	[4976]
STX4	OTQ7YUX1	Strong	Biomarker	[4977]
STX5	OTQ0024B	Strong	Biomarker	[4978]
STX6	OTC5F5M6	Strong	Biomarker	[4979]
STXBP3	OTTTYMAQ	Strong	Biomarker	[1132]
SUB1	OTK71JYU	Strong	Altered Expression	[3197]
SUDS3	OTZ1AARI	Strong	Biomarker	[4980]
SUFU	OT0IRYG1	Strong	Genetic Variation	[4981]
SUN1	OTIU8V4U	Strong	Biomarker	[4982]
SUPT20H	OTTMC0LH	Strong	Altered Expression	[4983]
SUSD2	OTSJTAZP	Strong	Biomarker	[4984]
SUV39H2	OTU0F4LL	Strong	Biomarker	[4985]
SUZ12	OT655XF8	Strong	Altered Expression	[4986]
SWAP70	OTPHT2QD	Strong	Biomarker	[4987]
SYCP3	OTKOF54H	Strong	Biomarker	[4988]
SYF2	OTY2ZW1H	Strong	Altered Expression	[4989]
SYN1	OTMNPWC1	Strong	Altered Expression	[4990]
SYNJ2BP	OT2Q677P	Strong	Biomarker	[4991]
SYNM	OTOI8TRJ	Strong	Altered Expression	[4992]
SYNPO	OTICDJAB	Strong	Altered Expression	[4993]
SYP	OTFJKMO4	Strong	Altered Expression	[4994]
SYTL2	OTUIOWKL	Strong	Altered Expression	[1427]
TAB3	OT1ECMDL	Strong	Genetic Variation	[2850]
TAC1	OTM842YW	Strong	Biomarker	[4995]
TACC1	OTGX20TE	Strong	Biomarker	[4996]
TACC2	OTW4M7HI	Strong	Biomarker	[4997]
TAF1	OTDYS5G4	Strong	Genetic Variation	[4998]
TAF15	OTNE038N	Strong	Biomarker	[4999]
TAF1L	OT9Z7EVA	Strong	Genetic Variation	[4998]
TAFA5	OT2SWBT6	Strong	Altered Expression	[5000]
TAL1	OTX4K6QZ	Strong	Altered Expression	[5001]
TALDO1	OTDKV2S2	Strong	Genetic Variation	[4042]
TANK	OTZSGFIK	Strong	Altered Expression	[5002]
TAOK2	OTNUMOZ1	Strong	Altered Expression	[1436]
TARBP1	OT14Z6RJ	Strong	Altered Expression	[5003]
TAT	OT2CJ91O	Strong	Biomarker	[5004]
TAX1BP3	OTQ6IB4T	Strong	Altered Expression	[5005]
TBC1D24	OTKZUSMD	Strong	Altered Expression	[5006]
TBC1D2B	OT1GVN5H	Strong	Biomarker	[5007]
TBC1D5	OTNHLLAX	Strong	Biomarker	[4159]
TBP	OT6C0S52	Strong	Biomarker	[5008]
TBPL1	OT4I143E	Strong	Biomarker	[321]
TBRG4	OT6KXSXD	Strong	Biomarker	[5009]
TBX1	OTQLBPRA	Strong	Biomarker	[5010]
TBX3	OTM64N7K	Strong	Biomarker	[5011]
TBX4	OTW58FG4	Strong	Biomarker	[5012]
TC2N	OT6482WN	Strong	Biomarker	[5013]
TCEA1	OTBFO594	Strong	Biomarker	[5014]
TCEA2	OT1OS9TY	Strong	Biomarker	[5014]
TCEA3	OTLTRSK4	Strong	Biomarker	[5014]
TCEAL7	OTNPDZCN	Strong	Altered Expression	[5015]
TCF12	OTZVONNU	Strong	Genetic Variation	[5016]
TCF4	OTB9ASTK	Strong	Altered Expression	[5017]
TCF7	OT1ID822	Strong	Altered Expression	[5018]
TCF7L1	OTTUTF0O	Strong	Altered Expression	[5019]
TCHP	OTVDMHSY	Strong	Biomarker	[5020]
TCIM	OTARUXQF	Strong	Altered Expression	[5021]
TCN1	OTW6A49Y	Strong	Biomarker	[5022]
TCP1	OT1MGUX9	Strong	Biomarker	[5023]
TDRD9	OTS4UBI8	Strong	Biomarker	[3850]
TEKT5	OTZ5OUHY	Strong	Biomarker	[5024]
TELO2	OT2YQ9L8	Strong	Biomarker	[5025]
TENT5A	OTSYF511	Strong	Biomarker	[3873]
TENT5B	OTO2P28B	Strong	Altered Expression	[5026]
TENT5C	OTOWVQ4O	Strong	Altered Expression	[5027]
TERF2IP	OT3M5P3G	Strong	Altered Expression	[4614]
TESMIN	OTZ5UILU	Strong	Altered Expression	[5028]
TET1	OTZDHT1D	Strong	Altered Expression	[5029]
TEX11	OTJDBGSS	Strong	Altered Expression	[1608]
TEX19	OTY6MIZ9	Strong	Biomarker	[5030]
TFAM	OTXXV5V7	Strong	Biomarker	[5031]
TFAP2B	OTR1T8E9	Strong	Biomarker	[2952]
TFAP2E	OTA4B1SG	Strong	Altered Expression	[5032]
TFAP4	OT1KQIUX	Strong	Genetic Variation	[5033]
TFCP2	OTA246TE	Strong	Altered Expression	[5034]
TFCP2L1	OT7QIJ0X	Strong	Biomarker	[5035]
TFF2	OTRXB19X	Strong	Biomarker	[5036]
TFF3	OTJJDRTU	Strong	Altered Expression	[1454]
TFG	OT2KJENI	Strong	Altered Expression	[5037]
TFPI2	OTZCRWOR	Strong	Biomarker	[5038]
TFR2	OTMYCCEO	Strong	Altered Expression	[5039]
TG	OT3ELHIJ	Strong	Biomarker	[5040]
TGFBRAP1	OT80QNR5	Strong	Biomarker	[5041]
THBS4	OTA1T9KK	Strong	Altered Expression	[5042]
THEM4	OTSIZU8Y	Strong	Biomarker	[5043]
THEMIS	OTXODBXJ	Strong	Biomarker	[5044]
THEMIS2	OTI1OBLN	Strong	Biomarker	[5045]
THSD1	OTKPGFHS	Strong	Altered Expression	[5046]
TIAM2	OTPYIPT6	Strong	Biomarker	[5047]
TIGAR	OTR7NMRJ	Strong	Biomarker	[5048]
TIGD1	OTEQ4UT0	Strong	Biomarker	[5049]
TIMM13	OTYZQJD3	Strong	Biomarker	[5050]
TIMM8A	OTDX9687	Strong	Biomarker	[5051]
TIMP3	OTDGQAD1	Strong	Biomarker	[5052]
TIMP4	OT8A68SW	Strong	Altered Expression	[5053]
TKTL2	OTULV5TA	Strong	Biomarker	[1465]
TLCD3A	OTVZUR1Z	Strong	Genetic Variation	[5054]
TLCD3B	OTM6EPUS	Strong	Biomarker	[5055]
TLE2	OT2KSZ9B	Strong	Biomarker	[5056]
TLE3	OTR9PH95	Strong	Biomarker	[1314]
TLE5	OTEH0BFG	Strong	Altered Expression	[5057]
TLK1	OTICTXI8	Strong	Genetic Variation	[3195]
TLK2	OTZ09CG8	Strong	Altered Expression	[5058]
TLN2	OT10QQBC	Strong	Biomarker	[1466]
TLX2	OTPFAUM8	Strong	Biomarker	[1639]
TM4SF1	OTY0ECQN	Strong	Biomarker	[5059]
TM7SF2	OTILU5S7	Strong	Biomarker	[1547]
TM9SF4	OT85D4H9	Strong	Biomarker	[5060]
TMC6	OTKH50J4	Strong	Biomarker	[5061]
TMC8	OTUAD95X	Strong	Biomarker	[5061]
TMCO1	OTSME34W	Strong	Biomarker	[5062]
TMED10	OTUXSHH7	Strong	Altered Expression	[60]
TMED5	OT70W1J8	Strong	Biomarker	[3448]
TMEFF1	OTH6M3CH	Strong	Altered Expression	[5063]
TMEFF2	OT1WZ2QO	Strong	Biomarker	[5064]
TMEM106A	OTHTBYDN	Strong	Biomarker	[5065]
TMEM106B	OTUWA6NW	Strong	Biomarker	[5066]
TMEM11	OTL9HDEY	Strong	Biomarker	[5067]
TMEM127	OTYHUXC1	Strong	Biomarker	[5068]
TMEM132D	OTV6I4Z0	Strong	Biomarker	[5069]
TMEM158	OT0KUBBI	Strong	Biomarker	[5070]
TMEM17	OTEU00OH	Strong	Altered Expression	[5071]
TMEM176A	OTOZDWXX	Strong	Biomarker	[5072]
TMEM196	OTPFLB1R	Strong	Biomarker	[5073]
TMEM201	OTZBZ4MC	Strong	Biomarker	[5074]
TMEM205	OTGV8KK4	Strong	Biomarker	[5075]
TMEM243	OT8NQ79G	Strong	Biomarker	[5076]
TMEM25	OTIMMWZ6	Strong	Altered Expression	[5077]
TMEM31	OTKDPZD4	Strong	Biomarker	[5078]
TMEM45A	OT54KJG6	Strong	Biomarker	[5079]
TMEM54	OTPQEFR0	Strong	Biomarker	[3115]
TMEM63B	OTQNB4KI	Strong	Biomarker	[5080]
TMEM88	OTA96YEL	Strong	Biomarker	[5081]
TMEM8B	OTJZWPS6	Strong	Posttranslational Modification	[5082]
TMOD1	OTTRYF9Y	Strong	Altered Expression	[5083]
TMOD2	OTTTUH2W	Strong	Biomarker	[2878]
TMOD3	OTQPNSTH	Strong	Biomarker	[5084]
TMPO	OTL68EL4	Strong	Altered Expression	[5085]
TMPRSS11F	OTRUQ164	Strong	Altered Expression	[5086]
TMPRSS13	OTMAOAP3	Strong	Biomarker	[4019]
TMPRSS3	OT0GTO1Z	Strong	Altered Expression	[5087]
TMPRSS4	OTCCGY2K	Strong	Altered Expression	[5088]
TMX1	OTX4FHYQ	Strong	Genetic Variation	[2863]
TNFAIP1	OT37EWR0	Strong	Biomarker	[5089]
TNFAIP8L1	OTVVKOTV	Strong	Biomarker	[5090]
TNFAIP8L2	OTII0RM0	Strong	Biomarker	[5091]
TNFAIP8L3	OTHSBS1B	Strong	Biomarker	[5092]
TNFRSF10C	OTVHOL9B	Strong	Altered Expression	[5093]
TNFRSF10D	OTOSRDJT	Strong	Biomarker	[5094]
TNFRSF6B	OTKAN9G7	Strong	Biomarker	[5095]
TNFSF8	OTDYGDJ3	Strong	Biomarker	[3978]
TNFSF9	OTV9L89D	Strong	Biomarker	[5096]
TNKS1BP1	OTBIZECQ	Strong	Biomarker	[5097]
TNMD	OTHLVA9G	Strong	Genetic Variation	[5098]
TNN	OTQK2AMX	Strong	Altered Expression	[5099]
TNR	OTVJGAFN	Strong	Altered Expression	[5100]
TNRC6A	OT493IOM	Strong	Biomarker	[3236]
TOB1	OTNW949D	Strong	Biomarker	[5101]
TOB2	OTEEHL60	Strong	Biomarker	[5102]
TOGARAM1	OTG6CYJ0	Strong	Genetic Variation	[2589]
TOMM20	OT76TPR2	Strong	Biomarker	[5103]
TOMM34	OTH6MITE	Strong	Biomarker	[5104]
TOP3A	OT3CKUI9	Strong	Genetic Variation	[5105]
TOP3B	OTNFEUOO	Strong	Biomarker	[5106]
TOX	OTE8BL5Z	Strong	Biomarker	[5107]
TOX2	OT7RZRVK	Strong	Posttranslational Modification	[5108]
TOX4	OTSOXQFN	Strong	Biomarker	[5108]
TP53BP2	OTOWJ2Y4	Strong	Altered Expression	[5109]
TP53INP2	OT0GTBXO	Strong	Biomarker	[5110]
TP53TG3	OTWS7OY4	Strong	Altered Expression	[5111]
TPD52	OTPKSK43	Strong	Altered Expression	[5112]
TPD52L2	OTTOG0NK	Strong	Biomarker	[5113]
TPK1	OTCHPUD0	Strong	Altered Expression	[5114]
TPM2	OTA1L0P8	Strong	Biomarker	[5115]
TPM3	OT5RU5G6	Strong	Biomarker	[5116]
TPM4	OTN4YLYR	Strong	Biomarker	[5117]
TPPP	OTCFMSUF	Strong	Biomarker	[5118]
TPPP2	OTI3WA6X	Strong	Biomarker	[568]
TPR	OTUBBA4W	Strong	Biomarker	[5119]
TPRKB	OTV4QEVT	Strong	Biomarker	[5120]
TPTE	OT0JNP52	Strong	Genetic Variation	[5121]
TRA2B	OTZYQW52	Strong	Biomarker	[5122]
TRAF1	OTTLM5RU	Strong	Biomarker	[5123]
TRAF2	OT1MEZZN	Strong	Biomarker	[5124]
TRAF3	OT5TQBGV	Strong	Biomarker	[5125]
TRAF3IP2	OTLLZERL	Strong	Biomarker	[5126]
TRAF4	OTJLRVMC	Strong	Altered Expression	[5127]
TRAIP	OTMPT9Y2	Strong	Altered Expression	[2539]
TRAK1	OTMQVYNP	Strong	Altered Expression	[5128]
TRAM2	OTSFG0ST	Strong	Biomarker	[5129]
TRAPPC9	OTF0CVMC	Strong	Biomarker	[5130]
TREH	OTJE0NOY	Strong	Biomarker	[5131]
TRIAP1	OTEAUJXN	Strong	Altered Expression	[5132]
TRIB2	OTHSX3MX	Strong	Biomarker	[195]
TRIB3	OTG5OS7X	Strong	Biomarker	[1817]
TRIM11	OTMD6IM2	Strong	Biomarker	[5133]
TRIM15	OTNYAKP6	Strong	Biomarker	[5134]
TRIM23	OTVIGJ4T	Strong	Biomarker	[2164]
TRIM26	OTS0DJIP	Strong	Biomarker	[5135]
TRIM29	OT2DNESG	Strong	Biomarker	[1001]
TRIM32	OTJOV0PG	Strong	Altered Expression	[5136]
TRIM45	OTFDQT4E	Strong	Biomarker	[5137]
TRIM47	OTM9DGUD	Strong	Biomarker	[5138]
TRIM52	OTKTKCT1	Strong	Biomarker	[5139]
TRIM56	OTFGU8E3	Strong	Biomarker	[5140]
TRIM58	OT7OIIRH	Strong	Biomarker	[5141]
TRIM71	OTH8UB6H	Strong	Altered Expression	[5142]
TRIML2	OT5QWTD2	Strong	Biomarker	[5143]
TRIP13	OTFM3TI9	Strong	Biomarker	[5144]
TRIP6	OTIPA4ZR	Strong	Biomarker	[5145]
TRIT1	OTCU9FS5	Strong	Biomarker	[5146]
TRMO	OTNJ7K9K	Strong	Genetic Variation	[2850]
TRMT9B	OTU3UPEE	Strong	Biomarker	[5147]
TROAP	OTC8CE0R	Strong	Altered Expression	[887]
TRPC4AP	OTNJ9IFS	Strong	Altered Expression	[5148]
TRPV5	OTWF4L0U	Strong	Genetic Variation	[2863]
TSC1	OTFF4YZ7	Strong	Altered Expression	[3895]
TSC2	OT47LWI9	Strong	Biomarker	[5149]
TSC22D2	OTFXF349	Strong	Biomarker	[3997]
TSC22D3	OT03UM03	Strong	Altered Expression	[5150]
TSGA10	OTIF1O1T	Strong	Biomarker	[5151]
TSPAN12	OTF9I3CX	Strong	Biomarker	[5152]
TSPAN13	OTCS9BZY	Strong	Altered Expression	[5153]
TSPAN15	OTNQXXIG	Strong	Biomarker	[5154]
TSPAN18	OTHSGPVB	Strong	Altered Expression	[5155]
TSPAN33	OTH6C0WU	Strong	Biomarker	[4391]
TSPAN8	OT1F68WQ	Strong	Biomarker	[5156]
TSPY3	OTQK3AKI	Strong	Biomarker	[3393]
TSPYL2	OTGGW2EF	Strong	Biomarker	[5157]
TSPYL5	OT7QEI2X	Strong	Biomarker	[5158]
TSTD1	OT5DMKFX	Strong	Biomarker	[2631]
TTBK2	OT90YSM5	Strong	Biomarker	[5159]
TTC21A	OTBJ9JKF	Strong	Biomarker	[5160]
TTC4	OTAPMYXU	Strong	Biomarker	[5161]
TTLL5	OTUKOVEM	Strong	Altered Expression	[5162]
ABCF1	OT6Q079J	Definitive	Biomarker	[5163]
ACADS	OTGFANYQ	Definitive	Altered Expression	[5164]
ACSL5	OT3L9XO3	Definitive	Altered Expression	[5165]
ADIPOR2	OT2HDTL8	Definitive	Genetic Variation	[5166]
ADRM1	OTOU4EY6	Definitive	Biomarker	[5167]
AKAP1	OTIIB2JB	Definitive	Genetic Variation	[5168]
ANKLE1	OTQ7WN9J	Definitive	Biomarker	[5169]
ATG10	OTVRPC5X	Definitive	Biomarker	[5170]
ATG14	OTPZDKI0	Definitive	Biomarker	[5171]
ATOX1	OT05LF59	Definitive	Altered Expression	[5172]
AVEN	OTGIN5YK	Definitive	Biomarker	[5173]
B4GALNT4	OTKSQD3S	Definitive	Altered Expression	[3050]
BCCIP	OTFFKG79	Definitive	Biomarker	[5174]
BDH1	OT62RL5P	Definitive	Altered Expression	[5175]
BIK	OTTH1T3D	Definitive	Biomarker	[5176]
C2CD5	OTI495RD	Definitive	Altered Expression	[5177]
CARD14	OTADQHOV	Definitive	Biomarker	[3109]
CBFA2T3	OTOJ10S1	Definitive	Biomarker	[3715]
CCDC62	OTTIAOBP	Definitive	Altered Expression	[5178]
CCL19	OTQ2UJMH	Definitive	Biomarker	[5179]
CD226	OT4UG0KB	Definitive	Biomarker	[5180]
CD3D	OTRBLP0R	Definitive	Biomarker	[3761]
CDC20B	OTO5F8CF	Definitive	Genetic Variation	[5181]
CDK5RAP1	OTDEJXD0	Definitive	Biomarker	[5182]
CIAPIN1	OTWS90F9	Definitive	Biomarker	[5183]
CITED1	OTUJQ3VL	Definitive	Altered Expression	[5184]
CKAP2	OTCLTC0J	Definitive	Altered Expression	[5185]
CPEB2	OTKES4YR	Definitive	Biomarker	[5186]
CRTAP	OT53H5U6	Definitive	Biomarker	[5187]
CST6	OTZVHJTF	Definitive	Posttranslational Modification	[5188]
CTHRC1	OTV88X2G	Definitive	Biomarker	[5189]
CYB561D2	OT1ZXC66	Definitive	Biomarker	[5190]
CYTIP	OTRJ3ZC5	Definitive	Biomarker	[5187]
DACT3	OTSNQ55G	Definitive	Biomarker	[5191]
DCSTAMP	OTFKRP2H	Definitive	Biomarker	[5192]
DIXDC1	OT87DXEG	Definitive	Biomarker	[5193]
DOP1A	OTBKLQH5	Definitive	Genetic Variation	[5194]
DPP3	OTUIVL1C	Definitive	Biomarker	[5195]
DRG1	OTIFYMI3	Definitive	Altered Expression	[5196]
ECHS1	OTS0593S	Definitive	Biomarker	[5197]
EEA1	OTIBXC1B	Definitive	Altered Expression	[5198]
EPN3	OTNNYDT6	Definitive	Altered Expression	[5199]
ETV5	OTE2OBM4	Definitive	Biomarker	[5200]
EYA4	OTINGR3Z	Definitive	Biomarker	[5201]
FASTKD2	OTD635WX	Definitive	Biomarker	[5202]
FERMT2	OTZNPWWX	Definitive	Biomarker	[5203]
FGF3	OT9PK2SI	Definitive	Biomarker	[5204]
FIP1L1	OTF91GTL	Definitive	Biomarker	[5205]
FKBPL	OTR9ND6K	Definitive	Biomarker	[778]
FNIP1	OTB1CC41	Definitive	Biomarker	[5206]
FNIP2	OT7EX8JJ	Definitive	Biomarker	[5206]
FOXP4	OTHCGIEZ	Definitive	Biomarker	[5207]
FRZB	OTTO3DPY	Definitive	Biomarker	[5208]
GADD45A	OTDRV63V	Definitive	Biomarker	[5209]
GBGT1	OTRB3JK7	Definitive	Biomarker	[5210]
GML	OTHKIB62	Definitive	Biomarker	[5211]
GPN1	OTM03SFL	Definitive	Genetic Variation	[5212]
GPX7	OTINT9Z4	Definitive	Biomarker	[5213]
GTF2H5	OTRL219S	Definitive	Genetic Variation	[5214]
HABP2	OTAUIPW0	Definitive	Biomarker	[5215]
HAND2	OTCXYW4Y	Definitive	Biomarker	[5216]
HCFC1R1	OTGDPS5C	Definitive	Biomarker	[5217]
HEBP2	OTVDIMLM	Definitive	Biomarker	[5218]
HIPK1	OTSEA8RS	Definitive	Biomarker	[5219]
HOXA10	OTB6GQ09	Definitive	Altered Expression	[5220]
HPX	OT14T7Q1	Definitive	Biomarker	[5221]
IFT88	OTDR3VBD	Definitive	Biomarker	[5222]
IGF2BP1	OT9G360P	Definitive	Altered Expression	[3807]
IL1RAPL1	OTW3T4B2	Definitive	Biomarker	[5223]
IMMP1L	OTA6LOLR	Definitive	Altered Expression	[3807]
INTS2	OT2N5TCK	Definitive	Biomarker	[5204]
ISCU	OTSW6DQP	Definitive	Altered Expression	[5224]
ITGB4	OT28UK84	Definitive	Biomarker	[5225]
JPT1	OT6CRZEU	Definitive	Genetic Variation	[5167]
KCTD12	OTPYKT4Z	Definitive	Altered Expression	[5226]
KIF18A	OTSMBJ24	Definitive	Altered Expression	[5227]
KRT7	OTLT3JFN	Definitive	Biomarker	[5228]
KRT80	OTAU54U3	Definitive	Altered Expression	[5229]
LAMTOR3	OTG93MCO	Definitive	Altered Expression	[5230]
LEPROT	OT2EENVA	Definitive	Altered Expression	[5231]
LGALS13	OTEV3DD7	Definitive	Biomarker	[5232]
LIMD2	OTSIFTD8	Definitive	Altered Expression	[5233]
MAPK15	OT8SW0L7	Definitive	Biomarker	[5234]
MEFV	OTRJ6S6K	Definitive	Altered Expression	[3060]
MEP1A	OTY2Z48T	Definitive	Biomarker	[5235]
MFN2	OTPYN8A3	Definitive	Biomarker	[5236]
MOB4	OTOQRMAS	Definitive	Altered Expression	[5237]
MPRIP	OT5FV5NS	Definitive	Biomarker	[5238]
MRGBP	OTXBPDMS	Definitive	Genetic Variation	[5239]
MUC3A	OTI4XUDY	Definitive	Posttranslational Modification	[5240]
MYBL2	OTZ3JX8Q	Definitive	Biomarker	[5241]
NANOS2	OTFM2IDJ	Definitive	Biomarker	[5242]
NAP1L1	OTI7WBZV	Definitive	Biomarker	[5243]
NCAN	OT8OO6ZE	Definitive	Altered Expression	[5244]
NCF4	OTX007YL	Definitive	Biomarker	[5245]
NDUFS1	OTTIZDFR	Definitive	Altered Expression	[5246]
NEK11	OTMYENTC	Definitive	Biomarker	[5247]
NET1	OTZHNMJV	Definitive	Biomarker	[5248]
NIBAN2	OTVDQSPI	Definitive	Altered Expression	[5249]
NOLC1	OTKDZU0D	Definitive	Biomarker	[4642]
NOP14	OTKPM0Z5	Definitive	Biomarker	[5250]
NPTN	OTAQKSAU	Definitive	Biomarker	[5251]
NUS1	OT4DQ82L	Definitive	Biomarker	[5252]
OBP2A	OTBIJ5TI	Definitive	Biomarker	[5253]
OMD	OTFRELBB	Definitive	Altered Expression	[5254]
OTUD4	OT7U62SW	Definitive	Posttranslational Modification	[5255]
PBXIP1	OTEAAUBY	Definitive	Biomarker	[5217]
PDCD5	OT6T2DDL	Definitive	Altered Expression	[5256]
PEG3	OTHQW98S	Definitive	Biomarker	[5257]
PENK	OT8P3HMP	Definitive	Genetic Variation	[5258]
PIWIL3	OTQ1B8R4	Definitive	Altered Expression	[5259]
PLAGL1	OTZAO900	Definitive	Biomarker	[5260]
PLEC	OTU4XDEG	Definitive	Biomarker	[2713]
PLEKHA8	OT03870U	Definitive	Biomarker	[5261]
PLIN5	OTV8G50L	Definitive	Genetic Variation	[3177]
PPP1R1A	OTGTAGCV	Definitive	Biomarker	[5262]
PPP2R1B	OTFIHQGD	Definitive	Biomarker	[5263]
PRELID1	OTWP3WLV	Definitive	Altered Expression	[5264]
PROCR	OTRHED17	Definitive	Biomarker	[5265]
PRPS1	OTN3A6CN	Definitive	Genetic Variation	[5266]
PSMC3IP	OT9UB5UO	Definitive	Biomarker	[5267]
PTCH2	OTOQ0K9V	Definitive	Biomarker	[5268]
PTTG1	OTIMYS4W	Definitive	Biomarker	[5269]
RAB23	OTBAKFBR	Definitive	Altered Expression	[5270]
RAB3GAP1	OT4DQ8F2	Definitive	Biomarker	[4642]
RABIF	OTEW72FR	Definitive	Genetic Variation	[4450]
RALY	OT78NNWY	Definitive	Altered Expression	[5271]
RASAL1	OTAHUNN7	Definitive	Biomarker	[5272]
RB1CC1	OTZK8PFX	Definitive	Biomarker	[5273]
RBM14	OTO9GMBD	Definitive	Genetic Variation	[5274]
RBM25	OTVOUOAG	Definitive	Biomarker	[5025]
RFX5	OT73KJ5P	Definitive	Altered Expression	[5275]
RGMB	OT2DROYU	Definitive	Biomarker	[1589]
RGS1	OTGXJYMG	Definitive	Biomarker	[5276]
RIOX2	OT2YFPI2	Definitive	Biomarker	[5277]
RIPK3	OTL1D484	Definitive	Altered Expression	[5238]
RRP15	OTE8CQ7K	Definitive	Biomarker	[5278]
SAE1	OT18HFX5	Definitive	Biomarker	[5279]
SALL1	OTYYZGLH	Definitive	Biomarker	[5280]
SCYL1	OTQ0IN7P	Definitive	Biomarker	[5281]
SEC14L2	OTJST64D	Definitive	Genetic Variation	[1599]
SETD6	OTH5APN1	Definitive	Biomarker	[5282]
SGMS1	OTZQE7PW	Definitive	Altered Expression	[5237]
SHISA2	OT4GMTML	Definitive	Biomarker	[5283]
SMS	OT8JYKNH	Definitive	Biomarker	[5284]
SMYD5	OTE5VET6	Definitive	Biomarker	[5285]
SNRPB	OT3UJ4ZU	Definitive	Biomarker	[5286]
SOX14	OTPEKVOM	Definitive	Biomarker	[5287]
SPINK5	OT61IIAO	Definitive	Biomarker	[5288]
STIM2	OTYNXAW0	Definitive	Biomarker	[5289]
SUGCT	OTA8L0TN	Definitive	Altered Expression	[5290]
SYNE3	OTEOJBYB	Definitive	Biomarker	[5291]
SZRD1	OTJMEJWT	Definitive	Altered Expression	[5292]
TAS2R13	OTSTOX5G	Definitive	Biomarker	[5293]
TBX2	OTTOT7A9	Definitive	Altered Expression	[5294]
TCERG1L	OTSBSCLF	Definitive	Posttranslational Modification	[5295]
TCF21	OT393IMA	Definitive	Biomarker	[5296]
TCN2	OT41D0L3	Definitive	Biomarker	[2556]
TFEC	OTUST8MR	Definitive	Altered Expression	[5297]
TIFA	OTIRCVG7	Definitive	Altered Expression	[5298]
TLX1	OTVN0MNW	Definitive	Altered Expression	[5299]
TOPBP1	OT6UPZPD	Definitive	Biomarker	[5300]
TRAF3IP3	OTNG0L8X	Definitive	Biomarker	[5301]
TRIM8	OTS6JFR0	Definitive	Biomarker	[5302]
TRO	OTRZQMU8	Definitive	Altered Expression	[5303]
TTF1	OT4K90WD	Definitive	Biomarker	[5304]

References

• [1] Cortisone acetate FDA Label
• [2] Cyclophosphamide FDA Label
• [3] Dactinomycin FDA Label
• [4] Docetaxel FDA Label
• [5] Donepezil FDA Label
• [6] Everolimus FDA Label
• [7] Ifosfamide FDA Label
• [8] Irinotecan FDA Label
• [9] Lenalidomide FDA Label
• [10] Methadone FDA Label
• [11] Methyltestosterone FDA Label
• [12] Morphine FDA Label
• [13] A standard database for drug repositioning. Sci Data. 2017 Mar 14;4:170029.
• [14] Norethindrone FDA Label
• [15] Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma. J Clin Oncol. 2022 Jul 1;40(19):2106-2118.
• [16] Sirolimus FDA Label
• [17] Thalidomide FDA Label
• [18] Tolbutamide FDA Label
• [19] Vinblastine FDA Label
• [20] Vinorelbine FDA Label
• [21] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [22] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [23] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7412).
• [24] Perspectives of antimony compounds in oncology. Acta Pharmacol Sin. 2008 Aug;29(8):881-90.
• [25] Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Signaling Pathway.J Med Chem. 2019 Feb 28;62(4):1715-1730.
• [26] ClinicalTrials.gov (NCT02221882) A Study of LY3164530 in Participants With Cancer
• [27] The ABC subfamily A transporters: Multifaceted players with incipient potentialities in cancer.Semin Cancer Biol. 2020 Feb;60:57-71. doi: 10.1016/j.semcancer.2019.10.004. Epub 2019 Oct 9.
• [28] A Survey Regarding the Knowledge, Attitudes, and Beliefs of Graduates of Cancer Rehabilitation Fellowship Program.J Cancer Educ. 2019 Apr;34(2):402-405. doi: 10.1007/s13187-018-1385-x.
• [29] In Systemic Sclerosis, a Unique Long Non Coding RNA Regulates Genes and Pathways Involved in the Three Main Features of the Disease (Vasculopathy, Fibrosis and Autoimmunity) and in Carcinogenesis.J Clin Med. 2019 Mar 7;8(3):320. doi: 10.3390/jcm8030320.
• [30] Metalloprotease inhibitor profiles of human ADAM8 in vitro and in cell-based assays.Biol Chem. 2019 May 27;400(6):801-810. doi: 10.1515/hsz-2018-0396.
• [31] Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies.J Clin Invest. 2017 Jun 1;127(6):2066-2080. doi: 10.1172/JCI83936. Epub 2017 May 15.
• [32] Adenosine A2b receptor promotes progression of human oral cancer.BMC Cancer. 2015 Jul 31;15:563. doi: 10.1186/s12885-015-1577-2.
• [33] Angiomotin-p130 inhibits -catenin stability by competing with Axin for binding to tankyrase in breast cancer.Cell Death Dis. 2019 Feb 21;10(3):179. doi: 10.1038/s41419-019-1427-2.
• [34] Antiproliferative and antiangiogenic effect of Amblyomma sculptum (Acari: Ixodidae) crude saliva in endothelial cells in vitro.Biomed Pharmacother. 2019 Feb;110:353-361. doi: 10.1016/j.biopha.2018.11.107. Epub 2018 Dec 5.
• [35] The association between apelin polymorphisms and hypertension in China: A meta-analysis.J Renin Angiotensin Aldosterone Syst. 2019 Jan-Mar;20(1):1470320319827204. doi: 10.1177/1470320319827204.
• [36] Glycoproteomic identification of novel plasma biomarkers for oral cancer.J Food Drug Anal. 2019 Apr;27(2):483-493. doi: 10.1016/j.jfda.2018.12.008. Epub 2019 Jan 8.
• [37] Association of APOBEC3 deletion with cancer risk: A meta-analysis of 26225 cases and 37201 controls.Asia Pac J Clin Oncol. 2019 Dec;15(6):275-287. doi: 10.1111/ajco.13107. Epub 2019 Jan 29.
• [38] Revealing A-Raf functions through its interactome.Biochim Biophys Acta Proteins Proteom. 2018 Aug;1866(8):849-856. doi: 10.1016/j.bbapap.2018.05.009. Epub 2018 May 16.
• [39] Bone Pain Induced by Multiple Myeloma Is Reduced by Targeting V-ATPase and ASIC3.Cancer Res. 2017 Mar 15;77(6):1283-1295. doi: 10.1158/0008-5472.CAN-15-3545. Epub 2017 Mar 2.
• [40] Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.Nat Genet. 2015 Oct;47(10):1131-40. doi: 10.1038/ng.3380. Epub 2015 Aug 17.
• [41] Copper-dependent ATP7B up-regulation drives the resistance of TMEM16A-overexpressing head-and-neck cancer models to platinum toxicity.Biochem J. 2019 Dec 19;476(24):3705-3719. doi: 10.1042/BCJ20190591.
• [42] AZGP1 is androgen responsive and involved in AR-induced prostate cancer cell proliferation and metastasis.J Cell Physiol. 2019 Aug;234(10):17444-17458. doi: 10.1002/jcp.28366. Epub 2019 Feb 28.
• [43] The value of pretreatment serum butyrylcholinesterase level as anovel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy.Strahlenther Onkol. 2019 May;195(5):430-440. doi: 10.1007/s00066-019-01430-z. Epub 2019 Feb 8.
• [44] In silico design and molecular basis for the selectivity of Olinone toward the first over the second bromodomain of BRD4.Proteins. 2020 Mar;88(3):414-430. doi: 10.1002/prot.25818. Epub 2019 Oct 21.
• [45] Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.EMBO Rep. 2019 May;20(5):e46166. doi: 10.15252/embr.201846166. Epub 2019 Apr 2.
• [46] BTLA-HVEM Checkpoint Axis Regulates Hepatic Homeostasis and Inflammation in a ConA-Induced Hepatitis Model in Zebrafish.J Immunol. 2019 Nov 1;203(9):2425-2442. doi: 10.4049/jimmunol.1900458. Epub 2019 Sep 27.
• [47] Colonic Mucosal Transcriptomic Changes in Patients with Long-Duration Ulcerative Colitis Revealed Colitis-Associated Cancer Pathways.J Crohns Colitis. 2019 May 27;13(6):755-763. doi: 10.1093/ecco-jcc/jjz002.
• [48] Meta-Analysis of Public Microarray Datasets Reveals Voltage-Gated Calcium Gene Signatures in Clinical Cancer Patients.PLoS One. 2015 Jul 6;10(7):e0125766. doi: 10.1371/journal.pone.0125766. eCollection 2015.
• [49] Core 1-derived mucin-type O-glycosylation protects against spontaneous gastritis and gastric cancer.J Exp Med. 2020 Jan 6;217(1):e20182325. doi: 10.1084/jem.20182325.
• [50] Caspase-10, matrix metalloproteinase-9 and total laminin are correlated with the tumor malignancy of clear cell renal cell carcinoma.Oncol Lett. 2018 Aug;16(2):2039-2045. doi: 10.3892/ol.2018.8845. Epub 2018 May 30.
• [51] Embryonal rhabdomyosarcoma in a patient with a germline CBL pathogenic variant.Cancer Genet. 2019 Feb;231-232:62-66. doi: 10.1016/j.cancergen.2018.12.006. Epub 2018 Dec 30.
• [52] CCR4 Expression Is Associated With Poor Prognosis in Patients With Early Stage (pN0) Oral Tongue Cancer.J Oral Maxillofac Surg. 2019 Feb;77(2):426-432. doi: 10.1016/j.joms.2018.09.035. Epub 2018 Oct 11.
• [53] Association of tumour-associated macrophages with cancer cell EMT, invasion, and metastasis of Kazakh oesophageal squamous cell cancer.Diagn Pathol. 2019 Jun 12;14(1):55. doi: 10.1186/s13000-019-0834-0.
• [54] Antibody-Drug Conjugates: Future Directions in Clinical and Translational Strategies to Improve the Therapeutic Index.Clin Cancer Res. 2019 Sep 15;25(18):5441-5448. doi: 10.1158/1078-0432.CCR-19-0272. Epub 2019 Apr 12.
• [55] CD59: a promising target for tumor immunotherapy.Future Oncol. 2018 Apr;14(8):781-791. doi: 10.2217/fon-2017-0498. Epub 2018 Mar 9.
• [56] Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo.BMC Cancer. 2019 Jun 27;19(1):634. doi: 10.1186/s12885-019-5811-1.
• [57] Meta-Analysis of miRNAs and Their Involvement as Biomarkers in Oral Cancers.Biomed Res Int. 2018 Jan 4;2018:8439820. doi: 10.1155/2018/8439820. eCollection 2018.
• [58] Increased expression of P-cadherin is an indicator of poor prognosis in breast cancer: a systematic review and meta-analysis.Breast Cancer Res Treat. 2020 Jan;179(2):301-313. doi: 10.1007/s10549-019-05477-5. Epub 2019 Oct 29.
• [59] Identifying Cancers Impacted by CDK8/19.Cells. 2019 Aug 3;8(8):821. doi: 10.3390/cells8080821.
• [60] Down-Regulation of p23 in Normal Lung Epithelial Cells Reduces Toxicities From Exposure to Benzo[a]pyrene and Cigarette Smoke Condensate via an Aryl Hydrocarbon Receptor-Dependent Mechanism.Toxicol Sci. 2019 Jan 1;167(1):239-248. doi: 10.1093/toxsci/kfy234.
• [61] CDKL1 promotes tumor proliferation and invasion in colorectal cancer.Onco Targets Ther. 2017 Mar 16;10:1613-1624. doi: 10.2147/OTT.S133014. eCollection 2017.
• [62] Chitotriosidase, a marker of innate immunity, is elevated in patients with primary breast cancer.Cancer Biomark. 2017 Jul 4;19(4):383-391. doi: 10.3233/CBM-160101.
• [63] Radiation-induced optic neuropathy after pencil beam scanning proton therapy for skull-base and head and neck tumours.Br J Radiol. 2020 Mar;93(1107):20190028. doi: 10.1259/bjr.20190028. Epub 2019 Aug 1.
• [64] DICER1 regulated let-7 expression levels in p53-induced cancer repression requires cyclin D1.J Cell Mol Med. 2015 Jun;19(6):1357-65. doi: 10.1111/jcmm.12522. Epub 2015 Feb 20.
• [65] Comparative genomic analysis of collagen gene diversity.3 Biotech. 2019 Mar;9(3):83. doi: 10.1007/s13205-019-1616-9. Epub 2019 Feb 14.
• [66] A lysosome-targeting and polarity-specific fluorescent probe for cancer diagnosis.Chem Commun (Camb). 2019 Apr 16;55(32):4703-4706. doi: 10.1039/c9cc00962k.
• [67] Caspase recruitment domain family member 10 regulates carbamoyl phosphate synthase 1 and promotes cancer growth in bladder cancer cells.J Cell Mol Med. 2019 Dec;23(12):8128-8138. doi: 10.1111/jcmm.14683. Epub 2019 Sep 29.
• [68] Regulation of human Cripto-1 expression by nuclear receptors and DNA promoter methylation in human embryonal and breast cancer cells.J Cell Physiol. 2013 Jun;228(6):1174-88. doi: 10.1002/jcp.24271.
• [69] Phase I study of orally administered (14)Carbon-isotope labelled-vistusertib (AZD2014), a dual TORC1/2 kinase inhibitor, to assess the absorption, metabolism, excretion, and pharmacokinetics in patients with advanced solid malignancies.Cancer Chemother Pharmacol. 2019 Apr;83(4):787-795. doi: 10.1007/s00280-019-03781-x. Epub 2019 Feb 13.
• [70] M2 macrophages promote NSCLC metastasis by upregulating CRYAB.Cell Death Dis. 2019 May 16;10(6):377. doi: 10.1038/s41419-019-1618-x.
• [71] Network-based identification of feedback modules that control RhoA activity and cell migration.J Mol Cell Biol. 2015 Jun;7(3):242-52. doi: 10.1093/jmcb/mjv017. Epub 2015 Mar 16.
• [72] Silencing of casein kinase 1 delta reduces migration and metastasis of triple negative breast cancer cells.Oncotarget. 2018 Jul 20;9(56):30821-30836. doi: 10.18632/oncotarget.25738. eCollection 2018 Jul 20.
• [73] Raman spectroscopy discriminates malignant follicular lymphoma from benign follicular hyperplasia and from tumour metastasis.Talanta. 2019 Mar 1;194:763-770. doi: 10.1016/j.talanta.2018.10.086. Epub 2018 Oct 28.
• [74] A novel derivative of artemisinin inhibits cell proliferation and metastasis via down-regulation of cathepsin K in breast cancer.Eur J Pharmacol. 2019 Sep 5;858:172382. doi: 10.1016/j.ejphar.2019.05.011. Epub 2019 May 18.
• [75] CX3CL1/CX3CR1 Axis, as the Therapeutic Potential in Renal Diseases: Friend or Foe?.Curr Gene Ther. 2017;17(6):442-452. doi: 10.2174/1566523218666180214092536.
• [76] CXCL13/CXCR5 signaling axis in cancer.Life Sci. 2019 Jun 15;227:175-186. doi: 10.1016/j.lfs.2019.04.053. Epub 2019 Apr 23.
• [77] Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells.Clin Chem. 2016 Nov;62(11):1504-1515. doi: 10.1373/clinchem.2016.260299. Epub 2016 Sep 14.
• [78] Plasma IFN--inducible chemokines CXCL9 and CXCL10 correlate with survival and chemotherapeutic efficacy in advanced pancreatic ductal adenocarcinoma.Pancreatology. 2019 Mar;19(2):340-345. doi: 10.1016/j.pan.2019.01.015. Epub 2019 Jan 19.
• [79] Targeting CXCR1/2: The medicinal potential as cancer immunotherapy agents, antagonists research highlights and challenges ahead.Eur J Med Chem. 2020 Jan 1;185:111853. doi: 10.1016/j.ejmech.2019.111853. Epub 2019 Nov 6.
• [80] RelA driven co-expression of CXCL13 and CXCR5 is governed by a multifaceted transcriptional program regulating breast cancer progression.Biochim Biophys Acta Mol Basis Dis. 2019 Feb 1;1865(2):502-511. doi: 10.1016/j.bbadis.2018.12.002. Epub 2018 Dec 12.
• [81] NOX2 in autoimmunity, tumor growth and metastasis.J Pathol. 2019 Feb;247(2):151-154. doi: 10.1002/path.5175. Epub 2018 Nov 29.
• [82] Molecular Design Strategy to Construct the Near-Infrared Fluorescent Probe for Selectively Sensing Human Cytochrome P450 2J2.J Am Chem Soc. 2019 Jan 16;141(2):1126-1134. doi: 10.1021/jacs.8b12136. Epub 2019 Jan 2.
• [83] Current understanding and recent advances in myositis-specific and -associated autoantibodies detected in patients with dermatomyositis.Expert Rev Clin Immunol. 2020 Jan;16(1):79-89. doi: 10.1080/1744666X.2019.1699059. Epub 2019 Dec 8.
• [84] Induction of HSP27 and HSP70 by constitutive overexpression of Redd1 confers resistance of lung cancer cells to ionizing radiation.Oncol Rep. 2019 May;41(5):3119-3126. doi: 10.3892/or.2019.7036. Epub 2019 Feb 28.
• [85] Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts disease-free and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression.BMC Cancer. 2018 Apr 13;18(1):418. doi: 10.1186/s12885-018-4333-6.
• [86] Stabilization of Intrinsically Disordered DKK2 Protein by Fusion to RNA-Binding Domain.Int J Mol Sci. 2019 Jun 11;20(11):2847. doi: 10.3390/ijms20112847.
• [87] Distinct hypoxic regulation of preadipocyte factor-1 (Pref-1) in preadipocytes and mature adipocytes.Biochim Biophys Acta Mol Cell Res. 2018 Feb;1865(2):334-342. doi: 10.1016/j.bbamcr.2017.11.008. Epub 2017 Nov 11.
• [88] Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer.Oncogene. 2019 Mar;38(12):2092-2107. doi: 10.1038/s41388-018-0562-z. Epub 2018 Nov 15.
• [89] Low bone mineral density may be associated with long-term risk of cancer in the middle-aged population: A retrospective observational study from a single center.J Formos Med Assoc. 2018 Apr;117(4):339-345. doi: 10.1016/j.jfma.2017.04.021. Epub 2017 May 16.
• [90] Unique genomic profile of fibrolamellar hepatocellular carcinoma.Gastroenterology. 2015 Apr;148(4):806-18.e10. doi: 10.1053/j.gastro.2014.12.028. Epub 2014 Dec 31.
• [91] Dysregulation of CRMP2 Post-Translational Modifications Drive Its Pathological Functions.Mol Neurobiol. 2019 Oct;56(10):6736-6755. doi: 10.1007/s12035-019-1568-4. Epub 2019 Mar 27.
• [92] Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism.Clin Cancer Res. 2019 Apr 1;25(7):2305-2313. doi: 10.1158/1078-0432.CCR-18-2572. Epub 2018 Dec 17.
• [93] The Dual-Specificity Phosphatase 10 (DUSP10): Its Role in Cancer, Inflammation, and Immunity.Int J Mol Sci. 2019 Apr 1;20(7):1626. doi: 10.3390/ijms20071626.
• [94] microRNA-95 knockdown inhibits epithelial-mesenchymal transition and cancer stem cell phenotype in gastric cancer cells through MAPK pathway by upregulating DUSP5.J Cell Physiol. 2020 Feb;235(2):944-956. doi: 10.1002/jcp.29010. Epub 2019 Jul 15.
• [95] Forced expression of DYRK2 exerts anti-tumor effects via apoptotic induction in liver cancer.Cancer Lett. 2019 Jun 1;451:100-109. doi: 10.1016/j.canlet.2019.02.046. Epub 2019 Mar 6.
• [96] PPAR- Ligand Inhibits Nasopharyngeal Carcinoma Cell Proliferation and Metastasis by Regulating E2F2.PPAR Res. 2019 Aug 1;2019:8679271. doi: 10.1155/2019/8679271. eCollection 2019.
• [97] E2F3 promotes cancer growth and is overexpressed through copy number variation in human melanoma.Onco Targets Ther. 2018 Aug 30;11:5303-5313. doi: 10.2147/OTT.S174103. eCollection 2018.
• [98] EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesis.Oncogene. 2019 Mar;38(12):2123-2134. doi: 10.1038/s41388-018-0565-9. Epub 2018 Nov 19.
• [99] The roles and signaling pathways of prolyl-4-hydroxylase 2 in the tumor microenvironment.Chem Biol Interact. 2019 Apr 25;303:40-49. doi: 10.1016/j.cbi.2019.02.019. Epub 2019 Feb 25.
• [100] Association between an indel polymorphism within the distal promoter of EGLN2 and cancer risk: An updated meta-analysis.Mol Genet Genomic Med. 2019 Oct;7(10):e00936. doi: 10.1002/mgg3.936. Epub 2019 Aug 15.
• [101] Hypoxia activates cadherin-22 synthesis via eIF4E2 to drive cancer cell migration, invasion and adhesion.Oncogene. 2018 Feb 1;37(5):651-662. doi: 10.1038/onc.2017.372. Epub 2017 Oct 9.
• [102] MicroRNA-588 regulates migration capacity and invasiveness of renal cancer cells by targeting EIF5A2.Eur Rev Med Pharmacol Sci. 2019 Dec;23(23):10248-10256. doi: 10.26355/eurrev_201912_19662.
• [103] Epigenetic Suppression of SERPINB1 Promotes Inflammation-Mediated Prostate Cancer Progression.Mol Cancer Res. 2019 Apr;17(4):845-859. doi: 10.1158/1541-7786.MCR-18-0638. Epub 2019 Jan 4.
• [104] Regulation of tNOX expression through the ROS-p53-POU3F2 axis contributes to cellular responses against oxaliplatin in human colon cancer cells.J Exp Clin Cancer Res. 2018 Jul 20;37(1):161. doi: 10.1186/s13046-018-0837-9.
• [105] Dysregulated ENPP1 increases the malignancy of human lung cancer by inducing epithelial-mesenchymal transition phenotypes and stem cell features.Am J Cancer Res. 2019 Jan 1;9(1):134-144. eCollection 2019.
• [106] MicroRNA-335 suppresses the proliferation, migration, and invasion of breast cancer cells by targeting EphA4.Mol Cell Biochem. 2018 Feb;439(1-2):95-104. doi: 10.1007/s11010-017-3139-1. Epub 2017 Aug 9.
• [107] Regulation of ERAP1 and ERAP2 genes and their disfunction in human cancer.Hum Immunol. 2019 May;80(5):318-324. doi: 10.1016/j.humimm.2019.02.014. Epub 2019 Feb 27.
• [108] Eya2 Is Overexpressed in Human Prostate Cancer and Regulates Docetaxel Sensitivity and Mitochondrial Membrane Potential through AKT/Bcl-2 Signaling.Biomed Res Int. 2019 Jun 16;2019:3808432. doi: 10.1155/2019/3808432. eCollection 2019.
• [109] Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking.Nat Commun. 2018 May 18;9(1):1988. doi: 10.1038/s41467-018-04355-w.
• [110] Inhibition of oncogenic Src induces FABP4-mediated lipolysis via PPAR activation exerting cancer growth suppression.EBioMedicine. 2019 Mar;41:134-145. doi: 10.1016/j.ebiom.2019.02.015. Epub 2019 Feb 10.
• [111] High Expression of FAM83B Predicts Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma and Correlates with Cell Cycle and Cell Proliferation.J Cancer. 2017 Sep 12;8(16):3154-3165. doi: 10.7150/jca.20086. eCollection 2017.
• [112] Assessment of FBA Based Gene Essentiality Analysis in Cancer with a Fast Context-Specific Network Reconstruction Method.PLoS One. 2016 May 4;11(5):e0154583. doi: 10.1371/journal.pone.0154583. eCollection 2016.
• [113] iNK-CD64/16A cells: a promising approach for ADCC?.Expert Opin Biol Ther. 2019 Dec;19(12):1229-1232. doi: 10.1080/14712598.2019.1667974. Epub 2019 Sep 19.
• [114] Cancer cell-derived immunoglobulin G activates platelets by binding to platelet FcRIIa.Cell Death Dis. 2019 Jan 28;10(2):87. doi: 10.1038/s41419-019-1367-x.
• [115] Structure-based virtual screening and biological evaluation of novel non-bisphosphonate farnesyl pyrophosphate synthase inhibitors.Eur J Med Chem. 2020 Jan 15;186:111905. doi: 10.1016/j.ejmech.2019.111905. Epub 2019 Nov 22.
• [116] Identification of FES as a Novel Radiosensitizing Target in Human Cancers.Clin Cancer Res. 2020 Jan 1;26(1):265-273. doi: 10.1158/1078-0432.CCR-19-0610. Epub 2019 Oct 1.
• [117] Aberrant fatty acid profile and FFAR4 signaling confer endocrine resistance in breast cancer.J Exp Clin Cancer Res. 2019 Feb 22;38(1):100. doi: 10.1186/s13046-019-1040-3.
• [118] Nonremission and Recurrent Tumor-Induced Osteomalacia: A Retrospective Study.J Bone Miner Res. 2020 Mar;35(3):469-477. doi: 10.1002/jbmr.3903. Epub 2019 Nov 15.
• [119] Epigenetic analysis of FHL1 tumor suppressor gene in human liver cancer. Oncol Lett. 2017 Nov;14(5):6109-6116.
• [120] Expression of FK506-binding protein 51 (FKBP51) in Mycosis fungoides.J Eur Acad Dermatol Venereol. 2018 May;32(5):735-744. doi: 10.1111/jdv.14614. Epub 2017 Nov 9.
• [121] FMNL1 down-regulation suppresses bone metastasis through reducing TGF-1 expression in non-small cell lung cancer (NSCLC).Biomed Pharmacother. 2019 Sep;117:109126. doi: 10.1016/j.biopha.2019.109126. Epub 2019 Jul 12.
• [122] Overexpression of FNDC1 in Gastric Cancer and its Prognostic Significance.J Cancer. 2018 Nov 13;9(24):4586-4595. doi: 10.7150/jca.27672. eCollection 2018.
• [123] Selective participation of c-Jun with Fra-2/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer.Sci Rep. 2015 Nov 19;5:16811. doi: 10.1038/srep16811.
• [124] Abnormal expression of Forkhead Box J2 (FOXJ2) suppresses migration and invasion in extrahepatic cholangiocarcinoma and is associated with prognosis.Int J Oncol. 2015;46(6):2449-58. doi: 10.3892/ijo.2015.2957. Epub 2015 Apr 7.
• [125] Expression and prognostic value of FOXP1 in esophageal squamous cell carcinoma.Pathol Res Pract. 2019 Dec;215(12):152645. doi: 10.1016/j.prp.2019.152645. Epub 2019 Oct 23.
• [126] Reciprocal transrepression between FOXF2 and FOXQ1 controls basal-like breast cancer aggressiveness.FASEB J. 2019 May;33(5):6564-6573. doi: 10.1096/fj.201801916R. Epub 2019 Feb 26.
• [127] The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis.Oncogene. 2015 Jul;34(29):3826-38. doi: 10.1038/onc.2014.309. Epub 2014 Sep 29.
• [128] The Activin Social Network: Activin, Inhibin, and Follistatin in Breast Development and Cancer.Endocrinology. 2019 May 1;160(5):1097-1110. doi: 10.1210/en.2019-00015.
• [129] Value of Ferritin Heavy Chain (FTH1) Expression in Diagnosis and Prognosis of Renal Cell Carcinoma.Med Sci Monit. 2019 May 19;25:3700-3715. doi: 10.12659/MSM.914162.
• [130] Rasputin a decade on and more promiscuous than ever? A review of G3BPs.Biochim Biophys Acta Mol Cell Res. 2019 Mar;1866(3):360-370. doi: 10.1016/j.bbamcr.2018.09.001. Epub 2018 Sep 5.
• [131] Linked Hexokinase and Glucose-6-Phosphatase Activities Reflect Grade of Ovarian Malignancy.Mol Imaging Biol. 2019 Apr;21(2):375-381. doi: 10.1007/s11307-018-1247-2.
• [132] A review of gigaxonin mutations in giant axonal neuropathy (GAN) and cancer.Hum Genet. 2016 Jul;135(7):675-84. doi: 10.1007/s00439-016-1659-5. Epub 2016 Mar 29.
• [133] GATA3 Expression in Common Gynecologic Carcinomas: A Potential Pitfall.Int J Gynecol Pathol. 2019 Sep;38(5):485-492. doi: 10.1097/PGP.0000000000000541.
• [134] Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.BMC Cancer. 2015 Oct 21;15:756. doi: 10.1186/s12885-015-1760-5.
• [135] S-Geranylgeranyl-L-glutathione is a ligand for human B cell-confinement receptor P2RY8.Nature. 2019 Mar;567(7747):244-248. doi: 10.1038/s41586-019-1003-z. Epub 2019 Mar 6.
• [136] First evidence of changes in enzyme kinetics and stability of glucokinase affected by somatic cancer-associated variations.Biochim Biophys Acta Proteins Proteom. 2019 Mar;1867(3):213-218. doi: 10.1016/j.bbapap.2018.12.008. Epub 2018 Dec 24.
• [137] ID2 and GJB2 promote early-stage breast cancer progression by regulating cancer stemness.Breast Cancer Res Treat. 2019 May;175(1):77-90. doi: 10.1007/s10549-018-05126-3. Epub 2019 Feb 6.
• [138] Design, synthesis, and biological activity evaluation of (-)-6-O-desmethylantofine analogues as potent anti-cancer agents.Bioorg Med Chem. 2019 Jul 15;27(14):3070-3081. doi: 10.1016/j.bmc.2019.05.030. Epub 2019 May 21.
• [139] EBI2 overexpression in mice leads to B1 B-cell expansion and chronic lymphocytic leukemia-like B-cell malignancies.Blood. 2017 Feb 16;129(7):866-878. doi: 10.1182/blood-2016-02-697185. Epub 2016 Dec 21.
• [140] Stabilization of Angiotensin-(1-7) by key substitution with a cyclic non-natural amino acid.Amino Acids. 2017 Oct;49(10):1733-1742. doi: 10.1007/s00726-017-2471-9. Epub 2017 Jul 25.
• [141] Features of Patients With Hereditary Mixed Polyposis Syndrome Caused by Duplication of GREM1 and Implications for Screening and Surveillance.Gastroenterology. 2017 Jun;152(8):1876-1880.e1. doi: 10.1053/j.gastro.2017.02.014. Epub 2017 Feb 24.
• [142] Grainyhead-like Protein 2: The Emerging Role in Hormone-Dependent Cancers and Epigenetics.Endocrinology. 2019 May 1;160(5):1275-1288. doi: 10.1210/en.2019-00213.
• [143] Glutamate Ionotropic Receptor Kainate Type Subunit 3 (GRIK3) promotes epithelial-mesenchymal transition in breast cancer cells by regulating SPDEF/CDH1 signaling.Mol Carcinog. 2019 Jul;58(7):1314-1323. doi: 10.1002/mc.23014. Epub 2019 Apr 11.
• [144] The N-methyl-D-aspartate receptor type 2A is frequently methylated in human colorectal carcinoma and suppresses cell growth.Oncogene. 2008 Mar 27;27(14):2045-54. doi: 10.1038/sj.onc.1210842. Epub 2007 Oct 8.
• [145] GRK5 promotes tumor progression in renal cell carcinoma.Neoplasma. 2019 Feb 6;66(2):261-270. doi: 10.4149/neo_2018_180621N409.
• [146] Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis.Oncotarget. 2018 Feb 3;9(17):13407-13422. doi: 10.18632/oncotarget.24388. eCollection 2018 Mar 2.
• [147] Advances in In-Silico based Predictive In-Vivo Profiling of Novel Potent -Glucuronidase Inhibitors.Curr Cancer Drug Targets. 2019;19(11):906-918. doi: 10.2174/1568009619666190320102238.
• [148] Cell-surface G-protein-coupled receptors for tumor-associated metabolites: A direct link to mitochondrial dysfunction in cancer.Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):246-257. doi: 10.1016/j.bbcan.2017.05.003. Epub 2017 May 13.
• [149] HDAC5 Expression in Urothelial Carcinoma Cell Lines Inhibits Long-Term Proliferation but Can Promote Epithelial-to-Mesenchymal Transition.Int J Mol Sci. 2019 Apr 30;20(9):2135. doi: 10.3390/ijms20092135.
• [150] Piperidine carbamate peptidomimetic inhibitors of the serine proteases HGFA, matriptase and hepsin.Medchemcomm. 2019 Jul 18;10(9):1646-1655. doi: 10.1039/c9md00234k. eCollection 2019 Sep 1.
• [151] Mendelian Randomization Study of ACLY and Cardiovascular Disease.N Engl J Med. 2019 Mar 14;380(11):1033-1042. doi: 10.1056/NEJMoa1806747.
• [152] The expression and significance of the HOXA7 gene in oral squamous cell carcinoma.J Oral Sci. 2017 Sep 14;59(3):329-335. doi: 10.2334/josnusd.16-0634. Epub 2017 May 19.
• [153] 4-hydroxyphenylpyruvate dioxygenase promotes lung cancer growth via pentose phosphate pathway (PPP) flux mediated by LKB1-AMPK/HDAC10/G6PD axis.Cell Death Dis. 2019 Jul 8;10(7):525. doi: 10.1038/s41419-019-1756-1.
• [154] Expression of 17-hydroxysteroid dehydrogenase type 2 is associated with some clinicopathological features in gastric cancer.Biomed Pharmacother. 2015 Mar;70:24-7. doi: 10.1016/j.biopha.2014.12.042. Epub 2015 Jan 9.
• [155] Hsp90ab1 stabilizes LRP5 to promote epithelial-mesenchymal transition via activating of AKT and Wnt/-catenin signaling pathways in gastric cancer progression.Oncogene. 2019 Feb;38(9):1489-1507. doi: 10.1038/s41388-018-0532-5. Epub 2018 Oct 10.
• [156] IFNAR2-dependent gene expression profile induced by IFN- in Pteropus alecto bat cells and impact of IFNAR2 knockout on virus infection.PLoS One. 2017 Aug 9;12(8):e0182866. doi: 10.1371/journal.pone.0182866. eCollection 2017.
• [157] YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.Mol Cancer. 2019 Nov 18;18(1):163. doi: 10.1186/s12943-019-1082-3.
• [158] IL-21R functions as an oncogenic factor and is regulated by the lncRNA MALAT1/miR-125a-3p axis in gastric cancer.Int J Oncol. 2019 Jan;54(1):7-16. doi: 10.3892/ijo.2018.4612. Epub 2018 Oct 31.
• [159] Hitting the bullseye with a nonlethal payload: resistance in CD123-positive malignancies.J Clin Invest. 2019 Nov 1;129(11):4590-4592. doi: 10.1172/JCI132443.
• [160] Targeting the Innate Immune Kinase IRAK1 in Radioresistant Cancer: Double-Edged Sword or One-Two Punch?.Front Oncol. 2019 Nov 13;9:1174. doi: 10.3389/fonc.2019.01174. eCollection 2019.
• [161] Discovery of potent IRAK-4 inhibitors as potential anti-inflammatory and anticancer agents using structure-based exploration of IRAK-4 pharmacophoric space coupled with QSAR analyses.Comput Biol Chem. 2019 Apr;79:147-154. doi: 10.1016/j.compbiolchem.2019.02.005. Epub 2019 Feb 20.
• [162] Interferon regulatory factor 1 and a variant of heterogeneous nuclear ribonucleoprotein L coordinately silence the gene for adhesion protein CEACAM1.J Biol Chem. 2018 Jun 15;293(24):9277-9291. doi: 10.1074/jbc.RA117.001507. Epub 2018 May 2.
• [163] SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells.Cancer Res. 2017 Jun 1;77(11):2834-2843. doi: 10.1158/0008-5472.CAN-16-2238. Epub 2017 Apr 5.
• [164] Identification of a Novel Invasion-Promoting Region in Insulin Receptor Substrate 2.Mol Cell Biol. 2018 Jun 28;38(14):e00590-17. doi: 10.1128/MCB.00590-17. Print 2018 Jul 15.
• [165] Integrin 11 expression is controlled by c-MYC in colorectal cancer cells.Oncogene. 2016 Mar 31;35(13):1671-8. doi: 10.1038/onc.2015.231. Epub 2015 Jun 22.
• [166] Insights into Fibroblast Plasticity: Cellular Communication Network 2 Is Required for Activation of Cancer-Associated Fibroblasts in a Murine Model of Melanoma.Am J Pathol. 2020 Jan;190(1):206-221. doi: 10.1016/j.ajpath.2019.09.006. Epub 2019 Oct 11.
• [167] Is Integrin Subunit Alpha 2 Expression a Prognostic Factor for Liver Carcinoma? A Validation Experiment Based on Bioinformatics Analysis.Pathol Oncol Res. 2019 Oct;25(4):1545-1552. doi: 10.1007/s12253-018-0551-0. Epub 2018 Dec 4.
• [168] Integrin 6 (CD49f), The Microenvironment and Cancer Stem Cells.Curr Stem Cell Res Ther. 2019;14(5):428-436. doi: 10.2174/1574888X13666181002151330.
• [169] Self-Maintaining CD103(+) Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses.Cancer Immunol Res. 2020 Feb;8(2):203-216. doi: 10.1158/2326-6066.CIR-19-0554. Epub 2019 Nov 26.
• [170] Sema4C mediates EMT inducing chemotherapeutic resistance of miR-31-3p in cervical cancer cells.Sci Rep. 2019 Nov 27;9(1):17727. doi: 10.1038/s41598-019-54177-z.
• [171] Jagged2 promotes cancer stem cell properties of triple negative breast cancer cells and paclitaxel resistance via regulating microRNA-200.Eur Rev Med Pharmacol Sci. 2018 Sep;22(18):6008-6014. doi: 10.26355/eurrev_201809_15936.
• [172] KCNJ1 inhibits tumor proliferation and metastasis and is a prognostic factor in clear cell renal cell carcinoma.Tumour Biol. 2015 Feb;36(2):1251-9. doi: 10.1007/s13277-014-2746-7. Epub 2014 Oct 26.
• [173] Changes in the expression of the potassium channels TASK1, TASK3 and TRESK in a rat model of oral squamous cell carcinoma and their relation to malignancy.Arch Oral Biol. 2019 Apr;100:75-85. doi: 10.1016/j.archoralbio.2019.02.007. Epub 2019 Feb 16.
• [174] KCNN4 channels participate in the EMT induced by PRL-3 in colorectal cancer.Med Oncol. 2013;30(2):566. doi: 10.1007/s12032-013-0566-z. Epub 2013 Apr 10.
• [175] Functional characterization of lysine-specific demethylase 2 (LSD2/KDM1B) in breast cancer progression.Oncotarget. 2017 Jul 19;8(47):81737-81753. doi: 10.18632/oncotarget.19387. eCollection 2017 Oct 10.
• [176] p300 Acetylates JHDM1A to inhibit osteosarcoma carcinogenesis.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):2891-2899. doi: 10.1080/21691401.2019.1638790.
• [177] Histone H3 binding to the PHD1 domain of histone demethylase KDM5A enables active site remodeling.Nat Commun. 2019 Jan 9;10(1):94. doi: 10.1038/s41467-018-07829-z.
• [178] Histone demethylase KDM7A is required for stem cell maintenance and apoptosis inhibition in breast cancer.J Cell Physiol. 2020 Feb;235(2):932-943. doi: 10.1002/jcp.29008. Epub 2019 Jun 24.
• [179] Kinesin family member 20B regulates tongue cancer progression by promoting cell proliferation.Mol Med Rep. 2019 Mar;19(3):2202-2210. doi: 10.3892/mmr.2019.9851. Epub 2019 Jan 11.
• [180] Large-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression Signature Associated with Colorectal Cancer Distant Recurrence.PLoS One. 2016 Dec 9;11(12):e0167455. doi: 10.1371/journal.pone.0167455. eCollection 2016.
• [181] NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment.Front Immunol. 2019 Mar 29;10:661. doi: 10.3389/fimmu.2019.00661. eCollection 2019.
• [182] Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models.Oncotarget. 2019 Feb 15;10(14):1399-1406. doi: 10.18632/oncotarget.26659. eCollection 2019 Feb 15.
• [183] Association of Cerebrospinal Fluid Biomarkers of Central Nervous System Injury With Neurocognitive and Brain Imaging Outcomes in Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia.JAMA Oncol. 2018 Jul 12;4(7):e180089. doi: 10.1001/jamaoncol.2018.0089. Epub 2018 Jul 12.
• [184] FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer.Cancers (Basel). 2019 Oct 16;11(10):1576. doi: 10.3390/cancers11101576.
• [185] Legumain acts on neuroinflammatory to affect CUS-induced cognitive impairment.Behav Brain Res. 2019 Dec 30;376:112219. doi: 10.1016/j.bbr.2019.112219. Epub 2019 Sep 8.
• [186] Circular RNA ciRS-7 promotes the proliferation and metastasis of pancreatic cancer by regulating miR-7-mediated EGFR/STAT3 signaling pathway.Hepatobiliary Pancreat Dis Int. 2019 Dec;18(6):580-586. doi: 10.1016/j.hbpd.2019.03.003. Epub 2019 Mar 9.
• [187] Identification of LIMK2 as a therapeutic target in castration resistant prostate cancer.Cancer Lett. 2019 Apr 28;448:182-196. doi: 10.1016/j.canlet.2019.01.035. Epub 2019 Feb 1.
• [188] Multi-Institutional Evaluation of Interrater Agreement of Variant Classification Based on the 2017 Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer.J Mol Diagn. 2020 Feb;22(2):284-293. doi: 10.1016/j.jmoldx.2019.10.010. Epub 2019 Dec 16.
• [189] Genome scale metabolic models as tools for drug design and personalized medicine.PLoS One. 2018 Jan 5;13(1):e0190636. doi: 10.1371/journal.pone.0190636. eCollection 2018.
• [190] Lymphotoxin- receptor-NIK signaling induces alternative RELB/NF-B2 activation to promote metastatic gene expression and cell migration in head and neck cancer.Mol Carcinog. 2019 Mar;58(3):411-425. doi: 10.1002/mc.22938. Epub 2018 Nov 28.
• [191] NIK-IKK complex interaction controls NF-B-dependent inflammatory activation of endothelium in response to LTR ligation.J Cell Sci. 2019 Apr 3;132(7):jcs225615. doi: 10.1242/jcs.225615.
• [192] MEN1309/OBT076, a First-In-Class Antibody-Drug Conjugate Targeting CD205 in Solid Tumors. Mol Cancer Ther. 2019 Sep;18(9):1533-1543.
• [193] mTORC1 regulates mannose-6-phosphate receptor transport and T-cell vulnerability to regulatory T cells by controlling kinesin KIF13A.Cell Discov. 2017 Apr 25;3:17011. doi: 10.1038/celldisc.2017.11. eCollection 2017.
• [194] Prognostic value of MAGEA4 in primary lung cancer depends on subcellular localization and p53 status.Int J Oncol. 2018 Aug;53(2):713-724. doi: 10.3892/ijo.2018.4425. Epub 2018 May 31.
• [195] Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma.CNS Neurosci Ther. 2020 Mar;26(3):297-308. doi: 10.1111/cns.13197. Epub 2019 Jul 18.
• [196] PARP-14 Promotes Survival of Mammalian but Not Pancreatic Cells Following Cytokine Treatment.Front Endocrinol (Lausanne). 2019 May 3;10:271. doi: 10.3389/fendo.2019.00271. eCollection 2019.
• [197] Multimodal Action of Mas Activation for Systemic Cancer Cachexia Therapy.Cancer Res. 2019 Feb 15;79(4):699-700. doi: 10.1158/0008-5472.CAN-18-3910.
• [198] The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.J Biol Chem. 2018 Mar 23;293(12):4334-4349. doi: 10.1074/jbc.RA117.000333. Epub 2018 Feb 6.
• [199] Discovery and Structure-Based Optimization of Next-Generation Reversible Methionine Aminopeptidase-2 (MetAP-2) Inhibitors.J Med Chem. 2019 May 23;62(10):5025-5039. doi: 10.1021/acs.jmedchem.9b00041. Epub 2019 May 2.
• [200] Label-free quantitative proteomic analysis of milk fat globule membrane proteins of yak and cow and identification of proteins associated with glucose and lipid metabolism.Food Chem. 2019 Mar 1;275:59-68. doi: 10.1016/j.foodchem.2018.09.044. Epub 2018 Sep 8.
• [201] Anti-Cholinesterase Activity of Chalcone Derivatives: Synthesis, In Vitro Assay and Molecular Docking Study.Med Chem. 2021;17(5):442-452. doi: 10.2174/1573406415666191206095032.
• [202] Transcriptome-wide analysis uncovers the targets of the RNA-binding protein MSI2 and effects of MSI2's RNA-binding activity on IL-6 signaling.J Biol Chem. 2018 Oct 5;293(40):15359-15369. doi: 10.1074/jbc.RA118.002243. Epub 2018 Aug 20.
• [203] Mucin 17 inhibits the progression of human gastric cancer by limiting inflammatory responses through a MYH9-p53-RhoA regulatory feedback loop.J Exp Clin Cancer Res. 2019 Jul 1;38(1):283. doi: 10.1186/s13046-019-1279-8.
• [204] Main pancreatic duct dilation greater than 6mm is associated with an increased risk of high-grade dysplasia and cancer in IPMN patients.Langenbecks Arch Surg. 2019 Feb;404(1):31-37. doi: 10.1007/s00423-018-1740-8. Epub 2019 Jan 5.
• [205] Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment.Cell. 2019 Feb 7;176(4):757-774.e23. doi: 10.1016/j.cell.2018.12.038. Epub 2019 Jan 31.
• [206] Regulation of Krppel-like factor 8 by the NEDD4 E3 ubiquitin ligase.Am J Transl Res. 2019 Mar 15;11(3):1521-1530. eCollection 2019.
• [207] NRP-1 interacts with GIPC1 and SYX to activate p38 MAPK signaling and cancer stem cell survival.Mol Carcinog. 2019 Apr;58(4):488-499. doi: 10.1002/mc.22943. Epub 2018 Dec 21.
• [208] Knockout model reveals the role of Nischarin in mammary gland development, breast tumorigenesis and response to metformin treatment.Int J Cancer. 2020 May 1;146(9):2576-2587. doi: 10.1002/ijc.32690. Epub 2019 Oct 31.
• [209] Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.Immunogenetics. 2019 Mar;71(3):273-282. doi: 10.1007/s00251-019-01106-z. Epub 2019 Jan 31.
• [210] The Innate Immune Receptor NLRX1 Functions as a Tumor Suppressor by Reducing Colon Tumorigenesis and Key Tumor-Promoting Signals.Cell Rep. 2016 Mar 22;14(11):2562-75. doi: 10.1016/j.celrep.2016.02.064. Epub 2016 Mar 10.
• [211] Nod1 Imprints Inflammatory and Carcinogenic Responses toward the Gastric Pathogen Helicobacter pylori.Cancer Res. 2019 Apr 1;79(7):1600-1611. doi: 10.1158/0008-5472.CAN-18-2651. Epub 2019 Jan 29.
• [212] Discovery of potent 4-aminoquinoline hydrazone inhibitors of NRH:quinoneoxidoreductase-2 (NQO2).Eur J Med Chem. 2019 Nov 15;182:111649. doi: 10.1016/j.ejmech.2019.111649. Epub 2019 Aug 27.
• [213] First synthesis of merged hybrids phosphorylated azirino[2,1-b]benzo[e][1,3]oxazine derivatives as anticancer agents.Eur J Med Chem. 2020 Jan 1;185:111771. doi: 10.1016/j.ejmech.2019.111771. Epub 2019 Oct 19.
• [214] The NOR1/OSCP1 proteins in cancer: from epigenetic silencing to functional characterization of a novel tumor suppressor.J Cancer. 2017 Feb 25;8(4):626-635. doi: 10.7150/jca.17579. eCollection 2017.
• [215] Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate.Oncotarget. 2017 Jul 6;8(44):76141-76152. doi: 10.18632/oncotarget.19056. eCollection 2017 Sep 29.
• [216] Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis.Oncogene. 2018 Feb 8;37(6):756-767. doi: 10.1038/onc.2017.365. Epub 2017 Oct 23.
• [217] Effect of Gender on the Pharmacokinetics of ON 123300, A Dual Inhibitor of ARK5 and CDK4/6 for the Treatment of Cancer, in Rats.Eur J Drug Metab Pharmacokinet. 2019 Aug;44(4):531-538. doi: 10.1007/s13318-019-00542-2.
• [218] Prospective oncotarget for gynecological cancer: Opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis.Int Immunopharmacol. 2019 Oct;75:105723. doi: 10.1016/j.intimp.2019.105723. Epub 2019 Aug 9.
• [219] Targeted OMA1 therapies for cancer.Int J Cancer. 2019 Nov 1;145(9):2330-2341. doi: 10.1002/ijc.32177. Epub 2019 Feb 21.
• [220] Epidural analgesia with sufentanil in relation to OPRM1 and ABCB1 polymorphisms.Physiol Res. 2019 Nov 22;68(Suppl 1):S59-S64. doi: 10.33549/physiolres.934325.
• [221] Enhanced anticancer effect of oncostatin M combined with salinomycin in CD133(+) HepG2 liver cancer cells.Oncol Lett. 2019 Feb;17(2):1798-1806. doi: 10.3892/ol.2018.9796. Epub 2018 Dec 5.
• [222] Involvement of the P2X7 purinergic receptor in inflammation: an update of antagonists series since 2009 and their promising therapeutic potential.Curr Med Chem. 2015;22(6):713-29. doi: 10.2174/0929867322666141212120926.
• [223] Cell Death Induced by Cationic Amphiphilic Drugs Depends on Lysosomal Ca(2+) Release and Cyclic AMP.Mol Cancer Ther. 2019 Sep;18(9):1602-1614. doi: 10.1158/1535-7163.MCT-18-1406. Epub 2019 Jul 8.
• [224] Dual NRASQ61R and BRAFV600E mutation-specific immunohistochemistry completes molecular screening in melanoma samples in a routine practice.Hum Pathol. 2015 Nov;46(11):1582-91. doi: 10.1016/j.humpath.2015.06.023. Epub 2015 Jul 15.
• [225] Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting Cancer Cell Glycolysis.Clin Cancer Res. 2019 Feb 15;25(4):1318-1330. doi: 10.1158/1078-0432.CCR-18-2297. Epub 2018 Nov 12.
• [226] High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent-free survival in head and neck squamous cell carcinoma.J Clin Lab Anal. 2020 Mar;34(3):e23107. doi: 10.1002/jcla.23107. Epub 2019 Nov 29.
• [227] Impact of wood combustion on indoor air quality.Sci Total Environ. 2020 Feb 25;705:135769. doi: 10.1016/j.scitotenv.2019.135769. Epub 2019 Nov 27.
• [228] P21 activated kinase 2 promotes pancreatic cancer growth and metastasis.Oncol Lett. 2019 Apr;17(4):3709-3718. doi: 10.3892/ol.2019.10040. Epub 2019 Feb 14.
• [229] Elucidation of in vitro cellular steps induced by antitumor treatment with plasma-activated medium.Sci Rep. 2019 Mar 19;9(1):4866. doi: 10.1038/s41598-019-41408-6.
• [230] Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death.Nat Commun. 2019 Dec 11;10(1):5654. doi: 10.1038/s41467-019-13508-4.
• [231] PARP3 comes to light as a prime target in cancer therapy.Cell Cycle. 2019 Jun;18(12):1295-1301. doi: 10.1080/15384101.2019.1617454. Epub 2019 May 29.
• [232] Design, purification and assessment of GRP78 binding peptide-linked Subunit A of Subtilase cytotoxic for targeting cancer cells.BMC Biotechnol. 2016 Sep 1;16(1):65. doi: 10.1186/s12896-016-0294-5.
• [233] -catenin nuclear translocation in colorectal cancer cells is suppressed by PDE10A inhibition, cGMP elevation, and activation of PKG.Oncotarget. 2016 Feb 2;7(5):5353-65. doi: 10.18632/oncotarget.6705.
• [234] RSK Regulates PFK-2 Activity to Promote Metabolic Rewiring in Melanoma.Cancer Res. 2018 May 1;78(9):2191-2204. doi: 10.1158/0008-5472.CAN-17-2215. Epub 2018 Feb 12.
• [235] Two well-differentiated pancreatic neuroendocrine tumor mouse models.Cell Death Differ. 2020 Jan;27(1):269-283. doi: 10.1038/s41418-019-0355-0. Epub 2019 Jun 3.
• [236] Small molecule PIKfyve inhibitors as cancer therapeutics: Translational promises and limitations.Toxicol Appl Pharmacol. 2019 Nov 15;383:114771. doi: 10.1016/j.taap.2019.114771. Epub 2019 Oct 16.
• [237] Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors.Eur J Med Chem. 2019 Apr 15;168:87-109. doi: 10.1016/j.ejmech.2019.02.022. Epub 2019 Feb 19.
• [238] A Concise Update on the Relevance of Secretory Phospholipase A2 Group IIA and its Inhibitors with Cancer.Med Chem. 2017;13(7):606-615. doi: 10.2174/1573406413666170209121317.
• [239] Cytosolic Phospholipase A2 Alpha Regulates TLR Signaling and Migration in Metastatic 4T1 Cells.Int J Mol Sci. 2019 Sep 27;20(19):4800. doi: 10.3390/ijms20194800.
• [240] Phospholipase D2 in prostate cancer: protein expression changes with Gleason score.Br J Cancer. 2019 Dec;121(12):1016-1026. doi: 10.1038/s41416-019-0610-7. Epub 2019 Nov 1.
• [241] Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiforme.PeerJ. 2019 Nov 19;7:e7974. doi: 10.7717/peerj.7974. eCollection 2019.
• [242] Deficiency of lysyl hydroxylase 2 in mice causes systemic endoplasmic reticulum stress leading to early embryonic lethality.Biochem Biophys Res Commun. 2019 May 7;512(3):486-491. doi: 10.1016/j.bbrc.2019.03.091. Epub 2019 Mar 21.
• [243] Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition.BMC Med. 2017 Jul 5;15(1):122. doi: 10.1186/s12916-017-0885-6.
• [244] PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer.Cancer Discov. 2019 Feb;9(2):220-229. doi: 10.1158/2159-8290.CD-18-0706. Epub 2018 Nov 15.
• [245] Retinoic acid directs breast cancer cell state changes through regulation of TET2-PKC pathway.Oncogene. 2017 Jun 1;36(22):3193-3206. doi: 10.1038/onc.2016.467. Epub 2017 Feb 20.
• [246] COX-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesis.Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5223-5232. doi: 10.1073/pnas.1819303116. Epub 2019 Feb 28.
• [247] Anion-specific interaction with human NQO1 inhibits flavin binding.Int J Biol Macromol. 2019 Apr 1;126:1223-1233. doi: 10.1016/j.ijbiomac.2019.01.016. Epub 2019 Jan 4.
• [248] Presenilin Mutation Suppresses Lung Tumorigenesis via Inhibition of Peroxiredoxin 6 Activity and Expression.Theranostics. 2017 Sep 1;7(15):3624-3637. doi: 10.7150/thno.21408. eCollection 2017.
• [249] Effects of anti-inflammatory and adaptogenic herbal extracts on gene expression of eicosanoids signaling pathways in isolated brain cells.Phytomedicine. 2019 Jul;60:152881. doi: 10.1016/j.phymed.2019.152881. Epub 2019 Mar 10.
• [250] The Expression, Functions, Interactions and Prognostic Values of PTPRZ1: A Review and Bioinformatic Analysis.J Cancer. 2019 Apr 2;10(7):1663-1674. doi: 10.7150/jca.28231. eCollection 2019.
• [251] How safe and effective is denosumab for bone giant cell tumour?.Int Orthop. 2017 Nov;41(11):2397-2400. doi: 10.1007/s00264-017-3536-9. Epub 2017 Jun 23.
• [252] MicroRNA-193b acts as a tumor suppressor in colon cancer progression via targeting RAB22A.Exp Ther Med. 2019 May;17(5):3921-3928. doi: 10.3892/etm.2019.7435. Epub 2019 Mar 26.
• [253] RBCK1 contributes to chemoresistance and stemness in colorectal cancer (CRC).Biomed Pharmacother. 2019 Oct;118:109250. doi: 10.1016/j.biopha.2019.109250. Epub 2019 Aug 13.
• [254] Rce1 suppresses invasion and metastasis of hepatocellular carcinoma via epithelial-mesenchymal transition induced by the TGF-1/H-Ras signaling pathway.J Cell Physiol. 2020 Mar;235(3):2506-2520. doi: 10.1002/jcp.29155. Epub 2019 Sep 11.
• [255] Diversity of mechanisms in Ras-GAP catalysis of guanosine triphosphate hydrolysis revealed by molecular modeling.Org Biomol Chem. 2019 May 15;17(19):4879-4891. doi: 10.1039/c9ob00463g.
• [256] Transcriptional and post-transcriptional regulation of the genes encoding the small GTPases RhoA, RhoB, and RhoC: implications for the pathogenesis of human diseases.Cell Mol Life Sci. 2018 Jun;75(12):2111-2124. doi: 10.1007/s00018-018-2787-y. Epub 2018 Mar 2.
• [257] Regulation of RhoB Gene Expression during Tumorigenesis and Aging Process and Its Potential Applications in These Processes.Cancers (Basel). 2019 Jun 13;11(6):818. doi: 10.3390/cancers11060818.
• [258] The role of RICTOR downstream of receptor tyrosine kinase in cancers.Mol Cancer. 2018 Feb 19;17(1):39. doi: 10.1186/s12943-018-0794-0.
• [259] RIPK4 promoted the tumorigenicity of nasopharyngeal carcinoma cells.Biomed Pharmacother. 2018 Dec;108:1-6. doi: 10.1016/j.biopha.2018.08.147. Epub 2018 Sep 10.
• [260] Complete Genome Sequence of Streptomyces olivoreticuli ATCC 31159 Which can Produce Anticancer Bestatin and Show Diverse Secondary Metabolic Potentials.Curr Microbiol. 2019 Mar;76(3):370-375. doi: 10.1007/s00284-019-01638-3. Epub 2019 Jan 31.
• [261] Robo1 and vimentin regulate radiation-induced motility of human glioblastoma cells.PLoS One. 2018 Jun 4;13(6):e0198508. doi: 10.1371/journal.pone.0198508. eCollection 2018.
• [262] LINC01638 lncRNA mediates the postoperative distant recurrence of bladder cancer by upregulating ROCK2.Oncol Lett. 2019 Nov;18(5):5392-5398. doi: 10.3892/ol.2019.10924. Epub 2019 Sep 26.
• [263] ROR1 and ROR2-novel targets for neuroblastoma.Pediatr Hematol Oncol. 2019 Sep;36(6):352-364. doi: 10.1080/08880018.2019.1646365. Epub 2019 Aug 23.
• [264] DNA methylation accumulation in gastric mucosa adjacent to cancer after Helicobacter pylori eradication.Int J Cancer. 2019 Jan 1;144(1):80-88. doi: 10.1002/ijc.31667. Epub 2018 Nov 12.
• [265] R-spondin3 Is Associated with Basal-Progenitor Behavior in Normal and Tumor Mammary Cells.Cancer Res. 2018 Aug 15;78(16):4497-4511. doi: 10.1158/0008-5472.CAN-17-2676. Epub 2018 May 10.
• [266] Impact of RTN4 gene polymorphism and its plasma level on susceptibility to nasopharyngeal carcinoma: A case-control study.Medicine (Baltimore). 2019 Nov;98(47):e17831. doi: 10.1097/MD.0000000000017831.
• [267] Oncogenic potential of truncated RXR during colitis-associated colorectal tumorigenesis by promoting IL-6-STAT3 signaling.Nat Commun. 2019 Apr 1;10(1):1463. doi: 10.1038/s41467-019-09375-8.
• [268] Combination of S100B and procalcitonin improves prognostic performance compared to either alone in patients with cardiac arrest: A prospective observational study.Medicine (Baltimore). 2019 Feb;98(6):e14496. doi: 10.1097/MD.0000000000014496.
• [269] Sexually dimorphic therapeutic response in bortezomib-induced neuropathic pain reveals altered pain physiology in female rodents.Pain. 2020 Jan;161(1):177-184. doi: 10.1097/j.pain.0000000000001697.
• [270] Differential expression of S1P receptor subtypes in human bladder transitional cell carcinoma.Clin Transl Oncol. 2019 Sep;21(9):1240-1249. doi: 10.1007/s12094-019-02049-3. Epub 2019 Feb 2.
• [271] Sumoylation Negatively Regulates CSR1-Dependent Prostate Cancer Cell Death.Cell Physiol Biochem. 2018;46(5):1861-1867. doi: 10.1159/000489370. Epub 2018 Apr 25.
• [272] Mutational hotspots of HSP47 and its potential role in cancer and bone-disorders.Genomics. 2020 Jan;112(1):552-566. doi: 10.1016/j.ygeno.2019.04.007. Epub 2019 Apr 12.
• [273] ER-mitochondria interactions: Both strength and weakness within cancer cells.Biochim Biophys Acta Mol Cell Res. 2019 Apr;1866(4):650-662. doi: 10.1016/j.bbamcr.2019.01.009. Epub 2019 Jan 19.
• [274] Probing Medulloblastoma Initiation at the Single-Cell Level.Trends Cancer. 2019 Dec;5(12):759-761. doi: 10.1016/j.trecan.2019.10.002. Epub 2019 Oct 28.
• [275] Salt-Inducible Kinase 2: An Oncogenic Signal Transmitter and Potential Target for Cancer Therapy.Front Oncol. 2019 Jan 22;9:18. doi: 10.3389/fonc.2019.00018. eCollection 2019.
• [276] SLAMF6 clustering is required to augment T cell activation.PLoS One. 2019 Jun 14;14(6):e0218109. doi: 10.1371/journal.pone.0218109. eCollection 2019.
• [277] A new target ligand Ser-Glu for PEPT1-overexpressing cancer imaging.Int J Nanomedicine. 2016 Jan 11;11:203-12. doi: 10.2147/IJN.S97207. eCollection 2016.
• [278] A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy.BMC Cancer. 2017 Jul 12;17(1):481. doi: 10.1186/s12885-017-3476-1.
• [279] Affinity, binding kinetics and functional characterization of draflazine analogues for human equilibrative nucleoside transporter 1 (SLC29A1).Biochem Pharmacol. 2020 Feb;172:113747. doi: 10.1016/j.bcp.2019.113747. Epub 2019 Dec 10.
• [280] Regulation of differential proton-coupled folate transporter gene expression in human tumors: transactivation by KLF15 with NRF-1 and the role of Sp1.Biochem J. 2019 Apr 26;476(8):1247-1266. doi: 10.1042/BCJ20180394.
• [281] MATE2 Expression Is Associated with Cancer Cell Response to Metformin.PLoS One. 2016 Dec 13;11(12):e0165214. doi: 10.1371/journal.pone.0165214. eCollection 2016.
• [282] Inhibition of skin squamous cell carcinoma proliferation and promote apoptosis by dual silencing of NET-1 and survivin.Oncol Rep. 2015 Aug;34(2):811-22. doi: 10.3892/or.2015.4062. Epub 2015 Jun 15.
• [283] Calreticulin in phagocytosis and cancer: opposite roles in immune response outcomes.Apoptosis. 2019 Apr;24(3-4):245-255. doi: 10.1007/s10495-019-01532-0.
• [284] Multiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancer.Prostaglandins Other Lipid Mediat. 2015 Jan-Mar;116-117:99-103. doi: 10.1016/j.prostaglandins.2014.11.003. Epub 2014 Nov 27.
• [285] Gentamicin Targets Acid Sphingomyelinase in Cancer: The Case of the Human Gastric Cancer NCI-N87 Cells.Int J Mol Sci. 2019 Sep 6;20(18):4375. doi: 10.3390/ijms20184375.
• [286] SOSTDC1 inhibits bone metastasis in non-small cell lung cancer and may serve as a clinical therapeutic target.Int J Mol Med. 2018 Dec;42(6):3424-3436. doi: 10.3892/ijmm.2018.3926. Epub 2018 Oct 10.
• [287] The Emerging Role of Sperm-Associated Antigen 6 Gene in the Microtubule Function of Cells and Cancer.Mol Ther Oncolytics. 2019 Sep 10;15:101-107. doi: 10.1016/j.omto.2019.08.011. eCollection 2019 Dec 20.
• [288] New insights into the roles and regulation of SphK2 as a therapeutic target in cancer chemoresistance.J Cell Physiol. 2019 Jun;234(6):8162-8181. doi: 10.1002/jcp.27612. Epub 2018 Nov 19.
• [289] Registry of Buildings With Transformer Stations as a Basis for Epidemiological Studies on Health Effects of Extremely Low-Frequency Magnetic Fields.Bioelectromagnetics. 2020 Jan;41(1):34-40. doi: 10.1002/bem.22228. Epub 2019 Nov 19.
• [290] p38/S1P/SREBP2 activation by the SAM-competitive EZH2 inhibitor GSK343 limits its anticancer activity but creates a druggable vulnerability in hepatocellular carcinoma.Am J Cancer Res. 2019 Oct 1;9(10):2120-2139. eCollection 2019.
• [291] Tumorigenic functions of serglycin: Regulatory roles in epithelial to mesenchymal transition and oncogenic signaling.Semin Cancer Biol. 2020 May;62:108-115. doi: 10.1016/j.semcancer.2019.07.004. Epub 2019 Jul 4.
• [292] Serine/arginine protein-specific kinase 2 promotes the development and progression of pancreatic cancer by downregulating Numb and p53.FEBS J. 2019 May;286(9):1668-1682. doi: 10.1111/febs.14778. Epub 2019 Mar 1.
• [293] Characterization of HMGB1/2 Interactome in Prostate Cancer by Yeast Two Hybrid Approach: Potential Pathobiological Implications.Cancers (Basel). 2019 Nov 5;11(11):1729. doi: 10.3390/cancers11111729.
• [294] Overcoming drug-resistance in lung cancer cells by paclitaxel loaded galactoxyloglucan nanoparticles.Int J Biol Macromol. 2019 Sep 1;136:266-274. doi: 10.1016/j.ijbiomac.2019.06.075. Epub 2019 Jun 12.
• [295] Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8(+) T-cell Response against Immunosuppressive Tumors.Clin Cancer Res. 2019 Jun 1;25(11):3289-3303. doi: 10.1158/1078-0432.CCR-18-3016. Epub 2019 Feb 12.
• [296] MLL2 promotes cancer cell lymph node metastasis by interacting with RelA and facilitating STC1 transcription.Cell Signal. 2020 Jan;65:109457. doi: 10.1016/j.cellsig.2019.109457. Epub 2019 Oct 30.
• [297] Six-Transmembrane Epithelial Antigen of the Prostate-1 (STEAP-1)-Targeted Ultrasound Imaging Microbubble Improves Detection of Prostate Cancer In Vivo.J Ultrasound Med. 2019 Feb;38(2):299-305. doi: 10.1002/jum.14689. Epub 2018 Jul 19.
• [298] STEAP2 is down-regulated in breast cancer tissue and suppresses PI3K/AKT signaling and breast cancer cell invasion in vitro and in vivo.Cancer Biol Ther. 2020;21(3):278-291. doi: 10.1080/15384047.2019.1685290. Epub 2019 Nov 7.
• [299] Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene body demethylation.Leukemia. 2019 Apr;33(4):945-956. doi: 10.1038/s41375-018-0293-8. Epub 2018 Nov 23.
• [300] Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway.J Exp Clin Cancer Res. 2018 Jun 28;37(1):128. doi: 10.1186/s13046-018-0787-2.
• [301] Downregulation of transgelin 2 promotes breast cancer metastasis by activating the reactive oxygen species/nuclear factorB signaling pathway.Mol Med Rep. 2019 Nov;20(5):4045-4258. doi: 10.3892/mmr.2019.10643. Epub 2019 Sep 3.
• [302] T-cell immune regulator 1 enhances metastasis in hepatocellular carcinoma.Exp Mol Med. 2018 Jan 5;50(1):e420. doi: 10.1038/emm.2017.166.
• [303] Transferrin Receptor Targeted Cellular Delivery of Doxorubicin Via a Reduction-Responsive Peptide-Drug Conjugate.Pharm Res. 2019 Oct 25;36(12):168. doi: 10.1007/s11095-019-2688-2.
• [304] Author Correction: AMP kinase promotes glioblastoma bioenergetics and tumour growth.Nat Cell Biol. 2018 Nov;20(11):1328. doi: 10.1038/s41556-018-0203-3.
• [305] Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer.Dis Markers. 2019 Jan 10;2019:5160565. doi: 10.1155/2019/5160565. eCollection 2019.
• [306] A Common Variant in the Adaptor Mal Regulates Interferon Gamma Signaling.Immunity. 2016 Feb 16;44(2):368-79. doi: 10.1016/j.immuni.2016.01.019.
• [307] p53-responsive TLR8 SNP enhances human innate immune response to respiratory syncytial virus.J Clin Invest. 2019 Nov 1;129(11):4875-4884. doi: 10.1172/JCI128626.
• [308] Expression of TMBIM6 in Cancers: The Involvement of Sp1 and PKC.Cancers (Basel). 2019 Jul 11;11(7):974. doi: 10.3390/cancers11070974.
• [309] Thymosin -4 is a novel regulator for primary cilium formation by nephronophthisis 3 in HeLa human cervical cancer cells.Sci Rep. 2019 May 2;9(1):6849. doi: 10.1038/s41598-019-43235-1.
• [310] HVEM network signaling in cancer.Adv Cancer Res. 2019;142:145-186. doi: 10.1016/bs.acr.2019.01.004. Epub 2019 Feb 27.
• [311] Death Receptor 6 (DR6) Is Overexpressed in Astrocytomas.Anticancer Res. 2019 May;39(5):2299-2306. doi: 10.21873/anticanres.13346.
• [312] TWEAK/Fn14 Interaction Confers AggressiveProperties to Cutaneous SquamousCell Carcinoma.J Invest Dermatol. 2019 Apr;139(4):796-806. doi: 10.1016/j.jid.2018.09.035. Epub 2018 Nov 8.
• [313] Distinct Expression Patterns of Two Tumor Necrosis Factor Superfamily Member 15 Gene Isoforms in Human Colon Cancer.Dig Dis Sci. 2019 Jul;64(7):1857-1867. doi: 10.1007/s10620-019-05507-8. Epub 2019 Feb 20.
• [314] TREM2 Acts as a Tumor Suppressor in Colorectal Carcinoma through Wnt1/-catenin and Erk Signaling.Cancers (Basel). 2019 Sep 6;11(9):1315. doi: 10.3390/cancers11091315.
• [315] Dermatomyositis: Clinical features and pathogenesis.J Am Acad Dermatol. 2020 Feb;82(2):267-281. doi: 10.1016/j.jaad.2019.06.1309. Epub 2019 Jul 4.
• [316] Luminescent nanomaterials for droplet tracking in a microfluidic trapping array.Anal Bioanal Chem. 2019 Jan;411(1):157-170. doi: 10.1007/s00216-018-1448-1. Epub 2018 Nov 28.
• [317] TRPC1 and ORAI1 channels in colon cancer.Cell Calcium. 2019 Jul;81:59-66. doi: 10.1016/j.ceca.2019.06.003. Epub 2019 Jun 7.
• [318] TRPM1 Autoantibodies in Melanoma Patients Without Self-Reported Visual Symptoms.Invest Ophthalmol Vis Sci. 2019 May 1;60(6):2330-2335. doi: 10.1167/iovs.19-26775.
• [319] TRPM4 channel and cancer.Cancer Lett. 2019 Jul 10;454:66-69. doi: 10.1016/j.canlet.2019.04.012. Epub 2019 Apr 10.
• [320] RETRACTED: TRPV6 calcium channel regulation, downstream pathways, and therapeutic targeting in cancer.Cell Calcium. 2019 Jun;80:117-124. doi: 10.1016/j.ceca.2019.04.006. Epub 2019 Apr 22.
• [321] Calcium Signaling and the Regulation of Chemosensitivity in Cancer Cells: Role of the Transient Receptor Potential Channels.Adv Exp Med Biol. 2020;1131:505-517. doi: 10.1007/978-3-030-12457-1_20.
• [322] A personalized approach identifies disturbed pathways and key genes in hepatitis C virus-cirrhosis with hepatocellular carcinoma.Eur Rev Med Pharmacol Sci. 2016 Oct;20(20):4266-4273.
• [323] UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.Mol Med Rep. 2019 Aug;20(2):1212-1220. doi: 10.3892/mmr.2019.10322. Epub 2019 Jun 3.
• [324] Inhibition of USP2 eliminates cancer stem cells and enhances TNBC responsiveness to chemotherapy.Cell Death Dis. 2019 Mar 28;10(4):285. doi: 10.1038/s41419-019-1512-6.
• [325] Amplification of Glyceronephosphate O-Acyltransferase and Recruitment of USP30 Stabilize DRP1 to Promote Hepatocarcinogenesis.Cancer Res. 2018 Oct 15;78(20):5808-5819. doi: 10.1158/0008-5472.CAN-18-0340. Epub 2018 Aug 24.
• [326] USP44 Promotes the Tumorigenesis of Prostate Cancer Cells through EZH2 Protein Stabilization.Mol Cells. 2019 Jan 31;42(1):17-27. doi: 10.14348/molcells.2018.0329. Epub 2019 Jan 2.
• [327] Hippo/Mst1 overexpression induces mitochondrial death in head and neck squamous cell carcinoma via activating -catenin/Drp1 pathway.Cell Stress Chaperones. 2019 Jul;24(4):807-816. doi: 10.1007/s12192-019-01008-9. Epub 2019 May 24.
• [328] VCAM-1 Density and Tumor Perfusion Predict T-cell Infiltration and Treatment Response in Preclinical Models.Neoplasia. 2019 Oct;21(10):1036-1050. doi: 10.1016/j.neo.2019.08.003. Epub 2019 Sep 11.
• [329] Pharmacogenomics: from bedside to clinical practice.Hum Mol Genet. 2006 Apr 15;15 Spec No 1:R89-93. doi: 10.1093/hmg/ddl087.
• [330] WWP2 Is One Promising Novel Oncogene.Pathol Oncol Res. 2019 Apr;25(2):443-446. doi: 10.1007/s12253-018-0506-5. Epub 2018 Nov 10.
• [331] YES1 Is a Targetable Oncogene in Cancers Harboring YES1 Gene Amplification.Cancer Res. 2019 Nov 15;79(22):5734-5745. doi: 10.1158/0008-5472.CAN-18-3376. Epub 2019 Aug 7.
• [332] The crucial role of ZEB2: From development to epithelial-to-mesenchymal transition and cancer complexity.J Cell Physiol. 2019 Sep;234(9):14783-14799. doi: 10.1002/jcp.28277. Epub 2019 Feb 17.
• [333] Identification of the zinc finger 216 (ZNF216) in human carcinoma cells: a potential regulator of EGFR activity.Oncotarget. 2016 Nov 15;7(46):74947-74965. doi: 10.18632/oncotarget.12509.
• [334] Targeting AU-rich element-mediated mRNA decay with a truncated active form of the zinc-finger protein TIS11b/BRF1 impairs major hallmarks of mammary tumorigenesis.Oncogene. 2019 Jun;38(26):5174-5190. doi: 10.1038/s41388-019-0784-8. Epub 2019 Mar 26.
• [335] The Emerging Role of Zfp217 in Adipogenesis.Int J Mol Sci. 2017 Jun 27;18(7):1367. doi: 10.3390/ijms18071367.
• [336] ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma.Mol Oncol. 2019 Feb;13(2):456-479. doi: 10.1002/1878-0261.12426. Epub 2019 Jan 9.
• [337] Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis.Cancer Immunol Immunother. 2013 Oct;62(10):1609-18. doi: 10.1007/s00262-013-1463-1. Epub 2013 Aug 17.
• [338] A novel BLK-induced tumor model.Tumour Biol. 2017 Jul;39(7):1010428317714196. doi: 10.1177/1010428317714196.
• [339] NOD mice, susceptible to pancreatic autoimmunity, demonstrate delayed growth of pancreatic cancer.Oncotarget. 2017 Sep 24;8(46):80167-80174. doi: 10.18632/oncotarget.21261. eCollection 2017 Oct 6.
• [340] -Dystroglycan hypoglycosylation affects cell migration by influencing -dystroglycan membrane clustering and filopodia length: A multiscale confocal microscopy analysis.Biochim Biophys Acta Mol Basis Dis. 2017 Sep;1863(9):2182-2191. doi: 10.1016/j.bbadis.2017.05.025. Epub 2017 May 29.
• [341] Prion Protein Family Contributes to Tumorigenesis via Multiple Pathways.Adv Exp Med Biol. 2017;1018:207-224. doi: 10.1007/978-981-10-5765-6_13.
• [342] Identification of glycerol-3-phosphate dehydrogenase 1 as a tumour suppressor in human breast cancer.Oncotarget. 2017 Sep 19;8(60):101309-101324. doi: 10.18632/oncotarget.21087. eCollection 2017 Nov 24.
• [343] Adipocytes: A Novel Target for IL-15/IL-15R Cancer Gene Therapy.Mol Ther. 2019 May 8;27(5):922-932. doi: 10.1016/j.ymthe.2019.02.011. Epub 2019 Feb 16.
• [344] Interleukin-27 is abrogated in gastric cancer, but highly expressed in other Helicobacter pylori-associated gastroduodenal diseases.Helicobacter. 2020 Feb;25(1):e12667. doi: 10.1111/hel.12667. Epub 2019 Nov 8.
• [345] Multiple myeloma BM-MSCs increase the tumorigenicity of MM cells via transfer of VLA4-enriched microvesicles.Carcinogenesis. 2020 Mar 13;41(1):100-110. doi: 10.1093/carcin/bgz169.
• [346] The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 and Promotes Tumorigenesis in Mice.Gastroenterology. 2019 Dec;157(6):1646-1659.e11. doi: 10.1053/j.gastro.2019.08.018. Epub 2019 Aug 20.
• [347] Consistent expression of guanylyl cyclase-C in primary and metastatic gastrointestinal cancers.PLoS One. 2017 Dec 19;12(12):e0189953. doi: 10.1371/journal.pone.0189953. eCollection 2017.
• [348] Constitutive expression of c-REL in uveal melanoma patients: correlation with clinicopathological parameters and patient outcome.Clin Transl Oncol. 2020 Jul;22(7):1193-1204. doi: 10.1007/s12094-019-02247-z. Epub 2019 Nov 25.
• [349] Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.J Ovarian Res. 2019 Nov 15;12(1):110. doi: 10.1186/s13048-019-0578-1.
• [350] Prognostic values of transketolase family genes in ovarian cancer.Oncol Lett. 2019 Nov;18(5):4845-4857. doi: 10.3892/ol.2019.10818. Epub 2019 Sep 6.
• [351] A LIN28B Tumor-Specific Transcript in Cancer.Cell Rep. 2018 Feb 20;22(8):2016-2025. doi: 10.1016/j.celrep.2018.02.002.
• [352] ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapy.Oncotarget. 2016 Aug 8;8(51):88410-88420. doi: 10.18632/oncotarget.11120. eCollection 2017 Oct 24.
• [353] Presence and Effects of Pituitary Adenylate Cyclase Activating Polypeptide Under Physiological and Pathological Conditions in the Stomach.Front Endocrinol (Lausanne). 2018 Mar 19;9:90. doi: 10.3389/fendo.2018.00090. eCollection 2018.
• [354] Therapeutic targeting of the PI4K2A/PKR lysosome network is critical for misfolded protein clearance and survival in cancer cells.Oncogene. 2020 Jan;39(4):801-813. doi: 10.1038/s41388-019-1010-4. Epub 2019 Sep 25.
• [355] Expression of AGPAT2, an enzyme involved in the glycerophospholipid/triacylglycerol biosynthesis pathway, is directly regulated by HIF-1 and promotes survival and etoposide resistance of cancer cells under hypoxia.Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Sep;1863(9):1142-1152. doi: 10.1016/j.bbalip.2018.06.015. Epub 2018 Jun 15.
• [356] Case-only gene-environment interaction between ALAD tagSNPs and occupational lead exposure in prostate cancer.Prostate. 2014 May;74(6):637-46. doi: 10.1002/pros.22781. Epub 2014 Feb 5.
• [357] Primary Immunoprevention of Epithelial Ovarian Carcinoma by Vaccination against the Extracellular Domain of Anti-Mllerian Hormone Receptor II.Cancer Prev Res (Phila). 2017 Nov;10(11):612-624. doi: 10.1158/1940-6207.CAPR-17-0154.
• [358] Non-Hodgkin and Hodgkin Lymphomas Select for Overexpression of BCLW.Clin Cancer Res. 2017 Nov 15;23(22):7119-7129. doi: 10.1158/1078-0432.CCR-17-1144. Epub 2017 Aug 29.
• [359] Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases.Oncogene. 2019 Jun;38(24):4685-4699. doi: 10.1038/s41388-019-0756-z. Epub 2019 Feb 22.
• [360] Etk Interaction with PFKFB4 Modulates Chemoresistance of Small-cell Lung Cancer by Regulating Autophagy.Clin Cancer Res. 2018 Feb 15;24(4):950-962. doi: 10.1158/1078-0432.CCR-17-1475. Epub 2017 Dec 5.
• [361] Down-regulation of B-Cell Translocation Gene 1 by Promoter Methylation in Colorectal Carcinoma.Anticancer Res. 2018 Feb;38(2):691-697. doi: 10.21873/anticanres.12274.
• [362] Characterization of CACNA2D3 as a putative tumor suppressor gene in the development and progression of nasopharyngeal carcinoma.Int J Cancer. 2013 Nov 15;133(10):2284-95. doi: 10.1002/ijc.28252. Epub 2013 Jul 13.
• [363] E3 ubiquitin ligase Cbl-b in innate and adaptive immunity.Cell Cycle. 2014;13(12):1875-84. doi: 10.4161/cc.29213. Epub 2014 May 14.
• [364] Differential expression of cholecystokinin A receptor in gallbladder cancer in the young and elderly suggests two subsets of the same disease?.Biomed Res Int. 2014;2014:625695. doi: 10.1155/2014/625695. Epub 2014 Jun 15.
• [365] The role of chemokine receptor 9/chemokine ligand 25 signaling: From immune cells to cancer cells.Oncol Lett. 2018 Aug;16(2):2071-2077. doi: 10.3892/ol.2018.8896. Epub 2018 Jun 4.
• [366] Sequencing of DC-SIGN promoter indicates an association between promoter variation and risk of nasopharyngeal carcinoma in cantonese.BMC Med Genet. 2010 Nov 11;11:161. doi: 10.1186/1471-2350-11-161.
• [367] Loss of the GPI-anchor in B-lymphoblastic leukemia by epigenetic downregulation of PIGH expression.Am J Hematol. 2019 Jan;94(1):93-102. doi: 10.1002/ajh.25337. Epub 2018 Nov 25.
• [368] Human hepatocellular carcinoma-infiltrating CD4CD69Foxp3?regulatory T cell suppresses T cell response via membrane-bound TGF-1.J Mol Med (Berl). 2014 May;92(5):539-50. doi: 10.1007/s00109-014-1143-4. Epub 2014 Mar 26.
• [369] Accumulation of cytoplasmic CDC25A in cutaneous squamous cell carcinoma leads to a dependency on CDC25A for cancer cell survival and tumor growth.Cancer Lett. 2017 Dec 1;410:41-49. doi: 10.1016/j.canlet.2017.09.023. Epub 2017 Sep 23.
• [370] Discovery of Potent and Selective MRCK Inhibitors with Therapeutic Effect on Skin Cancer.Cancer Res. 2018 Apr 15;78(8):2096-2114. doi: 10.1158/0008-5472.CAN-17-2870. Epub 2018 Jan 30.
• [371] CDK3, target of miR-4469, suppresses breast cancer metastasis via inhibiting Wnt/-catenin pathway.Oncotarget. 2017 May 25;8(49):84917-84927. doi: 10.18632/oncotarget.18171. eCollection 2017 Oct 17.
• [372] Predicting Malignancy Risk in Gastrointestinal Subepithelial Tumors with Contrast-Enhanced Harmonic Endoscopic Ultrasonography Using Perfusion Analysis Software.Gut Liver. 2019 Mar 15;13(2):161-168. doi: 10.5009/gnl18185.
• [373] Complement factor H in host defense and immune evasion.Cell Mol Life Sci. 2017 May;74(9):1605-1624. doi: 10.1007/s00018-016-2418-4. Epub 2016 Dec 10.
• [374] Oncogenic role of rab escort protein 1 through EGFR and STAT3 pathway.Cell Death Dis. 2017 Feb 23;8(2):e2621. doi: 10.1038/cddis.2017.50.
• [375] CHRNA9 polymorphisms and smoking exposure synergize to increase the risk of breast cancer in Taiwan.Carcinogenesis. 2014 Nov;35(11):2520-5. doi: 10.1093/carcin/bgu179. Epub 2014 Aug 20.
• [376] Immunocytochemistry for Claudin-18 and Maspin in biliary brushing cytology increases the accuracy of diagnosing pancreatobiliary malignancies.Cytopathology. 2017 Apr;28(2):116-121. doi: 10.1111/cyt.12368. Epub 2016 Aug 16.
• [377] Autoregulation of the human splice factor kinase CLK1 through exon skipping and intron retention.Gene. 2018 Sep 5;670:46-54. doi: 10.1016/j.gene.2018.05.095. Epub 2018 May 24.
• [378] KNOCKDOWN OF CASEIN KINASE 1e INHIBITS CELL PROLIFERATION AND INVASION OF COLORECTAL CANCER CELLS VIA INHIBITION OF THE Wnt/-CATENIN SIGNALING.J Biol Regul Homeost Agents. 2015 Apr-Jun;29(2):307-15.
• [379] Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts.Clin Cancer Res. 2017 Aug 15;23(16):4865-4874. doi: 10.1158/1078-0432.CCR-16-2987. Epub 2017 Apr 19.
• [380] Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.Nature. 2018 Jan 4;553(7686):91-95. doi: 10.1038/nature25015. Epub 2017 Nov 16.
• [381] Association study between CYP24A1 gene polymorphisms and cancer risk.Pathol Res Pract. 2020 Jan;216(1):152735. doi: 10.1016/j.prp.2019.152735. Epub 2019 Nov 11.
• [382] The emerging role of zinc transporters in cellular homeostasis and cancer.Signal Transduct Target Ther. 2017;2:17029-. doi: 10.1038/sigtrans.2017.29. Epub 2017 Jul 28.
• [383] Bystander killing of malignant cells via the delivery of engineered thymidine-active deoxycytidine kinase for suicide gene therapy of cancer.Cancer Gene Ther. 2012 May;19(5):320-7. doi: 10.1038/cgt.2012.4. Epub 2012 Mar 2.
• [384] The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin.Brain. 2018 May 1;141(5):1434-1454. doi: 10.1093/brain/awy057.
• [385] Dehydropeptidase 1 promotes metastasis through regulation of E-cadherin expression in colon cancer.Oncotarget. 2016 Feb 23;7(8):9501-12. doi: 10.18632/oncotarget.7033.
• [386] MKP-4 suppresses hepatocarcinogenesis by targeting ERK1/2 pathway.Cancer Cell Int. 2019 Mar 18;19:61. doi: 10.1186/s12935-019-0776-3. eCollection 2019.
• [387] Modality of tumor endothelial VEGFR2 silencing-mediated improvement in intratumoral distribution of lipid nanoparticles.J Control Release. 2017 Apr 10;251:1-10. doi: 10.1016/j.jconrel.2017.02.010. Epub 2017 Feb 10.
• [388] Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-B.Oncotarget. 2016 Jun 28;7(26):39796-39808. doi: 10.18632/oncotarget.9290.
• [389] Regulation of PERK expression by FOXO3: a vulnerability of drug-resistant cancer cells.Oncogene. 2019 Sep;38(36):6382-6398. doi: 10.1038/s41388-019-0890-7. Epub 2019 Jul 16.
• [390] The significance of ENAH in carcinogenesis and prognosis in gastric cancer.Oncotarget. 2017 Aug 2;8(42):72466-72479. doi: 10.18632/oncotarget.19801. eCollection 2017 Sep 22.
• [391] AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell Carcinoma.Clin Cancer Res. 2016 Apr 15;22(8):1989-99. doi: 10.1158/1078-0432.CCR-15-1542. Epub 2015 Nov 20.
• [392] ENSA expression correlates with attenuated tumor propagation in liver cancer.Biochem Biophys Res Commun. 2013 Dec 6;442(1-2):56-61. doi: 10.1016/j.bbrc.2013.10.165. Epub 2013 Nov 8.
• [393] Junctional adhesion molecule-A is down-regulated in anaplastic thyroid carcinomas and reduces cancer cell aggressiveness by modulating p53 and GSK3 / pathways.Mol Carcinog. 2019 Jul;58(7):1181-1193. doi: 10.1002/mc.23001. Epub 2019 Mar 4.
• [394] Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma.Oncotarget. 2017 May 9;8(19):31254-31269. doi: 10.18632/oncotarget.16115.
• [395] PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker.Cancer Cytopathol. 2020 Mar;128(3):177-189. doi: 10.1002/cncy.22224. Epub 2019 Dec 10.
• [396] Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation.Nat Commun. 2018 Feb 2;9(1):476. doi: 10.1038/s41467-017-02811-7.
• [397] Steroid Receptor Coactivator-2 Controls the Pentose Phosphate Pathway through RPIA in Human Endometrial Cancer Cells.Sci Rep. 2018 Sep 3;8(1):13134. doi: 10.1038/s41598-018-31372-y.
• [398] The stromal loss of miR-4516 promotes the FOSL1-dependent proliferation and malignancy of triple negative breast cancer.Cancer Lett. 2020 Jan 28;469:256-265. doi: 10.1016/j.canlet.2019.10.039. Epub 2019 Oct 28.
• [399] p38-regulated FOXC1 stability is required for colorectal cancer metastasis.J Pathol. 2020 Feb;250(2):217-230. doi: 10.1002/path.5362. Epub 2019 Nov 28.
• [400] Alterations in gene expression of proprotein convertases in human lung cancer have a limited number of scenarios.PLoS One. 2013;8(2):e55752. doi: 10.1371/journal.pone.0055752. Epub 2013 Feb 7.
• [401] A novel cancer-germline transcript carrying pro-metastatic miR-105 and TET-targeting miR-767 induced by DNA hypomethylation in tumors.Epigenetics. 2014 Aug;9(8):1163-71. doi: 10.4161/epi.29628. Epub 2014 Jul 8.
• [402] Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy.Clin Cancer Res. 2014 Apr 15;20(8):2169-81. doi: 10.1158/1078-0432.CCR-13-2642.
• [403] Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.Cancer. 2014 Jan 15;120(2):205-13. doi: 10.1002/cncr.28411. Epub 2013 Oct 10.
• [404] Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression.Cancer Cell. 2015 Feb 9;27(2):211-22. doi: 10.1016/j.ccell.2014.11.019. Epub 2015 Jan 22.
• [405] Novel Insights into Gonadotropin-Releasing Hormone Action in the Pituitary Gonadotrope.Semin Reprod Med. 2017 Mar;35(2):130-138. doi: 10.1055/s-0037-1599084. Epub 2017 Feb 17.
• [406] Cannabidiol, a novel inverse agonist for GPR12.Biochem Biophys Res Commun. 2017 Nov 4;493(1):451-454. doi: 10.1016/j.bbrc.2017.09.001. Epub 2017 Sep 6.
• [407] Chemoresistance is associated with overexpression of HAX-1, inhibition of which resensitizes drug-resistant breast cancer cells to chemotherapy.Tumour Biol. 2017 Mar;39(3):1010428317692228. doi: 10.1177/1010428317692228.
• [408] Human polyomavirus and human papillomavirus prevalence and viral load in non-malignant tonsillar tissue and tonsillar carcinoma.Med Microbiol Immunol. 2017 Apr;206(2):93-103. doi: 10.1007/s00430-016-0486-6. Epub 2016 Nov 10.
• [409] The Orexin-A-Regulated Akt/mTOR Pathway Promotes Cell Proliferation Through Inhibiting Apoptosis in Pancreatic Cancer Cells.Front Endocrinol (Lausanne). 2018 Oct 31;9:647. doi: 10.3389/fendo.2018.00647. eCollection 2018.
• [410] Polyamine Deacetylase Structure and Catalysis: Prokaryotic Acetylpolyamine Amidohydrolase and Eukaryotic HDAC10.Biochemistry. 2018 Jun 5;57(22):3105-3114. doi: 10.1021/acs.biochem.8b00079. Epub 2018 Mar 21.
• [411] Hypermethylation contributes to down-regulation of lysosomal -hexosaminidase subunit in prostate cancer cells.Biochimie. 2014 Jun;101:75-82. doi: 10.1016/j.biochi.2013.12.016. Epub 2014 Jan 2.
• [412] Inferring therapeutic targets from heterogeneous data: HKDC1 is a novel potential therapeutic target for cancer.Bioinformatics. 2014 Mar 15;30(6):748-52. doi: 10.1093/bioinformatics/btt606. Epub 2013 Oct 24.
• [413] The functional consequences and prognostic value of dosage sensitivity in ovarian cancer.Mol Biosyst. 2017 Jan 31;13(2):380-391. doi: 10.1039/c6mb00625f.
• [414] Estrogen and androgen-converting enzymes 17-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.Oncotarget. 2017 May 2;8(18):30552-30562. doi: 10.18632/oncotarget.15547.
• [415] Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic cancer cells.PLoS One. 2014 Aug 29;9(8):e105245. doi: 10.1371/journal.pone.0105245. eCollection 2014.
• [416] Small interfering RNAs based on huntingtin trinucleotide repeats are highly toxic to cancer cells.EMBO Rep. 2018 Mar;19(3):e45336. doi: 10.15252/embr.201745336. Epub 2018 Feb 12.
• [417] Iduronate-2-Sulfatase-Regulated Dermatan Sulfate Levels Potentiate the Invasion of Breast Cancer Epithelia through Collagen Matrix.J Clin Med. 2019 Sep 30;8(10):1562. doi: 10.3390/jcm8101562.
• [418] IL-29 Exhibits Anti-Tumor Effect on Pan-48 Pancreatic Cancer Cells by Up-regulation of P21 and Bax.Anticancer Res. 2019 Jul;39(7):3493-3498. doi: 10.21873/anticanres.13495.
• [419] IFNL4-G Allele Is Associated with an Interferon Signature in Tumors and Survival of African-American Men with Prostate Cancer.Clin Cancer Res. 2018 Nov 1;24(21):5471-5481. doi: 10.1158/1078-0432.CCR-18-1060. Epub 2018 Jul 16.
• [420] From fever to immunity: A new role for IGFBP-6?.J Cell Mol Med. 2018 Oct;22(10):4588-4596. doi: 10.1111/jcmm.13738. Epub 2018 Aug 17.
• [421] Synthesis, Radiosynthesis and Metabolism of 131I-Y-c(CGRRAGGSC).Anticancer Agents Med Chem. 2017;17(13):1769-1776. doi: 10.2174/1871520617666170713151647.
• [422] Retracted: Long Noncoding RNA SOX2OT Accelerates the Carcinogenesis of Wilms' Tumor Through ceRNA Through miR-363/FOXP4 Axis.DNA Cell Biol. 2018 Nov 27. doi: 10.1089/dna.2018.4420. Online ahead of print.
• [423] Estradiol Promotes Breast Cancer Cell Migration via Recruitment and Activation of Neutrophils.Cancer Immunol Res. 2017 Mar;5(3):234-247. doi: 10.1158/2326-6066.CIR-16-0150. Epub 2017 Feb 3.
• [424] Cooperation between ETS variant 2 and Jumonji domaincontaining 2 histone demethylases.Mol Med Rep. 2018 Apr;17(4):5518-5527. doi: 10.3892/mmr.2018.8507. Epub 2018 Jan 26.
• [425] Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.Tissue Antigens. 2015 Sep;86(3):172-7. doi: 10.1111/tan.12608. Epub 2015 Jul 22.
• [426] KIR downregulation by IL-12/15/18 unleashes human NK cells from KIR/HLA-I inhibition and enhances killing of tumor cells.Eur J Immunol. 2018 Feb;48(2):355-365. doi: 10.1002/eji.201747128. Epub 2017 Nov 29.
• [427] ILT3.Fc-CD166 Interaction Induces Inactivation of p70 S6 Kinase and Inhibits Tumor Cell Growth.J Immunol. 2018 Feb 1;200(3):1207-1219. doi: 10.4049/jimmunol.1700553. Epub 2017 Dec 20.
• [428] PI3K Catalytic Isoform Alteration Promotes the LIMK1-related Metastasis Through the PAK1 or ROCK1/2 Activation in Cigarette Smoke-exposed Ovarian Cancer Cells.Anticancer Res. 2017 Apr;37(4):1805-1818. doi: 10.21873/anticanres.11515.
• [429] MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice.Gastroenterology. 2017 Oct;153(4):1120-1132.e15. doi: 10.1053/j.gastro.2016.12.036. Epub 2017 Feb 27.
• [430] Genetic Predisposition to Glioma Mediated by a MAPKAP1 Enhancer Variant.Cell Mol Neurobiol. 2020 May;40(4):643-652. doi: 10.1007/s10571-019-00763-8. Epub 2019 Nov 26.
• [431] Overexpression of long non-coding RNA MFI2 promotes cell proliferation and suppresses apoptosis in human osteosarcoma.Oncol Rep. 2016 Oct;36(4):2033-40. doi: 10.3892/or.2016.5013. Epub 2016 Aug 11.
• [432] LPP inhibits collective cell migration during lung cancer dissemination.Oncogene. 2016 Feb 25;35(8):952-64. doi: 10.1038/onc.2015.155. Epub 2015 Jun 1.
• [433] Mass Spectrometry-Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers.Cancer Res. 2018 May 15;78(10):2732-2746. doi: 10.1158/0008-5472.CAN-17-1990. Epub 2018 Feb 22.
• [434] miR-223 promotes colon cancer by directly targeting p120 catenin.Oncotarget. 2017 Jul 25;8(38):63764-63779. doi: 10.18632/oncotarget.19541. eCollection 2017 Sep 8.
• [435] Association of Notch4 with metastasis in human oral squamous cell carcinoma.Life Sci. 2016 Jul 1;156:38-46. doi: 10.1016/j.lfs.2016.05.019. Epub 2016 May 16.
• [436] Nucleolin and nucleophosmin expression in seminomas and non-seminomatous testicular tumors.Folia Histochem Cytobiol. 2019;57(3):139-145. doi: 10.5603/FHC.a2019.0015. Epub 2019 Sep 12.
• [437] Identification of breast cancer candidate genes using gene co-expression and protein-protein interaction information.Oncotarget. 2016 Jun 14;7(24):36092-36100. doi: 10.18632/oncotarget.9132.
• [438] UNR/CSDE1 Drives a Post-transcriptional Program to Promote Melanoma Invasion and Metastasis.Cancer Cell. 2016 Nov 14;30(5):694-707. doi: 10.1016/j.ccell.2016.10.004. Epub 2016 Oct 27.
• [439] Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines.J Med Chem. 2018 Sep 27;61(18):8457-8467. doi: 10.1021/acs.jmedchem.8b01144. Epub 2018 Sep 17.
• [440] Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas.Br J Cancer. 2009 Sep 15;101(6):973-82. doi: 10.1038/sj.bjc.6605225. Epub 2009 Aug 25.
• [441] Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance.Nat Rev Clin Oncol. 2017 Dec;14(12):735-748. doi: 10.1038/nrclinonc.2017.127. Epub 2017 Aug 31.
• [442] Deficiency of phospholipase A2 group 7 decreases intestinal polyposis and colon tumorigenesis in Apc(Min/+) mice.Cancer Res. 2013 May 1;73(9):2806-16. doi: 10.1158/0008-5472.CAN-12-2374. Epub 2013 Jan 29.
• [443] Investigation of Phospholipase C1 Interaction with SLP76 Using Molecular Modeling Methods for Identifying Novel Inhibitors.Int J Mol Sci. 2019 Sep 23;20(19):4721. doi: 10.3390/ijms20194721.
• [444] Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review.Onco Targets Ther. 2018 Apr 20;11:2287-2293. doi: 10.2147/OTT.S140756. eCollection 2018.
• [445] PPAR agonist enhances colitis-associated colorectal cancer.Eur J Pharmacol. 2019 Jan 5;842:248-254. doi: 10.1016/j.ejphar.2018.10.050. Epub 2018 Nov 2.
• [446] Fast therapeutic hypothermia prevents post-cardiac arrest syndrome through cyclophilin D-mediated mitochondrial permeability transition inhibition.Basic Res Cardiol. 2017 Jul;112(4):35. doi: 10.1007/s00395-017-0624-3. Epub 2017 May 10.
• [447] A stable association with PME-1 may be dispensable for PP2A demethylation - implications for the detection of PP2A methylation and immunoprecipitation.FEBS Open Bio. 2018 Aug 1;8(9):1486-1496. doi: 10.1002/2211-5463.12485. eCollection 2018 Sep.
• [448] The Combination Of Weak Expression Of PRDX4 And Very High MIB-1 Labelling Index Independently Predicts Shorter Disease-free Survival In Stage I Lung Adenocarcinoma.Int J Med Sci. 2018 Jun 14;15(10):1025-1034. doi: 10.7150/ijms.25734. eCollection 2018.
• [449] Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide: a potent protein kinase C- inhibitor as a potential prostate carcinoma therapeutic.Anticancer Drugs. 2019 Jan;30(1):65-71. doi: 10.1097/CAD.0000000000000694.
• [450] DNA-PKcs Mediates An Epithelial-Mesenchymal Transition Process Promoting Cutaneous Squamous Cell Carcinoma Invasion And Metastasis By Targeting The TGF-1/Smad Signaling Pathway.Onco Targets Ther. 2019 Nov 7;12:9395-9405. doi: 10.2147/OTT.S205017. eCollection 2019.
• [451] PSMB5 is associated with proliferation and drug resistance in triple-negative breast cancer.Int J Biol Markers. 2018 Jan;33(1):102-108. doi: 10.5301/ijbm.5000283.
• [452] RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway.Cancer Cell. 2014 Jul 14;26(1):61-76. doi: 10.1016/j.ccr.2014.04.030. Epub 2014 Jun 26.
• [453] The cancer-retina antigen recoverin as a potential biomarker for renal tumors.Tumour Biol. 2016 Jul;37(7):9899-907. doi: 10.1007/s13277-016-4885-5. Epub 2016 Jan 26.
• [454] A mutant KRAS-induced factor REG4 promotes cancer stem cell properties via Wnt/-catenin signaling.Int J Cancer. 2020 May 15;146(10):2877-2890. doi: 10.1002/ijc.32728. Epub 2019 Nov 23.
• [455] Mechanisms of neuroblastoma cell growth inhibition by CARP-1 functional mimetics.PLoS One. 2014 Jul 17;9(7):e102567. doi: 10.1371/journal.pone.0102567. eCollection 2014.
• [456] Isobavachalcone exerts antiproliferative and proapoptotic effects on human liver cancer cells by targeting the ERKs/RSK2 signaling pathway.Oncol Rep. 2019 Jun;41(6):3355-3366. doi: 10.3892/or.2019.7090. Epub 2019 Apr 2.
• [457] Effect of RSK4 on biological characteristics of colorectal cancer.World J Surg Oncol. 2018 Dec 22;16(1):240. doi: 10.1186/s12957-018-1474-7.
• [458] Cost effectiveness of EML4-ALK fusion testing and first-line crizotinib treatment for patients with advanced ALK-positive non-small-cell lung cancer.J Clin Oncol. 2014 Apr 1;32(10):1012-9. doi: 10.1200/JCO.2013.53.1186. Epub 2014 Feb 24.
• [459] Development and current use of in hematopoietic stem cell transplantation in children and adolescents in Poland: Report of the Polish pediatric study group for hematopoietic stem cell transplantation of the Polish society for pediatric oncology and hematology.Transfus Apher Sci. 2018 Jun;57(3):316-322. doi: 10.1016/j.transci.2018.05.012. Epub 2018 May 16.
• [460] Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.J Thorac Oncol. 2017 Jun;12(6):943-953. doi: 10.1016/j.jtho.2017.03.010. Epub 2017 Mar 21.
• [461] Tumor suppressor microRNA-27a in colorectal carcinogenesis and progression by targeting SGPP1 and Smad2.PLoS One. 2014 Aug 28;9(8):e105991. doi: 10.1371/journal.pone.0105991. eCollection 2014.
• [462] Quantitative analysis and diagnostic significance of methylated SLC19A3 DNA in the plasma of breast and gastric cancer patients. PLoS One. 2011;6(7):e22233.
• [463] Ablation of the ASCT2 (SLC1A5) gene encoding a neutral amino acid transporter reveals transporter plasticity and redundancy in cancer cells.J Biol Chem. 2019 Mar 15;294(11):4012-4026. doi: 10.1074/jbc.RA118.006378. Epub 2019 Jan 11.
• [464] The Mitochondrial Citrate Carrier (SLC25A1) Sustains Redox Homeostasis and Mitochondrial Metabolism Supporting Radioresistance of Cancer Cells With Tolerance to Cycling Severe Hypoxia.Front Oncol. 2018 May 25;8:170. doi: 10.3389/fonc.2018.00170. eCollection 2018.
• [465] Structural Studies of Predicted Ligand Binding Sites and Molecular Docking Analysis of Slc2a4 as a Therapeutic Target for the Treatment of Cancer.Int J Mol Sci. 2018 Jan 28;19(2):386. doi: 10.3390/ijms19020386.
• [466] Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest.Oncol Rep. 2017 Nov;38(5):2825-2835. doi: 10.3892/or.2017.5977. Epub 2017 Sep 20.
• [467] Limitations of the 2015 ATA Guidelines for Prediction of Thyroid Cancer: A Review of 1947 Consecutive Aspirations.J Clin Endocrinol Metab. 2018 Sep 1;103(9):3496-3502. doi: 10.1210/jc.2018-00792.
• [468] Aberrant Hypomethylation of Solute Carrier Family 6 Member 12 Promoter Induces Metastasis of Ovarian Cancer. Yonsei Med J. 2017 Jan;58(1):27-34.
• [469] Dimerization of sortilin regulates its trafficking to extracellular vesicles.J Biol Chem. 2018 Mar 23;293(12):4532-4544. doi: 10.1074/jbc.RA117.000732. Epub 2018 Jan 30.
• [470] Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinoma.BMC Cancer. 2014 May 7;14:324. doi: 10.1186/1471-2407-14-324.
• [471] The NDR/LATS protein kinases in immunology and cancer biology.Semin Cancer Biol. 2018 Feb;48:104-114. doi: 10.1016/j.semcancer.2017.04.010. Epub 2017 Jun 1.
• [472] The NLRP1 Inflammasome Pathway Is Silenced in Cutaneous Squamous Cell Carcinoma.J Invest Dermatol. 2019 Aug;139(8):1788-1797.e6. doi: 10.1016/j.jid.2019.01.025. Epub 2019 Feb 7.
• [473] SGT1 regulates Akt signaling by promoting beta-TrCP-dependent PHLPP1 degradation in gastric cancer cells.Mol Biol Rep. 2013 Apr;40(4):2947-53. doi: 10.1007/s11033-012-2363-8. Epub 2013 Feb 26.
• [474] PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11467-72. doi: 10.1073/pnas.1317751111. Epub 2014 Jul 21.
• [475] Matriptase-2: monitoring and inhibiting its proteolytic activity.Future Med Chem. 2018 Dec;10(23):2745-2761. doi: 10.4155/fmc-2018-0346. Epub 2018 Dec 6.
• [476] BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8(+) cytotoxic T lymphocytes against multiple myeloma: clinical applications.Leukemia. 2020 Jan;34(1):210-223. doi: 10.1038/s41375-019-0540-7. Epub 2019 Aug 19.
• [477] Trophoblast Glycoprotein (TPGB/5T4) in Human Placenta: Expression, Regulation, and Presence in Extracellular Microvesicles and Exosomes.Reprod Sci. 2018 Feb;25(2):185-197. doi: 10.1177/1933719117707053. Epub 2017 May 8.
• [478] Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy.Cancer Immunol Res. 2018 Feb;6(2):178-188. doi: 10.1158/2326-6066.CIR-17-0035. Epub 2017 Dec 7.
• [479] The forgotten effects of thyrotropin-releasing hormone: Metabolic functions and medical applications.Front Neuroendocrinol. 2019 Jan;52:29-43. doi: 10.1016/j.yfrne.2018.06.006. Epub 2018 Jun 22.
• [480] Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress Tolerance.Cancer Cell. 2018 Jun 11;33(6):985-1003.e7. doi: 10.1016/j.ccell.2018.05.001. Epub 2018 May 24.
• [481] TRPC4/TRPC5 channels mediate adverse reaction to the cancer cell cytotoxic agent (-)-Englerin A.Oncotarget. 2018 Jul 3;9(51):29634-29643. doi: 10.18632/oncotarget.25659. eCollection 2018 Jul 3.
• [482] High Expression of Ubiquitin-Specific Protease 8 (USP8) Is Associated with Poor Prognosis in Patients with Cervical Squamous Cell Carcinoma.Med Sci Monit. 2018 Jul 16;24:4934-4943. doi: 10.12659/MSM.909235.
• [483] Cellular and molecular mechanisms underlying planar cell polarity pathway contributions to cancer malignancy.Semin Cell Dev Biol. 2018 Sep;81:78-87. doi: 10.1016/j.semcdb.2017.09.026. Epub 2017 Nov 4.
• [484] B7-H4 facilitates proliferation and metastasis of colorectal carcinoma cell through PI3K/Akt/mTOR signaling pathway.Clin Exp Med. 2020 Feb;20(1):79-86. doi: 10.1007/s10238-019-00590-7. Epub 2019 Oct 29.
• [485] Loss of ABAT-Mediated GABAergic System Promotes Basal-Like Breast Cancer Progression by Activating Ca(2+)-NFAT1 Axis.Theranostics. 2019 Jan 1;9(1):34-47. doi: 10.7150/thno.29407. eCollection 2019.
• [486] The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI.Mol Ther Oncolytics. 2018 Dec 8;12:9-15. doi: 10.1016/j.omto.2018.12.002. eCollection 2019 Mar 29.
• [487] Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families.Gastroenterology. 2008 Apr;134(4):1203-14. doi: 10.1053/j.gastro.2008.01.038. Epub 2008 Jan 18.
• [488] MRP4 sustains Wnt/-catenin signaling for pregnancy, endometriosis and endometrial cancer.Theranostics. 2019 Jul 9;9(17):5049-5064. doi: 10.7150/thno.32097. eCollection 2019.
• [489] ABCG1 as a potential oncogene in lung cancer. Exp Ther Med. 2017 Jun;13(6):3189-3194.
• [490] Monoacylglycerol signalling and ABHD6 in health and disease.Diabetes Obes Metab. 2017 Sep;19 Suppl 1:76-89. doi: 10.1111/dom.13008.
• [491] High Expression of ABL2 Suppresses Apoptosis in Gastric Cancer.Dig Dis Sci. 2018 Sep;63(9):2294-2300. doi: 10.1007/s10620-018-5111-7. Epub 2018 May 16.
• [492] Prediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal Cancer.Technol Cancer Res Treat. 2018 Jan 1;17:1533033818806905. doi: 10.1177/1533033818806905.
• [493] The recent insights into the function of ACAT1: A possible anti-cancer therapeutic target.Life Sci. 2019 Sep 1;232:116592. doi: 10.1016/j.lfs.2019.116592. Epub 2019 Jun 19.
• [494] Bioactive Bromotyrosine-Derived Alkaloids from the Polynesian Sponge Suberea ianthelliformis.Mar Drugs. 2018 Apr 27;16(5):146. doi: 10.3390/md16050146.
• [495] Conjugable A(3) adenosine receptor antagonists for the development of functionalized ligands and their use in fluorescent probes.Eur J Med Chem. 2020 Jan 15;186:111886. doi: 10.1016/j.ejmech.2019.111886. Epub 2019 Nov 22.
• [496] Feasibility of the ACL (albumin, C-reactive protein and lactate dehydrogenase) model as a novel prognostic tool in patients with metastatic renal cell carcinoma previously receiving first-line targeted therapy.Urol Oncol. 2020 Jan;38(1):6.e9-6.e16. doi: 10.1016/j.urolonc.2019.07.013. Epub 2019 Aug 8.
• [497] Aconitase 2 inhibits the proliferation of MCF-7 cells promoting mitochondrial oxidative metabolism and ROS/FoxO1-mediated autophagic response.Br J Cancer. 2020 Jan;122(2):182-193. doi: 10.1038/s41416-019-0641-0. Epub 2019 Dec 10.
• [498] Linkage of the ACR National Mammography Database to the Network of State Cancer Registries: Proof of Concept Evaluation by the ACR National Mammography Database Committee.J Am Coll Radiol. 2019 Jan;16(1):8-14. doi: 10.1016/j.jacr.2018.06.027. Epub 2018 Aug 9.
• [499] Dual-Tracer PET/CT Differentiates 2 Types of Primary Cancers and Metastases in a Patient With Crossed Fused Renal Ectopia.Clin Nucl Med. 2019 Feb;44(2):157-158. doi: 10.1097/RLU.0000000000002390.
• [500] ACVR1 Function in Health and Disease.Cells. 2019 Oct 31;8(11):1366. doi: 10.3390/cells8111366.
• [501] Muscle and serum metabolomes are dysregulated in colon-26 tumor-bearing mice despite amelioration of cachexia with activin receptor type 2B ligand blockade.Am J Physiol Endocrinol Metab. 2019 May 1;316(5):E852-E865. doi: 10.1152/ajpendo.00526.2018. Epub 2019 Mar 12.
• [502] A new mixed inhibitor of adenosine deaminase produced by endophytic Cochliobolus sp. from medicinal plant seeds.Folia Microbiol (Praha). 2020 Apr;65(2):293-302. doi: 10.1007/s12223-019-00723-1. Epub 2019 Jul 4.
• [503] Exosomes Derived from Human Primary and Metastatic Colorectal Cancer Cells Contribute to Functional Heterogeneity of Activated Fibroblasts by Reprogramming Their Proteome.Proteomics. 2019 Apr;19(8):e1800148. doi: 10.1002/pmic.201800148. Epub 2019 Jan 31.
• [504] von Willebrand Factor and Venous Thromboembolism: Pathogenic Link and Therapeutic Implications.Semin Thromb Hemost. 2018 Apr;44(3):249-260. doi: 10.1055/s-0037-1605564. Epub 2017 Sep 12.
• [505] Increased mRNA expression of ADAMTS metalloproteinases in metastatic foci of head and neck cancer.Head Neck. 2009 Jun;31(6):793-801. doi: 10.1002/hed.21045.
• [506] Epigenetic silencing of ADAMTS5 is associated with increased invasiveness and poor survival in patients with colorectal cancer.J Cancer Res Clin Oncol. 2018 Feb;144(2):215-227. doi: 10.1007/s00432-017-2545-9. Epub 2017 Nov 15.
• [507] Clinical phenotype and prevalence of hereditary nonpolyposis colorectal cancer syndrome in Chinese population.World J Gastroenterol. 2005 Mar 14;11(10):1481-8. doi: 10.3748/wjg.v11.i10.1481.
• [508] In silico Designing of Novel Inhibitors for Triple Inhibition of Aldose Reductase, Aldose Reductase Like Protein 1, and Aldehyde Reductase.Curr Comput Aided Drug Des. 2020;16(6):707-717. doi: 10.2174/1573409915666191015111200.
• [509] Impact of multiple alcohol dehydrogenase gene polymorphisms on risk of upper aerodigestive tract cancers in a Japanese population.Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):3097-102. doi: 10.1158/1055-9965.EPI-09-0499. Epub 2009 Oct 27.
• [510] Lipoyl-Homotaurine Derivative (ADM_12) Reverts Oxaliplatin-Induced Neuropathy and Reduces Cancer Cells Malignancy by Inhibiting Carbonic Anhydrase IX (CAIX).J Med Chem. 2017 Nov 9;60(21):9003-9011. doi: 10.1021/acs.jmedchem.7b01237. Epub 2017 Oct 27.
• [511] Intermedin: a novel regulator for vascular remodeling and tumor vessel normalization by regulating vascular endothelial-cadherin and extracellular signal-regulated kinase.Arterioscler Thromb Vasc Biol. 2012 Nov;32(11):2721-32. doi: 10.1161/ATVBAHA.112.300185. Epub 2012 Aug 23.
• [512] Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth.Cancer Biol Ther. 2013 Sep;14(9):860-8. doi: 10.4161/cbt.25643. Epub 2013 Jul 17.
• [513] Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature.Recent Pat Anticancer Drug Discov. 2018;13(1):40-69. doi: 10.2174/1574892812666171108115959.
• [514] Human breast cell lines exhibit functional alpha2-adrenoceptors.Cancer Chemother Pharmacol. 2006 Jul;58(1):50-61. doi: 10.1007/s00280-005-0130-4. Epub 2005 Nov 15.
• [515] Role of beta1-adrenoceptor in increased lipolysis in cancer cachexia.Cancer Sci. 2010 Jul;101(7):1639-45. doi: 10.1111/j.1349-7006.2010.01582.x. Epub 2010 Apr 2.
• [516] 3-Adrenoreceptor Activity Limits Apigenin Efficacy in Ewing Sarcoma Cells: A Dual Approach to Prevent Cell Survival.Int J Mol Sci. 2019 Apr 30;20(9):2149. doi: 10.3390/ijms20092149.
• [517] The Role of Vitamin D and Sunlight Incidence in Cancer.Anticancer Agents Med Chem. 2019;19(11):1418-1436. doi: 10.2174/1389557519666190312123212.
• [518] Overexpression of acylglycerol kinase is associated with poorer prognosis and lymph node metastasis in nasopharyngeal carcinoma.Tumour Biol. 2016 Mar;37(3):3349-57. doi: 10.1007/s13277-015-4148-x. Epub 2015 Oct 7.
• [519] Ectopic expression of the heterotrimeric G15 protein in pancreatic carcinoma and its potential in cancer signal transduction.Cell Signal. 2013 Mar;25(3):651-9. doi: 10.1016/j.cellsig.2012.11.018. Epub 2012 Nov 29.
• [520] Risk of cancer in children and young adults conceived by assisted reproductive technology.Hum Reprod. 2019 Apr 1;34(4):740-750. doi: 10.1093/humrep/dey394.
• [521] Significance of intranuclear angiotensin-II type 2 receptor in oral squamous cell carcinoma.Oncotarget. 2018 Nov 27;9(93):36561-36574. doi: 10.18632/oncotarget.26337. eCollection 2018 Nov 27.
• [522] Knock-down of AHCY and depletion of adenosine induces DNA damage and cell cycle arrest.Sci Rep. 2018 Sep 18;8(1):14012. doi: 10.1038/s41598-018-32356-8.
• [523] Lower rates of cancer and all-cause mortality in an Adventist cohort compared with a US Census population.Cancer. 2020 Mar 1;126(5):1102-1111. doi: 10.1002/cncr.32571. Epub 2019 Nov 25.
• [524] Pichia pastoris as a host for production and isolation of mutagenic AID/APOBEC enzymes involved in cancer and immunity.N Biotechnol. 2019 Jul 25;51:67-79. doi: 10.1016/j.nbt.2019.02.006. Epub 2019 Feb 27.
• [525] Aldo-Keto Reductases: Multifunctional Proteins as Therapeutic Targets in Diabetes and Inflammatory Disease.Adv Exp Med Biol. 2018;1032:173-202. doi: 10.1007/978-3-319-98788-0_13.
• [526] Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3.ACS Med Chem Lett. 2019 Jan 28;10(4):437-443. doi: 10.1021/acsmedchemlett.8b00484. eCollection 2019 Apr 11.
• [527] Modulation of cell adhesion and migration through regulation of the immunoglobulin superfamily member ALCAM/CD166.Clin Exp Metastasis. 2019 Apr;36(2):87-95. doi: 10.1007/s10585-019-09957-2. Epub 2019 Feb 18.
• [528] Changes of N6-methyladenosine modulators promote breast cancer progression.BMC Cancer. 2019 Apr 5;19(1):326. doi: 10.1186/s12885-019-5538-z.
• [529] IAP genes partake weighty roles in the astogeny and whole body regeneration in the colonial urochordate Botryllus schlosseri.Dev Biol. 2019 Apr 15;448(2):320-341. doi: 10.1016/j.ydbio.2018.10.015. Epub 2018 Oct 30.
• [530] CORVET, CHEVI and HOPS - multisubunit tethers of the endo-lysosomal system in health and disease.J Cell Sci. 2019 May 15;132(10):jcs189134. doi: 10.1242/jcs.189134.
• [531] A novel colorimetric assay for -methylacyl-CoA racemase 1A (AMACR; P504S) utilizing the elimination of 2,4-dinitrophenolate.Chem Commun (Camb). 2017 May 4;53(37):5087-5090. doi: 10.1039/c7cc00476a.
• [532] Novel VEGF decoy receptor fusion protein conbercept targeting multiple VEGF isoforms provide remarkable anti-angiogenesis effect in vivo.PLoS One. 2013 Aug 12;8(8):e70544. doi: 10.1371/journal.pone.0070544. eCollection 2013.
• [533] A collagen IV-derived peptide disrupts 51 integrin and potentiates Ang2/Tie2 signaling.JCI Insight. 2019 Feb 21;4(4):e122043. doi: 10.1172/jci.insight.122043. eCollection 2019 Feb 21.
• [534] Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4.Oncogene. 2019 Mar;38(13):2351-2363. doi: 10.1038/s41388-018-0592-6. Epub 2018 Dec 5.
• [535] The cytoskeleton adaptor protein ankyrin-1 is upregulated by p53 following DNA damage and alters cell migration.Cell Death Dis. 2016 Apr 7;7(4):e2184. doi: 10.1038/cddis.2016.91.
• [536] Prediction of cardiovascular risk in cancer patients of South India using WHO/ISH risk prediction charts and Framingham score - A prospective study.J Oncol Pharm Pract. 2018 Jul;24(5):354-358. doi: 10.1177/1078155217707334. Epub 2017 Apr 28.
• [537] Annexin-A1 - A Blessing or a Curse in Cancer?.Trends Mol Med. 2019 Apr;25(4):315-327. doi: 10.1016/j.molmed.2019.02.004. Epub 2019 Mar 11.
• [538] Prognostic Significance of Increased Expression of Annexin A10 (ANXA10) in Serous Epithelial Ovarian Cancer.Med Sci Monit. 2019 Jul 31;25:5666-5673. doi: 10.12659/MSM.915911.
• [539] High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer.Ann Surg Oncol. 2020 Mar;27(3):924-930. doi: 10.1245/s10434-019-07708-x. Epub 2019 Aug 28.
• [540] Gene expression patterns of hemizygous and heterozygous KIT mutations suggest distinct oncogenic pathways: a study in NIH3T3 cell lines and GIST samples.PLoS One. 2013 Apr 12;8(4):e61103. doi: 10.1371/journal.pone.0061103. Print 2013.
• [541] Low-molecular-weight polysaccharides from Agaricus blazei Murrill modulate the Th1 response in cancer immunity.Oncol Lett. 2018 Mar;15(3):3429-3436. doi: 10.3892/ol.2018.7794. Epub 2018 Jan 15.
• [542] Vascular Adhesion Protein-1: A Cell Surface Amine Oxidase in Translation.Antioxid Redox Signal. 2019 Jan 20;30(3):314-332. doi: 10.1089/ars.2017.7418. Epub 2017 Dec 7.
• [543] Identification of APC2, a homologue of the adenomatous polyposis coli tumour suppressor.Curr Biol. 1999 Jan 28;9(2):105-8. doi: 10.1016/s0960-9822(99)80024-4.
• [544] A gene near the D3F15S2 site on 3p is expressed in normal human kidney but not or only at a severely reduced level in 11 of 15 primary renal cell carcinomas (RCC).Oncogene. 1990 Aug;5(8):1207-11.
• [545] Tumor apelin immunoreactivity is correlated with body mass index in ovarian high grade serous carcinoma.Biotech Histochem. 2020 Jan;95(1):27-36. doi: 10.1080/10520295.2019.1627419. Epub 2019 Jul 2.
• [546] Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population study.J Clin Lipidol. 2018 Nov-Dec;12(6):1493-1501.e11. doi: 10.1016/j.jacl.2018.08.010. Epub 2018 Aug 29.
• [547] Development of a Human APOE Knock-in Mouse Model for Study of Cognitive Function After Cancer Chemotherapy.Neurotox Res. 2019 Feb;35(2):291-303. doi: 10.1007/s12640-018-9954-7. Epub 2018 Oct 4.
• [548] ApolipoproteinL1 is expressed in papillary thyroid carcinomas.Pathol Res Pract. 2016 Jul;212(7):631-5. doi: 10.1016/j.prp.2016.04.004. Epub 2016 Apr 24.
• [549] Reduced aquaporin-1 transcript expression in colorectal carcinoma is associated with promoter hypermethylation.Epigenetics. 2019 Feb;14(2):158-170. doi: 10.1080/15592294.2019.1580112. Epub 2019 Feb 20.
• [550] Subcellular localization of aquaporin 3 in prostate cancer is regulated by RalA.Oncol Rep. 2018 May;39(5):2171-2177. doi: 10.3892/or.2018.6308. Epub 2018 Mar 9.
• [551] Role of AQP9 in transport of monomethyselenic acid and selenite. Biometals. 2017 Oct;30(5):747-755. doi: 10.1007/s10534-017-0042-x. Epub 2017 Aug 10.
• [552] Significance of Amphiregulin (AREG) for the Outcome of Low and High Grade Astrocytoma Patients.J Cancer. 2019 Feb 23;10(6):1479-1488. doi: 10.7150/jca.29282. eCollection 2019.
• [553] Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines.Genes Chromosomes Cancer. 2005 Jan;42(1):58-67. doi: 10.1002/gcc.20119.
• [554] Metabolic pathways of L-arginine and therapeutic consequences in tumors.Adv Med Sci. 2019 Mar;64(1):104-110. doi: 10.1016/j.advms.2018.08.018. Epub 2018 Dec 31.
• [555] ARL2 overexpression inhibits glioma proliferation and tumorigenicity via down-regulating AXL.BMC Cancer. 2018 May 29;18(1):599. doi: 10.1186/s12885-018-4517-0.
• [556] Methods to Investigate -Arrestin-1/-Catenin Signaling in Ovarian Cancer Cells.Methods Mol Biol. 2019;1957:393-406. doi: 10.1007/978-1-4939-9158-7_25.
• [557] -Arrestins Regulate Stem Cell-Like Phenotype and Response to Chemotherapy in Bladder Cancer.Mol Cancer Ther. 2019 Apr;18(4):801-811. doi: 10.1158/1535-7163.MCT-18-1167. Epub 2019 Feb 20.
• [558] Loss of ASAP3 destabilizes cytoskeletal protein ACTG1 to suppress cancer cell migration.Mol Med Rep. 2014 Feb;9(2):387-94. doi: 10.3892/mmr.2013.1831. Epub 2013 Nov 27.
• [559] A novel strategy for cancer therapy by mutated mammalian degenerin gene transfer.Cancer Gene Ther. 2000 Oct;7(10):1341-7. doi: 10.1038/sj.cgt.7700249.
• [560] AS1041, a Novel Synthesized Derivative of Marine Natural Compound Aspergiolide A, Arrests Cell Cycle, Induces Apoptosis, and Inhibits ERK Activation in K562 Cells.Mar Drugs. 2017 Nov 4;15(11):346. doi: 10.3390/md15110346.
• [561] Bacterial l-asparaginases for cancer therapy: Current knowledge and future perspectives.J Cell Physiol. 2019 Nov;234(11):19271-19279. doi: 10.1002/jcp.28563. Epub 2019 Apr 16.
• [562] Alpha-tubulin acetyltransferase/MEC-17 regulates cancer cell migration and invasion through epithelial-mesenchymal transition suppression and cell ... Sci Rep. 2018 Nov 30;8(1):17477.
• [563] ATF3 and JDP2 deficiency in cancer associated fibroblasts promotes tumor growth via SDF-1 transcription.Oncogene. 2019 May;38(20):3812-3823. doi: 10.1038/s41388-019-0692-y. Epub 2019 Jan 22.
• [564] Therapeutic Effects of AICAR and DOX Conjugated Multifunctional Nanoparticles in Sensitization and Elimination of Cancer Cells via Survivin Targeting.Pharm Res. 2017 Jan;34(1):175-184. doi: 10.1007/s11095-016-2053-7. Epub 2016 Oct 25.
• [565] Downregulation of ATP1A1 promotes cancer development in renal cell carcinoma.Clin Proteomics. 2017 May 4;14:15. doi: 10.1186/s12014-017-9150-4. eCollection 2017.
• [566] Alterations in the ATP2A2 gene in correlation with colon and lung cancer.Cancer Genet Cytogenet. 2006 Dec;171(2):105-11. doi: 10.1016/j.cancergencyto.2006.06.016.
• [567] Potential Medication-Related Problems in Older Breast, Colon, and Lung Cancer Patients in the United States.Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):41-49. doi: 10.1158/1055-9965.EPI-17-0523. Epub 2017 Oct 4.
• [568] Host Tumor Suppressor p18(INK4c) Functions as a Potent Cell-Intrinsic Inhibitor of Murine Gammaherpesvirus 68 Reactivation and Pathogenesis.J Virol. 2018 Feb 26;92(6):e01604-17. doi: 10.1128/JVI.01604-17. Print 2018 Mar 15.
• [569] Cancer in Machado-Joseph disease patients-low frequency as a cause of death.Cancer Genet. 2017 Apr;212-213:19-23. doi: 10.1016/j.cancergen.2017.03.008. Epub 2017 Mar 30.
• [570] Regulation of AURKC expression by CpG island methylation in human cancer cells.Tumour Biol. 2015 Sep;36(10):8147-58. doi: 10.1007/s13277-015-3553-5. Epub 2015 May 20.
• [571] Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.Cancer Med. 2017 Apr;6(4):723-729. doi: 10.1002/cam4.805. Epub 2017 Mar 2.
• [572] Therapeutic activity of DCC-2036, a novel tyrosine kinase inhibitor, against triple-negative breast cancer patient-derived xenografts by targeting AXL/MET.Int J Cancer. 2019 Feb 1;144(3):651-664. doi: 10.1002/ijc.31915. Epub 2018 Nov 7.
• [573] Functional selection of protease inhibitory antibodies.Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16314-16319. doi: 10.1073/pnas.1903330116. Epub 2019 Jul 30.
• [574] A novel aspartate protease gene, ALP56, is related to morphological features of colorectal adenomas.Int J Colorectal Dis. 2004 Jan;19(1):43-8. doi: 10.1007/s00384-003-0510-3. Epub 2003 Jun 11.
• [575] MAGE, BAGE and GAGE gene expression in human rhabdomyosarcomas.Int J Cancer. 2001 Jul 1;93(1):85-90. doi: 10.1002/ijc.1307.
• [576] Identification of four novel associations for B-cell acute lymphoblastic leukaemia risk.Nat Commun. 2019 Nov 25;10(1):5348. doi: 10.1038/s41467-019-13069-6.
• [577] Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series.Am J Dermatopathol. 2019 Mar;41(3):167-179. doi: 10.1097/DAD.0000000000001217.
• [578] Paradoxical Puma Prohibits Pyruvate Pumps to Prime Pathology.Cancer Cell. 2019 Feb 11;35(2):163-165. doi: 10.1016/j.ccell.2019.01.016.
• [579] Branched-chain amino acid metabolism in cancer.Curr Opin Clin Nutr Metab Care. 2018 Jan;21(1):64-70. doi: 10.1097/MCO.0000000000000430.
• [580] BCL11A enhances stemness and promotes progression by activating Wnt/-catenin signaling in breast cancer.Cancer Manag Res. 2019 Apr 11;11:2997-3007. doi: 10.2147/CMAR.S199368. eCollection 2019.
• [581] ACC1 is overexpressed in liver cancers and contributes to the proliferation of human hepatoma Hep G2 cells and the rat liver cell line BRL 3A.Mol Med Rep. 2019 May;19(5):3431-3440. doi: 10.3892/mmr.2019.9994. Epub 2019 Feb 27.
• [582] Small Leucine Rich Proteoglycans (decorin, biglycan and lumican) in cancer.Clin Chim Acta. 2019 Apr;491:1-7. doi: 10.1016/j.cca.2019.01.003. Epub 2019 Jan 7.
• [583] S-Nitrosylation of cIAP1 Switches Cancer Cell Fate from TNF/TNFR1-Mediated Cell Survival to Cell Death.Cancer Res. 2018 Apr 15;78(8):1948-1957. doi: 10.1158/0008-5472.CAN-17-2078. Epub 2018 Feb 5.
• [584] TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer.Oncoimmunology. 2017 Oct 11;7(12):e1386826. doi: 10.1080/2162402X.2017.1386826. eCollection 2018.
• [585] What is the impact of BIRC5 gene polymorphisms on urinary cancer susceptibility? Evidence from 9348 subjects.Gene. 2020 Apr 5;733:144268. doi: 10.1016/j.gene.2019.144268. Epub 2019 Dec 3.
• [586] Distinct Cancer-Promoting Stromal Gene Expression Depending on Lung Function.Am J Respir Crit Care Med. 2019 Aug 1;200(3):348-358. doi: 10.1164/rccm.201801-0080OC.
• [587] Loss of BMP-10 is correlated with poor survival in ovarian cancer.Pathol Res Pract. 2019 Jan;215(1):121-126. doi: 10.1016/j.prp.2018.10.025. Epub 2018 Oct 28.
• [588] Spatiotemporal Control Strategies for Bone Formation through Tissue Engineering and Regenerative Medicine Approaches.Adv Healthc Mater. 2019 Jan;8(2):e1801044. doi: 10.1002/adhm.201801044. Epub 2018 Dec 17.
• [589] Bone morphogenetic protein 4 provides cancer-supportive phenotypes to liver fibroblasts in patients with hepatocellular carcinoma.J Gastroenterol. 2019 Nov;54(11):1007-1018. doi: 10.1007/s00535-019-01579-5. Epub 2019 Apr 2.
• [590] Identification of Pathogenic Genes and Transcription Factors in Osteosarcoma.Pathol Oncol Res. 2020 Apr;26(2):1041-1048. doi: 10.1007/s12253-019-00645-w. Epub 2019 Apr 13.
• [591] BMP7 Signaling in TGFBR2-Deficient Stromal Cells Provokes Epithelial Carcinogenesis.Mol Cancer Res. 2018 Oct;16(10):1568-1578. doi: 10.1158/1541-7786.MCR-18-0120. Epub 2018 Jun 22.
• [592] BMPR2 promotes invasion and metastasis via the RhoA-ROCK-LIMK2 pathway in human osteosarcoma cells.Oncotarget. 2017 Apr 24;8(35):58625-58641. doi: 10.18632/oncotarget.17382. eCollection 2017 Aug 29.
• [593] Reflexology in the management of chemotherapy induced peripheral neuropathy: A pilot randomized controlled trial.Eur J Oncol Nurs. 2018 Feb;32:12-19. doi: 10.1016/j.ejon.2017.11.001. Epub 2017 Nov 14.
• [594] BET-ting on Nrf2: How Nrf2 Signaling can Influence the Therapeutic Activities of BET Protein Inhibitors.Bioessays. 2018 May;40(5):e1800007. doi: 10.1002/bies.201800007. Epub 2018 Mar 30.
• [595] Inhibition of BRD4 suppresses the malignancy of breast cancer cells via regulation of Snail.Cell Death Differ. 2020 Jan;27(1):255-268. doi: 10.1038/s41418-019-0353-2. Epub 2019 May 21.
• [596] Genomic characterization of genes encoding histone acetylation modulator proteins identifies therapeutic targets for cancer treatment.Nat Commun. 2019 Feb 13;10(1):733. doi: 10.1038/s41467-019-08554-x.
• [597] Bromodomains as therapeutic targets in cancer.Brief Funct Genomics. 2013 May;12(3):219-30. doi: 10.1093/bfgp/elt007. Epub 2013 Mar 28.
• [598] Rare BRIP1 Missense Alleles Confer Risk for Ovarian and Breast Cancer.Cancer Res. 2020 Feb 15;80(4):857-867. doi: 10.1158/0008-5472.CAN-19-1991. Epub 2019 Dec 10.
• [599] CD317 Activates EGFR by Regulating Its Association with Lipid Rafts.Cancer Res. 2019 May 1;79(9):2220-2231. doi: 10.1158/0008-5472.CAN-18-2603. Epub 2019 Mar 19.
• [600] Systematic Multiomics Analysis of Alterations in C1QBP mRNA Expression and Relevance for Clinical Outcomes in Cancers.J Clin Med. 2019 Apr 15;8(4):513. doi: 10.3390/jcm8040513.
• [601] Enhancement of cancer invasion and growth via the C5a-C5a receptor system: Implications for cancer promotion by autoimmune diseases and association with cervical cancer invasion.Oncol Lett. 2019 Jan;17(1):913-920. doi: 10.3892/ol.2018.9715. Epub 2018 Nov 16.
• [602] Low Prevalence of Cancer in Patients withFrontotemporal Lobar Degeneration.J Alzheimers Dis. 2018;62(2):789-794. doi: 10.3233/JAD-170854.
• [603] Drug Repurposing as an Antitumor Agent: Disulfiram-Mediated Carbonic Anhydrase 12 and Anion Exchanger 2 Modulation to Inhibit Cancer Cell Migration.Molecules. 2019 Sep 19;24(18):3409. doi: 10.3390/molecules24183409.
• [604] Effects of von Hippel-Lindau gene mutation and methylation status on expression of transmembrane carbonic anhydrases in renal cell carcinoma.J Cancer Res Clin Oncol. 2002 Oct;128(10):561-8. doi: 10.1007/s00432-002-0374-x. Epub 2002 Aug 30.
• [605] Human Gyrovirus-Apoptin Interferes with the Cell Cycle and Induces G2/M Arrest Prior to Apoptosis.Arch Immunol Ther Exp (Warsz). 2017 Dec;65(6):545-552. doi: 10.1007/s00005-017-0464-8. Epub 2017 Apr 6.
• [606] Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5' CpG island in human tumors.Cancer Res. 1999 Sep 15;59(18):4535-41.
• [607] Tumour-specific amplitude-modulated radiofrequency electromagnetic fields induce differentiation of hepatocellular carcinoma via targeting Ca(v)3.2T-type voltage-gated calcium channels and Ca(2+) influx.EBioMedicine. 2019 Jun;44:209-224. doi: 10.1016/j.ebiom.2019.05.034. Epub 2019 May 31.
• [608] MicroRNA-107 inhibits proliferation and invasion of laryngeal squamous cell carcinoma cells by targeting CACNA2D1 in vitro.Anticancer Drugs. 2020 Mar;31(3):260-271. doi: 10.1097/CAD.0000000000000865.
• [609] Integrated genomic analysis of mitochondrial RNA processing in human cancers.Genome Med. 2017 Apr 18;9(1):36. doi: 10.1186/s13073-017-0426-0.
• [610] 14-3-3 protein directly interacts with the kinase domain of calcium/calmodulin-dependent protein kinase kinase (CaMKK2).Biochim Biophys Acta Gen Subj. 2018 Jul;1862(7):1612-1625. doi: 10.1016/j.bbagen.2018.04.006. Epub 2018 Apr 10.
• [611] Disorder-to-helix conformational conversion of the human immunomodulatory peptide LL-37 induced by antiinflammatory drugs, food dyes and some metabolites.Int J Biol Macromol. 2019 May 15;129:50-60. doi: 10.1016/j.ijbiomac.2019.01.209. Epub 2019 Feb 1.
• [612] Genetic disruption of calpain-1 and calpain-2 attenuates tumorigenesis in mouse models of HER2+ breast cancer and sensitizes cancer cells to doxorubicin and lapatinib.Oncotarget. 2018 Sep 7;9(70):33382-33395. doi: 10.18632/oncotarget.26078. eCollection 2018 Sep 7.
• [613] A chemical probe of CARM1 alters epigenetic plasticity against breast cancer cell invasion.Elife. 2019 Oct 28;8:e47110. doi: 10.7554/eLife.47110.
• [614] MiR-125a-5p decreases after long non-coding RNA HOTAIR knockdown to promote cancer cell apoptosis by releasing caspase 2.Cell Death Dis. 2016 Mar 10;7(3):e2137. doi: 10.1038/cddis.2016.41.
• [615] Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype.Cancer Res. 1999 Jun 15;59(12):2995-3002.
• [616] Tri-arginine exosite patch of caspase-6 recruits substrates for hydrolysis.J Biol Chem. 2019 Jan 4;294(1):71-88. doi: 10.1074/jbc.RA118.005914. Epub 2018 Nov 12.
• [617] Suppression of tumor cell proliferation and migration by human umbilical cord mesenchymal stem cells: A possible role for apoptosis and Wnt signaling.Oncol Lett. 2018 Jun;15(6):8536-8544. doi: 10.3892/ol.2018.8368. Epub 2018 Mar 28.
• [618] The non-apoptotic role of caspase-9 promotes differentiation in leukemic cells.Biochim Biophys Acta Mol Cell Res. 2019 Dec;1866(12):118524. doi: 10.1016/j.bbamcr.2019.118524. Epub 2019 Aug 6.
• [619] Inhibitory effect of carbonyl reductase 1 against peritoneal progression of ovarian cancer: evaluation by ex vivo 3D-human peritoneal model.Mol Biol Rep. 2019 Oct;46(5):4685-4697. doi: 10.1007/s11033-019-04788-6. Epub 2019 Apr 25.
• [620] Heme interaction of the intrinsically disordered N-terminal peptide segment of human cystathionine--synthase.Sci Rep. 2018 Feb 6;8(1):2474. doi: 10.1038/s41598-018-20841-z.
• [621] The complex CBX7-PRMT1 has a critical role in regulating E-cadherin gene expression and cell migration.Biochim Biophys Acta Gene Regul Mech. 2019 Apr;1862(4):509-521. doi: 10.1016/j.bbagrm.2019.02.006. Epub 2019 Feb 28.
• [622] DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use.J Nucl Med. 2019 Jul;60(7):1010-1016. doi: 10.2967/jnumed.118.221283. Epub 2018 Dec 7.
• [623] Eotaxin-1 promotes prostate cancer cell invasion via activation of the CCR3-ERK pathway and upregulation of MMP-3 expression.Oncol Rep. 2014 May;31(5):2049-54. doi: 10.3892/or.2014.3060. Epub 2014 Mar 5.
• [624] Intratumoral IFN- gene delivery reduces tumor-infiltrating regulatory T cells through the downregulation of tumor CCL17 expression.Cancer Gene Ther. 2019 Sep;26(9-10):334-343. doi: 10.1038/s41417-018-0059-5. Epub 2018 Nov 12.
• [625] Co-delivery of immunomodulators in biodegradable nanoparticles improves therapeutic efficacy of cancer vaccines.Biomaterials. 2019 Nov;220:119417. doi: 10.1016/j.biomaterials.2019.119417. Epub 2019 Aug 7.
• [626] Unraveling 'The Cancer Genome Atlas' information on the role of SLC transporters in anticancer drug uptake.Expert Rev Clin Pharmacol. 2019 Apr;12(4):329-341. doi: 10.1080/17512433.2019.1581605. Epub 2019 Feb 26.
• [627] C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer.Oncoimmunology. 2018 Mar 6;7(6):e1433517. doi: 10.1080/2162402X.2018.1433517. eCollection 2018.
• [628] Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures.PLoS One. 2019 Jun 26;14(6):e0218674. doi: 10.1371/journal.pone.0218674. eCollection 2019.
• [629] Garlic-derived organosulfur compound exerts antitumor efficacy via activation of MAPK pathway and modulation of cytokines in SGC-7901 tumor-bearing mice.Int Immunopharmacol. 2017 Jul;48:135-145. doi: 10.1016/j.intimp.2017.05.004. Epub 2017 May 11.
• [630] Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer.J Cell Physiol. 2018 Jan;234(1):619-631. doi: 10.1002/jcp.26816. Epub 2018 Aug 2.
• [631] Prognostic significance of cyclin D3 expression in malignancy patients: a meta-analysis.Cancer Cell Int. 2019 Jun 10;19:158. doi: 10.1186/s12935-019-0865-3. eCollection 2019.
• [632] MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells.Anticancer Drugs. 2019 Jan;30(1):81-88. doi: 10.1097/CAD.0000000000000700.
• [633] Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma.Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):9282-9287. doi: 10.1073/pnas.1807155115. Epub 2018 Aug 27.
• [634] HIF-2 Promotes Dissemination of Plasma Cells in Multiple Myeloma by Regulating CXCL12/CXCR4 and CCR1.Cancer Res. 2017 Oct 15;77(20):5452-5463. doi: 10.1158/0008-5472.CAN-17-0115. Epub 2017 Aug 30.
• [635] MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis.Oncogene. 2020 Feb;39(8):1681-1695. doi: 10.1038/s41388-019-1090-1. Epub 2019 Nov 8.
• [636] A novel CXCR3-B chemokine receptor-induced growth-inhibitory signal in cancer cells is mediated through the regulation of Bach-1 protein and Nrf2 protein nuclear translocation.J Biol Chem. 2014 Feb 7;289(6):3126-37. doi: 10.1074/jbc.M113.508044. Epub 2013 Dec 23.
• [637] EVI1 promotes epithelial-to-mesenchymal transition, cancer stem cell features and chemo-/radioresistance in nasopharyngeal carcinoma.J Exp Clin Cancer Res. 2019 Feb 15;38(1):82. doi: 10.1186/s13046-019-1077-3.
• [638] CCL18 enhances migration, invasion and EMT by binding CCR8 in bladder cancer cells.Mol Med Rep. 2019 Mar;19(3):1678-1686. doi: 10.3892/mmr.2018.9791. Epub 2018 Dec 24.
• [639] Differential and tumor-specific expression of CD160 in B-cell malignancies.Blood. 2011 Aug 25;118(8):2174-83. doi: 10.1182/blood-2011-02-334326. Epub 2011 Jun 28.
• [640] Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.Blood. 2016 Apr 14;127(15):1863-9. doi: 10.1182/blood-2015-08-661702. Epub 2016 Jan 8.
• [641] CD2 promoter regulated nucleophosmin-anaplastic lymphoma kinase in transgenic mice causes B lymphoid malignancy.Anticancer Res. 2006 Sep-Oct;26(5A):3275-9.
• [642] Identification of Human Cutaneous Basal Cell Carcinoma Cancer Stem Cells.Methods Mol Biol. 2019;1879:435-450. doi: 10.1007/7651_2018_133.
• [643] Characterisation of the Dynamic Interactions between Complex N-Glycans and Human CD22.Chembiochem. 2020 Jan 15;21(1-2):129-140. doi: 10.1002/cbic.201900295. Epub 2019 Oct 17.
• [644] CD248: A therapeutic target in cancer and fibrotic diseases.Oncotarget. 2019 Jan 29;10(9):993-1009. doi: 10.18632/oncotarget.26590. eCollection 2019 Jan 29.
• [645] Tailoring early-phase clinical trial design to address multiple research objectives.Cancer Immunol Immunother. 2020 Jan;69(1):95-102. doi: 10.1007/s00262-019-02442-5. Epub 2019 Dec 5.
• [646] CAF-induced placental growth factor facilitates neoangiogenesis in hepatocellular carcinoma.Acta Biochim Biophys Sin (Shanghai). 2020 Jan 2;52(1):18-25. doi: 10.1093/abbs/gmz134.
• [647] Targeting B-cell malignancies with the beta-emitting anti-CD37 radioimmunoconjugate (177)Lu-NNV003.Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2311-2321. doi: 10.1007/s00259-019-04417-1. Epub 2019 Jul 15.
• [648] Reprint of "Immunomodulatory effects of CD38-targeting antibodies".Immunol Lett. 2019 Jan;205:71-77. doi: 10.1016/j.imlet.2019.02.002. Epub 2019 Feb 28.
• [649] Interleukin-15 (dys)regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer.J Exp Med. 2020 Jan 6;217(1):e20191062. doi: 10.1084/jem.20191062.
• [650] Novel Combination Oncolytic Adenoviral Gene Therapy Armed with Dm-dNK and CD40L for Breast Cancer.Curr Gene Ther. 2019;19(1):54-65. doi: 10.2174/1566523219666190307094713.
• [651] Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer.Endocr Relat Cancer. 2018 Jan;25(1):35-50. doi: 10.1530/ERC-17-0280. Epub 2017 Oct 17.
• [652] CD47: role in the immune system and application to cancer therapy.Cell Oncol (Dordr). 2020 Feb;43(1):19-30. doi: 10.1007/s13402-019-00469-5. Epub 2019 Aug 14.
• [653] A novel therapeutic antiCD55 monoclonal antibody inhibits the proliferation and metastasis of colorectal cancer cells.Oncol Rep. 2019 Dec;42(6):2686-2693. doi: 10.3892/or.2019.7337. Epub 2019 Sep 26.
• [654] CD58, anovel surface marker, promotes self-renewal of tumor-initiating cells in colorectal cancer.Oncogene. 2015 Mar 19;34(12):1520-31. doi: 10.1038/onc.2014.95. Epub 2014 Apr 14.
• [655] Selective targeting of collagen IV in the cancer cell microenvironment reduces tumor burden.Oncotarget. 2018 Jan 19;9(13):11020-11045. doi: 10.18632/oncotarget.24280. eCollection 2018 Feb 16.
• [656] Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential.Int J Nanomedicine. 2017 Mar 13;12:1969-1983. doi: 10.2147/IJN.S127575. eCollection 2017.
• [657] CD70 expression correlates with a worse prognosis in malignant pleural mesothelioma patients via immune evasion and enhanced invasiveness.J Pathol. 2020 Feb;250(2):205-216. doi: 10.1002/path.5361. Epub 2019 Dec 3.
• [658] MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential.Nat Rev Urol. 2019 May;16(5):318-328. doi: 10.1038/s41585-019-0171-9.
• [659] Anti-CD22 and anti-CD79b antibody-drug conjugates preferentially target proliferating B cells.Br J Pharmacol. 2017 Apr;174(8):628-640. doi: 10.1111/bph.13697. Epub 2017 Mar 6.
• [660] Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of micebearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation.Cancer Immunol Immunother. 2019 Nov;68(11):1805-1817. doi: 10.1007/s00262-019-02397-7. Epub 2019 Oct 18.
• [661] Visual Electrofluorochromic Detection of Cancer Cell Surface Glycoprotein on a Closed Bipolar Electrode Chip.Anal Chem. 2019 Jun 18;91(12):7902-7910. doi: 10.1021/acs.analchem.9b01760. Epub 2019 Jun 7.
• [662] CD96 Is an Immune Checkpoint That Regulates CD8(+) T-cell Antitumor Function.Cancer Immunol Res. 2019 Apr;7(4):559-571. doi: 10.1158/2326-6066.CIR-18-0637. Epub 2019 Mar 20.
• [663] A novel strategy to block mitotic progression for targeted therapy.EBioMedicine. 2019 Nov;49:40-54. doi: 10.1016/j.ebiom.2019.10.013. Epub 2019 Oct 25.
• [664] CDC25B and CDC25C overexpression in nonmelanoma skin cancer suppresses cell death.Mol Carcinog. 2019 Sep;58(9):1691-1700. doi: 10.1002/mc.23075. Epub 2019 Jun 24.
• [665] Identification of highly potent and selective Cdc25 protein phosphatases inhibitors from miniaturization click-chemistry-based combinatorial libraries.Eur J Med Chem. 2019 Dec 1;183:111696. doi: 10.1016/j.ejmech.2019.111696. Epub 2019 Sep 14.
• [666] Structure-based virtual screening and optimization of modulators targeting Hsp90-Cdc37 interaction.Eur J Med Chem. 2017 Aug 18;136:63-73. doi: 10.1016/j.ejmech.2017.04.074. Epub 2017 Apr 30.
• [667] Targeting CDC7 sensitizes resistance melanoma cells to BRAF(V600E)-specific inhibitor by blocking the CDC7/MCM2-7 pathway.Sci Rep. 2019 Oct 2;9(1):14197. doi: 10.1038/s41598-019-50732-w.
• [668] Long Non-Coding RNA HOXA-AS2 Regulates Malignant Glioma Behaviors and Vasculogenic Mimicry Formation via the MiR-373/EGFR Axis.Cell Physiol Biochem. 2018;45(1):131-147. doi: 10.1159/000486253. Epub 2017 Dec 25.
• [669] Combined overexpression of cadherin 6, cadherin 11 and cluster of differentiation 44 is associated with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.Oncol Lett. 2018 Jun;15(6):9498-9506. doi: 10.3892/ol.2018.8509. Epub 2018 Apr 17.
• [670] Transcriptional Basis of Mouse and Human Dendritic Cell Heterogeneity.Cell. 2019 Oct 31;179(4):846-863.e24. doi: 10.1016/j.cell.2019.09.035. Epub 2019 Oct 24.
• [671] The Emerging Picture of CDK11: Genetic, Functional and Medicinal Aspects.Curr Med Chem. 2018;25(8):880-888. doi: 10.2174/0929867324666170815102036.
• [672] CDK12 Promotes Breast Cancer Progression and Maintains Stemness by Activating c-myc/ -catenin Signaling.Curr Cancer Drug Targets. 2020;20(2):156-165. doi: 10.2174/1568009619666191118113220.
• [673] CDK13 RNA Over-Editing Mediated by ADAR1 Associates with Poor Prognosis of Hepatocellular Carcinoma Patients.Cell Physiol Biochem. 2018;47(6):2602-2612. doi: 10.1159/000491656. Epub 2018 Jul 11.
• [674] PES1 promotes BET inhibitors resistance and cells proliferation through increasing c-Myc expression in pancreatic cancer.J Exp Clin Cancer Res. 2019 Nov 12;38(1):463. doi: 10.1186/s13046-019-1466-7.
• [675] Downregulation of lncRNA NR2F2 Antisense RNA 1 Induces G1 Arrest of Colorectal Cancer Cells by Downregulating Cyclin-Dependent Kinase 6.Dig Dis Sci. 2020 Feb;65(2):464-469. doi: 10.1007/s10620-019-05782-5. Epub 2019 Aug 20.
• [676] The covalent CDK7 inhibitor THZ1 enhances temsirolimus-induced cytotoxicity via autophagy suppression in human renal cell carcinoma.Cancer Lett. 2020 Feb 28;471:27-37. doi: 10.1016/j.canlet.2019.12.005. Epub 2019 Dec 6.
• [677] CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors.Eur J Med Chem. 2019 Feb 15;164:77-91. doi: 10.1016/j.ejmech.2018.11.076. Epub 2018 Dec 21.
• [678] Ligand- and structure-based pharmacophore modeling, docking study reveals 2-[[4-[6-(isopropylamino) pyrimidin-4-yl]-1H-pyrrolo[2,3-b] pyridin-6-yl] amino] ethanol as a potential anticancer agent of CDK9/cyclin T1 kinase.J Cancer Res Ther. 2019 Jul-Sep;15(5):1131-1140. doi: 10.4103/jcrt.JCRT_47_18.
• [679] Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression.Oncotarget. 2017 Apr 25;8(17):28297-28311. doi: 10.18632/oncotarget.16044.
• [680] Quantifying Carcinoembryonic Antigen-like Cell Adhesion Molecule-Targeted Liposome Delivery Using Imaging Flow Cytometry.Mol Pharm. 2019 Jun 3;16(6):2354-2363. doi: 10.1021/acs.molpharmaceut.8b01274. Epub 2019 May 13.
• [681] Carcinoembryonic antigen (CEACAM) family members and Inflammatory Bowel Disease.Cytokine Growth Factor Rev. 2019 Jun;47:21-31. doi: 10.1016/j.cytogfr.2019.05.008. Epub 2019 May 18.
• [682] Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers.Prostate. 2019 Feb;79(3):302-311. doi: 10.1002/pros.23736. Epub 2018 Nov 14.
• [683] p300 Mediates Muscle Wasting in Lewis Lung Carcinoma.Cancer Res. 2019 Apr 1;79(7):1331-1342. doi: 10.1158/0008-5472.CAN-18-1653. Epub 2019 Jan 31.
• [684] Serial transcriptome analysis and cross-species integration identifies centromere-associated protein E as a novel neuroblastoma target.Cancer Res. 2010 Apr 1;70(7):2749-58. doi: 10.1158/0008-5472.CAN-09-3844. Epub 2010 Mar 16.
• [685] Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigens.PLoS One. 2011;6(8):e23916. doi: 10.1371/journal.pone.0023916. Epub 2011 Aug 22.
• [686] Construction of diagnosis system and gene regulatory networks based on microarray analysis.J Biomed Inform. 2018 May;81:61-73. doi: 10.1016/j.jbi.2018.03.008. Epub 2018 Mar 14.
• [687] Pirfenidone inhibits TGF-beta expression in malignant glioma cells.Biochem Biophys Res Commun. 2007 Mar 9;354(2):542-7. doi: 10.1016/j.bbrc.2007.01.012. Epub 2007 Jan 10.
• [688] Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer. Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3127-3132.
• [689] miR-150-504-519d inhibits the growth of human colorectal cancer cell line SW48 and downregulates c-FLIP receptor.J Cell Biochem. 2019 May;120(5):7962-7969. doi: 10.1002/jcb.28073. Epub 2018 Dec 12.
• [690] Choline kinase inhibitors EB-3D and EB-3P interferes with lipid homeostasis in HepG2 cells.Sci Rep. 2019 Mar 25;9(1):5109. doi: 10.1038/s41598-019-40885-z.
• [691] Mucin O-glycosylating enzyme GALNT2 facilitates the malignant character of glioma by activating the EGFR/PI3K/Akt/mTOR axis.Clin Sci (Lond). 2019 May 21;133(10):1167-1184. doi: 10.1042/CS20190145. Print 2019 May 31.
• [692] Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness.Cancer Discov. 2018 Nov;8(11):1458-1473. doi: 10.1158/2159-8290.CD-18-0046. Epub 2018 Sep 5.
• [693] 7-Nicotinic acetylcholine receptor antagonist QND7 suppresses non-small cell lung cancer cell proliferation and migration via inhibition of Akt/mTOR signaling.Biochem Biophys Res Commun. 2020 Jan 22;521(4):977-983. doi: 10.1016/j.bbrc.2019.11.018. Epub 2019 Nov 11.
• [694] Gene variance in the nicotinic receptor cluster (CHRNA5-CHRNA3-CHRNB4) predicts death from cardiopulmonary disease and cancer in smokers.J Intern Med. 2016 Apr;279(4):388-98. doi: 10.1111/joim.12454. Epub 2015 Dec 22.
• [695] Overexpression of carbohydrate sulfotransferase 15 in pancreatic cancer stroma is associated with worse prognosis.Oncol Lett. 2019 Oct;18(4):4100-4105. doi: 10.3892/ol.2019.10764. Epub 2019 Aug 16.
• [696] The Emerging Role of Calcium-activated Chloride Channel Regulator 1 in Cancer.Anticancer Res. 2019 Apr;39(4):1661-1666. doi: 10.21873/anticanres.13271.
• [697] Cardiotrophin-like cytokine factor 1 (CLCF1) and neuropoietin (NP) signalling and their roles in development, adulthood, cancer and degenerative di... Cytokine Growth Factor Rev. 2015 Oct;26(5):517-22.
• [698] Chloride channel-3 mediates multidrug resistance of cancer by upregulating P-glycoprotein expression.J Cell Physiol. 2019 May;234(5):6611-6623. doi: 10.1002/jcp.27402. Epub 2018 Sep 19.
• [699] Epithelial cell adhesion molecule (EpCAM) from pleural fluid cell lysates is a highly accurate diagnostic biomarker of adenocarcinomatous effusions.Respirology. 2019 Aug;24(8):799-804. doi: 10.1111/resp.13539. Epub 2019 Mar 22.
• [700] Expression of CLDN6 in tissues of gastric cancer patients: Association with clinical pathology and prognosis.Oncol Lett. 2019 May;17(5):4621-4625. doi: 10.3892/ol.2019.10129. Epub 2019 Mar 8.
• [701] Mapping the CLEC12A expression on myeloid progenitors in normal bone marrow; implications for understanding CLEC12A-related cancer stem cell biology.J Cell Mol Med. 2018 Apr;22(4):2311-2318. doi: 10.1111/jcmm.13519. Epub 2018 Feb 7.
• [702] The innate immune receptor Dectin-2 mediates the phagocytosis of cancer cells by Kupffer cells for the suppression of liver metastasis.Proc Natl Acad Sci U S A. 2016 Dec 6;113(49):14097-14102. doi: 10.1073/pnas.1617903113. Epub 2016 Nov 21.
• [703] Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity.Front Oncol. 2019 Mar 13;9:135. doi: 10.3389/fonc.2019.00135. eCollection 2019.
• [704] Overexpression of CLN3 contributes to tumour progression and predicts poor prognosis in hepatocellular carcinoma.Surg Oncol. 2019 Mar;28:180-189. doi: 10.1016/j.suronc.2018.12.003. Epub 2018 Dec 20.
• [705] Targeting Clusterin Induces Apoptosis, Reduces Growth Ability and Invasion and Mediates Sensitivity to Chemotherapy in Human Osteosarcoma Cells.Curr Pharm Biotechnol. 2020;21(2):131-139. doi: 10.2174/1389201020666190821151120.
• [706] Tumoral microvesicle-activated glycometabolic reprogramming in fibroblasts promotes the progression of oral squamous cell carcinoma.FASEB J. 2019 Apr;33(4):5690-5703. doi: 10.1096/fj.201802226R. Epub 2019 Jan 30.
• [707] Expression of Bioactive Chemerin by Keratinocytes Inhibits Late Stages of Tumor Development in a Chemical Model of Skin Carcinogenesis.Front Oncol. 2019 Nov 15;9:1253. doi: 10.3389/fonc.2019.01253. eCollection 2019.
• [708] Down-Regulation of Cannabinoid Type 1 (CB1) Receptor and its Downstream Signaling Pathways in Metastatic Colorectal Cancer.Cancers (Basel). 2019 May 22;11(5):708. doi: 10.3390/cancers11050708.
• [709] Emerging therapeutic targets in cancer induced bone disease: A focus on the peripheral type 2 cannabinoid receptor.Pharmacol Res. 2017 May;119:391-403. doi: 10.1016/j.phrs.2017.02.023. Epub 2017 Mar 6.
• [710] Neural Cell Adhesion Protein CNTN1 Promotes the Metastatic Progression of Prostate Cancer.Cancer Res. 2016 Mar 15;76(6):1603-14. doi: 10.1158/0008-5472.CAN-15-1898. Epub 2016 Jan 21.
• [711] Conservative Surgical Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw with Er,Cr:YSGG Laser and Platelet-Rich Plasma: A Longitudinal Study.Biomed Res Int. 2018 Aug 19;2018:3982540. doi: 10.1155/2018/3982540. eCollection 2018.
• [712] Collagen Type VI Alpha 3 Chain Promotes Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Transforming Growth Factor (TGF-)/Smad Pathway.Med Sci Monit. 2018 Aug 1;24:5346-5354. doi: 10.12659/MSM.909811.
• [713] Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa.Sci Transl Med. 2014 Nov 26;6(264):264ra163. doi: 10.1126/scitranslmed.3009540.
• [714] The novel Jab1 inhibitor CSN5i-3 suppresses cell proliferation and induces apoptosis in human breast cancer cells.Neoplasma. 2019 May 23;66(3):481-486. doi: 10.4149/neo_2018_181016N772. Epub 2019 Mar 7.
• [715] IL-10 correlates with the expression of carboxypeptidase B2 and lymphovascular invasion in inflammatory breast cancer: The potential role of tumor infiltrated macrophages.Curr Probl Cancer. 2018 Mar-Apr;42(2):215-230. doi: 10.1016/j.currproblcancer.2018.01.009. Epub 2018 Jan 10.
• [716] JAK/STAT3-Regulated Fatty Acid -Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance.Cell Metab. 2018 Jan 9;27(1):136-150.e5. doi: 10.1016/j.cmet.2017.11.001. Epub 2017 Dec 14.
• [717] Activation of human thymocytes after infection by EBV.J Immunol. 1995 Feb 1;154(3):1440-9.
• [718] The adaptor protein and Arf GTPase-activating protein Cat-1/Git-1 is required for cellular transformation.J Biol Chem. 2012 Sep 7;287(37):31462-70. doi: 10.1074/jbc.M112.353615. Epub 2012 Jul 17.
• [719] Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon.J Biol Chem. 2018 Apr 20;293(16):6187-6200. doi: 10.1074/jbc.M117.816868. Epub 2018 Feb 15.
• [720] CREB promotes laryngeal cancer cell migration via MYCT1/NAT10 axis.Onco Targets Ther. 2018 Mar 8;11:1323-1331. doi: 10.2147/OTT.S156582. eCollection 2018.
• [721] Development of a Taiwan cancer-related fatigue cognition questionnaire: reliability and validity.Oncotarget. 2017 Apr 25;8(17):28880-28887. doi: 10.18632/oncotarget.16285.
• [722] Novel significant stage-specific differentially expressed genes in hepatocellular carcinoma.BMC Cancer. 2019 Jul 5;19(1):663. doi: 10.1186/s12885-019-5838-3.
• [723] CRH promotes human colon cancer cell proliferation via IL-6/JAK2/STAT3 signaling pathway and VEGF-induced tumor angiogenesis.Mol Carcinog. 2017 Nov;56(11):2434-2445. doi: 10.1002/mc.22691. Epub 2017 Jul 13.
• [724] Expression of CRF1 and CRF2 receptors in human cancers.J Clin Endocrinol Metab. 2003 Jul;88(7):3312-20. doi: 10.1210/jc.2002-021853.
• [725] IKK Promotes the Progression and Metastasis of Non-Small Cell Lung Cancer Independently of its Subcellular Localization.Comput Struct Biotechnol J. 2019 Feb 7;17:251-262. doi: 10.1016/j.csbj.2019.02.003. eCollection 2019.
• [726] SIN1 promotes the proliferation and migration of breast cancer cells by Akt activation.Biosci Rep. 2016 Dec 9;36(6):e00424. doi: 10.1042/BSR20160192. Print 2016 Dec.
• [727] Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia.PLoS One. 2012;7(3):e34347. doi: 10.1371/journal.pone.0034347. Epub 2012 Mar 28.
• [728] The expression of clock genes cry1 and cry2 in human colorectal cancer and tumor adjacent tissues correlates differently dependent on tumor location.Neoplasma. 2018 Nov 15;65(6):986-992. doi: 10.4149/neo_2018_180122N47. Epub 2018 Jun 18.
• [729] Identification of novel NAD(P)H dehydrogenase [quinone] 1 antagonist using computational approaches.J Biomol Struct Dyn. 2020 Feb;38(3):682-696. doi: 10.1080/07391102.2019.1585291. Epub 2019 Mar 22.
• [730] Loss of the respiratory enzyme citrate synthase directly links the Warburg effect to tumor malignancy.Sci Rep. 2012;2:785. doi: 10.1038/srep00785. Epub 2012 Nov 8.
• [731] Expression of cellular apoptosis susceptibility (CAS) in the human testis and testicular germ cell tumors.Med Oncol. 2019 May 29;36(7):61. doi: 10.1007/s12032-019-1281-1.
• [732] Reprofiling of pyrimidine-based DAPK1/CSF1R dual inhibitors: identification of 2,5-diamino-4-pyrimidinol derivatives as novel potential anticancer lead compounds.J Enzyme Inhib Med Chem. 2020 Dec;35(1):311-324. doi: 10.1080/14756366.2019.1699554.
• [733] Altered expression of CSF3R splice variants impacts signal response and is associated with SRSF2 mutations.Leukemia. 2020 Feb;34(2):369-379. doi: 10.1038/s41375-019-0567-9. Epub 2019 Aug 28.
• [734] Differential expression patterns of capping protein, protein phosphatase 1, and casein kinase 1 may serve as diagnostic markers for malignant melanoma.Melanoma Res. 2011 Aug;21(4):335-43. doi: 10.1097/CMR.0b013e328346b715.
• [735] Phosphorylation of IRS4 by CK12 promotes its degradation by CHIP through the ubiquitin/lysosome pathway.Theranostics. 2018 Jun 7;8(13):3643-3653. doi: 10.7150/thno.26021. eCollection 2018.
• [736] RNAi-based screening of the human kinome identifies Akt-cooperating kinases: a new approach to designing efficacious multitargeted kinase inhibitors.Oncogene. 2006 Mar 2;25(9):1340-8. doi: 10.1038/sj.onc.1209169.
• [737] Lentivirus-mediated down-regulation of CK2 inhibits proliferation and induces apoptosis of malignant lymphoma and leukemia cells.Biochem Cell Biol. 2018 Dec;96(6):786-796. doi: 10.1139/bcb-2017-0345. Epub 2018 May 17.
• [738] Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma.Ther Adv Med Oncol. 2019 Jun 6;11:1758835919855491. doi: 10.1177/1758835919855491. eCollection 2019.
• [739] BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells.Nature. 2019 Aug;572(7771):676-680. doi: 10.1038/s41586-019-1472-0. Epub 2019 Aug 7.
• [740] The Small C-terminal Domain Phosphatase 1 Inhibits Cancer Cell Migration and Invasion by Dephosphorylating Ser(P)68-Twist1 to Accelerate Twist1 Protein Degradation.J Biol Chem. 2016 May 27;291(22):11518-28. doi: 10.1074/jbc.M116.721795. Epub 2016 Mar 14.
• [741] Hydrogen Sulfide Is Increased in Oral Squamous Cell Carcinoma Compared to Adjacent Benign Oral Mucosae.Anticancer Res. 2018 Jul;38(7):3843-3852. doi: 10.21873/anticanres.12668.
• [742] Ectopic miR-975 induces CTP synthase directed cell proliferation and differentiation in Drosophila melanogaster.Sci Rep. 2019 Apr 15;9(1):6096. doi: 10.1038/s41598-019-42369-6.
• [743] CNF1-like deamidase domains: common Lego bricks among cancer-promoting immunomodulatory bacterial virulence factors.Pathog Dis. 2018 Jul 1;76(5):fty045. doi: 10.1093/femspd/fty045.
• [744] Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies.BJU Int. 2019 May;123(5):826-833. doi: 10.1111/bju.14540. Epub 2018 Oct 11.
• [745] Cathepsin F Knockdown Induces Proliferation and Inhibits Apoptosis in Gastric Cancer Cells.Oncol Res. 2018 Jan 19;26(1):83-93. doi: 10.3727/096504017X14928634401204. Epub 2017 Apr 25.
• [746] Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines.Cancer Sci. 2003 Dec;94(12):1074-82. doi: 10.1111/j.1349-7006.2003.tb01403.x.
• [747] Cathepsin S regulates renal fibrosis in mouse models of mild and severe hydronephrosis.Mol Med Rep. 2019 Jul;20(1):141-150. doi: 10.3892/mmr.2019.10230. Epub 2019 May 9.
• [748] CUL7 promotes cancer cell survival through promoting Caspase-8 ubiquitination.Int J Cancer. 2019 Sep 1;145(5):1371-1381. doi: 10.1002/ijc.32239. Epub 2019 Mar 18.
• [749] Transcription profiling of peripheral B cells in antibody-positive primary Sjgren's syndrome reveals upregulated expression of CX3CR1 and a type I and type II interferon signature.Scand J Immunol. 2018 May;87(5):e12662. doi: 10.1111/sji.12662.
• [750] Reciprocal activation of cancer-associated fibroblasts and oral squamous carcinoma cells through CXCL1.Oral Oncol. 2019 Jan;88:115-123. doi: 10.1016/j.oraloncology.2018.11.002. Epub 2018 Nov 23.
• [751] Quantitative profiling of cytokines and chemokines in DOCK8-deficient and atopic dermatitis patients.Allergy. 2019 Feb;74(2):370-379. doi: 10.1111/all.13610. Epub 2018 Oct 15.
• [752] The IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling to promote prostate cancer growth.Cancer Res. 2011 May 1;71(9):3268-77. doi: 10.1158/0008-5472.CAN-10-2769. Epub 2011 Mar 11.
• [753] CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7.Cytokine. 2020 Jan;125:154809. doi: 10.1016/j.cyto.2019.154809. Epub 2019 Aug 19.
• [754] Overexpression of CXXC5 is a strong poor prognostic factor in ER+ breast cancer.Oncol Lett. 2018 Jul;16(1):395-401. doi: 10.3892/ol.2018.8647. Epub 2018 May 7.
• [755] The impact of gene polymorphisms in angiotensin receptor 1 and aldosterone synthase in peritoneal dialysis patients.Clin Nephrol. 2017 Supplement 1;88(13):73-77. doi: 10.5414/CNP88FX18.
• [756] Enhanced expression of retinoic acid-metabolizing enzyme CYP26A1 in sunlight-damaged human skin.Med Mol Morphol. 2011 Dec;44(4):200-6. doi: 10.1007/s00795-010-0528-x. Epub 2011 Dec 17.
• [757] Roles of Cytochrome P450 in Metabolism of Ethanol and Carcinogens.Adv Exp Med Biol. 2018;1032:15-35. doi: 10.1007/978-3-319-98788-0_2.
• [758] Association of Genetic Variants of CYP2C19 and CYP2D6 with Esophageal Squamous Cell Carcinoma Risk in Northern India, Kashmir.Nutr Cancer. 2017 May-Jun;69(4):585-592. doi: 10.1080/01635581.2017.1299874. Epub 2017 Apr 3.
• [759] Novel isomeric metabolite profiles correlate with warfarin metabolism phenotype during maintenance dosing in a pilot study of 29 patients.Blood Coagul Fibrinolysis. 2018 Nov;29(7):602-612. doi: 10.1097/MBC.0000000000000752.
• [760] Validation of Human Sterol 14-Demethylase (CYP51) Druggability: Structure-Guided Design, Synthesis, and Evaluation of Stoichiometric, Functionally Irreversible Inhibitors.J Med Chem. 2019 Nov 27;62(22):10391-10401. doi: 10.1021/acs.jmedchem.9b01485. Epub 2019 Nov 11.
• [761] Daam2 driven degradation of VHL promotes gliomagenesis. Elife. 2017 Oct 20;6. pii: e31926.
• [762] PEG-DAAO conjugate: A promising tool for cancer therapy optimized by protein engineering.Nanomedicine. 2020 Feb;24:102122. doi: 10.1016/j.nano.2019.102122. Epub 2019 Nov 6.
• [763] Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model.Sci Rep. 2019 Apr 8;9(1):5760. doi: 10.1038/s41598-019-42214-w.
• [764] Autophagy induced by overexpression of DCTPP1 promotes tumor progression and predicts poor clinical outcome in prostate cancer.Int J Biol Macromol. 2018 Oct 15;118(Pt A):599-609. doi: 10.1016/j.ijbiomac.2018.06.005. Epub 2018 Jun 3.
• [765] The effect of linkers on the self-assembling and anti-tumor efficacy of disulfide-linked doxorubicin drug-drug conjugate nanoparticles.J Control Release. 2018 Jun 10;279:136-146. doi: 10.1016/j.jconrel.2018.04.019. Epub 2018 Apr 12.
• [766] Heat shock protein 47 (HSP47) binds to discoidin domain-containing receptor 2 (DDR2) and regulates its protein stability.J Biol Chem. 2019 Nov 8;294(45):16846-16854. doi: 10.1074/jbc.RA119.009312. Epub 2019 Sep 30.
• [767] Roles of DDX5 in the tumorigenesis, proliferation, differentiation, metastasis and pathway regulation of human malignancies.Biochim Biophys Acta Rev Cancer. 2019 Jan;1871(1):85-98. doi: 10.1016/j.bbcan.2018.11.003. Epub 2018 Nov 9.
• [768] Harnessing the immune system to fight cancer with Toll-like receptor and RIG-I-like receptor agonists.Pharmacol Res. 2020 Apr;154:104192. doi: 10.1016/j.phrs.2019.03.001. Epub 2019 Mar 2.
• [769] Recombinant Oncolytic Vaccinia Viruses Expressing Human -Defensin 2 Enhance Anti-tumor Immunity.Mol Ther Oncolytics. 2019 Apr 4;13:49-57. doi: 10.1016/j.omto.2019.03.010. eCollection 2019 Jun 28.
• [770] Deptor Is a Novel Target of Wnt/-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth.Cancer Res. 2018 Jun 15;78(12):3163-3175. doi: 10.1158/0008-5472.CAN-17-3107. Epub 2018 Apr 17.
• [771] The diacylglycerol kinase (DGK)/Akt/NF-B feedforward loop promotes esophageal squamous cell carcinoma (ESCC) progression via FAK-dependent and FAK-independent manner.Oncogene. 2019 Apr;38(14):2533-2550. doi: 10.1038/s41388-018-0604-6. Epub 2018 Dec 7.
• [772] T Cells Deficient in Diacylglycerol Kinase Are Resistant to PD-1 Inhibition and Help Create Persistent Host Immunity to Leukemia.Cancer Res. 2017 Oct 15;77(20):5676-5686. doi: 10.1158/0008-5472.CAN-17-1309. Epub 2017 Sep 15.
• [773] Dynamic contrast enhancedmagnetic resonance imaging for the early evaluation of the response to docetaxel in rats with epithelial ovarian cancer.Oncol Rep. 2019 Jun;41(6):3335-3346. doi: 10.3892/or.2019.7124. Epub 2019 Apr 17.
• [774] The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies.Leukemia. 2019 Oct;33(10):2403-2415. doi: 10.1038/s41375-019-0461-5. Epub 2019 Apr 2.
• [775] Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma.Biochem J. 2018 Jan 31;475(2):531-545. doi: 10.1042/BCJ20170597.
• [776] Restoration of type 1 iodothyronine deiodinase expression in renal cancer cells downregulates oncoproteins and affects key metabolic pathways as well as anti-oxidative system.PLoS One. 2017 Dec 22;12(12):e0190179. doi: 10.1371/journal.pone.0190179. eCollection 2017.
• [777] Delta-like 3 localizes to neuroendocrine cells and plays a pivotal role in gastrointestinal neuroendocrine malignancy.Cancer Sci. 2019 Oct;110(10):3122-3131. doi: 10.1111/cas.14157. Epub 2019 Aug 14.
• [778] FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4.BMC Cancer. 2019 Apr 11;19(1):351. doi: 10.1186/s12885-019-5500-0.
• [779] Systematic thyroid screening in myotonic dystrophy: link between thyroid volume and insulin resistance.Orphanet J Rare Dis. 2019 Feb 13;14(1):42. doi: 10.1186/s13023-019-1019-3.
• [780] Distinct functions of dynamin isoforms in tumorigenesis and their potential as therapeutic targets in cancer.Oncotarget. 2017 Jun 20;8(25):41701-41716. doi: 10.18632/oncotarget.16678.
• [781] Functions of DNA methyltransferase 3-like in germ cells and beyond.Biol Cell. 2012 Oct;104(10):571-87. doi: 10.1111/boc.201100109. Epub 2012 Jul 10.
• [782] Decrease in dipeptidyl peptidase IV activity is linked to the efficacy of differentiating compounds in follicular thyroid carcinoma cell lines.Horm Metab Res. 2011 May;43(5):364-6. doi: 10.1055/s-0031-1273682. Epub 2011 Mar 16.
• [783] CD26/DPP4 - a potential biomarker and target for cancer therapy.Pharmacol Ther. 2019 Jun;198:135-159. doi: 10.1016/j.pharmthera.2019.02.015. Epub 2019 Feb 26.
• [784] 1,4-Dihydropyridine: A Dependable Heterocyclic Ring with the Promising and the Most Anticipable Therapeutic Effects.Mini Rev Med Chem. 2019;19(15):1219-1254. doi: 10.2174/1389557519666190425184749.
• [785] The desmosomal cadherin desmoglein-3 acts as a keratinocyte anti-stress protein via suppression of p53.Cell Death Dis. 2019 Oct 3;10(10):750. doi: 10.1038/s41419-019-1988-0.
• [786] DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation.J Exp Clin Cancer Res. 2019 Aug 13;38(1):350. doi: 10.1186/s13046-019-1358-x.
• [787] Niacin deficiency modulates genes involved in cancer: Are smokers at higher risk?.J Cell Biochem. 2019 Jan;120(1):232-242. doi: 10.1002/jcb.27324. Epub 2018 Sep 1.
• [788] DUSP3/VHR is a pro-angiogenic atypical dual-specificity phosphatase.Mol Cancer. 2014 May 15;13:108. doi: 10.1186/1476-4598-13-108.
• [789] PPP2R1B gene alterations inhibit interaction of PP2A-Abeta and PP2A-C proteins in colorectal cancers.Oncol Rep. 2004 Mar;11(3):655-9.
• [790] ATP-Linked Chimeric Nucleotide as a Specific Luminescence Reporter of Deoxyuridine Triphosphatase.Bioconjug Chem. 2018 May 16;29(5):1614-1621. doi: 10.1021/acs.bioconjchem.8b00124. Epub 2018 Mar 29.
• [791] Human Dynactin-Associated Protein Transforms NIH3T3 Cells to Generate Highly Vascularized Tumors with Weak Cell-Cell Interaction.PLoS One. 2015 Aug 18;10(8):e0135836. doi: 10.1371/journal.pone.0135836. eCollection 2015.
• [792] DYRK1A inhibition suppresses STAT3/EGFR/Met signalling and sensitizes EGFR wild-type NSCLC cells to AZD9291.J Cell Mol Med. 2019 Nov;23(11):7427-7437. doi: 10.1111/jcmm.14609. Epub 2019 Aug 27.
• [793] Toll-like receptor 4 regulates spontaneous intestinal tumorigenesis by up-regulating IL-6 and GM-CSF.J Cell Mol Med. 2020 Jan;24(1):385-397. doi: 10.1111/jcmm.14742. Epub 2019 Oct 25.
• [794] Endothelin-converting enzyme-1 in cancer aggressiveness.Cancer Lett. 2019 Jun 28;452:152-157. doi: 10.1016/j.canlet.2019.03.033. Epub 2019 Mar 26.
• [795] The clinical significance of endothelin receptor type B in hepatocellular carcinoma and its potential molecular mechanism.Exp Mol Pathol. 2019 Apr;107:141-157. doi: 10.1016/j.yexmp.2019.02.002. Epub 2019 Feb 12.
• [796] Polycomb repression regulates Schwann cell proliferation and axon regeneration after nerve injury.Glia. 2018 Nov;66(11):2487-2502. doi: 10.1002/glia.23500. Epub 2018 Oct 11.
• [797] New sorbicillinoid derivatives with GLP-1R and eEF2K affinities from a sponge-derived fungus Penicillium chrysogenum 581F1.Nat Prod Res. 2020 Oct;34(20):2880-2886. doi: 10.1080/14786419.2019.1596099. Epub 2019 Apr 16.
• [798] The eIF2-alpha kinase HRI: a potential target beyond the red blood cell.Expert Opin Ther Targets. 2017 Dec;21(12):1171-1177. doi: 10.1080/14728222.2017.1397133. Epub 2017 Oct 30.
• [799] The Noncoding RNA nc886 Regulates PKR Signaling and Cytokine Production in Human Cells.J Immunol. 2019 Jan 1;202(1):131-141. doi: 10.4049/jimmunol.1701234. Epub 2018 Dec 5.
• [800] The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitation.Oncogene. 2019 Apr;38(17):3216-3231. doi: 10.1038/s41388-018-0651-z. Epub 2019 Jan 9.
• [801] Frenolicin B Targets Peroxiredoxin 1 and Glutaredoxin 3 to Trigger ROS/4E-BP1-Mediated Antitumor Effects. Cell Chem Biol. 2019 Mar 21;26(3):366-377.e12. doi: 10.1016/j.chembiol.2018.11.013. Epub 2019 Jan 17.
• [802] eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies.Cancer Res. 2012 Dec 15;72(24):6468-76. doi: 10.1158/0008-5472.CAN-12-2395. Epub 2012 Oct 24.
• [803] EIF5A regulates proliferation and chemoresistance in pancreatic cancer through the sHH signalling pathway.J Cell Mol Med. 2019 Apr;23(4):2678-2688. doi: 10.1111/jcmm.14167. Epub 2019 Feb 14.
• [804] The HuR CMLD-2 inhibitor exhibits antitumor effects via MAD2 downregulation in thyroid cancer cells.Sci Rep. 2019 May 14;9(1):7374. doi: 10.1038/s41598-019-43894-0.
• [805] Genome-wide colocalization of RNA-DNA interactions and fusion RNA pairs.Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):3328-3337. doi: 10.1073/pnas.1819788116. Epub 2019 Feb 4.
• [806] Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma.Stem Cells Int. 2019 Mar 19;2019:9060152. doi: 10.1155/2019/9060152. eCollection 2019.
• [807] Comprehensive Characterization of Alternative Polyadenylation in Human Cancer.J Natl Cancer Inst. 2018 Apr 1;110(4):379-389. doi: 10.1093/jnci/djx223.
• [808] Serum ATX as a novel biomarker for breast cancer.Medicine (Baltimore). 2019 Mar;98(13):e14973. doi: 10.1097/MD.0000000000014973.
• [809] EPHA2 feedback activation limits the response to PDE inhibition in KRAS-dependent cancer cells.Acta Pharmacol Sin. 2020 Feb;41(2):270-277. doi: 10.1038/s41401-019-0268-y. Epub 2019 Jul 17.
• [810] EPHA5 mediates trastuzumab resistance in HER2-positive breast cancers through regulating cancer stem cell-like properties.FASEB J. 2019 Apr;33(4):4851-4865. doi: 10.1096/fj.201701561RRRR. Epub 2019 Jan 8.
• [811] Tyrosine kinase Eph receptor A6 sensitizes glioma-initiating cells towards bone morphogenetic protein-induced apoptosis.Cancer Sci. 2019 Nov;110(11):3486-3496. doi: 10.1111/cas.14187. Epub 2019 Sep 20.
• [812] A CATH domain functional family based approach to identify putative cancer driver genes and driver mutations.Sci Rep. 2019 Jan 22;9(1):263. doi: 10.1038/s41598-018-36401-4.
• [813] Structure and dynamic regulation of Abl kinases.J Biol Chem. 2013 Feb 22;288(8):5443-50. doi: 10.1074/jbc.R112.438382. Epub 2013 Jan 11.
• [814] Mps1 is associated with the BRAF(V600E) mutation and predicts poor outcome in patients with colorectal cancer.Oncol Lett. 2019 Mar;17(3):2809-2817. doi: 10.3892/ol.2019.9924. Epub 2019 Jan 14.
• [815] Screening for therapeutic targets of tumor angiogenesis signatures in 31 cancer types and potential insights.Biochem Biophys Res Commun. 2019 Jan 8;508(2):465-471. doi: 10.1016/j.bbrc.2018.11.095. Epub 2018 Nov 29.
• [816] Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release.Mater Sci Eng C Mater Biol Appl. 2018 Jan 1;82:291-298. doi: 10.1016/j.msec.2017.07.051. Epub 2017 Jul 31.
• [817] Erythropoietin inhibits chemotherapy-induced cell death and promotes a senescence-like state in leukemia cells.Cell Death Dis. 2019 Jan 8;10(1):22. doi: 10.1038/s41419-018-1274-6.
• [818] Eosinophil peroxidase over-expression predicts the clinical outcome of patients with primary lung adenocarcinoma.J Cancer. 2019 Jan 29;10(4):1032-1038. doi: 10.7150/jca.24314. eCollection 2019.
• [819] A disassembling strategy overcomes the EPR effect and renal clearance dilemma of the multifunctional theranostic nanoparticles for cancer therapy.Biomaterials. 2019 Mar;197:284-293. doi: 10.1016/j.biomaterials.2019.01.025. Epub 2019 Jan 18.
• [820] Generation of two ERF gene knockout human embryonic stem cell lines using CRISPR/Cas9 system.Stem Cell Res. 2019 Dec;41:101644. doi: 10.1016/j.scr.2019.101644. Epub 2019 Nov 6.
• [821] Subresidue-Resolution Footprinting of Ligand-Protein Interactions by Carbene Chemistry and Ion Mobility-Mass Spectrometry.Anal Chem. 2020 Jan 7;92(1):947-956. doi: 10.1021/acs.analchem.9b03827. Epub 2019 Dec 11.
• [822] Targeting LRH? in hepatoblastoma cell lines causes decreased proliferation.Oncol Rep. 2019 Jan;41(1):143-153. doi: 10.3892/or.2018.6793. Epub 2018 Oct 15.
• [823] Estrogen-related receptor gamma functions as a tumor suppressor in gastric cancer.Nat Commun. 2018 May 15;9(1):1920. doi: 10.1038/s41467-018-04244-2.
• [824] ETS1 is coexpressed with ZEB2 and mediates ZEB2-induced epithelial-mesenchymal transition in human tumors.Mol Carcinog. 2019 Jun;58(6):1068-1081. doi: 10.1002/mc.22994. Epub 2019 Mar 6.
• [825] Ezrin promotes breast cancer progression by modulating AKT signals.Br J Cancer. 2019 Apr;120(7):703-713. doi: 10.1038/s41416-019-0383-z. Epub 2019 Feb 26.
• [826] New Class of Half-Sandwich Ruthenium(II) Arene Complexes Bearing the Water-Soluble CAP Ligand as an in Vitro Anticancer Agent.Inorg Chem. 2017 May 15;56(10):5514-5518. doi: 10.1021/acs.inorgchem.7b00915. Epub 2017 Apr 26.
• [827] The hypoxia-associated factor switches cells from HIF-1- to HIF-2-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion.Cancer Res. 2011 Jun 1;71(11):4015-27. doi: 10.1158/0008-5472.CAN-10-4142. Epub 2011 Apr 21.
• [828] Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.World J Gastroenterol. 2018 Mar 14;24(10):1120-1133. doi: 10.3748/wjg.v24.i10.1120.
• [829] Shared and independent functions of aPKC and Par3 in skin tumorigenesis.Oncogene. 2018 Sep;37(37):5136-5146. doi: 10.1038/s41388-018-0313-1. Epub 2018 May 23.
• [830] Potential Therapeutic Agents Against Par-4 Target for Cancer Treatment: Where Are We Going?.Curr Drug Targets. 2019;20(6):635-654. doi: 10.2174/1389450120666181126122440.
• [831] Diverse roles of fatty acid binding proteins (FABPs) in development and pathogenesis of cancers.Gene. 2018 Nov 15;676:171-183. doi: 10.1016/j.gene.2018.07.035. Epub 2018 Jul 18.
• [832] FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway.Int J Oncol. 2019 Apr;54(4):1221-1232. doi: 10.3892/ijo.2019.4721. Epub 2019 Feb 22.
• [833] A rare eicosanoid precursor analogue, sciadonic acid (5Z,11Z,14Z-20:3), detected in vivo in hormone positive breast cancer tissue.Prostaglandins Leukot Essent Fatty Acids. 2018 Jul;134:1-6. doi: 10.1016/j.plefa.2018.05.002. Epub 2018 May 16.
• [834] Prognostic significance of FAM83D gene expression across human cancer types.Oncotarget. 2016 Jan 19;7(3):3332-40. doi: 10.18632/oncotarget.6620.
• [835] No evidence of significant silencing of Fanconi genes FANCF and FANCB or Nijmegen breakage syndrome gene NBS1 by DNA hyper-methylation in sporadic childhood leukaemia.Br J Haematol. 2006 Jul;134(1):61-3. doi: 10.1111/j.1365-2141.2006.06107.x.
• [836] Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.BMC Cancer. 2019 Feb 11;19(1):137. doi: 10.1186/s12885-019-5353-6.
• [837] Asunercept as an innovative therapeutic approach for recurrent glioblastoma and other malignancies.Cancer Manag Res. 2019 Sep 2;11:8095-8100. doi: 10.2147/CMAR.S216675. eCollection 2019.
• [838] Variants in FAT1 and COL9A1 genes in male population with or without substance use to assess the risk factors for oral malignancy.PLoS One. 2019 Jan 18;14(1):e0210901. doi: 10.1371/journal.pone.0210901. eCollection 2019.
• [839] Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.BMC Cancer. 2019 Jun 3;19(1):534. doi: 10.1186/s12885-019-5736-8.
• [840] Monoclonal antibody-mediated killing of tumour cells by neutrophils.Eur J Clin Invest. 2018 Nov;48 Suppl 2(Suppl Suppl 2):e12962. doi: 10.1111/eci.12962. Epub 2018 Jul 5.
• [841] Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy.Blood. 2011 Sep 1;118(9):2530-40. doi: 10.1182/blood-2011-01-330357. Epub 2011 Jul 18.
• [842] Identification of anti-CD16a single domain antibodies and their application in bispecific antibodies.Cancer Biol Ther. 2020;21(1):72-80. doi: 10.1080/15384047.2019.1665953. Epub 2019 Sep 29.
• [843] Characterization of farnesyl diphosphate farnesyl transferase 1 (FDFT1) expression in cancer.Per Med. 2019 Jan;16(1):51-65. doi: 10.2217/pme-2016-0058. Epub 2018 Nov 23.
• [844] Novel Nitric Oxide Donors of Phenylsulfonylfuroxan and 3-Benzyl Coumarin Derivatives as Potent Antitumor Agents.ACS Med Chem Lett. 2018 Apr 20;9(5):502-506. doi: 10.1021/acsmedchemlett.8b00125. eCollection 2018 May 10.
• [845] Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40.J Biol Chem. 2005 Apr 8;280(14):13285-91. doi: 10.1074/jbc.M410922200. Epub 2005 Feb 4.
• [846] Oncoprotective Effects of Short-Chain Fatty Acids on Uterine Cervical Neoplasia.Nutr Cancer. 2019;71(2):312-319. doi: 10.1080/01635581.2019.1578388. Epub 2019 Mar 5.
• [847] Intrinsic FGFR2 and Ectopic FGFR1 Signaling in the Prostate and Prostate Cancer.Front Genet. 2019 Jan 30;10:12. doi: 10.3389/fgene.2019.00012. eCollection 2019.
• [848] Function of fibroblast growth factor 2 in gastric cancer occurrence and prognosis.Mol Med Rep. 2020 Feb;21(2):575-582. doi: 10.3892/mmr.2019.10850. Epub 2019 Nov 26.
• [849] Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21.Proc Natl Acad Sci U S A. 2014 Aug 12;111(32):11592-9. doi: 10.1073/pnas.1412047111. Epub 2014 Jul 31.
• [850] Selective Uptake Into Drug Resistant Mammalian Cancer by Cell Penetrating Peptide-Mediated Delivery.Bioconjug Chem. 2018 Oct 17;29(10):3273-3284. doi: 10.1021/acs.bioconjchem.8b00429. Epub 2018 Oct 8.
• [851] Fibroblast growth factor, estrogen, and prolactin receptor features in different grades of prostatic adenocarcinoma in elderly men.Microsc Res Tech. 2013 Mar;76(3):321-30. doi: 10.1002/jemt.22170. Epub 2013 Jan 30.
• [852] FGG promotes migration and invasion in hepatocellular carcinoma cells through activating epithelial to mesenchymal transition. Cancer Manag Res. 2019 Feb 19;11:1653-1665.
• [853] The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma.J Natl Cancer Inst. 2019 Mar 1;111(3):292-300. doi: 10.1093/jnci/djy107.
• [854] Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer.Oncol Rep. 2019 Aug;42(2):615-628. doi: 10.3892/or.2019.7195. Epub 2019 Jun 11.
• [855] FKBP12 enhances sensitivity to chemotherapy-induced cancer cell apoptosis by inhibiting MDM2.Oncogene. 2017 Mar 23;36(12):1678-1686. doi: 10.1038/onc.2016.331. Epub 2016 Sep 12.
• [856] Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate Cancer.Clin Cancer Res. 2019 Jan 15;25(2):710-723. doi: 10.1158/1078-0432.CCR-18-0704. Epub 2018 Oct 15.
• [857] Primary Preclinical and Clinical Evaluation of (68)Ga-DOTA-TMVP1 as a Novel VEGFR-3 PET Imaging Radiotracer in Gynecological Cancer.Clin Cancer Res. 2020 Mar 15;26(6):1318-1326. doi: 10.1158/1078-0432.CCR-19-1845. Epub 2019 Dec 16.
• [858] The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase.Cell. 2019 Aug 8;178(4):807-819.e21. doi: 10.1016/j.cell.2019.07.031.
• [859] Folate-targeted immunotherapies: Passive and active strategies for cancer.Cytokine Growth Factor Rev. 2019 Feb;45:45-52. doi: 10.1016/j.cytogfr.2019.02.001. Epub 2019 Feb 7.
• [860] An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis.J Vis Exp. 2019 Feb 8;(144). doi: 10.3791/58713.
• [861] Identification and characterization of differentially expressed genes in Type 2 Diabetes using in silico approach.Comput Biol Chem. 2019 Apr;79:24-35. doi: 10.1016/j.compbiolchem.2019.01.010. Epub 2019 Jan 24.
• [862] Novel biomarkers for risk stratification of Barrett's oesophagus associated neoplastic progression-epithelial HMGB1 expression and stromal lymphocytic phenotype.Br J Cancer. 2020 Feb;122(4):545-554. doi: 10.1038/s41416-019-0685-1. Epub 2019 Dec 13.
• [863] Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP.J Exp Clin Cancer Res. 2019 Apr 18;38(1):170. doi: 10.1186/s13046-019-1163-6.
• [864] Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer.Prostate. 2002 Jan 1;50(1):54-63. doi: 10.1002/pros.10032.
• [865] MiR-133a-5p inhibits androgen receptor (AR)-induced proliferation in prostate cancer cells via targeting FUsed in Sarcoma (FUS) and AR.Cancer Biol Ther. 2020;21(1):34-42. doi: 10.1080/15384047.2019.1665393. Epub 2019 Nov 17.
• [866] Fucosylated TGF- receptors transduces a signal for epithelial-mesenchymal transition in colorectal cancer cells.Br J Cancer. 2014 Jan 7;110(1):156-63. doi: 10.1038/bjc.2013.699. Epub 2013 Nov 19.
• [867] FZD10 Carried by Exosomes Sustains Cancer Cell Proliferation.Cells. 2019 Jul 25;8(8):777. doi: 10.3390/cells8080777.
• [868] Frizzled-7-targeted delivery of zinc oxide nanoparticles to drug-resistant breast cancer cells.Nanoscale. 2019 Jul 11;11(27):12858-12870. doi: 10.1039/c9nr01277j.
• [869] Systematic characterisation of GABRP expression in sporadic breast cancer and normal breast tissue.Int J Cancer. 2006 Mar 15;118(6):1453-9. doi: 10.1002/ijc.21517.
• [870] GAD1 Upregulation Programs Aggressive Features of Cancer Cell Metabolism in the Brain Metastatic Microenvironment.Cancer Res. 2017 Jun 1;77(11):2844-2856. doi: 10.1158/0008-5472.CAN-16-2289. Epub 2017 Apr 11.
• [871] Anti-glutamic acid decarboxylase (GAD) positive cerebellar Ataxia with transitioning to progressive encephalomyelitis with rigidity and myoclonus (PERM), responsive to immunotherapy: A case report and review of literature.J Neuroimmunol. 2019 Jul 15;332:135-137. doi: 10.1016/j.jneuroim.2019.04.003. Epub 2019 Apr 6.
• [872] Human Galectin-1 and its inhibitors: Privileged target for cancer and HIV. Mini Rev Med Chem. 2019 Mar 4.
• [873] Epithelial-mesenchymal transition and GALC expression of circulating tumor cells indicate metastasis and poor prognosis in non-small cell lung cancer.Cancer Biomark. 2018;22(3):417-426. doi: 10.3233/CBM-170995.
• [874] N-acetylgalactosamine-6-sulfatase (GALNS), Similar to Glycodelin, Is a Potential General Biomarker for Multiple Malignancies.Anticancer Res. 2019 Nov;39(11):6317-6324. doi: 10.21873/anticanres.13842.
• [875] GALR1 methylation in vaginal swabs is highly accurate in identifying women with endometrial cancer.Int J Gynecol Cancer. 2013 Jul;23(6):1050-5. doi: 10.1097/IGC.0b013e3182959103.
• [876] Regulation of Autophagy by Nuclear GAPDH and Its Aggregates in Cancer and Neurodegenerative Disorders.Int J Mol Sci. 2019 Apr 26;20(9):2062. doi: 10.3390/ijms20092062.
• [877] ssExpression level of GAS6-mRNA influences the prognosis of acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation.Biosci Rep. 2019 May 21;39(5):BSR20190389. doi: 10.1042/BSR20190389. Print 2019 May 31.
• [878] Gastrin stimulates pancreatic cancer cell directional migration by activating the G12/13-RhoA-ROCK signaling pathway.Exp Mol Med. 2018 May 1;50(5):1-14. doi: 10.1038/s12276-018-0081-6.
• [879] Glucagon Receptor Signaling and Glucagon Resistance.Int J Mol Sci. 2019 Jul 5;20(13):3314. doi: 10.3390/ijms20133314.
• [880] Glucagon promotes colon cancer cell growth via regulating AMPK and MAPK pathways.Oncotarget. 2018 Jan 31;9(12):10650-10664. doi: 10.18632/oncotarget.24367. eCollection 2018 Feb 13.
• [881] A GTP cyclohydrolase 1 genetic variant delays cancer pain.Pain. 2010 Jan;148(1):103-106. doi: 10.1016/j.pain.2009.10.021. Epub 2009 Dec 2.
• [882] GDA, a web-based tool for Genomics and Drugs integrated analysis.Nucleic Acids Res. 2018 Jul 2;46(W1):W148-W156. doi: 10.1093/nar/gky434.
• [883] Epithelialmesenchymal transition induced by bone morphogenetic protein 9 hinders cisplatin efficacy in ovarian cancer cells.Mol Med Rep. 2019 Mar;19(3):1501-1508. doi: 10.3892/mmr.2019.9814. Epub 2019 Jan 3.
• [884] The GDNF Family: A Role in Cancer?.Neoplasia. 2018 Jan;20(1):99-117. doi: 10.1016/j.neo.2017.10.010. Epub 2017 Dec 12.
• [885] Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer.Biomaterials. 2019 Jul;208:83-97. doi: 10.1016/j.biomaterials.2019.04.005. Epub 2019 Apr 8.
• [886] High gamma-glutamyl hydrolase and low folylpolyglutamate synthetase expression as prognostic biomarkers in patients with locally advanced gastric cancer who were administrated postoperative adjuvant chemotherapy with S-1.J Cancer Res Clin Oncol. 2020 Jan;146(1):75-86. doi: 10.1007/s00432-019-03087-8. Epub 2019 Nov 21.
• [887] The Upregulation of Trophinin-Associated Protein (TROAP) Predicts a Poor Prognosis in Hepatocellular Carcinoma.J Cancer. 2019 Jan 29;10(4):957-967. doi: 10.7150/jca.26666. eCollection 2019.
• [888] MECHANISMS IN ENDOCRINOLOGY: Lessons from growth hormone receptor gene-disrupted mice: are there benefits of endocrine defects?.Eur J Endocrinol. 2018 May;178(5):R155-R181. doi: 10.1530/EJE-18-0018. Epub 2018 Feb 19.
• [889] Development of a Cx46 Targeting Strategy for Cancer Stem Cells.Cell Rep. 2019 Apr 23;27(4):1062-1072.e5. doi: 10.1016/j.celrep.2019.03.079.
• [890] Unexpected role for the human Cx37 C1019T polymorphism in tumour cell proliferation.Carcinogenesis. 2010 Nov;31(11):1922-31. doi: 10.1093/carcin/bgq170. Epub 2010 Aug 12.
• [891] Downregulated connexin32 promotes EMT through the Wnt/-catenin pathway by targeting Snail expression in hepatocellular carcinoma.Int J Oncol. 2017 Jun;50(6):1977-1988. doi: 10.3892/ijo.2017.3985. Epub 2017 May 8.
• [892] Gjb4 serves as a novel biomarker for lung cancer and promotes metastasis and chemoresistance via Src activation.Oncogene. 2019 Feb;38(6):822-837. doi: 10.1038/s41388-018-0471-1. Epub 2018 Sep 3.
• [893] GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin.PLoS One. 2017 Aug 3;12(8):e0182410. doi: 10.1371/journal.pone.0182410. eCollection 2017.
• [894] Hallmarks of the cancer cell of origin: Comparisons with "energetic" cancer stem cells (e-CSCs).Aging (Albany NY). 2019 Feb 13;11(3):1065-1068. doi: 10.18632/aging.101822.
• [895] Dysregulation of glutaminase and glutamine synthetase in cancer.Cancer Lett. 2019 Dec 28;467:29-39. doi: 10.1016/j.canlet.2019.09.011. Epub 2019 Sep 28.
• [896] Identification of ganglioside GM2 activator playing a role in cancer cell migration through proteomic analysis of breast cancer secretomes.Cancer Sci. 2016 Jun;107(6):828-35. doi: 10.1111/cas.12935. Epub 2016 Apr 27.
• [897] Geminin Is Essential for Pluripotent Cell Viability During Teratoma Formation, but Not for Differentiated Cell Viability During Teratoma Expansion.Stem Cells Dev. 2017 Feb 15;26(4):285-302. doi: 10.1089/scd.2016.0260. Epub 2016 Nov 7.
• [898] GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Down-regulating Expression of GNAI2.Gastroenterology. 2019 Jun;156(8):2297-2312. doi: 10.1053/j.gastro.2019.02.040. Epub 2019 Mar 2.
• [899] Loss of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) induces apoptotic processes in pancreatic carcinoma cells.FASEB J. 2012 Feb;26(2):938-46. doi: 10.1096/fj.11-186700. Epub 2011 Nov 2.
• [900] Loss of protein expression and recurrent DNA hypermethylation of the GNG7 gene in squamous cell carcinoma of the head and neck.J Appl Genet. 2012 May;53(2):167-74. doi: 10.1007/s13353-011-0079-4. Epub 2011 Dec 20.
• [901] Inhibition of glutamate oxaloacetate transaminase 1 in cancer cell lines results in altered metabolism with increased dependency of glucose.BMC Cancer. 2018 May 11;18(1):559. doi: 10.1186/s12885-018-4443-1.
• [902] The platelet glycoprotein Ibalpha VNTR polymorphism is associated with risk for oral cancer.Anticancer Res. 2007 Nov-Dec;27(6B):4121-5.
• [903] Clinical significance of altered collagen-receptor functioning in platelets with emphasis on glycoprotein VI.Blood Rev. 2019 Nov;38:100592. doi: 10.1016/j.blre.2019.100592. Epub 2019 Jul 22.
• [904] GPER1 influences cellular homeostasis and cytostatic drug resistance via influencing long chain ceramide synthesis in breast cancer cells.Int J Biochem Cell Biol. 2019 Jul;112:95-106. doi: 10.1016/j.biocel.2019.05.002. Epub 2019 May 11.
• [905] A Human Organotypic Microfluidic Tumor Model Permits Investigation of the Interplay between Patient-Derived Fibroblasts and Breast Cancer Cells.Cancer Res. 2019 Jun 15;79(12):3139-3151. doi: 10.1158/0008-5472.CAN-18-2293. Epub 2019 Apr 16.
• [906] Mutations in GPR101 as a potential cause of X-linked acrogigantism and acromegaly.Prog Mol Biol Transl Sci. 2019;161:47-67. doi: 10.1016/bs.pmbts.2018.10.003. Epub 2018 Nov 23.
• [907] Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis.Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):580-585. doi: 10.1073/pnas.1614035114. Epub 2017 Jan 3.
• [908] Down regulation of G protein-coupled receptor 137 expression inhibits proliferation and promotes apoptosis in leukemia cells.Cancer Cell Int. 2018 Jan 29;18:13. doi: 10.1186/s12935-018-0507-1. eCollection 2018.
• [909] Structure-activity relationships of imidazothiazinones and analogs as antagonists of the cannabinoid-activated orphan G protein-coupled receptor GPR18.Eur J Med Chem. 2018 Jul 15;155:381-397. doi: 10.1016/j.ejmech.2018.05.050. Epub 2018 Jun 1.
• [910] The role of the 12(S)-HETE/GPR31/12-HETER axis in cancer and ischemia-reperfusion injury.Biochem Soc Trans. 2019 Apr 30;47(2):743-754. doi: 10.1042/BST20180635. Epub 2019 Mar 22.
• [911] GPR55 controls functional differentiation of self-renewing epithelial progenitors for salivation.JCI Insight. 2019 Feb 21;4(4):e122947. doi: 10.1172/jci.insight.122947. eCollection 2019 Feb 21.
• [912] G Protein-Coupled Receptor 87 (GPR87) Promotes Cell Proliferation in Human Bladder Cancer Cells.Int J Mol Sci. 2015 Oct 14;16(10):24319-31. doi: 10.3390/ijms161024319.
• [913] Association between genetic variants in the promoter region of a novel antisense long noncoding RNA RP11-392P7.6 and colorectal cancer risk.Environ Mol Mutagen. 2017 Jul;58(6):434-442. doi: 10.1002/em.22100. Epub 2017 Jun 14.
• [914] Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection.Curr Drug Targets. 2019;20(5):522-539. doi: 10.2174/1389450120666181105152439.
• [915] Liposomal Grb2 antisense oligodeoxynucleotide (BP1001) in patients with refractory or relapsed haematological malignancies: a single-centre, open-label, dose-escalation, phase 1/1b trial.Lancet Haematol. 2018 Apr;5(4):e136-e146. doi: 10.1016/S2352-3026(18)30021-8. Epub 2018 Mar 14.
• [916] A genome-wide association study of aging.Neurobiol Aging. 2011 Nov;32(11):2109.e15-28. doi: 10.1016/j.neurobiolaging.2011.05.026. Epub 2011 Jul 22.
• [917] Silencing of selected glutamate receptor subunits modulates cancer growth.Anticancer Res. 2011 Oct;31(10):3181-92.
• [918] FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801.BMC Cancer. 2013 Oct 10;13:468. doi: 10.1186/1471-2407-13-468.
• [919] Dissecting the sources of gene expression variation in a pan-cancer analysis identifies novel regulatory mutations.Nucleic Acids Res. 2018 May 18;46(9):4370-4381. doi: 10.1093/nar/gky271.
• [920] G-Protein-Coupled Receptor Kinase 2 as a Potential Modulator of the Hallmarks of Cancer.Mol Pharmacol. 2017 Mar;91(3):220-228. doi: 10.1124/mol.116.107185. Epub 2016 Nov 28.
• [921] Allosteric and Orthosteric Activators of mGluR8 Differentially Affect the Chemotherapeutic-Induced Human Neuroblastoma SH-SY5Y Cell Damage: The Impact of Cell Differentiation State.Basic Clin Pharmacol Toxicol. 2018 Oct;123(4):443-451. doi: 10.1111/bcpt.13041. Epub 2018 Jun 29.
• [922] Identification of patients at risk of metastasis using a prognostic 31-gene expression profile in subpopulations of melanoma patients with favorable outcomes by standard criteria.J Am Acad Dermatol. 2019 Jan;80(1):149-157.e4. doi: 10.1016/j.jaad.2018.07.028. Epub 2018 Aug 4.
• [923] Comparison of biological properties of [(177) Lu]Lu-ProBOMB1 and [(177) Lu]Lu-NeoBOMB1 for GRPR targeting.J Labelled Comp Radiopharm. 2020 Feb;63(2):56-64. doi: 10.1002/jlcr.3815. Epub 2020 Jan 11.
• [924] GSK3/: A Novel Therapeutic Target for Neuroendocrine Tumors.Neuroendocrinology. 2018;106(4):335-351. doi: 10.1159/000481887. Epub 2017 Oct 2.
• [925] Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses.Cancer Biol Ther. 2019;20(8):1047-1056. doi: 10.1080/15384047.2019.1595283. Epub 2019 Apr 12.
• [926] Perforin and Granzyme B Expressed by Murine Myeloid-Derived Suppressor Cells: A Study on Their Role in Outgrowth of Cancer Cells.Cancers (Basel). 2019 Jun 11;11(6):808. doi: 10.3390/cancers11060808.
• [927] Microenvironment-regulated lncRNA-HAL is able to promote stemness in breast cancer cells.Biochim Biophys Acta Mol Cell Res. 2019 Dec;1866(12):118523. doi: 10.1016/j.bbamcr.2019.118523. Epub 2019 Aug 8.
• [928] Effect of tetramethylpyrazine and hyperlipidemia on hepcidin homeostasis in mice.Int J Mol Med. 2019 Jan;43(1):501-506. doi: 10.3892/ijmm.2018.3968. Epub 2018 Nov 1.
• [929] SMARCA4-deficient Thoracic Sarcomas: Clinicopathologic Study of 30 Cases With an Emphasis on Their Nosology and Differential Diagnoses.Am J Surg Pathol. 2019 Apr;43(4):455-465. doi: 10.1097/PAS.0000000000001188.
• [930] Hydroxycarboxylic acid receptors are essential for breast cancer cells to control their lipid/fatty acid metabolism.Oncotarget. 2015 Aug 14;6(23):19706-20. doi: 10.18632/oncotarget.3565.
• [931] The identification of specific methylation patterns across different cancers.PLoS One. 2015 Mar 16;10(3):e0120361. doi: 10.1371/journal.pone.0120361. eCollection 2015.
• [932] Silencing of histone deacetylase 2 suppresses malignancy for proliferation, migration, and invasion of glioblastoma cells and enhances temozolomide sensitivity.Cancer Chemother Pharmacol. 2016 Dec;78(6):1289-1296. doi: 10.1007/s00280-016-3188-2. Epub 2016 Nov 10.
• [933] Tumor Necrosis Factor Receptor-Associated Factor 6 Promotes Hepatocarcinogenesis by Interacting With Histone Deacetylase 3 to Enhance c-Myc Gene Expression and Protein Stability.Hepatology. 2020 Jan;71(1):148-163. doi: 10.1002/hep.30801. Epub 2019 Aug 7.
• [934] Histone deacetylase 6 promotes growth of glioblastoma through the MKK7/JNK/c-Jun signaling pathway.J Neurochem. 2020 Jan;152(2):221-234. doi: 10.1111/jnc.14849. Epub 2019 Aug 25.
• [935] Screening of novel histone deacetylase 7 inhibitors through molecular docking followed by a combination of molecular dynamics simulations and ligand-based approach.J Biomol Struct Dyn. 2019 Sep;37(15):4092-4103. doi: 10.1080/07391102.2018.1541141. Epub 2018 Dec 5.
• [936] The enzyme activity of histone deacetylase 8 is modulated by a redox-switch.Redox Biol. 2019 Jan;20:60-67. doi: 10.1016/j.redox.2018.09.013. Epub 2018 Sep 27.
• [937] Stabilized Peptide HDAC Inhibitors Derived from HDAC1 Substrate H3K56 for the Treatment of Cancer Stem-Like Cells In Vivo.Cancer Res. 2019 Apr 15;79(8):1769-1783. doi: 10.1158/0008-5472.CAN-18-1421. Epub 2019 Mar 6.
• [938] Immunohistochemical detection of histidine decarboxylase in neoplastic mast cells in patients with systemic mastocytosis.Hum Pathol. 2006 Apr;37(4):439-47. doi: 10.1016/j.humpath.2005.11.015. Epub 2006 Feb 7.
• [939] Inhibition of the histone demethylase, KDM5B, directly induces re-expression of tumor suppressor protein HEXIM1 in cancer cells.Breast Cancer Res. 2019 Dec 5;21(1):138. doi: 10.1186/s13058-019-1228-7.
• [940] AS1411 Aptamer/Hyaluronic Acid-Bifunctionalized Microemulsion Co-Loading Shikonin and Docetaxel for Enhanced Antiglioma Therapy.J Pharm Sci. 2019 Nov;108(11):3684-3694. doi: 10.1016/j.xphs.2019.08.017. Epub 2019 Aug 26.
• [941] The crystal structure of the protein kinase HIPK2 reveals a unique architecture of its CMGC-insert region.J Biol Chem. 2019 Sep 13;294(37):13545-13559. doi: 10.1074/jbc.RA119.009725. Epub 2019 Jul 24.
• [942] An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1(-)HK2(+) Multiple Myeloma.Cancer Res. 2019 May 15;79(10):2748-2760. doi: 10.1158/0008-5472.CAN-18-2799. Epub 2019 Mar 18.
• [943] High Expression of HLA-G in Ovarian Carcinomatosis: The Role of Interleukin-1.Neoplasia. 2019 Mar;21(3):331-342. doi: 10.1016/j.neo.2019.01.001. Epub 2019 Feb 22.
• [944] Modulation of cardiac AKT and STAT3 signalling in preclinical cancer models and their impact on the heart.Biochim Biophys Acta Mol Cell Res. 2020 Mar;1867(3):118519. doi: 10.1016/j.bbamcr.2019.07.014. Epub 2019 Jul 31.
• [945] HMGB2 promotes the malignancy of human gastric cancer and indicates poor survival outcome. Hum Pathol. 2019 Feb;84:133-141.
• [946] HMGCS2 functions as a tumor suppressor and has a prognostic impact in prostate cancer.Pathol Res Pract. 2019 Aug;215(8):152464. doi: 10.1016/j.prp.2019.152464. Epub 2019 May 22.
• [947] A Near-Infrared Probe Tracks and Treats Lung Tumor Initiating Cells by Targeting HMOX2.J Am Chem Soc. 2019 Sep 18;141(37):14673-14686. doi: 10.1021/jacs.9b06068. Epub 2019 Sep 4.
• [948] A Newly Established Murine Cell Line as a Model for Hepatocellular Cancer in Non-Alcoholic Steatohepatitis.Int J Mol Sci. 2019 Nov 12;20(22):5658. doi: 10.3390/ijms20225658.
• [949] Recent progress in the discovery of small-molecule inhibitors of the HMT EZH2 for the treatment of cancer.Future Med Chem. 2013 Sep;5(14):1661-70. doi: 10.4155/fmc.13.136.
• [950] Computer-Aided Discovery of Small Molecules Targeting the RNA Splicing Activity of hnRNP A1 in Castration-Resistant Prostate Cancer.Molecules. 2019 Feb 20;24(4):763. doi: 10.3390/molecules24040763.
• [951] Silencing of long noncoding RNA HOXA11-AS inhibits the Wnt signaling pathway via the upregulation of HOXA11 and thereby inhibits the proliferation, invasion, and self-renewal of hepatocellular carcinoma stem cells.Exp Mol Med. 2019 Nov 22;51(11):1-20. doi: 10.1038/s12276-019-0328-x.
• [952] Integrative genomic analyses of the histamine H1 receptor and its role in cancer prediction.Int J Mol Med. 2014 Apr;33(4):1019-26. doi: 10.3892/ijmm.2014.1649. Epub 2014 Feb 10.
• [953] Upregulated histamine receptorH3 promotes tumor growth and metastasis in hepatocellular carcinoma.Oncol Rep. 2019 Jun;41(6):3347-3354. doi: 10.3892/or.2019.7119. Epub 2019 Apr 16.
• [954] Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications.Front Pharmacol. 2019 Jun 5;10:556. doi: 10.3389/fphar.2019.00556. eCollection 2019.
• [955] Harnessing the gatekeepers of glucocorticoids for chemoprevention of non-melanoma skin cancer.Mol Carcinog. 2019 Jan;58(1):102-112. doi: 10.1002/mc.22912. Epub 2018 Oct 9.
• [956] Ultrasound Microvascular Blood Flow Evaluation: A New Tool for the Management of Thyroid Nodule?.Int J Endocrinol. 2019 Mar 25;2019:7874890. doi: 10.1155/2019/7874890. eCollection 2019.
• [957] Targeting hsp90 family members: A strategy to improve cancer cell death.Biochem Pharmacol. 2019 Jun;164:177-187. doi: 10.1016/j.bcp.2019.04.010. Epub 2019 Apr 11.
• [958] Overexpression of HSP27 and HSP70 is associated with decreased survival among patients with esophageal adenocarcinoma.World J Clin Cases. 2019 Feb 6;7(3):260-269. doi: 10.12998/wjcc.v7.i3.260.
• [959] Exploring the multifaceted roles of heat shock protein B8 (HSPB8) in diseases.Eur J Cell Biol. 2018 Apr;97(3):216-229. doi: 10.1016/j.ejcb.2018.03.003. Epub 2018 Mar 13.
• [960] CCAR2/DBC1 and Hsp60 Positively Regulate Expression of Survivin in Neuroblastoma Cells.Int J Mol Sci. 2019 Jan 1;20(1):131. doi: 10.3390/ijms20010131.
• [961] Human Hsp10 and Early Pregnancy Factor (EPF) and their relationship and involvement in cancer and immunity: current knowledge and perspectives.Life Sci. 2010 Jan 30;86(5-6):145-52. doi: 10.1016/j.lfs.2009.11.004. Epub 2009 Nov 12.
• [962] Pembrolizumab-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in a Patient With Metastatic Cervical Squamous Cell Carcinoma: A Case Report.Am J Dermatopathol. 2020 Apr;42(4):292-296. doi: 10.1097/DAD.0000000000001527.
• [963] The Role of 5-HT1A Receptor in Cancer as a New Opportunity in Medicinal Chemistry.Curr Med Chem. 2018;25(27):3214-3227. doi: 10.2174/0929867325666180209141650.
• [964] Depletion of serotonin and selective inhibition of 2B receptor suppressed tumor angiogenesis by inhibiting endothelial nitric oxide synthase and extracellular signal-regulated kinase 1/2 phosphorylation.Neoplasia. 2009 Apr;11(4):408-17. doi: 10.1593/neo.81630.
• [965] Altered RNA editing of serotonin 5-HT2C receptor induced by interferon: implications for depression associated with cytokine therapy.Brain Res Mol Brain Res. 2004 Apr 29;124(1):70-8. doi: 10.1016/j.molbrainres.2004.02.010.
• [966] Association of the ABCB1 3435C>T polymorphism with antiemetic efficacy of 5-hydroxytryptamine type 3 antagonists.Clin Pharmacol Ther. 2005 Dec;78(6):619-26. doi: 10.1016/j.clpt.2005.08.015.
• [967] New variants of the human and rat nuclear hormone receptor, TR4: expression and chromosomal localization of the human gene.Genomics. 1996 Jul 15;35(2):361-6. doi: 10.1006/geno.1996.0368.
• [968] HTRA1 promotes transdifferentiation of normal fibroblasts to cancer-associated fibroblasts through activation of the NF-B/bFGF signaling pathway in gastric cancer.Biochem Biophys Res Commun. 2019 Jun 30;514(3):933-939. doi: 10.1016/j.bbrc.2019.05.076. Epub 2019 May 11.
• [969] The Infiltration of ICOS(+) Cells in Nasopharyngeal Carcinoma is Beneficial for Improved Prognosis.Pathol Oncol Res. 2020 Jan;26(1):365-370. doi: 10.1007/s12253-018-0509-2. Epub 2018 Oct 25.
• [970] ICOSL-augmented adenoviral-based vaccination induces a bipolar Th17/Th1 T cell response against unglycosylated MUC1 antigen.Vaccine. 2018 Oct 8;36(42):6262-6269. doi: 10.1016/j.vaccine.2018.09.010. Epub 2018 Sep 12.
• [971] Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discov. 2019 May;18(5):379-401.
• [972] Type I IFN protects cancer cells from CD8+ T cell-mediated cytotoxicity after radiation.J Clin Invest. 2019 Oct 1;129(10):4224-4238. doi: 10.1172/JCI127458.
• [973] Interferon- sensitizes human malignant melanoma cells to temozolomide-induced apoptosis and autophagy.Int J Oncol. 2019 May;54(5):1864-1874. doi: 10.3892/ijo.2019.4743. Epub 2019 Mar 7.
• [974] The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies.Int J Cancer. 2019 Dec 15;145(12):3244-3256. doi: 10.1002/ijc.32276. Epub 2019 Apr 4.
• [975] Proteome Analyses Reveal Positive Association of COL2A1, MPO, TYMS, and IGFBP5 with Canine Mammary Gland Malignancy.Proteomics Clin Appl. 2019 Jul;13(4):e1800151. doi: 10.1002/prca.201800151. Epub 2019 Jan 4.
• [976] IKK targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target.Lung Cancer. 2019 Apr;130:169-178. doi: 10.1016/j.lungcan.2019.02.027. Epub 2019 Feb 25.
• [977] Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial.JAMA Oncol. 2017 Sep 1;3(9):1237-1244. doi: 10.1001/jamaoncol.2017.0515.
• [978] Role of interleukin-12 gene polymorphisms in the onset risk of cancer: a meta-analysis.Oncotarget. 2017 May 2;8(18):29795-29807. doi: 10.18632/oncotarget.16080.
• [979] Selective neutralization of IL-12 p40 monomer induces death in prostate cancer cells via IL-12-IFN-.Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11482-11487. doi: 10.1073/pnas.1705536114. Epub 2017 Oct 9.
• [980] Epithelial interleukin-4 receptor expression promotes colon tumor growth.Carcinogenesis. 2010 Jun;31(6):1010-7. doi: 10.1093/carcin/bgq044. Epub 2010 Feb 22.
• [981] Results From a First-in-Human Study of BNZ-1, a Selective Multicytokine Inhibitor Targeting Members of the Common Gamma (c) Family of Cytokines.J Clin Pharmacol. 2020 Feb;60(2):264-273. doi: 10.1002/jcph.1522. Epub 2019 Aug 29.
• [982] Functional analysis of a zebrafish myd88 mutant identifies key transcriptional components of the innate immune system.Dis Model Mech. 2013 May;6(3):841-54. doi: 10.1242/dmm.010843. Epub 2013 Feb 21.
• [983] IL1RAP potentiates multiple oncogenic signaling pathways in AML.J Exp Med. 2018 Jun 4;215(6):1709-1727. doi: 10.1084/jem.20180147. Epub 2018 May 17.
• [984] Worsening cognitive performance is associated with increases in systemic inflammation following hematopoietic cell transplantation.Brain Behav Immun. 2019 Aug;80:308-314. doi: 10.1016/j.bbi.2019.04.008. Epub 2019 Apr 3.
• [985] A transcriptional complex composed of ER(), GATA3, FOXA1 and ELL3 regulates IL-20 expression in breast cancer cells.Oncotarget. 2017 Jun 27;8(26):42752-42760. doi: 10.18632/oncotarget.17459.
• [986] Prostate cancer cells enhance interleukin-15-mediated expansion of NK cells.BJU Int. 2020 Jan;125(1):89-102. doi: 10.1111/bju.14893. Epub 2019 Aug 7.
• [987] Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment.J Exp Clin Cancer Res. 2019 Jul 11;38(1):303. doi: 10.1186/s13046-019-1271-3.
• [988] Prediction of the Optimal Dosing Regimen Using a Mathematical Model of Tumor Uptake for Immunocytokine-Based Cancer Immunotherapy.Clin Cancer Res. 2018 Jul 15;24(14):3325-3333. doi: 10.1158/1078-0432.CCR-17-2953. Epub 2018 Feb 20.
• [989] The IL-31/IL-31 receptor axis: general features and role in tumor microenvironment.J Leukoc Biol. 2017 Sep;102(3):711-717. doi: 10.1189/jlb.3MR0117-033R. Epub 2017 Apr 13.
• [990] The potential role of interleukin-37 in infectious diseases.Int Rev Immunol. 2020;39(1):3-10. doi: 10.1080/08830185.2019.1677644. Epub 2019 Oct 21.
• [991] ILDR2 Is a Novel B7-like Protein That Negatively Regulates T Cell Responses.J Immunol. 2018 Mar 15;200(6):2025-2037. doi: 10.4049/jimmunol.1700325. Epub 2018 Feb 5.
• [992] Mutational profiling and immunohistochemical analysis of a surgical series of ampullary carcinomas.J Clin Pathol. 2019 Nov;72(11):762-770. doi: 10.1136/jclinpath-2019-205912. Epub 2019 Jun 29.
• [993] Dysregulation of the miR-25-IMPA2 axis promotes metastatic progression in clear cell renal cell carcinoma.EBioMedicine. 2019 Jul;45:220-230. doi: 10.1016/j.ebiom.2019.06.006. Epub 2019 Jun 12.
• [994] Targeting INHBA in Ovarian Cancer Cells Suppresses Cancer Xenograft Growth by Attenuating Stromal Fibroblast Activation.Dis Markers. 2019 Nov 11;2019:7275289. doi: 10.1155/2019/7275289. eCollection 2019.
• [995] Inositol phosphate recycling regulates glycolytic and lipid metabolism that drives cancer aggressiveness.ACS Chem Biol. 2014 Jun 20;9(6):1340-50. doi: 10.1021/cb5001907. Epub 2014 Apr 28.
• [996] Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells.Clin Cancer Res. 2020 Apr 1;26(7):1700-1711. doi: 10.1158/1078-0432.CCR-19-2202. Epub 2019 Dec 12.
• [997] The expression of the insulin receptor in gastric cancer correlates with the HER2 status and may have putative therapeutic implications.Gastric Cancer. 2019 Nov;22(6):1130-1142. doi: 10.1007/s10120-019-00964-6. Epub 2019 Apr 15.
• [998] Expression of IRAK? is associated with colitisassociated tumorigenesis in mice.Mol Med Rep. 2017 Sep;16(3):3415-3420. doi: 10.3892/mmr.2017.6958. Epub 2017 Jul 12.
• [999] An Analysis of the Expression and Association with Immune Cell Infiltration of the cGAS/STING Pathway in Pan-Cancer.Mol Ther Nucleic Acids. 2019 Mar 1;14:80-89. doi: 10.1016/j.omtn.2018.11.003. Epub 2018 Nov 20.
• [1000] Identification of novel mutations of Insulin Receptor Substrate 1 (IRS1) in tumor samples of non-small cell lung cancer (NSCLC): Implications for aberrant insulin signaling in development of cancer.Genet Mol Biol. 2019 Feb 25;42(1):15-25. doi: 10.1590/1678-4685-gmb-2017-0307. Print 2019 Jan-Mar.
• [1001] Loss of TRIM29 suppresses cancer stem cell-like characteristics of PDACs via accelerating ISG15 degradation.Oncogene. 2020 Jan;39(3):546-559. doi: 10.1038/s41388-019-0992-2. Epub 2019 Sep 9.
• [1002] Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer.J Exp Med. 2019 Mar 4;216(3):688-703. doi: 10.1084/jem.20180765. Epub 2019 Feb 1.
• [1003] Visualization and quantification of in vivo homing kinetics of myeloid-derived suppressor cells in primary and metastatic cancer.Theranostics. 2019 Aug 12;9(20):5869-5885. doi: 10.7150/thno.33275. eCollection 2019.
• [1004] Down-regulation and clinical significance of miR-7-2-3p in papillary thyroid carcinoma with multiple detecting methods.IET Syst Biol. 2019 Oct;13(5):225-233. doi: 10.1049/iet-syb.2019.0025.
• [1005] Kaposi's Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin 3 Levels and Is Dependent on STAT3.J Virol. 2020 Feb 14;94(5):e01384-19. doi: 10.1128/JVI.01384-19. Print 2020 Feb 14.
• [1006] Integrin 6 can be translationally regulated by eukaryotic initiation factor 4E: Contributing to colonic tumor malignancy.Tumour Biol. 2015 Aug;36(8):6541-50. doi: 10.1007/s13277-015-3348-8. Epub 2015 May 17.
• [1007] Integrin Subunit beta 8 (ITGB8) Upregulation Is an Independent Predictor of Unfavorable Survival of High-Grade Serous Ovarian Carcinoma Patients.Med Sci Monit. 2018 Dec 10;24:8933-8940. doi: 10.12659/MSM.911518.
• [1008] Ai-lncRNA EGOT enhancing autophagy sensitizes paclitaxel cytotoxicity via upregulation of ITPR1 expression by RNA-RNA and RNA-protein interactions in human cancer.Mol Cancer. 2019 Apr 18;18(1):89. doi: 10.1186/s12943-019-1017-z.
• [1009] Type 3 Inositol 1,4,5-Trisphosphate Receptor Is Increased and Enhances Malignant Properties in Cholangiocarcinoma.Hepatology. 2020 Feb;71(2):583-599. doi: 10.1002/hep.30839. Epub 2019 Aug 19.
• [1010] Genome-Wide CRISPR Screening Identifies JAK1 Deficiency as a Mechanism of T-Cell Resistance.Front Immunol. 2019 Feb 19;10:251. doi: 10.3389/fimmu.2019.00251. eCollection 2019.
• [1011] Are peptides a solution for the treatment of hyperactivated JAK3 pathways?.Inflammopharmacology. 2019 Jun;27(3):433-452. doi: 10.1007/s10787-019-00589-2. Epub 2019 Mar 30.
• [1012] Deciphering the binding mode and mechanistic insights of pentadecylidenemalonate (1b) as activator of histone acetyltransferase PCAF.J Biomol Struct Dyn. 2019 Jun;37(9):2296-2309. doi: 10.1080/07391102.2018.1479658. Epub 2018 Nov 4.
• [1013] Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth.Nature. 2018 Aug;560(7717):253-257. doi: 10.1038/s41586-018-0387-5. Epub 2018 Aug 1.
• [1014] Caveolin-1 facilitated KCNA5 expression, promoting breast cancer viability.Oncol Lett. 2018 Oct;16(4):4829-4838. doi: 10.3892/ol.2018.9261. Epub 2018 Aug 3.
• [1015] Eag1 Voltage-Dependent Potassium Channels: Structure, Electrophysiological Characteristics, and Function in Cancer.J Membr Biol. 2017 Apr;250(2):123-132. doi: 10.1007/s00232-016-9944-8. Epub 2017 Feb 3.
• [1016] Generation and characterization of novel recombinant anti-hERG1 scFv antibodies for cancer molecular imaging.Oncotarget. 2018 Oct 9;9(79):34972-34989. doi: 10.18632/oncotarget.26200. eCollection 2018 Oct 9.
• [1017] XIAP BIR domain suppresses miR-200a expression and subsequently promotes EGFR protein translation and anchorage-independent growth of bladder cancer cell.J Hematol Oncol. 2017 Jan 5;10(1):6. doi: 10.1186/s13045-016-0376-9.
• [1018] Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway. Mol Cancer. 2015 Mar 12;14:59.
• [1019] Relative expression of mRNAS coding for glutaminase isoforms in CNS tissues and CNS tumors.Neurochem Res. 2008 May;33(5):808-13. doi: 10.1007/s11064-007-9507-6. Epub 2007 Oct 17.
• [1020] Overexpression of KCNJ4 correlates with cancer progression and unfavorable prognosis in lung adenocarcinoma.J Biochem Mol Toxicol. 2019 Apr;33(4):e22270. doi: 10.1002/jbt.22270. Epub 2018 Dec 4.
• [1021] Zileuton, a 5-Lipoxygenase Inhibitor, Exerts Anti-Angiogenic Effect by Inducing Apoptosis of HUVEC via BK Channel Activation.Cells. 2019 Sep 30;8(10):1182. doi: 10.3390/cells8101182.
• [1022] Identification of SK3 channel as a new mediator of breast cancer cell migration.Mol Cancer Ther. 2006 Nov;5(11):2946-53. doi: 10.1158/1535-7163.MCT-06-0194.
• [1023] The role of KCNQ1 in mouse and human gastrointestinal cancers.Oncogene. 2014 Jul 17;33(29):3861-8. doi: 10.1038/onc.2013.350. Epub 2013 Aug 26.
• [1024] ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway.Cancer Lett. 2019 Jul 10;454:179-190. doi: 10.1016/j.canlet.2019.03.052. Epub 2019 Apr 10.
• [1025] Histone demethylase JMJD2B and JMJD2C induce fibroblast growth factor 2: mediated tumorigenesis of osteosarcoma.Med Oncol. 2015 Mar;32(3):53. doi: 10.1007/s12032-015-0503-4. Epub 2015 Jan 31.
• [1026] Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target.Eur J Med Chem. 2019 Jan 1;161:131-140. doi: 10.1016/j.ejmech.2018.10.040. Epub 2018 Oct 17.
• [1027] E6 Protein Expressed by High-Risk HPV Activates Super-Enhancers of the EGFR and c-MET Oncogenes by Destabilizing the Histone Demethylase KDM5C.Cancer Res. 2018 Mar 15;78(6):1418-1430. doi: 10.1158/0008-5472.CAN-17-2118. Epub 2018 Jan 16.
• [1028] Comprehensive profiling of JMJD3 in gastric cancer and its influence on patient survival.Sci Rep. 2019 Jan 29;9(1):868. doi: 10.1038/s41598-018-37340-w.
• [1029] Identification of novel Nrf2/Keap1 pathway mutations in pediatric acute lymphoblastic leukemia.Pediatr Hematol Oncol. 2020 Feb;37(1):58-75. doi: 10.1080/08880018.2019.1682090. Epub 2019 Oct 29.
• [1030] p62 functions as an oncogene in colorectal cancer through inhibiting apoptosis and promoting cell proliferation by interacting with the vitamin D receptor.Cell Prolif. 2019 May;52(3):e12585. doi: 10.1111/cpr.12585. Epub 2019 Feb 22.
• [1031] Ketohexokinase is involved in fructose utilization and promotes tumor progression in glioma.Biochem Biophys Res Commun. 2018 Sep 10;503(3):1298-1306. doi: 10.1016/j.bbrc.2018.07.040. Epub 2018 Jul 19.
• [1032] Comparison of the Effects of Monastrol and Oxomonastrol on Human Hepatoma Cell Line HepG2/C3A.Anticancer Res. 2017 Mar;37(3):1197-1204. doi: 10.21873/anticanres.11434.
• [1033] The Activating Human NK Cell Receptor KIR2DS2 Recognizes a (2)-Microglobulin-Independent Ligand on Cancer Cells.J Immunol. 2017 Apr 1;198(7):2556-2567. doi: 10.4049/jimmunol.1600930. Epub 2017 Feb 15.
• [1034] KISS1 and KISS1R expression in gastric cancer.J BUON. 2018 Jan-Feb;23(1):79-84.
• [1035] Proteomic Analysis of Breast Cancer Resistance to the Anticancer Drug RH1 Reveals the Importance of Cancer Stem Cells.Cancers (Basel). 2019 Jul 11;11(7):972. doi: 10.3390/cancers11070972.
• [1036] Gamma-Klotho exhibits multiple roles in tumor growth of human bladder cancer.Oncotarget. 2018 Apr 13;9(28):19508-19524. doi: 10.18632/oncotarget.24628. eCollection 2018 Apr 13.
• [1037] Reactivation of super-enhancers by KLF4 in human Head and Neck Squamous Cell Carcinoma.Oncogene. 2020 Jan;39(2):262-277. doi: 10.1038/s41388-019-0990-4. Epub 2019 Sep 2.
• [1038] Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer.Expert Opin Ther Targets. 2018 Sep;22(9):745-763. doi: 10.1080/14728222.2018.1512587. Epub 2018 Sep 6.
• [1039] Kallikrein-related peptidase 14 is the second KLK protease targeted by the serpin vaspin.Biol Chem. 2018 Sep 25;399(9):1079-1084. doi: 10.1515/hsz-2018-0108.
• [1040] Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.Cancer Prev Res (Phila). 2010 May;3(5):611-9. doi: 10.1158/1940-6207.CAPR-09-0206. Epub 2010 Apr 27.
• [1041] Uncovering the clinical impact of kallikrein-related peptidase 5 (KLK5) mRNA expression in the colorectal adenoma-carcinoma sequence.Clin Chem Lab Med. 2019 Jul 26;57(8):1251-1260. doi: 10.1515/cclm-2018-1010.
• [1042] Elevated expression of KLK8 predicts poor prognosis in colorectal cancer.Biomed Pharmacother. 2017 Apr;88:595-602. doi: 10.1016/j.biopha.2017.01.112. Epub 2017 Jan 28.
• [1043] Overexpression of Kynurenine 3-Monooxygenase Correlates with Cancer Malignancy and Predicts Poor Prognosis in Canine Mammary Gland Tumors.J Oncol. 2019 May 2;2019:6201764. doi: 10.1155/2019/6201764. eCollection 2019.
• [1044] Somatic Cancer Mutations in the SUV420H1 Protein Lysine Methyltransferase Modulate Its Catalytic Activity.J Mol Biol. 2019 Aug 9;431(17):3068-3080. doi: 10.1016/j.jmb.2019.06.021. Epub 2019 Jun 27.
• [1045] Serum bradykinin levels as a diagnostic marker in cervical cancer with a potential mechanism to promote VEGF expression via BDKRB2.Int J Oncol. 2019 Jul;55(1):131-141. doi: 10.3892/ijo.2019.4792. Epub 2019 May 2.
• [1046] Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells.Cell Death Dis. 2019 Feb 11;10(2):118. doi: 10.1038/s41419-019-1383-x.
• [1047] Keratin 17 in disease pathogenesis: from cancer to dermatoses.J Pathol. 2019 Feb;247(2):158-165. doi: 10.1002/path.5178. Epub 2018 Dec 7.
• [1048] A novel role of kynureninase in the growth control of breast cancer cells and its relationships with breast cancer.J Cell Mol Med. 2019 Oct;23(10):6700-6707. doi: 10.1111/jcmm.14547. Epub 2019 Jul 22.
• [1049] Vascular co-option in brain metastasis.Angiogenesis. 2020 Feb;23(1):3-8. doi: 10.1007/s10456-019-09693-x. Epub 2019 Nov 7.
• [1050] Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.Cancer Discov. 2016 Sep;6(9):1052-67. doi: 10.1158/2159-8290.CD-15-1227. Epub 2016 Jul 17.
• [1051] Treatment of cancer with a combination of LAG-3Ig and anti-PD-1/anti-PD-L1 antibodies: a patent evaluation of US2018271940 A1.Expert Opin Ther Pat. 2019 May;29(5):311-314. doi: 10.1080/13543776.2019.1608947. Epub 2019 Apr 24.
• [1052] Clinicopathologic significance of LAIR-1 expression in hepatocellular carcinoma.Curr Probl Cancer. 2019 Feb;43(1):18-26. doi: 10.1016/j.currproblcancer.2018.04.005. Epub 2018 Apr 30.
• [1053] Lysosome imaging in cancer cells by pyrene-benzothiazolium dyes: An alternative imaging approach for LAMP-1 expression based visualization methods to avoid background interference.Bioorg Chem. 2019 Oct;91:103144. doi: 10.1016/j.bioorg.2019.103144. Epub 2019 Jul 24.
• [1054] The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer.Nucleic Acids Res. 2016 Feb 18;44(3):1227-46. doi: 10.1093/nar/gkv1515. Epub 2015 Dec 29.
• [1055] Prognostic value of procalcitonin and lipopolysaccharide binding protein in cancer patients with chemotherapy-associated febrile neutropenia presenting to an emergency department.Biochem Med (Zagreb). 2019 Feb 15;29(1):010702. doi: 10.11613/BM.2019.010702. Epub 2018 Dec 15.
• [1056] Tumor-associated macrophages and individual chemo-susceptibility are influenced by iron chelation in human slice cultures of gastric cancer.Oncotarget. 2019 Jul 30;10(46):4731-4742. doi: 10.18632/oncotarget.27089. eCollection 2019 Jul 30.
• [1057] Genetic variation in the lactase gene, dairy product intake and risk for prostate cancer in the European prospective investigation into cancer and nutrition.Int J Cancer. 2013 Apr 15;132(8):1901-10. doi: 10.1002/ijc.27836. Epub 2012 Oct 17.
• [1058] Warburg effect, lactate dehydrogenase, and radio/chemo-therapy efficacy.Int J Radiat Biol. 2019 Apr;95(4):408-426. doi: 10.1080/09553002.2018.1490041. Epub 2018 Oct 16.
• [1059] Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization.Cancer Res. 2018 Sep 1;78(17):4929-4942. doi: 10.1158/0008-5472.CAN-18-0152. Epub 2018 Jul 2.
• [1060] Luteinizing hormone receptor mutations in disorders of sexual development and cancer.Front Biosci. 2000 Mar 1;5:D343-52. doi: 10.2741/wu.
• [1061] Identification of a Specific Translational Machinery via TCTP-EF1A2 Interaction Regulating NF1-associated Tumor Growth by Affinity Purification and Data-independent Mass Spectrometry Acquisition (AP-DIA).Mol Cell Proteomics. 2019 Feb;18(2):245-262. doi: 10.1074/mcp.RA118.001014. Epub 2018 Oct 31.
• [1062] Framework for microRNA variant annotation and prioritization using human population and disease datasets.Hum Mutat. 2019 Jan;40(1):73-89. doi: 10.1002/humu.23668. Epub 2018 Nov 8.
• [1063] Adipose triglyceride lipase contributes to cancer-associated cachexia.Science. 2011 Jul 8;333(6039):233-8. doi: 10.1126/science.1198973. Epub 2011 Jun 16.
• [1064] The role of endothelial lipase in lipid metabolism, inflammation, and cancer.Histol Histopathol. 2018 Jan;33(1):1-10. doi: 10.14670/HH-11-905. Epub 2017 May 25.
• [1065] LMO2 as a Biomarker for Hypersensitivity to Genotoxic Therapy.Cancer Cell. 2019 Sep 16;36(3):211-212. doi: 10.1016/j.ccell.2019.08.011.
• [1066] Lysyl oxidase assists tumorinitiating cells to enhance angiogenesis in hepatocellular carcinoma.Int J Oncol. 2019 Apr;54(4):1398-1408. doi: 10.3892/ijo.2019.4705. Epub 2019 Jan 31.
• [1067] Lysyl Oxidase-Like Protein 2 Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer.Neoplasia. 2019 Apr;21(4):413-427. doi: 10.1016/j.neo.2019.03.003. Epub 2019 Mar 27.
• [1068] Lysophosphatidic Acid Receptor 6 (LPAR6) Expression and Prospective Signaling Pathway Analysis in Breast Cancer.Mol Diagn Ther. 2019 Feb;23(1):127-138. doi: 10.1007/s40291-019-00384-3.
• [1069] Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells.Am J Pathol. 2012 May;180(5):2170-81. doi: 10.1016/j.ajpath.2012.03.003. Epub 2012 Mar 30.
• [1070] Participation of the SMAD2/3 signalling pathway in the down regulation of megalin/LRP2 by transforming growth factor beta (TGF-1).PLoS One. 2019 May 23;14(5):e0213127. doi: 10.1371/journal.pone.0213127. eCollection 2019.
• [1071] The Roles of Low-Density Lipoprotein Receptor-Related Proteins 5, 6, and 8 in Cancer: A Review.J Oncol. 2019 Mar 26;2019:4536302. doi: 10.1155/2019/4536302. eCollection 2019.
• [1072] GARP Dampens Cancer Immunity by Sustaining Function and Accumulation of Regulatory T Cells in the Colon.Cancer Res. 2019 Mar 15;79(6):1178-1190. doi: 10.1158/0008-5472.CAN-18-2623. Epub 2019 Jan 23.
• [1073] Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls.Mov Disord. 2019 Sep;34(9):1392-1398. doi: 10.1002/mds.27807. Epub 2019 Jul 26.
• [1074] Target identification reveals lanosterol synthase as a vulnerability in glioma.Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7957-7962. doi: 10.1073/pnas.1820989116. Epub 2019 Mar 28.
• [1075] Leukotriene A4 hydrolase: an emerging target of natural products for cancer chemoprevention and chemotherapy.Ann N Y Acad Sci. 2018 Nov;1431(1):3-13. doi: 10.1111/nyas.13929. Epub 2018 Jul 29.
• [1076] The yin and yang of leukotriene B(4) mediated inflammation in cancer.Semin Immunol. 2017 Oct;33:58-64. doi: 10.1016/j.smim.2017.09.005. Epub 2017 Oct 2.
• [1077] ALK-activating homologous mutations in LTK induce cellular transformation.PLoS One. 2012;7(2):e31733. doi: 10.1371/journal.pone.0031733. Epub 2012 Feb 9.
• [1078] Emerging Role of Novel Biomarkers of Ly6 Gene Family in Pan Cancer.Adv Exp Med Biol. 2019;1164:47-61. doi: 10.1007/978-3-030-22254-3_4.
• [1079] Transgenic overexpression of human LY6K in mice suppresses mature T cell development in the thymus.Oncol Lett. 2019 Jan;17(1):379-387. doi: 10.3892/ol.2018.9548. Epub 2018 Oct 4.
• [1080] Serum sLYVE-1 is not associated with coronary disease but with renal dysfunction: a retrospective study.Sci Rep. 2019 Jul 25;9(1):10816. doi: 10.1038/s41598-019-47367-2.
• [1081] The RARS-MAD1L1 Fusion Gene Induces Cancer Stem Cell-like Properties and Therapeutic Resistance in Nasopharyngeal Carcinoma. Clin Cancer Res. 2018 Feb 1;24(3):659-673.
• [1082] Eicosapentaenoic acid monoglyceride resolves inflammation in an ex vivo model of human peripheral blood mononuclear cell.Eur J Pharmacol. 2017 Jul 15;807:205-211. doi: 10.1016/j.ejphar.2017.05.018. Epub 2017 May 10.
• [1083] Melanoma-associated antigen A2 is overexpressed in glioma and associated with poor prognosis in glioma patients.Neoplasma. 2018;65(4):604-609. doi: 10.4149/neo_2018_170625N440.
• [1084] MAGE-12 and MAGE-6 are frequently expressed in malignant melanoma.Melanoma Res. 2000 Jun;10(3):259-64.
• [1085] Identification of novel epithelial ovarian cancer loci in women of African ancestry.Int J Cancer. 2020 Jun 1;146(11):2987-2998. doi: 10.1002/ijc.32653. Epub 2019 Oct 8.
• [1086] Study on Attenuating Angiogenesis and Epithelial-Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating MAGEC2.Technol Cancer Res Treat. 2018 Jan 1;17:1533033818797587. doi: 10.1177/1533033818797587.
• [1087] Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1 signalosome in T cells.Cell Immunol. 2019 Jun;340:103877. doi: 10.1016/j.cellimm.2018.11.001. Epub 2018 Dec 1.
• [1088] Mesencephalic Astrocyte-Derived Neurotrophic Factor Inhibits Liver Cancer Through Small Ubiquitin-Related Modifier (SUMO)ylation-Related Suppression of NF-B/Snail Signaling Pathway and Epithelial-Mesenchymal Transition.Hepatology. 2020 Apr;71(4):1262-1278. doi: 10.1002/hep.30917. Epub 2020 Jan 26.
• [1089] Increased expression of monoamine oxidase A is associated with epithelial to mesenchymal transition and clinicopathological features in non-small cell lung cancer.Oncol Lett. 2018 Mar;15(3):3245-3251. doi: 10.3892/ol.2017.7683. Epub 2017 Dec 21.
• [1090] Isatin, an endogenous nonpeptide biofactor: A review of its molecular targets, mechanisms of actions, and their biomedical implications.Biofactors. 2018 Mar;44(2):95-108. doi: 10.1002/biof.1408. Epub 2018 Jan 16.
• [1091] Copper is required for oncogenic BRAF signalling and tumorigenesis.Nature. 2014 May 22;509(7501):492-6. doi: 10.1038/nature13180. Epub 2014 Apr 9.
• [1092] A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.Oncogene. 2018 Aug;37(31):4197-4213. doi: 10.1038/s41388-018-0270-8. Epub 2018 May 1.
• [1093] Telomere-Mitochondrion Links Contribute to Induction of Senescence in MCF-7 Cells after Carbon-Ion Irradiation.Asian Pac J Cancer Prev. 2016;17(4):1993-8. doi: 10.7314/apjcp.2016.17.4.1993.
• [1094] Mixed lineage kinase 3 promotes breast tumorigenesis via phosphorylation and activation of p21-activated kinase 1.Oncogene. 2019 May;38(19):3569-3584. doi: 10.1038/s41388-019-0690-0. Epub 2019 Jan 21.
• [1095] miR-302a inhibits human HepG2 and SMMC-7721 cells proliferation and promotes apoptosis by targeting MAP3K2 and PBX3.Sci Rep. 2019 Feb 14;9(1):2032. doi: 10.1038/s41598-018-38435-0.
• [1096] MEKK3 expression correlates with nuclear factor kappa B activity and with expression of antiapoptotic genes in serous ovarian carcinoma.Cancer. 2009 Sep 1;115(17):3897-908. doi: 10.1002/cncr.24445.
• [1097] Large tumor suppressor 2, LATS2, activates JNK in a kinase-independent mechanism through ASK1.J Mol Cell Biol. 2018 Dec 1;10(6):549-558. doi: 10.1093/jmcb/mjy061.
• [1098] Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability.Clin Cancer Res. 2018 Oct 15;24(20):5072-5084. doi: 10.1158/1078-0432.CCR-18-0504. Epub 2018 Jul 3.
• [1099] Interactions between hematopoietic progenitor kinase 1 and its adaptor proteins (Review).Mol Med Rep. 2017 Nov;16(5):6472-6482. doi: 10.3892/mmr.2017.7494. Epub 2017 Sep 13.
• [1100] MAP4K3/GLK in autoimmune disease, cancer and aging.J Biomed Sci. 2019 Oct 22;26(1):82. doi: 10.1186/s12929-019-0570-5.
• [1101] Elevated NIBP/TRAPPC9 mediates tumorigenesis of cancer cells through NFB signaling.Oncotarget. 2015 Mar 20;6(8):6160-78. doi: 10.18632/oncotarget.3349.
• [1102] Activation loop phosphorylation of ERK3 is important for its kinase activity and ability to promote lung cancer cell invasiveness.J Biol Chem. 2018 Oct 19;293(42):16193-16205. doi: 10.1074/jbc.RA118.003699. Epub 2018 Aug 30.
• [1103] Impact of ERK5 on the Hallmarks of Cancer.Int J Mol Sci. 2019 Mar 21;20(6):1426. doi: 10.3390/ijms20061426.
• [1104] Molecular functions of brain expressed X-linked 2 (BEX2) in malignancies.Exp Cell Res. 2019 Mar 15;376(2):221-226. doi: 10.1016/j.yexcr.2019.02.014. Epub 2019 Feb 16.
• [1105] Characterization of the binding mode of JNK-interacting protein 1 (JIP1) to kinesin-light chain 1 (KLC1).J Biol Chem. 2018 Sep 7;293(36):13946-13960. doi: 10.1074/jbc.RA118.003916. Epub 2018 Jul 19.
• [1106] The protease activated receptor 1 gene variation IVSn -14 A>T is associated with distant metastasis and cancer specific survival in renal cell carcinoma.J Urol. 2013 Oct;190(4):1392-7. doi: 10.1016/j.juro.2013.03.041. Epub 2013 Mar 19.
• [1107] A SMAP in the face for cancer.J Clin Invest. 2017 Jun 1;127(6):2048-2050. doi: 10.1172/JCI94763. Epub 2017 May 15.
• [1108] S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability of cancer stem cells.Breast Cancer Res Treat. 2019 May;175(1):39-50. doi: 10.1007/s10549-019-05146-7. Epub 2019 Feb 2.
• [1109] Routine preoperative mechanical bowel preparation with additive oral antibiotics is associated with a reduced risk of anastomotic leakage in patients undergoing elective oncologic resection for colorectal cancer.World J Surg Oncol. 2019 Jan 16;17(1):20. doi: 10.1186/s12957-019-1563-2.
• [1110] MC1R signaling. Intracellular partners and pathophysiological implications.Biochim Biophys Acta Mol Basis Dis. 2017 Oct;1863(10 Pt A):2448-2461. doi: 10.1016/j.bbadis.2017.02.027. Epub 2017 Mar 1.
• [1111] ACTH receptor mRNA in human adrenocortical tumors: overexpression in aldosteronomas.Endocr Res. 1998 Aug-Nov;24(3-4):845-9. doi: 10.3109/07435809809032695.
• [1112] Structure and allosteric inhibition of excitatory amino acid transporter 1. Nature. 2017 Apr 27;544(7651):446-451.
• [1113] Immunohistochemical Expression of MCM-2 in Oral Epithelial Dysplasias.Appl Immunohistochem Mol Morphol. 2018 Aug;26(7):509-513. doi: 10.1097/PAI.0000000000000330.
• [1114] HRAS-driven cancer cells are vulnerable to TRPML1 inhibition.EMBO Rep. 2019 Apr;20(4):e46685. doi: 10.15252/embr.201846685. Epub 2019 Feb 20.
• [1115] Demethylated HSATII DNA and HSATII RNA Foci Sequester PRC1 and MeCP2 into Cancer-Specific Nuclear Bodies.Cell Rep. 2017 Mar 21;18(12):2943-2956. doi: 10.1016/j.celrep.2017.02.072.
• [1116] TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer.Br J Cancer. 2019 Mar;120(5):555-564. doi: 10.1038/s41416-019-0397-6. Epub 2019 Feb 15.
• [1117] N-acetylglucosaminyltransferase-I as a novel regulator of epithelial-mesenchymal transition. FASEB J. 2019 Feb;33(2):2823-2835.
• [1118] -Quinazolinonylalkyl aryl ureas as reversible inhibitors of monoacylglycerol lipase.Bioorg Chem. 2020 Jan;94:103352. doi: 10.1016/j.bioorg.2019.103352. Epub 2019 Oct 12.
• [1119] Macrophage migration inhibitory factor regulates mitochondrial dynamics and cell growth of human cancer cell lines through CD74-NF-B signaling.J Biol Chem. 2018 Dec 21;293(51):19740-19760. doi: 10.1074/jbc.RA118.003935. Epub 2018 Oct 26.
• [1120] Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors.Curr Med Chem. 2017;24(28):3025-3053. doi: 10.2174/0929867324666170203123427.
• [1121] Design, synthesis and activity of Mnk1 and Mnk2 selective inhibitors containing thieno[2,3-d]pyrimidine scaffold.Eur J Med Chem. 2019 Jan 15;162:735-751. doi: 10.1016/j.ejmech.2018.10.070. Epub 2018 Nov 2.
• [1122] Eicosapentaenoic acid and docosahexaenoic acid inhibit macrophage-induced gastric cancer cell migration by attenuating the expression of matrix metalloproteinase 10. J Nutr Biochem. 2012 Nov;23(11):1434-9. doi: 10.1016/j.jnutbio.2011.09.004. Epub 2012 Jan 27.
• [1123] Matrix Metalloproteinase 11 Is a Potential Therapeutic Target in Lung Adenocarcinoma.Mol Ther Oncolytics. 2019 Apr 6;14:82-93. doi: 10.1016/j.omto.2019.03.012. eCollection 2019 Sep 27.
• [1124] Gene expression profiling informs HPV cervical histopathology but not recurrence/relapse after LEEP in ART-suppressed HIV+HPV+ women.Carcinogenesis. 2019 Apr 29;40(2):225-233. doi: 10.1093/carcin/bgy149.
• [1125] Matrix metalloproteinase-21 is expressed epithelially during development and in cancer and is up-regulated by transforming growth factor-beta1 in keratinocytes.Lab Invest. 2003 Dec;83(12):1887-99. doi: 10.1097/01.lab.0000106721.86126.39.
• [1126] The Role of MMP8 in Cancer: A Systematic Review.Int J Mol Sci. 2019 Sep 11;20(18):4506. doi: 10.3390/ijms20184506.
• [1127] CD110 promotes pancreatic cancer progression and its expression is correlated with poor prognosis.J Cancer Res Clin Oncol. 2019 May;145(5):1147-1164. doi: 10.1007/s00432-019-02860-z. Epub 2019 Feb 15.
• [1128] The collagen receptor uPARAP/Endo180 as a novel target for antibody-drug conjugate mediated treatment of mesenchymal and leukemic cancers.Oncotarget. 2017 Jul 4;8(27):44605-44624. doi: 10.18632/oncotarget.17883.
• [1129] MiR-542-3p exerts tumor suppressive functions in non-small cell lung cancer cells by upregulating FTSJ2.Life Sci. 2017 Nov 1;188:87-95. doi: 10.1016/j.lfs.2017.08.018. Epub 2017 Sep 1.
• [1130] Knockdown of MSI1 inhibits the proliferation of human oral squamous cell carcinoma by inactivating STAT3 signaling.Int J Mol Med. 2019 Jul;44(1):115-124. doi: 10.3892/ijmm.2019.4181. Epub 2019 May 6.
• [1131] Synergistic Effect of a Mesothelin-Targeted (227)Th Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models.J Nucl Med. 2019 Sep;60(9):1293-1300. doi: 10.2967/jnumed.118.223701. Epub 2019 Mar 8.
• [1132] Analyzing the capability of PSP, PCT and sCD25 to support the diagnosis of infection in cancer patients with febrile neutropenia.Clin Chem Lab Med. 2019 Mar 26;57(4):540-548. doi: 10.1515/cclm-2018-0154.
• [1133] Correction to: Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy.J Immunother Cancer. 2019 Apr 2;7(1):94. doi: 10.1186/s40425-019-0571-7.
• [1134] A novel metadherin7 splice variant enhances triple negative breast cancer aggressiveness by modulating mitochondrial function via NFB-SIRT3 axis.Oncogene. 2020 Mar;39(10):2088-2102. doi: 10.1038/s41388-019-1126-6. Epub 2019 Dec 5.
• [1135] Myotubularin phosphoinositide phosphatases: cellular functions and disease pathophysiology.Trends Mol Med. 2012 Jun;18(6):317-27. doi: 10.1016/j.molmed.2012.04.004. Epub 2012 May 11.
• [1136] Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapy.Oncotarget. 2018 Apr 27;9(32):22254-22268. doi: 10.18632/oncotarget.24962. eCollection 2018 Apr 27.
• [1137] Frameshift mutations of MUC15 gene in gastric and its regional heterogeneity in gastric and colorectal cancers.Pathol Oncol Res. 2015 Jul;21(3):713-8. doi: 10.1007/s12253-014-9878-3. Epub 2015 Jan 9.
• [1138] Overexpression of MYC binding protein promotes invasion and migration in gastric cancer.Oncol Lett. 2018 Apr;15(4):5243-5249. doi: 10.3892/ol.2018.7944. Epub 2018 Feb 2.
• [1139] MYLK promotes hepatocellular carcinoma progression through regulating cytoskeleton to enhance epithelial-mesenchymal transition.Clin Exp Med. 2018 Nov;18(4):523-533. doi: 10.1007/s10238-018-0509-2. Epub 2018 May 31.
• [1140] Clinical features and outcomes in secondary adult hemophagocytic lymphohistiocytosis.QJM. 2018 Jan 1;111(1):23-31. doi: 10.1093/qjmed/hcx183.
• [1141] GCPII and its close homolog GCPIII: from a neuropeptidase to a cancer marker and beyond.Front Biosci (Landmark Ed). 2019 Mar 1;24(4):648-687. doi: 10.2741/4742.
• [1142] Identification of a small-molecule compound that inhibits homodimerization of oncogenic NAC1 protein and sensitizes cancer cells to anticancer agents.J Biol Chem. 2019 Jun 21;294(25):10006-10017. doi: 10.1074/jbc.RA119.007664. Epub 2019 May 17.
• [1143] Molecular defects identified by whole exome sequencing in a child with atypical mucopolysaccharidosis IIIB.J Pediatr Endocrinol Metab. 2017 Apr 1;30(4):463-469. doi: 10.1515/jpem-2016-0333.
• [1144] NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling.Nature. 2019 May;569(7757):570-575. doi: 10.1038/s41586-019-1150-2. Epub 2019 Apr 24.
• [1145] Expression of NADPH oxidase homologues and accessory genes in human cancer cell lines, tumours and adjacent normal tissues.Free Radic Res. 2009 Jun;43(6):523-32. doi: 10.1080/10715760902918683.
• [1146] NCK1 promotes the angiogenesis of cervical squamous carcinoma via Rac1/PAK1/MMP2 signal pathway.Gynecol Oncol. 2019 Feb;152(2):387-395. doi: 10.1016/j.ygyno.2018.11.013. Epub 2018 Nov 13.
• [1147] Let There Be Light: Targeted Photodynamic Therapy Using High Aspect Ratio Plant Viral Nanoparticles.Macromol Biosci. 2019 May;19(5):e1800407. doi: 10.1002/mabi.201800407. Epub 2019 Feb 5.
• [1148] C/EBP-Slug-Lox1 axis promotes metastasis of lung adenocarcinoma via oxLDL uptake.Oncogene. 2020 Jan;39(4):833-848. doi: 10.1038/s41388-019-1015-z. Epub 2019 Sep 27.
• [1149] Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples.BMC Med Genomics. 2011 Jan 24;4:11. doi: 10.1186/1755-8794-4-11.
• [1150] Conditional Genetic Ablation Mouse Models as a Tool to Study Cancer Immunosurveillance In Vivo.Methods Mol Biol. 2019;1884:161-176. doi: 10.1007/978-1-4939-8885-3_11.
• [1151] Upregulation of GRIM-19 suppresses the growth of oral squamous cell carcinoma in vitro and in vivo.Oncol Rep. 2014 Nov;32(5):2183-90. doi: 10.3892/or.2014.3423. Epub 2014 Aug 20.
• [1152] Clinical significance of a pvrl 4 encoded gene Nectin-4 in metastasis and angiogenesis for tumor relapse.J Cancer Res Clin Oncol. 2020 Jan;146(1):245-259. doi: 10.1007/s00432-019-03055-2. Epub 2019 Oct 15.
• [1153] NEDD9 overexpression predicts poor prognosis in solid cancers: a meta-analysis.Onco Targets Ther. 2019 May 28;12:4213-4222. doi: 10.2147/OTT.S205760. eCollection 2019.
• [1154] NEK1 kinase domain structure and its dynamic protein interactome after exposure to Cisplatin.Sci Rep. 2017 Jul 14;7(1):5445. doi: 10.1038/s41598-017-05325-w.
• [1155] NIMA-related kinase 2 overexpression is associated with poor survival in cancer patients: a systematic review and meta-analysis.Cancer Manag Res. 2019 Jan 3;11:455-465. doi: 10.2147/CMAR.S188347. eCollection 2019.
• [1156] Overexpression of NIMA-related kinase 6 (NEK6) contributes to malignant growth and dismal prognosis in Human Breast Cancer.Pathol Res Pract. 2018 Oct;214(10):1648-1654. doi: 10.1016/j.prp.2018.07.030. Epub 2018 Jul 27.
• [1157] The co-chaperone UNC45A is essential for the expression of mitotic kinase NEK7 and tumorigenesis.J Biol Chem. 2019 Apr 5;294(14):5246-5260. doi: 10.1074/jbc.RA118.006597. Epub 2019 Feb 8.
• [1158] IB-: At the crossroad between oncogenic and tumor-suppressive signals.Oncol Lett. 2017 Feb;13(2):531-534. doi: 10.3892/ol.2016.5465. Epub 2016 Dec 6.
• [1159] Fulranumab as Adjunctive Therapy for Cancer-Related Pain: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.J Pain. 2019 Apr;20(4):440-452. doi: 10.1016/j.jpain.2018.09.014. Epub 2018 Oct 25.
• [1160] Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.Carcinogenesis. 2020 Jun 17;41(4):458-466. doi: 10.1093/carcin/bgz182.
• [1161] Mechanisms of NLRP1-Mediated Autoinflammatory Disease in Humans and Mice.J Mol Biol. 2018 Jan 19;430(2):142-152. doi: 10.1016/j.jmb.2017.07.012. Epub 2017 Jul 19.
• [1162] NLRP3 inflammasome inactivation driven by miR?23?p reduces tumor growth and increases anticancer immunity in breast cancer.Mol Med Rep. 2019 Mar;19(3):2180-2188. doi: 10.3892/mmr.2019.9889. Epub 2019 Jan 23.
• [1163] Thioredoxin-like protein 2 is overexpressed in colon cancer and promotes cancer cell metastasis by interaction with ran.Antioxid Redox Signal. 2013 Sep 20;19(9):899-911. doi: 10.1089/ars.2012.4736. Epub 2013 Mar 4.
• [1164] Long noncoding RNA NNT-AS1 enhances the malignant phenotype of bladder cancer by acting as a competing endogenous RNA on microRNA-496 thereby increasing HMGB1 expression.Aging (Albany NY). 2019 Dec 17;11(24):12624-12640. doi: 10.18632/aging.102591. Epub 2019 Dec 17.
• [1165] MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ.Cancer Res. 2019 Apr 1;79(7):1646-1657. doi: 10.1158/0008-5472.CAN-18-1602. Epub 2019 Jan 18.
• [1166] The role of oncogenic Notch2 signaling in cancer: a novel therapeutic target.Am J Cancer Res. 2019 May 1;9(5):837-854. eCollection 2019.
• [1167] Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4.Mol Cancer Ther. 2019 Feb;18(2):421-436. doi: 10.1158/1535-7163.MCT-18-0365. Epub 2018 Nov 12.
• [1168] Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta-analysis.Eur J Heart Fail. 2020 Feb;22(2):350-361. doi: 10.1002/ejhf.1631. Epub 2019 Nov 12.
• [1169] NPR-A: A Therapeutic Target in Inflammation and Cancer.Crit Rev Eukaryot Gene Expr. 2015;25(1):41-6. doi: 10.1615/critreveukaryotgeneexpr.2015012447.
• [1170] Neuropeptide Y is Up-regulated and Induces Antinociception in Cancer-induced Bone Pain.Neuroscience. 2018 Aug 1;384:111-119. doi: 10.1016/j.neuroscience.2018.05.025. Epub 2018 May 29.
• [1171] Cloning and functional expression of the hNPY Y5 receptor in human endometrial cancer (HEC-1B) cells.Can J Physiol Pharmacol. 2000 Feb;78(2):134-42.
• [1172] NR1D1 Recruitment to Sites of DNA Damage Inhibits Repair and Is Associated with Chemosensitivity of Breast Cancer.Cancer Res. 2017 May 1;77(9):2453-2463. doi: 10.1158/0008-5472.CAN-16-2099. Epub 2017 Mar 1.
• [1173] Solar UV damage to cellular DNA: from mechanisms to biological effects.Photochem Photobiol Sci. 2018 Dec 5;17(12):1842-1852. doi: 10.1039/c8pp00182k.
• [1174] The Proteome of Pancreatic Cancer-Derived Exosomes Reveals Signatures Rich in Key Signaling Pathways.Proteomics. 2019 Jul;19(13):e1800394. doi: 10.1002/pmic.201800394. Epub 2019 Jun 11.
• [1175] Clinical applications of small molecule inhibitors of Pregnane X receptor.Mol Cell Endocrinol. 2019 Apr 5;485:61-71. doi: 10.1016/j.mce.2019.02.002. Epub 2019 Feb 3.
• [1176] Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer.Clin Cancer Res. 2018 Jul 15;24(14):3433-3446. doi: 10.1158/1078-0432.CCR-17-2793. Epub 2018 Apr 10.
• [1177] Pro-angiogenic Ginsenosides F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1.Sci Rep. 2019 Mar 14;9(1):4502. doi: 10.1038/s41598-019-41115-2.
• [1178] NRAS associated RASopathy and embryonal rhabdomyosarcoma.Am J Med Genet A. 2020 Jan;182(1):195-200. doi: 10.1002/ajmg.a.61395. Epub 2019 Nov 7.
• [1179] Characterization of the expression of the hypoxia-induced genes neuritin, TXNIP and IGFBP3 in cancer.FEBS Lett. 2006 Jun 12;580(14):3395-400. doi: 10.1016/j.febslet.2006.05.011. Epub 2006 May 11.
• [1180] Expression of NRP-1 and NRP-2 in Endometrial Cancer.Curr Pharm Biotechnol. 2019;20(3):254-260. doi: 10.2174/1389201020666190219121602.
• [1181] CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.J Exp Clin Cancer Res. 2019 Nov 14;38(1):467. doi: 10.1186/s13046-019-1462-y.
• [1182] MiR-429 suppresses neurotrophin-3 to alleviate perineural invasion of pancreatic cancer.Biochem Biophys Res Commun. 2018 Nov 10;505(4):1077-1083. doi: 10.1016/j.bbrc.2018.09.147. Epub 2018 Oct 9.
• [1183] A subtype of oral, laryngeal, esophageal, and lung, squamous cell carcinoma with high levels of TrkB-T1 neurotrophin receptor mRNA.BMC Cancer. 2019 Jun 20;19(1):607. doi: 10.1186/s12885-019-5789-8.
• [1184] A feed forward loop enforces YAP/TAZ signaling during tumorigenesis.Nat Commun. 2018 Aug 29;9(1):3510. doi: 10.1038/s41467-018-05939-2.
• [1185] Viral expression and molecular profiling in liver tissue versus microdissected hepatocytes in hepatitis B virus-associated hepatocellular carcinoma.J Transl Med. 2014 Aug 21;12:230. doi: 10.1186/s12967-014-0230-1.
• [1186] Vinorelbine's anti-tumor actions may depend on the mitotic apoptosis, autophagy and inflammation: hypotheses with implications for chemo-immunotherapy of advanced cancers and pediatric gliomas.J Chemother. 2018 Jul;30(4):203-212. doi: 10.1080/1120009X.2018.1487149. Epub 2018 Jul 20.
• [1187] -Difluoromethylornithine reduces gastric carcinogenesis by causing mutations in Helicobacter pylori cagY.Proc Natl Acad Sci U S A. 2019 Mar 12;116(11):5077-5085. doi: 10.1073/pnas.1814497116. Epub 2019 Feb 25.
• [1188] Consequences of blunting the mevalonate pathway in cancer identified by a pluri-omics approach.Cell Death Dis. 2018 Jul 3;9(7):745. doi: 10.1038/s41419-018-0761-0.
• [1189] Olfactomedin-4 in digestive diseases: A mini-review.World J Gastroenterol. 2018 May 7;24(17):1881-1887. doi: 10.3748/wjg.v24.i17.1881.
• [1190] The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis.PLoS One. 2018 Jul 19;13(7):e0200735. doi: 10.1371/journal.pone.0200735. eCollection 2018.
• [1191] The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase.Prostate. 2006 Jun 1;66(8):847-57. doi: 10.1002/pros.20389.
• [1192] Store-independent Orai1-mediated Ca(2+) entry and cancer.Cell Calcium. 2019 Jun;80:1-7. doi: 10.1016/j.ceca.2019.02.012. Epub 2019 Mar 7.
• [1193] Overexpression of oncostatin M receptor regulates local immune response in glioblastoma.J Cell Physiol. 2019 Sep;234(9):15496-15509. doi: 10.1002/jcp.28197. Epub 2019 Jan 28.
• [1194] Low-dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patients.Dermatol Ther. 2018 Nov;31(6):e12741. doi: 10.1111/dth.12741. Epub 2018 Oct 8.
• [1195] Expression of Oxytocin Receptors in Canine Mammary Tumours.J Comp Pathol. 2019 Jul;170:26-33. doi: 10.1016/j.jcpa.2019.05.005. Epub 2019 Jun 12.
• [1196] Copy number variability analysis of pharmacogenes in patients with lymphoma, leukemia, hepatocellular, and lung carcinoma using The Cancer Genome Atlas data.Pharmacogenet Genomics. 2015 Jan;25(1):1-7. doi: 10.1097/FPC.0000000000000097.
• [1197] Increased risk of acute myocardial infarction and elevated levels of C-reactive protein in carriers of the Thr-87 variant of the ATP receptor P2Y11.Eur Heart J. 2007 Jan;28(1):13-8. doi: 10.1093/eurheartj/ehl410. Epub 2006 Nov 29.
• [1198] Is P2Y12 inhibitor therapy associated with an increased risk of cancer?.Eur Heart J Cardiovasc Pharmacother. 2019 Apr 1;5(2):100-104. doi: 10.1093/ehjcvp/pvz003.
• [1199] Melanoma-associated cancer-testis antigen 16 (CT16) regulates the expression of apoptotic and antiapoptotic genes and promotes cell survival. PLoS One. 2012;7(9):e45382.
• [1200] Targeting PAK1 with the Small Molecule Drug AK963/40708899 Suppresses Gastric Cancer Cell Proliferation and Invasion by Downregulation of PAK1 Activity and PAK1-Related Signaling Pathways.Anat Rec (Hoboken). 2019 Sep;302(9):1571-1579. doi: 10.1002/ar.24095. Epub 2019 Mar 27.
• [1201] Dual PAK4-NAMPT Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in Waldenstrm Macroglobulinemia.Clin Cancer Res. 2019 Jan 1;25(1):369-377. doi: 10.1158/1078-0432.CCR-18-1776. Epub 2018 Sep 11.
• [1202] Potent anti-myeloma activity of the TOPK inhibitor OTS514 in pre-clinical models.Cancer Med. 2020 Jan;9(1):324-334. doi: 10.1002/cam4.2695. Epub 2019 Nov 12.
• [1203] Prognostic impact of concomitant loss of PBRM1 and BAP1 protein expression in early stages of clear cell renal cell carcinoma.Urol Oncol. 2018 May;36(5):243.e1-243.e8. doi: 10.1016/j.urolonc.2018.01.002. Epub 2018 Feb 14.
• [1204] Nec-1 enhances shikonin-induced apoptosis in leukemia cells by inhibition of RIP-1 and ERK1/2.Int J Mol Sci. 2012;13(6):7212-7225. doi: 10.3390/ijms13067212. Epub 2012 Jun 12.
• [1205] A Novel Strategy for Targeted Lipidomics Based on LC-Tandem-MS Parameters Prediction, Quantification, and Multiple Statistical Data Mining: Evaluation of Lysophosphatidylcholines as Potential Cancer Biomarkers.Anal Chem. 2019 Mar 5;91(5):3389-3396. doi: 10.1021/acs.analchem.8b04715. Epub 2019 Feb 12.
• [1206] Chaperonin Containing TCP-1 Protein Level in Breast Cancer Cells Predicts Therapeutic Application of a Cytotoxic Peptide.Clin Cancer Res. 2016 Sep 1;22(17):4366-79. doi: 10.1158/1078-0432.CCR-15-2502. Epub 2016 Mar 24.
• [1207] Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study.J Endocrinol Invest. 2020 Mar;43(3):337-345. doi: 10.1007/s40618-019-01112-8. Epub 2019 Sep 21.
• [1208] PDCD2 sensitizes HepG2 cells to sorafenib by suppressing epithelialmesenchymal transition.Mol Med Rep. 2019 Mar;19(3):2173-2179. doi: 10.3892/mmr.2019.9860. Epub 2019 Jan 15.
• [1209] Optimization of PDE3A Modulators for SLFN12-Dependent Cancer Cell Killing.ACS Med Chem Lett. 2019 Oct 18;10(11):1537-1542. doi: 10.1021/acsmedchemlett.9b00360. eCollection 2019 Nov 14.
• [1210] PDE4 and Epac1 Synergistically Promote Rectal Carcinoma via the cAMP Pathway.Anal Cell Pathol (Amst). 2019 Jan 23;2019:7145198. doi: 10.1155/2019/7145198. eCollection 2019.
• [1211] Disruption of the Myc-PDE4B regulatory circuitry impairs B-cell lymphoma survival.Leukemia. 2019 Dec;33(12):2912-2923. doi: 10.1038/s41375-019-0492-y. Epub 2019 May 28.
• [1212] Repurposing mechanistic insight of PDE-5 inhibitor in cancer chemoprevention through mitochondrial-oxidative stress intervention and blockade of DuCLOX signalling.BMC Cancer. 2019 Oct 24;19(1):996. doi: 10.1186/s12885-019-6152-9.
• [1213] The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancer.Int J Oncol. 2015 Jul;47(1):325-34. doi: 10.3892/ijo.2015.2986. Epub 2015 May 5.
• [1214] Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances.Hepatology. 2019 Apr;69(4):1803-1815. doi: 10.1002/hep.30289. Epub 2019 Mar 25.
• [1215] Hypomethylated gene NRP1 is co-expressed with PDGFRB and associated with poor overall survival in gastric cancer patients.Biomed Pharmacother. 2019 Mar;111:1334-1341. doi: 10.1016/j.biopha.2019.01.023. Epub 2019 Jan 16.
• [1216] miR-128-3p contributes to mitochondrial dysfunction and induces apoptosis in glioma cells via targeting pyruvate dehydrogenase kinase 1.IUBMB Life. 2020 Mar;72(3):465-475. doi: 10.1002/iub.2212. Epub 2019 Dec 11.
• [1217] Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer.Oncogene. 2013 Mar 28;32(13):1638-50. doi: 10.1038/onc.2012.198. Epub 2012 May 21.
• [1218] Investigation of inhibitory potential of quercetin to the pyruvate dehydrogenase kinase 3: Towards implications in anticancer therapy.Int J Biol Macromol. 2019 Sep 1;136:1076-1085. doi: 10.1016/j.ijbiomac.2019.06.158. Epub 2019 Jun 22.
• [1219] The expression of four pyridoxal kinase (PDXK) human variants in Drosophila impacts on genome integrity.Sci Rep. 2019 Oct 2;9(1):14188. doi: 10.1038/s41598-019-50673-4.
• [1220] PDZK1, a novel PDZ domain-containing protein up-regulated in carcinomas and mapped to chromosome 1q21, interacts with cMOAT (MRP2), the multidrug resistance-associated protein.Lab Invest. 1999 Sep;79(9):1161-70.
• [1221] Self-Illuminating Photodynamic Therapy with Enhanced Therapeutic Effect by Optimization of the Chemiluminescence Resonance Energy Transfer Step to the Photosensitizer.Bioconjug Chem. 2020 Mar 18;31(3):595-604. doi: 10.1021/acs.bioconjchem.9b00740. Epub 2020 Jan 8.
• [1222] Proline prodrug of melphalan targeted to prolidase, a prodrug activating enzyme overexpressed in melanoma.Pharm Res. 2007 Jul;24(7):1290-8. doi: 10.1007/s11095-007-9249-9. Epub 2007 Mar 22.
• [1223] Non-platelet-derived CXCL4 differentially regulates cytotoxic and regulatory T cells through CXCR3 to suppress the immune response to colon cancer.Cancer Lett. 2019 Feb 28;443:1-12. doi: 10.1016/j.canlet.2018.11.017. Epub 2018 Nov 24.
• [1224] 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer.Mol Metab. 2019 Feb;20:1-13. doi: 10.1016/j.molmet.2018.11.013. Epub 2018 Dec 5.
• [1225] Peroxisome Proliferator-Activated Receptor and PGC-1 in Cancer: Dual Actions as Tumor Promoter and Suppressor.PPAR Res. 2018 Jan 21;2018:6727421. doi: 10.1155/2018/6727421. eCollection 2018.
• [1226] PHF8 Plays an Oncogene Function in Hepatocellular Carcinoma Formation.Oncol Res. 2019 May 7;27(5):613-621. doi: 10.3727/096504018X15410353669149. Epub 2019 Feb 14.
• [1227] Kinesin family member 15 promotes cancer stem cell phenotype and malignancy via reactive oxygen species imbalance in hepatocellular carcinoma.Cancer Lett. 2020 Jul 10;482:112-125. doi: 10.1016/j.canlet.2019.11.008. Epub 2019 Nov 13.
• [1228] Pleckstrin homology domain-containing protein PHLDB3 supports cancer growth via a negative feedback loop involving p53. Nat Commun. 2016 Dec 23;7:13755.
• [1229] Current perspectives on targeting PIM kinases to overcome mechanisms of drug resistance and immune evasion in cancer.Pharmacol Ther. 2020 Mar;207:107454. doi: 10.1016/j.pharmthera.2019.107454. Epub 2019 Dec 11.
• [1230] PinX1 represses renal cancer angiogenesis via the mir-125a-3p/VEGF signaling pathway.Angiogenesis. 2019 Nov;22(4):507-519. doi: 10.1007/s10456-019-09675-z. Epub 2019 Jun 28.
• [1231] Laden Nanofiber Capsules for Local Malignancy Chemotherapy.J Biomed Nanotechnol. 2019 May 1;15(5):939-950. doi: 10.1166/jbn.2019.2745.
• [1232] PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cells.Oncotarget. 2014 Dec 30;5(24):12646-64. doi: 10.18632/oncotarget.2653.
• [1233] The interaction of p130Cas with PKN3 promotes malignant growth.Mol Oncol. 2019 Feb;13(2):264-289. doi: 10.1002/1878-0261.12401. Epub 2018 Dec 3.
• [1234] Current Anti-Inflammatory Therapies and the Potential of Secretory Phospholipase A2 Inhibitors in the Design of New Anti-Inflammatory Drugs: A Review of 2012 - 2018.Curr Med Chem. 2020;27(3):477-497. doi: 10.2174/0929867326666190201120646.
• [1235] Current insights into functions of phospholipase A2 receptor in normal and cancer cells: More questions than answers.Semin Cancer Biol. 2019 Jun;56:116-127. doi: 10.1016/j.semcancer.2017.11.002. Epub 2017 Nov 2.
• [1236] PLAC1: biology and potential application in cancer immunotherapy.Cancer Immunol Immunother. 2019 Jul;68(7):1039-1058. doi: 10.1007/s00262-019-02350-8. Epub 2019 Jun 5.
• [1237] Mitochondrial targeting of TR3 is involved in TPA induced apoptosis in breast cancer cells.Gene. 2019 Apr 20;693:61-68. doi: 10.1016/j.gene.2018.12.072. Epub 2019 Jan 11.
• [1238] Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.Front Oncol. 2018 Feb 12;8:24. doi: 10.3389/fonc.2018.00024. eCollection 2018.
• [1239] Polo-like kinases and acute leukemia.Oncogene. 2019 Jan;38(1):1-16. doi: 10.1038/s41388-018-0443-5. Epub 2018 Aug 13.
• [1240] Aberrantly expressed PLOD1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target.Mol Oncol. 2019 Sep;13(9):1898-1912. doi: 10.1002/1878-0261.12532. Epub 2019 Jun 27.
• [1241] Serum TEM5 and TEM7 concentrations correlate with clinicopathologic features and poor prognosis of colorectal cancer patients.Adv Med Sci. 2019 Sep;64(2):402-408. doi: 10.1016/j.advms.2019.07.001. Epub 2019 Jul 25.
• [1242] The Transitional Endoplasmic Reticulum ATPase p97 Regulates the Alternative Nuclear Factor NF-B Signaling via Partial Degradation of the NF-B Subunit p100.J Biol Chem. 2015 Aug 7;290(32):19558-68. doi: 10.1074/jbc.M114.630061. Epub 2015 Jun 25.
• [1243] A comprehensive analysis of polymorphic variants in steroid hormone and insulin-like growth factor-1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium.Int J Cancer. 2018 Mar 15;142(6):1182-1188. doi: 10.1002/ijc.31145. Epub 2017 Nov 17.
• [1244] AQP3 is regulated by PPAR and JNK in hepatic stellate cells carrying PNPLA3 I148M.Sci Rep. 2017 Nov 7;7(1):14661. doi: 10.1038/s41598-017-14557-9.
• [1245] DNA Polymerase Cancer-Associated Variant I260M Exhibits Nonspecific Selectivity toward the - Bridging Group of the Incoming dNTP.Biochemistry. 2017 Oct 10;56(40):5449-5456. doi: 10.1021/acs.biochem.7b00713. Epub 2017 Sep 20.
• [1246] Do CO(2) and oxidative stress induce cancer?: a brief study about the evaluation of PON 1, CAT, CA and XO enzyme levels on head and neck cancer patients.J Enzyme Inhib Med Chem. 2019 Dec;34(1):459-464. doi: 10.1080/14756366.2018.1555157.
• [1247] Suppression of PPN/MG61 attenuates Wnt/beta-catenin signaling pathway and induces apoptosis in human lung cancer.Oncogene. 2008 May 29;27(24):3483-8. doi: 10.1038/sj.onc.1211006. Epub 2008 Jan 14.
• [1248] Prognostic value of periostin in multiple solid cancers: A systematic review with meta-analysis.J Cell Physiol. 2020 Mar;235(3):2800-2808. doi: 10.1002/jcp.29184. Epub 2019 Sep 13.
• [1249] Promoter methylation of PGC1A and PGC1B predicts cancer incidence in a veteran cohort.Epigenomics. 2018 Jun;10(6):733-743. doi: 10.2217/epi-2017-0141. Epub 2018 Jun 11.
• [1250] PPM1A is a RelA phosphatase with tumor suppressor-like activity.Oncogene. 2014 May 29;33(22):2918-27. doi: 10.1038/onc.2013.246. Epub 2013 Jul 1.
• [1251] Clonal hematopoiesis: Pre-cancer PLUS.Adv Cancer Res. 2019;141:85-128. doi: 10.1016/bs.acr.2018.12.003. Epub 2019 Jan 14.
• [1252] PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer.Front Oncol. 2019 Jun 4;9:462. doi: 10.3389/fonc.2019.00462. eCollection 2019.
• [1253] Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors.Oncogene. 2016 May;35(21):2777-88. doi: 10.1038/onc.2015.341. Epub 2015 Sep 21.
• [1254] PPP2R5A: A multirole protein phosphatase subunit in regulating cancer development.Cancer Lett. 2018 Feb 1;414:222-229. doi: 10.1016/j.canlet.2017.11.024. Epub 2017 Nov 23.
• [1255] Knockdown of serine/threonine protein phosphatase 5 enhances gemcitabine sensitivity by promoting apoptosis in pancreatic cancer cells in vitro.Oncol Lett. 2018 Jun;15(6):8761-8769. doi: 10.3892/ol.2018.8363. Epub 2018 Mar 28.
• [1256] Evaluation of cancer testis antigen (CT10, PRAME) and MHC I expression in high-grade urothelial carcinoma of the bladder.Virchows Arch. 2020 Apr;476(4):535-542. doi: 10.1007/s00428-019-02661-2. Epub 2019 Sep 2.
• [1257] Activatable Fluorescence Imaging and Targeted Drug Delivery via Extracellular Vesicle-Like Porous Coordination Polymer Nanoparticles.Anal Chem. 2019 Nov 5;91(21):14036-14042. doi: 10.1021/acs.analchem.9b03679. Epub 2019 Oct 17.
• [1258] Thioredoxin Reductase Activity Predicts Gold Nanoparticle Radiosensitization Effect.Nanomaterials (Basel). 2019 Feb 19;9(2):295. doi: 10.3390/nano9020295.
• [1259] The development and validation of a combined kinetic fluorometric activity assay for fibroblast activation protein alpha and prolyl oligopeptidase in plasma.Clin Chim Acta. 2019 Aug;495:154-160. doi: 10.1016/j.cca.2019.04.063. Epub 2019 Apr 11.
• [1260] Distinctive requirement of PKC in the control of Rho GTPases in epithelial and mesenchymally transformed lung cancer cells.Oncogene. 2019 Jul;38(27):5396-5412. doi: 10.1038/s41388-019-0796-4. Epub 2019 Mar 28.
• [1261] Protein Kinase C Quality Control by Phosphatase PHLPP1Unveils Loss-of-Function Mechanism in Cancer.Mol Cell. 2019 Apr 18;74(2):378-392.e5. doi: 10.1016/j.molcel.2019.02.018. Epub 2019 Mar 20.
• [1262] PKC Controls Mitotic Progression by Regulating Centrosome Migration and Mitotic Spindle Assembly.Mol Cancer Res. 2018 Jan;16(1):3-15. doi: 10.1158/1541-7786.MCR-17-0244. Epub 2017 Oct 11.
• [1263] The Enigmatic Protein Kinase C-eta.Cancers (Basel). 2019 Feb 13;11(2):214. doi: 10.3390/cancers11020214.
• [1264] NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC- and reactive oxygen species.Nat Med. 2012 Nov;18(11):1693-8. doi: 10.1038/nm.2960. Epub 2012 Oct 21.
• [1265] PRMT7 as a unique member of the protein arginine methyltransferase family: A review.Arch Biochem Biophys. 2019 Apr 15;665:36-45. doi: 10.1016/j.abb.2019.02.014. Epub 2019 Feb 22.
• [1266] Prion Protein Protects Cancer Cells against Endoplasmic Reticulum Stress Induced Apoptosis.Virol Sin. 2019 Apr;34(2):222-234. doi: 10.1007/s12250-019-00107-2. Epub 2019 Apr 24.
• [1267] EPCR promotes MGC803 human gastric cancer cell tumor angiogenesis in vitro through activating ERK1/2 and AKT in a PAR1-dependent manner.Oncol Lett. 2018 Aug;16(2):1565-1570. doi: 10.3892/ol.2018.8869. Epub 2018 Jun 1.
• [1268] The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy.Endocrinology. 2006 Sep;147(9):4245-51. doi: 10.1210/en.2006-0614. Epub 2006 Jun 8.
• [1269] A Thai family with hereditary pancreatitis and increased cancer risk due to a mutation in PRSS1 gene.World J Gastroenterol. 2005 Mar 21;11(11):1634-8. doi: 10.3748/wjg.v11.i11.1634.
• [1270] PRSS8 suppresses colorectal carcinogenesis and metastasis.Oncogene. 2019 Jan;38(4):497-517. doi: 10.1038/s41388-018-0453-3. Epub 2018 Aug 16.
• [1271] Interaction between Tumor Cell Surface Receptor RAGE and Proteinase 3 Mediates Prostate Cancer Metastasis to Bone.Cancer Res. 2017 Jun 15;77(12):3144-3150. doi: 10.1158/0008-5472.CAN-16-0708. Epub 2017 Apr 20.
• [1272] Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients.Int J Oncol. 2012 Apr;40(4):965-74. doi: 10.3892/ijo.2011.1274. Epub 2011 Nov 30.
• [1273] Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.Am J Hematol. 1996 Jul;52(3):171-7. doi: 10.1002/(SICI)1096-8652(199607)52:3<171::AID-AJH6>3.0.CO;2-Q.
• [1274] Impact of LMP7 (rs2071543) gene polymorphism in increasing cancer risk: evidence from a meta-analysis and trial sequential analysis.Oncotarget. 2017 Dec 21;9(5):6572-6585. doi: 10.18632/oncotarget.23547. eCollection 2018 Jan 19.
• [1275] Gankyrin Contributes to Tumorigenesis and Chemoresistance in Sporadic Colorectal Cancer.Digestion. 2019;100(3):192-200. doi: 10.1159/000494969. Epub 2018 Dec 4.
• [1276] Expression of a splice variant of the platelet-activating factor receptor transcript 2 in various human cancer cell lines.Mediators Inflamm. 2002 Oct;11(5):329-31. doi: 10.1080/09629350210000015755.
• [1277] RNA-Binding Protein HuR Regulates Both Mutant and Wild-Type IDH1 in IDH1-Mutated Cancer.Mol Cancer Res. 2019 Feb;17(2):508-520. doi: 10.1158/1541-7786.MCR-18-0557. Epub 2018 Sep 28.
• [1278] A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA.Clin Cancer Res. 2017 Nov 15;23(22):7141-7152. doi: 10.1158/1078-0432.CCR-17-1222. Epub 2017 Aug 29.
• [1279] Peripherally Restricted, Highly Potent, Selective, Aqueous-Soluble EP2 Antagonist with Anti-Inflammatory Properties.Mol Pharm. 2018 Dec 3;15(12):5809-5817. doi: 10.1021/acs.molpharmaceut.8b00764. Epub 2018 Nov 15.
• [1280] Microsomal Prostaglandin E2 Synthase-1 as a New Macromolecular Drug Target in the Prevention of Inflammation and Cancer.Anticancer Agents Med Chem. 2019;19(10):1205-1222. doi: 10.2174/1871520619666190227174137.
• [1281] eQTL analysis from co-localization of 2739 GWAS loci detects associated genes across 14 human cancers.J Theor Biol. 2019 Feb 7;462:240-246. doi: 10.1016/j.jtbi.2018.10.059. Epub 2018 Nov 2.
• [1282] The SuprMam1 breast cancer susceptibility locus disrupts the vitamin D/ calcium/ parathyroid hormone pathway and alters bone structure in congenic mice.J Steroid Biochem Mol Biol. 2019 Apr;188:48-58. doi: 10.1016/j.jsbmb.2018.12.004. Epub 2018 Dec 7.
• [1283] Clinical Evolution of Epithelial-Mesenchymal Transition in Human Carcinomas.Cancer Res. 2020 Jan 15;80(2):304-318. doi: 10.1158/0008-5472.CAN-18-3539. Epub 2019 Nov 15.
• [1284] Two-dimensional oriented growth of Zn-MOF-on-Zr-MOF architecture: A highly sensitive and selective platform for detecting cancer markers.Biosens Bioelectron. 2019 Jan 1;123:51-58. doi: 10.1016/j.bios.2018.09.079. Epub 2018 Sep 22.
• [1285] Circular RNA Pleiotrophin promotes carcinogenesis in glioma via regulation of microRNA-122/SRY-box transcription factor 6 axis.Eur J Cancer Prev. 2020 Mar;29(2):165-173. doi: 10.1097/CEJ.0000000000000535.
• [1286] Curcumin and Cinnamaldehyde as PTP1B Inhibitors With Antidiabetic and Anticancer Potential.Anticancer Res. 2019 Feb;39(2):745-749. doi: 10.21873/anticanres.13171.
• [1287] PTPL1 and PKC contribute to proapoptotic signalling in prostate cancer cells.Cell Death Dis. 2013 Apr 4;4(4):e576. doi: 10.1038/cddis.2013.90.
• [1288] The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7.J Virol. 2017 Mar 13;91(7):e00057-17. doi: 10.1128/JVI.00057-17. Print 2017 Apr 1.
• [1289] In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.Nature. 2017 Jul 27;547(7664):413-418. doi: 10.1038/nature23270. Epub 2017 Jul 19.
• [1290] A signalling cascade involving receptor-activated phospholipase A(2), glycerophosphoinositol 4-phosphate, Shp1 and Src in the activation of cell motility.Cell Commun Signal. 2019 Mar 1;17(1):20. doi: 10.1186/s12964-019-0329-3.
• [1291] A hematopoietic protein tyrosine phosphatase (HePTP) gene that is amplified and overexpressed in myeloid malignancies maps to chromosome 1q32.1.Leukemia. 1994 Feb;8(2):236-44.
• [1292] Increase of CD45-positive Immune Cells in Liver Parenchyma Indicates a More Favorable Prognosis for Patients With Barrett's Cancer.Anticancer Res. 2019 Mar;39(3):1191-1196. doi: 10.21873/anticanres.13229.
• [1293] PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8(+) T-cell Function.Cancer Immunol Res. 2019 Feb;7(2):257-268. doi: 10.1158/2326-6066.CIR-18-0442. Epub 2019 Jan 18.
• [1294] Peptide YY and cancer: current findings and potential clinical applications.Peptides. 2002 Feb;23(2):389-95. doi: 10.1016/s0196-9781(01)00616-7.
• [1295] Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer. Nat Genet. 2019 Sep;51(9):1308-1314. doi: 10.1038/s41588-019-0475-y. Epub 2019 Aug 12.
• [1296] Potential targets for intervention against doxorubicin-induced cardiotoxicity based on genetic studies: a systematic review of the literature.J Mol Cell Cardiol. 2020 Jan;138:88-98. doi: 10.1016/j.yjmcc.2019.11.150. Epub 2019 Nov 18.
• [1297] The Rac3 GTPase in Neuronal Development, Neurodevelopmental Disorders, and Cancer.Cells. 2019 Sep 11;8(9):1063. doi: 10.3390/cells8091063.
• [1298] RACK1 promotes the invasive activities and lymph node metastasis of cervical cancer via galectin-1.Cancer Lett. 2020 Jan 28;469:287-300. doi: 10.1016/j.canlet.2019.11.002. Epub 2019 Nov 6.
• [1299] Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer. ACS Med Chem Lett. 2019 May 9;10(6):857-862.
• [1300] Exchange proteins directly activated by cAMP (EPACs): Emerging therapeutic targets.Bioorg Med Chem Lett. 2017 Apr 15;27(8):1633-1639. doi: 10.1016/j.bmcl.2017.02.065. Epub 2017 Feb 27.
• [1301] SP1 and RAR regulate AGAP2 expression in cancer.Sci Rep. 2019 Jan 23;9(1):390. doi: 10.1038/s41598-018-36888-x.
• [1302] Targeting to the non-genomic activity of retinoic acid receptor-gamma by acacetin in hepatocellular carcinoma.Sci Rep. 2017 Mar 23;7(1):348. doi: 10.1038/s41598-017-00233-5.
• [1303] Intrinsic GTPase Activity of K-RAS Monitored by Native Mass Spectrometry.Biochemistry. 2019 Aug 6;58(31):3396-3405. doi: 10.1021/acs.biochem.9b00532. Epub 2019 Jul 22.
• [1304] Human retinoblastoma binding protein 9, a serine hydrolase implicated in pancreatic cancers.Protein Pept Lett. 2012 Feb;19(2):194-7. doi: 10.2174/092986612799080356.
• [1305] Adipokine RBP4 drives ovarian cancer cell migration.J Ovarian Res. 2018 Apr 11;11(1):29. doi: 10.1186/s13048-018-0397-9.
• [1306] CSL controls telomere maintenance and genome stability in human dermal fibroblasts.Nat Commun. 2019 Aug 29;10(1):3884. doi: 10.1038/s41467-019-11785-7.
• [1307] The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro.Melanoma Res. 2020 Jun;30(3):223-234. doi: 10.1097/CMR.0000000000000650.
• [1308] Downregulation of regulator of G protein signaling 2 expression in breast invasive carcinoma of no special type: Clinicopathological associations and prognostic relevance.Oncol Lett. 2018 Jan;15(1):213-220. doi: 10.3892/ol.2017.7351. Epub 2017 Nov 3.
• [1309] Correlation of RGS4 and P16 expressions with pediatric nephroblastoma and its significance on prognosis.Eur Rev Med Pharmacol Sci. 2017 Oct;21(20):4577-4583.
• [1310] Pan-cancer analysis of the metabolic reaction network.Metab Eng. 2020 Jan;57:51-62. doi: 10.1016/j.ymben.2019.09.006. Epub 2019 Sep 14.
• [1311] Deletions in the cytoplasmic domain of iRhom1 and iRhom2 promote shedding of the TNF receptor by the protease ADAM17.Sci Signal. 2015 Nov 3;8(401):ra109. doi: 10.1126/scisignal.aac5356.
• [1312] RIP2 promotes glioma cell growth by regulating TRAF3 and activating the NFB and p38 signaling pathways.Oncol Rep. 2018 Jun;39(6):2915-2923. doi: 10.3892/or.2018.6397. Epub 2018 Apr 23.
• [1313] IFN- restores the impaired function of RNase L and induces mitochondria-mediated apoptosis in lung cancer.Cell Death Dis. 2019 Sep 9;10(9):642. doi: 10.1038/s41419-019-1902-9.
• [1314] RNF6 Promotes Colorectal Cancer by Activating the Wnt/-Catenin Pathway via Ubiquitination of TLE3.Cancer Res. 2018 Apr 15;78(8):1958-1971. doi: 10.1158/0008-5472.CAN-17-2683. Epub 2018 Jan 26.
• [1315] Methioninase gene therapy of human cancer cells is synergistic with recombinant methioninase treatment.Cancer Res. 2000 May 15;60(10):2696-702.
• [1316] Robo 4 - the double-edged sword in prostate cancer: impact on cancer cell aggressiveness and tumor vasculature.Int J Med Sci. 2019 Jan 1;16(1):115-124. doi: 10.7150/ijms.28735. eCollection 2019.
• [1317] lncRNA HAND2-AS1 inhibits cancer cell proliferation, migration and invasion by downregulating ROCK1 in HPV-positive and negative cervical squamous cell carcinoma.Exp Ther Med. 2019 Oct;18(4):2512-2518. doi: 10.3892/etm.2019.7830. Epub 2019 Jul 30.
• [1318] Immobilization of HIV-1 TAT peptide on gold nanoparticles: A feasible approach for siRNA delivery.J Cell Physiol. 2020 Mar;235(3):2049-2059. doi: 10.1002/jcp.29105. Epub 2019 Jul 31.
• [1319] Genetic variation of clock genes and cancer risk: a field synopsis and meta-analysis.Oncotarget. 2017 Apr 4;8(14):23978-23995. doi: 10.18632/oncotarget.15074.
• [1320] Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix. Br J Cancer. 2002 Jan 21;86(2):274-81.
• [1321] ER-Mediated Nuclear Sequestration of RSK2 Is Required for ER(+) Breast Cancer Tumorigenesis.Cancer Res. 2018 Apr 15;78(8):2014-2025. doi: 10.1158/0008-5472.CAN-17-2063. Epub 2018 Jan 19.
• [1322] Mitogen- and stress-activated Kinase 1 mediates Epstein-Barr virus latent membrane protein 1-promoted cell transformation in nasopharyngeal carcinoma through its induction of Fra-1 and c-Jun genes.BMC Cancer. 2015 May 10;15:390. doi: 10.1186/s12885-015-1398-3.
• [1323] A Preexisting Rare PIK3CA(E545K) Subpopulation Confers Clinical Resistance to MEK plus CDK4/6 Inhibition in NRAS Melanoma and Is Dependent on S6K1 Signaling.Cancer Discov. 2018 May;8(5):556-567. doi: 10.1158/2159-8290.CD-17-0745. Epub 2018 Mar 1.
• [1324] S6K2 promises an important therapeutic potential for cancer.Future Oncol. 2019 Jan;15(1):95-102. doi: 10.2217/fon-2018-0332. Epub 2018 Nov 1.
• [1325] RRM1 predicts clinical outcome of high-andintermediate-risk non-muscle-invasive bladder cancer patients treated with intravesical gemcitabine monotherapy.BMC Urol. 2019 Jul 24;19(1):69. doi: 10.1186/s12894-019-0497-x.
• [1326] Selective Targeting and Eradication of LGR5(+) Cancer Stem Cells Using RSPO-Conjugated Doxorubicin Liposomes.Mol Cancer Ther. 2018 Jul;17(7):1475-1485. doi: 10.1158/1535-7163.MCT-17-0694. Epub 2018 Apr 25.
• [1327] Peptide Multifunctionalized Gold Nanorods with Dual pH/NIR Responsive Release of Doxorubicin for High-Efficiency Cancer Treatment.J Biomed Nanotechnol. 2019 Nov 1;15(11):2164-2178. doi: 10.1166/jbn.2019.2843.
• [1328] Emerging roles for the relaxin/RXFP1 system in cancer therapy.Mol Cell Endocrinol. 2019 May 1;487:85-93. doi: 10.1016/j.mce.2019.02.001. Epub 2019 Feb 11.
• [1329] Prominent role of RAB39A-RXRB axis in cancer development and stemness.Oncotarget. 2018 Jan 4;9(11):9852-9866. doi: 10.18632/oncotarget.23955. eCollection 2018 Feb 9.
• [1330] Prognostic significance of vitamin D receptor and retinoid X receptor expression in renal cell carcinoma.J Urol. 2007 Oct;178(4 Pt 1):1497-503. doi: 10.1016/j.juro.2007.05.119. Epub 2007 Aug 16.
• [1331] Surgical injury: comparing open surgery and laparoscopy by markers of tissue damage.Ther Clin Risk Manag. 2018 May 30;14:999-1006. doi: 10.2147/TCRM.S153359. eCollection 2018.
• [1332] S100A6 promotes the proliferation and migration of cervical cancer cells via the PI3K/Akt signaling pathway.Oncol Lett. 2018 Apr;15(4):5685-5693. doi: 10.3892/ol.2018.8018. Epub 2018 Feb 9.
• [1333] Target-Specific Imaging of Cathepsin and S100A8/A9 Reflects Specific Features of Malignancy and Enables Estimation of Tumor Malignancy.Mol Imaging Biol. 2020 Feb;22(1):66-72. doi: 10.1007/s11307-019-01370-1.
• [1334] Elevated Serum S100A9 Indicated Poor Prognosis in Hepatocellular Carcinoma after Curative Resection.J Cancer. 2019 Jan 1;10(2):408-415. doi: 10.7150/jca.28409. eCollection 2019.
• [1335] Conjugated Bile Acids Promote Invasive Growth of Esophageal Adenocarcinoma Cells and Cancer Stem Cell Expansion via Sphingosine 1-Phosphate Receptor 2-Mediated Yes-Associated Protein Activation.Am J Pathol. 2018 Sep;188(9):2042-2058. doi: 10.1016/j.ajpath.2018.05.015. Epub 2018 Jun 30.
• [1336] Divergent SATB1 expression across human life span and tissue compartments.Immunol Cell Biol. 2019 May;97(5):498-511. doi: 10.1111/imcb.12233. Epub 2019 Feb 25.
• [1337] Specifically blocking the fatty acid synthesis to inhibit the malignant phenotype of bladder cancer.Int J Biol Sci. 2019 Jun 4;15(8):1610-1617. doi: 10.7150/ijbs.32518. eCollection 2019.
• [1338] Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies.BMC Cancer. 2006 Apr 9;6:88. doi: 10.1186/1471-2407-6-88.
• [1339] Mammaglobin 1 promotes breast cancer malignancy and confers sensitivity to anticancer drugs.Mol Carcinog. 2016 Jul;55(7):1150-62. doi: 10.1002/mc.22358. Epub 2015 Jul 24.
• [1340] Pseudoalteromonas haloplanktis TAC125 produces 4-hydroxybenzoic acid that induces pyroptosis in human A459 lung adenocarcinoma cells.Sci Rep. 2018 Jan 19;8(1):1190. doi: 10.1038/s41598-018-19536-2.
• [1341] Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy.BMC Cancer. 2017 Jan 19;17(1):63. doi: 10.1186/s12885-016-3031-5.
• [1342] Patch-based generative adversarial neural network models for head and neck MR-only planning.Med Phys. 2020 Feb;47(2):626-642. doi: 10.1002/mp.13927. Epub 2019 Dec 25.
• [1343] Overexpression of SCUBE2 Inhibits Proliferation, Migration, and Invasion in Glioma Cells.Oncol Res. 2017 Mar 13;25(3):437-444. doi: 10.3727/096504016X14747335734344. Epub 2016 Sep 30.
• [1344] Relationship between SDC1 and cadherin signalling activation in cancer.Pathol Res Pract. 2020 Jan;216(1):152756. doi: 10.1016/j.prp.2019.152756. Epub 2019 Nov 18.
• [1345] Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via (v)(3)/pp60src/pp125FAK pathway.Oncogene. 2017 May 4;36(18):2609-2618. doi: 10.1038/onc.2016.420. Epub 2016 Nov 7.
• [1346] Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma.Ann Surg Oncol. 2017 Nov;24(12):3624-3630. doi: 10.1245/s10434-017-6074-1. Epub 2017 Sep 7.
• [1347] Foliate Lymphoid Aggregates as Novel Forms of Serous Lymphocyte Entry Sites of Peritoneal B Cells and High-Grade B Cell Lymphomas.J Immunol. 2020 Jan 1;204(1):23-36. doi: 10.4049/jimmunol.1900851. Epub 2019 Nov 25.
• [1348] Relationship Between -2028 C/T SELP Gene Polymorphism, Concentration of Plasma P-Selectin and Risk of Malnutrition in Head and Neck Cancer Patients.Pathol Oncol Res. 2019 Apr;25(2):741-749. doi: 10.1007/s12253-018-00578-w. Epub 2019 Jan 8.
• [1349] Overexpression of semaphorin 3A in patients with urothelial cancer.Urol Oncol. 2018 Apr;36(4):161.e1-161.e6. doi: 10.1016/j.urolonc.2017.12.007. Epub 2017 Dec 27.
• [1350] Protein biomarker identification in the CSF of patients with CNS lymphoma.J Clin Oncol. 2008 Jan 1;26(1):96-105. doi: 10.1200/JCO.2007.12.1053. Epub 2007 Dec 3.
• [1351] Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.Vaccine. 2008 Aug 19;26 Suppl 10:K29-41. doi: 10.1016/j.vaccine.2008.06.019.
• [1352] Therapeutic Potential of Pigment Epithelium-derived Factor in Cancer.Curr Pharm Des. 2019;25(3):313-324. doi: 10.2174/1381612825666190319112106.
• [1353] Angioedema due to acquired C1-inhibitor deficiency: spectrum and treatment with C1-inhibitor concentrate.Orphanet J Rare Dis. 2019 Mar 13;14(1):65. doi: 10.1186/s13023-019-1043-3.
• [1354] Histone-lysine N-methyltransferase SETD7 is a potential serum biomarker for colorectal cancer patients.EBioMedicine. 2018 Nov;37:134-143. doi: 10.1016/j.ebiom.2018.10.036. Epub 2018 Oct 22.
• [1355] Novel DDX41 variants in Thai patients with myeloid neoplasms.Int J Hematol. 2020 Feb;111(2):241-246. doi: 10.1007/s12185-019-02770-3. Epub 2019 Nov 11.
• [1356] Association between SFRP promoter hypermethylation and different types of cancer: A systematic review and meta-analysis.Oncol Lett. 2019 Oct;18(4):3481-3492. doi: 10.3892/ol.2019.10709. Epub 2019 Aug 2.
• [1357] Human SP-D Acts as an Innate Immune Surveillance Molecule Against Androgen-Responsive and Androgen-Resistant Prostate Cancer Cells.Front Oncol. 2019 Jul 11;9:565. doi: 10.3389/fonc.2019.00565. eCollection 2019.
• [1358] The influence of coping strategies on subsequent well-being in older patients with cancer: A comparison with 2 control groups.Psychooncology. 2018 Mar;27(3):864-870. doi: 10.1002/pon.4587. Epub 2017 Dec 7.
• [1359] Heterogeneous impact of smoking on major salivary gland cancer according to histopathological subtype: A case-control study.Cancer. 2018 Jan 1;124(1):118-124. doi: 10.1002/cncr.30957. Epub 2017 Sep 7.
• [1360] Lentivirus-mediated siRNA interference targeting SGO-1 inhibits human NSCLC cell growth.Tumour Biol. 2012 Apr;33(2):515-21. doi: 10.1007/s13277-011-0284-0. Epub 2011 Dec 8.
• [1361] Measuring Burnout in Pediatric Oncology Staff: Should We Be Using the Maslach Burnout Inventory?.J Pediatr Oncol Nurs. 2020 Jan/Feb;37(1):55-64. doi: 10.1177/1043454219873638. Epub 2019 Sep 17.
• [1362] Comparison of analgesia, adverse effects, and quality of life in cancer patients during treatment of procedural pain with intravenous morphine, fentanyl nasal spray, and fentanyl buccal tablets.Cancer Manag Res. 2019 Feb 18;11:1587-1600. doi: 10.2147/CMAR.S179012. eCollection 2019.
• [1363] Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy. Nat Med. 2019 Apr;25(4):656-666.
• [1364] High salt induces P-glycoprotein mediated treatment resistance in breast cancer cells through store operated calcium influx.Oncotarget. 2018 May 18;9(38):25193-25205. doi: 10.18632/oncotarget.25391. eCollection 2018 May 18.
• [1365] A Small-Molecule SIRT2 Inhibitor That Promotes K-Ras4a Lysine Fatty-Acylation.ChemMedChem. 2019 Apr 3;14(7):744-748. doi: 10.1002/cmdc.201800715. Epub 2019 Feb 25.
• [1366] Cyclic Tripeptide-based Potent and Selective Human SIRT5 Inhibitors.Med Chem. 2020;16(3):358-367. doi: 10.2174/1573406415666190603101937.
• [1367] Role of Sodium Taurocholate Cotransporting Polypeptide as a New Reporter and Drug-Screening Platform: Implications for Preventing Hepatitis B Virus Infections.Mol Imaging Biol. 2020 Apr;22(2):313-323. doi: 10.1007/s11307-019-01373-y.
• [1368] NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways.J Cell Physiol. 2019 Feb;234(2):1630-1642. doi: 10.1002/jcp.27033. Epub 2018 Aug 29.
• [1369] SLC14A1: a novel target for human urothelial cancer.Clin Transl Oncol. 2017 Dec;19(12):1438-1446. doi: 10.1007/s12094-017-1693-3. Epub 2017 Jun 6.
• [1370] The NSD family of protein methyltransferases in human cancer.Epigenomics. 2015 Aug;7(5):863-74. doi: 10.2217/epi.15.32. Epub 2015 May 5.
• [1371] Expression of the Vesicular Monoamine Transporter Gene Solute Carrier Family 18 Member 1 (SLC18A1) in Lung Cancer.Cancer Genomics Proteomics. 2018 Sep-Oct;15(5):387-393. doi: 10.21873/cgp.20097.
• [1372] DNA methylation and expression of the folate transporter genes in colorectal cancer.Tumour Biol. 2015 Jul;36(7):5581-90. doi: 10.1007/s13277-015-3228-2. Epub 2015 Feb 21.
• [1373] Down-regulation of thiamine transporter THTR2 gene expression in breast cancer and its association with resistance to apoptosis.Mol Cancer Res. 2003 Jul;1(9):665-73.
• [1374] SLC1A3 contributes to L-asparaginase resistance in solid tumors.EMBO J. 2019 Oct 4;38(21):e102147. doi: 10.15252/embj.2019102147. Epub 2019 Sep 16.
• [1375] DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.Gastric Cancer. 2020 Mar;23(2):212-227. doi: 10.1007/s10120-019-01002-1. Epub 2019 Aug 28.
• [1376] The ovarian germinal reserve and apoptosis-related proteins in the infant and adolescent human ovary.J Ovarian Res. 2019 Mar 11;12(1):22. doi: 10.1186/s13048-019-0496-2.
• [1377] Hormetic dose response to (L)-ascorbic acid as an anti-cancer drug in colorectal cancer cell lines according to SVCT-2 expression.Sci Rep. 2018 Jul 27;8(1):11372. doi: 10.1038/s41598-018-29386-7.
• [1378] Over-expression of adenine nucleotide translocase 1 (ANT1) induces apoptosis and tumor regression in vivo.BMC Cancer. 2008 Jun 4;8:160. doi: 10.1186/1471-2407-8-160.
• [1379] The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense.Oncogene. 2015 Apr 2;34(14):1799-810. doi: 10.1038/onc.2014.119. Epub 2014 May 26.
• [1380] Novel insights into breast cancer genetic variance through RNA sequencing.Sci Rep. 2013;3:2256. doi: 10.1038/srep02256.
• [1381] Necrosis induction in glioblastoma cells reveals a new "bioswitch" function for the MT1-MMP/G6PT signaling axis in proMMP-2 activation versus cell death decision.Neoplasia. 2007 Apr;9(4):332-40. doi: 10.1593/neo.07142.
• [1382] Effects of Sodium and Amino Acid Substrate Availability upon the Expression and Stability of the SNAT2 (SLC38A2) Amino Acid Transporter.Front Pharmacol. 2018 Feb 7;9:63. doi: 10.3389/fphar.2018.00063. eCollection 2018.
• [1383] Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer.Cancer Commun (Lond). 2018 Apr 25;38(1):12. doi: 10.1186/s40880-018-0288-x.
• [1384] Zinc Transporters and the Progression of Breast Cancers.Biol Pharm Bull. 2018;41(10):1517-1522. doi: 10.1248/bpb.b18-00086.
• [1385] Structural differences between the ectodomains of murine and human CD98hc. Proteins. 2019 Aug;87(8):693-698.
• [1386] The Discovery and Preclinical Development of ASG-5ME, an Antibody-Drug Conjugate Targeting SLC44A4-Positive Epithelial Tumors Including Pancreatic and Prostate Cancer.Mol Cancer Ther. 2016 Nov;15(11):2679-2687. doi: 10.1158/1535-7163.MCT-16-0225. Epub 2016 Aug 22.
• [1387] Signaling Crosstalk of TGF-/ALK5 and PAR2/PAR1: A Complex Regulatory Network Controlling Fibrosis and Cancer.Int J Mol Sci. 2018 May 24;19(6):1568. doi: 10.3390/ijms19061568.
• [1388] Sodium-glucose transporter as a novel therapeutic target in disease.Eur J Pharmacol. 2018 Mar 5;822:25-31. doi: 10.1016/j.ejphar.2018.01.003. Epub 2018 Jan 9.
• [1389] Targeting Novel Sodium Iodide Symporter Interactors ADP-Ribosylation Factor 4 and Valosin-Containing Protein Enhances Radioiodine Uptake.Cancer Res. 2020 Jan 1;80(1):102-115. doi: 10.1158/0008-5472.CAN-19-1957. Epub 2019 Oct 31.
• [1390] Amino acid transporter SLC6A14 depends on heat shock protein HSP90 in trafficking to the cell surface.Biochim Biophys Acta Mol Cell Res. 2019 Oct;1866(10):1544-1555. doi: 10.1016/j.bbamcr.2019.07.009. Epub 2019 Jul 18.
• [1391] Susceptibility and severity of cancer-related fatigue in colorectal cancer patients is associated with SLC6A4 gene single nucleotide polymorphism rs25531 A>G genotype.Eur J Oncol Nurs. 2018 Apr;33:97-101. doi: 10.1016/j.ejon.2018.02.003. Epub 2018 Mar 1.
• [1392] Xenopus slc7a5 is essential for notochord function and eye development.Mech Dev. 2019 Feb;155:48-59. doi: 10.1016/j.mod.2019.01.001. Epub 2019 Jan 6.
• [1393] The Regulation of NRF2 by Nutrient-Responsive Signaling and Its Role in Anabolic Cancer Metabolism.Antioxid Redox Signal. 2018 Dec 10;29(17):1774-1791. doi: 10.1089/ars.2017.7356. Epub 2017 Oct 16.
• [1394] Integrative Data Mining, Scaffold Analysis, and Sequential Binary Classification Models for Exploring Ligand Profiles of Hepatic Organic Anion Transporting Polypeptides.J Chem Inf Model. 2019 May 28;59(5):1811-1825. doi: 10.1021/acs.jcim.8b00466. Epub 2018 Nov 8.
• [1395] Ste20-like kinase SLK, at the crossroads: a matter of life and death.Cell Adh Migr. 2013 Jan-Feb;7(1):1-10. doi: 10.4161/cam.22495. Epub 2012 Nov 15.
• [1396] Mediator kinase CDK8/CDK19 drives YAP1-dependent BMP4-induced EMT in cancer.Oncogene. 2018 Aug;37(35):4792-4808. doi: 10.1038/s41388-018-0316-y. Epub 2018 May 21.
• [1397] SMAD7 is a novel independent predictor of survival in patients with cutaneous melanoma.Transl Res. 2019 Feb;204:72-81. doi: 10.1016/j.trsl.2018.09.002. Epub 2018 Sep 27.
• [1398] Elucidation of epigenetic inactivation of SMAD8 in cancer using targeted expressed gene display. Cancer Res. 2004 Mar 1;64(5):1639-46.
• [1399] A BAFfling liver aspirate: Metastatic high grade SMARCA4 deficient undifferentiated gastroesophageal junction carcinoma masquerading as a hematolymphoid malignancy.Diagn Cytopathol. 2019 Jul;47(7):725-732. doi: 10.1002/dc.24174. Epub 2019 Mar 21.
• [1400] 8-bromo-7-methoxychrysin suppress stemness of SMMC-7721 cells induced by co-culture of liver cancer stem-like cells with hepatic stellate cells.BMC Cancer. 2019 Mar 12;19(1):224. doi: 10.1186/s12885-019-5419-5.
• [1401] Overexpression of SET and MYND domain-containing protein 2 (SMYD2) is associated with poor prognosis in pediatric B lineage acute lymphoblastic leukemia.Leuk Lymphoma. 2020 Feb;61(2):437-444. doi: 10.1080/10428194.2019.1675875. Epub 2019 Oct 15.
• [1402] Suppression, disaggregation, and modulation of -Synuclein fibrillation pathway by green tea polyphenol EGCG.Protein Sci. 2019 Feb;28(2):382-402. doi: 10.1002/pro.3549. Epub 2018 Dec 20.
• [1403] SOCS1: Regulator of T Cells in Autoimmunity and Cancer.Curr Top Microbiol Immunol. 2017;410:159-189. doi: 10.1007/82_2017_63.
• [1404] Imaging Features of Succinate Dehydrogenase-deficient Pheochromocytoma-Paraganglioma Syndromes.Radiographics. 2019 Sep-Oct;39(5):1393-1410. doi: 10.1148/rg.2019180151.
• [1405] SOX5 predicts poor prognosis in lung adenocarcinoma and promotes tumor metastasis through epithelial-mesenchymal transition.Oncotarget. 2017 Nov 6;9(13):10891-10904. doi: 10.18632/oncotarget.22443. eCollection 2018 Feb 16.
• [1406] Phenethyl Isothiocyanate Exposure Promotes Oxidative Stress and Suppresses Sp1 Transcription Factor in Cancer Stem Cells.Int J Mol Sci. 2019 Feb 27;20(5):1027. doi: 10.3390/ijms20051027.
• [1407] Expression of CD43 in chronic lymphoproliferative leukemias.Cytometry B Clin Cytom. 2018 Jan;94(1):136-142. doi: 10.1002/cyto.b.21509. Epub 2017 Jan 25.
• [1408] SPOCK1 promotes the invasion and metastasis of gastric cancer through Slug-induced epithelial-mesenchymal transition.J Cell Mol Med. 2018 Feb;22(2):797-807. doi: 10.1111/jcmm.13357. Epub 2017 Sep 22.
• [1409] Sprouty1 induces a senescence-associated secretory phenotype by regulating NFB activity: implications for tumorigenesis.Cell Death Differ. 2014 Feb;21(2):333-43. doi: 10.1038/cdd.2013.161. Epub 2013 Nov 22.
• [1410] The shape of human squalene epoxidase expands the arsenal against cancer.Nat Commun. 2019 Feb 21;10(1):888. doi: 10.1038/s41467-019-08866-y.
• [1411] SULT2B1b sulfotransferase: induction by vitamin D receptor and reduced expression in prostate cancer.Mol Endocrinol. 2013 Jun;27(6):925-39. doi: 10.1210/me.2012-1369. Epub 2013 Apr 11.
• [1412] Differential expression of steroid 5alpha-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer.Endocr Relat Cancer. 2010 Aug 16;17(3):757-70. doi: 10.1677/ERC-10-0022. Print 2010 Sep.
• [1413] Serine arginine protein kinase 1 (SRPK1): a moonlighting protein with theranostic ability in cancer prevention.Mol Biol Rep. 2019 Feb;46(1):1487-1497. doi: 10.1007/s11033-018-4545-5. Epub 2018 Dec 8.
• [1414] mRNA expression of somatostatin receptor subtypes SSTR-2, SSTR-3, and SSTR-5 and its significance in pancreatic cancer.World J Surg Oncol. 2015 Feb 13;13:46. doi: 10.1186/s12957-015-0467-z.
• [1415] Somatostatin receptor expression in parathyroid neoplasms.Endocr Connect. 2019 Aug;8(8):1213-1223. doi: 10.1530/EC-19-0260.
• [1416] SSX2IP: an emerging role in cancer.Biochem Biophys Res Commun. 2007 Nov 23;363(3):462-5. doi: 10.1016/j.bbrc.2007.09.052. Epub 2007 Sep 24.
• [1417] Overexpression of matriptase in tumor stroma is a poor prognostic indicator of extrahepatic bile duct cancer.Pathol Int. 2019 Feb;69(2):86-93. doi: 10.1111/pin.12769. Epub 2019 Feb 6.
• [1418] Crystal structure of the FAS1 domain of the hyaluronic acid receptor stabilin-2.Acta Crystallogr D Struct Biol. 2018 Jul 1;74(Pt 7):695-701. doi: 10.1107/S2059798318007271. Epub 2018 Jun 27.
• [1419] Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods.Genome Biol. 2019 Oct 21;20(1):213. doi: 10.1186/s13059-019-1842-9.
• [1420] Non-hematopoietic STAT6 induces epithelial tight junction dysfunction and promotes intestinal inflammation and tumorigenesis.Mucosal Immunol. 2019 Nov;12(6):1304-1315. doi: 10.1038/s41385-019-0204-y. Epub 2019 Sep 18.
• [1421] Upregulation of STC2 in colorectal cancer and its clinicopathological significance.Onco Targets Ther. 2019 Feb 15;12:1249-1258. doi: 10.2147/OTT.S191609. eCollection 2019.
• [1422] Specific regulation of HSPs in human tumor cell lines by PSK.In Vivo. 1997 May-Jun;11(3):261-4.
• [1423] Serine/threonine kinase 17A is a novel candidate for therapeutic targeting in glioblastoma.PLoS One. 2013 Nov 28;8(11):e81803. doi: 10.1371/journal.pone.0081803. eCollection 2013.
• [1424] Knockdown of human serine/threonine kinase 33 suppresses human small cell lung carcinoma by blocking RPS6/BAD signaling transduction.Neoplasma. 2017;64(6):869-879. doi: 10.4149/neo_2017_608.
• [1425] Hedgehog signaling pathway and gastrointestinal stem cell signaling network (review).Int J Mol Med. 2006 Dec;18(6):1019-23.
• [1426] STK39, overexpressed in osteosarcoma, regulates osteosarcoma cell invasion and proliferation.Oncol Lett. 2017 Oct;14(4):4599-4604. doi: 10.3892/ol.2017.6728. Epub 2017 Aug 7.
• [1427] Stomatin-like protein 2 inhibits cisplatin-induced apoptosis through MEK/ERK signaling and the mitochondrial apoptosis pathway in cervical cancer cells.Cancer Sci. 2018 May;109(5):1357-1368. doi: 10.1111/cas.13563. Epub 2018 Apr 24.
• [1428] Dual Roles of Serine-Threonine Kinase Receptor-Associated Protein (STRAP) in Redox-Sensitive Signaling Pathways Related to Cancer Development.Oxid Med Cell Longev. 2018 Apr 19;2018:5241524. doi: 10.1155/2018/5241524. eCollection 2018.
• [1429] Aberrantly High Expression Of NOK/STYK1 Is Tightly Associated With The Activation Of The AKT/GSK3/N-Cadherin Pathway In Non-Small Cell Lung Cancer.Onco Targets Ther. 2019 Nov 27;12:10299-10309. doi: 10.2147/OTT.S210014. eCollection 2019.
• [1430] Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation.Oncotarget. 2017 Feb 21;8(8):13174-13185. doi: 10.18632/oncotarget.14485.
• [1431] SYK Targeting Represents a Potential Therapeutic Option for Relapsed Resistant Pediatric ETV6-RUNX1 B-Acute Lymphoblastic Leukemia Patients.Int J Mol Sci. 2019 Dec 7;20(24):6175. doi: 10.3390/ijms20246175.
• [1432] TAAR1 levels and sub-cellular distribution are cell line but not breast cancer subtype specific.Histochem Cell Biol. 2019 Aug;152(2):155-166. doi: 10.1007/s00418-019-01791-7. Epub 2019 May 21.
• [1433] Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions.Oncogenesis. 2018 Jan 23;7(1):4. doi: 10.1038/s41389-017-0018-2.
• [1434] Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in breast cancer.Mol Biol Rep. 2019 Feb;46(1):1285-1293. doi: 10.1007/s11033-019-04599-9. Epub 2019 Jan 25.
• [1435] Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis.mSphere. 2019 Mar 27;4(2):e00129-19. doi: 10.1128/mSphere.00129-19.
• [1436] Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas.FEBS Lett. 1999 Nov 26;462(1-2):129-34. doi: 10.1016/s0014-5793(99)01493-3.
• [1437] Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell-Like Phenotype.Mol Cancer Ther. 2019 Nov;18(11):2097-2110. doi: 10.1158/1535-7163.MCT-18-1011. Epub 2019 Aug 8.
• [1438] TBK1 Is a Synthetic Lethal Target in Cancer with VHL Loss.Cancer Discov. 2020 Mar;10(3):460-475. doi: 10.1158/2159-8290.CD-19-0837. Epub 2019 Dec 6.
• [1439] Expression and prognosis analyses of forkhead box A (FOXA) family in human lung cancer.Gene. 2019 Feb 15;685:202-210. doi: 10.1016/j.gene.2018.11.022. Epub 2018 Nov 9.
• [1440] Overexpression of TBL1XR1 confers tumorigenic capability and promotes recurrence of osteosarcoma.Eur J Pharmacol. 2019 Feb 5;844:259-267. doi: 10.1016/j.ejphar.2018.12.013. Epub 2018 Dec 7.
• [1441] TBX21 predicts prognosis of patients and drives cancer stem cell maintenance via the TBX21-IL-4 pathway in lung adenocarcinoma.Stem Cell Res Ther. 2018 Apr 3;9(1):89. doi: 10.1186/s13287-018-0820-6.
• [1442] Activation of thromboxane A2 receptor (TP) increases the expression of monocyte chemoattractant protein -1 (MCP-1)/chemokine (C-C motif) ligand 2 (CCL2) and recruits macrophages to promote invasion of lung cancer cells.PLoS One. 2013;8(1):e54073. doi: 10.1371/journal.pone.0054073. Epub 2013 Jan 17.
• [1443] Label-free and amplified electrogenerated chemiluminescence biosensing for the detection of thymine DNA glycosylase activity using DNA-functionalized gold nanoparticles triggered hybridization chain reaction.Anal Chim Acta. 2019 Jul 11;1061:101-109. doi: 10.1016/j.aca.2019.01.053. Epub 2019 Feb 5.
• [1444] CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.J Pathol. 2018 Jul;245(3):297-310. doi: 10.1002/path.5083. Epub 2018 May 9.
• [1445] A highly efficient modality to block the degradation of tryptophan for cancer immunotherapy: locked nucleic acid-modified antisense oligonucleotides to inhibit human indoleamine 2,3-dioxygenase 1/tryptophan 2,3-dioxygenase expression.Cancer Immunol Immunother. 2020 Jan;69(1):57-67. doi: 10.1007/s00262-019-02438-1. Epub 2019 Dec 4.
• [1446] Identification of novel inhibitors for the tyrosyl-DNA-phosphodiesterase 1 (Tdp1) mutant SCAN1 using virtual screening.Bioorg Med Chem. 2020 Jan 1;28(1):115234. doi: 10.1016/j.bmc.2019.115234. Epub 2019 Nov 30.
• [1447] Novel Deazaflavin Analogues Potently Inhibited Tyrosyl DNA Phosphodiesterase 2 (TDP2) and Strongly Sensitized Cancer Cells toward Treatment with Topoisomerase II (TOP2) Poison Etoposide.J Med Chem. 2019 May 9;62(9):4669-4682. doi: 10.1021/acs.jmedchem.9b00274. Epub 2019 Apr 30.
• [1448] PI3K signaling in cancer: beyond AKT.Curr Opin Cell Biol. 2017 Apr;45:62-71. doi: 10.1016/j.ceb.2017.02.007. Epub 2017 Mar 24.
• [1449] Angiopoietin-1 and Angiopoietin-2 Inhibitors: Clinical Development.Curr Oncol Rep. 2019 Feb 26;21(3):22. doi: 10.1007/s11912-019-0771-9.
• [1450] Zebrafish pten genes have overlapping and non-redundant functions in tumorigenesis and embryonic development.Oncogene. 2008 Feb 14;27(8):1079-86. doi: 10.1038/sj.onc.1210730. Epub 2007 Aug 20.
• [1451] Tankyrase as a Novel Molecular Target in Cancer and Fibrotic Diseases.Curr Drug Targets. 2017;18(10):1214-1224. doi: 10.2174/1389450117666160715152503.
• [1452] TRF2 positively regulates SULF2 expression increasing VEGF-A release and activity in tumor microenvironment.Nucleic Acids Res. 2019 Apr 23;47(7):3365-3382. doi: 10.1093/nar/gkz041.
• [1453] Regulation of human chorionic gonadotropin beta subunit expression in ovarian cancer.BMC Cancer. 2019 Jul 30;19(1):746. doi: 10.1186/s12885-019-5960-2.
• [1454] TFF3 and TFF1 expression levels are elevated in colorectal cancer and promote the malignant behavior of colon cancer by activating the EMT process.Int J Oncol. 2019 Oct;55(4):789-804. doi: 10.3892/ijo.2019.4854. Epub 2019 Aug 5.
• [1455] Validation of SE-EPI-based T2 mapping for characterization of prostate cancer: a new method compared with the traditional CPMG method.Abdom Radiol (NY). 2019 Oct;44(10):3432-3440. doi: 10.1007/s00261-019-02105-0.
• [1456] An IgG1 Version of the Anti-transferrin Receptor 1 Antibody ch128.1 Shows Significant Antitumor Activity Against Different Xenograft Models of Multiple Myeloma: A Brief Communication.J Immunother. 2020 Feb/Mar;43(2):48-52. doi: 10.1097/CJI.0000000000000304.
• [1457] Low Transforming Growth Factor-3 Expression Predicts Tumor Malignancy in Meningiomas.World Neurosurg. 2019 May;125:e353-e360. doi: 10.1016/j.wneu.2019.01.077. Epub 2019 Jan 28.
• [1458] Differential Induction of Immunogenic Cell Death and Interferon Expression in Cancer Cells by Structured ssRNAs.Mol Ther. 2017 Jun 7;25(6):1295-1305. doi: 10.1016/j.ymthe.2017.03.014. Epub 2017 Mar 31.
• [1459] Transglutaminase 2 takes center stage as a cancer cell survival factor and therapy target.Mol Carcinog. 2019 Jun;58(6):837-853. doi: 10.1002/mc.22986. Epub 2019 Mar 28.
• [1460] Thyroid hormone receptors/THR genes in human cancer.Cancer Lett. 2003 Mar 31;192(2):121-32. doi: 10.1016/s0304-3835(02)00614-6.
• [1461] Reduced expression of THR in papillary thyroid carcinomas: relationship with BRAF mutation, aggressiveness and miR expression.J Endocrinol Invest. 2015 Dec;38(12):1283-9. doi: 10.1007/s40618-015-0309-4. Epub 2015 May 24.
• [1462] The prognostic value of Tiam1 correlates with its roles in epithelial-mesenchymal transition progression and angiogenesis in lung adenocarcinoma.Cancer Manag Res. 2019 Feb 21;11:1741-1752. doi: 10.2147/CMAR.S195093. eCollection 2019.
• [1463] SnapShot: Angiopoietins and Their Functions.Cell. 2017 Oct 19;171(3):724-724.e1. doi: 10.1016/j.cell.2017.10.009.
• [1464] TCDD-Inducible Poly-ADP-Ribose Polymerase (TIPARP), A Novel Therapeutic Target Of Breast Cancer.Cancer Manag Res. 2019 Oct 18;11:8991-9004. doi: 10.2147/CMAR.S219289. eCollection 2019.
• [1465] The human transketolase-like proteins TKTL1 and TKTL2 are bona fide transketolases.BMC Struct Biol. 2019 Jan 15;19(1):2. doi: 10.1186/s12900-018-0099-y.
• [1466] Both Talin-1 and Talin-2 correlate with malignancy potential of the human hepatocellular carcinoma MHCC-97 L cell.BMC Cancer. 2016 Jan 28;16:45. doi: 10.1186/s12885-016-2076-9.
• [1467] Evaluation of toll-like receptors as prognostic biomarkers in gastric cancer: high tissue TLR5 predicts a better outcome.Sci Rep. 2019 Aug 29;9(1):12553. doi: 10.1038/s41598-019-49111-2.
• [1468] Further exploration of the structure-activity relationship of imidazoquinolines; identification of potent C7-substituted imidazoquinolines.Bioorg Med Chem Lett. 2020 Jan 15;30(2):126788. doi: 10.1016/j.bmcl.2019.126788. Epub 2019 Nov 9.
• [1469] Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer.J Biol Chem. 2010 Sep 24;285(39):30233-46. doi: 10.1074/jbc.M110.122226. Epub 2010 Mar 30.
• [1470] Bicycloheptylamine-Doxorubicin Conjugate: Synthesis and Anticancer Activities in 2 Receptor-Expressing Cell Lines.Med Chem. 2020;16(2):192-201. doi: 10.2174/1573406415666190301145203.
• [1471] Combination Targeting of the Bromodomain and Acetyltransferase Active Site of p300/CBP.Biochemistry. 2019 Apr 23;58(16):2133-2143. doi: 10.1021/acs.biochem.9b00160. Epub 2019 Apr 11.
• [1472] The Transcription Factor ERG Regulates Super-Enhancers Associated With an Endothelial-Specific Gene Expression Program.Circ Res. 2019 Apr 26;124(9):1337-1349. doi: 10.1161/CIRCRESAHA.118.313788.
• [1473] Emerging role of zinc finger protein A20 as a suppressor of hepatocellular carcinoma.J Cell Physiol. 2019 Dec;234(12):21479-21484. doi: 10.1002/jcp.28877. Epub 2019 May 27.
• [1474] Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging.JCI Insight. 2019 Jun 11;5(14):e124716. doi: 10.1172/jci.insight.124716.
• [1475] The RANK-RANKL axis: an opportunity for drug repurposing in cancer?.Clin Transl Oncol. 2019 Aug;21(8):977-991. doi: 10.1007/s12094-018-02023-5. Epub 2019 Jan 17.
• [1476] Harnessing the versatile role of OPG in bone oncology: counterbalancing RANKL and TRAIL signaling and beyond.Clin Exp Metastasis. 2020 Feb;37(1):13-30. doi: 10.1007/s10585-019-09997-8. Epub 2019 Oct 1.
• [1477] A single molecule assay for ultrasensitive detection of Fn14 in human serum.Anal Biochem. 2019 Dec 15;587:113467. doi: 10.1016/j.ab.2019.113467. Epub 2019 Sep 30.
• [1478] Silencing of the cytokine receptor TNFRSF13B: A new therapeutic target for triple-negative breast cancer.Cytokine. 2020 Jan;125:154790. doi: 10.1016/j.cyto.2019.154790. Epub 2019 Aug 7.
• [1479] Up-regulation of tumor necrosis factor- pathway survival genes and of the receptor TNFR2 in gastric cancer.World J Gastrointest Oncol. 2019 Apr 15;11(4):281-294. doi: 10.4251/wjgo.v11.i4.281.
• [1480] A TRAMP-derived orthotopic prostate syngeneic (TOPS) cancer model for investigating anti-tumor treatments.Prostate. 2018 May;78(6):457-468. doi: 10.1002/pros.23490. Epub 2018 Feb 16.
• [1481] An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors.Clin Cancer Res. 2019 Nov 15;25(22):6709-6720. doi: 10.1158/1078-0432.CCR-19-0526. Epub 2019 Oct 1.
• [1482] An Update on Anti-CD137 Antibodies in Immunotherapies for Cancer.Int J Mol Sci. 2019 Apr 12;20(8):1822. doi: 10.3390/ijms20081822.
• [1483] Inhibition of NK Reactivity Against Solid Tumors by Platelet-Derived RANKL.Cancers (Basel). 2019 Feb 26;11(3):277. doi: 10.3390/cancers11030277.
• [1484] APRIL and BAFF: novel biomarkers for central nervous system lymphoma.J Hematol Oncol. 2019 Oct 15;12(1):102. doi: 10.1186/s13045-019-0796-4.
• [1485] Regulatory effect of Act1 on the BAFF pathway in B-cell malignancy.Oncol Lett. 2019 Apr;17(4):3727-3734. doi: 10.3892/ol.2019.10047. Epub 2019 Feb 18.
• [1486] LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases.Cancer Res. 2017 Apr 15;77(8):1880-1891. doi: 10.1158/0008-5472.CAN-16-1655. Epub 2017 Mar 1.
• [1487] OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer.Onco Targets Ther. 2019 Sep 6;12:7347-7353. doi: 10.2147/OTT.S214211. eCollection 2019.
• [1488] The non-receptor tyrosine kinase ACK: regulatory mechanisms, signalling pathways and opportunities for attACKing cancer.Biochem Soc Trans. 2019 Dec 20;47(6):1715-1731. doi: 10.1042/BST20190176.
• [1489] Tankyrase (PARP5) Inhibition Induces Bone Loss through Accumulation of Its Substrate SH3BP2.Cells. 2019 Feb 22;8(2):195. doi: 10.3390/cells8020195.
• [1490] Involvement of tenascin-C in proliferation and migration of laryngeal carcinoma cells.Virchows Arch. 1999 Nov;435(5):496-500. doi: 10.1007/s004280050433.
• [1491] Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?.Cancer Chemother Pharmacol. 2017 Jul;80(1):15-25. doi: 10.1007/s00280-017-3309-6. Epub 2017 Apr 25.
• [1492] Correction: Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junction.Oncotarget. 2019 Oct 1;10(55):5726. doi: 10.18632/oncotarget.27229. eCollection 2019 Oct 1.
• [1493] Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors.Comput Struct Biotechnol J. 2019 Feb 10;17:291-310. doi: 10.1016/j.csbj.2019.02.006. eCollection 2019.
• [1494] Topoisomerase II and its role in different biological contexts.Arch Biochem Biophys. 2017 Nov 1;633:78-84. doi: 10.1016/j.abb.2017.06.021. Epub 2017 Jun 29.
• [1495] Radiosensitivity of Cancer Cells Is Regulated by Translationally Controlled Tumor Protein.Cancers (Basel). 2019 Mar 19;11(3):386. doi: 10.3390/cancers11030386.
• [1496] TPX2 silencing mediated by joint action of microvesicles and ultrasonic radiation inhibits the migration and invasion of SKOV3 cells.Mol Med Rep. 2018 Jun;17(6):7627-7635. doi: 10.3892/mmr.2018.8810. Epub 2018 Mar 28.
• [1497] Shuffling the deck with CTLA-4 therapy: Deep sequencing of rearranged TCRB genes demonstrates T cell repertoire remodeling in cancer patients.Oncoimmunology. 2018 Mar 13;7(4):e956016. doi: 10.4161/21624011.2014.956016. eCollection 2018.
• [1498] Single Antibody Detection of T-Cell Receptor Clonality by Flow Cytometry Rapidly Identifies Mature T-Cell Neoplasms and Monotypic Small CD8-Positive Subsets of Uncertain Significance.Cytometry B Clin Cytom. 2020 Jan;98(1):99-107. doi: 10.1002/cyto.b.21782. Epub 2019 Apr 11.
• [1499] Nuclear receptor ligands induce TREM-1 expression on dendritic cells: analysis of their role in tumors.Oncoimmunology. 2018 Dec 13;8(3):1554967. doi: 10.1080/2162402X.2018.1554967. eCollection 2019.
• [1500] An ATM/TRIM37/NEMO Axis Counteracts Genotoxicity by Activating Nuclear-to-Cytoplasmic NF-B Signaling.Cancer Res. 2018 Nov 15;78(22):6399-6412. doi: 10.1158/0008-5472.CAN-18-2063. Epub 2018 Sep 25.
• [1501] TRIM59 deficiency curtails breast cancer metastasis through SQSTM1-selective autophagic degradation of PDCD10.Autophagy. 2019 Apr;15(4):747-749. doi: 10.1080/15548627.2019.1569951. Epub 2019 Jan 22.
• [1502] Identification of a CIP4 PKA phosphorylation site involved in the regulation of cancer cell invasiveness and metastasis.Cancer Lett. 2019 Oct 1;461:65-77. doi: 10.1016/j.canlet.2019.07.006. Epub 2019 Jul 15.
• [1503] The NCX1/TRPC6 Complex Mediates TGF-Driven Migration and Invasion of Human Hepatocellular Carcinoma Cells.Cancer Res. 2018 May 15;78(10):2564-2576. doi: 10.1158/0008-5472.CAN-17-2061. Epub 2018 Mar 2.
• [1504] Characterization and Optimization of the Novel Transient Receptor Potential Melastatin 2 Antagonist tatM2NX.Mol Pharmacol. 2020 Feb;97(2):102-111. doi: 10.1124/mol.119.117549. Epub 2019 Nov 26.
• [1505] Ion channels expression and function are strongly modified in solid tumors and vascular malformations.J Transl Med. 2016 Oct 4;14(1):285. doi: 10.1186/s12967-016-1038-y.
• [1506] TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling.J Exp Clin Cancer Res. 2019 Feb 28;38(1):106. doi: 10.1186/s13046-019-1061-y.
• [1507] TRPM8 and prostate: a cold case?.Pflugers Arch. 2018 Oct;470(10):1419-1429. doi: 10.1007/s00424-018-2169-1. Epub 2018 Jun 20.
• [1508] Role of transient receptor potential vanilloid subtype 4 in the regulation of azoymethane/dextran sulphate sodium-induced colitis-associated cancer in mice.Eur J Pharmacol. 2020 Jan 15;867:172853. doi: 10.1016/j.ejphar.2019.172853. Epub 2019 Dec 10.
• [1509] Cancer risk and clinicopathological characteristics of thyroid nodules harboring thyroid-stimulating hormone receptor gene mutations.Diagn Cytopathol. 2018 May;46(5):369-377. doi: 10.1002/dc.23915. Epub 2018 Mar 8.
• [1510] The IL-1/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancer.J Immunother Cancer. 2019 Feb 13;7(1):45. doi: 10.1186/s40425-019-0521-4.
• [1511] Early 7-day supplemental parenteral nutrition improves body composition and muscle strength in hypophagic cancer patients at nutritional risk.Support Care Cancer. 2019 Jul;27(7):2497-2506. doi: 10.1007/s00520-018-4527-0. Epub 2018 Nov 1.
• [1512] SK channel activation potentiates auranofin-induced cell death in glio- and neuroblastoma cells.Biochem Pharmacol. 2020 Jan;171:113714. doi: 10.1016/j.bcp.2019.113714. Epub 2019 Nov 15.
• [1513] Downregulation of TXNIP leads to high proliferative activity and estrogen-dependent cell growth in breast cancer.Biochem Biophys Res Commun. 2018 Apr 6;498(3):566-572. doi: 10.1016/j.bbrc.2018.03.020. Epub 2018 Mar 13.
• [1514] Design, synthesis, and biological evaluation of novel derivatives of dithiodiglycolic acid prepared via oxidative coupling of thiols.J Enzyme Inhib Med Chem. 2019 Dec;34(1):665-671. doi: 10.1080/14756366.2019.1575372.
• [1515] TYK2: An Upstream Kinase of STATs in Cancer.Cancers (Basel). 2019 Nov 5;11(11):1728. doi: 10.3390/cancers11111728.
• [1516] Identification of 1,2,4-triazoles as new thymidine phosphorylase inhibitors: Future anti-tumor drugs.Bioorg Chem. 2019 Apr;85:209-220. doi: 10.1016/j.bioorg.2019.01.005. Epub 2019 Jan 4.
• [1517] Antimelanoma activity of perphenazine and prochlorperazine in human COLO829 and C32 cell lines.Naunyn Schmiedebergs Arch Pharmacol. 2019 Oct;392(10):1257-1264. doi: 10.1007/s00210-019-01668-5. Epub 2019 Jun 6.
• [1518] TYRO3: A potential therapeutic target in cancer.Exp Biol Med (Maywood). 2019 Feb;244(2):83-99. doi: 10.1177/1535370219828195. Epub 2019 Feb 2.
• [1519] Proteotranscriptomic Measurements of E6-Associated Protein (E6AP) Targets in DU145 Prostate Cancer Cells.Mol Cell Proteomics. 2018 Jun;17(6):1170-1183. doi: 10.1074/mcp.RA117.000504. Epub 2018 Feb 20.
• [1520] A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination.Genes Dev. 2016 Dec 1;30(23):2581-2595. doi: 10.1101/gad.289439.116. Epub 2016 Dec 9.
• [1521] The proteasome deubiquitinase inhibitor bAP15 downregulates TGF-/Smad signaling and induces apoptosis via UCHL5 inhibition in ovarian cancer. Oncotarget. 2019 Oct 15;10(57):5932-5948.
• [1522] Melatonin/PGC1A/UCP1 promotes tumor slimming and represses tumor progression by initiating autophagy and lipid browning.J Pineal Res. 2019 Nov;67(4):e12607. doi: 10.1111/jpi.12607. Epub 2019 Sep 13.
• [1523] UCP2 promotes proliferation and chemoresistance through regulating the NF-B/-catenin axis and mitochondrial ROS in gallbladder cancer.Biochem Pharmacol. 2020 Feb;172:113745. doi: 10.1016/j.bcp.2019.113745. Epub 2019 Dec 5.
• [1524] UDP-glucose ceramide glucosyltransferase activates AKT, promoted proliferation, and doxorubicin resistance in breast cancer cells.Cell Mol Life Sci. 2018 Sep;75(18):3393-3410. doi: 10.1007/s00018-018-2799-7. Epub 2018 Mar 17.
• [1525] The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms.Physiol Rev. 2019 Apr 1;99(2):1153-1222. doi: 10.1152/physrev.00058.2017.
• [1526] Loss of BRUCE reduces cellular energy level and induces autophagy by driving activation of the AMPK-ULK1 autophagic initiating axis.PLoS One. 2019 May 15;14(5):e0216553. doi: 10.1371/journal.pone.0216553. eCollection 2019.
• [1527] Expression of thymidylate synthase, orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in thymic epithelial tumors.Lung Cancer. 2011 Dec;74(3):419-25. doi: 10.1016/j.lungcan.2011.04.001. Epub 2011 May 7.
• [1528] Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor Prognosis in Patients With Epithelial Ovarian Cancer.Cancer Genomics Proteomics. 2019 Nov-Dec;16(6):553-562. doi: 10.21873/cgp.20157.
• [1529] Amplification of USP13 drives non-small cell lung cancer progression mediated by AKT/MAPK signaling.Biomed Pharmacother. 2019 Jun;114:108831. doi: 10.1016/j.biopha.2019.108831. Epub 2019 Apr 12.
• [1530] Emerging role of ubiquitin-specific protease 14 in oncogenesis and development of tumor: Therapeutic implication.Life Sci. 2019 Dec 15;239:116875. doi: 10.1016/j.lfs.2019.116875. Epub 2019 Oct 30.
• [1531] Reduced USP33 expression in gastric cancer decreases inhibitory effects of Slit2-Robo1 signalling on cell migration and EMT.Cell Prolif. 2019 May;52(3):e12606. doi: 10.1111/cpr.12606. Epub 2019 Mar 21.
• [1532] Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients.Oncol Res Treat. 2018;41(9):545-549. doi: 10.1159/000490120. Epub 2018 Aug 20.
• [1533] A functional variant at the miRNA binding site in E2F1 gene is associated with risk and tumor HPV16 status of oropharynx squamous cell carcinoma.Mol Carcinog. 2017 Mar;56(3):1100-1106. doi: 10.1002/mc.22576. Epub 2016 Oct 20.
• [1534] Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival.Oncotarget. 2019 Feb 26;10(17):1606-1624. doi: 10.18632/oncotarget.26600. eCollection 2019 Feb 26.
• [1535] Resveratrol plays dual roles in pancreatic cancer cells. J Cancer Res Clin Oncol. 2014 May;140(5):749-55. doi: 10.1007/s00432-014-1624-4. Epub 2014 Mar 7.
• [1536] Expression of V-set immunoregulatory receptor in malignant mesothelioma.Mod Pathol. 2020 Feb;33(2):263-270. doi: 10.1038/s41379-019-0328-3. Epub 2019 Jul 30.
• [1537] von Willebrand Factor Antigen Predicts Outcomes in Patients after Liver Resection of Hepatocellular Carcinoma.Gut Liver. 2020 Mar 15;14(2):218-224. doi: 10.5009/gnl17115.
• [1538] Wiskott-Aldrich syndrome gene mutations modulate cancer susceptibility in the p53() murine model.Oncoimmunology. 2018 Jul 30;7(9):e1468954. doi: 10.1080/2162402X.2018.1468954. eCollection 2018.
• [1539] Genome-Wide CRISPR-Cas9 Screen Reveals Selective Vulnerability of ATRX-Mutant Cancers to WEE1 Inhibition.Cancer Res. 2020 Feb 1;80(3):510-523. doi: 10.1158/0008-5472.CAN-18-3374. Epub 2019 Sep 24.
• [1540] Cancer cell niche factors secreted from cancer-associated fibroblast by loss of H3K27me3.Gut. 2020 Feb;69(2):243-251. doi: 10.1136/gutjnl-2018-317645. Epub 2019 May 13.
• [1541] Wnt7a, frequently silenced by CpG methylation, inhibits tumor growth and metastasis via suppressing epithelial-mesenchymal transition in gastric cancer.J Cell Biochem. 2019 Oct;120(10):18142-18151. doi: 10.1002/jcb.29118. Epub 2019 May 29.
• [1542] Functional conservation of RecQ helicase BLM between humans and Drosophila melanogaster.Sci Rep. 2019 Nov 26;9(1):17527. doi: 10.1038/s41598-019-54101-5.
• [1543] Expression of domains for protein-protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability.Clin Exp Pharmacol Physiol. 2014 Oct;41(10):817-24. doi: 10.1111/1440-1681.12282.
• [1544] The Complex Role of the ZNF224 Transcription Factor in Cancer.Adv Protein Chem Struct Biol. 2017;107:191-222. doi: 10.1016/bs.apcsb.2016.11.003. Epub 2016 Dec 5.
• [1545] Deubiquitinases in cancer: new functions and therapeutic options.Oncogene. 2012 May 10;31(19):2373-88. doi: 10.1038/onc.2011.443. Epub 2011 Sep 26.
• [1546] Analysis of somatic microsatellite indels identifies driver events in human tumors.Nat Biotechnol. 2017 Oct;35(10):951-959. doi: 10.1038/nbt.3966. Epub 2017 Sep 11.
• [1547] Mir-513a-3p contributes to the controlling of cellular migration processes in the A549 lung tumor cells by modulating integrin -8 expression.Mol Cell Biochem. 2018 Jul;444(1-2):43-52. doi: 10.1007/s11010-017-3229-0. Epub 2017 Dec 4.
• [1548] Aberrant expression of CD13 and stem cell markers in CD133-induced liver cancer in mice.J BUON. 2019 Jul-Aug;24(4):1408-1413.
• [1549] SAP domain-dependent Mkl1 signaling stimulates proliferation and cell migration by induction of a distinct gene set indicative of poor prognosis in breast cancer patients.Mol Cancer. 2014 Feb 5;13:22. doi: 10.1186/1476-4598-13-22.
• [1550] ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis.Mol Cancer. 2019 Nov 7;18(1):156. doi: 10.1186/s12943-019-1077-0.
• [1551] ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation.Int J Oncol. 2020 Jan;56(1):219-231. doi: 10.3892/ijo.2019.4913. Epub 2019 Nov 14.
• [1552] Racial disparities in molecular subtypes of endometrial cancer.Gynecol Oncol. 2018 Apr;149(1):106-116. doi: 10.1016/j.ygyno.2017.12.009.
• [1553] High calpain-1 expression predicts a poor clinical outcome and contributes to tumor progression in pancreatic cancer patients.Clin Transl Oncol. 2019 Jul;21(7):924-932. doi: 10.1007/s12094-018-02006-6. Epub 2018 Dec 18.
• [1554] Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis.Int J Mol Med. 2019 Jan;43(1):404-412. doi: 10.3892/ijmm.2018.3985. Epub 2018 Nov 7.
• [1555] Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin.Cell Rep. 2017 Jan 24;18(4):977-990. doi: 10.1016/j.celrep.2017.01.003.
• [1556] Carboxypeptidase E-N promotes migration, invasiveness, and epithelial-mesenchymal transition of human osteosarcoma cells via the Wnt--catenin pathway.Biochem Cell Biol. 2019 Aug;97(4):446-453. doi: 10.1139/bcb-2018-0236. Epub 2018 Dec 3.
• [1557] Tumor-Derived Thymic Stromal Lymphopoietin Expands Bone Marrow B-cell Precursors in Circulation to Support Metastasis.Cancer Res. 2019 Nov 15;79(22):5826-5838. doi: 10.1158/0008-5472.CAN-19-1058. Epub 2019 Oct 1.
• [1558] A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.BMC Cancer. 2017 Jan 4;17(1):9. doi: 10.1186/s12885-016-3030-6.
• [1559] Neutrophil extracellular traps sequester circulating tumor cells via 1-integrin mediated interactions.Int J Cancer. 2017 May 15;140(10):2321-2330. doi: 10.1002/ijc.30635. Epub 2017 Mar 2.
• [1560] Dynamin 2 along with microRNA-199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis.Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):5331-6. doi: 10.1073/pnas.1317242111. Epub 2014 Mar 24.
• [1561] microRNA-126 Is a Tumor Suppressor of Granulosa Cell Tumor Mediated by Its Host Gene EGFL7.Front Oncol. 2019 Jun 11;9:486. doi: 10.3389/fonc.2019.00486. eCollection 2019.
• [1562] Construction of an M1GS Ribozyme for Targeted and Rapid mRNA Cleavage; Application on the Ets-2 Oncogene.Med Chem. 2018;14(6):604-616. doi: 10.2174/1573406414666180112115201.
• [1563] EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancer.Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6075-6080. doi: 10.1073/pnas.1814634116. Epub 2019 Mar 13.
• [1564] Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis.Gynecol Oncol. 2019 May;153(2):405-415. doi: 10.1016/j.ygyno.2019.01.020. Epub 2019 Feb 20.
• [1565] Distinct mechanisms are utilized to induce stress sensor gadd45b by different stress stimuli.J Cell Biochem. 2009 Dec 1;108(5):1220-31. doi: 10.1002/jcb.22354.
• [1566] Cellular mechanisms of growth inhibition of human endometrial cancer cell line by an antagonist of growth hormone-releasing hormone.Int J Oncol. 2008 Mar;32(3):593-601.
• [1567] The G-protein-coupled bile acid receptor Gpbar1 (TGR5) protects against renal inflammation and renal cancer cell proliferation and migration through antagonizing NF-B and STAT3 signaling pathways.Oncotarget. 2017 Apr 29;8(33):54378-54387. doi: 10.18632/oncotarget.17533. eCollection 2017 Aug 15.
• [1568] Overexpression of GRK3, Promoting Tumor Proliferation, Is Predictive of Poor Prognosis in Colon Cancer.Dis Markers. 2017;2017:1202710. doi: 10.1155/2017/1202710. Epub 2017 Dec 28.
• [1569] The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance.Oncogene. 2020 Feb;39(7):1600-1616. doi: 10.1038/s41388-019-1087-9. Epub 2019 Nov 7.
• [1570] NFKB1 -94insertion/deletion ATTG polymorphism and cancer risk: Evidence from 50 case-control studies.Oncotarget. 2017 Feb 7;8(6):9806-9822. doi: 10.18632/oncotarget.14190.
• [1571] KiSS1 in regulation of metastasis and response to antitumor drugs.Drug Resist Updat. 2019 Jan;42:12-21. doi: 10.1016/j.drup.2019.02.001. Epub 2019 Feb 11.
• [1572] Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients.PLoS One. 2019 Feb 27;14(2):e0212968. doi: 10.1371/journal.pone.0212968. eCollection 2019.
• [1573] Divergent Anticancer Activity of Free and Formulated Camel Milk -Lactalbumin.Cancer Invest. 2017 Oct 21;35(9):610-623. doi: 10.1080/07357907.2017.1373783. Epub 2017 Sep 26.
• [1574] Leukotriene B(4) receptor 2 gene polymorphism (rs1950504, Asp196Gly) leads to enhanced cell motility under low-dose ligand stimulation.Exp Mol Med. 2017 Nov 24;49(11):e402. doi: 10.1038/emm.2017.192.
• [1575] Anticancer effects of lactoferrin: underlying mechanisms and future trends in cancer therapy.Nutr Rev. 2014 Dec;72(12):763-73. doi: 10.1111/nure.12155. Epub 2014 Nov 18.
• [1576] MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells.Oncogene. 2017 Aug 31;36(35):5023-5034. doi: 10.1038/onc.2017.131. Epub 2017 May 1.
• [1577] MCAM abnormal expression and clinical outcome associations are highly cancer dependent as revealed through pan-cancer analysis.Brief Bioinform. 2020 Mar 23;21(2):709-718. doi: 10.1093/bib/bbz019.
• [1578] Immunotherapy Resistance by Inflammation-Induced Dedifferentiation.Cancer Discov. 2018 Aug;8(8):935-943. doi: 10.1158/2159-8290.CD-17-1178. Epub 2018 Jun 13.
• [1579] Membranous type matrix metalloproteinase 16 induces human prostate cancer metastasis.Oncol Lett. 2017 Sep;14(3):3096-3102. doi: 10.3892/ol.2017.6536. Epub 2017 Jul 7.
• [1580] Clinical characteristics of acinic cell carcinoma and secretory carcinoma of the parotid gland.Eur Arch Otorhinolaryngol. 2019 Dec;276(12):3461-3466. doi: 10.1007/s00405-019-05604-4. Epub 2019 Aug 22.
• [1581] Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer.Clin Cancer Res. 2018 Apr 15;24(8):1987-2001. doi: 10.1158/1078-0432.CCR-17-2776. Epub 2018 Jan 31.
• [1582] Expression of Pentose Phosphate Pathway-Related Proteins in Breast Cancer.Dis Markers. 2018 Feb 25;2018:9369358. doi: 10.1155/2018/9369358. eCollection 2018.
• [1583] Phospholipase D1 Acts through Akt/TopBP1 and RB1 to Regulate the E2F1-Dependent Apoptotic Program in Cancer Cells.Cancer Res. 2017 Jan 1;77(1):142-152. doi: 10.1158/0008-5472.CAN-15-3032. Epub 2016 Oct 28.
• [1584] Lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancer.Lipids Health Dis. 2017 Aug 22;16(1):159. doi: 10.1186/s12944-017-0547-x.
• [1585] Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.Eur J Cancer Prev. 2000 Jun;9(3):139-50.
• [1586] Lingering single-strand breaks trigger Rad51-independent homology-directed repair of collapsed replication forks in the polynucleotide kinase/phosphatase mutant of fission yeast.PLoS Genet. 2017 Sep 18;13(9):e1007013. doi: 10.1371/journal.pgen.1007013. eCollection 2017 Sep.
• [1587] The therapeutic potential of CRTH2/DP2 beyond allergy and asthma.Prostaglandins Other Lipid Mediat. 2017 Nov;133:42-48. doi: 10.1016/j.prostaglandins.2017.08.006. Epub 2017 Aug 14.
• [1588] Association between age factors and strategies for promoting participation in gastric and colorectal cancer screenings.BMC Cancer. 2018 Mar 27;18(1):345. doi: 10.1186/s12885-018-4244-6.
• [1589] RGMs: Structural Insights, Molecular Regulation, and Downstream Signaling.Trends Cell Biol. 2017 May;27(5):365-378. doi: 10.1016/j.tcb.2016.11.009. Epub 2016 Dec 19.
• [1590] Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue.Am J Pathol. 2002 Jun;160(6):2169-80. doi: 10.1016/S0002-9440(10)61165-0.
• [1591] Transcriptional inhibition by CDK7/9 inhibitor SNS-032 abrogates oncogene addiction and reduces liver metastasis in uveal melanoma.Mol Cancer. 2019 Sep 16;18(1):140. doi: 10.1186/s12943-019-1070-7.
• [1592] First evidence of SGPL1 expression in the cell membrane silencing the extracellular S1P siren in mammary epithelial cells.PLoS One. 2018 May 2;13(5):e0196854. doi: 10.1371/journal.pone.0196854. eCollection 2018.
• [1593] Allosteric and ATP-Competitive Inhibitors of mTOR Effectively Suppress Tumor Progression-Associated Epithelial-Mesenchymal Transition in the Kidneys of Tsc2(+/-) Mice.Neoplasia. 2019 Aug;21(8):731-739. doi: 10.1016/j.neo.2019.05.003. Epub 2019 Jun 14.
• [1594] Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer.Cell Death Dis. 2018 Feb 15;9(3):265. doi: 10.1038/s41419-018-0330-6.
• [1595] Discovery of gastric cancer specific biomarkers by the application of serum proteomics.Proteomics. 2017 Mar;17(6). doi: 10.1002/pmic.201600332.
• [1596] Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer.Prostate. 2017 Nov;77(15):1499-1511. doi: 10.1002/pros.23426. Epub 2017 Sep 14.
• [1597] Mapping the STK4/Hippo signaling network in prostate cancer cell.PLoS One. 2017 Sep 7;12(9):e0184590. doi: 10.1371/journal.pone.0184590. eCollection 2017.
• [1598] STXBP4 Drives Tumor Growth and Is Associated with Poor Prognosis through PDGF Receptor Signaling in Lung Squamous Cell Carcinoma.Clin Cancer Res. 2017 Jul 1;23(13):3442-3452. doi: 10.1158/1078-0432.CCR-16-1815. Epub 2017 Jan 13.
• [1599] Quantitative assessment of the association between TAP2 rs241447 polymorphism and cancer risk.J Cell Biochem. 2019 Sep;120(9):15867-15873. doi: 10.1002/jcb.28857. Epub 2019 May 9.
• [1600] Knockdown of Tripartite Motif Containing 28 suppresses the migration, invasion and epithelial-mesenchymal transition in ovarian carcinoma cells through down-regulation of Wnt/-catenin signaling pathway.Neoplasma. 2017;64(6):893-900. doi: 10.4149/neo_2017_611.
• [1601] The ULK3 Kinase Is Critical for Convergent Control of Cancer-Associated Fibroblast Activation by CSL and GLI.Cell Rep. 2017 Sep 5;20(10):2468-2479. doi: 10.1016/j.celrep.2017.08.048.
• [1602] A highly conserved redox-active Mx(2)CWx(6)R motif regulates Zap70 stability and activity.Oncotarget. 2017 May 9;8(19):30805-30816. doi: 10.18632/oncotarget.16486.
• [1603] Cyanidin-3-o-Glucoside Pharmacologically Inhibits Tumorigenesis via Estrogen Receptor in Melanoma Mice.Front Oncol. 2019 Oct 22;9:1110. doi: 10.3389/fonc.2019.01110. eCollection 2019.
• [1604] SIRT6 is upregulated and associated with cancer aggressiveness in papillary thyroid cancer via BRAF/ERK/Mcl? pathway.Int J Oncol. 2017 May;50(5):1683-1692. doi: 10.3892/ijo.2017.3951. Epub 2017 Apr 5.
• [1605] Adenine Nucleotide Translocase 2 as an Enzyme Related to [(18)F] FDG Accumulation in Various Cancers.Mol Imaging Biol. 2019 Aug;21(4):722-730. doi: 10.1007/s11307-018-1268-x.
• [1606] c-Abl inhibits breast cancer tumorigenesis through reactivation of p53-mediated p21 expression.Oncotarget. 2016 Nov 8;7(45):72777-72794. doi: 10.18632/oncotarget.11909.
• [1607] Decreased zinc and downregulation of ZIP3 zinc uptake transporter in the development of pancreatic adenocarcinoma.Cancer Biol Ther. 2011 Aug 15;12(4):297-303. doi: 10.4161/cbt.12.4.16356. Epub 2011 Aug 15.
• [1608] ZIP4 Promotes Pancreatic Cancer Progression by Repressing ZO-1 and Claudin-1 through a ZEB1-Dependent Transcriptional Mechanism.Clin Cancer Res. 2018 Jul 1;24(13):3186-3196. doi: 10.1158/1078-0432.CCR-18-0263. Epub 2018 Apr 3.
• [1609] SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity.Cancer Immunol Res. 2017 Aug;5(8):618-629. doi: 10.1158/2326-6066.CIR-17-0051. Epub 2017 Jun 19.
• [1610] Age and Cancer Treatment Are Related to Receiving Treatment Summaries and Survivorship Care Plans in Female Young Adult Cancer Survivors.J Adolesc Young Adult Oncol. 2017 Dec;6(4):573-578. doi: 10.1089/jayao.2017.0003. Epub 2017 Jul 21.
• [1611] Sodium-coupled monocarboxylate transporter is a target of epigenetic repression in cervical cancer.Int J Oncol. 2019 May;54(5):1613-1624. doi: 10.3892/ijo.2019.4749. Epub 2019 Mar 14.
• [1612] Dual-action CXCR4-targeting liposomes in leukemia: function blocking and drug delivery.Blood Adv. 2019 Jul 23;3(14):2069-2081. doi: 10.1182/bloodadvances.2019000098.
• [1613] The anti-inflammatory NHE-06 restores antitumor immunity by targeting NF-B/IL-6/STAT3 signaling in hepatocellular carcinoma.Biomed Pharmacother. 2018 Jun;102:420-427. doi: 10.1016/j.biopha.2018.03.099. Epub 2018 Mar 22.
• [1614] Microarray Gene-expression Profiling Analysis Comparing PCNSL and Non-CNS Diffuse Large B-Cell Lymphoma.Anticancer Res. 2015 Jun;35(6):3333-40.
• [1615] Gefitinib inhibits sodium phosphate co-transporter III isoform 1 in a model of human malignant glioma.Anticancer Res. 2014 Nov;34(11):6527-35.
• [1616] Different involvement of promoter methylation in the expression of organic cation/carnitine transporter 2 (OCTN2) in cancer cell lines. PLoS One. 2013 Oct 16;8(10):e76474.
• [1617] Polyamine synthesis as a target of MYC oncogenes.J Biol Chem. 2018 Nov 30;293(48):18757-18769. doi: 10.1074/jbc.TM118.003336. Epub 2018 Nov 7.
• [1618] Suppression of peritoneal tumorigenesis by placenta-derived mesenchymal stem cells expressing endostatin on colorectal cancer.Int J Med Sci. 2014 Jun 13;11(9):870-9. doi: 10.7150/ijms.8758. eCollection 2014.
• [1619] NEAT1 acts as an inducer of cancer stem cell-like phenotypes in NSCLC by inhibiting EGCG-upregulated CTR1.J Cell Physiol. 2018 Jun;233(6):4852-4863. doi: 10.1002/jcp.26288. Epub 2018 Jan 4.
• [1620] Copper transporter 2 regulates intracellular copper and sensitivity to cisplatin. Metallomics. 2014 Mar;6(3):654-61. doi: 10.1039/c3mt00331k. Epub 2014 Feb 13.
• [1621] L-type amino acid transporters LAT1 and LAT4 in cancer: uptake of 3-O-methyl-6-18F-fluoro-L-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo.J Nucl Med. 2007 Dec;48(12):2063-71. doi: 10.2967/jnumed.107.043620.
• [1622] ATP-binding cassette transporter-2 (ABCA2) as a therapeutic target.Biochem Pharmacol. 2018 May;151:188-200. doi: 10.1016/j.bcp.2017.11.018. Epub 2017 Dec 6.
• [1623] The influence of nano-TiO2 on metabolic activity, cytotoxicity and ABCB5 mRNA expression in WM-266-4 human metastatic melanoma cell line.J BUON. 2019 Jan-Feb;24(1):338-346.
• [1624] Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications.Front Pharmacol. 2019 Mar 5;10:208. doi: 10.3389/fphar.2019.00208. eCollection 2019.
• [1625] ATP binding cassette subfamily B member 9 (ABCB9) is a prognostic indicator of overall survival in ovarian cancer.Medicine (Baltimore). 2019 May;98(19):e15698. doi: 10.1097/MD.0000000000015698.
• [1626] Loss of miR-516a-3p mediates upregulation of ABCC5 in prostate cancer and drives its progression.Onco Targets Ther. 2018 Jul 6;11:3853-3867. doi: 10.2147/OTT.S167463. eCollection 2018.
• [1627] Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer.Blood. 2000 May 15;95(10):3176-82.
• [1628] ER-Mediated Alteration of circATP2B1 and miR-204-3p Signaling Promotes Invasion of Clear Cell Renal Cell Carcinoma.Cancer Res. 2018 May 15;78(10):2550-2563. doi: 10.1158/0008-5472.CAN-17-1575. Epub 2018 Feb 28.
• [1629] ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis.Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):6836-6841. doi: 10.1073/pnas.1817473116. Epub 2019 Mar 19.
• [1630] Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2.Genome Res. 2010 Sep;20(9):1180-90. doi: 10.1101/gr.104976.110. Epub 2010 Aug 5.
• [1631] A role for two-pore potassium (K2P) channels in endometrial epithelial function.J Cell Mol Med. 2013 Jan;17(1):134-46. doi: 10.1111/j.1582-4934.2012.01656.x. Epub 2013 Jan 11.
• [1632] The human solute carrier family 11 member 1 protein (SLC11A1): linking infections, autoimmunity and cancer?.FEMS Immunol Med Microbiol. 2007 Apr;49(3):324-9. doi: 10.1111/j.1574-695X.2007.00231.x.
• [1633] DNA cytometric features in biopsies of TaT1 urothelial cell cancer predict recurrence and stage progression more accurately than stage, grade, or treatment modality.Urology. 2003 Jun;61(6):1266-72. doi: 10.1016/s0090-4295(03)00024-4.
• [1634] Adipocytes promote malignant growth of breast tumours with monocarboxylate transporter 2 expression via beta-hydroxybutyrate. Nat Commun. 2017 Mar 10;8:14706.
• [1635] Rebmab200, a humanized monoclonal antibody targeting the sodium phosphate transporter NaPi2b displays strong immune mediated cytotoxicity against cancer: a novel reagent for targeted antibody therapy of cancer.PLoS One. 2013 Jul 31;8(7):e70332. doi: 10.1371/journal.pone.0070332. Print 2013.
• [1636] High expression of SLC17A9 correlates with poor prognosis in colorectal cancer.Hum Pathol. 2019 Feb;84:62-70. doi: 10.1016/j.humpath.2018.09.002. Epub 2018 Sep 18.
• [1637] The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancer.EBioMedicine. 2019 Aug;46:94-104. doi: 10.1016/j.ebiom.2019.07.036. Epub 2019 Jul 31.
• [1638] NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.Cancer Epidemiol. 2012 Oct;36(5):e294-9. doi: 10.1016/j.canep.2012.05.012. Epub 2012 Jun 23.
• [1639] Na(+)/Ca(2+) exchangers: Unexploited opportunities for cancer therapy?.Biochem Pharmacol. 2019 May;163:357-361. doi: 10.1016/j.bcp.2019.02.032. Epub 2019 Feb 28.
• [1640] Loss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation.EBioMedicine. 2019 Feb;40:184-197. doi: 10.1016/j.ebiom.2019.01.036. Epub 2019 Jan 25.
• [1641] SLC25A22 promotes proliferation and metastasis by activating MAPK/ERK pathway in gallbladder cancer.Cancer Cell Int. 2019 Feb 14;19:33. doi: 10.1186/s12935-019-0746-9. eCollection 2019.
• [1642] Elevated mitochondrial SLC25A29 in cancer modulates metabolic status by increasing mitochondria-derived nitric oxide.Oncogene. 2018 May;37(19):2545-2558. doi: 10.1038/s41388-018-0139-x. Epub 2018 Feb 20.
• [1643] Design, Synthesis, and In Vitro Activity of Pyrazine Compounds.Molecules. 2019 Dec 1;24(23):4389. doi: 10.3390/molecules24234389.
• [1644] Epigenetic silencing of the sulfate transporter gene DTDST induces sialyl Lewisx expression and accelerates proliferation of colon cancer cells. Cancer Res. 2010 May 15;70(10):4064-73.
• [1645] Fatty acid transport protein2 reprograms neutrophils in cancer.Nature. 2019 May;569(7754):73-78. doi: 10.1038/s41586-019-1118-2. Epub 2019 Apr 17.
• [1646] Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity.BMC Cancer. 2014 Jun 4;14:401. doi: 10.1186/1471-2407-14-401.
• [1647] H?myo-inositol transporter SLC2A13 as a potential marker for cancer stem cells in an oral squamous cell carcinoma.Curr Cancer Drug Targets. 2011 Oct;11(8):966-75. doi: 10.2174/156800911797264752.
• [1648] Expressions of Carbohydrate Response Element Binding Protein and Glucose Transporters in Liver Cancer and Clinical Significance.Pathol Oncol Res. 2020 Apr;26(2):1331-1340. doi: 10.1007/s12253-019-00708-y. Epub 2019 Aug 12.
• [1649] Hypoxia drives glucose transporter 3 expression through hypoxia-inducible transcription factor (HIF)-mediated induction of the long noncoding RNA NICI.J Biol Chem. 2020 Mar 27;295(13):4065-4078. doi: 10.1074/jbc.RA119.009827. Epub 2019 Nov 5.
• [1650] An essential role for GLUT5-mediated fructose utilization in exacerbating the malignancy of clear cell renal cell carcinoma.Cell Biol Toxicol. 2019 Oct;35(5):471-483. doi: 10.1007/s10565-019-09478-4. Epub 2019 May 17.
• [1651] Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues.J Cell Physiol. 2006 Jun;207(3):614-27. doi: 10.1002/jcp.20606.
• [1652] Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.Front Genet. 2016 Oct 13;7:179. doi: 10.3389/fgene.2016.00179. eCollection 2016.
• [1653] The novel human HUEL (C4orf1) protein shares homology with the DNA-binding domain of the XPA DNA repair protein and displays nuclear translocation in a cell cycle-dependent manner.Int J Biochem Cell Biol. 2002 May;34(5):487-504. doi: 10.1016/s1357-2725(01)00156-x.
• [1654] Immunoglobulin V gene expression in CD5 B-cell malignancies.Ann N Y Acad Sci. 1992 May 4;651:373-83. doi: 10.1111/j.1749-6632.1992.tb24638.x.
• [1655] The Physiopathological Role of the Exchangers Belonging to the SLC37 Family.Front Chem. 2018 Apr 17;6:122. doi: 10.3389/fchem.2018.00122. eCollection 2018.
• [1656] hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer.Mol Cancer. 2005 Sep 9;4:32. doi: 10.1186/1476-4598-4-32.
• [1657] Reassessment of the Transport Mechanism of the Human Zinc Transporter SLC39A2. Biochemistry. 2018 Jul 3;57(26):3976-3986.
• [1658] Role of Equilibrative Nucleobase Transporter 1/SLC43A3 as a Ganciclovir Transporter in the Induction of Cytotoxic Effect of Ganciclovir in a Suicide Gene Therapy with Herpes Simplex Virus Thymidine Kinase.J Pharmacol Exp Ther. 2017 Jan;360(1):59-68. doi: 10.1124/jpet.116.236984. Epub 2016 Nov 2.
• [1659] Anti-tumour effects of small interfering RNA targeting anion exchanger 1 in experimental gastric cancer.Br J Pharmacol. 2012 Jan;165(1):135-47. doi: 10.1111/j.1476-5381.2011.01521.x.
• [1660] Contribution of Na+,HCO3(-)-cotransport to cellular pH control in human breast cancer: a role for the breast cancer susceptibility locus NBCn1 (SLC4A7).Int J Cancer. 2013 Mar 15;132(6):1288-99. doi: 10.1002/ijc.27782. Epub 2012 Sep 7.
• [1661] SLC52A3 expression is activated by NF-B p65/Rel-B and serves as a prognostic biomarker in esophageal cancer.Cell Mol Life Sci. 2018 Jul;75(14):2643-2661. doi: 10.1007/s00018-018-2757-4. Epub 2018 Feb 10.
• [1662] Targeting Taurine Transporter (TauT) for Cancer Immunotherapy of p53 Mutation Mediated Cancers - Molecular Basis and Preclinical Implication.Adv Exp Med Biol. 2019;1155:543-553. doi: 10.1007/978-981-13-8023-5_50.
• [1663] Genetic variation in SLC7A2 interacts with calcium and magnesium intakes in modulating the risk of colorectal polyps.J Nutr Biochem. 2017 Sep;47:35-40. doi: 10.1016/j.jnutbio.2017.04.016. Epub 2017 May 5.
• [1664] p53 Promotes Cancer Cell Adaptation to Glutamine Deprivation by Upregulating Slc7a3 to Increase Arginine Uptake.Cell Rep. 2019 Mar 12;26(11):3051-3060.e4. doi: 10.1016/j.celrep.2019.02.037.
• [1665] Genetic variants in SLC7A7 are associated with risk of glioma in a Chinese population.Exp Biol Med (Maywood). 2013 Sep;238(9):1075-81. doi: 10.1177/1535370213498977. Epub 2013 Aug 23.
• [1666] Polymeric Micellar Formulation Enhances Antimicrobial and Anticancer Properties of Salinomycin.Pharm Res. 2019 Apr 15;36(6):83. doi: 10.1007/s11095-019-2615-6.
• [1667] AKR1C1-3, notably AKR1C3, are distinct biomarkers for liver cancer diagnosis and prognosis: Database mining in malignancies.Oncol Lett. 2019 Nov;18(5):4515-4522. doi: 10.3892/ol.2019.10802. Epub 2019 Sep 4.
• [1668] Evaluation of microsatellite instability in tumor and tumor marginal samples of sporadic colorectal cancer using mononucleotide markers.EXCLI J. 2018 Sep 24;17:945-951. doi: 10.17179/excli2018-1455. eCollection 2018.
• [1669] Diagnostic and Prognostic Significance of Carboxypeptidase A4 (CPA4) in Breast Cancer.Biomolecules. 2019 Mar 14;9(3):103. doi: 10.3390/biom9030103.
• [1670] Intratumoral Sterol-27-Hydroxylase (CYP27A1) Expression in Relation to Cholesterol Synthesis and Vitamin D Signaling and Its Association with Lethal Prostate Cancer.Cancer Epidemiol Biomarkers Prev. 2019 Jun;28(6):1052-1058. doi: 10.1158/1055-9965.EPI-18-1083. Epub 2019 Mar 13.
• [1671] PHD3 Controls Lung Cancer Metastasis and Resistance to EGFR Inhibitors through TGF.Cancer Res. 2018 Apr 1;78(7):1805-1819. doi: 10.1158/0008-5472.CAN-17-1346. Epub 2018 Jan 16.
• [1672] New Approaches to Cancer Therapy: Combining Fatty Acid Amide Hydrolase (FAAH) Inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) Activation.J Med Chem. 2019 Dec 26;62(24):10995-11003. doi: 10.1021/acs.jmedchem.9b00885. Epub 2019 Aug 22.
• [1673] Folylpoly--glutamate synthetase: A key determinant of folate homeostasis and antifolate resistance in cancer.Drug Resist Updat. 2016 Sep;28:43-64. doi: 10.1016/j.drup.2016.06.004. Epub 2016 Jul 4.
• [1674] Phosphatidylinositol 3,4-bisphosphate synthesis and turnover are spatially segregated in the endocytic pathway.J Biol Chem. 2020 Jan 24;295(4):1091-1104. doi: 10.1074/jbc.RA119.011774. Epub 2019 Dec 12.
• [1675] Methionyl-tRNA synthetase overexpression is associated with poor clinical outcomes in non-small cell lung cancer.BMC Cancer. 2017 Jul 5;17(1):467. doi: 10.1186/s12885-017-3452-9.
• [1676] Circular RNA MAT2B Promotes Glycolysis and Malignancy of Hepatocellular Carcinoma Through the miR-338-3p/PKM2 Axis Under Hypoxic Stress.Hepatology. 2019 Oct;70(4):1298-1316. doi: 10.1002/hep.30671. Epub 2019 May 28.
• [1677] OncoScape: Exploring the cancer aberration landscape by genomic data fusion.Sci Rep. 2016 Jun 20;6:28103. doi: 10.1038/srep28103.
• [1678] Associations between arsenic (+3 oxidation state) methyltransferase (AS3MT) and N-6 adenine-specific DNA methyltransferase 1 (N6AMT1) polymorphisms, arsenic metabolism, and cancer risk in a chilean population.Environ Mol Mutagen. 2017 Jul;58(6):411-422. doi: 10.1002/em.22104. Epub 2017 Jun 22.
• [1679] Inhibition of NAT10 Suppresses Melanogenesis and Melanoma Growth by Attenuating Microphthalmia-Associated Transcription Factor (MITF) Expression.Int J Mol Sci. 2017 Sep 7;18(9):1924. doi: 10.3390/ijms18091924.
• [1680] Phosphoglucomutase 1 inhibits hepatocellular carcinoma progression by regulating glucose trafficking.PLoS Biol. 2018 Oct 18;16(10):e2006483. doi: 10.1371/journal.pbio.2006483. eCollection 2018 Oct.
• [1681] Pyridoxine 5'-phosphate oxidase is a novel therapeutic target and regulated by the TGF-beta signalling pathway in epithelial ovarian cancer. Cell Death Dis. 2017 Dec 13;8(12):3214.
• [1682] Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers.Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1175-1184. doi: 10.1158/1055-9965.EPI-15-1245. Epub 2016 May 9.
• [1683] Associations between UGT2B7 polymorphisms and cancer susceptibility: A meta-analysis.Gene. 2019 Jul 20;706:115-123. doi: 10.1016/j.gene.2019.05.025. Epub 2019 May 10.
• [1684] Genetic variation of Aflatoxin B1 aldehyde reductase genes (AFAR) in human tumour cells.Cancer Lett. 2008 Dec 8;272(1):160-6. doi: 10.1016/j.canlet.2008.07.013. Epub 2008 Aug 26.
• [1685] Urothelial cancer gene regulatory networks inferred from large-scale RNAseq, Bead and Oligo gene expression data.BMC Syst Biol. 2015 May 14;9:21. doi: 10.1186/s12918-015-0165-z.
• [1686] Snail mediates repression of the Dlk1-Dio3 locus in lung tumor-infiltrating immune cells.Oncotarget. 2018 Aug 17;9(64):32331-32345. doi: 10.18632/oncotarget.25965. eCollection 2018 Aug 17.
• [1687] Severe congenital neutropenia due to G6PC3 deficiency: early and delayed phenotype in two patients with two novel mutations.Ital J Pediatr. 2014 Nov 14;40:80. doi: 10.1186/s13052-014-0080-8.
• [1688] Osteopontin promotes cancer cell drug resistance, invasion, and lactate production and is associated with poor outcome of patients with advanced non-small-cell lung cancer.Onco Targets Ther. 2018 Sep 19;11:5933-5941. doi: 10.2147/OTT.S164007. eCollection 2018.
• [1689] Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation. Cancer Discov. 2013 Jan;3(1):96-111. doi: 10.1158/2159-8290.CD-12-0031. Epub 2012 Nov 2.
• [1690] An integrated approach identifies new oncotargets in melanoma.Oncotarget. 2017 Dec 15;9(14):11489-11502. doi: 10.18632/oncotarget.23727. eCollection 2018 Feb 20.
• [1691] Do Future Limitation Perspective in Cancer Patients Predict Fear of Cancer Recurrence, Mental Distress, and the Ventromedial Prefrontal Cortex Activity?.Front Psychol. 2018 Mar 28;9:420. doi: 10.3389/fpsyg.2018.00420. eCollection 2018.
• [1692] Dopamine-induced SULT1A3/4 promotes EMT and cancer stemness in hepatocellular carcinoma.Tumour Biol. 2017 Oct;39(10):1010428317719272. doi: 10.1177/1010428317719272.
• [1693] Characterization of UDP-glucuronosyltransferase 2A1 (UGT2A1) variants and their potential role in tobacco carcinogenesis. Pharmacogenet Genomics. 2011 Feb;21(2):55-65. doi: 10.1097/FPC.0b013e328341db05.
• [1694] UGT2B17 Expedites Progression of Castration-Resistant Prostate Cancers by Promoting Ligand-Independent AR Signaling.Cancer Res. 2016 Nov 15;76(22):6701-6711. doi: 10.1158/0008-5472.CAN-16-1518. Epub 2016 Sep 22.
• [1695] Regulation of UDP-Glucuronosyltransferases UGT2B4 and UGT2B7 by MicroRNAs in Liver Cancer Cells.J Pharmacol Exp Ther. 2017 Jun;361(3):386-397. doi: 10.1124/jpet.116.239707. Epub 2017 Apr 7.
• [1696] Overexpressed ACP5 has prognostic value in colorectal cancer and promotes cell proliferation and tumorigenesis via FAK/PI3K/AKT signaling pathway.Am J Cancer Res. 2019 Jan 1;9(1):22-35. eCollection 2019.
• [1697] Association of preoperative biliary drainage technique with postoperative outcomes among patients with resectable hepatobiliary malignancy.HPB (Oxford). 2020 Feb;22(2):249-257. doi: 10.1016/j.hpb.2019.06.011. Epub 2019 Jul 23.
• [1698] Engineering aldo-keto reductase 1B10 to mimic the distinct 1B15 topology and specificity towards inhibitors and substrates, including retinoids and steroids.Chem Biol Interact. 2019 Jul 1;307:186-194. doi: 10.1016/j.cbi.2019.04.030. Epub 2019 Apr 24.
• [1699] Prediction of potential cancer-related molecular targets of North African plants constituents using network pharmacology-based analysis.J Ethnopharmacol. 2019 Jun 28;238:111826. doi: 10.1016/j.jep.2019.111826. Epub 2019 Mar 22.
• [1700] Inhibitors of aldehyde dehydrogenases of the 1A subfamily as putative anticancer agents: Kinetic characterization and effect on human cancer cells.Chem Biol Interact. 2019 Jun 1;306:123-130. doi: 10.1016/j.cbi.2019.04.004. Epub 2019 Apr 5.
• [1701] MUL1 E3 ligase regulates the antitumor effects of metformin in chemoresistant ovarian cancer cells via AKT degradation.Int J Oncol. 2019 May;54(5):1833-1842. doi: 10.3892/ijo.2019.4730. Epub 2019 Feb 27.
• [1702] Selective inhibition of RNA polymerase I transcription as a potential approach to treat African trypanosomiasis.PLoS Negl Trop Dis. 2017 Mar 6;11(3):e0005432. doi: 10.1371/journal.pntd.0005432. eCollection 2017 Mar.
• [1703] P53 ICE CRIM mouse: a tool to generate mutant allelic series in somatic cells and germ lines for cancer studies.FASEB J. 2019 Apr;33(4):5571-5584. doi: 10.1096/fj.201802027R. Epub 2019 Jan 14.
• [1704] Associations of calcium and dairy product intakes with all-cause, all-cancer, colorectal cancer and CHD mortality among older women in the Iowa Women's Health Study.Br J Nutr. 2019 May;121(10):1188-1200. doi: 10.1017/S000711451900045X. Epub 2019 Mar 5.
• [1705] Human 3-hydroxysteroid dehydrogenase type 1 in human breast cancer: clinical significance and prognostic associations.Cancer Med. 2016 Jul;5(7):1405-15. doi: 10.1002/cam4.708. Epub 2016 May 3.
• [1706] Association between NME1 polymorphisms and cancer susceptibility: A meta-analysis based on 1644 cases and 2038 controls.Pathol Res Pract. 2018 Apr;214(4):467-474. doi: 10.1016/j.prp.2018.02.020. Epub 2018 Mar 6.
• [1707] NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer.Mol Cell Proteomics. 2015 Nov;14(11):2988-99. doi: 10.1074/mcp.M115.050385. Epub 2015 Sep 8.
• [1708] Functional characterization of 9 CYP2A13 allelic variants by assessment of nicotine C-oxidation and coumarin 7-hydroxylation.Drug Metab Pharmacokinet. 2018 Feb;33(1):82-89. doi: 10.1016/j.dmpk.2017.11.004. Epub 2017 Nov 22.
• [1709] Retroviral transfer of human cytochrome P450 genes for oxazaphosphorine-based cancer gene therapy. Cancer Res. 1998 Oct 1;58(19):4391-401.
• [1710] Implications of cytochrome P450 genetic polymorphisms on the toxicity of antitumor agents.Ther Drug Monit. 2004 Apr;26(2):236-40. doi: 10.1097/00007691-200404000-00027.
• [1711] Based on an analysis of mode of action, styrene-induced mouse lung tumors are not a human cancer concern.Regul Toxicol Pharmacol. 2018 Jun;95:17-28. doi: 10.1016/j.yrtph.2018.02.010. Epub 2018 Feb 26.
• [1712] Association between Vitamin D Genetic Risk Score and Cancer Risk in a Large Cohort of U.S. Women.Nutrients. 2018 Jan 9;10(1):55. doi: 10.3390/nu10010055.
• [1713] CYP2S1 depletion enhances colorectal cell proliferation is associated with PGE2-mediated activation of -catenin signaling.Exp Cell Res. 2015 Feb 15;331(2):377-86. doi: 10.1016/j.yexcr.2014.12.008. Epub 2014 Dec 31.
• [1714] Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism.Arch Biochem Biophys. 2019 Sep 30;673:108078. doi: 10.1016/j.abb.2019.108078. Epub 2019 Aug 22.
• [1715] MicroRNA-17 induces epithelial-mesenchymal transition consistent with the cancer stem cell phenotype by regulating CYP7B1 expression in colon cancer. Int J Mol Med. 2016 Aug;38(2):499-506.
• [1716] Small molecule inhibition of DDAH1 significantly attenuates triple negative breast cancer cell vasculogenic mimicry in vitro.Biomed Pharmacother. 2019 Mar;111:602-612. doi: 10.1016/j.biopha.2018.12.117. Epub 2019 Jan 3.
• [1717] p53-Inducible DHRS3 is an endoplasmic reticulum protein associated with lipid droplet accumulation.J Biol Chem. 2011 Aug 12;286(32):28343-56. doi: 10.1074/jbc.M111.254227. Epub 2011 Jun 9.
• [1718] Downregulation of DHRS9 is associated with poor prognosis in oral squamous cell carcinoma.Pathology. 2018 Oct;50(6):642-647. doi: 10.1016/j.pathol.2018.06.002. Epub 2018 Aug 24.
• [1719] Evaluation of Bystander Cell Killing Effects in Suicide Gene Therapy of Cancer: Engineered Thymidylate Kinase (TMPK)/AZT Enzyme-Prodrug Axis.Methods Mol Biol. 2015;1317:55-67. doi: 10.1007/978-1-4939-2727-2_4.
• [1720] Inhibition of cancer migration and invasion by knocking down delta-5-desaturase in COX-2 overexpressed cancer cells.Redox Biol. 2017 Apr;11:653-662. doi: 10.1016/j.redox.2017.01.016. Epub 2017 Jan 26.
• [1721] Overexpression of flavin-containing monooxygenase 5 predicts poor prognosis in patients with colorectal cancer.Oncol Lett. 2018 Mar;15(3):3923-3927. doi: 10.3892/ol.2018.7724. Epub 2018 Jan 4.
• [1722] Constitutional trisomy 8p11.21-q11.21 mosaicism: a germline alteration predisposing to myeloid leukaemia.Br J Haematol. 2011 Oct;155(2):209-17. doi: 10.1111/j.1365-2141.2011.08817.x. Epub 2011 Aug 18.
• [1723] High GCLC level in tumor tissues is associated with poor prognosis of hepatocellular carcinoma after curative resection.J Cancer. 2019 Jun 2;10(15):3333-3343. doi: 10.7150/jca.29769. eCollection 2019.
• [1724] Cellular glycosylation senses metabolic changes and modulates cell plasticity during epithelial to mesenchymal transition.Dev Dyn. 2018 Mar;247(3):481-491. doi: 10.1002/dvdy.24553. Epub 2017 Aug 18.
• [1725] Glycine decarboxylase regulates the maintenance and induction of pluripotency via metabolic control.Metab Eng. 2019 May;53:35-47. doi: 10.1016/j.ymben.2019.02.003. Epub 2019 Feb 16.
• [1726] The role of glutaminase in cancer.Histopathology. 2020 Mar;76(4):498-508. doi: 10.1111/his.14014. Epub 2020 Feb 18.
• [1727] Mutation of GDP-mannose-4,6-dehydratase in colorectal cancer metastasis.PLoS One. 2013 Jul 29;8(7):e70298. doi: 10.1371/journal.pone.0070298. Print 2013.
• [1728] Extrahepatic Portal Venous Obstruction With Hepatic Enzyme Elevation Resembling Hepatitis in Patients With Cancer.In Vivo. 2019 Sep-Oct;33(5):1697-1702. doi: 10.21873/invivo.11658.
• [1729] The novel hypoxia-inducible factor-1 inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growth.Cell Death Dis. 2017 Jun 1;8(6):e2843. doi: 10.1038/cddis.2017.235.
• [1730] Loss of PKM2 in Lgr5(+) intestinal stem cells promotes colitis-associated colorectal cancer.Sci Rep. 2019 Apr 17;9(1):6212. doi: 10.1038/s41598-019-42707-8.
• [1731] 15-Keto prostaglandin E(2) induces heme oxygenase-1 expression through activation of Nrf2 in human colon epithelial CCD 841 CoN cells.Arch Biochem Biophys. 2020 Jan 15;679:108162. doi: 10.1016/j.abb.2019.108162. Epub 2019 Dec 24.
• [1732] Potential new biomarkers for endometrial cancer.Cancer Cell Int. 2019 Jan 21;19:19. doi: 10.1186/s12935-019-0731-3. eCollection 2019.
• [1733] Identification of Hydroxysteroid (17) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinomas.Cancer Immunol Immunother. 2011 Jul;60(7):919-29. doi: 10.1007/s00262-011-1001-y. Epub 2011 Mar 16.
• [1734] Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer.Proteomics. 2019 Nov;19(21-22):e1800451. doi: 10.1002/pmic.201800451. Epub 2019 Aug 1.
• [1735] Leucine aminopeptidase 3 promotes migration and invasion of breast cancer cells through upregulation of fascin and matrix metalloproteinases-2/9 expression.J Cell Biochem. 2019 Mar;120(3):3611-3620. doi: 10.1002/jcb.27638. Epub 2018 Nov 11.
• [1736] Diagnostic and prognostic value of the cancer-testis antigen lactate dehydrogenase C4 in breast cancer.Clin Chim Acta. 2020 Apr;503:203-209. doi: 10.1016/j.cca.2019.11.032. Epub 2019 Nov 30.
• [1737] Methionine adenosyltransferases in cancers: Mechanisms of dysregulation and implications for therapy.Exp Biol Med (Maywood). 2018 Jan;243(2):107-117. doi: 10.1177/1535370217740860. Epub 2017 Nov 15.
• [1738] Polymorphism of angiotensin I-converting enzyme gene is related to oral cancer and lymph node metastasis in male betel quid chewers.Oral Oncol. 2012 Dec;48(12):1257-62. doi: 10.1016/j.oraloncology.2012.06.003. Epub 2012 Jul 7.
• [1739] Association of MTRR A66G polymorphism with cancer susceptibility: Evidence from 85 studies.J Cancer. 2017 Jan 15;8(2):266-277. doi: 10.7150/jca.17379. eCollection 2017.
• [1740] Trimodal distribution of arylamine N-acetyltransferase 1 mRNA in breast cancer tumors: association with overall survival and drug resistance.BMC Genomics. 2018 Jul 3;19(1):513. doi: 10.1186/s12864-018-4894-4.
• [1741] S100A4 alters metabolism and promotes invasion of lung cancer cells by up-regulating mitochondrial complex I protein NDUFS2.J Biol Chem. 2019 May 3;294(18):7516-7527. doi: 10.1074/jbc.RA118.004365. Epub 2019 Mar 18.
• [1742] Downregulated SIRT6 and upregulated NMNAT2 are associated with the presence, depth and stage of colorectal cancer.Oncol Lett. 2018 Nov;16(5):5829-5837. doi: 10.3892/ol.2018.9400. Epub 2018 Sep 5.
• [1743] Expression and Clinical Significance of Nicotinamide N-Methyltransferase in Cervical Squamous Cell Carcinoma.Int J Gynecol Pathol. 2020 May;39(3):289-295. doi: 10.1097/PGP.0000000000000605.
• [1744] Quantitative analysis of thymidine kinase 1 and 5'(3')-deoxyribonucleotidase mRNA expression: the role of fluorothymidine uptake.Anticancer Res. 2011 Jun;31(6):2135-9.
• [1745] RASSF1A controls tissue stiffness and cancer stem-like cells in lung adenocarcinoma.EMBO J. 2019 Jul 1;38(13):e100532. doi: 10.15252/embj.2018100532. Epub 2019 May 27.
• [1746] P4HA3 is Epigenetically Activated by Slug in Gastric Cancer and its Deregulation is Associated With Enhanced Metastasis and Poor Survival.Technol Cancer Res Treat. 2018 Jan 1;17:1533033818796485. doi: 10.1177/1533033818796485.
• [1747] Hepatic transcriptome and proteome analyses provide new insights into the regulator mechanism of dietary avicularin in diabetic mice.Food Res Int. 2019 Nov;125:108570. doi: 10.1016/j.foodres.2019.108570. Epub 2019 Jul 19.
• [1748] PCK1 Downregulation Promotes TXNRD1 Expression and Hepatoma Cell Growth via the Nrf2/Keap1 Pathway.Front Oncol. 2018 Dec 17;8:611. doi: 10.3389/fonc.2018.00611. eCollection 2018.
• [1749] Breast cancer cells adapt to metabolic stress by increasing ethanolamine phospholipid synthesis and CTP:ethanolaminephosphate cytidylyltransferase-Pcyt2 activity.Biochem Cell Biol. 2012 Apr;90(2):188-99. doi: 10.1139/o11-081. Epub 2012 Feb 16.
• [1750] Downregulation of the circadian Period family genes is positively correlated with poor head and neck squamous cell carcinoma prognosis.Chronobiol Int. 2019 Dec;36(12):1723-1732. doi: 10.1080/07420528.2019.1648486. Epub 2019 Oct 14.
• [1751] Hypoxia Downregulates LPP3 and Promotes the Spatial Segregation of ATX and LPP1 During Cancer Cell Invasion.Cancers (Basel). 2019 Sep 19;11(9):1403. doi: 10.3390/cancers11091403.
• [1752] Impact of novel oncogenic pathways regulated by antitumor miR-451a in renal cell carcinoma.Cancer Sci. 2018 Apr;109(4):1239-1253. doi: 10.1111/cas.13526. Epub 2018 Mar 9.
• [1753] Expression and Intracellular Localization of Paraoxonase 2 in Different Types of Malignancies.Acta Naturae. 2018 Jul-Sep;10(3):92-99.
• [1754] Paraoxonase 3 promotes cell proliferation and metastasis by PI3K/Akt in oral squamous cell carcinoma.Biomed Pharmacother. 2017 Jan;85:712-717. doi: 10.1016/j.biopha.2016.11.084. Epub 2016 Dec 4.
• [1755] Constituents of Propolis: Chrysin, Caffeic Acid, p-Coumaric Acid, and Ferulic Acid Induce PRODH/POX-Dependent Apoptosis in Human Tongue Squamous Cell Carcinoma Cell (CAL-27).Front Pharmacol. 2018 Apr 6;9:336. doi: 10.3389/fphar.2018.00336. eCollection 2018.
• [1756] Lewis and secretor gene dosages affect CA19-9 and DU-PAN-2 serum levels in normal individuals and colorectal cancer patients.Cancer Res. 1998 Feb 1;58(3):512-8.
• [1757] Rewiring of cisplatin-resistant bladder cancer cells through epigenetic regulation of genes involved in amino acid metabolism.Theranostics. 2018 Aug 10;8(16):4520-4534. doi: 10.7150/thno.25130. eCollection 2018.
• [1758] Reactive oxygen species spermine metabolites generated from amine oxidases and radiation represent a therapeutic gain in cancer treatments.Int J Oncol. 2013 Sep;43(3):813-20. doi: 10.3892/ijo.2013.2013. Epub 2013 Jul 12.
• [1759] Ultrasensitive detection of miRNA with an antimonene-based surface plasmon resonance sensor.Nat Commun. 2019 Jan 3;10(1):28. doi: 10.1038/s41467-018-07947-8.
• [1760] Drug-induced down-regulation of topoisomerase I in human epidermoid cancer cells resistant to saintopin and camptothecins.Cancer Res. 1996 May 15;56(10):2348-54.
• [1761] TGM3 promotes epithelial-mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resection.Dig Liver Dis. 2020 Jun;52(6):668-676. doi: 10.1016/j.dld.2019.10.010. Epub 2019 Dec 9.
• [1762] Thimet Oligopeptidase (EC 3.4.24.15) Key Functions Suggested by Knockout Mice Phenotype Characterization.Biomolecules. 2019 Aug 19;9(8):382. doi: 10.3390/biom9080382.
• [1763] Identification of 4-Aminopyrazolopyrimidine Metabolite That May Contribute to the Hypolipidemic Effects of LY2584702 in Long Evans Diet-Induced Obese Rats.J Pharmacol Exp Ther. 2017 Jul;362(1):108-118. doi: 10.1124/jpet.117.240242. Epub 2017 May 2.
• [1764] Involvement of the uridine cytidine kinase 2 enzyme in cancer cell death: A molecular crosstalk between the enzyme and cellular apoptosis induction.Biomed Pharmacother. 2019 Jan;109:1506-1510. doi: 10.1016/j.biopha.2018.10.200. Epub 2018 Nov 14.
• [1765] Uridine phosphorylase 1 associates to biological and clinical significance in thyroid carcinoma cell lines.J Cell Mol Med. 2019 Nov;23(11):7438-7448. doi: 10.1111/jcmm.14612. Epub 2019 Sep 9.
• [1766] Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.Clin Cancer Res. 2000 Aug;6(8):3166-71.
• [1767] Adenovirus-mediated transduction of Escherichia coli uracil phosphoribosyltransferase gene sensitizes cancer cells to low concentrations of 5-fluorouracil.Cancer Res. 1998 May 1;58(9):1946-51.
• [1768] Expression of Indoleamine 2, 3-dioxygenase 1 (IDO1) and Tryptophanyl-tRNA Synthetase (WARS) in Gastric Cancer Molecular Subtypes.Appl Immunohistochem Mol Morphol. 2020 May/Jun;28(5):360-368. doi: 10.1097/PAI.0000000000000761.
• [1769] Chondroitin synthases I, II, III and chondroitin sulfate glucuronyltransferase expression in colorectal cancer.Mol Med Rep. 2011 Mar-Apr;4(2):363-8. doi: 10.3892/mmr.2011.431. Epub 2011 Jan 25.
• [1770] Factors affecting cytochrome P-450 3A activity in cancer patients.Clin Cancer Res. 2004 Dec 15;10(24):8341-50. doi: 10.1158/1078-0432.CCR-04-1371.
• [1771] The impact of angio-associated migratory cell protein (AAMP) on breast cancer cells in vitro and its clinical significance.Anticancer Res. 2013 Apr;33(4):1499-509.
• [1772] Human ACAP2 is a homolog of C. elegans CNT-1 that promotes apoptosis in cancer cells.Cell Cycle. 2015;14(12):1771-8. doi: 10.1080/15384101.2015.1026518.
• [1773] Exploiting the passenger ACO1-deficiency arising from 9p21 deletions to kill T-cell lymphoblastic neoplasia cells.Carcinogenesis. 2020 Aug 12;41(8):1113-1122. doi: 10.1093/carcin/bgz185.
• [1774] Upregulated expression of ACTL8 contributes to invasion and metastasis and indicates poor prognosis in colorectal cancer.Onco Targets Ther. 2019 Mar 1;12:1749-1763. doi: 10.2147/OTT.S185858. eCollection 2019.
• [1775] Benproperine, an ARPC2 inhibitor, suppresses cancer cell migration and tumor metastasis.Biochem Pharmacol. 2019 May;163:46-59. doi: 10.1016/j.bcp.2019.01.017. Epub 2019 Jan 30.
• [1776] A disintegrin and metalloprotease 23 hypermethylation predicts decreased disease-free survival in low-risk breast cancer patients.Cancer Sci. 2019 May;110(5):1695-1704. doi: 10.1111/cas.13985. Epub 2019 Mar 18.
• [1777] Comprehensive Analysis of Genome Rearrangements in Eight Human Malignant Tumor Tissues.PLoS One. 2016 Jul 8;11(7):e0158995. doi: 10.1371/journal.pone.0158995. eCollection 2016.
• [1778] A-to-I-edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosis.J Clin Invest. 2019 Dec 2;129(12):5343-5356. doi: 10.1172/JCI123396.
• [1779] Aberrant Epigenetic Modifications of LPHN2 Function as a Potential Cisplatin-Specific Biomarker for Human Gastrointestinal Cancer.Cancer Res Treat. 2016 Apr;48(2):676-86. doi: 10.4143/crt.2015.153. Epub 2015 Sep 22.
• [1780] AEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-B pathway and predicts poor outcome of the patients.Sci Rep. 2018 Aug 10;8(1):11955. doi: 10.1038/s41598-018-29878-6.
• [1781] Overexpression of lncRNA AFAP1-AS1 promotes cell proliferation and invasion in gastric cancer.Oncol Lett. 2019 Sep;18(3):3211-3217. doi: 10.3892/ol.2019.10640. Epub 2019 Jul 22.
• [1782] The super elongation complex family of RNA polymerase II elongation factors: gene target specificity and transcriptional output.Mol Cell Biol. 2012 Jul;32(13):2608-17. doi: 10.1128/MCB.00182-12. Epub 2012 Apr 30.
• [1783] Targeting high transcriptional control activity of long mononucleotide A-T repeats in cancer by Argonaute 1.Gene. 2019 May 30;699:54-61. doi: 10.1016/j.gene.2019.03.010. Epub 2019 Mar 9.
• [1784] Upregulation of nucleoprotein AHNAK is associated with poor outcome of pancreatic ductal adenocarcinoma prognosis via mediating epithelial-mesenchymal transition.J Cancer. 2019 Jun 10;10(16):3860-3870. doi: 10.7150/jca.31291. eCollection 2019.
• [1785] Searching for cancer vulnerabilities amid genetic chaos.Genome Biol. 2017 Aug 3;18(1):147. doi: 10.1186/s13059-017-1283-2.
• [1786] AJUBA promotes the migration and invasion of esophageal squamous cell carcinoma cells through upregulation of MMP10 and MMP13 expression.Oncotarget. 2016 Jun 14;7(24):36407-36418. doi: 10.18632/oncotarget.9239.
• [1787] ALKBH overexpression in head and neck cancer: potential target for novel anticancer therapy.Sci Rep. 2019 Sep 13;9(1):13249. doi: 10.1038/s41598-019-49550-x.
• [1788] Expression of Gp78/Autocrine Motility Factor Receptor and Endocytosis of Autocrine Motility Factor in Human Thyroid Cancer Cells.Cureus. 2019 Jun 17;11(6):e4928. doi: 10.7759/cureus.4928.
• [1789] A circular RNA promotes tumorigenesis by inducing c-myc nuclear translocation.Cell Death Differ. 2017 Sep;24(9):1609-1620. doi: 10.1038/cdd.2017.86. Epub 2017 Jun 16.
• [1790] Synthesis of 5-[(18)F]Fluoro--methyl Tryptophan: New Trp Based PET Agents.Theranostics. 2017 Apr 7;7(6):1524-1530. doi: 10.7150/thno.19371. eCollection 2017.
• [1791] Development of a biodosimeter for radiation triage using novel blood protein biomarker panels in humans and non-human primates.Int J Radiat Biol. 2020 Jan;96(1):22-34. doi: 10.1080/09553002.2018.1532611. Epub 2019 Jan 3.
• [1792] Ankyrin G expression is associated with androgen receptor stability, invasiveness, and lethal outcome in prostate cancer patients.J Mol Med (Berl). 2016 Dec;94(12):1411-1422. doi: 10.1007/s00109-016-1458-4. Epub 2016 Aug 18.
• [1793] Maternal intake of high n-6 polyunsaturated fatty acid diet during pregnancy causes transgenerational increase in mammary cancer risk in mice.Breast Cancer Res. 2017 Jul 3;19(1):77. doi: 10.1186/s13058-017-0866-x.
• [1794] Interaction between the obesity-risk gene FTO and the dopamine D2 receptor gene ANKK1/TaqIA on insulin sensitivity.Diabetologia. 2016 Dec;59(12):2622-2631. doi: 10.1007/s00125-016-4095-0. Epub 2016 Sep 6.
• [1795] ANP32A modulates cell growth by regulating p38 and Akt activity in colorectal cancer.Oncol Rep. 2017 Sep;38(3):1605-1612. doi: 10.3892/or.2017.5845. Epub 2017 Jul 21.
• [1796] Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced disease.Bone Marrow Transplant. 2019 Jun;54(6):877-884. doi: 10.1038/s41409-018-0360-9. Epub 2018 Nov 9.
• [1797] Mouse APOBEC1 cytidine deaminase can induce somatic mutations in chromosomal DNA.BMC Genomics. 2019 Nov 14;20(1):858. doi: 10.1186/s12864-019-6216-x.
• [1798] Integrative genomic analysis reveals functional diversification of APOBEC gene family in breast cancer.Hum Genomics. 2015 Dec 18;9:34. doi: 10.1186/s40246-015-0056-9.
• [1799] Conceptual framework for living with and beyond cancer: A systematic review and narrative synthesis.Psychooncology. 2019 May;28(5):948-959. doi: 10.1002/pon.5046. Epub 2019 Mar 25.
• [1800] HGF-induced migration depends on the PI(3,4,5)P(3)-binding microexon-spliced variant of the Arf6 exchange factor cytohesin-1.J Cell Biol. 2019 Jan 7;218(1):285-298. doi: 10.1083/jcb.201804106. Epub 2018 Nov 7.
• [1801] ARHGAP10, downregulated in ovarian cancer, suppresses tumorigenicity of ovarian cancer cells.Cell Death Dis. 2016 Mar 24;7(3):e2157. doi: 10.1038/cddis.2015.401.
• [1802] Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.Cell Death Dis. 2018 Jun 4;9(6):673. doi: 10.1038/s41419-018-0707-6.
• [1803] Mitotic-dependent phosphorylation of leukemia-associated RhoGEF (LARG) by Cdk1.Cell Signal. 2016 Jan;28(1):43-52. doi: 10.1016/j.cellsig.2015.10.004. Epub 2015 Oct 19.
• [1804] A novel overlapping NLS/NES region within the PH domain of Rho Guanine Nucleotide Exchange Factor (RGNEF) regulates its nuclear-cytoplasmic localization.Eur J Cell Biol. 2019 Jan;98(1):27-35. doi: 10.1016/j.ejcb.2018.11.001. Epub 2018 Nov 19.
• [1805] Arl13b Promotes Gastric Tumorigenesis by Regulating Smo Trafficking and Activation of the Hedgehog Signaling Pathway.Cancer Res. 2017 Aug 1;77(15):4000-4013. doi: 10.1158/0008-5472.CAN-16-2461. Epub 2017 Jun 13.
• [1806] Armc8 is an evolutionarily conserved armadillo protein involved in cell-cell adhesion complexes through multiple molecular interactions.Biosci Rep. 2019 Aug 2;39(8):BSR20180604. doi: 10.1042/BSR20180604. Print 2019 Aug 30.
• [1807] Glutamate E15 and E171 are Hotspots in p60TRP-Related Cancer.Cancer Invest. 2016;34(2):64-9. doi: 10.3109/07357907.2015.1088949. Epub 2016 Feb 6.
• [1808] Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin/integrin 1/FAK axis.Oncotarget. 2015 May 10;6(13):11530-46. doi: 10.18632/oncotarget.3448.
• [1809] The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1.Cell Death Differ. 2019 Sep;26(9):1813-1831. doi: 10.1038/s41418-018-0248-7. Epub 2018 Dec 11.
• [1810] MKL1 potentiates lung cancer cell migration and invasion by epigenetically activating MMP9 transcription.Oncogene. 2015 Oct 29;34(44):5570-81. doi: 10.1038/onc.2015.14. Epub 2015 Mar 9.
• [1811] Cytoplasmic Asporin promotes cell migration by regulating TGF-/Smad2/3 pathway and indicates a poor prognosis in colorectal cancer.Cell Death Dis. 2019 Feb 6;10(2):109. doi: 10.1038/s41419-019-1376-9.
• [1812] ATAD3A on the Path to Cancer.Adv Exp Med Biol. 2019;1134:259-269. doi: 10.1007/978-3-030-12668-1_14.
• [1813] Systematic Functional Interrogation of Genes in GWAS Loci Identified ATF1 as a Key Driver in Colorectal Cancer Modulated by a Promoter-Enhancer Interaction.Am J Hum Genet. 2019 Jul 3;105(1):29-47. doi: 10.1016/j.ajhg.2019.05.004. Epub 2019 Jun 13.
• [1814] Dominant-Negative ATF5 Compromises Cancer Cell Survival by Targeting CEBPB and CEBPD.Mol Cancer Res. 2020 Feb;18(2):216-228. doi: 10.1158/1541-7786.MCR-19-0631. Epub 2019 Nov 1.
• [1815] An Integrative Systems Biology and Experimental Approach Identifies Convergence of Epithelial Plasticity, Metabolism, and Autophagy to Promote Chemoresistance.J Clin Med. 2019 Feb 7;8(2):205. doi: 10.3390/jcm8020205.
• [1816] MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy.Autophagy. 2019 Jun;15(6):1100-1111. doi: 10.1080/15548627.2019.1569947. Epub 2019 Jan 31.
• [1817] DNA methylation changes involved in the tumor increase in F2 males born to gestationally arsenite-exposed F1 male mice.Cancer Sci. 2019 Aug;110(8):2629-2642. doi: 10.1111/cas.14104. Epub 2019 Jul 25.
• [1818] ATP11B mediates platinum resistance in ovarian cancer.J Clin Invest. 2013 May;123(5):2119-30. doi: 10.1172/JCI65425. Epub 2013 Apr 15.
• [1819] PMCA2 silencing potentiates MDA-MB-231 breast cancer cell death initiated with the Bcl-2 inhibitor ABT-263.Biochem Biophys Res Commun. 2016 Sep 30;478(4):1792-7. doi: 10.1016/j.bbrc.2016.09.030. Epub 2016 Sep 7.
• [1820] ATP5A1 and ATP5B are highly expressed in glioblastoma tumor cells and endothelial cells of microvascular proliferation.J Neurooncol. 2016 Feb;126(3):405-13. doi: 10.1007/s11060-015-1984-x. Epub 2015 Nov 2.
• [1821] POLR2F, ATP6V0A1 and PRNP expression in colorectal cancer: new molecules with prognostic significance?.Anticancer Res. 2008 Mar-Apr;28(2B):1221-7.
• [1822] Increased B3GALNT2 in hepatocellular carcinoma promotes macrophage recruitment via reducing acetoacetate secretion and elevating MIF activity.J Hematol Oncol. 2018 Apr 4;11(1):50. doi: 10.1186/s13045-018-0595-3.
• [1823] Biphasic squamoid alveolar renal carcinoma with positive CD57 expression: A clinicopathologic study of three cases.Pathol Int. 2019 Sep;69(9):519-525. doi: 10.1111/pin.12844. Epub 2019 Aug 1.
• [1824] B4GALT3 up-regulation by miR-27a contributes to the oncogenic activity in human cervical cancer cells.Cancer Lett. 2016 Jun 1;375(2):284-292. doi: 10.1016/j.canlet.2016.03.016. Epub 2016 Mar 14.
• [1825] The BAF complex in development and disease.Epigenetics Chromatin. 2019 Mar 21;12(1):19. doi: 10.1186/s13072-019-0264-y.
• [1826] SARI suppresses colitis-associated cancer development by maintaining MCP-1-mediated tumour-associated macrophage recruitment.J Cell Mol Med. 2020 Jan;24(1):189-201. doi: 10.1111/jcmm.14699. Epub 2019 Oct 2.
• [1827] Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics.J Immunother Cancer. 2019 Jan 9;7(1):6. doi: 10.1186/s40425-018-0495-7.
• [1828] Histone acetyltransferase 1 up regulates Bcl2L12 expression in nasopharyngeal cancer cells.Arch Biochem Biophys. 2018 May 15;646:72-79. doi: 10.1016/j.abb.2018.03.040. Epub 2018 Apr 3.
• [1829] BCL6B suppresses proliferation and migration of colorectal carcinoma cells through inhibition of the PI3K/AKT signaling pathway.Int J Mol Med. 2018 May;41(5):2660-2668. doi: 10.3892/ijmm.2018.3451. Epub 2018 Feb 1.
• [1830] The Tumor Suppressor BCL7B Functions in the Wnt Signaling Pathway.PLoS Genet. 2015 Jan 8;11(1):e1004921. doi: 10.1371/journal.pgen.1004921. eCollection 2015 Jan.
• [1831] Mitochondrial -Carotene 9',10' Oxygenase Modulates Prostate Cancer Growth via NF-B Inhibition: A Lycopene-Independent Function.Mol Cancer Res. 2016 Oct;14(10):966-975. doi: 10.1158/1541-7786.MCR-16-0075. Epub 2016 Jul 12.
• [1832] Bcor loss perturbs myeloid differentiation and promotes leukaemogenesis.Nat Commun. 2019 Mar 22;10(1):1347. doi: 10.1038/s41467-019-09250-6.
• [1833] Low bone turnover levels predict increased risk of cancer.Bone. 2019 Oct;127:75-81. doi: 10.1016/j.bone.2019.05.032. Epub 2019 May 28.
• [1834] Mist1 Expressing Gastric Stem Cells Maintain the Normal and Neoplastic Gastric Epithelium and Are Supported by a Perivascular Stem Cell Niche.Cancer Cell. 2015 Dec 14;28(6):800-814. doi: 10.1016/j.ccell.2015.10.003. Epub 2015 Nov 12.
• [1835] Overexpression of BHLHE41, correlated with DNA hypomethylation in 3'UTR region, promotes the growth of human clear cell renal cell carcinoma.Oncol Rep. 2019 Apr;41(4):2137-2147. doi: 10.3892/or.2019.7004. Epub 2019 Feb 7.
• [1836] Pharmacokinetics of crizotinib in NSCLC patients.Expert Opin Drug Metab Toxicol. 2015 May;11(5):835-42. doi: 10.1517/17425255.2015.1021685. Epub 2015 Mar 3.
• [1837] BLID: A Novel Tumor-Suppressor Gene.Oncol Res. 2014;22(5-6):333-8. doi: 10.3727/096504015X14410238486568.
• [1838] Epigallocatechin gallate inhibits the growth of salivary adenoid cystic carcinoma cells via the EGFR/Erk signal transduction pathway and the mitochondria apoptosis pathway.Neoplasma. 2017;64(4):563-570. doi: 10.4149/neo_2017_410.
• [1839] Discovery of alkoxy benzamide derivatives as novel BPTF bromodomain inhibitors via structure-based virtual screening.Bioorg Chem. 2019 May;86:494-500. doi: 10.1016/j.bioorg.2019.01.035. Epub 2019 Jan 28.
• [1840] Betacellulin enhances ovarian cancer cell migration by up-regulating Connexin43 via MEK-ERK signaling.Cell Signal. 2020 Jan;65:109439. doi: 10.1016/j.cellsig.2019.109439. Epub 2019 Oct 22.
• [1841] Upregulation of BTF3 affects the proliferation, apoptosis, and cell cycle regulation in hypopharyngeal squamous cell carcinoma.Biomed Pharmacother. 2019 Oct;118:109211. doi: 10.1016/j.biopha.2019.109211. Epub 2019 Aug 9.
• [1842] Blood vessel epicardial substance reduces LRP6 receptor and cytoplasmic -catenin levels to modulate Wnt signaling and intestinal homeostasis.Carcinogenesis. 2019 Sep 18;40(9):1086-1098. doi: 10.1093/carcin/bgz007.
• [1843] C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation.Nat Commun. 2016 Feb 1;7:10346. doi: 10.1038/ncomms10346.
• [1844] Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.Cancer Gene Ther. 2016 Jun;23(6):157-61. doi: 10.1038/cgt.2016.7. Epub 2016 May 13.
• [1845] Carbonic anhydrase-related protein VIII increases invasiveness of non-small cell lung adenocarcinoma.Virchows Arch. 2006 Jun;448(6):830-7. doi: 10.1007/s00428-006-0199-0. Epub 2006 Apr 12.
• [1846] Clinical aspects of tacrolimus use in paediatric renal transplant recipients.Pediatr Nephrol. 2019 Jan;34(1):31-43. doi: 10.1007/s00467-018-3892-8. Epub 2018 Feb 26.
• [1847] Clinicopathological significance of Necl-4 expression in pancreatic ductal adenocarcinoma.J Clin Pathol. 2017 Jul;70(7):619-624. doi: 10.1136/jclinpath-2016-204028. Epub 2016 Dec 15.
• [1848] Proteomic characterization of early lung response to breast cancer metastasis in mice.Exp Mol Pathol. 2019 Apr;107:129-140. doi: 10.1016/j.yexmp.2019.02.001. Epub 2019 Feb 11.
• [1849] Cancer Biomarkers for Integrative Oncology.Curr Oncol Rep. 2019 Mar 5;21(4):32. doi: 10.1007/s11912-019-0782-6.
• [1850] miR-33a inhibits cell proliferation and invasion by targeting CAND1 in lung cancer.Clin Transl Oncol. 2018 Apr;20(4):457-466. doi: 10.1007/s12094-017-1730-2. Epub 2017 Sep 4.
• [1851] CAP2 is a Valuable Biomarker for Diagnosis and Prognostic in Patients with Gastric Cancer.Pathol Oncol Res. 2020 Jan;26(1):273-279. doi: 10.1007/s12253-018-0450-4. Epub 2018 Jul 26.
• [1852] Calpain-5 Expression in the Retina Localizes to Photoreceptor Synapses.Invest Ophthalmol Vis Sci. 2016 May 1;57(6):2509-21. doi: 10.1167/iovs.15-18680.
• [1853] Prostate Cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assembly.Mol Cancer. 2019 Nov 26;18(1):170. doi: 10.1186/s12943-019-1096-x.
• [1854] Prognostic value of CAPZA1 overexpression in gastric cancer.Int J Oncol. 2013 May;42(5):1569-77. doi: 10.3892/ijo.2013.1867. Epub 2013 Mar 27.
• [1855] The Role of Adaptor Protein CARD9 in Colitis-Associated Cancer.Mol Ther Oncolytics. 2019 Aug 30;15:1-6. doi: 10.1016/j.omto.2019.08.007. eCollection 2019 Dec 20.
• [1856] Molecular Insights Into Withaferin-A-Induced Senescence: Bioinformatics and Experimental Evidence to the Role of NFB and CARF.J Gerontol A Biol Sci Med Sci. 2019 Jan 16;74(2):183-191. doi: 10.1093/gerona/gly107.
• [1857] Caspase14 expression is associated with triple negative phenotypes and cancer stem cell marker expression in breast cancer patients.J Surg Oncol. 2017 Nov;116(6):706-715. doi: 10.1002/jso.24705. Epub 2017 Jun 1.
• [1858] An integrated physico-chemical approach for explaining the differential impact of FLASH versus conventional dose rate irradiation on cancer and normal tissue responses.Radiother Oncol. 2019 Oct;139:23-27. doi: 10.1016/j.radonc.2019.03.028. Epub 2019 Apr 19.
• [1859] Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases.Front Immunol. 2018 Mar 19;9:575. doi: 10.3389/fimmu.2018.00575. eCollection 2018.
• [1860] Beyond EZH2: is the polycomb protein CBX2 an emerging target for anti-cancer therapy?.Expert Opin Ther Targets. 2019 Jul;23(7):565-578. doi: 10.1080/14728222.2019.1627329. Epub 2019 Jun 10.
• [1861] m(6)A modification-mediated CBX8 induction regulates stemness and chemosensitivity of colon cancer via upregulation of LGR5.Mol Cancer. 2019 Dec 18;18(1):185. doi: 10.1186/s12943-019-1116-x.
• [1862] ROS1 Rearrangement in Thyroid Cancer.Thyroid. 2016 Jun;26(6):794-7. doi: 10.1089/thy.2016.0101.
• [1863] CCL27/CCL28-CCR10 Chemokine Signaling Mediates Migration of Lymphatic Endothelial Cells.Cancer Res. 2019 Apr 1;79(7):1558-1572. doi: 10.1158/0008-5472.CAN-18-1858. Epub 2019 Feb 1.
• [1864] Cost-utility analysis of aprepitant for patients who truly need it in Japan.Support Care Cancer. 2019 Oct;27(10):3749-3758. doi: 10.1007/s00520-019-04672-w. Epub 2019 Feb 1.
• [1865] Likert vs PI-RADS v2: a comparison of two radiological scoring systems for detection of clinically significant prostate cancer.BJU Int. 2020 Jan;125(1):49-55. doi: 10.1111/bju.14916. Epub 2019 Nov 1.
• [1866] High CCL7 expression is associated with migration, invasion and bone metastasis of non-small cell lung cancer cells.Am J Transl Res. 2019 Jan 15;11(1):442-452. eCollection 2019.
• [1867] Wnt1-inducible signaling protein 1 regulates laryngeal squamous cell carcinoma glycolysis and chemoresistance via the YAP1/TEAD1/GLUT1 pathway.J Cell Physiol. 2019 Sep;234(9):15941-15950. doi: 10.1002/jcp.28253. Epub 2019 Feb 25.
• [1868] A role for WISP2 in colorectal cancer cell invasion and motility.Cancer Genomics Proteomics. 2013 Jul-Aug;10(4):187-96.
• [1869] BCOR-CCNB3-positive soft tissue sarcoma with round-cell and spindle-cell histology: a series of four cases highlighting the pitfall of mimicking poorly differentiated synovial sarcoma.Histopathology. 2016 Nov;69(5):792-801. doi: 10.1111/his.13001. Epub 2016 Jul 15.
• [1870] Phosphoregulation of the oncogenic protein regulator of cytokinesis 1 (PRC1) by the atypical CDK16/CCNY complex.Exp Mol Med. 2019 Apr 16;51(4):1-17. doi: 10.1038/s12276-019-0242-2.
• [1871] Molecular chaperone CCT3 supports proper mitotic progression and cell proliferation in hepatocellular carcinoma cells.Cancer Lett. 2016 Mar 1;372(1):101-9. doi: 10.1016/j.canlet.2015.12.029. Epub 2015 Dec 29.
• [1872] CD177+ neutrophils suppress epithelial cell tumourigenesis in colitis-associated cancer and predict good prognosis in colorectal cancer.Carcinogenesis. 2018 Feb 9;39(2):272-282. doi: 10.1093/carcin/bgx142.
• [1873] Myeloid-derived suppressor cells expansion is closely associated with disease severity and progression in HBV-related acute-on-chronic liver failure.J Med Virol. 2019 Aug;91(8):1510-1518. doi: 10.1002/jmv.25466. Epub 2019 Apr 4.
• [1874] Electrochemical immunosensing of nanovesicles as biomarkers for breast cancer.Biosens Bioelectron. 2020 Feb 15;150:111882. doi: 10.1016/j.bios.2019.111882. Epub 2019 Nov 13.
• [1875] CDC27 Induces Metastasis and Invasion in Colorectal Cancer via the Promotion of Epithelial-To-Mesenchymal Transition.J Cancer. 2017 Aug 21;8(13):2626-2635. doi: 10.7150/jca.19381. eCollection 2017.
• [1876] Radiation-promoted CDC6 protein stability contributes to radioresistance by regulating senescence and epithelial to mesenchymal transition.Oncogene. 2019 Jan;38(4):549-563. doi: 10.1038/s41388-018-0460-4. Epub 2018 Aug 29.
• [1877] Overexpression of CDCA7 predicts poor prognosis and induces EZH2-mediated progression of triple-negative breast cancer.Int J Cancer. 2018 Nov 15;143(10):2602-2613. doi: 10.1002/ijc.31766. Epub 2018 Sep 19.
• [1878] RGD cadherins and 21 integrin in cancer metastasis: A dangerous liaison.Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):321-332. doi: 10.1016/j.bbcan.2018.04.005. Epub 2018 Apr 17.
• [1879] CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cells.Oncogene. 2017 Sep 14;36(37):5321-5330. doi: 10.1038/onc.2017.161. Epub 2017 May 22.
• [1880] A CEP215-HSET complex links centrosomes with spindle poles and drives centrosome clustering in cancer.Nat Commun. 2016 Mar 18;7:11005. doi: 10.1038/ncomms11005.
• [1881] The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model.BMC Med Genet. 2015 Jul 3;16:46. doi: 10.1186/s12881-015-0184-z.
• [1882] The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo.Cell. 2015 Apr 9;161(2):319-32. doi: 10.1016/j.cell.2015.02.043. Epub 2015 Apr 2.
• [1883] CDX1/2 and KLF5 Expression and Epigenetic Modulation of Sonic Hedgehog Signaling in Gastric Adenocarcinoma.Pathol Oncol Res. 2019 Jul;25(3):1215-1222. doi: 10.1007/s12253-019-00594-4. Epub 2019 Jan 26.
• [1884] Systems analysis identifies melanoma-enriched pro-oncogenic networks controlled by the RNA binding protein CELF1.Nat Commun. 2017 Dec 21;8(1):2249. doi: 10.1038/s41467-017-02353-y.
• [1885] Centromeric and ectopic assembly of CENP-A chromatin in health and cancer: old marks and new tracks.Nucleic Acids Res. 2019 Feb 20;47(3):1051-1069. doi: 10.1093/nar/gky1298.
• [1886] CEP131 indicates poor prognosis and promotes cell proliferation and migration in hepatocellular carcinoma.Int J Biochem Cell Biol. 2017 Sep;90:1-8. doi: 10.1016/j.biocel.2017.07.001. Epub 2017 Jul 8.
• [1887] Inhibition of centrosomal protein 164 sensitizes rhabdomyosarcoma cells to radiotherapy.Exp Ther Med. 2017 May;13(5):2311-2315. doi: 10.3892/etm.2017.4281. Epub 2017 Mar 29.
• [1888] Opposing post-translational modifications regulate Cep76 function to suppress centriole amplification.Oncogene. 2016 Oct 13;35(41):5377-5387. doi: 10.1038/onc.2016.74. Epub 2016 Apr 11.
• [1889] S100 proteins: Diagnostic and prognostic biomarkers in laboratory medicine.Biochim Biophys Acta Mol Cell Res. 2019 Jul;1866(7):1197-1206. doi: 10.1016/j.bbamcr.2018.10.015. Epub 2018 Oct 28.
• [1890] CHD4 regulates the DNA damage response and RAD51 expression in glioblastoma.Sci Rep. 2019 Mar 14;9(1):4444. doi: 10.1038/s41598-019-40327-w.
• [1891] Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression.Oncotarget. 2016 Apr 19;7(16):21840-52. doi: 10.18632/oncotarget.8187.
• [1892] YKL-40 Promotes Proliferation of Cutaneous T-Cell Lymphoma Tumor Cells through Extracellular Signal-Regulated Kinase Pathways.J Invest Dermatol. 2020 Apr;140(4):860-868.e3. doi: 10.1016/j.jid.2019.09.007. Epub 2019 Oct 14.
• [1893] Antiproliferative and Proapoptotic Effects of a Protein Component Purified from Aspongopus chinensis Dallas on Cancer Cells In Vitro and In Vivo.Evid Based Complement Alternat Med. 2019 Jan 3;2019:8934794. doi: 10.1155/2019/8934794. eCollection 2019.
• [1894] CIB2 Negatively Regulates Oncogenic Signaling in Ovarian Cancer via Sphingosine Kinase 1.Cancer Res. 2017 Sep 15;77(18):4823-4834. doi: 10.1158/0008-5472.CAN-17-0025. Epub 2017 Jul 20.
• [1895] Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1.Retrovirology. 2019 Nov 29;16(1):34. doi: 10.1186/s12977-019-0498-6.
• [1896] Isoliquiritigenin Induces Mitochondrial Dysfunction and Apoptosis by Inhibiting mitoNEET in a Reactive Oxygen Species-Dependent Manner in A375 Human Melanoma Cells.Oxid Med Cell Longev. 2019 Jan 21;2019:9817576. doi: 10.1155/2019/9817576. eCollection 2019.
• [1897] Effects of CKMT1 on radiosensitivity of nasopharyngeal carcinoma cells.Int J Radiat Biol. 2019 May;95(5):597-606. doi: 10.1080/09553002.2019.1554919. Epub 2019 Jan 4.
• [1898] Prognostic value of chloride channel accessory mRNA expression in colon cancer.Oncol Lett. 2019 Sep;18(3):2967-2976. doi: 10.3892/ol.2019.10615. Epub 2019 Jul 15.
• [1899] Claudin 3, 4, and 15 expression in solid tumors of lung adenocarcinoma versus malignant pleural mesothelioma.Ann Diagn Pathol. 2015 Aug;19(4):193-7. doi: 10.1016/j.anndiagpath.2015.03.007. Epub 2015 Apr 14.
• [1900] Afadin cooperates with Claudin-2 to promote breast cancer metastasis.Genes Dev. 2019 Feb 1;33(3-4):180-193. doi: 10.1101/gad.319194.118. Epub 2019 Jan 28.
• [1901] Functional significance of the platelet immune receptors GPVI and CLEC-2.J Clin Invest. 2019 Jan 2;129(1):12-23. doi: 10.1172/JCI122955. Epub 2019 Jan 2.
• [1902] Optimal sequence of antisense DNA to silence YB-1 in lung cancer by use of a novel polysaccharide drug delivery system.Int J Oncol. 2016 Jun;48(6):2472-8. doi: 10.3892/ijo.2016.3451. Epub 2016 Mar 23.
• [1903] Role of wedge resection in bronchial carcinoid (BC) tumors: SEER database analysis.J Thorac Dis. 2019 Apr;11(4):1355-1362. doi: 10.21037/jtd.2019.03.89.
• [1904] CMTM1_v17 is a novel potential therapeutic target in breast cancer.Oncol Rep. 2014 Nov;32(5):1829-36. doi: 10.3892/or.2014.3429. Epub 2014 Aug 20.
• [1905] CMTM4 inhibits cell proliferation and migration via AKT, ERK1/2, and STAT3 pathway in colorectal cancer.Acta Biochim Biophys Sin (Shanghai). 2019 Sep 6;51(9):915-924. doi: 10.1093/abbs/gmz084.
• [1906] CMTM5 inhibits renal cancer cell growth through inducing cell-cycle arrest and apoptosis.Oncol Lett. 2017 Aug;14(2):1536-1542. doi: 10.3892/ol.2017.6350. Epub 2017 Jun 8.
• [1907] Sterol Regulatory Element Binding Protein Regulates the Expression and Metabolic Functions of Wild-Type and Oncogenic IDH1.Mol Cell Biol. 2016 Aug 26;36(18):2384-95. doi: 10.1128/MCB.00163-16. Print 2016 Sep 15.
• [1908] Increased expression of calponin 2 is a positive prognostic factor in pancreatic ductal adenocarcinoma.Oncotarget. 2017 May 9;8(34):56428-56442. doi: 10.18632/oncotarget.17701. eCollection 2017 Aug 22.
• [1909] The protein tyrosine phosphatase PRL-2 interacts with the magnesium transporter CNNM3 to promote oncogenesis.Oncogene. 2015 Feb 19;34(8):986-95. doi: 10.1038/onc.2014.33. Epub 2014 Mar 17.
• [1910] CNOT3 targets negative cell cycle regulators in non-small cell lung cancer development.Oncogene. 2019 Apr;38(14):2580-2594. doi: 10.1038/s41388-018-0603-7. Epub 2018 Dec 10.
• [1911] COMMD7 functions as molecular target in pancreatic ductal adenocarcinoma.Mol Carcinog. 2017 Feb;56(2):607-624. doi: 10.1002/mc.22520. Epub 2016 Jul 8.
• [1912] The Emerging Role of CSN6 in Biological Behavior and Cancer Progress.Anticancer Agents Med Chem. 2019;19(10):1198-1204. doi: 10.2174/1871520619666190408142131.
• [1913] The components of somatostatin and ghrelin systems are altered in neuroendocrine lung carcinoids and associated to clinical-histological features.Lung Cancer. 2017 Jul;109:128-136. doi: 10.1016/j.lungcan.2017.05.006. Epub 2017 May 13.
• [1914] COX7AR is a Stress-inducible Mitochondrial COX Subunit that Promotes Breast Cancer Malignancy.Sci Rep. 2016 Aug 23;6:31742. doi: 10.1038/srep31742.
• [1915] Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2.Mol Cell. 2016 Feb 18;61(4):520-534. doi: 10.1016/j.molcel.2016.01.015. Epub 2016 Feb 4.
• [1916] Effects of carnitine palmitoyltransferases on cancer cellular senescence.J Cell Physiol. 2019 Feb;234(2):1707-1719. doi: 10.1002/jcp.27042. Epub 2018 Aug 2.
• [1917] Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression.Mol Cancer. 2019 Apr 2;18(1):73. doi: 10.1186/s12943-019-1007-1.
• [1918] CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy.BMC Cancer. 2018 Aug 13;18(1):813. doi: 10.1186/s12885-018-4724-8.
• [1919] SOST Inhibits Prostate Cancer Invasion.PLoS One. 2015 Nov 6;10(11):e0142058. doi: 10.1371/journal.pone.0142058. eCollection 2015.
• [1920] Small-molecule binding sites to explore protein-protein interactions in the cancer proteome.Mol Biosyst. 2016 Oct 20;12(10):3067-87. doi: 10.1039/c6mb00231e. Epub 2016 Jul 25.
• [1921] In vivo siRNA distribution and pharmacokinetics assessed by nuclear imaging are modulated according to radiolabelling site.Nucl Med Biol. 2015 Dec;42(12):958-66. doi: 10.1016/j.nucmedbio.2015.04.007. Epub 2015 Apr 24.
• [1922] Nuclear CSPP1 expression defined subtypes of basal-like breast cancer.Br J Cancer. 2014 Jul 15;111(2):326-38. doi: 10.1038/bjc.2014.297. Epub 2014 Jun 5.
• [1923] Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.EBioMedicine. 2016 Dec;14:32-43. doi: 10.1016/j.ebiom.2016.11.012. Epub 2016 Nov 10.
• [1924] Identifying prognostic signature in ovarian cancer using DirGenerank.Oncotarget. 2017 Jul 11;8(28):46398-46413. doi: 10.18632/oncotarget.18189.
• [1925] C-terminal binding protein-2 promotes cell proliferation and migration in breast cancer via suppression of p16INK4A.Oncotarget. 2017 Apr 18;8(16):26154-26168. doi: 10.18632/oncotarget.15402.
• [1926] CTNNBIP1 downregulation is associated with tumor grade and viral infections in gastric adenocarcinoma.J Cell Physiol. 2019 Mar;234(3):2895-2904. doi: 10.1002/jcp.27106. Epub 2018 Aug 4.
• [1927] Changes in taste and food preferences in breast cancer patients receiving chemotherapy: a pilot study.Support Care Cancer. 2020 Mar;28(3):1265-1275. doi: 10.1007/s00520-019-04924-9. Epub 2019 Jun 22.
• [1928] Plasma levels of the proangiogenic protein CXCL16 remains elevated for 1month after minimally invasive colorectal cancer resection.World J Surg Oncol. 2018 Jul 7;16(1):132. doi: 10.1186/s12957-018-1418-2.
• [1929] MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy.Cancer Discov. 2016 Jan;6(1):45-58. doi: 10.1158/2159-8290.CD-15-0341. Epub 2015 Nov 6.
• [1930] Targeting the WASF3-CYFIP1 Complex Using Stapled Peptides Suppresses Cancer Cell Invasion.Cancer Res. 2016 Feb 15;76(4):965-73. doi: 10.1158/0008-5472.CAN-15-1680. Epub 2015 Dec 16.
• [1931] Dachshund Depletion Disrupts Mammary Gland Development and Diverts the Composition of the Mammary Gland Progenitor Pool.Stem Cell Reports. 2019 Jan 8;12(1):135-151. doi: 10.1016/j.stemcr.2018.11.010. Epub 2018 Dec 13.
• [1932] Downregulation of DACT-2 by Promoter Methylation and its Clinicopathological Significance in Prostate Cancer.J Cancer. 2019 Apr 20;10(7):1755-1763. doi: 10.7150/jca.28577. eCollection 2019.
• [1933] Human DBR1 modulates the recycling of snRNPs to affect alternative RNA splicing and contributes to the suppression of cancer development.Oncogene. 2017 Sep 21;36(38):5382-5391. doi: 10.1038/onc.2017.150. Epub 2017 May 15.
• [1934] Genome-wide screening identifies novel genes implicated in cellular sensitivity to BRAF(V600E) expression.Oncogene. 2020 Jan;39(4):723-738. doi: 10.1038/s41388-019-1022-0. Epub 2019 Sep 23.
• [1935] Emerging Roles of DDB2 in Cancer.Int J Mol Sci. 2019 Oct 18;20(20):5168. doi: 10.3390/ijms20205168.
• [1936] Oncogene RNA helicase DDX6 promotes the process of c-Myc expression in gastric cancer cells.Mol Carcinog. 2018 May;57(5):579-589. doi: 10.1002/mc.22781. Epub 2018 Jan 30.
• [1937] Human -defensin (DEFA) gene expression helps to characterise benign and malignant salivary gland tumours.BMC Cancer. 2012 Oct 11;12:465. doi: 10.1186/1471-2407-12-465.
• [1938] Human Beta Defensins and Cancer: Contradictions and Common Ground.Front Oncol. 2019 May 3;9:341. doi: 10.3389/fonc.2019.00341. eCollection 2019.
• [1939] DEPDC1B knockdown inhibits the development of malignant melanoma through suppressing cell proliferation and inducing cell apoptosis.Exp Cell Res. 2019 Jun 1;379(1):48-54. doi: 10.1016/j.yexcr.2019.03.021. Epub 2019 Mar 14.
• [1940] Characterization of the novel tumor-suppressor gene CCDC67 in papillary thyroid carcinoma.Oncotarget. 2016 Feb 2;7(5):5830-41. doi: 10.18632/oncotarget.6709.
• [1941] Molecular Pathways: Targeting Diacylglycerol Kinase Alpha in Cancer.Clin Cancer Res. 2015 Nov 15;21(22):5008-12. doi: 10.1158/1078-0432.CCR-15-0413. Epub 2015 Sep 29.
• [1942] Diacylglycerol kinase predicts prognosis and functions as a tumor suppressor by negatively regulating glucose transporter 1 in hepatocellular carcinoma.Exp Cell Res. 2018 Dec 15;373(1-2):211-220. doi: 10.1016/j.yexcr.2018.11.001. Epub 2018 Nov 3.
• [1943] DHX32 expression is an indicator of poor breast cancer prognosis.Oncol Lett. 2017 Feb;13(2):942-948. doi: 10.3892/ol.2016.5503. Epub 2016 Dec 14.
• [1944] The Promoter-Associated Noncoding RNA pncCCND1_B Assembles a Protein-RNA Complex to Regulate Cyclin D1 Transcription in Ewing Sarcoma.Cancer Res. 2019 Jul 15;79(14):3570-3582. doi: 10.1158/0008-5472.CAN-18-2403. Epub 2019 May 9.
• [1945] Epigenetic regulation of active Chinese herbal components for cancer prevention and treatment: A follow-up review.Pharmacol Res. 2016 Dec;114:1-12. doi: 10.1016/j.phrs.2016.09.023. Epub 2016 Sep 30.
• [1946] DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways.Int J Oncol. 2019 Mar;54(3):1021-1032. doi: 10.3892/ijo.2018.4667. Epub 2018 Dec 14.
• [1947] Effect of radical prostatectomy on levels of cancer related epitopes in circulating macrophages of patients with clinically localized prostate cancer.Prostate. 2017 Sep;77(12):1251-1258. doi: 10.1002/pros.23384. Epub 2017 Jul 20.
• [1948] Skewed B cell receptor repertoire and reduced antibody avidity in patients with DOCK8 deficiency.Scand J Immunol. 2019 Jun;89(6):e12759. doi: 10.1111/sji.12759. Epub 2019 Mar 18.
• [1949] Elevated DSN1 expression is associated with poor survival in patients with hepatocellular carcinoma.Hum Pathol. 2018 Nov;81:113-120. doi: 10.1016/j.humpath.2018.06.032. Epub 2018 Jul 3.
• [1950] IL-4 and IL-17A Cooperatively Promote Hydrogen Peroxide Production, Oxidative DNA Damage, and Upregulation of Dual Oxidase 2 in Human Colon and Pancreatic Cancer Cells.J Immunol. 2019 Nov 1;203(9):2532-2544. doi: 10.4049/jimmunol.1800469. Epub 2019 Sep 23.
• [1951] Dusp6 inhibits epithelial-mesenchymal transition in endometrial adenocarcinoma via ERK signaling pathway.Radiol Oncol. 2019 Sep 24;53(3):307-315. doi: 10.2478/raon-2019-0034.
• [1952] Interplay between NRF1, E2F4 and MYC transcription factors regulating common target genes contributes to cancer development and progression.Cell Oncol (Dordr). 2018 Oct;41(5):465-484. doi: 10.1007/s13402-018-0395-3. Epub 2018 Jul 25.
• [1953] The expression profile and prognostic significance of eukaryotic translation elongation factors in different cancers.PLoS One. 2018 Jan 17;13(1):e0191377. doi: 10.1371/journal.pone.0191377. eCollection 2018.
• [1954] Analysis of fibulin-3 after exposure to asbestos-like fibers.Environ Res. 2017 Jul;156:381-387. doi: 10.1016/j.envres.2017.03.055. Epub 2017 Apr 10.
• [1955] Roles of EphA1/A2 and ephrin-A1 in cancer.Cancer Sci. 2019 Mar;110(3):841-848. doi: 10.1111/cas.13942. Epub 2019 Feb 15.
• [1956] Ligand-dependent EphB4 activation serves as an anchoring signal in glioma cells.Cancer Lett. 2019 May 1;449:56-65. doi: 10.1016/j.canlet.2019.02.021. Epub 2019 Feb 15.
• [1957] Upregulated expression of eIF3C is associated with malignant behavior in renal cell carcinoma.Int J Oncol. 2019 Dec;55(6):1385-1395. doi: 10.3892/ijo.2019.4903. Epub 2019 Oct 21.
• [1958] LncRNA FAL1 promotes carcinogenesis by regulation of miR-637/NUPR1 pathway in colorectal cancer.Int J Biochem Cell Biol. 2019 Jan;106:46-56. doi: 10.1016/j.biocel.2018.09.015. Epub 2018 Sep 26.
• [1959] Translation control during prolonged mTORC1 inhibition mediated by 4E-BP3.Nat Commun. 2016 Jun 20;7:11776. doi: 10.1038/ncomms11776.
• [1960] Intermolecular steric inhibition of Ephexin4 is relieved by Elmo1.Sci Rep. 2017 Jun 30;7(1):4404. doi: 10.1038/s41598-017-04810-6.
• [1961] New HIF2 inhibitors: potential implications as therapeutics for advanced pheochromocytomas and paragangliomas.Endocr Relat Cancer. 2017 Sep;24(9):C9-C19. doi: 10.1530/ERC-16-0479. Epub 2017 Jun 30.
• [1962] CD22E12 as a molecular target for corrective repair using RNA trans-splicing: anti-leukemic activity of a rationally designed RNA trans-splicing molecule.Integr Biol (Camb). 2015 Feb;7(2):237-49. doi: 10.1039/c4ib00221k.
• [1963] The Pivotal Roles of the Epithelial Membrane Protein Family in Cancer Invasiveness and Metastasis.Cancers (Basel). 2019 Oct 23;11(11):1620. doi: 10.3390/cancers11111620.
• [1964] Selective inhibitor of platelet-activating factor acetylhydrolases 1b2 and 1b3 that impairs cancer cell survival.ACS Chem Biol. 2015 Apr 17;10(4):925-32. doi: 10.1021/cb500893q. Epub 2015 Jan 20.
• [1965] ENKUR Is Involved in the Regulation of Cellular Biology in Colorectal Cancer Cells via PI3K/Akt Signaling Pathway.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819841433. doi: 10.1177/1533033819841433.
• [1966] Invisible hemolysis in serum samples interferes in NSE measurement.Tumori. 2020 Feb;106(1):79-81. doi: 10.1177/0300891619867836. Epub 2019 Aug 9.
• [1967] Identifying small molecule probes of ENTPD5 through high throughput screening.PLoS One. 2019 Jun 26;14(6):e0210305. doi: 10.1371/journal.pone.0210305. eCollection 2019.
• [1968] ATXN7L3 and ENY2 Coordinate Activity of Multiple H2B Deubiquitinases Important for Cellular Proliferation and Tumor Growth.Mol Cell. 2016 May 19;62(4):558-71. doi: 10.1016/j.molcel.2016.03.030. Epub 2016 Apr 28.
• [1969] Ossifying fibromyxoid tumor: morphology, genetics, and differential diagnosis.Ann Diagn Pathol. 2016 Feb;20:52-8. doi: 10.1016/j.anndiagpath.2015.11.002. Epub 2015 Dec 2.
• [1970] Regulation of inflammatory gene expression in macrophages by epithelial-stromal interaction 1 (Epsti1).Biochem Biophys Res Commun. 2018 Feb 5;496(2):778-783. doi: 10.1016/j.bbrc.2017.12.014. Epub 2017 Dec 5.
• [1971] Isolation and characterisation of a novel human gene (C9orf11) on chromosome 9p21, a region frequently deleted in human cancer.Biochim Biophys Acta. 2000 Dec 15;1517(1):128-34. doi: 10.1016/s0167-4781(00)00272-4.
• [1972] The CSB repair factor is overexpressed in cancer cells, increases apoptotic resistance, and promotes tumor growth.DNA Repair (Amst). 2013 Apr 1;12(4):293-9. doi: 10.1016/j.dnarep.2013.01.008. Epub 2013 Feb 16.
• [1973] ERMP1, a novel potential oncogene involved in UPR and oxidative stress defense, is highly expressed in human cancer.Oncotarget. 2016 Sep 27;7(39):63596-63610. doi: 10.18632/oncotarget.11550.
• [1974] Endoplasmic reticulum protein 29 (ERp29) as a novel prognostic marker and tumor suppressor in osteosarcoma.J Bone Oncol. 2019 Mar 19;16:100233. doi: 10.1016/j.jbo.2019.100233. eCollection 2019 Jun.
• [1975] Upregulation of syncytin-1 promotes invasion and metastasis by activating epithelial-mesenchymal transition-related pathway in endometrial carcinoma.Onco Targets Ther. 2018 Dec 17;12:31-40. doi: 10.2147/OTT.S191041. eCollection 2019.
• [1976] Identification of ESM1 overexpressed in head and neck squamous cell carcinoma.Cancer Cell Int. 2019 May 2;19:118. doi: 10.1186/s12935-019-0833-y. eCollection 2019.
• [1977] Splicing factor ESRP1 controls ER-positive breast cancer by altering metabolic pathways.EMBO Rep. 2019 Feb;20(2):e46078. doi: 10.15252/embr.201846078. Epub 2019 Jan 21.
• [1978] Dissecting the mechanism of colorectal tumorigenesis based on RNA-sequencing data.Exp Mol Pathol. 2015 Apr;98(2):246-53. doi: 10.1016/j.yexmp.2015.01.004. Epub 2015 Jan 7.
• [1979] Increased EXT1 gene copy number correlates with increased mRNA level predicts short disease-free survival in hepatocellular carcinoma without vascular invasion.Medicine (Baltimore). 2018 Sep;97(39):e12625. doi: 10.1097/MD.0000000000012625.
• [1980] The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.BMC Cancer. 2018 Mar 22;18(1):317. doi: 10.1186/s12885-018-4221-0.
• [1981] Alteration of gut microbiota-associated epitopes in children with autism spectrum disorders.Brain Behav Immun. 2019 Jan;75:192-199. doi: 10.1016/j.bbi.2018.10.006. Epub 2018 Oct 27.
• [1982] Disturbed alternative splicing of FIR (PUF60) directed cyclin E overexpression in esophageal cancers.Oncotarget. 2018 May 1;9(33):22929-22944. doi: 10.18632/oncotarget.25149. eCollection 2018 May 1.
• [1983] Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients.J Gastroenterol Hepatol. 2019 Jan;34(1):207-214. doi: 10.1111/jgh.14448. Epub 2018 Sep 18.
• [1984] Aqueous stable Pd nanoparticles/covalent organic framework nanocomposite: an efficient nanoenzyme for colorimetric detection and multicolor imaging of cancer cells.Nanoscale. 2020 Jan 2;12(2):825-831. doi: 10.1039/c9nr08486j.
• [1985] CRY2 and FBXL3 Cooperatively Degrade c-MYC.Mol Cell. 2016 Nov 17;64(4):774-789. doi: 10.1016/j.molcel.2016.10.012. Epub 2016 Nov 10.
• [1986] Identification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer.Sci Rep. 2017 Jul 11;7(1):5124. doi: 10.1038/s41598-017-05209-z.
• [1987] Expression analysis of two cancer-testis genes, FBXO39 and TDRD4, in breast cancer tissues and cell lines.Asian Pac J Cancer Prev. 2014 Jan;14(11):6625-9. doi: 10.7314/apjcp.2013.14.11.6625.
• [1988] Gsk3 and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease.Biochem J. 2016 Oct 15;473(20):3563-3580. doi: 10.1042/BCJ20160387. Epub 2016 Aug 8.
• [1989] Tip60-dependent acetylation of KDM2B promotes osteosarcoma carcinogenesis.J Cell Mol Med. 2019 Sep;23(9):6154-6163. doi: 10.1111/jcmm.14497. Epub 2019 Jun 20.
• [1990] Evaluation of CD307a expression patterns during normal B-cell maturation and in B-cell malignancies by flow cytometry.Cytometry B Clin Cytom. 2018 Jul;94(4):588-595. doi: 10.1002/cyto.b.21631. Epub 2018 Mar 9.
• [1991] C4orf7 contributes to ovarian cancer metastasis by promoting cancer cell migration and invasion.Oncol Rep. 2010 Oct;24(4):933-9.
• [1992] Expression of kindlin-3 in melanoma cells impedes cell migration and metastasis.Cell Adh Migr. 2017 Sep 3;11(5-6):419-433. doi: 10.1080/19336918.2016.1243645. Epub 2016 Nov 2.
• [1993] Minireview: Role of genetic changes of faciogenital dysplasia protein 1 in human disease.Physiol Genomics. 2016 Jul 1;48(7):446-54. doi: 10.1152/physiolgenomics.00101.2015. Epub 2016 May 6.
• [1994] FGD5 amplification in breast cancer patients is associated with tumour proliferation and a poorer prognosis.Breast Cancer Res Treat. 2017 Apr;162(2):243-253. doi: 10.1007/s10549-017-4125-8. Epub 2017 Jan 25.
• [1995] Enhanced expressions of FHL2 and iASPP predict poor prognosis in acute myeloid leukemia.Cancer Gene Ther. 2019 Feb;26(1-2):17-25. doi: 10.1038/s41417-018-0027-0. Epub 2018 Jun 18.
• [1996] Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/-catenin oncogenic pathways.Mol Carcinog. 2019 Aug;58(8):1450-1464. doi: 10.1002/mc.23027. Epub 2019 Apr 26.
• [1997] CDK4 Regulates Lysosomal Function and mTORC1 Activation to Promote Cancer Cell Survival.Cancer Res. 2019 Oct 15;79(20):5245-5259. doi: 10.1158/0008-5472.CAN-19-0708. Epub 2019 Aug 8.
• [1998] Novel 3-(2,6,9-trisubstituted-9H-purine)-8-chalcone derivatives as potent anti-gastric cancer agents: Design, synthesis and structural optimization.Eur J Med Chem. 2019 Jan 1;161:493-505. doi: 10.1016/j.ejmech.2018.10.058. Epub 2018 Oct 25.
• [1999] FNDC3B circular RNA promotes the migration and invasion of gastric cancer cells via the regulation of E-cadherin and CD44 expression.J Cell Physiol. 2019 Nov;234(11):19895-19910. doi: 10.1002/jcp.28588. Epub 2019 Apr 8.
• [2000] Expression of Irisin/FNDC5 in Cancer Cells and Stromal Fibroblasts of Non-small Cell Lung Cancer.Cancers (Basel). 2019 Oct 11;11(10):1538. doi: 10.3390/cancers11101538.
• [2001] IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner.Nucleic Acids Res. 2019 Jan 10;47(1):375-390. doi: 10.1093/nar/gky1012.
• [2002] FOXK2 Transcription Factor and Its Emerging Roles in Cancer.Cancers (Basel). 2019 Mar 20;11(3):393. doi: 10.3390/cancers11030393.
• [2003] KMT2D/MLL2 inactivation is associated with recurrence in adult-type granulosa cell tumors of the ovary.Nat Commun. 2018 Jun 27;9(1):2496. doi: 10.1038/s41467-018-04950-x.
• [2004] Forkhead box N1 inhibits the progression of non-small cell lung cancer and serves as a tumor suppressor.Oncol Lett. 2018 May;15(5):7221-7230. doi: 10.3892/ol.2018.8210. Epub 2018 Mar 8.
• [2005] High expression of FUNDC1 predicts poor prognostic outcomes and is a promising target to improve chemoradiotherapy effects in patients with cervical cancer.Cancer Med. 2017 Aug;6(8):1871-1881. doi: 10.1002/cam4.1112. Epub 2017 Jul 18.
• [2006] Requirement of the transcription factor YB-1 for maintaining the stemness of cancer stem cells and reverting differentiated cancer cells into cancer stem cells.Stem Cell Res Ther. 2019 Aug 2;10(1):233. doi: 10.1186/s13287-019-1360-4.
• [2007] lncRNA PCAT-1 interacting with FZD6 contributes to the malignancy of acute myeloid leukemia cells through activating Wnt/-catenin signaling pathway.Am J Transl Res. 2019 Nov 15;11(11):7104-7114. eCollection 2019.
• [2008] Screening analysis of ubiquitin ligases reveals G2E3 as a potential target for chemosensitizing cancer cells.Oncotarget. 2015 Jan 20;6(2):617-32. doi: 10.18632/oncotarget.2710.
• [2009] MAPK-induced Gab1 translocation to the plasma membrane depends on a regulated intramolecular switch.Cell Signal. 2015 Feb;27(2):340-52. doi: 10.1016/j.cellsig.2014.11.017. Epub 2014 Nov 25.
• [2010] Genome-wide DNA Methylation Analysis Reveals GABBR2 as a Novel Epigenetic Target for EGFR 19 Deletion Lung Adenocarcinoma with Induction Erlotinib Treatment.Clin Cancer Res. 2017 Sep 1;23(17):5003-5014. doi: 10.1158/1078-0432.CCR-16-2688. Epub 2017 May 10.
• [2011] FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression.Clin Cancer Res. 2018 Feb 15;24(4):916-926. doi: 10.1158/1078-0432.CCR-17-1347. Epub 2017 Dec 7.
• [2012] The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer.Oncotarget. 2016 Mar 1;7(9):9859-75. doi: 10.18632/oncotarget.7126.
• [2013] Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink.Rheumatology (Oxford). 2017 May 1;56(5):753-762. doi: 10.1093/rheumatology/kew482.
• [2014] GDF11 Implications in Cancer Biology and Metabolism. Facts and Controversies.Front Oncol. 2019 Oct 15;9:1039. doi: 10.3389/fonc.2019.01039. eCollection 2019.
• [2015] Herpes Simplex Virus Glycoprotein D Targets a Specific Dendritic Cell Subset and Improves the Performance of Vaccines to Human Papillomavirus-Associated Tumors.Mol Cancer Ther. 2017 Sep;16(9):1922-1933. doi: 10.1158/1535-7163.MCT-17-0071. Epub 2017 May 18.
• [2016] Prognostic significance of preoperative albumin-to-globulin ratio in patients with cholangiocarcinoma.Curr Res Transl Med. 2017 Apr-Jun;65(2):83-87. doi: 10.1016/j.retram.2017.06.002. Epub 2017 Jul 3.
• [2017] Modulation of cellular bioenergetics by CO-releasing molecules and NO-donors inhibits the interaction of cancer cells with human lung microvascular endothelial cells.Pharmacol Res. 2018 Oct;136:160-171. doi: 10.1016/j.phrs.2018.09.005. Epub 2018 Sep 6.
• [2018] The Potential Role of Krppel-Like Zinc-Finger Protein Glis3 in Genetic Diseases and Cancers.Arch Immunol Ther Exp (Warsz). 2017 Oct;65(5):381-389. doi: 10.1007/s00005-017-0470-x. Epub 2017 May 18.
• [2019] Multiomics Analysis Reveals that GLS and GLS2 Differentially Modulate the Clinical Outcomes of Cancer.J Clin Med. 2019 Mar 13;8(3):355. doi: 10.3390/jcm8030355.
• [2020] -Ketoglutarate-Activated NF-B Signaling Promotes Compensatory Glucose Uptake and Brain Tumor Development.Mol Cell. 2019 Oct 3;76(1):148-162.e7. doi: 10.1016/j.molcel.2019.07.007. Epub 2019 Aug 22.
• [2021] Transforming growth factor- promotes aggressiveness and invasion of clear cell renal cell carcinoma.Oncotarget. 2016 Jun 14;7(24):35917-35931. doi: 10.18632/oncotarget.9177.
• [2022] Lidocaine inhibits the proliferation of lung cancer by regulating the expression of GOLT1A.Cell Prolif. 2017 Oct;50(5):e12364. doi: 10.1111/cpr.12364. Epub 2017 Jul 24.
• [2023] GPAA1 promotes gastric cancer progression via upregulation of GPI-anchored protein and enhancement of ERBB signalling pathway.J Exp Clin Cancer Res. 2019 May 22;38(1):214. doi: 10.1186/s13046-019-1218-8.
• [2024] Glycerol-3-phosphate Acyltransferase 1 Promotes Tumor Cell Migration and Poor Survival in Ovarian Carcinoma.Cancer Res. 2017 Sep 1;77(17):4589-4601. doi: 10.1158/0008-5472.CAN-16-2065. Epub 2017 Jun 26.
• [2025] The Expression, Regulation, and Biomarker Potential of Glypican-1 in Cancer.Front Oncol. 2019 Jul 12;9:614. doi: 10.3389/fonc.2019.00614. eCollection 2019.
• [2026] The FRA14B common fragile site maps to a region prone to somatic and germline rearrangements within the large GPHN gene.Genes Chromosomes Cancer. 2019 May;58(5):284-294. doi: 10.1002/gcc.22706. Epub 2018 Dec 20.
• [2027] Expression and functional role of orphan receptor GPR158 in prostate cancer growth and progression.PLoS One. 2015 Feb 18;10(2):e0117758. doi: 10.1371/journal.pone.0117758. eCollection 2015.
• [2028] GPR68: An Emerging Drug Target in Cancer.Int J Mol Sci. 2019 Jan 28;20(3):559. doi: 10.3390/ijms20030559.
• [2029] High levels of RAI3 expression is linked to shortened survival in esophageal cancer patients.Exp Mol Pathol. 2019 Apr;107:51-56. doi: 10.1016/j.yexmp.2019.01.013. Epub 2019 Jan 29.
• [2030] Addiction to Coupling of the Warburg Effect with Glutamine Catabolism in Cancer Cells.Cell Rep. 2016 Oct 11;17(3):821-836. doi: 10.1016/j.celrep.2016.09.045.
• [2031] Roles of Grainyhead-like transcription factors in cancer.Oncogene. 2017 Nov 2;36(44):6067-6073. doi: 10.1038/onc.2017.178. Epub 2017 Jul 17.
• [2032] GRWD1 directly interacts with p53 and negatively regulates p53 transcriptional activity.J Biochem. 2020 Jan 1;167(1):15-24. doi: 10.1093/jb/mvz075.
• [2033] The H2A.Z histone variant integrates Wnt signaling in intestinal epithelial homeostasis.Nat Commun. 2019 Apr 23;10(1):1827. doi: 10.1038/s41467-019-09899-z.
• [2034] A Novel Indication for Panobinostat as a Senolytic Drug in NSCLC and HNSCC.Sci Rep. 2017 May 15;7(1):1900. doi: 10.1038/s41598-017-01964-1.
• [2035] Genotoxic and Epigenotoxic Alterations in the Lung and Liver of Mice Induced by Acrylamide: A 28 Day Drinking Water Study.Chem Res Toxicol. 2019 May 20;32(5):869-877. doi: 10.1021/acs.chemrestox.9b00020. Epub 2019 Mar 12.
• [2036] Genome-scale identification of microRNA-related SNPs associated with risk of head and neck squamous cell carcinoma.Carcinogenesis. 2017 Oct 1;38(10):986-993. doi: 10.1093/carcin/bgx056.
• [2037] Dissecting the role of hyaluronan synthases in the tumor microenvironment.FEBS J. 2019 Aug;286(15):2937-2949. doi: 10.1111/febs.14847. Epub 2019 Apr 22.
• [2038] Matrix metalloproteinase-13is a target gene of high-mobility group box-containing protein 1 in modulating oral cancer cell invasion.J Cell Physiol. 2019 Apr;234(4):4375-4384. doi: 10.1002/jcp.27223. Epub 2018 Sep 7.
• [2039] Long noncoding RNA HCP5 suppresses skin cutaneous melanoma development by regulating RARRES3 gene expression via sponging miR-12.Onco Targets Ther. 2019 Aug 12;12:6323-6335. doi: 10.2147/OTT.S195796. eCollection 2019.
• [2040] The human HELLS chromatin remodelling protein promotes end resection to facilitate homologous recombination and contributes to DSB repair within heterochromatin.Nucleic Acids Res. 2020 Feb 28;48(4):1872-1885. doi: 10.1093/nar/gkz1146.
• [2041] HepaCAM Regulates Warburg Effect of Renal Cell Carcinoma via HIF-1/NF-B Signaling Pathway.Urology. 2019 May;127:61-67. doi: 10.1016/j.urology.2018.11.033. Epub 2018 Dec 4.
• [2042] STRAP Promotes Stemness of Human Colorectal Cancer via Epigenetic Regulation of the NOTCH Pathway.Cancer Res. 2017 Oct 15;77(20):5464-5478. doi: 10.1158/0008-5472.CAN-17-0286. Epub 2017 Aug 21.
• [2043] Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.PLoS One. 2017 Aug 2;12(8):e0180541. doi: 10.1371/journal.pone.0180541. eCollection 2017.
• [2044] Homozygous deletion of the death receptor DR4 gene in a nasopharyngeal cancer cell line is associated with TRAIL resistance.Int J Oncol. 2000 May;16(5):917-25. doi: 10.3892/ijo.16.5.917.
• [2045] Capturing the antigen landscape: HLA-E, CD1 and MR1.Curr Opin Immunol. 2019 Aug;59:121-129. doi: 10.1016/j.coi.2019.07.006. Epub 2019 Aug 21.
• [2046] Abnormal expression of HMGB-3 is significantly associated with malignant transformation of hepatocytes.World J Gastroenterol. 2018 Aug 28;24(32):3650-3662. doi: 10.3748/wjg.v24.i32.3650.
• [2047] Mutations of HNRNPA0 and WIF1 predispose members of a large family to multiple cancers.Fam Cancer. 2015 Jun;14(2):297-306. doi: 10.1007/s10689-014-9758-8.
• [2048] Berberine Promotes Apoptosis of Colorectal Cancer via Regulation of the Long Non-Coding RNA (lncRNA) Cancer Susceptibility Candidate 2 (CASC2)/AU-Binding Factor 1 (AUF1)/B-Cell CLL/Lymphoma 2 (Bcl-2) Axis.Med Sci Monit. 2019 Jan 25;25:730-738. doi: 10.12659/MSM.912082.
• [2049] hnRNPM induces translation switch under hypoxia to promote colon cancer development.EBioMedicine. 2019 Mar;41:299-309. doi: 10.1016/j.ebiom.2019.02.059. Epub 2019 Mar 7.
• [2050] HORMAD1 Is a Negative Prognostic Indicator in Lung Adenocarcinoma and Specifies Resistance to Oxidative and Genotoxic Stress.Cancer Res. 2018 Nov 1;78(21):6196-6208. doi: 10.1158/0008-5472.CAN-18-1377. Epub 2018 Sep 5.
• [2051] HOXA1 upregulation is associated with poor prognosis and tumor progression in breast cancer.Exp Ther Med. 2019 Mar;17(3):1896-1902. doi: 10.3892/etm.2018.7145. Epub 2018 Dec 28.
• [2052] Deregulated HOXB7 expression predicts poor prognosis of patients with malignancies of digestive system.Minerva Chir. 2019 Oct;74(5):422-430. doi: 10.23736/S0026-4733.17.07325-4. Epub 2017 Jul 26.
• [2053] HOXC10 promotes migration and invasion via the WNT-EMT signaling pathway in oral squamous cell carcinoma.J Cancer. 2019 Jul 25;10(19):4540-4551. doi: 10.7150/jca.30645. eCollection 2019.
• [2054] HOXC8 regulates self-renewal, differentiation and transformation of breast cancer stem cells.Mol Cancer. 2017 Feb 16;16(1):38. doi: 10.1186/s12943-017-0605-z.
• [2055] Heat-shock factor 2 is a suppressor of prostate cancer invasion.Oncogene. 2016 Apr 7;35(14):1770-84. doi: 10.1038/onc.2015.241. Epub 2015 Jun 29.
• [2056] Low penetrance alleles as risk modifiers in familial and sporadic breast cancer.Fam Cancer. 2012 Dec;11(4):629-36. doi: 10.1007/s10689-012-9563-1.
• [2057] Expression of IARS2 gene in colon cancer and effect of its knockdown on biological behavior of RKO cells.Int J Clin Exp Pathol. 2015 Oct 1;8(10):12151-9. eCollection 2015.
• [2058] Inhibitor of DNA-Binding Protein 4 Suppresses Cancer Metastasis through the Regulation of Epithelial Mesenchymal Transition in Lung Adenocarcinoma.Cancers (Basel). 2019 Dec 14;11(12):2021. doi: 10.3390/cancers11122021.
• [2059] IER5 generates a novel hypo-phosphorylated active form of HSF1 and contributes to tumorigenesis.Sci Rep. 2016 Jan 12;6:19174. doi: 10.1038/srep19174.
• [2060] IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.BMC Cancer. 2018 May 30;18(1):609. doi: 10.1186/s12885-018-4529-9.
• [2061] IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling.Oncogene. 2019 Apr;38(17):3232-3247. doi: 10.1038/s41388-018-0662-9. Epub 2019 Jan 9.
• [2062] High IFITM3 expression predicts adverse prognosis in acute myeloid leukemia.Cancer Gene Ther. 2020 Feb;27(1-2):38-44. doi: 10.1038/s41417-019-0093-y. Epub 2019 Mar 29.
• [2063] Deficiency of interferon-gamma or its receptor promotes colorectal cancer development.J Interferon Cytokine Res. 2015 Apr;35(4):273-80. doi: 10.1089/jir.2014.0132. Epub 2014 Nov 10.
• [2064] An NF-kappaB- and IKK-Independent Function of NEMO Prevents Hepatocarcinogenesis by Suppressing Compensatory Liver Regeneration.Cancers (Basel). 2019 Jul 17;11(7):999. doi: 10.3390/cancers11070999.
• [2065] IL22 furthers malignant transformation of rat mesenchymal stem cells, possibly in association with IL22RA1/STAT3 signaling.Oncol Rep. 2019 Apr;41(4):2148-2158. doi: 10.3892/or.2019.7007. Epub 2019 Feb 11.
• [2066] ING5 inhibits cancer aggressiveness by inhibiting Akt and activating p53 in prostate cancer.Cell Biol Int. 2020 Jan;44(1):242-252. doi: 10.1002/cbin.11227. Epub 2019 Sep 10.
• [2067] A compartmentalized phosphoinositide signaling axis at cilia is regulated by INPP5E to maintain cilia and promote Sonic Hedgehog medulloblastoma.Oncogene. 2017 Oct 26;36(43):5969-5984. doi: 10.1038/onc.2017.208. Epub 2017 Jun 26.
• [2068] Descending-SHIP2-mediated radiosensitivity enhancement through PI3K/Akt signaling pathway in laryngeal squamous cell carcinoma.Biomed Pharmacother. 2019 Oct;118:109392. doi: 10.1016/j.biopha.2019.109392. Epub 2019 Aug 29.
• [2069] Elements of Palliative Care in the Last 6Months of Life: Frequency, Predictors, and Timing.J Gen Intern Med. 2020 Mar;35(3):753-761. doi: 10.1007/s11606-019-05349-0. Epub 2019 Oct 24.
• [2070] Inversin correlates with the malignant phenotype of non-small cell lung cancer and promotes the invasiveness of lung cancer cells.Tumour Biol. 2017 Jun;39(6):1010428317691177. doi: 10.1177/1010428317691177.
• [2071] Elevated levels of RanBP7 mRNA in colorectal carcinoma are associated with increased proliferation and are similar to the transcription pattern of the proto-oncogene c-myc.Biochem Biophys Res Commun. 2000 May 10;271(2):537-43. doi: 10.1006/bbrc.2000.2666.
• [2072] A promising role of interferon regulatory factor 5 as an early warning biomarker for the development of human non-small cell lung cancer.Lung Cancer. 2019 Sep;135:47-55. doi: 10.1016/j.lungcan.2019.07.008. Epub 2019 Jul 9.
• [2073] The discovery of potent and stable short peptide FGFR1 antagonist for cancer therapy.Eur J Pharm Sci. 2020 Feb 15;143:105179. doi: 10.1016/j.ejps.2019.105179. Epub 2019 Dec 10.
• [2074] A Phase Ib Study of Preoperative, Locoregional IRX-2 Cytokine Immunotherapy to Prime Immune Responses in Patients with Early-Stage Breast Cancer.Clin Cancer Res. 2020 Apr 1;26(7):1595-1605. doi: 10.1158/1078-0432.CCR-19-1119. Epub 2019 Dec 12.
• [2075] Knockdown of ISOC1 suppresses cell proliferation in pancreatic cancer in vitro.Oncol Lett. 2019 May;17(5):4263-4270. doi: 10.3892/ol.2019.10082. Epub 2019 Feb 28.
• [2076] Intestine-specific homeobox (ISX) induces intestinal metaplasia and cell proliferation to contribute to gastric carcinogenesis.J Gastroenterol. 2016 Oct;51(10):949-60. doi: 10.1007/s00535-016-1176-2. Epub 2016 Feb 12.
• [2077] Integrin-10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade Myxofibrosarcoma.Cancer Discov. 2016 Oct;6(10):1148-1165. doi: 10.1158/2159-8290.CD-15-1481. Epub 2016 Aug 30.
• [2078] Integrin -3 -1's central role in breast cancer, melanoma and glioblastoma cell aggregation revealed by antibodies with blocking activity.MAbs. 2019 May/Jun;11(4):691-708. doi: 10.1080/19420862.2019.1583987. Epub 2019 Apr 16.
• [2079] Integrin 7 correlates with worse clinical features and prognosis, and its knockdown inhibits cell proliferation and stemness in tongue squamous cell carcinoma.Int J Oncol. 2020 Jan;56(1):69-84. doi: 10.3892/ijo.2019.4927. Epub 2019 Nov 29.
• [2080] Integrin-5, a miR-185-targeted gene, promotes hepatocellular carcinoma tumorigenesis by regulating -catenin stability.J Exp Clin Cancer Res. 2018 Jan 31;37(1):17. doi: 10.1186/s13046-018-0691-9.
• [2081] Inositol-1,4,5-trisphosphate 3-kinase-A (ITPKA) is frequently over-expressed and functions as an oncogene in several tumor types.Biochem Pharmacol. 2017 Aug 1;137:1-9. doi: 10.1016/j.bcp.2017.03.023. Epub 2017 Apr 2.
• [2082] Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1.Eur J Immunol. 2017 Jul;47(7):1108-1118. doi: 10.1002/eji.201646903. Epub 2017 Jun 12.
• [2083] Dihydroartemisinin inhibits prostate cancer via JARID2/miR-7/miR-34a-dependent downregulation of Axl.Oncogenesis. 2019 Feb 19;8(3):14. doi: 10.1038/s41389-019-0122-6.
• [2084] JCAD Promotes Progression of Nonalcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity.Cancer Res. 2017 Oct 1;77(19):5287-5300. doi: 10.1158/0008-5472.CAN-17-0229. Epub 2017 Aug 3.
• [2085] A novel HIF1AN substrate KANK3 plays a tumor-suppressive role in hepatocellular carcinoma.Cell Biol Int. 2018 Mar;42(3):303-312. doi: 10.1002/cbin.10895. Epub 2017 Nov 15.
• [2086] TIP60-dependent acetylation of the SPZ1-TWIST complex promotes epithelial-mesenchymal transition and metastasis in liver cancer.Oncogene. 2019 Jan;38(4):518-532. doi: 10.1038/s41388-018-0457-z. Epub 2018 Aug 28.
• [2087] Cyclin D-CDK4 relieves cooperative repression of proliferation and cell cycle gene expression by DREAM and RB.Oncogene. 2019 Jun;38(25):4962-4976. doi: 10.1038/s41388-019-0767-9. Epub 2019 Mar 4.
• [2088] KDM4B: A Nail for Every Hammer?.Genes (Basel). 2019 Feb 12;10(2):134. doi: 10.3390/genes10020134.
• [2089] Effects of KIF2A on the prognosis of nasopharyngeal carcinoma and nasopharyngeal carcinoma cells.Oncol Lett. 2019 Sep;18(3):2718-2723. doi: 10.3892/ol.2019.10597. Epub 2019 Jul 9.
• [2090] Simul-seq: combined DNA and RNA sequencing for whole-genome and transcriptome profiling.Nat Methods. 2016 Nov;13(11):953-958. doi: 10.1038/nmeth.4028. Epub 2016 Oct 10.
• [2091] Loss of KLF14 triggers centrosome amplification and tumorigenesis.Nat Commun. 2015 Oct 6;6:8450. doi: 10.1038/ncomms9450.
• [2092] KLF16 promotes proliferation in gastric cancer cells via regulating p21 and CDK4.Am J Transl Res. 2017 Jun 15;9(6):3027-3036. eCollection 2017.
• [2093] Low expression of KLF17 is associated with tumor invasion in esophageal carcinoma.Int J Clin Exp Pathol. 2015 Sep 1;8(9):11157-63. eCollection 2015.
• [2094] Downregulation of Kruppel-like factor 2 is associated with poor prognosis for nonsmall-cell lung cancer.Tumour Biol. 2015 Apr;36(4):3075-84. doi: 10.1007/s13277-014-2943-4. Epub 2014 Dec 14.
• [2095] THBS4 predicts poor outcomes and promotes proliferation and metastasis in gastric cancer.J Physiol Biochem. 2019 Feb;75(1):117-123. doi: 10.1007/s13105-019-00665-9. Epub 2019 Feb 12.
• [2096] Prognostic value and clinicopathological significance of serum- and tissue-based cytokeratin 18 express level in breast cancer: a meta-analysis.Biosci Rep. 2018 Mar 21;38(2):BSR20171145. doi: 10.1042/BSR20171145. Print 2018 Apr 27.
• [2097] The expression of keratin 6 is regulated by the activation of the ERK1/2 pathway in arsenite transformed human urothelial cells.Toxicol Appl Pharmacol. 2017 Sep 15;331:41-53. doi: 10.1016/j.taap.2017.05.007. Epub 2017 May 10.
• [2098] LAMPs: Shedding light on cancer biology.Semin Oncol. 2017 Aug;44(4):239-253. doi: 10.1053/j.seminoncol.2017.10.013. Epub 2017 Nov 4.
• [2099] The RNA-binding protein LARP4 regulates cancer cell migration and invasion.Cytoskeleton (Hoboken). 2016 Nov;73(11):680-690. doi: 10.1002/cm.21336. Epub 2016 Sep 26.
• [2100] Consequences of Lamin B1 and Lamin B Receptor Downregulation in Senescence.Cells. 2018 Feb 6;7(2):11. doi: 10.3390/cells7020011.
• [2101] Importance of RIP140 and LCoR Sub-Cellular Localization for Their Association With Breast Cancer Aggressiveness and Patient Survival.Transl Oncol. 2018 Oct;11(5):1090-1096. doi: 10.1016/j.tranon.2018.06.006. Epub 2018 Jul 11.
• [2102] Dual inhibition of ABCE1 and LCP1 by microRNA-96 results in an additive effect in breast cancer mouse model.Oncotarget. 2019 Mar 12;10(21):2086-2094. doi: 10.18632/oncotarget.26747. eCollection 2019 Mar 12.
• [2103] Novel STAT3 Inhibitor LDOC1 Targets Phospho-JAK2 for Degradation by Interacting with LNX1 and Regulates the Aggressiveness of Lung Cancer.Cancers (Basel). 2019 Jan 9;11(1):63. doi: 10.3390/cancers11010063.
• [2104] LEM domain containing 1 promotes oral squamous cell carcinoma invasion and endothelial transmigration.Br J Cancer. 2016 Jun 28;115(1):52-8. doi: 10.1038/bjc.2016.167. Epub 2016 Jun 9.
• [2105] LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma.Exp Mol Pathol. 2020 Feb;112:104333. doi: 10.1016/j.yexmp.2019.104333. Epub 2019 Nov 6.
• [2106] Lhx3 is required to maintain cancer cell development of high-grade oligodendroglioma.Mol Cell Biochem. 2015 Jan;399(1-2):1-5. doi: 10.1007/s11010-014-2209-x. Epub 2014 Nov 16.
• [2107] Silencing of LIMD1 promotes proliferation and reverses cell adhesion-mediated drug resistance in non-Hodgkin's lymphoma.Oncol Lett. 2019 Mar;17(3):2993-3000. doi: 10.3892/ol.2019.9921. Epub 2019 Jan 11.
• [2108] Multifocal gastric adenocarcinoma in a patient with LRBA deficiency.Orphanet J Rare Dis. 2017 Jul 18;12(1):131. doi: 10.1186/s13023-017-0682-5.
• [2109] Agrin to YAP in Cancer and Neuromuscular Junctions.Trends Cancer. 2017 Apr;3(4):247-248. doi: 10.1016/j.trecan.2017.03.005. Epub 2017 Mar 28.
• [2110] Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15(+) Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy.Cancer Discov. 2020 Feb;10(2):232-253. doi: 10.1158/2159-8290.CD-19-0644. Epub 2019 Nov 7.
• [2111] Frequent downregulation of LRRC26 by epigenetic alterations is involved in the malignant progression of triple-negative breast cancer.Int J Oncol. 2018 May;52(5):1539-1558. doi: 10.3892/ijo.2018.4301. Epub 2018 Mar 5.
• [2112] A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression.Surgery. 2005 Dec;138(6):1050-6; discussion 1056-7. doi: 10.1016/j.surg.2005.09.010.
• [2113] Tricellular tight junction protein LSR/angulin-1 contributes to the epithelial barrier and malignancy in human pancreatic cancer cell line.Histochem Cell Biol. 2020 Jan;153(1):5-16. doi: 10.1007/s00418-019-01821-4. Epub 2019 Oct 24.
• [2114] Latent Transforming Growth Factor Binding Protein 2 (LTBP2) as a Novel Biomarker for the Diagnosis and Prognosis of Pancreatic Carcinoma.Med Sci Monit. 2017 Jul 3;23:3232-3239. doi: 10.12659/msm.905284.
• [2115] Cumulative asbestos exposure and mortality from asbestos related diseases in a pooled analysis of 21 asbestos cement cohorts in Italy.Environ Health. 2019 Aug 7;18(1):71. doi: 10.1186/s12940-019-0510-6.
• [2116] MTA1 promotes tumorigenesis and development of esophageal squamous cell carcinoma via activating the MEK/ERK/p90RSK signaling pathway.Carcinogenesis. 2020 Sep 24;41(9):1263-1272. doi: 10.1093/carcin/bgz200.
• [2117] Wnt5a signaling induced phosphorylation increases APT1 activity and promotes melanoma metastatic behavior.Elife. 2018 Apr 12;7:e34362. doi: 10.7554/eLife.34362.
• [2118] MADD silencing enhances anti-tumor activity of TRAIL in anaplastic thyroid cancer.Endocr Relat Cancer. 2019 Jun 1;26(6):551-563. doi: 10.1530/ERC-18-0517.
• [2119] Giant Pediatric Rhabdoid Meningioma Associated with a Germline BAP1 Pathogenic Variation: A Rare Clinical Case.World Neurosurg. 2018 Nov;119:402-415. doi: 10.1016/j.wneu.2018.06.227. Epub 2018 Jul 6.
• [2120] On The Role of Myelin and Lymphocyte Protein (MAL) In Cancer: A Puzzle With Two Faces.J Cancer. 2019 May 21;10(10):2312-2318. doi: 10.7150/jca.30376. eCollection 2019.
• [2121] Recombinant attenuated Salmonella typhimurium carrying a plasmid co-expressing ENDO-VEGI151 and survivin siRNA inhibits the growth of breast cancer in vivo.Mol Med Rep. 2013 Apr;7(4):1215-22. doi: 10.3892/mmr.2013.1308. Epub 2013 Feb 5.
• [2122] A cancer associated somatic mutation in LC3B attenuates its binding to E1-like ATG7 protein and subsequent lipidation.Autophagy. 2019 Mar;15(3):438-452. doi: 10.1080/15548627.2018.1525476. Epub 2018 Oct 8.
• [2123] Autophagosome Proteins LC3A, LC3B and LC3C Have Distinct Subcellular Distribution Kinetics and Expression in Cancer Cell Lines.PLoS One. 2015 Sep 17;10(9):e0137675. doi: 10.1371/journal.pone.0137675. eCollection 2015.
• [2124] Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis.Breast Cancer Res Treat. 2019 Feb;173(3):573-583. doi: 10.1007/s10549-018-5026-1. Epub 2018 Oct 27.
• [2125] Applications of mid-infrared spectroscopy in the clinical laboratory setting.Crit Rev Clin Lab Sci. 2018 Jan;55(1):1-20. doi: 10.1080/10408363.2017.1414142. Epub 2017 Dec 14.
• [2126] Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4).J Biomol Struct Dyn. 2019 Apr;37(7):1813-1829. doi: 10.1080/07391102.2018.1468282. Epub 2018 May 24.
• [2127] Purification, characterization and biological significance of mannose binding lectin from Dioscorea bulbifera bulbils.Int J Biol Macromol. 2017 Sep;102:1146-1155. doi: 10.1016/j.ijbiomac.2017.04.085. Epub 2017 May 1.
• [2128] Over expression of DNA damage and cell cycle dependent proteins are associated with poor survival in patients with adrenocortical carcinoma.Surgery. 2019 Jan;165(1):202-210. doi: 10.1016/j.surg.2018.04.080. Epub 2018 Nov 7.
• [2129] Inhibiting the MCM8-9 complex selectively sensitizes cancer cells to cisplatin and olaparib.Cancer Sci. 2019 Mar;110(3):1044-1053. doi: 10.1111/cas.13941. Epub 2019 Feb 14.
• [2130] MDGA2 is a novel tumour suppressor cooperating with DMAP1 in gastric cancer and is associated with disease outcome.Gut. 2016 Oct;65(10):1619-31. doi: 10.1136/gutjnl-2015-309276. Epub 2015 Jul 23.
• [2131] Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility.Genet Med. 2015 Jun;17(6):485-92. doi: 10.1038/gim.2014.134. Epub 2014 Oct 9.
• [2132] Low risk of solid tumors in persons with Down syndrome.Genet Med. 2016 Nov;18(11):1151-1157. doi: 10.1038/gim.2016.23. Epub 2016 Mar 31.
• [2133] Down-regulation of mediator complex subunit 19 (Med19) induces apoptosis in human laryngocarcinoma HEp2 cells in an Apaf-1-dependent pathway.Am J Transl Res. 2017 Feb 15;9(2):755-761. eCollection 2017.
• [2134] MEGSA: A Powerful and Flexible Framework for Analyzing Mutual Exclusivity of Tumor Mutations.Am J Hum Genet. 2016 Mar 3;98(3):442-455. doi: 10.1016/j.ajhg.2015.12.021. Epub 2016 Feb 18.
• [2135] MEF-2 isoforms' (A-D) roles in development and tumorigenesis.Oncotarget. 2019 Apr 12;10(28):2755-2787. doi: 10.18632/oncotarget.26763. eCollection 2019 Apr 12.
• [2136] MEIS1 knockdown may promote differentiation of esophageal squamous carcinoma cell line KYSE-30.Mol Genet Genomic Med. 2019 Jul;7(7):e00746. doi: 10.1002/mgg3.746. Epub 2019 May 14.
• [2137] Homozygous microdeletion of the ERI1 and MFHAS1 genes in a patient with intellectual disability, limb abnormalities, and cardiac malformation.Am J Med Genet A. 2017 Jul;173(7):1955-1960. doi: 10.1002/ajmg.a.38271. Epub 2017 May 9.
• [2138] Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancy.Sci Rep. 2019 Aug 19;9(1):11992. doi: 10.1038/s41598-019-48229-7.
• [2139] Combined pharmacological administration of AQP1 ion channel blocker AqB011 and water channel blocker Bacopaside II amplifies inhibition of colon cancer cell migration.Sci Rep. 2019 Sep 2;9(1):12635. doi: 10.1038/s41598-019-49045-9.
• [2140] Interferons Transcriptionally Up-Regulate MLKL Expression in Cancer Cells.Neoplasia. 2019 Jan;21(1):74-81. doi: 10.1016/j.neo.2018.11.002. Epub 2018 Dec 3.
• [2141] Matrix metalloproteinases 15 and 19 are stromal regulators of colorectal cancer development from the early stages.Int J Oncol. 2012 Jul;41(1):260-6. doi: 10.3892/ijo.2012.1441. Epub 2012 Apr 19.
• [2142] Activation of FGF receptor signaling promotes invasion of non-small-cell lung cancer.Tumour Biol. 2015 May;36(5):3637-42. doi: 10.1007/s13277-014-3001-y. Epub 2015 Jan 8.
• [2143] Immunity, Hypoxia, and Metabolism-the Mnage Trois of Cancer: Implications for Immunotherapy.Physiol Rev. 2020 Jan 1;100(1):1-102. doi: 10.1152/physrev.00018.2019. Epub 2019 Aug 15.
• [2144] RGS12 Is a Novel Tumor-Suppressor Gene in African American Prostate Cancer That Represses AKT and MNX1 Expression. Cancer Res. 2017 Aug 15;77(16):4247-4257.
• [2145] Infertility and Health-Related Quality of Life in United States Women Veterans.J Womens Health (Larchmt). 2020 Mar;29(3):412-419. doi: 10.1089/jwh.2019.7798. Epub 2019 Nov 22.
• [2146] Newly characterized motile sperm domain-containing protein 2 promotes human breast cancer metastasis.Int J Cancer. 2019 Jan 1;144(1):125-135. doi: 10.1002/ijc.31665. Epub 2018 Oct 29.
• [2147] Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?.Front Immunol. 2019 Feb 12;10:9. doi: 10.3389/fimmu.2019.00009. eCollection 2019.
• [2148] Potential role of the 3-mercaptopyruvate sulfurtransferase (3-MST)-hydrogen sulfide (H(2)S) pathway in cancer cells.Pharmacol Res. 2020 Apr;154:104083. doi: 10.1016/j.phrs.2018.11.034. Epub 2018 Nov 27.
• [2149] Rta-IgG as a biomarker for diagnosis and post treatment prognostic of nasopharyngeal carcinoma.Cancer Biomark. 2016;16(3):467-76. doi: 10.3233/CBM-160586.
• [2150] Ataxia-Telangiectasia Mutated Kinase in the Control of Oxidative Stress, Mitochondria, and Autophagy in Cancer: A Maestro With a Large Orchestra.Front Oncol. 2018 Mar 16;8:73. doi: 10.3389/fonc.2018.00073. eCollection 2018.
• [2151] Role for High-Affinity IgE Receptor in Prognosis of Lung Adenocarcinoma Patients.Cancer Immunol Res. 2017 Sep;5(9):821-829. doi: 10.1158/2326-6066.CIR-16-0392. Epub 2017 Aug 3.
• [2152] Characterization of the expression of HTm4 (MS4A3), a cell cycle regulator, in human peripheral blood cells and normal and malignant tissues.J Cell Mol Med. 2011 Jan;15(1):86-93. doi: 10.1111/j.1582-4934.2009.00925.x.
• [2153] Patient perspectives on molecular tumor profiling: "Why wouldn't you?".BMC Cancer. 2019 Jul 31;19(1):753. doi: 10.1186/s12885-019-5920-x.
• [2154] MTHFD1 interaction with BRD4 links folate metabolism to transcriptional regulation.Nat Genet. 2019 Jun;51(6):990-998. doi: 10.1038/s41588-019-0413-z. Epub 2019 May 27.
• [2155] PIKfyve, MTMR3 and their product PtdIns5P regulate cancer cell migration and invasion through activation of Rac1.Biochem J. 2014 Aug 1;461(3):383-90. doi: 10.1042/BJ20140132.
• [2156] High expression of diffuse panbronchiolitis critical region 1 gene promotes cell proliferation, migration and invasion in pancreatic ductal adenocarcinoma.Biochem Biophys Res Commun. 2018 Jan 8;495(2):1908-1914. doi: 10.1016/j.bbrc.2017.12.031. Epub 2017 Dec 11.
• [2157] Structural analysis of tumor-related single amino acid mutations in human MxA protein.Chin J Cancer. 2015 Sep 28;34(12):583-93. doi: 10.1186/s40880-015-0055-1.
• [2158] Pathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancers.Br J Haematol. 2017 Dec;179(5):724-738. doi: 10.1111/bjh.14917. Epub 2017 Nov 24.
• [2159] The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma.J Pathol. 2016 Sep;240(1):3-14. doi: 10.1002/path.4745.
• [2160] Myosin Heavy Chain 9: Oncogene or Tumor Suppressor Gene?.Med Sci Monit. 2019 Jan 31;25:888-892. doi: 10.12659/MSM.912320.
• [2161] Competition between two high- and low-affinity protein-binding sites in myosin VI controls its cellular function.J Biol Chem. 2020 Jan 10;295(2):337-347. doi: 10.1074/jbc.RA119.010142. Epub 2019 Nov 19.
• [2162] Myeloid zinc finger-1 regulates expression of cancer-associated fibroblast and cancer stemness profiles in breast cancer.Surgery. 2019 Oct;166(4):515-523. doi: 10.1016/j.surg.2019.05.042. Epub 2019 Jul 10.
• [2163] NEDD 4 binding protein 2-like 1 promotes cancer cell invasion in oral squamous cell carcinoma.Virchows Arch. 2016 Aug;469(2):163-72. doi: 10.1007/s00428-016-1955-4. Epub 2016 May 16.
• [2164] Diverse roles of arrest defective 1 in cancer development.Arch Pharm Res. 2019 Dec;42(12):1040-1051. doi: 10.1007/s12272-019-01195-0. Epub 2019 Dec 7.
• [2165] A homozygous mutation in CMAS causes autosomal recessive intellectual disability in a Kazakh family.Ann Hum Genet. 2020 Jan;84(1):46-53. doi: 10.1111/ahg.12349. Epub 2019 Sep 8.
• [2166] B7H6 is a functional ligand for NKp30 in rat and cattle and determines NKp30 reactivity toward human cancer cell lines.Eur J Immunol. 2019 Jan;49(1):54-65. doi: 10.1002/eji.201847746. Epub 2018 Dec 13.
• [2167] NDRG4 in gastric cancer determines tumor cell proliferation and clinical outcome.Mol Carcinog. 2018 Jun;57(6):762-771. doi: 10.1002/mc.22798. Epub 2018 Mar 24.
• [2168] NECAB3 Promotes Activation of Hypoxia-inducible factor-1 during Normoxia and Enhances Tumourigenicity of Cancer Cells.Sci Rep. 2016 Mar 7;6:22784. doi: 10.1038/srep22784.
• [2169] Abnormal Expressions of DNA Glycosylase Genes NEIL1, NEIL2, and NEIL3 Are Associated with Somatic Mutation Loads in Human Cancer.Oxid Med Cell Longev. 2016;2016:1546392. doi: 10.1155/2016/1546392. Epub 2016 Mar 3.
• [2170] Associations of the Intellectual Disability Gene MYT1L with Helix-Loop-Helix Gene Expression, Hippocampus Volume and Hippocampus Activation During Memory Retrieval.Neuropsychopharmacology. 2017 Dec;42(13):2516-2526. doi: 10.1038/npp.2017.91. Epub 2017 May 4.
• [2171] NFAT5 promotes invivo development of murine melanoma metastasis.Biochem Biophys Res Commun. 2018 Nov 2;505(3):748-754. doi: 10.1016/j.bbrc.2018.09.171. Epub 2018 Oct 5.
• [2172] Phosphorylation of NFATC1 at PIM1 target sites is essential for its ability to promote prostate cancer cell migration and invasion.Cell Commun Signal. 2019 Nov 15;17(1):148. doi: 10.1186/s12964-019-0463-y.
• [2173] Stress and interferon signalling-mediated apoptosis contributes to pleiotropic anticancer responses induced by targeting NGLY1.Br J Cancer. 2018 Dec;119(12):1538-1551. doi: 10.1038/s41416-018-0265-9. Epub 2018 Nov 2.
• [2174] Two different protein expression profiles of oral squamous cell carcinoma analyzed by immunoprecipitation high-performance liquid chromatography.World J Surg Oncol. 2017 Aug 8;15(1):151. doi: 10.1186/s12957-017-1213-5.
• [2175] Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics.Nat Commun. 2016 Jun 14;7:11889. doi: 10.1038/ncomms11889.
• [2176] NLRC3 inhibits MCT-induced pulmonary hypertension in rats via attenuating PI3K activation.J Cell Physiol. 2019 Sep;234(9):15963-15976. doi: 10.1002/jcp.28255. Epub 2019 Feb 14.
• [2177] Development of a Risk Score to Predict Anastomotic Leak After Left-Sided Colectomy: Which Patients Warrant Diversion?.J Gastrointest Surg. 2020 Jan;24(1):132-143. doi: 10.1007/s11605-019-04293-y. Epub 2019 Jun 26.
• [2178] Neuronatin gene: Imprinted and misfolded: Studies in Lafora disease, diabetes and cancer may implicate NNAT-aggregates as a common downstream participant in neuronal loss.Genomics. 2014 Feb-Mar;103(2-3):183-8. doi: 10.1016/j.ygeno.2013.12.001. Epub 2013 Dec 15.
• [2179] NOX5: Molecular biology and pathophysiology.Exp Physiol. 2019 May;104(5):605-616. doi: 10.1113/EP086204. Epub 2019 Mar 18.
• [2180] Functional polymorphisms in circadian positive feedback loop genes predict postsurgical prognosis of gastric cancer.Cancer Med. 2019 Apr;8(4):1919-1929. doi: 10.1002/cam4.2050. Epub 2019 Mar 7.
• [2181] Morphology based scoring of chromosomal instability and its correlation with cell viability.Pathol Res Pract. 2017 Sep;213(9):1231-1234. doi: 10.1016/j.prp.2017.06.015. Epub 2017 Jul 1.
• [2182] The SIAH2-NRF1 axis spatially regulates tumor microenvironment remodeling for tumor progression.Nat Commun. 2019 Mar 4;10(1):1034. doi: 10.1038/s41467-019-08618-y.
• [2183] An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia.Oncogene. 2019 Jan;38(5):671-686. doi: 10.1038/s41388-018-0474-y. Epub 2018 Aug 31.
• [2184] Trivial role for NSMCE2 during in vitro proliferation and differentiation of male germline stem cells.Reproduction. 2017 Sep;154(3):181-195. doi: 10.1530/REP-17-0173. Epub 2017 Jun 2.
• [2185] Expression profiles of long noncoding RNAs associated with the NSUN2 gene in HepG2 cells.Mol Med Rep. 2019 Apr;19(4):2999-3008. doi: 10.3892/mmr.2019.9984. Epub 2019 Feb 25.
• [2186] NUDT2 Disruption Elevates Diadenosine Tetraphosphate (Ap4A) and Down-Regulates Immune Response and Cancer Promotion Genes.PLoS One. 2016 May 4;11(5):e0154674. doi: 10.1371/journal.pone.0154674. eCollection 2016.
• [2187] Inhibition of nucleoporin member Nup214 expression by miR-133b perturbs mitotic timing and leads to cell death.Mol Cancer. 2015 Feb 15;14:42. doi: 10.1186/s12943-015-0299-z.
• [2188] Mapping of a Mycoplasma-Neutralizing Epitope on the Mycoplasmal p37 Protein.PLoS One. 2016 Dec 30;11(12):e0169091. doi: 10.1371/journal.pone.0169091. eCollection 2016.
• [2189] Extracellular 2'5'-oligoadenylate synthetase 2 mediates T-cell receptor CD3- chain down-regulation via caspase-3 activation in oral cancer.Immunology. 2016 Feb;147(2):251-64. doi: 10.1111/imm.12560. Epub 2015 Dec 27.
• [2190] Measles virus phosphoprotein inhibits apoptosis and enhances clonogenic and migratory properties in HeLa cells.J Biosci. 2019 Mar;44(1):10.
• [2191] OCIAD1 promoted pancreatic ductal adenocarcinoma migration by regulating ATM.Pancreatology. 2019 Jul;19(5):751-759. doi: 10.1016/j.pan.2019.01.009. Epub 2019 Jan 31.
• [2192] Expression of natural killer cell regulatory microRNA by uveal melanoma cancer stem cells.Clin Exp Metastasis. 2016 Dec;33(8):829-838. doi: 10.1007/s10585-016-9815-9. Epub 2016 Aug 26.
• [2193] The Deubiquitylase OTUB1 Mediates Ferroptosis via Stabilization of SLC7A11.Cancer Res. 2019 Apr 15;79(8):1913-1924. doi: 10.1158/0008-5472.CAN-18-3037. Epub 2019 Feb 1.
• [2194] In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type.Cancer. 2016 May 15;122(10):1513-22. doi: 10.1002/cncr.29959. Epub 2016 Mar 8.
• [2195] OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.Theranostics. 2018 Mar 8;8(8):2202-2216. doi: 10.7150/thno.24003. eCollection 2018.
• [2196] Nucleus-Targeted Organoiridium-Albumin Conjugate for Photodynamic Cancer Therapy.Angew Chem Int Ed Engl. 2019 Feb 18;58(8):2350-2354. doi: 10.1002/anie.201813002. Epub 2019 Jan 21.
• [2197] The role of OXCT1 in the pathogenesis of cancer as a rate-limiting enzyme of ketone body metabolism.Life Sci. 2017 Aug 15;183:110-115. doi: 10.1016/j.lfs.2017.07.003. Epub 2017 Jul 4.
• [2198] Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel.J Transl Med. 2017 Jun 29;15(1):149. doi: 10.1186/s12967-017-1248-y.
• [2199] Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface.Cancer Res. 2019 Nov 1;79(21):5652-5667. doi: 10.1158/0008-5472.CAN-19-1112. Epub 2019 Sep 9.
• [2200] Arginine Citrullination at the C-Terminal Domain Controls RNA Polymerase II Transcription.Mol Cell. 2019 Jan 3;73(1):84-96.e7. doi: 10.1016/j.molcel.2018.10.016. Epub 2018 Nov 21.
• [2201] Cis and trans interactions between genes encoding PAF1 complex and ESCRT machinery components in yeast.Curr Genet. 2018 Oct;64(5):1105-1116. doi: 10.1007/s00294-018-0828-6. Epub 2018 Mar 22.
• [2202] Human p21-activated kinase 5 (PAK5) expression and potential mechanisms in relevant cancers: Basic and clinical perspectives for molecular cancer therapeutics.Life Sci. 2020 Jan 15;241:117113. doi: 10.1016/j.lfs.2019.117113. Epub 2019 Dec 2.
• [2203] Panx3 links body mass index and tumorigenesis in a genetically heterogeneous mouse model of carcinogen-induced cancer.Genome Med. 2016 Aug 9;8(1):83. doi: 10.1186/s13073-016-0334-8.
• [2204] Clinical, pathological, and genomic features ofEWSR1-PATZ1 fusion sarcoma.Mod Pathol. 2019 Nov;32(11):1593-1604. doi: 10.1038/s41379-019-0301-1. Epub 2019 Jun 12.
• [2205] UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer.Cancers (Basel). 2018 Aug 8;10(8):262. doi: 10.3390/cancers10080262.
• [2206] PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer.Mol Cancer Ther. 2016 Jul;15(7):1669-81. doi: 10.1158/1535-7163.MCT-15-0182. Epub 2016 May 11.
• [2207] PBX1 promotes the cell proliferation via JAK2/STAT3 signaling in clear cell renal carcinoma.Biochem Biophys Res Commun. 2018 Jun 7;500(3):650-657. doi: 10.1016/j.bbrc.2018.04.127. Epub 2018 Apr 26.
• [2208] TGF-beta signaling in cancer: post-transcriptional regulation of EMT via hnRNP E1.Cytokine. 2019 Jun;118:19-26. doi: 10.1016/j.cyto.2017.12.032. Epub 2018 Feb 1.
• [2209] Methylation of PCDH19 predicts poor prognosis of hepatocellular carcinoma.Asia Pac J Clin Oncol. 2018 Oct;14(5):e352-e358. doi: 10.1111/ajco.12982. Epub 2018 May 11.
• [2210] ALG-2 participates in recovery of cells after plasma membrane damage by electroporation and digitonin treatment.PLoS One. 2018 Sep 21;13(9):e0204520. doi: 10.1371/journal.pone.0204520. eCollection 2018.
• [2211] Expression and functional characterization of platelet-derived growth factor receptor-like gene.World J Gastroenterol. 2010 Mar 28;16(12):1465-72. doi: 10.3748/wjg.v16.i12.1465.
• [2212] Care experiences among dually enrolled older adults with cancer: SEER-CAHPS, 2005-2013.Cancer Causes Control. 2019 Oct;30(10):1137-1144. doi: 10.1007/s10552-019-01218-7. Epub 2019 Aug 17.
• [2213] Knockdown long non-coding RNA PEG10 inhibits proliferation, migration and invasion of glioma cell line U251 by regulating miR-506.Gen Physiol Biophys. 2019 Jul;38(4):295-304. doi: 10.4149/gpb_2019018. Epub 2019 Jun 26.
• [2214] Peli1 Modulates the Subcellular Localization and Activity of Mdmx.Cancer Res. 2018 Jun 1;78(11):2897-2910. doi: 10.1158/0008-5472.CAN-17-3531. Epub 2018 Mar 9.
• [2215] PFKP Signaling at a Glance: An Emerging Mediator of Cancer Cell Metabolism.Adv Exp Med Biol. 2019;1134:243-258. doi: 10.1007/978-3-030-12668-1_13.
• [2216] A balanced level of profilin-1 promotes stemness and tumor-initiating potential of breast cancer cells.Cell Cycle. 2017;16(24):2366-2373. doi: 10.1080/15384101.2017.1346759.
• [2217] Profilin 2 Promotes Proliferation and Metastasis of Head and Neck Cancer Cells by Regulating PI3K/AKT/-Catenin Signaling Pathway.Oncol Res. 2019 Sep 23;27(9):1079-1088. doi: 10.3727/096504019X15579146061957. Epub 2019 May 15.
• [2218] PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis.Autophagy. 2020 Mar;16(3):419-434. doi: 10.1080/15548627.2019.1628520. Epub 2019 Jun 16.
• [2219] Transcriptional analysis of novel hormone receptors PGRMC1 and PGRMC2 as potential biomarkers of breast adenocarcinoma staging.J Surg Res. 2011 Dec;171(2):615-22. doi: 10.1016/j.jss.2010.04.034. Epub 2010 May 20.
• [2220] Acetylation of PHF5A Modulates Stress Responses and Colorectal Carcinogenesis through Alternative Splicing-Mediated Upregulation of KDM3A.Mol Cell. 2019 Jun 20;74(6):1250-1263.e6. doi: 10.1016/j.molcel.2019.04.009. Epub 2019 May 1.
• [2221] The potential role of PHF6 as an oncogene: a genotranscriptomic/proteomic meta-analysis.Tumour Biol. 2016 Apr;37(4):5317-25. doi: 10.1007/s13277-015-4250-0. Epub 2015 Nov 11.
• [2222] PHLPPing through history: a decade in the life of PHLPP phosphatases.Biochem Soc Trans. 2016 Dec 15;44(6):1675-1682. doi: 10.1042/BST20160170.
• [2223] Expression of polymeric immunoglobulin receptor and stromal activity in pancreatic ductal adenocarcinoma.Pancreatology. 2017 Mar-Apr;17(2):295-302. doi: 10.1016/j.pan.2017.01.013. Epub 2017 Feb 1.
• [2224] Pirin: a potential novel therapeutic target for castration-resistant prostate cancer regulated by miR-455-5p.Mol Oncol. 2019 Feb;13(2):322-337. doi: 10.1002/1878-0261.12405. Epub 2018 Dec 21.
• [2225] Silenced PITX1 promotes chemotherapeutic resistance to 5-fluorocytosine and cisplatin in gastric cancer cells.Exp Ther Med. 2019 May;17(5):4046-4054. doi: 10.3892/etm.2019.7459. Epub 2019 Apr 1.
• [2226] A RTK-based functional RNAi screen reveals determinants of PTX-3 expression.Int J Clin Exp Pathol. 2013;6(4):660-8. Epub 2013 Mar 15.
• [2227] Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.Pathol Res Pract. 2019 Jul;215(7):152438. doi: 10.1016/j.prp.2019.152438. Epub 2019 May 13.
• [2228] Quality and quantity control of gene expression by nonsense-mediated mRNA decay.Nat Rev Mol Cell Biol. 2019 Jul;20(7):406-420. doi: 10.1038/s41580-019-0126-2.
• [2229] Combination of phospholipase C knockdown with GANT61 sensitizes castrationresistant prostate cancer cells to enzalutamide by suppressing the androgen receptor signaling pathway.Oncol Rep. 2019 May;41(5):2689-2702. doi: 10.3892/or.2019.7054. Epub 2019 Mar 7.
• [2230] PLOD3 promotes lung metastasis via regulation of STAT3.Cell Death Dis. 2018 Nov 15;9(12):1138. doi: 10.1038/s41419-018-1186-5.
• [2231] Anterior high-resolution OCT in the diagnosis and management of corneal squamous hyperplasia mimicking a malignancy: a case report.BMC Ophthalmol. 2019 Nov 21;19(1):235. doi: 10.1186/s12886-019-1237-4.
• [2232] Association of DNA sequence variation in mitochondrial DNA polymerase with mitochondrial DNA synthesis and risk of oral cancer.Gene. 2016 Jan 10;575(2 Pt 3):650-4. doi: 10.1016/j.gene.2015.09.039. Epub 2015 Sep 25.
• [2233] Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression.J Clin Invest. 2016 Oct 3;126(10):4045-4060. doi: 10.1172/JCI86042. Epub 2016 Sep 19.
• [2234] Genome-wide expression analysis reveals six contravened targets of EZH2 associated with breast cancer patient survival.Sci Rep. 2019 Feb 13;9(1):1974. doi: 10.1038/s41598-019-39122-4.
• [2235] Investigation of deleterious effects of nsSNPs in the POT1 gene: a structural genomics-based approach to understand the mechanism of cancer development.J Cell Biochem. 2019 Jun;120(6):10281-10294. doi: 10.1002/jcb.28312. Epub 2018 Dec 16.
• [2236] LncRNA POU3F3 promotes proliferation and inhibits apoptosis of cancer cells in triple-negative breast cancer by inactivating caspase 9.Biosci Biotechnol Biochem. 2019 Jun;83(6):1117-1123. doi: 10.1080/09168451.2019.1588097. Epub 2019 Mar 7.
• [2237] The Octamer-Binding Transcription Factor 4 (OCT4) Pseudogene, POU Domain Class 5 Transcription Factor 1B (POU5F1B), is Upregulated in Cervical Cancer and Down-Regulation Inhibits Cell Proliferation and Migration and Induces Apoptosis in Cervical Cancer Cell Lines.Med Sci Monit. 2019 Feb 14;25:1204-1213. doi: 10.12659/MSM.912109.
• [2238] Acetonitrile-assisted enzymatic digestion can facilitate the bottom-up identification of proteins of cancer origin.Anal Biochem. 2019 Apr 1;570:1-4. doi: 10.1016/j.ab.2019.01.004. Epub 2019 Jan 17.
• [2239] Cyclophilin J PPIase Inhibitors Derived from 2,3-Quinoxaline-6 Amine Exhibit Antitumor Activity.Front Pharmacol. 2018 Feb 21;9:126. doi: 10.3389/fphar.2018.00126. eCollection 2018.
• [2240] pRb2/p130 localizes to the cytoplasm in diffuse gastric cancer.J Cell Physiol. 2015 Apr;230(4):802-5. doi: 10.1002/jcp.24805.
• [2241] PRDM16 functions as a suppressor of lung adenocarcinoma metastasis.J Exp Clin Cancer Res. 2019 Jan 25;38(1):35. doi: 10.1186/s13046-019-1042-1.
• [2242] High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines.Nat Biotechnol. 2016 Apr;34(4):419-23. doi: 10.1038/nbt.3460. Epub 2016 Feb 29.
• [2243] Prenatal phthalate exposure and altered patterns of DNA methylation in cord blood.Environ Mol Mutagen. 2017 Jul;58(6):398-410. doi: 10.1002/em.22095. Epub 2017 May 28.
• [2244] C-terminal domain of SMYD3 serves as a unique HSP90-regulated motif in oncogenesis.Oncotarget. 2015 Feb 28;6(6):4005-19. doi: 10.18632/oncotarget.2970.
• [2245] PRG3 induces Ras-dependent oncogenic cooperation in gliomas.Oncotarget. 2016 May 3;7(18):26692-708. doi: 10.18632/oncotarget.8592.
• [2246] AMP-activated protein kinase: a cellular energy sensor that comes in 12 flavours.FEBS J. 2016 Aug;283(16):2987-3001. doi: 10.1111/febs.13698. Epub 2016 Mar 24.
• [2247] Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.Carcinogenesis. 2010 Sep;31(9):1604-11. doi: 10.1093/carcin/bgq142. Epub 2010 Jul 9.
• [2248] PRMT6 Regulates RAS/RAF Binding and MEK/ERK-Mediated Cancer Stemness Activities in Hepatocellular Carcinoma through CRAF Methylation.Cell Rep. 2018 Oct 16;25(3):690-701.e8. doi: 10.1016/j.celrep.2018.09.053.
• [2249] GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI.Sci Rep. 2015 Nov 18;5:16214. doi: 10.1038/srep16214.
• [2250] PRRX1 Regulates Cellular Phenotype Plasticity and Dormancy of Head and Neck Squamous Cell Carcinoma Through miR-642b-3p.Neoplasia. 2019 Feb;21(2):216-229. doi: 10.1016/j.neo.2018.12.001. Epub 2019 Jan 7.
• [2251] Prx2 links ROS homeostasis to stemness of cancer stem cells.Free Radic Biol Med. 2019 Apr;134:260-267. doi: 10.1016/j.freeradbiomed.2019.01.001. Epub 2019 Jan 4.
• [2252] MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity.Cancer Res. 2016 Aug 15;76(16):4872-86. doi: 10.1158/0008-5472.CAN-15-1664. Epub 2016 May 24.
• [2253] The Pleckstrin and Sec7 domain-containing gene as a novel epigenetic modification marker in human gastric cancer and its clinical significance.Int J Oncol. 2015 Jan;46(1):195-204. doi: 10.3892/ijo.2014.2736. Epub 2014 Oct 30.
• [2254] Inhibition on Proteasome 1 Subunit Might Contribute to the Anti-Cancer Effects of Fangchinoline in Human Prostate Cancer Cells.PLoS One. 2015 Oct 29;10(10):e0141681. doi: 10.1371/journal.pone.0141681. eCollection 2015.
• [2255] PSMB4 overexpression enhances the cell growth and viability of breast cancer cells leading to a poor prognosis.Oncol Rep. 2018 Oct;40(4):2343-2352. doi: 10.3892/or.2018.6588. Epub 2018 Jul 20.
• [2256] The significance of PA28 and U2AF1 in oral mucosal carcinogenesis.Oral Dis. 2020 Jan;26(1):53-61. doi: 10.1111/odi.13213. Epub 2019 Oct 29.
• [2257] Design and synthesis of 4-piperazinyl quinoline derived urea/thioureas for anti-breast cancer activity by a hybrid pharmacophore approach.J Enzyme Inhib Med Chem. 2019 Dec;34(1):620-630. doi: 10.1080/14756366.2019.1571055.
• [2258] Important roles of protein tyrosine phosphatase PTPN12 in tumor progression.Pharmacol Res. 2019 Jun;144:73-78. doi: 10.1016/j.phrs.2019.04.011. Epub 2019 Apr 5.
• [2259] Development and validation of simple step protein precipitation UHPLC-MS/MS methods for quantitation of temozolomide in cancer patient plasma samples.J Pharm Biomed Anal. 2019 Jan 5;162:164-170. doi: 10.1016/j.jpba.2018.09.019. Epub 2018 Sep 8.
• [2260] MiR-6803-5p Promotes Cancer Cell Proliferation and Invasion via PTPRO/NF-B Axis in Colorectal Cancer.Mediators Inflamm. 2019 Nov 20;2019:8128501. doi: 10.1155/2019/8128501. eCollection 2019.
• [2261] Analysis of poliovirus receptor, CD155 expression in different human colorectal cancer cell lines: Implications for poliovirus virotherapy.J Cancer Res Ther. 2019 Jan-Mar;15(1):61-67. doi: 10.4103/jcrt.JCRT_13_17.
• [2262] SIRT3 regulates cancer cell proliferation through deacetylation of PYCR1 in proline metabolism.Neoplasia. 2019 Jul;21(7):665-675. doi: 10.1016/j.neo.2019.04.008. Epub 2019 May 17.
• [2263] Transcription Factors That Govern Development and Disease: An Achilles Heel in Cancer.Genes (Basel). 2019 Oct 12;10(10):794. doi: 10.3390/genes10100794.
• [2264] Rab25 and RCP in cancer progression.Arch Pharm Res. 2019 Feb;42(2):101-112. doi: 10.1007/s12272-019-01129-w. Epub 2019 Feb 14.
• [2265] Overexpression of Rab1B and MMP9 predicts poor survival and good response to chemotherapy in patients with colorectal cancer.Aging (Albany NY). 2017 Mar 18;9(3):914-931. doi: 10.18632/aging.101200.
• [2266] RAB38 is a potential prognostic factor for tumor recurrence in non-small cell lung cancer.Oncol Lett. 2019 Sep;18(3):2598-2604. doi: 10.3892/ol.2019.10547. Epub 2019 Jun 28.
• [2267] Epigenetic silencing of Rab39a promotes epithelial to mesenchymal transition of cervical cancer through AKT signaling.Exp Cell Res. 2019 May 15;378(2):139-148. doi: 10.1016/j.yexcr.2019.02.025. Epub 2019 Feb 28.
• [2268] Silencing of Rab3D suppresses the proliferation and invasion of esophageal squamous cell carcinoma cells.Biomed Pharmacother. 2017 Jul;91:402-407. doi: 10.1016/j.biopha.2017.04.010. Epub 2017 May 2.
• [2269] Small G protein signalling modulator 2 (SGSM2) is involved in oestrogen receptor-positive breast cancer metastasis through enhancement of migratory cell adhesion via interaction with E-cadherin.Cell Adh Migr. 2019 Dec;13(1):120-137. doi: 10.1080/19336918.2019.1568139. Epub 2019 Feb 11.
• [2270] RAD18 contributes to the migration and invasion of human cervical cancer cells via the interleukin? pathway.Mol Med Rep. 2019 Oct;20(4):3415-3423. doi: 10.3892/mmr.2019.10564. Epub 2019 Aug 6.
• [2271] Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations.Cancer. 2020 Feb 1;126(3):549-558. doi: 10.1002/cncr.32572. Epub 2019 Nov 4.
• [2272] Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer.Sci Rep. 2016 May 3;6:25369. doi: 10.1038/srep25369.
• [2273] RanBP3 Regulates Melanoma Cell Proliferation via Selective Control of Nuclear Export.J Invest Dermatol. 2016 Jan;136(1):264-74. doi: 10.1038/JID.2015.401.
• [2274] Function, Significance, and Regulation of Rap1b in Malignancy.Crit Rev Eukaryot Gene Expr. 2019;29(2):151-160. doi: 10.1615/CritRevEukaryotGeneExpr.2019025997.
• [2275] SmgGDS is a transient nucleolar protein that protects cells from nucleolar stress and promotes the cell cycle by regulating DREAM complex gene expression.Oncogene. 2017 Dec 14;36(50):6873-6883. doi: 10.1038/onc.2017.280. Epub 2017 Aug 14.
• [2276] RASAL2 Plays Inconsistent Roles in Different Cancers.Front Oncol. 2019 Nov 13;9:1235. doi: 10.3389/fonc.2019.01235. eCollection 2019.
• [2277] Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression.Cancer Res. 2018 Mar 1;78(5):1155-1168. doi: 10.1158/0008-5472.CAN-17-1544. Epub 2017 Dec 19.
• [2278] Expression Analysis of RbBP6 in human cancers: a Prospective biomarker.Anticancer Drugs. 2019 Sep;30(8):767-773. doi: 10.1097/CAD.0000000000000809.
• [2279] Rbfox2 dissociation from stress granules suppresses cancer progression.Exp Mol Med. 2019 Apr 26;51(4):1-12. doi: 10.1038/s12276-019-0246-y.
• [2280] RBFOX3 Regulates the Chemosensitivity of Cancer Cells to 5-Fluorouracil via the PI3K/AKT, EMT and Cytochrome-C/Caspase Pathways.Cell Physiol Biochem. 2018;46(4):1365-1380. doi: 10.1159/000489153. Epub 2018 Apr 18.
• [2281] Disruption of the Rbm38-eIF4E Complex with a Synthetic Peptide Pep8 Increases p53 Expression.Cancer Res. 2019 Feb 15;79(4):807-818. doi: 10.1158/0008-5472.CAN-18-2209. Epub 2018 Dec 27.
• [2282] No Matter How You Splice It, RBM39 Inhibition Targets Spliceosome Mutant AML.Cancer Cell. 2019 Mar 18;35(3):337-339. doi: 10.1016/j.ccell.2019.02.013.
• [2283] Vitamin A, cancer treatment and prevention: the new role of cellular retinol binding proteins.Biomed Res Int. 2015;2015:624627. doi: 10.1155/2015/624627. Epub 2015 Mar 24.
• [2284] Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer.Oncotarget. 2015 Mar 20;6(8):5903-17. doi: 10.18632/oncotarget.3464.
• [2285] MicroRNA-340 inhibits the proliferation and promotes the apoptosis of colon cancer cells by modulating REV3L.Oncotarget. 2017 Dec 26;9(4):5155-5168. doi: 10.18632/oncotarget.23703. eCollection 2018 Jan 12.
• [2286] Genome-wide RNAi Screening Identifies RFC4 as a Factor That Mediates Radioresistance in Colorectal Cancer by Facilitating Nonhomologous End Joining Repair.Clin Cancer Res. 2019 Jul 15;25(14):4567-4579. doi: 10.1158/1078-0432.CCR-18-3735. Epub 2019 Apr 12.
• [2287] Genome-wide transcript profiling reveals novel breast cancer-associated intronic sense RNAs.PLoS One. 2015 Mar 23;10(3):e0120296. doi: 10.1371/journal.pone.0120296. eCollection 2015.
• [2288] Overexpression of regulator of G protein signaling 11 promotes cell migration and associates with advanced stages and aggressiveness of lung adenocarcinoma.Oncotarget. 2016 May 24;7(21):31122-36. doi: 10.18632/oncotarget.8860.
• [2289] Lentivirus-mediated knockdown of rhomboid domain containing 1 inhibits colorectal cancer cell growth.Mol Med Rep. 2015 Jul;12(1):377-81. doi: 10.3892/mmr.2015.3365. Epub 2015 Feb 17.
• [2290] Synergistic inhibition of aggressive breast cancer cell migration and invasion by cytoplasmic delivery of anti-RhoC silencing RNA and presentation of EPPT1 peptide on "smart" particles.J Control Release. 2018 Nov 10;289:79-93. doi: 10.1016/j.jconrel.2018.07.042. Epub 2018 Aug 24.
• [2291] RIT1 oncoproteins escape LZTR1-mediated proteolysis.Science. 2019 Mar 15;363(6432):1226-1230. doi: 10.1126/science.aav1444.
• [2292] The prognostic value of theTau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.BMC Cancer. 2019 Jan 30;19(1):110. doi: 10.1186/s12885-019-5287-z.
• [2293] Rab1 in cell signaling, cancer and other diseases.Oncogene. 2016 Nov 3;35(44):5699-5704. doi: 10.1038/onc.2016.81. Epub 2016 Apr 4.
• [2294] Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-B Pathway in Melanoma.Clin Cancer Res. 2017 Aug 15;23(16):4831-4842. doi: 10.1158/1078-0432.CCR-17-0146. Epub 2017 Apr 7.
• [2295] TRC8 suppresses tumorigenesis through targeting heme oxygenase-1 for ubiquitination and degradation.Oncogene. 2013 May 2;32(18):2325-34. doi: 10.1038/onc.2012.244. Epub 2012 Jun 11.
• [2296] BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation.Mol Cell. 2019 Mar 21;73(6):1267-1281.e7. doi: 10.1016/j.molcel.2018.12.010. Epub 2019 Jan 28.
• [2297] The oncogenic impact of RNF2 on cell proliferation, invasion and migration through EMT on mammary carcinoma.Pathol Res Pract. 2019 Sep;215(9):152523. doi: 10.1016/j.prp.2019.152523. Epub 2019 Jun 28.
• [2298] The p97-Ataxin 3 complex regulates homeostasis of the DNA damage response E3 ubiquitin ligase RNF8.EMBO J. 2019 Oct 4;38(21):e102361. doi: 10.15252/embj.2019102361. Epub 2019 Oct 15.
• [2299] In silico identification of inhibitors targeting N-Terminal domain of human Replication Protein A.J Mol Graph Model. 2019 Jan;86:149-159. doi: 10.1016/j.jmgm.2018.10.011. Epub 2018 Oct 20.
• [2300] 5-FU targets rpL3 to induce mitochondrial apoptosis via cystathionine--synthase in colon cancer cells lacking p53.Oncotarget. 2016 Aug 2;7(31):50333-50348. doi: 10.18632/oncotarget.10385.
• [2301] p53-Dependent Apoptotic Effect of Puromycin via Binding of Ribosomal Protein L5 and L11 to MDM2 and its Combination Effect with RITA or Doxorubicin.Cancers (Basel). 2019 Apr 24;11(4):582. doi: 10.3390/cancers11040582.
• [2302] Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer.Clin Cancer Res. 2017 Oct 1;23(19):5757-5768. doi: 10.1158/1078-0432.CCR-16-3224. Epub 2017 Jun 13.
• [2303] Knockdown of ribosomal protein S15A inhibits human kidney cancer cell growth invitro and invivo.Mol Med Rep. 2019 Feb;19(2):1117-1127. doi: 10.3892/mmr.2018.9751. Epub 2018 Dec 12.
• [2304] Ribosomal protein gene RPL9 variants can differentially impair ribosome function and cellular metabolism.Nucleic Acids Res. 2020 Jan 24;48(2):770-787. doi: 10.1093/nar/gkz1042.
• [2305] Comparative transcriptome analysis reveals that the extracellular matrix receptor interaction contributes to the venous metastases of hepatocellular carcinoma.Cancer Genet. 2015 Oct;208(10):482-91. doi: 10.1016/j.cancergen.2015.06.002. Epub 2015 Jun 18.
• [2306] A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine.J Immunother Cancer. 2019 Feb 28;7(1):60. doi: 10.1186/s40425-019-0539-7.
• [2307] RPS7 promotes cell migration through targeting epithelial-mesenchymal transition in prostate cancer.Urol Oncol. 2019 May;37(5):297.e1-297.e7. doi: 10.1016/j.urolonc.2019.01.011. Epub 2019 Feb 6.
• [2308] Recurrent Mutations in the MTOR Regulator RRAGC in Follicular Lymphoma.Clin Cancer Res. 2016 Nov 1;22(21):5383-5393. doi: 10.1158/1078-0432.CCR-16-0609. Epub 2016 Jun 7.
• [2309] LKB1 promotes cell survival by modulating TIF-IA-mediated pre-ribosomal RNA synthesis under uridine downregulated conditions.Oncotarget. 2016 Jan 19;7(3):2519-31. doi: 10.18632/oncotarget.6224.
• [2310] Overexpression of RYBP inhibits proliferation, invasion, and chemoresistance to cisplatin in anaplastic thyroid cancer cells via the EGFR pathway.J Biochem Mol Toxicol. 2019 Feb;33(2):e22241. doi: 10.1002/jbt.22241. Epub 2018 Nov 15.
• [2311] Proteomic analysis of the effects of cell culture density on the metastasis of breast cancer cells.Cell Biochem Funct. 2019 Mar;37(2):72-83. doi: 10.1002/cbf.3377. Epub 2019 Feb 18.
• [2312] Expression profile and functional role of S100A14 in human cancer.Oncotarget. 2019 Apr 26;10(31):2996-3012. doi: 10.18632/oncotarget.26861. eCollection 2019 Apr 26.
• [2313] Psoriasin overexpression confers drug resistance to cisplatin by activating ERK in gastric cancer.Int J Oncol. 2018 Sep;53(3):1171-1182. doi: 10.3892/ijo.2018.4455. Epub 2018 Jun 26.
• [2314] Protein salvador homolog 1 acts as a tumor suppressor and is modulated by hypermethylation in pancreatic ductal adenocarcinoma.Oncotarget. 2017 May 18;8(38):62953-62961. doi: 10.18632/oncotarget.17972. eCollection 2017 Sep 8.
• [2315] Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers.Hum Pathol. 2015 Apr;46(4):514-23. doi: 10.1016/j.humpath.2014.06.006. Epub 2014 Jun 26.
• [2316] Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression.EBioMedicine. 2018 Nov;37:47-55. doi: 10.1016/j.ebiom.2018.10.002. Epub 2018 Oct 6.
• [2317] The Functional Role of SEC23 in Vesicle Transportation, Autophagy and Cancer.Int J Biol Sci. 2019 Sep 7;15(11):2419-2426. doi: 10.7150/ijbs.37008. eCollection 2019.
• [2318] Molecular Mechanisms by Which Selenoprotein K Regulates Immunity and Cancer.Biol Trace Elem Res. 2019 Nov;192(1):60-68. doi: 10.1007/s12011-019-01774-8. Epub 2019 Jun 11.
• [2319] Lipid peroxidation and glutathione peroxidase activity relationship in breast cancer depends on functional polymorphism of GPX1.BMC Cancer. 2015 Oct 7;15:657. doi: 10.1186/s12885-015-1680-4.
• [2320] Semaphorin 3C as a Therapeutic Target in Prostate and Other Cancers.Int J Mol Sci. 2019 Feb 12;20(3):774. doi: 10.3390/ijms20030774.
• [2321] Neuroimmune Semaphorin 4A in Cancer Angiogenesis and Inflammation: A Promoter or a Suppressor?.Int J Mol Sci. 2018 Dec 30;20(1):124. doi: 10.3390/ijms20010124.
• [2322] RNA sequencing of Sleeping Beauty transposon-induced tumors detects transposon-RNA fusions in forward genetic cancer screens.Genome Res. 2016 Jan;26(1):119-29. doi: 10.1101/gr.188649.114. Epub 2015 Nov 9.
• [2323] Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation. Cell Death Dis. 2012 Dec 6;3:e441.
• [2324] Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: A multicenter study.Eur J Surg Oncol. 2019 Dec;45(12):2386-2391. doi: 10.1016/j.ejso.2019.05.007. Epub 2019 May 9.
• [2325] Mechanism and efficacy of sub-50-nm tenfibgen nanocapsules for cancer cell-directed delivery of anti-CK2 RNAi to primary and metastatic squamous cell carcinoma.Mol Cancer Ther. 2014 Aug;13(8):2018-29. doi: 10.1158/1535-7163.MCT-14-0166. Epub 2014 May 27.
• [2326] The clinical value of serum squamous cell carcinoma antigens 1 and 2 in head and neck squamous cell carcinoma.Auris Nasus Larynx. 2019 Feb;46(1):135-140. doi: 10.1016/j.anl.2018.07.010. Epub 2018 Aug 2.
• [2327] Prognostic and Clinicopathological Significance of SERTAD1 in Various Types of Cancer Risk: A Systematic Review and Retrospective Analysis.Cancers (Basel). 2019 Mar 8;11(3):337. doi: 10.3390/cancers11030337.
• [2328] Growth-inhibitory effects of TGFL3-SEB chimeric protein on colon cancer cell line.Biomed Pharmacother. 2019 Feb;110:190-196. doi: 10.1016/j.biopha.2018.11.025. Epub 2018 Nov 22.
• [2329] Cell cycle-dependent degradation of the methyltransferase SETD3 attenuates cell proliferation and liver tumorigenesis.J Biol Chem. 2017 Jun 2;292(22):9022-9033. doi: 10.1074/jbc.M117.778001. Epub 2017 Apr 25.
• [2330] Sphingomyelin synthase 2 promotes an aggressive breast cancer phenotype by disrupting the homoeostasis of ceramide and sphingomyelin.Cell Death Dis. 2019 Feb 15;10(3):157. doi: 10.1038/s41419-019-1303-0.
• [2331] High expression of SHMT2 is correlated with tumor progression and predicts poor prognosis in gastrointestinal tumors.Eur Rev Med Pharmacol Sci. 2019 Nov;23(21):9379-9392. doi: 10.26355/eurrev_201911_19431.
• [2332] The value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disorders.Neoplasma. 2016;63(2):246-53. doi: 10.4149/210_150419N208.
• [2333] Phylogenetic analysis of the SINA/SIAH ubiquitin E3 ligase family in Metazoa.BMC Evol Biol. 2017 Aug 7;17(1):182. doi: 10.1186/s12862-017-1024-x.
• [2334] Siva-1 emerges as a tissue-specific oncogene beyond its classic role of a proapoptotic gene.Onco Targets Ther. 2018 Oct 1;11:6361-6367. doi: 10.2147/OTT.S173001. eCollection 2018.
• [2335] The regulatory protein SnoN antagonizes activin/Smad2 protein signaling and thereby promotes adipocyte differentiation and obesity in mice.J Biol Chem. 2018 Sep 7;293(36):14100-14111. doi: 10.1074/jbc.RA118.003678. Epub 2018 Jul 20.
• [2336] FBXO22 Suppresses Metastasis in Human Renal Cell Carcinoma via Inhibiting MMP-9-Mediated Migration and Invasion and VEGF-Mediated Angiogenesis.Int J Biol Sci. 2019 Jan 24;15(3):647-656. doi: 10.7150/ijbs.31293. eCollection 2019.
• [2337] Solute carrier family 35 member F2 is indispensable for papillary thyroid carcinoma progression through activation of transforming growth factor- type I receptor/apoptosis signal-regulating kinase 1/mitogen-activated protein kinase signaling axis.Cancer Sci. 2018 Mar;109(3):642-655. doi: 10.1111/cas.13478. Epub 2018 Feb 1.
• [2338] Copper Chelation Inhibits BRAF(V600E)-Driven Melanomagenesis and Counters Resistance to BRAF(V600E) and MEK1/2 Inhibitors.Cancer Res. 2017 Nov 15;77(22):6240-6252. doi: 10.1158/0008-5472.CAN-16-1190. Epub 2017 Oct 6.
• [2339] Mutations in Splicing Factor Genes in Myeloid Malignancies: Significance and Impact on Clinical Features.Cancers (Basel). 2019 Nov 22;11(12):1844. doi: 10.3390/cancers11121844.
• [2340] A basic motif anchoring ISWI to nucleosome acidic patch regulates nucleosome spacing.Nat Chem Biol. 2020 Feb;16(2):134-142. doi: 10.1038/s41589-019-0413-4. Epub 2019 Dec 9.
• [2341] SMC1A is associated with radioresistance in prostate cancer and acts by regulating epithelial-mesenchymal transition and cancer stem-like properties.Mol Carcinog. 2019 Jan;58(1):113-125. doi: 10.1002/mc.22913. Epub 2018 Oct 5.
• [2342] Structural maintenance of chromosomes 4 is a predictor of survival and a novel therapeutic target in colorectal cancer.Asian Pac J Cancer Prev. 2014;15(21):9459-65. doi: 10.7314/apjcp.2014.15.21.9459.
• [2343] Role of SNTA1 in Rac1 activation, modulation of ROS generation, and migratory potential of human breast cancer cells.Br J Cancer. 2014 Feb 4;110(3):706-14. doi: 10.1038/bjc.2013.723. Epub 2014 Jan 16.
• [2344] Downregulation of sorting nexin 10 is associated with overexpression of miR-30d during liver cancer progression in rats.Tumour Biol. 2017 Apr;39(4):1010428317695932. doi: 10.1177/1010428317695932.
• [2345] Translation termination depends on the sequential ribosomal entry of eRF1 and eRF3.Nucleic Acids Res. 2019 May 21;47(9):4798-4813. doi: 10.1093/nar/gkz177.
• [2346] SOX10/keratin dual-color immunohistochemistry: An effective first-line test for the workup of epithelioid malignant neoplasms in FNA and small biopsy specimens.Cancer Cytopathol. 2018 Mar;126(3):179-189. doi: 10.1002/cncy.21960. Epub 2018 Jan 31.
• [2347] Sox12 Is a Cancer Stem-Like Cell Marker in Hepatocellular Carcinoma.Mol Cells. 2017 Nov 30;40(11):847-854. doi: 10.14348/molcells.2017.0129. Epub 2017 Nov 10.
• [2348] STAT1-avtiviated LINC00961 regulates myocardial infarction by the PI3K/AKT/GSK3 signaling pathway.J Cell Biochem. 2019 Aug;120(8):13226-13236. doi: 10.1002/jcb.28596. Epub 2019 Mar 19.
• [2349] Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma.Science. 2018 Nov 30;362(6418):1055-1060. doi: 10.1126/science.aau6509. Epub 2018 Nov 1.
• [2350] Long non-coding RNA CASC2 regulates Sprouty2 via functioning as a competing endogenous RNA for miR-183 to modulate the sensitivity of prostate cancer cells to docetaxel.Arch Biochem Biophys. 2019 Apr 15;665:69-78. doi: 10.1016/j.abb.2018.01.013. Epub 2018 Jan 31.
• [2351] The Spanish biology/disease initiative within the human proteome project: Application to rheumatic diseases.J Proteomics. 2015 Sep 8;127(Pt B):406-13. doi: 10.1016/j.jprot.2015.01.023. Epub 2015 Feb 14.
• [2352] LncRNA SRA1 is down-regulated in HPV-negative cervical squamous cell carcinoma and regulates cancer cell behaviors.Biosci Rep. 2019 Aug 15;39(8):BSR20191226. doi: 10.1042/BSR20191226. Print 2019 Aug 30.
• [2353] Molecular characteristics of recurrent triple-negative breast cancer.Mol Med Rep. 2015 Nov;12(5):7326-34. doi: 10.3892/mmr.2015.4360. Epub 2015 Sep 24.
• [2354] Synthesis of New Derivatives of Benzofuran as Potential Anticancer Agents.Molecules. 2019 Apr 18;24(8):1529. doi: 10.3390/molecules24081529.
• [2355] Clinical potential of mass spectrometry-based proteogenomics.Nat Rev Clin Oncol. 2019 Apr;16(4):256-268. doi: 10.1038/s41571-018-0135-7.
• [2356] CA-SSR1 Polymorphism in Intron 1 of the EGFR Gene in Patients with Malignant Tumors Who Develop Acneiform Rash Associated with the Use of Cetuximab.Mol Diagn Ther. 2015 Apr;19(2):79-89. doi: 10.1007/s40291-015-0132-9.
• [2357] Overexpression of signal sequence receptor predicts poor survival in patients with hepatocellular carcinoma.Hum Pathol. 2018 Nov;81:47-54. doi: 10.1016/j.humpath.2018.06.014. Epub 2018 Jun 23.
• [2358] Glyco-genes change expression in cancer through aberrant methylation.Biochim Biophys Acta. 2016 Aug;1860(8):1776-85. doi: 10.1016/j.bbagen.2016.01.002. Epub 2016 Jan 12.
• [2359] A requirement for STAG2 in replication fork progression creates a targetable synthetic lethality in cohesin-mutant cancers.Nat Commun. 2019 Apr 11;10(1):1686. doi: 10.1038/s41467-019-09659-z.
• [2360] TNIK serves as a novel biomarker associated with poor prognosis in patients with pancreatic cancer.Tumour Biol. 2016 Jan;37(1):1035-40. doi: 10.1007/s13277-015-3881-5. Epub 2015 Aug 14.
• [2361] Fascin induces melanoma tumorigenesis and stemness through regulating the Hippo pathway.Cell Commun Signal. 2018 Jul 3;16(1):37. doi: 10.1186/s12964-018-0250-1.
• [2362] RBP4-STRA6 Pathway Drives Cancer Stem Cell Maintenance and Mediates High-Fat Diet-Induced Colon Carcinogenesis.Stem Cell Reports. 2017 Aug 8;9(2):438-450. doi: 10.1016/j.stemcr.2017.06.002. Epub 2017 Jul 6.
• [2363] STRIPAK components determine mode of cancer cell migration and metastasis.Nat Cell Biol. 2015 Jan;17(1):68-80. doi: 10.1038/ncb3083. Epub 2014 Dec 22.
• [2364] The ubiquitin ligase CHIP modulates cellular behaviors of gastric cancer cells by regulating TRAF2.Cancer Cell Int. 2019 May 16;19:132. doi: 10.1186/s12935-019-0832-z. eCollection 2019.
• [2365] Analysis of CYP1A1 and COMT polymorphisms in women with cervical cancer.Genet Mol Res. 2015 Dec 29;14(4):18965-73. doi: 10.4238/2015.December.29.3.
• [2366] Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.Oncotarget. 2015 Oct 20;6(32):32841-55. doi: 10.18632/oncotarget.5301.
• [2367] Tale of a multifaceted co-activator, hADA3: from embryogenesis to cancer and beyond.Open Biol. 2016 Sep;6(9):160153. doi: 10.1098/rsob.160153.
• [2368] TAF4b and Jun/activating protein-1 collaborate to regulate the expression of integrin alpha6 and cancer cell migration properties.Mol Cancer Res. 2010 Apr;8(4):554-68. doi: 10.1158/1541-7786.MCR-09-0159. Epub 2010 Mar 30.
• [2369] Intra- and inter-laboratory agreement of the FAM19A4/mir124-2 methylation test: Results from an international study.J Clin Lab Anal. 2019 May;33(4):e22854. doi: 10.1002/jcla.22854. Epub 2019 Feb 13.
• [2370] Up-regulation and worse prognostic marker of cytoplasmic TARBP2 expression in obstinate breast cancer.Med Oncol. 2014 Apr;31(4):868. doi: 10.1007/s12032-014-0868-9. Epub 2014 Feb 22.
• [2371] New Targeted Agents in Gynecologic Cancers: Synthetic Lethality, Homologous Recombination Deficiency, and PARP Inhibitors.Curr Treat Options Oncol. 2016 Mar;17(3):12. doi: 10.1007/s11864-015-0378-9.
• [2372] NF-B Mediates the Expression of TBX15 in Cancer Cells.PLoS One. 2016 Jun 21;11(6):e0157761. doi: 10.1371/journal.pone.0157761. eCollection 2016.
• [2373] Usefulness of Amplatzer Vascular Plug for Preoperative Embolization Before Distal Pancreatectomy with En Bloc Celiac Axis Resection.Cardiovasc Intervent Radiol. 2019 Sep;42(9):1352-1357. doi: 10.1007/s00270-019-02233-6. Epub 2019 May 10.
• [2374] Stratification of aggressive prostate cancer from indolent disease-Prospective controlled trial utilizing expression of 11 genes in apparently benign tissue.Urol Oncol. 2016 Jun;34(6):255.e15-22. doi: 10.1016/j.urolonc.2015.12.014. Epub 2016 Feb 5.
• [2375] Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers.BMC Cancer. 2019 Mar 12;19(1):219. doi: 10.1186/s12885-019-5403-0.
• [2376] Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).Bioorg Med Chem. 2017 May 1;25(9):2531-2544. doi: 10.1016/j.bmc.2017.01.028. Epub 2017 Jan 21.
• [2377] Randomized trial of Tibetan yoga in patients with breast cancer undergoing chemotherapy.Cancer. 2018 Jan 1;124(1):36-45. doi: 10.1002/cncr.30938. Epub 2017 Sep 20.
• [2378] Differential expression of the CCN family member WISP-1, WISP-2 and WISP-3 in human colorectal cancer and the prognostic implications.Int J Oncol. 2010 May;36(5):1129-36. doi: 10.3892/ijo_00000595.
• [2379] Testin is a tumor suppressor in non-small cell lung cancer.Oncol Rep. 2017 Feb;37(2):1027-1035. doi: 10.3892/or.2016.5316. Epub 2016 Dec 14.
• [2380] TFDP3 regulates the apoptosis and autophagy in breast cancer cell line MDA-MB-231.PLoS One. 2018 Sep 20;13(9):e0203833. doi: 10.1371/journal.pone.0203833. eCollection 2018.
• [2381] A mitochondrial ROS pathway controls matrix metalloproteinase 9 levels and invasive properties in RAS-activated cancer cells.FEBS J. 2019 Feb;286(3):459-478. doi: 10.1111/febs.14671. Epub 2018 Oct 13.
• [2382] Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer.Mol Cancer. 2019 May 20;18(1):96. doi: 10.1186/s12943-019-1023-1.
• [2383] Thrombospondin enhances RANKL-dependent osteoclastogenesis and facilitates lung cancer bone metastasis.Biochem Pharmacol. 2019 Aug;166:23-32. doi: 10.1016/j.bcp.2019.05.005. Epub 2019 May 7.
• [2384] mRNA export protein THOC5 as a tool for identification of target genes for cancer therapy.Cancer Lett. 2016 Apr 10;373(2):222-6. doi: 10.1016/j.canlet.2016.01.045. Epub 2016 Jan 28.
• [2385] Searching for microsatellite mutations in coding regions in lung, breast, ovarian and colorectal cancers.Oncogene. 2001 Feb 22;20(8):1005-9. doi: 10.1038/sj.onc.1204211.
• [2386] Defining clinically significant prostate cancer on the basis of pathological findings.Histopathology. 2019 Jan;74(1):135-145. doi: 10.1111/his.13712.
• [2387] Osteopontin production by TM4SF4 signaling drives a positive feedback autocrine loop with the STAT3 pathway to maintain cancer stem cell-like properties in lung cancer cells.Oncotarget. 2017 Sep 18;8(60):101284-101297. doi: 10.18632/oncotarget.21021. eCollection 2017 Nov 24.
• [2388] Clinicopathological significance of TM4SF5 expression in human hepatocellular carcinoma tissues.Oncol Lett. 2019 Jun;17(6):5187-5192. doi: 10.3892/ol.2019.10210. Epub 2019 Apr 3.
• [2389] Golgi anti-apoptotic protein: a tale of camels, calcium, channels and cancer.Open Biol. 2017 May;7(5):170045. doi: 10.1098/rsob.170045.
• [2390] Low-expression of TMEM100 is associated with poor prognosis in non-small-cell lung cancer.Am J Transl Res. 2017 May 15;9(5):2567-2578. eCollection 2017.
• [2391] Clinical and pathological characteristic of metastatic malignant mesothelioma initially diagnosed by lymph node biopsy.Pathol Res Pract. 2017 Jun;213(6):598-605. doi: 10.1016/j.prp.2017.05.003. Epub 2017 May 13.
• [2392] TMEM165, a Golgi transmembrane protein, is a novel marker for hepatocellular carcinoma and its depletion impairs invasion activity.Oncol Rep. 2018 Sep;40(3):1297-1306. doi: 10.3892/or.2018.6565. Epub 2018 Jul 12.
• [2393] MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways.Br J Cancer. 2015 Mar 3;112(5):891-900. doi: 10.1038/bjc.2015.19. Epub 2015 Feb 10.
• [2394] TMEM45B, up-regulated in human lung cancer, enhances tumorigenicity of lung cancer cells.Tumour Biol. 2016 Sep;37(9):12181-12191. doi: 10.1007/s13277-016-5063-5. Epub 2016 May 26.
• [2395] siRNA-TMEM98 inhibits the invasion and migration of lung cancer cells.Int J Clin Exp Pathol. 2015 Dec 1;8(12):15661-9. eCollection 2015.
• [2396] Prognostic and clinicopathological significance of CapG in various cancers: Evidence from a meta-analysis.Pathol Res Pract. 2019 Dec;215(12):152683. doi: 10.1016/j.prp.2019.152683. Epub 2019 Oct 12.
• [2397] TOX3 inhibits cancer cell migration and invasion via transcriptional regulation of SNAI1 and SNAI2 in clear cell renal cell carcinoma.Cancer Lett. 2019 May 1;449:76-86. doi: 10.1016/j.canlet.2019.02.020. Epub 2019 Feb 14.
• [2398] Extracellular vesicledelivered miR?05?p, as a diagnostic biomarker of early lung adenocarcinoma, inhibits cell apoptosis by targeting TP53AIP1.Int J Oncol. 2019 May;54(5):1821-1832. doi: 10.3892/ijo.2019.4738. Epub 2019 Mar 1.
• [2399] Somatic cancer mutations in the DNMT2 tRNA methyltransferase alter its catalytic properties.Biochimie. 2015 May;112:66-72. doi: 10.1016/j.biochi.2015.02.022. Epub 2015 Mar 5.
• [2400] Bayesian Network Inference Modeling Identifies TRIB1 as a Novel Regulator of Cell-Cycle Progression and Survival in Cancer Cells.Cancer Res. 2017 Apr 1;77(7):1575-1585. doi: 10.1158/0008-5472.CAN-16-0512. Epub 2017 Jan 13.
• [2401] Tripartite motif containing 14: An oncogene in papillary thyroid carcinoma.Biochem Biophys Res Commun. 2020 Jan 8;521(2):360-367. doi: 10.1016/j.bbrc.2019.10.127. Epub 2019 Oct 24.
• [2402] TRIM16 governs the biogenesis and disposal of stress-induced protein aggregates to evade cytotoxicity: implication for neurodegeneration and cancer.Autophagy. 2019 May;15(5):924-926. doi: 10.1080/15548627.2019.1586251. Epub 2019 Mar 5.
• [2403] Hemoglobins, Hemorphins, and 11p15.5 Chromosomal Region in Cancer Biology and mmunity with Special Emphasis for Brain Tumors.J Neurol Surg A Cent Eur Neurosurg. 2016 May;77(3):247-57. doi: 10.1055/s-0035-1566120. Epub 2016 Mar 2.
• [2404] Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma.Oncotarget. 2015 Feb 10;6(4):2538-48. doi: 10.18632/oncotarget.2991.
• [2405] High TRIM44 expression as a valuable biomarker for diagnosis and prognosis in cervical cancer.Biosci Rep. 2019 Mar 6;39(3):BSR20181639. doi: 10.1042/BSR20181639. Print 2019 Mar 29.
• [2406] TRIM65 is a potential oncogenic protein via ERK1/2 on Jurkat and Raji cells: A therapeutic target in human lymphoma malignancies.Cell Biol Int. 2018 Nov;42(11):1503-1510. doi: 10.1002/cbin.11035. Epub 2018 Sep 11.
• [2407] Tspan2: a tetraspanin protein involved in oligodendrogenesis and cancer metastasis.Biochem Soc Trans. 2017 Apr 15;45(2):465-475. doi: 10.1042/BST20160022.
• [2408] Testis-specific protein, Y-linked 1 activates PI3K/AKT and RAS signaling pathways through suppressing IGFBP3 expression during tumor progression.Cancer Sci. 2019 May;110(5):1573-1586. doi: 10.1111/cas.13984. Epub 2019 Mar 25.
• [2409] Targeting LMW-PTP to sensitize melanoma cancer cells toward chemo- and radiotherapy.Cancer Med. 2018 May;7(5):1933-1943. doi: 10.1002/cam4.1435. Epub 2018 Mar 24.
• [2410] BAG3 deletion suppresses stem cell-like features of pancreatic ductal adenocarcinoma via translational suppression of ISG15.Biochim Biophys Acta Mol Cell Res. 2019 May;1866(5):819-827. doi: 10.1016/j.bbamcr.2019.02.008. Epub 2019 Feb 14.
• [2411] HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinoma.Oncotarget. 2017 May 19;8(41):69559-69576. doi: 10.18632/oncotarget.18012. eCollection 2017 Sep 19.
• [2412] SRSF1 Prevents DNA Damage and Promotes Tumorigenesis through Regulation of DBF4B Pre-mRNA Splicing.Cell Rep. 2017 Dec 19;21(12):3406-3413. doi: 10.1016/j.celrep.2017.11.091.
• [2413] Cytoplasmic and membranous receptor-binding cancer antigens expressed on SiSo cells (RCAS1) immunoreactivity in epithelial ovarian cancer cells represent differing biological function of RCAS1.Folia Histochem Cytobiol. 2019;57(3):116-126. doi: 10.5603/FHC.a2019.0012. Epub 2019 Aug 7.
• [2414] Integrated analysis of the prognostic value of TP53 dependent etoposide-induced gene 24 in non-small cell lung cancer.Biomed Pharmacother. 2019 Apr;112:108590. doi: 10.1016/j.biopha.2019.01.051. Epub 2019 Feb 19.
• [2415] Novel mechanisms of eIF2B action and regulation by eIF2 phosphorylation.Nucleic Acids Res. 2017 Nov 16;45(20):11962-11979. doi: 10.1093/nar/gkx845.
• [2416] Elovl6 is a negative clinical predictor for liver cancer and knockdown of Elovl6 reduces murine liver cancer progression.Sci Rep. 2018 Apr 26;8(1):6586. doi: 10.1038/s41598-018-24633-3.
• [2417] Endogenous Retrovirus 3 - History, Physiology, and Pathology.Front Microbiol. 2018 Jan 15;8:2691. doi: 10.3389/fmicb.2017.02691. eCollection 2017.
• [2418] Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma.Nat Commun. 2019 Mar 21;10(1):1296. doi: 10.1038/s41467-019-09179-w.
• [2419] Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma.Biomed Pharmacother. 2019 Apr;112:108632. doi: 10.1016/j.biopha.2019.108632. Epub 2019 Feb 20.
• [2420] CD164 identifies CD4(+) T cells highly expressing genes associated with malignancy in Szary syndrome: the Szary signature genes, FCRL3, Tox, and miR-214.Arch Dermatol Res. 2017 Jan;309(1):11-19. doi: 10.1007/s00403-016-1698-8. Epub 2016 Oct 20.
• [2421] The heparan sulfate 3-O-sulfotransferases (HS3ST) 2, 3B and 4 enhance proliferation and survival in breast cancer MDA-MB-231 cells.PLoS One. 2018 Mar 16;13(3):e0194676. doi: 10.1371/journal.pone.0194676. eCollection 2018.
• [2422] MEST induces Twist-1-mediated EMT through STAT3 activation in breast cancers.Cell Death Differ. 2019 Dec;26(12):2594-2606. doi: 10.1038/s41418-019-0322-9. Epub 2019 Mar 22.
• [2423] Mitochondrial dynamics regulates migration and invasion of breast cancer cells.Oncogene. 2013 Oct;32(40):4814-24. doi: 10.1038/onc.2012.494. Epub 2012 Nov 5.
• [2424] Epigenetic silencing of neurofilament genes promotes an aggressive phenotype in breast cancer.Epigenetics. 2015;10(7):622-32. doi: 10.1080/15592294.2015.1050173.
• [2425] Blocking Myristoylation of Src Inhibits Its Kinase Activity and Suppresses Prostate Cancer Progression.Cancer Res. 2017 Dec 15;77(24):6950-6962. doi: 10.1158/0008-5472.CAN-17-0981. Epub 2017 Oct 16.
• [2426] Significant association of YAP1 and HSPC111 proteins with poor prognosis in Chinese gastric cancer patients.Oncotarget. 2017 May 17;8(46):80303-80314. doi: 10.18632/oncotarget.17932. eCollection 2017 Oct 6.
• [2427] Long-Fiber Carbon Nanotubes Replicate Asbestos-Induced Mesothelioma with Disruption of the Tumor Suppressor Gene Cdkn2a (Ink4a/Arf).Curr Biol. 2017 Nov 6;27(21):3302-3314.e6. doi: 10.1016/j.cub.2017.09.007.
• [2428] Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer.Oncogene. 2014 Jul 10;33(28):3707-16. doi: 10.1038/onc.2013.332. Epub 2013 Aug 26.
• [2429] Dual blockade of the lipid kinase PIP4Ks and mitotic pathways leads to cancer-selective lethality.Nat Commun. 2017 Dec 19;8(1):2200. doi: 10.1038/s41467-017-02287-5.
• [2430] Knockdown of PLCB2 expression reduces melanoma cell viability and promotes melanoma cell apoptosis by altering Ras/Raf/MAPK signals.Mol Med Rep. 2020 Jan;21(1):420-428. doi: 10.3892/mmr.2019.10798. Epub 2019 Nov 6.
• [2431] IL-17A-Induced PLET1 Expression Contributes to Tissue Repair and Colon Tumorigenesis.J Immunol. 2017 Dec 1;199(11):3849-3857. doi: 10.4049/jimmunol.1601540. Epub 2017 Oct 25.
• [2432] PACT is required for MDA5-mediated immunoresponses triggered by Cardiovirus infection via interaction with LGP2.Biochem Biophys Res Commun. 2017 Dec 9;494(1-2):227-233. doi: 10.1016/j.bbrc.2017.10.048. Epub 2017 Oct 12.
• [2433] Myeloid zinc finger 1 protein is a key transcription stimulating factor of PYROXD2 promoter.Oncol Rep. 2017 Nov;38(5):3245-3253. doi: 10.3892/or.2017.5990. Epub 2017 Sep 22.
• [2434] Aberrant expression of RasGRP1 cooperates with gain-of-function NOTCH1 mutations in T-cell leukemogenesis.Leukemia. 2012 May;26(5):1038-45. doi: 10.1038/leu.2011.328. Epub 2011 Nov 25.
• [2435] Clinical validation of colorectal cancer biomarkers identified from bioinformatics analysis of public expression data.Clin Cancer Res. 2011 Feb 15;17(4):700-9. doi: 10.1158/1078-0432.CCR-10-1300. Epub 2011 Feb 8.
• [2436] Cancer in the Solomon Islands.Cancer Epidemiol. 2017 Oct;50(Pt B):176-183. doi: 10.1016/j.canep.2017.04.016.
• [2437] Interferon-regulated suprabasin is essential for stress-induced stem-like cell conversion and therapy resistance of human malignancies.Mol Oncol. 2019 Jul;13(7):1467-1489. doi: 10.1002/1878-0261.12480. Epub 2019 Jun 10.
• [2438] Characterization of Distinct Populations of Carcinoma-Associated Fibroblasts from Non-Small Cell Lung Carcinoma Reveals a Role for ST8SIA2 in Cancer Cell Invasion.Neoplasia. 2019 May;21(5):482-493. doi: 10.1016/j.neo.2019.03.009. Epub 2019 Apr 9.
• [2439] Stomatin-like protein 2 overexpression in papillary thyroid carcinoma is significantly associated with high-risk clinicopathological parameters and BRAFV600E mutation.APMIS. 2016 Apr;124(4):271-7. doi: 10.1111/apm.12505. Epub 2016 Jan 11.
• [2440] Hypoxia-Induced TGFBI as a Serum Biomarker for Laboratory Diagnosis and Prognosis in Patients with Pancreatic Ductal Adenocarcinoma.Lab Med. 2020 Jul 8;51(4):352-361. doi: 10.1093/labmed/lmz063.
• [2441] The RNA processing factors THRAP3 and BCLAF1 promote the DNA damage response through selective mRNA splicing and nuclear export.Nucleic Acids Res. 2017 Dec 15;45(22):12816-12833. doi: 10.1093/nar/gkx1046.
• [2442] Tropomyosin-1 Functions as a Tumor Suppressor with Respect to Cell Proliferation, Angiogenesis and Metastasis in Renal Cell Carcinoma.J Cancer. 2019 May 21;10(10):2220-2228. doi: 10.7150/jca.28261. eCollection 2019.
• [2443] Usefulness of the real-time reverse transcription-polymerase chain reaction assay targeted to alpha1,4-N-acetylglucosaminyltransferase for the detection of gastric cancer.Lab Invest. 2003 Feb;83(2):187-97. doi: 10.1097/01.lab.0000057001.21187.a0.
• [2444] Comparison of breast cancer metastasis models reveals a possible mechanism of tumor aggressiveness.Cell Death Dis. 2018 Oct 10;9(10):1040. doi: 10.1038/s41419-018-1094-8.
• [2445] Downregulation of ACSM3 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma.Am J Cancer Res. 2017 Mar 1;7(3):543-553. eCollection 2017.
• [2446] A Novel Allosteric Inhibitor of Phosphoglycerate Mutase 1 Suppresses Growth and Metastasis of Non-Small-Cell Lung Cancer.Cell Metab. 2019 Dec 3;30(6):1107-1119.e8. doi: 10.1016/j.cmet.2019.09.014. Epub 2019 Oct 10.
• [2447] Single-Molecule Sequencing Reveals Patterns of Preexisting Drug Resistance That Suggest Treatment Strategies in Philadelphia-Positive Leukemias.Clin Cancer Res. 2018 Nov 1;24(21):5321-5334. doi: 10.1158/1078-0432.CCR-18-0167. Epub 2018 Jul 24.
• [2448] Cystatin C and Risk of Diabetes and the Metabolic Syndrome - Biomarker and Genotype Association Analyses.PLoS One. 2016 May 24;11(5):e0155735. doi: 10.1371/journal.pone.0155735. eCollection 2016.
• [2449] Activity-dependent neuroprotective protein recruits HP1 and CHD4 to control lineage-specifying genes.Nature. 2018 May;557(7707):739-743. doi: 10.1038/s41586-018-0153-8. Epub 2018 May 23.
• [2450] Importin- and CRM1 control a RANBP2 spatiotemporal switch essential for mitotic kinetochore function.J Cell Sci. 2017 Aug 1;130(15):2564-2578. doi: 10.1242/jcs.197905. Epub 2017 Jun 9.
• [2451] AGR3 promotes the stemness of colorectal cancer via modulating Wnt/-catenin signalling.Cell Signal. 2020 Jan;65:109419. doi: 10.1016/j.cellsig.2019.109419. Epub 2019 Sep 14.
• [2452] The ATPase hCINAP regulates 18S rRNA processing and is essential for embryogenesis and tumour growth.Nat Commun. 2016 Aug 1;7:12310. doi: 10.1038/ncomms12310.
• [2453] A surprising cross-species conservation in the genomic landscape of mouse and human oral cancer identifies a transcriptional signature predicting metastatic disease.Clin Cancer Res. 2014 Jun 1;20(11):2873-84. doi: 10.1158/1078-0432.CCR-14-0205. Epub 2014 Mar 25.
• [2454] 15-Lipoxygenase-2/15(S)-hydroxyeicosatetraenoic acid regulates cell proliferation and metastasis via the STAT3 pathway in lung adenocarcinoma.Prostaglandins Other Lipid Mediat. 2018 Sep;138:31-40. doi: 10.1016/j.prostaglandins.2018.07.003. Epub 2018 Aug 12.
• [2455] Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas.Gastroenterology. 2006 Nov;131(5):1418-30. doi: 10.1053/j.gastro.2006.08.034. Epub 2006 Aug 18.
• [2456] Molecular cloning and characterization of a RING-H2 finger protein, ANAPC11, the human homolog of yeast Apc11p.J Cell Biochem. 2001 Aug 1-9;83(2):249-58. doi: 10.1002/jcb.1217.
• [2457] Common genetic variants contribute to incomplete penetrance: evidence from cancer-free BRCA1 mutation carriers.Eur J Cancer. 2019 Jan;107:68-78. doi: 10.1016/j.ejca.2018.10.022. Epub 2018 Dec 11.
• [2458] Efficacy and Mechanism of Antitumor Activity of an Antibody Targeting Transferrin Receptor 1 in Mouse Models of Human Multiple Myeloma.J Immunol. 2018 May 15;200(10):3485-3494. doi: 10.4049/jimmunol.1700787. Epub 2018 Apr 13.
• [2459] The anticancer peptide RT53 induces immunogenic cell death.PLoS One. 2018 Aug 6;13(8):e0201220. doi: 10.1371/journal.pone.0201220. eCollection 2018.
• [2460] 51 integrin trafficking and Rac activation are regulated by APPL1 in a Rab5-dependent manner to inhibit cell migration.J Cell Sci. 2018 Mar 6;131(5):jcs207019. doi: 10.1242/jcs.207019.
• [2461] p190 RhoGAP promotes contact inhibition in epithelial cells by repressing YAP activity.J Cell Biol. 2018 Sep 3;217(9):3183-3201. doi: 10.1083/jcb.201710058. Epub 2018 Jun 22.
• [2462] ARHGAP42 promotes cell migration and invasion involving PI3K/Akt signaling pathway in nasopharyngeal carcinoma.Cancer Med. 2018 Aug;7(8):3862-3874. doi: 10.1002/cam4.1552. Epub 2018 Jun 24.
• [2463] Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma.FEBS Lett. 2014 Jan 31;588(3):503-8. doi: 10.1016/j.febslet.2013.12.016. Epub 2013 Dec 24.
• [2464] ARID2 modulates DNA damage response in human hepatocellular carcinoma cells.J Hepatol. 2017 May;66(5):942-951. doi: 10.1016/j.jhep.2016.12.026. Epub 2017 Feb 24.
• [2465] Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cells.PLoS One. 2011;6(10):e26595. doi: 10.1371/journal.pone.0026595. Epub 2011 Oct 20.
• [2466] Pimozide suppresses cancer cell migration and tumor metastasis through binding to ARPC2, a subunit of the Arp2/3 complex.Cancer Sci. 2019 Dec;110(12):3788-3801. doi: 10.1111/cas.14205. Epub 2019 Nov 15.
• [2467] Withania somnifera water extract as a potential candidate for differentiation based therapy of human neuroblastomas.PLoS One. 2013;8(1):e55316. doi: 10.1371/journal.pone.0055316. Epub 2013 Jan 31.
• [2468] MBASED: allele-specific expression detection in cancer tissues and cell lines.Genome Biol. 2014 Aug 7;15(8):405. doi: 10.1186/s13059-014-0405-3.
• [2469] Thromboembolism Incidence and Risk Factors in Children with Cancer: A Population-Based Cohort Study.Thromb Haemost. 2018 Sep;118(9):1646-1655. doi: 10.1055/s-0038-1668543. Epub 2018 Aug 13.
• [2470] Familial and Somatic BAP1 Mutations Inactivate ASXL1/2-Mediated Allosteric Regulation of BAP1 Deubiquitinase by Targeting Multiple Independent Domains.Cancer Res. 2018 Mar 1;78(5):1200-1213. doi: 10.1158/0008-5472.CAN-17-2876. Epub 2017 Dec 28.
• [2471] ASXL3 Is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung Cancer.Cancer Res. 2017 Nov 15;77(22):6267-6281. doi: 10.1158/0008-5472.CAN-17-0570. Epub 2017 Sep 21.
• [2472] A mammosphere formation RNAi screen reveals that ATG4A promotes a breast cancer stem-like phenotype.Breast Cancer Res. 2013 Nov 14;15(6):R109. doi: 10.1186/bcr3576.
• [2473] Histone deacetylase inhibitor- and PMA-induced upregulation of PMCA4b enhances Ca2+ clearance from MCF-7 breast cancer cells.Cell Calcium. 2014 Feb;55(2):78-92. doi: 10.1016/j.ceca.2013.12.003. Epub 2013 Dec 28.
• [2474] RIF1 promotes tumor growth and cancer stem cell-like traits in NSCLC by protein phosphatase 1-mediated activation of Wnt/-catenin signaling.Cell Death Dis. 2018 Sep 20;9(10):942. doi: 10.1038/s41419-018-0972-4.
• [2475] AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer.JCI Insight. 2018 Jun 21;3(12):e99976. doi: 10.1172/jci.insight.99976. eCollection 2018 Jun 21.
• [2476] Oligogenic germline mutations identified in early non-smokers lung adenocarcinoma patients.Lung Cancer. 2014 Aug;85(2):168-74. doi: 10.1016/j.lungcan.2014.05.020. Epub 2014 Jun 4.
• [2477] Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10.Cancer Res. 2018 Mar 15;78(6):1404-1417. doi: 10.1158/0008-5472.CAN-17-0846. Epub 2018 Jan 12.
• [2478] Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-modifying factor (BMF).Cell Death Dis. 2015 Jul 16;6(7):e1826. doi: 10.1038/cddis.2015.191.
• [2479] SPLUNC1 and MLL3 regulate cancer stem cells in nasopharyngeal carcinoma.J BUON. 2019 Jul-Aug;24(4):1700-1705.
• [2480] BRAT1 deficiency causes increased glucose metabolism and mitochondrial malfunction.BMC Cancer. 2014 Jul 29;14:548. doi: 10.1186/1471-2407-14-548.
• [2481] Association Between Germline Mutations in BRF1, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer.Gastroenterology. 2018 Jan;154(1):181-194.e20. doi: 10.1053/j.gastro.2017.09.005. Epub 2017 Sep 12.
• [2482] Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein.BMC Cancer. 2015 Nov 16;15:905. doi: 10.1186/s12885-015-1914-5.
• [2483] Fascin expression is inversely correlated with breast cancer metastasis suppressor 1 and predicts a worse survival outcome in node-negative breast cancer patients.J Cancer. 2017 Sep 6;8(16):3122-3129. doi: 10.7150/jca.22046. eCollection 2017.
• [2484] Lack of correlation of BTNL2 polymorphism and cancer risk in sarcoidosis. BTNL2 and cancer risk in sarcoidosis.Sarcoidosis Vasc Diffuse Lung Dis. 2014 Jul 8;31(2):136-41.
• [2485] C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer.Oncogene. 2018 Oct;37(43):5780-5793. doi: 10.1038/s41388-018-0375-0. Epub 2018 Jun 21.
• [2486] The role of c2orf68 and PI3K/Akt/mTOR pathway in human colorectal cancer.Med Oncol. 2014 Aug;31(8):92. doi: 10.1007/s12032-014-0092-7. Epub 2014 Jul 15.
• [2487] First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement.Cancer Discov. 2013 Apr;3(4):406-17. doi: 10.1158/2159-8290.CD-12-0429. Epub 2013 Jan 28.
• [2488] The Emerging Role of Cables1 in Cancer and Other Diseases.Mol Pharmacol. 2017 Sep;92(3):240-245. doi: 10.1124/mol.116.107730. Epub 2017 Jan 24.
• [2489] Calpain-6 controls the fate of sarcoma stem cells by promoting autophagy and preventing senescence.JCI Insight. 2018 Sep 6;3(17):e121225. doi: 10.1172/jci.insight.121225. eCollection 2018 Sep 6.
• [2490] CBX6 is negatively regulated by EZH2 and plays a potential tumor suppressor role in breast cancer.Sci Rep. 2019 Jan 17;9(1):197. doi: 10.1038/s41598-018-36560-4.
• [2491] CCDC178 promotes hepatocellular carcinoma metastasis through modulation of anoikis.Oncogene. 2017 Jul 13;36(28):4047-4059. doi: 10.1038/onc.2017.10. Epub 2017 Mar 20.
• [2492] Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study.BMC Cancer. 2018 Oct 11;18(1):970. doi: 10.1186/s12885-018-4880-x.
• [2493] CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis.Oncotarget. 2017 Jan 17;8(3):5135-5148. doi: 10.18632/oncotarget.14095.
• [2494] 4-XL-PPD, a novel ginsenoside derivative, as potential therapeutic agents for gastric cancer shows anti-cancer activity via inducing cell apoptosis medicated generation of reactive oxygen species and inhibiting migratory and invasive.Biomed Pharmacother. 2019 Oct;118:108589. doi: 10.1016/j.biopha.2019.01.050. Epub 2019 Aug 2.
• [2495] Cyclin F-Dependent Degradation of RBPJ Inhibits IDH1(R132H)-Mediated Tumorigenesis.Cancer Res. 2018 Nov 15;78(22):6386-6398. doi: 10.1158/0008-5472.CAN-18-1772. Epub 2018 Sep 25.
• [2496] Development of novel monoclonal antibodies against CD109 overexpressed in human pancreatic cancer.Oncotarget. 2018 Apr 13;9(28):19994-20007. doi: 10.18632/oncotarget.25017. eCollection 2018 Apr 13.
• [2497] The intricacies of self-lipid antigen presentation by CD1b.Mol Immunol. 2018 Dec;104:27-36. doi: 10.1016/j.molimm.2018.09.022. Epub 2018 Nov 3.
• [2498] A Subset of Human Autoreactive CD1c-Restricted T Cells Preferentially Expresses TRBV4-1(+) TCRs.J Immunol. 2018 Jan 15;200(2):500-511. doi: 10.4049/jimmunol.1700677. Epub 2017 Dec 13.
• [2499] CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.Oncotarget. 2017 Mar 21;8(12):19768-19779. doi: 10.18632/oncotarget.15519.
• [2500] CDCA3 mediates p21-dependent proliferation by regulating E2F1 expression in colorectal cancer.Int J Oncol. 2018 Nov;53(5):2021-2033. doi: 10.3892/ijo.2018.4538. Epub 2018 Aug 23.
• [2501] Upregulation of CDCA5 promotes gastric cancer malignant progression via influencing cyclin E1.Biochem Biophys Res Commun. 2018 Feb 5;496(2):482-489. doi: 10.1016/j.bbrc.2018.01.046. Epub 2018 Jan 8.
• [2502] The awakening of the CDK10/Cyclin M protein kinase.Oncotarget. 2017 Jul 25;8(30):50174-50186. doi: 10.18632/oncotarget.15024.
• [2503] Genetic variants for type 2 diabetes and new-onset cancer in Chinese with type 2 diabetes.Diabetes Res Clin Pract. 2014 Feb;103(2):328-37. doi: 10.1016/j.diabres.2013.12.016. Epub 2013 Dec 27.
• [2504] CEMP1 Induces Transformation in Human Gingival Fibroblasts.PLoS One. 2015 May 26;10(5):e0127286. doi: 10.1371/journal.pone.0127286. eCollection 2015.
• [2505] Molecular basis for unidirectional scaffold switching of human Plk4 in centriole biogenesis.Nat Struct Mol Biol. 2014 Aug;21(8):696-703. doi: 10.1038/nsmb.2846. Epub 2014 Jun 29.
• [2506] Nanoparticles That Reshape the Tumor Milieu Create a Therapeutic Window for Effective T-cell Therapy in Solid Malignancies.Cancer Res. 2018 Jul 1;78(13):3718-3730. doi: 10.1158/0008-5472.CAN-18-0306. Epub 2018 May 14.
• [2507] Altered mRNA expression levels of the major components of sphingolipid metabolism, ceramide synthases and their clinical implication in colorectal cancer.Oncol Rep. 2018 Dec;40(6):3489-3500. doi: 10.3892/or.2018.6712. Epub 2018 Sep 18.
• [2508] Novel insights into the expression of CGB1 & 2 genes by epithelial cancer cell lines secreting ectopic free hCG.Anticancer Res. 2014 May;34(5):2239-48.
• [2509] CGGBP1--an indispensable protein with ubiquitous cytoprotective functions.Ups J Med Sci. 2015;120(4):219-32. doi: 10.3109/03009734.2015.1086451.
• [2510] AURKA Phe31Ile polymorphism interacted with use of alcohol, betel quid, and cigarettes at multiplicative risk of oral cancer occurrence.Clin Oral Investig. 2015 Nov;19(8):1825-32. doi: 10.1007/s00784-015-1432-5. Epub 2015 Feb 21.
• [2511] CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients.J Cancer. 2019 Nov 1;10(27):6822-6828. doi: 10.7150/jca.31158. eCollection 2019.
• [2512] Mutations in CHD2 cause defective association with active chromatin in chronic lymphocytic leukemia.Blood. 2015 Jul 9;126(2):195-202. doi: 10.1182/blood-2014-10-604959. Epub 2015 Jun 1.
• [2513] CHSY1 promoted proliferation and suppressed apoptosis in colorectal cancer through regulation of the NFB and/or caspase-3/7 signaling pathway.Oncol Lett. 2018 Nov;16(5):6140-6146. doi: 10.3892/ol.2018.9385. Epub 2018 Sep 3.
• [2514] Structure of the human monomeric NEET protein MiNT and its role in regulating iron and reactive oxygen species in cancer cells.Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):272-277. doi: 10.1073/pnas.1715842115. Epub 2017 Dec 19.
• [2515] Eribulin targets a ch-TOG-dependent directed migration of cancer cells.Oncotarget. 2015 Dec 8;6(39):41667-78. doi: 10.18632/oncotarget.6147.
• [2516] NGS based identification of mutational hotspots for targeted therapy in anaplastic thyroid carcinoma.Oncotarget. 2017 Jun 27;8(26):42613-42620. doi: 10.18632/oncotarget.17300.
• [2517] Promoter CpG island hypermethylation in dysplastic nevus and melanoma: CLDN11 as an epigenetic biomarker for malignancy.J Invest Dermatol. 2014 Dec;134(12):2957-2966. doi: 10.1038/jid.2014.270. Epub 2014 Jul 7.
• [2518] Loss of the eukaryotic initiation factor 3f in melanoma.Mol Carcinog. 2008 Oct;47(10):806-13. doi: 10.1002/mc.20436.
• [2519] miR-135b-5p promotes gastric cancer progression by targeting CMTM3.Int J Oncol. 2018 Feb;52(2):589-598. doi: 10.3892/ijo.2017.4222. Epub 2017 Dec 11.
• [2520] CMTM8 inhibits the carcinogenesis and progression of bladder cancer.Oncol Rep. 2015 Dec;34(6):2853-63. doi: 10.3892/or.2015.4310.
• [2521] Tissue microarray-based evaluation of Chromatin Assembly Factor-1 (CAF-1)/p60 as tumour prognostic marker.Int J Mol Sci. 2012;13(9):11044-11062. doi: 10.3390/ijms130911044. Epub 2012 Sep 5.
• [2522] TNF-receptor-1 adaptor protein FAN mediates TNF-induced B16 melanoma motility and invasion.Br J Cancer. 2013 Jul 23;109(2):422-32. doi: 10.1038/bjc.2013.242. Epub 2013 May 14.
• [2523] Loss of CPSF2 expression is associated with increased thyroid cancer cellular invasion and cancer stem cell population, and more aggressive disease.J Clin Endocrinol Metab. 2014 Jul;99(7):E1173-82. doi: 10.1210/jc.2013-4140. Epub 2014 Mar 21.
• [2524] CRABP1 provides high malignancy of transformed mesenchymal cells and contributes to the pathogenesis of mesenchymal and neuroendocrine tumors.Cell Cycle. 2014;13(10):1530-9. doi: 10.4161/cc.28475. Epub 2014 Mar 12.
• [2525] The oncogene LRF is a survival factor in chondrosarcoma and contributes to tumor malignancy and drug resistance.Carcinogenesis. 2012 Nov;33(11):2076-83. doi: 10.1093/carcin/bgs254. Epub 2012 Jul 30.
• [2526] Hypomethylation-mediated activation of cancer/testis antigen KK-LC-1 facilitates hepatocellular carcinoma progression through activating the Notch1/Hes1 signalling.Cell Prolif. 2019 May;52(3):e12581. doi: 10.1111/cpr.12581. Epub 2019 Mar 20.
• [2527] -Catenin promotes tumorigenesis and metastasis of lung adenocarcinoma.Oncol Rep. 2018 Feb;39(2):809-817. doi: 10.3892/or.2017.6140. Epub 2017 Dec 8.
• [2528] Up-regulation of CHAF1A, a poor prognostic factor, facilitates cell proliferation of colon cancer.Biochem Biophys Res Commun. 2014 Jun 27;449(2):208-15. doi: 10.1016/j.bbrc.2014.05.006. Epub 2014 May 15.
• [2529] Identification and characterization of the novel reversible and selective cathepsin X inhibitors.Sci Rep. 2017 Sep 13;7(1):11459. doi: 10.1038/s41598-017-11935-1.
• [2530] Dissecting the function of Cullin-RING ubiquitin ligase complex genes in planarian regeneration.Dev Biol. 2018 Jan 15;433(2):210-217. doi: 10.1016/j.ydbio.2017.10.011. Epub 2017 Dec 25.
• [2531] False biomarker discovery due to reactivity of a commercial ELISA for CUZD1 with cancer antigen CA125.Clin Chem. 2014 Feb;60(2):381-8. doi: 10.1373/clinchem.2013.215236. Epub 2013 Oct 4.
• [2532] TSPAN12 is a critical factor for cancer-fibroblast cell contact-mediated cancer invasion.Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):18691-6. doi: 10.1073/pnas.1412062112. Epub 2014 Dec 15.
• [2533] Preclinical characterization of signal transducer and activator of transcription 3 small molecule inhibitors for primary and metastatic brain cancer therapy.J Pharmacol Exp Ther. 2014 Jun;349(3):458-69. doi: 10.1124/jpet.114.214619. Epub 2014 Apr 2.
• [2534] Anti-breast Cancer Activity of SPG-56 from Sweet Potato in MCF-7 Bearing Mice in Situ through Promoting Apoptosis and Inhibiting Metastasis.Sci Rep. 2019 Jan 16;9(1):146. doi: 10.1038/s41598-018-29099-x.
• [2535] RELN signaling modulates glioblastoma growth and substrate-dependent migration.Brain Pathol. 2018 Sep;28(5):695-709. doi: 10.1111/bpa.12584. Epub 2018 Jan 10.
• [2536] Promoter methylation induced epigenetic silencing of DAZAP2, a downstream effector of p38/MAPK pathway, in multiple myeloma cells.Cell Signal. 2019 Aug;60:136-145. doi: 10.1016/j.cellsig.2019.04.012. Epub 2019 Apr 26.
• [2537] Discoidin, CUB and LCCL domain-containing protein 2 (DCBLD2) is a novel biomarker of myxofibrosarcoma invasion identified by global protein expression profiling.Biochim Biophys Acta Proteins Proteom. 2017 Sep;1865(9):1160-1166. doi: 10.1016/j.bbapap.2017.06.023. Epub 2017 Jun 29.
• [2538] Development of P22 viral capsid nanocomposites as anti-cancer drug, bortezomib (BTZ), delivery nanoplatforms.Macromol Biosci. 2014 Apr;14(4):557-64. doi: 10.1002/mabi.201300401.
• [2539] DCUN1D1 facilitates tumor metastasis by activating FAK signaling and up-regulates PD-L1 in non-small-cell lung cancer.Exp Cell Res. 2019 Jan 15;374(2):304-314. doi: 10.1016/j.yexcr.2018.12.001. Epub 2018 Dec 4.
• [2540] Oncogenic function of SCCRO5/DCUN1D5 requires its Neddylation E3 activity and nuclear localization.Clin Cancer Res. 2014 Jan 15;20(2):372-81. doi: 10.1158/1078-0432.CCR-13-1252. Epub 2013 Nov 5.
• [2541] DEAD box protein DDX1 promotes colorectal tumorigenesis through transcriptional activation of the LGR5 gene.Cancer Sci. 2018 Aug;109(8):2479-2489. doi: 10.1111/cas.13661. Epub 2018 Jul 17.
• [2542] Molecular functions and cellular roles of the ChlR1 (DDX11) helicase defective in the rare cohesinopathy Warsaw breakage syndrome.Cell Mol Life Sci. 2014 Jul;71(14):2625-39. doi: 10.1007/s00018-014-1569-4. Epub 2014 Feb 1.
• [2543] Functionally relevant RNA helicase mutations in familial and sporadic myeloid malignancies.Cancer Cell. 2015 May 11;27(5):609-11. doi: 10.1016/j.ccell.2015.04.013.
• [2544] Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21.Mol Cell. 2019 Sep 19;75(6):1270-1285.e14. doi: 10.1016/j.molcel.2019.06.020. Epub 2019 Jul 24.
• [2545] A DDX31/Mutant-p53/EGFR Axis Promotes Multistep Progression of Muscle-Invasive Bladder Cancer.Cancer Res. 2018 May 1;78(9):2233-2247. doi: 10.1158/0008-5472.CAN-17-2528. Epub 2018 Feb 13.
• [2546] Use of the tumor repressor DEDD as a prognostic marker of cancer metastasis.Methods Mol Biol. 2014;1165:197-222. doi: 10.1007/978-1-4939-0856-1_14.
• [2547] META-GSA: Combining Findings from Gene-Set Analyses across Several Genome-Wide Association Studies.PLoS One. 2015 Oct 26;10(10):e0140179. doi: 10.1371/journal.pone.0140179. eCollection 2015.
• [2548] Aberrant accumulation of Dickkopf 4 promotes tumor progression via forming the immune suppressive microenvironment in gastrointestinal stromal tumor.Cancer Med. 2019 Sep;8(11):5352-5366. doi: 10.1002/cam4.2437. Epub 2019 Jul 29.
• [2549] Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancer.Int J Cancer. 2016 Jul 1;139(1):33-41. doi: 10.1002/ijc.30003. Epub 2016 Feb 8.
• [2550] HSP40 co-chaperone protein Tid1 suppresses metastasis of head and neck cancer by inhibiting Galectin-7-TCF3-MMP9 axis signaling.Theranostics. 2018 Jun 13;8(14):3841-3855. doi: 10.7150/thno.25784. eCollection 2018.
• [2551] DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.Cancer Med. 2019 Oct;8(14):6393-6402. doi: 10.1002/cam4.2540. Epub 2019 Sep 4.
• [2552] Development of a measure for evaluating lesion-wise performance of CAD algorithms in the context of mpMRI detection of prostate cancer.Med Phys. 2018 May;45(5):2076-2088. doi: 10.1002/mp.12861. Epub 2018 Apr 16.
• [2553] Enhancement of Cutaneous Wound Healing by Dsg2 Augmentation of uPAR Secretion.J Invest Dermatol. 2018 Nov;138(11):2470-2479. doi: 10.1016/j.jid.2018.04.024. Epub 2018 May 9.
• [2554] DSPP-MMP20 gene silencing downregulates cancer stem cell markers in human oral cancer cells.Cell Mol Biol Lett. 2018 Jul 11;23:30. doi: 10.1186/s11658-018-0096-y. eCollection 2018.
• [2555] LIPG signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer.Elife. 2018 Jan 19;7:e31334. doi: 10.7554/eLife.31334.
• [2556] Proteome Analysis of Hypoxic Glioblastoma Cells Reveals Sequential Metabolic Adaptation of One-Carbon Metabolic Pathways.Mol Cell Proteomics. 2017 Nov;16(11):1906-1921. doi: 10.1074/mcp.RA117.000154. Epub 2017 Sep 5.
• [2557] Taking cohesin and condensin in context.PLoS Genet. 2018 Jan 25;14(1):e1007118. doi: 10.1371/journal.pgen.1007118. eCollection 2018 Jan.
• [2558] DLC2 operates as a tumor suppressor gene in breast cancer via the RhoGTPase pathway.Oncol Lett. 2019 Feb;17(2):2107-2116. doi: 10.3892/ol.2018.9874. Epub 2018 Dec 28.
• [2559] Immunogenicity and therapeutic efficacy of a dual-component genetic cancer vaccine cotargeting carcinoembryonic antigen and HER2/neu in preclinical models.Hum Gene Ther. 2014 Feb;25(2):121-31. doi: 10.1089/hum.2013.103. Epub 2013 Dec 21.
• [2560] Serum exosomes contain ECRG4 mRNA that suppresses tumor growth via inhibition of genes involved in inflammation, cell proliferation, and angiogenesis.Cancer Gene Ther. 2018 Oct;25(9-10):248-259. doi: 10.1038/s41417-018-0032-3. Epub 2018 Jul 9.
• [2561] Binding of eEF1A2 to the RNA-dependent protein kinase PKR modulates its activity and promotes tumour cell survival.Br J Cancer. 2018 Nov;119(11):1410-1420. doi: 10.1038/s41416-018-0336-y. Epub 2018 Nov 13.
• [2562] Structural investigation of a C-terminal EphA2 receptor mutant: Does mutation affect the structure and interaction properties of the Sam domain?.Biochim Biophys Acta Proteins Proteom. 2017 Sep;1865(9):1095-1104. doi: 10.1016/j.bbapap.2017.06.003. Epub 2017 Jun 6.
• [2563] The expression of RUNDC3B is associated with promoter methylation in lymphoid malignancies.Hematol Oncol. 2017 Mar;35(1):25-33. doi: 10.1002/hon.2238. Epub 2015 May 25.
• [2564] Cullin-3/KCTD10 complex is essential for K27-polyubiquitination of EIF3D in human hepatocellular carcinoma HepG2 cells.Biochem Biophys Res Commun. 2019 Sep 3;516(4):1116-1122. doi: 10.1016/j.bbrc.2019.07.010. Epub 2019 Jul 5.
• [2565] eIF4E3 acts as a tumor suppressor by utilizing an atypical mode of methyl-7-guanosine cap recognition.Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3877-82. doi: 10.1073/pnas.1216862110. Epub 2013 Feb 19.
• [2566] Elp3 drives Wnt-dependent tumor initiation and regeneration in the intestine.J Exp Med. 2015 Nov 16;212(12):2057-75. doi: 10.1084/jem.20142288. Epub 2015 Nov 2.
• [2567] The function of EMSY in cancer development.Tumour Biol. 2014 Jun;35(6):5061-6. doi: 10.1007/s13277-013-1584-3. Epub 2014 Mar 9.
• [2568] Importance of HOX genes in normal prostate gland formation, prostate cancer development and its early detection.BJU Int. 2014 Apr;113(4):535-40. doi: 10.1111/bju.12269. Epub 2013 Aug 13.
• [2569] Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma.Nat Commun. 2017 Sep 11;8(1):517. doi: 10.1038/s41467-017-00530-7.
• [2570] The Metabolism of Separase Inhibitor Sepin-1 in Human, Mouse, and Rat Liver Microsomes.Front Pharmacol. 2018 May 7;9:313. doi: 10.3389/fphar.2018.00313. eCollection 2018.
• [2571] EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways.Front Oncol. 2019 Jul 18;9:643. doi: 10.3389/fonc.2019.00643. eCollection 2019.
• [2572] DRR1 is expressed in the developing nervous system and downregulated during neuroblastoma carcinogenesis.Biochem Biophys Res Commun. 2010 Apr 9;394(3):829-35. doi: 10.1016/j.bbrc.2010.03.085. Epub 2010 Mar 16.
• [2573] Fibulin-1 is downregulated through promoter hypermethylation in colorectal cancer: a CONSORT study.Medicine (Baltimore). 2015 Apr;94(13):e663. doi: 10.1097/MD.0000000000000663.
• [2574] Involvement of methylation-associated silencing of formin 2 in colorectal carcinogenesis.World J Gastroenterol. 2018 Nov 28;24(44):5013-5024. doi: 10.3748/wjg.v24.i44.5013.
• [2575] Inhibitory effects of forkhead box L1 gene on osteosarcoma growth through the induction of cell cycle arrest and apoptosis.Oncol Rep. 2015 Jul;34(1):265-71. doi: 10.3892/or.2015.3969. Epub 2015 May 11.
• [2576] FRK plays an oncogenic role in non-small cell lung cancer by enhancing the stemness phenotype via induction of metabolic reprogramming.Int J Cancer. 2020 Jan 1;146(1):208-222. doi: 10.1002/ijc.32530. Epub 2019 Jul 26.
• [2577] Down-regulated FSTL5 promotes cell proliferation and survival by affecting Wnt/-catenin signaling in hepatocellular carcinoma.Int J Clin Exp Pathol. 2015 Mar 1;8(3):3386-94. eCollection 2015.
• [2578] GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.Cell Death Differ. 2020 Jun;27(6):1862-1877. doi: 10.1038/s41418-019-0466-7. Epub 2019 Dec 4.
• [2579] Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.Oncotarget. 2014 Jan 30;5(2):544-60. doi: 10.18632/oncotarget.1652.
• [2580] Glycosyltransferase Gene Expression Identifies a Poor Prognostic Colorectal Cancer Subtype Associated with Mismatch Repair Deficiency and Incomplete Glycan Synthesis.Clin Cancer Res. 2018 Sep 15;24(18):4468-4481. doi: 10.1158/1078-0432.CCR-17-3533. Epub 2018 May 29.
• [2581] Chemical targeting of GAPDH moonlighting function in cancer cells reveals its role in tubulin regulation.Chem Biol. 2014 Nov 20;21(11):1533-45. doi: 10.1016/j.chembiol.2014.08.017. Epub 2014 Oct 9.
• [2582] Molecular Pathways: Mucins and Drug Delivery in Cancer.Clin Cancer Res. 2017 Mar 15;23(6):1373-1378. doi: 10.1158/1078-0432.CCR-16-0862. Epub 2016 Dec 30.
• [2583] HKH40A downregulates GRP78/BiP expression in cancer cells.Cell Death Dis. 2014 May 22;5(5):e1240. doi: 10.1038/cddis.2014.203.
• [2584] Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.NMR Biomed. 2012 Sep;25(9):1033-42. doi: 10.1002/nbm.2766. Epub 2012 Jan 26.
• [2585] A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancers: An NRG Oncology/Gynecologic Oncology Group study.Gynecol Oncol. 2017 Nov;147(2):283-290. doi: 10.1016/j.ygyno.2017.08.001. Epub 2017 Aug 10.
• [2586] GINS2 regulates matrix metallopeptidase 9 expression and cancer stem cell property in human triple negative Breast cancer.Biomed Pharmacother. 2016 Dec;84:1568-1574. doi: 10.1016/j.biopha.2016.10.032. Epub 2016 Nov 6.
• [2587] Glutamate production from ammonia via glutamate dehydrogenase 2 activity supports cancer cell proliferation under glutamine depletion.Biochem Biophys Res Commun. 2018 Jan 1;495(1):761-767. doi: 10.1016/j.bbrc.2017.11.088. Epub 2017 Nov 14.
• [2588] Loss of GM130 in breast cancer cells and its effects on cell migration, invasion and polarity.Cell Cycle. 2015;14(8):1139-47. doi: 10.1080/15384101.2015.1007771.
• [2589] A polymorphism at the microRNA binding site in the 3' untranslated region of C14orf101 is associated with non-Hodgkin lymphoma overall survival.Cancer Genet. 2014 Apr;207(4):141-6. doi: 10.1016/j.cancergen.2014.03.007. Epub 2014 Mar 22.
• [2590] A novel fatty acid-binding protein 5-estrogen-related receptor signaling pathway promotes cell growth and energy metabolism in prostate cancer cells.Oncotarget. 2018 Aug 3;9(60):31753-31770. doi: 10.18632/oncotarget.25878. eCollection 2018 Aug 3.
• [2591] Identification of GPM6A and GPM6B as potential new human lymphoid leukemia-associated oncogenes.Cell Oncol (Dordr). 2014 Jun;37(3):179-91. doi: 10.1007/s13402-014-0171-y. Epub 2014 Jun 12.
• [2592] YAP Suppresses Lung Squamous Cell Carcinoma Progression via Deregulation of the DNp63-GPX2 Axis and ROS Accumulation.Cancer Res. 2017 Nov 1;77(21):5769-5781. doi: 10.1158/0008-5472.CAN-17-0449. Epub 2017 Sep 15.
• [2593] Olea europaea leaf extract and bevacizumab synergistically exhibit beneficial efficacy upon human glioblastoma cancer stem cells through reducing angiogenesis and invasion in vitro.Biomed Pharmacother. 2017 Jun;90:713-723. doi: 10.1016/j.biopha.2017.04.022. Epub 2017 Apr 15.
• [2594] Studies on human eRF3-PABP interaction reveal the influence of eRF3a N-terminal glycin repeat on eRF3-PABP binding affinity and the lower affinity of eRF3a 12-GGC allele involved in cancer susceptibility.RNA Biol. 2016;13(3):306-15. doi: 10.1080/15476286.2015.1137421. Epub 2016 Jan 28.
• [2595] GTF2IRD1 on chromosome 7 is a novel oncogene regulating the tumor-suppressor gene TGFR2 in colorectal cancer.Cancer Sci. 2020 Feb;111(2):343-355. doi: 10.1111/cas.14248. Epub 2019 Dec 27.
• [2596] Knockdown of GTPBP4 inhibits cell growth and survival in human hepatocellular carcinoma and its prognostic significance.Oncotarget. 2017 Oct 5;8(55):93984-93997. doi: 10.18632/oncotarget.21500. eCollection 2017 Nov 7.
• [2597] GTSE1: a novel TEAD4-E2F1 target gene involved in cell protrusions formation in triple-negative breast cancer cell models.Oncotarget. 2017 Jun 27;8(40):67422-67438. doi: 10.18632/oncotarget.18691. eCollection 2017 Sep 15.
• [2598] Histone H3.3 G34 Mutations Alter Histone H3K36 and H3K27 Methylation In Cis.J Mol Biol. 2018 May 25;430(11):1562-1565. doi: 10.1016/j.jmb.2018.04.014. Epub 2018 Apr 22.
• [2599] Nuclear translocation of Hand-1 acts as a molecular switch to regulate vascular radiosensitivity in medulloblastoma tumors: the protein uPAR is a cytoplasmic sequestration factor for Hand-1.Mol Cancer Ther. 2014 May;13(5):1309-22. doi: 10.1158/1535-7163.MCT-13-0892. Epub 2014 Mar 12.
• [2600] Human hyaluronic acid synthase-1 promotes malignant transformation via epithelial-to-mesenchymal transition, micronucleation and centrosome abnormalities.Cell Commun Signal. 2017 Nov 14;15(1):48. doi: 10.1186/s12964-017-0204-z.
• [2601] HELQ reverses the malignant phenotype of osteosarcoma cells via CHK1-RAD51 signaling pathway.Oncol Rep. 2017 Feb;37(2):1107-1113. doi: 10.3892/or.2016.5329. Epub 2016 Dec 20.
• [2602] Homozygosity for the WRN Helicase-Inactivating Variant, R834C, does not confer a Werner syndrome clinical phenotype.Sci Rep. 2017 Mar 9;7:44081. doi: 10.1038/srep44081.
• [2603] Time trends in the prevalence of cancer and non-cancer diseases among older U.S. adults: Medicare-based analysis.Exp Gerontol. 2018 Sep;110:267-276. doi: 10.1016/j.exger.2018.06.017. Epub 2018 Jun 19.
• [2604] Inhibition of HHIP Promoter Methylation Suppresses Human Gastric Cancer Cell Proliferation and Migration.Cell Physiol Biochem. 2018;45(5):1840-1850. doi: 10.1159/000487875. Epub 2018 Feb 28.
• [2605] Tissue-specificity of heparan sulfate biosynthetic machinery in cancer.Cell Adh Migr. 2015;9(6):452-9. doi: 10.1080/19336918.2015.1049801.
• [2606] A cancer-associated mutation inactivates a region of the high-mobility group protein HMG20b essential for cytokinesis.Cell Cycle. 2014;13(16):2554-63. doi: 10.4161/15384101.2014.942204.
• [2607] Quantitative profiling of chromatome dynamics reveals a novel role for HP1BP3 in hypoxia-induced oncogenesis.Mol Cell Proteomics. 2014 Dec;13(12):3236-49. doi: 10.1074/mcp.M114.038232. Epub 2014 Aug 6.
• [2608] Mutations that disrupt PHOXB interaction with the neuronal calcium sensor HPCAL1 impede cellular differentiation in neuroblastoma.Oncogene. 2014 Jun 19;33(25):3316-24. doi: 10.1038/onc.2013.290. Epub 2013 Jul 22.
• [2609] Histidine-rich glycoprotein blocks collagen-binding integrins and adhesion of endothelial cells through low-affinity interaction with 2 integrin.Matrix Biol. 2015 Oct;48:89-99. doi: 10.1016/j.matbio.2015.06.002. Epub 2015 Jun 5.
• [2610] Blocking "don't eat me" signal of CD47-SIRP in hematological malignancies, an in-depth review.Blood Rev. 2018 Nov;32(6):480-489. doi: 10.1016/j.blre.2018.04.005. Epub 2018 Apr 14.
• [2611] HtrA4 Protease Promotes Chemotherapeutic-Dependent Cancer Cell Death.Cells. 2019 Sep 20;8(10):1112. doi: 10.3390/cells8101112.
• [2612] ID3 Promotes Stem Cell Features and Predicts Chemotherapeutic Response of Intrahepatic Cholangiocarcinoma.Hepatology. 2019 May;69(5):1995-2012. doi: 10.1002/hep.30404. Epub 2019 Mar 8.
• [2613] Interferon--inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.Virol J. 2017 Nov 13;14(1):221. doi: 10.1186/s12985-017-0891-5.
• [2614] Intraflagellar transport 20 promotes collective cancer cell invasion by regulating polarized organization of Golgi-associated microtubules.Cancer Sci. 2019 Apr;110(4):1306-1316. doi: 10.1111/cas.13970. Epub 2019 Feb 28.
• [2615] Alterations in the microbiota drive interleukin-17C production from intestinal epithelial cells to promote tumorigenesis.Immunity. 2014 Jan 16;40(1):140-52. doi: 10.1016/j.immuni.2013.11.018. Epub 2014 Jan 9.
• [2616] Identification of small molecule inhibitors of Interleukin-18.Sci Rep. 2017 Mar 28;7(1):483. doi: 10.1038/s41598-017-00532-x.
• [2617] Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth.Theranostics. 2017 Mar 16;7(5):1333-1345. doi: 10.7150/thno.17092. eCollection 2017.
• [2618] CR-LAAO, an L-amino acid oxidase from Calloselasma rhodostoma venom, as a potential tool for developing novel immunotherapeutic strategies against cancer.Sci Rep. 2017 Feb 16;7:42673. doi: 10.1038/srep42673.
• [2619] Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities.Curr Med Chem. 2018;25(36):4785-4806. doi: 10.2174/0929867324666170712160621.
• [2620] Transgenic expression of the RNA binding protein IMP2 stabilizes miRNA targets in murine microsteatosis.Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3099-3108. doi: 10.1016/j.bbadis.2018.05.024. Epub 2018 May 30.
• [2621] IMP-6 Carbapenemase-Producing Enterobacteriaceae Bacteremia Successfully Treated with Amikacin-Meropenem in Two Patients.Pharmacotherapy. 2017 Oct;37(10):e96-e102. doi: 10.1002/phar.1984. Epub 2017 Aug 23.
• [2622] Therapeutic advantage of genetically engineered Salmonella typhimurium carrying short hairpin RNA against inhibin alpha subunit in cancer treatment.Ann Oncol. 2018 Sep 1;29(9):2010-2017. doi: 10.1093/annonc/mdy240.
• [2623] Insulinoma-associated protein 1 is a sensitive and specific marker of neuroendocrine lung neoplasms in cytology specimens.Cancer Cytopathol. 2018 Apr;126(4):243-252. doi: 10.1002/cncy.21972. Epub 2018 Jan 23.
• [2624] Wnt3 knockdown sensitizes human non-small cell type lung cancer (NSCLC) cells to cisplatin via regulating the cell proliferation and apoptosis.Eur Rev Med Pharmacol Sci. 2018 Mar;22(5):1323-1332. doi: 10.26355/eurrev_201803_14474.
• [2625] Interferon regulatory factor 1 inactivation in human cancer.Biosci Rep. 2018 May 8;38(3):BSR20171672. doi: 10.1042/BSR20171672. Print 2018 Jun 29.
• [2626] Functional IRGM polymorphism is associated with language impairment in glioma and upregulates cytokine expressions.Tumour Biol. 2014 Aug;35(8):8343-8. doi: 10.1007/s13277-014-2091-x. Epub 2014 May 24.
• [2627] ISL1 promotes cancer progression and inhibits cisplatin sensitivity in triple-negative breast cancer cells.Int J Mol Med. 2018 Nov;42(5):2343-2352. doi: 10.3892/ijmm.2018.3842. Epub 2018 Aug 27.
• [2628] Isthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunction.Cell Death Differ. 2014 May;21(5):797-810. doi: 10.1038/cdd.2014.3. Epub 2014 Jan 24.
• [2629] Activating transcription factor 3 promotes colon cancer metastasis.Tumour Biol. 2014 Aug;35(8):8329-34. doi: 10.1007/s13277-014-2044-4. Epub 2014 May 24.
• [2630] Upregulation of the Kank1 gene inhibits human lung cancer progression invitro and invivo.Oncol Rep. 2018 Sep;40(3):1243-1250. doi: 10.3892/or.2018.6526. Epub 2018 Jun 26.
• [2631] Targeting cancer using KAT inhibitors to mimic lethal knockouts.Biochem Soc Trans. 2016 Aug 15;44(4):979-86. doi: 10.1042/BST20160081.
• [2632] KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders.CNS Neurosci Ther. 2019 Jul;25(7):887-902. doi: 10.1111/cns.13156.
• [2633] Functions of the multi-interacting protein KIDINS220/ARMS in cancer and other pathologies.Genes Chromosomes Cancer. 2018 Mar;57(3):114-122. doi: 10.1002/gcc.22514. Epub 2017 Dec 20.
• [2634] Interactions Between KIR3DS1 and HLA-F Activate Natural Killer Cells to Control HCV Replication in Cell Culture.Gastroenterology. 2018 Nov;155(5):1366-1371.e3. doi: 10.1053/j.gastro.2018.07.019. Epub 2018 Jul 19.
• [2635] Characterization of Kelch domain-containing protein 7B in breast tumours and breast cancer cell lines.Oncol Lett. 2019 Sep;18(3):2853-2860. doi: 10.3892/ol.2019.10672. Epub 2019 Jul 26.
• [2636] The effects of crocetin, extracted from saffron, in chemotherapy against the incidence of multiple drug resistance phenotype.Iran J Basic Med Sci. 2018 Nov;21(11):1192-1197. doi: 10.22038/IJBMS.2018.29474.7118.
• [2637] Expansion of CMV-mediated NKG2C+ NK cells associates with the development of specific de novo malignancies in liver-transplanted patients.J Immunol. 2014 Jan 1;192(1):503-11. doi: 10.4049/jimmunol.1301951. Epub 2013 Dec 4.
• [2638] Recurrent point mutations in the kinetochore gene KNSTRN in cutaneous squamous cell carcinoma.Nat Genet. 2014 Oct;46(10):1060-2. doi: 10.1038/ng.3091. Epub 2014 Sep 7.
• [2639] Expression of the RIP-1 gene and its role in growth and invasion of human gallbladder carcinoma.Cell Physiol Biochem. 2014;34(4):1152-65. doi: 10.1159/000366328. Epub 2014 Sep 22.
• [2640] A miR-SNP of the KRT81 gene is associated with the prognosis of non-Hodgkin's lymphoma.Gene. 2014 Apr 15;539(2):198-202. doi: 10.1016/j.gene.2014.02.010. Epub 2014 Feb 12.
• [2641] Transkingdom network reveals bacterial players associated with cervical cancer gene expression program.PeerJ. 2018 Sep 19;6:e5590. doi: 10.7717/peerj.5590. eCollection 2018.
• [2642] The La-Related Proteins, a Family with Connections to Cancer.Biomolecules. 2015 Oct 16;5(4):2701-22. doi: 10.3390/biom5042701.
• [2643] Identification of LCN1 as a Potential Biomarker for Breast Cancer by Bioinformatic Analysis.DNA Cell Biol. 2019 Oct;38(10):1088-1099. doi: 10.1089/dna.2019.4843. Epub 2019 Aug 19.
• [2644] Targeting HCCR expression resensitizes gastric cancer cells to chemotherapy via down-regulating the activation of STAT3.Sci Rep. 2016 Apr 7;6:24196. doi: 10.1038/srep24196.
• [2645] Galectin-8 predicts postoperative recurrence of patients with localized T1 clear cell renal cell carcinoma.Urol Oncol. 2015 Mar;33(3):112.e1-8. doi: 10.1016/j.urolonc.2014.11.001. Epub 2014 Nov 5.
• [2646] LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.Biomed Pharmacother. 2019 Sep;117:109174. doi: 10.1016/j.biopha.2019.109174. Epub 2019 Jul 8.
• [2647] LOXL1 Is Regulated by Integrin 11 and Promotes Non-Small Cell Lung Cancer Tumorigenicity.Cancers (Basel). 2019 May 22;11(5):705. doi: 10.3390/cancers11050705.
• [2648] LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.J Exp Clin Cancer Res. 2019 Feb 21;38(1):95. doi: 10.1186/s13046-019-1092-4.
• [2649] LRIG2 is a growth suppressor of Hec-1A and Ishikawa endometrial adenocarcinoma cells by regulating PI3K/AKT- and EGFR-mediated apoptosis and cell-cycle.Oncogenesis. 2018 Jan 23;7(1):3. doi: 10.1038/s41389-017-0019-1.
• [2650] Expression of a recombinant full-length LRP1B receptor in human non-small cell lung cancer cells confirms the postulated growth-suppressing function of this large LDL receptor family member.Oncotarget. 2016 Oct 18;7(42):68721-68733. doi: 10.18632/oncotarget.11897.
• [2651] Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/-catenin signaling pathway.Cancer Lett. 2015 Aug 28;365(1):132-40. doi: 10.1016/j.canlet.2015.05.023. Epub 2015 Jun 3.
• [2652] ORCA-010, a novel potency-enhanced oncolytic adenovirus, exerts strong antitumor activity in preclinical models.Hum Gene Ther. 2014 Oct;25(10):897-904. doi: 10.1089/hum.2013.229. Epub 2014 Sep 17.
• [2653] An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growth.Genes Dev. 2014 May 15;28(10):1068-84. doi: 10.1101/gad.237206.113. Epub 2014 May 1.
• [2654] Multiple Group Confirmatory Factor Analysis of the DASS-21 Depression and Anxiety Scales: How Do They Perform in a Cancer Sample?.Psychol Rep. 2018 Jun;121(3):548-565. doi: 10.1177/0033294117727747. Epub 2017 Aug 24.
• [2655] MACF1, versatility in tissue-specific function and in human disease.Semin Cell Dev Biol. 2017 Sep;69:3-8. doi: 10.1016/j.semcdb.2017.05.017. Epub 2017 May 31.
• [2656] Histone variant macroH2A1 rewires carbohydrate and lipid metabolism of hepatocellular carcinoma cells towards cancer stem cells.Epigenetics. 2018;13(8):829-845. doi: 10.1080/15592294.2018.1514239. Epub 2018 Sep 29.
• [2657] Expression and functionality of histone H2A variants in cancer.Oncotarget. 2014 Jun 15;5(11):3428-43. doi: 10.18632/oncotarget.2007.
• [2658] Proteomic analysis reveals that MAEL, a component of nuage, interacts with stress granule proteins in cancer cells.Oncol Rep. 2014 Jan;31(1):342-50. doi: 10.3892/or.2013.2836. Epub 2013 Nov 5.
• [2659] MKK3 sustains cell proliferation and survival through p38DELTA MAPK activation in colorectal cancer.Cell Death Dis. 2019 Nov 6;10(11):842. doi: 10.1038/s41419-019-2083-2.
• [2660] Survival of Head and Neck Cancer Cells Relies upon LZK Kinase-Mediated Stabilization of Mutant p53.Cancer Res. 2017 Sep 15;77(18):4961-4972. doi: 10.1158/0008-5472.CAN-17-0267. Epub 2017 Jul 31.
• [2661] MicroRNA-23a promotes colorectal cancer cell migration and proliferation by targeting at MARK1.Acta Biochim Biophys Sin (Shanghai). 2019 Jul 10;51(7):661-668. doi: 10.1093/abbs/gmz047.
• [2662] The Oncogenic Functions of MASTL Kinase.Front Cell Dev Biol. 2018 Nov 23;6:162. doi: 10.3389/fcell.2018.00162. eCollection 2018.
• [2663] CDKN2A/p16 Deletion in Head and Neck Cancer Cells Is Associated with CDK2 Activation, Replication Stress, and Vulnerability to CHK1 Inhibition.Cancer Res. 2018 Feb 1;78(3):781-797. doi: 10.1158/0008-5472.CAN-17-2802. Epub 2017 Dec 11.
• [2664] Italian cultural adaptation of the Memorial Anxiety for Prostate Cancer scale for the population of men on active surveillance.Tumori. 2018 Jun;104(3):172-178. doi: 10.5301/tj.5000646. Epub 2018 May 9.
• [2665] MDH2 Stimulated by Estrogen-GPR30 Pathway Down-Regulated PTEN Expression Promoting the Proliferation and Invasion of Cells in Endometrial Cancer.Transl Oncol. 2017 Apr;10(2):203-210. doi: 10.1016/j.tranon.2017.01.009. Epub 2017 Feb 9.
• [2666] Examination of VDR/RXR/DRIP205 Interaction, Intranuclear Localization, and DNA Binding in Ras-Transformed Keratinocytes and Its Implication for Designing Optimal Vitamin D Therapy in Cancer.Endocrinology. 2018 Mar 1;159(3):1303-1327. doi: 10.1210/en.2017-03098.
• [2667] MED30 Regulates the Proliferation and Motility of Gastric Cancer Cells.PLoS One. 2015 Jun 25;10(6):e0130826. doi: 10.1371/journal.pone.0130826. eCollection 2015.
• [2668] mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis.Nature. 2018 Sep;561(7724):556-560. doi: 10.1038/s41586-018-0538-8. Epub 2018 Sep 19.
• [2669] Frameshift Mutations in Repeat Sequences of ANK3, HACD4, TCP10L, TP53BP1, MFN1, LCMT2, RNMT, TRMT6, METTL8 and METTL16 Genes in Colon Cancers.Pathol Oncol Res. 2018 Jul;24(3):617-622. doi: 10.1007/s12253-017-0287-2. Epub 2017 Aug 12.
• [2670] Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer.Prostate. 2015 Oct;75(14):1586-600. doi: 10.1002/pros.23034. Epub 2015 Jun 12.
• [2671] MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression.PLoS One. 2018 Jan 2;13(1):e0190437. doi: 10.1371/journal.pone.0190437. eCollection 2018.
• [2672] Characterization of Copy Number Variations in Oral Cavity Squamous Cell Carcinoma Reveals a Novel Role for MLLT3 in Cell Invasiveness.Oncologist. 2019 Dec;24(12):e1388-e1400. doi: 10.1634/theoncologist.2019-0063. Epub 2019 Jul 4.
• [2673] Helical organization of microtubules occurs in a minority of tunneling membrane nanotubes in normal and cancer urothelial cells.Sci Rep. 2018 Nov 20;8(1):17133. doi: 10.1038/s41598-018-35370-y.
• [2674] MTBP inhibits migration and metastasis of hepatocellular carcinoma.Clin Exp Metastasis. 2015 Apr;32(4):301-11. doi: 10.1007/s10585-015-9706-5. Epub 2015 Mar 11.
• [2675] Oncogenic miR-19a and miR-19b co-regulate tumor suppressor MTUS1 to promote cell proliferation and migration in lung cancer.Protein Cell. 2017 Jun;8(6):455-466. doi: 10.1007/s13238-017-0393-7. Epub 2017 Mar 31.
• [2676] Protease activated receptor 2 mediates tryptase-induced cell migration through MYO10 in colorectal cancer.Am J Cancer Res. 2019 Sep 1;9(9):1995-2006. eCollection 2019.
• [2677] Myo9b is a key player in SLIT/ROBO-mediated lung tumor suppression.J Clin Invest. 2015 Nov 3;125(12):4407-20. doi: 10.1172/JCI81673.
• [2678] Characterization of a new SNP c767A/T (Arg222Trp) in the candidate TSG FUS2 on human chromosome 3p21.3: prevalence in Asian populations and analysis of association with nasopharyngeal cancer.Mol Cell Probes. 2004 Feb;18(1):39-44. doi: 10.1016/j.mcp.2003.09.002.
• [2679] N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype.Oncogene. 2014 Nov 6;33(45):5274-87. doi: 10.1038/onc.2013.464. Epub 2013 Nov 18.
• [2680] NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1/p53 activation in hepatocellular carcinoma.Cell Death Dis. 2019 May 8;10(5):369. doi: 10.1038/s41419-019-1603-4.
• [2681] Extra domain A-containing fibronectin expression in Spin90-deficient fibroblasts mediates cancer-stroma interaction and promotes breast cancer progression.J Cell Physiol. 2020 May;235(5):4494-4507. doi: 10.1002/jcp.29326. Epub 2019 Oct 21.
• [2682] Tamoxifen Resistance Trumped and Oral Selective Estrogen Receptor Degraders Arrive.Clin Cancer Res. 2018 Aug 1;24(15):3480-3482. doi: 10.1158/1078-0432.CCR-18-0759. Epub 2018 Apr 19.
• [2683] The role of polycomb group protein Bmi-1 and Notch4 in breast cancer stem cell inhibition by benzyl isothiocyanate.Breast Cancer Res Treat. 2015 Feb;149(3):681-92. doi: 10.1007/s10549-015-3279-5. Epub 2015 Feb 8.
• [2684] PEG-functionalized zinc oxide nanoparticles induce apoptosis in breast cancer cells through reactive oxygen species-dependent impairment of DNA damage repair enzyme NEIL2.Free Radic Biol Med. 2017 Feb;103:35-47. doi: 10.1016/j.freeradbiomed.2016.11.048. Epub 2016 Dec 7.
• [2685] NEK5 promotes breast cancer cell proliferation through up-regulation of Cyclin A2.Mol Carcinog. 2019 Jun;58(6):933-943. doi: 10.1002/mc.22982. Epub 2019 Feb 22.
• [2686] Discovery and Characterization of Dual Inhibitors of MDM2 and NFAT1 for Pancreatic Cancer Therapy.Cancer Res. 2018 Oct 1;78(19):5656-5667. doi: 10.1158/0008-5472.CAN-17-3939. Epub 2018 Sep 14.
• [2687] Gene expression profiling analysis contributes to understanding the association between non-syndromic cleft lip and palate, and cancer.Mol Med Rep. 2016 Mar;13(3):2110-6. doi: 10.3892/mmr.2016.4802. Epub 2016 Jan 20.
• [2688] The role of centrosomal Nlp in the control of mitotic progression and tumourigenesis.Br J Cancer. 2011 May 10;104(10):1523-8. doi: 10.1038/bjc.2011.130. Epub 2011 Apr 19.
• [2689] The actin-sequestering protein thymosin beta-4 is a novel target of hypoxia-inducible nitric oxide and HIF-1 regulation.PLoS One. 2014 Oct 1;9(10):e106532. doi: 10.1371/journal.pone.0106532. eCollection 2014.
• [2690] Suppression of GLTSCR2 expression in renal cell carcinomas.Pathol Res Pract. 2016 Feb;212(2):120-4. doi: 10.1016/j.prp.2015.12.005. Epub 2015 Dec 14.
• [2691] Biological characteristics of renal cancer cells after CTP-mediated cancer suppressor gene NPRL2 protein treatment.Biol Chem. 2016 Nov 1;397(11):1163-1171. doi: 10.1515/hsz-2016-0143.
• [2692] Breast cancer prognosis predicted by nuclear receptor-coregulator networks.Mol Oncol. 2014 Jul;8(5):998-1013. doi: 10.1016/j.molonc.2014.03.017. Epub 2014 Apr 4.
• [2693] Functional characterization of novelNR5A1variants reveals multiple complex roles in disorders of sex development.Hum Mutat. 2018 Jan;39(1):124-139. doi: 10.1002/humu.23354. Epub 2017 Nov 2.
• [2694] Down-Regulated NRSN2 Promotes Cell Proliferation and Survival Through PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma.Dig Dis Sci. 2015 Oct;60(10):3011-8. doi: 10.1007/s10620-015-3736-3. Epub 2015 Jun 9.
• [2695] Self-assembling HA/PEI/dsRNA-p21 ternary complexes for CD44 mediated small active RNA delivery to colorectal cancer.Drug Deliv. 2017 Nov;24(1):1537-1548. doi: 10.1080/10717544.2017.1386732.
• [2696] Three new abietane-type diterpenoids from the leaves of Indonesian Plectranthus scutellarioides.Fitoterapia. 2018 Jun;127:146-150. doi: 10.1016/j.fitote.2018.02.013. Epub 2018 Feb 12.
• [2697] Expression of Oncogenic Drivers in 3D Cell Culture Depends on Nuclear ATP Synthesis by NUDT5.Cancers (Basel). 2019 Sep 10;11(9):1337. doi: 10.3390/cancers11091337.
• [2698] Nuclear pore protein NUP88 activates anaphase-promoting complex to promote aneuploidy.J Clin Invest. 2016 Feb;126(2):543-59. doi: 10.1172/JCI82277. Epub 2016 Jan 5.
• [2699] Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangement.Mod Pathol. 2014 May;27(5):751-7. doi: 10.1038/modpathol.2013.199. Epub 2013 Nov 1.
• [2700] Pathway bridge based multiobjective optimization approach for lurking pathway prediction.Biomed Res Int. 2014;2014:351095. doi: 10.1155/2014/351095. Epub 2014 Apr 16.
• [2701] ODAM inhibits RhoA-dependent invasion in breast cancer.Cell Biochem Funct. 2015 Oct;33(7):451-61. doi: 10.1002/cbf.3132. Epub 2015 Sep 10.
• [2702] OIP5 Expression Sensitize Glioblastoma Cells to Lomustine Treatment.J Mol Neurosci. 2018 Nov;66(3):383-389. doi: 10.1007/s12031-018-1184-1. Epub 2018 Oct 3.
• [2703] Loss of opioid binding protein/cell adhesion molecule-like gene expression in gastric cancer.Oncol Lett. 2018 Jun;15(6):9973-9977. doi: 10.3892/ol.2018.8562. Epub 2018 Apr 24.
• [2704] Extracorporeal photochemotherapy induces bona fide immunogenic cell death.Cell Death Dis. 2019 Aug 2;10(8):578. doi: 10.1038/s41419-019-1819-3.
• [2705] Regulation of proto-oncogene Orai3 by miR18a/b and miR34a.Cell Calcium. 2018 Nov;75:101-111. doi: 10.1016/j.ceca.2018.08.006. Epub 2018 Sep 3.
• [2706] Genome-wide identification of OTP gene as a novel methylation marker of breast cancer.Oncol Rep. 2012 May;27(5):1681-8. doi: 10.3892/or.2012.1691. Epub 2012 Feb 17.
• [2707] OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma.Cancer Discov. 2017 Mar;7(3):288-301. doi: 10.1158/2159-8290.CD-16-0844. Epub 2017 Feb 17.
• [2708] Aberrant promoter methylation of the PAQR3 gene is associated with prostate cancer.Pathol Res Pract. 2018 Jan;214(1):126-129. doi: 10.1016/j.prp.2017.10.010. Epub 2017 Oct 10.
• [2709] Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma.Oncogene. 2018 Nov;37(45):5967-5981. doi: 10.1038/s41388-018-0373-2. Epub 2018 Jul 6.
• [2710] PBOV1 as a potential biomarker for more advanced prostate cancer based on protein and digital histomorphometric analysis.Prostate. 2018 May;78(7):547-559. doi: 10.1002/pros.23499. Epub 2018 Mar 9.
• [2711] Recurrent transcriptional loss of the PCDH17 tumor suppressor in laryngeal squamous cell carcinoma is partially mediated by aberrant promoter DNA methylation.Mol Carcinog. 2018 Jul;57(7):878-885. doi: 10.1002/mc.22808. Epub 2018 Apr 6.
• [2712] PCMT1 is an unfavorable predictor and functions as an oncogene in bladder cancer.IUBMB Life. 2018 Apr;70(4):291-299. doi: 10.1002/iub.1717. Epub 2018 Mar 8.
• [2713] Zirconium-Porphyrin PCN-222: pH-responsive Controlled Anticancer Drug Oridonin.Evid Based Complement Alternat Med. 2018 Dec 4;2018:3249023. doi: 10.1155/2018/3249023. eCollection 2018.
• [2714] Anti-apoptotic effects of PCP4/PEP19 in human breast cancer cell lines: a novel oncotarget.Oncotarget. 2014 Aug 15;5(15):6076-86. doi: 10.18632/oncotarget.2161.
• [2715] EGFR-TKI resistance and MAP17 are associated with cancer stem cell like properties.Oncol Lett. 2018 May;15(5):6655-6665. doi: 10.3892/ol.2018.8129. Epub 2018 Feb 27.
• [2716] PHD finger protein 1 (PHF1) is a novel reader for histone H4R3 symmetric dimethylation and coordinates with PRMT5-WDR77/CRL4B complex to promote tumorigenesis.Nucleic Acids Res. 2018 Jul 27;46(13):6608-6626. doi: 10.1093/nar/gky461.
• [2717] Oncogenic effect of PHLDB2 is associated with epithelial-mesenchymal transition and E-cadherin regulation in colorectal cancer.Cancer Cell Int. 2019 Jul 16;19:184. doi: 10.1186/s12935-019-0903-1. eCollection 2019.
• [2718] STAT3/PIAS3 Levels Serve as "Early Signature" Genes in the Development of High-Grade Serous Carcinoma from the Fallopian Tube.Cancer Res. 2018 Apr 1;78(7):1739-1750. doi: 10.1158/0008-5472.CAN-17-1671. Epub 2018 Jan 16.
• [2719] Monitoring genotoxicity in patients receiving chemotherapy for cancer: application of the PIG-A assay.Mutat Res Genet Toxicol Environ Mutagen. 2016 Sep 15;808:20-6. doi: 10.1016/j.mrgentox.2016.08.002. Epub 2016 Aug 10.
• [2720] Silibinin down-regulates expression of secreted phospholipase A2 enzymes in cancer cells.Anticancer Res. 2014 Apr;34(4):1723-9.
• [2721] Divergent roles of Plexin D1 in cancer.Biochim Biophys Acta Rev Cancer. 2019 Aug;1872(1):103-110. doi: 10.1016/j.bbcan.2019.05.004. Epub 2019 May 30.
• [2722] Pinin interacts with C-terminal binding proteins for RNA alternative splicing and epithelial cell identity of human ovarian cancer cells.Oncotarget. 2016 Mar 8;7(10):11397-411. doi: 10.18632/oncotarget.7242.
• [2723] DNA polymerase (POLQ) is important for repair of DNA double-strand breaks caused by fork collapse.J Biol Chem. 2019 Mar 15;294(11):3909-3919. doi: 10.1074/jbc.RA118.005188. Epub 2019 Jan 17.
• [2724] Anticancer Opportunity Created by Loss of Tumor Suppressor Genes.Technol Cancer Res Treat. 2016 Dec;15(6):729-731. doi: 10.1177/1533034615604798. Epub 2015 Sep 15.
• [2725] New addiction to the NRF2-related factor NRF3 in cancer cells: Ubiquitin-independent proteolysis through the 20S proteasome.Cancer Sci. 2020 Jan;111(1):6-14. doi: 10.1111/cas.14244. Epub 2019 Dec 14.
• [2726] Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin. Sci Transl Med. 2016 Jul 20;8(348):348ra97.
• [2727] Clinical significance and functional validation of inorganic pyrophosphatase in diffuse large B cell lymphoma in humans.Cytotechnology. 2018 Apr;70(2):641-649. doi: 10.1007/s10616-017-0165-5. Epub 2017 Dec 12.
• [2728] The incidence and multiplicity rates of keratinocyte cancers in Australia.Med J Aust. 2017 Oct 16;207(8):339-343. doi: 10.5694/mja17.00284.
• [2729] Epigenetic Regulation of iASPP-p63 Feedback Loop in Cutaneous Squamous Cell Carcinoma.J Invest Dermatol. 2019 Aug;139(8):1658-1671.e8. doi: 10.1016/j.jid.2019.01.020. Epub 2019 Jan 30.
• [2730] Protein phosphatase 1 and its complexes in carcinogenesis.Curr Cancer Drug Targets. 2014;14(1):2-29. doi: 10.2174/15680096113136660106.
• [2731] Protein Phosphatase 1 Regulatory Subunit SDS22 Inhibits Breast Cancer Cell Tumorigenesis by Functioning as a Negative Regulator of the AKT Signaling Pathway.Neoplasia. 2019 Jan;21(1):30-40. doi: 10.1016/j.neo.2018.10.009. Epub 2018 Nov 27.
• [2732] Utility of core biopsy with concurrent ROSE FNA in the diagnosis of pancreatic tumor-does the biopsy add any diagnostic benefit?.Diagn Cytopathol. 2018 Feb;46(2):154-159. doi: 10.1002/dc.23870. Epub 2017 Dec 11.
• [2733] P-Rex1 and P-Rex2 RacGEFs and cancer.Biochem Soc Trans. 2017 Aug 15;45(4):963-77. doi: 10.1042/BST20160269. Epub 2017 Jul 14.
• [2734] 25-methoxyl-dammarane-3, 12, 20-triol and artemisinin synergistically inhibit MDA-MB-231 cell proliferation through downregulation of testes-specific protease 50 (TSP50) expression.Tumour Biol. 2016 Sep;37(9):11805-11813. doi: 10.1007/s13277-016-5037-7. Epub 2016 Apr 2.
• [2735] Prognostic value of 68Ga PSMA I&T PET/CT SUV parameters on survival outcome in advanced prostat cancer.Ann Nucl Med. 2018 Oct;32(8):542-552. doi: 10.1007/s12149-018-1277-5. Epub 2018 Jul 13.
• [2736] SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance.EBioMedicine. 2018 Dec;38:113-126. doi: 10.1016/j.ebiom.2018.11.007. Epub 2018 Nov 11.
• [2737] The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells.Oncotarget. 2018 May 4;9(34):23334-23348. doi: 10.18632/oncotarget.25101. eCollection 2018 May 4.
• [2738] Functional consequences of the first reported mutations of the proto-oncogene PTTG1IP/PBF.Endocr Relat Cancer. 2017 Sep;24(9):459-474. doi: 10.1530/ERC-16-0340. Epub 2017 Jul 4.
• [2739] Down-regulation of Rab17 promotes tumourigenic properties of hepatocellular carcinoma cells via Erk pathway.Int J Clin Exp Pathol. 2015 May 1;8(5):4963-71. eCollection 2015.
• [2740] KDM4B-mediated epigenetic silencing of miRNA-615-5p augments RAB24 to facilitate malignancy of hepatoma cells.Oncotarget. 2017 Mar 14;8(11):17712-17725. doi: 10.18632/oncotarget.10832.
• [2741] RAB31 Targeted by MiR-30c-2-3p Regulates the GLI1 Signaling Pathway, Affecting Gastric Cancer Cell Proliferation and Apoptosis.Front Oncol. 2018 Nov 26;8:554. doi: 10.3389/fonc.2018.00554. eCollection 2018.
• [2742] Correlation between BRAF mutation and promoter methylation of TIMP3, RAR2 and RASSF1A in thyroid cancer.Epigenetics. 2012 Jul;7(7):710-9. doi: 10.4161/epi.20524. Epub 2012 Jul 1.
• [2743] The molecular physiology of nuclear retinoic acid receptors. From health to disease.Biochim Biophys Acta. 2011 Aug;1812(8):1023-31. doi: 10.1016/j.bbadis.2010.10.007. Epub 2010 Oct 20.
• [2744] RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.Tumour Biol. 2016 Nov;37(11):14969-14978. doi: 10.1007/s13277-016-5340-3. Epub 2016 Sep 20.
• [2745] Insights from engraftable immunodeficient mouse models of hyperinsulinaemia.Sci Rep. 2017 Mar 28;7(1):491. doi: 10.1038/s41598-017-00443-x.
• [2746] Knockdown of Rap2B, a Ras Superfamily Protein, Inhibits Proliferation, Migration, and Invasion in Cervical Cancer Cells via Regulating the ERK1/2 Signaling Pathway.Oncol Res. 2018 Jan 19;26(1):123-130. doi: 10.3727/096504017X14912172235777. Epub 2017 Apr 3.
• [2747] Lamellipodin promotes invasive 3D cancer cell migration via regulated interactions with Ena/VASP and SCAR/WAVE.Oncogene. 2016 Sep 29;35(39):5155-69. doi: 10.1038/onc.2016.47. Epub 2016 Mar 21.
• [2748] Recurrent inactivating RASA2 mutations in melanoma.Nat Genet. 2015 Dec;47(12):1408-10. doi: 10.1038/ng.3427. Epub 2015 Oct 26.
• [2749] Novel Mutations in RASGRP1 are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma.J Clin Immunol. 2018 Aug;38(6):699-710. doi: 10.1007/s10875-018-0533-8. Epub 2018 Jul 20.
• [2750] Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase.Proc Natl Acad Sci U S A. 2018 Apr 17;115(16):E3741-E3748. doi: 10.1073/pnas.1716029115. Epub 2018 Apr 2.
• [2751] High expression of the RNA-binding protein RBPMS2 in gastrointestinal stromal tumors.Exp Mol Pathol. 2013 Apr;94(2):314-21. doi: 10.1016/j.yexmp.2012.12.004. Epub 2013 Jan 4.
• [2752] RCAN1 in the inverse association between Alzheimer's disease and cancer.Oncotarget. 2017 Dec 11;9(1):54-66. doi: 10.18632/oncotarget.23094. eCollection 2018 Jan 2.
• [2753] Live and let die: epigenetic modifications of Survivin and Regucalcin in non-small cell lung cancer tissues contribute to malignancy.Clin Epigenetics. 2019 Nov 12;11(1):157. doi: 10.1186/s13148-019-0770-6.
• [2754] shRNA mediated RHOXF1 silencing influences expression of BCL2 but not CASP8 in MCF-7 and MDA-MB-231 cell lines.Asian Pac J Cancer Prev. 2012;13(11):5865-9. doi: 10.7314/apjcp.2012.13.11.5865.
• [2755] RIN1 promotes renal cell carcinoma malignancy by activating EGFR signaling through Rab25.Cancer Sci. 2017 Aug;108(8):1620-1627. doi: 10.1111/cas.13297. Epub 2017 Jul 3.
• [2756] Ring1 promotes the transformation of hepatic progenitor cells into cancer stem cells through the Wnt/-catenin signaling pathway.J Cell Biochem. 2020 Aug;121(8-9):3941-3951. doi: 10.1002/jcb.29496. Epub 2019 Nov 7.
• [2757] The human RNASET2 protein affects the polarization pattern of human macrophages in vitro.Immunol Lett. 2018 Nov;203:102-111. doi: 10.1016/j.imlet.2018.09.005. Epub 2018 Sep 12.
• [2758] RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2.Cell Death Differ. 2020 Mar;27(3):1105-1118. doi: 10.1038/s41418-019-0400-z. Epub 2019 Aug 13.
• [2759] CACYBP Enhances Cytoplasmic Retention of P27(Kip1) to Promote Hepatocellular Carcinoma Progression in the Absence of RNF41 Mediated Degradation.Theranostics. 2019 Oct 22;9(26):8392-8408. doi: 10.7150/thno.36838. eCollection 2019.
• [2760] Systemic analysis of the differential gene expression profile in a colonic adenoma-normal SSH library.Clin Chim Acta. 2007 Mar;378(1-2):42-7. doi: 10.1016/j.cca.2006.10.024. Epub 2006 Nov 14.
• [2761] Short hairpin RNA library-based functional screening identified ribosomal protein L31 that modulates prostate cancer cell growth via p53 pathway.PLoS One. 2014 Oct 6;9(10):e108743. doi: 10.1371/journal.pone.0108743. eCollection 2014.
• [2762] RPLP1 promotes tumor metastasis and is associated with a poor prognosis in triple-negative breast cancer patients.Cancer Cell Int. 2018 Oct 25;18:170. doi: 10.1186/s12935-018-0658-0. eCollection 2018.
• [2763] Association of ribosomal protein S6 kinase 1 with cellular radiosensitivity of non-small lung cancer.Int J Radiat Biol. 2017 Jun;93(6):581-589. doi: 10.1080/09553002.2017.1294273. Epub 2017 Mar 2.
• [2764] Association of the autoimmune disease scleroderma with an immunologic response to cancer.Science. 2014 Jan 10;343(6167):152-7. doi: 10.1126/science.1246886. Epub 2013 Dec 5.
• [2765] Genetic analysis of the relation of telomere length-related gene (RTEL1) and coronary heart disease risk.Mol Genet Genomic Med. 2019 Mar;7(3):e550. doi: 10.1002/mgg3.550. Epub 2019 Jan 8.
• [2766] RTN4IP1 is down-regulated in thyroid cancer and has tumor-suppressive function.J Clin Endocrinol Metab. 2013 Mar;98(3):E446-54. doi: 10.1210/jc.2012-3180. Epub 2013 Feb 7.
• [2767] Downregulation of SAFB Sustains the NF-B Pathway by Targeting TAK1 during the Progression of Colorectal Cancer.Clin Cancer Res. 2017 Nov 15;23(22):7108-7118. doi: 10.1158/1078-0432.CCR-17-0747. Epub 2017 Sep 14.
• [2768] Plasmonic Cu(2- x)S (y)Se(1- y) Nanoparticles Catalyzed Click Chemistry Reaction for SERS Immunoassay of Cancer Biomarker.Anal Chem. 2018 Oct 2;90(19):11728-11733. doi: 10.1021/acs.analchem.8b03791. Epub 2018 Sep 12.
• [2769] Discovery and expression analysis of novel transcripts of the human SR-related CTD-associated factor 1 (SCAF1) gene in human cancer cells using Next-Generation Sequencing.Gene. 2018 Sep 5;670:155-165. doi: 10.1016/j.gene.2018.05.044. Epub 2018 May 19.
• [2770] Molecular changes in appearance of a cancer cell among normal HEK293T cells.J Biosci Bioeng. 2017 Mar;123(3):281-286. doi: 10.1016/j.jbiosc.2016.09.012. Epub 2016 Oct 21.
• [2771] Autotaxin- interaction with the cell surface via syndecan-4 impacts on cancer cell proliferation and metastasis.Oncotarget. 2018 Sep 4;9(69):33170-33185. doi: 10.18632/oncotarget.26039. eCollection 2018 Sep 4.
• [2772] Selenium-Binding Protein 1 in Human Health and Disease.Int J Mol Sci. 2018 Nov 2;19(11):3437. doi: 10.3390/ijms19113437.
• [2773] Role of Selenoprotein F in Protein Folding and Secretion: Potential Involvement in Human Disease.Nutrients. 2018 Nov 2;10(11):1619. doi: 10.3390/nu10111619.
• [2774] PIWI-interacting RNA-36712 restrains breast cancer progression and chemoresistance by interaction with SEPW1 pseudogene SEPW1P RNA.Mol Cancer. 2019 Jan 12;18(1):9. doi: 10.1186/s12943-019-0940-3.
• [2775] Analysis of SEMA6B gene expression in breast cancer: identification of a new isoform.Biochim Biophys Acta. 2013 Oct;1830(10):4543-53. doi: 10.1016/j.bbagen.2013.05.003. Epub 2013 May 9.
• [2776] Semaphorin-7A contributes to growth, migration and invasion of oral tongue squamous cell carcinoma through TGF--mediated EMT signaling pathway.Eur Rev Med Pharmacol Sci. 2018 Feb;22(4):1035-1043. doi: 10.26355/eurrev_201802_14386.
• [2777] In-depth characterization of the secretome of colorectal cancer metastatic cells identifies key proteins in cell adhesion, migration, and invasion.Mol Cell Proteomics. 2013 Jun;12(6):1602-20. doi: 10.1074/mcp.M112.022848. Epub 2013 Feb 26.
• [2778] SF3A1 and pancreatic cancer: new evidence for the association of the spliceosome and cancer.Oncotarget. 2015 Nov 10;6(35):37750-7. doi: 10.18632/oncotarget.5647.
• [2779] Pleiomorphic adenoma gene-like 2 expression is associated with the development of lung adenocarcinoma and emphysema.Lung Cancer. 2011 Oct;74(1):12-24. doi: 10.1016/j.lungcan.2011.02.006. Epub 2011 Mar 11.
• [2780] Tumor suppressor microRNA-31 inhibits gastric carcinogenesis by targeting Smad4 and SGPP2.Cancer Gene Ther. 2015 Dec;22(12):564-72. doi: 10.1038/cgt.2015.41. Epub 2015 Oct 23.
• [2781] Dual-faced SH3BGRL: oncogenic in mice, tumor suppressive in humans.Oncogene. 2016 Jun 23;35(25):3303-13. doi: 10.1038/onc.2015.391. Epub 2015 Oct 12.
• [2782] Invadopodia are required for cancer cell extravasation and are a therapeutic target for metastasis.Cell Rep. 2014 Sep 11;8(5):1558-70. doi: 10.1016/j.celrep.2014.07.050. Epub 2014 Aug 28.
• [2783] SHC1 sensitizes cancer cells to the 8-Cl-cAMP treatment.Biochem Biophys Res Commun. 2015 Aug 7;463(4):673-8. doi: 10.1016/j.bbrc.2015.05.123. Epub 2015 Jun 1.
• [2784] Deletion of 3p13-14 locus spanning FOXP1 to SHQ1 cooperates with PTEN loss in prostate oncogenesis.Nat Commun. 2017 Oct 20;8(1):1081. doi: 10.1038/s41467-017-01198-9.
• [2785] Sirtuin-4 (SIRT4), a therapeutic target with oncogenic and tumor-suppressive activity in cancer.Onco Targets Ther. 2018 Jun 11;11:3395-3400. doi: 10.2147/OTT.S157724. eCollection 2018.
• [2786] Modeling cancer driver events in vitro using barrier bypass-clonal expansion assays and massively parallel sequencing.Oncogene. 2017 Oct 26;36(43):6041-6048. doi: 10.1038/onc.2017.215. Epub 2017 Jul 10.
• [2787] SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.Cell Death Dis. 2019 Aug 13;10(8):612. doi: 10.1038/s41419-019-1856-y.
• [2788] Use of Antimetastatic SOD3-Mimetic Albumin as a Primer in Triple Negative Breast Cancer.J Oncol. 2019 Feb 28;2019:3253696. doi: 10.1155/2019/3253696. eCollection 2019.
• [2789] The first report of a 5-year period cancer registry in Greece (2009-2013): a pathology-based cancer registry.Virchows Arch. 2018 Apr;472(4):677-682. doi: 10.1007/s00428-017-2287-8. Epub 2018 Jan 4.
• [2790] SOX8 acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.Carcinogenesis. 2019 Oct 16;40(10):1278-1287. doi: 10.1093/carcin/bgz034.
• [2791] Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth. Exp Cell Res. 2010 Aug 1;316(13):2174-88. doi: 10.1016/j.yexcr.2010.04.027. Epub 2010 May 8.
• [2792] Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma.Epigenetics. 2014 Mar;9(3):428-36. doi: 10.4161/epi.27554. Epub 2013 Dec 20.
• [2793] Post-transcriptional regulation of cyclins D1, D3 and G1 and proliferation of human cancer cells depend on IMP-3 nuclear localization.Oncogene. 2014 May 29;33(22):2866-75. doi: 10.1038/onc.2013.252. Epub 2013 Jul 1.
• [2794] Essential developmental, genomic stability, and tumour suppressor functions of the mouse orthologue of hSSB1/NABP2.PLoS Genet. 2013;9(2):e1003298. doi: 10.1371/journal.pgen.1003298. Epub 2013 Feb 7.
• [2795] SSX2-4 expression in early-stage non-small cell lung cancer.Tissue Antigens. 2014 May;83(5):344-9. doi: 10.1111/tan.12340. Epub 2014 Mar 20.
• [2796] Sticking to sugars at the metastatic site: sialyltransferase ST6GalNAc2 acts as a breast cancer metastasis suppressor.Cancer Discov. 2014 Mar;4(3):275-7. doi: 10.1158/2159-8290.CD-14-0075.
• [2797] miR-378 functions as an onco-miRNA by targeting the ST7L/Wnt/-catenin pathway in cervical cancer.Int J Mol Med. 2017 Oct;40(4):1047-1056. doi: 10.3892/ijmm.2017.3116. Epub 2017 Aug 30.
• [2798] Star-related lipid transfer protein 10 (STARD10): a novel key player in alcohol-induced breast cancer progression.J Exp Clin Cancer Res. 2019 Jan 5;38(1):4. doi: 10.1186/s13046-018-1013-y.
• [2799] Silencing of STRN4 suppresses the malignant characteristics of cancer cells.Cancer Sci. 2014 Dec;105(12):1526-32. doi: 10.1111/cas.12541. Epub 2014 Oct 23.
• [2800] Efficient antiproliferative and antiangiogenic effects on human ovarian cancer growth by gene transfer of attenuated mutants of Shiga-like toxin I.Int J Gynecol Cancer. 2008 Jul-Aug;18(4):677-91. doi: 10.1111/j.1525-1438.2007.01090.x. Epub 2007 Oct 18.
• [2801] SUMO1 promotes the proliferation and invasion of non-small cell lung cancer cells by regulating NF-B.Thorac Cancer. 2019 Jan;10(1):33-40. doi: 10.1111/1759-7714.12895. Epub 2018 Nov 4.
• [2802] SUN2: A potential therapeutic target in cancer.Oncol Lett. 2019 Feb;17(2):1401-1408. doi: 10.3892/ol.2018.9764. Epub 2018 Nov 27.
• [2803] Nonsteroidal anti-inflammatory drug sulindac sulfide suppresses structural protein Nesprin-2 expression in colorectal cancer cells.Biochim Biophys Acta. 2014 Jan;1840(1):322-31. doi: 10.1016/j.bbagen.2013.09.032. Epub 2013 Sep 27.
• [2804] The glutamine debate in surgery and critical care.Curr Opin Crit Care. 2019 Aug;25(4):322-328. doi: 10.1097/MCC.0000000000000633.
• [2805] The Function of Thioredoxin-Binding Protein-2 (TBP-2) in Different Diseases.Oxid Med Cell Longev. 2018 May 2;2018:4582130. doi: 10.1155/2018/4582130. eCollection 2018.
• [2806] A Non-canonical Role of YAP/TEAD Is Required for Activation of Estrogen-Regulated Enhancers in Breast Cancer.Mol Cell. 2019 Aug 22;75(4):791-806.e8. doi: 10.1016/j.molcel.2019.06.010. Epub 2019 Jul 11.
• [2807] Tex10 promotes stemness and EMT phenotypes in esophageal squamous cell carcinoma via the Wnt/catenin pathway.Oncol Rep. 2019 Dec;42(6):2600-2610. doi: 10.3892/or.2019.7376. Epub 2019 Oct 16.
• [2808] PSPC1-interchanged interactions with PTK6 and -catenin synergize oncogenic subcellular translocations and tumor progression.Nat Commun. 2019 Dec 16;10(1):5716. doi: 10.1038/s41467-019-13665-6.
• [2809] Identification of a Wells-Dawson polyoxometalate-based AP-2 inhibitor with pro-apoptotic activity.Biochem J. 2018 Jun 11;475(11):1965-1977. doi: 10.1042/BCJ20170942.
• [2810] Significance of TGFBR3 allelic loss in the deregulation of TGF signaling in primary human endometrial carcinomas.Oncol Rep. 2016 Feb;35(2):932-8. doi: 10.3892/or.2015.4400. Epub 2015 Nov 5.
• [2811] miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1.Mol Cancer. 2017 Mar 4;16(1):53. doi: 10.1186/s12943-017-0625-8.
• [2812] Effects of TIN2 on telomeres and chromosomes in the human gastric epithelial cell line GES-1.Oncol Lett. 2018 Apr;15(4):5161-5166. doi: 10.3892/ol.2018.7927. Epub 2018 Feb 2.
• [2813] The positive correlation of TIPRL with LC3 and CD133 contributes to cancer aggressiveness: potential biomarkers for early liver cancer.Sci Rep. 2019 Nov 14;9(1):16802. doi: 10.1038/s41598-019-53191-5.
• [2814] Involvement of androgen receptor and glucose-regulated protein 78 kDa in human hepatocarcinogenesis.Exp Cell Res. 2014 May 1;323(2):326-36. doi: 10.1016/j.yexcr.2014.02.017. Epub 2014 Feb 26.
• [2815] Down-regulation of C12orf59 is associated with a poor prognosis and VHL mutations in renal cell carcinoma.Oncotarget. 2016 Feb 9;7(6):6824-34. doi: 10.18632/oncotarget.6829.
• [2816] Overexpression of DCF1 inhibits glioma through destruction of mitochondria and activation of apoptosis pathway.Sci Rep. 2014 Jan 15;4:3702. doi: 10.1038/srep03702.
• [2817] The Expression of TMEM74 in Liver Cancer and Lung Cancer Correlating With Survival Outcomes.Appl Immunohistochem Mol Morphol. 2019 Sep;27(8):618-625. doi: 10.1097/PAI.0000000000000659.
• [2818] Transmembrane and Ubiquitin-Like Domain Containing 1 Protein (TMUB1) Negatively Regulates Hepatocellular Carcinoma Proliferation via Regulating Signal Transducer and Activator of Transcription 1 (STAT1).Med Sci Monit. 2019 Dec 12;25:9471-9482. doi: 10.12659/MSM.920319.
• [2819] TROY is a promising prognostic biomarker in patients with colorectal cancer.Oncol Lett. 2018 Apr;15(4):5989-5994. doi: 10.3892/ol.2018.8079. Epub 2018 Feb 16.
• [2820] Preclinical Evaluation of the Hsp70 Peptide Tracer TPP-PEG(24)-DFO[(89)Zr] for Tumor-Specific PET/CT Imaging.Cancer Res. 2018 Nov 1;78(21):6268-6281. doi: 10.1158/0008-5472.CAN-18-0707. Epub 2018 Sep 18.
• [2821] TREX1 Cuts Down on Cancer Immunogenicity.Trends Cell Biol. 2017 Aug;27(8):543-545. doi: 10.1016/j.tcb.2017.06.001. Epub 2017 Jun 15.
• [2822] The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.IUBMB Life. 2017 Oct;69(10):795-801. doi: 10.1002/iub.1661. Epub 2017 Aug 31.
• [2823] TRIM31 regulates chronic inflammation via NF-B signal pathway to promote invasion and metastasis in colorectal cancer.Am J Transl Res. 2018 Apr 15;10(4):1247-1259. eCollection 2018.
• [2824] TLRs: linking inflammation and breast cancer.Cell Signal. 2014 Nov;26(11):2350-7. doi: 10.1016/j.cellsig.2014.07.035. Epub 2014 Aug 3.
• [2825] Managing challenging interactions with family caregivers in the cancer setting: Guidelines for clinicians (TRIO Guidelines-2).Patient Educ Couns. 2018 Jun;101(6):983-994. doi: 10.1016/j.pec.2018.01.020. Epub 2018 Feb 2.
• [2826] Atypical GATA transcription factor TRPS1 represses gene expression by recruiting CHD4/NuRD(MTA2) and suppresses cell migration and invasion by repressing TP63 expression.Oncogenesis. 2018 Dec 19;7(12):96. doi: 10.1038/s41389-018-0108-9.
• [2827] Low levels of TSC22 enhance tumorigenesis by inducing cell proliferation in colorectal cancer.Biochem Biophys Res Commun. 2018 Mar 18;497(4):1062-1067. doi: 10.1016/j.bbrc.2018.02.177. Epub 2018 Feb 24.
• [2828] Two-step transplantation with adipose tissue-derived stem cells increases follicle survival by enhancing vascularization in xenografted frozen-thawed human ovarian tissue.Hum Reprod. 2018 Jun 1;33(6):1107-1116. doi: 10.1093/humrep/dey080.
• [2829] Identification of chimeric TSNAX-DISC1 resulting from intergenic splicing in endometrial carcinoma through high-throughput RNA sequencing.Carcinogenesis. 2014 Dec;35(12):2687-97. doi: 10.1093/carcin/bgu201. Epub 2014 Sep 19.
• [2830] Potential role of tubulin tyrosine ligase-like enzymes in tumorigenesis and cancer cell resistance.Cancer Lett. 2014 Aug 1;350(1-2):1-4. doi: 10.1016/j.canlet.2014.04.022. Epub 2014 May 6.
• [2831] Changes Due to Ageing in the Glycan Structure of Alpha-2-Macroglobulin and Its Reactivity with Ligands.Protein J. 2019 Feb;38(1):23-29. doi: 10.1007/s10930-018-9806-6.
• [2832] Cancer chemotherapy does not enhance MDR-associated 170 kd glycoprotein expression in normal blood mononuclear cells.Haematologica. 1992 Nov-Dec;77(6):470-2.
• [2833] Transition of Mesenchymal and Epithelial Cancer Cells Depends on 1-4 Galactosyltransferase-Mediated Glycosphingolipids.Cancer Res. 2018 Jun 1;78(11):2952-2965. doi: 10.1158/0008-5472.CAN-17-2223. Epub 2018 Mar 23.
• [2834] AA-NAT, MT1 and MT2 Correlates with Cancer Stem-Like Cell Markers in Colorectal Cancer: Study of the Influence of Stage and p53 Status of Tumors.Int J Mol Sci. 2017 Jun 11;18(6):1251. doi: 10.3390/ijms18061251.
• [2835] A polysaccharide from Antrodia cinnamomea mycelia exerts antitumor activity through blocking of TOP1/TDP1-mediated DNA repair pathway.Int J Biol Macromol. 2018 Dec;120(Pt B):1551-1560. doi: 10.1016/j.ijbiomac.2018.09.162. Epub 2018 Sep 26.
• [2836] AATF suppresses apoptosis, promotes proliferation and is critical for Kras-driven lung cancer.Oncogene. 2018 Mar;37(11):1503-1518. doi: 10.1038/s41388-017-0054-6. Epub 2018 Jan 11.
• [2837] Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases.FEBS J. 2011 Sep;278(18):3226-45. doi: 10.1111/j.1742-4658.2011.08235.x. Epub 2011 Aug 1.
• [2838] Can ABCF2 protein expression predict the prognosis of uterine cancer?.Br J Cancer. 2008 Nov 18;99(10):1651-5. doi: 10.1038/sj.bjc.6604734.
• [2839] Macrophage ABHD5 Suppresses NFB-Dependent Matrix Metalloproteinase Expression and Cancer Metastasis.Cancer Res. 2019 Nov 1;79(21):5513-5526. doi: 10.1158/0008-5472.CAN-19-1059. Epub 2019 Aug 22.
• [2840] Abl interactor 1: A novel biomarker for osteoporosis in Chinese elderly men.J Proteomics. 2019 Sep 15;207:103440. doi: 10.1016/j.jprot.2019.103440. Epub 2019 Jul 17.
• [2841] ABI3 ectopic expression reduces in vitro and in vivo cell growth properties while inducing senescence.BMC Cancer. 2011 Jan 11;11:11. doi: 10.1186/1471-2407-11-11.
• [2842] Long noncoding RNA MALAT1 potentiates growth and inhibits senescence by antagonizing ABI3BP in gallbladder cancer cells.J Exp Clin Cancer Res. 2019 Jun 7;38(1):244. doi: 10.1186/s13046-019-1237-5.
• [2843] Spatial organization of ABR and CRK genes on human chromosome band 17p13.3.Oncogene. 1995 Mar 2;10(5):1009-11.
• [2844] FAM175B promotes apoptosis by inhibiting ATF4 ubiquitination in esophageal squamous cell carcinoma.Mol Oncol. 2019 May;13(5):1150-1165. doi: 10.1002/1878-0261.12474. Epub 2019 Mar 23.
• [2845] Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway.Oncogene. 2001 Jul 27;20(33):4457-65. doi: 10.1038/sj.onc.1204608.
• [2846] Acyl-CoA dehydrogenase long chain expression is associated with esophageal squamous cell carcinoma progression and poor prognosis.Onco Targets Ther. 2018 Oct 31;11:7643-7653. doi: 10.2147/OTT.S171963. eCollection 2018.
• [2847] Tumor suppressor p53 links ceramide metabolism to DNA damage response through alkaline ceramidase 2.Cell Death Differ. 2018 May;25(5):841-856. doi: 10.1038/s41418-017-0018-y. Epub 2017 Dec 11.
• [2848] ACKR2: An Atypical Chemokine Receptor Regulating Lymphatic Biology.Front Immunol. 2017 Jan 11;7:691. doi: 10.3389/fimmu.2016.00691. eCollection 2016.
• [2849] CCX-CKR expression in colorectal cancer and patient survival.Int J Biol Markers. 2014 Mar 24;29(1):e40-8. doi: 10.5301/jbm.5000057.
• [2850] Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital.J Clin Microbiol. 2010 Dec;48(12):4519-24. doi: 10.1128/JCM.01648-10. Epub 2010 Oct 13.
• [2851] Tumor antigen acrosin binding protein normalizes mitotic spindle function to promote cancer cell proliferation.Cancer Res. 2010 Oct 1;70(19):7652-61. doi: 10.1158/0008-5472.CAN-10-0840. Epub 2010 Sep 28.
• [2852] Thyroid fine-needle aspiration and The Bethesda Classification System.Dan Med J. 2018 Mar;65(3):A5456.
• [2853] Fatty acid activation in carcinogenesis and cancer development: Essential roles of long-chain acyl-CoA synthetases.Oncol Lett. 2018 Aug;16(2):1390-1396. doi: 10.3892/ol.2018.8843. Epub 2018 May 30.
• [2854] Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism.Prostaglandins Other Lipid Mediat. 2019 Oct;144:106363. doi: 10.1016/j.prostaglandins.2019.106363. Epub 2019 Jul 12.
• [2855] Downregulation of acetyl-CoA synthetase 2 is a metabolic hallmark of tumor progression and aggressiveness in colorectal carcinoma.Mod Pathol. 2017 Feb;30(2):267-277. doi: 10.1038/modpathol.2016.172. Epub 2016 Oct 7.
• [2856] Mitochondrial Acetyl-CoA Synthetase 3 is Biosignature of Gastric Cancer Progression.Cancer Med. 2018 Apr;7(4):1240-1252. doi: 10.1002/cam4.1295. Epub 2018 Mar 1.
• [2857] Mutant ACTB mRNA 3'-UTR promotes hepatocellular carcinoma development by regulating miR-1 and miR-29a.Cell Signal. 2020 Mar;67:109479. doi: 10.1016/j.cellsig.2019.109479. Epub 2019 Dec 14.
• [2858] ACTL6A regulates follicle-stimulating hormone-driven glycolysis in ovarian cancer cells via PGK1.Cell Death Dis. 2019 Oct 24;10(11):811. doi: 10.1038/s41419-019-2050-y.
• [2859] Overexpression of Activin Receptor-like Kinase 7 in Breast Cancer Cells Is Associated with Decreased Cell Growth and Adhesion.Anticancer Res. 2017 Jul;37(7):3441-3451. doi: 10.21873/anticanres.11712.
• [2860] Study of the expression and function of ACY1 in patients with colorectal cancer.Oncol Lett. 2017 Apr;13(4):2459-2464. doi: 10.3892/ol.2017.5702. Epub 2017 Feb 8.
• [2861] Hepatoma targeting peptide conjugated bio-reducible polymer complexed with oncolytic adenovirus for cancer gene therapy.J Control Release. 2015 Dec 28;220(Pt B):691-703. doi: 10.1016/j.jconrel.2015.09.068. Epub 2015 Oct 3.
• [2862] Associations between polymorphisms of the ACYP2 gene and Liver cancer risk: A case-control study and meta-analysis.Mol Genet Genomic Med. 2019 Jul;7(7):e00716. doi: 10.1002/mgg3.716. Epub 2019 May 23.
• [2863] Cancer risk susceptibility loci in a Swedish population.Oncotarget. 2017 Nov 25;8(66):110300-110310. doi: 10.18632/oncotarget.22687. eCollection 2017 Dec 15.
• [2864] Identification of ADAM12 as a Novel Basigin Sheddase.Int J Mol Sci. 2019 Apr 22;20(8):1957. doi: 10.3390/ijms20081957.
• [2865] Oncogenic ADAM28 induces gemcitabine resistance and predicts a poor prognosis in pancreatic cancer.World J Gastroenterol. 2019 Oct 7;25(37):5590-5603. doi: 10.3748/wjg.v25.i37.5590.
• [2866] The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer.J Cell Sci. 2009 Aug 15;122(Pt 16):2906-13. doi: 10.1242/jcs.050468. Epub 2009 Jul 28.
• [2867] Genetic inactivation of ADAMTS15 metalloprotease in human colorectal cancer.Cancer Res. 2009 Jun 1;69(11):4926-34. doi: 10.1158/0008-5472.CAN-08-4155. Epub 2009 May 19.
• [2868] The development of monoclonal anti-ADAMTS18 antibodies with precise validation of ADAMTS18 post-translational modification status in living organisms.Biochem Biophys Res Commun. 2017 Oct 21;492(3):404-411. doi: 10.1016/j.bbrc.2017.08.086. Epub 2017 Aug 24.
• [2869] Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization.Cancer Res. 2009 Nov 1;69(21):8376-85. doi: 10.1158/0008-5472.CAN-09-1069. Epub 2009 Oct 20.
• [2870] ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.Exp Mol Pathol. 2018 Apr;104(2):134-139. doi: 10.1016/j.yexmp.2018.02.004. Epub 2018 Feb 21.
• [2871] ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and its mRNA is reduced in colon cancer.Int J Cancer. 2007 Oct 15;121(8):1710-6. doi: 10.1002/ijc.22882.
• [2872] Identification of genes potentially involved in the increased risk of malignancy in NF1-microdeleted patients.Mol Med. 2011 Jan-Feb;17(1-2):79-87. doi: 10.2119/molmed.2010.00079. Epub 2010 Sep 10.
• [2873] Dynamic inosinome profiles reveal novel patient stratification and gender-specific differences in glioblastoma.Genome Biol. 2019 Feb 13;20(1):33. doi: 10.1186/s13059-019-1647-x.
• [2874] Function of low ADARB1 expression in lung adenocarcinoma.PLoS One. 2019 Sep 6;14(9):e0222298. doi: 10.1371/journal.pone.0222298. eCollection 2019.
• [2875] ADAR3 expression is an independent prognostic factor in lower-grade diffuse gliomas and positively correlated with the editing level of GRIA2(Q607R).Cancer Cell Int. 2018 Dec 3;18:196. doi: 10.1186/s12935-018-0695-8. eCollection 2018.
• [2876] Airborne particulate matter induces mitotic slippage and chromosomal missegregation through disruption of the spindle assembly checkpoint (SAC).Chemosphere. 2019 Nov;235:794-804. doi: 10.1016/j.chemosphere.2019.06.232. Epub 2019 Jul 1.
• [2877] Evolution and heterogeneity of non-hereditary colorectal cancer revealed by single-cell exome sequencing.Oncogene. 2017 May 18;36(20):2857-2867. doi: 10.1038/onc.2016.438. Epub 2016 Dec 12.
• [2878] Profiling of transcripts and proteins modulated by K-ras oncogene in the lung tissues of K-ras transgenic mice by omics approaches.Int J Oncol. 2009 Jan;34(1):161-72.
• [2879] Elevated G-Protein Receptor 125 (GPR125) Expression Predicts Good Outcomes in Colorectal Cancer and Inhibits Wnt/-Catenin Signaling Pathway.Med Sci Monit. 2018 Sep 19;24:6608-6616. doi: 10.12659/MSM.910105.
• [2880] Regulatory roles of brain-specific angiogenesis inhibitor 1(BAI1) protein in inflammation, tumorigenesis and phagocytosis: A brief review.Crit Rev Oncol Hematol. 2017 Mar;111:81-86. doi: 10.1016/j.critrevonc.2017.01.006. Epub 2017 Jan 16.
• [2881] Clinical Significance of G Protein-Coupled Receptor 110 (GPR110) as a Novel Prognostic Biomarker in Osteosarcoma.Med Sci Monit. 2018 Jul 27;24:5216-5224. doi: 10.12659/MSM.909555.
• [2882] Analysis of the interplay between methylation and expression reveals its potential role in cancer aetiology.Funct Integr Genomics. 2017 Jan;17(1):53-68. doi: 10.1007/s10142-016-0533-9. Epub 2016 Nov 7.
• [2883] The Activation and Signaling Mechanisms of GPR56/ADGRG1 in Melanoma Cell.Front Oncol. 2018 Aug 8;8:304. doi: 10.3389/fonc.2018.00304. eCollection 2018.
• [2884] ELTD1 facilitates glioma proliferation, migration and invasion by activating JAK/STAT3/HIF-1 signaling axis.Sci Rep. 2019 Sep 25;9(1):13904. doi: 10.1038/s41598-019-50375-x.
• [2885] Upregulation of the adipokine genes ADIPOR1 and SPP1 is related to poor survival outcomes in colorectal cancer.J Surg Oncol. 2018 Jun;117(8):1833-1840. doi: 10.1002/jso.25078. Epub 2018 May 14.
• [2886] APM2 is a novel mediator of cisplatin resistance in a variety of cancer cell types regardless of p53 or MMR status.Int J Cancer. 2009 Sep 1;125(5):1193-204. doi: 10.1002/ijc.24465.
• [2887] Common and differentially expressed long noncoding RNAs for the characterization of high and low grade bladder cancer.Gene. 2016 Oct 30;592(1):78-85. doi: 10.1016/j.gene.2016.07.042. Epub 2016 Jul 20.
• [2888] Understanding human thiol dioxygenase enzymes: structure to function, and biology to pathology.Int J Exp Pathol. 2017 Apr;98(2):52-66. doi: 10.1111/iep.12222. Epub 2017 Apr 24.
• [2889] Knockdown of XB130 restrains cancer stem cell-like phenotype through inhibition of Wnt/-Catenin signaling in breast cancer.Mol Carcinog. 2019 Oct;58(10):1832-1845. doi: 10.1002/mc.23071. Epub 2019 Jun 20.
• [2890] CLDN6 enhances chemoresistance to ADM via AF-6/ERKs pathway in TNBC cell line MDAMB231.Mol Cell Biochem. 2018 Jun;443(1-2):169-180. doi: 10.1007/s11010-017-3221-8. Epub 2017 Nov 20.
• [2891] Gene structure and subcellular localization of FMR2, a member of a new family of putative transcription activators.Genomics. 1997 Sep 1;44(2):201-13. doi: 10.1006/geno.1997.4867.
• [2892] Role of a Kinesin Motor in Cancer Cell Mechanics.Nano Lett. 2019 Nov 13;19(11):7691-7702. doi: 10.1021/acs.nanolett.9b02592. Epub 2019 Oct 7.
• [2893] Cellular energy stress induces AMPK-mediated regulation of glioblastoma cell proliferation by PIKE-A phosphorylation.Cell Death Dis. 2019 Mar 4;10(3):222. doi: 10.1038/s41419-019-1452-1.
• [2894] RIP Kinases in Liver Cell Death, Inflammation and Cancer.Trends Mol Med. 2019 Jan;25(1):47-63. doi: 10.1016/j.molmed.2018.10.007. Epub 2018 Nov 16.
• [2895] Knockdown of AGGF1 inhibits the invasion and migration of gastric cancer via epithelial-mesenchymal transition through Wnt/-catenin pathway.Cancer Cell Int. 2019 Feb 27;19:41. doi: 10.1186/s12935-019-0765-6. eCollection 2019.
• [2896] The impact of variations in transcription of DICER and AGO2 on exacerbation of childhood B-cell lineage acute lymphoblastic leukaemia.Int J Exp Pathol. 2019 Jun;100(3):184-191. doi: 10.1111/iep.12316. Epub 2019 May 15.
• [2897] Effect of alkylglycerone phosphate synthase on the expression profile of circRNAs in the human thyroid cancer cell line FRO.Oncol Lett. 2018 May;15(5):7889-7899. doi: 10.3892/ol.2018.8356. Epub 2018 Mar 26.
• [2898] Oncogenic Properties of NEAT1 in Prostate Cancer Cells Depend on the CDC5L-AGRN Transcriptional Regulation Circuit.Cancer Res. 2018 Aug 1;78(15):4138-4149. doi: 10.1158/0008-5472.CAN-18-0688. Epub 2018 Jun 5.
• [2899] Oncogenic function for the Dlg1 mammalian homolog of the Drosophila discs-large tumor suppressor.EMBO J. 2006 Mar 22;25(6):1406-17. doi: 10.1038/sj.emboj.7601030. Epub 2006 Mar 2.
• [2900] AHNAK2 is a Novel Prognostic Marker and Oncogenic Protein for Clear Cell Renal Cell Carcinoma.Theranostics. 2017 Feb 27;7(5):1100-1113. doi: 10.7150/thno.18198. eCollection 2017.
• [2901] Frequency of the functionally relevant aryl hydrocarbon receptor repressor (AhRR) Pro185Ala SNP in Papua New Guinea.Drug Metab Pharmacokinet. 2013;28(6):519-21. doi: 10.2133/dmpk.dmpk-13-sc-035. Epub 2013 May 7.
• [2902] Absence of AIF1L contributes to cell migration and a poor prognosis of breast cancer.Onco Targets Ther. 2018 Sep 5;11:5485-5498. doi: 10.2147/OTT.S165874. eCollection 2018.
• [2903] Absent in melanoma 2 suppresses epithelial-mesenchymal transition via Akt and inflammasome pathways in human colorectal cancer cells.J Cell Biochem. 2019 Oct;120(10):17744-17756. doi: 10.1002/jcb.29040. Epub 2019 Jun 18.
• [2904] AIRE promotes androgen-independent prostate cancer by directly regulating IL-6 and modulating tumor microenvironment.Oncogenesis. 2018 May 25;7(5):43. doi: 10.1038/s41389-018-0053-7.
• [2905] -Catenin nuclear localization positively feeds back on EGF/EGFR-attenuated AJAP1 expression in breast cancer.J Exp Clin Cancer Res. 2019 Jun 6;38(1):238. doi: 10.1186/s13046-019-1252-6.
• [2906] Mechanistic insight into the procoagulant activity of tumor-derived apoptotic vesicles.Biochim Biophys Acta Gen Subj. 2017 Feb;1861(2):286-295. doi: 10.1016/j.bbagen.2016.11.020. Epub 2016 Nov 15.
• [2907] Adenylate kinase 4 modulates oxidative stress and stabilizes HIF-1 to drive lung adenocarcinoma metastasis.J Hematol Oncol. 2019 Jan 29;12(1):12. doi: 10.1186/s13045-019-0698-5.
• [2908] Diagnostic algorithm for determining primary tumor sites using peritoneal fluid.PLoS One. 2018 Jul 19;13(7):e0199715. doi: 10.1371/journal.pone.0199715. eCollection 2018.
• [2909] Genome-wide analysis of cancer/testis gene expression.Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20422-7. doi: 10.1073/pnas.0810777105. Epub 2008 Dec 16.
• [2910] Upregulation of AKIP1 contributes to metastasis and progression and predicts poor prognosis of patients with colorectal cancer.Onco Targets Ther. 2018 Oct 11;11:6795-6801. doi: 10.2147/OTT.S151952. eCollection 2018.
• [2911] Overexpression of proto-oncogene FBI-1 activates membrane type 1-matrix metalloproteinase in association with adverse outcome in ovarian cancers.Mol Cancer. 2010 Dec 21;9:318. doi: 10.1186/1476-4598-9-318.
• [2912] HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes.Cancer Res. 2011 Jan 15;71(2):349-59. doi: 10.1158/0008-5472.CAN-10-2550. Epub 2011 Jan 11.
• [2913] Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.Dig Dis Sci. 2018 Apr;63(4):934-944. doi: 10.1007/s10620-018-4943-5. Epub 2018 Jan 30.
• [2914] PRAS40 promotes NF-B transcriptional activity through association with p65.Oncogenesis. 2017 Sep 25;6(9):e381. doi: 10.1038/oncsis.2017.80.
• [2915] Loss of ALDH1L1 folate enzyme confers a selective metabolic advantage for tumor progression.Chem Biol Interact. 2019 Apr 1;302:149-155. doi: 10.1016/j.cbi.2019.02.013. Epub 2019 Feb 20.
• [2916] ALDH1L1 and ALDH1L2 Folate Regulatory Enzymes in Cancer.Adv Exp Med Biol. 2018;1032:127-143. doi: 10.1007/978-3-319-98788-0_10.
• [2917] Metabolic control of PPAR activity by aldehyde dehydrogenase regulates invasive cell behavior and predicts survival in hepatocellular and renal clear cell carcinoma.BMC Cancer. 2018 Nov 28;18(1):1180. doi: 10.1186/s12885-018-5061-7.
• [2918] High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased K(m)): relevance to genetic disease and polymorphisms.Am J Clin Nutr. 2002 Apr;75(4):616-58. doi: 10.1093/ajcn/75.4.616.
• [2919] Computational and Experimental Studies of Inhibitor Design for Aldolase A.J Phys Chem B. 2019 Jul 18;123(28):6034-6041. doi: 10.1021/acs.jpcb.9b04551. Epub 2019 Jul 3.
• [2920] Combined expression and prognostic significance of PPFIA1 and ALG3 in head and neck squamous cell carcinoma.Mol Biol Rep. 2019 Jun;46(3):2693-2701. doi: 10.1007/s11033-019-04712-y. Epub 2019 Feb 25.
• [2921] Human ALKBH3-induced m(1)A demethylation increases the CSF-1 mRNA stability in breast and ovarian cancer cells.Biochim Biophys Acta Gene Regul Mech. 2019 Jan;1862(1):35-46. doi: 10.1016/j.bbagrm.2018.10.008. Epub 2018 Oct 17.
• [2922] ALKBH7 Variant Related to Prostate Cancer Exhibits Altered Substrate Binding.PLoS Comput Biol. 2017 Feb 23;13(2):e1005345. doi: 10.1371/journal.pcbi.1005345. eCollection 2017 Feb.
• [2923] A novel human AlkB homologue, ALKBH8, contributes to human bladder cancer progression.Cancer Res. 2009 Apr 1;69(7):3157-64. doi: 10.1158/0008-5472.CAN-08-3530. Epub 2009 Mar 17.
• [2924] Down-regulated and Commonly mutated ALPK1 in Lung and Colorectal Cancers.Sci Rep. 2016 Jun 10;6:27350. doi: 10.1038/srep27350.
• [2925] An Alpha-kinase 2 Gene Variant Disrupts Filamentous Actin Localization in the Surface Cells of Colorectal Cancer Spheroids.Anticancer Res. 2017 Jul;37(7):3855-3862. doi: 10.21873/anticanres.11765.
• [2926] Isolation of a natural inhibitor of human malignant glial cell invasion: inter alpha-trypsin inhibitor heavy chain 2.Cancer Res. 2006 Feb 1;66(3):1464-72. doi: 10.1158/0008-5472.CAN-05-1913.
• [2927] Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks.Elife. 2017 Mar 31;6:e23172. doi: 10.7554/eLife.23172.
• [2928] In Vitro and In Vivo Activity of AMG 337, a Potent and Selective MET Kinase Inhibitor, in MET-Dependent Cancer Models.Mol Cancer Ther. 2016 Jul;15(7):1568-79. doi: 10.1158/1535-7163.MCT-15-0871. Epub 2016 Apr 19.
• [2929] Inactivation of the tumor suppressor WTX in a subset of pediatric tumors.Genes Chromosomes Cancer. 2014 Jan;53(1):67-77. doi: 10.1002/gcc.22118. Epub 2013 Nov 5.
• [2930] Changes in Anti-Mllerian Hormone and Inhibin B in Children Treated for Cancer.J Adolesc Young Adult Oncol. 2019 Jun;8(3):281-290. doi: 10.1089/jayao.2018.0130. Epub 2019 Jan 31.
• [2931] Too MAD or not MAD enough: The duplicitous role of the spindle assembly checkpoint protein MAD2 in cancer.Cancer Lett. 2020 Jan 28;469:11-21. doi: 10.1016/j.canlet.2019.10.005. Epub 2019 Oct 5.
• [2932] Amphiphilic polysaccharides as building blocks for self-assembled nanosystems: molecular design and application in cancer and inflammatory diseases.J Control Release. 2018 Feb 28;272:114-144. doi: 10.1016/j.jconrel.2017.12.033. Epub 2017 Dec 30.
• [2933] Expression of amphiphysin I, an autoantigen of paraneoplastic neurological syndromes, in breast cancer.Mol Med. 1998 Jan;4(1):29-39.
• [2934] A novel function of anaphase promoting complex subunit 10 in tumor progression in non-small cell lung cancer.Cell Cycle. 2019 May;18(9):1019-1032. doi: 10.1080/15384101.2019.1609830. Epub 2019 Apr 25.
• [2935] Angiopoietin-like protein 1 inhibits epithelial to mesenchymal transition in colorectal cancer cells via suppress Slug expression.Cytotechnology. 2019 Feb;71(1):35-44. doi: 10.1007/s10616-018-0259-8. Epub 2019 Jan 4.
• [2936] ANGPTL6-mediated angiogenesis promotes alpha fetoprotein-producing gastric cancer progression.Pathol Res Pract. 2019 Aug;215(8):152454. doi: 10.1016/j.prp.2019.152454. Epub 2019 May 23.
• [2937] Ankyrin repeat and single KH domain 1 (ANKHD1) drives renal cancer cell proliferation via binding to and altering a subset of miRNAs.J Biol Chem. 2018 Jun 22;293(25):9570-9579. doi: 10.1074/jbc.RA117.000975. Epub 2018 Apr 25.
• [2938] KBG syndrome patient due to 16q24.3 microdeletion presenting with a paratesticular rhabdoid tumor: Coincidence or cancer predisposition?.Am J Med Genet A. 2018 Jun;176(6):1449-1454. doi: 10.1002/ajmg.a.38724. Epub 2018 Apr 25.
• [2939] Hereditary myeloid malignancies.Best Pract Res Clin Haematol. 2019 Jun;32(2):163-176. doi: 10.1016/j.beha.2019.05.001. Epub 2019 May 3.
• [2940] Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts.Int J Cancer. 2008 Apr 1;122(7):1585-91. doi: 10.1002/ijc.23241.
• [2941] Cancer-testis antigens MAGEA proteins are incorporated into extracellular vesicles released by cells.Oncotarget. 2019 Jun 4;10(38):3694-3708. doi: 10.18632/oncotarget.26979. eCollection 2019 Jun 4.
• [2942] Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth.Breast Cancer Res. 2011 Jan 10;13(1):R2. doi: 10.1186/bcr2803.
• [2943] ANKRD9 is associated with tumor suppression as a substrate receptor subunit of ubiquitin ligase.Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3145-3153. doi: 10.1016/j.bbadis.2018.07.001. Epub 2018 Jul 3.
• [2944] Physiological roles and diseases of Tmem16/Anoctamin proteins: are they all chloride channels?.Acta Pharmacol Sin. 2011 Jun;32(6):685-92. doi: 10.1038/aps.2011.48.
• [2945] CXCL-8/IL8 Produced by Diffuse Large B-cell Lymphomas Recruits Neutrophils Expressing a Proliferation-Inducing Ligand APRIL.Cancer Res. 2017 Mar 1;77(5):1097-1107. doi: 10.1158/0008-5472.CAN-16-0786. Epub 2016 Dec 6.
• [2946] Vaccination with NY-ESO-1 overlapping peptides mixed with Picibanil OK-432 and montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen.J Immunother. 2014 Feb-Mar;37(2):84-92. doi: 10.1097/CJI.0000000000000017.
• [2947] Cancer-associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells.Cancer Sci. 2019 May;110(5):1609-1620. doi: 10.1111/cas.13998. Epub 2019 Apr 9.
• [2948] The role of annexin A4 in cancer.Front Biosci (Landmark Ed). 2016 Jun 1;21(5):949-57. doi: 10.2741/4432.
• [2949] The role of DEAD-box RNA helicase p68 (DDX5) in the development and treatment of breast cancer.J Cell Physiol. 2019 May;234(5):5478-5487. doi: 10.1002/jcp.26912. Epub 2018 Nov 11.
• [2950] Molecular pathogenesis of triple-negative breast cancer based on microRNA expression signatures: antitumor miR-204-5p targets AP1S3.J Hum Genet. 2018 Dec;63(12):1197-1210. doi: 10.1038/s10038-018-0510-3. Epub 2018 Sep 18.
• [2951] AP-2 reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway.Apoptosis. 2017 Jul;22(7):933-941. doi: 10.1007/s10495-017-1379-x.
• [2952] DHX33 Interacts with AP-2 To Regulate Bcl-2 Gene Expression and Promote Cancer Cell Survival.Mol Cell Biol. 2019 Aug 12;39(17):e00017-19. doi: 10.1128/MCB.00017-19. Print 2019 Sep 1.
• [2953] The AP2M1 gene expression is a promising biomarker for predicting survival of patients with hepatocellular carcinoma.J Cell Biochem. 2019 Mar;120(3):4140-4146. doi: 10.1002/jcb.27699. Epub 2018 Sep 27.
• [2954] Apoptotic protease activating factor-1 negatively regulates Wnt signaling in hepatocellular carcinoma.Kaohsiung J Med Sci. 2019 Aug;35(8):459-466. doi: 10.1002/kjm2.12089. Epub 2019 May 15.
• [2955] CpG island methylation in colorectal adenomas.Am J Pathol. 2001 Sep;159(3):1129-35. doi: 10.1016/S0002-9440(10)61789-0.
• [2956] Control of metastatic niche formation by targeting APBA3/Mint3 in inflammatory monocytes.Proc Natl Acad Sci U S A. 2017 May 30;114(22):E4416-E4424. doi: 10.1073/pnas.1703171114. Epub 2017 May 15.
• [2957] APBB1 reinforces cancer stem cell and epithelial-to-mesenchymal transition by regulating the IGF1R signaling pathway in non-small-cell lung cancer cells.Biochem Biophys Res Commun. 2017 Jan 1;482(1):35-42. doi: 10.1016/j.bbrc.2016.11.030. Epub 2016 Nov 9.
• [2958] Role of UHRF1 in malignancy and its function as a therapeutic target for molecular docking towards the SRA domain.Int J Biochem Cell Biol. 2019 Sep;114:105558. doi: 10.1016/j.biocel.2019.06.006. Epub 2019 Jun 22.
• [2959] Super-enhancer-associated MEIS1 promotes transcriptional dysregulation in Ewing sarcoma in co-operation with EWS-FLI1.Nucleic Acids Res. 2019 Feb 20;47(3):1255-1267. doi: 10.1093/nar/gky1207.
• [2960] Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor.Oncologist. 2018 Mar;23(3):360-366. doi: 10.1634/theoncologist.2017-0408. Epub 2017 Dec 6.
• [2961] The crystal structure of amyloid precursor-like protein 2 E2 domain completes the amyloid precursor protein family.FASEB J. 2019 Apr;33(4):5076-5081. doi: 10.1096/fj.201802315R. Epub 2019 Jan 4.
• [2962] A Tumor-Promoting Phorbol Ester Causes a Large Increase in APOBEC3A Expression and a Moderate Increase in APOBEC3B Expression in a Normal Human Keratinocyte Cell Line without Increasing Genomic Uracils.Mol Cell Biol. 2018 Dec 11;39(1):e00238-18. doi: 10.1128/MCB.00238-18. Print 2019 Jan 1.
• [2963] The Antiviral and Cancer Genomic DNA Deaminase APOBEC3H Is Regulated by an RNA-Mediated Dimerization Mechanism.Mol Cell. 2018 Jan 4;69(1):75-86.e9. doi: 10.1016/j.molcel.2017.12.010. Epub 2017 Dec 28.
• [2964] Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer.Cancer Manag Res. 2019 May 29;11:4917-4930. doi: 10.2147/CMAR.S192529. eCollection 2019.
• [2965] Expression and potential role of apolipoprotein D on the death-survival balance of human colorectal cancer cells under oxidative stress conditions.Int J Colorectal Dis. 2013 Jun;28(6):751-66. doi: 10.1007/s00384-012-1616-2. Epub 2013 Jan 8.
• [2966] Apolipoprotein M increases the expression of vitamin D receptor mRNA in colorectal cancer cells detected with duplex fluorescence reverse transcription-quantitative polymerase chain reaction.Mol Med Rep. 2017 Aug;16(2):1167-1172. doi: 10.3892/mmr.2017.6716. Epub 2017 Jun 7.
• [2967] APPL proteins promote TGF-induced nuclear transport of the TGF type I receptor intracellular domain.Oncotarget. 2016 Jan 5;7(1):279-92. doi: 10.18632/oncotarget.6346.
• [2968] Rap GTPase Interactor: A Potential Marker for Cancer Prognosis Following Kidney Transplantation.Front Oncol. 2019 Aug 7;9:737. doi: 10.3389/fonc.2019.00737. eCollection 2019.
• [2969] L-Carnitine Ameliorates the Decrease of Aquaporin 2 Levels in Rats with Cisplatin-Induced Kidney Injury.Nephron. 2017;135(4):315-325. doi: 10.1159/000455052. Epub 2017 Feb 4.
• [2970] Aquaporins differentially regulate cell-cell adhesion in MDCK cells.FASEB J. 2019 Jun;33(6):6980-6994. doi: 10.1096/fj.201802068RR. Epub 2019 Mar 6.
• [2971] ARAP3 inhibits peritoneal dissemination of scirrhous gastric carcinoma cells by regulating cell adhesion and invasion.Oncogene. 2011 Mar 24;30(12):1413-21. doi: 10.1038/onc.2010.522. Epub 2010 Nov 15.
• [2972] Structural insights into a HECT-type E3 ligase AREL1 and its ubiquitination activities in vitro.J Biol Chem. 2019 Dec 27;294(52):19934-19949. doi: 10.1074/jbc.RA119.010327. Epub 2019 Nov 15.
• [2973] Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer model.Oncogene. 2005 Sep 8;24(40):6174-84. doi: 10.1038/sj.onc.1208753.
• [2974] Downregulation of ARFGEF1 and CAMK2B by promoter hypermethylation in breast cancer cells.BMB Rep. 2011 Aug;44(8):523-8. doi: 10.5483/bmbrep.2011.44.8.523.
• [2975] Cell cycle-dependent Rho GTPase activity dynamically regulates cancer cell motility and invasion in vivo.PLoS One. 2013 Dec 30;8(12):e83629. doi: 10.1371/journal.pone.0083629. eCollection 2013.
• [2976] Tumor Suppressive Role of ARHGAP17 in Colon Cancer Through Wnt/-Catenin Signaling.Cell Physiol Biochem. 2018;46(5):2138-2148. doi: 10.1159/000489543. Epub 2018 Apr 28.
• [2977] Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer.Nat Commun. 2018 Jun 30;9(1):2447. doi: 10.1038/s41467-018-04907-0.
• [2978] Hypomethylating drugs convert HA-1-negative solid tumors into targets for stem cell-based immunotherapy. Blood. 2009 Mar 19;113(12):2715-22. doi: 10.1182/blood-2008-05-158956. Epub 2008 Dec 18.
• [2979] Silencing ARHGAP9 correlates with the risk of breast cancer and inhibits the proliferation, migration, and invasion of breast cancer.J Cell Biochem. 2018 Sep;119(9):7747-7756. doi: 10.1002/jcb.27127. Epub 2018 Jun 15.
• [2980] Depletion of RhoGDI2 expression inhibits the ability of invasion and migration in pancreatic carcinoma.Int J Mol Med. 2014 Jul;34(1):205-12. doi: 10.3892/ijmm.2014.1765. Epub 2014 Apr 30.
• [2981] A nonsynonymous single-nucleotide polymorphism in the PDZ-Rho guanine nucleotide exchange factor (Ser1416Gly) modulates the risk of lung cancer in Mexican Americans.Cancer. 2006 Jun 15;106(12):2716-24. doi: 10.1002/cncr.21944.
• [2982] Increased expression of GEF-H1 promotes colon cancer progression by RhoA signaling.Pathol Res Pract. 2019 May;215(5):1012-1019. doi: 10.1016/j.prp.2019.02.008. Epub 2019 Feb 27.
• [2983] GEFT protein expression in digestive tract malignant tumors and its clinical significance.Oncol Lett. 2019 Nov;18(5):5577-5590. doi: 10.3892/ol.2019.10915. Epub 2019 Sep 24.
• [2984] Expression of Rho Guanine Nucleotide Exchange Factor 39 (ARHGEF39) and Its Prognostic Significance in Hepatocellular Carcinoma.Med Sci Monit. 2019 Oct 18;25:7826-7835. doi: 10.12659/MSM.918270.
• [2985] Truncated Adenomatous Polyposis Coli Mutation Induces Asef-Activated Golgi Fragmentation.Mol Cell Biol. 2018 Aug 15;38(17):e00135-18. doi: 10.1128/MCB.00135-18. Print 2018 Sep 1.
• [2986] Paradoxical expression of anti-apoptotic and MRP genes on cancer stem-like cell isolated from TJ905 glioblastoma multiforme cell line.Cancer Invest. 2008 May;26(4):338-43. doi: 10.1080/07357900701788064.
• [2987] Indispensable role of STIL in the regulation of cancer cell motility through the lamellipodial accumulation of ARHGEF7-PAK1 complex.Oncogene. 2020 Feb;39(9):1931-1943. doi: 10.1038/s41388-019-1115-9. Epub 2019 Nov 21.
• [2988] Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma.Sci Rep. 2019 Feb 20;9(1):2397. doi: 10.1038/s41598-019-38653-0.
• [2989] A potentially functional variant of ARID1B interacts with physical activity in association with risk of hepatocellular carcinoma.Oncotarget. 2017 May 9;8(19):31057-31064. doi: 10.18632/oncotarget.16074.
• [2990] let-7 Modulates Chromatin Configuration and Target Gene Repression through Regulation of the ARID3B Complex.Cell Rep. 2016 Jan 26;14(3):520-533. doi: 10.1016/j.celrep.2015.12.064. Epub 2016 Jan 14.
• [2991] Overexpression of ARID4B predicts poor survival in patients with hepatocellular carcinoma.Hum Pathol. 2018 Mar;73:114-121. doi: 10.1016/j.humpath.2017.12.012. Epub 2017 Dec 27.
• [2992] Association of genetic variation in IKZF1, ARID5B, CDKN2A, and CEBPE with the risk of acute lymphoblastic leukemia in Tunisian children and their contribution to racial differences in leukemia incidence.Pediatr Hematol Oncol. 2016 Apr;33(3):157-67. doi: 10.3109/08880018.2016.1161685.
• [2993] Use of 5-reductase inhibitors for benign prostate hypertrophy and risk of high grade prostate cancer: a French population-based study.BJU Int. 2019 Feb;123(2):293-299. doi: 10.1111/bju.14495. Epub 2018 Sep 11.
• [2994] ARL3 is downregulated and acts as a prognostic biomarker in glioma.J Transl Med. 2019 Jun 24;17(1):210. doi: 10.1186/s12967-019-1914-3.
• [2995] Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor Growth.Mol Cancer Ther. 2019 Mar;18(3):602-612. doi: 10.1158/1535-7163.MCT-18-0824. Epub 2019 Jan 15.
• [2996] Emerging JWA-targeted Pt(IV) prodrugs conjugated with CX-4945 to overcome chemo-immune-resistance.Biochem Biophys Res Commun. 2020 Jan 15;521(3):753-761. doi: 10.1016/j.bbrc.2019.10.184. Epub 2019 Nov 6.
• [2997] Identification of a neoantigen epitope in a melanoma patient with good response to anti-PD-1 antibody therapy.Immunol Lett. 2019 Apr;208:52-59. doi: 10.1016/j.imlet.2019.02.004. Epub 2019 Mar 14.
• [2998] Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma.Int J Oncol. 2012 Jun;40(6):1770-8. doi: 10.3892/ijo.2012.1390. Epub 2012 Feb 29.
• [2999] Aberrant expression of Arpin in human breast cancer and its clinical significance.J Cell Mol Med. 2016 Mar;20(3):450-8. doi: 10.1111/jcmm.12740. Epub 2015 Dec 9.
• [3000] ARRDC3 suppresses breast cancer progression by negatively regulating integrin beta4.Oncogene. 2010 Sep 9;29(36):5032-47. doi: 10.1038/onc.2010.250. Epub 2010 Jul 5.
• [3001] Li-Fraumeni and Li-Fraumeni-like syndrome mutations in p53 are associated with exonic methylation and splicing regulatory elements.Mol Carcinog. 2009 Oct;48(10):895-902. doi: 10.1002/mc.20537.
• [3002] Effects of -caryophyllene on arginine ADP-ribosyltransferase 1-mediated regulation of glycolysis in colorectal cancer under high-glucose conditions.Int J Oncol. 2018 Oct;53(4):1613-1624. doi: 10.3892/ijo.2018.4506. Epub 2018 Jul 27.
• [3003] Acid Ceramidase: A Novel Therapeutic Target in Cancer.Curr Top Med Chem. 2019;19(17):1512-1520. doi: 10.2174/1568026619666190227222930.
• [3004] The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer.Cancer Immunol Res. 2018 Mar;6(3):358-369. doi: 10.1158/2326-6066.CIR-17-0518. Epub 2018 Jan 25.
• [3005] Protumor Steering of Cancer Inflammation by p50 NF-B Enhances Colorectal Cancer Progression.Cancer Immunol Res. 2018 May;6(5):578-593. doi: 10.1158/2326-6066.CIR-17-0036. Epub 2018 Mar 27.
• [3006] DNA unwinding by ASCC3 helicase is coupled to ALKBH3-dependent DNA alkylation repair and cancer cell proliferation.Mol Cell. 2011 Nov 4;44(3):373-84. doi: 10.1016/j.molcel.2011.08.039.
• [3007] SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance.Cancer Lett. 2018 Aug 28;430:11-24. doi: 10.1016/j.canlet.2018.05.003. Epub 2018 May 8.
• [3008] ASF1a inhibition induces p53-dependent growth arrest and senescence of cancer cells.Cell Death Dis. 2019 Jan 28;10(2):76. doi: 10.1038/s41419-019-1357-z.
• [3009] The Trithorax protein Ash1L promotes myoblast fusion by activating Cdon expression.Nat Commun. 2018 Nov 28;9(1):5026. doi: 10.1038/s41467-018-07313-8.
• [3010] Attenuation of argininosuccinate lyase inhibits cancer growth via cyclin A2 and nitric oxide.Mol Cancer Ther. 2013 Nov;12(11):2505-16. doi: 10.1158/1535-7163.MCT-12-0863. Epub 2013 Aug 26.
• [3011] High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.Int Urol Nephrol. 2017 May;49(5):817-823. doi: 10.1007/s11255-017-1545-7. Epub 2017 Feb 17.
• [3012] Ly6G(+) inflammatory cells enable the conversion of cancer cells to cancer stem cells in an irradiated glioblastoma model.Cell Death Differ. 2019 Oct;26(10):2139-2156. doi: 10.1038/s41418-019-0282-0. Epub 2019 Feb 25.
• [3013] Second Reported Case of Pediatric Bladder Alveolar Soft Part Sarcoma as Secondary Malignancy After Prior Cytotoxic Chemotherapy.Urology. 2019 Aug;130:148-150. doi: 10.1016/j.urology.2019.04.002. Epub 2019 Apr 12.
• [3014] Argininosuccinate synthase 1 suppresses cancer cell invasion by inhibiting STAT3 pathway in hepatocellular carcinoma.Acta Biochim Biophys Sin (Shanghai). 2019 Mar 1;51(3):263-276. doi: 10.1093/abbs/gmz005.
• [3015] Cleave but not leave: Astrotactin proteins in development and disease.IUBMB Life. 2017 Aug;69(8):572-577. doi: 10.1002/iub.1641. Epub 2017 May 18.
• [3016] Porcine circovirus type 2 ORF3 protein induces apoptosis in melanoma cells.BMC Cancer. 2018 Dec 10;18(1):1237. doi: 10.1186/s12885-018-5090-2.
• [3017] ATAD3, a vital membrane bound mitochondrial ATPase involved in tumor progression.J Bioenerg Biomembr. 2012 Feb;44(1):189-97. doi: 10.1007/s10863-012-9424-5.
• [3018] Predisposition to cancer caused by genetic and functional defects of mammalian Atad5.PLoS Genet. 2011 Aug;7(8):e1002245. doi: 10.1371/journal.pgen.1002245. Epub 2011 Aug 25.
• [3019] Reduced Arginyltransferase 1 is a driver and a potential prognostic indicator of prostate cancer metastasis.Oncogene. 2019 Feb;38(6):838-851. doi: 10.1038/s41388-018-0462-2. Epub 2018 Sep 3.
• [3020] MiR-657/ATF2 Signaling Pathway Has a Critical Role in Spatholobus suberectus Dunn Extract-Induced Apoptosis in U266 and U937 Cells.Cancers (Basel). 2019 Jan 28;11(2):150. doi: 10.3390/cancers11020150.
• [3021] Low CD4/CD8 T-cell ratio associated with inflammatory arthropathy in human T-cell leukemia virus type I Tax transgenic mice.PLoS One. 2011 Apr 1;6(4):e18518. doi: 10.1371/journal.pone.0018518.
• [3022] Autophagic Flux Is Regulated by Interaction Between the C-terminal Domain of PATCHED1 and ATG101.Mol Cancer Res. 2018 May;16(5):909-919. doi: 10.1158/1541-7786.MCR-17-0597. Epub 2018 Feb 16.
• [3023] ATG12 deficiency leads to tumor cell oncosis owing to diminished mitochondrial biogenesis and reduced cellular bioenergetics.Cell Death Differ. 2020 Jun;27(6):1965-1980. doi: 10.1038/s41418-019-0476-5. Epub 2019 Dec 16.
• [3024] A switch element in the autophagy E2 Atg3 mediates allosteric regulation across the lipidation cascade.Nat Commun. 2019 Aug 9;10(1):3600. doi: 10.1038/s41467-019-11435-y.
• [3025] Mammalian autophagy and the plasma membrane.FEBS J. 2017 Mar;284(5):672-679. doi: 10.1111/febs.13931. Epub 2016 Nov 6.
• [3026] The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.Nature. 2019 Nov;575(7784):688-692. doi: 10.1038/s41586-019-1705-2. Epub 2019 Oct 21.
• [3027] Prostate cancer sheds the v3 integrin in vivo through exosomes.Matrix Biol. 2019 Apr;77:41-57. doi: 10.1016/j.matbio.2018.08.004. Epub 2018 Aug 8.
• [3028] Merkel Cell Polyomavirus Small T Antigen Initiates Merkel Cell Carcinoma-like Tumor Development in Mice.Cancer Res. 2017 Jun 15;77(12):3151-3157. doi: 10.1158/0008-5472.CAN-17-0035. Epub 2017 May 16.
• [3029] The strategic function of the P5-ATPase ATP13A2 in toxic waste disposal.Neurochem Int. 2018 Jan;112:108-113. doi: 10.1016/j.neuint.2017.11.008. Epub 2017 Nov 21.
• [3030] AMOG/beta2 and glioma invasion: does loss of AMOG make tumour cells run amok?.Neuropathol Appl Neurobiol. 2003 Aug;29(4):370-7. doi: 10.1046/j.1365-2990.2003.00473.x.
• [3031] TRPM7 overexpression enhances the cancer stem cell-like and metastatic phenotypes of lung cancer through modulation of the Hsp90/uPA/MMP2 signaling pathway.BMC Cancer. 2018 Nov 26;18(1):1167. doi: 10.1186/s12885-018-5050-x.
• [3032] A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer.Breast Cancer Res Treat. 2019 Jul;176(2):271-289. doi: 10.1007/s10549-019-05174-3. Epub 2019 Apr 20.
• [3033] Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance.J Clin Invest. 2018 Aug 31;128(9):4098-4114. doi: 10.1172/JCI96804. Epub 2018 Aug 20.
• [3034] The (pro)renin receptor in health and disease.Nat Rev Nephrol. 2019 Nov;15(11):693-712. doi: 10.1038/s41581-019-0160-5.
• [3035] Silencing of vacuolar ATPase csubunit ATP6V0C inhibits the invasion of prostate cancer cells through a LASS2/TMSG1-independent manner.Oncol Rep. 2018 Jan;39(1):298-306. doi: 10.3892/or.2017.6092. Epub 2017 Nov 10.
• [3036] Elevated expression of the V-ATPase D2 subunit triggers increased energy metabolite levels in Kras(G12D) -driven cancer cells.J Cell Biochem. 2019 Jul;120(7):11690-11701. doi: 10.1002/jcb.28448. Epub 2019 Feb 11.
• [3037] Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity.Oncotarget. 2017 Jul 18;8(29):47675-47690. doi: 10.18632/oncotarget.17544.
• [3038] Epstein-Barr virus gene expression in human breast cancer: protagonist or passenger?.Br J Cancer. 2003 Jul 7;89(1):113-9. doi: 10.1038/sj.bjc.6601027.
• [3039] Human gastric adenocarcinoma cathepsin B: isolation and sequencing of full-length cDNAs and polymorphisms of the gene.Gene. 1994 Feb 25;139(2):163-9. doi: 10.1016/0378-1119(94)90750-1.
• [3040] Emerging Role of Lymphocyte Antigen-6 Family of Genes in Cancer and Immune Cells.Front Immunol. 2019 Apr 24;10:819. doi: 10.3389/fimmu.2019.00819. eCollection 2019.
• [3041] Transcriptomic analysis of CIC and ATXN1L reveal a functional relationship exploited by cancer.Oncogene. 2019 Jan;38(2):273-290. doi: 10.1038/s41388-018-0427-5. Epub 2018 Aug 9.
• [3042] ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance.Cell Death Dis. 2019 Feb 20;10(3):173. doi: 10.1038/s41419-019-1362-2.
• [3043] New concept of the Axin2 rs2240308 polymorphism and cancer risk: an updated meta-analysis.Neoplasma. 2017;64(2):269-277. doi: 10.4149/neo_2017_214.
• [3044] Comparison of pulsed and oscillating gradient diffusion-weighted MRI for characterizing hepatocellular nodules in liver cirrhosis: ex vivo study in a rat model.J Magn Reson Imaging. 2020 Apr;51(4):1065-1074. doi: 10.1002/jmri.26919. Epub 2019 Sep 11.
• [3045] iTRAQ-based quantitative proteomic analysis provides insight for molecular mechanism of neuroticism.Clin Proteomics. 2019 Nov 8;16:38. doi: 10.1186/s12014-019-9259-8. eCollection 2019.
• [3046] B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer.PLoS One. 2015 Dec 28;10(12):e0144360. doi: 10.1371/journal.pone.0144360. eCollection 2015.
• [3047] Expression of core 3 synthase in human pancreatic cancer cells suppresses tumor growth and metastasis.Int J Cancer. 2013 Dec 15;133(12):2824-33. doi: 10.1002/ijc.28322. Epub 2013 Aug 5.
• [3048] Overexpression of beta 1,4N-acetylgalactosaminyl- transferase mRNA as a molecular marker for various types of cancers.Oncology. 2002;62(2):149-56. doi: 10.1159/000048261.
• [3049] B4GALNT2 gene expression controls the biosynthesis of Sda and sialyl Lewis X antigens in healthy and cancer human gastrointestinal tract.Int J Biochem Cell Biol. 2014 Aug;53:442-9. doi: 10.1016/j.biocel.2014.06.009. Epub 2014 Jun 19.
• [3050] Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma.Mol Oncol. 2017 Nov;11(11):1595-1615. doi: 10.1002/1878-0261.12134. Epub 2017 Sep 29.
• [3051] B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients.BMC Cancer. 2018 May 24;18(1):590. doi: 10.1186/s12885-018-4497-0.
• [3052] Correlated gene expression between beta-1,4-galactosyltransferase V and N-acetylglucosaminyltransferase V in human cancer cell lines.Biochem Biophys Res Commun. 2000 Oct 5;276(3):1019-23. doi: 10.1006/bbrc.2000.3594.
• [3053] BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.Blood. 2010 Dec 16;116(25):5660-9. doi: 10.1182/blood-2010-06-290536. Epub 2010 Sep 14.
• [3054] Temporal DNA methylation pattern and targeted therapy in colitis-associated cancer.Carcinogenesis. 2020 Apr 22;41(2):235-244. doi: 10.1093/carcin/bgz199.
• [3055] BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses.Br J Cancer. 2017 Jun 6;116(12):1585-1594. doi: 10.1038/bjc.2017.130. Epub 2017 May 16.
• [3056] Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2?CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.Trials. 2018 Aug 9;19(1):432. doi: 10.1186/s13063-018-2790-5.
• [3057] BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer.PLoS One. 2015 Jul 29;10(7):e0133081. doi: 10.1371/journal.pone.0133081. eCollection 2015.
• [3058] BAI1associated protein 2like 2 is a potential biomarker in lung cancer.Oncol Rep. 2019 Feb;41(2):1304-1312. doi: 10.3892/or.2018.6883. Epub 2018 Nov 26.
• [3059] SMAR1 favors immunosurveillance of cancer cells by modulating calnexin and MHC I expression.Neoplasia. 2019 Oct;21(10):945-962. doi: 10.1016/j.neo.2019.07.002. Epub 2019 Aug 15.
• [3060] Chromatin remodeling factor BAZ1A regulates cellular senescence in both cancer and normal cells.Life Sci. 2019 Jul 15;229:225-232. doi: 10.1016/j.lfs.2019.05.023. Epub 2019 May 11.
• [3061] Williams syndrome transcription factor (WSTF) acts as an activator of estrogen receptor signaling in breast cancer cells and the effect can be abrogated by 1,25-dihydroxyvitamin D(3).J Steroid Biochem Mol Biol. 2018 Mar;177:171-178. doi: 10.1016/j.jsbmb.2017.06.003. Epub 2017 Jun 10.
• [3062] Tools for the assessment of breast cancer screening beliefs in women: a literature review.J Comp Eff Res. 2019 Jul;8(9):645-655. doi: 10.2217/cer-2018-0142. Epub 2019 Jul 12.
• [3063] Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target.Nat Commun. 2017 Jul 11;8:15987. doi: 10.1038/ncomms15987.
• [3064] Inhibition of BAP31 expression inhibits cervical cancer progression by suppressing metastasis and inducing intrinsic and extrinsic apoptosis.Biochem Biophys Res Commun. 2019 Jan 8;508(2):499-506. doi: 10.1016/j.bbrc.2018.11.017. Epub 2018 Nov 30.
• [3065] Characterization of the novel amplified in breast cancer-1 (NABC1) gene product.Exp Cell Res. 2003 Nov 1;290(2):402-13. doi: 10.1016/s0014-4827(03)00353-7.
• [3066] Breast cancer amplified sequence 2, a novel negative regulator of the p53 tumor suppressor.Cancer Res. 2009 Dec 1;69(23):8877-85. doi: 10.1158/0008-5472.CAN-09-2023. Epub 2009 Nov 10.
• [3067] Rudhira/BCAS3 is a cytoskeletal protein that controls Cdc42 activation and directional cell migration during angiogenesis.Exp Cell Res. 2012 Apr 1;318(6):753-67. doi: 10.1016/j.yexcr.2012.01.016. Epub 2012 Jan 25.
• [3068] Targeting Gene-Viro-Therapy with AFP driving Apoptin gene shows potent antitumor effect in hepatocarcinoma.J Biomed Sci. 2012 Feb 9;19(1):20. doi: 10.1186/1423-0127-19-20.
• [3069] BCL-3 promotes a cancer stem cell phenotype by enhancing -catenin signalling in colorectal tumour cells.Dis Model Mech. 2019 Mar 4;12(3):dmm037697. doi: 10.1242/dmm.037697.
• [3070] The BCL7 gene family: deletion of BCL7B in Williams syndrome.Gene. 1998 Dec 11;224(1-2):35-44. doi: 10.1016/s0378-1119(98)00514-9.
• [3071] Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer.Nat Commun. 2019 Feb 13;10(1):723. doi: 10.1038/s41467-019-08586-3.
• [3072] BCL9L expression in pancreatic neoplasia with a focus on SPN: a possible explanation for the enigma of the benign neoplasia.BMC Cancer. 2016 Aug 18;16:648. doi: 10.1186/s12885-016-2707-1.
• [3073] Preterm delivery and future maternal risk of female malignancies.Arch Gynecol Obstet. 2017 Jan;295(1):205-210. doi: 10.1007/s00404-016-4198-3. Epub 2016 Sep 10.
• [3074] Differential expression of the TFIIIB subunits Brf1 and Brf2 in cancer cells.BMC Mol Biol. 2008 Aug 12;9:74. doi: 10.1186/1471-2199-9-74.
• [3075] Hypermethylation of BEND5 contributes to cell proliferation and is a prognostic marker of colorectal cancer.Oncotarget. 2017 Nov 1;8(69):113431-113443. doi: 10.18632/oncotarget.22266. eCollection 2017 Dec 26.
• [3076] BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma.Cancer Med. 2017 Feb;6(2):439-451. doi: 10.1002/cam4.982. Epub 2017 Jan 13.
• [3077] Oncogenic potential of BEX4 is conferred by Polo-like kinase 1-mediated phosphorylation.Exp Mol Med. 2018 Oct 22;50(10):1-12. doi: 10.1038/s12276-018-0168-0.
• [3078] Identification of a novel effector domain of BIN1 for cancer suppression.J Cell Biochem. 2011 Oct;112(10):2992-3001. doi: 10.1002/jcb.23222.
• [3079] The antitumor properties of metformin and phenformin reflect their ability to inhibit the actions of differentiated embryo chondrocyte 1.Cancer Manag Res. 2019 Jul 15;11:6567-6579. doi: 10.2147/CMAR.S210637. eCollection 2019.
• [3080] High levels of glioma tumor suppressor candidate region gene 1 predicts a poor prognosis for prostate cancer.Oncol Lett. 2018 Nov;16(5):6749-6755. doi: 10.3892/ol.2018.9490. Epub 2018 Sep 24.
• [3081] SRSF1-dependent alternative splicing attenuates BIN1 expression in non-small cell lung cancer.J Cell Biochem. 2020 Feb;121(2):946-953. doi: 10.1002/jcb.29366. Epub 2019 Sep 3.
• [3082] RNA interference-mediated validation of survivin and Apollon/BRUCE as new therapeutic targets for cancer therapy.Curr Top Med Chem. 2012;12(2):69-78. doi: 10.2174/156802612798919169.
• [3083] Immunoexpression analysis and prognostic value of BLCAP in breast cancer.PLoS One. 2012;7(9):e45967. doi: 10.1371/journal.pone.0045967. Epub 2012 Sep 25.
• [3084] Heme degradation enzyme biliverdin IX reductase is required for stem cell glutamine metabolism.Biochem J. 2018 Mar 29;475(6):1211-1223. doi: 10.1042/BCJ20180016.
• [3085] Exome sequencing in 51 early onset non-familial CRC cases.Mol Genet Genomic Med. 2019 May;7(5):e605. doi: 10.1002/mgg3.605. Epub 2019 Feb 27.
• [3086] A miR-125b binding site polymorphism in bone morphogenetic protein membrane receptor type IB gene and prostate cancer risk in China.Mol Biol Rep. 2012 Jan;39(1):369-73. doi: 10.1007/s11033-011-0747-9. Epub 2011 May 10.
• [3087] p63 Transcriptionally regulates BNC1, a Pol I and Pol II transcription factor that regulates ribosomal biogenesis and epithelial differentiation.Eur J Cancer. 2012 Jun;48(9):1401-6. doi: 10.1016/j.ejca.2011.06.032. Epub 2011 Jul 7.
• [3088] ITGB4-mediated metabolic reprogramming of cancer-associated fibroblasts.Oncogene. 2020 Jan;39(3):664-676. doi: 10.1038/s41388-019-1014-0. Epub 2019 Sep 18.
• [3089] BolA family member 2 enhances cell proliferation and predicts a poor prognosis in hepatocellular carcinoma with tumor hemorrhage.J Cancer. 2019 Jul 10;10(18):4293-4304. doi: 10.7150/jca.31829. eCollection 2019.
• [3090] BRCA1-associated protein inhibits glioma cell proliferation and migration and glioma stem cell self-renewal via the TGF-/PI3K/AKT/mTOR signalling pathway.Cell Oncol (Dordr). 2020 Apr;43(2):223-235. doi: 10.1007/s13402-019-00482-8. Epub 2019 Nov 27.
• [3091] Silencing of the HCCR2 gene induces apoptosis and suppresses the aggressive phenotype of hepatocellular carcinoma cells in culture.J Gastrointest Surg. 2011 Oct;15(10):1807-13. doi: 10.1007/s11605-011-1633-4. Epub 2011 Jul 28.
• [3092] Preliminary investigation of the role of BTB domain-containing 3 gene in the proliferation and metastasis of hepatocellular carcinoma.Oncol Lett. 2017 Aug;14(2):2505-2510. doi: 10.3892/ol.2017.6369. Epub 2017 Jun 9.
• [3093] Silencing of Btbd7 Inhibited Epithelial-Mesenchymal Transition and Chemoresistance in CD133(+) Lung Carcinoma A549 Cells.Oncol Res. 2017 May 24;25(5):819-829. doi: 10.3727/096504016X14772349843854. Epub 2016 Oct 26.
• [3094] The cancer control status and APACHE II score are prognostic factors for critically ill patients with cancer and sepsis.J Formos Med Assoc. 2020 Jan;119(1 Pt 2):276-281. doi: 10.1016/j.jfma.2019.05.012. Epub 2019 May 30.
• [3095] Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker.BMC Cancer. 2010 Mar 26;10:114. doi: 10.1186/1471-2407-10-114.
• [3096] Tumor suppressors BTG1 and BTG2: Beyond growth control.J Cell Physiol. 2019 May;234(5):5379-5389. doi: 10.1002/jcp.27407. Epub 2018 Oct 23.
• [3097] Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival.Oncoimmunology. 2019 Mar 24;8(6):e1588084. doi: 10.1080/2162402X.2019.1588084. eCollection 2019.
• [3098] Evaluating in vivo efficacy - toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells.J Immunother Cancer. 2019 Mar 12;7(1):69. doi: 10.1186/s40425-019-0558-4.
• [3099] Butyrophilin-Like 9 (BTNL9) Suppresses Invasion and Correlates with Favorable Prognosis of Uveal Melanoma.Med Sci Monit. 2019 Apr 30;25:3190-3198. doi: 10.12659/MSM.914074.
• [3100] USP24 induces IL-6 in tumor-associated microenvironment by stabilizing p300 and -TrCP and promotes cancer malignancy.Nat Commun. 2018 Sep 28;9(1):3996. doi: 10.1038/s41467-018-06178-1.
• [3101] The methyltransferase WBSCR22/Merm1 enhances glucocorticoid receptor function and is regulated in lung inflammation and cancer.J Biol Chem. 2014 Mar 28;289(13):8931-46. doi: 10.1074/jbc.M113.540906. Epub 2014 Jan 31.
• [3102] Uncovering the signaling landscape controlling breast cancer cell migration identifies novel metastasis driver genes.Nat Commun. 2019 Jul 5;10(1):2983. doi: 10.1038/s41467-019-11020-3.
• [3103] C14orf28 downregulated by miR-519d contributes to oncogenicity and regulates apoptosis and EMT in colorectal cancer.Mol Cell Biochem. 2017 Oct;434(1-2):197-208. doi: 10.1007/s11010-017-3049-2. Epub 2017 Apr 28.
• [3104] Analysis of the methylation status of genes up-regulated by the demethylating agent, 5-aza-2'-deoxycytidine, in esophageal squamous cell carcinoma.Oncol Rep. 2008 Aug;20(2):405-12.
• [3105] Identification of novel sarcoma risk genes using a two-stage genome wide DNA sequencing strategy in cancer cluster families and population case and control cohorts.BMC Med Genet. 2019 May 3;20(1):69. doi: 10.1186/s12881-019-0808-9.
• [3106] Multiple cancer-specific antigens are targeted by a chimeric antigen receptor on a single cancer cell.JCI Insight. 2019 Nov 1;4(21):e130416. doi: 10.1172/jci.insight.130416.
• [3107] Anticancer activity of synthetic ()-kusunokinin and its derivative ()-bursehernin on human cancer cell lines.Biomed Pharmacother. 2019 Sep;117:109115. doi: 10.1016/j.biopha.2019.109115. Epub 2019 Jun 17.
• [3108] CTHRC1 overexpression predicts poor survival and enhances epithelial-mesenchymal transition in colorectal cancer.Cancer Med. 2018 Nov;7(11):5643-5654. doi: 10.1002/cam4.1807. Epub 2018 Oct 9.
• [3109] PRP? significantly decreases the ALDHhigh cancer stem cell population and regulates the aberrant Wnt/catenin pathway in human chondrosarcoma JJ012cells.Oncol Rep. 2019 Jul;42(1):103-114. doi: 10.3892/or.2019.7172. Epub 2019 May 24.
• [3110] UPLC-MS/MS based diagnostics for epithelial ovarian cancer using fully sialylated C4-binding protein.Biomed Chromatogr. 2018 May;32(5):e4180. doi: 10.1002/bmc.4180. Epub 2018 Jan 23.
• [3111] CD10(+)GPR77(+) Cancer-Associated Fibroblasts Promote Chemoresistance.Cancer Discov. 2018 Mar;8(3):264. doi: 10.1158/2159-8290.CD-RW2018-019. Epub 2018 Feb 2.
• [3112] Low C6orf141 Expression is Significantly Associated with a Poor Prognosis in Patients with Oral Cancer.Sci Rep. 2019 Mar 14;9(1):4520. doi: 10.1038/s41598-019-41194-1.
• [3113] Toxicity and Efficacy of a Novel GADD34-expressing Oncolytic HSV-1 for the Treatment of Experimental Glioblastoma.Clin Cancer Res. 2018 Jun 1;24(11):2574-2584. doi: 10.1158/1078-0432.CCR-17-2954. Epub 2018 Mar 6.
• [3114] Upregulated calcium-binding tyrosine phosphorylation-regulated protein-a/b regulates cell proliferation and apoptosis and predicts poor prognosis in hepatocellular carcinoma.J Cell Biochem. 2020 Apr;121(4):2938-2949. doi: 10.1002/jcb.29538. Epub 2019 Nov 6.
• [3115] Coronary artery calcium and the competing long-term risk of cardiovascular vs. cancer mortality: the CAC Consortium.Eur Heart J Cardiovasc Imaging. 2019 Apr 1;20(4):389-395. doi: 10.1093/ehjci/jey176.
• [3116] Downregulating SynCAM and MPP6 expression is associated with ovarian cancer progression.Oncol Lett. 2019 Sep;18(3):2477-2483. doi: 10.3892/ol.2019.10542. Epub 2019 Jun 28.
• [3117] Aberrant methylation and loss of CADM2 tumor suppressor expression is associated with human renal cell carcinoma tumor progression.Biochem Biophys Res Commun. 2013 Jun 14;435(4):526-32. doi: 10.1016/j.bbrc.2013.04.074. Epub 2013 May 3.
• [3118] Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.Int J Mol Med. 2006 Oct;18(4):547-57.
• [3119] CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer.Mol Oncol. 2008 Dec;2(4):327-39. doi: 10.1016/j.molonc.2008.09.004. Epub 2008 Oct 2.
• [3120] CAMK2 in intestinal epithelial cells modulates colitis-associated colorectal carcinogenesis via enhancing STAT3 activation.Oncogene. 2017 Jul 13;36(28):4060-4071. doi: 10.1038/onc.2017.16. Epub 2017 Mar 20.
• [3121] High throughput screening, docking, and molecular dynamics studies to identify potential inhibitors of human calcium/calmodulin-dependent protein kinase IV.J Biomol Struct Dyn. 2019 May;37(8):2179-2192. doi: 10.1080/07391102.2018.1479310. Epub 2018 Nov 1.
• [3122] Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1.Nature. 2005 Mar 3;434(7029):108-13. doi: 10.1038/nature03314.
• [3123] Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer.Oncogene. 2002 Jul 25;21(32):5006-15. doi: 10.1038/sj.onc.1205625.
• [3124] CAPG enhances breast cancer metastasis by competing with PRMT5 to modulate STC-1 transcription.Theranostics. 2018 Apr 3;8(9):2549-2564. doi: 10.7150/thno.22523. eCollection 2018.
• [3125] DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies.PLoS Genet. 2011 Apr;7(4):e1002042. doi: 10.1371/journal.pgen.1002042. Epub 2011 Apr 14.
• [3126] Capn4 promotes esophageal squamous cell carcinoma metastasis by regulating ZEB1 through the Wnt/-catenin signaling pathway.Thorac Cancer. 2019 Jan;10(1):24-32. doi: 10.1111/1759-7714.12893. Epub 2018 Nov 15.
• [3127] Genomic pattern of intratumor heterogeneity predicts the risk of progression in early stage diffuse large B-cell lymphoma.Carcinogenesis. 2019 Nov 25;40(11):1427-1434. doi: 10.1093/carcin/bgz068.
• [3128] TUCAN, an antiapoptotic caspase-associated recruitment domain family protein overexpressed in cancer.J Biol Chem. 2001 Aug 24;276(34):32220-9. doi: 10.1074/jbc.M100433200. Epub 2001 Jun 14.
• [3129] Distribution Patterns of Cocaine- and Amphetamine-Regulated Transcript- and/or Galanin-Containing Neurons and Nerve Fibers Located in the Human Stomach Wall Affected by Tumor.Int J Mol Sci. 2018 Oct 26;19(11):3357. doi: 10.3390/ijms19113357.
• [3130] The exon-junction-complex-component metastatic lymph node 51 functions in stress-granule assembly.J Cell Sci. 2007 Aug 15;120(Pt 16):2774-84. doi: 10.1242/jcs.009225. Epub 2007 Jul 24.
• [3131] Calpastatin phosphorylation regulates radiation-induced calpain activity in glioblastoma.Oncotarget. 2018 Feb 19;9(18):14597-14607. doi: 10.18632/oncotarget.24523. eCollection 2018 Mar 6.
• [3132] CASTOR1 suppresses the progression of lung adenocarcinoma and predicts poor prognosis.J Cell Biochem. 2018 Dec;119(12):10186-10194. doi: 10.1002/jcb.27360. Epub 2018 Aug 21.
• [3133] Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.J Exp Clin Cancer Res. 2018 Mar 5;37(1):45. doi: 10.1186/s13046-018-0720-8.
• [3134] CAV2 promotes the growth of renal cell carcinoma through the EGFR/PI3K/Akt pathway.Onco Targets Ther. 2018 Sep 25;11:6209-6216. doi: 10.2147/OTT.S172803. eCollection 2018.
• [3135] Integrated profiling identifies caveolae-associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients.CNS Neurosci Ther. 2019 Mar;25(3):343-354. doi: 10.1111/cns.13072. Epub 2018 Oct 11.
• [3136] A systematic analysis reveals gene expression alteration of serum deprivation response (SDPR) gene is significantly associated with the survival of patients with cancer.Oncol Rep. 2019 Sep;42(3):1161-1172. doi: 10.3892/or.2019.7212. Epub 2019 Jun 26.
• [3137] Frequent epigenetic inactivation of hSRBC in gastric cancer and its implication in attenuated p53 response to stresses.Int J Cancer. 2008 Apr 1;122(7):1573-84. doi: 10.1002/ijc.23166.
• [3138] The transcription factor CBFB suppresses breast cancer through orchestrating translation and transcription.Nat Commun. 2019 May 6;10(1):2071. doi: 10.1038/s41467-019-10102-6.
• [3139] Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR Dysregulation and Signaling in Lung Adenocarcinoma.Cancer Res. 2018 Sep 1;78(17):4984-4996. doi: 10.1158/0008-5472.CAN-17-3858. Epub 2018 Jun 26.
• [3140] CBLL1 is highly expressed in non-small cell lung cancer and promotes cell proliferation and invasion.Thorac Cancer. 2019 Jun;10(6):1479-1488. doi: 10.1111/1759-7714.13097. Epub 2019 May 23.
• [3141] CBX8 Suppresses Tumor Metastasis via Repressing Snail in Esophageal Squamous Cell Carcinoma.Theranostics. 2017 Aug 15;7(14):3478-3488. doi: 10.7150/thno.20717. eCollection 2017.
• [3142] CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma.Mol Med Rep. 2019 May;19(5):4205-4212. doi: 10.3892/mmr.2019.10104. Epub 2019 Mar 28.
• [3143] CCDC134 is down-regulated in gastric cancer and its silencing promotes cell migration and invasion of GES-1 and AGS cells via the MAPK pathway.Mol Cell Biochem. 2013 Jan;372(1-2):1-8. doi: 10.1007/s11010-012-1418-4. Epub 2012 Aug 18.
• [3144] High Expression of CCDC34 Is Associated with Poor Survival in Cervical Cancer Patients.Med Sci Monit. 2018 Nov 20;24:8383-8390. doi: 10.12659/MSM.913346.
• [3145] Targeting a mitochondrial potassium channel to fight cancer.Cell Calcium. 2015 Jul;58(1):131-8. doi: 10.1016/j.ceca.2014.09.006. Epub 2014 Oct 18.
• [3146] Coiled-coil domain-containing protein 8 inhibits the invasiveness and migration of non-small cell lung cancer cells.Hum Pathol. 2016 Oct;56:64-73. doi: 10.1016/j.humpath.2016.06.001. Epub 2016 Jun 21.
• [3147] Tumor suppressor role of the CL2/DRO1/CCDC80 gene in thyroid carcinogenesis.J Clin Endocrinol Metab. 2013 Jul;98(7):2834-43. doi: 10.1210/jc.2012-2926. Epub 2013 May 10.
• [3148] KP-CoT-23 (CCDC83) is a novel immunogenic cancer/testis antigen in colon cancer.Int J Oncol. 2012 Nov;41(5):1820-6. doi: 10.3892/ijo.2012.1601. Epub 2012 Aug 22.
• [3149] Expression of Ccdc85C, a causative protein for murine hydrocephalus, in the mammary gland tumors of dogs.Histol Histopathol. 2017 Apr;32(4):397-403. doi: 10.14670/HH-11-806. Epub 2016 Jul 26.
• [3150] The G-interacting vesicle-associated protein interacts with and promotes cell surface localization of GRP78 during endoplasmic reticulum stress.FEBS Lett. 2020 Mar;594(6):1088-1100. doi: 10.1002/1873-3468.13685. Epub 2019 Nov 30.
• [3151] Short tandem repeat polymorphism in a novel esophageal cancer-related gene (ECRG2) implicates susceptibility to esophageal cancer in Chinese population.Int J Cancer. 2004 Jan 10;108(2):232-6. doi: 10.1002/ijc.11560.
• [3152] Loss of SMAD4 Promotes Lung Metastasis of Colorectal Cancer by Accumulation of CCR1+ Tumor-Associated Neutrophils through CCL15-CCR1 Axis.Clin Cancer Res. 2017 Feb 1;23(3):833-844. doi: 10.1158/1078-0432.CCR-16-0520. Epub 2016 Aug 4.
• [3153] Increased Plasma Levels of the TH2 chemokine CCL18 associated with low CD4+ T cell counts in HIV-1-infected Patients with a Suppressed Viral Load.Sci Rep. 2019 Apr 12;9(1):5963. doi: 10.1038/s41598-019-41588-1.
• [3154] Nicaraven reduces cancer metastasis to irradiated lungs by decreasing CCL8 and macrophage recruitment.Cancer Lett. 2018 Apr 1;418:204-210. doi: 10.1016/j.canlet.2018.01.037. Epub 2018 Jan 13.
• [3155] Reduced NOV expression correlates with disease progression in colorectal cancer and is associated with survival, invasion and chemoresistance of cancer cells.Oncotarget. 2017 Apr 18;8(16):26231-26244. doi: 10.18632/oncotarget.15439.
• [3156] Prediction of pivotal pathways and hub genes associated with osteoporosis by Gibbs sampling.Exp Ther Med. 2019 Mar;17(3):2107-2112. doi: 10.3892/etm.2019.7180. Epub 2019 Jan 16.
• [3157] Cyclin B2 Overexpression in Human Hepatocellular Carcinoma is Associatedwith Poor Prognosis.Arch Med Res. 2019 Jan;50(1):10-17. doi: 10.1016/j.arcmed.2019.03.003. Epub 2019 Apr 4.
• [3158] Prognostic role of cyclin D2/D3 in multiple human malignant neoplasms: A systematic review and meta-analysis.Cancer Med. 2019 Jun;8(6):2717-2729. doi: 10.1002/cam4.2152. Epub 2019 Apr 5.
• [3159] CCNG1 (Cyclin G1) regulation by mutant-P53 via induction of Notch3 expression promotes high-grade serous ovarian cancer (HGSOC) tumorigenesis and progression.Cancer Med. 2019 Jan;8(1):351-362. doi: 10.1002/cam4.1812. Epub 2018 Dec 18.
• [3160] Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.Urol Oncol. 2018 Jun;36(6):311.e1-311.e13. doi: 10.1016/j.urolonc.2018.03.001. Epub 2018 Mar 27.
• [3161] CCNJ detected by triple combination array analysis as a tumor-related gene of hepatocellular carcinoma.Int J Oncol. 2015 May;46(5):1963-70. doi: 10.3892/ijo.2015.2892. Epub 2015 Feb 11.
• [3162] A fine balance between CCNL1 and TIMP1 contributes to the development of breast cancer cells.Biochem Biophys Res Commun. 2011 Jun 3;409(2):344-9. doi: 10.1016/j.bbrc.2011.05.021. Epub 2011 May 8.
• [3163] Molecular function and biological importance of CNNM family Mg2+ transporters.J Biochem. 2019 Mar 1;165(3):219-225. doi: 10.1093/jb/mvy095.
• [3164] Knockdown of CCNO decreases the tumorigenicity of gastric cancer by inducing apoptosis.Onco Targets Ther. 2018 Oct 26;11:7471-7481. doi: 10.2147/OTT.S176252. eCollection 2018.
• [3165] Genes associated with inflammation and the cell cycle may serve as biomarkers for the diagnosis and prognosis of acute myocardial infarction in a Chinese population.Mol Med Rep. 2018 Aug;18(2):1311-1322. doi: 10.3892/mmr.2018.9077. Epub 2018 May 25.
• [3166] Intra-abdominal recurrence from colorectal carcinoma: Differences and similarities between local and peritoneal recurrence.Surg Oncol. 2020 Mar;32:23-29. doi: 10.1016/j.suronc.2019.10.018. Epub 2019 Nov 4.
• [3167] FAM190A deficiency creates a cell division defect.Am J Pathol. 2013 Jul;183(1):296-303. doi: 10.1016/j.ajpath.2013.03.020. Epub 2013 May 10.
• [3168] Synthesis and preliminary biological evaluation for the anticancer activity of organochalcogen (S/se) tethered chrysin-based organometallic Ru(II)((6)-p-cymene) complexes.J Biomol Struct Dyn. 2019 Aug;37(13):3337-3353. doi: 10.1080/07391102.2018.1513867. Epub 2018 Nov 19.
• [3169] Bioinformatics analysis of the prognostic value of CCT6A and associated signalling pathways in breast cancer.Mol Med Rep. 2019 May;19(5):4344-4352. doi: 10.3892/mmr.2019.10100. Epub 2019 Mar 28.
• [3170] Integrin-independent support of cancer drug resistance by tetraspanin CD151.Cell Mol Life Sci. 2019 Apr;76(8):1595-1604. doi: 10.1007/s00018-019-03014-7. Epub 2019 Feb 18.
• [3171] Increased cytoplasmatic expression of cancer immune surveillance receptor CD1d in anaplastic thyroid carcinomas.Cancer Med. 2019 Nov;8(16):7065-7073. doi: 10.1002/cam4.2573. Epub 2019 Sep 27.
• [3172] Antitumor Activity of TLR7 Is Potentiated by CD200R Antibody Leading to Changes in the Tumor Microenvironment.Cancer Immunol Res. 2018 Aug;6(8):930-940. doi: 10.1158/2326-6066.CIR-17-0454. Epub 2018 Jul 18.
• [3173] 2B4 (CD244, SLAMF4) and CS1 (CD319, SLAMF7) in systemic lupus erythematosus and cancer.Clin Immunol. 2019 Jul;204:50-56. doi: 10.1016/j.clim.2018.10.009. Epub 2018 Oct 19.
• [3174] A high throughput method for identifying personalized tumor-associated antigens.Oncotarget. 2010 Jun;1(2):148-55. doi: 10.18632/oncotarget.118.
• [3175] CD5L Promotes M2 Macrophage Polarization through Autophagy-Mediated Upregulation of ID3.Front Immunol. 2018 Mar 12;9:480. doi: 10.3389/fimmu.2018.00480. eCollection 2018.
• [3176] Isolation and Profiling of Circulating Tumor-Associated Exosomes Using Extracellular Vesicular Lipid-Protein Binding Affinity Based Microfluidic Device.Small. 2019 Nov;15(47):e1903600. doi: 10.1002/smll.201903600. Epub 2019 Oct 7.
• [3177] Redox state of adipose tissue for patients with gastric cancer and its connection with the body mass index and distance from the tumor.Obes Res Clin Pract. 2020 Jan-Feb;14(1):34-38. doi: 10.1016/j.orcp.2019.10.003. Epub 2019 Nov 9.
• [3178] CD84 cell surface signaling molecule: An emerging biomarker and target for cancer and autoimmune disorders.Clin Immunol. 2019 Jul;204:43-49. doi: 10.1016/j.clim.2018.10.017. Epub 2018 Oct 26.
• [3179] Efficacy of a novel LyP-1-containing self-microemulsifying drug delivery system (SMEDDS) for active targeting to breast cancer.Eur J Pharm Biopharm. 2019 Mar;136:138-146. doi: 10.1016/j.ejpb.2019.01.017. Epub 2019 Jan 22.
• [3180] Classification of tumor microenvironment immune types based on immune response-associated gene expression.Int J Oncol. 2019 Jan;54(1):219-228. doi: 10.3892/ijo.2018.4617. Epub 2018 Nov 2.
• [3181] Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma.Biochem Biophys Res Commun. 2016 Aug 5;476(4):467-474. doi: 10.1016/j.bbrc.2016.05.146. Epub 2016 May 30.
• [3182] CD99 Expression in Glioblastoma Molecular Subtypes and Role in Migration and Invasion.Int J Mol Sci. 2019 Mar 6;20(5):1137. doi: 10.3390/ijms20051137.
• [3183] Mutational analysis of mononucleotide repeats in dual specificity tyrosine phosphatase genes in gastric and colon carcinomas with microsatellite instability.APMIS. 2010 May;118(5):389-93. doi: 10.1111/j.1600-0463.2010.02612.x.
• [3184] CDC23 regulates cancer cell phenotype and is overexpressed in papillary thyroid cancer.Endocr Relat Cancer. 2011 Nov 28;18(6):731-42. doi: 10.1530/ERC-11-0181. Print 2011.
• [3185] Egr-1 and serum response factor are involved in growth factors- and serum-mediated induction of E2-EPF UCP expression that regulates the VHL-HIF pathway.J Cell Biochem. 2008 Nov 1;105(4):1117-27. doi: 10.1002/jcb.21914.
• [3186] HBx-induced MiR-1269b in NF-B dependent manner upregulates cell division cycle 40 homolog (CDC40) to promote proliferation and migration in hepatoma cells.J Transl Med. 2016 Jun 27;14(1):189. doi: 10.1186/s12967-016-0949-y.
• [3187] Dissociation mechanism of GDP from Cdc42 via DOCK9 revealed by molecular dynamics simulations.Proteins. 2019 Jun;87(6):433-442. doi: 10.1002/prot.25665. Epub 2019 Feb 15.
• [3188] Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels.Mol Cell Proteomics. 2006 Mar;5(3):433-43. doi: 10.1074/mcp.M500140-MCP200. Epub 2005 Nov 30.
• [3189] Cadherin-12 enhances proliferation in colorectal cancer cells and increases progression by promoting EMT.Tumour Biol. 2016 Jul;37(7):9077-88. doi: 10.1007/s13277-015-4555-z. Epub 2016 Jan 14.
• [3190] Aberrant Methylation of T-cadherin Can Be a Diagnostic Biomarker for Colorectal Cancer.Cancer Genomics Proteomics. 2017 Jul-Aug;14(4):277-284. doi: 10.21873/cgp.20038.
• [3191] Electrochemical immunosensor for CDH22 biomarker based on benzaldehyde substituted poly(phosphazene) modified disposable ITO electrode: A new fabrication strategy for biosensors.Biosens Bioelectron. 2019 Feb 1;126:230-239. doi: 10.1016/j.bios.2018.10.051. Epub 2018 Nov 2.
• [3192] The strong propensity of Cadherin-23 for aggregation inhibits cell migration.Mol Oncol. 2019 May;13(5):1092-1109. doi: 10.1002/1878-0261.12469. Epub 2019 Mar 19.
• [3193] Cdh4 Down-Regulation Impairs in Vivo Infiltration and Malignancy in Patients Derived Glioblastoma Cells.Int J Mol Sci. 2019 Aug 18;20(16):4028. doi: 10.3390/ijms20164028.
• [3194] LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer.J Cell Biochem. 2019 Mar;120(3):3874-3886. doi: 10.1002/jcb.27669. Epub 2018 Nov 26.
• [3195] Single-Nucleotide Polymorphisms in TAOK3 Are Associated With High Opioid Requirement for Pain Management in Patients With Advanced Cancer Admitted to a Tertiary Palliative Care Unit.J Pain Symptom Manage. 2018 Oct;56(4):560-566. doi: 10.1016/j.jpainsymman.2018.07.011. Epub 2018 Jul 20.
• [3196] Knockdown of CDK2AP1 by RNA interference inhibits cell growth and tumorigenesis of human glioma.Neurol Res. 2014 Jul;36(7):659-65. doi: 10.1179/1743132813Y.0000000298. Epub 2013 Dec 19.
• [3197] An Oncolytic Adenovirus Vector Expressing p14 FAST Protein Induces Widespread Syncytium Formation and Reduces Tumor Growth Rate InVivo.Mol Ther Oncolytics. 2019 May 15;14:107-120. doi: 10.1016/j.omto.2019.05.001. eCollection 2019 Sep 27.
• [3198] Molecular characterization of apoptosis induced by CARF silencing in human cancer cells.Cell Death Differ. 2011 Apr;18(4):589-601. doi: 10.1038/cdd.2010.129. Epub 2010 Nov 5.
• [3199] Ironing out the role of the cyclin-dependent kinase inhibitor, p21 in cancer: Novel iron chelating agents to target p21 expression and activity.Free Radic Biol Med. 2019 Mar;133:276-294. doi: 10.1016/j.freeradbiomed.2018.03.027. Epub 2018 Mar 20.
• [3200] Epigenetic Status of CDO1 Gene May Reflect Chemosensitivity in Colon Cancer with Postoperative Adjuvant Chemotherapy.Ann Surg Oncol. 2019 Feb;26(2):406-414. doi: 10.1245/s10434-018-6865-z. Epub 2018 Oct 11.
• [3201] Induction of cytotoxic T lymphocytes specific for paraneoplastic cerebellar degeneration-associated antigen in vivo by DNA immunization.J Autoimmun. 2001 Dec;17(4):297-302. doi: 10.1006/jaut.2001.0553.
• [3202] Cdt1 and Geminin in cancer: markers or triggers of malignant transformation?.Front Biosci. 2008 May 1;13:4485-94. doi: 10.2741/3018.
• [3203] Synthesis and characterization of a hyperbranched grafting copolymer PEI-g-PLeu for gene and drug co-delivery.J Mater Sci Mater Med. 2018 Apr 17;29(5):47. doi: 10.1007/s10856-018-6057-1.
• [3204] Deletion of A-antigen in a human cancer cell line is associated with reduced promoter activity of CBF/NF-Y binding region, and possibly with enhanced DNA methylation of A transferase promoter.Glycoconj J. 1999 Oct;16(10):659-66. doi: 10.1023/a:1007085202379.
• [3205] MicroRNA-20a Regulates Glioma Cell Proliferation, Invasion, and Apoptosis by Targeting CUGBP Elav-Like Family Member 2.World Neurosurg. 2019 Jan;121:e519-e527. doi: 10.1016/j.wneu.2018.09.155. Epub 2018 Sep 28.
• [3206] Differential cellular localization of CELSR2 and ING4 and correlations with hormone receptor status in breast cancer.Histol Histopathol. 2018 Aug;33(8):835-842. doi: 10.14670/HH-11-979. Epub 2018 Feb 28.
• [3207] CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis.PeerJ. 2019 Oct 7;7:e7816. doi: 10.7717/peerj.7816. eCollection 2019.
• [3208] KIAA1199, a Target of MicoRNA-486-5p, Promotes Papillary Thyroid Cancer Invasion by Influencing Epithelial-Mesenchymal Transition (EMT).Med Sci Monit. 2019 Sep 10;25:6788-6796. doi: 10.12659/MSM.918682.
• [3209] Centromere protein F (CENPF), a microtubule binding protein, modulates cancer metabolism by regulating pyruvate kinase M2 phosphorylation signaling.Cell Cycle. 2018;17(24):2802-2818. doi: 10.1080/15384101.2018.1557496. Epub 2018 Dec 17.
• [3210] Overexpression of CENP-H as a novel prognostic biomarker for human hepatocellular carcinoma progression and patient survival.Oncol Rep. 2013 Nov;30(5):2238-44. doi: 10.3892/or.2013.2675. Epub 2013 Aug 20.
• [3211] CENPO expression regulates gastric cancer cell proliferation and is associated with poor patient prognosis.Mol Med Rep. 2019 Oct;20(4):3661-3670. doi: 10.3892/mmr.2019.10624. Epub 2019 Aug 29.
• [3212] The effect of centromere protein U silencing by lentiviral mediated RNA interference on the proliferation and apoptosis of breast cancer.Oncol Lett. 2018 Nov;16(5):6721-6728. doi: 10.3892/ol.2018.9477. Epub 2018 Sep 21.
• [3213] Adherence to Adjuvant Endocrine Therapy in Insured Black and White Breast Cancer Survivors: Exploring Adherence Measures in Patient Data.J Manag Care Spec Pharm. 2019 May;25(5):578-586. doi: 10.18553/jmcp.2019.25.5.578.
• [3214] Cancer upregulated gene (CUG)2 elevates YAP1 expression, leading to enhancement of epithelial-mesenchymal transition in human lung cancer cells.Biochem Biophys Res Commun. 2019 Mar 26;511(1):122-128. doi: 10.1016/j.bbrc.2019.02.036. Epub 2019 Feb 14.
• [3215] Basic helix-loop-helix transcription factors DEC1 and DEC2 regulate the paclitaxel-induced apoptotic pathway of MCF-7 human breast cancer cells.Int J Mol Med. 2011 Apr;27(4):491-5. doi: 10.3892/ijmm.2011.617. Epub 2011 Feb 14.
• [3216] Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis.Mol Med Rep. 2019 May;19(5):3485-3496. doi: 10.3892/mmr.2019.10042. Epub 2019 Mar 15.
• [3217] Mosaic-variegated aneuploidy syndrome mutation or haploinsufficiency in Cep57 impairs tumor suppression.J Clin Invest. 2018 Aug 1;128(8):3517-3534. doi: 10.1172/JCI120316. Epub 2018 Jul 23.
• [3218] Cep63 recruits Cdk1 to the centrosome: implications for regulation of mitotic entry, centrosome amplification, and genome maintenance.Cancer Res. 2011 Mar 15;71(6):2129-39. doi: 10.1158/0008-5472.CAN-10-2684.
• [3219] Overexpression of CEP72 Promotes Bladder Urothelial Carcinoma Cell Aggressiveness via Epigenetic CREB-Mediated Induction of SERPINE1.Am J Pathol. 2019 Jun;189(6):1284-1297. doi: 10.1016/j.ajpath.2019.02.014. Epub 2019 Apr 4.
• [3220] Low expression of centrosomal protein 78 (CEP78) is associated with poor prognosis of colorectal cancer patients.Chin J Cancer. 2016 Jun 29;35(1):62. doi: 10.1186/s40880-016-0121-3.
• [3221] Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma.Clin Cancer Res. 2018 Dec 15;24(24):6471-6482. doi: 10.1158/1078-0432.CCR-18-1052. Epub 2018 Aug 31.
• [3222] Concerted functions of HDAC1 and microRNA-574-5p repress alternatively spliced ceramide synthase 1 expression in human cancer cells.EMBO Mol Med. 2012 Feb;4(2):78-92. doi: 10.1002/emmm.201100189. Epub 2011 Dec 19.
• [3223] Clinical and pathological significance of Homo sapiens ceramide synthase 2 (CerS-2) in diverse human cancers.Biosci Rep. 2019 May 7;39(5):BSR20181743. doi: 10.1042/BSR20181743. Print 2019 May 31.
• [3224] N,O-Dialkyl deoxynojirimycin derivatives as CERT START domain ligands.Bioorg Med Chem Lett. 2020 Jan 15;30(2):126796. doi: 10.1016/j.bmcl.2019.126796. Epub 2019 Nov 9.
• [3225] Antibody to CCDC104 is associated with a paraneoplastic antibody to CDR2 (anti-Yo).Cancer Immunol Immunother. 2010 Feb;59(2):231-7. doi: 10.1007/s00262-009-0742-3.
• [3226] A genome wide dosage suppressor network reveals genomic robustness.Nucleic Acids Res. 2017 Jan 9;45(1):255-270. doi: 10.1093/nar/gkw1148. Epub 2016 Nov 29.
• [3227] Downregulated expression of CFHL1 is associated with unfavorable prognosis in postoperative patients with hepatocellular carcinoma.Exp Ther Med. 2019 May;17(5):4073-4079. doi: 10.3892/etm.2019.7455. Epub 2019 Mar 29.
• [3228] Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer.Cancer Sci. 2020 Feb;111(2):304-311. doi: 10.1111/cas.14266. Epub 2019 Dec 27.
• [3229] Higher expression of cation transport regulator-like protein 1 (CHAC1) predicts of poor outcomes in uveal melanoma (UM) patients.Int Ophthalmol. 2019 Dec;39(12):2825-2832. doi: 10.1007/s10792-019-01129-1. Epub 2019 Jun 3.
• [3230] Phenotypic Plasticity of Fibroblasts during Mammary Carcinoma Development.Int J Mol Sci. 2019 Sep 9;20(18):4438. doi: 10.3390/ijms20184438.
• [3231] CHTM1 regulates cancer cell sensitivity to metabolic stress via p38-AIF1 pathway.J Exp Clin Cancer Res. 2019 Jun 20;38(1):271. doi: 10.1186/s13046-019-1253-5.
• [3232] CHCM1/CHCHD6, novel mitochondrial protein linked to regulation of mitofilin and mitochondrial cristae morphology.J Biol Chem. 2012 Mar 2;287(10):7411-26. doi: 10.1074/jbc.M111.277103. Epub 2012 Jan 6.
• [3233] Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.Nat Genet. 2018 May;50(5):682-692. doi: 10.1038/s41588-018-0086-z. Epub 2018 Apr 16.
• [3234] Clinical significance of chromodomain helicase/ATPase DNA binding protein 1-like and human mutL homolog 1 gene expression in cholangiocarcinoma.Oncol Lett. 2018 Sep;16(3):2989-2994. doi: 10.3892/ol.2018.9043. Epub 2018 Jun 28.
• [3235] CHD5 is a potential tumor suppressor in non small cell lung cancer (NSCLC).Gene. 2017 Jun 30;618:65-68. doi: 10.1016/j.gene.2017.04.010. Epub 2017 Apr 8.
• [3236] miR-30 disrupts senescence and promotes cancer by targeting both p16(INK4A) and DNA damage pathways.Oncogene. 2018 Oct;37(42):5618-5632. doi: 10.1038/s41388-018-0358-1. Epub 2018 Jun 15.
• [3237] Identification of common differentially-expressed miRNAs in ovarian cancer cells and their exosomes compared with normal ovarian surface epithelial cell cells.Oncol Lett. 2018 Aug;16(2):2391-2401. doi: 10.3892/ol.2018.8954. Epub 2018 Jun 12.
• [3238] U2-related proteins CHERP and SR140 contribute to colorectal tumorigenesis via alternative splicing regulation.Int J Cancer. 2019 Nov 15;145(10):2728-2739. doi: 10.1002/ijc.32331. Epub 2019 Apr 25.
• [3239] Silencing of CHFR Sensitizes Gastric Carcinoma to PARP Inhibitor Treatment.Transl Oncol. 2020 Jan;13(1):113-121. doi: 10.1016/j.tranon.2019.10.004. Epub 2019 Dec 4.
• [3240] Mixed Malignant Pancreatic Tumour in a Rhesus Macaque (Macaca mullata).J Comp Pathol. 2019 Feb;167:46-49. doi: 10.1016/j.jcpa.2018.12.003. Epub 2019 Jan 21.
• [3241] CHL1 gene polymorphisms increase lung cancer susceptibility.Oncotarget. 2018 Jan 6;9(17):13545-13550. doi: 10.18632/oncotarget.24057. eCollection 2018 Mar 2.
• [3242] Chmp1A functions as a novel tumor suppressor gene in human embryonic kidney and ductal pancreatic tumor cells.Cell Cycle. 2008 Sep 15;7(18):2886-93. doi: 10.4161/cc.7.18.6677. Epub 2008 Sep 26.
• [3243] miR-122-5p promotes aggression and epithelial-mesenchymal transition in triple-negative breast cancer by suppressing charged multivesicular body protein 3 through mitogen-activated protein kinase signaling.J Cell Physiol. 2020 Mar;235(3):2825-2835. doi: 10.1002/jcp.29188. Epub 2019 Sep 20.
• [3244] A cancer-associated polymorphism in ESCRT-III disrupts the abscission checkpoint and promotes genome instability.Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):E8900-E8908. doi: 10.1073/pnas.1805504115. Epub 2018 Sep 4.
• [3245] The IKK/NF-B signalingpathway requires Morgana to drive breast cancer metastasis.Nat Commun. 2017 Nov 21;8(1):1636. doi: 10.1038/s41467-017-01829-1.
• [3246] Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies.J Immunol. 2002 Jul 15;169(2):1102-9. doi: 10.4049/jimmunol.169.2.1102.
• [3247] Development and validation of a UHPLC-MS/MS method for the identification of irinotecan photodegradation products in water samples.Environ Pollut. 2020 Jan;256:113370. doi: 10.1016/j.envpol.2019.113370. Epub 2019 Oct 10.
• [3248] Chordin is underexpressed in ovarian tumors and reduces tumor cell motility.FASEB J. 2006 Feb;20(2):240-50. doi: 10.1096/fj.05-4126com.
• [3249] A radiation hybrid map of the proximal long arm of human chromosome 11 containing the multiple endocrine neoplasia type 1 (MEN-1) and bcl-1 disease loci.Am J Hum Genet. 1991 Dec;49(6):1189-96.
• [3250] CB-6644 Is a Selective Inhibitor of the RUVBL1/2 Complex with Anticancer Activity.ACS Chem Biol. 2019 Feb 15;14(2):236-244. doi: 10.1021/acschembio.8b00904. Epub 2019 Jan 25.
• [3251] New insights into frequency and contents of fear of cancer progression/recurrence (FOP/FCR) in outpatients with colorectal carcinoma (CRC) receiving oral capecitabine: a pilot study at a comprehensive cancer center.Patient Prefer Adherence. 2017 Nov 14;11:1907-1914. doi: 10.2147/PPA.S142784. eCollection 2017.
• [3252] Quality of end-of-life care in patients with dementia compared to patients with cancer: A population-based register study.PLoS One. 2018 Jul 30;13(7):e0201051. doi: 10.1371/journal.pone.0201051. eCollection 2018.
• [3253] Genetic association between the cyclin-dependent kinase inhibitor gene p27/Kip1 polymorphism (rs34330) and cancer susceptibility: a meta-analysis.Sci Rep. 2017 Mar 20;7:44871. doi: 10.1038/srep44871.
• [3254] Interplay between heat shock proteins, inflammation and cancer: a potential cancer therapeutic target.Am J Cancer Res. 2019 Feb 1;9(2):242-249. eCollection 2019.
• [3255] Loss of Cirbp expression is correlated with the malignant progression and poor prognosis in nasopharyngeal carcinoma.Cancer Manag Res. 2019 Jul 24;11:6959-6969. doi: 10.2147/CMAR.S211389. eCollection 2019.
• [3256] Knockdown of Cbp/P300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 inhibits cell division and increases apoptosis in gastric cancer.J Surg Res. 2017 May 1;211:1-7. doi: 10.1016/j.jss.2016.11.049. Epub 2016 Dec 5.
• [3257] CDKN1A-interacting zinc finger protein 1 is a novel biomarker for lung squamous cell carcinoma.Oncol Lett. 2018 Jan;15(1):183-188. doi: 10.3892/ol.2017.7282. Epub 2017 Oct 26.
• [3258] Up-regulation of CKAP2L expression promotes lung adenocarcinoma invasion and is associated with poor prognosis.Onco Targets Ther. 2019 Feb 12;12:1171-1180. doi: 10.2147/OTT.S182242. eCollection 2019.
• [3259] Knockdown of creatine kinase B inhibits ovarian cancer progression by decreasing glycolysis.Int J Biochem Cell Biol. 2013 May;45(5):979-86. doi: 10.1016/j.biocel.2013.02.003. Epub 2013 Feb 14.
• [3260] CKLF1 Enhances Inflammation-Mediated Carcinogenesis and Prevents Doxorubicin-Induced Apoptosis via IL6/STAT3 Signaling in HCC.Clin Cancer Res. 2019 Jul 1;25(13):4141-4154. doi: 10.1158/1078-0432.CCR-18-3510. Epub 2019 Mar 27.
• [3261] Progressive decrease of phosphocreatine, creatine and creatine kinase in skeletal muscle upon transformation to sarcoma.FEBS J. 2008 Jun;275(12):3236-47. doi: 10.1111/j.1742-4658.2008.06475.x. Epub 2008 May 13.
• [3262] Overexpression of CKS2 is associated with a poor prognosis and promotes cell proliferation and invasion in breast cancer.Mol Med Rep. 2019 Jun;19(6):4761-4769. doi: 10.3892/mmr.2019.10134. Epub 2019 Apr 5.
• [3263] Calcium-Activated Chloride Channel A4 (CLCA4) Plays Inhibitory Roles in Invasion and Migration Through Suppressing Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Colorectal Cancer.Med Sci Monit. 2019 Jun 5;25:4176-4185. doi: 10.12659/MSM.914195.
• [3264] Inhibition of hepatocellular carcinoma invasion by suppression of claudin-10 in HLE cells.Mol Cancer Ther. 2007 Nov;6(11):2858-67. doi: 10.1158/1535-7163.MCT-07-0453.
• [3265] Claudin-16/paracellin-1, cloning, expression, and its role in tight junction functions in cancer and endothelial cells.Methods Mol Biol. 2011;762:383-407. doi: 10.1007/978-1-61779-185-7_28.
• [3266] Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy.BMC Cancer. 2017 Feb 13;17(1):129. doi: 10.1186/s12885-017-3123-x.
• [3267] Region Specific Differences of Claudin-5 Expression in Pediatric Intracranial Ependymomas: Potential Prognostic Role in Supratentorial Cases.Pathol Oncol Res. 2017 Apr;23(2):245-252. doi: 10.1007/s12253-016-0084-3. Epub 2016 Jul 9.
• [3268] Pinpointing a potential role for CLEC12B in cancer predisposition through familial exome sequencing.Pediatr Blood Cancer. 2019 Feb;66(2):e27513. doi: 10.1002/pbc.27513. Epub 2018 Oct 23.
• [3269] Activin receptor-like kinase 1 is associated with immune cell infiltration and regulates CLEC14A transcription in cancer.Angiogenesis. 2019 Feb;22(1):117-131. doi: 10.1007/s10456-018-9642-5. Epub 2018 Aug 21.
• [3270] Overexpression of CLEC18B Associates With the Proliferation, Migration, and Prognosis of Glioblastoma.ASN Neuro. 2018 Jan-Dec;10:1759091418781949. doi: 10.1177/1759091418781949.
• [3271] Biological and Clinical Significance of Human NKRP1A/LLT1 Receptor/Ligand Interactions.Crit Rev Immunol. 2018;38(6):479-489. doi: 10.1615/CritRevImmunol.2019029559.
• [3272] Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer.Onco Targets Ther. 2018 Jun 4;11:3303-3312. doi: 10.2147/OTT.S161311. eCollection 2018.
• [3273] Exome-wide Association Study Identifies CLEC3B Missense Variant p.S106G as Being Associated With Extreme Longevity in East Asian Populations.J Gerontol A Biol Sci Med Sci. 2017 Mar 1;72(3):309-318. doi: 10.1093/gerona/glw074.
• [3274] Increased MCL-1 expression predicts poor prognosis and disease recurrence in acute myeloid leukemia.Onco Targets Ther. 2019 May 1;12:3295-3304. doi: 10.2147/OTT.S194549. eCollection 2019.
• [3275] A Distributed Classifier for MicroRNA Target Prediction with Validation Through TCGA Expression Data.IEEE/ACM Trans Comput Biol Bioinform. 2018 Jul-Aug;15(4):1037-1051. doi: 10.1109/TCBB.2018.2828305. Epub 2018 Apr 19.
• [3276] Disruption of the Molecular Circadian Clock and Cancer: An Epigenetic Link.Biochem Genet. 2020 Feb;58(1):189-209. doi: 10.1007/s10528-019-09938-w. Epub 2019 Sep 24.
• [3277] The association of telomere length and genetic variation in telomere biology genes.Hum Mutat. 2010 Sep;31(9):1050-8. doi: 10.1002/humu.21314.
• [3278] Pathobiological role of cleft palate transmembrane protein 1 family proteins in oral squamous cell carcinoma.J Cancer Res Clin Oncol. 2019 Apr;145(4):851-859. doi: 10.1007/s00432-019-02843-0. Epub 2019 Jan 11.
• [3279] Claspin: From replication stress and DNA damage responses to cancer therapy.Adv Protein Chem Struct Biol. 2019;115:203-246. doi: 10.1016/bs.apcsb.2018.10.007. Epub 2018 Dec 5.
• [3280] Spindle Assembly Disruption and Cancer Cell Apoptosis with a CLTC-Binding Compound.Mol Cancer Res. 2018 Sep;16(9):1361-1372. doi: 10.1158/1541-7786.MCR-18-0178. Epub 2018 May 16.
• [3281] SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer.Clin Nucl Med. 2018 Apr;43(4):225-231. doi: 10.1097/RLU.0000000000001991.
• [3282] Targeting CMTM6 Suppresses Stem Cell-Like Properties and Enhances Antitumor Immunity in Head and Neck Squamous Cell Carcinoma.Cancer Immunol Res. 2020 Feb;8(2):179-191. doi: 10.1158/2326-6066.CIR-19-0394. Epub 2019 Nov 26.
• [3283] Carnosinases, their substrates and diseases.Molecules. 2014 Feb 21;19(2):2299-329. doi: 10.3390/molecules19022299.
• [3284] An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and Tumors.Cancer Res. 2019 Jun 15;79(12):3100-3111. doi: 10.1158/0008-5472.CAN-18-2372. Epub 2019 Apr 30.
• [3285] Chondromodulin-1 and vascular endothelial growth factor-A expression in esophageal squamous cell carcinoma: accelerator and brake theory for angiogenesis at the early stage of cancer progression.Esophagus. 2020 Apr;17(2):159-167. doi: 10.1007/s10388-019-00695-8. Epub 2019 Oct 8.
• [3286] Identification of the Critical Site of Calponin 1 for Suppression of Ovarian Cancer Properties.Anticancer Res. 2015 Nov;35(11):5993-9.
• [3287] Cnnm4 deficiency suppresses Ca(2+) signaling and promotes cell proliferation in the colon epithelia.Oncogene. 2019 May;38(20):3962-3969. doi: 10.1038/s41388-019-0682-0. Epub 2019 Jan 22.
• [3288] Molecular partners of hNOT/ALG3, the human counterpart of the Drosophila NOT and yeast ALG3 gene, suggest its involvement in distinct cellular processes relevant to congenital disorders of glycosylation, cancer, neurodegeneration and a variety of further pathologies.Hum Mol Genet. 2018 Jun 1;27(11):1858-1878. doi: 10.1093/hmg/ddy087.
• [3289] Inactivation of Rho GTPases by p190 RhoGAP reduces human pancreatic cancer cell invasion and metastasis.Cancer Sci. 2006 Sep;97(9):848-53. doi: 10.1111/j.1349-7006.2006.00242.x. Epub 2006 Jun 14.
• [3290] High expression of COL10A1 is associated with poor prognosis in colorectal cancer.Onco Targets Ther. 2018 Mar 20;11:1571-1581. doi: 10.2147/OTT.S160196. eCollection 2018.
• [3291] COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer.Mol Med Rep. 2019 Oct;20(4):3103-3112. doi: 10.3892/mmr.2019.10548. Epub 2019 Aug 1.
• [3292] Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder.Oncotarget. 2017 May 30;8(22):36099-36114. doi: 10.18632/oncotarget.16432.
• [3293] Bullous pemphigoid: What's ahead?.J Dermatol. 2016 Mar;43(3):237-40. doi: 10.1111/1346-8138.13207. Epub 2015 Nov 25.
• [3294] Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.World J Gastroenterol. 2019 Jan 14;25(2):233-244. doi: 10.3748/wjg.v25.i2.233.
• [3295] Epithelial but not stromal expression of collagen alpha-1(III) is a diagnostic and prognostic indicator of colorectal carcinoma.Oncotarget. 2016 Feb 23;7(8):8823-38. doi: 10.18632/oncotarget.6815.
• [3296] Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma.Mol Med Rep. 2019 Oct;20(4):3649-3660. doi: 10.3892/mmr.2019.10608. Epub 2019 Aug 23.
• [3297] Prospective molecular mechanism of COL5A1 in breast cancer based on a microarray, RNA sequencing and immunohistochemistry.Oncol Rep. 2019 Jul;42(1):151-175. doi: 10.3892/or.2019.7147. Epub 2019 May 3.
• [3298] Chimeric CLL-1 antibody fusion proteins containing granulocyte-macrophage colony-stimulating factor or interleukin-2 with specificity for B-cell malignancies exhibit enhanced effector functions while retaining tumor targeting properties.Blood. 1997 Jun 15;89(12):4437-47.
• [3299] Nuclear COMMD1 Is Associated with Cisplatin Sensitivity in Ovarian Cancer.PLoS One. 2016 Oct 27;11(10):e0165385. doi: 10.1371/journal.pone.0165385. eCollection 2016.
• [3300] Silencing of COPB2 inhibits the proliferation of gastric cancer cells and induces apoptosis via suppression of the RTK signaling pathway.Int J Oncol. 2019 Apr;54(4):1195-1208. doi: 10.3892/ijo.2019.4717. Epub 2019 Feb 18.
• [3301] Role of Patient Coping Strategies in Understanding the Effects of Early Palliative Care on Quality of Life and Mood.J Clin Oncol. 2018 Jan 1;36(1):53-60. doi: 10.1200/JCO.2017.73.7221. Epub 2017 Nov 15.
• [3302] Overexpression of COPS3 promotes clear cell renal cell carcinoma progression via regulation of Phospho-AKT(Thr308), Cyclin D1 and Caspase-3.Exp Cell Res. 2018 Apr 15;365(2):163-170. doi: 10.1016/j.yexcr.2018.02.025. Epub 2018 Feb 23.
• [3303] Roles of COP9 signalosome in cancer.Cell Cycle. 2011 Sep 15;10(18):3057-66. doi: 10.4161/cc.10.18.17320. Epub 2011 Sep 15.
• [3304] Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease.Aliment Pharmacol Ther. 2013 Mar;37(5):546-54. doi: 10.1111/apt.12218. Epub 2013 Jan 24.
• [3305] CRN2 binds to TIMP4 and MMP14 and promotes perivascular invasion of glioblastoma cells.Eur J Cell Biol. 2019 Dec;98(5-8):151046. doi: 10.1016/j.ejcb.2019.151046. Epub 2019 Oct 11.
• [3306] Downregulation of cyclooxygenase? stimulates mitochondrial apoptosis through the NFB signaling pathway in colorectal cancer cells.Oncol Rep. 2019 Jan;41(1):559-569. doi: 10.3892/or.2018.6785. Epub 2018 Oct 12.
• [3307] Identification of PCAG1 as a novel prostate cancer-associated gene.Mol Med Rep. 2013 Mar;7(3):755-60. doi: 10.3892/mmr.2012.1249. Epub 2012 Dec 24.
• [3308] Systematic expression analysis of the mitochondrial respiratory chain protein subunits identifies COX5B as a prognostic marker in clear cell renal cell carcinoma.Int J Urol. 2019 Sep;26(9):910-916. doi: 10.1111/iju.14040. Epub 2019 Jul 7.
• [3309] The pattern of natural selection in somatic cancer mutations of human mtDNA.J Hum Genet. 2010 Sep;55(9):605-12. doi: 10.1038/jhg.2010.76. Epub 2010 Jul 8.
• [3310] CircRNA_104916 regulates migration, apoptosis and epithelial-mesenchymal transition in colon cancer cells.Front Biosci (Landmark Ed). 2019 Mar 1;24(5):819-832. doi: 10.2741/4753.
• [3311] Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell Carcinoma.Am J Pathol. 2018 Jan;188(1):72-83. doi: 10.1016/j.ajpath.2017.09.013. Epub 2017 Oct 27.
• [3312] Overexpression of COX7A2 is associated with a good prognosis in patients with glioma.J Neurooncol. 2018 Jan;136(1):41-50. doi: 10.1007/s11060-017-2637-z. Epub 2017 Oct 27.
• [3313] Single-cell RNA-seq analysis reveals the platinum resistance gene COX7B and the surrogate marker CD63.Cancer Med. 2018 Dec;7(12):6193-6204. doi: 10.1002/cam4.1828. Epub 2018 Oct 26.
• [3314] DNA decorated Cu(9)S(5) nanoparticles as NIR light responsive drug carriers for tumor chemo-phototherapy.Dalton Trans. 2018 Jun 19;47(24):7916-7924. doi: 10.1039/c8dt01174e.
• [3315] CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance.Cell Death Dis. 2018 Sep 20;9(10):957. doi: 10.1038/s41419-018-0974-2.
• [3316] Effects of Lidocaine-Mediated CPEB3 Upregulation in Human Hepatocellular Carcinoma Cell Proliferation In Vitro.Biomed Res Int. 2018 Apr 17;2018:8403157. doi: 10.1155/2018/8403157. eCollection 2018.
• [3317] CPEB4 regulates glioblastoma cell proliferation and predicts poor outcome of patients.Clin Neurol Neurosurg. 2018 Jun;169:92-97. doi: 10.1016/j.clineuro.2018.04.008. Epub 2018 Apr 3.
• [3318] Copine5 expression predicts prognosis following curative resection of esophageal squamous cell carcinoma.Oncol Rep. 2018 Dec;40(6):3772-3780. doi: 10.3892/or.2018.6742. Epub 2018 Sep 27.
• [3319] Crystal structures of human procathepsin H.PLoS One. 2018 Jul 25;13(7):e0200374. doi: 10.1371/journal.pone.0200374. eCollection 2018.
• [3320] Molecular mechanisms underlying mifepristone's agonistic action on ovarian cancer progression.EBioMedicine. 2019 Sep;47:170-183. doi: 10.1016/j.ebiom.2019.08.035. Epub 2019 Aug 26.
• [3321] Improved Stable Indocyanine Green (ICG)-Mediated Cancer Optotheranostics with Naturalized Hepatitis B Core Particles.Adv Mater. 2018 Jul;30(28):e1707567. doi: 10.1002/adma.201707567. Epub 2018 May 22.
• [3322] Crabp2 Promotes Metastasis of Lung Cancer Cells via HuR and Integrin 1/FAK/ERK Signaling.Sci Rep. 2019 Jan 29;9(1):845. doi: 10.1038/s41598-018-37443-4.
• [3323] Correction: RCP induces Slug expression and cancer cell invasion by stabilizing 1 integrin.Oncogene. 2019 May;38(20):3970-3971. doi: 10.1038/s41388-019-0678-9.
• [3324] Promotion of Cancer Cell Proliferation by Cleaved and Secreted Luminal Domains of ER Stress Transducer BBF2H7.PLoS One. 2015 May 8;10(5):e0125982. doi: 10.1371/journal.pone.0125982. eCollection 2015.
• [3325] CREB5 promotes tumor cell invasion and correlates with poor prognosis in epithelial ovarian cancer.Oncol Lett. 2017 Dec;14(6):8156-8161. doi: 10.3892/ol.2017.7234. Epub 2017 Oct 20.
• [3326] Cysteine-Rich Intestinal Protein 1 Silencing Inhibits Migration and Invasion in Human Colorectal Cancer.Cell Physiol Biochem. 2017;44(3):897-906. doi: 10.1159/000485357. Epub 2017 Nov 24.
• [3327] Thrombospondin-1 promotes tumor progression in cutaneous T-cell lymphoma via CD47.Leukemia. 2020 Mar;34(3):845-856. doi: 10.1038/s41375-019-0622-6. Epub 2019 Nov 11.
• [3328] Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland.Prostate. 2006 May 1;66(6):591-603. doi: 10.1002/pros.20342.
• [3329] CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.BMC Cancer. 2019 May 27;19(1):499. doi: 10.1186/s12885-019-5671-8.
• [3330] Cornulin Is Induced in Psoriasis Lesions and Promotes Keratinocyte Proliferation via Phosphoinositide 3-Kinase/Akt Pathways.J Invest Dermatol. 2019 Jan;139(1):71-80. doi: 10.1016/j.jid.2018.06.184. Epub 2018 Sep 25.
• [3331] LOTUS: A single- and multitask machine learning algorithm for the prediction of cancer driver genes.PLoS Comput Biol. 2019 Sep 30;15(9):e1007381. doi: 10.1371/journal.pcbi.1007381. eCollection 2019 Sep.
• [3332] CRX is a diagnostic marker of retinal and pineal lineage tumors.PLoS One. 2009 Nov 20;4(11):e7932. doi: 10.1371/journal.pone.0007932.
• [3333] Long Noncoding RNA CRYBG3 Blocks Cytokinesis by Directly Binding G-Actin.Cancer Res. 2018 Aug 15;78(16):4563-4572. doi: 10.1158/0008-5472.CAN-18-0988. Epub 2018 Jun 22.
• [3334] Prostate-Specimen Antigen (PSA) Screening and Shared Decision Making Among Deaf and Hearing Male Patients.J Cancer Educ. 2020 Feb;35(1):28-35. doi: 10.1007/s13187-018-1436-3.
• [3335] Cryptochrome deletion in p53 mutant mice enhances apoptotic and anti-tumorigenic responses to UV damage at the transcriptome level.Funct Integr Genomics. 2019 Sep;19(5):729-742. doi: 10.1007/s10142-019-00680-5. Epub 2019 May 1.
• [3336] Identification of mu-crystallin as an androgen-regulated gene in human prostate cancer.Prostate. 2009 Jul 1;69(10):1109-18. doi: 10.1002/pros.20956.
• [3337] Loss of CSMD1 expression disrupts mammary duct formation while enhancing proliferation, migration and invasion.Oncol Rep. 2017 Jul;38(1):283-292. doi: 10.3892/or.2017.5656. Epub 2017 May 22.
• [3338] Methylation status of genes upregulated by demethylating agent 5-aza-2'-deoxycytidine in hepatocellular carcinoma.Oncology. 2006;71(1-2):77-85. doi: 10.1159/000100475. Epub 2007 Mar 6.
• [3339] Exosomal miR-27a Derived from Gastric Cancer Cells Regulates the Transformation of Fibroblasts into Cancer-Associated Fibroblasts.Cell Physiol Biochem. 2018;49(3):869-883. doi: 10.1159/000493218. Epub 2018 Sep 5.
• [3340] The preoperative serum cystatin-C as an independent prognostic factor for survival in upper tract urothelial carcinoma.Asian J Androl. 2019 Mar-Apr;21(2):163-169. doi: 10.4103/aja.aja_84_18.
• [3341] Stefin A-functionalized liposomes as a system for cathepsins S and L-targeted drug delivery.Biochimie. 2019 Nov;166:94-102. doi: 10.1016/j.biochi.2019.05.018. Epub 2019 Jun 1.
• [3342] Genome-wide profiling reveals alternative polyadenylation of mRNA in human non-small cell lung cancer.J Transl Med. 2019 Aug 7;17(1):257. doi: 10.1186/s12967-019-1986-0.
• [3343] CT45A1 acts as a new proto-oncogene to trigger tumorigenesis and cancer metastasis.Cell Death Dis. 2014 Jun 5;5(6):e1285. doi: 10.1038/cddis.2014.244.
• [3344] Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer.Int J Cancer. 2009 Jun 15;124(12):2893-8. doi: 10.1002/ijc.24296.
• [3345] Cancer testis antigen 55 deficiency attenuates colitis-associated colorectal cancer by inhibiting NF-B signaling.Cell Death Dis. 2019 Apr 3;10(4):304. doi: 10.1038/s41419-019-1537-x.
• [3346] Long-term safety and activity of NY-ESO-1 SPEAR T cells after autologous stem cell transplant for myeloma.Blood Adv. 2019 Jul 9;3(13):2022-2034. doi: 10.1182/bloodadvances.2019000194.
• [3347] cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing.J Invest Dermatol. 2003 Jul;121(1):198-206. doi: 10.1046/j.1523-1747.2003.12318.x.
• [3348] Synaptonemal complex protein 3 is associated with lymphangiogenesis in non-small cell lung cancer patients with lymph node metastasis.J Transl Med. 2017 Jun 17;15(1):138. doi: 10.1186/s12967-017-1241-5.
• [3349] Alpha-T-catenin (CTNNA3) displays tumour specific monoallelic expression in urothelial carcinoma of the bladder.Genes Chromosomes Cancer. 2007 Jun;46(6):587-93. doi: 10.1002/gcc.20443.
• [3350] -Catulin marks the invasion front of squamous cell carcinoma and is important for tumor cell metastasis.Mol Cancer Res. 2012 Jul;10(7):892-903. doi: 10.1158/1541-7786.MCR-12-0169. Epub 2012 May 30.
• [3351] Down-regulation of a novel gene, DRLM, in human liver malignancy from 4q22 that encodes a NAP-like protein.Gene. 2002 Aug 21;296(1-2):171-7. doi: 10.1016/s0378-1119(02)00855-7.
• [3352] CAS-viewer: web-based tool for splicing-guided integrative analysis of multi-omics cancer data.BMC Med Genomics. 2018 Apr 20;11(Suppl 2):25. doi: 10.1186/s12920-018-0348-8.
• [3353] Correlation of focal adhesion kinase expression with nodal metastasis in patients with head and neck cutaneous squamous cell carcinoma.Head Neck. 2019 May;41(5):1290-1296. doi: 10.1002/hed.25556. Epub 2018 Dec 10.
• [3354] Increased serological, cancer-associated protein biomarker levels at diagnosis of large bowel adenoma: Risk of subsequent primary malignancy?.Acta Oncol. 2019;58(sup1):S42-S48. doi: 10.1080/0284186X.2018.1540885. Epub 2018 Dec 7.
• [3355] CUE domain-containing protein 2 promotes the Warburg effect and tumorigenesis.EMBO Rep. 2017 May;18(5):809-825. doi: 10.15252/embr.201643617. Epub 2017 Mar 21.
• [3356] Inflammation-dependent overexpression of c-Myc enhances CRL4(DCAF4) E3 ligase activity and promotes ubiquitination of ST7 in colitis-associated cancer.J Pathol. 2019 Aug;248(4):464-475. doi: 10.1002/path.5273. Epub 2019 Apr 22.
• [3357] A Novel Autocrine CXCL14/ACKR2 Axis: The Achilles' Heel of Cancer Metastasis?.Clin Cancer Res. 2019 Jun 15;25(12):3476-3478. doi: 10.1158/1078-0432.CCR-19-0853. Epub 2019 Apr 5.
• [3358] Long term follow-up of Behet's syndrome patients treated with cyclophosphamide.Rheumatology (Oxford). 2020 Sep 1;59(9):2264-2271. doi: 10.1093/rheumatology/kez598.
• [3359] The roles of p53R2 in cancer progression based on the new function of mutant p53 and cytoplasmic p21.Life Sci. 2014 Mar 18;99(1-2):14-7. doi: 10.1016/j.lfs.2014.01.063. Epub 2014 Jan 28.
• [3360] Cytoglobin inhibits migration through PI3K/AKT/mTOR pathway in fibroblast cells.Mol Cell Biochem. 2018 Jan;437(1-2):133-142. doi: 10.1007/s11010-017-3101-2. Epub 2017 Jun 15.
• [3361] Proviral insertions near cyclin D1 in mouse lymphomas: a parallel for BCL1 translocations in human B-cell neoplasms.Oncogene. 1992 Dec;7(12):2381-7.
• [3362] Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India.Cancer Genet Cytogenet. 2005 Jan 1;156(1):68-73. doi: 10.1016/j.cancergencyto.2004.04.001.
• [3363] Cytochrome P450 2W1 (CYP2W1) - ready for use as the biomarker and drug target for cancer?.Xenobiotica. 2017 Oct;47(10):923-932. doi: 10.1080/00498254.2016.1244370. Epub 2016 Oct 24.
• [3364] Antibodies to watch in 2018.MAbs. 2018 Feb/Mar;10(2):183-203. doi: 10.1080/19420862.2018.1415671. Epub 2018 Jan 16.
• [3365] CYP4Z1 - A Human Cytochrome P450 Enzyme that Might Hold the Key to Curing Breast Cancer.Curr Pharm Des. 2017;23(14):2060-2064. doi: 10.2174/1381612823666170207150156.
• [3366] MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.N Engl J Med. 2018 May 10;378(19):1767-1777. doi: 10.1056/NEJMoa1801993. Epub 2018 Mar 18.
• [3367] Elevated d-2-hydroxyglutarate during colitis drives progression to colorectal cancer.Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1057-1062. doi: 10.1073/pnas.1712625115. Epub 2018 Jan 16.
• [3368] miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.IUBMB Life. 2018 Jan;70(1):71-80. doi: 10.1002/iub.1705. Epub 2017 Dec 16.
• [3369] Oncogenic function of DACT1 in colon cancer through the regulation of -catenin.PLoS One. 2012;7(3):e34004. doi: 10.1371/journal.pone.0034004. Epub 2012 Mar 21.
• [3370] Effects of the knockdown of death-associated protein 3 expression on cell adhesion, growth and migration in breast cancer cells.Oncol Rep. 2015 May;33(5):2575-82. doi: 10.3892/or.2015.3825. Epub 2015 Mar 2.
• [3371] Activation of death-associated protein kinase 1 promotes neutrophil apoptosis to accelerate inflammatory resolution in acute respiratory distress syndrome.Lab Invest. 2019 Jul;99(8):1143-1156. doi: 10.1038/s41374-019-0242-9. Epub 2019 Mar 25.
• [3372] DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors.Sci Rep. 2019 Dec 9;9(1):18614. doi: 10.1038/s41598-019-55156-0.
• [3373] Cloning and functional characterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia.Leukemia. 2005 May;19(5):806-13. doi: 10.1038/sj.leu.2403684.
• [3374] Gamma-aminobutyric acid transaminase genetic polymorphism is a candidate locus for responsiveness to opioid analgesics in patients with cancer pain: An exploratory study.Neuropsychopharmacol Rep. 2018 Dec;38(4):175-181. doi: 10.1002/npr2.12030. Epub 2018 Sep 14.
• [3375] Identification of Novel Cdc7 Kinase Inhibitors as Anti-Cancer Agents that Target the Interaction with Dbf4 by the Fragment Complementation and Drug Repositioning Approach.EBioMedicine. 2018 Oct;36:241-251. doi: 10.1016/j.ebiom.2018.09.030. Epub 2018 Oct 5.
• [3376] The drebrin/EB3 pathway drives invasive activity in prostate cancer.Oncogene. 2017 Jul 20;36(29):4111-4123. doi: 10.1038/onc.2017.45. Epub 2017 Mar 20.
• [3377] Symmetric dimeric bisbenzimidazoles DBP(n) reduce methylation of RARB and PTEN while significantly increase methylation of rRNA genes in MCF-7 cancer cells.PLoS One. 2018 Jan 12;13(1):e0189826. doi: 10.1371/journal.pone.0189826. eCollection 2018.
• [3378] The overexpression and prognostic role of DCAF13 in hepatocellular carcinoma.Tumour Biol. 2017 Jun;39(6):1010428317705753. doi: 10.1177/1010428317705753.
• [3379] Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.Cancer. 2018 Jul 1;124(13):2758-2765. doi: 10.1002/cncr.31398. Epub 2018 Apr 16.
• [3380] Photochemical property of two Ru(II) compounds based on 5-(2-pyrazinyl)tetrazole for cancer phototherapy by changing auxiliary ligand.J Inorg Biochem. 2019 Apr;193:124-129. doi: 10.1016/j.jinorgbio.2019.01.015. Epub 2019 Jan 28.
• [3381] Cellular Therapies for the Treatment of Hematological Malignancies; Swine Are an Ideal Preclinical Model.Front Oncol. 2019 Jun 21;9:418. doi: 10.3389/fonc.2019.00418. eCollection 2019.
• [3382] MALAT1 promotes the colorectal cancer malignancy by increasing DCP1A expression and miR203 downregulation.Mol Carcinog. 2018 Oct;57(10):1421-1431. doi: 10.1002/mc.22868. Epub 2018 Jul 12.
• [3383] Efficient co-delivery of neo-epitopes using dispersion-stable layered double hydroxide nanoparticles for enhanced melanoma immunotherapy.Biomaterials. 2018 Aug;174:54-66. doi: 10.1016/j.biomaterials.2018.05.015. Epub 2018 May 10.
• [3384] DDIAS suppresses TRAIL-mediated apoptosis by inhibiting DISC formation and destabilizing caspase-8 in cancer cells.Oncogene. 2018 Mar;37(9):1251-1262. doi: 10.1038/s41388-017-0025-y. Epub 2017 Dec 15.
• [3385] Ferroptosis-Induced Endoplasmic Reticulum Stress: Cross-talk between Ferroptosis and Apoptosis.Mol Cancer Res. 2018 Jul;16(7):1073-1076. doi: 10.1158/1541-7786.MCR-18-0055. Epub 2018 Mar 28.
• [3386] Oxidative Phosphorylation Impairment by DDT and DDE.Front Endocrinol (Lausanne). 2019 Mar 12;10:122. doi: 10.3389/fendo.2019.00122. eCollection 2019.
• [3387] NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogntique Hmatologique.Leukemia. 2006 Apr;20(4):696-706. doi: 10.1038/sj.leu.2404130.
• [3388] Regulation of miRNA Biogenesis and Histone Modification by K63-Polyubiquitinated DDX17 Controls Cancer Stem-like Features.Cancer Res. 2019 May 15;79(10):2549-2563. doi: 10.1158/0008-5472.CAN-18-2376. Epub 2019 Mar 15.
• [3389] Aberrant splice variants of HAS1 (Hyaluronan Synthase 1) multimerize with and modulate normally spliced HAS1 protein: a potential mechanism promoting human cancer.J Biol Chem. 2009 Jul 10;284(28):18840-50. doi: 10.1074/jbc.M109.013813. Epub 2009 May 18.
• [3390] The multiple lives of DEAD-box RNA helicase DP103/DDX20/Gemin3.Biochem Soc Trans. 2018 Apr 17;46(2):329-341. doi: 10.1042/BST20180016. Epub 2018 Mar 9.
• [3391] DEAD-box helicase 27 plays a tumor-promoter role by regulating the stem cell-like activity of human colorectal cancer cells.Onco Targets Ther. 2018 Dec 28;12:233-241. doi: 10.2147/OTT.S190814. eCollection 2019.
• [3392] From the magic bullet to the magic target: exploiting the diverse roles of DDX3X in viral infections and tumorigenesis.Future Med Chem. 2019 Jun;11(11):1357-1381. doi: 10.4155/fmc-2018-0451. Epub 2019 Feb 28.
• [3393] Gonadoblastoma Y locus genes expressed in germ cells of individuals with dysgenetic gonads and a Y chromosome in their karyotypes include DDX3Y and TSPY.Hum Reprod. 2019 Apr 1;34(4):770-779. doi: 10.1093/humrep/dez004.
• [3394] Germline factor DDX4 functions in blood-derived cancer cell phenotypes.Cancer Sci. 2017 Aug;108(8):1612-1619. doi: 10.1111/cas.13299. Epub 2017 Jul 11.
• [3395] DDX43 prefers single strand substrate and its full binding activity requires physical connection of all domains.Biochem Biophys Res Commun. 2019 Dec 10;520(3):594-599. doi: 10.1016/j.bbrc.2019.09.114. Epub 2019 Oct 14.
• [3396] DDX49 is an RNA helicase that affects translation by regulating mRNA export and the levels of pre-ribosomal RNA.Nucleic Acids Res. 2018 Jul 6;46(12):6304-6317. doi: 10.1093/nar/gky231.
• [3397] The DEAD-box RNA helicase 51 controls non-small cell lung cancer proliferation by regulating cell cycle progression via multiple pathways.Sci Rep. 2016 May 20;6:26108. doi: 10.1038/srep26108.
• [3398] Natural killer cell-mediated anticancer effects of an arabinogalactan derived from rice hull in CT26 colon cancer-bearing mice.Int J Biol Macromol. 2019 Mar 1;124:368-376. doi: 10.1016/j.ijbiomac.2018.11.200. Epub 2018 Nov 22.
• [3399] Target-Based Screening against eIF4A1 Reveals the Marine Natural Product Elatol as a Novel Inhibitor of Translation Initiation with In Vivo Antitumor Activity.Clin Cancer Res. 2018 Sep 1;24(17):4256-4270. doi: 10.1158/1078-0432.CCR-17-3645. Epub 2018 May 29.
• [3400] Altered subcellular localization of suppressin, a novel inhibitor of cell-cycle entry, is an independent prognostic factor in colorectal adenocarcinomas.Clin Cancer Res. 2001 Nov;7(11):3495-503.
• [3401] Activated glycine receptors may decrease endosomal NADPH oxidase activity by opposing ClC-3-mediated efflux of chloride from endosomes.Med Hypotheses. 2019 Feb;123:125-129. doi: 10.1016/j.mehy.2019.01.012. Epub 2019 Jan 16.
• [3402] Defensin alpha 6 (DEFA6) is a prognostic marker in colorectal cancer.Cancer Biomark. 2019;24(4):485-495. doi: 10.3233/CBM-182221.
• [3403] High expression of density-regulated re-initiation and release factor drives tumourigenesis and affects clinical outcome.Oncol Lett. 2019 Jan;17(1):141-148. doi: 10.3892/ol.2018.9620. Epub 2018 Oct 25.
• [3404] Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling.Oncotarget. 2017 Mar 7;8(10):17059-17069. doi: 10.18632/oncotarget.15001.
• [3405] CCRDB: a cancer circRNAs-related database and its application in hepatocellular carcinoma-related circRNAs.Database (Oxford). 2019 Jan 1;2019:baz063. doi: 10.1093/database/baz063.
• [3406] Cutaneous Presentation of Mesothelioma With a Sarcomatoid Transformation.Am J Dermatopathol. 2018 May;40(5):378-382. doi: 10.1097/DAD.0000000000001023.
• [3407] Perioperative Lung Resection Outcomes After Implementation of a Multidisciplinary, Evidence-based Thoracic ERAS Program.Ann Surg. 2021 Dec 1;274(6):e1008-e1013. doi: 10.1097/SLA.0000000000003719.
• [3408] Classification of condom lubricants in cyanoacrylate treated fingerprints by desorption electrospray ionization mass spectrometry.Forensic Sci Int. 2019 Dec;305:110005. doi: 10.1016/j.forsciint.2019.110005. Epub 2019 Oct 23.
• [3409] Diacylglycerol kinase modulates Akt phosphorylation through pleckstrin homology domain leucine-rich repeat protein phosphatase 2 (PHLPP2).J Biol Chem. 2013 Jan 18;288(3):1439-47. doi: 10.1074/jbc.M112.407379. Epub 2012 Nov 26.
• [3410] C14orf159 suppresses gastric cancer cells' invasion and proliferation by inactivating ERK signaling.Cancer Manag Res. 2019 Feb 19;11:1717-1723. doi: 10.2147/CMAR.S176771. eCollection 2019.
• [3411] Molecular pathogenesis of esophageal squamous cell carcinoma: Identification of the antitumor effects of miR?45?p on gene regulation.Int J Oncol. 2019 Feb;54(2):673-688. doi: 10.3892/ijo.2018.4657. Epub 2018 Dec 6.
• [3412] RNA helicase DHX15 acts as a tumour suppressor in glioma.Br J Cancer. 2017 Oct 24;117(9):1349-1359. doi: 10.1038/bjc.2017.273. Epub 2017 Aug 22.
• [3413] Prp8 regulates oncogene-induced hyperplastic growth in Drosophila.Development. 2018 Nov 12;145(22):dev162156. doi: 10.1242/dev.162156.
• [3414] Recombinant DHX33 Protein Possesses Dual DNA/RNA Helicase Activity.Biochemistry. 2019 Jan 29;58(4):250-258. doi: 10.1021/acs.biochem.8b00166. Epub 2018 Jun 13.
• [3415] Innate immune sensor laboratory of genetics and physiology 2 suppresses tumor cell growth and functions as a prognostic marker in neuroblastoma.Cancer Sci. 2018 Nov;109(11):3494-3502. doi: 10.1111/cas.13790. Epub 2018 Oct 4.
• [3416] Positive feedback between Dia1, LARG, and RhoA regulates cell morphology and invasion.Genes Dev. 2007 Jun 15;21(12):1478-83. doi: 10.1101/gad.424807.
• [3417] Stromal iodothyronine deiodinase 2 (DIO2) promotes the growth of intestinal tumors in Apc(716) mutant mice.Cancer Sci. 2019 Aug;110(8):2520-2528. doi: 10.1111/cas.14100. Epub 2019 Jul 7.
• [3418] Note of Caution for the Aqueous Behaviour of Metal-Based Drug Candidates.ChemMedChem. 2020 Feb 17;15(4):345-348. doi: 10.1002/cmdc.201900677. Epub 2020 Jan 21.
• [3419] DIRAS3-Derived Peptide Inhibits Autophagy in Ovarian Cancer Cells by Binding to Beclin1.Cancers (Basel). 2019 Apr 18;11(4):557. doi: 10.3390/cancers11040557.
• [3420] DIS3 isoforms vary in their endoribonuclease activity and are differentially expressed within haematological cancers.Biochem J. 2018 Jun 29;475(12):2091-2105. doi: 10.1042/BCJ20170962.
• [3421] Regulation of RNA decay and cellular function by 3'-5' exoribonuclease DIS3L2.RNA Biol. 2019 Feb;16(2):160-165. doi: 10.1080/15476286.2018.1564466. Epub 2019 Jan 13.
• [3422] Minimization of energy transduction confers resistance to phosphine in the rice weevil, Sitophilus oryzae.Sci Rep. 2019 Oct 10;9(1):14605. doi: 10.1038/s41598-019-50972-w.
• [3423] DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype.Virchows Arch. 2019 Jul;475(1):49-58. doi: 10.1007/s00428-018-02511-7. Epub 2019 Jan 4.
• [3424] Differential expression of DLG1 as a common trait in different human diseases: an encouraging issue in molecular pathology.Biol Chem. 2019 May 27;400(6):699-710. doi: 10.1515/hsz-2018-0350.
• [3425] SAP102 contributes to hyperalgesia formation in the cancer induced bone pain rat model by anchoring NMDA receptors.Neurosci Lett. 2020 Jan 1;714:134595. doi: 10.1016/j.neulet.2019.134595. Epub 2019 Nov 1.
• [3426] Examination of the expression and prognostic significance of DLGAPs in gastric cancer using the TCGA database and bioinformatic analysis.Mol Med Rep. 2018 Dec;18(6):5621-5629. doi: 10.3892/mmr.2018.9574. Epub 2018 Oct 23.
• [3427] EGFL9 promotes breast cancer metastasis by inducing cMET activation and metabolic reprogramming.Nat Commun. 2019 Nov 6;10(1):5033. doi: 10.1038/s41467-019-13034-3.
• [3428] DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-/SMAD4 signaling.Oncogene. 2017 Mar;36(10):1404-1416. doi: 10.1038/onc.2016.307. Epub 2016 Sep 5.
• [3429] Smad2/3-Regulated Expression of DLX2 Is Associated with Radiation-Induced Epithelial-Mesenchymal Transition and Radioresistance of A549 and MDA-MB-231 Human Cancer Cell Lines.PLoS One. 2016 Jan 22;11(1):e0147343. doi: 10.1371/journal.pone.0147343. eCollection 2016.
• [3430] IDO and TDO as a potential therapeutic target in different types of depression.Metab Brain Dis. 2018 Dec;33(6):1787-1800. doi: 10.1007/s11011-018-0290-7. Epub 2018 Jul 16.
• [3431] Overexpression of BP1, an isoform of Homeobox Gene DLX4, promotes cell proliferation, migration and predicts poor prognosis in endometrial cancer.Gene. 2019 Jul 30;707:216-223. doi: 10.1016/j.gene.2019.05.028. Epub 2019 May 15.
• [3432] Upregulation of DLX5 promotes ovarian cancer cell proliferation by enhancing IRS-2-AKT signaling.Cancer Res. 2010 Nov 15;70(22):9197-206. doi: 10.1158/0008-5472.CAN-10-1568. Epub 2010 Nov 2.
• [3433] DMBT1 suppresses progression of gallbladder carcinoma through PI3K/AKT signaling pathway by targeting PTEN.Biosci Biotechnol Biochem. 2019 Dec;83(12):2257-2264. doi: 10.1080/09168451.2019.1654361. Epub 2019 Aug 14.
• [3434] c-MYB and DMTF1 in Cancer.Cancer Invest. 2019;37(1):46-65. doi: 10.1080/07357907.2018.1550090. Epub 2019 Jan 2.
• [3435] Hypermethylation of DMTN promotes the metastasis of colorectal cancer cells by regulating the actin cytoskeleton through Rac1 signaling activation.J Exp Clin Cancer Res. 2018 Dec 4;37(1):299. doi: 10.1186/s13046-018-0958-1.
• [3436] Multiple roles of DNA2 nuclease/helicase in DNA metabolism, genome stability and human diseases.Nucleic Acids Res. 2020 Jan 10;48(1):16-35. doi: 10.1093/nar/gkz1101.
• [3437] Predictors of post-cancer diagnosis resignation among Japanese cancer survivors.J Cancer Surviv. 2020 Apr;14(2):106-113. doi: 10.1007/s11764-019-00827-0. Epub 2019 Nov 13.
• [3438] The dyslexia candidate gene DYX1C1 is a potential marker of poor survival in breast cancer.BMC Cancer. 2012 Feb 29;12:79. doi: 10.1186/1471-2407-12-79.
• [3439] Targeted molecular ablation of cancer stem cells for curing gastrointestinal cancers.Expert Rev Gastroenterol Hepatol. 2017 Nov;11(11):1059-1070. doi: 10.1080/17474124.2017.1356224. Epub 2017 Jul 27.
• [3440] Inhibition of mutant Kras and p53-driven pancreatic carcinogenesis by atorvastatin: Mainly via targeting of the farnesylated DNAJA1 in chaperoning mutant p53.Mol Carcinog. 2019 Nov;58(11):2052-2064. doi: 10.1002/mc.23097. Epub 2019 Aug 9.
• [3441] A Targeted Proteomic Approach for Heat Shock Proteins Reveals DNAJB4 as a Suppressor for Melanoma Metastasis.Anal Chem. 2018 Jun 5;90(11):6835-6842. doi: 10.1021/acs.analchem.8b00986. Epub 2018 May 11.
• [3442] Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer.Oncotarget. 2016 Aug 16;7(33):53984-53996. doi: 10.18632/oncotarget.9803.
• [3443] Cellular stress induces cancer stem-like cells through expression of DNAJB8 by activation of heat shock factor 1.Cancer Sci. 2018 Mar;109(3):741-750. doi: 10.1111/cas.13501. Epub 2018 Feb 20.
• [3444] Targeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis: the role of stress proteins ERdj5 and ERp57. Br J Cancer. 2007 Apr 10;96(7):1062-71. doi: 10.1038/sj.bjc.6603672. Epub 2007 Mar 13.
• [3445] RNA sequencing reveals upregulation of a transcriptomic program associated with stemness in metastatic prostate cancer cells selected for taxane resistance.Oncotarget. 2018 Jul 13;9(54):30363-30384. doi: 10.18632/oncotarget.25744. eCollection 2018 Jul 13.
• [3446] Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome of gastric carcinoma.Carcinogenesis. 2018 Feb 9;39(2):263-271. doi: 10.1093/carcin/bgx139.
• [3447] DNAJC21 Mutations Link a Cancer-Prone Bone Marrow Failure Syndrome to Corruption in 60S Ribosome Subunit Maturation. Am J Hum Genet. 2016 Jul 7;99(1):115-24. doi: 10.1016/j.ajhg.2016.05.002. Epub 2016 Jun 23.
• [3448] Secretion of novel SEL1L endogenous variants is promoted by ER stress/UPR via endosomes and shed vesicles in human cancer cells.PLoS One. 2011 Feb 17;6(2):e17206. doi: 10.1371/journal.pone.0017206.
• [3449] Oncogenic effects of germline variants in lysosomal storage disease genes.Genet Med. 2019 Dec;21(12):2695-2705. doi: 10.1038/s41436-019-0588-9. Epub 2019 Jul 25.
• [3450] Action of Thyroid Hormones, T3 and T2, on Hepatic Fatty Acids: Differences in Metabolic Effects and Molecular Mechanisms.Int J Mol Sci. 2017 Mar 31;18(4):744. doi: 10.3390/ijms18040744.
• [3451] RNA-binding protein Dnd1 inhibits epithelial-mesenchymal transition and cancer stem cell-related traits on hepatocellular carcinoma cells.Biotechnol Lett. 2017 Sep;39(9):1359-1367. doi: 10.1007/s10529-017-2375-5. Epub 2017 Jun 7.
• [3452] Discovery, synthesis and molecular substantiation of N-(benzo[d]thiazol-2-yl)-2-hydroxyquinoline-4-carboxamides as anticancer agents.Bioorg Chem. 2019 Oct;91:103171. doi: 10.1016/j.bioorg.2019.103171. Epub 2019 Jul 30.
• [3453] Construction of a recombinant eukaryotic expression vector containing DNM3 gene and its expression in colon cancer cells.Onco Targets Ther. 2018 Oct 9;11:6665-6671. doi: 10.2147/OTT.S176388. eCollection 2018.
• [3454] TdIF1: a putative oncogene in NSCLC tumor progression.Signal Transduct Target Ther. 2018 Oct 19;3:28. doi: 10.1038/s41392-018-0030-9. eCollection 2018.
• [3455] The role of DOC-2/DAB2 in modulating androgen receptor-mediated cell growth via the nongenomic c-Src-mediated pathway in normal prostatic epithelium and cancer.Cancer Res. 2005 Nov 1;65(21):9906-13. doi: 10.1158/0008-5472.CAN-05-1481.
• [3456] DOCK1 Regulates Growth and Motility through the RRP1B-Claudin-1 Pathway in Claudin-Low Breast Cancer Cells.Cancers (Basel). 2019 Nov 8;11(11):1762. doi: 10.3390/cancers11111762.
• [3457] Dock2 in the development of inflammation and cancer.Eur J Immunol. 2018 Jun;48(6):915-922. doi: 10.1002/eji.201747157. Epub 2018 Apr 11.
• [3458] CD147 regulates cancer migration via direct interaction with Annexin A2 and DOCK3--catenin-WAVE2 signaling.Oncotarget. 2016 Feb 2;7(5):5613-29. doi: 10.18632/oncotarget.6723.
• [3459] DOCK4, a GTPase activator, is disrupted during tumorigenesis.Cell. 2003 Mar 7;112(5):673-84. doi: 10.1016/s0092-8674(03)00155-7.
• [3460] MBD3/NuRD loss participates with KDM6A program to promote DOCK5/8 expression and Rac GTPase activation in human acute myeloid leukemia.FASEB J. 2019 Apr;33(4):5268-5286. doi: 10.1096/fj.201801035R. Epub 2019 Jan 22.
• [3461] Prognostic role of DOK family adapters in acute myeloid leukemia.Cancer Gene Ther. 2019 Sep;26(9-10):305-312. doi: 10.1038/s41417-018-0052-z. Epub 2018 Oct 22.
• [3462] Genomic functions of developmental pluripotency associated factor 4 (Dppa4) in pluripotent stem cells and cancer.Stem Cell Res. 2018 Aug;31:83-94. doi: 10.1016/j.scr.2018.07.009. Epub 2018 Jul 19.
• [3463] Suppression of Prostate Cancer Metastasis by DPYSL3-Targeted saRNA.Adv Exp Med Biol. 2017;983:207-216. doi: 10.1007/978-981-10-4310-9_15.
• [3464] p53-inducible DPYSL4 associates with mitochondrial supercomplexes and regulates energy metabolism in adipocytes and cancer cells.Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):8370-8375. doi: 10.1073/pnas.1804243115. Epub 2018 Jul 30.
• [3465] DRAM1 regulates the migration and invasion of hepatoblastoma cells via autophagy-EMT pathway.Oncol Lett. 2018 Aug;16(2):2427-2433. doi: 10.3892/ol.2018.8937. Epub 2018 Jun 8.
• [3466] Using Pan RNA-Seq Analysis to Reveal the Ubiquitous Existence of 5' and 3' End Small RNAs.Front Genet. 2019 Feb 14;10:105. doi: 10.3389/fgene.2019.00105. eCollection 2019.
• [3467] Lower DSC1 expression is related to the poor differentiation and prognosis of head and neck squamous cell carcinoma (HNSCC).J Cancer Res Clin Oncol. 2016 Dec;142(12):2461-2468. doi: 10.1007/s00432-016-2233-1. Epub 2016 Sep 6.
• [3468] Association of DSC3 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis.PLoS One. 2014 Mar 24;9(3):e92815. doi: 10.1371/journal.pone.0092815. eCollection 2014.
• [3469] Overexpression of cohesion establishment factor DSCC1 through E2F in colorectal cancer.PLoS One. 2014 Jan 17;9(1):e85750. doi: 10.1371/journal.pone.0085750. eCollection 2014.
• [3470] DSE regulates the malignant characters of hepatocellular carcinoma cells by modulating CCL5/CCR1 axis.Am J Cancer Res. 2019 Feb 1;9(2):347-362. eCollection 2019.
• [3471] Desmoglein 1 Regulates Invadopodia by Suppressing EGFR/Erk Signaling in an Erbin-Dependent Manner.Mol Cancer Res. 2019 May;17(5):1195-1206. doi: 10.1158/1541-7786.MCR-18-0048. Epub 2019 Jan 17.
• [3472] Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/-catenin signaling pathway in human lung cancer.Carcinogenesis. 2012 Oct;33(10):1863-70. doi: 10.1093/carcin/bgs226. Epub 2012 Jul 12.
• [3473] Mucus and adiponectin deficiency: role in chronic inflammation-induced colon cancer.Int J Colorectal Dis. 2013 Sep;28(9):1267-79. doi: 10.1007/s00384-013-1664-2. Epub 2013 Mar 9.
• [3474] The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme.Oncotarget. 2017 Nov 18;8(67):110743-110755. doi: 10.18632/oncotarget.22500. eCollection 2017 Dec 19.
• [3475] Guidelines for the Detection of NADPH Oxidases by Immunoblot and RT-qPCR.Methods Mol Biol. 2019;1982:191-229. doi: 10.1007/978-1-4939-9424-3_12.
• [3476] DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma.Br J Cancer. 2010 Jul 13;103(2):265-74. doi: 10.1038/sj.bjc.6605711. Epub 2010 Jun 15.
• [3477] Dysfunction of Poly (ADP-Ribose) Glycohydrolase Induces a Synthetic Lethal Effect in Dual Specificity Phosphatase 22-Deficient Lung Cancer Cells.Cancer Res. 2019 Aug 1;79(15):3851-3861. doi: 10.1158/0008-5472.CAN-18-1037. Epub 2019 May 29.
• [3478] VHZ is a novel centrosomal phosphatase associated with cell growth and human primary cancers.Mol Cancer. 2010 May 28;9:128. doi: 10.1186/1476-4598-9-128.
• [3479] Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma.Oncogene. 2010 Sep 2;29(35):4938-46. doi: 10.1038/onc.2010.244. Epub 2010 Jun 21.
• [3480] Scattered DUSP28 is a novel biomarker responsible for aggravating malignancy via the autocrine and paracrine signaling in metastatic pancreatic cancer.Cancer Lett. 2019 Aug 1;456:1-12. doi: 10.1016/j.canlet.2019.03.006. Epub 2019 Mar 19.
• [3481] Overexpression of the dual-specificity MAPK phosphatase PYST2 in acute leukemia.Cancer Lett. 2003 Sep 25;199(2):185-92. doi: 10.1016/s0304-3835(03)00352-5.
• [3482] Different behaviour of DVL1, DVL2, DVL3 in astrocytoma malignancy grades and their association to TCF1 and LEF1 upregulation.J Cell Mol Med. 2019 Jan;23(1):641-655. doi: 10.1111/jcmm.13969. Epub 2018 Nov 23.
• [3483] Computational prediction and analysis of deleterious cancer associated missense mutations in DYNC1H1.Mol Cell Probes. 2017 Aug;34:21-29. doi: 10.1016/j.mcp.2017.04.004. Epub 2017 Apr 26.
• [3484] Retrospective Analysis of Atypical Glands Suspicious for Carcinoma in Transurethral Resection of Prostate.Appl Immunohistochem Mol Morphol. 2018 Mar;26(3):186-191. doi: 10.1097/PAI.0000000000000407.
• [3485] MYCN-induced E2F5 promotes neuroblastoma cell proliferation through regulating cell cycle progression.Biochem Biophys Res Commun. 2019 Mar 26;511(1):35-40. doi: 10.1016/j.bbrc.2019.01.087. Epub 2019 Feb 11.
• [3486] Atypical E2Fs inhibit tumor angiogenesis.Oncogene. 2018 Jan 11;37(2):271-276. doi: 10.1038/onc.2017.336. Epub 2017 Sep 18.
• [3487] Integrated analysis of 10 lymphoma datasets identifies E2F8 as a key regulator in Burkitt's lymphoma and mantle cell lymphoma.Am J Transl Res. 2019 Jul 15;11(7):4382-4396. eCollection 2019.
• [3488] Identification of a genetic interaction between the tumor suppressor EAF2 and the retinoblastoma protein (Rb) signaling pathway in C. elegans and prostate cancer cells.Biochem Biophys Res Commun. 2014 May 2;447(2):292-8. doi: 10.1016/j.bbrc.2014.03.138. Epub 2014 Apr 12.
• [3489] Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis.Redox Biol. 2018 Apr;14:637-644. doi: 10.1016/j.redox.2017.11.011. Epub 2017 Nov 13.
• [3490] Apples to origins: identifying brain tumor stem cell genes by comparing transcriptomes of normal and cancer stem cells.Cancer Discov. 2012 Jun;2(6):492-4. doi: 10.1158/2159-8290.CD-12-0182.
• [3491] Values of mutations of K-ras oncogene at codon 12 in detection of pancreatic cancer: 15-year experience.World J Gastroenterol. 2004 Feb 15;10(4):471-5. doi: 10.3748/wjg.v10.i4.471.
• [3492] The health behaviour status of teenage and young adult cancer patients and survivors in the United Kingdom.Support Care Cancer. 2020 Feb;28(2):767-777. doi: 10.1007/s00520-019-04719-y. Epub 2019 May 29.
• [3493] Extracellular matrix protein 1 (ECM1) is associated with carcinogenesis potential of human bladder cancer.Onco Targets Ther. 2019 Feb 20;12:1423-1432. doi: 10.2147/OTT.S191321. eCollection 2019.
• [3494] Clinicopathological and prognostic significance of epithelial cell transforming sequence 2 expression in cancers: a systematic review and meta-analysis.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):4139-4148. doi: 10.1080/21691401.2019.1687503.
• [3495] Del-1 overexpression potentiates lung cancer cell proliferation and invasion.Biochem Biophys Res Commun. 2015 Dec 4-11;468(1-2):92-8. doi: 10.1016/j.bbrc.2015.10.159. Epub 2015 Nov 9.
• [3496] Epigenetic silencing of endothelin-3 in colorectal cancer.Int J Immunopathol Pharmacol. 2016 Jun;29(2):333-40. doi: 10.1177/0394632015600371. Epub 2015 Dec 18.
• [3497] EEF1D overexpression promotes osteosarcoma cell proliferation by facilitating Akt-mTOR and Akt-bad signaling.J Exp Clin Cancer Res. 2018 Mar 6;37(1):50. doi: 10.1186/s13046-018-0715-5.
• [3498] Identification of Potential Anticancer Protein Targets in Cytotoxicity Mediated by Tropical Medicinal Fern Extracts.Pharmacogn Mag. 2018 Apr-Jun;14(54):227-230. doi: 10.4103/pm.pm_282_17. Epub 2018 Apr 10.
• [3499] The translation elongation factor eEF2 is a novel tumorassociated antigen overexpressed in various types of cancers.Int J Oncol. 2014 May;44(5):1461-9. doi: 10.3892/ijo.2014.2318. Epub 2014 Mar 4.
• [3500] FBLN-4 and BCRP genes as two prognostic markers are downregulated in breast cancer tissue.Cancer Biomark. 2017;19(1):51-55. doi: 10.3233/CBM-160335.
• [3501] Swiprosin-1: Its Expression and Diverse Biological Functions.J Cell Biochem. 2018 Jan;119(1):150-156. doi: 10.1002/jcb.26199. Epub 2017 Jun 30.
• [3502] A naturally occurring cancer with molecular connectivity to human diseases.Cell Cycle. 2008 Aug;7(15):2286-9. doi: 10.4161/cc.6366. Epub 2008 May 29.
• [3503] Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancer.Oncotarget. 2016 Sep 13;7(37):60332-60347. doi: 10.18632/oncotarget.11219.
• [3504] The cyclooxygenase-2 inhibitor NS-398 inhibits proliferation and induces apoptosis in human osteosarcoma cells via downregulation of the survivin pathway.Oncol Rep. 2012 Nov;28(5):1693-700. doi: 10.3892/or.2012.1992. Epub 2012 Aug 24.
• [3505] Down-regulation of EGFL8: a novel biomarker for advanced gastric cancer.Anticancer Res. 2011 Oct;31(10):3377-80.
• [3506] Egr2-independent, Klf1-mediated induction of PD-L1 in CD4(+) T cells.Sci Rep. 2018 May 4;8(1):7021. doi: 10.1038/s41598-018-25302-1.
• [3507] NF-B-driven improvement of EHD1 contributes to erlotinib resistance in EGFR-mutant lung cancers.Cell Death Dis. 2018 Apr 1;9(4):418. doi: 10.1038/s41419-018-0447-7.
• [3508] Effect of EH domain containing protein 2 on the biological behavior of clear cell renal cell carcinoma.Hum Exp Toxicol. 2019 Aug;38(8):927-937. doi: 10.1177/0960327119842241. Epub 2019 Apr 17.
• [3509] Retrospective Analysis of Cancer-Associated Myositis Patients over the Past 3 Decades in a Hungarian Myositis Cohort.Pathol Oncol Res. 2020 Jul;26(3):1749-1755. doi: 10.1007/s12253-019-00756-4. Epub 2019 Oct 23.
• [3510] ESE3 Inhibits Pancreatic Cancer Metastasis by Upregulating E-Cadherin.Cancer Res. 2017 Feb 15;77(4):874-885. doi: 10.1158/0008-5472.CAN-16-2170. Epub 2016 Dec 6.
• [3511] Upregulation of EID3 sensitizes breast cancer cells to ionizing radiation-induced cellular senescence.Biomed Pharmacother. 2018 Nov;107:606-614. doi: 10.1016/j.biopha.2018.08.022. Epub 2018 Aug 14.
• [3512] eIF1A residues implicated in cancer stabilize translation preinitiation complexes and favor suboptimal initiation sites in yeast.Elife. 2017 Dec 5;6:e31250. doi: 10.7554/eLife.31250.
• [3513] High EIF2B5 mRNA expression and its prognostic significance in liver cancer: a study based on the TCGA and GEO database.Cancer Manag Res. 2018 Nov 20;10:6003-6014. doi: 10.2147/CMAR.S185459. eCollection 2018.
• [3514] Translational control: the cancer connection.Int J Biochem Cell Biol. 1999 Jan;31(1):1-23. doi: 10.1016/s1357-2725(98)00127-7.
• [3515] The Biological Roles of Translation Initiation Factor 3b.Int J Biol Sci. 2018 Sep 7;14(12):1630-1635. doi: 10.7150/ijbs.26932. eCollection 2018.
• [3516] The Bad, the Good and eIF3e/INT6.Front Biosci (Landmark Ed). 2017 Jan 1;22(1):1-20. doi: 10.2741/4469.
• [3517] Cancer Targeted Gene Therapy for Inhibition of Melanoma Lung Metastasis with eIF3i shRNA Loaded Liposomes.Mol Pharm. 2020 Jan 6;17(1):229-238. doi: 10.1021/acs.molpharmaceut.9b00943. Epub 2019 Dec 10.
• [3518] Association between eIF3 polymorphism and severe toxicity caused by platinum-based chemotherapy in non-small cell lung cancer patients.Br J Clin Pharmacol. 2013 Feb;75(2):516-23. doi: 10.1111/j.1365-2125.2012.04379.x.
• [3519] Anabolic and Pro-metabolic Functions of CREB-CRTC in Skeletal Muscle: Advantages and Obstacles for Type 2 Diabetes and Cancer Cachexia.Front Endocrinol (Lausanne). 2019 Aug 2;10:535. doi: 10.3389/fendo.2019.00535. eCollection 2019.
• [3520] eIF3m expression influences the regulation of tumorigenesis-related genes in human colon cancer.Oncogene. 2011 Jan 27;30(4):398-409. doi: 10.1038/onc.2010.422. Epub 2010 Sep 13.
• [3521] eIF4A Inhibitors Suppress Cell-Cycle Feedback Response and Acquired Resistance to CDK4/6 Inhibition in Cancer.Mol Cancer Ther. 2019 Nov;18(11):2158-2170. doi: 10.1158/1535-7163.MCT-19-0162. Epub 2019 Aug 8.
• [3522] Translating from cancer to the brain: regulation of protein synthesis by eIF4F.Learn Mem. 2019 Aug 15;26(9):332-342. doi: 10.1101/lm.050047.119. Print 2019 Sep.
• [3523] Eukaryotic Translation Initiation Factor 4 Gamma 1 (EIF4G1): a target for cancer therapeutic intervention?.Cancer Cell Int. 2019 Aug 31;19:224. doi: 10.1186/s12935-019-0947-2. eCollection 2019.
• [3524] Key contribution of eIF4H-mediated translational control in tumor promotion.Oncotarget. 2015 Nov 24;6(37):39924-40. doi: 10.18632/oncotarget.5442.
• [3525] Increased HE4 mRNA Expression Correlates with High Level Of eIF3a mRNA And Better Survival in Women with Epithelial Ovarian Cancer.J Cancer. 2018 Feb 28;9(6):1088-1095. doi: 10.7150/jca.23639. eCollection 2018.
• [3526] Polymorphisms in the HPC/ELAC-2 and alpha 1-antitrypsin genes that correlate with human diseases in a North Indian population.Mol Biol Rep. 2011 Jun;38(5):3137-44. doi: 10.1007/s11033-010-9984-6. Epub 2010 Feb 2.
• [3527] Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.Biomed Pharmacother. 2020 Jan;121:109647. doi: 10.1016/j.biopha.2019.109647. Epub 2019 Nov 13.
• [3528] Protein expression of the Ets transcription factor Elf-1 in breast cancer cells is negatively correlated with histological grading, but not with clinical outcome.Oncol Rep. 2011 Nov;26(5):1121-5. doi: 10.3892/or.2011.1409. Epub 2011 Aug 2.
• [3529] ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1.Cancer Biol Ther. 2019;20(1):90-100. doi: 10.1080/15384047.2018.1507256. Epub 2018 Aug 27.
• [3530] A new Elf5(Cre)(ERT)(2-)(GFP) BAC transgenic mouse model for tracing Elf5 cell lineages in adult tissues.FEBS Lett. 2019 May;593(10):1030-1039. doi: 10.1002/1873-3468.13390. Epub 2019 May 1.
• [3531] Suppression of Elk1 inhibits thyroid cancer progression by mediating PTEN expression.Oncol Rep. 2018 Sep;40(3):1769-1776. doi: 10.3892/or.2018.6554. Epub 2018 Jul 10.
• [3532] Silencing ELMO3 Inhibits the Growth, Invasion, and Metastasis of Gastric Cancer.Biomed Res Int. 2018 Sep 24;2018:3764032. doi: 10.1155/2018/3764032. eCollection 2018.
• [3533] The Expression of HSD17B12 Is Associated with COX-2 Expression and Is Increased in High-Grade Epithelial Ovarian Cancer.Oncology. 2018;94(4):233-242. doi: 10.1159/000485624. Epub 2018 Jan 12.
• [3534] Embigin Promotes Prostate Cancer Progression by S100A4-Dependent and-Independent Mechanisms.Cancers (Basel). 2018 Jul 23;10(7):239. doi: 10.3390/cancers10070239.
• [3535] hHSS1: a novel secreted factor and suppressor of glioma growth located at chromosome 19q13.33.J Neurooncol. 2011 Apr;102(2):197-211. doi: 10.1007/s11060-010-0314-6. Epub 2010 Jul 31.
• [3536] Emerin Deregulation Links Nuclear Shape Instability to Metastatic Potential.Cancer Res. 2018 Nov 1;78(21):6086-6097. doi: 10.1158/0008-5472.CAN-18-0608. Epub 2018 Aug 28.
• [3537] Rapid and accurate structure-based therapeutic peptide design using GPU accelerated thermodynamic integration.Proteins. 2019 Mar;87(3):236-244. doi: 10.1002/prot.25644. Epub 2019 Jan 4.
• [3538] EMP1, EMP 2, and EMP3 as novel therapeutic targets in human cancer.Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):199-211. doi: 10.1016/j.bbcan.2017.04.004. Epub 2017 Apr 10.
• [3539] Comprehensive study of tumour single nucleotide polymorphism array data reveals significant driver aberrations and disrupted signalling pathways in human hepatocellular cancer.IET Syst Biol. 2014 Apr;8(2):24-32. doi: 10.1049/iet-syb.2013.0027.
• [3540] Effects of Chronic and Intermittent Calorie Restriction on Adropin Levels in Breast Cancer.Nutr Cancer. 2017 Oct;69(7):1003-1010. doi: 10.1080/01635581.2017.1359314. Epub 2017 Sep 18.
• [3541] RecQL4 helicase amplification is involved in human breast tumorigenesis.PLoS One. 2013 Jul 22;8(7):e69600. doi: 10.1371/journal.pone.0069600. Print 2013.
• [3542] Cancer type-specific tNOX isoforms: A putative family of redox protein splice variants with cancer diagnostic and prognostic potential.Biofactors. 2008;34(3):201-7. doi: 10.3233/BIO-2009-1073.
• [3543] ENTPD5-mediated modulation of ATP results in altered metabolism and decreased survival in gliomablastoma multiforme.Tumour Biol. 2012 Dec;33(6):2411-21. doi: 10.1007/s13277-012-0505-1. Epub 2012 Sep 20.
• [3544] Reciprocal regulation of BMF and BIRC5 (Survivin) linked to Eomes overexpression in colorectal cancer.Cancer Lett. 2016 Oct 28;381(2):341-8. doi: 10.1016/j.canlet.2016.08.008. Epub 2016 Aug 15.
• [3545] miR-452 promotes the development of gastric cancer via targeting EPB41L3.Pathol Res Pract. 2020 Jan;216(1):152725. doi: 10.1016/j.prp.2019.152725. Epub 2019 Oct 31.
• [3546] Clinical implications of the influence of Ehm2 on the aggressiveness of breast cancer cells through regulation of matrix metalloproteinase-9 expression.Mol Cancer Res. 2010 Nov;8(11):1501-12. doi: 10.1158/1541-7786.MCR-10-0186. Epub 2010 Oct 5.
• [3547] Ectodomain shedding of the EGF-receptor ligand epigen is mediated by ADAM17.FEBS Lett. 2007 Jan 9;581(1):41-4. doi: 10.1016/j.febslet.2006.11.074. Epub 2006 Dec 6.
• [3548] Juxtacrine Signaling Inhibits Antitumor Immunity by Upregulating PD-L1 Expression.Cancer Res. 2018 Jul 15;78(14):3761-3768. doi: 10.1158/0008-5472.CAN-18-0040. Epub 2018 May 22.
• [3549] Laforin confers cancer resistance to energy deprivation-induced apoptosis.Cancer Res. 2008 Jun 1;68(11):4039-44. doi: 10.1158/0008-5472.CAN-07-6314.
• [3550] Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling.J Clin Invest. 2012 Dec;122(12):4424-38. doi: 10.1172/JCI64537. Epub 2012 Nov 26.
• [3551] Novel Nuclear Partnering Role of EPS8 With FOXM1 in Regulating Cell Proliferation.Front Oncol. 2019 Mar 19;9:154. doi: 10.3389/fonc.2019.00154. eCollection 2019.
• [3552] Effect of intrathecal morphine and epidural analgesia on postoperative recovery after abdominal surgery for gynecologic malignancy: an open-label randomised trial.BMJ Open. 2019 Mar 4;9(3):e024484. doi: 10.1136/bmjopen-2018-024484.
• [3553] Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer.Science. 2014 May 9;344(6184):641-5. doi: 10.1126/science.1251102.
• [3554] XPB and XPD helicases in TFIIH orchestrate DNA duplex opening and damage verification to coordinate repair with transcription and cell cycle via CAK kinase.DNA Repair (Amst). 2011 Jul 15;10(7):697-713. doi: 10.1016/j.dnarep.2011.04.028. Epub 2011 May 14.
• [3555] ERCC6L promotes cell growth and invasion in human colorectal cancer.Oncol Lett. 2019 Jul;18(1):237-246. doi: 10.3892/ol.2019.10297. Epub 2019 Apr 30.
• [3556] Endoplasmic reticulum factor ERLIN2 regulates cytosolic lipid content in cancer cells.Biochem J. 2012 Sep 15;446(3):415-25. doi: 10.1042/BJ20112050.
• [3557] Targeting the functional interplay between endoplasmic reticulum oxidoreductin-1 and protein disulfide isomerase suppresses the progression of cervical cancer.EBioMedicine. 2019 Mar;41:408-419. doi: 10.1016/j.ebiom.2019.02.041. Epub 2019 Feb 27.
• [3558] MEF2C promotes gefitinib resistance in hepatic cancer cells through regulating MIG6 transcription.Tumori. 2018 Jun;104(3):221-231. doi: 10.1177/0300891618765555. Epub 2018 Apr 11.
• [3559] HDAC1-mSin3a-NCOR1, Dnmt3b-HDAC1-Egr1 and Dnmt1-PCNA-UHRF1-G9a regulate the NY-ESO1 gene expression.Mol Oncol. 2013 Jun;7(3):452-63. doi: 10.1016/j.molonc.2012.11.004. Epub 2012 Dec 21.
• [3560] Controllable release of nitric oxide and doxorubicin from engineered nanospheres for synergistic tumor therapy.Acta Biomater. 2017 Jul 15;57:498-510. doi: 10.1016/j.actbio.2017.05.019. Epub 2017 May 9.
• [3561] Combining 1,3-Ditriazolylbenzene and Quinoline to Discover a New G-Quadruplex-Interactive Small Molecule Active against Cancer Stem-Like Cells.ChemMedChem. 2019 Jul 17;14(14):1325-1328. doi: 10.1002/cmdc.201900243. Epub 2019 Jun 14.
• [3562] Paired-like homeoprotein ESXR1 acts as a sequence-specific transcriptional repressor of the human K-ras gene.Oncogene. 2005 Sep 1;24(38):5878-87. doi: 10.1038/sj.onc.1208736.
• [3563] The oncogenic lung cancer fusion kinase CD74-ROS activates a novel invasiveness pathway through E-Syt1 phosphorylation.Cancer Res. 2012 Aug 1;72(15):3764-74. doi: 10.1158/0008-5472.CAN-11-3990. Epub 2012 Jun 1.
• [3564] Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients.Breast Cancer Res Treat. 2018 Jan;167(1):249-256. doi: 10.1007/s10549-017-4497-9. Epub 2017 Sep 14.
• [3565] A novel PTPRZ1-ETV1 fusion in gliomas.Brain Pathol. 2020 Mar;30(2):226-234. doi: 10.1111/bpa.12776. Epub 2019 Aug 27.
• [3566] ETV1 induces epithelial to mesenchymal transition in human gastric cancer cells through the upregulation of Snail expression.Oncol Rep. 2013 Dec;30(6):2859-63. doi: 10.3892/or.2013.2776. Epub 2013 Oct 2.
• [3567] ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancer. Sci Adv. 2018 Sep 12;4(9):eaar3938.
• [3568] EVA1A inhibits GBM cell proliferation by inducing autophagy and apoptosis.Exp Cell Res. 2017 Mar 1;352(1):130-138. doi: 10.1016/j.yexcr.2017.02.003. Epub 2017 Feb 6.
• [3569] Characterization of the CDR3 structure of the V21 T cell clone in patients with P210(BCR-ABL)-positive chronic myeloid leukemia and B-cell acute lymphoblastic leukemia.Hum Immunol. 2011 Oct;72(10):798-804. doi: 10.1016/j.humimm.2011.06.015. Epub 2011 Jul 20.
• [3570] Contribution of EVX1 in Aggressiveness of Esophageal Squamous Cell Carcinoma.Pathol Oncol Res. 2016 Apr;22(2):341-7. doi: 10.1007/s12253-015-0005-x. Epub 2015 Nov 9.
• [3571] Detecting episomal or integrated human papillomavirus 16 DNA using an exonuclease V-qPCR-based assay.Virology. 2019 Nov;537:149-156. doi: 10.1016/j.virol.2019.08.021. Epub 2019 Aug 22.
• [3572] Sec3 knockdown inhibits TGF- induced epithelial-mesenchymal transition through the down-regulation of Akt phosphorylation in A549 cells.Biochem Biophys Res Commun. 2019 Nov 5;519(2):253-260. doi: 10.1016/j.bbrc.2019.08.145. Epub 2019 Sep 5.
• [3573] RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival.Cell. 2006 Oct 6;127(1):157-70. doi: 10.1016/j.cell.2006.08.034.
• [3574] Exo70 isoform switching upon epithelial-mesenchymal transition mediates cancer cell invasion.Dev Cell. 2013 Dec 9;27(5):560-73. doi: 10.1016/j.devcel.2013.10.020.
• [3575] FA2H Exhibits Tumor Suppressive Roles on Breast Cancers via Cancer Stemness Control.Front Oncol. 2019 Oct 24;9:1089. doi: 10.3389/fonc.2019.01089. eCollection 2019.
• [3576] Fatty acid binding protein 6 is overexpressed in colorectal cancer.Clin Cancer Res. 2006 Sep 1;12(17):5090-5. doi: 10.1158/1078-0432.CCR-05-2045.
• [3577] Metabolic role of fatty acid binding protein 7 in mediating triple-negative breast cancer cell death via PPAR- signaling.J Lipid Res. 2019 Nov;60(11):1807-1817. doi: 10.1194/jlr.M092379. Epub 2019 Sep 4.
• [3578] FADD in Cancer: Mechanisms of Altered Expression and Function, and Clinical Implications.Cancers (Basel). 2019 Sep 29;11(10):1462. doi: 10.3390/cancers11101462.
• [3579] Dendrimer-Based Lipid Nanoparticles Deliver Therapeutic FAH mRNA to Normalize Liver Function and Extend Survival in a Mouse Model of Hepatorenal Tyrosinemia Type I.Adv Mater. 2018 Dec;30(52):e1805308. doi: 10.1002/adma.201805308. Epub 2018 Oct 25.
• [3580] FAM107B is regulated by S100A4 and mediates the effect of S100A4 on the proliferation and migration of MGC803 gastric cancer cells.Cell Biol Int. 2017 Oct;41(10):1103-1109. doi: 10.1002/cbin.10816. Epub 2017 Aug 29.
• [3581] Identification of genomic alterations in oesophageal squamous cell cancer.Nature. 2014 May 1;509(7498):91-5. doi: 10.1038/nature13176. Epub 2014 Mar 16.
• [3582] Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer.Oncotarget. 2017 May 9;8(19):31494-31508. doi: 10.18632/oncotarget.16357.
• [3583] Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastoma.Mol Cancer Ther. 2009 Aug;8(8):2478-89. doi: 10.1158/1535-7163.MCT-08-1132. Epub 2009 Aug 11.
• [3584] TCRP1 promotes NIH/3T3 cell transformation by over-activating PDK1 and AKT1.Oncogenesis. 2017 Apr 24;6(4):e323. doi: 10.1038/oncsis.2017.18.
• [3585] Muscle redox disturbances and oxidative stress as pathomechanisms and therapeutic targets in early-onset myopathies.Semin Cell Dev Biol. 2017 Apr;64:213-223. doi: 10.1016/j.semcdb.2016.08.003. Epub 2016 Aug 12.
• [3586] Loss of the novel mitochondrial protein FAM210B promotes metastasis via PDK4-dependent metabolic reprogramming.Cell Death Dis. 2017 Jun 8;8(6):e2870. doi: 10.1038/cddis.2017.273.
• [3587] Overexpression of FAM3C is associated with poor prognosis in oral squamous cell carcinoma.Pathol Res Pract. 2019 Apr;215(4):772-778. doi: 10.1016/j.prp.2019.01.019. Epub 2019 Jan 14.
• [3588] Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction.J Biol Chem. 2018 Aug 10;293(32):12542-12562. doi: 10.1074/jbc.RA118.002341. Epub 2018 Jun 15.
• [3589] FAM83A signaling induces epithelial-mesenchymal transition by the PI3K/AKT/Snail pathway in NSCLC.Aging (Albany NY). 2019 Aug 24;11(16):6069-6088. doi: 10.18632/aging.102163. Epub 2019 Aug 24.
• [3590] Family with Sequence Similarity 83 Member H Promotes the Viability and Metastasis of Cervical Cancer Cells and Indicates a Poor Prognosis.Yonsei Med J. 2019 Jul;60(7):611-618. doi: 10.3349/ymj.2019.60.7.611.
• [3591] Secondary acute leukemia and myelodysplastic syndrome with 11q23 abnormalities. EU Concerted Action 11q23 Workshop.Leukemia. 1998 May;12(5):840-4. doi: 10.1038/sj.leu.2401021.
• [3592] Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings.J Cancer Res Clin Oncol. 2018 Dec;144(12):2495-2513. doi: 10.1007/s00432-018-2763-9. Epub 2018 Oct 10.
• [3593] Areca nut induces miR-23a and inhibits repair of DNA double-strand breaks by targeting FANCG.Toxicol Sci. 2011 Oct;123(2):480-90. doi: 10.1093/toxsci/kfr182. Epub 2011 Jul 12.
• [3594] Biallelic truncating FANCM mutations cause early-onset cancer but not Fanconi anemia.Genet Med. 2018 Apr;20(4):458-463. doi: 10.1038/gim.2017.124. Epub 2017 Aug 24.
• [3595] FARP1 Facilitates Cell Proliferation Through Modulating MAPK Signaling Pathway in Cutaneous Melanoma.Am J Dermatopathol. 2019 Dec;41(12):908-913. doi: 10.1097/DAD.0000000000001426.
• [3596] Inhibition of Cancer Stem-Like Phenotype by Curcumin and Deguelin in CAL-62 Anaplastic Thyroid Cancer Cells.Anticancer Agents Med Chem. 2019;19(15):1887-1898. doi: 10.2174/1871520619666191004144025.
• [3597] Fibulin-5 downregulates Ki-67 and inhibits proliferation and invasion of breast cancer cells.Int J Oncol. 2016 Apr;48(4):1447-56. doi: 10.3892/ijo.2016.3394. Epub 2016 Feb 17.
• [3598] Fibulin-7 is overexpressed in glioblastomas and modulates glioblastoma neovascularization through interaction with angiopoietin-1.Int J Cancer. 2019 Oct 15;145(8):2157-2169. doi: 10.1002/ijc.32306. Epub 2019 Apr 15.
• [3599] Shift from stochastic to spatially-ordered expression of serine-glycine synthesis enzymes in 3D microtumors.Sci Rep. 2018 Jun 20;8(1):9388. doi: 10.1038/s41598-018-27266-8.
• [3600] Opisthorchis viverrini Draft Genome - Biomedical Implications and Future Avenues.Adv Parasitol. 2018;101:125-148. doi: 10.1016/bs.apar.2018.05.005. Epub 2018 Jun 6.
• [3601] Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression.Sci Rep. 2017 Mar 6;7:43864. doi: 10.1038/srep43864.
• [3602] F-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation.Blood. 2012 Mar 29;119(13):3132-41. doi: 10.1182/blood-2011-06-358911. Epub 2012 Feb 8.
• [3603] F-box protein FBXO16 functions as a tumor suppressor by attenuating nuclear -catenin function.J Pathol. 2019 Jul;248(3):266-279. doi: 10.1002/path.5252. Epub 2019 Mar 8.
• [3604] FBXO17 promotes cell proliferation through activation of Akt in lung adenocarcinoma cells.Respir Res. 2018 Oct 25;19(1):206. doi: 10.1186/s12931-018-0910-0.
• [3605] The role of F-box only protein 31 in cancer.Oncol Lett. 2018 Apr;15(4):4047-4052. doi: 10.3892/ol.2018.7816. Epub 2018 Jan 17.
• [3606] A Chalcone from Ashitaba (Angelica keiskei) Stimulates Myoblast Differentiation and Inhibits Dexamethasone-Induced Muscle Atrophy.Nutrients. 2019 Oct 10;11(10):2419. doi: 10.3390/nu11102419.
• [3607] Low Expression of FBXO45 Is Associated with Gastric Cancer Progression and Poor Prognosis.Anticancer Res. 2017 Jan;37(1):191-196. doi: 10.21873/anticanres.11305.
• [3608] The F box protein Fbx6 regulates Chk1 stability and cellular sensitivity to replication stress.Mol Cell. 2009 Aug 28;35(4):442-53. doi: 10.1016/j.molcel.2009.06.030.
• [3609] Role for ERK1/2-dependent activation of FCHSD2 in cancer cell-selective regulation of clathrin-mediated endocytosis.Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):E9570-E9579. doi: 10.1073/pnas.1810209115. Epub 2018 Sep 24.
• [3610] Ficolin-2 and ficolin-3 in women with malignant and benign ovarian tumours.Cancer Immunol Immunother. 2013 Aug;62(8):1411-9. doi: 10.1007/s00262-013-1445-3. Epub 2013 Jun 7.
• [3611] Interactions of ficolin-3 with ovarian cancer cells.Immunobiology. 2019 Mar;224(2):316-324. doi: 10.1016/j.imbio.2019.01.002. Epub 2019 Jan 30.
• [3612] IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy.Immunity. 2001 Mar;14(3):277-89. doi: 10.1016/s1074-7613(01)00109-1.
• [3613] Membrane-Proximal Epitope Facilitates Efficient T Cell Synapse Formation by Anti-FcRH5/CD3 and Is a Requirement for Myeloma Cell Killing.Cancer Cell. 2017 Mar 13;31(3):383-395. doi: 10.1016/j.ccell.2017.02.001. Epub 2017 Mar 2.
• [3614] An unusual Fc receptor-related protein expressed in human centroblasts.Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3776-81. doi: 10.1073/pnas.022042699. Epub 2002 Mar 12.
• [3615] MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer.Oncogene. 2020 Jan;39(1):234-247. doi: 10.1038/s41388-019-0986-0. Epub 2019 Aug 30.
• [3616] Kindlin-1 Promotes Pulmonary Breast Cancer Metastasis.Cancer Res. 2018 Mar 15;78(6):1484-1496. doi: 10.1158/0008-5472.CAN-17-1518. Epub 2018 Jan 12.
• [3617] Mammalian plasma fetuin-B is a selective inhibitor of ovastacin and meprin metalloproteinases.Sci Rep. 2019 Jan 24;9(1):546. doi: 10.1038/s41598-018-37024-5.
• [3618] In silico characterization of LZTS3, a potential tumor suppressor.Oncol Rep. 2005 Aug;14(2):547-51.
• [3619] Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.Medicine (Baltimore). 2019 Jun;98(24):e15982. doi: 10.1097/MD.0000000000015982.
• [3620] Identification and Validation of Fibroblast Growth Factor 12 Gene as a Novel Potential Biomarker in Esophageal Cancer Using Cancer Genomic Datasets.OMICS. 2017 Oct;21(10):616-631. doi: 10.1089/omi.2017.0116.
• [3621] Analyses of publicly available genomics resources define FGF-2-expressing bladder carcinomas as EMT-prone, proliferative tumors with low mutation rates and high expression of CTLA-4, PD-1 and PD-L1.Signal Transduct Target Ther. 2017;2:16045-. doi: 10.1038/sigtrans.2016.45. Epub 2017 Mar 17.
• [3622] FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development.EMBO J. 2005 Jan 12;24(1):73-84. doi: 10.1038/sj.emboj.7600460. Epub 2004 Dec 9.
• [3623] Downregulation of fibroblast growth factor 5 inhibits cell growth and invasion of human nonsmall-cell lung cancer cells.J Cell Biochem. 2019 May;120(5):8238-8246. doi: 10.1002/jcb.28107. Epub 2018 Dec 5.
• [3624] Pipeline for large-scale microdroplet bisulfite PCR-based sequencing allows the tracking of hepitype evolution in tumors.PLoS One. 2011;6(7):e21332. doi: 10.1371/journal.pone.0021332. Epub 2011 Jul 5.
• [3625] FGF9 inhibition by a novel binding peptide has efficacy in gastric and bladder cancer per se and reverses resistance to cisplatin.Pharmacol Res. 2020 Feb;152:104575. doi: 10.1016/j.phrs.2019.104575. Epub 2019 Dec 2.
• [3626] MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1).J Biol Chem. 2011 Jan 7;286(1):420-8. doi: 10.1074/jbc.M110.170852. Epub 2010 Nov 2.
• [3627] Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3.Cell. 2019 Jan 10;176(1-2):334-347.e12. doi: 10.1016/j.cell.2018.11.010. Epub 2018 Dec 20.
• [3628] Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.Oncotarget. 2016 Nov 22;7(47):77052-77070. doi: 10.18632/oncotarget.12784.
• [3629] An Oncogenic Role for Four-Jointed Box 1 (FJX1) in Nasopharyngeal Carcinoma.Dis Markers. 2019 May 19;2019:3857853. doi: 10.1155/2019/3857853. eCollection 2019.
• [3630] Increasing of FKBP9 can predict poor prognosis in patients with prostate cancer.Pathol Res Pract. 2020 Jan;216(1):152732. doi: 10.1016/j.prp.2019.152732. Epub 2019 Nov 11.
• [3631] A role of fukutin, a gene responsible for Fukuyama type congenital muscular dystrophy, in cancer cells: a possible role to suppress cell proliferation.Int J Exp Pathol. 2008 Oct;89(5):332-41. doi: 10.1111/j.1365-2613.2008.00599.x.
• [3632] Genetic variants of filaggrin are associated with occupational dermal exposure and blood DNA alterations in hairdressers.Sci Total Environ. 2019 Feb 25;653:45-54. doi: 10.1016/j.scitotenv.2018.10.328. Epub 2018 Oct 27.
• [3633] Filamin C, a dysregulated protein in cancer revealed by label-free quantitative proteomic analyses of human gastric cancer cells.Oncotarget. 2015 Jan 20;6(2):1171-89. doi: 10.18632/oncotarget.2645.
• [3634] Clinical significance and comparison of flotillin 1 expression in left and right colon cancer.Oncol Lett. 2019 Aug;18(2):997-1004. doi: 10.3892/ol.2019.10401. Epub 2019 May 27.
• [3635] FLOT2 overexpression is associated with the progression and prognosis of human colorectal cancer.Oncol Lett. 2019 Mar;17(3):2802-2808. doi: 10.3892/ol.2019.9882. Epub 2019 Jan 2.
• [3636] Epigenetically regulated Fibronectin leucine rich transmembrane protein 2 (FLRT2) shows tumor suppressor activity in breast cancer cells.Sci Rep. 2017 Mar 21;7(1):272. doi: 10.1038/s41598-017-00424-0.
• [3637] Formin-like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer.Cancer Sci. 2015 Oct;106(10):1385-93. doi: 10.1111/cas.12768.
• [3638] High expression of FMNL3 associates with cancer cell migration, invasion, and unfavorable prognosis in tongue squamous cell carcinoma.J Oral Pathol Med. 2019 Jul;48(6):459-467. doi: 10.1111/jop.12857. Epub 2019 Apr 25.
• [3639] Wnt/-Catenin Pathway-Regulated Fibromodulin Expression Is Crucial for Breast Cancer Metastasis and Inhibited by Aspirin.Front Pharmacol. 2019 Nov 25;10:1308. doi: 10.3389/fphar.2019.01308. eCollection 2019.
• [3640] Effect of cancer/testis antigen NY-SAR-35 on the proliferation, migration and invasion of cancer cells.Oncol Lett. 2017 Feb;13(2):784-790. doi: 10.3892/ol.2016.5498. Epub 2016 Dec 14.
• [3641] MAPT (Tau) expression is a biomarker for an increased rate of survival in pediatric neuroblastoma.Cell Cycle. 2018;17(21-22):2474-2483. doi: 10.1080/15384101.2018.1542898. Epub 2018 Nov 18.
• [3642] Interplay of transcription factors STAT3, STAT1 and AP-1 mediates activity of the matrix metallo-proteinase-1 promoter in colorectal carcinoma cells.Neoplasma. 2019 May 23;66(3):357-366. doi: 10.4149/neo_2018_180731N560. Epub 2018 Dec 12.
• [3643] The ubiquitinase ZFP91 promotes tumor cell survival and confers chemoresistance through FOXA1 destabilization.Carcinogenesis. 2020 Mar 13;41(1):56-66. doi: 10.1093/carcin/bgz085.
• [3644] Upregulated forkhead-box A3 elevates the expression of forkhead-box A1 and forkhead-box A2 to promote metastasis in esophageal cancer.Oncol Lett. 2019 May;17(5):4351-4360. doi: 10.3892/ol.2019.10078. Epub 2019 Feb 26.
• [3645] LncRNA FOXD1-AS1 acts as a potential oncogenic biomarker in glioma.CNS Neurosci Ther. 2020 Jan;26(1):66-75. doi: 10.1111/cns.13152. Epub 2019 May 17.
• [3646] Downregulation of the long noncoding RNA FOXD2AS1 inhibits cell proliferation, migration and invasion in osteosarcoma.Mol Med Rep. 2019 Jul;20(1):292-302. doi: 10.3892/mmr.2019.10254. Epub 2019 May 16.
• [3647] FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway.Oncotarget. 2017 Jan 17;8(3):5048-5056. doi: 10.18632/oncotarget.13790.
• [3648] What's the FOX Got to Do with the KITten? Regulating the Lineage-Specific Transcriptional Landscape in GIST.Cancer Discov. 2018 Feb;8(2):146-149. doi: 10.1158/2159-8290.CD-17-1370.
• [3649] Forkhead box (FOX) G1 promotes hepatocellular carcinoma epithelial-Mesenchymal transition by activating Wnt signal through forming T-cell factor-4/Beta-catenin/FOXG1 complex.J Exp Clin Cancer Res. 2019 Nov 27;38(1):475. doi: 10.1186/s13046-019-1433-3.
• [3650] FOXJ1 promotes bladder cancer cell growth and regulates Warburg effect.Biochem Biophys Res Commun. 2018 Jan 1;495(1):988-994. doi: 10.1016/j.bbrc.2017.11.063. Epub 2017 Nov 10.
• [3651] -Trcp ubiquitin ligase and RSK2 kinase-mediated degradation of FOXN2 promotes tumorigenesis and radioresistance in lung cancer.Cell Death Differ. 2018 Aug;25(8):1473-1485. doi: 10.1038/s41418-017-0055-6. Epub 2018 Feb 2.
• [3652] Checkpoint suppressor 1 suppresses transcriptional activity of ER and breast cancer cell proliferation via deacetylase SIRT1.Cell Death Dis. 2018 May 1;9(5):559. doi: 10.1038/s41419-018-0629-3.
• [3653] A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma.Oncogene. 2020 Jan;39(5):1080-1097. doi: 10.1038/s41388-019-1044-7. Epub 2019 Oct 7.
• [3654] Current perspective on the regulation of FOXO4 and its role in disease progression.Cell Mol Life Sci. 2020 Feb;77(4):651-663. doi: 10.1007/s00018-019-03297-w. Epub 2019 Sep 16.
• [3655] Elucidating mechanisms of sunitinib resistance in renal cancer: an integrated pathological-molecular analysis.Oncotarget. 2017 Dec 8;9(4):4661-4674. doi: 10.18632/oncotarget.23163. eCollection 2018 Jan 12.
• [3656] Overexpression of FRAT1 is associated with malignant phenotype and poor prognosis in human gliomas.Dis Markers. 2015;2015:289750. doi: 10.1155/2015/289750. Epub 2015 Apr 2.
• [3657] FRAT1 and FRAT2, clustered in human chromosome 10q24.1 region, are up-regulated in gastric cancer.Int J Oncol. 2001 Aug;19(2):311-5. doi: 10.3892/ijo.19.2.311.
• [3658] Whole-Exome Sequencing Identifies Two Discrete Druggable Signaling Pathways in Follicular Thyroid Cancer.J Am Coll Surg. 2018 Jun;226(6):950-959.e5. doi: 10.1016/j.jamcollsurg.2018.01.059. Epub 2018 Mar 20.
• [3659] Mapping of Mcs30, a new mammary carcinoma susceptibility quantitative trait locus (QTL30) on rat chromosome 12: identification of fry as a candidate Mcs gene.PLoS One. 2013 Sep 2;8(9):e70930. doi: 10.1371/journal.pone.0070930. eCollection 2013.
• [3660] miR-1-3p suppresses proliferation of hepatocellular carcinoma through targeting SOX9.Onco Targets Ther. 2019 Mar 22;12:2149-2157. doi: 10.2147/OTT.S197326. eCollection 2019.
• [3661] FSIP1 is correlated with estrogen receptor status and poor prognosis.Mol Carcinog. 2020 Jan;59(1):126-135. doi: 10.1002/mc.23134. Epub 2019 Nov 12.
• [3662] Follistatinlike protein 1 knockdown elicits human gastric cancer cell apoptosis via a STAT6dependent pathway.Oncol Rep. 2019 Dec;42(6):2806-2813. doi: 10.3892/or.2019.7334. Epub 2019 Sep 24.
• [3663] The master regulator FUBP1: its emerging role in normal cell function and malignant development.Cell Mol Life Sci. 2019 Jan;76(2):259-281. doi: 10.1007/s00018-018-2933-6. Epub 2018 Oct 20.
• [3664] Alpha-L-fucosidase-1 is a diagnostic marker that distinguishes mucoepidermoid carcinoma from squamous cell carcinoma.Pathol Int. 2019 Feb;69(2):76-85. doi: 10.1111/pin.12764. Epub 2019 Feb 6.
• [3665] Fucosyltransferase 2 induced epithelial-mesenchymal transition via TGF-/Smad signaling pathway in lung adenocarcinaoma.Exp Cell Res. 2018 Sep 15;370(2):613-622. doi: 10.1016/j.yexcr.2018.07.026. Epub 2018 Jul 18.
• [3666] Fucosyltransferase 8 deficiency suppresses breast cancer cell migration by interference of the FAK/integrin pathway.Cancer Biomark. 2019;25(4):303-311. doi: 10.3233/CBM-190209.
• [3667] An integrated computational and experimental study uncovers FUT9 as a metabolic driver of colorectal cancer.Mol Syst Biol. 2017 Dec 1;13(12):956. doi: 10.15252/msb.20177739.
• [3668] FXR1 expression domain in Wilms tumor.J Pediatr Surg. 2019 Jun;54(6):1198-1205. doi: 10.1016/j.jpedsurg.2019.02.030. Epub 2019 Feb 28.
• [3669] Prognostic significance of sodium-potassium ATPase regulator, FXYD3, in human hepatocellular carcinoma.Oncol Lett. 2018 Mar;15(3):3024-3030. doi: 10.3892/ol.2017.7688. Epub 2017 Dec 21.
• [3670] A FXYD5/TGF?SMAD positive feedback loop drives epithelialtomesenchymal transition and promotes tumor growth and metastasis in ovarian cancer.Int J Oncol. 2020 Jan;56(1):301-314. doi: 10.3892/ijo.2019.4911. Epub 2019 Nov 13.
• [3671] FYCO1 regulates accumulation of post-mitotic midbodies by mediating LC3-dependent midbody degradation.J Cell Sci. 2017 Dec 1;130(23):4051-4062. doi: 10.1242/jcs.208983.
• [3672] Frizzled 2-induced epithelial-mesenchymal transition correlates with vasculogenic mimicry, stemness, and Hippo signaling in hepatocellular carcinoma.Cancer Sci. 2019 Apr;110(4):1169-1182. doi: 10.1111/cas.13949. Epub 2019 Mar 6.
• [3673] MicroRNA-542-3p inhibits the growth of hepatocellular carcinoma cells by targeting FZD7/Wnt signaling pathway.Biochem Biophys Res Commun. 2017 Jan 1;482(1):100-105. doi: 10.1016/j.bbrc.2016.10.136. Epub 2016 Nov 1.
• [3674] Pathogenic Epigenetic Consequences of Genetic Alterations in IDH-Wild-Type Diffuse Astrocytic Gliomas.Cancer Res. 2019 Oct 1;79(19):4814-4827. doi: 10.1158/0008-5472.CAN-19-1272. Epub 2019 Aug 20.
• [3675] A comparative analysis of KMT2D missense variants in Kabuki syndrome, cancers and the general population.J Hum Genet. 2019 Feb;64(2):161-170. doi: 10.1038/s10038-018-0536-6. Epub 2018 Nov 20.
• [3676] Inhibition of adipose triglyceride lipase (ATGL) by the putative tumor suppressor G0S2 or a small molecule inhibitor attenuates the growth of cancer cells.Oncotarget. 2015 Sep 29;6(29):28282-95. doi: 10.18632/oncotarget.5061.
• [3677] Gab3 overexpression in human glioma mediates Akt activation and tumor cell proliferation.PLoS One. 2017 Mar 14;12(3):e0173473. doi: 10.1371/journal.pone.0173473. eCollection 2017.
• [3678] Identification of Kinases and Phosphatases That Regulate ATG4B Activity by siRNA and Small Molecule Screening in Cells.Front Cell Dev Biol. 2018 Nov 1;6:148. doi: 10.3389/fcell.2018.00148. eCollection 2018.
• [3679] GABARAPL1 suppresses metastasis by counteracting PI3K/Akt pathway in prostate cancer.Oncotarget. 2017 Jan 17;8(3):4449-4459. doi: 10.18632/oncotarget.13879.
• [3680] A Hypoxia-Inducible HIF1-GAL3ST1-Sulfatide Axis Enhances ccRCC Immune Evasion via Increased Tumor Cell-Platelet Binding.Mol Cancer Res. 2019 Nov;17(11):2306-2317. doi: 10.1158/1541-7786.MCR-19-0461. Epub 2019 Aug 19.
• [3681] Treatment of cancer stem cells from human colon adenocarcinoma cell line HT-29 with resveratrol and sulindac induced mesenchymal-endothelial transition rate.Cell Tissue Res. 2019 Jun;376(3):377-388. doi: 10.1007/s00441-019-02998-9. Epub 2019 Feb 13.
• [3682] Inherited deleterious variants in GALNT12 are associated with CRC susceptibility.Hum Mutat. 2012 Jul;33(7):1056-8. doi: 10.1002/humu.22088. Epub 2012 Apr 9.
• [3683] GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma.Oncotarget. 2015 Dec 8;6(39):41916-28. doi: 10.18632/oncotarget.6019.
• [3684] miR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5.Clin Cancer Res. 2017 Sep 1;23(17):5255-5266. doi: 10.1158/1078-0432.CCR-17-0023. Epub 2017 May 22.
• [3685] High expression of GALNT7 promotes invasion and proliferation of glioma cells.Oncol Lett. 2018 Nov;16(5):6307-6314. doi: 10.3892/ol.2018.9498. Epub 2018 Sep 25.
• [3686] Genomic profile of a Li-Fraumeni-like syndrome patient with a 45,X/46,XX karyotype, presenting neither mutations in TP53 nor clinical stigmata of Turner syndrome.Cancer Genet. 2015 Jun;208(6):341-4. doi: 10.1016/j.cancergen.2015.03.004. Epub 2015 Mar 19.
• [3687] Quantitative and qualitative impairments in GATA2 and myeloid neoplasms.IUBMB Life. 2020 Jan;72(1):142-150. doi: 10.1002/iub.2188. Epub 2019 Nov 1.
• [3688] GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes.J Cell Mol Med. 2019 Apr;23(4):2536-2548. doi: 10.1111/jcmm.14144. Epub 2019 Jan 22.
• [3689] GATAD1 gene amplification promotes glioma malignancy by directly regulating CCND1 transcription.Cancer Med. 2019 Sep;8(11):5242-5253. doi: 10.1002/cam4.2405. Epub 2019 Jul 8.
• [3690] Lung adenocarcinoma-intrinsic GBE1 signaling inhibits anti-tumor immunity.Mol Cancer. 2019 Jun 20;18(1):108. doi: 10.1186/s12943-019-1027-x.
• [3691] GBP-1 acts as a tumor suppressor in colorectal cancer cells.Carcinogenesis. 2013 Jan;34(1):153-62. doi: 10.1093/carcin/bgs310. Epub 2012 Oct 6.
• [3692] Downregulated GBX2 gene suppresses proliferation, invasion and angiogenesis of breast cancer cells through inhibiting the Wnt/-catenin signaling pathway.Cancer Biomark. 2018;23(3):405-418. doi: 10.3233/CBM-181466.
• [3693] Association of the vitamin D metabolism gene GC and CYP27B1 polymorphisms with cancer susceptibility: a meta-analysis and trial sequential analysis.Biosci Rep. 2019 Sep 13;39(9):BSR20190368. doi: 10.1042/BSR20190368. Print 2019 Sep 30.
• [3694] Effect of four genes (ALDH1, NRF1, JAM and KBL) on proliferation arrest in a non-small cell bronchopulmonary cancer line.Anticancer Res. 2002 Jul-Aug;22(4):2229-35.
• [3695] p35 is required for CDK5 activation in cellular senescence.J Biol Chem. 2010 May 7;285(19):14671-80. doi: 10.1074/jbc.M109.066118. Epub 2010 Feb 24.
• [3696] I-branched carbohydrates as emerging effectors of malignant progression.Proc Natl Acad Sci U S A. 2019 Jul 9;116(28):13729-13737. doi: 10.1073/pnas.1900268116. Epub 2019 Jun 18.
• [3697] Studies of a germinal centre B-cell expressed gene, GCET2, suggest its role as a membrane associated adapter protein.Br J Haematol. 2007 Jun;137(6):578-90. doi: 10.1111/j.1365-2141.2007.06597.x. Epub 2007 May 9.
• [3698] GCSH antisense regulation determines breast cancer cells' viability.Sci Rep. 2018 Oct 18;8(1):15399. doi: 10.1038/s41598-018-33677-4.
• [3699] (18)F-FDG-PET SUV AS A PROGNOSTIC MARKER OF INCREASING SIZE IN THYROID CANCER TUMORS.Endocr Pract. 2017 Feb;23(2):182-189. doi: 10.4158/EP161390.OR. Epub 2016 Nov 16.
• [3700] Monitoring the response of urothelial precancerous lesions to Bacillus Calmette-Guerin at the proteome level in an in vivo rat model.Cancer Immunol Immunother. 2018 Jan;67(1):67-77. doi: 10.1007/s00262-017-2063-2. Epub 2017 Sep 15.
• [3701] Knockdown of ARK5 Expression Suppresses Invasion and Metastasis of Gastric Cancer.Cell Physiol Biochem. 2017;42(3):1025-1036. doi: 10.1159/000478685. Epub 2017 Jun 28.
• [3702] Growth Factor-Independent 1 Is a Tumor Suppressor Gene in Colorectal Cancer.Mol Cancer Res. 2019 Mar;17(3):697-708. doi: 10.1158/1541-7786.MCR-18-0666. Epub 2019 Jan 3.
• [3703] Growth factor independent 1b (Gfi1b) and a new splice variant of Gfi1b are highly expressed in patients with acute and chronic leukemia.Int J Hematol. 2009 May;89(4):422-430. doi: 10.1007/s12185-009-0286-5. Epub 2009 Apr 10.
• [3704] RET Signaling in Prostate Cancer.Clin Cancer Res. 2017 Aug 15;23(16):4885-4896. doi: 10.1158/1078-0432.CCR-17-0528. Epub 2017 May 10.
• [3705] GGNBP2 suppresses triple-negative breast cancer aggressiveness through inhibition of IL-6/STAT3 signaling activation.Breast Cancer Res Treat. 2019 Feb;174(1):65-78. doi: 10.1007/s10549-018-5052-z. Epub 2018 Nov 19.
• [3706] -Methylation enhances the potency of isoprenoid triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors.Bioorg Med Chem. 2018 Jan 15;26(2):376-385. doi: 10.1016/j.bmc.2017.10.023. Epub 2017 Oct 19.
• [3707] hIan5: the human ortholog to the rat Ian4/Iddm1/lyp is a new member of the Ian family that is overexpressed in B-cell lymphoid malignancies.Genes Immun. 2004 Mar;5(2):109-16. doi: 10.1038/sj.gene.6364044.
• [3708] Soluble HLA-associated peptide from PSF1 has a cancer vaccine potency.Sci Rep. 2017 Sep 11;7(1):11137. doi: 10.1038/s41598-017-11605-2.
• [3709] Clinicopathological significance of PSF3 expression in uterine endometrial carcinomas.Hum Pathol. 2018 Oct;80:104-112. doi: 10.1016/j.humpath.2018.06.010. Epub 2018 Jun 21.
• [3710] Regulation of GKN1 expression in gastric carcinogenesis: A problem to resolve (Review).Int J Oncol. 2019 Sep;55(3):555-569. doi: 10.3892/ijo.2019.4843. Epub 2019 Jul 16.
• [3711] GKN2 promotes oxidative stress-induced gastric cancer cell apoptosis via the Hsc70 pathway.J Exp Clin Cancer Res. 2019 Aug 5;38(1):338. doi: 10.1186/s13046-019-1336-3.
• [3712] Heterogeneity of d-glucuronyl C5-epimerase expression and epigenetic regulation in prostate cancer.Cancer Med. 2013 Oct;2(5):654-61. doi: 10.1002/cam4.108. Epub 2013 Aug 5.
• [3713] Identification and characterization of CRG-L2, a new marker for liver tumor development.Oncogene. 2003 Mar 20;22(11):1730-6. doi: 10.1038/sj.onc.1206309.
• [3714] Identification of MG-160, a FGF binding medial Golgi sialoglycoprotein, in brain tumors: an index of malignancy in astrocytomas.Int J Oncol. 2003 May;22(5):1045-9.
• [3715] Emerging Roles of GLI-Similar Krppel-like Zinc Finger Transcription Factors in Leukemia and Other Cancers.Trends Cancer. 2019 Sep;5(9):547-557. doi: 10.1016/j.trecan.2019.07.005. Epub 2019 Aug 20.
• [3716] Factors Affecting Adolescents' Willingness to Communicate Symptoms During Cancer Treatment: A Systematic Review from the Children's Oncology Group.J Adolesc Young Adult Oncol. 2019 Apr;8(2):105-113. doi: 10.1089/jayao.2018.0111. Epub 2018 Nov 29.
• [3717] Glycine conjugation: importance in metabolism, the role of glycine N-acyltransferase, and factors that influence interindividual variation.Expert Opin Drug Metab Toxicol. 2013 Sep;9(9):1139-53. doi: 10.1517/17425255.2013.796929. Epub 2013 May 8.
• [3718] Characterization of glycine-N-acyltransferase like 1 (GLYATL1) in prostate cancer.Prostate. 2019 Oct;79(14):1629-1639. doi: 10.1002/pros.23887. Epub 2019 Aug 2.
• [3719] GNA13 promotes tumor growth and angiogenesis by upregulating CXC chemokines via the NF-B signaling pathway in colorectal cancer cells.Cancer Med. 2018 Nov;7(11):5611-5620. doi: 10.1002/cam4.1783. Epub 2018 Sep 28.
• [3720] Identification of novel GNAS mutations in intramuscular myxoma using next-generation sequencing with single-molecule tagged molecular inversion probes.Diagn Pathol. 2019 Feb 8;14(1):15. doi: 10.1186/s13000-019-0787-3.
• [3721] Mutations in G protein subunits promote transformation and kinase inhibitor resistance. Nat Med. 2015 Jan;21(1):71-5. doi: 10.1038/nm.3751. Epub 2014 Dec 8.
• [3722] Quantitative assessment of the association between GNB3 C825T polymorphism and cancer risk.J BUON. 2014 Oct-Dec;19(4):1092-5.
• [3723] DNA methylation of GHSR, GNG4, HOXD9 and SALL3 is a common epigenetic alteration in thymic carcinoma.Int J Oncol. 2020 Jan;56(1):315-326. doi: 10.3892/ijo.2019.4915. Epub 2019 Nov 18.
• [3724] Maintenance of tumor initiating cells of defined genetic composition by nucleostemin.Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20388-93. doi: 10.1073/pnas.1015171108. Epub 2011 Jul 5.
• [3725] Granulysin, a novel marker for extranodal NK/T cell lymphoma, nasal type.Virchows Arch. 2018 Dec;473(6):749-757. doi: 10.1007/s00428-018-2434-x. Epub 2018 Aug 27.
• [3726] Androgen response element of the glycine N-methyltransferase gene is located in the coding region of its first exon.Biosci Rep. 2013 Sep 17;33(5):e00070. doi: 10.1042/BSR20130030.
• [3727] Golgi tethering factor golgin-97 suppresses breast cancer cell invasiveness by modulating NF-B activity.Cell Commun Signal. 2018 Apr 27;16(1):19. doi: 10.1186/s12964-018-0230-5.
• [3728] An interstitial deletion at 3p21.3 results in the genetic fusion of MLH1 and ITGA9 in a Lynch syndrome family.Clin Cancer Res. 2009 Feb 1;15(3):762-9. doi: 10.1158/1078-0432.CCR-08-1908.
• [3729] Gene polymorphisms of folate metabolizing enzymes and the risk of gastric cancer.Cancer Lett. 2007 Jun 28;251(2):228-36. doi: 10.1016/j.canlet.2006.11.021. Epub 2007 Jan 8.
• [3730] c-Myc transactivates GP73 and promotes metastasis of hepatocellular carcinoma cells through GP73-mediated MMP-7 trafficking in a mildly hypoxic microenvironment.Oncogenesis. 2019 Oct 7;8(10):58. doi: 10.1038/s41389-019-0166-7.
• [3731] Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells.Cancer Res. 2001 Jul 15;61(14):5562-9.
• [3732] Targeting glypican-4 overcomes 5-FU resistance and attenuates stem cell-like properties via suppression of Wnt/-catenin pathway in pancreatic cancer cells.J Cell Biochem. 2018 Nov;119(11):9498-9512. doi: 10.1002/jcb.27266. Epub 2018 Jul 16.
• [3733] DNA methylation changes in genes frequently mutated in sporadic colorectal cancer and in the DNA repair and Wnt/-catenin signaling pathway genes.Epigenomics. 2014 Apr;6(2):179-91. doi: 10.2217/epi.14.7.
• [3734] Mitochondrial Damage Mediated by miR-1 Overexpression in Cancer Stem Cells.Mol Ther Nucleic Acids. 2019 Dec 6;18:938-953. doi: 10.1016/j.omtn.2019.10.016. Epub 2019 Oct 24.
• [3735] Nanoceria decorated flower-like molybdenum sulphide nanoflakes: an efficient nanozyme for tumour selective ROS generation and photo thermal therapy.Chem Commun (Camb). 2019 Jul 4;55(55):8017-8020. doi: 10.1039/c9cc03763b.
• [3736] Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation.Br J Cancer. 2018 Jan;118(2):189-199. doi: 10.1038/bjc.2017.391. Epub 2017 Nov 14.
• [3737] Gpn3 Is Essential for Cell Proliferation of Breast Cancer Cells Independent of Their Malignancy Degree.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819870823. doi: 10.1177/1533033819870823.
• [3738] The orphan GPR50 receptor promotes constitutive TGF receptor signaling and protects against cancer development.Nat Commun. 2018 Mar 23;9(1):1216. doi: 10.1038/s41467-018-03609-x.
• [3739] Overexpression of G-protein-coupled receptors 65 in glioblastoma predicts poor patient prognosis.Clin Neurol Neurosurg. 2018 Jan;164:132-137. doi: 10.1016/j.clineuro.2017.11.017. Epub 2017 Nov 29.
• [3740] The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK.Oncogene. 2011 Jan 13;30(2):245-52. doi: 10.1038/onc.2010.402. Epub 2010 Sep 6.
• [3741] Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men.Pharmacogenet Genomics. 2011 Dec;21(12):798-807. doi: 10.1097/FPC.0b013e32834b68f9.
• [3742] Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin.J Cell Physiol. 2020 Apr;235(4):3425-3437. doi: 10.1002/jcp.29232. Epub 2019 Sep 25.
• [3743] The Teesside cancer family history service: change management and innovation at cancer network level.Fam Cancer. 2007;6(2):181-7. doi: 10.1007/s10689-007-9125-0. Epub 2007 May 17.
• [3744] High expression of growth factor receptor-bound protein 14 predicts poor prognosis for colorectal cancer patients.Biotechnol Lett. 2016 Jun;38(6):1043-7. doi: 10.1007/s10529-016-2077-4. Epub 2016 Mar 10.
• [3745] Grb7, a Critical Mediator of EGFR/ErbB Signaling, in Cancer Development and as a Potential Therapeutic Target.Cells. 2019 May 10;8(5):435. doi: 10.3390/cells8050435.
• [3746] Serum estradiol levels associated with specific gene expression patterns in normal breast tissue and in breast carcinomas.BMC Cancer. 2011 Aug 3;11:332. doi: 10.1186/1471-2407-11-332.
• [3747] Randomised controlled trial protocol (GRIP study): examining the effect of involvement of a general practitioner and home care oncology nurse after a cancer diagnosis on patient reported outcomes and healthcare utilization.BMC Cancer. 2018 Feb 5;18(1):132. doi: 10.1186/s12885-018-4005-6.
• [3748] c-Src, Insulin-Like Growth Factor I Receptor, G-Protein-Coupled Receptor Kinases and Focal Adhesion Kinase are Enriched Into Prostate Cancer Cell Exosomes.J Cell Biochem. 2017 Jan;118(1):66-73. doi: 10.1002/jcb.25611. Epub 2016 Jul 12.
• [3749] Peptide receptors as cancer drug targets.Ann N Y Acad Sci. 2019 Nov;1455(1):141-148. doi: 10.1111/nyas.14100. Epub 2019 May 10.
• [3750] Integrative analysis of somatic mutations altering microRNA targeting in cancer genomes.PLoS One. 2012;7(10):e47137. doi: 10.1371/journal.pone.0047137. Epub 2012 Oct 16.
• [3751] A GSDMB enhancer-driven HSV thymidine kinase-expressing vector for controlling occult peritoneal dissemination of gastric cancer cells.BMC Cancer. 2015 May 29;15:439. doi: 10.1186/s12885-015-1436-1.
• [3752] Induction of Pyroptosis and Its Implications in Cancer Management.Front Oncol. 2019 Sep 26;9:971. doi: 10.3389/fonc.2019.00971. eCollection 2019.
• [3753] Methylation analysis of Gasdermin E shows great promise as a biomarker for colorectal cancer.Cancer Med. 2019 May;8(5):2133-2145. doi: 10.1002/cam4.2103. Epub 2019 Apr 16.
• [3754] Tracing biomarker of PAH-exposure and susceptibility factor (GSTM-polymorphism) among cancer patients in Pakistan.Chemosphere. 2017 Jul;178:384-390. doi: 10.1016/j.chemosphere.2017.03.017. Epub 2017 Mar 7.
• [3755] Association of a deletion of GSTT2B with an altered risk of oesophageal squamous cell carcinoma in a South African population: a case-control study.PLoS One. 2011;6(12):e29366. doi: 10.1371/journal.pone.0029366. Epub 2011 Dec 27.
• [3756] Rare diseases provide rare insights into DNA repair pathways, TFIIH, aging and cancer center.DNA Repair (Amst). 2005 Feb 3;4(2):293-302. doi: 10.1016/j.dnarep.2004.09.010.
• [3757] A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma.J Exp Med. 1999 Apr 5;189(7):1101-10. doi: 10.1084/jem.189.7.1101.
• [3758] Colonic epithelial cell diversity in health and inflammatory bowel disease.Nature. 2019 Mar;567(7746):49-55. doi: 10.1038/s41586-019-0992-y. Epub 2019 Feb 27.
• [3759] Solution structure and functional investigation of human guanylate kinase reveals allosteric networking and a crucial role for the enzyme in cancer.J Biol Chem. 2019 Aug 2;294(31):11920-11933. doi: 10.1074/jbc.RA119.009251. Epub 2019 Jun 14.
• [3760] Individual variation of somatic gene mutability in relation to cancer susceptibility: prospective study on erythrocyte glycophorin a gene mutations of atomic bomb survivors.Cancer Res. 2005 Jun 15;65(12):5462-9. doi: 10.1158/0008-5472.CAN-04-1188.
• [3761] Pathways- and epigenetic-based assessment of relative immune infiltration in various types of solid tumors.Adv Cancer Res. 2019;142:107-143. doi: 10.1016/bs.acr.2019.01.003. Epub 2019 Mar 6.
• [3762] The Met1-Linked Ubiquitin Machinery: Emerging Themes of (De)regulation.Mol Cell. 2017 Oct 19;68(2):265-280. doi: 10.1016/j.molcel.2017.09.001.
• [3763] Molecular Mechanism of the Pin1-Histone H1 Interaction.Biochemistry. 2019 Feb 12;58(6):788-798. doi: 10.1021/acs.biochem.8b01036. Epub 2018 Dec 18.
• [3764] Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug.PLoS One. 2018 Feb 2;13(2):e0190245. doi: 10.1371/journal.pone.0190245. eCollection 2018.
• [3765] Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer.Br J Haematol. 2019 Jul;186(2):311-320. doi: 10.1111/bjh.15906. Epub 2019 Apr 9.
• [3766] Hexose-6-phosphate dehydrogenase controls cancer cell proliferation and migration through pleiotropic effects on the unfolded-protein response, calcium homeostasis, and redox balance.FASEB J. 2018 May;32(5):2690-2705. doi: 10.1096/fj.201700870RR. Epub 2018 Jan 2.
• [3767] Loss of the Tumor Suppressor HACE1 Contributes to Cancer Progression.Curr Drug Targets. 2019;20(10):1018-1028. doi: 10.2174/1389450120666190227184654.
• [3768] Integrated analyses of multi-omics reveal global patterns of methylation and hydroxymethylation and screen the tumor suppressive roles of HADHB in colorectal cancer.Clin Epigenetics. 2018 Mar 2;10:30. doi: 10.1186/s13148-018-0458-3. eCollection 2018.
• [3769] HAO2 inhibits malignancy of clear cell renal cell carcinoma by promoting lipid catabolic process.J Cell Physiol. 2019 Dec;234(12):23005-23016. doi: 10.1002/jcp.28861. Epub 2019 May 24.
• [3770] Overexpressed histone acetyltransferase 1 regulates cancer immunity by increasing programmed death-ligand 1 expression in pancreatic cancer.J Exp Clin Cancer Res. 2019 Feb 1;38(1):47. doi: 10.1186/s13046-019-1044-z.
• [3771] High Expression of Human AugminComplex Submit 3 Indicates Poor Prognosis and Associates with Tumor Progression in Hepatocellular Carcinoma.J Cancer. 2019 Feb 23;10(6):1434-1443. doi: 10.7150/jca.28317. eCollection 2019.
• [3772] Pattern of mRNA expression of beta-defensins in basal cell carcinoma.BMC Cancer. 2006 Jun 23;6:163. doi: 10.1186/1471-2407-6-163.
• [3773] Self-assembled ruthenium (II) metallacycles and metallacages with imidazole-based ligands and their in vitro anticancer activity.Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4090-4098. doi: 10.1073/pnas.1818677116. Epub 2019 Feb 14.
• [3774] Role of the HTLV-1 viral factors in the induction of apoptosis.Biomed Pharmacother. 2017 Jan;85:334-347. doi: 10.1016/j.biopha.2016.11.034. Epub 2016 Nov 23.
• [3775] Immunobiology of human NKG2D and its ligands.Curr Top Microbiol Immunol. 2006;298:121-38. doi: 10.1007/3-540-27743-9_6.
• [3776] Insight into the roles of hepatoma derived growth factor related protein-3 under physiological and pathological conditions.Biochem Cell Biol. 2018 Dec;96(6):707-712. doi: 10.1139/bcb-2018-0098. Epub 2018 Aug 3.
• [3777] A new small cell lung cancer biomarker identified by Cell-SELEX generated aptamers.Exp Cell Res. 2019 Sep 15;382(2):111478. doi: 10.1016/j.yexcr.2019.06.023. Epub 2019 Jun 21.
• [3778] Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells.Cell Cycle. 2018;17(1):92-101. doi: 10.1080/15384101.2017.1403685. Epub 2017 Dec 10.
• [3779] AIB1 predicts tumor response to definitive chemoradiotherapy and prognosis in cervical squamous cell carcinoma.J Cancer. 2019 Aug 28;10(21):5212-5222. doi: 10.7150/jca.31697. eCollection 2019.
• [3780] The role of E3 ubiquitin ligase HECTD3 in cancer and beyond.Cell Mol Life Sci. 2020 Apr;77(8):1483-1495. doi: 10.1007/s00018-019-03339-3. Epub 2019 Oct 21.
• [3781] Evidence-Based Review of BioBran/MGN-3 Arabinoxylan Compound as a Complementary Therapy for Conventional Cancer Treatment.Integr Cancer Ther. 2018 Jun;17(2):165-178. doi: 10.1177/1534735417735379. Epub 2017 Oct 17.
• [3782] HERC2 Facilitates BLM and WRN Helicase Complex Interaction with RPA to Suppress G-Quadruplex DNA.Cancer Res. 2018 Nov 15;78(22):6371-6385. doi: 10.1158/0008-5472.CAN-18-1877. Epub 2018 Oct 2.
• [3783] The Emerging Roles of the HERC Ubiquitin Ligases in Cancer.Curr Pharm Des. 2018;24(15):1676-1681. doi: 10.2174/1381612824666180528081024.
• [3784] Germline minisatellite mutations in survivors of childhood and young adult cancer treated with radiation.Int J Radiat Biol. 2011 Mar;87(3):330-40. doi: 10.3109/09553002.2011.530338. Epub 2010 Nov 19.
• [3785] Age-related gene expression changes, and transcriptome wide association study of physical and cognitive aging traits, in the Lothian Birth Cohort 1936.Aging (Albany NY). 2017 Dec 1;9(12):2489-2503. doi: 10.18632/aging.101333.
• [3786] Hes3 Enhances the Malignant Phenotype of Lung Cancer through Upregulating Cyclin D1, Cyclin D3 and MMP7 Expression.Int J Med Sci. 2019 Mar 9;16(3):470-476. doi: 10.7150/ijms.28139. eCollection 2019.
• [3787] Overexpression of HES6 has prognostic value and promotes metastasis via the Wnt/-catenin signaling pathway in colorectal cancer.Oncol Rep. 2018 Sep;40(3):1261-1274. doi: 10.3892/or.2018.6539. Epub 2018 Jul 2.
• [3788] Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female Ldlr -/- mice.PLoS One. 2019 Apr 3;14(4):e0214387. doi: 10.1371/journal.pone.0214387. eCollection 2019.
• [3789] Systematic Selective Sampling of Cholecystectomy Specimens Is Adequate to Detect Incidental Gallbladder Adenocarcinoma.Am J Surg Pathol. 2019 Dec;43(12):1668-1673. doi: 10.1097/PAS.0000000000001351.
• [3790] Proline-Rich Homeodomain protein (PRH/HHEX) is a suppressor of breast tumour growth.Oncogenesis. 2017 Jun 12;6(6):e346. doi: 10.1038/oncsis.2017.42.
• [3791] Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients.Cancer Cell Int. 2019 Apr 16;19:101. doi: 10.1186/s12935-019-0813-2. eCollection 2019.
• [3792] Hypermethylated in cancer 1 (HIC1) suppresses bladder cancer progression by targeting yes-associated protein (YAP) pathway.J Cell Biochem. 2019 Apr;120(4):6471-6481. doi: 10.1002/jcb.27938. Epub 2018 Nov 11.
• [3793] Identification of DMC1, a novel gene in the TOC region on 17q25.1 that shows loss of expression in multiple human cancers.J Hum Genet. 2001;46(2):90-5. doi: 10.1007/s100380170115.
• [3794] Receptor and secreted targets of Wnt-1/beta-catenin signalling in mouse mammary epithelial cells.BMC Cancer. 2005 Jan 10;5:3. doi: 10.1186/1471-2407-5-3.
• [3795] Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemia.Sci Rep. 2017 Apr 28;7:45960. doi: 10.1038/srep45960.
• [3796] Upregulation of circRNA_0000285 serves as a prognostic biomarker for nasopharyngeal carcinoma and is involved in radiosensitivity.Oncol Lett. 2018 Nov;16(5):6495-6501. doi: 10.3892/ol.2018.9471. Epub 2018 Sep 20.
• [3797] MBP-1 inhibits breast cancer growth and metastasis in immunocompetent mice.Cancer Res. 2009 Dec 15;69(24):9354-9. doi: 10.1158/0008-5472.CAN-09-2974.
• [3798] Identification and characterization of human MIBP1 gene in glioma cell differentiation.J Mol Neurosci. 2014 Feb;52(2):294-301. doi: 10.1007/s12031-013-0144-z. Epub 2013 Oct 26.
• [3799] Targeting uPAR by CRISPR/Cas9 System Attenuates Cancer Malignancy and Multidrug Resistance.Front Oncol. 2019 Feb 27;9:80. doi: 10.3389/fonc.2019.00080. eCollection 2019.
• [3800] Novel polymorphisms in HLA-DOA and HLA-DOB in B-cell malignancies.Immunogenetics. 2002 Nov;54(8):591-5. doi: 10.1007/s00251-002-0500-6. Epub 2002 Oct 9.
• [3801] Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants.Bone Marrow Transplant. 2017 May;52(5):717-725. doi: 10.1038/bmt.2016.352. Epub 2017 Jan 16.
• [3802] Histone deacetylase inhibitor enhances the anti-tumor effect of gemcitabine: a special reference to gene-expression microarray analysis.Oncol Rep. 2011 Nov;26(5):1057-62. doi: 10.3892/or.2011.1407. Epub 2011 Jul 28.
• [3803] Anamnestic studies in multiple sclerosis: a relationship between familial multiple sclerosis and neoplasia.Neurology. 1978 Sep;28(9 Pt 2):125-8. doi: 10.1212/wnl.28.9_part_2.125.
• [3804] Human HLAF adjacent transcript 10 promotes the formation of cancer initiating cells and cisplatin resistance in bladder cancer.Mol Med Rep. 2018 Jul;18(1):308-314. doi: 10.3892/mmr.2018.9005. Epub 2018 May 9.
• [3805] HLF/miR-132/TTK axis regulates cell proliferation, metastasis and radiosensitivity of glioma cells.Biomed Pharmacother. 2016 Oct;83:898-904. doi: 10.1016/j.biopha.2016.08.004. Epub 2016 Aug 10.
• [3806] Co-regulation of senescence-associated genes by oncogenic homeobox proteins and polycomb repressive complexes.Cell Cycle. 2013 Jul 15;12(14):2194-9. doi: 10.4161/cc.25331.
• [3807] IMP1 KH1 and KH2 domains create a structural platform with unique RNA recognition and re-modelling properties.Nucleic Acids Res. 2019 May 7;47(8):4334-4348. doi: 10.1093/nar/gkz136.
• [3808] SRPX and HMCN1 regulate cancerassociated fibroblasts to promote the invasiveness of ovarian carcinoma.Oncol Rep. 2019 Dec;42(6):2706-2715. doi: 10.3892/or.2019.7379. Epub 2019 Oct 17.
• [3809] SRY-related high-mobility-group box 4: Crucial regulators of the EMT in cancer.Semin Cancer Biol. 2020 Dec;67(Pt 1):114-121. doi: 10.1016/j.semcancer.2019.06.008. Epub 2019 Jun 11.
• [3810] Hepatitis B Virus X Protein Induces RHAMM-Dependent Motility in Hepatocellular Carcinoma Cells via PI3K-Akt-Oct-1 Signaling.Mol Cancer Res. 2020 Mar;18(3):375-389. doi: 10.1158/1541-7786.MCR-19-0463. Epub 2019 Dec 2.
• [3811] Decoding a cancer-relevant splicing decision in the RON proto-oncogene using high-throughput mutagenesis.Nat Commun. 2018 Aug 17;9(1):3315. doi: 10.1038/s41467-018-05748-7.
• [3812] The emerging roles of hnRNPK.J Cell Physiol. 2020 Mar;235(3):1995-2008. doi: 10.1002/jcp.29186. Epub 2019 Sep 19.
• [3813] HnRNPR-CCNB1/CENPF axis contributes to gastric cancer proliferation and metastasis.Aging (Albany NY). 2019 Sep 16;11(18):7473-7491. doi: 10.18632/aging.102254. Epub 2019 Sep 16.
• [3814] Transcriptomics-based validation of the relatedness of heterogeneous nuclear ribonucleoproteins to chronic lymphocytic leukemia as potential biomarkers of the disease aggressiveness.Saudi Med J. 2019 Apr;40(4):328-338. doi: 10.15537/smj.2019.4.23380.
• [3815] Hook1 inhibits malignancy and epithelial-mesenchymal transition in hepatocellular carcinoma.Tumour Biol. 2017 Jul;39(7):1010428317711098. doi: 10.1177/1010428317711098.
• [3816] Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance.J Hepatol. 2004 Jan;40(1):117-23. doi: 10.1016/s0168-8278(03)00503-8.
• [3817] HSP70/HSP90-Organizing Protein Contributes to Gastric Cancer Progression in an Autocrine Fashion and Predicts Poor Survival in Gastric Cancer.Cell Physiol Biochem. 2018;47(2):879-892. doi: 10.1159/000490080. Epub 2018 May 22.
• [3818] Long Non-Coding RNA HOXA-AS2 Enhances The Malignant Biological Behaviors In Glioma By Epigenetically Regulating RND3 Expression.Onco Targets Ther. 2019 Nov 7;12:9407-9419. doi: 10.2147/OTT.S225678. eCollection 2019.
• [3819] Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis.Clin Cancer Res. 2007 Sep 1;13(17):5048-55. doi: 10.1158/1078-0432.CCR-07-0919.
• [3820] Direct and Indirect Targeting of HOXA9 Transcription Factor in Acute Myeloid Leukemia.Cancers (Basel). 2019 Jun 17;11(6):837. doi: 10.3390/cancers11060837.
• [3821] HOXB1 Is a Tumor Suppressor Gene Regulated by miR-3175 in Glioma.PLoS One. 2015 Nov 13;10(11):e0142387. doi: 10.1371/journal.pone.0142387. eCollection 2015.
• [3822] miR-375 inhibits cancer stem cell phenotype and tamoxifen resistance by degrading HOXB3 in human ER-positive breast cancer.Oncol Rep. 2017 Feb;37(2):1093-1099. doi: 10.3892/or.2017.5360. Epub 2017 Jan 9.
• [3823] HOXB8 enhances the proliferation and metastasis of colorectal cancer cells by promoting EMT via STAT3 activation.Cancer Cell Int. 2019 Jan 3;19:3. doi: 10.1186/s12935-018-0717-6. eCollection 2019.
• [3824] Regulation of Cancer Stem Cell Self-Renewal by HOXB9 Antagonizes Endoplasmic Reticulum Stress-Induced Melanoma Cell Apoptosis via the miR-765-FOXA2 Axis.J Invest Dermatol. 2018 Jul;138(7):1609-1619. doi: 10.1016/j.jid.2018.01.023. Epub 2018 Feb 3.
• [3825] Novel NUP98-HOXC11 fusion gene resulted from a chromosomal break within exon 1 of HOXC11 in acute myeloid leukemia with t(11;12)(p15;q13).Cancer Res. 2002 Aug 15;62(16):4571-4.
• [3826] Human homeobox gene HOXC13 is the partner of NUP98 in adult acute myeloid leukemia with t(11;12)(p15;q13).Genes Chromosomes Cancer. 2003 Apr;36(4):420-3. doi: 10.1002/gcc.10182.
• [3827] HOXC6 predicts invasion and poor survival in hepatocellular carcinoma by driving epithelial-mesenchymal transition.Aging (Albany NY). 2018 Jan 15;10(1):115-130. doi: 10.18632/aging.101363.
• [3828] Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma.Clin Epigenetics. 2017 Oct 23;9:116. doi: 10.1186/s13148-017-0412-9. eCollection 2017.
• [3829] Quantitative expression of the homeobox and integrin genes in human gastric carcinoma.Int J Mol Med. 2007 Oct;20(4):621-9.
• [3830] Association Between Activation of the Programmed Cell Death-1 (PD-1)/Programmed Death-Ligand 1 (PD-L1) Pathway and Pain in Patients with Cancer.Med Sci Monit. 2019 Feb 16;25:1275-1282. doi: 10.12659/MSM.912632.
• [3831] HOXD3 Plays a Critical Role in Breast Cancer Stemness and Drug Resistance.Cell Physiol Biochem. 2018;46(4):1737-1747. doi: 10.1159/000489249. Epub 2018 Apr 23.
• [3832] Mutation analysis of the HOX paralogous 4-13 genes in children with acute lymphoid malignancies: identification of a novel germline mutation of HOXD4 leading to a partial loss-of-function.Hum Mutat. 2005 Apr;25(4):384-95. doi: 10.1002/humu.20155.
• [3833] Potential role of the HOXD8 transcription factor in cisplatin resistance and tumour metastasis in advanced epithelial ovarian cancer.Sci Rep. 2018 Sep 7;8(1):13483. doi: 10.1038/s41598-018-31030-3.
• [3834] Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets -carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide 4-desaturase 1.PLoS One. 2017 Apr 27;12(4):e0176487. doi: 10.1371/journal.pone.0176487. eCollection 2017.
• [3835] The role of HRK gene in human cancer.Oncogene. 2008 Dec;27 Suppl 1:S105-13. doi: 10.1038/onc.2009.48.
• [3836] The trimeric coiled-coil HSBP1 protein promotes WASH complex assembly at centrosomes.EMBO J. 2018 Jul 2;37(13):e97706. doi: 10.15252/embj.201797706. Epub 2018 May 29.
• [3837] Whole exome sequencing study of a Chinese concurrent cancer family.Oncol Lett. 2019 Sep;18(3):2619-2627. doi: 10.3892/ol.2019.10573. Epub 2019 Jul 5.
• [3838] Lentivirus-mediated overexpression of HSDL2 suppresses cell proliferation and induces apoptosis in cholangiocarcinoma.Onco Targets Ther. 2018 Oct 17;11:7133-7142. doi: 10.2147/OTT.S176410. eCollection 2018.
• [3839] Correction: HSP70L1-mediated intracellular priming of dendritic cell vaccination induces more potent CTL response against cancer.Cell Mol Immunol. 2020 Jan;17(1):108-109. doi: 10.1038/s41423-019-0335-9.
• [3840] Association of HSP70-hom genetic variant with prostate cancer risk.Mol Biol Rep. 2008 Sep;35(3):459-64. doi: 10.1007/s11033-007-9107-1. Epub 2007 Jun 20.
• [3841] Decreased expression of heat shock protein 20 in colorectal cancer and its implication in tumorigenesis.J Cell Biochem. 2015 Feb;116(2):277-86. doi: 10.1002/jcb.24966.
• [3842] SRARP and HSPB7 are epigenetically regulated gene pairs that function as tumor suppressors and predict clinical outcome in malignancies.Mol Oncol. 2018 May;12(5):724-755. doi: 10.1002/1878-0261.12195. Epub 2018 Apr 16.
• [3843] Selecting the first chemical molecule inhibitor of HSP110 for colorectal cancer therapy.Cell Death Differ. 2020 Jan;27(1):117-129. doi: 10.1038/s41418-019-0343-4. Epub 2019 May 8.
• [3844] Investigation of HTR3C mutations for association with 5HT(3) receptor antagonist anti-emetic efficacy.Pharmacogenomics. 2008 Aug;9(8):1027-33. doi: 10.2217/14622416.9.8.1027.
• [3845] The expression levels and prognostic value of high temperature required A2 (HtrA2) in NSCLC.Pathol Res Pract. 2014 Dec;210(12):939-43. doi: 10.1016/j.prp.2014.06.030. Epub 2014 Jul 9.
• [3846] Identification of a distal allosteric ligand binding pocket in HtrA3.Biochem Biophys Res Commun. 2019 Sep 3;516(4):1130-1136. doi: 10.1016/j.bbrc.2019.07.005. Epub 2019 Jul 5.
• [3847] Meta-analysis of gene expression alterations and clinical significance of the HECT domain-containing ubiquitin ligase HUWE1 in cancer.Oncol Lett. 2019 Sep;18(3):2292-2303. doi: 10.3892/ol.2019.10579. Epub 2019 Jul 5.
• [3848] The suppressive role of HYAL1 and HYAL2 in the metastasis of colorectal cancer.J Gastroenterol Hepatol. 2019 Oct;34(10):1766-1776. doi: 10.1111/jgh.14660. Epub 2019 Apr 10.
• [3849] Alternative variants of human HYDIN are novel cancer-associated antigens recognized by adaptive immunity.Cancer Immunol Res. 2013 Sep;1(3):190-200. doi: 10.1158/2326-6066.CIR-13-0079. Epub 2013 Jul 5.
• [3850] Development and Psychometric Evaluation of the Cancer Health Literacy Scale in Newly Diagnosed Cancer Patients.Cancer Nurs. 2020 Sep/Oct;43(5):E291-E303. doi: 10.1097/NCC.0000000000000711.
• [3851] HYOU1 promotes cell growth and metastasis via activating PI3K/AKT signaling in epithelial ovarian cancer and predicts poor prognosis.Eur Rev Med Pharmacol Sci. 2019 Jan;23(10):4126-4135. doi: 10.26355/eurrev_201901_17914.
• [3852] The role of insulin receptor substrate (IRS) proteins in oncogenic transformation.Cell Mol Biol (Noisy-le-grand). 2017 Jan 30;63(1):1-5. doi: 10.14715/cmb/2017.63.1.1.
• [3853] Targeting Thioredoxin Reductase by Ibrutinib Promotes Apoptosis of SMMC-7721 Cells.J Pharmacol Exp Ther. 2019 May;369(2):212-222. doi: 10.1124/jpet.118.254862. Epub 2019 Feb 13.
• [3854] Identification and characterization of the intercellular adhesion molecule-2 gene as a novel p53 target.Oncotarget. 2016 Sep 20;7(38):61426-61437. doi: 10.18632/oncotarget.11366.
• [3855] ICAM3 mediates inflammatory signaling to promote cancer cell stemness.Cancer Lett. 2018 May 28;422:29-43. doi: 10.1016/j.canlet.2018.02.034. Epub 2018 Mar 2.
• [3856] ICAM-5 (telencephalin) gene expression in head and neck squamous carcinoma tumorigenesis and perineural invasion!.Oral Oncol. 2005 Jul;41(6):580-8. doi: 10.1016/j.oraloncology.2005.01.002. Epub 2005 Apr 9.
• [3857] The immediate early gene Ier2 promotes tumor cell motility and metastasis, and predicts poor survival of colorectal cancer patients.Oncogene. 2012 Aug 16;31(33):3796-806. doi: 10.1038/onc.2011.535. Epub 2011 Nov 28.
• [3858] Increased expression of immediate early response gene 3 protein promotes aggressive progression and predicts poor prognosis in human bladder cancer.BMC Urol. 2018 Sep 24;18(1):82. doi: 10.1186/s12894-018-0388-6.
• [3859] The hypoxia-inducible transcription factor ZNF395 is controlled by IB kinase-signaling and activates genes involved in the innate immune response and cancer.PLoS One. 2013 Sep 23;8(9):e74911. doi: 10.1371/journal.pone.0074911. eCollection 2013.
• [3860] Emerging roles of FAM14 family members (G1P3/ISG 6-16 and ISG12/IFI27) in innate immunity and cancer.J Interferon Cytokine Res. 2011 Jan;31(1):173-81. doi: 10.1089/jir.2010.0105. Epub 2010 Oct 12.
• [3861] Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays.Autoimmun Rev. 2019 Mar;18(3):293-305. doi: 10.1016/j.autrev.2018.10.004. Epub 2019 Jan 11.
• [3862] Decreased IFIT2 Expression Promotes Gastric Cancer Progression and Predicts Poor Prognosis of the Patients.Cell Physiol Biochem. 2018;45(1):15-25. doi: 10.1159/000486219. Epub 2017 Dec 22.
• [3863] Overexpression of IFITM3 predicts poor prognosis in stage IIA esophageal squamous cell carcinoma after Ivor Lewis esophagectomy.Thorac Cancer. 2017 Nov;8(6):592-599. doi: 10.1111/1759-7714.12488. Epub 2017 Aug 30.
• [3864] Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers.Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):6203-8. doi: 10.1073/pnas.93.12.6203.
• [3865] Integrative genomic analyses on IL28RA, the common receptor of interferon-lambda1, -lambda2 and -lambda3.Int J Mol Med. 2010 May;25(5):807-12.
• [3866] IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader.Cell Death Differ. 2020 Jun;27(6):1782-1794. doi: 10.1038/s41418-019-0461-z. Epub 2019 Dec 5.
• [3867] Exploration of potential key pathways and genes in multiple ocular cancers through bioinformatics analysis.Graefes Arch Clin Exp Ophthalmol. 2019 Oct;257(10):2329-2341. doi: 10.1007/s00417-019-04410-2. Epub 2019 Jul 15.
• [3868] Hippo, Drosophila MST, is a novel modifier of motor neuron degeneration induced by knockdown of Caz, Drosophila FUS.Exp Cell Res. 2018 Oct 15;371(2):311-321. doi: 10.1016/j.yexcr.2018.08.001. Epub 2018 Aug 6.
• [3869] Serum Levels of Activins, Follistatins, and Growth Factors in Neoplasms of the Breast: A Case-Control Study.J Clin Endocrinol Metab. 2019 Feb 1;104(2):349-358. doi: 10.1210/jc.2018-01581.
• [3870] Epigenetic inactivation implies independent functions for insulin-like growth factor binding protein (IGFBP)-related protein 1 and the related IGFBPL1 in inhibiting breast cancer phenotypes.Clin Cancer Res. 2007 Jul 15;13(14):4061-8. doi: 10.1158/1078-0432.CCR-06-3052.
• [3871] Construction of a versatile expression library for all human single-pass transmembrane proteins for receptor pairings by high throughput screening.J Biotechnol. 2017 Oct 20;260:18-30. doi: 10.1016/j.jbiotec.2017.08.023. Epub 2017 Sep 1.
• [3872] RNA-seq Reveals the Overexpression of IGSF9 in Endometrial Cancer.J Oncol. 2018 Feb 14;2018:2439527. doi: 10.1155/2018/2439527. eCollection 2018.
• [3873] Identification of the potential biomarkers in patients with glioma: a weighted gene co-expression network analysis.Carcinogenesis. 2020 Jul 10;41(6):743-750. doi: 10.1093/carcin/bgz194.
• [3874] Advances in IKBKE as a potential target for cancer therapy.Cancer Med. 2020 Jan;9(1):247-258. doi: 10.1002/cam4.2678. Epub 2019 Nov 15.
• [3875] IL17RB expression might predict prognosis and benefit from gemcitabine in patients with resectable pancreatic cancer.Pathol Res Pract. 2019 Dec;215(12):152650. doi: 10.1016/j.prp.2019.152650. Epub 2019 Sep 17.
• [3876] Cul4 E3 ubiquitin ligase regulates ovarian cancer drug resistance by targeting the antiapoptotic protein BIRC3.Cell Death Dis. 2019 Feb 4;10(2):104. doi: 10.1038/s41419-018-1200-y.
• [3877] Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism?.J Dermatolog Treat. 2018 Aug;29(5):475-480. doi: 10.1080/09546634.2017.1398396. Epub 2017 Nov 21.
• [3878] Interleukin-1 Family Cytokines: Keystones in Liver Inflammatory Diseases.Front Immunol. 2019 Aug 27;10:2014. doi: 10.3389/fimmu.2019.02014. eCollection 2019.
• [3879] Protective function of interleukin 27 in colitis-associated cancer via suppression of inflammatory cytokines in intestinal epithelial cells.Oncoimmunology. 2017 Jan 20;6(2):e1268309. doi: 10.1080/2162402X.2016.1268309. eCollection 2017.
• [3880] IL-36 suppresses proliferation of ovarian cancer cells.Tumour Biol. 2017 Jun;39(6):1010428317706918. doi: 10.1177/1010428317706918.
• [3881] Th9 lymphocytes and functions of interleukin 9 with the focus on IBD pathology.Adv Med Sci. 2018 Sep;63(2):278-284. doi: 10.1016/j.advms.2018.03.002. Epub 2018 Mar 20.
• [3882] Interleukin enhancer binding factor 2 is a prognostic biomarker for breast cancer that also predicts neoadjuvant chemotherapy responses.Am J Transl Res. 2018 Jun 15;10(6):1677-1689. eCollection 2018.
• [3883] Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation.RNA. 2019 May;25(5):630-644. doi: 10.1261/rna.068619.118. Epub 2019 Feb 22.
• [3884] PP2C inhibits p300-mediated p53 acetylation via ATM/BRCA1 pathway to impede DNA damage response in breast cancer.Sci Adv. 2019 Oct 16;5(10):eaaw8417. doi: 10.1126/sciadv.aaw8417. eCollection 2019 Oct.
• [3885] C6orf106 accelerates pancreatic cancer cell invasion and proliferation via activating ERK signaling pathway.Mol Cell Biochem. 2019 Apr;454(1-2):87-95. doi: 10.1007/s11010-018-3455-0. Epub 2018 Oct 11.
• [3886] Bringing Prostate Cancer Germline Genetics into Clinical Practice.J Urol. 2019 Aug;202(2):223-230. doi: 10.1097/JU.0000000000000137. Epub 2019 Jul 8.
• [3887] Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951.Cancer. 2011 Jul 1;117(13):3014-26. doi: 10.1002/cncr.25827. Epub 2011 Jan 18.
• [3888] Suppression of Tafazzin promotes thyroid cancer apoptosis via activating the JNK signaling pathway and enhancing INF2-mediated mitochondrial fission.J Cell Physiol. 2019 Sep;234(9):16238-16251. doi: 10.1002/jcp.28287. Epub 2019 Feb 11.
• [3889] Loss of heterozygosity of chromosome 13q33-34 region and molecular analysis of ING1 and p53 genes in bladder carcinoma.Mol Biol Rep. 2015 Feb;42(2):507-16. doi: 10.1007/s11033-014-3794-1. Epub 2014 Oct 17.
• [3890] Immunohistochemical profile of ING3 protein in normal and cancerous tissues.Oncol Lett. 2017 Mar;13(3):1631-1636. doi: 10.3892/ol.2017.5632. Epub 2017 Jan 23.
• [3891] ING4 suppresses hepatocellular carcinoma via a NF-B/miR-155/FOXO3a signaling axis.Int J Biol Sci. 2019 Jan 1;15(2):369-385. doi: 10.7150/ijbs.28422. eCollection 2019.
• [3892] INKA2, a novel p53 target that interacts with the serine/threonine kinase PAK4.Int J Oncol. 2019 Jun;54(6):1907-1920. doi: 10.3892/ijo.2019.4786. Epub 2019 Apr 15.
• [3893] INO80 is required for oncogenic transcription and tumor growth in non-small cell lung cancer.Oncogene. 2017 Mar;36(10):1430-1439. doi: 10.1038/onc.2016.311. Epub 2016 Sep 19.
• [3894] Investigating the duality of Inpp4b function in the cellular transformation of mouse fibroblasts.Oncotarget. 2019 Oct 29;10(59):6378-6390. doi: 10.18632/oncotarget.27293. eCollection 2019 Oct 29.
• [3895] Oncogenic Roles of the PI3K/AKT/mTOR Axis.Curr Top Microbiol Immunol. 2017;407:153-189. doi: 10.1007/82_2017_6.
• [3896] Role of INSL4 Signaling in Sustaining the Growth and Viability of LKB1-Inactivated Lung Cancer.J Natl Cancer Inst. 2019 Jul 1;111(7):664-674. doi: 10.1093/jnci/djy166.
• [3897] Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.BMC Cancer. 2017 Sep 12;17(1):644. doi: 10.1186/s12885-017-3628-3.
• [3898] Identification of novel Sp1 targets involved in proliferation and cancer by functional genomics.Biochem Pharmacol. 2012 Dec 15;84(12):1581-91. doi: 10.1016/j.bcp.2012.09.014. Epub 2012 Sep 25.
• [3899] Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis.Oncogene. 2012 Apr 19;31(16):2062-74. doi: 10.1038/onc.2011.383. Epub 2011 Aug 29.
• [3900] Differential Proteomic Analysis between Small Cell Lung Carcinoma (SCLC) and Pulmonary Carcinoid Tumors Reveals Molecular Signatures for Malignancy in Lung Cancer.Proteomics Clin Appl. 2018 Nov;12(6):e1800015. doi: 10.1002/prca.201800015. Epub 2018 Jul 5.
• [3901] A PI3K/AKT Scaffolding Protein, IQ Motif-Containing GTPase Associating Protein 1 (IQGAP1), Promotes Head and Neck Carcinogenesis.Clin Cancer Res. 2020 Jan 1;26(1):301-311. doi: 10.1158/1078-0432.CCR-19-1063. Epub 2019 Oct 9.
• [3902] IQ Motif-Containing GTPase-Activating Protein 2 (IQGAP2) Is a Novel Regulator of Colonic Inflammation in Mice.PLoS One. 2015 Jun 5;10(6):e0129314. doi: 10.1371/journal.pone.0129314. eCollection 2015.
• [3903] Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.J Transl Med. 2017 Aug 15;15(1):176. doi: 10.1186/s12967-017-1275-8.
• [3904] Multiple interactions between an Arf/GEF complex and charged lipids determine activation kinetics on the membrane.Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11416-11421. doi: 10.1073/pnas.1707970114. Epub 2017 Sep 18.
• [3905] BRAF mutations are associated with increased iron regulatory protein-2 expression in colorectal tumorigenesis.Cancer Sci. 2017 Jun;108(6):1135-1143. doi: 10.1111/cas.13234. Epub 2017 Jun 2.
• [3906] Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myeloma.Oncotarget. 2019 Oct 15;10(57):5993-6005. doi: 10.18632/oncotarget.27243. eCollection 2019 Oct 15.
• [3907] Candidate tumor suppressor gene IRF6 is involved in human breast cancer pathogenesis via modulating PI3K-regulatory subunit PIK3R2 expression.Cancer Manag Res. 2019 Jun 21;11:5557-5572. doi: 10.2147/CMAR.S203060. eCollection 2019.
• [3908] Interferon Regulatory Factor 7 Promoted Glioblastoma Progression and Stemness by Modulating IL-6 Expression in Microglia.J Cancer. 2017 Jan 13;8(2):207-219. doi: 10.7150/jca.16415. eCollection 2017.
• [3909] Age-related changes in CD4+CD25+FOXP3+ regulatory T cells and their relationship with lung cancer.PLoS One. 2017 Mar 2;12(3):e0173048. doi: 10.1371/journal.pone.0173048. eCollection 2017.
• [3910] TIP: A Web Server for Resolving Tumor Immunophenotype Profiling.Cancer Res. 2018 Dec 1;78(23):6575-6580. doi: 10.1158/0008-5472.CAN-18-0689. Epub 2018 Aug 28.
• [3911] Design and development of ICCA as a dual inhibitor of GPIIb/IIIa and P-selectin receptors.Drug Des Devel Ther. 2018 Jul 9;12:2097-2110. doi: 10.2147/DDDT.S169238. eCollection 2018.
• [3912] Integrin 9 depletion promotes -catenin degradation to suppress triple-negative breast cancer tumor growth and metastasis.Int J Cancer. 2019 Nov 15;145(10):2767-2780. doi: 10.1002/ijc.32359. Epub 2019 May 3.
• [3913] Upregulation of ITGBL1 predicts poor prognosis and promotes chemoresistance in ovarian cancer.Cancer Biomark. 2020;27(1):51-61. doi: 10.3233/CBM-190460.
• [3914] Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis.BMC Cancer. 2008 Jan 28;8:25. doi: 10.1186/1471-2407-8-25.
• [3915] Inter-alpha Inhibitor H4 as a Potential Biomarker Predicting the Treatment Outcomes in Patients with Hepatocellular Carcinoma.Cancer Res Treat. 2018 Jul;50(3):646-657. doi: 10.4143/crt.2016.550. Epub 2017 Jul 17.
• [3916] ITIH5 mediates epigenetic reprogramming of breast cancer cells.Mol Cancer. 2017 Feb 23;16(1):44. doi: 10.1186/s12943-017-0610-2.
• [3917] Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance.J Clin Invest. 2019 May 13;129(6):2431-2445. doi: 10.1172/JCI124550. eCollection 2019 May 13.
• [3918] Assessment of cellular and serum proteome from tongue squamous cell carcinoma patient lacking addictive proclivities for tobacco, betel nut, and alcohol: Case study.J Cell Biochem. 2018 Jul;119(7):5186-5221. doi: 10.1002/jcb.26554. Epub 2018 Mar 25.
• [3919] Epigenetic IVD Tests for Personalized Precision Medicine in Cancer.Front Genet. 2019 Jun 28;10:621. doi: 10.3389/fgene.2019.00621. eCollection 2019.
• [3920] Total inhibition of involucrin synthesis by a novel two-step antisense procedure. Further examination of the relationship between differentiation and malignancy in hybrid cells.J Cell Sci. 1992 Aug;102 ( Pt 4):799-805. doi: 10.1242/jcs.102.4.799.
• [3921] Effect of the parvovirus H-1 non-structural protein NS1 on the tumorigenicity of human gastric cancer cells.J Dig Dis. 2012 Jul;13(7):366-73. doi: 10.1111/j.1751-2980.2012.00601.x.
• [3922] Jade family PHD finger 3 (JADE3) increases cancer stem cell-like properties and tumorigenicity in colon cancer.Cancer Lett. 2018 Aug 1;428:1-11. doi: 10.1016/j.canlet.2018.04.012. Epub 2018 Apr 13.
• [3923] Junctional adhesion molecule C (JAM-C) dimerization aids cancer cell migration and metastasis.Biochim Biophys Acta Mol Cell Res. 2018 Apr;1865(4):638-649. doi: 10.1016/j.bbamcr.2018.01.008. Epub 2018 Jan 31.
• [3924] Refining the prostate cancer genetic association within the JAZF1 gene on chromosome 7p15.2.Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1349-55. doi: 10.1158/1055-9965.EPI-09-1181. Epub 2010 Apr 20.
• [3925] Jun Dimerization Protein 2 Activates Mc2r Transcriptional Activity: Role of Phosphorylation and SUMOylation.Int J Mol Sci. 2017 Jan 31;18(2):304. doi: 10.3390/ijms18020304.
• [3926] 2-(2-nitrobenzylidene) indolin-3-one compound inhibits transmembrane prostate androgen-induced protein (TMEPAI) expression and cancer cell proliferation.Cell Prolif. 2018 Oct;51(5):e12469. doi: 10.1111/cpr.12469. Epub 2018 Aug 2.
• [3927] Inhibition of JMJD6 expression reduces the proliferation, migration and invasion of neuroglioma stem cells.Neoplasma. 2017;64(5):700-708. doi: 10.4149/neo_2017_507.
• [3928] JOSD1 inhibits mitochondrial apoptotic signalling to drive acquired chemoresistance in gynaecological cancer by stabilizing MCL1.Cell Death Differ. 2020 Jan;27(1):55-70. doi: 10.1038/s41418-019-0339-0. Epub 2019 May 1.
• [3929] JRK is a positive regulator of -catenin transcriptional activity commonly overexpressed in colon, breast and ovarian cancer.Oncogene. 2016 Jun 2;35(22):2834-41. doi: 10.1038/onc.2015.347. Epub 2015 Oct 12.
• [3930] Suppression of Oncolytic Adenovirus-Mediated Hepatotoxicity by Liver-Specific Inhibition of NF-B.Mol Ther Oncolytics. 2017 Oct 26;7:76-85. doi: 10.1016/j.omto.2017.10.003. eCollection 2017 Dec 15.
• [3931] Risk of ovarian cancer and inherited variants in relapse-associated genes.PLoS One. 2010 Jan 27;5(1):e8884. doi: 10.1371/journal.pone.0008884.
• [3932] Lysyl-tRNA synthetase-expressing colon spheroids induce M2 macrophage polarization to promote metastasis.J Clin Invest. 2018 Nov 1;128(11):5034-5055. doi: 10.1172/JCI99806. Epub 2018 Oct 8.
• [3933] Nonhistone targets of KAT2A and KAT2B implicated in cancer biology (1).Biochem Cell Biol. 2019 Feb;97(1):30-45. doi: 10.1139/bcb-2017-0297. Epub 2018 Apr 19.
• [3934] miR-639 Expression Is Silenced by DNMT3A-Mediated Hypermethylation and Functions as a Tumor Suppressor in Liver Cancer Cells.Mol Ther. 2020 Feb 5;28(2):587-598. doi: 10.1016/j.ymthe.2019.11.021. Epub 2019 Nov 28.
• [3935] Bimetallic ZrHf-based metal-organic framework embedded with carbon dots: Ultra-sensitive platform for early diagnosis of HER2 and HER2-overexpressed living cancer cells.Biosens Bioelectron. 2019 Jun 1;134:8-15. doi: 10.1016/j.bios.2019.03.043. Epub 2019 Mar 22.
• [3936] The zinc-finger protein KCMF1 is overexpressed during pancreatic cancer development and downregulation of KCMF1 inhibits pancreatic cancer development in mice.Oncogene. 2010 Jul 15;29(28):4058-67. doi: 10.1038/onc.2010.156. Epub 2010 May 17.
• [3937] KDELR2 Promotes Glioblastoma Tumorigenesis Targeted by HIF1a via mTOR Signaling Pathway.Cell Mol Neurobiol. 2019 Nov;39(8):1207-1215. doi: 10.1007/s10571-019-00715-2. Epub 2019 Jul 25.
• [3938] UTX Mutations in Human Cancer.Cancer Cell. 2019 Feb 11;35(2):168-176. doi: 10.1016/j.ccell.2019.01.001.
• [3939] Soybean (Glycine max) prevents the progression of breast cancer cells by downregulating the level of histone demethylase JMJD5.J Cancer Res Ther. 2018 Sep;14(Supplement):S609-S615. doi: 10.4103/0973-1482.187292.
• [3940] FVT-1, a novel human transcription unit affected by variant translocation t(2;18)(p11;q21) of follicular lymphoma.Blood. 1993 Jan 1;81(1):136-42.
• [3941] Antiangiogenic Therapeutic Potential of Peptides Derived from the Molecular Motor KIF13B that Transports VEGFR2 to Plasmalemma in Endothelial Cells.Am J Pathol. 2017 Jan;187(1):214-224. doi: 10.1016/j.ajpath.2016.09.010. Epub 2016 Nov 15.
• [3942] Bioinformatics Analysis Suggests the Combined Expression of AURKB and KIF18B Being an Important Event in the Development of Clear Cell Renal Cell Carcinoma.Pathol Oncol Res. 2020 Jul;26(3):1583-1594. doi: 10.1007/s12253-019-00740-y. Epub 2019 Sep 5.
• [3943] Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers.Nat Genet. 2010 Sep;42(9):755-8. doi: 10.1038/ng.638. Epub 2010 Aug 1.
• [3944] KIF20A silence inhibits the migration, invasion and proliferation of non-small cell lung cancer and regulates the JNK pathway.Clin Exp Pharmacol Physiol. 2020 Jan;47(1):135-142. doi: 10.1111/1440-1681.13183. Epub 2019 Oct 22.
• [3945] Prognostic significance of KIF2A and KIF20A expression in human cancer: A systematic review and meta-analysis.Medicine (Baltimore). 2019 Nov;98(46):e18040. doi: 10.1097/MD.0000000000018040.
• [3946] Methylation-mediated repression of MiR-424/503 cluster promotes proliferation and migration of ovarian cancer cells through targeting the hub gene KIF23.Cell Cycle. 2019 Jul;18(14):1601-1618. doi: 10.1080/15384101.2019.1624112. Epub 2019 Jun 9.
• [3947] KIF2C exerts an oncogenic role in nonsmall cell lung cancer and is negatively regulated by miR-325-3p.Cell Biochem Funct. 2019 Aug;37(6):424-431. doi: 10.1002/cbf.3420. Epub 2019 Jul 22.
• [3948] Enhanced expression of KIF4A in colorectal cancer is associated with lymph node metastasis.Oncol Lett. 2018 Feb;15(2):2188-2194. doi: 10.3892/ol.2017.7555. Epub 2017 Dec 8.
• [3949] Selective RET kinase inhibition for patients with RET-altered cancers.Ann Oncol. 2018 Aug 1;29(8):1869-1876. doi: 10.1093/annonc/mdy137.
• [3950] Prognostic and clinicopathological significance of kinesin family member C1 in various cancers: A meta-analysis.Medicine (Baltimore). 2019 Oct;98(40):e17346. doi: 10.1097/MD.0000000000017346.
• [3951] Molecular Profiling Establishes Genetic Features Predictive of the Efficacy of the p110 Inhibitor KIN-193.Cancer Res. 2019 Sep 1;79(17):4524-4531. doi: 10.1158/0008-5472.CAN-19-0588. Epub 2019 Jul 10.
• [3952] Survey and evaluation of mutations in the human KLF1 transcription unit.Sci Rep. 2018 Apr 26;8(1):6587. doi: 10.1038/s41598-018-24962-3.
• [3953] KLF10 as a Tumor Suppressor Gene and Its TGF- Signaling.Cancers (Basel). 2018 May 25;10(6):161. doi: 10.3390/cancers10060161.
• [3954] A novel role of the Sp/KLF transcription factor KLF11 in arresting progression of endometriosis.PLoS One. 2013;8(3):e60165. doi: 10.1371/journal.pone.0060165. Epub 2013 Mar 28.
• [3955] Krppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression.Int J Cancer. 2009 Oct 15;125(8):1859-67. doi: 10.1002/ijc.24538.
• [3956] Overexpression of KLF13 and FGFR3 in oral cancer cells.Cytogenet Genome Res. 2010 Jun;128(4):192-8. doi: 10.1159/000308303. Epub 2010 Jun 2.
• [3957] KLF15 promotes the proliferation and metastasis of lung adenocarcinoma cells and has potential as a cancer prognostic marker.Oncotarget. 2017 Oct 19;8(66):109952-109961. doi: 10.18632/oncotarget.21972. eCollection 2017 Dec 15.
• [3958] NEAT1/miR-23a-3p/KLF3: a novel regulatory axis in melanoma cancer progression.Cancer Cell Int. 2019 Aug 22;19:217. doi: 10.1186/s12935-019-0927-6. eCollection 2019.
• [3959] Multifunctional lipid-coated calcium phosphate nanoplatforms for complete inhibition of large triple negative breast cancer via targeted combined therapy.Biomaterials. 2019 Sep;216:119232. doi: 10.1016/j.biomaterials.2019.119232. Epub 2019 May 31.
• [3960] Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells. Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14920-5. doi: 10.1073/pnas.0904231106. Epub 2009 Aug 12.
• [3961] KLHL5 knockdown increases cellular sensitivity to anticancer drugs.Oncotarget. 2018 Dec 21;9(100):37429-37438. doi: 10.18632/oncotarget.26462. eCollection 2018 Dec 21.
• [3962] KLHL6 is a tumor suppressor gene in diffuse large B-cell lymphoma.Cell Cycle. 2019 Feb;18(3):249-256. doi: 10.1080/15384101.2019.1568765. Epub 2019 Jan 24.
• [3963] Prognostic value of the cancer oncogene Kelch-like 6 in gastric cancer.Br J Surg. 2017 Dec;104(13):1847-1856. doi: 10.1002/bjs.10628. Epub 2017 Oct 17.
• [3964] Anionic carboxymethylagarose-based pH-responsive smart superabsorbent hydrogels for controlled release of anticancer drug.Int J Biol Macromol. 2019 Mar 1;124:1220-1229. doi: 10.1016/j.ijbiomac.2018.12.045. Epub 2018 Dec 4.
• [3965] Splice-site genetic polymorphism of the human kallikrein 12 (KLK12) gene correlates with no substantial expression of KLK12 protein having serine protease activity.Hum Mutat. 2004 Sep;24(3):273-4. doi: 10.1002/humu.9270.
• [3966] Epigenetic activation of human kallikrein 13 enhances malignancy of lung adenocarcinoma by promoting N-cadherin expression and laminin degradation.Biochem Biophys Res Commun. 2011 Jun 10;409(3):442-7. doi: 10.1016/j.bbrc.2011.05.022. Epub 2011 May 8.
• [3967] Biochemical characterization of human tissue kallikrein 15 and examination of its potential role in cancer.Clin Biochem. 2018 Aug;58:108-115. doi: 10.1016/j.clinbiochem.2018.06.007. Epub 2018 Jun 18.
• [3968] MLL5 Orchestrates a Cancer Self-Renewal State by Repressing the Histone Variant H3.3 and Globally Reorganizing Chromatin.Cancer Cell. 2015 Dec 14;28(6):715-729. doi: 10.1016/j.ccell.2015.10.005. Epub 2015 Nov 25.
• [3969] Targeted Knockdown of the Kinetochore Protein D40/Knl-1 Inhibits Human Cancer in a p53 Status-Independent Manner.Sci Rep. 2015 Sep 8;5:13676. doi: 10.1038/srep13676.
• [3970] shRNAmediated knockdown of KNTC1 suppresses cell viability and induces apoptosis in esophageal squamous cell carcinoma.Int J Oncol. 2019 Mar;54(3):1053-1060. doi: 10.3892/ijo.2019.4672. Epub 2019 Jan 3.
• [3971] The emerging roles of KPNA2 in cancer.Life Sci. 2020 Jan 15;241:117140. doi: 10.1016/j.lfs.2019.117140. Epub 2019 Dec 6.
• [3972] Keratin 14-high subpopulation mediates lung cancer metastasis potentially through Gkn1 upregulation.Oncogene. 2019 Sep;38(36):6354-6369. doi: 10.1038/s41388-019-0889-0. Epub 2019 Jul 18.
• [3973] Aberrant cytokeratin expression during arsenic-induced acquired malignant phenotype in human HaCaT keratinocytes consistent with epidermal carcinogenesis.Toxicology. 2009 Aug 3;262(2):162-70. doi: 10.1016/j.tox.2009.06.003. Epub 2009 Jun 12.
• [3974] Keratin 16 regulates innate immunity in response to epidermal barrier breach.Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):19537-42. doi: 10.1073/pnas.1309576110. Epub 2013 Nov 11.
• [3975] Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth.Cell Death Dis. 2017 Jul 27;8(7):e2961. doi: 10.1038/cddis.2017.339.
• [3976] Eight potential biomarkers for distinguishing between lung adenocarcinoma and squamous cell carcinoma.Oncotarget. 2017 May 3;8(42):71759-71771. doi: 10.18632/oncotarget.17606. eCollection 2017 Sep 22.
• [3977] Downregulation of keratin 76 expression during oral carcinogenesis of human, hamster and mouse.PLoS One. 2013 Jul 30;8(7):e70688. doi: 10.1371/journal.pone.0070688. Print 2013.
• [3978] Therapeutic effects of lentinan on inflammatory bowel disease and colitis-associated cancer.J Cell Mol Med. 2019 Feb;23(2):750-760. doi: 10.1111/jcmm.13897. Epub 2018 Nov 24.
• [3979] Differentiation Therapy Targeting the -Catenin/CBP Interaction in Pancreatic Cancer.Cancers (Basel). 2018 Mar 29;10(4):95. doi: 10.3390/cancers10040095.
• [3980] RNA-binding protein L1TD1 interacts with LIN28 via RNA and is required for human embryonic stem cell self-renewal and cancer cell proliferation.Stem Cells. 2012 Mar;30(3):452-60. doi: 10.1002/stem.1013.
• [3981] L3MBTL1 polycomb protein, a candidate tumor suppressor in del(20q12) myeloid disorders, is essential for genome stability.Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22552-7. doi: 10.1073/pnas.1017092108. Epub 2010 Dec 13.
• [3982] Upregulation of miR-374a promotes tumor metastasis and progression by downregulating LACTB and predicts unfavorable prognosis in breast cancer.Cancer Med. 2018 Jul;7(7):3351-3362. doi: 10.1002/cam4.1576. Epub 2018 May 23.
• [3983] Laminin alpha 2 enables glioblastoma stem cell growth.Ann Neurol. 2012 Nov;72(5):766-78. doi: 10.1002/ana.23674.
• [3984] Identification of the first dominant mutation of LAMA5 gene causing a complex multisystem syndrome due to dysfunction of the extracellular matrix. J Med Genet. 2017 Oct;54(10):710-720. doi: 10.1136/jmedgenet-2017-104555. Epub 2017 Jul 22.
• [3985] Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement.Am J Surg Pathol. 1996;20 Suppl 1:S8-22. doi: 10.1097/00000478-199600001-00003.
• [3986] Laminin gene LAMB4 is somatically mutated and expressionally altered in gastric and colorectal cancers.APMIS. 2015 Jan;123(1):65-71. doi: 10.1111/apm.12309. Epub 2014 Sep 25.
• [3987] miR-506 contributes to malignancy of cutaneous squamous cell carcinoma via targeting of P65 and LAMC1.Cell Cycle. 2019 Feb;18(3):333-345. doi: 10.1080/15384101.2019.1568747. Epub 2019 Jan 24.
• [3988] A novel messenger RNA and long noncoding RNA signature associated with the progression of nonmuscle invasive bladder cancer.J Cell Biochem. 2019 May;120(5):8101-8109. doi: 10.1002/jcb.28089. Epub 2018 Nov 13.
• [3989] Oncoprotein LAMTOR5 Activates GLUT1 Via Upregulating NF-B in Liver Cancer.Open Med (Wars). 2019 Feb 26;14:264-270. doi: 10.1515/med-2019-0022. eCollection 2019.
• [3990] Stage-specific expression of Clast6/E3/LAPTM5 during B cell differentiation: elevated expression in human B lymphomas.Int J Oncol. 2003 Feb;22(2):301-4.
• [3991] Expression of La Ribonucleoprotein Domain Family Member 4B (LARP4B) in Liver Cancer and Their Clinical and Prognostic Significance.Dis Markers. 2019 Oct 22;2019:1569049. doi: 10.1155/2019/1569049. eCollection 2019.
• [3992] Identification of N-arylsulfonylpyrimidones as anticancer agents.Arch Pharm Res. 2018 Mar;41(3):251-258. doi: 10.1007/s12272-018-1003-9. Epub 2018 Jan 13.
• [3993] Linker for activation of T-cell family member2 (LAT2) a lipid raft adaptor protein for AKT signaling, is an early mediator of alkylphospholipid anti-leukemic activity. Mol Cell Proteomics. 2012 Dec;11(12):1898-912. doi: 10.1074/mcp.M112.019661. Epub 2012 Sep 22.
• [3994] LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.Front Immunol. 2019 Jan 29;10:6. doi: 10.3389/fimmu.2019.00006. eCollection 2019.
• [3995] Genotype-phenotype correlation of xeroderma pigmentosum in a Chinese Han population.Br J Dermatol. 2015 Apr;172(4):1096-102. doi: 10.1111/bjd.13429. Epub 2015 Feb 27.
• [3996] Enhancer long-range contacts: The multi-adaptor protein LDB1 is the tie that binds.Biochim Biophys Acta Gene Regul Mech. 2019 Jun;1862(6):625-633. doi: 10.1016/j.bbagrm.2019.04.003. Epub 2019 Apr 22.
• [3997] TSC22D2 interacts with PKM2 and inhibits cell growth in colorectal cancer.Int J Oncol. 2016 Sep;49(3):1046-56. doi: 10.3892/ijo.2016.3599. Epub 2016 Jul 4.
• [3998] Secreted Gal-3BP is a novel promising target for non-internalizing Antibody-Drug Conjugates.J Control Release. 2019 Jan 28;294:176-184. doi: 10.1016/j.jconrel.2018.12.018. Epub 2018 Dec 13.
• [3999] Detection of malignancy-associated phosphoproteome changes in human colorectal cancer induced by cell surface binding of growth-inhibitory galectin-4.IUBMB Life. 2019 Mar;71(3):364-375. doi: 10.1002/iub.1987. Epub 2018 Dec 14.
• [4000] Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients.Ann Neurol. 2017 Jul;82(1):79-92. doi: 10.1002/ana.24979.
• [4001] Leucine-rich glioma inactivated 3: Integrative analyses reveal its potential prognostic role in cancer.Mol Med Rep. 2018 Mar;17(3):3993-4002. doi: 10.3892/mmr.2017.8279. Epub 2017 Dec 14.
• [4002] Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning.Cancer Res. 2008 Apr 1;68(7):2489-97. doi: 10.1158/0008-5472.CAN-07-3194.
• [4003] Specific Fluorescent Probe for Protein Histidine Phosphatase Activity.ACS Sens. 2019 Apr 26;4(4):1055-1062. doi: 10.1021/acssensors.9b00242. Epub 2019 Apr 3.
• [4004] LHX2 promotes malignancy and inhibits autophagy via mTOR in osteosarcoma and is negatively regulated by miR-129-5p.Aging (Albany NY). 2019 Nov 13;11(21):9794-9810. doi: 10.18632/aging.102427. Epub 2019 Nov 13.
• [4005] Inhibition of miR-214-3p Aids in Preventing Epithelial Ovarian Cancer Malignancy by Increasing the Expression of LHX6.Cancers (Basel). 2019 Dec 2;11(12):1917. doi: 10.3390/cancers11121917.
• [4006] Identification and characterization of novel ligase I inhibitors.Mol Carcinog. 2017 Feb;56(2):550-566. doi: 10.1002/mc.22516. Epub 2016 Jun 27.
• [4007] LIG3 gene polymorphisms and risk of gastric cancer in a Southern Chinese population.Gene. 2019 Jul 15;705:90-94. doi: 10.1016/j.gene.2019.04.072. Epub 2019 Apr 26.
• [4008] Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasis.Int J Cancer. 2018 Nov 15;143(10):2537-2550. doi: 10.1002/ijc.31786. Epub 2018 Sep 19.
• [4009] LIMCH1 suppress the growth of lung cancer by interacting with HUWE1 to sustain p53 stability.Gene. 2019 Sep 5;712:143963. doi: 10.1016/j.gene.2019.143963. Epub 2019 Jul 5.
• [4010] Overexpression of lipid metabolism genes and PBX1 in the contralateral breasts of women with estrogen receptor-negative breast cancer.Int J Cancer. 2017 Jun 1;140(11):2484-2497. doi: 10.1002/ijc.30680. Epub 2017 Mar 21.
• [4011] PINCH-1 interacts with myoferlin to promote breast cancer progression and metastasis.Oncogene. 2020 Mar;39(10):2069-2087. doi: 10.1038/s41388-019-1135-5. Epub 2019 Dec 4.
• [4012] PINCH-2 expression in cancers involving serosal effusions using quantitative PCR.Cytopathology. 2011 Feb;22(1):22-9. doi: 10.1111/j.1365-2303.2010.00757.x.
• [4013] Long noncoding RNA CASC9 promotes LIN7A expression via miR-758-3p to facilitate the malignancy of ovarian cancer.J Cell Physiol. 2019 Jul;234(7):10800-10808. doi: 10.1002/jcp.27903. Epub 2018 Dec 7.
• [4014] Mitotic Vulnerability in Triple-Negative Breast Cancer Associated with LIN9 Is Targetable with BET Inhibitors.Cancer Res. 2017 Oct 1;77(19):5395-5408. doi: 10.1158/0008-5472.CAN-17-1571. Epub 2017 Aug 14.
• [4015] Metabolic enzymes expressed by cancer cells impact the immune infiltrate.Oncoimmunology. 2019 Mar 30;8(6):e1571389. doi: 10.1080/2162402X.2019.1571389. eCollection 2019.
• [4016] Lipase member H is a downstream molecular target of hypoxia inducible factor-1 and promotes papillary thyroid carcinoma cell migration in BCPAP and KTC-1 cell lines.Cancer Manag Res. 2019 Jan 22;11:931-941. doi: 10.2147/CMAR.S183355. eCollection 2019.
• [4017] LITAF is a potential tumor suppressor in pancreatic cancer.Oncotarget. 2017 Dec 14;9(3):3131-3142. doi: 10.18632/oncotarget.23220. eCollection 2018 Jan 9.
• [4018] LLGL2 rescues nutrient stress by promoting leucine uptake in ER(+) breast cancer.Nature. 2019 May;569(7755):275-279. doi: 10.1038/s41586-019-1126-2. Epub 2019 Apr 17.
• [4019] Inhibition of MSP-RON signaling pathway in cancer cells by a novel soluble form of RON comprising the entire sema sequence.Int J Oncol. 2010 Jun;36(6):1551-61. doi: 10.3892/ijo_00000642.
• [4020] Lamin B1 loss promotes lung cancer development and metastasis by epigenetic derepression of RET.J Exp Med. 2019 Jun 3;216(6):1377-1395. doi: 10.1084/jem.20181394. Epub 2019 Apr 23.
• [4021] Lamin B2 binding to minichromosome maintenance complex component 7 promotes non-small cell lung carcinogenesis.Oncotarget. 2017 Aug 18;8(62):104813-104830. doi: 10.18632/oncotarget.20338. eCollection 2017 Dec 1.
• [4022] LMO1 is a novel oncogene in colorectal cancer and its overexpression is a new predictive marker for anti-EGFR therapy.Tumour Biol. 2014 Aug;35(8):8161-7. doi: 10.1007/s13277-014-2066-y. Epub 2014 May 21.
• [4023] Integrative genomics identifies LMO1 as a neuroblastoma oncogene.Nature. 2011 Jan 13;469(7329):216-20. doi: 10.1038/nature09609. Epub 2010 Dec 1.
• [4024] Unraveling the Function of Lemur Tyrosine Kinase 2 Network.Front Pharmacol. 2019 Jan 29;10:24. doi: 10.3389/fphar.2019.00024. eCollection 2019.
• [4025] An epigenetic marker panel for screening and prognostic prediction of ovarian cancer.Int J Cancer. 2009 Jan 15;124(2):387-93. doi: 10.1002/ijc.23957.
• [4026] Suppression of cancer stemness by upregulating Ligand-of-Numb protein X1 in colorectal carcinoma.PLoS One. 2017 Nov 30;12(11):e0188665. doi: 10.1371/journal.pone.0188665. eCollection 2017.
• [4027] Lon Peptidase 2, Peroxisomal (LONP2) Contributes to Cervical Carcinogenesis via Oxidative Stress.Med Sci Monit. 2018 Mar 4;24:1310-1320. doi: 10.12659/msm.908966.
• [4028] Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo.Cancer Res. 2003 Apr 1;63(7):1657-66.
• [4029] The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis.J Cell Mol Med. 2019 Mar;23(3):1759-1770. doi: 10.1111/jcmm.14074. Epub 2018 Dec 9.
• [4030] Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis.Mol Cancer. 2019 Jan 31;18(1):18. doi: 10.1186/s12943-019-0948-8.
• [4031] Lipin-1 regulation of phospholipid synthesis maintains endoplasmic reticulum homeostasis and is critical for triple-negative breast cancer cell survival.FASEB J. 2017 Jul;31(7):2893-2904. doi: 10.1096/fj.201601353R. Epub 2017 Mar 27.
• [4032] Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance.J Clin Invest. 2018 Feb 1;128(2):589-606. doi: 10.1172/JCI95200. Epub 2017 Dec 18.
• [4033] Leupaxin Promotes Bladder Cancer Proliferation, Metastasis, and Angiogenesis Through the PI3K/AKT Pathway.Cell Physiol Biochem. 2018;47(6):2250-2260. doi: 10.1159/000491536. Epub 2018 Jul 5.
• [4034] Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.PLoS One. 2008 Apr 30;3(4):e2079. doi: 10.1371/journal.pone.0002079.
• [4035] Long non-coding RNA FAM84B-AS promotes resistance of gastric cancer to platinum drugs through inhibition of FAM84B expression.Biochem Biophys Res Commun. 2019 Feb 12;509(3):753-762. doi: 10.1016/j.bbrc.2018.12.177. Epub 2019 Jan 9.
• [4036] A protein interaction network centered on leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) regulates growth factor receptors.J Biol Chem. 2018 Mar 2;293(9):3421-3435. doi: 10.1074/jbc.M117.807487. Epub 2018 Jan 9.
• [4037] LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor.Br J Cancer. 2013 May 14;108(9):1765-70. doi: 10.1038/bjc.2013.138. Epub 2013 Apr 4.
• [4038] Recombinant human TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer: the effect of pre-treatment with furosemide and furosemide plus lithium.Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):242-9. doi: 10.1007/s00259-009-1254-2. Epub 2009 Sep 4.
• [4039] Frequent overexpression, but not activation by point mutation, of ras genes in primary human gastric cancers.Gastroenterology. 1987 Dec;93(6):1339-45. doi: 10.1016/0016-5085(87)90264-2.
• [4040] Protective role of LRRC3B in preventing breast cancer metastasis and recurrence post-bupivacaine.Oncol Lett. 2017 Oct;14(4):5013-5017. doi: 10.3892/ol.2017.6773. Epub 2017 Aug 18.
• [4041] TTYH1 and TTYH2 Serve as LRRC8A-Independent Volume-Regulated Anion Channels in Cancer Cells.Cells. 2019 Jun 9;8(6):562. doi: 10.3390/cells8060562.
• [4042] Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951.Blood. 2004 Jan 15;103(2):442-50. doi: 10.1182/blood-2003-05-1495. Epub 2003 Sep 22.
• [4043] LST1: A multifunctional gene encoded in the MHC class III region.Immunobiology. 2018 Nov;223(11):699-708. doi: 10.1016/j.imbio.2018.07.018. Epub 2018 Jul 17.
• [4044] The function of ORAOV1/LTO1, a gene that is overexpressed frequently in cancer: essential roles in the function and biogenesis of the ribosome.Oncogene. 2014 Jan 23;33(4):484-94. doi: 10.1038/onc.2012.604. Epub 2013 Jan 14.
• [4045] The association between nonalcoholic fatty liver disease and risk of colorectal adenoma and cancer incident and recurrence: a meta-analysis of observational studies.Expert Rev Gastroenterol Hepatol. 2019 Apr;13(4):385-395. doi: 10.1080/17474124.2019.1580143. Epub 2019 Feb 19.
• [4046] Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancreatic ductal adenocarcinoma.Cell Death Differ. 2019 Jan;26(2):382-393. doi: 10.1038/s41418-018-0207-3. Epub 2018 Oct 3.
• [4047] The putative tumour suppressor protein Latexin is secreted by prostate luminal cells and is downregulated in malignancy.Sci Rep. 2019 Mar 26;9(1):5120. doi: 10.1038/s41598-019-41379-8.
• [4048] LY6E: a conductor of malignant tumor growth through modulation of the PTEN/PI3K/Akt/HIF-1 axis.Oncotarget. 2016 Oct 4;7(40):65837-65848. doi: 10.18632/oncotarget.11670.
• [4049] LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas data.BMC Cancer. 2018 May 2;18(1):494. doi: 10.1186/s12885-018-4429-z.
• [4050] Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.PLoS Genet. 2018 Apr 23;14(4):e1007352. doi: 10.1371/journal.pgen.1007352. eCollection 2018 Apr.
• [4051] Preclinical Antitumor Efficacy of BAY 1129980-a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody-Drug Conjugate for the Treatment of Non-Small Cell Lung Cancer.Mol Cancer Ther. 2017 May;16(5):893-904. doi: 10.1158/1535-7163.MCT-16-0474. Epub 2017 Mar 14.
• [4052] The driver landscape of sporadic chordoma.Nat Commun. 2017 Oct 12;8(1):890. doi: 10.1038/s41467-017-01026-0.
• [4053] MicroRNA-135b Regulates Leucine Zipper Tumor Suppressor 1 in Cutaneous Squamous Cell Carcinoma.PLoS One. 2015 May 4;10(5):e0125412. doi: 10.1371/journal.pone.0125412. eCollection 2015.
• [4054] LAPSER1 is a putative cytokinetic tumor suppressor that shows the same centrosome and midbody subcellular localization pattern as p80 katanin.FASEB J. 2007 Jul;21(9):2086-100. doi: 10.1096/fj.06-7254com. Epub 2007 Mar 9.
• [4055] MacroD1 Is a Promiscuous ADP-Ribosyl Hydrolase Localized to Mitochondria.Front Microbiol. 2018 Jan 23;9:20. doi: 10.3389/fmicb.2018.00020. eCollection 2018.
• [4056] Mono-ADP-Ribosylhydrolase MACROD2 Is Dispensable for Murine Responses to Metabolic and Genotoxic Insults.Front Genet. 2018 Dec 12;9:654. doi: 10.3389/fgene.2018.00654. eCollection 2018.
• [4057] Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis.Breast Cancer Res Treat. 2018 May;169(1):83-92. doi: 10.1007/s10549-017-4656-z. Epub 2018 Jan 16.
• [4058] A new MAFia in cancer.Nat Rev Cancer. 2008 Sep;8(9):683-93. doi: 10.1038/nrc2460.
• [4059] The RNA polymerase III repressor MAF1 is regulated by ubiquitin-dependent proteasome degradation and modulates cancer drug resistance and apoptosis. J Biol Chem. 2019 Dec 13;294(50):19255-19268. doi: 10.1074/jbc.RA119.008849. Epub 2019 Oct 23.
• [4060] DNA methylation and nucleosome occupancy regulate the cancer germline antigen gene MAGEA11.Epigenetics. 2013 Aug;8(8):849-63. doi: 10.4161/epi.25500. Epub 2013 Jul 9.
• [4061] Identification of MAGEA12 as a prognostic outlier gene in gastric cancers.Neoplasma. 2017;64(2):238-243. doi: 10.4149/neo_2017_210.
• [4062] Aberrant demethylation and expression of MAGEB2 in a subset of malignant peripheral nerve sheath tumors from neurofibromatosis type 1.J Dermatol Sci. 2016 Feb;81(2):118-23. doi: 10.1016/j.jdermsci.2015.11.004. Epub 2015 Nov 28.
• [4063] Drivers of 30- and 90-day Postoperative Death After Neoadjuvant Chemoradiation for Esophageal Cancer.Ann Thorac Surg. 2020 Mar;109(3):921-926. doi: 10.1016/j.athoracsur.2019.10.057. Epub 2019 Dec 14.
• [4064] Dlxin-1, a member of MAGE family, inhibits cell proliferation, invasion and tumorigenicity of glioma stem cells.Cancer Gene Ther. 2011 Mar;18(3):206-18. doi: 10.1038/cgt.2010.71. Epub 2010 Nov 26.
• [4065] Melanoma antigen-D2 controls cell cycle progression and modulates the DNA damage response.Biochem Pharmacol. 2018 Jul;153:217-229. doi: 10.1016/j.bcp.2018.01.035. Epub 2018 Feb 1.
• [4066] Opa interacting protein 5 (OIP5) is a novel cancer-testis specific gene in gastric cancer.Ann Surg Oncol. 2007 Feb;14(2):885-92. doi: 10.1245/s10434-006-9121-x. Epub 2006 Dec 7.
• [4067] Design, synthesis and biological evaluation of novel ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as potent carbonic anhydrase IX inhibitors.Bioorg Chem. 2019 Feb;82:117-122. doi: 10.1016/j.bioorg.2018.10.005. Epub 2018 Oct 5.
• [4068] Cytosolic Iron-Sulfur Assembly Is Evolutionarily Tuned by a Cancer-Amplified Ubiquitin Ligase.Mol Cell. 2018 Jan 4;69(1):113-125.e6. doi: 10.1016/j.molcel.2017.11.010. Epub 2017 Dec 7.
• [4069] Apoptosis-related protein-1 acts as a tumor suppressor in cholangiocarcinoma cells by inducing cell cycle arrest via downregulation of cyclin-dependent kinase subunits.Oncol Rep. 2016 Feb;35(2):809-16. doi: 10.3892/or.2015.4422. Epub 2015 Nov 16.
• [4070] MAGI2 is an independent predictor of biochemical recurrence in prostate cancer.Prostate. 2018 Jun;78(8):616-622. doi: 10.1002/pros.23506. Epub 2018 Mar 14.
• [4071] Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancer.Nat Genet. 2018 Jul;50(7):937-943. doi: 10.1038/s41588-018-0155-3. Epub 2018 Jun 28.
• [4072] Contribution of MAML1 in esophageal squamous cell carcinoma tumorigenesis.Ann Diagn Pathol. 2017 Apr;27:79-82. doi: 10.1016/j.anndiagpath.2017.01.010. Epub 2017 Feb 1.
• [4073] CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB-MYC involvement.Proc Natl Acad Sci U S A. 2014 Aug 12;111(32):E3260-8. doi: 10.1073/pnas.1319176111. Epub 2014 Jul 28.
• [4074] Mastermind-Like 3 Controls Proliferation and Differentiation in Neuroblastoma.Mol Cancer Res. 2016 May;14(5):411-22. doi: 10.1158/1541-7786.MCR-15-0291-T. Epub 2016 Jan 19.
• [4075] ERManI is a target of miR-125b and promotes transformation phenotypes in hepatocellular carcinoma (HCC).PLoS One. 2013 Aug 5;8(8):e72829. doi: 10.1371/journal.pone.0072829. Print 2013.
• [4076] Discovery of the cancer cell selective dual acting anti-cancer agent (Z)-2-(1H-indol-3-yl)-3-(isoquinolin-5-yl)acrylonitrile (A131).Eur J Med Chem. 2018 Aug 5;156:344-367. doi: 10.1016/j.ejmech.2018.07.011. Epub 2018 Jul 7.
• [4077] Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in Cancer.Cancers (Basel). 2018 May 3;10(5):131. doi: 10.3390/cancers10050131.
• [4078] Outcomes and Safety Among Patients With Obstructive Sleep Apnea Undergoing Cancer Surgery Procedures in a Freestanding Ambulatory Surgical Facility.Anesth Analg. 2019 Aug;129(2):360-368. doi: 10.1213/ANE.0000000000004111.
• [4079] Expression of the microtubule-associated protein MAP9/ASAP and its partners AURKA and PLK1 in colorectal and breast cancers.Dis Markers. 2014;2014:798170. doi: 10.1155/2014/798170. Epub 2014 Apr 30.
• [4080] MAPK13 is preferentially expressed in gynecological cancer stem cells and has a role in the tumor-initiation.Biochem Biophys Res Commun. 2016 Apr 15;472(4):643-7. doi: 10.1016/j.bbrc.2016.03.004. Epub 2016 Mar 9.
• [4081] MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signaling.J Clin Invest. 2019 Mar 1;129(3):1015-1029. doi: 10.1172/JCI97712. Epub 2019 Jan 28.
• [4082] ARF6-JIP3/4 regulate endosomal tubules for MT1-MMP exocytosis in cancer invasion.J Cell Biol. 2015 Oct 26;211(2):339-58. doi: 10.1083/jcb.201506002.
• [4083] Using patient-reported religious/spiritual concerns to identify patients who accept chaplain interventions in an outpatient oncology setting.Support Care Cancer. 2019 May;27(5):1861-1869. doi: 10.1007/s00520-018-4447-z. Epub 2018 Sep 6.
• [4084] Systems biology: confronting the complexity of cancer.Cancer Res. 2011 Sep 15;71(18):5961-4. doi: 10.1158/0008-5472.CAN-11-1569. Epub 2011 Sep 6.
• [4085] Comparison and screening of different risk assessment models for deep vein thrombosis in patients with solid tumors.J Thromb Thrombolysis. 2019 Aug;48(2):292-298. doi: 10.1007/s11239-019-01840-x.
• [4086] Effect of ALDH2 polymorphism on cancer risk in Asians: A meta-analysis.Medicine (Baltimore). 2019 Mar;98(13):e14855. doi: 10.1097/MD.0000000000014855.
• [4087] Computational Characterization of Suppressive Immune Microenvironments in Glioblastoma.Cancer Res. 2018 Oct 1;78(19):5574-5585. doi: 10.1158/0008-5472.CAN-17-3714. Epub 2018 Jun 19.
• [4088] Pulling a MAST1 on Cisplatin Resistance.Cancer Cell. 2018 Aug 13;34(2):183-185. doi: 10.1016/j.ccell.2018.07.010.
• [4089] Astaxanthin inhibits hallmarks of cancer by targeting the PI3K/NF-/STAT3 signalling axis in oral squamous cell carcinoma models.IUBMB Life. 2019 Oct;71(10):1595-1610. doi: 10.1002/iub.2104. Epub 2019 Jun 28.
• [4090] Targeted endostatin-cytosine deaminase fusion gene therapy plus 5-fluorocytosine suppresses ovarian tumor growth.Oncogene. 2013 Feb 28;32(9):1082-90. doi: 10.1038/onc.2012.134. Epub 2012 May 7.
• [4091] Methyl-CpG-DNA binding proteins in human prostate cancer: expression of CXXC sequence containing MBD1 and repression of MBD2 and MeCP2.Biochem Biophys Res Commun. 2003 Mar 21;302(4):759-66. doi: 10.1016/s0006-291x(03)00253-5.
• [4092] Modification of the base excision repair enzyme MBD4 by the small ubiquitin-like molecule SUMO1.DNA Repair (Amst). 2019 Oct;82:102687. doi: 10.1016/j.dnarep.2019.102687. Epub 2019 Aug 8.
• [4093] Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease.Elife. 2018 Dec 3;7:e39865. doi: 10.7554/eLife.39865.
• [4094] Nelfinavir induces liposarcoma apoptosis through inhibition of regulated intramembrane proteolysis of SREBP-1 and ATF6. Clin Cancer Res. 2011 Apr 1;17(7):1796-806. doi: 10.1158/1078-0432.CCR-10-3216. Epub 2011 Feb 25.
• [4095] DBS is activated by EPHB2/SRC signaling-mediated tyrosine phosphorylation in HEK293 cells.Mol Cell Biochem. 2019 Sep;459(1-2):83-93. doi: 10.1007/s11010-019-03552-5. Epub 2019 May 14.
• [4096] Multiple coagulation factor deficiency protein 2 as a crucial component in metastasis of human oral cancer.Exp Cell Res. 2018 Jul 1;368(1):119-125. doi: 10.1016/j.yexcr.2018.04.021. Epub 2018 Apr 19.
• [4097] Mindfulness and Meditative Movement Interventions for Men Living With Cancer: A Meta-analysis.Ann Behav Med. 2020 Apr 20;54(5):360-373. doi: 10.1093/abm/kaz053.
• [4098] Minichromosome maintenance protein 10 as a marker for proliferation and prognosis in lung cancer.Int J Oncol. 2019 Dec;55(6):1349-1360. doi: 10.3892/ijo.2019.4899. Epub 2019 Oct 14.
• [4099] Decreased expression of germinal center-associated nuclear protein is involved in chromosomal instability in malignant gliomas.Cancer Sci. 2009 Nov;100(11):2069-76. doi: 10.1111/j.1349-7006.2009.01293.x. Epub 2009 Jul 21.
• [4100] MCM5 Expression Is Associated With the Grade of Malignancy and Ki-67 Antigen in LSCC.Anticancer Res. 2019 May;39(5):2325-2335. doi: 10.21873/anticanres.13349. Epub 2019 May 15.
• [4101] Cellular Uptake of MCT1 Inhibitors AR-C155858 and AZD3965 and Their Effects on MCT-Mediated Transport of L-Lactate in Murine 4T1 Breast Tumor Cancer Cells.AAPS J. 2019 Jan 7;21(2):13. doi: 10.1208/s12248-018-0279-5.
• [4102] Knockdown of MSP58 inhibits the proliferation and metastasis in human renal cell carcinoma cells.Biomed Pharmacother. 2017 Jul;91:54-59. doi: 10.1016/j.biopha.2017.04.036. Epub 2017 May 23.
• [4103] New insights into the role of mitochondrial calcium homeostasis in cell migration.Biochem Biophys Res Commun. 2018 May 27;500(1):75-86. doi: 10.1016/j.bbrc.2017.05.039. Epub 2017 May 8.
• [4104] A Newfound association between MDC1 functional polymorphism and lung cancer risk in Chinese.PLoS One. 2014 Sep 8;9(9):e106794. doi: 10.1371/journal.pone.0106794. eCollection 2014.
• [4105] A systematic review of integrative clinical trials for supportive care in pediatric oncology: a report from the International Society of Pediatric Oncology, T&CM collaborative.Support Care Cancer. 2018 Feb;26(2):375-391. doi: 10.1007/s00520-017-3908-0. Epub 2017 Oct 13.
• [4106] Malic enzyme 2 as a potential therapeutic drug target for cancer.IUBMB Life. 2018 Nov;70(11):1076-1083. doi: 10.1002/iub.1930. Epub 2018 Aug 29.
• [4107] Effects of ME3 on the proliferation, invasion and metastasis of pancreatic cancer cells through epithelial-mesenchymal transition.Neoplasma. 2019 Nov;66(6):896-907. doi: 10.4149/neo_2019_190119N59. Epub 2019 Oct 8.
• [4108] Increased mediator complex subunit 15 expression is associated with poor prognosis in hepatocellular carcinoma.Oncol Lett. 2018 Apr;15(4):4303-4313. doi: 10.3892/ol.2018.7820. Epub 2018 Jan 18.
• [4109] Gene expression profile of the whole Mediator complex in human osteosarcoma and normal osteoblasts.Med Oncol. 2013 Dec;30(4):739. doi: 10.1007/s12032-013-0739-9. Epub 2013 Oct 8.
• [4110] MED28 Over-Expression Shortens the Cell Cycle and Induces Genomic Instability.Int J Mol Sci. 2019 Apr 9;20(7):1746. doi: 10.3390/ijms20071746.
• [4111] Linked CD4 T Cell Help: Broadening Immune Attack Against Cancer by Vaccination.Curr Top Microbiol Immunol. 2017;405:123-143. doi: 10.1007/82_2016_500.
• [4112] The Cancer Mutation D83V Induces an -Helix to -Strand Conformation Switch in MEF2B.J Mol Biol. 2018 Apr 13;430(8):1157-1172. doi: 10.1016/j.jmb.2018.02.012. Epub 2018 Feb 22.
• [4113] The MicroRNA-551a/MEF2C Axis Regulates the Survival and Sphere Formation of Cancer Cells in Response to 5-Fluorouracil.Mol Cells. 2019 Feb 28;42(2):175-182. doi: 10.14348/molcells.2018.0288. Epub 2019 Jan 24.
• [4114] Overexpression of MEF2D contributes to oncogenic malignancy and chemotherapeutic resistance in ovarian carcinoma.Am J Cancer Res. 2019 May 1;9(5):887-905. eCollection 2019.
• [4115] MEIS2 promotes cell migration and invasion in colorectal cancer.Oncol Rep. 2019 Jul;42(1):213-223. doi: 10.3892/or.2019.7161. Epub 2019 May 15.
• [4116] Over-expression of MEOX2 promotes apoptosis through inhibiting the PI3K/Akt pathway in laryngeal cancer cells.Neoplasma. 2018 Sep 19;65(5):745-752. doi: 10.4149/neo_2018_171218N824. Epub 2018 Jun 18.
• [4117] Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis.EBioMedicine. 2019 Dec;50:55-66. doi: 10.1016/j.ebiom.2019.11.012. Epub 2019 Nov 21.
• [4118] Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells.EMBO Mol Med. 2012 Jul;4(7):577-93. doi: 10.1002/emmm.201200235. Epub 2012 Apr 11.
• [4119] The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression.Clin Cancer Res. 2018 Jul 15;24(14):3366-3376. doi: 10.1158/1078-0432.CCR-17-2483. Epub 2018 Mar 1.
• [4120] Proteomic Analysis of Cancer-Associated Fibroblasts Reveals a Paracrine Role for MFAP5 in Human Oral Tongue Squamous Cell Carcinoma.J Proteome Res. 2018 Jun 1;17(6):2045-2059. doi: 10.1021/acs.jproteome.7b00925. Epub 2018 May 2.
• [4121] MFF Regulation of Mitochondrial Cell Death Is a Therapeutic Target in Cancer.Cancer Res. 2019 Dec 15;79(24):6215-6226. doi: 10.1158/0008-5472.CAN-19-1982. Epub 2019 Oct 3.
• [4122] Novel protein pp3501 mediates the inhibitory effect of sodium butyrate on SH-SY5Y cell proliferation.J Cell Biochem. 2012 Aug;113(8):2696-703. doi: 10.1002/jcb.24145.
• [4123] MFSD2A expression predicts better prognosis in gastric cancer.Biochem Biophys Res Commun. 2018 Nov 2;505(3):699-704. doi: 10.1016/j.bbrc.2018.09.156. Epub 2018 Oct 3.
• [4124] The glycosyltransferase GnT-III activates Notch signaling and drives stem cell expansion to promote the growth and invasion of ovarian cancer.J Biol Chem. 2017 Sep 29;292(39):16351-16359. doi: 10.1074/jbc.M117.783936. Epub 2017 Aug 23.
• [4125] N-acetylglucosaminyltransferase IVa promotes invasion of choriocarcinoma.Oncol Rep. 2017 Jul;38(1):440-448. doi: 10.3892/or.2017.5661. Epub 2017 May 23.
• [4126] Unusually high expression of N-acetylglucosaminyltransferase-IVa in human choriocarcinoma cell lines: a possible enzymatic basis of the formation of abnormal biantennary sugar chain.Cancer Res. 1999 Aug 15;59(16):3949-53.
• [4127] 1,6-N-acetylglucosaminyltransferase V predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection.World J Urol. 2015 Nov;33(11):1791-9. doi: 10.1007/s00345-014-1451-x. Epub 2015 Jan 29.
• [4128] Evaluation of MGP gene expression in colorectal cancer.Gene. 2020 Jan 10;723:144120. doi: 10.1016/j.gene.2019.144120. Epub 2019 Oct 4.
• [4129] A comprehensive expression analysis of the MIA gene family in malignancies: MIA gene family members are novel, useful markers of esophageal, lung, and cervical squamous cell carcinoma.Oncotarget. 2016 May 24;7(21):31137-52. doi: 10.18632/oncotarget.9082.
• [4130] Evidence for genetic association between chromosome 1q loci and predisposition to colorectal neoplasia.Br J Cancer. 2017 Sep 5;117(6):1215-1223. doi: 10.1038/bjc.2017.240. Epub 2017 Jul 25.
• [4131] Genomics and epigenetics: A study of ependymomas in pediatric patients.Clin Neurol Neurosurg. 2016 May;144:53-8. doi: 10.1016/j.clineuro.2016.02.041. Epub 2016 Mar 5.
• [4132] Defective HLA class I antigen processing machinery in cancer.Cancer Immunol Immunother. 2018 Jun;67(6):999-1009. doi: 10.1007/s00262-018-2131-2. Epub 2018 Feb 27.
• [4133] Identification of novel TGF- regulated genes with pro-migratory roles.Biochim Biophys Acta Mol Basis Dis. 2019 Dec 1;1865(12):165537. doi: 10.1016/j.bbadis.2019.165537. Epub 2019 Aug 23.
• [4134] MICAL2 is expressed in cancer associated neo-angiogenic capillary endothelia and it is required for endothelial cell viability, motility and VEGF response.Biochim Biophys Acta Mol Basis Dis. 2019 Sep 1;1865(9):2111-2124. doi: 10.1016/j.bbadis.2019.04.008. Epub 2019 Apr 18.
• [4135] Silencing of MICAL-L2 suppresses malignancy of ovarian cancer by inducing mesenchymal-epithelial transition.Cancer Lett. 2015 Jul 10;363(1):71-82. doi: 10.1016/j.canlet.2015.04.002. Epub 2015 Apr 9.
• [4136] Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca(2+) levels and tumor growth.EMBO J. 2019 Jan 15;38(2):e99435. doi: 10.15252/embj.201899435. Epub 2018 Nov 30.
• [4137] Genetic ablation of TAZ induces HepG2 liver cancer cell apoptosis through activating the CaMKII/MIEF1 signaling pathway.Onco Targets Ther. 2019 Mar 1;12:1765-1779. doi: 10.2147/OTT.S196142. eCollection 2019.
• [4138] MIER3 suppresses colorectal cancer progression by down-regulating Sp1, inhibiting epithelial-mesenchymal transition.Sci Rep. 2017 Sep 8;7(1):11000. doi: 10.1038/s41598-017-11374-y.
• [4139] Analysis of transcripts from 17p13.3 in medulloblastoma suggests ROX/MNT as a potential tumour suppressor gene.Eur J Cancer. 2004 Nov;40(16):2525-32. doi: 10.1016/j.ejca.2004.08.005.
• [4140] Macrophage inflammatory protein-1alpha C-C chemokine in parapneumonic pleural effusions.J Lab Clin Med. 1998 Sep;132(3):202-9. doi: 10.1016/s0022-2143(98)90169-x.
• [4141] ncRNA-Encoded Peptides or Proteins and Cancer.Mol Ther. 2019 Oct 2;27(10):1718-1725. doi: 10.1016/j.ymthe.2019.09.001. Epub 2019 Sep 6.
• [4142] Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma.Transl Oncol. 2019 Feb;12(2):350-360. doi: 10.1016/j.tranon.2018.10.014. Epub 2018 Nov 28.
• [4143] The first functional study of MLH3 mutations found in cancer patients.Genes Chromosomes Cancer. 2008 Sep;47(9):803-9. doi: 10.1002/gcc.20581.
• [4144] Ciz1 promotes tumorigenicity of prostate carcinoma cells.Front Biosci (Landmark Ed). 2015 Jan 1;20(4):705-15. doi: 10.2741/4331.
• [4145] Novel Lysine-Based Thioureas as Mechanism-Based Inhibitors of Sirtuin 2 (SIRT2) with Anticancer Activity in a Colorectal Cancer Murine Model. J Med Chem. 2019 Apr 25; 62(8):4131-4141.
• [4146] The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer.Cells. 2019 Oct 30;8(11):1357. doi: 10.3390/cells8111357.
• [4147] Enterohormonal disturbances in colorectal cancer patients.Neoplasma. 2017;64(3):421-429. doi: 10.4149/neo_2017_313.
• [4148] MMP23B expression and protein levels in blood and urine are associated with bladder cancer.Carcinogenesis. 2018 Oct 8;39(10):1254-1263. doi: 10.1093/carcin/bgy098.
• [4149] Biochemical characterization of the cellular glycosylphosphatidylinositol-linked membrane type-6 matrix metalloproteinase.J Biol Chem. 2010 May 21;285(21):16076-86. doi: 10.1074/jbc.M110.107094. Epub 2010 Mar 22.
• [4150] Citrullination of fibronectin alters integrin clustering and focal adhesion stability promoting stromal cell invasion.Matrix Biol. 2019 Sep;82:86-104. doi: 10.1016/j.matbio.2019.04.002. Epub 2019 Apr 17.
• [4151] Proteomic alterations in early stage cervical cancer.Oncotarget. 2018 Apr 6;9(26):18128-18147. doi: 10.18632/oncotarget.24773. eCollection 2018 Apr 6.
• [4152] Two unbalanced translocations, t(12;22)(p13;q11) and t(12;?)(p13;?), in an aggressive chronic B-cell leukemia: TEL gene analysis using FISH.Cancer Genet Cytogenet. 1997 Jun;95(2):137-40. doi: 10.1016/s0165-4608(96)00257-9.
• [4153] Expression and mutation analysis of genes that encode the Myc antagonists Mad1, Mxi1 and Rox in acute leukaemia.Leuk Lymphoma. 2007 Jun;48(6):1200-7. doi: 10.1080/10428190701342018.
• [4154] Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice.J Clin Invest. 2012 Dec;122(12):4505-18. doi: 10.1172/JCI63735. Epub 2012 Nov 12.
• [4155] DNA methylation signatures for prediction of biochemical recurrence after radical prostatectomy of clinically localized prostate cancer.J Clin Oncol. 2013 Sep 10;31(26):3250-8. doi: 10.1200/JCO.2012.47.1847. Epub 2013 Aug 5.
• [4156] Association of RAGE rs1800625 Polymorphism and Cancer Risk: A Meta-Analysis of 18 Case-Control Studies.Med Sci Monit. 2019 Sep 19;25:7026-7034. doi: 10.12659/MSM.916260.
• [4157] The Emerging Role of MORC Family Proteins in Cancer Development and Bone Homeostasis.J Cell Physiol. 2017 May;232(5):928-934. doi: 10.1002/jcp.25665. Epub 2016 Nov 30.
• [4158] Epigenetic restriction of Hippo signaling by MORC2 underlies stemness of hepatocellular carcinoma cells.Cell Death Differ. 2018 Dec;25(12):2086-2100. doi: 10.1038/s41418-018-0095-6. Epub 2018 Mar 19.
• [4159] Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.Genes Chromosomes Cancer. 2007 Mar;46(3):288-301. doi: 10.1002/gcc.20411.
• [4160] Bone marrow endothelium-targeted therapeutics for metastatic breast cancer.J Control Release. 2014 Aug 10;187:22-9. doi: 10.1016/j.jconrel.2014.04.057. Epub 2014 May 10.
• [4161] Mitochondrial pyruvate carrier 1 expression controls cancer epithelial-mesenchymal transition and radioresistance.Cancer Sci. 2019 Apr;110(4):1331-1339. doi: 10.1111/cas.13980.
• [4162] Function of mitochondrial pyruvate carriers in hepatocellular carcinoma patients.Oncol Lett. 2018 Jun;15(6):9110-9116. doi: 10.3892/ol.2018.8466. Epub 2018 Apr 11.
• [4163] Oral Targeted Delivery by Nanoparticles Enhances Efficacy of an Hsp90 Inhibitor by Reducing Systemic Exposure in Murine Models of Colitis and Colitis-Associated Cancer.J Crohns Colitis. 2020 Jan 1;14(1):130-141. doi: 10.1093/ecco-jcc/jjz113.
• [4164] Knockdown of MPP8 suppresses cell proliferation via regulation of HOXA5 in non-small cell lung cancer cells.Cell Mol Biol (Noisy-le-grand). 2018 Jan 31;64(1):27-31. doi: 10.14715/cmb/2018.64.1.6.
• [4165] Hepatic Hemangioma on SPECT Myocardial Perfusion Imaging.Clin Nucl Med. 2018 Jun;43(6):468-470. doi: 10.1097/RLU.0000000000002090.
• [4166] MRAS: A Close but Understudied Member of the RAS Family.Cold Spring Harb Perspect Med. 2018 Dec 3;8(12):a033621. doi: 10.1101/cshperspect.a033621.
• [4167] Long Noncoding RNA ANRIL Regulates Proliferation of Non-small Cell Lung Cancer and Cervical Cancer Cells.Anticancer Res. 2015 Oct;35(10):5377-82.
• [4168] Isoforms S and L of MRPL33 from alternative splicing have isoformspecific roles in the chemoresponse to epirubicin in gastric cancer cells via the PI3K/AKT signaling pathway.Int J Oncol. 2019 May;54(5):1591-1600. doi: 10.3892/ijo.2019.4728. Epub 2019 Feb 27.
• [4169] Four common polymorphisms of BRIP1 (rs2048718, rs4988344, rs4986764, and rs6504074) and cancer risk: evidence from 13,716 cancer patients and 15,590 cancer-free controls.Aging (Albany NY). 2018 Feb 16;10(2):266-277. doi: 10.18632/aging.101388.
• [4170] The miR-608 rs4919510 polymorphism may modify cancer susceptibility based on type.Tumour Biol. 2017 Jun;39(6):1010428317703819. doi: 10.1177/1010428317703819.
• [4171] High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomes.Tumour Biol. 2017 Jul;39(7):1010428317709127. doi: 10.1177/1010428317709127.
• [4172] LncRNA HOTAIR promotes cell migration and invasion by regulating MKL1 via inhibition miR206 expression in HeLa cells.Cell Commun Signal. 2018 Feb 1;16(1):5. doi: 10.1186/s12964-018-0216-3.
• [4173] Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn's Disease Perianal Fistulas.J Crohns Colitis. 2020 Jan 1;14(1):64-70. doi: 10.1093/ecco-jcc/jjz116.
• [4174] The polymorphic hMSH5 C85T allele augments radiotherapy-induced spermatogenic impairment.Andrology. 2016 Sep;4(5):873-9. doi: 10.1111/andr.12203. Epub 2016 Jul 1.
• [4175] MsrB3 deficiency induces cancer cell apoptosis through p53-independent and ER stress-dependent pathways.Arch Biochem Biophys. 2017 May 1;621:1-5. doi: 10.1016/j.abb.2017.04.001. Epub 2017 Apr 5.
• [4176] Mst1 inhibition attenuates non-alcoholic fatty liver disease via reversing Parkin-related mitophagy.Redox Biol. 2019 Feb;21:101120. doi: 10.1016/j.redox.2019.101120. Epub 2019 Jan 23.
• [4177] Homeobox protein MSX1 inhibits the growth and metastasis of breast cancer cells and is frequently silenced by promoter methylation.Int J Mol Med. 2018 May;41(5):2986-2996. doi: 10.3892/ijmm.2018.3468. Epub 2018 Feb 7.
• [4178] Expression of MSX2 predicts malignancy of branch duct intraductal papillary mucinous neoplasm of the pancreas.J Gastroenterol. 2010 Jul;45(7):763-70. doi: 10.1007/s00535-010-0200-1. Epub 2010 Jan 28.
• [4179] Dendritic Cell-Based Immunotherapy in Advanced Sarcoma and Neuroblastoma Pediatric Patients: Anti-cancer Treatment Preceding Monocyte Harvest Impairs the Immunostimulatory and Antigen-Presenting Behavior of DCs and Manufacturing Process Outcome.Front Oncol. 2019 Oct 25;9:1034. doi: 10.3389/fonc.2019.01034. eCollection 2019.
• [4180] Expression of MT-3 mRNA in human kidney, proximal tubule cell cultures, and renal cell carcinoma.Toxicol Lett. 1997 Jul 21;92(2):149-60. doi: 10.1016/s0378-4274(97)00049-0.
• [4181] miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2.Am J Pathol. 2013 Jun;182(6):2058-70. doi: 10.1016/j.ajpath.2013.02.046. Epub 2013 Apr 23.
• [4182] Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy.Cancer Discov. 2018 Nov;8(11):1376-1389. doi: 10.1158/2159-8290.CD-17-0841. Epub 2018 Aug 16.
• [4183] Adjunctive fecal microbiota transplantation in supportive oncology: Emerging indications and considerations in immunocompromised patients.EBioMedicine. 2019 Jun;44:730-740. doi: 10.1016/j.ebiom.2019.03.070. Epub 2019 Mar 30.
• [4184] Hybrid QM/MM vs Pure MM Molecular Dynamics for Evaluating Water Distribution within p21(N-ras) and the Resulting GTP Electronic Density.J Phys Chem B. 2019 May 9;123(18):3935-3944. doi: 10.1021/acs.jpcb.9b02660. Epub 2019 Apr 25.
• [4185] A novel mitochondrial C1-tetrahydrofolate synthetase is upregulated in human colon adenocarcinoma.Biochem Biophys Res Commun. 2004 Feb 27;315(1):204-11. doi: 10.1016/j.bbrc.2004.01.035.
• [4186] Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2.Oncogene. 2019 Apr;38(14):2464-2481. doi: 10.1038/s41388-018-0589-1. Epub 2018 Dec 7.
• [4187] Mitochondrial MTHFD isozymes display distinct expression, regulation, and association with cancer.Gene. 2019 Oct 20;716:144032. doi: 10.1016/j.gene.2019.144032. Epub 2019 Aug 1.
• [4188] The resistance of B-CLL cells to DNA damage-induced apoptosis defined by DNA microarrays.Blood. 2003 Jun 1;101(11):4598-606. doi: 10.1182/blood-2002-06-1743. Epub 2003 Feb 13.
• [4189] Myotubularin-related protein 7 inhibits insulin signaling in colorectal cancer.Oncotarget. 2016 Aug 2;7(31):50490-50506. doi: 10.18632/oncotarget.10466.
• [4190] Nuclear-encoded mitochondrial MTO1 and MRPL41 are regulated in an opposite epigenetic mode based on estrogen receptor status in breast cancer.BMC Cancer. 2013 Oct 27;13:502. doi: 10.1186/1471-2407-13-502.
• [4191] MUC13 promotes intrahepatic cholangiocarcinoma progression viaEGFR/PI3K/AKT pathways.J Hepatol. 2020 Apr;72(4):761-773. doi: 10.1016/j.jhep.2019.11.021. Epub 2019 Dec 16.
• [4192] MUC4-ErbB2 Oncogenic Complex: Binding studies using Microscale Thermophoresis.Sci Rep. 2019 Nov 13;9(1):16678. doi: 10.1038/s41598-019-53099-0.
• [4193] Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in ALK-positive lung cancer: Comparison with EGFR-mutated lung cancer.Pathol Res Pract. 2019 Mar;215(3):459-465. doi: 10.1016/j.prp.2018.12.011. Epub 2018 Dec 10.
• [4194] In silico and in vitro analysis of small breast epithelial mucin as a marker for bone marrow micrometastasis in breast cancer.Adv Exp Med Biol. 2008;617:331-9. doi: 10.1007/978-0-387-69080-3_31.
• [4195] DNA REPAIR. Mus81 and converging forks limit the mutagenicity of replication fork breakage.Science. 2015 Aug 14;349(6249):742-7. doi: 10.1126/science.aaa8391.
• [4196] Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation.Oncogene. 2019 Jan;38(1):88-102. doi: 10.1038/s41388-018-0407-9. Epub 2018 Aug 6.
• [4197] The MicroRNA-382-5p/MXD1 Axis Relates to Breast Cancer Progression and Promotes Cell Malignant Phenotypes.J Surg Res. 2020 Feb;246:442-449. doi: 10.1016/j.jss.2019.09.018. Epub 2019 Oct 18.
• [4198] Alternative Splicing of MXD3 and Its Regulation of MXD3 Levels in Glioblastoma.Front Mol Biosci. 2019 Feb 19;6:5. doi: 10.3389/fmolb.2019.00005. eCollection 2019.
• [4199] Matrix remodeling associated 5 expression in trunk and limb during avian development.Int J Dev Biol. 2018;62(4-5):335-340. doi: 10.1387/ijdb.170225ac.
• [4200] Protective immunity elicited by measles vaccine exerts anti-tumor effects on measles virus hemagglutinin gene-modified cancer cells in a mouse model.J Cancer Res Clin Oncol. 2018 Oct;144(10):1945-1957. doi: 10.1007/s00432-018-2720-7. Epub 2018 Aug 6.
• [4201] ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer.Proc Natl Acad Sci U S A. 2019 Aug 27;116(35):17450-17459. doi: 10.1073/pnas.1901765116. Epub 2019 Aug 9.
• [4202] Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels.Blood. 2004 Aug 15;104(4):1120-6. doi: 10.1182/blood-2003-11-3837. Epub 2004 Apr 13.
• [4203] Clinical importance of cytogenetics in acute myeloid leukaemia.Best Pract Res Clin Haematol. 2001 Mar;14(1):19-47. doi: 10.1053/beha.2000.0114.
• [4204] Formoterol attenuates increased oxidative stress and myosin protein loss in respiratory and limb muscles of cancer cachectic rats.PeerJ. 2017 Dec 13;5:e4109. doi: 10.7717/peerj.4109. eCollection 2017.
• [4205] Truncation of MYH8 tail in AML: a novel prognostic marker with increase cell migration and epithelial-mesenchymal transition utilizing RAF/MAPK pathway.Carcinogenesis. 2020 Jul 10;41(6):817-827. doi: 10.1093/carcin/bgz146.
• [4206] Emerging themes of regulation at the Golgi.Curr Opin Cell Biol. 2017 Apr;45:17-23. doi: 10.1016/j.ceb.2017.01.004. Epub 2017 Feb 16.
• [4207] Upregulation of myosin Va by Snail is involved in cancer cell migration and metastasis.Int J Cancer. 2010 Jan 1;126(1):53-64. doi: 10.1002/ijc.24641.
• [4208] Cystatin a, a potential common link for mutant myocilin causative glaucoma.PLoS One. 2012;7(5):e36301. doi: 10.1371/journal.pone.0036301. Epub 2012 May 15.
• [4209] Myocardin inhibits estrogen receptor alpha-mediated proliferation of human breast cancer MCF-7 cells via regulating MicroRNA expression.IUBMB Life. 2016 Jun;68(6):477-87. doi: 10.1002/iub.1507. Epub 2016 May 9.
• [4210] The current landscape of rhabdomyosarcomas: an update.Virchows Arch. 2020 Jan;476(1):97-108. doi: 10.1007/s00428-019-02676-9. Epub 2019 Nov 6.
• [4211] Laboratory testing for monoclonal gammopathies: Focus on monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.Clin Biochem. 2018 Jan;51:38-47. doi: 10.1016/j.clinbiochem.2017.05.001. Epub 2017 May 4.
• [4212] Upregulation of Myt1 Promotes Acquired Resistance of Cancer Cells to Wee1 Inhibition.Cancer Res. 2019 Dec 1;79(23):5971-5985. doi: 10.1158/0008-5472.CAN-19-1961. Epub 2019 Oct 8.
• [4213] The product of Kaposi's sarcoma-associated herpesvirus immediate early gene K4.2 regulates immunoglobulin secretion and calcium homeostasis by interacting with and inhibiting pERP1.J Virol. 2013 Nov;87(22):12069-79. doi: 10.1128/JVI.01900-13. Epub 2013 Aug 28.
• [4214] Depletion of the human N-terminal acetyltransferase A induces p53-dependent apoptosis and p53-independent growth inhibition.Int J Cancer. 2010 Dec 15;127(12):2777-89. doi: 10.1002/ijc.25275.
• [4215] NGFI-A Binding Protein 2 Promotes EGF-Dependent HNSCC Cell Invasion.Cancers (Basel). 2019 Mar 6;11(3):315. doi: 10.3390/cancers11030315.
• [4216] hSSB1 associates with and promotes stability of the BLM helicase.BMC Mol Biol. 2017 May 15;18(1):13. doi: 10.1186/s12867-017-0090-3.
• [4217] An overactive neddylation pathway serves as a therapeutic target and MLN4924 enhances the anticancer activity of cisplatin in pancreatic cancer.Oncol Lett. 2019 Sep;18(3):2724-2732. doi: 10.3892/ol.2019.10596. Epub 2019 Jul 9.
• [4218] Is -N-acetylgalactosaminidase the key to curing cancer? A mini-review and hypothesis.J BUON. 2017 Nov-Dec;22(6):1372-1377.
• [4219] Expression of IAP family proteins in esophageal cancer.Exp Mol Pathol. 2004 Jun;76(3):253-9. doi: 10.1016/j.yexmp.2004.01.001.
• [4220] Ectopic Expression of miR-147 Inhibits Stem Cell Marker and Epithelial-Mesenchymal Transition (EMT)-Related Protein Expression in Colon Cancer Cells.Oncol Res. 2019 Mar 29;27(4):399-406. doi: 10.3727/096504018X15179675206495. Epub 2018 Feb 9.
• [4221] A new mouse model to study the role of ectopic Nanos3 expression in cancer.BMC Cancer. 2019 Jun 17;19(1):598. doi: 10.1186/s12885-019-5807-x.
• [4222] MiR-381-3p suppresses biological characteristics of cancer in head-neck squamous cell carcinoma cells by targeting nuclear autoantigenic sperm protein (NASP).Biosci Biotechnol Biochem. 2020 Apr;84(4):703-713. doi: 10.1080/09168451.2019.1697195. Epub 2019 Dec 4.
• [4223] Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis.Genes Chromosomes Cancer. 2013 Feb;52(2):191-201. doi: 10.1002/gcc.22019. Epub 2012 Oct 25.
• [4224] AIBP and APOA-I synergistically inhibit intestinal tumor growth and metastasis by promoting cholesterol efflux.J Transl Med. 2019 May 17;17(1):161. doi: 10.1186/s12967-019-1910-7.
• [4225] Human health risks in an old gold mining area with circum-neutral drainage, central Portugal.Environ Geochem Health. 2017 Feb;39(1):43-62. doi: 10.1007/s10653-016-9806-4. Epub 2016 Mar 1.
• [4226] Decomposing Oncogenic Transcriptional Signatures to Generate Maps of Divergent Cellular States.Cell Syst. 2017 Aug 23;5(2):105-118.e9. doi: 10.1016/j.cels.2017.08.002.
• [4227] Inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving G2/M arrest, and p53-dependent apoptosis.Cell Death Dis. 2018 May 1;9(5):448. doi: 10.1038/s41419-018-0476-2.
• [4228] Depletion of NBR1 in urothelial carcinoma cells enhances rapamycin-induced apoptosis through impaired autophagy and mitochondrial dysfunction.J Cell Biochem. 2019 Nov;120(11):19186-19201. doi: 10.1002/jcb.29248. Epub 2019 Jul 11.
• [4229] Non-SMC Condensin I Complex Subunit D2 Is a Prognostic Factor in Triple-Negative Breast Cancer for the Ability to Promote Cell Cycle and Enhance Invasion.Am J Pathol. 2020 Jan;190(1):37-47. doi: 10.1016/j.ajpath.2019.09.014. Epub 2019 Oct 12.
• [4230] Regulation of NCAPG by miR-99a-3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC.Cancer Med. 2018 May;7(5):1988-2002. doi: 10.1002/cam4.1455. Epub 2018 Apr 2.
• [4231] NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma.J Cell Mol Med. 2017 Apr;21(4):665-676. doi: 10.1111/jcmm.13010. Epub 2016 Nov 15.
• [4232] Signet ring stomach cancer: morphological characterization and antigenic profile of a newly established cell line (Mz-Sto-1).Eur J Cancer Clin Oncol. 1987 Jun;23(6):697-706. doi: 10.1016/0277-5379(87)90265-3.
• [4233] Knockout of NCOA5 impairs proliferation and migration of hepatocellular carcinoma cells by suppressing epithelial-to-mesenchymal transition.Biochem Biophys Res Commun. 2018 Jun 2;500(2):177-183. doi: 10.1016/j.bbrc.2018.04.017. Epub 2018 Apr 14.
• [4234] Deletion of the cancer-amplified coactivator AIB3 results in defective placentation and embryonic lethality.J Biol Chem. 2002 Nov 22;277(47):45356-60. doi: 10.1074/jbc.C200509200. Epub 2002 Oct 3.
• [4235] Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression.Clin Cancer Res. 2016 Aug 1;22(15):3937-49. doi: 10.1158/1078-0432.CCR-15-1983. Epub 2016 Mar 11.
• [4236] Regulation of NKG2D-Dependent NK Cell Functions: The Yin and the Yang of Receptor Endocytosis.Int J Mol Sci. 2017 Aug 2;18(8):1677. doi: 10.3390/ijms18081677.
• [4237] A mutation threshold distinguishes the antitumorigenic effects of the mitochondrial gene MTND1, an oncojanus function.Cancer Res. 2011 Oct 1;71(19):6220-9. doi: 10.1158/0008-5472.CAN-11-1042. Epub 2011 Aug 18.
• [4238] miRNA-mediated apoptosis activation through TMEM 48 inhibition in A549 cell line.Biochem Biophys Res Commun. 2018 Sep 3;503(1):323-329. doi: 10.1016/j.bbrc.2018.06.023. Epub 2018 Jun 14.
• [4239] Antitumor activity of kinetochore-associated protein 2 siRNA against lung cancer patient-derived tumor xenografts.Oncol Lett. 2018 Apr;15(4):4676-4682. doi: 10.3892/ol.2018.7890. Epub 2018 Jan 29.
• [4240] NDN is an imprinted tumor suppressor gene that is downregulated in ovarian cancers through genetic and epigenetic mechanisms.Oncotarget. 2016 Jan 19;7(3):3018-32. doi: 10.18632/oncotarget.6576.
• [4241] Expression of p53 and NDP-K/nm23 in gastric carcinomas--association with metastasis and clinicopathologic parameters.J Korean Med Sci. 1995 Dec;10(6):406-13. doi: 10.3346/jkms.1995.10.6.406.
• [4242] Bidirectional Regulation between NDRG1 and GSK3 Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.Cancer Res. 2020 Jan 15;80(2):234-248. doi: 10.1158/0008-5472.CAN-19-0438. Epub 2019 Nov 13.
• [4243] Combined Aberrant Expression of NDRG2 and LDHA Predicts Hepatocellular Carcinoma Prognosis and Mediates the Anti-tumor Effect of Gemcitabine.Int J Biol Sci. 2019 Jul 3;15(9):1771-1786. doi: 10.7150/ijbs.35094. eCollection 2019.
• [4244] NDST4 is a novel candidate tumor suppressor gene at chromosome 4q26 and its genetic loss predicts adverse prognosis in colorectal cancer.PLoS One. 2013 Jun 25;8(6):e67040. doi: 10.1371/journal.pone.0067040. Print 2013.
• [4245] NDUFA4L2 is associated with clear cell renal cell carcinoma malignancy and is regulated by ELK1.PeerJ. 2017 Nov 17;5:e4065. doi: 10.7717/peerj.4065. eCollection 2017.
• [4246] Acid phosphatase locus 1 genetic polymorphism and cancer grading.Am J Med Sci. 2012 Jul;344(1):32-4. doi: 10.1097/MAJ.0b013e31823e5cfa.
• [4247] LASP2 suppressed malignancy and Wnt/-catenin signaling pathway activation in bladder cancer.Exp Ther Med. 2018 Dec;16(6):5215-5223. doi: 10.3892/etm.2018.6836. Epub 2018 Oct 9.
• [4248] Nectin-1 Expression in Colorectal Cancer: Is There a Group of Patients with High Risk for Early Disease Recurrence?.Oncology. 2019;96(6):318-325. doi: 10.1159/000499569. Epub 2019 Mar 27.
• [4249] Nectin-3 is a new biomarker that mediates the upregulation of MMP2 and MMP9 in ovarian cancer cells.Biomed Pharmacother. 2019 Feb;110:139-144. doi: 10.1016/j.biopha.2018.11.020. Epub 2018 Nov 20.
• [4250] Genetic variation in NEDD4L, an epithelial sodium channel regulator, is associated with cardiovascular disease and cardiovascular death.J Hypertens. 2014 Feb;32(2):294-9. doi: 10.1097/HJH.0000000000000044.
• [4251] Autonomy of the epithelial phenotype in human ovarian surface epithelium: changes with neoplastic progression and with a family history of ovarian cancer.Int J Cancer. 1996 Dec 20;69(6):429-36. doi: 10.1002/(SICI)1097-0215(19961220)69:6<429::AID-IJC1>3.0.CO;2-6.
• [4252] The IgLON family in epithelial ovarian cancer: expression profiles and clinicopathologic correlates.Clin Cancer Res. 2005 Aug 15;11(16):5764-8. doi: 10.1158/1078-0432.CCR-04-2388.
• [4253] The NEIL1 G83D germline DNA glycosylase variant induces genomic instability and cellular transformation.Oncotarget. 2017 Sep 8;8(49):85883-85895. doi: 10.18632/oncotarget.20716. eCollection 2017 Oct 17.
• [4254] Overexpression of NEK3 is associated with poor prognosis in patients with gastric cancer.Medicine (Baltimore). 2018 Jan;97(3):e9630. doi: 10.1097/MD.0000000000009630.
• [4255] Upregulation of NETO2 gene in colorectal cancer.BMC Genet. 2017 Dec 28;18(Suppl 1):117. doi: 10.1186/s12863-017-0581-8.
• [4256] Overexpression of sialidase NEU3 increases the cellular radioresistance potential of U87MG glioblastoma cells.Biochem Biophys Res Commun. 2019 Jan 1;508(1):31-36. doi: 10.1016/j.bbrc.2018.11.086. Epub 2018 Nov 20.
• [4257] Deregulation of sialidases in human normal and tumor tissues.Cancer Biomark. 2018 Feb 14;21(3):591-601. doi: 10.3233/CBM-170548.
• [4258] Expression of the neurogenic basic helix-loop-helix transcription factor NEUROG1 identifies a subgroup of medulloblastomas not expressing ATOH1.Neuro Oncol. 2007 Jul;9(3):298-307. doi: 10.1215/15228517-2007-014. Epub 2007 May 23.
• [4259] Coactosin-like protein CLP/Cotl1 suppresses breast cancer growth through activation of IL-24/PERP and inhibition of non-canonical TGF signaling.Oncogene. 2018 Jan 18;37(3):323-331. doi: 10.1038/onc.2017.342. Epub 2017 Sep 18.
• [4260] NFATc3 plays an oncogenic role in oral/oropharyngeal squamous cell carcinomas by promoting cancer stemness via expression of OCT4.Oncotarget. 2019 Mar 19;10(23):2306-2319. doi: 10.18632/oncotarget.26774. eCollection 2019 Mar 19.
• [4261] ERK and PI3K signaling cascades induce Nrf2 activation and regulate cell viability partly through Nrf2 in human glioblastoma cells.Oncol Rep. 2013 Aug;30(2):715-22. doi: 10.3892/or.2013.2485. Epub 2013 May 23.
• [4262] miR-302a Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44.Theranostics. 2019 Oct 22;9(26):8409-8425. doi: 10.7150/thno.36605. eCollection 2019.
• [4263] The convergent roles of the nuclear factor I transcription factors in development and cancer.Cancer Lett. 2017 Dec 1;410:124-138. doi: 10.1016/j.canlet.2017.09.015. Epub 2017 Sep 28.
• [4264] E4BP4 promotes thyroid cancer proliferation by modulating iron homeostasis through repression of hepcidin.Cell Death Dis. 2018 Sep 24;9(10):987. doi: 10.1038/s41419-018-1001-3.
• [4265] Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type.J Invest Dermatol. 2018 Nov;138(11):2365-2376. doi: 10.1016/j.jid.2018.04.038. Epub 2018 May 30.
• [4266] NF-YA overexpression protects from glutamine deprivation.Biochim Biophys Acta Mol Cell Res. 2020 Feb;1867(2):118571. doi: 10.1016/j.bbamcr.2019.118571. Epub 2019 Nov 9.
• [4267] An autoregulatory loop controls the expression of the transcription factor NF-Y.Biochim Biophys Acta Gene Regul Mech. 2018 May;1861(5):509-518. doi: 10.1016/j.bbagrm.2018.02.008. Epub 2018 Mar 2.
• [4268] Neuroglobin As Key Mediator in the 17-Estradiol-Induced Antioxidant Cell Response to Oxidative Stress.Antioxid Redox Signal. 2020 Feb 1;32(4):217-227. doi: 10.1089/ars.2019.7870.
• [4269] Stepped approach to improving sexual function after gynaecological cancer: the SAFFRON feasibility RCT.Health Technol Assess. 2019 Feb;23(6):1-92. doi: 10.3310/hta23060.
• [4270] The possible roles of B-cell novel protein-1 (BCNP1) in cellular signalling pathways and in cancer.J Cell Mol Med. 2017 Mar;21(3):456-466. doi: 10.1111/jcmm.12989. Epub 2016 Sep 29.
• [4271] Nidogen-1 Degraded by Cathepsin S can be Quantified in Serum and is Associated with Non-Small Cell Lung Cancer.Neoplasia. 2017 Apr;19(4):271-278. doi: 10.1016/j.neo.2017.01.008. Epub 2017 Mar 7.
• [4272] NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer.Pathol Res Pract. 2019 Oct;215(10):152553. doi: 10.1016/j.prp.2019.152553. Epub 2019 Jul 23.
• [4273] Ninjurin 1 has two opposing functions in tumorigenesis in a p53-dependent manner.Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11500-11505. doi: 10.1073/pnas.1711814114. Epub 2017 Oct 9.
• [4274] NIPA-like domain containing 1 is a novel tumor-promoting factor in oral squamous cell carcinoma.J Cancer Res Clin Oncol. 2018 May;144(5):875-882. doi: 10.1007/s00432-018-2612-x. Epub 2018 Feb 20.
• [4275] Biological functions of mammalian Nit1, the counterpart of the invertebrate NitFhit Rosetta stone protein, a possible tumor suppressor.J Biol Chem. 2006 Sep 22;281(38):28244-53. doi: 10.1074/jbc.M603590200. Epub 2006 Jul 24.
• [4276] Growth inhibitory effect of the human NIT2 gene and its allelic imbalance in cancers.FEBS J. 2007 Jun;274(11):2946-56. doi: 10.1111/j.1742-4658.2007.05828.x. Epub 2007 May 4.
• [4277] NKD1 correlates with a poor prognosis and inhibits cell proliferation by inducing p53 expression in hepatocellular carcinoma.Tumour Biol. 2016 Oct;37(10):14059-14067. doi: 10.1007/s13277-016-5173-0. Epub 2016 Aug 9.
• [4278] The tumor-suppressor gene Nkx2.8 suppresses bladder cancer proliferation through upregulation of FOXO3a and inhibition of the MEK/ERK signaling pathway.Carcinogenesis. 2012 Mar;33(3):678-86. doi: 10.1093/carcin/bgr321. Epub 2012 Jan 4.
• [4279] Aberrant activity of NKL homeobox gene NKX3-2 in a T-ALL subset.PLoS One. 2018 May 10;13(5):e0197194. doi: 10.1371/journal.pone.0197194. eCollection 2018.
• [4280] Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survival.PLoS One. 2017 Dec 15;12(12):e0189662. doi: 10.1371/journal.pone.0189662. eCollection 2017.
• [4281] Expression of Nemo-like kinase in cervical squamous cell carcinoma: a clinicopathological study.Onco Targets Ther. 2018 Feb 8;11:743-749. doi: 10.2147/OTT.S154188. eCollection 2018.
• [4282] Upregulation of the NLRC4 inflammasome contributes to poor prognosis in glioma patients.Sci Rep. 2019 May 27;9(1):7895. doi: 10.1038/s41598-019-44261-9.
• [4283] Transcatheter aortic valve replacement for oncology patients with severe symptomatic aortic stenosis: New hope for a complicated medical condition.Catheter Cardiovasc Interv. 2019 Sep 1;94(3):446-447. doi: 10.1002/ccd.28484.
• [4284] A possible new target in lung-cancer cells: The orphan receptor, bombesin receptor subtype-3.Peptides. 2018 Mar;101:213-226. doi: 10.1016/j.peptides.2018.01.016. Epub 2018 Feb 2.
• [4285] NME4 may enhance nonsmall cell lung cancer progression by overcoming cell cycle arrest and promoting cellular proliferation.Mol Med Rep. 2019 Aug;20(2):1629-1636. doi: 10.3892/mmr.2019.10413. Epub 2019 Jun 24.
• [4286] Transactivation of the human NME5 gene by Sp1 in pancreatic cancer cells.Gene. 2012 Jul 25;503(2):200-7. doi: 10.1016/j.gene.2012.04.088. Epub 2012 May 4.
• [4287] Discovery of Stereospecific PARP-1 Inhibitor Isoindolinone NMS-P515.ACS Med Chem Lett. 2019 Mar 13;10(4):534-538. doi: 10.1021/acsmedchemlett.8b00569. eCollection 2019 Apr 11.
• [4288] Neuromedin U: A Small Peptide in the Big World of Cancer.Cancers (Basel). 2019 Sep 5;11(9):1312. doi: 10.3390/cancers11091312.
• [4289] Cancer neovasculature-targeted near-infrared photoimmunotherapy (NIR-PIT) for gastric cancer: different mechanisms of phototoxicity compared to cell membrane-targeted NIR-PIT.Gastric Cancer. 2020 Jan;23(1):82-94. doi: 10.1007/s10120-019-00988-y. Epub 2019 Jul 13.
• [4290] Combinatorial use of bone morphogenetic protein 6, noggin and SOST significantly predicts cancer progression.Cancer Sci. 2012 Jun;103(6):1145-54. doi: 10.1111/j.1349-7006.2012.02252.x. Epub 2012 Apr 3.
• [4291] The RB tumor suppressor positively regulates transcription of the anti-angiogenic protein NOL7.Neoplasia. 2012 Dec;14(12):1213-22. doi: 10.1593/neo.121422.
• [4292] PLAIDOH: a novel method for functional prediction of long non-coding RNAs identifies cancer-specific LncRNA activities.BMC Genomics. 2019 Feb 15;20(1):137. doi: 10.1186/s12864-019-5497-4.
• [4293] NOVA1 directs PTBP1 to hTERT pre-mRNA and promotes telomerase activity in cancer cells.Oncogene. 2019 Apr;38(16):2937-2952. doi: 10.1038/s41388-018-0639-8. Epub 2018 Dec 19.
• [4294] Nox1 downregulators: A new class of therapeutics.Steroids. 2019 Dec;152:108494. doi: 10.1016/j.steroids.2019.108494. Epub 2019 Sep 10.
• [4295] Significant association of the cytokine variants with head and neck cancer risk: evidence from meta-analysis.Eur Arch Otorhinolaryngol. 2018 Feb;275(2):483-496. doi: 10.1007/s00405-017-4820-4. Epub 2017 Nov 28.
• [4296] Characterization of Niemann-Pick Type C2 protein expression in multiple cancers using a novel NPC2 monoclonal antibody.PLoS One. 2013 Oct 17;8(10):e77586. doi: 10.1371/journal.pone.0077586. eCollection 2013.
• [4297] The 2018 ISDE achalasia guidelines.Dis Esophagus. 2018 Sep 1;31(9). doi: 10.1093/dote/doy071.
• [4298] Nutritional quality of food as represented by the FSAm-NPS nutrient profiling system underlying the Nutri-Score label and cancer risk in Europe: Results from the EPIC prospective cohort study.PLoS Med. 2018 Sep 18;15(9):e1002651. doi: 10.1371/journal.pmed.1002651. eCollection 2018 Sep.
• [4299] Specific sensitivity of small cell lung cancer cell lines to the snake venom toxin taipoxin.Lung Cancer. 2005 Dec;50(3):329-37. doi: 10.1016/j.lungcan.2005.06.011. Epub 2005 Aug 22.
• [4300] The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1.Nat Commun. 2018 Apr 30;9(1):1723. doi: 10.1038/s41467-018-04010-4.
• [4301] Orphan nuclear receptor PNR/NR2E3 stimulates p53 functions by enhancing p53 acetylation.Mol Cell Biol. 2012 Jan;32(1):26-35. doi: 10.1128/MCB.05513-11. Epub 2011 Oct 24.
• [4302] NR2F1 contributes to cancer cell dormancy, invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12/CXCR4 pathway.BMC Cancer. 2019 Jul 29;19(1):743. doi: 10.1186/s12885-019-5925-5.
• [4303] Overexpression of COUPTFII suppresses proliferation and metastasis of human gastric cancer cells.Mol Med Rep. 2018 Feb;17(2):2393-2401. doi: 10.3892/mmr.2017.8164. Epub 2017 Nov 27.
• [4304] Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway.Int J Cancer. 2019 Oct 1;145(7):1921-1934. doi: 10.1002/ijc.32293. Epub 2019 Apr 4.
• [4305] Notch-regulated ankyrin-repeat protein is a novel tissue biomarker that predicts poor prognosis in non-small cell lung cancer.Oncol Lett. 2018 Aug;16(2):1885-1891. doi: 10.3892/ol.2018.8826. Epub 2018 May 30.
• [4306] NRBP2 Overexpression Increases the Chemosensitivity of Hepatocellular Carcinoma Cells via Akt Signaling.Cancer Res. 2016 Dec 1;76(23):7059-7071. doi: 10.1158/0008-5472.CAN-16-0937. Epub 2016 Sep 7.
• [4307] The integral nuclear membrane protein nurim plays a role in the suppression of apoptosis.Curr Mol Med. 2012 Dec;12(10):1372-82. doi: 10.2174/156652412803833571.
• [4308] (1) H NMR metabolomics reveals increased glutaminolysis upon overexpression of NSD3s or Pdp3 in Saccharomyces cerevisiae.J Cell Biochem. 2019 Apr;120(4):5377-5385. doi: 10.1002/jcb.27816. Epub 2018 Oct 15.
• [4309] Mutational Signature Analysis Reveals NTHL1 Deficiency to Cause a Multi-tumor Phenotype.Cancer Cell. 2019 Feb 11;35(2):256-266.e5. doi: 10.1016/j.ccell.2018.12.011.
• [4310] An unbalanced translocation involving loss of 10q26.2 and gain of 11q25 in a pedigree with autism spectrum disorder and cerebellar juvenile pilocytic astrocytoma.Am J Med Genet A. 2013 Apr;161A(4):787-91. doi: 10.1002/ajmg.a.35841. Epub 2013 Mar 12.
• [4311] Select human cancer mutants of NRMT1 alter its catalytic activity and decrease N-terminal trimethylation.Protein Sci. 2017 Aug;26(8):1639-1652. doi: 10.1002/pro.3202. Epub 2017 Jun 11.
• [4312] NTN4 is associated with breast cancer metastasis via regulation of EMT-related biomarkers.Oncol Rep. 2017 Jan;37(1):449-457. doi: 10.3892/or.2016.5239. Epub 2016 Nov 9.
• [4313] Changes in plasma levels of cholecystokinin, neurotensin, VIP and PYY in gastric and colorectal cancer - Preliminary results.Peptides. 2019 Dec;122:170148. doi: 10.1016/j.peptides.2019.170148. Epub 2019 Sep 18.
• [4314] OVA66 promotes tumour angiogenesis and progression through enhancing autocrine VEGF-VEGFR2 signalling.EBioMedicine. 2019 Mar;41:156-166. doi: 10.1016/j.ebiom.2019.02.051. Epub 2019 Mar 1.
• [4315] The Existence of MTH1-independent 8-oxodGTPase Activity in Cancer Cells as a Compensatory Mechanism against On-target Effects of MTH1 Inhibitors.Mol Cancer Ther. 2020 Feb;19(2):432-446. doi: 10.1158/1535-7163.MCT-19-0437. Epub 2019 Nov 19.
• [4316] NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children's Cancer Center of Lebanon.Pediatr Blood Cancer. 2017 Jan;64(1):146-150. doi: 10.1002/pbc.26189. Epub 2016 Aug 31.
• [4317] CFIm25 and alternative polyadenylation: Conflicting roles in cancer.Cancer Lett. 2019 Sep 10;459:112-121. doi: 10.1016/j.canlet.2019.114430. Epub 2019 Jun 7.
• [4318] Novel t(5;11)(q32;q13.4) with NUMA1-PDGFRB fusion in a myeloid neoplasm with eosinophilia with response to imatinib mesylate.Cancer Genet. 2017 Apr;212-213:38-44. doi: 10.1016/j.cancergen.2017.03.004. Epub 2017 Mar 27.
• [4319] Loss of nuclear NOTCH1, but not its negative regulator NUMB, is an independent predictor of cervical malignancy.Oncotarget. 2018 Apr 10;9(27):18916-18928. doi: 10.18632/oncotarget.24828. eCollection 2018 Apr 10.
• [4320] Changes in DNA methylation of tandem DNA repeats are different from interspersed repeats in cancer.Int J Cancer. 2009 Aug 1;125(3):723-9. doi: 10.1002/ijc.24384.
• [4321] NUP153 overexpression suppresses the proliferation of colorectal cancer by negatively regulating Wnt/-catenin signaling pathway and predicts good prognosis.Cancer Biomark. 2019;24(1):61-70. doi: 10.3233/CBM-181703.
• [4322] Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma.Genome Biol. 2015 Jan 13;16(1):5. doi: 10.1186/s13059-014-0575-z.
• [4323] Fluorofenidone Inhibits the Proliferation of Lung Adenocarcinoma Cells.J Cancer. 2017 Jul 4;8(10):1917-1926. doi: 10.7150/jca.18040. eCollection 2017.
• [4324] Nucleolar and spindle associated protein 1 promotes metastasis of cervical carcinoma cells by activating Wnt/-catenin signaling.J Exp Clin Cancer Res. 2019 Jan 24;38(1):33. doi: 10.1186/s13046-019-1037-y.
• [4325] Identification of genes involved in the regulation of TERT in hepatocellular carcinoma.Cancer Sci. 2019 Feb;110(2):550-560. doi: 10.1111/cas.13884. Epub 2019 Jan 4.
• [4326] Cryo-EM structure of the essential ribosome assembly AAA-ATPase Rix7.Nat Commun. 2019 Jan 31;10(1):513. doi: 10.1038/s41467-019-08373-0.
• [4327] Assessing prostate cancer growth with mRNA of spermine metabolic enzymes.Cancer Biol Ther. 2010 May 1;9(9):736-42. doi: 10.4161/cbt.9.9.11549. Epub 2010 May 18.
• [4328] Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma.Cancer Res. 2007 Apr 15;67(8):3545-50. doi: 10.1158/0008-5472.CAN-07-0065.
• [4329] Occludin protein expression in human cervical cancer and its association with patient's clinical characteristics.J Cancer Res Ther. 2018 Jan;14(1):124-127. doi: 10.4103/jcrt.JCRT_664_17.
• [4330] Real Talk: The Inter-play Between the mTOR, AMPK, and Hexosamine Biosynthetic Pathways in Cell Signaling.Front Endocrinol (Lausanne). 2018 Sep 6;9:522. doi: 10.3389/fendo.2018.00522. eCollection 2018.
• [4331] Osteoglycin-induced VEGF Inhibition Enhances T Lymphocytes Infiltrating in Colorectal Cancer.EBioMedicine. 2018 Aug;34:35-45. doi: 10.1016/j.ebiom.2018.07.021. Epub 2018 Jul 21.
• [4332] Novel glucopyranoside C2-derived 1,2,3-triazoles displaying selective inhibition of O-GlcNAcase (OGA).Carbohydr Res. 2019 Jan 1;471:43-55. doi: 10.1016/j.carres.2018.10.007. Epub 2018 Oct 26.
• [4333] Molecular mechanisms of OLIG2 transcription factor in brain cancer.Oncotarget. 2016 Aug 16;7(33):53074-53101. doi: 10.18632/oncotarget.10628.
• [4334] VDAC electronics: 4. Novel electrical mechanism and thermodynamic estimations of glucose repression of yeast respiration.Biochim Biophys Acta Biomembr. 2017 Nov;1859(11):2213-2223. doi: 10.1016/j.bbamem.2017.09.001. Epub 2017 Sep 6.
• [4335] Inhibition of the liver enriched protein FOXA2 recovers HNF6 activity in human colon carcinoma and liver hepatoma cells.PLoS One. 2010 Oct 13;5(10):e13344. doi: 10.1371/journal.pone.0013344.
• [4336] Chemotherapy-Induced Extracellular Vesicle miRNAs Promote Breast Cancer Stemness by Targeting ONECUT2.Cancer Res. 2019 Jul 15;79(14):3608-3621. doi: 10.1158/0008-5472.CAN-18-4055. Epub 2019 May 22.
• [4337] Role of Optineurin in the Mitochondrial Dysfunction: Potential Implications in Neurodegenerative Diseases and Cancer.Front Immunol. 2018 Jun 19;9:1243. doi: 10.3389/fimmu.2018.01243. eCollection 2018.
• [4338] Haptoglobin groups in ovarian carcinoma.Hum Hered. 1988;38(3):180-2. doi: 10.1159/000153782.
• [4339] Tropisetron suppresses colitis-associated cancer in a mouse model in the remission stage.Int Immunopharmacol. 2016 Jul;36:9-16. doi: 10.1016/j.intimp.2016.04.014. Epub 2016 Apr 19.
• [4340] Mutation analysis of the origin recognition complex subunit 5 (ORC5L) gene in adult patients with myeloid leukemias exhibiting deletions of chromosome band 7q22.Hum Genet. 2001 Apr;108(4):304-9. doi: 10.1007/s004390100498.
• [4341] Reduction of Orc6 expression sensitizes human colon cancer cells to 5-fluorouracil and cisplatin.PLoS One. 2008;3(12):e4054. doi: 10.1371/journal.pone.0004054. Epub 2008 Dec 29.
• [4342] Association between orosomucoid types and cancer.Oncology. 1995 Nov-Dec;52(6):498-500. doi: 10.1159/000227518.
• [4343] The Oxysterol-Binding Protein Cycle: Burning Off PI(4)P to Transport Cholesterol.Annu Rev Biochem. 2018 Jun 20;87:809-837. doi: 10.1146/annurev-biochem-061516-044924. Epub 2018 Mar 29.
• [4344] Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysis.BMC Genomics. 2011 Oct 14;12:505. doi: 10.1186/1471-2164-12-505.
• [4345] Aneuploidy-inducing gene knockdowns overlap with cancer mutations and identify Orp3 as a B-cell lymphoma suppressor.Oncogene. 2020 Feb;39(7):1445-1465. doi: 10.1038/s41388-019-1073-2. Epub 2019 Oct 28.
• [4346] Oxysterol-binding protein-related protein 5 (ORP5) promotes cell proliferation by activation of mTORC1 signaling.J Biol Chem. 2018 Mar 9;293(10):3806-3818. doi: 10.1074/jbc.RA117.001558. Epub 2018 Jan 22.
• [4347] Genomic structure of human OKL38 gene and its differential expression in kidney carcinogenesis.J Biol Chem. 2004 Jan 2;279(1):743-54. doi: 10.1074/jbc.M308668200. Epub 2003 Oct 21.
• [4348] Ascorbic acid metabolism and functions: A comparison of plants and mammals.Free Radic Biol Med. 2018 Jul;122:116-129. doi: 10.1016/j.freeradbiomed.2018.03.033. Epub 2018 Mar 20.
• [4349] Wild-type p53 regulates OTOP2 transcription through DNA loop alteration of the promoter in colorectal cancer.FEBS Open Bio. 2018 Dec 20;9(1):26-34. doi: 10.1002/2211-5463.12554. eCollection 2019 Jan.
• [4350] OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ.Mol Cell. 2019 Jan 3;73(1):7-21.e7. doi: 10.1016/j.molcel.2018.10.030. Epub 2018 Nov 21.
• [4351] Breast cancer metastasis suppressor OTUD1 deubiquitinates SMAD7.Nat Commun. 2017 Dec 13;8(1):2116. doi: 10.1038/s41467-017-02029-7.
• [4352] Snail1-dependent transcriptional repression of Cezanne2 in hepatocellular carcinoma.Oncogene. 2014 May 29;33(22):2836-45. doi: 10.1038/onc.2013.243. Epub 2013 Jun 24.
• [4353] CYLD, A20 and OTULIN deubiquitinases in NF-B signaling and cell death: so similar, yet so different.Cell Death Differ. 2017 Jul;24(7):1172-1183. doi: 10.1038/cdd.2017.46. Epub 2017 Mar 31.
• [4354] Useful genetic variation databases for oncologists investigating the genetic basis of variable treatment response and survival in cancer.Acta Oncol. 2010 Nov;49(8):1217-26. doi: 10.3109/0284186X.2010.500297. Epub 2010 Jul 29.
• [4355] P3H4 is correlated with clinicopathological features and prognosis in bladder cancer.World J Surg Oncol. 2018 Oct 15;16(1):206. doi: 10.1186/s12957-018-1507-2.
• [4356] Apicidin upregulates PHD2 prolyl hydroxylase gene expression in cervical cancer cells.Anticancer Drugs. 2010 Jul;21(6):619-24. doi: 10.1097/cad.0b013e328339848b.
• [4357] TMEM206 promotes the malignancy of colorectal cancer cells by interacting with AKT and extracellular signal-regulated kinase signaling pathways.J Cell Physiol. 2019 Jul;234(7):10888-10898. doi: 10.1002/jcp.27751. Epub 2018 Nov 11.
• [4358] Expression of protein disulfide isomerase family members correlates with tumor progression and patient survival in ovarian cancer.Oncotarget. 2017 Oct 6;8(61):103543-103556. doi: 10.18632/oncotarget.21569. eCollection 2017 Nov 28.
• [4359] Doxorubicin-Loaded Bi-PEG Nanoparticles as Novel Chemo-Photothermal Nanoagents for Efficiently Killing Cancer Cells.J Nanosci Nanotechnol. 2020 Apr 1;20(4):2032-2039. doi: 10.1166/jnn.2020.17212.
• [4360] PAGE-1, an X chromosome-linked GAGE-like gene that is expressed in normal and neoplastic prostate, testis, and uterus.Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10757-62. doi: 10.1073/pnas.95.18.10757.
• [4361] Somatic mutation in peripheral lymphocytes of former workers at the Okunojima poison gas factory.Jpn J Cancer Res. 1988 Dec;79(12):1276-83. doi: 10.1111/j.1349-7006.1988.tb01556.x.
• [4362] SMO Inhibition Modulates Cellular Plasticity and Invasiveness in Colorectal Cancer.Front Pharmacol. 2018 Feb 2;8:956. doi: 10.3389/fphar.2017.00956. eCollection 2017.
• [4363] Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.Int J Cancer. 2017 Aug 15;141(4):678-686. doi: 10.1002/ijc.30762. Epub 2017 May 15.
• [4364] p21-Activated kinase 3 promotes cancer stem cell phenotypes through activating the Akt-GSK3--catenin signaling pathway in pancreatic cancer cells.Cancer Lett. 2019 Aug 1;456:13-22. doi: 10.1016/j.canlet.2019.04.026. Epub 2019 Apr 30.
• [4365] Survey of differentially methylated promoters in prostate cancer cell lines.Neoplasia. 2005 Aug;7(8):748-60. doi: 10.1593/neo.05289.
• [4366] Twist1-induced activation of human fibroblasts promotes matrix stiffness by upregulating palladin and collagen 1(VI).Oncogene. 2016 Oct 6;35(40):5224-5236. doi: 10.1038/onc.2016.57. Epub 2016 Mar 14.
• [4367] AKAP2 is upregulated in ovarian cancer, and promotes growth and migration of cancer cells.Mol Med Rep. 2017 Oct;16(4):5151-5156. doi: 10.3892/mmr.2017.7286. Epub 2017 Aug 18.
• [4368] Ki-ras mutations as a prognostic factor in extrahepatic bile system cancer. PANK-ras I Project Investigators.J Clin Oncol. 1995 Jul;13(7):1679-86. doi: 10.1200/JCO.1995.13.7.1679.
• [4369] Cancer metabolism in a snapshot: MRS(I).NMR Biomed. 2019 Oct;32(10):e4054. doi: 10.1002/nbm.4054. Epub 2019 Jan 11.
• [4370] TDP-43 regulates cancer-associated microRNAs.Protein Cell. 2018 Oct;9(10):848-866. doi: 10.1007/s13238-017-0480-9. Epub 2017 Sep 26.
• [4371] Identification and characterization of cancer mutations in Japanese lung adenocarcinoma without sequencing of normal tissue counterparts.PLoS One. 2013 Sep 12;8(9):e73484. doi: 10.1371/journal.pone.0073484. eCollection 2013.
• [4372] High expression of partitioning defective 3-like protein is associated with malignancy in colorectal cancer.Tumour Biol. 2017 Apr;39(4):1010428317698393. doi: 10.1177/1010428317698393.
• [4373] Nuclear Tau, p53 and Pin1 Regulate PARN-Mediated Deadenylation and Gene Expression.Front Mol Neurosci. 2019 Oct 15;12:242. doi: 10.3389/fnmol.2019.00242. eCollection 2019.
• [4374] Genetic Association of PARP15 Polymorphisms with Clinical Outcome of Acute Myeloid Leukemia in a Korean Population.Genet Test Mol Biomarkers. 2016 Nov;20(11):696-701. doi: 10.1089/gtmb.2016.0007. Epub 2016 Sep 9.
• [4375] PARP6, a mono(ADP-ribosyl) transferase and a negative regulator of cell proliferation, is involved in colorectal cancer development.Int J Oncol. 2012 Dec;41(6):2079-86. doi: 10.3892/ijo.2012.1652. Epub 2012 Oct 4.
• [4376] Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma.Dig Dis Sci. 2019 Oct;64(10):2878-2892. doi: 10.1007/s10620-019-05608-4. Epub 2019 Apr 4.
• [4377] Differential expressions of integrin-linked kinase, -parvin and cofilin 1 in high-fat diet induced prostate cancer progression in a transgenic mouse model.Oncol Lett. 2018 Oct;16(4):4945-4952. doi: 10.3892/ol.2018.9276. Epub 2018 Aug 7.
• [4378] No evidence of INI1hSNF5 (SMARCB1) and PARVG point mutations in oligodendroglial neoplasms.Cancer Genet Cytogenet. 2005 Jul 15;160(2):169-73. doi: 10.1016/j.cancergencyto.2004.12.020.
• [4379] PAS Domain Containing Repressor 1 (PASD1) Promotes Glioma Cell Proliferation Through Inhibiting Apoptosis In Vitro.Med Sci Monit. 2019 Sep 16;25:6955-6964. doi: 10.12659/MSM.916308.
• [4380] The promising role of PAX1 (aliases: HUP48, OFC2) gene methylation in cancer screening.Mol Genet Genomic Med. 2019 Mar;7(3):e506. doi: 10.1002/mgg3.506. Epub 2019 Jan 12.
• [4381] PAX7 immunohistochemical evaluation of Ewing sarcoma and other small round cell tumours.Histopathology. 2018 Oct;73(4):645-652. doi: 10.1111/his.13689. Epub 2018 Aug 2.
• [4382] Prognostic value of PAX9 in patients with esophageal squamous cell carcinoma and its prediction value to radiation sensitivity.Mol Med Rep. 2017 Jul;16(1):806-816. doi: 10.3892/mmr.2017.6626. Epub 2017 May 25.
• [4383] PCB levels in adipose tissue of dogs from illegal dumping sites in Campania region (Italy).Chemosphere. 2020 Apr;244:125478. doi: 10.1016/j.chemosphere.2019.125478. Epub 2019 Nov 27.
• [4384] Decreased expression of cell adhesion genes in cancer stem-like cells isolated from primary oral squamous cell carcinomas.Tumour Biol. 2018 May;40(5):1010428318780859. doi: 10.1177/1010428318780859.
• [4385] Protocadherin-8 promotes invasion and metastasis via laminin subunit 2 in gastric cancer.Cancer Sci. 2018 Mar;109(3):732-740. doi: 10.1111/cas.13502. Epub 2018 Feb 20.
• [4386] Loss of PCDH9 is associated with the differentiation of tumor cells and metastasis and predicts poor survival in gastric cancer.Clin Exp Metastasis. 2015 Jun;32(5):417-28. doi: 10.1007/s10585-015-9712-7. Epub 2015 Apr 14.
• [4387] Epigenetic Deregulation of Protocadherin PCDHGC3 in Pheochromocytomas/Paragangliomas Associated With SDHB Mutations.J Clin Endocrinol Metab. 2019 Nov 1;104(11):5673-5692. doi: 10.1210/jc.2018-01471.
• [4388] NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of all-trans retinoic acid via targeting RDH16 in malignant glioma.Oncogene. 2017 Aug 17;36(33):4706-4718. doi: 10.1038/onc.2017.34. Epub 2017 Apr 10.
• [4389] Piccolo mediates EGFR signaling and acts as a prognostic biomarker in esophageal squamous cell carcinoma.Oncogene. 2017 Jul 6;36(27):3890-3902. doi: 10.1038/onc.2017.15. Epub 2017 Mar 6.
• [4390] Taking a holistic view of PEST-containing nuclear protein (PCNP) in cancer biology.Cancer Med. 2019 Oct;8(14):6335-6343. doi: 10.1002/cam4.2465. Epub 2019 Sep 5.
• [4391] Penicisulfuranol A, a novel C-terminal inhibitor disrupting molecular chaperone function of Hsp90 independent of ATP binding domain.Biochem Pharmacol. 2019 May;163:404-415. doi: 10.1016/j.bcp.2019.03.012. Epub 2019 Mar 8.
• [4392] Plasmacytoid dendritic cell in immunity and cancer.J Neuroimmunol. 2018 Sep 15;322:63-73. doi: 10.1016/j.jneuroim.2018.06.012. Epub 2018 Jun 26.
• [4393] Dual function of programmed cell death 10 (PDCD10) in drug resistance.Biomed Pharmacother. 2018 May;101:129-136. doi: 10.1016/j.biopha.2018.02.020. Epub 2018 Feb 23.
• [4394] Programmed cell death factor 4 enhances the chemosensitivity of colorectal cancer cells to Taxol.Oncol Lett. 2019 Aug;18(2):1402-1408. doi: 10.3892/ol.2019.10398. Epub 2019 May 27.
• [4395] T-cell Receptors Engineered De Novo for Peptide Specificity Can Mediate Optimal T-cell Activity without Self Cross-Reactivity.Cancer Immunol Res. 2019 Dec;7(12):2025-2035. doi: 10.1158/2326-6066.CIR-19-0035. Epub 2019 Sep 23.
• [4396] miR?1?p targets PDHA1 to regulate glycolysis and cancer progression in gastric cancer.Oncol Rep. 2018 Nov;40(5):2955-2963. doi: 10.3892/or.2018.6695. Epub 2018 Sep 10.
• [4397] PDIA4: The basic characteristics, functions and its potential connection with cancer.Biomed Pharmacother. 2020 Feb;122:109688. doi: 10.1016/j.biopha.2019.109688. Epub 2019 Nov 30.
• [4398] Chronic cadmium exposure aggravates malignant phenotypes of nasopharyngeal carcinoma by activating the Wnt/-catenin signaling pathway via hypermethylation of the casein kinase 1 promoter.Cancer Manag Res. 2018 Dec 19;11:81-93. doi: 10.2147/CMAR.S171200. eCollection 2019.
• [4399] Benzyl butyl phthalate (BBP) triggers the malignancy of acute myeloid leukemia cells via upregulation of PDK4.Toxicol In Vitro. 2020 Feb;62:104693. doi: 10.1016/j.tiv.2019.104693. Epub 2019 Oct 17.
• [4400] Pull-down Assay on Streptavidin Beads and Surface Plasmon Resonance Chips for SWATH-MS-based Interactomics.Cancer Genomics Proteomics. 2018 Sep-Oct;15(5):395-404. doi: 10.21873/cgp.20098.
• [4401] An Sp1/Sp3 binding polymorphism confers methylation protection.PLoS Genet. 2008 Aug 22;4(8):e1000162. doi: 10.1371/journal.pgen.1000162.
• [4402] mTORC2-mediated PDHE1 nuclear translocation links EBV-LMP1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma.Oncogene. 2019 Jun;38(24):4669-4684. doi: 10.1038/s41388-019-0749-y. Epub 2019 Feb 11.
• [4403] Deficiency of the adrenomedullin-RAMP3 system suppresses metastasis through the modification of cancer-associated fibroblasts.Oncogene. 2020 Feb;39(9):1914-1930. doi: 10.1038/s41388-019-1112-z. Epub 2019 Nov 21.
• [4404] PDRG1, a novel tumor marker for multiple malignancies that is selectively regulated by genotoxic stress.Cancer Biol Ther. 2011 Mar 15;11(6):567-73. doi: 10.4161/cbt.11.6.14412. Epub 2011 Mar 15.
• [4405] PDSS2 Deficiency Induces Hepatocarcinogenesis by Decreasing Mitochondrial Respiration and Reprogramming Glucose Metabolism.Cancer Res. 2018 Aug 15;78(16):4471-4481. doi: 10.1158/0008-5472.CAN-17-2172. Epub 2018 Jul 2.
• [4406] PEA15 promotes liver metastasis of colorectal cancer by upregulating the ERK/MAPK signaling pathway.Oncol Rep. 2019 Jan;41(1):43-56. doi: 10.3892/or.2018.6825. Epub 2018 Oct 25.
• [4407] The PEAK1-PPP1R12B axis inhibits tumor growth and metastasis by regulating Grb2/PI3K/Akt signalling in colorectal cancer.Cancer Lett. 2019 Feb 1;442:383-395. doi: 10.1016/j.canlet.2018.11.014. Epub 2018 Nov 22.
• [4408] Knockdown of PEBP4 inhibits human glioma cell growth and invasive potential via ERK1/2 signaling pathway.Mol Carcinog. 2019 Jan;58(1):135-143. doi: 10.1002/mc.22915. Epub 2018 Oct 5.
• [4409] Mutation of the gene encoding the circadian clock component PERIOD2 in oncogenic cells confers chemoresistance by up-regulating the Aldh3a1 gene.J Biol Chem. 2019 Jan 11;294(2):547-558. doi: 10.1074/jbc.RA118.004942. Epub 2018 Nov 14.
• [4410] Single-nucleotide polymorphisms in the p53 pathway genes modify cancer risk in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.Mol Carcinog. 2010 Jun;49(6):545-55. doi: 10.1002/mc.20618.
• [4411] PF4V1, an miRNA-875-3p target, suppresses cell proliferation, migration, and invasion in prostate cancer and serves as a potential prognostic biomarker.Cancer Manag Res. 2019 Mar 21;11:2299-2312. doi: 10.2147/CMAR.S187831. eCollection 2019.
• [4412] Common mechanisms of onset of cancer and neurodegenerative diseases.Biol Pharm Bull. 2015;38(6):795-808. doi: 10.1248/bpb.b15-00125.
• [4413] Characterization of HKE2: an ancient antigen encoded in the major histocompatibility complex.Tissue Antigens. 2007 Feb;69(2):181-8. doi: 10.1111/j.1399-0039.2006.00730.x.
• [4414] The influence of PFK-II overexpression on neuroblastoma patients' survival may be dependent on the particular isoenzyme expressed, PFKFB3 or PFKFB4.Cancer Cell Int. 2019 Nov 14;19:292. doi: 10.1186/s12935-019-1005-9. eCollection 2019.
• [4415] ATP citrate lyase: A central metabolic enzyme in cancer.Cancer Lett. 2020 Feb 28;471:125-134. doi: 10.1016/j.canlet.2019.12.010. Epub 2019 Dec 9.
• [4416] Synthesis and biological evaluation of anthraquinone derivatives as allosteric phosphoglycerate mutase 1 inhibitors for cancer treatment.Eur J Med Chem. 2019 Apr 15;168:45-57. doi: 10.1016/j.ejmech.2019.01.085. Epub 2019 Feb 8.
• [4417] Human FRAG1 encodes a novel membrane-spanning protein that localizes to chromosome 11p15.5, a region of frequent loss of heterozygosity in cancer.Genomics. 1999 Nov 15;62(1):59-66. doi: 10.1006/geno.1999.5980.
• [4418] Tumor-Derived Peptidoglycan Recognition Protein 2 Predicts Survival and Antitumor Immune Responses in Hepatocellular Carcinoma.Hepatology. 2020 May;71(5):1626-1642. doi: 10.1002/hep.30924. Epub 2020 Jan 24.
• [4419] Chemopreventive activity of celastrol in drug-resistant human colon carcinoma cell cultures.Oncotarget. 2018 Apr 20;9(30):21211-21223. doi: 10.18632/oncotarget.25014. eCollection 2018 Apr 20.
• [4420] miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8(+) T cell fate.Nat Commun. 2019 May 14;10(1):2157. doi: 10.1038/s41467-019-09882-8.
• [4421] Histone Demethylase Gene PHF2 Is Mutated in Gastric and Colorectal Cancers.Pathol Oncol Res. 2017 Jul;23(3):471-476. doi: 10.1007/s12253-016-0130-1. Epub 2016 Oct 15.
• [4422] An integrated genomic analysis of Tudor domain-containing proteins identifies PHD finger protein 20-like 1 (PHF20L1) as a candidate oncogene in breast cancer.Mol Oncol. 2016 Feb;10(2):292-302. doi: 10.1016/j.molonc.2015.10.013. Epub 2015 Oct 28.
• [4423] PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/-catenin signaling pathway.J Exp Clin Cancer Res. 2017 Jun 23;36(1):85. doi: 10.1186/s13046-017-0560-y.
• [4424] The histone code reader PHD finger protein 7 controls sex-linked disparities in gene expression and malignancy in Drosophila.Sci Adv. 2019 Aug 14;5(8):eaaw7965. doi: 10.1126/sciadv.aaw7965. eCollection 2019 Aug.
• [4425] Role of Elevated PHIP Copy Number as a Prognostic and Progression Marker for Cutaneous Melanoma.Clin Cancer Res. 2018 Sep 1;24(17):4119-4125. doi: 10.1158/1078-0432.CCR-18-0791. Epub 2018 May 18.
• [4426] A critical review of the role of M(2)PYK in the Warburg effect.Biochim Biophys Acta Rev Cancer. 2019 Apr;1871(2):225-239. doi: 10.1016/j.bbcan.2019.01.004. Epub 2019 Jan 29.
• [4427] PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer.Cell Rep. 2018 Feb 27;22(9):2469-2481. doi: 10.1016/j.celrep.2018.02.028.
• [4428] Molecular pathogenesis of pancreatic ductal adenocarcinoma: Impact of passenger strand of pre-miR-148a on gene regulation.Cancer Sci. 2018 Jun;109(6):2013-2026. doi: 10.1111/cas.13610. Epub 2018 May 22.
• [4429] Low PHLDA3 expression in oesophageal squamous cell carcinomas is associated with poor prognosis.Anticancer Res. 2015 Feb;35(2):949-54.
• [4430] Retrospective evaluation of a decision-support algorithm (MIPOGG) for genetic referrals for children with neuroblastic tumors.Pediatr Blood Cancer. 2018 Dec;65(12):e27390. doi: 10.1002/pbc.27390. Epub 2018 Aug 16.
• [4431] Regulation of RIP3 by the transcription factor Sp1 and the epigenetic regulator UHRF1 modulates cancer cell necroptosis.Cell Death Dis. 2017 Oct 5;8(10):e3084. doi: 10.1038/cddis.2017.483.
• [4432] PIAS1 is not suitable as a urothelial carcinoma biomarker protein and pharmacological target.PLoS One. 2019 Oct 22;14(10):e0224085. doi: 10.1371/journal.pone.0224085. eCollection 2019.
• [4433] PIASy mediates hypoxia-induced SIRT1 transcriptional repression and epithelial-to-mesenchymal transition in ovarian cancer cells.J Cell Sci. 2013 Sep 1;126(Pt 17):3939-47. doi: 10.1242/jcs.127381. Epub 2013 Jul 10.
• [4434] A critical role for CRM1 in regulating HOXA gene transcription in CALM-AF10 leukemias.Leukemia. 2015 Feb;29(2):423-32. doi: 10.1038/leu.2014.221. Epub 2014 Jul 16.
• [4435] PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas.Clin Cancer Res. 2014 Feb 15;20(4):827-36. doi: 10.1158/1078-0432.CCR-13-2053. Epub 2013 Dec 3.
• [4436] A Systematic Review on Predisposition to Lymphoid (B and T cell) Neoplasias in Patients With Primary Immunodeficiencies and Immune Dysregulatory Disorders (Inborn Errors of Immunity).Front Immunol. 2019 Apr 16;10:777. doi: 10.3389/fimmu.2019.00777. eCollection 2019.
• [4437] The increased expression of Piezo1 and Piezo2 ion channels in human and mouse bladder carcinoma.Adv Clin Exp Med. 2018 Aug;27(8):1025-1031. doi: 10.17219/acem/71080.
• [4438] Five miRNAs-mediated PIEZO2 downregulation, accompanied with activation of Hedgehog signaling pathway, predicts poor prognosis of breast cancer.Aging (Albany NY). 2019 May 6;11(9):2628-2652. doi: 10.18632/aging.101934.
• [4439] Biomineralized Gd(2) O(3) @HSA Nanoparticles as a Versatile Platform for Dual-Modal Imaging and Chemo-Phototherapy-Synergized Tumor Ablation.Adv Healthc Mater. 2019 Dec;8(24):e1901005. doi: 10.1002/adhm.201901005. Epub 2019 Nov 18.
• [4440] A method to generate genetically defined tumors in pigs.Methods Enzymol. 2008;439:39-51. doi: 10.1016/S0076-6879(07)00404-1.
• [4441] Phosphatidylinositol glycan anchor biosynthesis, class X containing complex promotes cancer cell proliferation through suppression of EHD2 and ZIC1, putative tumor suppressors.Int J Oncol. 2016 Sep;49(3):868-76. doi: 10.3892/ijo.2016.3607. Epub 2016 Jul 6.
• [4442] PIK3C2A mRNA functions as a miR-124 sponge to facilitate CD151 expression and enhance malignancy of hepatocellular carcinoma cells.Oncotarget. 2016 Jul 12;7(28):43376-43389. doi: 10.18632/oncotarget.9716.
• [4443] Analyses of FGFR3 and PIK3CA mutations in neuroblastomas and the effects of the corresponding inhibitors on neuroblastoma cell lines.Int J Oncol. 2019 Dec;55(6):1372-1384. doi: 10.3892/ijo.2019.4896. Epub 2019 Oct 7.
• [4444] Targeting Autophagy by MPT0L145, a Highly Potent PIK3C3 Inhibitor, Provides Synergistic Interaction to Targeted or Chemotherapeutic Agents in Cancer Cells.Cancers (Basel). 2019 Sep 11;11(9):1345. doi: 10.3390/cancers11091345.
• [4445] PIK3R3 Promotes Metastasis of Pancreatic Cancer via ZEB1 Induced Epithelial-Mesenchymal Transition.Cell Physiol Biochem. 2018;46(5):1930-1938. doi: 10.1159/000489382. Epub 2018 Apr 28.
• [4446] Differential roles for the p101 and p84 regulatory subunits of PI3K in tumor growth and metastasis.Oncogene. 2012 May 3;31(18):2350-61. doi: 10.1038/onc.2011.414. Epub 2011 Sep 26.
• [4447] FAM64A positively regulates STAT3 activity to promote Th17 differentiation and colitis-associated carcinogenesis.Proc Natl Acad Sci U S A. 2019 May 21;116(21):10447-10452. doi: 10.1073/pnas.1814336116. Epub 2019 May 6.
• [4448] PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia.Cancer Genet. 2019 Apr;233-234:56-66. doi: 10.1016/j.cancergen.2019.04.002. Epub 2019 Apr 11.
• [4449] Decrease in Multidrug Resistance-associated Protein 2 Activities by Knockdown of Phosphatidylinositol 4-phosphate 5-kinase in Hepatocytes and Cancer Cells.J Pharm Pharm Sci. 2019;22(1):576-584. doi: 10.18433/jpps30444.
• [4450] Risk Stratification by Urinary Prostate Cancer Gene 3 Testing Before Magnetic Resonance Imaging-Ultrasound Fusion-targeted Prostate Biopsy Among Men With No History of Biopsy.Urology. 2017 Jan;99:174-179. doi: 10.1016/j.urology.2016.08.022. Epub 2016 Aug 22.
• [4451] Overexpression of PIP5KL1 suppresses cell proliferation and migration in human gastric cancer cells.Mol Biol Rep. 2010 Jun;37(5):2189-98. doi: 10.1007/s11033-009-9701-5. Epub 2009 Aug 13.
• [4452] Cancer Diagnosis Epigenomics Scientific Workflow Scheduling in the Cloud Computing Environment Using an Improved PSO Algorithm.Asian Pac J Cancer Prev. 2018 Jan 27;19(1):243-246. doi: 10.22034/APJCP.2018.19.1.243.
• [4453] Functional Isolation of Tumor-Initiating Cells using Microfluidic-Based Migration Identifies Phosphatidylserine Decarboxylase as a Key Regulator.Sci Rep. 2018 Jan 10;8(1):244. doi: 10.1038/s41598-017-18610-5.
• [4454] A nano-cocktail of an NIR-II emissive fluorophore and organoplatinum(ii) metallacycle for efficient cancer imaging and therapy.Chem Sci. 2019 Jun 13;10(29):7023-7028. doi: 10.1039/c9sc02466b. eCollection 2019 Aug 7.
• [4455] A molecular design strategy toward enzyme-activated probes with near-infrared I and II fluorescence for targeted cancer imaging.Chem Sci. 2019 Jun 14;10(30):7222-7227. doi: 10.1039/c9sc02093d. eCollection 2019 Aug 14.
• [4456] Regulator of G-protein signaling (RGS) proteins as drug targets: Progress and future potentials.J Biol Chem. 2019 Dec 6;294(49):18571-18585. doi: 10.1074/jbc.REV119.007060. Epub 2019 Oct 21.
• [4457] Expression of PIWIL2 in oral cancer and leukoplakia: Prognostic implications and insights from tumors.Cancer Biomark. 2019;26(1):11-20. doi: 10.3233/CBM-182009.
• [4458] Expression of the ring ligase PRAJA2 in thyroid cancer.J Clin Endocrinol Metab. 2012 Nov;97(11):4253-9. doi: 10.1210/jc.2012-2360. Epub 2012 Sep 4.
• [4459] lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma.Int J Oncol. 2019 Jul;55(1):45-58. doi: 10.3892/ijo.2019.4798. Epub 2019 May 6.
• [4460] Periampullary malignancy in Gardner's syndrome.Ann Surg. 1977 May;185(5):565-73. doi: 10.1097/00000658-197705000-00009.
• [4461] Cellular distribution, post-translational modification, and tumorigenic potential of human group III secreted phospholipase A(2).J Biol Chem. 2005 Jul 1;280(26):24987-98. doi: 10.1074/jbc.M502088200. Epub 2005 Apr 29.
• [4462] Screening of urine identifies PLA2G16 as a field defect methylation biomarker for prostate cancer detection.PLoS One. 2019 Jun 24;14(6):e0218950. doi: 10.1371/journal.pone.0218950. eCollection 2019.
• [4463] PLAGL2 promotes epithelial-mesenchymal transition and mediates colorectal cancer metastasis via -catenin-dependent regulation of ZEB1.Br J Cancer. 2020 Feb;122(4):578-589. doi: 10.1038/s41416-019-0679-z. Epub 2019 Dec 12.
• [4464] Diagnostic and prognostic value of mRNA expression of phospholipase C family genes in hepatitis B virusassociated hepatocellular carcinoma.Oncol Rep. 2019 May;41(5):2855-2875. doi: 10.3892/or.2019.7066. Epub 2019 Mar 14.
• [4465] Phospholipase C1 induces E-cadherin expression and suppresses malignancy in colorectal cancer cells.Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):13505-10. doi: 10.1073/pnas.1405374111. Epub 2014 Sep 2.
• [4466] Correlation between PLCE1 rs2274223 variant and digestive tract cancer: A meta-analysis.Mol Genet Genomic Med. 2019 Apr;7(4):e00589. doi: 10.1002/mgg3.589. Epub 2019 Feb 19.
• [4467] Dynamic Allostery in PLC1 and Its Modulation by a Cancer Mutation Revealed by MD Simulation and NMR.Biophys J. 2018 Jul 3;115(1):31-45. doi: 10.1016/j.bpj.2018.05.031.
• [4468] TAT-apoptin is efficiently delivered and induces apoptosis in cancer cells.Oncogene. 2004 Feb 5;23(5):1153-65. doi: 10.1038/sj.onc.1207224.
• [4469] Silencing of CKIP-1 promotes tumor proliferation and cell adhesion-mediated drug resistance via regulating AKT activity in non-Hodgkin's lymphoma.Oncol Rep. 2017 Jan;37(1):622-630. doi: 10.3892/or.2016.5233. Epub 2016 Nov 8.
• [4470] Genome-wide analysis of noncoding regulatory mutations in cancer.Nat Genet. 2014 Nov;46(11):1160-5. doi: 10.1038/ng.3101. Epub 2014 Sep 28.
• [4471] Bioplasmonic paper-based assay for perilipin-2 non-invasively detects renal cancer.Kidney Int. 2019 Dec;96(6):1417-1421. doi: 10.1016/j.kint.2019.08.020. Epub 2019 Sep 3.
• [4472] Polo-like kinase 3 inhibits glucose metabolism in colorectal cancer by targeting HSP90/STAT3/HK2 signaling.J Exp Clin Cancer Res. 2019 Oct 26;38(1):426. doi: 10.1186/s13046-019-1418-2.
• [4473] Cancer Characteristic Gene Selection via Sample Learning Based on Deep Sparse Filtering.Sci Rep. 2018 May 29;8(1):8270. doi: 10.1038/s41598-018-26666-0.
• [4474] Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets.Mol Cancer Ther. 2009 Jan;8(1):249-60. doi: 10.1158/1535-7163.MCT-08-0636.
• [4475] A Novel Peptide Probe for Identification of PLS3-Expressed Cancer Cells.Anal Chem. 2019 Aug 6;91(15):9640-9647. doi: 10.1021/acs.analchem.9b01061. Epub 2019 Jul 24.
• [4476] The role of plasmalemma vesicle-associated protein in pathological breakdown of blood-brain and blood-retinal barriers: potential novel therapeutic target for cerebral edema and diabetic macular edema.Fluids Barriers CNS. 2018 Sep 20;15(1):24. doi: 10.1186/s12987-018-0109-2.
• [4477] NOV is upregulated and promotes migration and invasion in bladder cancer.Tumour Biol. 2014 Jul;35(7):6749-55. doi: 10.1007/s13277-014-1919-8. Epub 2014 Apr 10.
• [4478] Identification of Circadian Determinants of Cancer Chronotherapy through In Vitro Chronopharmacology and Mathematical Modeling.Mol Cancer Ther. 2015 Sep;14(9):2154-64. doi: 10.1158/1535-7163.MCT-15-0129. Epub 2015 Jul 3.
• [4479] Association between prognosis and SEMA4D/Plexin-B1 expression in various malignancies: A meta-analysis.Medicine (Baltimore). 2019 Feb;98(7):e13298. doi: 10.1097/MD.0000000000013298.
• [4480] Plexin-B2 Mediates Physiologic and Pathologic Functions of Angiogenin.Cell. 2017 Nov 2;171(4):849-864.e25. doi: 10.1016/j.cell.2017.10.005.
• [4481] Molecular profiling of the "plexinome" in melanoma and pancreatic cancer.Hum Mutat. 2009 Aug;30(8):1167-74. doi: 10.1002/humu.21017.
• [4482] Plexin C1 Marks Liver Cancer Cells with Epithelial Phenotype and Is Overexpressed in Hepatocellular Carcinoma.Can J Gastroenterol Hepatol. 2018 Sep 19;2018:4040787. doi: 10.1155/2018/4040787. eCollection 2018.
• [4483] Genetic identification of intestinal microsporidia species in immunocompromised patients in Tunisia.Am J Trop Med Hyg. 2009 Jan;80(1):24-7.
• [4484] Myofibrillogenesis regulator 1 (MR-1): a potential therapeutic target for cancer and PNKD.J Drug Target. 2018 Sep;26(8):643-648. doi: 10.1080/1061186X.2017.1401077. Epub 2017 Nov 15.
• [4485] EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.Cancer Res. 2019 May 1;79(9):2257-2270. doi: 10.1158/0008-5472.CAN-18-3238. Epub 2019 Mar 12.
• [4486] Progression elevated gene-3 promoter (PEG-Prom) confers cancer cell selectivity to human polynucleotide phosphorylase (hPNPase(old-35))-mediated growth suppression.J Cell Physiol. 2008 May;215(2):401-9. doi: 10.1002/jcp.21320.
• [4487] Next-generation sequencing reveals hsa_circ_0058092 being a potential oncogene candidate involved in gastric cancer.Gene. 2020 Feb 5;726:144176. doi: 10.1016/j.gene.2019.144176. Epub 2019 Oct 26.
• [4488] Human CAP10-Like Protein 46kDa Gene Promotes Malignancy in Colorectal Cancer.OMICS. 2017 May;21(5):266-274. doi: 10.1089/omi.2017.0037.
• [4489] A meta-analysis of multiple matched aCGH/expression cancer datasets reveals regulatory relationships and pathway enrichment of potential oncogenes.PLoS One. 2019 Jul 23;14(7):e0213221. doi: 10.1371/journal.pone.0213221. eCollection 2019.
• [4490] Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population.Sci Rep. 2019 Oct 31;9(1):15767. doi: 10.1038/s41598-019-52414-z.
• [4491] Enhanced expression of p46 Shc in the nucleus and p52 Shc in the cytoplasm of human gastric cancer.Int J Oncol. 2005 Apr;26(4):905-11.
• [4492] DNA polymerase mutational signatures are found in a variety of different types of cancer.Cell Cycle. 2018;17(3):348-355. doi: 10.1080/15384101.2017.1404208. Epub 2018 Feb 15.
• [4493] Association Between Single Nucleotide Polymorphisms in DNA Polymerase Kappa Gene and Breast Cancer Risk in Chinese Han Population: A STROBE-Compliant Observational Study.Medicine (Baltimore). 2016 Jan;95(2):e2466. doi: 10.1097/MD.0000000000002466.
• [4494] Hypothesis driven single nucleotide polymorphism search (HyDn-SNP-S).DNA Repair (Amst). 2013 Sep;12(9):733-40. doi: 10.1016/j.dnarep.2013.06.001. Epub 2013 Jul 5.
• [4495] Protective Effect Against Cancer of Antibodies to the LargeSubunits of Both RNA Polymerases I and III in Scleroderma.Arthritis Rheumatol. 2019 Sep;71(9):1571-1579. doi: 10.1002/art.40893. Epub 2019 Aug 1.
• [4496] The POLR2E rs3787016 polymorphism is strongly associated with the risk of female breast and cervical cancer.Pathol Res Pract. 2019 May;215(5):1061-1065. doi: 10.1016/j.prp.2019.02.015. Epub 2019 Feb 27.
• [4497] Rectus Sheath Block (RSB) Analgesia Could Enhance Significantly the Patient Satisfaction Following Midline Laparotomy in Benign Disease and in Cancer: A Prospective Study With Special Reference to Nitrosative Stress Marker Nitrotyrosine (NT) Plasma Concentrations.Anticancer Res. 2019 Mar;39(3):1383-1389. doi: 10.21873/anticanres.13252.
• [4498] Epigenetic activation of POTE genes in ovarian cancer.Epigenetics. 2019 Feb;14(2):185-197. doi: 10.1080/15592294.2019.1581590. Epub 2019 Mar 4.
• [4499] Fabrication of 3D continuous-flow reverse-transcription polymerase chain reaction microdevice integrated with on-chip fluorescence detection for semi-quantitative assessment of gene expression.Analyst. 2018 Nov 19;143(23):5692-5701. doi: 10.1039/c8an01739e.
• [4500] TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1.Blood. 2017 Mar 9;129(10):1284-1295. doi: 10.1182/blood-2016-09-737536. Epub 2017 Jan 4.
• [4501] POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer.Genes Dev. 2018 Jul 1;32(13-14):915-928. doi: 10.1101/gad.314815.118. Epub 2018 Jun 26.
• [4502] The cellular transcription factor Brn-3a and the smoking-related substance nicotine interact to regulate the activity of the HPV URR in the cervix.Oncogene. 2010 May 6;29(18):2701-11. doi: 10.1038/onc.2010.33. Epub 2010 Mar 1.
• [4503] Genome-wide profiling in melatonin-exposed human breast cancer cell lines identifies differentially methylated genes involved in the anticancer effect of melatonin.J Pineal Res. 2013 Jan;54(1):80-8. doi: 10.1111/j.1600-079X.2012.01027.x. Epub 2012 Aug 1.
• [4504] Performance of a new HPV and biomarker assay in the management of hrHPV positive women: Subanalysis of the ongoing multicenter TRACE clinical trial (n??,000) to evaluate POU4F3 methylation as a potential biomarker of cervical precancer and cancer.Int J Cancer. 2017 Mar 1;140(5):1119-1133. doi: 10.1002/ijc.30534.
• [4505] POU6F1 is the transcription factor that might be involved in cell proliferation of clear cell adenocarcinoma of the ovary.Hum Cell. 2009 Nov;22(4):94-100. doi: 10.1111/j.1749-0774.2009.00074.x.
• [4506] Whole-Exome Sequencing of Salivary Gland Mucoepidermoid Carcinoma.Clin Cancer Res. 2017 Jan 1;23(1):283-288. doi: 10.1158/1078-0432.CCR-16-0720. Epub 2016 Jun 23.
• [4507] CXCL7 promotes proliferation and invasion of cholangiocarcinoma cells.Oncol Rep. 2017 Feb;37(2):1114-1122. doi: 10.3892/or.2016.5312. Epub 2016 Dec 12.
• [4508] Liprin-1 modulates cancer cell signaling by transmembrane protein CD82 in adhesive membrane domains linked to cytoskeleton.Cell Commun Signal. 2018 Jul 13;16(1):41. doi: 10.1186/s12964-018-0253-y.
• [4509] U-box ubiquitin ligase PPIL2 suppresses breast cancer invasion and metastasis by altering cell morphology and promoting SNAI1 ubiquitination and degradation.Cell Death Dis. 2018 Jan 19;9(2):63. doi: 10.1038/s41419-017-0094-4.
• [4510] Functions and dysfunctions of Ca(2+)/calmodulin-dependent protein kinase phosphatase (CaMKP/PPM1F) and CaMKP-N/PPM1E.Arch Biochem Biophys. 2018 Feb 15;640:83-92. doi: 10.1016/j.abb.2018.01.001. Epub 2018 Jan 6.
• [4511] PPM1H is a p27 phosphatase implicated in trastuzumab resistance.Cancer Discov. 2011 Sep;1(4):326-37. doi: 10.1158/2159-8290.CD-11-0062. Epub 2011 Jul 20.
• [4512] A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity.Mol Cell. 2006 Apr 21;22(2):217-30. doi: 10.1016/j.molcel.2006.03.027.
• [4513] Phosphatase 1 Nuclear Targeting Subunit, a Novel DNA Repair Partner of PARP1.Cancer Res. 2019 May 15;79(10):2460-2461. doi: 10.1158/0008-5472.CAN-19-0798.
• [4514] Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells.Gastroenterology. 2017 Aug;153(2):505-520. doi: 10.1053/j.gastro.2017.04.017. Epub 2017 Apr 20.
• [4515] Nuclear localization of CPI-17, a protein phosphatase-1 inhibitor protein, affects histone H3 phosphorylation and corresponds to proliferation of cancer and smooth muscle cells.Biochem Biophys Res Commun. 2013 Apr 26;434(1):137-42. doi: 10.1016/j.bbrc.2013.03.055. Epub 2013 Mar 26.
• [4516] In vivo molecular mediators of cancer growth suppression and apoptosis by selenium in mammary and prostate models: lack of involvement of gadd genes.Mol Cancer Ther. 2009 Mar;8(3):682-91. doi: 10.1158/1535-7163.MCT-08-0908. Epub 2009 Mar 10.
• [4517] Infant acute lymphoblastic leukemia with t(11;16)(q23;p13.3) and lineage switch into acute monoblastic leukemia.Cancer Genet Cytogenet. 2006 Jul 15;168(2):146-9. doi: 10.1016/j.cancergencyto.2006.02.013.
• [4518] DARPP-32: from neurotransmission to cancer.Oncotarget. 2016 Apr 5;7(14):17631-40. doi: 10.18632/oncotarget.7268.
• [4519] The role of rumination in posttraumatic growth in people struggling with cancer.J Psychosoc Oncol. 2019 Sep-Oct;37(5):652-664. doi: 10.1080/07347332.2019.1600628. Epub 2019 May 14.
• [4520] Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer.BMC Cancer. 2015 Apr 15;15:285. doi: 10.1186/s12885-015-1266-1.
• [4521] Protein phosphatase 2 regulatory subunit B''Alpha silencing inhibits tumor cell proliferation in liver cancer.Cancer Med. 2019 Dec;8(18):7741-7753. doi: 10.1002/cam4.2620. Epub 2019 Oct 24.
• [4522] Expression and distribution of PPP2R5C gene in leukemia.J Hematol Oncol. 2011 May 6;4:21. doi: 10.1186/1756-8722-4-21.
• [4523] Downregulation of PPP2R5E expression by miR-23a suppresses apoptosis to facilitate the growth of gastric cancer cells.FEBS Lett. 2014 Aug 25;588(17):3160-9. doi: 10.1016/j.febslet.2014.05.068. Epub 2014 Jul 2.
• [4524] Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.Nat Genet. 2012 Sep;44(9):1006-14. doi: 10.1038/ng.2359. Epub 2012 Jul 29.
• [4525] Candidemia in a major regional tertiary referral hospital - epidemiology, practice patterns and outcomes.Antimicrob Resist Infect Control. 2017 Mar 11;6:27. doi: 10.1186/s13756-017-0184-1. eCollection 2017.
• [4526] Polycomb Repressor Complex 2 in Genomic Instability and Cancer.Int J Mol Sci. 2017 Jul 30;18(8):1657. doi: 10.3390/ijms18081657.
• [4527] Biodistribution and Pharmacokinetic Evaluations of a Novel Taxoid DHA-SBT-1214 in an Oil-in-Water Nanoemulsion Formulation in Nave and Tumor-Bearing Mice.Pharm Res. 2018 Mar 8;35(4):91. doi: 10.1007/s11095-018-2349-x.
• [4528] Subcellular distribution and expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in malignant glioma: Influence on cell survival and migration.Cancer Sci. 2010 Jul;101(7):1624-31. doi: 10.1111/j.1349-7006.2010.01570.x. Epub 2010 Mar 19.
• [4529] The pseudokinases SgK269 and SgK223: A novel oncogenic alliance in human cancer.Cell Adh Migr. 2018;12(6):524-528. doi: 10.1080/19336918.2017.1394570. Epub 2017 Dec 21.
• [4530] Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study.Blood. 1997 Aug 15;90(4):1656-63.
• [4531] Impairment of MAD2B-PRCC interaction in mitotic checkpoint defective t(X;1)-positive renal cell carcinomas.Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13808-13. doi: 10.1073/pnas.241304198.
• [4532] The Pluripotency Regulator PRDM14 Requires Hematopoietic Regulator CBFA2T3 to Initiate Leukemia in Mice.Mol Cancer Res. 2019 Jul;17(7):1468-1479. doi: 10.1158/1541-7786.MCR-18-1327. Epub 2019 Apr 23.
• [4533] PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer.Clin Transl Oncol. 2020 Jul;22(7):1126-1137. doi: 10.1007/s12094-019-02239-z. Epub 2019 Nov 18.
• [4534] Peroxiredoxin2 downregulation enhances hepatocellular carcinoma proliferation and migration, and is associated with unfavorable prognosis in patients.Oncol Rep. 2019 Mar;41(3):1539-1548. doi: 10.3892/or.2019.6977. Epub 2019 Jan 22.
• [4535] Interplay Between Mitochondrial Peroxiredoxins and ROS in Cancer Development and Progression.Int J Mol Sci. 2019 Sep 7;20(18):4407. doi: 10.3390/ijms20184407.
• [4536] Peroxiredoxin 6 Serum Levels and Risk of Neutropenic Infections in Diffuse Large B-cell Lymphoma.Anticancer Res. 2019 Sep;39(9):4925-4931. doi: 10.21873/anticanres.13680.
• [4537] Enrichment of B cell receptor signaling and epidermal growth factor receptor pathways in monoclonal gammopathy of undetermined significance: a genome-wide genetic interaction study.Mol Med. 2018 Jun 11;24(1):30. doi: 10.1186/s10020-018-0031-8.
• [4538] Failure of immunosurveillance accelerates aging.Oncoimmunology. 2019 Feb 9;8(4):e1575117. doi: 10.1080/2162402X.2019.1575117. eCollection 2019.
• [4539] Inactivation of PRIM1 Function Sensitizes Cancer Cells to ATR and CHK1 Inhibitors.Neoplasia. 2018 Nov;20(11):1135-1143. doi: 10.1016/j.neo.2018.08.009. Epub 2018 Sep 23.
• [4540] PRIMA-1MET induces apoptosis through accumulation of intracellular reactive oxygen species irrespective of p53 status and chemo-sensitivity in epithelial ovarian cancer cells.Oncol Rep. 2016 May;35(5):2543-52. doi: 10.3892/or.2016.4653. Epub 2016 Mar 3.
• [4541] Ouabain impairs cancer metabolism and activates AMPK-Src signaling pathway in human cancer cell lines.Acta Pharmacol Sin. 2020 Jan;41(1):110-118. doi: 10.1038/s41401-019-0290-0. Epub 2019 Sep 12.
• [4542] Protein kinase D2: a versatile player in cancer biology.Oncogene. 2018 Mar;37(10):1263-1278. doi: 10.1038/s41388-017-0052-8. Epub 2017 Dec 20.
• [4543] The GEF-H1/PKD3 signaling pathway promotes the maintenance of triple-negative breast cancer stem cells.Int J Cancer. 2020 Jun 15;146(12):3423-3434. doi: 10.1002/ijc.32798. Epub 2019 Dec 14.
• [4544] Hypermethylation and aberrant expression of secreted frizzled-related protein genes in pancreatic cancer.World J Gastroenterol. 2008 Jun 7;14(21):3421-4. doi: 10.3748/wjg.14.3421.
• [4545] PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma.Nat Commun. 2018 Oct 31;9(1):4552. doi: 10.1038/s41467-018-06968-7.
• [4546] Diagnostic value of PRND gene expression profiles in astrocytomas: relationship to tumor grades of malignancy.Oncol Rep. 2007 May;17(5):989-96. doi: 10.3892/or.17.5.989.
• [4547] Prokineticin 2 expression as a novel prognostic biomarker for human colorectal cancer.Oncotarget. 2018 Jul 10;9(53):30079-30091. doi: 10.18632/oncotarget.25706. eCollection 2018 Jul 10.
• [4548] PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer: a multiomics analysis.Cancer Gene Ther. 2020 Apr;27(3-4):147-167. doi: 10.1038/s41417-019-0109-7. Epub 2019 Jun 5.
• [4549] Pheno-seq - linking visual features and gene expression in 3D cell culture systems.Sci Rep. 2019 Aug 26;9(1):12367. doi: 10.1038/s41598-019-48771-4.
• [4550] RP11-284F21.9 promotes oral squamous cell carcinoma development via the miR-383-5p/MAL2 axis.J Oral Pathol Med. 2020 Jan;49(1):21-29. doi: 10.1111/jop.12946. Epub 2019 Sep 27.
• [4551] Human PRPF40B regulates hundreds of alternative splicing targets and represses a hypoxia expression signature.RNA. 2019 Aug;25(8):905-920. doi: 10.1261/rna.069534.118. Epub 2019 May 14.
• [4552] MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4.Oncotarget. 2016 Aug 23;7(34):54937-54951. doi: 10.18632/oncotarget.10709.
• [4553] Proline-rich protein 11 silencing inhibits hepatocellular carcinoma growth and epithelial-mesenchymal transition through -catenin signaling.Gene. 2019 Jan 10;681:7-14. doi: 10.1016/j.gene.2018.09.036. Epub 2018 Sep 21.
• [4554] Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer.Mol Carcinog. 2009 Jul;48(7):648-61. doi: 10.1002/mc.20511.
• [4555] Intracellular co-localization of trypsin-2 and matrix metalloprotease-9: possible proteolytic cascade of trypsin-2, MMP-9 and enterokinase in carcinoma.Exp Cell Res. 2008 Feb 15;314(4):914-26. doi: 10.1016/j.yexcr.2007.10.025. Epub 2007 Nov 12.
• [4556] Thyroid hormone enhanced human hepatoma cell motility involves brain-specific serine protease 4 activation via ERK signaling.Mol Cancer. 2014 Jul 1;13:162. doi: 10.1186/1476-4598-13-162.
• [4557] PRSS23 knockdown inhibits gastric tumorigenesis through EIF2 signaling.Pharmacol Res. 2019 Apr;142:50-57. doi: 10.1016/j.phrs.2019.02.008. Epub 2019 Feb 12.
• [4558] pH-sensitive metal-phenolic network capsules for targeted photodynamic therapy against cancer cells.Artif Cells Nanomed Biotechnol. 2018 Dec;46(8):1552-1561. doi: 10.1080/21691401.2017.1377724. Epub 2017 Sep 18.
• [4559] PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinoma.Sci Rep. 2019 Feb 12;9(1):1844. doi: 10.1038/s41598-018-38362-0.
• [4560] A competitive cell-permeable peptide impairs Nme-1 (NDPK-A) and Prune-1 interaction: therapeutic applications in cancer.Lab Invest. 2018 May;98(5):571-581. doi: 10.1038/s41374-017-0011-6. Epub 2018 Feb 15.
• [4561] Cancer-related PRUNE2 protein is associated with nucleotides and is highly expressed in mature nerve tissues.J Mol Neurosci. 2011 Jun;44(2):103-14. doi: 10.1007/s12031-010-9490-2. Epub 2011 Jan 14.
• [4562] ER stress-mediated autophagic cell death induction through methylated -cyclodextrins-threaded acid-labile polyrotaxanes.J Control Release. 2018 Apr 10;275:20-31. doi: 10.1016/j.jconrel.2018.02.010. Epub 2018 Feb 8.
• [4563] AAED1 modulates proliferation and glycolysis in gastric cancer.Oncol Rep. 2018 Aug;40(2):1156-1164. doi: 10.3892/or.2018.6478. Epub 2018 Jun 7.
• [4564] EFA6B antagonizes breast cancer.Cancer Res. 2014 Oct 1;74(19):5493-506. doi: 10.1158/0008-5472.CAN-14-0298. Epub 2014 Aug 12.
• [4565] Recombinant Pregnancy-Specific Glycoprotein 1 Has a Protective Role in a Murine Model of Acute Graft-versus-Host Disease.Biol Blood Marrow Transplant. 2019 Feb;25(2):193-203. doi: 10.1016/j.bbmt.2018.09.022. Epub 2018 Sep 22.
• [4566] Evaluation of AAV-mediated delivery of shRNA to target basal-like breast cancer genetic vulnerabilities.J Biotechnol. 2019 Jul 20;300:70-77. doi: 10.1016/j.jbiotec.2019.05.016. Epub 2019 May 28.
• [4567] Haplotype and cell proliferation analyses of candidate lung cancer susceptibility genes on chromosome 15q24-25.1.Cancer Res. 2009 Oct 1;69(19):7844-50. doi: 10.1158/0008-5472.CAN-09-1833. Epub 2009 Sep 29.
• [4568] Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer.Cancer Sci. 2017 Apr;108(4):732-743. doi: 10.1111/cas.13185. Epub 2017 Apr 25.
• [4569] Overexpression of PSMA7 predicts poor prognosis in patients with gastric cancer.Oncol Lett. 2019 Nov;18(5):5341-5349. doi: 10.3892/ol.2019.10879. Epub 2019 Sep 19.
• [4570] Silencing of Proteasome 26S Subunit ATPase 2 Regulates Colorectal Cancer Cell Proliferation, Apoptosis, and Migration.Chemotherapy. 2019;64(3):146-154. doi: 10.1159/000502224. Epub 2019 Nov 12.
• [4571] The deubiquitinating enzyme PSMD14 facilitates tumor growth and chemoresistance through stabilizing the ALK2 receptor in the initiation of BMP6 signaling pathway.EBioMedicine. 2019 Nov;49:55-71. doi: 10.1016/j.ebiom.2019.10.039. Epub 2019 Nov 1.
• [4572] Inhibition of PSMD4 blocks the tumorigenesis of hepatocellular carcinoma.Gene. 2019 Jun 20;702:66-74. doi: 10.1016/j.gene.2019.03.063. Epub 2019 Mar 28.
• [4573] Identification of PA28 as a potential novel biomarker in human esophageal squamous cell carcinoma.Tumour Biol. 2017 Oct;39(10):1010428317719780. doi: 10.1177/1010428317719780.
• [4574] PTBP3-Mediated Regulation of ZEB1 mRNA Stability Promotes Epithelial-Mesenchymal Transition in Breast Cancer.Cancer Res. 2018 Jan 15;78(2):387-398. doi: 10.1158/0008-5472.CAN-17-0883. Epub 2017 Nov 29.
• [4575] Aggressive variants of papillary thyroid microcarcinoma are associated with high-risk features, but not decreased survival.Surgery. 2020 Jan;167(1):19-27. doi: 10.1016/j.surg.2019.03.030. Epub 2019 Oct 16.
• [4576] Systematic acute and subchronic toxicity evaluation of polysaccharide-protein complex-functionalized selenium nanoparticles with anticancer potency.Biomater Sci. 2019 Nov 19;7(12):5112-5123. doi: 10.1039/c9bm01104h.
• [4577] Expression of prothymosin in lung cancer is associated with squamous cell carcinoma and smoking.Oncol Lett. 2019 Jun;17(6):5740-5746. doi: 10.3892/ol.2019.10248. Epub 2019 Apr 12.
• [4578] Role of ESCRT component HD-PTP/PTPN23 in cancer.Biochem Soc Trans. 2017 Jun 15;45(3):845-854. doi: 10.1042/BST20160332.
• [4579] PTPH1 immunohistochemical expression and promoter methylation in breast cancer patients from India: A retrospective study.J Cell Physiol. 2019 Feb;234(2):1071-1079. doi: 10.1002/jcp.27211. Epub 2018 Sep 6.
• [4580] PTPN3 and PTPN4 tyrosine phosphatase expression in human gastric adenocarcinoma.Anticancer Res. 2006 Mar-Apr;26(2B):1643-9.
• [4581] Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma.Tumour Biol. 2017 Mar;39(3):1010428317691427. doi: 10.1177/1010428317691427.
• [4582] Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification.Clin Cancer Res. 2018 Apr 15;24(8):1845-1852. doi: 10.1158/1078-0432.CCR-17-1912. Epub 2018 Jan 29.
• [4583] Targeting PTPRZ inhibits stem cell-like properties and tumorigenicity in glioblastoma cells.Sci Rep. 2017 Jul 17;7(1):5609. doi: 10.1038/s41598-017-05931-8.
• [4584] AlloDriver: a method for the identification and analysis of cancer driver targets.Nucleic Acids Res. 2019 Jul 2;47(W1):W315-W321. doi: 10.1093/nar/gkz350.
• [4585] Qualitative and quantitative changes in nuclear DNA and phenotypic gene expression in human malignant skin tumors during their progression.Eur J Histochem. 1992;36(3):289-302.
• [4586] MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies.Leukemia. 2000 Mar;14(3):449-56. doi: 10.1038/sj.leu.2401696.
• [4587] High expression of PXDN is associated with poor prognosis and promotes proliferation, invasion as well as migration in ovarian cancer.Ann Diagn Pathol. 2018 Jun;34:161-165. doi: 10.1016/j.anndiagpath.2018.03.002. Epub 2018 Mar 14.
• [4588] Characterization of Hepatocellular Carcinoma Cell Lines Using a Fractionation-Then-Sequencing Approach Reveals Nuclear-Enriched HCC-Associated lncRNAs.Front Genet. 2019 Nov 8;10:1081. doi: 10.3389/fgene.2019.01081. eCollection 2019.
• [4589] A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo.J Biol Chem. 1999 Nov 26;274(48):34283-93. doi: 10.1074/jbc.274.48.34283.
• [4590] Glycogen phosphorylase B promotes ovarian cancer progression via Wnt/-catenin signaling and is regulated by miR-133a-3p.Biomed Pharmacother. 2019 Dec;120:109449. doi: 10.1016/j.biopha.2019.109449. Epub 2019 Oct 15.
• [4591] Immunohistochemistry analysis of Pygo2 expression in central nervous system tumors.J Cell Commun Signal. 2019 Mar;13(1):75-84. doi: 10.1007/s12079-018-0476-0. Epub 2018 Jul 5.
• [4592] RNA-binding protein QKI regulates contact inhibition via Yes-associate protein in ccRCC.Acta Biochim Biophys Sin (Shanghai). 2019 Jan 1;51(1):9-19. doi: 10.1093/abbs/gmy142.
• [4593] Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRP axis and a target for cancer immunotherapy.Nat Med. 2019 Apr;25(4):612-619. doi: 10.1038/s41591-019-0356-z. Epub 2019 Mar 4.
• [4594] A conserved major facilitator superfamily member orchestrates a subset of O-glycosylation to aid macrophage tissue invasion.Elife. 2019 Mar 26;8:e41801. doi: 10.7554/eLife.41801.
• [4595] Rab11a promotes proliferation and invasion through regulation of YAP in non-small cell lung cancer.Oncotarget. 2017 Apr 25;8(17):27800-27811. doi: 10.18632/oncotarget.15359.
• [4596] Garlic extract in bladder cancer prevention: Evidence from T24 bladder cancer cell xenograft model, tissue microarray, and gene network analysis.Int J Oncol. 2017 Jul;51(1):204-212. doi: 10.3892/ijo.2017.3993. Epub 2017 May 11.
• [4597] Rab14 Act as Oncogene and Induce Proliferation of Gastric Cancer Cells via AKT Signaling Pathway.PLoS One. 2017 Jan 20;12(1):e0170620. doi: 10.1371/journal.pone.0170620. eCollection 2017.
• [4598] Rab1A promotes proliferation and migration abilities via regulation of the HER2/AKT-independent mTOR/S6K1 pathway in colorectal cancer.Oncol Rep. 2019 May;41(5):2717-2728. doi: 10.3892/or.2019.7071. Epub 2019 Mar 15.
• [4599] Cytokinesis failure due to derailed integrin traffic induces aneuploidy and oncogenic transformation in vitro and in vivo.Oncogene. 2012 Aug 2;31(31):3597-606. doi: 10.1038/onc.2011.527. Epub 2011 Nov 28.
• [4600] Rab25 augments cancer cell invasiveness through a 1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin.Exp Mol Med. 2018 Jan 26;50(1):e435. doi: 10.1038/emm.2017.248.
• [4601] Functional implications of Rab27 GTPases in Cancer.Cell Commun Signal. 2018 Aug 6;16(1):44. doi: 10.1186/s12964-018-0255-9.
• [4602] RAB27B-activated secretion of stem-like tumor exosomes delivers the biomarker microRNA-146a-5p, which promotes tumorigenesis and associates with an immunosuppressive tumor microenvironment in colorectal cancer.Int J Cancer. 2019 Oct 15;145(8):2209-2224. doi: 10.1002/ijc.32338. Epub 2019 Apr 30.
• [4603] Overexpression of the ras-related rab2 gene product in peripheral blood mononuclear cells from patients with hematological and solid neoplasms.Cancer Res. 1992 Jun 1;52(11):3083-8.
• [4604] Rab34 regulates adhesion, migration, and invasion of breast cancer cells.Oncogene. 2018 Jul;37(27):3698-3714. doi: 10.1038/s41388-018-0202-7. Epub 2018 Apr 6.
• [4605] Rab35-dependent extracellular nanovesicles are required for induction of tumour supporting stroma.Nanoscale. 2018 May 10;10(18):8547-8559. doi: 10.1039/c8nr02417k.
• [4606] VAMP8, a vesicle-SNARE required for RAB37-mediated exocytosis, possesses a tumor metastasis suppressor function.Cancer Lett. 2018 Nov 28;437:79-88. doi: 10.1016/j.canlet.2018.08.023. Epub 2018 Aug 27.
• [4607] A germline mutation in Rab43 gene identified from a cancer family predisposes to a hereditary liver-colon cancer syndrome.BMC Cancer. 2019 Jun 21;19(1):613. doi: 10.1186/s12885-019-5845-4.
• [4608] Disruption of Endolysosomal RAB5/7 Efficiently Eliminates Colorectal Cancer Stem Cells.Cancer Res. 2019 Apr 1;79(7):1426-1437. doi: 10.1158/0008-5472.CAN-18-2192. Epub 2019 Feb 14.
• [4609] Rab5c promotes AMAP1-PRKD2 complex formation to enhance 1 integrin recycling in EGF-induced cancer invasion.J Cell Biol. 2012 Jun 25;197(7):983-96. doi: 10.1083/jcb.201201065.
• [4610] Rab GTPases implicated in inherited and acquired disorders.Semin Cell Dev Biol. 2011 Feb;22(1):57-68. doi: 10.1016/j.semcdb.2010.12.005. Epub 2010 Dec 13.
• [4611] Pyridazinone-substituted benzenesulfonamides display potent inhibition of membrane-bound human carbonic anhydrase IX and promising antiproliferative activity against cancer cell lines.Eur J Med Chem. 2019 Apr 15;168:301-314. doi: 10.1016/j.ejmech.2019.02.044. Epub 2019 Feb 15.
• [4612] Prenylated Rab acceptor RABAC1 inhibits anti-apoptotic protein BCL2A1 and induces apoptosis.Biochem Biophys Res Commun. 2019 Jun 11;513(4):940-946. doi: 10.1016/j.bbrc.2019.04.080. Epub 2019 Apr 17.
• [4613] CVID-Associated Tumors: Czech Nationwide Study Focused on Epidemiology, Immunology, and Genetic Background in a Cohort of Patients With CVID.Front Immunol. 2019 Jan 22;9:3135. doi: 10.3389/fimmu.2018.03135. eCollection 2018.
• [4614] Ras and Rap1: A tale of two GTPases.Semin Cancer Biol. 2019 Feb;54:29-39. doi: 10.1016/j.semcancer.2018.03.005. Epub 2018 Apr 3.
• [4615] Lambda-Carrageenan Enhances the Effects of Radiation Therapy in Cancer Treatment by Suppressing Cancer Cell Invasion and Metastasis through Racgap1 Inhibition.Cancers (Basel). 2019 Aug 16;11(8):1192. doi: 10.3390/cancers11081192.
• [4616] Overexpression of Hrad17 gene in non-small cell lung cancers correlated with lymph node metastasis.Lung Cancer. 2001 Oct;34(1):47-52. doi: 10.1016/s0169-5002(01)00223-9.
• [4617] HR23A-knockdown lung cancer cells exhibit epithelial-to-mesenchymal transition and gain stemness properties through increased Twist1 stability.Biochim Biophys Acta Mol Cell Res. 2019 Dec;1866(12):118537. doi: 10.1016/j.bbamcr.2019.118537. Epub 2019 Sep 2.
• [4618] The association between RAD23B Ala249Val polymorphism and cancer susceptibility: evidence from a meta-analysis.PLoS One. 2014 Mar 18;9(3):e91922. doi: 10.1371/journal.pone.0091922. eCollection 2014.
• [4619] Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast Cancer.J Natl Cancer Inst. 2019 Dec 1;111(12):1332-1338. doi: 10.1093/jnci/djz045.
• [4620] Human RAD52 protein regulates homologous recombination and checkpoint function in BRCA2 deficient cells.Int J Biochem Cell Biol. 2019 Feb;107:128-139. doi: 10.1016/j.biocel.2018.12.013. Epub 2018 Dec 24.
• [4621] Inhibition of RAD54B suppresses proliferation and promotes apoptosis in hepatoma cells.Oncol Rep. 2018 Sep;40(3):1233-1242. doi: 10.3892/or.2018.6522. Epub 2018 Jun 25.
• [4622] The role of RAD9 in tumorigenesis.J Mol Cell Biol. 2011 Feb;3(1):39-43. doi: 10.1093/jmcb/mjq039.
• [4623] Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor.PLoS One. 2012;7(6):e39626. doi: 10.1371/journal.pone.0039626. Epub 2012 Jun 21.
• [4624] Smith-Magenis Syndrome Patients Often Display Antibody Deficiency but Not Other Immune Pathologies.J Allergy Clin Immunol Pract. 2017 Sep-Oct;5(5):1344-1350.e3. doi: 10.1016/j.jaip.2017.01.028. Epub 2017 Mar 9.
• [4625] Suppression of early hematogenous dissemination of human breast cancer cells to bone marrow by retinoic Acid-induced 2.Cancer Discov. 2015 May;5(5):506-19. doi: 10.1158/2159-8290.CD-14-1042. Epub 2015 Feb 25.
• [4626] RAL GTPases: Biology and Potential as Therapeutic Targets in Cancer.Pharmacol Rev. 2018 Jan;70(1):1-11. doi: 10.1124/pr.117.014415.
• [4627] Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS.EMBO J. 2007 Jul 11;26(13):3250-9. doi: 10.1038/sj.emboj.7601744. Epub 2007 Jun 14.
• [4628] RanGTPase: a candidate for Myc-mediated cancer progression.J Natl Cancer Inst. 2013 Apr 3;105(7):475-88. doi: 10.1093/jnci/djt028. Epub 2013 Mar 6.
• [4629] EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer.Nat Commun. 2017 Dec 11;8(1):2035. doi: 10.1038/s41467-017-02185-w.
• [4630] Cell signalling pathway regulation by RanBPM: molecular insights and disease implications.Open Biol. 2017 Jun;7(6):170081. doi: 10.1098/rsob.170081.
• [4631] Reduced expression of Rap1GAP as a prognostic biomarker for primary gastric cancer patients.Cancer Biomark. 2018;22(3):375-384. doi: 10.3233/CBM-170832.
• [4632] Frequent somatic demethylation of RAPGEF1/C3G intronic sequences in gastrointestinal and gynecological cancer.Int J Oncol. 2011 Jun;38(6):1575-7. doi: 10.3892/ijo.2011.972. Epub 2011 Mar 11.
• [4633] Chemerin acts via CMKLR1 and GPR1 to stimulate migration and invasion of gastric cancer cells: putative role of decreased TIMP-1 and TIMP-2.Oncotarget. 2019 Jan 4;10(2):98-112. doi: 10.18632/oncotarget.26414. eCollection 2019 Jan 4.
• [4634] Vascular Endothelial Growth Factor-A Exerts Diverse Cellular Effects via Small G Proteins, Rho and Rap.Int J Mol Sci. 2018 Apr 16;19(4):1203. doi: 10.3390/ijms19041203.
• [4635] RasGRF2 promotes migration and invasion of colorectal cancer cells by modulating expression of MMP9 through Src/Akt/NF-B pathway.Cancer Biol Ther. 2019;20(4):435-443. doi: 10.1080/15384047.2018.1529117. Epub 2018 Oct 25.
• [4636] RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma.Cancer Cell. 2017 May 8;31(5):685-696.e6. doi: 10.1016/j.ccell.2017.04.002.
• [4637] RAIN Is a Novel Enhancer-Associated lncRNA That Controls RUNX2 Expression and Promotes Breast and Thyroid Cancer.Mol Cancer Res. 2020 Jan;18(1):140-152. doi: 10.1158/1541-7786.MCR-19-0564. Epub 2019 Oct 17.
• [4638] RASSF3 downregulation increases malignant phenotypes of non-small cell lung cancer.Lung Cancer. 2014 Jan;83(1):23-9. doi: 10.1016/j.lungcan.2013.10.014. Epub 2013 Oct 31.
• [4639] The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function.J Biol Chem. 2018 Oct 5;293(40):15691-15705. doi: 10.1074/jbc.RA118.004452. Epub 2018 Aug 23.
• [4640] Prediction of radiation sensitivity using a gene expression classifier.Cancer Res. 2005 Aug 15;65(16):7169-76. doi: 10.1158/0008-5472.CAN-05-0656.
• [4641] RBBP7 is a prognostic biomarker in patients with esophageal squamous cell carcinoma.Oncol Lett. 2018 Dec;16(6):7204-7211. doi: 10.3892/ol.2018.9543. Epub 2018 Oct 3.
• [4642] The specific role of pRb in p16 (INK4A) -mediated arrest of normal and malignant human breast cells.Cell Cycle. 2012 Mar 1;11(5):1008-13. doi: 10.4161/cc.11.5.19492. Epub 2012 Mar 1.
• [4643] RNA-binding motif protein 10 induces apoptosis and suppresses proliferation by activating p53.Oncogene. 2020 Jan;39(5):1031-1040. doi: 10.1038/s41388-019-1034-9. Epub 2019 Oct 7.
• [4644] The molecular basis of leukemia.Hematology Am Soc Hematol Educ Program. 2004:80-97. doi: 10.1182/asheducation-2004.1.80.
• [4645] Downregulation of RNA binding motif protein 17 expression inhibits proliferation of hypopharyngeal carcinoma FaDu cells.Oncol Lett. 2018 Apr;15(4):5680-5684. doi: 10.3892/ol.2018.8012. Epub 2018 Feb 9.
• [4646] Prevalence and clinical significance of RBM3 immunostaining in non-small cell lung cancers.J Cancer Res Clin Oncol. 2019 Apr;145(4):873-879. doi: 10.1007/s00432-019-02850-1. Epub 2019 Feb 13.
• [4647] Transcriptome-wide targets of alternative splicing by RBM4 and possible role in cancer.Genomics. 2016 Apr;107(4):138-44. doi: 10.1016/j.ygeno.2016.02.003. Epub 2016 Feb 17.
• [4648] Sex-specific survival difference in association with HLA-DRB1?4 following allogeneic haematopoietic stem cell transplantation for lymphoid malignancies.Hum Immunol. 2018 Jan;79(1):13-19. doi: 10.1016/j.humimm.2017.10.010. Epub 2017 Oct 31.
• [4649] In vivo evidence that RBM5 is a tumour suppressor in the lung.Sci Rep. 2017 Nov 24;7(1):16323. doi: 10.1038/s41598-017-15874-9.
• [4650] RNA-binding protein RBM6 as a tumor suppressor gene represses the growth and progression in laryngocarcinoma.Gene. 2019 May 20;697:26-34. doi: 10.1016/j.gene.2019.02.025. Epub 2019 Feb 15.
• [4651] Total arch replacement versus debranching thoracic endovascular aortic repair for aortic arch aneurysm: what indicates a high-risk patient for arch repair in octogenarians?.Gen Thorac Cardiovasc Surg. 2018 May;66(5):263-269. doi: 10.1007/s11748-018-0894-1. Epub 2018 Jan 31.
• [4652] RBP7 is a clinically prognostic biomarker and linked to tumor invasion and EMT in colon cancer.J Cancer. 2019 Aug 27;10(20):4883-4891. doi: 10.7150/jca.35180. eCollection 2019.
• [4653] CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis.Blood. 2018 Nov 1;132(18):1936-1950. doi: 10.1182/blood-2018-02-833582. Epub 2018 Jul 17.
• [4654] Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.Br J Cancer. 2016 Feb 2;114(3):305-13. doi: 10.1038/bjc.2015.444. Epub 2016 Jan 7.
• [4655] Novel Ran-RCC1 Inhibitory Peptide-Loaded Nanoparticles Have Anti-Cancer Efficacy In Vitro and In Vivo.Cancers (Basel). 2019 Feb 14;11(2):222. doi: 10.3390/cancers11020222.
• [4656] RCC2 is a novel p53 target in suppressing metastasis.Oncogene. 2018 Jan 4;37(1):8-17. doi: 10.1038/onc.2017.306. Epub 2017 Sep 4.
• [4657] Downregulation of reticulocalbin-1 differentially facilitates apoptosis and necroptosis in human prostate cancer cells.Cancer Sci. 2018 Apr;109(4):1147-1157. doi: 10.1111/cas.13541. Epub 2018 Mar 31.
• [4658] Chromatin repressive complexes in stem cells, development, and cancer.Cell Stem Cell. 2014 Jun 5;14(6):735-51. doi: 10.1016/j.stem.2014.05.006.
• [4659] MT1MMP promotes the proliferation and invasion of gastric carcinoma cells via regulating vimentin and Ecadherin.Mol Med Rep. 2019 Apr;19(4):2519-2526. doi: 10.3892/mmr.2019.9918. Epub 2019 Jan 31.
• [4660] Transformation of Ba/F3 cells and Rat-1 cells by ETV6/ARG.Oncogene. 2002 Jun 27;21(28):4374-83. doi: 10.1038/sj.onc.1205544.
• [4661] RERG suppresses cell proliferation, migration and angiogenesis through ERK/NF-B signaling pathway in nasopharyngeal carcinoma.J Exp Clin Cancer Res. 2017 Jun 28;36(1):88. doi: 10.1186/s13046-017-0554-9.
• [4662] RETREG1 (FAM134B): A new player in human diseases: 15 years after the discovery in cancer.J Cell Physiol. 2018 Jun;233(6):4479-4489. doi: 10.1002/jcp.26384. Epub 2018 Jan 15.
• [4663] Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A.Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):2204-2209. doi: 10.1073/pnas.1717363115. Epub 2018 Feb 12.
• [4664] REV1-POL Inhibition and Cancer Therapy.Mol Cell. 2019 Aug 8;75(3):419-420. doi: 10.1016/j.molcel.2019.07.012.
• [4665] Knockdown of the potential cancer stem-like cell marker Rex-1 improves chemotherapeutic effects in gliomas.Hum Gene Ther. 2011 Dec;22(12):1551-62. doi: 10.1089/hum.2011.096. Epub 2011 Sep 29.
• [4666] Integrative genomics identified RFC3 as an amplified candidate oncogene in esophageal adenocarcinoma.Clin Cancer Res. 2012 Apr 1;18(7):1936-46. doi: 10.1158/1078-0432.CCR-11-1431. Epub 2012 Feb 10.
• [4667] AMPA Receptor Antagonist CFM-2 Decreases Survivin Expression in Cancer Cells.Anticancer Agents Med Chem. 2018;18(4):591-596. doi: 10.2174/1871520618666180228123406.
• [4668] RFPL4A increases the G1 population and decreases sensitivity to chemotherapy in human colorectal cancer cells.J Biol Chem. 2015 Mar 6;290(10):6326-37. doi: 10.1074/jbc.M114.614859. Epub 2015 Jan 20.
• [4669] Downregulation of RFX1 predicts poor prognosis of patients with small hepatocellular carcinoma.Eur J Surg Oncol. 2018 Jul;44(7):1087-1093. doi: 10.1016/j.ejso.2018.04.017. Epub 2018 Apr 27.
• [4670] RFX-B, a MHC class II transcription factor, suppressed in human colorectal adenocarcinomas.Int J Mol Med. 2002 Mar;9(3):213-6.
• [4671] Human rgr: transforming activity and alteration in T-cell malignancies.Oncogene. 2002 Aug 1;21(33):5108-16. doi: 10.1038/sj.onc.1205694.
• [4672] MiR-203 inhibits the malignant behavior of prostate cancer cells by targeting RGS17.Eur Rev Med Pharmacol Sci. 2019 Jul;23(13):5667-5674. doi: 10.26355/eurrev_201907_18303.
• [4673] RGS22, a novel cancer/testis antigen, inhibits epithelial cell invasion and metastasis.Clin Exp Metastasis. 2011 Aug;28(6):541-9. doi: 10.1007/s10585-011-9390-z. Epub 2011 May 1.
• [4674] RGS5 decreases the proliferation of human ovarian carcinomaderived primary endothelial cells through the MAPK/ERK signaling pathway in hypoxia.Oncol Rep. 2019 Jan;41(1):165-177. doi: 10.3892/or.2018.6811. Epub 2018 Oct 22.
• [4675] Structural organization of a major neuronal G protein regulator, the RGS7-G5-R7BP complex.Elife. 2018 Dec 12;7:e42150. doi: 10.7554/eLife.42150.
• [4676] Spatiotemporal expression of Rhomboid domain containing 2 (Rhbdd2) during rat development.Acta Histochem. 2015 Sep;117(7):635-41. doi: 10.1016/j.acthis.2015.06.005. Epub 2015 Jun 18.
• [4677] Human rhomboid family-1 modulates clathrin coated vesicle-dependent pro-transforming growth factor membrane trafficking to promote breast cancer progression.EBioMedicine. 2018 Oct;36:229-240. doi: 10.1016/j.ebiom.2018.09.038. Epub 2018 Sep 29.
• [4678] An oncogenic mutant of RHEB, RHEB Y35N, exhibits an altered interaction with BRAF resulting in cancer transformation.BMC Cancer. 2018 Jan 10;18(1):69. doi: 10.1186/s12885-017-3938-5.
• [4679] RhoBTB1 interacts with ROCKs and inhibits invasion.Biochem J. 2019 Sep 13;476(17):2499-2514. doi: 10.1042/BCJ20190203.
• [4680] RhoBTB2 (DBC2) functions as tumor suppressor via inhibiting proliferation, preventing colony formation and inducing apoptosis in breast cancer cells.Gene. 2011 Oct 15;486(1-2):74-80. doi: 10.1016/j.gene.2011.07.018. Epub 2011 Jul 23.
• [4681] RHOG Activates RAC1 through CDC42 Leading to Tube Formation in Vascular Endothelial Cells.Cells. 2019 Feb 18;8(2):171. doi: 10.3390/cells8020171.
• [4682] Genomic structure and assignment of the RhoH/TTF small GTPase gene (ARHH) to 4p13 by in situ hybridization.Genomics. 1997 Jul 1;43(1):89-94. doi: 10.1006/geno.1997.4788.
• [4683] A Protective Role for RHOJ in NonSmall Cell Lung Cancer Based on Integrated Bioinformatics Analysis.J Comput Biol. 2020 Jul;27(7):1092-1103. doi: 10.1089/cmb.2019.0209. Epub 2019 Oct 23.
• [4684] RNA editing in RHOQ promotes invasion potential in colorectal cancer.J Exp Med. 2014 Apr 7;211(4):613-21. doi: 10.1084/jem.20132209. Epub 2014 Mar 24.
• [4685] Expression of WRCH1 in human cancer and down-regulation of WRCH1 by beta-estradiol in MCF-7 cells.Int J Oncol. 2002 Apr;20(4):777-83.
• [4686] Identification of RHOXF2 (PEPP2) as a cancer-promoting gene by expression cloning.Int J Oncol. 2012 Jan;40(1):93-8. doi: 10.3892/ijo.2011.1173. Epub 2011 Aug 19.
• [4687] Co-expression of key gene modules and pathways of human breast cancer cell lines.Biosci Rep. 2019 Jul 18;39(7):BSR20181925. doi: 10.1042/BSR20181925. Print 2019 Jul 31.
• [4688] Pseudokinases: a tribble-edged sword.FEBS J. 2020 Oct;287(19):4170-4182. doi: 10.1111/febs.15096. Epub 2019 Oct 31.
• [4689] Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway.Cell Physiol Biochem. 2018;46(5):1971-1984. doi: 10.1159/000489418. Epub 2018 Apr 26.
• [4690] Evaluation of Rint1 as a modifier of intestinal tumorigenesis and cancer risk.PLoS One. 2017 Mar 6;12(3):e0172247. doi: 10.1371/journal.pone.0172247. eCollection 2017.
• [4691] Integrating Rio1 activities discloses its nutrient-activated network in Saccharomyces cerevisiae.Nucleic Acids Res. 2018 Sep 6;46(15):7586-7611. doi: 10.1093/nar/gky618.
• [4692] The atypical protein kinase RIOK3 contributes to glioma cell proliferation/survival, migration/invasion and the AKT/mTOR signaling pathway.Cancer Lett. 2018 Feb 28;415:151-163. doi: 10.1016/j.canlet.2017.12.010. Epub 2017 Dec 9.
• [4693] Clinical Significance of Histone Demethylase NO66 in Invasive Colorectal Cancer.Ann Surg Oncol. 2017 Mar;24(3):841-849. doi: 10.1245/s10434-016-5395-9. Epub 2016 Jul 29.
• [4694] PC3 prostate tumor-initiating cells with molecular profile FAM65Bhigh/MFI2low/LEF1low increase tumor angiogenesis.Mol Cancer. 2010 Dec 29;9:319. doi: 10.1186/1476-4598-9-319.
• [4695] Interaction between angiotensin II and relaxin 2 in the progress of growth and spread of prostate cancer cells.Int J Oncol. 2016 Jun;48(6):2619-28. doi: 10.3892/ijo.2016.3458. Epub 2016 Mar 24.
• [4696] A Meta-Analysis of Genome-Wide Association Studies of Growth Differentiation Factor-15 Concentration in Blood.Front Genet. 2018 Mar 23;9:97. doi: 10.3389/fgene.2018.00097. eCollection 2018.
• [4697] Risk of Ovarian Malignancy Algorithm versus Risk Malignancy Index-I for Preoperative Assessment of Adnexal Masses: A Systematic Review and Meta-Analysis.Gynecol Obstet Invest. 2019;84(6):591-598. doi: 10.1159/000501681. Epub 2019 Jul 16.
• [4698] Developing chemically modified redox-responsive proteins as smart therapeutics.Chem Commun (Camb). 2019 Apr 25;55(35):5163-5166. doi: 10.1039/c9cc00519f.
• [4699] Unique recombinant human ribonuclease and inhibition of Kaposi's sarcoma cell growth.J Natl Cancer Inst. 1998 Dec 2;90(23):1787-91. doi: 10.1093/jnci/90.23.1787.
• [4700] Prognostic Value of RNASEH2A-, CDK1-, and CD151-Related Pathway Gene Profiling for Kidney Cancers.Int J Mol Sci. 2018 May 28;19(6):1586. doi: 10.3390/ijms19061586.
• [4701] The Rho GTPase Rnd1 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target.Cell Death Dis. 2018 May 1;9(5):486. doi: 10.1038/s41419-018-0517-x.
• [4702] Rnd3 in Cancer: A Review of the Evidence for Tumor Promoter or Suppressor.Mol Cancer Res. 2016 Nov;14(11):1033-1044. doi: 10.1158/1541-7786.MCR-16-0164. Epub 2016 Aug 23.
• [4703] RNF11 is a multifunctional modulator of growth factor receptor signalling and transcriptional regulation.Eur J Cancer. 2005 Nov;41(16):2549-60. doi: 10.1016/j.ejca.2005.08.020. Epub 2005 Oct 13.
• [4704] Arkadia regulates tumor metastasis by modulation of the TGF- pathway.Cancer Res. 2013 Mar 15;73(6):1800-10. doi: 10.1158/0008-5472.CAN-12-1916. Epub 2013 Mar 6.
• [4705] RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.Int J Oncol. 2018 Mar;52(3):861-871. doi: 10.3892/ijo.2018.4253. Epub 2018 Jan 24.
• [4706] Really interesting new gene finger protein 121 is a tumor suppressor of renal cell carcinoma.Gene. 2018 Nov 15;676:322-328. doi: 10.1016/j.gene.2018.08.067. Epub 2018 Aug 25.
• [4707] RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells.Clin Cancer Res. 2018 Apr 1;24(7):1629-1643. doi: 10.1158/1078-0432.CCR-17-2242. Epub 2018 Jan 11.
• [4708] Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signalling.Nat Commun. 2019 Sep 25;10(1):4363. doi: 10.1038/s41467-019-12377-1.
• [4709] Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer.Cancer. 2012 Feb 15;118(4):947-59. doi: 10.1002/cncr.26189. Epub 2011 Jun 29.
• [4710] An essential role of RNF187 in Notch1 mediated metastasis of hepatocellular carcinoma.J Exp Clin Cancer Res. 2019 Sep 2;38(1):384. doi: 10.1186/s13046-019-1382-x.
• [4711] Role of RNF20 in cancer development and progression - a comprehensive review.Biosci Rep. 2018 Jul 12;38(4):BSR20171287. doi: 10.1042/BSR20171287. Print 2018 Aug 31.
• [4712] Molecular cloning and characterization of RNF26 on human chromosome 11q23 region, encoding a novel RING finger protein with leucine zipper.Biochem Biophys Res Commun. 2001 Apr 13;282(4):1038-44. doi: 10.1006/bbrc.2001.4671.
• [4713] RNF20 Links Histone H2B Ubiquitylation with Inflammation and Inflammation-Associated Cancer.Cell Rep. 2016 Feb 16;14(6):1462-1476. doi: 10.1016/j.celrep.2016.01.020. Epub 2016 Feb 4.
• [4714] Two variants of the human hepatocellular carcinoma-associated HCAP1 gene and their effect on the growth of the human liver cancer cell line Hep3B.Genes Chromosomes Cancer. 2004 Jan;39(1):48-58. doi: 10.1002/gcc.10293.
• [4715] A Human Ribonuclease Variant and ERK-Pathway Inhibitors Exhibit Highly Synergistic Toxicity for Cancer Cells.Mol Cancer Ther. 2018 Dec;17(12):2622-2632. doi: 10.1158/1535-7163.MCT-18-0724. Epub 2018 Oct 3.
• [4716] Brief Report: Anti-RNPC-3 Antibodies As a Marker of Cancer-Associated Scleroderma.Arthritis Rheumatol. 2017 Jun;69(6):1306-1312. doi: 10.1002/art.40065.
• [4717] Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC.Cell Rep. 2012 Feb 23;1(2):110-7. doi: 10.1016/j.celrep.2011.12.001.
• [4718] Clinical associations of the positive anti Ro52 without Ro60 autoantibodies: undifferentiated connective tissue diseases.J Clin Pathol. 2018 Jan;71(1):12-19. doi: 10.1136/jclinpath-2015-203587. Epub 2017 Jun 29.
• [4719] Pre-diagnostic derivatives of reactive oxygen metabolites and the occurrence of lung, colorectal, breast and prostate cancer: An individual participant data meta-analysis of two large population-based studies.Int J Cancer. 2019 Jul 1;145(1):49-57. doi: 10.1002/ijc.32073. Epub 2019 Jan 5.
• [4720] Reactive Oxygen Species Modulator 1 As An Adverse Prognostic Marker In Stage III Non-Small Cell Lung Cancer Treated With Radiotherapy: A Retrospective Pilot Study.Onco Targets Ther. 2019 Oct 9;12:8263-8273. doi: 10.2147/OTT.S217514. eCollection 2019.
• [4721] The molecular differences between human papillomavirus-positive and -negative oropharyngeal squamous cell carcinoma: A bioinformatics study.Am J Otolaryngol. 2019 Jul-Aug;40(4):547-554. doi: 10.1016/j.amjoto.2019.04.015. Epub 2019 Apr 23.
• [4722] Centrosome amplification induces high grade features and is prognostic of worse outcomes in breast cancer.BMC Cancer. 2016 Jan 29;16:47. doi: 10.1186/s12885-016-2083-x.
• [4723] PD-1 disrupted CAR-T cells in the treatment of solid tumors: Promises and challenges.Biomed Pharmacother. 2020 Jan;121:109625. doi: 10.1016/j.biopha.2019.109625. Epub 2019 Nov 13.
• [4724] Salicylic acid-related cotton (Gossypium arboreum) ribosomal protein GaRPL18 contributes to resistance to Verticillium dahliae.BMC Plant Biol. 2017 Mar 3;17(1):59. doi: 10.1186/s12870-017-1007-5.
• [4725] Ribosomal L22-like1 (RPL22L1) Promotes Ovarian Cancer Metastasis by Inducing Epithelial-to-Mesenchymal Transition.PLoS One. 2015 Nov 30;10(11):e0143659. doi: 10.1371/journal.pone.0143659. eCollection 2015.
• [4726] Inhibition of the p53-MDM2 interaction by adenovirus delivery of ribosomal protein L23 stabilizes p53 and induces cell cycle arrest and apoptosis in gastric cancer.J Gene Med. 2010 Feb;12(2):147-56. doi: 10.1002/jgm.1424.
• [4727] RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth.Oncotarget. 2014 Jul 15;5(13):5165-76. doi: 10.18632/oncotarget.2099.
• [4728] Identification of valid reference genes for gene expression studies of human stomach cancer by reverse transcription-qPCR.BMC Cancer. 2010 May 28;10:240. doi: 10.1186/1471-2407-10-240.
• [4729] Constructing disease-specific gene networks using pair-wise relevance metric: application to colon cancer identifies interleukin 8, desmin and enolase 1 as the central elements.BMC Syst Biol. 2008 Aug 10;2:72. doi: 10.1186/1752-0509-2-72.
• [4730] Silencing of Ribosomal Protein L34 (RPL34) Inhibits the Proliferation and Invasion of Esophageal Cancer Cells.Oncol Res. 2017 Aug 7;25(7):1061-1068. doi: 10.3727/096504016X14830466773541. Epub 2017 Jan 20.
• [4731] Ribophorin II potentiates P-glycoprotein- and ABCG2-mediated multidrug resistance via activating ERK pathway in gastric cancer.Int J Biol Macromol. 2019 May 1;128:574-582. doi: 10.1016/j.ijbiomac.2019.01.195. Epub 2019 Jan 30.
• [4732] Cellular and molecular evidence for malignancy-inhibitory functions of p15RS.Cell Cycle. 2012 May 15;11(10):1988-98. doi: 10.4161/cc.20400. Epub 2012 May 15.
• [4733] Morin suppresses cachexia-induced muscle wasting by binding to ribosomal protein S10 in carcinoma cells.Biochem Biophys Res Commun. 2018 Dec 2;506(4):773-779. doi: 10.1016/j.bbrc.2018.10.184. Epub 2018 Oct 31.
• [4734] Expression profiling of fecal colonocytes for RNA-based screening of colorectal cancer.Int J Oncol. 2007 Nov;31(5):1029-37.
• [4735] A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes.Cancer Genet. 2011 Apr;204(4):187-94. doi: 10.1016/j.cancergen.2011.02.001.
• [4736] Ribosomal Lesions Promote Oncogenic Mutagenesis.Cancer Res. 2019 Jan 15;79(2):320-327. doi: 10.1158/0008-5472.CAN-18-1987. Epub 2018 Nov 27.
• [4737] Active regulator of SIRT1 is required for cancer cell survival but not for SIRT1 activity.Open Biol. 2013 Nov 20;3(11):130130. doi: 10.1098/rsob.130130.
• [4738] RPS2: a novel therapeutic target in prostate cancer.J Exp Clin Cancer Res. 2009 Jan 12;28(1):6. doi: 10.1186/1756-9966-28-6.
• [4739] RRAD suppresses the Warburg effect by downregulating ACTG1 in hepatocellular carcinoma.Onco Targets Ther. 2019 Feb 28;12:1691-1703. doi: 10.2147/OTT.S197844. eCollection 2019.
• [4740] R-loop-mediated genome instability in mRNA cleavage and polyadenylation mutants.Genes Dev. 2012 Jan 15;26(2):163-75. doi: 10.1101/gad.179721.111.
• [4741] Clinical significance of TC21 overexpression in oral cancer.J Oral Pathol Med. 2010 Jul;39(6):477-85. doi: 10.1111/j.1600-0714.2009.00854.x. Epub 2009 Dec 16.
• [4742] Expression of RRBP1 in epithelial ovarian cancer and its clinical significance.Biosci Rep. 2019 Jul 23;39(7):BSR20190656. doi: 10.1042/BSR20190656. Print 2019 Jul 31.
• [4743] Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice.Mol Cancer Ther. 2011 Aug;10(8):1470-80. doi: 10.1158/1535-7163.MCT-11-0152. Epub 2011 May 27.
• [4744] Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin.Gene. 2018 Feb 5;642:249-255. doi: 10.1016/j.gene.2017.11.008. Epub 2017 Nov 7.
• [4745] Novel products of the HUD, HUC, NNP-1 and alpha-internexin genes identified by autologous antibody screening of a pediatric neuroblastoma library.Int J Cancer. 2002 Aug 20;100(6):669-77. doi: 10.1002/ijc.10550.
• [4746] Endoplasmic reticulum stress contributes to vitamin E succinate-induced apoptosis in human gastric cancer SGC-7901 cells.Cancer Lett. 2010 Oct 1;296(1):123-31. doi: 10.1016/j.canlet.2010.04.002.
• [4747] Cmannosylation of Rspondin2 activates Wnt/catenin signaling and migration activity in human tumor cells.Int J Oncol. 2019 Jun;54(6):2127-2138. doi: 10.3892/ijo.2019.4767. Epub 2019 Apr 1.
• [4748] MicroRNA-409-5p is upregulated in breast cancer and its downregulation inhibits cancer development through downstream target of RSU1.Tumour Biol. 2017 May;39(5):1010428317701647. doi: 10.1177/1010428317701647.
• [4749] MicroRNA-152 inhibits tumor cell growth by directly targeting RTKN in hepatocellular carcinoma.Oncol Rep. 2017 Feb;37(2):1227-1234. doi: 10.3892/or.2016.5290. Epub 2016 Dec 5.
• [4750] Silencing of RTKN2 by siRNA suppresses proliferation, and induces G1 arrest and apoptosis in human bladder cancer cells.Mol Med Rep. 2016 Jun;13(6):4872-8. doi: 10.3892/mmr.2016.5127. Epub 2016 Apr 14.
• [4751] Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma.Cell Death Differ. 2006 Apr;13(4):619-27. doi: 10.1038/sj.cdd.4401782.
• [4752] Breast cancer screening: Impact on care pathways.Cancer Med. 2019 Jul;8(8):4070-4078. doi: 10.1002/cam4.2283. Epub 2019 Jun 6.
• [4753] C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer.Tumour Biol. 2016 Jan;37(1):369-79. doi: 10.1007/s13277-015-3806-3. Epub 2015 Jul 29.
• [4754] Podocalyxin-like protein promotes gastric cancer progression through interacting with RUN and FYVE domain containing 1 protein.Cancer Sci. 2019 Jan;110(1):118-134. doi: 10.1111/cas.13864. Epub 2018 Dec 15.
• [4755] Rufy3 promotes metastasis through epithelial-mesenchymal transition in colorectal cancer.Cancer Lett. 2017 Apr 1;390:30-38. doi: 10.1016/j.canlet.2017.01.001. Epub 2017 Jan 13.
• [4756] The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation.Cancer Cell. 2018 Oct 8;34(4):626-642.e8. doi: 10.1016/j.ccell.2018.08.015.
• [4757] Functional genetic variants of RUVBL1 predict overall survival of Chinese patients with epithelial ovarian cancer.Carcinogenesis. 2019 Oct 16;40(10):1209-1219. doi: 10.1093/carcin/bgz092.
• [4758] AAA+ ATPases Reptin and Pontin as potential diagnostic and prognostic biomarkers in salivary gland cancer - a short report.Cell Oncol (Dordr). 2018 Aug;41(4):455-462. doi: 10.1007/s13402-018-0382-8. Epub 2018 Jun 5.
• [4759] The biochemistry, signalling and disease relevance of RYK and other WNT-binding receptor tyrosine kinases.Growth Factors. 2018 Apr;36(1-2):15-40. doi: 10.1080/08977194.2018.1472089. Epub 2018 May 28.
• [4760] Ca(2+)-Binding Proteins of the EF-Hand Superfamily: Diagnostic and Prognostic Biomarkers and Novel Therapeutic Targets.Methods Mol Biol. 2019;1929:157-186. doi: 10.1007/978-1-4939-9030-6_11.
• [4761] iTRAQ-based proteomic analysis of DMH-induced colorectal cancer in mice reveals the expressions of -catenin, decorin, septin-7, and S100A10 expression in 53 cases of human hereditary polyposis colorectal cancer.Clin Transl Oncol. 2019 Feb;21(2):220-231. doi: 10.1007/s12094-018-1912-6. Epub 2018 Jun 28.
• [4762] S100A16 up-regulates Oct4 and Nanog expression in cancer stem-like cells of Yumoto human cervical carcinoma cells.Oncol Lett. 2018 Jun;15(6):9929-9933. doi: 10.3892/ol.2018.8568. Epub 2018 Apr 25.
• [4763] Protumorigenic actions of S100A2 involve regulation of PI3/Akt signaling and functional interaction with Smad3.Carcinogenesis. 2014 Jan;35(1):14-23. doi: 10.1093/carcin/bgt287. Epub 2013 Aug 29.
• [4764] Novel S100A7 (psoriasin)/S100A15 (koebnerisin) subfamily: highly homologous but distinct in regulation and function.Amino Acids. 2011 Oct;41(4):789-96. doi: 10.1007/s00726-010-0666-4. Epub 2010 Jul 2.
• [4765] S100P-binding protein, S100PBP, mediates adhesion through regulation of cathepsin Z in pancreatic cancer cells.Am J Pathol. 2012 Apr;180(4):1485-94. doi: 10.1016/j.ajpath.2011.12.031. Epub 2012 Feb 11.
• [4766] SAFB1- and SAFB2-mediated transcriptional repression: relevance to cancer.Biochem Soc Trans. 2012 Aug;40(4):826-30. doi: 10.1042/BST20120030.
• [4767] Expression and mutations of BRCA in breast cancer and ovarian cancer: Evidence from bioinformatics analyses.Int J Mol Med. 2018 Dec;42(6):3542-3550. doi: 10.3892/ijmm.2018.3870. Epub 2018 Sep 11.
• [4768] SALL2 represses cyclins D1 and E1 expression and restrains G1/S cell cycle transition and cancer-related phenotypes.Mol Oncol. 2018 Jun;12(7):1026-1046. doi: 10.1002/1878-0261.12308. Epub 2018 May 21.
• [4769] Circular RNA CpG island hypermethylation-associated silencing in human cancer.Oncotarget. 2018 Jun 26;9(49):29208-29219. doi: 10.18632/oncotarget.25673. eCollection 2018 Jun 26.
• [4770] SAMD5 mRNA was overexpressed in prostate cancer and can predict biochemical recurrence after radical prostatectomy.Int Urol Nephrol. 2019 Mar;51(3):443-451. doi: 10.1007/s11255-019-02096-3. Epub 2019 Feb 9.
• [4771] Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes.JCI Insight. 2018 Jul 26;3(14):e121086. doi: 10.1172/jci.insight.121086. eCollection 2018 Jul 26.
• [4772] Defective modulation of LINE-1 retrotransposition by cancer-associated SAMHD1 mutants.Biochem Biophys Res Commun. 2019 Nov 5;519(2):213-219. doi: 10.1016/j.bbrc.2019.08.155. Epub 2019 Sep 4.
• [4773] Overexpression of HCC1/CAPER may play a role in lung cancer carcinogenesis.Tumour Biol. 2014 Jul;35(7):6311-7. doi: 10.1007/s13277-014-1819-y. Epub 2014 Mar 19.
• [4774] A new HIF-1/RANTES-driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF in mice.Hepatology. 2016 May;63(5):1576-91. doi: 10.1002/hep.28468. Epub 2016 Mar 7.
• [4775] MiR-130b promotes the progression of oesophageal squamous cell carcinoma by targeting SASH1.J Cell Mol Med. 2019 Jan;23(1):93-103. doi: 10.1111/jcmm.13887. Epub 2018 Nov 15.
• [4776] SASS6 overexpression is associated with mitotic chromosomal abnormalities and a poor prognosis in patients with colorectal cancer.Oncol Rep. 2015 Aug;34(2):727-38. doi: 10.3892/or.2015.4014. Epub 2015 May 28.
• [4777] Deregulation of SATB2 in carcinogenesis with emphasis on miRNA-mediated control.Carcinogenesis. 2019 May 14;40(3):393-402. doi: 10.1093/carcin/bgz020.
• [4778] Totipotent stem cells bearing del(20q) maintain multipotential differentiation in Shwachman Diamond syndrome.Br J Haematol. 2009 Jan;144(1):116-9. doi: 10.1111/j.1365-2141.2008.07448.x. Epub 2008 Nov 11.
• [4779] Human SBK1 is dysregulated in multiple cancers and promotes survival of ovary cancer SK-OV-3 cells.Mol Biol Rep. 2011 Jun;38(5):3551-9. doi: 10.1007/s11033-010-0465-8. Epub 2010 Nov 20.
• [4780] Dpy-19 like 3-mediated C-mannosylation and expression levels of RPE-spondin in human tumor cell lines.Oncol Lett. 2017 Aug;14(2):2537-2544. doi: 10.3892/ol.2017.6465. Epub 2017 Jun 22.
• [4781] Alterations in SCAI Expression during Cell Plasticity, Fibrosis and Cancer.Pathol Oncol Res. 2018 Jul;24(3):641-651. doi: 10.1007/s12253-017-0293-4. Epub 2017 Aug 16.
• [4782] Downregulation of SCARA5 may contribute to breast cancer via promoter hypermethylation.Gene. 2018 Oct 5;673:102-106. doi: 10.1016/j.gene.2018.06.036. Epub 2018 Jun 13.
• [4783] Prognostic significance of downregulated expression of the candidate tumour suppressor gene SASH1 in colon cancer.Br J Cancer. 2006 Nov 20;95(10):1419-23. doi: 10.1038/sj.bjc.6603452. Epub 2006 Oct 31.
• [4784] Differential expression and processing of secretogranin II in relation to the status of pheochromocytoma: implications for the production of the tumoral marker EM66.J Mol Endocrinol. 2012 Feb 6;48(2):115-27. doi: 10.1530/JME-11-0077. Print 2012 Apr.
• [4785] Cancer, type 2 diabetes, and ageing: news from flies and worms.Swiss Med Wkly. 2004 Dec 18;134(49-50):711-9. doi: 10.4414/smw.2004.09885.
• [4786] SCGB2A1 is a novel prognostic marker for colorectal cancer associated with chemoresistance and radioresistance.Int J Oncol. 2014 May;44(5):1521-8. doi: 10.3892/ijo.2014.2316. Epub 2014 Feb 28.
• [4787] Aberrant promoter methylation of HIN-1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis.Tumour Biol. 2014 Aug;35(8):8209-16. doi: 10.1007/s13277-014-2055-1. Epub 2014 May 22.
• [4788] A novel pathway of LPS uptake through syndecan-1 leading to pyroptotic cell death.Elife. 2018 Dec 7;7:e37854. doi: 10.7554/eLife.37854.
• [4789] Scinderin-knockdown inhibits proliferation and promotes apoptosis in human breast carcinoma cells.Oncol Lett. 2018 Sep;16(3):3207-3214. doi: 10.3892/ol.2018.9009. Epub 2018 Jun 21.
• [4790] SCN4B acts as a metastasis-suppressor gene preventing hyperactivation of cell migration in breast cancer.Nat Commun. 2016 Dec 5;7:13648. doi: 10.1038/ncomms13648.
• [4791] Sodium Channel Subunit SCNN1B Suppresses Gastric Cancer Growth and Metastasis via GRP78 Degradation.Cancer Res. 2017 Apr 15;77(8):1968-1982. doi: 10.1158/0008-5472.CAN-16-1595. Epub 2017 Feb 15.
• [4792] Secernin-1 contributes to colon cancer progression through enhancing matrix metalloproteinase-2/9 exocytosis.Dis Markers. 2015;2015:230703. doi: 10.1155/2015/230703. Epub 2015 Feb 26.
• [4793] The SNAIL family member SCRATCH1 is not expressed in human tumors.Oncol Rep. 2010 Feb;23(2):523-9.
• [4794] Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkers.Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):148-59. doi: 10.1158/1055-9965.EPI-10-0719. Epub 2010 Nov 23.
• [4795] Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma.Oncogene. 2011 Mar 24;30(12):1390-401. doi: 10.1038/onc.2010.525. Epub 2010 Dec 6.
• [4796] Regulation of antitumor miR-144-5p targets oncogenes: Direct regulation of syndecan-3 and its clinical significance.Cancer Sci. 2018 Sep;109(9):2919-2936. doi: 10.1111/cas.13722. Epub 2018 Jul 28.
• [4797] A PDZ Protein MDA-9/Syntenin: As a Target for Cancer Therapy.Comput Struct Biotechnol J. 2019 Jan 8;17:136-141. doi: 10.1016/j.csbj.2019.01.002. eCollection 2019.
• [4798] Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cells.Urol Oncol. 2013 Nov;31(8):1576-83. doi: 10.1016/j.urolonc.2012.05.006. Epub 2012 Jun 12.
• [4799] Interaction of germline variants in a family with a history of early-onset clear cell renal cell carcinoma.Mol Genet Genomic Med. 2019 Mar;7(3):e556. doi: 10.1002/mgg3.556. Epub 2019 Jan 24.
• [4800] Sec62/Ki67 dual staining in cervical cytology specimens: a new marker for high-grade dysplasia.Arch Gynecol Obstet. 2019 Feb;299(2):481-488. doi: 10.1007/s00404-018-4981-4. Epub 2018 Nov 29.
• [4801] Endoplasmic reticulum quality control in cancer: Friend or foe.Semin Cancer Biol. 2015 Aug;33:25-33. doi: 10.1016/j.semcancer.2015.02.003. Epub 2015 Mar 18.
• [4802] Selenoprotein H controls cell cycle progression and proliferation of human colorectal cancer cells.Free Radic Biol Med. 2018 Nov 1;127:98-107. doi: 10.1016/j.freeradbiomed.2018.01.010. Epub 2018 Jan 9.
• [4803] Selenoprotein M stimulates the proliferative and metastatic capacities of renal cell carcinoma through activating the PI3K/AKT/mTOR pathway.Cancer Med. 2019 Aug;8(10):4836-4844. doi: 10.1002/cam4.2403. Epub 2019 Jul 5.
• [4804] Single nucleotide polymorphism in the SEPS1 gene may contribute to the risk of various human diseases: a meta-analysis.Ann Hum Biol. 2016 Sep;43(5):469-79. doi: 10.3109/03014460.2015.1070903. Epub 2015 Sep 18.
• [4805] Establishment and characterization of a new human extragonadal germ cell line, SEM-1, and its comparison with TCam-2 and JKT-1.Urology. 2013 Feb;81(2):464.e1-9. doi: 10.1016/j.urology.2012.09.029.
• [4806] Expression of Semaphorin 3B (SEMA3B) in Various Grades of Endometrial Cancer.Med Sci Monit. 2019 Jun 20;25:4569-4574. doi: 10.12659/MSM.916762.
• [4807] Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform.EMBO Mol Med. 2012 Mar;4(3):234-50. doi: 10.1002/emmm.201100205. Epub 2012 Jan 13.
• [4808] The crucial role of SEMA3F in suppressing the progression of oral squamous cell carcinoma.Cell Mol Biol Lett. 2017 Dec 28;22:32. doi: 10.1186/s11658-017-0064-y. eCollection 2017.
• [4809] SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis.Oncogene. 2020 Jan;39(5):1049-1062. doi: 10.1038/s41388-019-1041-x. Epub 2019 Oct 3.
• [4810] Semaphorin 4F as a critical regulator of neuroepithelial interactions and a biomarker of aggressive prostate cancer.Clin Cancer Res. 2013 Nov 15;19(22):6101-11. doi: 10.1158/1078-0432.CCR-12-3669. Epub 2013 Oct 4.
• [4811] Semaphorin 5A, an axon guidance molecule, enhances the invasion and metastasis of human gastric cancer through activation of MMP9.Pathol Oncol Res. 2013 Jan;19(1):11-8. doi: 10.1007/s12253-012-9550-8. Epub 2012 Jul 21.
• [4812] Semaphorin 6A Attenuates the Migration Capability of Lung Cancer Cells via the NRF2/HMOX1 Axis.Sci Rep. 2019 Sep 16;9(1):13302. doi: 10.1038/s41598-019-49874-8.
• [4813] SPIRE - combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial.Trials. 2018 Apr 3;19(1):216. doi: 10.1186/s13063-018-2586-7.
• [4814] SENP2 exerts an antitumor effect on chronic lymphocytic leukemia cells through the inhibition of the Notch and NFB signaling pathways.Int J Oncol. 2019 Feb;54(2):455-466. doi: 10.3892/ijo.2018.4635. Epub 2018 Nov 14.
• [4815] Mitotic Phosphorylation of SENP3 Regulates DeSUMOylation of Chromosome-Associated Proteins and Chromosome Stability.Cancer Res. 2018 May 1;78(9):2171-2178. doi: 10.1158/0008-5472.CAN-17-2288. Epub 2018 Feb 8.
• [4816] Claudin 1 expression in basal-like breast cancer is related to patient age.BMC Cancer. 2013 May 30;13:268. doi: 10.1186/1471-2407-13-268.
• [4817] Overexpression of Septin1: possible contribution to the development of oral cancer.Int J Oncol. 2007 Nov;31(5):1021-8.
• [4818] Linking the septin expression with carcinogenesis.Mol Biol Rep. 2010 Oct;37(7):3601-8. doi: 10.1007/s11033-010-0009-2. Epub 2010 Feb 27.
• [4819] The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential.Int J Mol Sci. 2016 Apr 21;17(4):606. doi: 10.3390/ijms17040606.
• [4820] Safety of an Oncolytic Myxoma Virus in Dogs with Soft Tissue Sarcoma.Viruses. 2018 Jul 28;10(8):398. doi: 10.3390/v10080398.
• [4821] TRIP-Br2 promotes oncogenesis in nude mice and is frequently overexpressed in multiple human tumors.J Transl Med. 2009 Jan 20;7:8. doi: 10.1186/1479-5876-7-8.
• [4822] Hypoxia Induced ER Stress Response as an Adaptive Mechanism in Cancer.Int J Mol Sci. 2019 Feb 11;20(3):749. doi: 10.3390/ijms20030749.
• [4823] Differential methylation hybridization array of endometrial cancers reveals two novel cancer-specific methylation markers.Clin Cancer Res. 2007 May 15;13(10):2882-9. doi: 10.1158/1078-0432.CCR-06-2367.
• [4824] Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2.Oncogene. 2019 Jun;38(25):4948-4961. doi: 10.1038/s41388-019-0766-x. Epub 2019 Mar 6.
• [4825] DPY30 is required for the enhanced proliferation, motility and epithelial-mesenchymal transition of epithelial ovarian cancer cells.Int J Mol Med. 2018 Dec;42(6):3065-3072. doi: 10.3892/ijmm.2018.3869. Epub 2018 Sep 11.
• [4826] SET Domain-Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence.Cancer Res. 2019 Sep 15;79(18):4729-4743. doi: 10.1158/0008-5472.CAN-19-1084. Epub 2019 Jul 15.
• [4827] Histone methyltransferase SETDB1 promotes colorectal cancer proliferation through the STAT1-CCND1/CDK6 axis.Carcinogenesis. 2020 Jul 10;41(5):678-688. doi: 10.1093/carcin/bgz131.
• [4828] Novel mutations in ataxia telangiectasia and AOA2 associated with prolonged survival.J Neurol Sci. 2013 Dec 15;335(1-2):134-8. doi: 10.1016/j.jns.2013.09.014. Epub 2013 Sep 17.
• [4829] SF3B2-Mediated RNA Splicing Drives Human Prostate Cancer Progression.Cancer Res. 2019 Oct 15;79(20):5204-5217. doi: 10.1158/0008-5472.CAN-18-3965. Epub 2019 Aug 20.
• [4830] Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer.Clin Cancer Res. 2017 Jul 1;23(13):3428-3441. doi: 10.1158/1078-0432.CCR-16-2020. Epub 2016 Nov 22.
• [4831] The malignant brain tumor (MBT) domain protein SFMBT1 is an integral histone reader subunit of the LSD1 demethylase complex for chromatin association and epithelial-to-mesenchymal transition.J Biol Chem. 2013 Sep 20;288(38):27680-27691. doi: 10.1074/jbc.M113.482349. Epub 2013 Aug 8.
• [4832] sFRP1 has a biphasic effect on doxorubicin-induced cardiotoxicity in a cellular location-dependent manner in NRCMs and Rats.Arch Toxicol. 2019 Feb;93(2):533-546. doi: 10.1007/s00204-018-2342-5. Epub 2018 Oct 30.
• [4833] Secreted Frizzled-Related Protein 2 Is Associated with Disease Progression and Poor Prognosis in Breast Cancer.Dis Markers. 2019 Mar 3;2019:6149381. doi: 10.1155/2019/6149381. eCollection 2019.
• [4834] Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer.Hum Mol Genet. 2016 Apr 15;25(8):1457-67. doi: 10.1093/hmg/ddw014. Epub 2016 Jan 19.
• [4835] DNA methylation profile and expression of surfactant protein A2 gene in lung cancer.Exp Lung Res. 2015 Mar;41(2):93-102. doi: 10.3109/01902148.2014.976298. Epub 2014 Dec 16.
• [4836] Novel molecular tumor cell markers in regional lymph nodes and blood samples from patients undergoing surgery for non-small cell lung cancer.PLoS One. 2013 May 3;8(5):e62153. doi: 10.1371/journal.pone.0062153. Print 2013.
• [4837] Design and Characterization of SGK3-PROTAC1, an Isoform Specific SGK3 Kinase PROTAC Degrader.ACS Chem Biol. 2019 Sep 20;14(9):2024-2034. doi: 10.1021/acschembio.9b00505. Epub 2019 Sep 5.
• [4838] Targeting ERK1/2 protein-serine/threonine kinases in human cancers.Pharmacol Res. 2019 Apr;142:151-168. doi: 10.1016/j.phrs.2019.01.039. Epub 2019 Feb 20.
• [4839] New perspective on SH2B1: An accelerator of cancer progression.Biomed Pharmacother. 2020 Jan;121:109651. doi: 10.1016/j.biopha.2019.109651. Epub 2019 Nov 15.
• [4840] Association studies of serum prostate-specific antigen levels and the genetic polymorphisms at the androgen receptor and prostate-specific antigen genes.Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):664-9.
• [4841] SH3BGRL3 Protein as a Potential Prognostic Biomarker for Urothelial Carcinoma: A Novel Binding Partner of Epidermal Growth Factor Receptor.Clin Cancer Res. 2015 Dec 15;21(24):5601-11. doi: 10.1158/1078-0432.CCR-14-3308. Epub 2015 Aug 18.
• [4842] SH3BP1-induced Rac-Wave2 pathway activation regulates cervical cancer cell migration, invasion, and chemoresistance to cisplatin.J Cell Biochem. 2018 Feb;119(2):1733-1745. doi: 10.1002/jcb.26334. Epub 2017 Sep 18.
• [4843] The mRNA-binding Protein TTP/ZFP36 in Hepatocarcinogenesis and Hepatocellular Carcinoma.Cancers (Basel). 2019 Nov 8;11(11):1754. doi: 10.3390/cancers11111754.
• [4844] Competition between TIAM1 and Membranes Balances Endophilin A3 Activity in Cancer Metastasis.Dev Cell. 2018 Jun 18;45(6):738-752.e6. doi: 10.1016/j.devcel.2018.05.021.
• [4845] The Pro-Oncogenic Adaptor CIN85 Acts as an Inhibitory Binding Partner of Hypoxia-Inducible Factor Prolyl Hydroxylase 2.Cancer Res. 2019 Aug 15;79(16):4042-4056. doi: 10.1158/0008-5472.CAN-18-3852. Epub 2019 May 29.
• [4846] (68)Ga-DOTA-E[c(RGDfK)](2) PET Imaging of SHARPIN-Regulated Integrin Activity in Mice.J Nucl Med. 2019 Oct;60(10):1380-1387. doi: 10.2967/jnumed.118.222026. Epub 2019 Mar 8.
• [4847] Mediation analysis of the alcohol-postmenopausal breast cancer relationship by sex hormones in the EPIC cohort.Int J Cancer. 2020 Feb 1;146(3):759-768. doi: 10.1002/ijc.32324. Epub 2019 Apr 30.
• [4848] Demethylation-Induced Overexpression of Shc3 Drives c-Raf-Independent Activation of MEK/ERK in HCC.Cancer Res. 2018 May 1;78(9):2219-2232. doi: 10.1158/0008-5472.CAN-17-2432. Epub 2018 Jan 12.
• [4849] Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties.J Exp Clin Cancer Res. 2019 Dec 4;38(1):481. doi: 10.1186/s13046-019-1486-3.
• [4850] The TGF-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells.J Exp Clin Cancer Res. 2019 May 28;38(1):226. doi: 10.1186/s13046-019-1195-y.
• [4851] SNF2 histone linker PHD RING helicase related Has_circ_0001649 as a diagnostic and prognostic biomarker in solid cancer: A PRISMA-compliant meta-analysis based on the Chinese population.Medicine (Baltimore). 2019 Nov;98(44):e17488. doi: 10.1097/MD.0000000000017488.
• [4852] Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8.Immunol Rev. 2018 Jan;281(1):233-247. doi: 10.1111/imr.12609.
• [4853] High CD169 expression in lymph node macrophages predicts a favorable clinical course in patients with esophageal cancer.Pathol Int. 2018 Dec;68(12):685-693. doi: 10.1111/pin.12736. Epub 2018 Dec 5.
• [4854] Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer.Front Immunol. 2019 May 9;10:1047. doi: 10.3389/fimmu.2019.01047. eCollection 2019.
• [4855] Aberrant single-minded homolog 1 methylation as a potential biomarker for cervical cancer.Diagn Cytopathol. 2018 Jan;46(1):15-21. doi: 10.1002/dc.23838. Epub 2017 Oct 24.
• [4856] Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells.Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11811-6. doi: 10.1073/pnas.1006737107. Epub 2010 Jun 14.
• [4857] The potential of targeting Sin3B and its associated complexes for cancer therapy.Expert Opin Ther Targets. 2017 Nov;21(11):1051-1061. doi: 10.1080/14728222.2017.1386655. Epub 2017 Oct 9.
• [4858] SIPA1 promotes invasion and migration in human oral squamous cell carcinoma by ITGB1 and MMP7.Exp Cell Res. 2017 Mar 15;352(2):357-363. doi: 10.1016/j.yexcr.2017.02.026. Epub 2017 Feb 22.
• [4859] Role of N-terminus in function and dynamics of sirtuin 7: an in silico study.J Biomol Struct Dyn. 2020 Mar;38(5):1283-1291. doi: 10.1080/07391102.2019.1600585. Epub 2019 Apr 26.
• [4860] Exploring Associations of Sedentary Behavior and Physical Activity with Quality of Life in Young Adult Cancer Survivors.J Adolesc Young Adult Oncol. 2018 Dec;7(6):643-651. doi: 10.1089/jayao.2018.0032. Epub 2018 Jul 23.
• [4861] Regulation of cancer stem cell properties by SIX1, a member of the PAX-SIX-EYA-DACH network.Adv Cancer Res. 2019;141:1-42. doi: 10.1016/bs.acr.2018.12.001. Epub 2019 Jan 16.
• [4862] SIX2 Mediates Late-Stage Metastasis via Direct Regulation of SOX2 and Induction of a Cancer Stem Cell Program.Cancer Res. 2019 Feb 15;79(4):720-734. doi: 10.1158/0008-5472.CAN-18-1791. Epub 2019 Jan 3.
• [4863] miR-802 inhibits the proliferation, invasion, and epithelial-mesenchymal transition of glioblastoma multiforme cells by directly targeting SIX4.Cell Biochem Funct. 2020 Jan;38(1):66-76. doi: 10.1002/cbf.3451. Epub 2019 Nov 8.
• [4864] SKA1 overexpression is associated with theprognosis of esophageal squamous cell carcinoma and regulates cell proliferation and migration.Int J Mol Med. 2019 Nov;44(5):1971-1978. doi: 10.3892/ijmm.2019.4343. Epub 2019 Sep 17.
• [4865] SKA2 mediates invasion and metastasis in human breast cancer via EMT.Mol Med Rep. 2019 Jan;19(1):515-523. doi: 10.3892/mmr.2018.9623. Epub 2018 Nov 2.
• [4866] SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis.Science. 2018 May 18;360(6390):800-805. doi: 10.1126/science.aao2793. Epub 2018 Apr 5.
• [4867] Costimulatory checkpoint SLAMF8 is an independent prognosis factor in glioma.CNS Neurosci Ther. 2019 Mar;25(3):333-342. doi: 10.1111/cns.13041. Epub 2018 Aug 13.
• [4868] Epigenetic Regulation of p21(cip1/waf1) in Human Cancer.Cancers (Basel). 2019 Sep 11;11(9):1343. doi: 10.3390/cancers11091343.
• [4869] Status and significance of CpG island methylator phenotype in endometrial cancer.Gynecol Obstet Invest. 2011;72(3):183-91. doi: 10.1159/000324496. Epub 2011 Sep 27.
• [4870] The mitochondrial transport protein SLC25A43 affects drug efficacy and drug-induced cell cycle arrest in breast cancer cell lines.Oncol Rep. 2013 Apr;29(4):1268-74. doi: 10.3892/or.2013.2247. Epub 2013 Jan 23.
• [4871] Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.Biomed Pharmacother. 2019 Jun;114:108864. doi: 10.1016/j.biopha.2019.108864. Epub 2019 Apr 10.
• [4872] Identification of malignant cells in multiple myeloma bone marrow with immunoglobulin VH gene probes by fluorescent in situ hybridization and flow cytometry.J Clin Invest. 1995 Mar;95(3):964-72. doi: 10.1172/JCI117805.
• [4873] SLFN11 is a general target for enhancing the sensitivity of cancer to chemotherapy (DNA-damaging agents).J Drug Target. 2020 Jan;28(1):33-40. doi: 10.1080/1061186X.2019.1616746. Epub 2019 Jun 27.
• [4874] SLFN5 suppresses cancer cell migration and invasion by inhibiting MT1-MMP expression via AKT/GSK-3/-catenin pathway.Cell Signal. 2019 Jul;59:1-12. doi: 10.1016/j.cellsig.2019.03.004. Epub 2019 Mar 4.
• [4875] Toward stimulating apoptosis in human lung adenocarcinoma cells by novel nano-carmofur compound treatment.Anticancer Drugs. 2021 Jun 1;32(6):657-663. doi: 10.1097/CAD.0000000000000720.
• [4876] Tumor-Associated Macrophages Derived TGF-Induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells through Smad2,3-4/Snail Signaling Pathway.Cancer Res Treat. 2019 Jan;51(1):252-266. doi: 10.4143/crt.2017.613. Epub 2018 Apr 25.
• [4877] SMAGP, a new small trans-membrane glycoprotein altered in cancer.Oncogene. 2004 Apr 22;23(19):3395-403. doi: 10.1038/sj.onc.1207469.
• [4878] The novel protein complex with SMARCAD1/KIAA1122 binds to the vicinity of TSS.J Mol Biol. 2008 Oct 3;382(2):257-65. doi: 10.1016/j.jmb.2008.07.031. Epub 2008 Jul 17.
• [4879] Defective replication stress response inhibits lymphomagenesis and impairs lymphocyte reconstitution.Oncogene. 2017 May 4;36(18):2553-2564. doi: 10.1038/onc.2016.408. Epub 2016 Oct 31.
• [4880] p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.Cancer Cell. 2019 Feb 11;35(2):204-220.e9. doi: 10.1016/j.ccell.2019.01.006.
• [4881] Smc3 is required for mouse embryonic and adult hematopoiesis.Exp Hematol. 2019 Feb;70:70-84.e6. doi: 10.1016/j.exphem.2018.11.008. Epub 2018 Dec 13.
• [4882] SMDT1-driven change in mitochondrial dynamics mediate cell apoptosis in PDAC.Biochem Biophys Res Commun. 2019 Apr 2;511(2):323-329. doi: 10.1016/j.bbrc.2019.02.043. Epub 2019 Feb 16.
• [4883] Long Noncoding RNA LINC0086 Functions as a Tumor Suppressor in Nasopharyngeal Carcinoma by Targeting miR-214.Oncol Res. 2017 Aug 7;25(7):1189-1197. doi: 10.3727/096504017X14865126670075. Epub 2017 Feb 13.
• [4884] CanDrA: cancer-specific driver missense mutation annotation with optimized features.PLoS One. 2013 Oct 30;8(10):e77945. doi: 10.1371/journal.pone.0077945. eCollection 2013.
• [4885] Deletion of SMURF 1 represses ovarian cancer invasion and EMT by modulating the DAB2IP/AKT/Skp2 feedback loop.J Cell Biochem. 2019 Jun;120(6):10643-10651. doi: 10.1002/jcb.28354. Epub 2019 Jan 22.
• [4886] Altered Expression and Localization of Tumor Suppressive E3 Ubiquitin Ligase SMURF2 in Human Prostate and Breast Cancer.Cancers (Basel). 2019 Apr 18;11(4):556. doi: 10.3390/cancers11040556.
• [4887] Control of the Epithelial-to-Mesenchymal Transition and Cancer Metastasis by Autophagy-Dependent SNAI1 Degradation.Cells. 2019 Feb 6;8(2):129. doi: 10.3390/cells8020129.
• [4888] Silencing of Synuclein- inhibits human cervical cancer through the AKT signaling pathway.Cell Mol Biol Lett. 2019 Jul 10;24:49. doi: 10.1186/s11658-019-0172-y. eCollection 2019.
• [4889] The fission yeast homolog of the human transcription factor EAP30 blocks meiotic spindle pole body amplification.Dev Cell. 2005 Jul;9(1):63-73. doi: 10.1016/j.devcel.2005.04.016.
• [4890] Regulation of cyclin D1 RNA stability by SNIP1.Cancer Res. 2008 Sep 15;68(18):7621-8. doi: 10.1158/0008-5472.CAN-08-1217.
• [4891] Syntaphilin controls a mitochondrial rheostat for proliferation-motility decisions in cancer.J Clin Invest. 2017 Oct 2;127(10):3755-3769. doi: 10.1172/JCI93172. Epub 2017 Sep 11.
• [4892] An oncogenic gene, SNRPA1, regulates PIK3R1, VEGFC, MKI67, CDK1 and other genes in colorectal cancer.Biomed Pharmacother. 2019 Sep;117:109076. doi: 10.1016/j.biopha.2019.109076. Epub 2019 Jun 14.
• [4893] The oncogenic potential of small nuclear ribonucleoprotein polypeptide G: a comprehensive and perspective view.Am J Transl Res. 2019 Nov 15;11(11):6702-6716. eCollection 2019.
• [4894] SNW1 is a prognostic biomarker in prostate cancer.Diagn Pathol. 2019 May 1;14(1):33. doi: 10.1186/s13000-019-0810-8.
• [4895] Sorting nexin-1 is a candidate tumor suppressor and potential prognostic marker in gastric cancer.PeerJ. 2018 May 29;6:e4829. doi: 10.7717/peerj.4829. eCollection 2018.
• [4896] SNX5, a new member of the sorting nexin family, binds to the Fanconi anemia complementation group A protein.Biochem Biophys Res Commun. 1999 Nov 30;265(3):630-5. doi: 10.1006/bbrc.1999.1731.
• [4897] The emerging role of WISP proteins in tumorigenesis and cancer therapy.J Transl Med. 2019 Jan 16;17(1):28. doi: 10.1186/s12967-019-1769-7.
• [4898] JAKs to STATs: A tantalizing therapeutic target in acute myeloid leukemia.Blood Rev. 2020 Mar;40:100634. doi: 10.1016/j.blre.2019.100634. Epub 2019 Oct 25.
• [4899] SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer.Endocr Relat Cancer. 2014 Jan 30;21(2):175-87. doi: 10.1530/ERC-13-0446. Print 2014 Apr.
• [4900] SOCS6 Functions as a Tumor Suppressor by Inducing Apoptosis and Inhibiting Angiogenesis in Human Prostate Cancer.Curr Cancer Drug Targets. 2018;18(9):894-904. doi: 10.2174/1568009618666180102101442.
• [4901] Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/-catenin signaling.Mol Carcinog. 2018 Apr;57(4):494-502. doi: 10.1002/mc.22774. Epub 2018 Jan 5.
• [4902] Sohlh2 alleviates malignancy of EOC cells under hypoxia via inhibiting the HIF1/CA9 signaling pathway.Biol Chem. 2020 Feb 25;401(2):263-271. doi: 10.1515/hsz-2019-0119.
• [4903] The RNA binding protein SORBS2 suppresses metastatic colonization of ovarian cancer by stabilizing tumor-suppressive immunomodulatory transcripts.Genome Biol. 2018 Mar 16;19(1):35. doi: 10.1186/s13059-018-1412-6.
• [4904] SORLA regulates endosomal trafficking and oncogenic fitness of HER2.Nat Commun. 2019 May 28;10(1):2340. doi: 10.1038/s41467-019-10275-0.
• [4905] Aberrant DNA methylation of PAX1, SOX1 and ZNF582 genes as potential biomarkers for esophageal squamous cell carcinoma.Biomed Pharmacother. 2019 Dec;120:109488. doi: 10.1016/j.biopha.2019.109488. Epub 2019 Oct 16.
• [4906] Diagnostic accuracy of SOX11 immunohistochemistry in mantle cell lymphoma: Ameta-analysis.PLoS One. 2019 Nov 12;14(11):e0225096. doi: 10.1371/journal.pone.0225096. eCollection 2019.
• [4907] The cross-regulation between SOX15 and Wnt signaling pathway.J Cell Physiol. 2017 Dec;232(12):3221-3225. doi: 10.1002/jcp.25802. Epub 2017 Mar 27.
• [4908] The role of SOX family members in solid tumours and metastasis.Semin Cancer Biol. 2020 Dec;67(Pt 1):122-153. doi: 10.1016/j.semcancer.2019.03.004. Epub 2019 Mar 23.
• [4909] SOX21-AS1 is associated with clinical stage and regulates cell proliferation in nephroblastoma.Biosci Rep. 2019 May 17;39(5):BSR20190602. doi: 10.1042/BSR20190602. Print 2019 May 31.
• [4910] SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients.Respir Res. 2018 Dec 4;19(1):241. doi: 10.1186/s12931-018-0952-3.
• [4911] The positive feedback loop of lncRNA DANCR/miR-138/Sox4 facilitates malignancy in non-small cell lung cancer.Am J Cancer Res. 2019 Feb 1;9(2):270-284. eCollection 2019.
• [4912] SOX6 suppresses the development of lung adenocarcinoma by regulating expression of p53, p21(CIPI) , cyclin D1 and -catenin.FEBS Open Bio. 2020 Jan;10(1):135-146. doi: 10.1002/2211-5463.12762. Epub 2019 Dec 12.
• [4913] Classic SRY-box protein SOX7 functions as a tumor suppressor regulating WNT signaling and is methylated in renal cell carcinoma.FASEB J. 2019 Jan;33(1):254-263. doi: 10.1096/fj.201701453RR. Epub 2018 Jun 29.
• [4914] The SOX9-Aldehyde Dehydrogenase Axis Determines Resistance to Chemotherapy in Non-Small-Cell Lung Cancer.Mol Cell Biol. 2020 Jan 3;40(2):e00307-19. doi: 10.1128/MCB.00307-19. Print 2020 Jan 3.
• [4915] SP100 reduces malignancy of human glioma cells.Int J Oncol. 2011 Apr;38(4):1023-30. doi: 10.3892/ijo.2011.927. Epub 2011 Jan 27.
• [4916] Expression Data Analysis for the Identification of Potential Biomarker of Pregnancy Associated Breast Cancer.Pathol Oncol Res. 2017 Jul;23(3):537-544. doi: 10.1007/s12253-016-0133-y. Epub 2016 Nov 10.
• [4917] Sp140 is a multi-SUMO-1 target and its PHD finger promotes SUMOylation of the adjacent Bromodomain.Biochim Biophys Acta Gen Subj. 2019 Feb;1863(2):456-465. doi: 10.1016/j.bbagen.2018.11.011. Epub 2018 Nov 19.
• [4918] Evaluation of a telehealth psychological support intervention for people with primary brain tumour and their family members: Study protocol for a randomised controlled trial.Eur J Cancer Care (Engl). 2019 Jul;28(4):e13132. doi: 10.1111/ecc.13132. Epub 2019 Jul 10.
• [4919] Human sperm-associated antigen 4 as a potential biomarker of glioblastoma progression and prognosis.Neuroreport. 2019 Apr 10;30(6):446-451. doi: 10.1097/WNR.0000000000001226.
• [4920] High expression of SPAG5 sustains the malignant growth and invasion of breast cancer cells through the activation of Wnt/-catenin signalling.Clin Exp Pharmacol Physiol. 2019 Jun;46(6):597-606. doi: 10.1111/1440-1681.13082. Epub 2019 Apr 3.
• [4921] Protective role of c-Jun NH(2)-terminal kinase-associated leucine zipper protein (JLP) in curcumin-induced cancer cell death.Biochem Biophys Res Commun. 2020 Feb 12;522(3):697-703. doi: 10.1016/j.bbrc.2019.11.154. Epub 2019 Nov 28.
• [4922] Cancer/testis antigens trigger epithelial-mesenchymal transition and genesis of cancer stem-like cells.Curr Pharm Des. 2015;21(10):1292-300. doi: 10.2174/1381612821666141211154707.
• [4923] Elevated expression levels of testis-specific genes TEX101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features.Br J Dermatol. 2010 Apr;162(4):772-9. doi: 10.1111/j.1365-2133.2009.09568.x. Epub 2009 Nov 3.
• [4924] A potential prognostic biomarker SPC24 promotes tumorigenesis and metastasis in lung cancer.Oncotarget. 2017 Jul 4;8(39):65469-65480. doi: 10.18632/oncotarget.18971. eCollection 2017 Sep 12.
• [4925] SPC25 upregulation increases cancer stem cell properties in non-small cell lung adenocarcinoma cells and independently predicts poor survival.Biomed Pharmacother. 2018 Apr;100:233-239. doi: 10.1016/j.biopha.2018.02.015. Epub 2018 Feb 16.
• [4926] Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins.EMBO J. 2017 Aug 1;36(15):2251-2262. doi: 10.15252/embj.201796905. Epub 2017 Jun 30.
• [4927] Validation of the Spanish Version of the Quality of Dying and Death Questionnaire (QODD-ESP) in a Home-Based Cancer Palliative Care Program and Development of the QODD-ESP-12.J Pain Symptom Manage. 2017 Jun;53(6):1042-1049.e3. doi: 10.1016/j.jpainsymman.2017.02.005. Epub 2017 Mar 16.
• [4928] SPIN1 triggers abnormal lipid metabolism and enhances tumor growth in liver cancer.Cancer Lett. 2020 Feb 1;470:54-63. doi: 10.1016/j.canlet.2019.11.032. Epub 2019 Nov 29.
• [4929] SPIN1 is a proto-oncogene and SPIN3 is a tumor suppressor in human seminoma.Oncotarget. 2018 Aug 21;9(65):32466-32477. doi: 10.18632/oncotarget.25977. eCollection 2018 Aug 21.
• [4930] LSD1/KDM1A inhibitors in clinical trials: advances and prospects.J Hematol Oncol. 2019 Dec 4;12(1):129. doi: 10.1186/s13045-019-0811-9.
• [4931] Identification of trypsin-inhibitory site and structure determination of human SPINK2 serine proteinase inhibitor.Proteins. 2009 Oct;77(1):209-19. doi: 10.1002/prot.22432.
• [4932] Wild-type and splice-variant secretin receptors in lung cancer: overexpression in carcinoid tumors and peritumoral lung tissue.Mod Pathol. 2008 Apr;21(4):387-95. doi: 10.1038/modpathol.3801005. Epub 2008 Jan 25.
• [4933] The serine protease inhibitor of Kazal-type 7 (SPINK7) is expressed in human skin.Arch Dermatol Res. 2017 Nov;309(9):767-771. doi: 10.1007/s00403-017-1773-9. Epub 2017 Aug 29.
• [4934] SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activation.J Neurooncol. 2019 May;142(3):423-434. doi: 10.1007/s11060-019-03126-x. Epub 2019 Mar 5.
• [4935] SPNS2 promotes the malignancy of colorectal cancer cells via regulating Akt and ERK pathway.Clin Exp Pharmacol Physiol. 2019 Sep;46(9):861-871. doi: 10.1111/1440-1681.13124. Epub 2019 Jun 30.
• [4936] Spondin-2 is a novel diagnostic biomarker for laryngeal squamous cell carcinoma.Pathol Res Pract. 2019 Feb;215(2):286-291. doi: 10.1016/j.prp.2018.11.017. Epub 2018 Nov 29.
• [4937] Association between the expression of secreted phosphoprotein - related genes and prognosis of human cancer.BMC Cancer. 2019 Dec 18;19(1):1230. doi: 10.1186/s12885-019-6441-3.
• [4938] Mesenchymal stem/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential.J Clin Endocrinol Metab. 2013 Sep;98(9):3765-75. doi: 10.1210/jc.2013-1923. Epub 2013 Jul 3.
• [4939] Metalloprotease SPRTN/DVC1 Orchestrates Replication-Coupled DNA-Protein Crosslink Repair.Mol Cell. 2016 Nov 17;64(4):704-719. doi: 10.1016/j.molcel.2016.09.032. Epub 2016 Oct 27.
• [4940] Sprouty3 and Sprouty4, Two Members of a Family Known to Inhibit FGF-Mediated Signaling, Exert Opposing Roles on Proliferation and Migration of Glioblastoma-Derived Cells.Cells. 2019 Aug 1;8(8):808. doi: 10.3390/cells8080808.
• [4941] SPSB3 targets SNAIL for degradation in GSK-3 phosphorylation-dependent manner and regulates metastasis.Oncogene. 2018 Feb 8;37(6):768-776. doi: 10.1038/onc.2017.370. Epub 2017 Oct 23.
• [4942] Downregulation of SPTAN1 is related to MLH1 deficiency and metastasis in colorectal cancer.PLoS One. 2019 Mar 11;14(3):e0213411. doi: 10.1371/journal.pone.0213411. eCollection 2019.
• [4943] The human homologue of the ninjurin gene maps to the candidate region of hereditary sensory neuropathy type I (HSNI).Genomics. 1998 Jan 1;47(1):58-63. doi: 10.1006/geno.1997.5084.
• [4944] Dissecting the Shared and Context-Dependent Pathways Mediated by the p140Cap Adaptor Protein in Cancer and in Neurons.Front Cell Dev Biol. 2019 Oct 15;7:222. doi: 10.3389/fcell.2019.00222. eCollection 2019.
• [4945] Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological Malignancies.Cancer Cell. 2019 Jul 8;36(1):17-34.e7. doi: 10.1016/j.ccell.2019.06.005.
• [4946] Human apo-SRP72 and SRP68/72 complex structures reveal the molecular basis of protein translocation.J Mol Cell Biol. 2017 Jun 1;9(3):220-230. doi: 10.1093/jmcb/mjx010.
• [4947] SRPX2 knockdown inhibits cell proliferation and metastasis and promotes chemosensitivity in esophageal squamous cell carcinoma.Biomed Pharmacother. 2019 Jan;109:671-678. doi: 10.1016/j.biopha.2018.10.042. Epub 2018 Nov 5.
• [4948] Obesity impacts the regulation of miR-10b and its targets in primary breast tumors.BMC Cancer. 2019 Jan 18;19(1):86. doi: 10.1186/s12885-019-5300-6.
• [4949] SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer.Gut. 2019 Jan;68(1):118-129. doi: 10.1136/gutjnl-2017-314983. Epub 2017 Nov 7.
• [4950] SRSF7 knockdown promotes apoptosis of colon and lung cancer cells.Oncol Lett. 2018 Apr;15(4):5545-5552. doi: 10.3892/ol.2018.8072. Epub 2018 Feb 16.
• [4951] Sulfiredoxin May Promote Cervical Cancer Metastasis via Wnt/-Catenin Signaling Pathway.Int J Mol Sci. 2017 Apr 27;18(5):917. doi: 10.3390/ijms18050917.
• [4952] Single-stranded DNA binding protein 2 expression is associated with patient survival in hepatocellular carcinoma.BMC Cancer. 2018 Dec 12;18(1):1244. doi: 10.1186/s12885-018-5158-z.
• [4953] SSH3 facilitates colorectal cancer cell invasion and metastasis by affecting signaling cascades involving LIMK1/Rac1.Am J Cancer Res. 2019 May 1;9(5):1061-1073. eCollection 2019.
• [4954] Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines.Cancer Res. 2000 Mar 15;60(6):1654-62.
• [4955] Oxidative damage and response to Bacillus Calmette-Gurin in bladder cancer cells expressing sialyltransferase ST3GAL1.BMC Cancer. 2018 Feb 17;18(1):198. doi: 10.1186/s12885-018-4107-1.
• [4956] Alpha2,3-sialyltransferase III knockdown sensitized ovarian cancer cells to cisplatin-induced apoptosis.Biochem Biophys Res Commun. 2017 Jan 22;482(4):758-763. doi: 10.1016/j.bbrc.2016.11.107. Epub 2016 Nov 19.
• [4957] Expression analysis of ST3GAL4 transcripts in cervical cancer cells.Mol Med Rep. 2018 Jul;18(1):617-621. doi: 10.3892/mmr.2018.8938. Epub 2018 Apr 27.
• [4958] B cells suppress medullary granulopoiesis by an extracellular glycosylation-dependent mechanism.Elife. 2019 Aug 13;8:e47328. doi: 10.7554/eLife.47328.
• [4959] RNA splicing and splicing regulator changes in prostate cancer pathology.Hum Genet. 2017 Sep;136(9):1143-1154. doi: 10.1007/s00439-017-1792-9. Epub 2017 Apr 5.
• [4960] Genes that mediate breast cancer metastasis to the brain.Nature. 2009 Jun 18;459(7249):1005-9. doi: 10.1038/nature08021. Epub 2009 May 6.
• [4961] Absence of ST7 gene alterations in human cancer.Clin Cancer Res. 2002 Sep;8(9):2939-41.
• [4962] Accumulation of unusual gangliosides G(Q3) and G(P3) in breast cancer cells expressing the G(D3) synthase.Molecules. 2012 Aug 10;17(8):9559-72. doi: 10.3390/molecules17089559.
• [4963] Synthetic lethality between the cohesin subunits STAG1 and STAG2 in diverse cancer contexts.Elife. 2017 Jul 10;6:e26980. doi: 10.7554/eLife.26980.
• [4964] Signal-transducing adaptor protein-2 promotes generation of functional long-term memory CD8+ T cells by preventing terminal effector differentiation.Oncotarget. 2017 May 9;8(19):30766-30780. doi: 10.18632/oncotarget.15403.
• [4965] First-of-its-kind STARD(3) Inhibitor: In Silico Identification and Biological Evaluation as Anticancer Agent.ACS Med Chem Lett. 2019 Feb 20;10(4):475-480. doi: 10.1021/acsmedchemlett.8b00509. eCollection 2019 Apr 11.
• [4966] Gastric cancer cells escape metabolic stress via the DLC3/MACC1 axis.Theranostics. 2019 Apr 6;9(7):2100-2114. doi: 10.7150/thno.29538. eCollection 2019.
• [4967] The role of signal transducer and activator of transcription-2 in the interferon response.J Interferon Cytokine Res. 2012 Mar;32(3):103-10. doi: 10.1089/jir.2011.0099. Epub 2012 Jan 26.
• [4968] The potential and controversy of targeting STAT family members in cancer.Semin Cancer Biol. 2020 Feb;60:41-56. doi: 10.1016/j.semcancer.2019.10.002. Epub 2019 Oct 9.
• [4969] Long-term exposure of MCF-7 breast cancer cells to ethanol stimulates oncogenic features.Int J Oncol. 2017 Jan;50(1):49-65. doi: 10.3892/ijo.2016.3800. Epub 2016 Dec 9.
• [4970] The distinct role of STIM1 and STIM2 in the regulation of store-operated Ca(2+) entry and cellular function.J Cell Physiol. 2019 Jun;234(6):8727-8739. doi: 10.1002/jcp.27532. Epub 2018 Oct 14.
• [4971] Synergistic STING activation by PC7A nanovaccine and ionizing radiation improves cancer immunotherapy.J Control Release. 2019 Apr 28;300:154-160. doi: 10.1016/j.jconrel.2019.02.036. Epub 2019 Mar 4.
• [4972] Revealing the interaction mode of the highly flexible Sorghum bicolor Hsp70/Hsp90 organizing protein (Hop): A conserved carboxylate clamp confers high affinity binding to Hsp90.J Proteomics. 2019 Jan 16;191:191-201. doi: 10.1016/j.jprot.2018.02.007. Epub 2018 Feb 6.
• [4973] MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastoma.Cancer Cell. 2017 Dec 11;32(6):840-855.e8. doi: 10.1016/j.ccell.2017.11.005.
• [4974] Evaluation of the potential of a new ribavirin analog impairing the dissemination of ovarian cancer cells.PLoS One. 2019 Dec 11;14(12):e0225860. doi: 10.1371/journal.pone.0225860. eCollection 2019.
• [4975] Spectrum and clinical implications of syntaxin 11 gene mutations in familial haemophagocytic lymphohistiocytosis: association with disease-free remissions and haematopoietic malignancies.J Med Genet. 2006 Apr;43(4):e14. doi: 10.1136/jmg.2005.035253.
• [4976] The subcellular localization of syntaxin 17 varies among different cell types and is altered in some malignant cells.J Histochem Cytochem. 2005 Nov;53(11):1371-82. doi: 10.1369/jhc.4A6508.2005. Epub 2005 Jun 13.
• [4977] Nitric Oxide Generated by Tumor-Associated Macrophages Is Responsible for Cancer Resistance to Cisplatin and Correlated With Syntaxin 4 and Acid Sphingomyelinase Inhibition.Front Immunol. 2018 May 29;9:1186. doi: 10.3389/fimmu.2018.01186. eCollection 2018.
• [4978] Panel of Autoimmune Markers for Noninvasive Diagnosis of Minimal-Mild Endometriosis.Reprod Sci. 2017 Mar;24(3):413-420. doi: 10.1177/1933719116657190. Epub 2016 Sep 27.
• [4979] Syntaxin 6-mediated exosome secretion regulates enzalutamide resistance in prostate cancer.Mol Carcinog. 2020 Jan;59(1):62-72. doi: 10.1002/mc.23129. Epub 2019 Nov 1.
• [4980] Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.J Biol Chem. 2011 Mar 25;286(12):10505-14. doi: 10.1074/jbc.M110.162321. Epub 2011 Jan 14.
• [4981] Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis.Neuro Oncol. 2018 Jul 5;20(8):1122-1132. doi: 10.1093/neuonc/nox228.
• [4982] Detection of SUN1 Splicing Variants at the mRNA and Protein Levels in Cancer.Methods Mol Biol. 2018;1840:307-319. doi: 10.1007/978-1-4939-8691-0_21.
• [4983] Quantification of C13orf19/P38IP mRNA expression by quantitative real-time PCR in patients with urological malignancies.Cancer Lett. 2005 Jul 28;225(2):253-60. doi: 10.1016/j.canlet.2004.10.037. Epub 2004 Dec 9.
• [4984] SUSD2 promotes cancer metastasis and confers cisplatin resistance in high grade serous ovarian cancer.Exp Cell Res. 2018 Feb 15;363(2):160-170. doi: 10.1016/j.yexcr.2017.12.029. Epub 2018 Jan 2.
• [4985] The Oncogenic Potential of SUV39H2: A Comprehensive and Perspective View.J Cancer. 2019 Jan 1;10(3):721-729. doi: 10.7150/jca.28254. eCollection 2019.
• [4986] Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer.Clin Cancer Res. 2015 Dec 1;21(23):5391-403. doi: 10.1158/1078-0432.CCR-14-2680. Epub 2015 Aug 12.
• [4987] SWAP-70 promotes glioblastoma cellular migration and invasion by regulating the expression of CD44s.Cancer Cell Int. 2019 Nov 21;19:305. doi: 10.1186/s12935-019-1035-3. eCollection 2019.
• [4988] Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3-NANOG Axis.Cancer Res. 2018 May 15;78(10):2638-2653. doi: 10.1158/0008-5472.CAN-17-2325. Epub 2018 Feb 6.
• [4989] Knocking down the expression of SYF2 inhibits the proliferation of glioma cells.Med Oncol. 2014 Aug;31(8):101. doi: 10.1007/s12032-014-0101-x. Epub 2014 Jul 2.
• [4990] Expression profiling of RE1-silencing transcription factor (REST), REST corepressor 1 (RCOR1), and Synapsin 1 (SYN1) genes in human gliomas.J BUON. 2016 Jul-Aug;21(4):964-972.
• [4991] SYNJ2BP inhibits tumor growth and metastasis by activating DLL4 pathway in hepatocellular carcinoma.J Exp Clin Cancer Res. 2016 Jul 20;35(1):115. doi: 10.1186/s13046-016-0385-0.
• [4992] Intermediate filament dynamics and breast cancer: aberrant promoter methylation of the Synemin gene is associated with early tumor relapse.Oncogene. 2010 Aug 26;29(34):4814-25. doi: 10.1038/onc.2010.229. Epub 2010 Jun 14.
• [4993] Spinal miRNA-124 regulates synaptopodin and nociception in an animal model of bone cancer pain.Sci Rep. 2017 Sep 8;7(1):10949. doi: 10.1038/s41598-017-10224-1.
• [4994] A typical carcinoid of the lung - a case report with pathological correlation and propagation of the cancer stem cell line BKZ1 with synaptophysin expression.Medicine (Baltimore). 2019 Dec;98(49):e18174. doi: 10.1097/MD.0000000000018174.
• [4995] Synthesis of New Proteomimetic Quinazolinone Alkaloids and Evaluation of Their Neuroprotective and Antitumor Effects.Molecules. 2019 Feb 1;24(3):534. doi: 10.3390/molecules24030534.
• [4996] Efficient downregulation of ErbB-2 induces TACC1 upregulation in breast cancer cell lines.Oncol Rep. 2013 Apr;29(4):1517-23. doi: 10.3892/or.2013.2253. Epub 2013 Jan 24.
• [4997] Transforming acidic coiled-coil-containing protein 2 (TACC2) in human breast cancer, expression pattern and clinical/prognostic relevance.Cancer Genomics Proteomics. 2010 Mar-Apr;7(2):67-73.
• [4998] Frameshift Mutations in the Mononucleotide Repeats of TAF1 and TAF1L Genes in Gastric and Colorectal Cancers with Regional Heterogeneity.Pathol Oncol Res. 2017 Jan;23(1):125-130. doi: 10.1007/s12253-016-0107-0. Epub 2016 Aug 29.
• [4999] The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ.Oncogene. 2009 Jan 15;28(2):270-8. doi: 10.1038/onc.2008.378. Epub 2008 Oct 13.
• [5000] TAFA5 promotes proliferation and migration in gastric cancer.Mol Med Rep. 2019 Nov;20(5):4477-4488. doi: 10.3892/mmr.2019.10724. Epub 2019 Oct 2.
• [5001] The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics.Cancers (Basel). 2019 Feb 26;11(3):276. doi: 10.3390/cancers11030276.
• [5002] Telomere length modulation in human astroglial brain tumors.PLoS One. 2013 May 14;8(5):e64296. doi: 10.1371/journal.pone.0064296. Print 2013.
• [5003] Expression of TARBP1 protein in human non-small-cell lung cancer and its prognostic significance.Oncol Lett. 2018 May;15(5):7182-7190. doi: 10.3892/ol.2018.8202. Epub 2018 Mar 7.
• [5004] From perinuclear to intranuclear localization: A cell-penetrating peptide modification strategy to modulate cancer cell migration under mild laser irradiation and improve photothermal therapeutic performance.Biomaterials. 2019 Dec;223:119443. doi: 10.1016/j.biomaterials.2019.119443. Epub 2019 Aug 23.
• [5005] PEGylated peptide to TIP1 is a novel targeting agent that binds specifically to various cancers in vivo.J Control Release. 2019 Mar 28;298:194-201. doi: 10.1016/j.jconrel.2019.02.008. Epub 2019 Feb 11.
• [5006] Downregulation of TBC1 Domain Family Member 24 (BC1D24) Inhibits Breast Carcinoma Growth via IGF1R/PI3K/AKT Pathway.Med Sci Monit. 2018 Jun 12;24:3987-3996. doi: 10.12659/MSM.906736.
• [5007] ZEB1/NuRD complex suppresses TBC1D2b to stimulate E-cadherin internalization and promote metastasis in lung cancer.Nat Commun. 2019 Nov 12;10(1):5125. doi: 10.1038/s41467-019-12832-z.
• [5008] Cervical cancer stem-like cells: systematic review and identification of reference genes for gene expression.Cell Biol Int. 2018 Feb;42(2):139-152. doi: 10.1002/cbin.10878. Epub 2017 Nov 9.
• [5009] Knockdown of TBRG4 affects tumorigenesis in human H1299 lung cancer cells by regulating DDIT3, CAV1 and RRM2.Oncol Lett. 2018 Jan;15(1):121-128. doi: 10.3892/ol.2017.7328. Epub 2017 Nov 2.
• [5010] Deep gene selection method to select genes from microarray datasets for cancer classification.BMC Bioinformatics. 2019 Nov 27;20(1):608. doi: 10.1186/s12859-019-3161-2.
• [5011] The roles and regulation of TBX3 in development and disease.Gene. 2020 Feb 5;726:144223. doi: 10.1016/j.gene.2019.144223. Epub 2019 Oct 26.
• [5012] Oral Submucous Fibrosis as an Overhealing Wound: Implications in Malignant Transformation.Recent Pat Anticancer Drug Discov. 2018;13(3):272-291. doi: 10.2174/1574892813666180227103147.
• [5013] Identification of TC2N as a novel promising suppressor of PI3K-AKT signaling in breast cancer.Cell Death Dis. 2019 May 29;10(6):424. doi: 10.1038/s41419-019-1663-5.
• [5014] Knockdown of TFIIS by RNA silencing inhibits cancer cell proliferation and induces apoptosis.BMC Cancer. 2008 May 12;8:133. doi: 10.1186/1471-2407-8-133.
• [5015] A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation.Oncogene. 2008 Dec 11;27(58):7223-34. doi: 10.1038/onc.2008.360. Epub 2008 Sep 22.
• [5016] Genetic and epigenetic stability of oligodendrogliomas at recurrence.Acta Neuropathol Commun. 2017 Mar 7;5(1):18. doi: 10.1186/s40478-017-0422-z.
• [5017] Octamer binding transcription factor-4 expression is associated with cervical cancer malignancy and histological differentiation: a systematic review and meta-analysis.Biosci Rep. 2019 May 10;39(5):BSR20182328. doi: 10.1042/BSR20182328. Print 2019 May 31.
• [5018] USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation.Genes Dev. 2019 Oct 1;33(19-20):1361-1366. doi: 10.1101/gad.326314.119. Epub 2019 Sep 5.
• [5019] TCF7L1 indicates prognosis and promotes proliferation through activation of Keap1/NRF2 in gastric cancer.Acta Biochim Biophys Sin (Shanghai). 2019 Apr 1;51(4):375-385. doi: 10.1093/abbs/gmz015.
• [5020] Detection of tumor suppressor protein p53 with special emphasis on biosensors: A review.Anal Biochem. 2020 Jan 1;588:113473. doi: 10.1016/j.ab.2019.113473. Epub 2019 Oct 11.
• [5021] Association of C8orf4 expression with its methylation status, aberrant -catenin expression, and the development of cervical squamous cell carcinoma.Medicine (Baltimore). 2019 Aug;98(31):e16715. doi: 10.1097/MD.0000000000016715.
• [5022] Vitamin B12 and its binding proteins in patients with non-small cell lung cancer referred to fast-track diagnostic work-up for lung cancer.Scand J Clin Lab Invest. 2020 Feb;80(1):14-19. doi: 10.1080/00365513.2019.1692232. Epub 2019 Nov 18.
• [5023] Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transport.Pharmacol Res. 2017 Jul;121:184-193. doi: 10.1016/j.phrs.2017.04.025. Epub 2017 Apr 26.
• [5024] Comprehensive Analysis of Mouse Cancer/Testis Antigen Functions in Cancer Cells and Roles of TEKT5 in Cancer Cells and Testicular Germ Cells.Mol Cell Biol. 2019 Aug 12;39(17):e00154-19. doi: 10.1128/MCB.00154-19. Print 2019 Sep 1.
• [5025] Cdc7-Dbf4-mediated phosphorylation of HSP90-S164 stabilizes HSP90-HCLK2-MRN complex to enhance ATR/ATM signaling that overcomes replication stress in cancer.Sci Rep. 2017 Dec 5;7(1):17024. doi: 10.1038/s41598-017-17126-2.
• [5026] FAM46B inhibits cell proliferation and cell cycle progression in prostate cancer through ubiquitination of -catenin.Exp Mol Med. 2018 Dec 10;50(12):1-12. doi: 10.1038/s12276-018-0184-0.
• [5027] Antimetastatic effects of norcantharidin on hepatocellular carcinoma cells by up-regulating FAM46C expression.Am J Transl Res. 2017 Jan 15;9(1):155-166. eCollection 2017.
• [5028] Expression of tesmin (MTL5) in nonsmall cell lung cancer: A preliminary study.Oncol Rep. 2019 Jul;42(1):253-262. doi: 10.3892/or.2019.7145. Epub 2019 May 2.
• [5029] TET1 suppresses colon cancer proliferation by impairing -catenin signal pathway.J Cell Biochem. 2019 Aug;120(8):12559-12565. doi: 10.1002/jcb.28522. Epub 2019 Mar 1.
• [5030] Human germ/stem cell-specific gene TEX19 influences cancer cell proliferation and cancer prognosis.Mol Cancer. 2017 Apr 26;16(1):84. doi: 10.1186/s12943-017-0653-4.
• [5031] Cyclooxygenase-2-Mediated Up-Regulation of Mitochondrial Transcription Factor A Mitigates the Radio-Sensitivity of Cancer Cells.Int J Mol Sci. 2019 Mar 11;20(5):1218. doi: 10.3390/ijms20051218.
• [5032] Efficacy of decitabine-loaded gelatinases-stimuli nanoparticles in overcoming cancer drug resistance is mediated via its enhanced demethylating activity to transcription factor AP-2 epsilon.Oncotarget. 2017 Sep 26;8(70):114495-114505. doi: 10.18632/oncotarget.21274. eCollection 2017 Dec 29.
• [5033] The non-coding variant rs1800734 enhances DCLK3 expression through long-range interaction and promotes colorectal cancer progression.Nat Commun. 2017 Feb 14;8:14418. doi: 10.1038/ncomms14418.
• [5034] CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer.Cell Death Dis. 2019 Sep 9;10(9):644. doi: 10.1038/s41419-019-1894-5.
• [5035] TFCP2/TFCP2L1/UBP1 transcription factors in cancer.Cancer Lett. 2018 Apr 28;420:72-79. doi: 10.1016/j.canlet.2018.01.078. Epub 2018 Feb 7.
• [5036] Therapeutic potential of adenovirus-mediated TFF2-CTP-Flag peptide for treatment of colorectal cancer.Cancer Gene Ther. 2019 Feb;26(1-2):48-57. doi: 10.1038/s41417-018-0036-z. Epub 2018 Jul 25.
• [5037] Indocyanine green-loaded hollow mesoporous silica nanoparticles as an activatable theranostic agent.Nanotechnology. 2017 May 5;28(18):185102. doi: 10.1088/1361-6528/aa66b0. Epub 2017 Apr 10.
• [5038] TFPI-2 suppresses breast cancer cell proliferation and invasion through regulation of ERK signaling and interaction with actinin-4 and myosin-9.Sci Rep. 2018 Sep 26;8(1):14402. doi: 10.1038/s41598-018-32698-3.
• [5039] Transferrin receptor 2 is frequently expressed in human cancer cell lines.Blood Cells Mol Dis. 2007 Jul-Aug;39(1):82-91. doi: 10.1016/j.bcmd.2007.02.003. Epub 2007 Apr 10.
• [5040] Anti-Thyroid Antibodies and TSH as Potential Markers of Thyroid Carcinoma and Aggressive Behavior in Patients with Indeterminate Fine-Needle Aspiration Cytology.World J Surg. 2020 Feb;44(2):363-370. doi: 10.1007/s00268-019-05153-1.
• [5041] Overexpression of the mitochondrial chaperone tumor necrosis factor receptor-associated protein 1 is associated with the poor prognosis of patients with colorectal cancer.Oncol Lett. 2018 Apr;15(4):5451-5458. doi: 10.3892/ol.2018.8042. Epub 2018 Feb 13.
• [5042] Thrombospondin-4 expression as a prognostic marker in hepatocellular carcinoma.Gene. 2019 May 15;696:219-224. doi: 10.1016/j.gene.2019.02.049. Epub 2019 Feb 22.
• [5043] Translational control and the cancer cell response to stress.Curr Opin Cell Biol. 2017 Apr;45:102-109. doi: 10.1016/j.ceb.2017.05.007. Epub 2017 Jun 2.
• [5044] Genomic analysis of cancer tissue reveals that somatic mutations commonly occur in a specific motif.Hum Mutat. 2009 Jan;30(1):39-48. doi: 10.1002/humu.20810.
• [5045] Knockdown of ICB-1 gene enhanced estrogen responsiveness of ovarian and breast cancer cells.Endocr Relat Cancer. 2010 Feb 18;17(1):147-57. doi: 10.1677/ERC-09-0095. Print 2010 Mar.
• [5046] Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma.Mol Cancer Res. 2008 Apr;6(4):592-603. doi: 10.1158/1541-7786.MCR-07-0154.
• [5047] The Fibroblast TIAM2 Promotes Lung Cancer Cell Invasion and Metastasis.J Cancer. 2019 Apr 21;10(8):1879-1889. doi: 10.7150/jca.30477. eCollection 2019.
• [5048] TIGAR knockdown enhanced the anticancer effect of aescin via regulating autophagy and apoptosis in colorectal cancer cells.Acta Pharmacol Sin. 2019 Jan;40(1):111-121. doi: 10.1038/s41401-018-0001-2. Epub 2018 May 16.
• [5049] TIGD1, a gene of unknown function, involves cell-cycle progression and correlates with poor prognosis in human cancer.J Cell Biochem. 2019 Jun;120(6):9758-9767. doi: 10.1002/jcb.28256. Epub 2018 Dec 11.
• [5050] Breast cancer screening with digital breast tomosynthesis - 4 year experience and comparison with national data.J Chin Med Assoc. 2018 Jan;81(1):70-80. doi: 10.1016/j.jcma.2017.05.013. Epub 2017 Nov 9.
• [5051] Sesquiterpenes from the Leaves of Magnolia delavayi Franch. and Their Cytotoxic Activities.Chem Biodivers. 2019 May;16(5):e1900013. doi: 10.1002/cbdv.201900013. Epub 2019 Apr 4.
• [5052] Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.Biosci Rep. 2019 May 10;39(5):BSR20190478. doi: 10.1042/BSR20190478. Print 2019 May 31.
• [5053] TIMP4 expression is regulated by miR-200b-3p in prostate cancer cells.APMIS. 2017 Feb;125(2):101-105. doi: 10.1111/apm.12638. Epub 2016 Dec 28.
• [5054] Altered gene expression profiles of NIH3T3 cells regulated by human lung cancer associated gene CT120.Cell Res. 2004 Dec;14(6):487-96. doi: 10.1038/sj.cr.7290252.
• [5055] Dihydroceramide desaturase knockdown impacts sphingolipids and apoptosis after photodamage in human head and neck squamous carcinoma cells.Anticancer Res. 2013 Jan;33(1):77-84.
• [5056] ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data.Cancers (Basel). 2019 Nov 21;11(12):1840. doi: 10.3390/cancers11121840.
• [5057] Groucho related gene 5 (GRG5) is involved in embryonic and neural stem cell state decisions.Sci Rep. 2018 Sep 13;8(1):13790. doi: 10.1038/s41598-018-31696-9.
• [5058] TLK2 enhances aggressive phenotypes of glioblastoma cells through the activation of SRC signaling pathway.Cancer Biol Ther. 2019;20(1):101-108. doi: 10.1080/15384047.2018.1507257. Epub 2018 Sep 12.
• [5059] Endoplasmic reticulum-targeting sequence enhanced the cellular immunity of a tumor-associated antigen L6-based DNA vaccine.Am J Cancer Res. 2019 Sep 1;9(9):2028-2036. eCollection 2019.
• [5060] The human homologue of Dictyostelium discoideum phg1A is expressed by human metastatic melanoma cells.EMBO Rep. 2009 Dec;10(12):1348-54. doi: 10.1038/embor.2009.236. Epub 2009 Nov 6.
• [5061] Common genetic variants and risk for HPV persistence and progression to cervical cancer.PLoS One. 2010 Jan 13;5(1):e8667. doi: 10.1371/journal.pone.0008667.
• [5062] TMCO1-mediated Ca(2+) leak underlies osteoblast functions via CaMKII signaling.Nat Commun. 2019 Apr 8;10(1):1589. doi: 10.1038/s41467-019-09653-5.
• [5063] TMEFF1 and brain tumors.Oncogene. 2003 May 8;22(18):2723-7. doi: 10.1038/sj.onc.1206351.
• [5064] Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients.Inflamm Bowel Dis. 2013 Jan;19(1):165-73. doi: 10.1002/ibd.22994.
• [5065] Transmembrane protein 106A is silenced by promoter region hypermethylation and suppresses gastric cancer growth by inducing apoptosis.J Cell Mol Med. 2014 Aug;18(8):1655-66. doi: 10.1111/jcmm.12352. Epub 2014 Jun 28.
• [5066] TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins.Nat Commun. 2018 Jul 16;9(1):2731. doi: 10.1038/s41467-018-05013-x.
• [5067] In vivo activation of the p53 tumor suppressor pathway by an engineered cyclotide.J Am Chem Soc. 2013 Aug 7;135(31):11623-11633. doi: 10.1021/ja405108p. Epub 2013 Jul 25.
• [5068] Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).Endocr Pathol. 2017 Sep;28(3):253-268. doi: 10.1007/s12022-017-9489-0.
• [5069] Vernodalidimer L, a sesquiterpene lactone dimer from Vernonia extensa and anti-tumor effects of vernodalin, vernolepin, and vernolide on HepG2 liver cancer cells.Bioorg Chem. 2019 Nov;92:103197. doi: 10.1016/j.bioorg.2019.103197. Epub 2019 Aug 16.
• [5070] Analysis of the candidate tumor suppressor Ris-1 in primary human breast carcinomas.Mutat Res. 2006 Feb 22;594(1-2):78-85. doi: 10.1016/j.mrfmmm.2005.07.017. Epub 2005 Nov 8.
• [5071] TMEM17 promotes malignant progression of breast cancer via AKT/GSK3 signaling.Cancer Manag Res. 2018 Aug 2;10:2419-2428. doi: 10.2147/CMAR.S168723. eCollection 2018.
• [5072] Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development.Oncotarget. 2017 Jul 25;8(41):70035-70048. doi: 10.18632/oncotarget.19550. eCollection 2017 Sep 19.
• [5073] TMEM196 hypermethylation as a novel diagnostic and prognostic biomarker for lung cancer.Mol Carcinog. 2019 Apr;58(4):474-487. doi: 10.1002/mc.22942. Epub 2018 Dec 11.
• [5074] A novel model of colitis-associated cancer in SAMP1/YitFc mice with Crohn's disease-like ileitis.PLoS One. 2017 Mar 16;12(3):e0174121. doi: 10.1371/journal.pone.0174121. eCollection 2017.
• [5075] Elevated expression of TMEM205, a hypothetical membrane protein, is associated with cisplatin resistance. J Cell Physiol. 2010 Nov;225(3):822-8. doi: 10.1002/jcp.22287.
• [5076] MM-TRAG (MGC4175), a novel intracellular mitochondrial protein, is associated with the taxol- and doxorubicin-resistant phenotype in human cancer cell lines. Gene. 2004 Sep 29;340(1):53-9. doi: 10.1016/j.gene.2004.06.013.
• [5077] TMEM25 is a candidate biomarker methylated and down-regulated in colorectal cancer.Dis Markers. 2013;34(2):93-104. doi: 10.3233/DMA-120948.
• [5078] In silico analysis of transmembrane protein 31 (TMEM31) antigen to design novel multiepitope peptide and DNA cancer vaccines against melanoma.Mol Immunol. 2019 Aug;112:93-102. doi: 10.1016/j.molimm.2019.04.030. Epub 2019 May 9.
• [5079] Characterization of the role of TMEM45A in cancer cell sensitivity to cisplatin.Cell Death Dis. 2019 Dec 4;10(12):919. doi: 10.1038/s41419-019-2088-x.
• [5080] Overexpression of Osmosensitive Ca(2+)-Permeable Channel TMEM63B Promotes Migration in HEK293T Cells.Biochemistry. 2019 Jul 2;58(26):2861-2866. doi: 10.1021/acs.biochem.9b00224. Epub 2019 Jun 20.
• [5081] New advances of TMEM88 in cancer initiation and progression, with special emphasis on Wnt signaling pathway.J Cell Physiol. 2018 Jan;233(1):79-87. doi: 10.1002/jcp.25853. Epub 2017 Apr 27.
• [5082] NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.BMC Cancer. 2010 Apr 27;10:160. doi: 10.1186/1471-2407-10-160.
• [5083] Targeted regulation of miR-17-5p on TMOD1 promotes the development of cardia cancer.Eur Rev Med Pharmacol Sci. 2019 Jul;23(14):6170-6178. doi: 10.26355/eurrev_201907_18430.
• [5084] Tropomodulin3 promotes liver cancer progression by activating the MAPK/ERK signaling pathway.Oncol Rep. 2019 May;41(5):3060-3068. doi: 10.3892/or.2019.7052. Epub 2019 Mar 7.
• [5085] LAP2 is widely overexpressed in diverse digestive tract cancers and regulates motility of cancer cells.PLoS One. 2012;7(6):e39482. doi: 10.1371/journal.pone.0039482. Epub 2012 Jun 20.
• [5086] Ectopic expression of human airway trypsin-like protease 4 in acute myeloid leukemia promotes cancer cell invasion and tumor growth.Cancer Med. 2019 May;8(5):2348-2359. doi: 10.1002/cam4.2074. Epub 2019 Mar 7.
• [5087] A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer.Cancer Res. 2000 May 15;60(10):2602-6.
• [5088] Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery.Cancer Lett. 2019 Jul 1;453:21-33. doi: 10.1016/j.canlet.2019.03.013. Epub 2019 Mar 21.
• [5089] Knockdown of TNFAIP1 inhibits growth and induces apoptosis in osteosarcoma cells through inhibition of the nuclear factor-B pathway.Oncol Rep. 2014 Sep;32(3):1149-55. doi: 10.3892/or.2014.3291. Epub 2014 Jun 25.
• [5090] TIPE1 Inhibits Breast Cancer Proliferation by Downregulating ERK Phosphorylation and Predicts a Favorable Prognosis.Front Oncol. 2019 May 22;9:400. doi: 10.3389/fonc.2019.00400. eCollection 2019.
• [5091] Tumour necrosis factor--induced protein 8-like 2 is a novel regulator of proliferation, migration, and invasion in human rectal adenocarcinoma cells.J Cell Mol Med. 2019 Mar;23(3):1698-1713. doi: 10.1111/jcmm.14065. Epub 2019 Jan 13.
• [5092] TIPE3 protein promotes breast cancer metastasis through activating AKT and NF-B signaling pathways.Oncotarget. 2017 Jul 25;8(30):48889-48904. doi: 10.18632/oncotarget.16522.
• [5093] Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancer.Prostate. 2009 Feb 15;69(3):327-35. doi: 10.1002/pros.20882.
• [5094] TRAIL-Receptor 4 Modulates T Cell-Cytotoxicity Toward Cancer Cells.Front Immunol. 2019 Aug 28;10:2044. doi: 10.3389/fimmu.2019.02044. eCollection 2019.
• [5095] Role of TGF3-Smads-Sp1 axis in DcR3-mediated immune escape of hepatocellular carcinoma.Oncogenesis. 2019 Aug 13;8(8):43. doi: 10.1038/s41389-019-0152-0.
• [5096] A Novel Form of 4-1BBL Prevents Cancer Development via Nonspecific Activation of CD4(+) T and Natural Killer Cells.Cancer Res. 2019 Feb 15;79(4):783-794. doi: 10.1158/0008-5472.CAN-18-2401.
• [5097] Tankyrase-Binding Protein TNKS1BP1 Regulates Actin Cytoskeleton Rearrangement and Cancer Cell Invasion.Cancer Res. 2017 May 1;77(9):2328-2338. doi: 10.1158/0008-5472.CAN-16-1846. Epub 2017 Feb 15.
• [5098] Biosynthesis of selenium nanoparticles, characterization and X-ray induced radiotherapy for the treatment of lung cancer with interstitial lung disease.J Photochem Photobiol B. 2019 Feb;191:123-127. doi: 10.1016/j.jphotobiol.2018.12.008. Epub 2018 Dec 11.
• [5099] Tenascins and the importance of adhesion modulation.Cold Spring Harb Perspect Biol. 2011 May 1;3(5):a004960. doi: 10.1101/cshperspect.a004960.
• [5100] KIAA0510, the 3'-untranslated region of the tenascin-R gene, and tenascin-R are overexpressed in pilocytic astrocytomas.Neuropathol Appl Neurobiol. 2010 Aug;36(5):399-410. doi: 10.1111/j.1365-2990.2010.01074.x. Epub 2010 Feb 25.
• [5101] Transducer of ERBB2.1 (TOB1) as a Tumor Suppressor: A Mechanistic Perspective.Int J Mol Sci. 2015 Dec 15;16(12):29815-28. doi: 10.3390/ijms161226203.
• [5102] Upregulation of miR-362-3p Modulates Proliferation and Anchorage-Independent Growth by Directly Targeting Tob2 in Hepatocellular Carcinoma.J Cell Biochem. 2015 Aug;116(8):1563-73. doi: 10.1002/jcb.25110.
• [5103] TOMM20 as a potential therapeutic target of colorectal cancer.BMB Rep. 2019 Dec;52(12):712-717. doi: 10.5483/BMBRep.2019.52.12.249.
• [5104] Tomm34 is commonly expressed in epithelial ovarian cancer and associates with tumour type and high FIGO stage.J Ovarian Res. 2019 Mar 27;12(1):30. doi: 10.1186/s13048-019-0498-0.
• [5105] Association between polymorphisms in RMI1, TOP3A, and BLM and risk of cancer, a case-control study.BMC Cancer. 2009 May 11;9:140. doi: 10.1186/1471-2407-9-140.
• [5106] Loss of TOP3B leads to increased R-loop formation and genome instability.Open Biol. 2019 Dec;9(12):190222. doi: 10.1098/rsob.190222. Epub 2019 Dec 4.
• [5107] TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic Leukemia.Cancer Discov. 2017 Nov;7(11):1336-1353. doi: 10.1158/2159-8290.CD-17-0267. Epub 2017 Oct 3.
• [5108] Differential epigenetic regulation of TOX subfamily high mobility group box genes in lung and breast cancers.PLoS One. 2012;7(4):e34850. doi: 10.1371/journal.pone.0034850. Epub 2012 Apr 4.
• [5109] ASPP2 enhances chemotherapeutic sensitivity through the down-regulation of XIAP expression in a p53 independent manner in hepatocellular carcinoma.Biochem Biophys Res Commun. 2019 Jan 15;508(3):769-774. doi: 10.1016/j.bbrc.2018.11.181. Epub 2018 Dec 6.
• [5110] Regulation of death receptor signaling by the autophagy protein TP53INP2.EMBO J. 2019 May 15;38(10):e99300. doi: 10.15252/embj.201899300. Epub 2019 Apr 12.
• [5111] Isolation and characterization of a novel TP53-inducible gene, TP53TG3.Genes Chromosomes Cancer. 1999 Dec;26(4):329-35.
• [5112] Tumor protein D52 (isoform 3) interacts with and promotes peroxidase activity of Peroxiredoxin 1 in prostate cancer cells implicated in cell growth and migration.Biochim Biophys Acta Mol Cell Res. 2019 Aug;1866(8):1298-1309. doi: 10.1016/j.bbamcr.2019.04.007. Epub 2019 Apr 11.
• [5113] Correction to: Retraction of: Tumor Protein D52-Like 2 Contributes to Proliferation of Breast Cancer Cells; 10.10.89/cbr.2014.1723Cancer Biother Radiopharm 2017;32(10):387. DOI: 10.1089/cbr.2014.1723.retract.Cancer Biother Radiopharm. 2018 Oct 1;33(8):361. doi: 10.1089/cbr.2014.1723.retract.correx. Epub 2018 Oct 18.
• [5114] The adaptive regulation of thiamine pyrophosphokinase-1 facilitates malignant growth during supplemental thiamine conditions.Oncotarget. 2018 Oct 23;9(83):35422-35438. doi: 10.18632/oncotarget.26259. eCollection 2018 Oct 23.
• [5115] Hypoxia-Induced TPM2 Methylation is Associated with Chemoresistance and Poor Prognosis in Breast Cancer.Cell Physiol Biochem. 2018;45(2):692-705. doi: 10.1159/000487162. Epub 2018 Jan 31.
• [5116] Resistance to TRK inhibition mediated by convergent MAPK pathway activation.Nat Med. 2019 Sep;25(9):1422-1427. doi: 10.1038/s41591-019-0542-z. Epub 2019 Aug 12.
• [5117] The effects of crizotinib in a transgenic Drosophila model expressing the human TPM4-ALK fusion gene or TPM4.Biol Open. 2019 Jul 5;8(7):bio044362. doi: 10.1242/bio.044362.
• [5118] Role of the microtubule-associated TPPP/p25 in Parkinson's and related diseases and its therapeutic potential.Expert Rev Proteomics. 2017 Apr;14(4):301-309. doi: 10.1080/14789450.2017.1304216. Epub 2017 Mar 15.
• [5119] Chromosomal rearrangements involving the NTRK1 gene in colorectal carcinoma.Cancer Lett. 2015 Aug 28;365(1):107-11. doi: 10.1016/j.canlet.2015.05.013. Epub 2015 May 19.
• [5120] Identification of TP53RK-Binding Protein (TPRKB) Dependency in TP53-Deficient Cancers.Mol Cancer Res. 2019 Aug;17(8):1652-1664. doi: 10.1158/1541-7786.MCR-19-0144. Epub 2019 May 20.
• [5121] Next-Generation Sequencing Approach to Non-Small Cell Lung Carcinoma Yields More Actionable Alterations.Arch Pathol Lab Med. 2018 Mar;142(3):353-357. doi: 10.5858/arpa.2017-0046-OA. Epub 2017 Dec 8.
• [5122] Tra2 silencing suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting PI3K/AKT signaling.Laryngoscope. 2019 Sep;129(9):E318-E328. doi: 10.1002/lary.27716. Epub 2018 Dec 31.
• [5123] TRAF1 Is Critical for Regulating the BRAF/MEK/ERK Pathway in Non-Small Cell Lung Carcinogenesis.Cancer Res. 2018 Jul 15;78(14):3982-3994. doi: 10.1158/0008-5472.CAN-18-0429. Epub 2018 May 10.
• [5124] TRAF2 Cooperates with Focal Adhesion Signaling to Regulate Cancer Cell Susceptibility to Anoikis.Mol Cancer Ther. 2019 Jan;18(1):139-146. doi: 10.1158/1535-7163.MCT-17-1261. Epub 2018 Oct 29.
• [5125] Elevated Choline Kinase -Mediated Choline Metabolism Supports the Prolonged Survival of TRAF3-Deficient B Lymphocytes.J Immunol. 2020 Jan 15;204(2):459-471. doi: 10.4049/jimmunol.1900658. Epub 2019 Dec 11.
• [5126] Anti-inflammatory Effects of Atorvastatin in Human Glioblastoma Spheroids Cultured in a Three-dimensional Model: Possible Relevance to Glioblastoma Treatment.Mol Neurobiol. 2018 Mar;55(3):2102-2110. doi: 10.1007/s12035-017-0445-2. Epub 2017 Mar 10.
• [5127] Expression and Association of Tumor Necrosis Factor Receptor Associated Factor 4 (TRAF4) in Esophageal Squamous Cell Carcinoma.Med Sci Monit. 2019 Apr 1;25:2368-2376. doi: 10.12659/MSM.915474.
• [5128] Hypertonia-linked protein Trak1 functions with mitofusins to promote mitochondrial tethering and fusion.Protein Cell. 2018 Aug;9(8):693-716. doi: 10.1007/s13238-017-0469-4. Epub 2017 Sep 18.
• [5129] Overexpression of Translocation Associated Membrane Protein 2 Leading to Cancer-Associated Matrix Metalloproteinase Activation as a Putative Metastatic Factor for Human Oral Cancer.J Cancer. 2018 Sep 7;9(18):3326-3333. doi: 10.7150/jca.25666. eCollection 2018.
• [5130] NIK?and IKKbinding protein contributes to gastric cancer chemoresistance by promoting epithelialmesenchymal transition through the NFB signaling pathway.Oncol Rep. 2018 Jun;39(6):2721-2730. doi: 10.3892/or.2018.6348. Epub 2018 Mar 30.
• [5131] Adeno-associated virus-mediated doxycycline-regulatable TRAIL expression suppresses growth of human breast carcinoma in nude mice.BMC Cancer. 2012 Apr 24;12:153. doi: 10.1186/1471-2407-12-153.
• [5132] High TRIAP1 expression in penile carcinoma is associated with high risk of recurrence and poor survival.Ann Transl Med. 2019 Jul;7(14):330. doi: 10.21037/atm.2019.06.47.
• [5133] TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.Oncogene. 2013 Oct 17;32(42):5038-47. doi: 10.1038/onc.2012.531. Epub 2012 Nov 26.
• [5134] TRIM15 Exerts Anti-Tumor Effects Through Suppressing Cancer Cell Invasion in Gastric Adenocarcinoma.Med Sci Monit. 2018 Nov 9;24:8033-8041. doi: 10.12659/MSM.911142.
• [5135] TRIM26 functions as a novel tumor suppressor of hepatocellular carcinoma and its downregulation contributes to worse prognosis.Biochem Biophys Res Commun. 2015 Jul 31;463(3):458-65. doi: 10.1016/j.bbrc.2015.05.117. Epub 2015 Jun 1.
• [5136] Overexpression of E3 ubiquitin ligase tripartite motif 32 correlates with a poor prognosis in patients with gastric cancer.Oncol Lett. 2017 May;13(5):3131-3138. doi: 10.3892/ol.2017.5806. Epub 2017 Mar 6.
• [5137] TRIM45 functions as a tumor suppressor in the brain via its E3 ligase activity by stabilizing p53 through K63-linked ubiquitination.Cell Death Dis. 2017 May 25;8(5):e2831. doi: 10.1038/cddis.2017.149.
• [5138] TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.J Exp Clin Cancer Res. 2019 Apr 12;38(1):159. doi: 10.1186/s13046-019-1143-x.
• [5139] TRIM52 plays an oncogenic role in ovarian cancer associated with NF-kB pathway.Cell Death Dis. 2018 Sep 5;9(9):908. doi: 10.1038/s41419-018-0881-6.
• [5140] Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines.Blood. 2011 Aug 18;118(7):e32-9. doi: 10.1182/blood-2010-12-323659. Epub 2011 Jun 17.
• [5141] Downregulation of TRIM58 expression is associated with a poor patient outcome and enhances colorectal cancer cell invasion.Oncol Rep. 2018 Sep;40(3):1251-1260. doi: 10.3892/or.2018.6525. Epub 2018 Jun 26.
• [5142] TRIM71 suppresses tumorigenesis via modulation of Lin28B-let-7-HMGA2 signaling.Oncotarget. 2016 Nov 29;7(48):79854-79868. doi: 10.18632/oncotarget.13036.
• [5143] Increased expression of tripartite motif (TRIM) like 2 promotes tumoral growth in human oral cancer.Biochem Biophys Res Commun. 2019 Jan 22;508(4):1133-1138. doi: 10.1016/j.bbrc.2018.12.060. Epub 2018 Dec 13.
• [5144] Four novel biomarkers for bladder cancer identified by weighted gene coexpression network analysis.J Cell Physiol. 2019 Aug;234(10):19073-19087. doi: 10.1002/jcp.28546. Epub 2019 Mar 29.
• [5145] Defining the role of TRIP6 in cell physiology and cancer.Biol Cell. 2011 Dec 1;103(12):573-91. doi: 10.1042/BC20110077.
• [5146] Four individually druggable MET hotspots mediate HGF-driven tumor progression.J Clin Invest. 2014 Jul;124(7):3172-86. doi: 10.1172/JCI72316. Epub 2014 May 27.
• [5147] Phosphorylation of human TRM9L integrates multiple stress-signaling pathways for tumor growth suppression.Sci Adv. 2018 Jul 11;4(7):eaas9184. doi: 10.1126/sciadv.aas9184. eCollection 2018 Jul.
• [5148] Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells.Genes Dev. 2010 Jun 15;24(12):1236-41. doi: 10.1101/gad.1920310.
• [5149] Novel thiosemicarbazones induce high toxicity in estrogen-receptor-positive breast cancer cells (MCF7) and exacerbate cisplatin effectiveness in triple-negative breast (MDA-MB231) and lung adenocarcinoma (A549) cells.Invest New Drugs. 2020 Jun;38(3):558-573. doi: 10.1007/s10637-019-00789-1. Epub 2019 Jun 8.
• [5150] Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity.Nat Med. 2019 Sep;25(9):1428-1441. doi: 10.1038/s41591-019-0566-4. Epub 2019 Sep 9.
• [5151] Expression of Testis-Specific Gene Antigen 10 (TSGA10) is Associated with Apoptosis and Cell Migration in Bladder Cancer Cells and Tumor Stage and Overall Survival in Patients with Bladder Cancer.Med Sci Monit. 2019 Jul 16;25:5289-5298. doi: 10.12659/MSM.915682.
• [5152] TSPAN12 Precedes Tumor Proliferation by Cell Cycle Control in Ovarian Cancer.Mol Cells. 2019 Jul 31;42(7):557-567. doi: 10.14348/molcells.2019.0015.
• [5153] Downregulation of TSPAN13 by miR-369-3p inhibits cell proliferation in papillary thyroid cancer (PTC).Bosn J Basic Med Sci. 2019 May 20;19(2):146-154. doi: 10.17305/bjbms.2018.2865.
• [5154] Tspan15 Is a New Stemness-Related Marker in Hepatocellular Carcinoma.Proteomics. 2019 Nov;19(21-22):e1900025. doi: 10.1002/pmic.201900025. Epub 2019 Sep 2.
• [5155] TSPAN1 upregulates MMP2 to promote pancreatic cancer cell migration and invasion via PLC.Oncol Rep. 2019 Apr;41(4):2117-2125. doi: 10.3892/or.2019.6989. Epub 2019 Jan 30.
• [5156] TSPAN8 promotes cancer cell stemness via activation of sonic Hedgehog signaling.Nat Commun. 2019 Jun 28;10(1):2863. doi: 10.1038/s41467-019-10739-3.
• [5157] Synthesis and Investigation of Therapeutic Potential of Isoform-Specific HDAC8 Inhibitors for the Treatment of Cutaneous T Cell Lymphoma.Anticancer Agents Med Chem. 2019;19(7):916-934. doi: 10.2174/1871520619666190301150254.
• [5158] Knockdown of miR-629 Inhibits Ovarian Cancer Malignant Behaviors by Targeting Testis-Specific Y-Like Protein 5.DNA Cell Biol. 2017 Dec;36(12):1108-1116. doi: 10.1089/dna.2017.3904. Epub 2017 Oct 3.
• [5159] TTBK2 circular RNA promotes glioma malignancy by regulating miR-217/HNF1/Derlin-1 pathway.J Hematol Oncol. 2017 Feb 20;10(1):52. doi: 10.1186/s13045-017-0422-2.
• [5160] Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.Int Immunopharmacol. 2020 Jan;78:106077. doi: 10.1016/j.intimp.2019.106077. Epub 2019 Dec 5.
• [5161] Neuromyelitis optica spectrum disorder after treatment with pembrolizumab.Mult Scler Relat Disord. 2020 Jan;37:101447. doi: 10.1016/j.msard.2019.101447. Epub 2019 Oct 14.
• [5162] STAMP alters the growth of transformed and ovarian cancer cells.BMC Cancer. 2010 Apr 7;10:128. doi: 10.1186/1471-2407-10-128.
• [5163] The ATP-binding cassette transporter ABCF1 is a hepatic oncofetal protein that promotes chemoresistance, EMT and cancer stemness in hepatocellular carcinoma.Cancer Lett. 2019 Aug 10;457:98-109. doi: 10.1016/j.canlet.2019.05.010. Epub 2019 May 14.
• [5164] ACADS acts as a potential methylation biomarker associated with the proliferation and metastasis of hepatocellular carcinomas.Aging (Albany NY). 2019 Oct 25;11(20):8825-8844. doi: 10.18632/aging.102292. Epub 2019 Oct 25.
• [5165] Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions.Oncogene. 2009 Jan 8;28(1):9-19. doi: 10.1038/onc.2008.355. Epub 2008 Sep 22.
• [5166] Genetic analysis of ADIPOQ variants and gastric cancer risk: a hospital-based case-control study in China.Med Oncol. 2013;30(3):658. doi: 10.1007/s12032-013-0658-9. Epub 2013 Jul 25.
• [5167] Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women.Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1383-93. doi: 10.1158/1055-9965.EPI-13-1361. Epub 2014 May 1.
• [5168] Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs).BMC Cancer. 2018 Feb 12;18(1):174. doi: 10.1186/s12885-018-4021-6.
• [5169] Identification of breast cancer associated variants that modulate transcription factor binding.PLoS Genet. 2017 Sep 28;13(9):e1006761. doi: 10.1371/journal.pgen.1006761. eCollection 2017 Sep.
• [5170] Increased expression of ATG10 in colorectal cancer is associated with lymphovascular invasion and lymph node metastasis.PLoS One. 2012;7(12):e52705. doi: 10.1371/journal.pone.0052705. Epub 2012 Dec 20.
• [5171] ATG14 facilitated lipophagy in cancer cells induce ER stress mediated mitoptosis through a ROS dependent pathway.Free Radic Biol Med. 2017 Mar;104:199-213. doi: 10.1016/j.freeradbiomed.2017.01.007. Epub 2017 Jan 6.
• [5172] Copper chaperone ATOX1 is required for MAPK signaling and growth in BRAF mutation-positive melanoma.Metallomics. 2019 Aug 1;11(8):1430-1440. doi: 10.1039/c9mt00042a. Epub 2019 Jul 18.
• [5173] Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms.Oncogene. 2013 May 16;32(20):2586-91. doi: 10.1038/onc.2012.263. Epub 2012 Jul 2.
• [5174] Mutation analysis of the BCCIP gene for breast cancer susceptibility in breast/ovarian cancer families.Gynecol Oncol. 2013 Nov;131(2):460-3. doi: 10.1016/j.ygyno.2013.07.104. Epub 2013 Jul 31.
• [5175] Mechanisms for Hepatobiliary Toxicity in Rats Treated with an Antagonist of Melanin Concentrating Hormone Receptor 1 (MCHR1).Toxicol Sci. 2017 Feb;155(2):379-388. doi: 10.1093/toxsci/kfw216. Epub 2016 Oct 20.
• [5176] BAK, BAX, and NBK/BIK proapoptotic gene alterations in Iranian patients with ataxia telangiectasia.J Clin Immunol. 2010 Jan;30(1):132-7. doi: 10.1007/s10875-009-9340-6. Epub 2009 Nov 7.
• [5177] CDP138 silencing inhibits TGF-/Smad signaling to impair radioresistance and metastasis via GDF15 in lung cancer.Cell Death Dis. 2017 Sep 7;8(9):e3036. doi: 10.1038/cddis.2017.434.
• [5178] Identification of CCDC62-2 as a novel cancer/testis antigen and its immunogenicity.Int J Cancer. 2009 May 15;124(10):2347-52. doi: 10.1002/ijc.24220.
• [5179] CCR7 Sulfotyrosine Enhances CCL21 Binding.Int J Mol Sci. 2017 Aug 25;18(9):1857. doi: 10.3390/ijms18091857.
• [5180] Interaction of PVR/PVRL2 with TIGIT/DNAM-1 as a novel immune checkpoint axis and therapeutic target in cancer.Mamm Genome. 2018 Dec;29(11-12):694-702. doi: 10.1007/s00335-018-9770-7. Epub 2018 Aug 21.
• [5181] miR-449a: a potential therapeutic agent for cancer.Anticancer Drugs. 2017 Nov;28(10):1067-1078. doi: 10.1097/CAD.0000000000000555.
• [5182] CDK5RAP1 targeting NF-B signaling pathway in human malignant melanoma A375 cell apoptosis.Oncol Lett. 2018 Apr;15(4):4767-4774. doi: 10.3892/ol.2018.7920. Epub 2018 Feb 1.
• [5183] Down regulation of CIAPIN1 reverses multidrug resistance in human breast cancer cells by inhibiting MDR1.Molecules. 2012 Jun 20;17(6):7595-611. doi: 10.3390/molecules17067595.
• [5184] CITED1 promotes proliferation of papillary thyroid cancer cells via the regulation of p21 and p27.Cell Biosci. 2018 Nov 6;8:57. doi: 10.1186/s13578-018-0256-9. eCollection 2018.
• [5185] CKAP2 expression is associated with glioma tumor growth and acts as a prognostic factor in highgradeglioma.Oncol Rep. 2018 Oct;40(4):2036-2046. doi: 10.3892/or.2018.6611. Epub 2018 Aug 1.
• [5186] Splice variants of cytosolic polyadenylation element-binding protein 2 (CPEB2) differentially regulate pathways linked to cancer metastasis.J Biol Chem. 2017 Oct 27;292(43):17909-17918. doi: 10.1074/jbc.M117.810127. Epub 2017 Sep 13.
• [5187] Polymorphisms in the Caspase7 gene and the risk of lung cancer.Lung Cancer. 2009 Jul;65(1):19-24. doi: 10.1016/j.lungcan.2008.10.022. Epub 2008 Dec 6.
• [5188] A closed-tube methylation-sensitive high resolution melting assay (MS-HRMA) for the semi-quantitative determination of CST6 promoter methylation in clinical samples.BMC Cancer. 2012 Oct 22;12:486. doi: 10.1186/1471-2407-12-486.
• [5189] CTHRC1 promotes M2-like macrophage recruitment and myometrial invasion in endometrial carcinoma by integrin-Akt signaling pathway.Clin Exp Metastasis. 2019 Aug;36(4):351-363. doi: 10.1007/s10585-019-09971-4. Epub 2019 May 22.
• [5190] Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagy.Cancer Res. 2007 Jul 1;67(13):6293-303. doi: 10.1158/0008-5472.CAN-06-3884.
• [5191] MiRNA-638 promotes autophagy and malignant phenotypes of cancer cells via directly suppressing DACT3.Cancer Lett. 2017 Apr 1;390:126-136. doi: 10.1016/j.canlet.2017.01.009. Epub 2017 Jan 18.
• [5192] Downregulation of TM7SF4 inhibits cell proliferation and metastasis of A549 cells through regulating the PI3K/AKT/mTOR signaling pathway.Mol Med Rep. 2017 Nov;16(5):6122-6127. doi: 10.3892/mmr.2017.7324. Epub 2017 Aug 22.
• [5193] Inhibition of DIXDC1 by microRNA-1271 suppresses the proliferation and invasion of prostate cancer cells.Biochem Biophys Res Commun. 2017 Mar 18;484(4):794-800. doi: 10.1016/j.bbrc.2017.01.169. Epub 2017 Jan 31.
• [5194] Diagnostic significance of alternative splice variants of REST and DOPEY1 in the peripheral blood of patients with breast cancer.Tumour Biol. 2015 Apr;36(4):2473-80. doi: 10.1007/s13277-014-2860-6. Epub 2014 Nov 26.
• [5195] NRF2 Induction Supporting Breast Cancer Cell Survival Is Enabled by Oxidative Stress-Induced DPP3-KEAP1 Interaction.Cancer Res. 2017 Jun 1;77(11):2881-2892. doi: 10.1158/0008-5472.CAN-16-2204. Epub 2017 Apr 17.
• [5196] Metastasis suppressors in human benign prostate, intraepithelial neoplasia, and invasive cancer: their prospects as therapeutic agents.Med Res Rev. 2012 Sep;32(5):1026-77. doi: 10.1002/med.20232. Epub 2011 Jan 16.
• [5197] Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients.Nat Commun. 2017 Sep 6;8(1):464. doi: 10.1038/s41467-017-00489-5.
• [5198] BPGAP1 spatially integrates JNK/ERK signaling crosstalk in oncogenesis.Oncogene. 2017 Jun 1;36(22):3178-3192. doi: 10.1038/onc.2016.466. Epub 2017 Jan 16.
• [5199] Overexpression of Epsin3 enhances migration and invasion of glioma cells by inducing epithelialmesenchymal transition.Oncol Rep. 2018 Nov;40(5):3049-3059. doi: 10.3892/or.2018.6691. Epub 2018 Sep 10.
• [5200] ceRNA network analysis reveals prognostic markers for glioblastoma.Oncol Lett. 2019 Jun;17(6):5545-5557. doi: 10.3892/ol.2019.10275. Epub 2019 Apr 18.
• [5201] EYA4 Promotes Cell Proliferation Through Downregulation of p27Kip1 in Glioma.Cell Physiol Biochem. 2018;49(5):1856-1869. doi: 10.1159/000493631. Epub 2018 Sep 19.
• [5202] FASTKD2 promotes cancer cell progression through upregulating Myc expression in pancreatic ductal adenocarcinoma.J Cell Biochem. 2020 Mar;121(3):2458-2466. doi: 10.1002/jcb.29468. Epub 2019 Nov 6.
• [5203] Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/-catenin signaling.J Exp Clin Cancer Res. 2017 Sep 29;36(1):134. doi: 10.1186/s13046-017-0603-4.
• [5204] 11q13 allelic imbalance discriminates pulmonary carcinoids from tumorlets. A microdissection-based genotyping approach useful in clinical practice.Am J Pathol. 1999 Aug;155(2):633-40. doi: 10.1016/S0002-9440(10)65159-0.
• [5205] ETV6-PDGFRB and FIP1L1-PDGFRA stimulate human hematopoietic progenitor cell proliferation and differentiation into eosinophils: the role of nuclear factor-B.Haematologica. 2012 Jul;97(7):1064-72. doi: 10.3324/haematol.2011.047530. Epub 2012 Jan 22.
• [5206] Nutrient-induced FNIP degradation by SCF-TRCP regulates FLCN complex localization and promotes renal cancer progression.Oncotarget. 2017 Feb 7;8(6):9947-9960. doi: 10.18632/oncotarget.14221.
• [5207] Upregulation of FOXP4 in breast cancer promotes migration and invasion through facilitating EMT.Cancer Manag Res. 2019 Apr 8;11:2783-2793. doi: 10.2147/CMAR.S191641. eCollection 2019.
• [5208] Transcriptional inactivation of secreted frizzled-related protein 1 by promoter hypermethylation as a potential biomarker for non-small cell lung cancer.Neoplasma. 2010;57(3):228-33. doi: 10.4149/neo_2010_03_228.
• [5209] Down-regulation of GADD45A enhances chemosensitivity in melanoma.Sci Rep. 2018 Mar 7;8(1):4111. doi: 10.1038/s41598-018-22484-6.
• [5210] Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells.BMC Mol Biol. 2014 Oct 7;15:24. doi: 10.1186/1471-2199-15-24.
• [5211] Induction of apoptosis in T98G glioblastoma cells by transfection of GML, a p53 target gene.Oncol Res. 1999;11(3):125-32.
• [5212] The Gpn3 Q279* cancer-associated mutant inhibits Gpn1 nuclear export and is deficient in RNA polymerase II nuclear targeting.FEBS Lett. 2017 Nov;591(21):3555-3566. doi: 10.1002/1873-3468.12856. Epub 2017 Oct 11.
• [5213] Glutathione peroxidase 7 suppresses cancer cell growth and is hypermethylated in gastric cancer.Oncotarget. 2017 Apr 29;8(33):54345-54356. doi: 10.18632/oncotarget.17527. eCollection 2017 Aug 15.
• [5214] An Xpd mouse model for the combined xeroderma pigmentosum/Cockayne syndrome exhibiting both cancer predisposition and segmental progeria.Cancer Cell. 2006 Aug;10(2):121-32. doi: 10.1016/j.ccr.2006.05.027.
• [5215] Segregation and expression analyses of hyaluronan-binding protein 2 (HABP2): insights from a large series of familial non-medullary thyroid cancers and literature review.Clin Endocrinol (Oxf). 2017 Jun;86(6):837-844. doi: 10.1111/cen.13316. Epub 2017 Mar 23.
• [5216] LncRNA HAND2-AS1 overexpression inhibits cancer cell proliferation in melanoma by downregulating ROCK1.Oncol Lett. 2019 Aug;18(2):1005-1010. doi: 10.3892/ol.2019.10402. Epub 2019 May 27.
• [5217] HPIP silencing inhibits TGF-1-induced EMT in lung cancer cells.Int J Mol Med. 2017 Feb;39(2):479-483. doi: 10.3892/ijmm.2017.2851. Epub 2017 Jan 5.
• [5218] Deregulated ALG-2/HEBP2 axis alters microtubule dynamics and mitotic spindle behavior to stimulate cancer development.J Cell Physiol. 2017 Nov;232(11):3067-3076. doi: 10.1002/jcp.25754. Epub 2017 Mar 1.
• [5219] Sipi soup inhibits cancerassociated fibroblast activation and the inflammatory process by downregulating long noncoding RNA HIPK1AS.Mol Med Rep. 2018 Aug;18(2):1361-1368. doi: 10.3892/mmr.2018.9144. Epub 2018 Jun 6.
• [5220] miR-494 represses HOXA10 expression and inhibits cell proliferation in oral cancer.Oral Oncol. 2015 Feb;51(2):151-7. doi: 10.1016/j.oraloncology.2014.11.019. Epub 2014 Dec 12.
• [5221] Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions.ACS Chem Biol. 2017 Nov 17;12(11):2788-2803. doi: 10.1021/acschembio.7b00758. Epub 2017 Oct 10.
• [5222] Loss-of-function of IFT88 determines metabolic phenotypes in thyroid cancer.Oncogene. 2018 Aug;37(32):4455-4474. doi: 10.1038/s41388-018-0211-6. Epub 2018 May 10.
• [5223] Cancer Hallmarks and MicroRNAs: The Therapeutic Connection.Adv Cancer Res. 2017;135:119-149. doi: 10.1016/bs.acr.2017.06.002. Epub 2017 Aug 12.
• [5224] Comprehensive Characterization of the Human Endogenous Retrovirus HERV-K(HML-6) Group: Overview of Structure, Phylogeny, and Contribution to the Human Genome.J Virol. 2019 Jul 30;93(16):e00110-19. doi: 10.1128/JVI.00110-19. Print 2019 Aug 15.
• [5225] Integrin 4-Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis.Cancer Res. 2020 Feb 15;80(4):771-783. doi: 10.1158/0008-5472.CAN-19-1145. Epub 2019 Dec 16.
• [5226] KCTD12 promotes tumorigenesis by facilitating CDC25B/CDK1/Aurora A-dependent G2/M transition.Oncogene. 2017 Nov 2;36(44):6177-6189. doi: 10.1038/onc.2017.287. Epub 2017 Sep 4.
• [5227] Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+breast cancer.Breast Cancer Res Treat. 2019 Jan;173(1):93-102. doi: 10.1007/s10549-018-4978-5. Epub 2018 Oct 10.
• [5228] FOXA1 promotes proliferation, migration and invasion by transcriptional activating KRT7 in human gastric cancer cells.J Biol Regul Homeost Agents. 2019 Jul-Aug;33(4):1041-1050.
• [5229] SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ER breast cancer.Nat Commun. 2019 May 9;10(1):2115. doi: 10.1038/s41467-019-09676-y.
• [5230] Role of MEK partner-1 in cancer stemness through MEK/ERK pathway in cancerous neural stem cells, expressing EGFRviii.Mol Cancer. 2017 Aug 22;16(1):140. doi: 10.1186/s12943-017-0703-y.
• [5231] Superactive human leptin antagonist (SHLA), triple Lan1 and quadruple Lan2 leptin mutein as a promising treatment for human folliculoma.Cancer Chemother Pharmacol. 2017 Oct;80(4):815-827. doi: 10.1007/s00280-017-3423-5. Epub 2017 Aug 31.
• [5232] Identification of pyrrolopyrimidine derivative PP-13 as a novel microtubule-destabilizing agent with promising anticancer properties.Sci Rep. 2017 Aug 31;7(1):10209. doi: 10.1038/s41598-017-09491-9.
• [5233] LIMD2 Is Overexpressed in BRAF V600E-Positive Papillary Thyroid Carcinomas and Matched Lymph Node Metastases.Endocr Pathol. 2018 Sep;29(3):222-230. doi: 10.1007/s12022-018-9526-7.
• [5234] Purification and characterization of a highly specific polyclonal antibody against human extracellular signal-regulated kinase 8 and its detection in lung cancer.PLoS One. 2017 Sep 13;12(9):e0184755. doi: 10.1371/journal.pone.0184755. eCollection 2017.
• [5235] Metalloproteinase meprin regulates migration and invasion of human hepatocarcinoma cells and is a mediator of the oncoprotein Reptin.Oncotarget. 2017 Jan 31;8(5):7839-7851. doi: 10.18632/oncotarget.13975.
• [5236] Sphingosine kinase 1 overexpression induces MFN2 fragmentation and alters mitochondrial matrix Ca(2+) handling in HeLa cells.Biochim Biophys Acta Mol Cell Res. 2019 Sep;1866(9):1475-1486. doi: 10.1016/j.bbamcr.2019.06.006. Epub 2019 Jun 17.
• [5237] Human MOB1 expression in non-small-cell lung cancer.Clin Lung Cancer. 2007 Jan;8(4):273-6. doi: 10.3816/CLC.2007.n.006.
• [5238] RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression.Theranostics. 2019 Jun 2;9(12):3659-3673. doi: 10.7150/thno.32126. eCollection 2019.
• [5239] MRGBP as a potential biomarker for the malignancy of pancreatic ductal adenocarcinoma.Oncotarget. 2017 Jul 22;8(38):64224-64236. doi: 10.18632/oncotarget.19451. eCollection 2017 Sep 8.
• [5240] Promoter hypomethylation contributes to the expression of MUC3A in cancer cells.Biochem Biophys Res Commun. 2010 Jun 25;397(2):333-9. doi: 10.1016/j.bbrc.2010.05.124. Epub 2010 May 27.
• [5241] The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb.Oncogene. 2019 Feb;38(7):1080-1092. doi: 10.1038/s41388-018-0490-y. Epub 2018 Sep 11.
• [5242] Decreased levels of nitric oxide production and nitric oxide synthase-2 expression are associated with the development and metastasis of hepatocellular carcinoma.Mol Med Rep. 2012 Dec;6(6):1261-6. doi: 10.3892/mmr.2012.1096. Epub 2012 Sep 24.
• [5243] Neuropilin signalling in angiogenesis.Biochem Soc Trans. 2012 Feb;40(1):20-5. doi: 10.1042/BST20110689.
• [5244] Neurocan, an extracellular chondroitin sulfate proteoglycan, stimulates neuroblastoma cells to promote malignant phenotypes.Oncotarget. 2017 Nov 15;8(63):106296-106310. doi: 10.18632/oncotarget.22435. eCollection 2017 Dec 5.
• [5245] Cell-Surface Integrins and CAR Are Both Essential for Adenovirus Type 5 Transduction of Canine Cells of Lymphocytic Origin.PLoS One. 2017 Jan 9;12(1):e0169532. doi: 10.1371/journal.pone.0169532. eCollection 2017.
• [5246] Systematic Expression Analysis of Mitochondrial Complex I Identifies NDUFS1 as a Biomarker in Clear-Cell Renal-Cell Carcinoma.Clin Genitourin Cancer. 2017 Aug;15(4):e551-e562. doi: 10.1016/j.clgc.2016.11.010. Epub 2016 Dec 1.
• [5247] Downregulation of NEK11 is associated with drug resistance in ovarian cancer.Int J Oncol. 2014 Sep;45(3):1266-74. doi: 10.3892/ijo.2014.2503. Epub 2014 Jun 18.
• [5248] NET1 Enhances Proliferation and Chemoresistance in Acute Lymphoblastic Leukemia Cells.Oncol Res. 2019 Aug 8;27(8):935-944. doi: 10.3727/096504019X15555388198071. Epub 2019 Apr 17.
• [5249] FAM129B, an antioxidative protein, reduces chemosensitivity by competing with Nrf2 for Keap1 binding.EBioMedicine. 2019 Jul;45:25-38. doi: 10.1016/j.ebiom.2019.06.022. Epub 2019 Jun 28.
• [5250] NOP14 inhibits melanoma proliferation and metastasis by regulating Wnt/-catenin signaling pathway.Braz J Med Biol Res. 2018 Nov 23;52(1):e7952. doi: 10.1590/1414-431X20187952.
• [5251] -1,3-Galactosyl-O-Glycosyl-Glycoprotein -1,6-N-Acetylglucosaminyltransferase 3 Increases MCAM Stability, Which Enhances S100A8/A9-Mediated Cancer Motility.Oncol Res. 2018 Apr 10;26(3):431-444. doi: 10.3727/096504017X15031557924123. Epub 2017 Sep 18.
• [5252] Correlation of Expression of CHI3L1 and Nogo-A and their Role in Angiogenesis in Invasive Ductal Breast Carcinoma.Anticancer Res. 2019 May;39(5):2341-2350. doi: 10.21873/anticanres.13351.
• [5253] OBP-401-GFP telomerase-dependent adenovirus illuminates and kills high-metastatic more effectively than low-metastatic triple-negative breast cancer in vitro.Cancer Gene Ther. 2017 Feb;24(2):45-47. doi: 10.1038/cgt.2016.67. Epub 2017 Jan 20.
• [5254] Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes.Oncogene. 2005 May 12;24(21):3419-26. doi: 10.1038/sj.onc.1208506.
• [5255] Promoter methylation of HIN-1 in the progression to esophageal squamous cancer.Epigenetics. 2008 Nov;3(6):336-41. doi: 10.4161/epi.3.6.7158. Epub 2008 Nov 8.
• [5256] Low programmed cell death 5 expression is a prognostic factor in ovarian cancer.Chin Med J (Engl). 2015 Apr 20;128(8):1084-90. doi: 10.4103/0366-6999.155100.
• [5257] Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach.Mol Ther. 2010 Feb;18(2):295-306. doi: 10.1038/mt.2009.252. Epub 2009 Nov 3.
• [5258] Gene therapy for the treatment of chronic peripheral nervous system pain.Neurobiol Dis. 2012 Nov;48(2):255-70. doi: 10.1016/j.nbd.2012.05.005. Epub 2012 Jun 2.
• [5259] Click Quantitative Mass Spectrometry Identifies PIWIL3 as a Mechanistic Target of RNA Interference Activator Enoxacin in Cancer Cells.J Am Chem Soc. 2017 Feb 1;139(4):1400-1403. doi: 10.1021/jacs.6b11751. Epub 2017 Jan 23.
• [5260] DNA methylation at imprint regulatory regions in preterm birth and infection.Am J Obstet Gynecol. 2013 May;208(5):395.e1-7. doi: 10.1016/j.ajog.2013.02.006. Epub 2013 Mar 8.
• [5261] FAPP2 gene downregulation increases tumor cell sensitivity to Fas-induced apoptosis.Biochem Biophys Res Commun. 2009 May 29;383(2):167-71. doi: 10.1016/j.bbrc.2009.03.126. Epub 2009 Mar 31.
• [5262] Targeting Epigenetics to Prevent Obesity Promoted Cancers.Cancer Prev Res (Phila). 2018 Mar;11(3):125-128. doi: 10.1158/1940-6207.CAPR-18-0043. Epub 2018 Feb 23.
• [5263] The tumor suppressor PP2A Abeta regulates the RalA GTPase.Cell. 2007 Jun 1;129(5):969-82. doi: 10.1016/j.cell.2007.03.047.
• [5264] Alternative Polyadenylation of PRELID1 Regulates Mitochondrial ROS Signaling and Cancer Outcomes.Mol Cancer Res. 2017 Dec;15(12):1741-1751. doi: 10.1158/1541-7786.MCR-17-0010. Epub 2017 Sep 14.
• [5265] Protein C receptor is a therapeutic stem cell target in a distinct group of breast cancers.Cell Res. 2019 Oct;29(10):832-845. doi: 10.1038/s41422-019-0225-9. Epub 2019 Sep 3.
• [5266] ARTS-based anticancer therapy: taking aim at cancer stem cells.Future Oncol. 2011 Oct;7(10):1185-94. doi: 10.2217/fon.11.96.
• [5267] Malignant pericytes expressing GT198 give rise to tumor cells through angiogenesis.Oncotarget. 2017 May 25;8(31):51591-51607. doi: 10.18632/oncotarget.18196. eCollection 2017 Aug 1.
• [5268] Molecular changes in endometriosis-associated ovarian clear cell carcinoma.Eur J Cancer. 2015 Sep;51(13):1831-42. doi: 10.1016/j.ejca.2015.05.011. Epub 2015 Jun 6.
• [5269] In silico repurposing the Rac1 inhibitor NSC23766 for treating PTTG1-high expressing clear cell renal carcinoma.Pathol Res Pract. 2019 Jun;215(6):152373. doi: 10.1016/j.prp.2019.03.002. Epub 2019 Mar 4.
• [5270] RAB23, regulated by miR-92b, promotes the progression of esophageal squamous cell carcinoma.Gene. 2016 Dec 20;595(1):31-38. doi: 10.1016/j.gene.2016.09.028. Epub 2016 Sep 19.
• [5271] The hnRNP RALY regulates transcription and cell proliferation by modulating the expression of specific factors including the proliferation marker E2F1.J Biol Chem. 2017 Dec 1;292(48):19674-19692. doi: 10.1074/jbc.M117.795591. Epub 2017 Sep 27.
• [5272] RASAL1 inhibits HepG2 cell growth via HIF-2 mediated gluconeogenesis.Oncol Lett. 2017 Dec;14(6):7344-7352. doi: 10.3892/ol.2017.7123. Epub 2017 Oct 3.
• [5273] RB1CC1 activates RB1 pathway and inhibits proliferation and cologenic survival in human cancer.PLoS One. 2010 Jun 30;5(6):e11404. doi: 10.1371/journal.pone.0011404.
• [5274] Gene amplification and associated loss of 5' regulatory sequences of CoAA in human cancers.Oncogene. 2007 Feb 8;26(6):822-35. doi: 10.1038/sj.onc.1209847. Epub 2006 Jul 31.
• [5275] Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis.Chin Med J (Engl). 2019 Jul 5;132(13):1572-1581. doi: 10.1097/CM9.0000000000000296.
• [5276] Critical role for nonGAP function of Gs in RGS1mediated promotion of melanoma progression through AKT and ERK phosphorylation.Oncol Rep. 2018 Jun;39(6):2673-2680. doi: 10.3892/or.2018.6341. Epub 2018 Mar 30.
• [5277] MINA53 deficiency leads to glioblastoma cell apoptosis via inducing DNA replication stress and diminishing DNA damage response.Cell Death Dis. 2018 Oct 17;9(11):1062. doi: 10.1038/s41419-018-1084-x.
• [5278] The roles of RRP15 in nucleolar formation, ribosome biogenesis and checkpoint control in human cells.Oncotarget. 2017 Feb 21;8(8):13240-13252. doi: 10.18632/oncotarget.14658.
• [5279] Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study.Arthritis Res Ther. 2017 Nov 25;19(1):259. doi: 10.1186/s13075-017-1469-8.
• [5280] SALL1 functions as a tumor suppressor in breast cancer by regulating cancer cell senescence and metastasis through the NuRD complex.Mol Cancer. 2018 Apr 6;17(1):78. doi: 10.1186/s12943-018-0824-y.
• [5281] Localization of TEIF in the centrosome and its functional association with centrosome amplification in DNA damage, telomere dysfunction and human cancers.Oncogene. 2009 Mar 26;28(12):1549-60. doi: 10.1038/onc.2008.503. Epub 2009 Feb 9.
• [5282] SETD6 dominant negative mutation in familial colorectal cancer type X.Hum Mol Genet. 2017 Nov 15;26(22):4481-4493. doi: 10.1093/hmg/ddx336.
• [5283] SHISA2 enhances the aggressive phenotype in prostate cancer through the regulation of WNT5A expression.Oncol Lett. 2017 Dec;14(6):6650-6658. doi: 10.3892/ol.2017.7099. Epub 2017 Sep 28.
• [5284] Text Messaging Interventions on Cancer Screening Rates: A Systematic Review.J Med Internet Res. 2017 Aug 24;19(8):e296. doi: 10.2196/jmir.7893.
• [5285] SMYD5 Controls Heterochromatin and Chromosome Integrity during Embryonic Stem Cell Differentiation.Cancer Res. 2017 Dec 1;77(23):6729-6745. doi: 10.1158/0008-5472.CAN-17-0828. Epub 2017 Sep 26.
• [5286] Analysis of the relationship between coexpression domains and chromatin 3D organization.PLoS Comput Biol. 2017 Sep 13;13(9):e1005708. doi: 10.1371/journal.pcbi.1005708. eCollection 2017 Sep.
• [5287] SOX14 activates the p53 signaling pathway and induces apoptosis in a cervical carcinoma cell line.PLoS One. 2017 Sep 19;12(9):e0184686. doi: 10.1371/journal.pone.0184686. eCollection 2017.
• [5288] Adaptive Estimation of Personalized Maximum Tolerated Dose in Cancer Phase I Clinical Trials Based on All Toxicities and Individual Genomic Profile.PLoS One. 2017 Jan 26;12(1):e0170187. doi: 10.1371/journal.pone.0170187. eCollection 2017.
• [5289] Role of STIM2 in cell function and physiopathology.J Physiol. 2017 May 15;595(10):3111-3128. doi: 10.1113/JP273889. Epub 2017 Feb 19.
• [5290] Synthesis, crystal structure and antiproliferative mechanisms of 2-acetylpyridine-thiosemicarbazones Ga(III) with a greater selectivity against tumor cells.J Inorg Biochem. 2017 Dec;177:110-117. doi: 10.1016/j.jinorgbio.2017.09.012. Epub 2017 Sep 19.
• [5291] Relationship between LINC00341 expression and cancer prognosis.Oncotarget. 2017 Feb 28;8(9):15283-15293. doi: 10.18632/oncotarget.14843.
• [5292] SZRD1 is a Novel Protein that Functions as a Potential Tumor Suppressor in Cervical Cancer.J Cancer. 2017 Jul 14;8(11):2132-2141. doi: 10.7150/jca.18806. eCollection 2017.
• [5293] Cellular stress induces TRB3/USP9x-dependent Notch activation in cancer.Oncogene. 2017 Feb 23;36(8):1048-1057. doi: 10.1038/onc.2016.276. Epub 2016 Sep 5.
• [5294] Expression Pattern of Cdkn2b and Its Regulators in Canine Mammary Tumors.Anticancer Res. 2018 Nov;38(11):6333-6338. doi: 10.21873/anticanres.12991.
• [5295] DNA methylation biomarker candidates for early detection of colon cancer.Tumour Biol. 2012 Apr;33(2):363-72. doi: 10.1007/s13277-011-0302-2. Epub 2012 Jan 12.
• [5296] TCF21/POD-1, a Transcritional Regulator of SF-1/NR5A1, as a Potential Prognosis Marker in Adult and Pediatric Adrenocortical Tumors.Front Endocrinol (Lausanne). 2018 Feb 22;9:38. doi: 10.3389/fendo.2018.00038. eCollection 2018.
• [5297] The MiTF/TFE Family of Transcription Factors: Master Regulators of Organelle Signaling, Metabolism, and Stress Adaptation.Mol Cancer Res. 2017 Dec;15(12):1637-1643. doi: 10.1158/1541-7786.MCR-17-0320. Epub 2017 Aug 29.
• [5298] TIFA Signaling in Gastric Epithelial Cells Initiates the cag Type 4 Secretion System-Dependent Innate Immune Response to Helicobacter pylori Infection.mBio. 2017 Aug 15;8(4):e01168-17. doi: 10.1128/mBio.01168-17.
• [5299] Loss of Ubr1 promotes aneuploidy and accelerates B-cell lymphomagenesis in TLX1/HOX11-transgenic mice.Oncogene. 2006 Sep 21;25(42):5752-63. doi: 10.1038/sj.onc.1209573. Epub 2006 Jul 24.
• [5300] TOPBP1 regulates RAD51 phosphorylation and chromatin loading and determines PARP inhibitor sensitivity.J Cell Biol. 2016 Feb 1;212(3):281-8. doi: 10.1083/jcb.201507042. Epub 2016 Jan 25.
• [5301] TRAF3-interacting protein 3, a new oncotarget, promotes tumor growth in melanoma.Melanoma Res. 2018 Jun;28(3):185-194. doi: 10.1097/CMR.0000000000000440.
• [5302] TRIM8: Making the Right Decision between the Oncogene and Tumour Suppressor Role.Genes (Basel). 2017 Nov 28;8(12):354. doi: 10.3390/genes8120354.
• [5303] Influence of novel supramolecular substance, [2] rotaxane, on the caspase signaling pathway in melanoma and colon cancer cells in vitro.J Pharmacol Sci. 2013;122(2):153-7. doi: 10.1254/jphs.12244sc. Epub 2013 Jun 5.
• [5304] Thyroid transcription factor 1 enhances cellular statin sensitivity via perturbing cholesterol metabolism.Oncogene. 2018 Jun;37(24):3290-3300. doi: 10.1038/s41388-018-0174-7. Epub 2018 Mar 19.